date,stock_id,type,value,origin_name,stock_name,industry
2019-03-31,4152,EPS,-1.76,基本每股盈餘（元）,台微體,生技醫療業
2019-03-31,4152,EquityAttributableToOwnersOfParent,-111143000.0,綜合損益總額歸屬於母公司業主,台微體,生技醫療業
2019-03-31,4152,GrossProfit,157765000.0,營業毛利（毛損）淨額,台微體,生技醫療業
2019-03-31,4152,IncomeAfterTaxes,-111685000.0,本期淨利（淨損）,台微體,生技醫療業
2019-03-31,4152,IncomeBeforeIncomeTax,-111408000.0,稅前淨利(淨損),台微體,生技醫療業
2019-03-31,4152,IncomeFromContinuingOperations,-111685000.0,繼續營業單位本期淨利（淨損）,台微體,生技醫療業
2019-03-31,4152,NetIncome,-111685000.0,本期淨利(淨損),台微體,生技醫療業
2019-03-31,4152,OperatingExpenses,269932000.0,營業費用,台微體,生技醫療業
2019-03-31,4152,OperatingIncome,-112167000.0,營業利益（損失）,台微體,生技醫療業
2019-03-31,4152,OtherComprehensiveIncome,542000.0,其他綜合損益（淨額）,台微體,生技醫療業
2019-03-31,4152,PreTaxIncome,-111408000.0,稅前淨利（淨損）,台微體,生技醫療業
2019-03-31,4152,Revenue,157765000.0,營業收入,台微體,生技醫療業
2019-03-31,4152,TAX,277000.0,所得稅費用（利益）,台微體,生技醫療業
2019-03-31,4152,TotalConsolidatedProfitForThePeriod,-111143000.0,本期綜合損益總額,台微體,生技醫療業
2019-03-31,4152,TotalNonoperatingIncomeAndExpense,759000.0,營業外收入及支出,台微體,生技醫療業
2019-06-30,4152,EPS,-3.79,基本每股盈餘（元）,台微體,生技醫療業
2019-06-30,4152,EquityAttributableToOwnersOfParent,-241102000.0,綜合損益總額歸屬於母公司業主,台微體,生技醫療業
2019-06-30,4152,GrossProfit,20592000.0,營業毛利（毛損）淨額,台微體,生技醫療業
2019-06-30,4152,IncomeAfterTaxes,-241476000.0,本期淨利（淨損）,台微體,生技醫療業
2019-06-30,4152,IncomeBeforeIncomeTax,-240622000.0,稅前淨利(淨損),台微體,生技醫療業
2019-06-30,4152,IncomeFromContinuingOperations,-241476000.0,繼續營業單位本期淨利（淨損）,台微體,生技醫療業
2019-06-30,4152,NetIncome,-241476000.0,本期淨利(淨損),台微體,生技醫療業
2019-06-30,4152,OperatingExpenses,262343000.0,營業費用,台微體,生技醫療業
2019-06-30,4152,OperatingIncome,-241751000.0,營業利益（損失）,台微體,生技醫療業
2019-06-30,4152,OtherComprehensiveIncome,374000.0,其他綜合損益（淨額）,台微體,生技醫療業
2019-06-30,4152,PreTaxIncome,-240622000.0,稅前淨利（淨損）,台微體,生技醫療業
2019-06-30,4152,Revenue,20592000.0,營業收入,台微體,生技醫療業
2019-06-30,4152,TAX,854000.0,所得稅費用（利益）,台微體,生技醫療業
2019-06-30,4152,TotalConsolidatedProfitForThePeriod,-241102000.0,本期綜合損益總額,台微體,生技醫療業
2019-06-30,4152,TotalNonoperatingIncomeAndExpense,1129000.0,營業外收入及支出,台微體,生技醫療業
2019-09-30,4152,EPS,-2.8,基本每股盈餘（元）,台微體,生技醫療業
2019-09-30,4152,EquityAttributableToOwnersOfParent,-180100000.0,綜合損益總額歸屬於母公司業主,台微體,生技醫療業
2019-09-30,4152,GrossProfit,18837000.0,營業毛利（毛損）淨額,台微體,生技醫療業
2019-09-30,4152,IncomeAfterTaxes,-178425000.0,本期淨利（淨損）,台微體,生技醫療業
2019-09-30,4152,IncomeBeforeIncomeTax,-178301000.0,稅前淨利(淨損),台微體,生技醫療業
2019-09-30,4152,IncomeFromContinuingOperations,-178425000.0,繼續營業單位本期淨利（淨損）,台微體,生技醫療業
2019-09-30,4152,NetIncome,-178425000.0,本期淨利(淨損),台微體,生技醫療業
2019-09-30,4152,OperatingExpenses,198127000.0,營業費用,台微體,生技醫療業
2019-09-30,4152,OperatingIncome,-179290000.0,營業利益（損失）,台微體,生技醫療業
2019-09-30,4152,OtherComprehensiveIncome,-1675000.0,其他綜合損益（淨額）,台微體,生技醫療業
2019-09-30,4152,PreTaxIncome,-178301000.0,稅前淨利（淨損）,台微體,生技醫療業
2019-09-30,4152,Revenue,18837000.0,營業收入,台微體,生技醫療業
2019-09-30,4152,TAX,124000.0,所得稅費用（利益）,台微體,生技醫療業
2019-09-30,4152,TotalConsolidatedProfitForThePeriod,-180100000.0,本期綜合損益總額,台微體,生技醫療業
2019-09-30,4152,TotalNonoperatingIncomeAndExpense,989000.0,營業外收入及支出,台微體,生技醫療業
2019-12-31,4152,EPS,-3.97,基本每股盈餘（元）,台微體,生技醫療業
2019-12-31,4152,EquityAttributableToOwnersOfParent,-277959000.0,綜合損益總額歸屬於母公司業主,台微體,生技醫療業
2019-12-31,4152,GrossProfit,11946000.0,營業毛利（毛損）淨額,台微體,生技醫療業
2019-12-31,4152,IncomeAfterTaxes,-275936000.0,本期淨利（淨損）,台微體,生技醫療業
2019-12-31,4152,IncomeBeforeIncomeTax,-273071000.0,稅前淨利(淨損),台微體,生技醫療業
2019-12-31,4152,IncomeFromContinuingOperations,-275936000.0,繼續營業單位本期淨利（淨損）,台微體,生技醫療業
2019-12-31,4152,NetIncome,-275936000.0,本期淨利(淨損),台微體,生技醫療業
2019-12-31,4152,OperatingExpenses,296394000.0,營業費用,台微體,生技醫療業
2019-12-31,4152,OperatingIncome,-284448000.0,營業利益（損失）,台微體,生技醫療業
2019-12-31,4152,OtherComprehensiveIncome,-2023000.0,其他綜合損益（淨額）,台微體,生技醫療業
2019-12-31,4152,PreTaxIncome,-273071000.0,稅前淨利（淨損）,台微體,生技醫療業
2019-12-31,4152,Revenue,11946000.0,營業收入,台微體,生技醫療業
2019-12-31,4152,TAX,2865000.0,所得稅費用（利益）,台微體,生技醫療業
2019-12-31,4152,TotalConsolidatedProfitForThePeriod,-277959000.0,本期綜合損益總額,台微體,生技醫療業
2019-12-31,4152,TotalNonoperatingIncomeAndExpense,11377000.0,營業外收入及支出,台微體,生技醫療業
2020-03-31,4152,EPS,-2.9,基本每股盈餘（元）,台微體,生技醫療業
2020-03-31,4152,IncomeAfterTaxes,-214585000.0,本期淨利（淨損）,台微體,生技醫療業
2020-03-31,4152,IncomeFromContinuingOperations,-214585000.0,繼續營業單位本期淨利（淨損）,台微體,生技醫療業
2020-03-31,4152,OperatingExpenses,224658000.0,營業費用,台微體,生技醫療業
2020-03-31,4152,OperatingIncome,-212684000.0,營業利益（損失）,台微體,生技醫療業
2020-03-31,4152,OtherComprehensiveIncome,-3506000.0,其他綜合損益（淨額）,台微體,生技醫療業
2020-03-31,4152,PreTaxIncome,-214164000.0,稅前淨利（淨損）,台微體,生技醫療業
2020-03-31,4152,Revenue,11974000.0,營業收入,台微體,生技醫療業
2020-03-31,4152,TAX,421000.0,所得稅費用（利益）,台微體,生技醫療業
2020-03-31,4152,TotalConsolidatedProfitForThePeriod,-218091000.0,本期綜合損益總額,台微體,生技醫療業
2020-03-31,4152,TotalNonoperatingIncomeAndExpense,-1480000.0,營業外收入及支出,台微體,生技醫療業
2020-03-31,4152,EquityAttributableToOwnersOfParent,-218091000.0,綜合損益總額歸屬於母公司業主,台微體,生技醫療業
2020-03-31,4152,GrossProfit,11974000.0,營業毛利（毛損）淨額,台微體,生技醫療業
2020-06-30,4152,EPS,-3.28,基本每股盈餘（元）,台微體,生技醫療業
2020-06-30,4152,IncomeAfterTaxes,-242437000.0,本期淨利（淨損）,台微體,生技醫療業
2020-06-30,4152,IncomeFromContinuingOperations,-242437000.0,繼續營業單位本期淨利（淨損）,台微體,生技醫療業
2020-06-30,4152,OperatingExpenses,268368000.0,營業費用,台微體,生技醫療業
2020-06-30,4152,OperatingIncome,-256592000.0,營業利益（損失）,台微體,生技醫療業
2020-06-30,4152,OtherComprehensiveIncome,1698000.0,其他綜合損益（淨額）,台微體,生技醫療業
2020-06-30,4152,PreTaxIncome,-242089000.0,稅前淨利（淨損）,台微體,生技醫療業
2020-06-30,4152,Revenue,11776000.0,營業收入,台微體,生技醫療業
2020-06-30,4152,TAX,348000.0,所得稅費用（利益）,台微體,生技醫療業
2020-06-30,4152,TotalConsolidatedProfitForThePeriod,-240739000.0,本期綜合損益總額,台微體,生技醫療業
2020-06-30,4152,TotalNonoperatingIncomeAndExpense,14503000.0,營業外收入及支出,台微體,生技醫療業
2020-06-30,4152,EquityAttributableToOwnersOfParent,-240739000.0,綜合損益總額歸屬於母公司業主,台微體,生技醫療業
2020-06-30,4152,GrossProfit,11776000.0,營業毛利（毛損）淨額,台微體,生技醫療業
2020-09-30,4152,EPS,-2.75,基本每股盈餘（元）,台微體,生技醫療業
2020-09-30,4152,IncomeAfterTaxes,-233693000.0,本期淨利（淨損）,台微體,生技醫療業
2020-09-30,4152,IncomeFromContinuingOperations,-233693000.0,繼續營業單位本期淨利（淨損）,台微體,生技醫療業
2020-09-30,4152,OperatingExpenses,309707000.0,營業費用,台微體,生技醫療業
2020-09-30,4152,OperatingIncome,-243612000.0,營業利益（損失）,台微體,生技醫療業
2020-09-30,4152,OtherComprehensiveIncome,-183000.0,其他綜合損益（淨額）,台微體,生技醫療業
2020-09-30,4152,PreTaxIncome,-233576000.0,稅前淨利（淨損）,台微體,生技醫療業
2020-09-30,4152,Revenue,66095000.0,營業收入,台微體,生技醫療業
2020-09-30,4152,TAX,117000.0,所得稅費用（利益）,台微體,生技醫療業
2020-09-30,4152,TotalConsolidatedProfitForThePeriod,-233876000.0,本期綜合損益總額,台微體,生技醫療業
2020-09-30,4152,TotalNonoperatingIncomeAndExpense,10036000.0,營業外收入及支出,台微體,生技醫療業
2020-09-30,4152,EquityAttributableToOwnersOfParent,-233876000.0,綜合損益總額歸屬於母公司業主,台微體,生技醫療業
2020-09-30,4152,GrossProfit,66095000.0,營業毛利（毛損）淨額,台微體,生技醫療業
2020-12-31,4152,PreTaxIncome,-292348000.0,稅前淨利（淨損）,台微體,生技醫療業
2020-12-31,4152,TAX,246000.0,所得稅費用（利益）,台微體,生技醫療業
2020-12-31,4152,IncomeFromContinuingOperations,-292594000.0,繼續營業單位本期淨利（淨損）,台微體,生技醫療業
2020-12-31,4152,IncomeAfterTaxes,-292594000.0,本期淨利（淨損）,台微體,生技醫療業
2020-12-31,4152,TotalConsolidatedProfitForThePeriod,-290341000.0,本期綜合損益總額,台微體,生技醫療業
2020-12-31,4152,EPS,-3.49,基本每股盈餘（元）,台微體,生技醫療業
2020-12-31,4152,Revenue,12083000.0,營業收入,台微體,生技醫療業
2020-12-31,4152,OperatingExpenses,310539000.0,營業費用,台微體,生技醫療業
2020-12-31,4152,OperatingIncome,-298456000.0,營業利益（損失）,台微體,生技醫療業
2020-12-31,4152,TotalNonoperatingIncomeAndExpense,6108000.0,營業外收入及支出,台微體,生技醫療業
2020-12-31,4152,OtherComprehensiveIncome,2253000.0,其他綜合損益（淨額）,台微體,生技醫療業
2020-12-31,4152,GrossProfit,12083000.0,營業毛利（毛損）淨額,台微體,生技醫療業
2020-12-31,4152,EquityAttributableToOwnersOfParent,-290802000.0,淨利（淨損）歸屬於母公司業主,台微體,生技醫療業
2020-12-31,4152,NoncontrollingInterests,-1792000.0,綜合損益總額歸屬於非控制權益,台微體,生技醫療業
2021-03-31,4152,PreTaxIncome,-217998000.0,稅前淨利（淨損）,台微體,生技醫療業
2021-03-31,4152,TAX,239000.0,所得稅費用（利益）,台微體,生技醫療業
2021-03-31,4152,IncomeFromContinuingOperations,-218237000.0,繼續營業單位本期淨利（淨損）,台微體,生技醫療業
2021-03-31,4152,IncomeAfterTaxes,-218237000.0,本期淨利（淨損）,台微體,生技醫療業
2021-03-31,4152,TotalConsolidatedProfitForThePeriod,-226432000.0,本期綜合損益總額,台微體,生技醫療業
2021-03-31,4152,EPS,-2.39,基本每股盈餘（元）,台微體,生技醫療業
2021-03-31,4152,Revenue,37618000.0,營業收入,台微體,生技醫療業
2021-03-31,4152,OperatingExpenses,253821000.0,營業費用,台微體,生技醫療業
2021-03-31,4152,OperatingIncome,-216203000.0,營業利益（損失）,台微體,生技醫療業
2021-03-31,4152,TotalNonoperatingIncomeAndExpense,-1795000.0,營業外收入及支出,台微體,生技醫療業
2021-03-31,4152,OtherComprehensiveIncome,-8195000.0,其他綜合損益（淨額）,台微體,生技醫療業
2021-03-31,4152,EquityAttributableToOwnersOfParent,-205868000.0,綜合損益總額歸屬於母公司業主,台微體,生技醫療業
2021-03-31,4152,NoncontrollingInterests,-20564000.0,綜合損益總額歸屬於非控制權益,台微體,生技醫療業
2021-03-31,4152,GrossProfit,37618000.0,營業毛利（毛損）,台微體,生技醫療業
2021-06-30,4152,PreTaxIncome,-75144000.0,稅前淨利（淨損）,台微體,生技醫療業
2021-06-30,4152,TAX,363000.0,所得稅費用（利益）,台微體,生技醫療業
2021-06-30,4152,IncomeFromContinuingOperations,-75507000.0,繼續營業單位本期淨利（淨損）,台微體,生技醫療業
2021-06-30,4152,IncomeAfterTaxes,-75507000.0,本期淨利（淨損）,台微體,生技醫療業
2021-06-30,4152,TotalConsolidatedProfitForThePeriod,-88597000.0,本期綜合損益總額,台微體,生技醫療業
2021-06-30,4152,Revenue,160176000.0,營業收入,台微體,生技醫療業
2021-06-30,4152,OperatingExpenses,251709000.0,營業費用,台微體,生技醫療業
2021-06-30,4152,OperatingIncome,-91533000.0,營業利益（損失）,台微體,生技醫療業
2021-06-30,4152,TotalNonoperatingIncomeAndExpense,16389000.0,營業外收入及支出,台微體,生技醫療業
2021-06-30,4152,OtherComprehensiveIncome,-13090000.0,其他綜合損益（淨額）,台微體,生技醫療業
2021-06-30,4152,EquityAttributableToOwnersOfParent,-63388000.0,綜合損益總額歸屬於母公司業主,台微體,生技醫療業
2021-06-30,4152,NoncontrollingInterests,-25209000.0,綜合損益總額歸屬於非控制權益,台微體,生技醫療業
2021-06-30,4152,EPS,-0.66,基本每股盈餘（元）,台微體,生技醫療業
2021-06-30,4152,GrossProfit,160176000.0,營業毛利（毛損）,台微體,生技醫療業
2019-03-31,4152,AccountsReceivableNet,8939000.0,應收帳款淨額,台微體,生技醫療業
2019-03-31,4152,AccountsReceivableNet_per,0.64,應收帳款淨額,台微體,生技醫療業
2019-03-31,4152,CapitalStock,640451000.0,股本合計,台微體,生技醫療業
2019-03-31,4152,CapitalStock_per,45.66,股本合計,台微體,生技醫療業
2019-03-31,4152,CapitalSurplus,957008000.0,資本公積合計,台微體,生技醫療業
2019-03-31,4152,CapitalSurplus_per,68.23,資本公積合計,台微體,生技醫療業
2019-03-31,4152,CapitalSurplusAdditionalPaidInCapital,733287000.0,資本公積－發行溢價,台微體,生技醫療業
2019-03-31,4152,CapitalSurplusAdditionalPaidInCapital_per,52.28,資本公積－發行溢價,台微體,生技醫療業
2019-03-31,4152,CashAndCashEquivalents,988284000.0,現金及約當現金,台微體,生技醫療業
2019-03-31,4152,CashAndCashEquivalents_per,70.46,現金及約當現金,台微體,生技醫療業
2019-03-31,4152,CurrentAssets,1083620000.0,流動資產合計,台微體,生技醫療業
2019-03-31,4152,CurrentAssets_per,77.26,流動資產合計,台微體,生技醫療業
2019-03-31,4152,CurrentIncomeTaxAssets,695000.0,本期所得稅資產,台微體,生技醫療業
2019-03-31,4152,CurrentIncomeTaxAssets_per,0.05,本期所得稅資產,台微體,生技醫療業
2019-03-31,4152,CurrentLiabilities,403509000.0,流動負債合計,台微體,生技醫療業
2019-03-31,4152,CurrentLiabilities_per,28.77,流動負債合計,台微體,生技醫療業
2019-03-31,4152,DeferredTaxAssets,81000.0,遞延所得稅資產,台微體,生技醫療業
2019-03-31,4152,DeferredTaxAssets_per,0.01,遞延所得稅資產,台微體,生技醫療業
2019-03-31,4152,Equity,565294000.0,權益總額,台微體,生技醫療業
2019-03-31,4152,Equity_per,40.31,權益總額,台微體,生技醫療業
2019-03-31,4152,EquityAttributableToOwnersOfParent,565294000.0,歸屬於母公司業主之權益合計,台微體,生技醫療業
2019-03-31,4152,EquityAttributableToOwnersOfParent_per,40.31,歸屬於母公司業主之權益合計,台微體,生技醫療業
2019-03-31,4152,IntangibleAssets,6262000.0,無形資產,台微體,生技醫療業
2019-03-31,4152,IntangibleAssets_per,0.45,無形資產,台微體,生技醫療業
2019-03-31,4152,Liabilities,837233000.0,負債總額,台微體,生技醫療業
2019-03-31,4152,Liabilities_per,60.0,負債總額,台微體,生技醫療業
2019-03-31,4152,LongtermBorrowings,336055000.0,長期借款,台微體,生技醫療業
2019-03-31,4152,LongtermBorrowings_per,23.96,長期借款,台微體,生技醫療業
2019-03-31,4152,NoncurrentAssets,318906000.0,非流動資產合計,台微體,生技醫療業
2019-03-31,4152,NoncurrentAssets_per,22.74,非流動資產合計,台微體,生技醫療業
2019-03-31,4152,NoncurrentLiabilities,433724000.0,非流動負債合計,台微體,生技醫療業
2019-03-31,4152,NoncurrentLiabilities_per,30.92,非流動負債合計,台微體,生技醫療業
2019-03-31,4152,OrdinaryShare,640451000.0,普通股股本,台微體,生技醫療業
2019-03-31,4152,OrdinaryShare_per,45.66,普通股股本,台微體,生技醫療業
2019-03-31,4152,OtherCurrentLiabilities,98981000.0,其他流動負債,台微體,生技醫療業
2019-03-31,4152,OtherCurrentLiabilities_per,7.06,其他流動負債,台微體,生技醫療業
2019-03-31,4152,OtherEquityInterest,10438000.0,其他權益合計,台微體,生技醫療業
2019-03-31,4152,OtherEquityInterest_per,0.74,其他權益合計,台微體,生技醫療業
2019-03-31,4152,OtherNoncurrentAssets,99123000.0,其他非流動資產,台微體,生技醫療業
2019-03-31,4152,OtherNoncurrentAssets_per,7.07,其他非流動資產,台微體,生技醫療業
2019-03-31,4152,OtherNoncurrentLiabilities,5502000.0,其他非流動負債,台微體,生技醫療業
2019-03-31,4152,OtherNoncurrentLiabilities_per,0.39,其他非流動負債,台微體,生技醫療業
2019-03-31,4152,OtherPayables,190481000.0,其他應付款,台微體,生技醫療業
2019-03-31,4152,OtherPayables_per,13.58,其他應付款,台微體,生技醫療業
2019-03-31,4152,OtherReceivable,6749000.0,其他應收款淨額,台微體,生技醫療業
2019-03-31,4152,OtherReceivable_per,0.48,其他應收款淨額,台微體,生技醫療業
2019-03-31,4152,PropertyPlantAndEquipment,71138000.0,不動產、廠房及設備,台微體,生技醫療業
2019-03-31,4152,PropertyPlantAndEquipment_per,5.07,不動產、廠房及設備,台微體,生技醫療業
2019-03-31,4152,RetainedEarnings,1021730000.0,保留盈餘合計,台微體,生技醫療業
2019-03-31,4152,RetainedEarnings_per,72.85,保留盈餘合計,台微體,生技醫療業
2019-03-31,4152,ShorttermBorrowings,46000000.0,短期借款,台微體,生技醫療業
2019-03-31,4152,ShorttermBorrowings_per,3.28,短期借款,台微體,生技醫療業
2019-03-31,4152,TotalAssets,1402530000.0,資產總額,台微體,生技醫療業
2019-03-31,4152,TotalAssets_per,100.0,資產總額,台微體,生技醫療業
2019-03-31,4152,TotalLiabilitiesEquity,1402530000.0,負債及權益總計,台微體,生技醫療業
2019-03-31,4152,TotalLiabilitiesEquity_per,100.0,負債及權益總計,台微體,生技醫療業
2019-03-31,4152,UnappropriatedRetainedEarningsAaccumulatedDeficit,-1021730000.0,未分配盈餘,台微體,生技醫療業
2019-03-31,4152,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-73.0,未分配盈餘,台微體,生技醫療業
2019-06-30,4152,AccountsReceivableNet,14719000.0,應收帳款淨額,台微體,生技醫療業
2019-06-30,4152,AccountsReceivableNet_per,1.36,應收帳款淨額,台微體,生技醫療業
2019-06-30,4152,CapitalStock,640275000.0,股本合計,台微體,生技醫療業
2019-06-30,4152,CapitalStock_per,59.34,股本合計,台微體,生技醫療業
2019-06-30,4152,CapitalSurplus,962808000.0,資本公積合計,台微體,生技醫療業
2019-06-30,4152,CapitalSurplus_per,89.23,資本公積合計,台微體,生技醫療業
2019-06-30,4152,CapitalSurplusAdditionalPaidInCapital,742484000.0,資本公積－發行溢價,台微體,生技醫療業
2019-06-30,4152,CapitalSurplusAdditionalPaidInCapital_per,68.81,資本公積－發行溢價,台微體,生技醫療業
2019-06-30,4152,CashAndCashEquivalents,685108000.0,現金及約當現金,台微體,生技醫療業
2019-06-30,4152,CashAndCashEquivalents_per,63.49,現金及約當現金,台微體,生技醫療業
2019-06-30,4152,CurrentAssets,767133000.0,流動資產合計,台微體,生技醫療業
2019-06-30,4152,CurrentAssets_per,71.09,流動資產合計,台微體,生技醫療業
2019-06-30,4152,CurrentIncomeTaxAssets,558000.0,本期所得稅資產,台微體,生技醫療業
2019-06-30,4152,CurrentIncomeTaxAssets_per,0.05,本期所得稅資產,台微體,生技醫療業
2019-06-30,4152,CurrentLiabilities,606616000.0,流動負債合計,台微體,生技醫療業
2019-06-30,4152,CurrentLiabilities_per,56.22,流動負債合計,台微體,生技醫療業
2019-06-30,4152,DeferredTaxAssets,80000.0,遞延所得稅資產,台微體,生技醫療業
2019-06-30,4152,DeferredTaxAssets_per,0.01,遞延所得稅資產,台微體,生技醫療業
2019-06-30,4152,Equity,332070000.0,權益總額,台微體,生技醫療業
2019-06-30,4152,Equity_per,30.77,權益總額,台微體,生技醫療業
2019-06-30,4152,EquityAttributableToOwnersOfParent,332070000.0,歸屬於母公司業主之權益合計,台微體,生技醫療業
2019-06-30,4152,EquityAttributableToOwnersOfParent_per,30.77,歸屬於母公司業主之權益合計,台微體,生技醫療業
2019-06-30,4152,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,0.0,預收股款（權益項下）之約當發行股數,台微體,生技醫療業
2019-06-30,4152,IntangibleAssets,4672000.0,無形資產,台微體,生技醫療業
2019-06-30,4152,IntangibleAssets_per,0.43,無形資產,台微體,生技醫療業
2019-06-30,4152,Liabilities,746988000.0,負債總額,台微體,生技醫療業
2019-06-30,4152,Liabilities_per,69.0,負債總額,台微體,生技醫療業
2019-06-30,4152,LongtermBorrowings,58189000.0,長期借款,台微體,生技醫療業
2019-06-30,4152,LongtermBorrowings_per,5.39,長期借款,台微體,生技醫療業
2019-06-30,4152,NoncurrentAssets,311925000.0,非流動資產合計,台微體,生技醫療業
2019-06-30,4152,NoncurrentAssets_per,28.91,非流動資產合計,台微體,生技醫療業
2019-06-30,4152,NoncurrentLiabilities,140372000.0,非流動負債合計,台微體,生技醫療業
2019-06-30,4152,NoncurrentLiabilities_per,13.01,非流動負債合計,台微體,生技醫療業
2019-06-30,4152,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,台微體,生技醫療業
2019-06-30,4152,OrdinaryShare,640275000.0,普通股股本,台微體,生技醫療業
2019-06-30,4152,OrdinaryShare_per,59.34,普通股股本,台微體,生技醫療業
2019-06-30,4152,OtherCurrentLiabilities,379129000.0,其他流動負債,台微體,生技醫療業
2019-06-30,4152,OtherCurrentLiabilities_per,35.14,其他流動負債,台微體,生技醫療業
2019-06-30,4152,OtherEquityInterest,7810000.0,其他權益合計,台微體,生技醫療業
2019-06-30,4152,OtherEquityInterest_per,0.72,其他權益合計,台微體,生技醫療業
2019-06-30,4152,OtherNoncurrentAssets,107963000.0,其他非流動資產,台微體,生技醫療業
2019-06-30,4152,OtherNoncurrentAssets_per,10.01,其他非流動資產,台微體,生技醫療業
2019-06-30,4152,OtherNoncurrentLiabilities,5502000.0,其他非流動負債,台微體,生技醫療業
2019-06-30,4152,OtherNoncurrentLiabilities_per,0.51,其他非流動負債,台微體,生技醫療業
2019-06-30,4152,OtherPayables,114568000.0,其他應付款,台微體,生技醫療業
2019-06-30,4152,OtherPayables_per,10.62,其他應付款,台微體,生技醫療業
2019-06-30,4152,OtherReceivable,6105000.0,其他應收款淨額,台微體,生技醫療業
2019-06-30,4152,OtherReceivable_per,0.57,其他應收款淨額,台微體,生技醫療業
2019-06-30,4152,PropertyPlantAndEquipment,68345000.0,不動產、廠房及設備,台微體,生技醫療業
2019-06-30,4152,PropertyPlantAndEquipment_per,6.33,不動產、廠房及設備,台微體,生技醫療業
2019-06-30,4152,RetainedEarnings,1263200000.0,保留盈餘合計,台微體,生技醫療業
2019-06-30,4152,RetainedEarnings_per,117.07,保留盈餘合計,台微體,生技醫療業
2019-06-30,4152,ShorttermBorrowings,46000000.0,短期借款,台微體,生技醫療業
2019-06-30,4152,ShorttermBorrowings_per,4.26,短期借款,台微體,生技醫療業
2019-06-30,4152,TotalAssets,1079060000.0,資產總額,台微體,生技醫療業
2019-06-30,4152,TotalAssets_per,100.0,資產總額,台微體,生技醫療業
2019-06-30,4152,TotalLiabilitiesEquity,1079060000.0,負債及權益總計,台微體,生技醫療業
2019-06-30,4152,TotalLiabilitiesEquity_per,100.0,負債及權益總計,台微體,生技醫療業
2019-06-30,4152,UnappropriatedRetainedEarningsAaccumulatedDeficit,-1263200000.0,未分配盈餘,台微體,生技醫療業
2019-06-30,4152,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-117.0,未分配盈餘,台微體,生技醫療業
2019-09-30,4152,AccountsReceivableNet,9471000.0,應收帳款淨額,台微體,生技醫療業
2019-09-30,4152,AccountsReceivableNet_per,0.69,應收帳款淨額,台微體,生技醫療業
2019-09-30,4152,CapitalStock,1193630000.0,股本合計,台微體,生技醫療業
2019-09-30,4152,CapitalStock_per,86.99,股本合計,台微體,生技醫療業
2019-09-30,4152,CapitalSurplus,968549000.0,資本公積合計,台微體,生技醫療業
2019-09-30,4152,CapitalSurplus_per,70.58,資本公積合計,台微體,生技醫療業
2019-09-30,4152,CapitalSurplusAdditionalPaidInCapital,764832000.0,資本公積－發行溢價,台微體,生技醫療業
2019-09-30,4152,CapitalSurplusAdditionalPaidInCapital_per,55.74,資本公積－發行溢價,台微體,生技醫療業
2019-09-30,4152,CashAndCashEquivalents,1007540000.0,現金及約當現金,台微體,生技醫療業
2019-09-30,4152,CashAndCashEquivalents_per,73.42,現金及約當現金,台微體,生技醫療業
2019-09-30,4152,CurrentAssets,1078570000.0,流動資產合計,台微體,生技醫療業
2019-09-30,4152,CurrentAssets_per,78.6,流動資產合計,台微體,生技醫療業
2019-09-30,4152,CurrentIncomeTaxAssets,810000.0,本期所得稅資產,台微體,生技醫療業
2019-09-30,4152,CurrentIncomeTaxAssets_per,0.06,本期所得稅資產,台微體,生技醫療業
2019-09-30,4152,CurrentLiabilities,536234000.0,流動負債合計,台微體,生技醫療業
2019-09-30,4152,CurrentLiabilities_per,39.08,流動負債合計,台微體,生技醫療業
2019-09-30,4152,DeferredTaxAssets,77000.0,遞延所得稅資產,台微體,生技醫療業
2019-09-30,4152,DeferredTaxAssets_per,0.01,遞延所得稅資產,台微體,生技醫療業
2019-09-30,4152,Equity,713152000.0,權益總額,台微體,生技醫療業
2019-09-30,4152,Equity_per,51.97,權益總額,台微體,生技醫療業
2019-09-30,4152,EquityAttributableToOwnersOfParent,713152000.0,歸屬於母公司業主之權益合計,台微體,生技醫療業
2019-09-30,4152,EquityAttributableToOwnersOfParent_per,51.97,歸屬於母公司業主之權益合計,台微體,生技醫療業
2019-09-30,4152,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,6748300.0,預收股款（權益項下）之約當發行股數,台微體,生技醫療業
2019-09-30,4152,IntangibleAssets,2938000.0,無形資產,台微體,生技醫療業
2019-09-30,4152,IntangibleAssets_per,0.21,無形資產,台微體,生技醫療業
2019-09-30,4152,Liabilities,659061000.0,負債總額,台微體,生技醫療業
2019-09-30,4152,Liabilities_per,48.0,負債總額,台微體,生技醫療業
2019-09-30,4152,LongtermBorrowings,56000000.0,長期借款,台微體,生技醫療業
2019-09-30,4152,LongtermBorrowings_per,4.08,長期借款,台微體,生技醫療業
2019-09-30,4152,NoncurrentAssets,293642000.0,非流動資產合計,台微體,生技醫療業
2019-09-30,4152,NoncurrentAssets_per,21.4,非流動資產合計,台微體,生技醫療業
2019-09-30,4152,NoncurrentLiabilities,122827000.0,非流動負債合計,台微體,生技醫療業
2019-09-30,4152,NoncurrentLiabilities_per,8.95,非流動負債合計,台微體,生技醫療業
2019-09-30,4152,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,台微體,生技醫療業
2019-09-30,4152,OrdinaryShare,640275000.0,普通股股本,台微體,生技醫療業
2019-09-30,4152,OrdinaryShare_per,46.66,普通股股本,台微體,生技醫療業
2019-09-30,4152,OtherCurrentLiabilities,347754000.0,其他流動負債,台微體,生技醫療業
2019-09-30,4152,OtherCurrentLiabilities_per,25.34,其他流動負債,台微體,生技醫療業
2019-09-30,4152,OtherEquityInterest,7404000.0,其他權益合計,台微體,生技醫療業
2019-09-30,4152,OtherEquityInterest_per,0.54,其他權益合計,台微體,生技醫療業
2019-09-30,4152,OtherNoncurrentAssets,106011000.0,其他非流動資產,台微體,生技醫療業
2019-09-30,4152,OtherNoncurrentAssets_per,7.73,其他非流動資產,台微體,生技醫療業
2019-09-30,4152,OtherNoncurrentLiabilities,5502000.0,其他非流動負債,台微體,生技醫療業
2019-09-30,4152,OtherNoncurrentLiabilities_per,0.4,其他非流動負債,台微體,生技醫療業
2019-09-30,4152,OtherPayables,76375000.0,其他應付款,台微體,生技醫療業
2019-09-30,4152,OtherPayables_per,5.57,其他應付款,台微體,生技醫療業
2019-09-30,4152,OtherReceivable,6301000.0,其他應收款淨額,台微體,生技醫療業
2019-09-30,4152,OtherReceivable_per,0.46,其他應收款淨額,台微體,生技醫療業
2019-09-30,4152,PropertyPlantAndEquipment,64875000.0,不動產、廠房及設備,台微體,生技醫療業
2019-09-30,4152,PropertyPlantAndEquipment_per,4.73,不動產、廠房及設備,台微體,生技醫療業
2019-09-30,4152,RetainedEarnings,1441630000.0,保留盈餘合計,台微體,生技醫療業
2019-09-30,4152,RetainedEarnings_per,105.06,保留盈餘合計,台微體,生技醫療業
2019-09-30,4152,ShorttermBorrowings,46000000.0,短期借款,台微體,生技醫療業
2019-09-30,4152,ShorttermBorrowings_per,3.35,短期借款,台微體,生技醫療業
2019-09-30,4152,TotalAssets,1372210000.0,資產總額,台微體,生技醫療業
2019-09-30,4152,TotalAssets_per,100.0,資產總額,台微體,生技醫療業
2019-09-30,4152,TotalLiabilitiesEquity,1372210000.0,負債及權益總計,台微體,生技醫療業
2019-09-30,4152,TotalLiabilitiesEquity_per,100.0,負債及權益總計,台微體,生技醫療業
2019-09-30,4152,UnappropriatedRetainedEarningsAaccumulatedDeficit,-1441630000.0,未分配盈餘,台微體,生技醫療業
2019-09-30,4152,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-105.0,未分配盈餘,台微體,生技醫療業
2019-12-31,4152,AccountsReceivableNet,15120000.0,應收帳款淨額,台微體,生技醫療業
2019-12-31,4152,AccountsReceivableNet_per,1.09,應收帳款淨額,台微體,生技醫療業
2019-12-31,4152,CapitalStock,741939000.0,股本合計,台微體,生技醫療業
2019-12-31,4152,CapitalStock_per,53.53,股本合計,台微體,生技醫療業
2019-12-31,4152,CapitalSurplus_per,123.04,資本公積合計,台微體,生技醫療業
2019-12-31,4152,CapitalSurplusAdditionalPaidInCapital_per,109.12,資本公積－發行溢價,台微體,生技醫療業
2019-12-31,4152,CashAndCashEquivalents_per,73.87,現金及約當現金,台微體,生技醫療業
2019-12-31,4152,CurrentAssets_per,79.05,流動資產合計,台微體,生技醫療業
2019-12-31,4152,CurrentIncomeTaxAssets,982000.0,本期所得稅資產,台微體,生技醫療業
2019-12-31,4152,CurrentIncomeTaxAssets_per,0.07,本期所得稅資產,台微體,生技醫療業
2019-12-31,4152,CurrentLiabilities,556697000.0,流動負債合計,台微體,生技醫療業
2019-12-31,4152,CurrentLiabilities_per,40.17,流動負債合計,台微體,生技醫療業
2019-12-31,4152,DeferredTaxAssets,76000.0,遞延所得稅資產,台微體,生技醫療業
2019-12-31,4152,DeferredTaxAssets_per,0.01,遞延所得稅資產,台微體,生技醫療業
2019-12-31,4152,Equity,721910000.0,權益總額,台微體,生技醫療業
2019-12-31,4152,Equity_per,52.09,權益總額,台微體,生技醫療業
2019-12-31,4152,EquityAttributableToOwnersOfParent,721910000.0,歸屬於母公司業主之權益合計,台微體,生技醫療業
2019-12-31,4152,EquityAttributableToOwnersOfParent_per,52.09,歸屬於母公司業主之權益合計,台微體,生技醫療業
2019-12-31,4152,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,0.0,預收股款（權益項下）之約當發行股數,台微體,生技醫療業
2019-12-31,4152,IntangibleAssets,1802000.0,無形資產,台微體,生技醫療業
2019-12-31,4152,IntangibleAssets_per,0.13,無形資產,台微體,生技醫療業
2019-12-31,4152,Liabilities,664068000.0,負債總額,台微體,生技醫療業
2019-12-31,4152,Liabilities_per,48.0,負債總額,台微體,生技醫療業
2019-12-31,4152,LongtermBorrowings,55508000.0,長期借款,台微體,生技醫療業
2019-12-31,4152,LongtermBorrowings_per,4.0,長期借款,台微體,生技醫療業
2019-12-31,4152,NoncurrentAssets,290364000.0,非流動資產合計,台微體,生技醫療業
2019-12-31,4152,NoncurrentAssets_per,20.95,非流動資產合計,台微體,生技醫療業
2019-12-31,4152,NoncurrentLiabilities,107371000.0,非流動負債合計,台微體,生技醫療業
2019-12-31,4152,NoncurrentLiabilities_per,7.75,非流動負債合計,台微體,生技醫療業
2019-12-31,4152,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,台微體,生技醫療業
2019-12-31,4152,OrdinaryShare,741939000.0,普通股股本,台微體,生技醫療業
2019-12-31,4152,OrdinaryShare_per,53.53,普通股股本,台微體,生技醫療業
2019-12-31,4152,OtherCurrentLiabilities,316198000.0,其他流動負債,台微體,生技醫療業
2019-12-31,4152,OtherCurrentLiabilities_per,22.81,其他流動負債,台微體,生技醫療業
2019-12-31,4152,OtherEquityInterest,7578000.0,其他權益合計,台微體,生技醫療業
2019-12-31,4152,OtherEquityInterest_per,0.55,其他權益合計,台微體,生技醫療業
2019-12-31,4152,OtherNoncurrentAssets,119192000.0,其他非流動資產,台微體,生技醫療業
2019-12-31,4152,OtherNoncurrentAssets_per,8.6,其他非流動資產,台微體,生技醫療業
2019-12-31,4152,OtherNoncurrentLiabilities,5597000.0,其他非流動負債,台微體,生技醫療業
2019-12-31,4152,OtherNoncurrentLiabilities_per,0.4,其他非流動負債,台微體,生技醫療業
2019-12-31,4152,OtherPayables,131064000.0,其他應付款,台微體,生技醫療業
2019-12-31,4152,OtherPayables_per,9.46,其他應付款,台微體,生技醫療業
2019-12-31,4152,OtherReceivable,4654000.0,其他應收款淨額,台微體,生技醫療業
2019-12-31,4152,OtherReceivable_per,0.34,其他應收款淨額,台微體,生技醫療業
2019-12-31,4152,PropertyPlantAndEquipment,61683000.0,不動產、廠房及設備,台微體,生技醫療業
2019-12-31,4152,PropertyPlantAndEquipment_per,4.45,不動產、廠房及設備,台微體,生技醫療業
2019-12-31,4152,RetainedEarnings_per,123.94,保留盈餘合計,台微體,生技醫療業
2019-12-31,4152,ShorttermBorrowings,46000000.0,短期借款,台微體,生技醫療業
2019-12-31,4152,ShorttermBorrowings_per,3.32,短期借款,台微體,生技醫療業
2019-12-31,4152,TotalAssets_per,100.0,資產總額,台微體,生技醫療業
2019-12-31,4152,TotalLiabilitiesEquity_per,100.0,負債及權益總計,台微體,生技醫療業
2019-12-31,4152,UnappropriatedRetainedEarningsAaccumulatedDeficit,-1717770000.0,未分配盈餘,台微體,生技醫療業
2019-12-31,4152,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-124.0,未分配盈餘,台微體,生技醫療業
2019-12-31,4152,CashAndCashEquivalents,1023874000.0,現金及約當現金,台微體,生技醫療業
2019-12-31,4152,CurrentAssets,1095614000.0,流動資產合計,台微體,生技醫療業
2019-12-31,4152,TotalAssets,1385978000.0,資產總額,台微體,生技醫療業
2019-12-31,4152,CapitalSurplusAdditionalPaidInCapital,1512438000.0,資本公積－發行溢價,台微體,生技醫療業
2019-12-31,4152,CapitalSurplus,1705324000.0,資本公積合計,台微體,生技醫療業
2019-12-31,4152,RetainedEarnings,1717775000.0,保留盈餘合計,台微體,生技醫療業
2019-12-31,4152,NoncontrollingInterests,0.0,非控制權益,台微體,生技醫療業
2019-12-31,4152,NoncontrollingInterests_per,0.0,非控制權益,台微體,生技醫療業
2019-12-31,4152,TotalLiabilitiesEquity,1385978000.0,負債及權益總計,台微體,生技醫療業
2020-03-31,4152,AccountsReceivableNet,7384000.0,應收帳款淨額,台微體,生技醫療業
2020-03-31,4152,AccountsReceivableNet_per,0.66,應收帳款淨額,台微體,生技醫療業
2020-03-31,4152,CapitalStock,741889000.0,股本合計,台微體,生技醫療業
2020-03-31,4152,CapitalStock_per,66.09,股本合計,台微體,生技醫療業
2020-03-31,4152,CapitalSurplus_per,152.21,資本公積合計,台微體,生技醫療業
2020-03-31,4152,CapitalSurplusAdditionalPaidInCapital_per,138.29,資本公積－發行溢價,台微體,生技醫療業
2020-03-31,4152,CashAndCashEquivalents,680643000.0,現金及約當現金,台微體,生技醫療業
2020-03-31,4152,CashAndCashEquivalents_per,60.63,現金及約當現金,台微體,生技醫療業
2020-03-31,4152,CurrentAssets,842395000.0,流動資產合計,台微體,生技醫療業
2020-03-31,4152,CurrentAssets_per,75.04,流動資產合計,台微體,生技醫療業
2020-03-31,4152,CurrentIncomeTaxAssets,576000.0,本期所得稅資產,台微體,生技醫療業
2020-03-31,4152,CurrentIncomeTaxAssets_per,0.05,本期所得稅資產,台微體,生技醫療業
2020-03-31,4152,CurrentLiabilities,517156000.0,流動負債合計,台微體,生技醫療業
2020-03-31,4152,CurrentLiabilities_per,46.07,流動負債合計,台微體,生技醫療業
2020-03-31,4152,DeferredTaxAssets,0.0,遞延所得稅資產,台微體,生技醫療業
2020-03-31,4152,DeferredTaxAssets_per,0.0,遞延所得稅資產,台微體,生技醫療業
2020-03-31,4152,Equity,508191000.0,權益總額,台微體,生技醫療業
2020-03-31,4152,Equity_per,45.27,權益總額,台微體,生技醫療業
2020-03-31,4152,EquityAttributableToOwnersOfParent,508191000.0,歸屬於母公司業主之權益合計,台微體,生技醫療業
2020-03-31,4152,EquityAttributableToOwnersOfParent_per,45.27,歸屬於母公司業主之權益合計,台微體,生技醫療業
2020-03-31,4152,IntangibleAssets,2859000.0,無形資產,台微體,生技醫療業
2020-03-31,4152,IntangibleAssets_per,0.25,無形資產,台微體,生技醫療業
2020-03-31,4152,LongtermBorrowings,53314000.0,長期借款,台微體,生技醫療業
2020-03-31,4152,LongtermBorrowings_per,4.75,長期借款,台微體,生技醫療業
2020-03-31,4152,NoncurrentAssets,280194000.0,非流動資產合計,台微體,生技醫療業
2020-03-31,4152,NoncurrentAssets_per,24.96,非流動資產合計,台微體,生技醫療業
2020-03-31,4152,NoncurrentLiabilities,97242000.0,非流動負債合計,台微體,生技醫療業
2020-03-31,4152,NoncurrentLiabilities_per,8.66,非流動負債合計,台微體,生技醫療業
2020-03-31,4152,OrdinaryShare,741889000.0,普通股股本,台微體,生技醫療業
2020-03-31,4152,OrdinaryShare_per,66.09,普通股股本,台微體,生技醫療業
2020-03-31,4152,OtherCurrentLiabilities,278286000.0,其他流動負債,台微體,生技醫療業
2020-03-31,4152,OtherCurrentLiabilities_per,24.79,其他流動負債,台微體,生技醫療業
2020-03-31,4152,OtherEquityInterest,9989000.0,其他權益合計,台微體,生技醫療業
2020-03-31,4152,OtherEquityInterest_per,0.89,其他權益合計,台微體,生技醫療業
2020-03-31,4152,OtherNoncurrentAssets,122140000.0,其他非流動資產,台微體,生技醫療業
2020-03-31,4152,OtherNoncurrentAssets_per,10.88,其他非流動資產,台微體,生技醫療業
2020-03-31,4152,OtherNoncurrentLiabilities,5752000.0,其他非流動負債,台微體,生技醫療業
2020-03-31,4152,OtherNoncurrentLiabilities_per,0.51,其他非流動負債,台微體,生技醫療業
2020-03-31,4152,OtherPayables,138221000.0,其他應付款,台微體,生技醫療業
2020-03-31,4152,OtherPayables_per,12.31,其他應付款,台微體,生技醫療業
2020-03-31,4152,OtherReceivable,1282000.0,其他應收款淨額,台微體,生技醫療業
2020-03-31,4152,OtherReceivable_per,0.11,其他應收款淨額,台微體,生技醫療業
2020-03-31,4152,PropertyPlantAndEquipment,58512000.0,不動產、廠房及設備,台微體,生技醫療業
2020-03-31,4152,PropertyPlantAndEquipment_per,5.21,不動產、廠房及設備,台微體,生技醫療業
2020-03-31,4152,RetainedEarnings,1932360000.0,保留盈餘合計,台微體,生技醫療業
2020-03-31,4152,RetainedEarnings_per,172.13,保留盈餘合計,台微體,生技醫療業
2020-03-31,4152,ShorttermBorrowings,46000000.0,短期借款,台微體,生技醫療業
2020-03-31,4152,ShorttermBorrowings_per,4.1,短期借款,台微體,生技醫療業
2020-03-31,4152,TotalAssets_per,100.0,資產總額,台微體,生技醫療業
2020-03-31,4152,TotalLiabilitiesEquity_per,100.0,負債及權益總計,台微體,生技醫療業
2020-03-31,4152,TotalAssets,1122589000.0,資產總額,台微體,生技醫療業
2020-03-31,4152,CapitalSurplusAdditionalPaidInCapital,1552392000.0,資本公積－發行溢價,台微體,生技醫療業
2020-03-31,4152,CapitalSurplus,1708651000.0,資本公積合計,台微體,生技醫療業
2020-03-31,4152,NoncontrollingInterests,0.0,非控制權益,台微體,生技醫療業
2020-03-31,4152,NoncontrollingInterests_per,0.0,非控制權益,台微體,生技醫療業
2020-03-31,4152,TotalLiabilitiesEquity,1122589000.0,負債及權益總計,台微體,生技醫療業
2020-06-30,4152,AccountsReceivableNet,8164000.0,應收帳款淨額,台微體,生技醫療業
2020-06-30,4152,AccountsReceivableNet_per,0.47,應收帳款淨額,台微體,生技醫療業
2020-06-30,4152,CapitalStock,841889000.0,股本合計,台微體,生技醫療業
2020-06-30,4152,CapitalStock_per,48.72,股本合計,台微體,生技醫療業
2020-06-30,4152,CapitalSurplus_per,132.66,資本公積合計,台微體,生技醫療業
2020-06-30,4152,CapitalSurplusAdditionalPaidInCapital_per,123.62,資本公積－發行溢價,台微體,生技醫療業
2020-06-30,4152,CashAndCashEquivalents_per,71.46,現金及約當現金,台微體,生技醫療業
2020-06-30,4152,CurrentAssets_per,81.37,流動資產合計,台微體,生技醫療業
2020-06-30,4152,CurrentIncomeTaxAssets,565000.0,本期所得稅資產,台微體,生技醫療業
2020-06-30,4152,CurrentIncomeTaxAssets_per,0.03,本期所得稅資產,台微體,生技醫療業
2020-06-30,4152,CurrentLiabilities,241242000.0,流動負債合計,台微體,生技醫療業
2020-06-30,4152,CurrentLiabilities_per,13.96,流動負債合計,台微體,生技醫療業
2020-06-30,4152,DeferredTaxAssets,0.0,遞延所得稅資產,台微體,生技醫療業
2020-06-30,4152,DeferredTaxAssets_per,0.0,遞延所得稅資產,台微體,生技醫療業
2020-06-30,4152,Equity,951994000.0,權益總額,台微體,生技醫療業
2020-06-30,4152,Equity_per,55.1,權益總額,台微體,生技醫療業
2020-06-30,4152,EquityAttributableToOwnersOfParent,951994000.0,歸屬於母公司業主之權益合計,台微體,生技醫療業
2020-06-30,4152,EquityAttributableToOwnersOfParent_per,55.1,歸屬於母公司業主之權益合計,台微體,生技醫療業
2020-06-30,4152,IntangibleAssets,1805000.0,無形資產,台微體,生技醫療業
2020-06-30,4152,IntangibleAssets_per,0.1,無形資產,台微體,生技醫療業
2020-06-30,4152,LongtermBorrowings,451370000.0,長期借款,台微體,生技醫療業
2020-06-30,4152,LongtermBorrowings_per,26.12,長期借款,台微體,生技醫療業
2020-06-30,4152,NoncurrentAssets,321915000.0,非流動資產合計,台微體,生技醫療業
2020-06-30,4152,NoncurrentAssets_per,18.63,非流動資產合計,台微體,生技醫療業
2020-06-30,4152,NoncurrentLiabilities,534623000.0,非流動負債合計,台微體,生技醫療業
2020-06-30,4152,NoncurrentLiabilities_per,30.94,非流動負債合計,台微體,生技醫療業
2020-06-30,4152,OrdinaryShare,841889000.0,普通股股本,台微體,生技醫療業
2020-06-30,4152,OrdinaryShare_per,48.72,普通股股本,台微體,生技醫療業
2020-06-30,4152,OtherCurrentLiabilities,55007000.0,其他流動負債,台微體,生技醫療業
2020-06-30,4152,OtherCurrentLiabilities_per,3.18,其他流動負債,台微體,生技醫療業
2020-06-30,4152,OtherEquityInterest,7196000.0,其他權益合計,台微體,生技醫療業
2020-06-30,4152,OtherEquityInterest_per,0.42,其他權益合計,台微體,生技醫療業
2020-06-30,4152,OtherNoncurrentAssets,118832000.0,其他非流動資產,台微體,生技醫療業
2020-06-30,4152,OtherNoncurrentAssets_per,6.88,其他非流動資產,台微體,生技醫療業
2020-06-30,4152,OtherNoncurrentLiabilities,11742000.0,其他非流動負債,台微體,生技醫療業
2020-06-30,4152,OtherNoncurrentLiabilities_per,0.68,其他非流動負債,台微體,生技醫療業
2020-06-30,4152,OtherPayables,113698000.0,其他應付款,台微體,生技醫療業
2020-06-30,4152,OtherPayables_per,6.58,其他應付款,台微體,生技醫療業
2020-06-30,4152,OtherReceivable,11779000.0,其他應收款淨額,台微體,生技醫療業
2020-06-30,4152,OtherReceivable_per,0.68,其他應收款淨額,台微體,生技醫療業
2020-06-30,4152,PropertyPlantAndEquipment,121678000.0,不動產、廠房及設備,台微體,生技醫療業
2020-06-30,4152,PropertyPlantAndEquipment_per,7.04,不動產、廠房及設備,台微體,生技醫療業
2020-06-30,4152,RetainedEarnings_per,125.87,保留盈餘合計,台微體,生技醫療業
2020-06-30,4152,ShorttermBorrowings,46000000.0,短期借款,台微體,生技醫療業
2020-06-30,4152,ShorttermBorrowings_per,2.66,短期借款,台微體,生技醫療業
2020-06-30,4152,TotalAssets_per,100.0,資產總額,台微體,生技醫療業
2020-06-30,4152,TotalLiabilitiesEquity_per,100.0,負債及權益總計,台微體,生技醫療業
2020-06-30,4152,CashAndCashEquivalents,1234795000.0,現金及約當現金,台微體,生技醫療業
2020-06-30,4152,CurrentAssets,1405944000.0,流動資產合計,台微體,生技醫療業
2020-06-30,4152,TotalAssets,1727859000.0,資產總額,台微體,生技醫療業
2020-06-30,4152,CapitalSurplusAdditionalPaidInCapital,2136026000.0,資本公積－發行溢價,台微體,生技醫療業
2020-06-30,4152,CapitalSurplus,2292098000.0,資本公積合計,台微體,生技醫療業
2020-06-30,4152,RetainedEarnings,2174797000.0,保留盈餘合計,台微體,生技醫療業
2020-06-30,4152,NoncontrollingInterests,0.0,非控制權益,台微體,生技醫療業
2020-06-30,4152,NoncontrollingInterests_per,0.0,非控制權益,台微體,生技醫療業
2020-06-30,4152,TotalLiabilitiesEquity,1727859000.0,負債及權益總計,台微體,生技醫療業
2020-09-30,4152,AccountsReceivableNet,64994000.0,應收帳款淨額,台微體,生技醫療業
2020-09-30,4152,AccountsReceivableNet_per,4.37,應收帳款淨額,台微體,生技醫療業
2020-09-30,4152,CapitalStock,841549000.0,股本合計,台微體,生技醫療業
2020-09-30,4152,CapitalStock_per,56.63,股本合計,台微體,生技醫療業
2020-09-30,4152,CapitalSurplus,2295660000.0,資本公積合計,台微體,生技醫療業
2020-09-30,4152,CapitalSurplus_per,154.48,資本公積合計,台微體,生技醫療業
2020-09-30,4152,CapitalSurplusAdditionalPaidInCapital,2142950000.0,資本公積－發行溢價,台微體,生技醫療業
2020-09-30,4152,CapitalSurplusAdditionalPaidInCapital_per,144.2,資本公積－發行溢價,台微體,生技醫療業
2020-09-30,4152,CashAndCashEquivalents,1015090000.0,現金及約當現金,台微體,生技醫療業
2020-09-30,4152,CashAndCashEquivalents_per,68.31,現金及約當現金,台微體,生技醫療業
2020-09-30,4152,CurrentAssets,1158520000.0,流動資產合計,台微體,生技醫療業
2020-09-30,4152,CurrentAssets_per,77.96,流動資產合計,台微體,生技醫療業
2020-09-30,4152,CurrentIncomeTaxAssets,565000.0,本期所得稅資產,台微體,生技醫療業
2020-09-30,4152,CurrentIncomeTaxAssets_per,0.04,本期所得稅資產,台微體,生技醫療業
2020-09-30,4152,CurrentLiabilities,285411000.0,流動負債合計,台微體,生技醫療業
2020-09-30,4152,CurrentLiabilities_per,19.21,流動負債合計,台微體,生技醫療業
2020-09-30,4152,DeferredTaxAssets,0.0,遞延所得稅資產,台微體,生技醫療業
2020-09-30,4152,DeferredTaxAssets_per,0.0,遞延所得稅資產,台微體,生技醫療業
2020-09-30,4152,Equity,722441000.0,權益總額,台微體,生技醫療業
2020-09-30,4152,Equity_per,48.61,權益總額,台微體,生技醫療業
2020-09-30,4152,EquityAttributableToOwnersOfParent,722441000.0,歸屬於母公司業主之權益合計,台微體,生技醫療業
2020-09-30,4152,EquityAttributableToOwnersOfParent_per,48.61,歸屬於母公司業主之權益合計,台微體,生技醫療業
2020-09-30,4152,IntangibleAssets,1576000.0,無形資產,台微體,生技醫療業
2020-09-30,4152,IntangibleAssets_per,0.11,無形資產,台微體,生技醫療業
2020-09-30,4152,LongtermBorrowings,401710000.0,長期借款,台微體,生技醫療業
2020-09-30,4152,LongtermBorrowings_per,27.03,長期借款,台微體,生技醫療業
2020-09-30,4152,NoncurrentAssets,327552000.0,非流動資產合計,台微體,生技醫療業
2020-09-30,4152,NoncurrentAssets_per,22.04,非流動資產合計,台微體,生技醫療業
2020-09-30,4152,NoncurrentLiabilities,478216000.0,非流動負債合計,台微體,生技醫療業
2020-09-30,4152,NoncurrentLiabilities_per,32.18,非流動負債合計,台微體,生技醫療業
2020-09-30,4152,OrdinaryShare,841549000.0,普通股股本,台微體,生技醫療業
2020-09-30,4152,OrdinaryShare_per,56.63,普通股股本,台微體,生技醫療業
2020-09-30,4152,OtherCurrentLiabilities,85397000.0,其他流動負債,台微體,生技醫療業
2020-09-30,4152,OtherCurrentLiabilities_per,5.75,其他流動負債,台微體,生技醫療業
2020-09-30,4152,OtherEquityInterest,6283000.0,其他權益合計,台微體,生技醫療業
2020-09-30,4152,OtherEquityInterest_per,0.42,其他權益合計,台微體,生技醫療業
2020-09-30,4152,OtherNoncurrentAssets,137500000.0,其他非流動資產,台微體,生技醫療業
2020-09-30,4152,OtherNoncurrentAssets_per,9.25,其他非流動資產,台微體,生技醫療業
2020-09-30,4152,OtherNoncurrentLiabilities,11632000.0,其他非流動負債,台微體,生技醫療業
2020-09-30,4152,OtherNoncurrentLiabilities_per,0.78,其他非流動負債,台微體,生技醫療業
2020-09-30,4152,OtherPayables,158174000.0,其他應付款,台微體,生技醫療業
2020-09-30,4152,OtherPayables_per,10.64,其他應付款,台微體,生技醫療業
2020-09-30,4152,OtherReceivable,17547000.0,其他應收款淨額,台微體,生技醫療業
2020-09-30,4152,OtherReceivable_per,1.18,其他應收款淨額,台微體,生技醫療業
2020-09-30,4152,PropertyPlantAndEquipment,115913000.0,不動產、廠房及設備,台微體,生技醫療業
2020-09-30,4152,PropertyPlantAndEquipment_per,7.8,不動產、廠房及設備,台微體,生技醫療業
2020-09-30,4152,RetainedEarnings,2408490000.0,保留盈餘合計,台微體,生技醫療業
2020-09-30,4152,RetainedEarnings_per,162.07,保留盈餘合計,台微體,生技醫療業
2020-09-30,4152,ShorttermBorrowings,16000000.0,短期借款,台微體,生技醫療業
2020-09-30,4152,ShorttermBorrowings_per,1.08,短期借款,台微體,生技醫療業
2020-09-30,4152,TotalAssets,1486070000.0,資產總額,台微體,生技醫療業
2020-09-30,4152,TotalAssets_per,100.0,資產總額,台微體,生技醫療業
2020-09-30,4152,TotalLiabilitiesEquity,1486070000.0,負債及權益總計,台微體,生技醫療業
2020-09-30,4152,TotalLiabilitiesEquity_per,100.0,負債及權益總計,台微體,生技醫療業
2020-12-31,4152,CashAndCashEquivalents,1342667000.0,現金及約當現金,台微體,生技醫療業
2020-12-31,4152,CashAndCashEquivalents_per,76.75,現金及約當現金,台微體,生技醫療業
2020-12-31,4152,AccountsReceivableNet,9287000.0,應收帳款淨額,台微體,生技醫療業
2020-12-31,4152,AccountsReceivableNet_per,0.53,應收帳款淨額,台微體,生技醫療業
2020-12-31,4152,CurrentAssets,1431977000.0,流動資產合計,台微體,生技醫療業
2020-12-31,4152,CurrentAssets_per,81.85,流動資產合計,台微體,生技醫療業
2020-12-31,4152,PropertyPlantAndEquipment,124499000.0,不動產、廠房及設備,台微體,生技醫療業
2020-12-31,4152,PropertyPlantAndEquipment_per,7.12,不動產、廠房及設備,台微體,生技醫療業
2020-12-31,4152,IntangibleAssets,1002000.0,無形資產,台微體,生技醫療業
2020-12-31,4152,IntangibleAssets_per,0.06,無形資產,台微體,生技醫療業
2020-12-31,4152,DeferredTaxAssets,0.0,遞延所得稅資產,台微體,生技醫療業
2020-12-31,4152,DeferredTaxAssets_per,0.0,遞延所得稅資產,台微體,生技醫療業
2020-12-31,4152,OtherNoncurrentAssets,126429000.0,其他非流動資產,台微體,生技醫療業
2020-12-31,4152,OtherNoncurrentAssets_per,7.23,其他非流動資產,台微體,生技醫療業
2020-12-31,4152,NoncurrentAssets,317484000.0,非流動資產合計,台微體,生技醫療業
2020-12-31,4152,NoncurrentAssets_per,18.15,非流動資產合計,台微體,生技醫療業
2020-12-31,4152,TotalAssets,1749461000.0,資產總額,台微體,生技醫療業
2020-12-31,4152,TotalAssets_per,100.0,資產總額,台微體,生技醫療業
2020-12-31,4152,ShorttermBorrowings,16000000.0,短期借款,台微體,生技醫療業
2020-12-31,4152,ShorttermBorrowings_per,0.91,短期借款,台微體,生技醫療業
2020-12-31,4152,OtherPayables,189141000.0,其他應付款,台微體,生技醫療業
2020-12-31,4152,OtherPayables_per,10.81,其他應付款,台微體,生技醫療業
2020-12-31,4152,OtherCurrentLiabilities,117858000.0,其他流動負債,台微體,生技醫療業
2020-12-31,4152,OtherCurrentLiabilities_per,6.74,其他流動負債,台微體,生技醫療業
2020-12-31,4152,CurrentLiabilities,348127000.0,流動負債合計,台微體,生技醫療業
2020-12-31,4152,CurrentLiabilities_per,19.9,流動負債合計,台微體,生技醫療業
2020-12-31,4152,LongtermBorrowings,469076000.0,長期借款,台微體,生技醫療業
2020-12-31,4152,LongtermBorrowings_per,26.81,長期借款,台微體,生技醫療業
2020-12-31,4152,OtherNoncurrentLiabilities,10189000.0,其他非流動負債,台微體,生技醫療業
2020-12-31,4152,OtherNoncurrentLiabilities_per,0.58,其他非流動負債,台微體,生技醫療業
2020-12-31,4152,NoncurrentLiabilities,538007000.0,非流動負債合計,台微體,生技醫療業
2020-12-31,4152,NoncurrentLiabilities_per,30.75,非流動負債合計,台微體,生技醫療業
2020-12-31,4152,OrdinaryShare,841549000.0,普通股股本,台微體,生技醫療業
2020-12-31,4152,OrdinaryShare_per,48.1,普通股股本,台微體,生技醫療業
2020-12-31,4152,CapitalStock,841549000.0,股本合計,台微體,生技醫療業
2020-12-31,4152,CapitalStock_per,48.1,股本合計,台微體,生技醫療業
2020-12-31,4152,CapitalSurplusAdditionalPaidInCapital,2167954000.0,資本公積－發行溢價,台微體,生技醫療業
2020-12-31,4152,CapitalSurplusAdditionalPaidInCapital_per,123.92,資本公積－發行溢價,台微體,生技醫療業
2020-12-31,4152,CapitalSurplus,2300541000.0,資本公積合計,台微體,生技醫療業
2020-12-31,4152,CapitalSurplus_per,131.5,資本公積合計,台微體,生技醫療業
2020-12-31,4152,RetainedEarnings,2699974000.0,保留盈餘合計,台微體,生技醫療業
2020-12-31,4152,RetainedEarnings_per,154.33,保留盈餘合計,台微體,生技醫療業
2020-12-31,4152,OtherEquityInterest,4194000.0,其他權益合計,台微體,生技醫療業
2020-12-31,4152,OtherEquityInterest_per,0.24,其他權益合計,台微體,生技醫療業
2020-12-31,4152,EquityAttributableToOwnersOfParent,437922000.0,歸屬於母公司業主之權益合計,台微體,生技醫療業
2020-12-31,4152,EquityAttributableToOwnersOfParent_per,25.03,歸屬於母公司業主之權益合計,台微體,生技醫療業
2020-12-31,4152,NoncontrollingInterests,425405000.0,非控制權益,台微體,生技醫療業
2020-12-31,4152,NoncontrollingInterests_per,24.32,非控制權益,台微體,生技醫療業
2020-12-31,4152,Equity,863327000.0,權益總額,台微體,生技醫療業
2020-12-31,4152,Equity_per,49.35,權益總額,台微體,生技醫療業
2020-12-31,4152,TotalLiabilitiesEquity,1749461000.0,負債及權益總計,台微體,生技醫療業
2020-12-31,4152,TotalLiabilitiesEquity_per,100.0,負債及權益總計,台微體,生技醫療業
2020-12-31,4152,OtherReceivable,25489000.0,其他應收款淨額,台微體,生技醫療業
2020-12-31,4152,OtherReceivable_per,1.46,其他應收款淨額,台微體,生技醫療業
2020-12-31,4152,CurrentIncomeTaxAssets,571000.0,本期所得稅資產,台微體,生技醫療業
2020-12-31,4152,CurrentIncomeTaxAssets_per,0.03,本期所得稅資產,台微體,生技醫療業
2021-03-31,4152,CashAndCashEquivalents,1080009000.0,現金及約當現金,台微體,生技醫療業
2021-03-31,4152,CashAndCashEquivalents_per,71.55,現金及約當現金,台微體,生技醫療業
2021-03-31,4152,AccountsReceivableNet,34684000.0,應收帳款淨額,台微體,生技醫療業
2021-03-31,4152,AccountsReceivableNet_per,2.3,應收帳款淨額,台微體,生技醫療業
2021-03-31,4152,CurrentAssets,1173607000.0,流動資產合計,台微體,生技醫療業
2021-03-31,4152,CurrentAssets_per,77.75,流動資產合計,台微體,生技醫療業
2021-03-31,4152,PropertyPlantAndEquipment,119298000.0,不動產、廠房及設備,台微體,生技醫療業
2021-03-31,4152,PropertyPlantAndEquipment_per,7.9,不動產、廠房及設備,台微體,生技醫療業
2021-03-31,4152,IntangibleAssets,998000.0,無形資產,台微體,生技醫療業
2021-03-31,4152,IntangibleAssets_per,0.07,無形資產,台微體,生技醫療業
2021-03-31,4152,OtherNoncurrentAssets,156668000.0,其他非流動資產,台微體,生技醫療業
2021-03-31,4152,OtherNoncurrentAssets_per,10.38,其他非流動資產,台微體,生技醫療業
2021-03-31,4152,NoncurrentAssets,335789000.0,非流動資產合計,台微體,生技醫療業
2021-03-31,4152,NoncurrentAssets_per,22.25,非流動資產合計,台微體,生技醫療業
2021-03-31,4152,TotalAssets,1509396000.0,資產總額,台微體,生技醫療業
2021-03-31,4152,TotalAssets_per,100.0,資產總額,台微體,生技醫療業
2021-03-31,4152,ShorttermBorrowings,16000000.0,短期借款,台微體,生技醫療業
2021-03-31,4152,ShorttermBorrowings_per,1.06,短期借款,台微體,生技醫療業
2021-03-31,4152,OtherPayables,185884000.0,其他應付款,台微體,生技醫療業
2021-03-31,4152,OtherPayables_per,12.32,其他應付款,台微體,生技醫療業
2021-03-31,4152,OtherCurrentLiabilities,152099000.0,其他流動負債,台微體,生技醫療業
2021-03-31,4152,OtherCurrentLiabilities_per,10.08,其他流動負債,台微體,生技醫療業
2021-03-31,4152,CurrentLiabilities,378463000.0,流動負債合計,台微體,生技醫療業
2021-03-31,4152,CurrentLiabilities_per,25.07,流動負債合計,台微體,生技醫療業
2021-03-31,4152,LongtermBorrowings,421589000.0,長期借款,台微體,生技醫療業
2021-03-31,4152,LongtermBorrowings_per,27.93,長期借款,台微體,生技醫療業
2021-03-31,4152,OtherNoncurrentLiabilities,15967000.0,其他非流動負債,台微體,生技醫療業
2021-03-31,4152,OtherNoncurrentLiabilities_per,1.06,其他非流動負債,台微體,生技醫療業
2021-03-31,4152,NoncurrentLiabilities,490299000.0,非流動負債合計,台微體,生技醫療業
2021-03-31,4152,NoncurrentLiabilities_per,32.48,非流動負債合計,台微體,生技醫療業
2021-03-31,4152,OrdinaryShare,841549000.0,普通股股本,台微體,生技醫療業
2021-03-31,4152,OrdinaryShare_per,55.75,普通股股本,台微體,生技醫療業
2021-03-31,4152,CapitalStock,841549000.0,股本合計,台微體,生技醫療業
2021-03-31,4152,CapitalStock_per,55.75,股本合計,台微體,生技醫療業
2021-03-31,4152,CapitalSurplusAdditionalPaidInCapital,2197503000.0,資本公積－發行溢價,台微體,生技醫療業
2021-03-31,4152,CapitalSurplusAdditionalPaidInCapital_per,145.59,資本公積－發行溢價,台微體,生技醫療業
2021-03-31,4152,CapitalSurplus,2304216000.0,資本公積合計,台微體,生技醫療業
2021-03-31,4152,CapitalSurplus_per,152.66,資本公積合計,台微體,生技醫療業
2021-03-31,4152,RetainedEarnings,2901343000.0,保留盈餘合計,台微體,生技醫療業
2021-03-31,4152,RetainedEarnings_per,192.22,保留盈餘合計,台微體,生技醫療業
2021-03-31,4152,OtherEquityInterest,8629000.0,其他權益合計,台微體,生技醫療業
2021-03-31,4152,OtherEquityInterest_per,0.57,其他權益合計,台微體,生技醫療業
2021-03-31,4152,EquityAttributableToOwnersOfParent,235793000.0,歸屬於母公司業主之權益合計,台微體,生技醫療業
2021-03-31,4152,EquityAttributableToOwnersOfParent_per,15.62,歸屬於母公司業主之權益合計,台微體,生技醫療業
2021-03-31,4152,NoncontrollingInterests,404841000.0,非控制權益,台微體,生技醫療業
2021-03-31,4152,NoncontrollingInterests_per,26.82,非控制權益,台微體,生技醫療業
2021-03-31,4152,Equity,640634000.0,權益總額,台微體,生技醫療業
2021-03-31,4152,Equity_per,42.44,權益總額,台微體,生技醫療業
2021-03-31,4152,TotalLiabilitiesEquity,1509396000.0,負債及權益總計,台微體,生技醫療業
2021-03-31,4152,TotalLiabilitiesEquity_per,100.0,負債及權益總計,台微體,生技醫療業
2021-03-31,4152,OtherReceivable,2971000.0,其他應收款淨額,台微體,生技醫療業
2021-03-31,4152,OtherReceivable_per,0.2,其他應收款淨額,台微體,生技醫療業
2021-03-31,4152,CurrentIncomeTaxAssets,609000.0,本期所得稅資產,台微體,生技醫療業
2021-03-31,4152,CurrentIncomeTaxAssets_per,0.04,本期所得稅資產,台微體,生技醫療業
2021-06-30,4152,CashAndCashEquivalents,696737000.0,現金及約當現金,台微體,生技醫療業
2021-06-30,4152,CashAndCashEquivalents_per,52.35,現金及約當現金,台微體,生技醫療業
2021-06-30,4152,AccountsReceivableNet,157460000.0,應收帳款淨額,台微體,生技醫療業
2021-06-30,4152,AccountsReceivableNet_per,11.83,應收帳款淨額,台微體,生技醫療業
2021-06-30,4152,CurrentAssets,986874000.0,流動資產合計,台微體,生技醫療業
2021-06-30,4152,CurrentAssets_per,74.15,流動資產合計,台微體,生技醫療業
2021-06-30,4152,PropertyPlantAndEquipment,112821000.0,不動產、廠房及設備,台微體,生技醫療業
2021-06-30,4152,PropertyPlantAndEquipment_per,8.48,不動產、廠房及設備,台微體,生技醫療業
2021-06-30,4152,IntangibleAssets,692000.0,無形資產,台微體,生技醫療業
2021-06-30,4152,IntangibleAssets_per,0.05,無形資產,台微體,生技醫療業
2021-06-30,4152,OtherNoncurrentAssets,164178000.0,其他非流動資產,台微體,生技醫療業
2021-06-30,4152,OtherNoncurrentAssets_per,12.34,其他非流動資產,台微體,生技醫療業
2021-06-30,4152,NoncurrentAssets,344095000.0,非流動資產合計,台微體,生技醫療業
2021-06-30,4152,NoncurrentAssets_per,25.85,非流動資產合計,台微體,生技醫療業
2021-06-30,4152,TotalAssets,1330969000.0,資產總額,台微體,生技醫療業
2021-06-30,4152,TotalAssets_per,100.0,資產總額,台微體,生技醫療業
2021-06-30,4152,ShorttermBorrowings,16000000.0,短期借款,台微體,生技醫療業
2021-06-30,4152,ShorttermBorrowings_per,1.2,短期借款,台微體,生技醫療業
2021-06-30,4152,OtherPayables,94313000.0,其他應付款,台微體,生技醫療業
2021-06-30,4152,OtherPayables_per,7.09,其他應付款,台微體,生技醫療業
2021-06-30,4152,OtherCurrentLiabilities,181158000.0,其他流動負債,台微體,生技醫療業
2021-06-30,4152,OtherCurrentLiabilities_per,13.61,其他流動負債,台微體,生技醫療業
2021-06-30,4152,CurrentLiabilities,327849000.0,流動負債合計,台微體,生技醫療業
2021-06-30,4152,CurrentLiabilities_per,24.63,流動負債合計,台微體,生技醫療業
2021-06-30,4152,LongtermBorrowings,372809000.0,長期借款,台微體,生技醫療業
2021-06-30,4152,LongtermBorrowings_per,28.01,長期借款,台微體,生技醫療業
2021-06-30,4152,OtherNoncurrentLiabilities,10065000.0,其他非流動負債,台微體,生技醫療業
2021-06-30,4152,OtherNoncurrentLiabilities_per,0.76,其他非流動負債,台微體,生技醫療業
2021-06-30,4152,NoncurrentLiabilities,447342000.0,非流動負債合計,台微體,生技醫療業
2021-06-30,4152,NoncurrentLiabilities_per,33.61,非流動負債合計,台微體,生技醫療業
2021-06-30,4152,OrdinaryShare,841549000.0,普通股股本,台微體,生技醫療業
2021-06-30,4152,OrdinaryShare_per,63.23,普通股股本,台微體,生技醫療業
2021-06-30,4152,CapitalStock,841549000.0,股本合計,台微體,生技醫療業
2021-06-30,4152,CapitalStock_per,63.23,股本合計,台微體,生技醫療業
2021-06-30,4152,CapitalSurplusAdditionalPaidInCapital,2199814000.0,資本公積－發行溢價,台微體,生技醫療業
2021-06-30,4152,CapitalSurplusAdditionalPaidInCapital_per,165.28,資本公積－發行溢價,台微體,生技醫療業
2021-06-30,4152,CapitalSurplus,2307893000.0,資本公積合計,台微體,生技醫療業
2021-06-30,4152,CapitalSurplus_per,173.4,資本公積合計,台微體,生技醫療業
2021-06-30,4152,RetainedEarnings,2956797000.0,保留盈餘合計,台微體,生技醫療業
2021-06-30,4152,RetainedEarnings_per,222.15,保留盈餘合計,台微體,生技醫療業
2021-06-30,4152,OtherEquityInterest,16499000.0,其他權益合計,台微體,生技醫療業
2021-06-30,4152,OtherEquityInterest_per,1.24,其他權益合計,台微體,生技醫療業
2021-06-30,4152,EquityAttributableToOwnersOfParent,176146000.0,歸屬於母公司業主之權益合計,台微體,生技醫療業
2021-06-30,4152,EquityAttributableToOwnersOfParent_per,13.23,歸屬於母公司業主之權益合計,台微體,生技醫療業
2021-06-30,4152,NoncontrollingInterests,379632000.0,非控制權益,台微體,生技醫療業
2021-06-30,4152,NoncontrollingInterests_per,28.52,非控制權益,台微體,生技醫療業
2021-06-30,4152,Equity,555778000.0,權益總額,台微體,生技醫療業
2021-06-30,4152,Equity_per,41.76,權益總額,台微體,生技醫療業
2021-06-30,4152,TotalLiabilitiesEquity,1330969000.0,負債及權益總計,台微體,生技醫療業
2021-06-30,4152,TotalLiabilitiesEquity_per,100.0,負債及權益總計,台微體,生技醫療業
2021-06-30,4152,OtherReceivable,481000.0,其他應收款淨額,台微體,生技醫療業
2021-06-30,4152,OtherReceivable_per,0.04,其他應收款淨額,台微體,生技醫療業
2021-06-30,4152,CurrentIncomeTaxAssets,619000.0,本期所得稅資產,台微體,生技醫療業
2021-06-30,4152,CurrentIncomeTaxAssets_per,0.05,本期所得稅資產,台微體,生技醫療業
2019-03-31,4152,DecreaseInDepositDeposit,0.0,存出保證金減少,台微體,生技醫療業
2019-03-31,4152,ProceedsFromLongTermDebt,0.0,舉借長期借款,台微體,生技醫療業
2019-03-31,4152,CashFlowsProvidedFromFinancingActivities,13457000.0,籌資活動之淨現金流入（流出）,台微體,生技醫療業
2019-03-31,4152,ReceivableIncrease,404000.0,應收帳款（增加）減少,台微體,生技醫療業
2019-03-31,4152,PropertyAndPlantAndEquipment,-31074000.0,取得不動產、廠房及設備,台微體,生技醫療業
2019-03-31,4152,NetIncomeBeforeTax,-111408000.0,本期稅前淨利（淨損）,台微體,生技醫療業
2019-03-31,4152,CashProvidedByInvestingActivities,276293000.0,投資活動之淨現金流入(流出),台微體,生技醫療業
2019-03-31,4152,InterestExpense,6134000.0,利息費用,台微體,生技醫療業
2019-03-31,4152,CashFlowsFromOperatingActivities,-109478000.0,營業活動之淨現金流入（流出）,台微體,生技醫療業
2019-03-31,4152,CashBalancesEndOfPeriod,988284000.0,期末現金及約當現金餘額,台微體,生技醫療業
2019-03-31,4152,CashBalancesBeginningOfPeriod,807484000.0,期初現金及約當現金餘額,台微體,生技醫療業
2019-03-31,4152,CashBalancesIncrease,180800000.0,本期現金及約當現金增加（減少）數,台微體,生技醫療業
2019-03-31,4152,TotalIncomeLossItems,31449000.0,收益費損項目合計,台微體,生技醫療業
2019-03-31,4152,PayTheInterest,-4101000.0,支付之利息,台微體,生技醫療業
2019-03-31,4152,Depreciation,18752000.0,折舊費用,台微體,生技醫療業
2019-03-31,4152,RentalPrincipalRepayments,-14367000.0,租賃本金償還,台微體,生技醫療業
2019-03-31,4152,RepaymentOfLongTermDebt,-2176000.0,償還長期借款,台微體,生技醫療業
2019-03-31,4152,AmortizationExpense,1779000.0,攤銷費用,台微體,生技醫療業
2019-03-31,4152,InterestIncome,-2457000.0,利息收入,台微體,生技醫療業
2019-03-31,4152,CashReceivedThroughOperations,-107461000.0,營運產生之現金流入（流出）,台微體,生技醫療業
2019-03-31,4152,IncomeBeforeIncomeTaxFromContinuingOperations,-111408000.0,繼續營業單位稅前淨利（淨損）,台微體,生技醫療業
2019-06-30,4152,CashFlowsFromOperatingActivities,-387018000.0,營業活動之淨現金流入(流出),台微體,生技醫療業
2019-06-30,4152,CashBalancesBeginningOfPeriod,807484000.0,期初現金及約當現金餘額,台微體,生技醫療業
2019-06-30,4152,ReceivableIncrease,-5376000.0,應收帳款（增加）減少,台微體,生技醫療業
2019-06-30,4152,CashBalancesIncrease,-122376000.0,本期現金及約當現金增加（減少）數,台微體,生技醫療業
2019-06-30,4152,CashProvidedByInvestingActivities,264249000.0,投資活動之淨現金流入（流出）,台微體,生技醫療業
2019-06-30,4152,NetIncomeBeforeTax,-352030000.0,本期稅前淨利（淨損）,台微體,生技醫療業
2019-06-30,4152,PropertyAndPlantAndEquipment,-41810000.0,取得不動產、廠房及設備,台微體,生技醫療業
2019-06-30,4152,CashBalancesEndOfPeriod,685108000.0,期末現金及約當現金餘額,台微體,生技醫療業
2019-06-30,4152,Depreciation,34656000.0,折舊費用,台微體,生技醫療業
2019-06-30,4152,RentalPrincipalRepayments,-31038000.0,租賃本金償還,台微體,生技醫療業
2019-06-30,4152,RepaymentOfLongTermDebt,-2654000.0,償還長期借款,台微體,生技醫療業
2019-06-30,4152,AmortizationExpense,3579000.0,攤銷費用,台微體,生技醫療業
2019-06-30,4152,ProceedsFromLongTermDebt,0.0,舉借長期借款,台微體,生技醫療業
2019-06-30,4152,DecreaseInShortTermLoans,-30000000.0,短期借款減少,台微體,生技醫療業
2019-06-30,4152,CashFlowsProvidedFromFinancingActivities,-3692000.0,籌資活動之淨現金流入（流出）,台微體,生技醫療業
2019-06-30,4152,InterestIncome,-4949000.0,利息收入,台微體,生技醫療業
2019-06-30,4152,InterestExpense,12561000.0,利息費用,台微體,生技醫療業
2019-06-30,4152,CashReceivedThroughOperations,-379196000.0,營運產生之現金流入（流出）,台微體,生技醫療業
2019-06-30,4152,TotalIncomeLossItems,60617000.0,收益費損項目合計,台微體,生技醫療業
2019-06-30,4152,PayTheInterest,-12033000.0,支付之利息,台微體,生技醫療業
2019-06-30,4152,IncomeBeforeIncomeTaxFromContinuingOperations,-352030000.0,繼續營業單位稅前淨利（淨損）,台微體,生技醫療業
2019-09-30,4152,CashFlowsFromOperatingActivities,-566836000.0,營業活動之淨現金流入(流出),台微體,生技醫療業
2019-09-30,4152,CashBalancesBeginningOfPeriod,807484000.0,期初現金及約當現金餘額,台微體,生技醫療業
2019-09-30,4152,ReceivableIncrease,-128000.0,應收帳款（增加）減少,台微體,生技醫療業
2019-09-30,4152,CashBalancesIncrease,200055000.0,本期現金及約當現金增加（減少）數,台微體,生技醫療業
2019-09-30,4152,CashProvidedByInvestingActivities,263332000.0,投資活動之淨現金流入（流出）,台微體,生技醫療業
2019-09-30,4152,NetIncomeBeforeTax,-530331000.0,本期稅前淨利（淨損）,台微體,生技醫療業
2019-09-30,4152,PropertyAndPlantAndEquipment,-42260000.0,取得不動產、廠房及設備,台微體,生技醫療業
2019-09-30,4152,CashBalancesEndOfPeriod,1007539000.0,期末現金及約當現金餘額,台微體,生技醫療業
2019-09-30,4152,Depreciation,50058000.0,折舊費用,台微體,生技醫療業
2019-09-30,4152,RentalPrincipalRepayments,-48220000.0,租賃本金償還,台微體,生技醫療業
2019-09-30,4152,RepaymentOfLongTermDebt,-35498000.0,償還長期借款,台微體,生技醫療業
2019-09-30,4152,AmortizationExpense,5367000.0,攤銷費用,台微體,生技醫療業
2019-09-30,4152,ProceedsFromLongTermDebt,0.0,舉借長期借款,台微體,生技醫療業
2019-09-30,4152,DecreaseInShortTermLoans,-30000000.0,短期借款減少,台微體,生技醫療業
2019-09-30,4152,CashFlowsProvidedFromFinancingActivities,499466000.0,籌資活動之淨現金流入（流出）,台微體,生技醫療業
2019-09-30,4152,InterestIncome,-6391000.0,利息收入,台微體,生技醫療業
2019-09-30,4152,InterestExpense,18654000.0,利息費用,台微體,生技醫療業
2019-09-30,4152,CashReceivedThroughOperations,-555272000.0,營運產生之現金流入（流出）,台微體,生技醫療業
2019-09-30,4152,TotalIncomeLossItems,90403000.0,收益費損項目合計,台微體,生技醫療業
2019-09-30,4152,PayTheInterest,-16835000.0,支付之利息,台微體,生技醫療業
2019-09-30,4152,IncomeBeforeIncomeTaxFromContinuingOperations,-530331000.0,繼續營業單位稅前淨利（淨損）,台微體,生技醫療業
2019-12-31,4152,AmortizationExpense,6648000.0,攤銷費用,台微體,生技醫療業
2019-12-31,4152,CashBalancesBeginningOfPeriod,807484000.0,期初現金及約當現金餘額,台微體,生技醫療業
2019-12-31,4152,CashBalancesIncrease,216390000.0,本期現金及約當現金增加（減少）數,台微體,生技醫療業
2019-12-31,4152,CashFlowsFromOperatingActivities,777562000.0,營業活動之淨現金流入（流出）,台微體,生技醫療業
2019-12-31,4152,CashFlowsProvidedFromFinancingActivities,744008000.0,籌資活動之淨現金流入（流出）,台微體,生技醫療業
2019-12-31,4152,CashProvidedByInvestingActivities,252191000.0,投資活動之淨現金流入(流出),台微體,生技醫療業
2019-12-31,4152,CashReceivedThroughOperations,759662000.0,營運產生之現金流入（流出）,台微體,生技醫療業
2019-12-31,4152,DecreaseInDepositDeposit,2171000.0,存出保證金減少,台微體,生技醫療業
2019-12-31,4152,DecreaseInShortTermLoans,30000000.0,短期借款減少,台微體,生技醫療業
2019-12-31,4152,Depreciation,64754000.0,折舊費用,台微體,生技醫療業
2019-12-31,4152,IncomeBeforeIncomeTaxFromContinuingOperations,803402000.0,繼續營業單位稅前淨利（淨損）,台微體,生技醫療業
2019-12-31,4152,InterestExpense,23656000.0,利息費用,台微體,生技醫療業
2019-12-31,4152,InterestIncome,7399000.0,利息收入,台微體,生技醫療業
2019-12-31,4152,NetIncomeBeforeTax,803402000.0,本期稅前淨利（淨損）,台微體,生技醫療業
2019-12-31,4152,PayTheInterest,22366000.0,支付之利息,台微體,生技醫療業
2019-12-31,4152,ProceedsFromLongTermDebt,0.0,舉借長期借款,台微體,生技醫療業
2019-12-31,4152,PropertyAndPlantAndEquipment,55592000.0,取得不動產、廠房及設備,台微體,生技醫療業
2019-12-31,4152,RentalPrincipalRepayments,65455000.0,租賃本金償還,台微體,生技醫療業
2019-12-31,4152,RepaymentOfLongTermDebt,56425000.0,償還長期借款,台微體,生技醫療業
2019-12-31,4152,TotalIncomeLossItems,104930000.0,收益費損項目合計,台微體,生技醫療業
2019-12-31,4152,ReceivableIncrease,5777000.0,應收帳款(增加)減少,台微體,生技醫療業
2019-12-31,4152,CashBalancesEndOfPeriod,1023874000.0,期末現金及約當現金餘額,台微體,生技醫療業
2019-12-31,4152,UnrealizedGain,9034000.0,未實現銷貨利益（損失）,台微體,生技醫療業
2020-03-31,4152,AmortizationExpense,970000.0,攤銷費用,台微體,生技醫療業
2020-03-31,4152,CashBalancesEndOfPeriod,680643000.0,期末現金及約當現金餘額,台微體,生技醫療業
2020-03-31,4152,CashBalancesIncrease,343231000.0,本期現金及約當現金增加（減少）數,台微體,生技醫療業
2020-03-31,4152,CashFlowsProvidedFromFinancingActivities,59530000.0,籌資活動之淨現金流入（流出）,台微體,生技醫療業
2020-03-31,4152,CashReceivedThroughOperations,272932000.0,營運產生之現金流入（流出）,台微體,生技醫療業
2020-03-31,4152,DecreaseInDepositDeposit,234000.0,存出保證金減少,台微體,生技醫療業
2020-03-31,4152,Depreciation,14555000.0,折舊費用,台微體,生技醫療業
2020-03-31,4152,IncomeBeforeIncomeTaxFromContinuingOperations,214164000.0,繼續營業單位稅前淨利（淨損）,台微體,生技醫療業
2020-03-31,4152,InterestExpense,4401000.0,利息費用,台微體,生技醫療業
2020-03-31,4152,InterestIncome,517000.0,利息收入,台微體,生技醫療業
2020-03-31,4152,NetIncomeBeforeTax,214164000.0,本期稅前淨利（淨損）,台微體,生技醫療業
2020-03-31,4152,PayTheInterest,5674000.0,支付之利息,台微體,生技醫療業
2020-03-31,4152,ProceedsFromLongTermDebt,30000000.0,舉借長期借款,台微體,生技醫療業
2020-03-31,4152,PropertyAndPlantAndEquipment,3972000.0,取得不動產、廠房及設備,台微體,生技醫療業
2020-03-31,4152,ReceivableIncrease,7736000.0,應收帳款(增加)減少,台微體,生技醫療業
2020-03-31,4152,RentalPrincipalRepayments,17202000.0,租賃本金償還,台微體,生技醫療業
2020-03-31,4152,RepaymentOfLongTermDebt,72158000.0,償還長期借款,台微體,生技醫療業
2020-03-31,4152,TotalIncomeLossItems,23770000.0,收益費損項目合計,台微體,生技醫療業
2020-03-31,4152,DecreaseInShortTermLoans,0.0,短期借款減少,台微體,生技醫療業
2020-03-31,4152,CashBalancesBeginningOfPeriod,1023874000.0,期初現金及約當現金餘額,台微體,生技醫療業
2020-03-31,4152,CashProvidedByInvestingActivities,4222000.0,投資活動之淨現金流入(流出),台微體,生技醫療業
2020-03-31,4152,CashFlowsFromOperatingActivities,278448000.0,營業活動之淨現金流入（流出）,台微體,生技醫療業
2020-06-30,4152,AmortizationExpense,2024000.0,攤銷費用,台微體,生技醫療業
2020-06-30,4152,CashBalancesIncrease,210921000.0,本期現金及約當現金增加（減少）數,台微體,生技醫療業
2020-06-30,4152,CashFlowsProvidedFromFinancingActivities,751028000.0,籌資活動之淨現金流入（流出）,台微體,生技醫療業
2020-06-30,4152,Depreciation,27929000.0,折舊費用,台微體,生技醫療業
2020-06-30,4152,InterestExpense,7530000.0,利息費用,台微體,生技醫療業
2020-06-30,4152,ProceedsFromLongTermDebt,479880000.0,舉借長期借款,台微體,生技醫療業
2020-06-30,4152,TotalIncomeLossItems,45468000.0,收益費損項目合計,台微體,生技醫療業
2020-06-30,4152,CashBalancesEndOfPeriod,1234795000.0,期末現金及約當現金餘額,台微體,生技醫療業
2020-06-30,4152,CashBalancesBeginningOfPeriod,1023874000.0,期初現金及約當現金餘額,台微體,生技醫療業
2020-06-30,4152,ReceivableIncrease,6956000.0,應收帳款(增加)減少,台微體,生技醫療業
2020-06-30,4152,InterestIncome,-755000.0,利息收入,台微體,生技醫療業
2020-06-30,4152,PropertyAndPlantAndEquipment,-9505000.0,取得不動產、廠房及設備,台微體,生技醫療業
2020-06-30,4152,CashProvidedByInvestingActivities,-12042000.0,投資活動之淨現金流入(流出),台微體,生技醫療業
2020-06-30,4152,PayTheInterest,-8623000.0,支付之利息,台微體,生技醫療業
2020-06-30,4152,RentalPrincipalRepayments,-60011000.0,租賃本金償還,台微體,生技醫療業
2020-06-30,4152,RepaymentOfLongTermDebt,-348671000.0,償還長期借款,台微體,生技醫療業
2020-06-30,4152,DecreaseInShortTermLoans,-30000000.0,短期借款減少,台微體,生技醫療業
2020-06-30,4152,CashReceivedThroughOperations,-520693000.0,營運產生之現金流入（流出）,台微體,生技醫療業
2020-06-30,4152,CashFlowsFromOperatingActivities,-528731000.0,營業活動之淨現金流入(流出),台微體,生技醫療業
2020-06-30,4152,IncomeBeforeIncomeTaxFromContinuingOperations,-456253000.0,繼續營業單位稅前淨利（淨損）,台微體,生技醫療業
2020-06-30,4152,NetIncomeBeforeTax,-456253000.0,本期稅前淨利（淨損）,台微體,生技醫療業
2020-09-30,4152,AmortizationExpense,2633000.0,攤銷費用,台微體,生技醫療業
2020-09-30,4152,CashBalancesBeginningOfPeriod,1023870000.0,期初現金及約當現金餘額,台微體,生技醫療業
2020-09-30,4152,CashBalancesEndOfPeriod,1015090000.0,期末現金及約當現金餘額,台微體,生技醫療業
2020-09-30,4152,CashBalancesIncrease,8781000.0,本期現金及約當現金增加（減少）數,台微體,生技醫療業
2020-09-30,4152,CashFlowsFromOperatingActivities,671661000.0,營業活動之淨現金流入(流出),台微體,生技醫療業
2020-09-30,4152,CashFlowsProvidedFromFinancingActivities,699991000.0,籌資活動之淨現金流入（流出）,台微體,生技醫療業
2020-09-30,4152,CashProvidedByInvestingActivities,31838000.0,投資活動之淨現金流入（流出）,台微體,生技醫療業
2020-09-30,4152,CashReceivedThroughOperations,658168000.0,營運產生之現金流入（流出）,台微體,生技醫療業
2020-09-30,4152,DecreaseInShortTermLoans,60000000.0,短期借款減少,台微體,生技醫療業
2020-09-30,4152,Depreciation,40427000.0,折舊費用,台微體,生技醫療業
2020-09-30,4152,IncomeBeforeIncomeTaxFromContinuingOperations,689829000.0,繼續營業單位稅前淨利（淨損）,台微體,生技醫療業
2020-09-30,4152,InterestExpense,12193000.0,利息費用,台微體,生技醫療業
2020-09-30,4152,InterestIncome,873000.0,利息收入,台微體,生技醫療業
2020-09-30,4152,NetIncomeBeforeTax,689829000.0,本期稅前淨利（淨損）,台微體,生技醫療業
2020-09-30,4152,PayTheInterest,13510000.0,支付之利息,台微體,生技醫療業
2020-09-30,4152,ProceedsFromLongTermDebt,479880000.0,舉借長期借款,台微體,生技醫療業
2020-09-30,4152,PropertyAndPlantAndEquipment,29355000.0,取得不動產、廠房及設備,台微體,生技醫療業
2020-09-30,4152,ReceivableIncrease,49874000.0,應收帳款（增加）減少,台微體,生技醫療業
2020-09-30,4152,RentalPrincipalRepayments,66637000.0,租賃本金償還,台微體,生技醫療業
2020-09-30,4152,RepaymentOfLongTermDebt,362862000.0,償還長期借款,台微體,生技醫療業
2020-09-30,4152,TotalIncomeLossItems,67661000.0,收益費損項目合計,台微體,生技醫療業
2020-12-31,4152,CashProvidedByInvestingActivities,35443000.0,投資活動之淨現金流入(流出),台微體,生技醫療業
2020-12-31,4152,CashBalancesIncrease,318793000.0,本期現金及約當現金增加（減少）數,台微體,生技醫療業
2020-12-31,4152,PropertyAndPlantAndEquipment,32503000.0,取得不動產、廠房及設備,台微體,生技醫療業
2020-12-31,4152,CashBalancesEndOfPeriod,1342667000.0,期末現金及約當現金餘額,台微體,生技醫療業
2020-12-31,4152,PayTheInterest,18322000.0,支付之利息,台微體,生技醫療業
2020-12-31,4152,CashBalancesBeginningOfPeriod,1023874000.0,期初現金及約當現金餘額,台微體,生技醫療業
2020-12-31,4152,IncomeBeforeIncomeTaxFromContinuingOperations,982177000.0,繼續營業單位稅前淨利（淨損）,台微體,生技醫療業
2020-12-31,4152,RepaymentOfLongTermDebt,375356000.0,償還長期借款,台微體,生技醫療業
2020-12-31,4152,NetIncomeBeforeTax,982177000.0,本期稅前淨利（淨損）,台微體,生技醫療業
2020-12-31,4152,CashFlowsFromOperatingActivities,875190000.0,營業活動之淨現金流入（流出）,台微體,生技醫療業
2020-12-31,4152,Depreciation,52960000.0,折舊費用,台微體,生技醫療業
2020-12-31,4152,AmortizationExpense,3207000.0,攤銷費用,台微體,生技醫療業
2020-12-31,4152,InterestExpense,17051000.0,利息費用,台微體,生技醫療業
2020-12-31,4152,RentalPrincipalRepayments,73194000.0,租賃本金償還,台微體,生技醫療業
2020-12-31,4152,UnrealizedGain,10915000.0,未實現銷貨利益（損失）,台微體,生技醫療業
2020-12-31,4152,ReceivableIncrease,5833000.0,應收帳款（增加）減少,台微體,生技醫療業
2020-12-31,4152,CashReceivedThroughOperations,856951000.0,營運產生之現金流入（流出）,台微體,生技醫療業
2020-12-31,4152,CashFlowsProvidedFromFinancingActivities,1228137000.0,籌資活動之淨現金流入（流出）,台微體,生技醫療業
2020-12-31,4152,DecreaseInShortTermLoans,60000000.0,短期借款減少,台微體,生技醫療業
2020-12-31,4152,ProceedsFromLongTermDebt,599880000.0,舉借長期借款,台微體,生技醫療業
2020-12-31,4152,TotalIncomeLossItems,78430000.0,收益費損項目合計,台微體,生技醫療業
2020-12-31,4152,InterestIncome,1193000.0,利息收入,台微體,生技醫療業
2021-03-31,4152,CashProvidedByInvestingActivities,30468000.0,投資活動之淨現金流入(流出),台微體,生技醫療業
2021-03-31,4152,CashBalancesIncrease,262658000.0,本期現金及約當現金增加（減少）數,台微體,生技醫療業
2021-03-31,4152,PropertyAndPlantAndEquipment,30468000.0,取得不動產、廠房及設備,台微體,生技醫療業
2021-03-31,4152,CashBalancesEndOfPeriod,1080009000.0,期末現金及約當現金餘額,台微體,生技醫療業
2021-03-31,4152,PayTheInterest,4783000.0,支付之利息,台微體,生技醫療業
2021-03-31,4152,CashBalancesBeginningOfPeriod,1342667000.0,期初現金及約當現金餘額,台微體,生技醫療業
2021-03-31,4152,IncomeBeforeIncomeTaxFromContinuingOperations,217998000.0,繼續營業單位稅前淨利（淨損）,台微體,生技醫療業
2021-03-31,4152,RepaymentOfLongTermDebt,13865000.0,償還長期借款,台微體,生技醫療業
2021-03-31,4152,NetIncomeBeforeTax,217998000.0,本期稅前淨利（淨損）,台微體,生技醫療業
2021-03-31,4152,CashFlowsFromOperatingActivities,203498000.0,營業活動之淨現金流入（流出）,台微體,生技醫療業
2021-03-31,4152,Depreciation,12801000.0,折舊費用,台微體,生技醫療業
2021-03-31,4152,AmortizationExpense,372000.0,攤銷費用,台微體,生技醫療業
2021-03-31,4152,DecreaseInDepositDeposit,0.0,存出保證金減少,台微體,生技醫療業
2021-03-31,4152,RentalPrincipalRepayments,6629000.0,租賃本金償還,台微體,生技醫療業
2021-03-31,4152,InterestExpense,4782000.0,利息費用,台微體,生技醫療業
2021-03-31,4152,ReceivableIncrease,25397000.0,應收帳款（增加）減少,台微體,生技醫療業
2021-03-31,4152,CashReceivedThroughOperations,198676000.0,營運產生之現金流入（流出）,台微體,生技醫療業
2021-03-31,4152,CashFlowsProvidedFromFinancingActivities,20494000.0,籌資活動之淨現金流入（流出）,台微體,生技醫療業
2021-03-31,4152,DecreaseInShortTermLoans,16000000.0,短期借款減少,台微體,生技醫療業
2021-03-31,4152,ProceedsFromLongTermDebt,0.0,舉借長期借款,台微體,生技醫療業
2021-03-31,4152,TotalIncomeLossItems,22116000.0,收益費損項目合計,台微體,生技醫療業
2021-03-31,4152,InterestIncome,238000.0,利息收入,台微體,生技醫療業
2021-06-30,4152,CashBalancesBeginningOfPeriod,1342667000.0,期初現金及約當現金餘額,台微體,生技醫療業
2021-06-30,4152,CashBalancesEndOfPeriod,696737000.0,期末現金及約當現金餘額,台微體,生技醫療業
2021-06-30,4152,Depreciation,25447000.0,折舊費用,台微體,生技醫療業
2021-06-30,4152,AmortizationExpense,678000.0,攤銷費用,台微體,生技醫療業
2021-06-30,4152,ProceedsFromLongTermDebt,0.0,舉借長期借款,台微體,生技醫療業
2021-06-30,4152,InterestExpense,9502000.0,利息費用,台微體,生技醫療業
2021-06-30,4152,TotalIncomeLossItems,34747000.0,收益費損項目合計,台微體,生技醫療業
2021-06-30,4152,CashFlowsFromOperatingActivities,-547001000.0,營業活動之淨現金流入(流出),台微體,生技醫療業
2021-06-30,4152,ReceivableIncrease,-148173000.0,應收帳款（增加）減少,台微體,生技醫療業
2021-06-30,4152,CashBalancesIncrease,-645930000.0,本期現金及約當現金增加（減少）數,台微體,生技醫療業
2021-06-30,4152,CashProvidedByInvestingActivities,-38553000.0,投資活動之淨現金流入（流出）,台微體,生技醫療業
2021-06-30,4152,NetIncomeBeforeTax,-293142000.0,本期稅前淨利（淨損）,台微體,生技醫療業
2021-06-30,4152,PropertyAndPlantAndEquipment,-39116000.0,取得不動產、廠房及設備,台微體,生技醫療業
2021-06-30,4152,RentalPrincipalRepayments,-13307000.0,租賃本金償還,台微體,生技醫療業
2021-06-30,4152,RepaymentOfLongTermDebt,-25865000.0,償還長期借款,台微體,生技醫療業
2021-06-30,4152,DecreaseInShortTermLoans,-16000000.0,短期借款減少,台微體,生技醫療業
2021-06-30,4152,CashFlowsProvidedFromFinancingActivities,-39172000.0,籌資活動之淨現金流入（流出）,台微體,生技醫療業
2021-06-30,4152,InterestIncome,-611000.0,利息收入,台微體,生技醫療業
2021-06-30,4152,CashReceivedThroughOperations,-537455000.0,營運產生之現金流入（流出）,台微體,生技醫療業
2021-06-30,4152,PayTheInterest,-9506000.0,支付之利息,台微體,生技醫療業
2021-06-30,4152,IncomeBeforeIncomeTaxFromContinuingOperations,-293142000.0,繼續營業單位稅前淨利（淨損）,台微體,生技醫療業
2019-03-31,8406,CostOfGoodsSold,731399000.0,營業成本,金可-KY,生技醫療業
2019-03-31,8406,EPS,1.87,基本每股盈餘（元）,金可-KY,生技醫療業
2019-03-31,8406,EquityAttributableToOwnersOfParent,475989000.0,綜合損益總額歸屬於母公司業主,金可-KY,生技醫療業
2019-03-31,8406,GrossProfit,1002840000.0,營業毛利（毛損）淨額,金可-KY,生技醫療業
2019-03-31,8406,IncomeAfterTaxes,171844000.0,本期淨利（淨損）,金可-KY,生技醫療業
2019-03-31,8406,IncomeBeforeIncomeTax,239455000.0,稅前淨利(淨損),金可-KY,生技醫療業
2019-03-31,8406,IncomeFromContinuingOperations,171844000.0,繼續營業單位本期淨利（淨損）,金可-KY,生技醫療業
2019-03-31,8406,NetIncome,171844000.0,本期淨利(淨損),金可-KY,生技醫療業
2019-03-31,8406,NoncontrollingInterests,-732000.0,綜合損益總額歸屬於非控制權益,金可-KY,生技醫療業
2019-03-31,8406,OperatingExpenses,714325000.0,營業費用,金可-KY,生技醫療業
2019-03-31,8406,OperatingIncome,288515000.0,營業利益（損失）,金可-KY,生技醫療業
2019-03-31,8406,OtherComprehensiveIncome,303413000.0,其他綜合損益（淨額）,金可-KY,生技醫療業
2019-03-31,8406,PreTaxIncome,239455000.0,稅前淨利（淨損）,金可-KY,生技醫療業
2019-03-31,8406,Revenue,1734240000.0,營業收入,金可-KY,生技醫療業
2019-03-31,8406,TAX,67611000.0,所得稅費用（利益）,金可-KY,生技醫療業
2019-03-31,8406,TotalConsolidatedProfitForThePeriod,475257000.0,本期綜合損益總額,金可-KY,生技醫療業
2019-03-31,8406,TotalNonoperatingIncomeAndExpense,-49060000.0,營業外收入及支出,金可-KY,生技醫療業
2019-06-30,8406,CostOfGoodsSold,901112000.0,營業成本,金可-KY,生技醫療業
2019-06-30,8406,EPS,2.93,基本每股盈餘（元）,金可-KY,生技醫療業
2019-06-30,8406,EquityAttributableToOwnersOfParent,133293000.0,綜合損益總額歸屬於母公司業主,金可-KY,生技醫療業
2019-06-30,8406,GrossProfit,1091130000.0,營業毛利（毛損）淨額,金可-KY,生技醫療業
2019-06-30,8406,IncomeAfterTaxes,270691000.0,本期淨利（淨損）,金可-KY,生技醫療業
2019-06-30,8406,IncomeBeforeIncomeTax,343582000.0,稅前淨利(淨損),金可-KY,生技醫療業
2019-06-30,8406,IncomeFromContinuingOperations,270691000.0,繼續營業單位本期淨利（淨損）,金可-KY,生技醫療業
2019-06-30,8406,NetIncome,270691000.0,本期淨利(淨損),金可-KY,生技醫療業
2019-06-30,8406,NoncontrollingInterests,-1071000.0,綜合損益總額歸屬於非控制權益,金可-KY,生技醫療業
2019-06-30,8406,OperatingExpenses,692921000.0,營業費用,金可-KY,生技醫療業
2019-06-30,8406,OperatingIncome,398210000.0,營業利益（損失）,金可-KY,生技醫療業
2019-06-30,8406,OtherComprehensiveIncome,-138469000.0,其他綜合損益（淨額）,金可-KY,生技醫療業
2019-06-30,8406,PreTaxIncome,343582000.0,稅前淨利（淨損）,金可-KY,生技醫療業
2019-06-30,8406,Revenue,1992240000.0,營業收入,金可-KY,生技醫療業
2019-06-30,8406,TAX,72891000.0,所得稅費用（利益）,金可-KY,生技醫療業
2019-06-30,8406,TotalConsolidatedProfitForThePeriod,132222000.0,本期綜合損益總額,金可-KY,生技醫療業
2019-06-30,8406,TotalNonoperatingIncomeAndExpense,-54628000.0,營業外收入及支出,金可-KY,生技醫療業
2019-09-30,8406,CostOfGoodsSold,936243000.0,營業成本,金可-KY,生技醫療業
2019-09-30,8406,EPS,3.72,基本每股盈餘（元）,金可-KY,生技醫療業
2019-09-30,8406,EquityAttributableToOwnersOfParent,-100589000.0,綜合損益總額歸屬於母公司業主,金可-KY,生技醫療業
2019-09-30,8406,GrossProfit,1168070000.0,營業毛利（毛損）淨額,金可-KY,生技醫療業
2019-09-30,8406,IncomeAfterTaxes,345188000.0,本期淨利（淨損）,金可-KY,生技醫療業
2019-09-30,8406,IncomeBeforeIncomeTax,421741000.0,稅前淨利(淨損),金可-KY,生技醫療業
2019-09-30,8406,IncomeFromContinuingOperations,345188000.0,繼續營業單位本期淨利（淨損）,金可-KY,生技醫療業
2019-09-30,8406,NetIncome,345188000.0,本期淨利(淨損),金可-KY,生技醫療業
2019-09-30,8406,NoncontrollingInterests,936000.0,綜合損益總額歸屬於非控制權益,金可-KY,生技醫療業
2019-09-30,8406,OperatingExpenses,724007000.0,營業費用,金可-KY,生技醫療業
2019-09-30,8406,OperatingIncome,444059000.0,營業利益（損失）,金可-KY,生技醫療業
2019-09-30,8406,OtherComprehensiveIncome,-444841000.0,其他綜合損益（淨額）,金可-KY,生技醫療業
2019-09-30,8406,PreTaxIncome,421741000.0,稅前淨利（淨損）,金可-KY,生技醫療業
2019-09-30,8406,Revenue,2104310000.0,營業收入,金可-KY,生技醫療業
2019-09-30,8406,TAX,76553000.0,所得稅費用（利益）,金可-KY,生技醫療業
2019-09-30,8406,TotalConsolidatedProfitForThePeriod,-99653000.0,本期綜合損益總額,金可-KY,生技醫療業
2019-09-30,8406,TotalNonoperatingIncomeAndExpense,-22318000.0,營業外收入及支出,金可-KY,生技醫療業
2019-12-31,8406,CostOfGoodsSold,1164160000.0,營業成本,金可-KY,生技醫療業
2019-12-31,8406,EPS,4.46,基本每股盈餘（元）,金可-KY,生技醫療業
2019-12-31,8406,EquityAttributableToOwnersOfParent,305915000.0,綜合損益總額歸屬於母公司業主,金可-KY,生技醫療業
2019-12-31,8406,GrossProfit,1185240000.0,營業毛利（毛損）淨額,金可-KY,生技醫療業
2019-12-31,8406,IncomeAfterTaxes,411920000.0,本期淨利（淨損）,金可-KY,生技醫療業
2019-12-31,8406,IncomeBeforeIncomeTax,548923000.0,稅前淨利(淨損),金可-KY,生技醫療業
2019-12-31,8406,IncomeFromContinuingOperations,411920000.0,繼續營業單位本期淨利（淨損）,金可-KY,生技醫療業
2019-12-31,8406,NetIncome,411920000.0,本期淨利(淨損),金可-KY,生技醫療業
2019-12-31,8406,NoncontrollingInterests,996000.0,綜合損益總額歸屬於非控制權益,金可-KY,生技醫療業
2019-12-31,8406,OperatingExpenses,706725000.0,營業費用,金可-KY,生技醫療業
2019-12-31,8406,OperatingIncome,478511000.0,營業利益（損失）,金可-KY,生技醫療業
2019-12-31,8406,OtherComprehensiveIncome,-105009000.0,其他綜合損益（淨額）,金可-KY,生技醫療業
2019-12-31,8406,PreTaxIncome,548923000.0,稅前淨利（淨損）,金可-KY,生技醫療業
2019-12-31,8406,Revenue,2349390000.0,營業收入,金可-KY,生技醫療業
2019-12-31,8406,TAX,137003000.0,所得稅費用（利益）,金可-KY,生技醫療業
2019-12-31,8406,TotalConsolidatedProfitForThePeriod,306911000.0,本期綜合損益總額,金可-KY,生技醫療業
2019-12-31,8406,TotalNonoperatingIncomeAndExpense,70412000.0,營業外收入及支出,金可-KY,生技醫療業
2020-03-31,8406,CostOfGoodsSold,625010000.0,營業成本,金可-KY,生技醫療業
2020-03-31,8406,EPS,0.66,基本每股盈餘（元）,金可-KY,生技醫療業
2020-03-31,8406,IncomeAfterTaxes,63653000.0,本期淨利（淨損）,金可-KY,生技醫療業
2020-03-31,8406,IncomeFromContinuingOperations,63653000.0,繼續營業單位本期淨利（淨損）,金可-KY,生技醫療業
2020-03-31,8406,OperatingExpenses,619689000.0,營業費用,金可-KY,生技醫療業
2020-03-31,8406,OperatingIncome,185750000.0,營業利益（損失）,金可-KY,生技醫療業
2020-03-31,8406,OtherComprehensiveIncome,-98565000.0,其他綜合損益（淨額）,金可-KY,生技醫療業
2020-03-31,8406,PreTaxIncome,103916000.0,稅前淨利（淨損）,金可-KY,生技醫療業
2020-03-31,8406,TAX,40263000.0,所得稅費用（利益）,金可-KY,生技醫療業
2020-03-31,8406,TotalConsolidatedProfitForThePeriod,-34912000.0,本期綜合損益總額,金可-KY,生技醫療業
2020-03-31,8406,TotalNonoperatingIncomeAndExpense,-81834000.0,營業外收入及支出,金可-KY,生技醫療業
2020-03-31,8406,Revenue,1430449000.0,營業收入,金可-KY,生技醫療業
2020-03-31,8406,GrossProfit,805439000.0,營業毛利（毛損）,金可-KY,生技醫療業
2020-03-31,8406,EquityAttributableToOwnersOfParent,60688000.0,淨利（淨損）歸屬於母公司業主,金可-KY,生技醫療業
2020-03-31,8406,NoncontrollingInterests,2965000.0,淨利（淨損）歸屬於非控制權益,金可-KY,生技醫療業
2020-06-30,8406,CostOfGoodsSold,796590000.0,營業成本,金可-KY,生技醫療業
2020-06-30,8406,EPS,2.17,基本每股盈餘（元）,金可-KY,生技醫療業
2020-06-30,8406,IncomeAfterTaxes,200525000.0,本期淨利（淨損）,金可-KY,生技醫療業
2020-06-30,8406,IncomeFromContinuingOperations,200525000.0,繼續營業單位本期淨利（淨損）,金可-KY,生技醫療業
2020-06-30,8406,OperatingExpenses,671022000.0,營業費用,金可-KY,生技醫療業
2020-06-30,8406,OperatingIncome,222203000.0,營業利益（損失）,金可-KY,生技醫療業
2020-06-30,8406,OtherComprehensiveIncome,-175002000.0,其他綜合損益（淨額）,金可-KY,生技醫療業
2020-06-30,8406,PreTaxIncome,248748000.0,稅前淨利（淨損）,金可-KY,生技醫療業
2020-06-30,8406,TAX,48223000.0,所得稅費用（利益）,金可-KY,生技醫療業
2020-06-30,8406,TotalConsolidatedProfitForThePeriod,25523000.0,本期綜合損益總額,金可-KY,生技醫療業
2020-06-30,8406,TotalNonoperatingIncomeAndExpense,26545000.0,營業外收入及支出,金可-KY,生技醫療業
2020-06-30,8406,Revenue,1689815000.0,營業收入,金可-KY,生技醫療業
2020-06-30,8406,GrossProfit,893225000.0,營業毛利（毛損）,金可-KY,生技醫療業
2020-06-30,8406,EquityAttributableToOwnersOfParent,201014000.0,淨利（淨損）歸屬於母公司業主,金可-KY,生技醫療業
2020-06-30,8406,NoncontrollingInterests,-489000.0,淨利（淨損）歸屬於非控制權益,金可-KY,生技醫療業
2020-09-30,8406,CostOfGoodsSold,818010000.0,營業成本,金可-KY,生技醫療業
2020-09-30,8406,EPS,3.67,基本每股盈餘（元）,金可-KY,生技醫療業
2020-09-30,8406,IncomeAfterTaxes,370317000.0,本期淨利（淨損）,金可-KY,生技醫療業
2020-09-30,8406,IncomeFromContinuingOperations,370317000.0,繼續營業單位本期淨利（淨損）,金可-KY,生技醫療業
2020-09-30,8406,OperatingExpenses,655413000.0,營業費用,金可-KY,生技醫療業
2020-09-30,8406,OperatingIncome,355759000.0,營業利益（損失）,金可-KY,生技醫療業
2020-09-30,8406,OtherComprehensiveIncome,123102000.0,其他綜合損益（淨額）,金可-KY,生技醫療業
2020-09-30,8406,PreTaxIncome,450005000.0,稅前淨利（淨損）,金可-KY,生技醫療業
2020-09-30,8406,TAX,79688000.0,所得稅費用（利益）,金可-KY,生技醫療業
2020-09-30,8406,TotalConsolidatedProfitForThePeriod,493419000.0,本期綜合損益總額,金可-KY,生技醫療業
2020-09-30,8406,TotalNonoperatingIncomeAndExpense,94246000.0,營業外收入及支出,金可-KY,生技醫療業
2020-09-30,8406,Revenue,1829182000.0,營業收入,金可-KY,生技醫療業
2020-09-30,8406,GrossProfit,1011172000.0,營業毛利（毛損）淨額,金可-KY,生技醫療業
2020-09-30,8406,EquityAttributableToOwnersOfParent,369452000.0,淨利（淨損）歸屬於母公司業主,金可-KY,生技醫療業
2020-09-30,8406,NoncontrollingInterests,865000.0,淨利（淨損）歸屬於非控制權益,金可-KY,生技醫療業
2020-12-31,8406,PreTaxIncome,453533000.0,稅前淨利（淨損）,金可-KY,生技醫療業
2020-12-31,8406,TAX,90808000.0,所得稅費用（利益）,金可-KY,生技醫療業
2020-12-31,8406,IncomeFromContinuingOperations,362725000.0,繼續營業單位本期淨利（淨損）,金可-KY,生技醫療業
2020-12-31,8406,IncomeAfterTaxes,362725000.0,本期淨利（淨損）,金可-KY,生技醫療業
2020-12-31,8406,TotalConsolidatedProfitForThePeriod,632335000.0,本期綜合損益總額,金可-KY,生技醫療業
2020-12-31,8406,EPS,3.74,基本每股盈餘（元）,金可-KY,生技醫療業
2020-12-31,8406,Revenue,2380279000.0,營業收入,金可-KY,生技醫療業
2020-12-31,8406,CostOfGoodsSold,1091709000.0,營業成本,金可-KY,生技醫療業
2020-12-31,8406,OperatingExpenses,898329000.0,營業費用,金可-KY,生技醫療業
2020-12-31,8406,OperatingIncome,390241000.0,營業利益（損失）,金可-KY,生技醫療業
2020-12-31,8406,TotalNonoperatingIncomeAndExpense,63292000.0,營業外收入及支出,金可-KY,生技醫療業
2020-12-31,8406,OtherComprehensiveIncome,269610000.0,其他綜合損益（淨額）,金可-KY,生技醫療業
2020-12-31,8406,GrossProfit,1288570000.0,營業毛利（毛損）淨額,金可-KY,生技醫療業
2020-12-31,8406,EquityAttributableToOwnersOfParent,362622000.0,淨利（淨損）歸屬於母公司業主,金可-KY,生技醫療業
2020-12-31,8406,NoncontrollingInterests,103000.0,淨利（淨損）歸屬於非控制權益,金可-KY,生技醫療業
2021-03-31,8406,PreTaxIncome,341673000.0,稅前淨利（淨損）,金可-KY,生技醫療業
2021-03-31,8406,TAX,78930000.0,所得稅費用（利益）,金可-KY,生技醫療業
2021-03-31,8406,IncomeFromContinuingOperations,262743000.0,繼續營業單位本期淨利（淨損）,金可-KY,生技醫療業
2021-03-31,8406,IncomeAfterTaxes,262743000.0,本期淨利（淨損）,金可-KY,生技醫療業
2021-03-31,8406,TotalConsolidatedProfitForThePeriod,224038000.0,本期綜合損益總額,金可-KY,生技醫療業
2021-03-31,8406,EPS,2.7,基本每股盈餘（元）,金可-KY,生技醫療業
2021-03-31,8406,Revenue,2040553000.0,營業收入,金可-KY,生技醫療業
2021-03-31,8406,CostOfGoodsSold,944179000.0,營業成本,金可-KY,生技醫療業
2021-03-31,8406,OperatingExpenses,701729000.0,營業費用,金可-KY,生技醫療業
2021-03-31,8406,OperatingIncome,394645000.0,營業利益（損失）,金可-KY,生技醫療業
2021-03-31,8406,TotalNonoperatingIncomeAndExpense,-52972000.0,營業外收入及支出,金可-KY,生技醫療業
2021-03-31,8406,OtherComprehensiveIncome,-38705000.0,其他綜合損益（淨額）,金可-KY,生技醫療業
2021-03-31,8406,GrossProfit,1096374000.0,營業毛利（毛損）淨額,金可-KY,生技醫療業
2021-03-31,8406,EquityAttributableToOwnersOfParent,262303000.0,淨利（淨損）歸屬於母公司業主,金可-KY,生技醫療業
2021-03-31,8406,NoncontrollingInterests,440000.0,淨利（淨損）歸屬於非控制權益,金可-KY,生技醫療業
2021-06-30,8406,PreTaxIncome,442106000.0,稅前淨利（淨損）,金可-KY,生技醫療業
2021-06-30,8406,TAX,40485000.0,所得稅費用（利益）,金可-KY,生技醫療業
2021-06-30,8406,IncomeFromContinuingOperations,401621000.0,繼續營業單位本期淨利（淨損）,金可-KY,生技醫療業
2021-06-30,8406,IncomeAfterTaxes,401621000.0,本期淨利（淨損）,金可-KY,生技醫療業
2021-06-30,8406,TotalConsolidatedProfitForThePeriod,308036000.0,本期綜合損益總額,金可-KY,生技醫療業
2021-06-30,8406,EPS,4.14,基本每股盈餘（元）,金可-KY,生技醫療業
2021-06-30,8406,Revenue,2351880000.0,營業收入,金可-KY,生技醫療業
2021-06-30,8406,CostOfGoodsSold,1169295000.0,營業成本,金可-KY,生技醫療業
2021-06-30,8406,OperatingExpenses,818435000.0,營業費用,金可-KY,生技醫療業
2021-06-30,8406,OperatingIncome,364150000.0,營業利益（損失）,金可-KY,生技醫療業
2021-06-30,8406,TotalNonoperatingIncomeAndExpense,77956000.0,營業外收入及支出,金可-KY,生技醫療業
2021-06-30,8406,OtherComprehensiveIncome,-93585000.0,其他綜合損益（淨額）,金可-KY,生技醫療業
2021-06-30,8406,GrossProfit,1182585000.0,營業毛利（毛損）淨額,金可-KY,生技醫療業
2021-06-30,8406,EquityAttributableToOwnersOfParent,401242000.0,淨利（淨損）歸屬於母公司業主,金可-KY,生技醫療業
2021-06-30,8406,NoncontrollingInterests,379000.0,淨利（淨損）歸屬於非控制權益,金可-KY,生技醫療業
2021-09-30,8406,PreTaxIncome,169684000.0,稅前淨利（淨損）,金可-KY,生技醫療業
2021-09-30,8406,TAX,45931000.0,所得稅費用（利益）,金可-KY,生技醫療業
2021-09-30,8406,IncomeFromContinuingOperations,123753000.0,繼續營業單位本期淨利（淨損）,金可-KY,生技醫療業
2021-09-30,8406,IncomeAfterTaxes,123753000.0,本期淨利（淨損）,金可-KY,生技醫療業
2021-09-30,8406,TotalConsolidatedProfitForThePeriod,60975000.0,本期綜合損益總額,金可-KY,生技醫療業
2021-09-30,8406,Revenue,2041537000.0,營業收入,金可-KY,生技醫療業
2021-09-30,8406,CostOfGoodsSold,1004268000.0,營業成本,金可-KY,生技醫療業
2021-09-30,8406,OperatingExpenses,868866000.0,營業費用,金可-KY,生技醫療業
2021-09-30,8406,OperatingIncome,168403000.0,營業利益（損失）,金可-KY,生技醫療業
2021-09-30,8406,TotalNonoperatingIncomeAndExpense,1281000.0,營業外收入及支出,金可-KY,生技醫療業
2021-09-30,8406,OtherComprehensiveIncome,-62778000.0,其他綜合損益（淨額）,金可-KY,生技醫療業
2021-09-30,8406,EquityAttributableToOwnersOfParent,61432000.0,綜合損益總額歸屬於母公司業主,金可-KY,生技醫療業
2021-09-30,8406,NoncontrollingInterests,-457000.0,綜合損益總額歸屬於非控制權益,金可-KY,生技醫療業
2021-09-30,8406,EPS,1.27,基本每股盈餘（元）,金可-KY,生技醫療業
2021-09-30,8406,GrossProfit,1037269000.0,營業毛利（毛損）,金可-KY,生技醫療業
2021-12-31,8406,PreTaxIncome,141672000.0,稅前淨利（淨損）,金可-KY,生技醫療業
2021-12-31,8406,TAX,-26655000.0,所得稅費用（利益）,金可-KY,生技醫療業
2021-12-31,8406,IncomeFromContinuingOperations,168327000.0,繼續營業單位本期淨利（淨損）,金可-KY,生技醫療業
2021-12-31,8406,IncomeAfterTaxes,168327000.0,本期淨利（淨損）,金可-KY,生技醫療業
2021-12-31,8406,TotalConsolidatedProfitForThePeriod,275935000.0,本期綜合損益總額,金可-KY,生技醫療業
2021-12-31,8406,Revenue,2467278000.0,營業收入,金可-KY,生技醫療業
2021-12-31,8406,CostOfGoodsSold,1212663000.0,營業成本,金可-KY,生技醫療業
2021-12-31,8406,OperatingExpenses,1109483000.0,營業費用,金可-KY,生技醫療業
2021-12-31,8406,OperatingIncome,145132000.0,營業利益（損失）,金可-KY,生技醫療業
2021-12-31,8406,TotalNonoperatingIncomeAndExpense,-3460000.0,營業外收入及支出,金可-KY,生技醫療業
2021-12-31,8406,OtherComprehensiveIncome,107608000.0,其他綜合損益（淨額）,金可-KY,生技醫療業
2021-12-31,8406,EquityAttributableToOwnersOfParent,276074000.0,綜合損益總額歸屬於母公司業主,金可-KY,生技醫療業
2021-12-31,8406,NoncontrollingInterests,-139000.0,綜合損益總額歸屬於非控制權益,金可-KY,生技醫療業
2021-12-31,8406,EPS,1.74,基本每股盈餘（元）,金可-KY,生技醫療業
2021-12-31,8406,GrossProfit,1254615000.0,營業毛利（毛損）,金可-KY,生技醫療業
2019-03-31,8406,AccountsPayable,372551000.0,應付帳款,金可-KY,生技醫療業
2019-03-31,8406,AccountsPayable_per,1.73,應付帳款,金可-KY,生技醫療業
2019-03-31,8406,AccountsPayableToRelatedParties,47834000.0,應付帳款－關係人,金可-KY,生技醫療業
2019-03-31,8406,AccountsPayableToRelatedParties_per,0.22,應付帳款－關係人,金可-KY,生技醫療業
2019-03-31,8406,AccountsReceivableDuefromRelatedPartiesNet,117306000.0,應收帳款－關係人淨額,金可-KY,生技醫療業
2019-03-31,8406,AccountsReceivableDuefromRelatedPartiesNet_per,0.54,應收帳款－關係人淨額,金可-KY,生技醫療業
2019-03-31,8406,AccountsReceivableNet,3788940000.0,應收帳款淨額,金可-KY,生技醫療業
2019-03-31,8406,AccountsReceivableNet_per,17.59,應收帳款淨額,金可-KY,生技醫療業
2019-03-31,8406,CapitalStock,924505000.0,股本合計,金可-KY,生技醫療業
2019-03-31,8406,CapitalStock_per,4.29,股本合計,金可-KY,生技醫療業
2019-03-31,8406,CapitalSurplus,3073230000.0,資本公積合計,金可-KY,生技醫療業
2019-03-31,8406,CapitalSurplus_per,14.27,資本公積合計,金可-KY,生技醫療業
2019-03-31,8406,CashAndCashEquivalents,3126690000.0,現金及約當現金,金可-KY,生技醫療業
2019-03-31,8406,CashAndCashEquivalents_per,14.52,現金及約當現金,金可-KY,生技醫療業
2019-03-31,8406,CurrentAssets,12755600000.0,流動資產合計,金可-KY,生技醫療業
2019-03-31,8406,CurrentAssets_per,59.23,流動資產合計,金可-KY,生技醫療業
2019-03-31,8406,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,金可-KY,生技醫療業
2019-03-31,8406,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,金可-KY,生技醫療業
2019-03-31,8406,CurrentIncomeTaxAssets,4101000.0,本期所得稅資產,金可-KY,生技醫療業
2019-03-31,8406,CurrentIncomeTaxAssets_per,0.0,本期所得稅資產,金可-KY,生技醫療業
2019-03-31,8406,CurrentLiabilities,7707240000.0,流動負債合計,金可-KY,生技醫療業
2019-03-31,8406,CurrentLiabilities_per,35.79,流動負債合計,金可-KY,生技醫療業
2019-03-31,8406,CurrentProvisions,0.0,負債準備－流動,金可-KY,生技醫療業
2019-03-31,8406,CurrentProvisions_per,0.0,負債準備－流動,金可-KY,生技醫療業
2019-03-31,8406,DeferredTaxAssets,158041000.0,遞延所得稅資產,金可-KY,生技醫療業
2019-03-31,8406,DeferredTaxAssets_per,0.73,遞延所得稅資產,金可-KY,生技醫療業
2019-03-31,8406,Equity,10861400000.0,權益總額,金可-KY,生技醫療業
2019-03-31,8406,Equity_per,50.43,權益總額,金可-KY,生技醫療業
2019-03-31,8406,EquityAttributableToOwnersOfParent,10879000000.0,歸屬於母公司業主之權益合計,金可-KY,生技醫療業
2019-03-31,8406,EquityAttributableToOwnersOfParent_per,50.51,歸屬於母公司業主之權益合計,金可-KY,生技醫療業
2019-03-31,8406,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,0.0,預收股款（權益項下）之約當發行股數,金可-KY,生技醫療業
2019-03-31,8406,IntangibleAssets,51179000.0,無形資產,金可-KY,生技醫療業
2019-03-31,8406,IntangibleAssets_per,0.24,無形資產,金可-KY,生技醫療業
2019-03-31,8406,Inventories,2447770000.0,存貨,金可-KY,生技醫療業
2019-03-31,8406,Inventories_per,11.37,存貨,金可-KY,生技醫療業
2019-03-31,8406,Liabilities,10675400000.0,負債總額,金可-KY,生技醫療業
2019-03-31,8406,Liabilities_per,50.0,負債總額,金可-KY,生技醫療業
2019-03-31,8406,LongtermBorrowings,2642000000.0,長期借款,金可-KY,生技醫療業
2019-03-31,8406,LongtermBorrowings_per,12.27,長期借款,金可-KY,生技醫療業
2019-03-31,8406,NoncontrollingInterests,17587000.0,非控制權益,金可-KY,生技醫療業
2019-03-31,8406,NoncontrollingInterests_per,0.08,非控制權益,金可-KY,生技醫療業
2019-03-31,8406,NoncurrentAssets,8781180000.0,非流動資產合計,金可-KY,生技醫療業
2019-03-31,8406,NoncurrentAssets_per,40.77,非流動資產合計,金可-KY,生技醫療業
2019-03-31,8406,NoncurrentLiabilities,2968130000.0,非流動負債合計,金可-KY,生技醫療業
2019-03-31,8406,NoncurrentLiabilities_per,13.78,非流動負債合計,金可-KY,生技醫療業
2019-03-31,8406,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,金可-KY,生技醫療業
2019-03-31,8406,OrdinaryShare,924505000.0,普通股股本,金可-KY,生技醫療業
2019-03-31,8406,OrdinaryShare_per,4.29,普通股股本,金可-KY,生技醫療業
2019-03-31,8406,OtherCurrentAssets,2566680000.0,其他流動資產,金可-KY,生技醫療業
2019-03-31,8406,OtherCurrentAssets_per,11.92,其他流動資產,金可-KY,生技醫療業
2019-03-31,8406,OtherCurrentLiabilities,516206000.0,其他流動負債,金可-KY,生技醫療業
2019-03-31,8406,OtherCurrentLiabilities_per,2.4,其他流動負債,金可-KY,生技醫療業
2019-03-31,8406,OtherEquityInterest,272147000.0,其他權益合計,金可-KY,生技醫療業
2019-03-31,8406,OtherEquityInterest_per,1.26,其他權益合計,金可-KY,生技醫療業
2019-03-31,8406,OtherNoncurrentAssets,377503000.0,其他非流動資產,金可-KY,生技醫療業
2019-03-31,8406,OtherNoncurrentAssets_per,1.75,其他非流動資產,金可-KY,生技醫療業
2019-03-31,8406,OtherPayables,412052000.0,其他應付款,金可-KY,生技醫療業
2019-03-31,8406,OtherPayables_per,1.91,其他應付款,金可-KY,生技醫療業
2019-03-31,8406,OtherReceivable,94302000.0,其他應收款淨額,金可-KY,生技醫療業
2019-03-31,8406,OtherReceivable_per,0.44,其他應收款淨額,金可-KY,生技醫療業
2019-03-31,8406,OtherReceivablesDueFromRelatedParties,5430000.0,其他應收款－關係人淨額,金可-KY,生技醫療業
2019-03-31,8406,OtherReceivablesDueFromRelatedParties_per,0.03,其他應收款－關係人淨額,金可-KY,生技醫療業
2019-03-31,8406,PropertyPlantAndEquipment,7742300000.0,不動產、廠房及設備,金可-KY,生技醫療業
2019-03-31,8406,PropertyPlantAndEquipment_per,35.95,不動產、廠房及設備,金可-KY,生技醫療業
2019-03-31,8406,RetainedEarnings,7153390000.0,保留盈餘合計,金可-KY,生技醫療業
2019-03-31,8406,RetainedEarnings_per,33.21,保留盈餘合計,金可-KY,生技醫療業
2019-03-31,8406,ShorttermBorrowings,6066400000.0,短期借款,金可-KY,生技醫療業
2019-03-31,8406,ShorttermBorrowings_per,28.17,短期借款,金可-KY,生技醫療業
2019-03-31,8406,TotalAssets,21536800000.0,資產總額,金可-KY,生技醫療業
2019-03-31,8406,TotalAssets_per,100.0,資產總額,金可-KY,生技醫療業
2019-03-31,8406,TotalLiabilitiesEquity,21536800000.0,負債及權益總計,金可-KY,生技醫療業
2019-03-31,8406,TotalLiabilitiesEquity_per,100.0,負債及權益總計,金可-KY,生技醫療業
2019-06-30,8406,AccountsPayable,368158000.0,應付帳款,金可-KY,生技醫療業
2019-06-30,8406,AccountsPayable_per,1.7,應付帳款,金可-KY,生技醫療業
2019-06-30,8406,AccountsPayableToRelatedParties,46679000.0,應付帳款－關係人,金可-KY,生技醫療業
2019-06-30,8406,AccountsPayableToRelatedParties_per,0.22,應付帳款－關係人,金可-KY,生技醫療業
2019-06-30,8406,AccountsReceivableDuefromRelatedPartiesNet,116104000.0,應收帳款－關係人淨額,金可-KY,生技醫療業
2019-06-30,8406,AccountsReceivableDuefromRelatedPartiesNet_per,0.54,應收帳款－關係人淨額,金可-KY,生技醫療業
2019-06-30,8406,AccountsReceivableNet,4139130000.0,應收帳款淨額,金可-KY,生技醫療業
2019-06-30,8406,AccountsReceivableNet_per,19.09,應收帳款淨額,金可-KY,生技醫療業
2019-06-30,8406,CapitalStock,924505000.0,股本合計,金可-KY,生技醫療業
2019-06-30,8406,CapitalStock_per,4.26,股本合計,金可-KY,生技醫療業
2019-06-30,8406,CapitalSurplus,3073230000.0,資本公積合計,金可-KY,生技醫療業
2019-06-30,8406,CapitalSurplus_per,14.18,資本公積合計,金可-KY,生技醫療業
2019-06-30,8406,CashAndCashEquivalents,2224910000.0,現金及約當現金,金可-KY,生技醫療業
2019-06-30,8406,CashAndCashEquivalents_per,10.26,現金及約當現金,金可-KY,生技醫療業
2019-06-30,8406,CurrentAssets,12879300000.0,流動資產合計,金可-KY,生技醫療業
2019-06-30,8406,CurrentAssets_per,59.41,流動資產合計,金可-KY,生技醫療業
2019-06-30,8406,CurrentIncomeTaxAssets,36101000.0,本期所得稅資產,金可-KY,生技醫療業
2019-06-30,8406,CurrentIncomeTaxAssets_per,0.17,本期所得稅資產,金可-KY,生技醫療業
2019-06-30,8406,CurrentLiabilities,8237730000.0,流動負債合計,金可-KY,生技醫療業
2019-06-30,8406,CurrentLiabilities_per,38.0,流動負債合計,金可-KY,生技醫療業
2019-06-30,8406,DeferredTaxAssets,159397000.0,遞延所得稅資產,金可-KY,生技醫療業
2019-06-30,8406,DeferredTaxAssets_per,0.74,遞延所得稅資產,金可-KY,生技醫療業
2019-06-30,8406,Equity,10531400000.0,權益總額,金可-KY,生技醫療業
2019-06-30,8406,Equity_per,48.58,權益總額,金可-KY,生技醫療業
2019-06-30,8406,EquityAttributableToOwnersOfParent,10550000000.0,歸屬於母公司業主之權益合計,金可-KY,生技醫療業
2019-06-30,8406,EquityAttributableToOwnersOfParent_per,48.66,歸屬於母公司業主之權益合計,金可-KY,生技醫療業
2019-06-30,8406,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,0.0,預收股款（權益項下）之約當發行股數,金可-KY,生技醫療業
2019-06-30,8406,IntangibleAssets,49087000.0,無形資產,金可-KY,生技醫療業
2019-06-30,8406,IntangibleAssets_per,0.23,無形資產,金可-KY,生技醫療業
2019-06-30,8406,Inventories,2489580000.0,存貨,金可-KY,生技醫療業
2019-06-30,8406,Inventories_per,11.48,存貨,金可-KY,生技醫療業
2019-06-30,8406,Liabilities,11148300000.0,負債總額,金可-KY,生技醫療業
2019-06-30,8406,Liabilities_per,51.0,負債總額,金可-KY,生技醫療業
2019-06-30,8406,LongtermBorrowings,2594000000.0,長期借款,金可-KY,生技醫療業
2019-06-30,8406,LongtermBorrowings_per,11.97,長期借款,金可-KY,生技醫療業
2019-06-30,8406,NoncontrollingInterests,18658000.0,非控制權益,金可-KY,生技醫療業
2019-06-30,8406,NoncontrollingInterests_per,0.09,非控制權益,金可-KY,生技醫療業
2019-06-30,8406,NoncurrentAssets,8800360000.0,非流動資產合計,金可-KY,生技醫療業
2019-06-30,8406,NoncurrentAssets_per,40.59,非流動資產合計,金可-KY,生技醫療業
2019-06-30,8406,NoncurrentLiabilities,2910620000.0,非流動負債合計,金可-KY,生技醫療業
2019-06-30,8406,NoncurrentLiabilities_per,13.43,非流動負債合計,金可-KY,生技醫療業
2019-06-30,8406,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,金可-KY,生技醫療業
2019-06-30,8406,OrdinaryShare,924505000.0,普通股股本,金可-KY,生技醫療業
2019-06-30,8406,OrdinaryShare_per,4.26,普通股股本,金可-KY,生技醫療業
2019-06-30,8406,OtherCurrentAssets,3267240000.0,其他流動資產,金可-KY,生技醫療業
2019-06-30,8406,OtherCurrentAssets_per,15.07,其他流動資產,金可-KY,生技醫療業
2019-06-30,8406,OtherCurrentLiabilities,440643000.0,其他流動負債,金可-KY,生技醫療業
2019-06-30,8406,OtherCurrentLiabilities_per,2.03,其他流動負債,金可-KY,生技醫療業
2019-06-30,8406,OtherEquityInterest,409946000.0,其他權益合計,金可-KY,生技醫療業
2019-06-30,8406,OtherEquityInterest_per,1.89,其他權益合計,金可-KY,生技醫療業
2019-06-30,8406,OtherNoncurrentAssets,228951000.0,其他非流動資產,金可-KY,生技醫療業
2019-06-30,8406,OtherNoncurrentAssets_per,1.06,其他非流動資產,金可-KY,生技醫療業
2019-06-30,8406,OtherPayables,951973000.0,其他應付款,金可-KY,生技醫療業
2019-06-30,8406,OtherPayables_per,4.39,其他應付款,金可-KY,生技醫療業
2019-06-30,8406,OtherReceivable,64196000.0,其他應收款淨額,金可-KY,生技醫療業
2019-06-30,8406,OtherReceivable_per,0.3,其他應收款淨額,金可-KY,生技醫療業
2019-06-30,8406,OtherReceivablesDueFromRelatedParties,826000.0,其他應收款－關係人淨額,金可-KY,生技醫療業
2019-06-30,8406,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,金可-KY,生技醫療業
2019-06-30,8406,PropertyPlantAndEquipment,7925340000.0,不動產、廠房及設備,金可-KY,生技醫療業
2019-06-30,8406,PropertyPlantAndEquipment_per,36.56,不動產、廠房及設備,金可-KY,生技醫療業
2019-06-30,8406,RetainedEarnings,6962230000.0,保留盈餘合計,金可-KY,生技醫療業
2019-06-30,8406,RetainedEarnings_per,32.11,保留盈餘合計,金可-KY,生技醫療業
2019-06-30,8406,ShorttermBorrowings,6209780000.0,短期借款,金可-KY,生技醫療業
2019-06-30,8406,ShorttermBorrowings_per,28.64,短期借款,金可-KY,生技醫療業
2019-06-30,8406,TotalAssets,21679700000.0,資產總額,金可-KY,生技醫療業
2019-06-30,8406,TotalAssets_per,100.0,資產總額,金可-KY,生技醫療業
2019-06-30,8406,TotalLiabilitiesEquity,21679700000.0,負債及權益總計,金可-KY,生技醫療業
2019-06-30,8406,TotalLiabilitiesEquity_per,100.0,負債及權益總計,金可-KY,生技醫療業
2019-09-30,8406,AccountsPayable,396616000.0,應付帳款,金可-KY,生技醫療業
2019-09-30,8406,AccountsPayable_per,1.77,應付帳款,金可-KY,生技醫療業
2019-09-30,8406,AccountsPayableToRelatedParties,51536000.0,應付帳款－關係人,金可-KY,生技醫療業
2019-09-30,8406,AccountsPayableToRelatedParties_per,0.23,應付帳款－關係人,金可-KY,生技醫療業
2019-09-30,8406,AccountsReceivableDuefromRelatedPartiesNet,179620000.0,應收帳款－關係人淨額,金可-KY,生技醫療業
2019-09-30,8406,AccountsReceivableDuefromRelatedPartiesNet_per,0.8,應收帳款－關係人淨額,金可-KY,生技醫療業
2019-09-30,8406,AccountsReceivableNet,3936210000.0,應收帳款淨額,金可-KY,生技醫療業
2019-09-30,8406,AccountsReceivableNet_per,17.54,應收帳款淨額,金可-KY,生技醫療業
2019-09-30,8406,CapitalStock,924505000.0,股本合計,金可-KY,生技醫療業
2019-09-30,8406,CapitalStock_per,4.12,股本合計,金可-KY,生技醫療業
2019-09-30,8406,CapitalSurplus,3073230000.0,資本公積合計,金可-KY,生技醫療業
2019-09-30,8406,CapitalSurplus_per,13.69,資本公積合計,金可-KY,生技醫療業
2019-09-30,8406,CashAndCashEquivalents,2112650000.0,現金及約當現金,金可-KY,生技醫療業
2019-09-30,8406,CashAndCashEquivalents_per,9.41,現金及約當現金,金可-KY,生技醫療業
2019-09-30,8406,CurrentAssets,13342700000.0,流動資產合計,金可-KY,生技醫療業
2019-09-30,8406,CurrentAssets_per,59.46,流動資產合計,金可-KY,生技醫療業
2019-09-30,8406,CurrentIncomeTaxAssets,171000.0,本期所得稅資產,金可-KY,生技醫療業
2019-09-30,8406,CurrentIncomeTaxAssets_per,0.0,本期所得稅資產,金可-KY,生技醫療業
2019-09-30,8406,CurrentLiabilities,8056110000.0,流動負債合計,金可-KY,生技醫療業
2019-09-30,8406,CurrentLiabilities_per,35.9,流動負債合計,金可-KY,生技醫療業
2019-09-30,8406,CurrentProvisions,0.0,負債準備－流動,金可-KY,生技醫療業
2019-09-30,8406,CurrentProvisions_per,0.0,負債準備－流動,金可-KY,生技醫療業
2019-09-30,8406,DeferredTaxAssets,144653000.0,遞延所得稅資產,金可-KY,生技醫療業
2019-09-30,8406,DeferredTaxAssets_per,0.64,遞延所得稅資產,金可-KY,生技醫療業
2019-09-30,8406,Equity,10431700000.0,權益總額,金可-KY,生技醫療業
2019-09-30,8406,Equity_per,46.48,權益總額,金可-KY,生技醫療業
2019-09-30,8406,EquityAttributableToOwnersOfParent,10449400000.0,歸屬於母公司業主之權益合計,金可-KY,生技醫療業
2019-09-30,8406,EquityAttributableToOwnersOfParent_per,46.56,歸屬於母公司業主之權益合計,金可-KY,生技醫療業
2019-09-30,8406,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,0.0,預收股款（權益項下）之約當發行股數,金可-KY,生技醫療業
2019-09-30,8406,IntangibleAssets,45203000.0,無形資產,金可-KY,生技醫療業
2019-09-30,8406,IntangibleAssets_per,0.2,無形資產,金可-KY,生技醫療業
2019-09-30,8406,Inventories,2509880000.0,存貨,金可-KY,生技醫療業
2019-09-30,8406,Inventories_per,11.18,存貨,金可-KY,生技醫療業
2019-09-30,8406,Liabilities,12009400000.0,負債總額,金可-KY,生技醫療業
2019-09-30,8406,Liabilities_per,54.0,負債總額,金可-KY,生技醫療業
2019-09-30,8406,LongtermBorrowings,3623600000.0,長期借款,金可-KY,生技醫療業
2019-09-30,8406,LongtermBorrowings_per,16.15,長期借款,金可-KY,生技醫療業
2019-09-30,8406,NoncontrollingInterests,17722000.0,非控制權益,金可-KY,生技醫療業
2019-09-30,8406,NoncontrollingInterests_per,0.08,非控制權益,金可-KY,生技醫療業
2019-09-30,8406,NoncurrentAssets,9098440000.0,非流動資產合計,金可-KY,生技醫療業
2019-09-30,8406,NoncurrentAssets_per,40.54,非流動資產合計,金可-KY,生技醫療業
2019-09-30,8406,NoncurrentLiabilities,3953300000.0,非流動負債合計,金可-KY,生技醫療業
2019-09-30,8406,NoncurrentLiabilities_per,17.62,非流動負債合計,金可-KY,生技醫療業
2019-09-30,8406,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,金可-KY,生技醫療業
2019-09-30,8406,OrdinaryShare,924505000.0,普通股股本,金可-KY,生技醫療業
2019-09-30,8406,OrdinaryShare_per,4.12,普通股股本,金可-KY,生技醫療業
2019-09-30,8406,OtherCurrentAssets,3946470000.0,其他流動資產,金可-KY,生技醫療業
2019-09-30,8406,OtherCurrentAssets_per,17.59,其他流動資產,金可-KY,生技醫療業
2019-09-30,8406,OtherCurrentLiabilities,148071000.0,其他流動負債,金可-KY,生技醫療業
2019-09-30,8406,OtherCurrentLiabilities_per,0.66,其他流動負債,金可-KY,生技醫療業
2019-09-30,8406,OtherEquityInterest,854862000.0,其他權益合計,金可-KY,生技醫療業
2019-09-30,8406,OtherEquityInterest_per,3.81,其他權益合計,金可-KY,生技醫療業
2019-09-30,8406,OtherNoncurrentAssets,249084000.0,其他非流動資產,金可-KY,生技醫療業
2019-09-30,8406,OtherNoncurrentAssets_per,1.11,其他非流動資產,金可-KY,生技醫療業
2019-09-30,8406,OtherPayables,653642000.0,其他應付款,金可-KY,生技醫療業
2019-09-30,8406,OtherPayables_per,2.91,其他應付款,金可-KY,生技醫療業
2019-09-30,8406,OtherReceivable,60801000.0,其他應收款淨額,金可-KY,生技醫療業
2019-09-30,8406,OtherReceivable_per,0.27,其他應收款淨額,金可-KY,生技醫療業
2019-09-30,8406,OtherReceivablesDueFromRelatedParties,808000.0,其他應收款－關係人淨額,金可-KY,生技醫療業
2019-09-30,8406,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,金可-KY,生技醫療業
2019-09-30,8406,PropertyPlantAndEquipment,8236620000.0,不動產、廠房及設備,金可-KY,生技醫療業
2019-09-30,8406,PropertyPlantAndEquipment_per,36.7,不動產、廠房及設備,金可-KY,生技醫療業
2019-09-30,8406,RetainedEarnings,7306560000.0,保留盈餘合計,金可-KY,生技醫療業
2019-09-30,8406,RetainedEarnings_per,32.56,保留盈餘合計,金可-KY,生技醫療業
2019-09-30,8406,ShorttermBorrowings,6629220000.0,短期借款,金可-KY,生技醫療業
2019-09-30,8406,ShorttermBorrowings_per,29.54,短期借款,金可-KY,生技醫療業
2019-09-30,8406,TotalAssets,22441100000.0,資產總額,金可-KY,生技醫療業
2019-09-30,8406,TotalAssets_per,100.0,資產總額,金可-KY,生技醫療業
2019-09-30,8406,TotalLiabilitiesEquity,22441100000.0,負債及權益總計,金可-KY,生技醫療業
2019-09-30,8406,TotalLiabilitiesEquity_per,100.0,負債及權益總計,金可-KY,生技醫療業
2019-12-31,8406,AccountsPayable,442824000.0,應付帳款,金可-KY,生技醫療業
2019-12-31,8406,AccountsPayable_per,1.99,應付帳款,金可-KY,生技醫療業
2019-12-31,8406,AccountsPayableToRelatedParties,64370000.0,應付帳款－關係人,金可-KY,生技醫療業
2019-12-31,8406,AccountsPayableToRelatedParties_per,0.29,應付帳款－關係人,金可-KY,生技醫療業
2019-12-31,8406,AccountsReceivableDuefromRelatedPartiesNet,169574000.0,應收帳款－關係人淨額,金可-KY,生技醫療業
2019-12-31,8406,AccountsReceivableDuefromRelatedPartiesNet_per,0.76,應收帳款－關係人淨額,金可-KY,生技醫療業
2019-12-31,8406,AccountsReceivableNet,3809500000.0,應收帳款淨額,金可-KY,生技醫療業
2019-12-31,8406,AccountsReceivableNet_per,17.13,應收帳款淨額,金可-KY,生技醫療業
2019-12-31,8406,CapitalStock,924505000.0,股本合計,金可-KY,生技醫療業
2019-12-31,8406,CapitalStock_per,4.16,股本合計,金可-KY,生技醫療業
2019-12-31,8406,CapitalSurplus_per,13.82,資本公積合計,金可-KY,生技醫療業
2019-12-31,8406,CashAndCashEquivalents_per,10.56,現金及約當現金,金可-KY,生技醫療業
2019-12-31,8406,CurrentAssets_per,59.17,流動資產合計,金可-KY,生技醫療業
2019-12-31,8406,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,金可-KY,生技醫療業
2019-12-31,8406,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,金可-KY,生技醫療業
2019-12-31,8406,CurrentIncomeTaxAssets,0.0,本期所得稅資產,金可-KY,生技醫療業
2019-12-31,8406,CurrentIncomeTaxAssets_per,0.0,本期所得稅資產,金可-KY,生技醫療業
2019-12-31,8406,CurrentLiabilities_per,35.06,流動負債合計,金可-KY,生技醫療業
2019-12-31,8406,CurrentProvisions,0.0,負債準備－流動,金可-KY,生技醫療業
2019-12-31,8406,CurrentProvisions_per,0.0,負債準備－流動,金可-KY,生技醫療業
2019-12-31,8406,DeferredTaxAssets,133157000.0,遞延所得稅資產,金可-KY,生技醫療業
2019-12-31,8406,DeferredTaxAssets_per,0.6,遞延所得稅資產,金可-KY,生技醫療業
2019-12-31,8406,Equity_per,48.28,權益總額,金可-KY,生技醫療業
2019-12-31,8406,EquityAttributableToOwnersOfParent_per,48.35,歸屬於母公司業主之權益合計,金可-KY,生技醫療業
2019-12-31,8406,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,0.0,預收股款（權益項下）之約當發行股數,金可-KY,生技醫療業
2019-12-31,8406,IntangibleAssets,43216000.0,無形資產,金可-KY,生技醫療業
2019-12-31,8406,IntangibleAssets_per,0.19,無形資產,金可-KY,生技醫療業
2019-12-31,8406,Inventories_per,10.89,存貨,金可-KY,生技醫療業
2019-12-31,8406,Liabilities,11505700000.0,負債總額,金可-KY,生技醫療業
2019-12-31,8406,Liabilities_per,52.0,負債總額,金可-KY,生技醫療業
2019-12-31,8406,LongtermBorrowings,3391600000.0,長期借款,金可-KY,生技醫療業
2019-12-31,8406,LongtermBorrowings_per,15.25,長期借款,金可-KY,生技醫療業
2019-12-31,8406,NoncontrollingInterests,16639000.0,非控制權益,金可-KY,生技醫療業
2019-12-31,8406,NoncontrollingInterests_per,0.07,非控制權益,金可-KY,生技醫療業
2019-12-31,8406,NoncurrentAssets_per,40.83,非流動資產合計,金可-KY,生技醫療業
2019-12-31,8406,NoncurrentLiabilities_per,16.67,非流動負債合計,金可-KY,生技醫療業
2019-12-31,8406,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,金可-KY,生技醫療業
2019-12-31,8406,OrdinaryShare,924505000.0,普通股股本,金可-KY,生技醫療業
2019-12-31,8406,OrdinaryShare_per,4.16,普通股股本,金可-KY,生技醫療業
2019-12-31,8406,OtherCurrentAssets_per,17.44,其他流動資產,金可-KY,生技醫療業
2019-12-31,8406,OtherCurrentLiabilities,204603000.0,其他流動負債,金可-KY,生技醫療業
2019-12-31,8406,OtherCurrentLiabilities_per,0.92,其他流動負債,金可-KY,生技醫療業
2019-12-31,8406,OtherEquityInterest,960598000.0,其他權益合計,金可-KY,生技醫療業
2019-12-31,8406,OtherEquityInterest_per,4.32,其他權益合計,金可-KY,生技醫療業
2019-12-31,8406,OtherNoncurrentAssets,212717000.0,其他非流動資產,金可-KY,生技醫療業
2019-12-31,8406,OtherNoncurrentAssets_per,0.96,其他非流動資產,金可-KY,生技醫療業
2019-12-31,8406,OtherPayables,620120000.0,其他應付款,金可-KY,生技醫療業
2019-12-31,8406,OtherPayables_per,2.79,其他應付款,金可-KY,生技醫療業
2019-12-31,8406,OtherReceivable_per,0.31,其他應收款淨額,金可-KY,生技醫療業
2019-12-31,8406,OtherReceivablesDueFromRelatedParties,799000.0,其他應收款－關係人淨額,金可-KY,生技醫療業
2019-12-31,8406,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,金可-KY,生技醫療業
2019-12-31,8406,PropertyPlantAndEquipment_per,37.15,不動產、廠房及設備,金可-KY,生技醫療業
2019-12-31,8406,RetainedEarnings_per,34.7,保留盈餘合計,金可-KY,生技醫療業
2019-12-31,8406,ShorttermBorrowings_per,27.25,短期借款,金可-KY,生技醫療業
2019-12-31,8406,TotalAssets_per,100.0,資產總額,金可-KY,生技醫療業
2019-12-31,8406,TotalLiabilitiesEquity_per,100.0,負債及權益總計,金可-KY,生技醫療業
2019-12-31,8406,CashAndCashEquivalents,2349467000.0,現金及約當現金,金可-KY,生技醫療業
2019-12-31,8406,Inventories,2422528000.0,存貨,金可-KY,生技醫療業
2019-12-31,8406,OtherCurrentAssets,3879338000.0,其他流動資產,金可-KY,生技醫療業
2019-12-31,8406,CurrentAssets,13161204000.0,流動資產合計,金可-KY,生技醫療業
2019-12-31,8406,PropertyPlantAndEquipment,8263435000.0,不動產、廠房及設備,金可-KY,生技醫療業
2019-12-31,8406,NoncurrentAssets,9083153000.0,非流動資產合計,金可-KY,生技醫療業
2019-12-31,8406,TotalAssets,22244357000.0,資產總額,金可-KY,生技醫療業
2019-12-31,8406,ShorttermBorrowings,6061008000.0,短期借款,金可-KY,生技醫療業
2019-12-31,8406,CurrentLiabilities,7798276000.0,流動負債合計,金可-KY,生技醫療業
2019-12-31,8406,NoncurrentLiabilities,3707461000.0,非流動負債合計,金可-KY,生技醫療業
2019-12-31,8406,CapitalSurplus,3073227000.0,資本公積合計,金可-KY,生技醫療業
2019-12-31,8406,RetainedEarnings,7718125000.0,保留盈餘合計,金可-KY,生技醫療業
2019-12-31,8406,EquityAttributableToOwnersOfParent,10755259000.0,歸屬於母公司業主之權益合計,金可-KY,生技醫療業
2019-12-31,8406,Equity,10738620000.0,權益總額,金可-KY,生技醫療業
2019-12-31,8406,TotalLiabilitiesEquity,22244357000.0,負債及權益總計,金可-KY,生技醫療業
2019-12-31,8406,OtherReceivable,69141000.0,其他應收款淨額,金可-KY,生技醫療業
2020-03-31,8406,AccountsPayable,517148000.0,應付帳款,金可-KY,生技醫療業
2020-03-31,8406,AccountsPayable_per,2.32,應付帳款,金可-KY,生技醫療業
2020-03-31,8406,AccountsPayableToRelatedParties,59899000.0,應付帳款－關係人,金可-KY,生技醫療業
2020-03-31,8406,AccountsPayableToRelatedParties_per,0.27,應付帳款－關係人,金可-KY,生技醫療業
2020-03-31,8406,AccountsReceivableDuefromRelatedPartiesNet,146244000.0,應收帳款－關係人淨額,金可-KY,生技醫療業
2020-03-31,8406,AccountsReceivableDuefromRelatedPartiesNet_per,0.66,應收帳款－關係人淨額,金可-KY,生技醫療業
2020-03-31,8406,AccountsReceivableNet_per,17.79,應收帳款淨額,金可-KY,生技醫療業
2020-03-31,8406,CapitalStock,924505000.0,股本合計,金可-KY,生技醫療業
2020-03-31,8406,CapitalStock_per,4.15,股本合計,金可-KY,生技醫療業
2020-03-31,8406,CapitalSurplus_per,13.81,資本公積合計,金可-KY,生技醫療業
2020-03-31,8406,CashAndCashEquivalents_per,9.84,現金及約當現金,金可-KY,生技醫療業
2020-03-31,8406,CurrentAssets_per,59.88,流動資產合計,金可-KY,生技醫療業
2020-03-31,8406,CurrentLiabilities_per,33.8,流動負債合計,金可-KY,生技醫療業
2020-03-31,8406,DeferredTaxAssets,154171000.0,遞延所得稅資產,金可-KY,生技醫療業
2020-03-31,8406,DeferredTaxAssets_per,0.69,遞延所得稅資產,金可-KY,生技醫療業
2020-03-31,8406,Equity_per,48.08,權益總額,金可-KY,生技醫療業
2020-03-31,8406,EquityAttributableToOwnersOfParent_per,48.15,歸屬於母公司業主之權益合計,金可-KY,生技醫療業
2020-03-31,8406,IntangibleAssets,41665000.0,無形資產,金可-KY,生技醫療業
2020-03-31,8406,IntangibleAssets_per,0.19,無形資產,金可-KY,生技醫療業
2020-03-31,8406,Inventories,2700960000.0,存貨,金可-KY,生技醫療業
2020-03-31,8406,Inventories_per,12.13,存貨,金可-KY,生技醫療業
2020-03-31,8406,LongtermBorrowings,3736600000.0,長期借款,金可-KY,生技醫療業
2020-03-31,8406,LongtermBorrowings_per,16.79,長期借款,金可-KY,生技醫療業
2020-03-31,8406,NoncontrollingInterests,13820000.0,非控制權益,金可-KY,生技醫療業
2020-03-31,8406,NoncontrollingInterests_per,0.06,非控制權益,金可-KY,生技醫療業
2020-03-31,8406,NoncurrentAssets_per,40.12,非流動資產合計,金可-KY,生技醫療業
2020-03-31,8406,NoncurrentLiabilities_per,18.11,非流動負債合計,金可-KY,生技醫療業
2020-03-31,8406,OrdinaryShare,924505000.0,普通股股本,金可-KY,生技醫療業
2020-03-31,8406,OrdinaryShare_per,4.15,普通股股本,金可-KY,生技醫療業
2020-03-31,8406,OtherCurrentAssets_per,16.93,其他流動資產,金可-KY,生技醫療業
2020-03-31,8406,OtherCurrentLiabilities,62880000.0,其他流動負債,金可-KY,生技醫療業
2020-03-31,8406,OtherCurrentLiabilities_per,0.28,其他流動負債,金可-KY,生技醫療業
2020-03-31,8406,OtherEquityInterest_per,4.76,其他權益合計,金可-KY,生技醫療業
2020-03-31,8406,OtherNoncurrentAssets,90555000.0,其他非流動資產,金可-KY,生技醫療業
2020-03-31,8406,OtherNoncurrentAssets_per,0.41,其他非流動資產,金可-KY,生技醫療業
2020-03-31,8406,OtherPayables,468324000.0,其他應付款,金可-KY,生技醫療業
2020-03-31,8406,OtherPayables_per,2.1,其他應付款,金可-KY,生技醫療業
2020-03-31,8406,OtherReceivable_per,0.13,其他應收款淨額,金可-KY,生技醫療業
2020-03-31,8406,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,金可-KY,生技醫療業
2020-03-31,8406,PropertyPlantAndEquipment_per,36.97,不動產、廠房及設備,金可-KY,生技醫療業
2020-03-31,8406,RetainedEarnings_per,34.94,保留盈餘合計,金可-KY,生技醫療業
2020-03-31,8406,ShorttermBorrowings_per,26.93,短期借款,金可-KY,生技醫療業
2020-03-31,8406,TotalAssets_per,100.0,資產總額,金可-KY,生技醫療業
2020-03-31,8406,TotalLiabilitiesEquity_per,100.0,負債及權益總計,金可-KY,生技醫療業
2020-03-31,8406,CashAndCashEquivalents,2191399000.0,現金及約當現金,金可-KY,生技醫療業
2020-03-31,8406,AccountsReceivableNet,3960694000.0,應收帳款淨額,金可-KY,生技醫療業
2020-03-31,8406,OtherReceivablesDueFromRelatedParties,0.0,其他應收款－關係人淨額,金可-KY,生技醫療業
2020-03-31,8406,OtherCurrentAssets,3768283000.0,其他流動資產,金可-KY,生技醫療業
2020-03-31,8406,CurrentAssets,13329138000.0,流動資產合計,金可-KY,生技醫療業
2020-03-31,8406,PropertyPlantAndEquipment,8228949000.0,不動產、廠房及設備,金可-KY,生技醫療業
2020-03-31,8406,NoncurrentAssets,8931426000.0,非流動資產合計,金可-KY,生技醫療業
2020-03-31,8406,TotalAssets,22260564000.0,資產總額,金可-KY,生技醫療業
2020-03-31,8406,ShorttermBorrowings,5995739000.0,短期借款,金可-KY,生技醫療業
2020-03-31,8406,CurrentLiabilities,7524737000.0,流動負債合計,金可-KY,生技醫療業
2020-03-31,8406,NoncurrentLiabilities,4032119000.0,非流動負債合計,金可-KY,生技醫療業
2020-03-31,8406,CapitalSurplus,3073227000.0,資本公積合計,金可-KY,生技醫療業
2020-03-31,8406,RetainedEarnings,7778813000.0,保留盈餘合計,金可-KY,生技醫療業
2020-03-31,8406,OtherEquityInterest,1059017000.0,其他權益合計,金可-KY,生技醫療業
2020-03-31,8406,EquityAttributableToOwnersOfParent,10717528000.0,歸屬於母公司業主之權益合計,金可-KY,生技醫療業
2020-03-31,8406,Equity,10703708000.0,權益總額,金可-KY,生技醫療業
2020-03-31,8406,TotalLiabilitiesEquity,22260564000.0,負債及權益總計,金可-KY,生技醫療業
2020-03-31,8406,OtherReceivable,29415000.0,其他應收款淨額,金可-KY,生技醫療業
2020-06-30,8406,AccountsPayable,466275000.0,應付帳款,金可-KY,生技醫療業
2020-06-30,8406,AccountsPayable_per,2.19,應付帳款,金可-KY,生技醫療業
2020-06-30,8406,AccountsPayableToRelatedParties,64871000.0,應付帳款－關係人,金可-KY,生技醫療業
2020-06-30,8406,AccountsPayableToRelatedParties_per,0.31,應付帳款－關係人,金可-KY,生技醫療業
2020-06-30,8406,AccountsReceivableDuefromRelatedPartiesNet,112996000.0,應收帳款－關係人淨額,金可-KY,生技醫療業
2020-06-30,8406,AccountsReceivableDuefromRelatedPartiesNet_per,0.53,應收帳款－關係人淨額,金可-KY,生技醫療業
2020-06-30,8406,AccountsReceivableNet_per,17.61,應收帳款淨額,金可-KY,生技醫療業
2020-06-30,8406,CapitalStock,970730000.0,股本合計,金可-KY,生技醫療業
2020-06-30,8406,CapitalStock_per,4.56,股本合計,金可-KY,生技醫療業
2020-06-30,8406,CapitalSurplus_per,14.45,資本公積合計,金可-KY,生技醫療業
2020-06-30,8406,CashAndCashEquivalents_per,7.86,現金及約當現金,金可-KY,生技醫療業
2020-06-30,8406,CurrentAssets_per,58.19,流動資產合計,金可-KY,生技醫療業
2020-06-30,8406,CurrentIncomeTaxAssets,4557000.0,本期所得稅資產,金可-KY,生技醫療業
2020-06-30,8406,CurrentIncomeTaxAssets_per,0.02,本期所得稅資產,金可-KY,生技醫療業
2020-06-30,8406,CurrentLiabilities_per,30.1,流動負債合計,金可-KY,生技醫療業
2020-06-30,8406,DeferredTaxAssets,167273000.0,遞延所得稅資產,金可-KY,生技醫療業
2020-06-30,8406,DeferredTaxAssets_per,0.79,遞延所得稅資產,金可-KY,生技醫療業
2020-06-30,8406,Equity_per,49.14,權益總額,金可-KY,生技醫療業
2020-06-30,8406,EquityAttributableToOwnersOfParent_per,49.21,歸屬於母公司業主之權益合計,金可-KY,生技醫療業
2020-06-30,8406,IntangibleAssets,39834000.0,無形資產,金可-KY,生技醫療業
2020-06-30,8406,IntangibleAssets_per,0.19,無形資產,金可-KY,生技醫療業
2020-06-30,8406,Inventories_per,13.05,存貨,金可-KY,生技醫療業
2020-06-30,8406,LongtermBorrowings,4136600000.0,長期借款,金可-KY,生技醫療業
2020-06-30,8406,LongtermBorrowings_per,19.45,長期借款,金可-KY,生技醫療業
2020-06-30,8406,NoncontrollingInterests,14132000.0,非控制權益,金可-KY,生技醫療業
2020-06-30,8406,NoncontrollingInterests_per,0.07,非控制權益,金可-KY,生技醫療業
2020-06-30,8406,NoncurrentAssets_per,41.81,非流動資產合計,金可-KY,生技醫療業
2020-06-30,8406,NoncurrentLiabilities_per,20.76,非流動負債合計,金可-KY,生技醫療業
2020-06-30,8406,OrdinaryShare,924505000.0,普通股股本,金可-KY,生技醫療業
2020-06-30,8406,OrdinaryShare_per,4.35,普通股股本,金可-KY,生技醫療業
2020-06-30,8406,OtherCurrentAssets_per,16.22,其他流動資產,金可-KY,生技醫療業
2020-06-30,8406,OtherCurrentLiabilities,63455000.0,其他流動負債,金可-KY,生技醫療業
2020-06-30,8406,OtherCurrentLiabilities_per,0.3,其他流動負債,金可-KY,生技醫療業
2020-06-30,8406,OtherEquityInterest_per,5.8,其他權益合計,金可-KY,生技醫療業
2020-06-30,8406,OtherNoncurrentAssets,131990000.0,其他非流動資產,金可-KY,生技醫療業
2020-06-30,8406,OtherNoncurrentAssets_per,0.62,其他非流動資產,金可-KY,生技醫療業
2020-06-30,8406,OtherPayables,747956000.0,其他應付款,金可-KY,生技醫療業
2020-06-30,8406,OtherPayables_per,3.52,其他應付款,金可-KY,生技醫療業
2020-06-30,8406,OtherReceivable,33039000.0,其他應收款淨額,金可-KY,生技醫療業
2020-06-30,8406,OtherReceivable_per,0.16,其他應收款淨額,金可-KY,生技醫療業
2020-06-30,8406,PropertyPlantAndEquipment_per,38.28,不動產、廠房及設備,金可-KY,生技醫療業
2020-06-30,8406,RetainedEarnings_per,36.0,保留盈餘合計,金可-KY,生技醫療業
2020-06-30,8406,ShorttermBorrowings_per,22.17,短期借款,金可-KY,生技醫療業
2020-06-30,8406,TotalAssets_per,100.0,資產總額,金可-KY,生技醫療業
2020-06-30,8406,TotalLiabilitiesEquity_per,100.0,負債及權益總計,金可-KY,生技醫療業
2020-06-30,8406,CashAndCashEquivalents,1672185000.0,現金及約當現金,金可-KY,生技醫療業
2020-06-30,8406,AccountsReceivableNet,3744628000.0,應收帳款淨額,金可-KY,生技醫療業
2020-06-30,8406,Inventories,2774671000.0,存貨,金可-KY,生技醫療業
2020-06-30,8406,OtherCurrentAssets,3449409000.0,其他流動資產,金可-KY,生技醫療業
2020-06-30,8406,CurrentAssets,12377097000.0,流動資產合計,金可-KY,生技醫療業
2020-06-30,8406,PropertyPlantAndEquipment,8142334000.0,不動產、廠房及設備,金可-KY,生技醫療業
2020-06-30,8406,NoncurrentAssets,8892075000.0,非流動資產合計,金可-KY,生技醫療業
2020-06-30,8406,TotalAssets,21269172000.0,資產總額,金可-KY,生技醫療業
2020-06-30,8406,ShorttermBorrowings,4714506000.0,短期借款,金可-KY,生技醫療業
2020-06-30,8406,CurrentLiabilities,6401079000.0,流動負債合計,金可-KY,生技醫療業
2020-06-30,8406,NoncurrentLiabilities,4416213000.0,非流動負債合計,金可-KY,生技醫療業
2020-06-30,8406,CapitalSurplus,3073227000.0,資本公積合計,金可-KY,生技醫療業
2020-06-30,8406,RetainedEarnings,7656251000.0,保留盈餘合計,金可-KY,生技醫療業
2020-06-30,8406,OtherEquityInterest,1234196000.0,其他權益合計,金可-KY,生技醫療業
2020-06-30,8406,EquityAttributableToOwnersOfParent,10466012000.0,歸屬於母公司業主之權益合計,金可-KY,生技醫療業
2020-06-30,8406,Equity,10451880000.0,權益總額,金可-KY,生技醫療業
2020-06-30,8406,TotalLiabilitiesEquity,21269172000.0,負債及權益總計,金可-KY,生技醫療業
2020-09-30,8406,AccountsPayable,406457000.0,應付帳款,金可-KY,生技醫療業
2020-09-30,8406,AccountsPayable_per,1.89,應付帳款,金可-KY,生技醫療業
2020-09-30,8406,AccountsPayableToRelatedParties,61979000.0,應付帳款－關係人,金可-KY,生技醫療業
2020-09-30,8406,AccountsPayableToRelatedParties_per,0.29,應付帳款－關係人,金可-KY,生技醫療業
2020-09-30,8406,AccountsReceivableDuefromRelatedPartiesNet,122734000.0,應收帳款－關係人淨額,金可-KY,生技醫療業
2020-09-30,8406,AccountsReceivableDuefromRelatedPartiesNet_per,0.57,應收帳款－關係人淨額,金可-KY,生技醫療業
2020-09-30,8406,AccountsReceivableNet_per,17.27,應收帳款淨額,金可-KY,生技醫療業
2020-09-30,8406,CapitalStock,970730000.0,股本合計,金可-KY,生技醫療業
2020-09-30,8406,CapitalStock_per,4.51,股本合計,金可-KY,生技醫療業
2020-09-30,8406,CapitalSurplus_per,14.29,資本公積合計,金可-KY,生技醫療業
2020-09-30,8406,CashAndCashEquivalents_per,10.24,現金及約當現金,金可-KY,生技醫療業
2020-09-30,8406,CurrentAssets_per,59.28,流動資產合計,金可-KY,生技醫療業
2020-09-30,8406,CurrentIncomeTaxAssets,1016000.0,本期所得稅資產,金可-KY,生技醫療業
2020-09-30,8406,CurrentIncomeTaxAssets_per,0.0,本期所得稅資產,金可-KY,生技醫療業
2020-09-30,8406,CurrentLiabilities_per,28.96,流動負債合計,金可-KY,生技醫療業
2020-09-30,8406,DeferredTaxAssets,148527000.0,遞延所得稅資產,金可-KY,生技醫療業
2020-09-30,8406,DeferredTaxAssets_per,0.69,遞延所得稅資產,金可-KY,生技醫療業
2020-09-30,8406,Equity_per,50.89,權益總額,金可-KY,生技醫療業
2020-09-30,8406,EquityAttributableToOwnersOfParent_per,50.95,歸屬於母公司業主之權益合計,金可-KY,生技醫療業
2020-09-30,8406,IntangibleAssets,39005000.0,無形資產,金可-KY,生技醫療業
2020-09-30,8406,IntangibleAssets_per,0.18,無形資產,金可-KY,生技醫療業
2020-09-30,8406,Inventories_per,13.38,存貨,金可-KY,生技醫療業
2020-09-30,8406,LongtermBorrowings,4061600000.0,長期借款,金可-KY,生技醫療業
2020-09-30,8406,LongtermBorrowings_per,18.88,長期借款,金可-KY,生技醫療業
2020-09-30,8406,NoncontrollingInterests,13296000.0,非控制權益,金可-KY,生技醫療業
2020-09-30,8406,NoncontrollingInterests_per,0.06,非控制權益,金可-KY,生技醫療業
2020-09-30,8406,NoncurrentAssets_per,40.72,非流動資產合計,金可-KY,生技醫療業
2020-09-30,8406,NoncurrentLiabilities_per,20.15,非流動負債合計,金可-KY,生技醫療業
2020-09-30,8406,OrdinaryShare,970730000.0,普通股股本,金可-KY,生技醫療業
2020-09-30,8406,OrdinaryShare_per,4.51,普通股股本,金可-KY,生技醫療業
2020-09-30,8406,OtherCurrentAssets_per,15.18,其他流動資產,金可-KY,生技醫療業
2020-09-30,8406,OtherCurrentLiabilities,157349000.0,其他流動負債,金可-KY,生技醫療業
2020-09-30,8406,OtherCurrentLiabilities_per,0.73,其他流動負債,金可-KY,生技醫療業
2020-09-30,8406,OtherEquityInterest_per,5.17,其他權益合計,金可-KY,生技醫療業
2020-09-30,8406,OtherNoncurrentAssets,176731000.0,其他非流動資產,金可-KY,生技醫療業
2020-09-30,8406,OtherNoncurrentAssets_per,0.82,其他非流動資產,金可-KY,生技醫療業
2020-09-30,8406,OtherPayables,463844000.0,其他應付款,金可-KY,生技醫療業
2020-09-30,8406,OtherPayables_per,2.16,其他應付款,金可-KY,生技醫療業
2020-09-30,8406,OtherReceivable,44083000.0,其他應收款淨額,金可-KY,生技醫療業
2020-09-30,8406,OtherReceivable_per,0.2,其他應收款淨額,金可-KY,生技醫療業
2020-09-30,8406,PropertyPlantAndEquipment_per,37.16,不動產、廠房及設備,金可-KY,生技醫療業
2020-09-30,8406,RetainedEarnings_per,37.31,保留盈餘合計,金可-KY,生技醫療業
2020-09-30,8406,ShorttermBorrowings_per,22.3,短期借款,金可-KY,生技醫療業
2020-09-30,8406,TotalAssets_per,100.0,資產總額,金可-KY,生技醫療業
2020-09-30,8406,TotalLiabilitiesEquity_per,100.0,負債及權益總計,金可-KY,生技醫療業
2020-09-30,8406,CashAndCashEquivalents,2201435000.0,現金及約當現金,金可-KY,生技醫療業
2020-09-30,8406,AccountsReceivableNet,3715209000.0,應收帳款淨額,金可-KY,生技醫療業
2020-09-30,8406,Inventories,2877447000.0,存貨,金可-KY,生技醫療業
2020-09-30,8406,OtherCurrentAssets,3265883000.0,其他流動資產,金可-KY,生技醫療業
2020-09-30,8406,CurrentAssets,12750293000.0,流動資產合計,金可-KY,生技醫療業
2020-09-30,8406,PropertyPlantAndEquipment,7991923000.0,不動產、廠房及設備,金可-KY,生技醫療業
2020-09-30,8406,NoncurrentAssets,8758222000.0,非流動資產合計,金可-KY,生技醫療業
2020-09-30,8406,TotalAssets,21508515000.0,資產總額,金可-KY,生技醫療業
2020-09-30,8406,ShorttermBorrowings,4795721000.0,短期借款,金可-KY,生技醫療業
2020-09-30,8406,CurrentLiabilities,6228218000.0,流動負債合計,金可-KY,生技醫療業
2020-09-30,8406,NoncurrentLiabilities,4334998000.0,非流動負債合計,金可-KY,生技醫療業
2020-09-30,8406,CapitalSurplus,3073227000.0,資本公積合計,金可-KY,生技醫療業
2020-09-30,8406,RetainedEarnings,8025703000.0,保留盈餘合計,金可-KY,生技醫療業
2020-09-30,8406,OtherEquityInterest,1111065000.0,其他權益合計,金可-KY,生技醫療業
2020-09-30,8406,EquityAttributableToOwnersOfParent,10958595000.0,歸屬於母公司業主之權益合計,金可-KY,生技醫療業
2020-09-30,8406,Equity,10945299000.0,權益總額,金可-KY,生技醫療業
2020-09-30,8406,TotalLiabilitiesEquity,21508515000.0,負債及權益總計,金可-KY,生技醫療業
2020-12-31,8406,CashAndCashEquivalents,2863887000.0,現金及約當現金,金可-KY,生技醫療業
2020-12-31,8406,CashAndCashEquivalents_per,12.91,現金及約當現金,金可-KY,生技醫療業
2020-12-31,8406,AccountsReceivableNet,3702182000.0,應收帳款淨額,金可-KY,生技醫療業
2020-12-31,8406,AccountsReceivableNet_per,16.69,應收帳款淨額,金可-KY,生技醫療業
2020-12-31,8406,AccountsReceivableDuefromRelatedPartiesNet,115007000.0,應收帳款－關係人淨額,金可-KY,生技醫療業
2020-12-31,8406,AccountsReceivableDuefromRelatedPartiesNet_per,0.52,應收帳款－關係人淨額,金可-KY,生技醫療業
2020-12-31,8406,OtherReceivablesDueFromRelatedParties,0.0,其他應收款－關係人淨額,金可-KY,生技醫療業
2020-12-31,8406,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,金可-KY,生技醫療業
2020-12-31,8406,Inventories,2843228000.0,存貨,金可-KY,生技醫療業
2020-12-31,8406,Inventories_per,12.82,存貨,金可-KY,生技醫療業
2020-12-31,8406,OtherCurrentAssets,3422921000.0,其他流動資產,金可-KY,生技醫療業
2020-12-31,8406,OtherCurrentAssets_per,15.43,其他流動資產,金可-KY,生技醫療業
2020-12-31,8406,CurrentAssets,13516681000.0,流動資產合計,金可-KY,生技醫療業
2020-12-31,8406,CurrentAssets_per,60.93,流動資產合計,金可-KY,生技醫療業
2020-12-31,8406,PropertyPlantAndEquipment,8012537000.0,不動產、廠房及設備,金可-KY,生技醫療業
2020-12-31,8406,PropertyPlantAndEquipment_per,36.12,不動產、廠房及設備,金可-KY,生技醫療業
2020-12-31,8406,IntangibleAssets,38378000.0,無形資產,金可-KY,生技醫療業
2020-12-31,8406,IntangibleAssets_per,0.17,無形資產,金可-KY,生技醫療業
2020-12-31,8406,DeferredTaxAssets,148589000.0,遞延所得稅資產,金可-KY,生技醫療業
2020-12-31,8406,DeferredTaxAssets_per,0.67,遞延所得稅資產,金可-KY,生技醫療業
2020-12-31,8406,OtherNoncurrentAssets,80025000.0,其他非流動資產,金可-KY,生技醫療業
2020-12-31,8406,OtherNoncurrentAssets_per,0.36,其他非流動資產,金可-KY,生技醫療業
2020-12-31,8406,NoncurrentAssets,8665792000.0,非流動資產合計,金可-KY,生技醫療業
2020-12-31,8406,NoncurrentAssets_per,39.07,非流動資產合計,金可-KY,生技醫療業
2020-12-31,8406,TotalAssets,22182473000.0,資產總額,金可-KY,生技醫療業
2020-12-31,8406,TotalAssets_per,100.0,資產總額,金可-KY,生技醫療業
2020-12-31,8406,ShorttermBorrowings,4496451000.0,短期借款,金可-KY,生技醫療業
2020-12-31,8406,ShorttermBorrowings_per,20.27,短期借款,金可-KY,生技醫療業
2020-12-31,8406,AccountsPayable,475321000.0,應付帳款,金可-KY,生技醫療業
2020-12-31,8406,AccountsPayable_per,2.14,應付帳款,金可-KY,生技醫療業
2020-12-31,8406,AccountsPayableToRelatedParties,54025000.0,應付帳款－關係人,金可-KY,生技醫療業
2020-12-31,8406,AccountsPayableToRelatedParties_per,0.24,應付帳款－關係人,金可-KY,生技醫療業
2020-12-31,8406,OtherPayables,575184000.0,其他應付款,金可-KY,生技醫療業
2020-12-31,8406,OtherPayables_per,2.59,其他應付款,金可-KY,生技醫療業
2020-12-31,8406,OtherCurrentLiabilities,324519000.0,其他流動負債,金可-KY,生技醫療業
2020-12-31,8406,OtherCurrentLiabilities_per,1.46,其他流動負債,金可-KY,生技醫療業
2020-12-31,8406,CurrentLiabilities,6286655000.0,流動負債合計,金可-KY,生技醫療業
2020-12-31,8406,CurrentLiabilities_per,28.34,流動負債合計,金可-KY,生技醫療業
2020-12-31,8406,LongtermBorrowings,4027600000.0,長期借款,金可-KY,生技醫療業
2020-12-31,8406,LongtermBorrowings_per,18.16,長期借款,金可-KY,生技醫療業
2020-12-31,8406,NoncurrentLiabilities,4318184000.0,非流動負債合計,金可-KY,生技醫療業
2020-12-31,8406,NoncurrentLiabilities_per,19.47,非流動負債合計,金可-KY,生技醫療業
2020-12-31,8406,OrdinaryShare,970730000.0,普通股股本,金可-KY,生技醫療業
2020-12-31,8406,OrdinaryShare_per,4.38,普通股股本,金可-KY,生技醫療業
2020-12-31,8406,CapitalStock,970730000.0,股本合計,金可-KY,生技醫療業
2020-12-31,8406,CapitalStock_per,4.38,股本合計,金可-KY,生技醫療業
2020-12-31,8406,CapitalSurplus,3073227000.0,資本公積合計,金可-KY,生技醫療業
2020-12-31,8406,CapitalSurplus_per,13.85,資本公積合計,金可-KY,生技醫療業
2020-12-31,8406,RetainedEarnings,8388325000.0,保留盈餘合計,金可-KY,生技醫療業
2020-12-31,8406,RetainedEarnings_per,37.82,保留盈餘合計,金可-KY,生技醫療業
2020-12-31,8406,OtherEquityInterest,841369000.0,其他權益合計,金可-KY,生技醫療業
2020-12-31,8406,OtherEquityInterest_per,3.79,其他權益合計,金可-KY,生技醫療業
2020-12-31,8406,EquityAttributableToOwnersOfParent,11590913000.0,歸屬於母公司業主之權益合計,金可-KY,生技醫療業
2020-12-31,8406,EquityAttributableToOwnersOfParent_per,52.25,歸屬於母公司業主之權益合計,金可-KY,生技醫療業
2020-12-31,8406,NoncontrollingInterests,13279000.0,非控制權益,金可-KY,生技醫療業
2020-12-31,8406,NoncontrollingInterests_per,0.06,非控制權益,金可-KY,生技醫療業
2020-12-31,8406,Equity,11577634000.0,權益總額,金可-KY,生技醫療業
2020-12-31,8406,Equity_per,52.19,權益總額,金可-KY,生技醫療業
2020-12-31,8406,TotalLiabilitiesEquity,22182473000.0,負債及權益總計,金可-KY,生技醫療業
2020-12-31,8406,TotalLiabilitiesEquity_per,100.0,負債及權益總計,金可-KY,生技醫療業
2020-12-31,8406,OtherReceivable,36718000.0,其他應收款淨額,金可-KY,生技醫療業
2020-12-31,8406,OtherReceivable_per,0.17,其他應收款淨額,金可-KY,生技醫療業
2020-12-31,8406,CurrentIncomeTaxAssets,0.0,本期所得稅資產,金可-KY,生技醫療業
2020-12-31,8406,CurrentIncomeTaxAssets_per,0.0,本期所得稅資產,金可-KY,生技醫療業
2021-03-31,8406,CashAndCashEquivalents,3210322000.0,現金及約當現金,金可-KY,生技醫療業
2021-03-31,8406,CashAndCashEquivalents_per,14.31,現金及約當現金,金可-KY,生技醫療業
2021-03-31,8406,AccountsReceivableNet,3676188000.0,應收帳款淨額,金可-KY,生技醫療業
2021-03-31,8406,AccountsReceivableNet_per,16.38,應收帳款淨額,金可-KY,生技醫療業
2021-03-31,8406,AccountsReceivableDuefromRelatedPartiesNet,119441000.0,應收帳款－關係人淨額,金可-KY,生技醫療業
2021-03-31,8406,AccountsReceivableDuefromRelatedPartiesNet_per,0.53,應收帳款－關係人淨額,金可-KY,生技醫療業
2021-03-31,8406,OtherReceivablesDueFromRelatedParties,0.0,其他應收款－關係人淨額,金可-KY,生技醫療業
2021-03-31,8406,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,金可-KY,生技醫療業
2021-03-31,8406,Inventories,2951421000.0,存貨,金可-KY,生技醫療業
2021-03-31,8406,Inventories_per,13.15,存貨,金可-KY,生技醫療業
2021-03-31,8406,OtherCurrentAssets,3353185000.0,其他流動資產,金可-KY,生技醫療業
2021-03-31,8406,OtherCurrentAssets_per,14.94,其他流動資產,金可-KY,生技醫療業
2021-03-31,8406,CurrentAssets,13911637000.0,流動資產合計,金可-KY,生技醫療業
2021-03-31,8406,CurrentAssets_per,61.99,流動資產合計,金可-KY,生技醫療業
2021-03-31,8406,PropertyPlantAndEquipment,7837042000.0,不動產、廠房及設備,金可-KY,生技醫療業
2021-03-31,8406,PropertyPlantAndEquipment_per,34.92,不動產、廠房及設備,金可-KY,生技醫療業
2021-03-31,8406,IntangibleAssets,69119000.0,無形資產,金可-KY,生技醫療業
2021-03-31,8406,IntangibleAssets_per,0.31,無形資產,金可-KY,生技醫療業
2021-03-31,8406,DeferredTaxAssets,144913000.0,遞延所得稅資產,金可-KY,生技醫療業
2021-03-31,8406,DeferredTaxAssets_per,0.65,遞延所得稅資產,金可-KY,生技醫療業
2021-03-31,8406,OtherNoncurrentAssets,98039000.0,其他非流動資產,金可-KY,生技醫療業
2021-03-31,8406,OtherNoncurrentAssets_per,0.44,其他非流動資產,金可-KY,生技醫療業
2021-03-31,8406,NoncurrentAssets,8530016000.0,非流動資產合計,金可-KY,生技醫療業
2021-03-31,8406,NoncurrentAssets_per,38.01,非流動資產合計,金可-KY,生技醫療業
2021-03-31,8406,TotalAssets,22441653000.0,資產總額,金可-KY,生技醫療業
2021-03-31,8406,TotalAssets_per,100.0,資產總額,金可-KY,生技醫療業
2021-03-31,8406,ShorttermBorrowings,4721450000.0,短期借款,金可-KY,生技醫療業
2021-03-31,8406,ShorttermBorrowings_per,21.04,短期借款,金可-KY,生技醫療業
2021-03-31,8406,AccountsPayable,464787000.0,應付帳款,金可-KY,生技醫療業
2021-03-31,8406,AccountsPayable_per,2.07,應付帳款,金可-KY,生技醫療業
2021-03-31,8406,AccountsPayableToRelatedParties,62623000.0,應付帳款－關係人,金可-KY,生技醫療業
2021-03-31,8406,AccountsPayableToRelatedParties_per,0.28,應付帳款－關係人,金可-KY,生技醫療業
2021-03-31,8406,OtherPayables,380571000.0,其他應付款,金可-KY,生技醫療業
2021-03-31,8406,OtherPayables_per,1.7,其他應付款,金可-KY,生技醫療業
2021-03-31,8406,OtherCurrentLiabilities,330830000.0,其他流動負債,金可-KY,生技醫療業
2021-03-31,8406,OtherCurrentLiabilities_per,1.47,其他流動負債,金可-KY,生技醫療業
2021-03-31,8406,CurrentLiabilities,6289760000.0,流動負債合計,金可-KY,生技醫療業
2021-03-31,8406,CurrentLiabilities_per,28.03,流動負債合計,金可-KY,生技醫療業
2021-03-31,8406,LongtermBorrowings,4047960000.0,長期借款,金可-KY,生技醫療業
2021-03-31,8406,LongtermBorrowings_per,18.04,長期借款,金可-KY,生技醫療業
2021-03-31,8406,NoncurrentLiabilities,4350221000.0,非流動負債合計,金可-KY,生技醫療業
2021-03-31,8406,NoncurrentLiabilities_per,19.38,非流動負債合計,金可-KY,生技醫療業
2021-03-31,8406,OrdinaryShare,970730000.0,普通股股本,金可-KY,生技醫療業
2021-03-31,8406,OrdinaryShare_per,4.33,普通股股本,金可-KY,生技醫療業
2021-03-31,8406,CapitalStock,970730000.0,股本合計,金可-KY,生技醫療業
2021-03-31,8406,CapitalStock_per,4.33,股本合計,金可-KY,生技醫療業
2021-03-31,8406,CapitalSurplus,3073227000.0,資本公積合計,金可-KY,生技醫療業
2021-03-31,8406,CapitalSurplus_per,13.69,資本公積合計,金可-KY,生技醫療業
2021-03-31,8406,RetainedEarnings,8650628000.0,保留盈餘合計,金可-KY,生技醫療業
2021-03-31,8406,RetainedEarnings_per,38.55,保留盈餘合計,金可-KY,生技醫療業
2021-03-31,8406,OtherEquityInterest,881532000.0,其他權益合計,金可-KY,生技醫療業
2021-03-31,8406,OtherEquityInterest_per,3.93,其他權益合計,金可-KY,生技醫療業
2021-03-31,8406,EquityAttributableToOwnersOfParent,11813053000.0,歸屬於母公司業主之權益合計,金可-KY,生技醫療業
2021-03-31,8406,EquityAttributableToOwnersOfParent_per,52.64,歸屬於母公司業主之權益合計,金可-KY,生技醫療業
2021-03-31,8406,NoncontrollingInterests,11381000.0,非控制權益,金可-KY,生技醫療業
2021-03-31,8406,NoncontrollingInterests_per,0.05,非控制權益,金可-KY,生技醫療業
2021-03-31,8406,Equity,11801672000.0,權益總額,金可-KY,生技醫療業
2021-03-31,8406,Equity_per,52.59,權益總額,金可-KY,生技醫療業
2021-03-31,8406,TotalLiabilitiesEquity,22441653000.0,負債及權益總計,金可-KY,生技醫療業
2021-03-31,8406,TotalLiabilitiesEquity_per,100.0,負債及權益總計,金可-KY,生技醫療業
2021-03-31,8406,OtherReceivable,41120000.0,其他應收款淨額,金可-KY,生技醫療業
2021-03-31,8406,OtherReceivable_per,0.18,其他應收款淨額,金可-KY,生技醫療業
2021-06-30,8406,CashAndCashEquivalents,3724082000.0,現金及約當現金,金可-KY,生技醫療業
2021-06-30,8406,CashAndCashEquivalents_per,16.64,現金及約當現金,金可-KY,生技醫療業
2021-06-30,8406,AccountsReceivableNet,3582240000.0,應收帳款淨額,金可-KY,生技醫療業
2021-06-30,8406,AccountsReceivableNet_per,16.01,應收帳款淨額,金可-KY,生技醫療業
2021-06-30,8406,AccountsReceivableDuefromRelatedPartiesNet,87090000.0,應收帳款－關係人淨額,金可-KY,生技醫療業
2021-06-30,8406,AccountsReceivableDuefromRelatedPartiesNet_per,0.39,應收帳款－關係人淨額,金可-KY,生技醫療業
2021-06-30,8406,Inventories,2825184000.0,存貨,金可-KY,生技醫療業
2021-06-30,8406,Inventories_per,12.63,存貨,金可-KY,生技醫療業
2021-06-30,8406,OtherCurrentAssets,3154173000.0,其他流動資產,金可-KY,生技醫療業
2021-06-30,8406,OtherCurrentAssets_per,14.1,其他流動資產,金可-KY,生技醫療業
2021-06-30,8406,CurrentAssets,13944838000.0,流動資產合計,金可-KY,生技醫療業
2021-06-30,8406,CurrentAssets_per,62.32,流動資產合計,金可-KY,生技醫療業
2021-06-30,8406,PropertyPlantAndEquipment,7782865000.0,不動產、廠房及設備,金可-KY,生技醫療業
2021-06-30,8406,PropertyPlantAndEquipment_per,34.78,不動產、廠房及設備,金可-KY,生技醫療業
2021-06-30,8406,IntangibleAssets,67274000.0,無形資產,金可-KY,生技醫療業
2021-06-30,8406,IntangibleAssets_per,0.3,無形資產,金可-KY,生技醫療業
2021-06-30,8406,DeferredTaxAssets,145357000.0,遞延所得稅資產,金可-KY,生技醫療業
2021-06-30,8406,DeferredTaxAssets_per,0.65,遞延所得稅資產,金可-KY,生技醫療業
2021-06-30,8406,OtherNoncurrentAssets,72208000.0,其他非流動資產,金可-KY,生技醫療業
2021-06-30,8406,OtherNoncurrentAssets_per,0.32,其他非流動資產,金可-KY,生技醫療業
2021-06-30,8406,NoncurrentAssets,8432046000.0,非流動資產合計,金可-KY,生技醫療業
2021-06-30,8406,NoncurrentAssets_per,37.68,非流動資產合計,金可-KY,生技醫療業
2021-06-30,8406,TotalAssets,22376884000.0,資產總額,金可-KY,生技醫療業
2021-06-30,8406,TotalAssets_per,100.0,資產總額,金可-KY,生技醫療業
2021-06-30,8406,ShorttermBorrowings,4358137000.0,短期借款,金可-KY,生技醫療業
2021-06-30,8406,ShorttermBorrowings_per,19.48,短期借款,金可-KY,生技醫療業
2021-06-30,8406,AccountsPayable,415908000.0,應付帳款,金可-KY,生技醫療業
2021-06-30,8406,AccountsPayable_per,1.86,應付帳款,金可-KY,生技醫療業
2021-06-30,8406,AccountsPayableToRelatedParties,51509000.0,應付帳款－關係人,金可-KY,生技醫療業
2021-06-30,8406,AccountsPayableToRelatedParties_per,0.23,應付帳款－關係人,金可-KY,生技醫療業
2021-06-30,8406,OtherPayables,1059618000.0,其他應付款,金可-KY,生技醫療業
2021-06-30,8406,OtherPayables_per,4.74,其他應付款,金可-KY,生技醫療業
2021-06-30,8406,OtherCurrentLiabilities,239006000.0,其他流動負債,金可-KY,生技醫療業
2021-06-30,8406,OtherCurrentLiabilities_per,1.07,其他流動負債,金可-KY,生技醫療業
2021-06-30,8406,CurrentLiabilities,6365030000.0,流動負債合計,金可-KY,生技醫療業
2021-06-30,8406,CurrentLiabilities_per,28.44,流動負債合計,金可-KY,生技醫療業
2021-06-30,8406,LongtermBorrowings,4172842000.0,長期借款,金可-KY,生技醫療業
2021-06-30,8406,LongtermBorrowings_per,18.65,長期借款,金可-KY,生技醫療業
2021-06-30,8406,NoncurrentLiabilities,4484584000.0,非流動負債合計,金可-KY,生技醫療業
2021-06-30,8406,NoncurrentLiabilities_per,20.04,非流動負債合計,金可-KY,生技醫療業
2021-06-30,8406,OrdinaryShare,970730000.0,普通股股本,金可-KY,生技醫療業
2021-06-30,8406,OrdinaryShare_per,4.34,普通股股本,金可-KY,生技醫療業
2021-06-30,8406,CapitalStock,970730000.0,股本合計,金可-KY,生技醫療業
2021-06-30,8406,CapitalStock_per,4.34,股本合計,金可-KY,生技醫療業
2021-06-30,8406,CapitalSurplus,3073227000.0,資本公積合計,金可-KY,生技醫療業
2021-06-30,8406,CapitalSurplus_per,13.73,資本公積合計,金可-KY,生技醫療業
2021-06-30,8406,RetainedEarnings,8469432000.0,保留盈餘合計,金可-KY,生技醫療業
2021-06-30,8406,RetainedEarnings_per,37.85,保留盈餘合計,金可-KY,生技醫療業
2021-06-30,8406,OtherEquityInterest,975364000.0,其他權益合計,金可-KY,生技醫療業
2021-06-30,8406,OtherEquityInterest_per,4.36,其他權益合計,金可-KY,生技醫療業
2021-06-30,8406,EquityAttributableToOwnersOfParent,11538025000.0,歸屬於母公司業主之權益合計,金可-KY,生技醫療業
2021-06-30,8406,EquityAttributableToOwnersOfParent_per,51.56,歸屬於母公司業主之權益合計,金可-KY,生技醫療業
2021-06-30,8406,NoncontrollingInterests,10755000.0,非控制權益,金可-KY,生技醫療業
2021-06-30,8406,NoncontrollingInterests_per,0.05,非控制權益,金可-KY,生技醫療業
2021-06-30,8406,Equity,11527270000.0,權益總額,金可-KY,生技醫療業
2021-06-30,8406,Equity_per,51.51,權益總額,金可-KY,生技醫療業
2021-06-30,8406,TotalLiabilitiesEquity,22376884000.0,負債及權益總計,金可-KY,生技醫療業
2021-06-30,8406,TotalLiabilitiesEquity_per,100.0,負債及權益總計,金可-KY,生技醫療業
2021-06-30,8406,OtherReceivable,70988000.0,其他應收款淨額,金可-KY,生技醫療業
2021-06-30,8406,OtherReceivable_per,0.32,其他應收款淨額,金可-KY,生技醫療業
2021-06-30,8406,CurrentIncomeTaxAssets,0.0,本期所得稅資產,金可-KY,生技醫療業
2021-06-30,8406,CurrentIncomeTaxAssets_per,0.0,本期所得稅資產,金可-KY,生技醫療業
2021-09-30,8406,CashAndCashEquivalents,3012511000.0,現金及約當現金,金可-KY,生技醫療業
2021-09-30,8406,CashAndCashEquivalents_per,13.15,現金及約當現金,金可-KY,生技醫療業
2021-09-30,8406,AccountsReceivableNet,3435211000.0,應收帳款淨額,金可-KY,生技醫療業
2021-09-30,8406,AccountsReceivableNet_per,15.0,應收帳款淨額,金可-KY,生技醫療業
2021-09-30,8406,AccountsReceivableDuefromRelatedPartiesNet,147894000.0,應收帳款－關係人淨額,金可-KY,生技醫療業
2021-09-30,8406,AccountsReceivableDuefromRelatedPartiesNet_per,0.65,應收帳款－關係人淨額,金可-KY,生技醫療業
2021-09-30,8406,Inventories,2887191000.0,存貨,金可-KY,生技醫療業
2021-09-30,8406,Inventories_per,12.61,存貨,金可-KY,生技醫療業
2021-09-30,8406,OtherCurrentAssets,3981357000.0,其他流動資產,金可-KY,生技醫療業
2021-09-30,8406,OtherCurrentAssets_per,17.38,其他流動資產,金可-KY,生技醫療業
2021-09-30,8406,CurrentAssets,14107622000.0,流動資產合計,金可-KY,生技醫療業
2021-09-30,8406,CurrentAssets_per,61.59,流動資產合計,金可-KY,生技醫療業
2021-09-30,8406,PropertyPlantAndEquipment,8082380000.0,不動產、廠房及設備,金可-KY,生技醫療業
2021-09-30,8406,PropertyPlantAndEquipment_per,35.29,不動產、廠房及設備,金可-KY,生技醫療業
2021-09-30,8406,IntangibleAssets,65709000.0,無形資產,金可-KY,生技醫療業
2021-09-30,8406,IntangibleAssets_per,0.29,無形資產,金可-KY,生技醫療業
2021-09-30,8406,DeferredTaxAssets,143423000.0,遞延所得稅資產,金可-KY,生技醫療業
2021-09-30,8406,DeferredTaxAssets_per,0.63,遞延所得稅資產,金可-KY,生技醫療業
2021-09-30,8406,OtherNoncurrentAssets,93953000.0,其他非流動資產,金可-KY,生技醫療業
2021-09-30,8406,OtherNoncurrentAssets_per,0.41,其他非流動資產,金可-KY,生技醫療業
2021-09-30,8406,NoncurrentAssets,8797054000.0,非流動資產合計,金可-KY,生技醫療業
2021-09-30,8406,NoncurrentAssets_per,38.41,非流動資產合計,金可-KY,生技醫療業
2021-09-30,8406,TotalAssets,22904676000.0,資產總額,金可-KY,生技醫療業
2021-09-30,8406,TotalAssets_per,100.0,資產總額,金可-KY,生技醫療業
2021-09-30,8406,ShorttermBorrowings,4996975000.0,短期借款,金可-KY,生技醫療業
2021-09-30,8406,ShorttermBorrowings_per,21.82,短期借款,金可-KY,生技醫療業
2021-09-30,8406,AccountsPayable,482339000.0,應付帳款,金可-KY,生技醫療業
2021-09-30,8406,AccountsPayable_per,2.11,應付帳款,金可-KY,生技醫療業
2021-09-30,8406,AccountsPayableToRelatedParties,0.0,應付帳款－關係人,金可-KY,生技醫療業
2021-09-30,8406,AccountsPayableToRelatedParties_per,0.0,應付帳款－關係人,金可-KY,生技醫療業
2021-09-30,8406,OtherPayables,843708000.0,其他應付款,金可-KY,生技醫療業
2021-09-30,8406,OtherPayables_per,3.68,其他應付款,金可-KY,生技醫療業
2021-09-30,8406,OtherCurrentLiabilities,270010000.0,其他流動負債,金可-KY,生技醫療業
2021-09-30,8406,OtherCurrentLiabilities_per,1.18,其他流動負債,金可-KY,生技醫療業
2021-09-30,8406,CurrentLiabilities,6823683000.0,流動負債合計,金可-KY,生技醫療業
2021-09-30,8406,CurrentLiabilities_per,29.79,流動負債合計,金可-KY,生技醫療業
2021-09-30,8406,LongtermBorrowings,4107782000.0,長期借款,金可-KY,生技醫療業
2021-09-30,8406,LongtermBorrowings_per,17.93,長期借款,金可-KY,生技醫療業
2021-09-30,8406,NoncurrentLiabilities,4492748000.0,非流動負債合計,金可-KY,生技醫療業
2021-09-30,8406,NoncurrentLiabilities_per,19.61,非流動負債合計,金可-KY,生技醫療業
2021-09-30,8406,OrdinaryShare,970730000.0,普通股股本,金可-KY,生技醫療業
2021-09-30,8406,OrdinaryShare_per,4.24,普通股股本,金可-KY,生技醫療業
2021-09-30,8406,CapitalStock,970730000.0,股本合計,金可-KY,生技醫療業
2021-09-30,8406,CapitalStock_per,4.24,股本合計,金可-KY,生技醫療業
2021-09-30,8406,CapitalSurplus,3073227000.0,資本公積合計,金可-KY,生技醫療業
2021-09-30,8406,CapitalSurplus_per,13.42,資本公積合計,金可-KY,生技醫療業
2021-09-30,8406,RetainedEarnings,8582925000.0,保留盈餘合計,金可-KY,生技醫療業
2021-09-30,8406,RetainedEarnings_per,37.47,保留盈餘合計,金可-KY,生技醫療業
2021-09-30,8406,OtherEquityInterest,1038133000.0,其他權益合計,金可-KY,生技醫療業
2021-09-30,8406,OtherEquityInterest_per,4.53,其他權益合計,金可-KY,生技醫療業
2021-09-30,8406,EquityAttributableToOwnersOfParent,11588749000.0,歸屬於母公司業主之權益合計,金可-KY,生技醫療業
2021-09-30,8406,EquityAttributableToOwnersOfParent_per,50.6,歸屬於母公司業主之權益合計,金可-KY,生技醫療業
2021-09-30,8406,NoncontrollingInterests,504000.0,非控制權益,金可-KY,生技醫療業
2021-09-30,8406,NoncontrollingInterests_per,0.0,非控制權益,金可-KY,生技醫療業
2021-09-30,8406,Equity,11588245000.0,權益總額,金可-KY,生技醫療業
2021-09-30,8406,Equity_per,50.59,權益總額,金可-KY,生技醫療業
2021-09-30,8406,TotalLiabilitiesEquity,22904676000.0,負債及權益總計,金可-KY,生技醫療業
2021-09-30,8406,TotalLiabilitiesEquity_per,100.0,負債及權益總計,金可-KY,生技醫療業
2021-09-30,8406,OtherReceivable,56809000.0,其他應收款淨額,金可-KY,生技醫療業
2021-09-30,8406,OtherReceivable_per,0.25,其他應收款淨額,金可-KY,生技醫療業
2021-09-30,8406,CurrentIncomeTaxAssets,0.0,本期所得稅資產,金可-KY,生技醫療業
2021-09-30,8406,CurrentIncomeTaxAssets_per,0.0,本期所得稅資產,金可-KY,生技醫療業
2019-03-31,8406,PayTheInterest,-59463000.0,支付之利息,金可-KY,生技醫療業
2019-03-31,8406,RedemptionOfBonds,0.0,償還公司債,金可-KY,生技醫療業
2019-03-31,8406,CashProvidedByInvestingActivities,-564146000.0,投資活動之淨現金流入（流出）,金可-KY,生技醫療業
2019-03-31,8406,CashBalancesBeginningOfPeriod,2725908000.0,期初現金及約當現金餘額,金可-KY,生技醫療業
2019-03-31,8406,CashBalancesEndOfPeriod,3126688000.0,期末現金及約當現金餘額,金可-KY,生技醫療業
2019-03-31,8406,OtherNonCurrentLiabilitiesIncrease,10436000.0,其他流動資產(增加)減少,金可-KY,生技醫療業
2019-03-31,8406,CashBalancesIncrease,400780000.0,本期現金及約當現金增加（減少）數,金可-KY,生技醫療業
2019-03-31,8406,PropertyAndPlantAndEquipment,-262692000.0,取得不動產、廠房及設備,金可-KY,生技醫療業
2019-03-31,8406,IncomeBeforeIncomeTaxFromContinuingOperations,239455000.0,繼續營業單位稅前淨利（淨損）,金可-KY,生技醫療業
2019-03-31,8406,RepaymentOfLongTermDebt,-34000000.0,償還長期借款,金可-KY,生技醫療業
2019-03-31,8406,NetIncomeBeforeTax,239455000.0,本期稅前淨利（淨損）,金可-KY,生技醫療業
2019-03-31,8406,Depreciation,191463000.0,折舊費用,金可-KY,生技醫療業
2019-03-31,8406,AmortizationExpense,2512000.0,攤銷費用,金可-KY,生技醫療業
2019-03-31,8406,AccountsPayable,-17019000.0,應付帳款增加(減少),金可-KY,生技醫療業
2019-03-31,8406,AmountDueToRelatedParties,47834000.0,應付帳款-關係人增加(減少),金可-KY,生技醫療業
2019-03-31,8406,RentalPrincipalRepayments,-13019000.0,租賃本金償還,金可-KY,生技醫療業
2019-03-31,8406,InterestExpense,59165000.0,利息費用,金可-KY,生技醫療業
2019-03-31,8406,CashFlowsProvidedFromFinancingActivities,581051000.0,籌資活動之淨現金流入（流出）,金可-KY,生技醫療業
2019-03-31,8406,InterestIncome,-6345000.0,利息收入,金可-KY,生技醫療業
2019-03-31,8406,ProceedsFromLongTermDebt,200000000.0,舉借長期借款,金可-KY,生技醫療業
2019-03-31,8406,TotalIncomeLossItems,272800000.0,收益費損項目合計,金可-KY,生技醫療業
2019-03-31,8406,CashReceivedThroughOperations,108788000.0,營運產生之現金流入（流出）,金可-KY,生技醫療業
2019-03-31,8406,InventoryIncrease,-138166000.0,存貨(增加)減少,金可-KY,生技醫療業
2019-03-31,8406,ReceivableIncrease,1049000.0,應收帳款(增加)減少,金可-KY,生技醫療業
2019-03-31,8406,CashFlowsFromOperatingActivities,81510000.0,營業活動之淨現金流入(流出),金可-KY,生技醫療業
2019-06-30,8406,PropertyAndPlantAndEquipment,-518364000.0,取得不動產、廠房及設備,金可-KY,生技醫療業
2019-06-30,8406,NetIncomeBeforeTax,583037000.0,本期稅前淨利（淨損）,金可-KY,生技醫療業
2019-06-30,8406,InterestExpense,122269000.0,利息費用,金可-KY,生技醫療業
2019-06-30,8406,CashFlowsFromOperatingActivities,169386000.0,營業活動之淨現金流入（流出）,金可-KY,生技醫療業
2019-06-30,8406,CashBalancesEndOfPeriod,2224913000.0,期末現金及約當現金餘額,金可-KY,生技醫療業
2019-06-30,8406,CashBalancesBeginningOfPeriod,2725908000.0,期初現金及約當現金餘額,金可-KY,生技醫療業
2019-06-30,8406,CashBalancesIncrease,-500995000.0,本期現金及約當現金增加（減少）數,金可-KY,生技醫療業
2019-06-30,8406,InventoryIncrease,-179983000.0,存貨(增加)減少,金可-KY,生技醫療業
2019-06-30,8406,CashFlowsProvidedFromFinancingActivities,503105000.0,籌資活動之淨現金流入（流出）,金可-KY,生技醫療業
2019-06-30,8406,Depreciation,387653000.0,折舊費用,金可-KY,生技醫療業
2019-06-30,8406,OtherNonCurrentLiabilitiesIncrease,7012000.0,其他流動資產(增加)減少,金可-KY,生技醫療業
2019-06-30,8406,TotalIncomeLossItems,521631000.0,收益費損項目合計,金可-KY,生技醫療業
2019-06-30,8406,RentalPrincipalRepayments,-25598000.0,租賃本金償還,金可-KY,生技醫療業
2019-06-30,8406,AmortizationExpense,5075000.0,攤銷費用,金可-KY,生技醫療業
2019-06-30,8406,RepaymentOfLongTermDebt,-168000000.0,償還長期借款,金可-KY,生技醫療業
2019-06-30,8406,ProceedsFromLongTermDebt,200000000.0,舉借長期借款,金可-KY,生技醫療業
2019-06-30,8406,AccountsPayable,-21412000.0,應付帳款增加(減少),金可-KY,生技醫療業
2019-06-30,8406,InterestIncome,-16563000.0,利息收入,金可-KY,生技醫療業
2019-06-30,8406,AmountDueToRelatedParties,46679000.0,應付帳款-關係人增加(減少),金可-KY,生技醫療業
2019-06-30,8406,CashReceivedThroughOperations,389366000.0,營運產生之現金流入（流出）,金可-KY,生技醫療業
2019-06-30,8406,PayTheInterest,-122069000.0,支付之利息,金可-KY,生技醫療業
2019-06-30,8406,IncomeBeforeIncomeTaxFromContinuingOperations,583037000.0,繼續營業單位稅前淨利（淨損）,金可-KY,生技醫療業
2019-06-30,8406,ReceivableIncrease,-442658000.0,應收帳款(增加)減少,金可-KY,生技醫療業
2019-06-30,8406,CashProvidedByInvestingActivities,-1415680000.0,投資活動之淨現金流入（流出）,金可-KY,生技醫療業
2019-09-30,8406,CashBalancesIncrease,-613254000.0,本期現金及約當現金增加（減少）數,金可-KY,生技醫療業
2019-09-30,8406,CashBalancesBeginningOfPeriod,2725908000.0,期初現金及約當現金餘額,金可-KY,生技醫療業
2019-09-30,8406,CashFlowsFromOperatingActivities,1178770000.0,營業活動之淨現金流入(流出),金可-KY,生技醫療業
2019-09-30,8406,ReceivableIncrease,-226121000.0,應收帳款（增加）減少,金可-KY,生技醫療業
2019-09-30,8406,Depreciation,588069000.0,折舊費用,金可-KY,生技醫療業
2019-09-30,8406,CashProvidedByInvestingActivities,-2709997000.0,投資活動之淨現金流入(流出),金可-KY,生技醫療業
2019-09-30,8406,PropertyAndPlantAndEquipment,-1132629000.0,取得不動產、廠房及設備,金可-KY,生技醫療業
2019-09-30,8406,NetIncomeBeforeTax,1004778000.0,本期稅前淨利（淨損）,金可-KY,生技醫療業
2019-09-30,8406,RedemptionOfBonds,0.0,償還公司債,金可-KY,生技醫療業
2019-09-30,8406,CashBalancesEndOfPeriod,2112654000.0,期末現金及約當現金餘額,金可-KY,生技醫療業
2019-09-30,8406,AmortizationExpense,7221000.0,攤銷費用,金可-KY,生技醫療業
2019-09-30,8406,OtherNonCurrentLiabilitiesIncrease,92240000.0,其他流動資產(增加)減少,金可-KY,生技醫療業
2019-09-30,8406,TotalIncomeLossItems,750985000.0,收益費損項目合計,金可-KY,生技醫療業
2019-09-30,8406,InventoryIncrease,-200280000.0,存貨（增加）減少,金可-KY,生技醫療業
2019-09-30,8406,InterestExpense,188808000.0,利息費用,金可-KY,生技醫療業
2019-09-30,8406,CashReceivedThroughOperations,1453468000.0,營運產生之現金流入（流出）,金可-KY,生技醫療業
2019-09-30,8406,PayTheInterest,-188827000.0,支付之利息,金可-KY,生技醫療業
2019-09-30,8406,CashFlowsProvidedFromFinancingActivities,1140617000.0,籌資活動之淨現金流入（流出）,金可-KY,生技醫療業
2019-09-30,8406,AmountDueToRelatedParties,51536000.0,應付帳款-關係人增加(減少),金可-KY,生技醫療業
2019-09-30,8406,DecreaseInShortTermLoans,-1723863000.0,短期借款減少,金可-KY,生技醫療業
2019-09-30,8406,ProceedsFromLongTermDebt,1104600000.0,舉借長期借款,金可-KY,生技醫療業
2019-09-30,8406,AccountsPayable,7046000.0,應付帳款增加(減少),金可-KY,生技醫療業
2019-09-30,8406,RepaymentOfLongTermDebt,-368000000.0,償還長期借款,金可-KY,生技醫療業
2019-09-30,8406,RentalPrincipalRepayments,-38472000.0,租賃本金償還,金可-KY,生技醫療業
2019-09-30,8406,InterestIncome,-62261000.0,利息收入,金可-KY,生技醫療業
2019-09-30,8406,IncomeBeforeIncomeTaxFromContinuingOperations,1004778000.0,繼續營業單位稅前淨利（淨損）,金可-KY,生技醫療業
2019-12-31,8406,CashBalancesIncrease,-376441000.0,本期現金及約當現金增加（減少）數,金可-KY,生技醫療業
2019-12-31,8406,CashBalancesBeginningOfPeriod,2725908000.0,期初現金及約當現金餘額,金可-KY,生技醫療業
2019-12-31,8406,CashFlowsFromOperatingActivities,2454166000.0,營業活動之淨現金流入(流出),金可-KY,生技醫療業
2019-12-31,8406,ReceivableIncrease,-26667000.0,應收帳款（增加）減少,金可-KY,生技醫療業
2019-12-31,8406,Depreciation,790550000.0,折舊費用,金可-KY,生技醫療業
2019-12-31,8406,CashProvidedByInvestingActivities,-2879672000.0,投資活動之淨現金流入(流出),金可-KY,生技醫療業
2019-12-31,8406,PropertyAndPlantAndEquipment,-1340116000.0,取得不動產、廠房及設備,金可-KY,生技醫療業
2019-12-31,8406,NetIncomeBeforeTax,1553701000.0,本期稅前淨利（淨損）,金可-KY,生技醫療業
2019-12-31,8406,RedemptionOfBonds,0.0,償還公司債,金可-KY,生技醫療業
2019-12-31,8406,CashBalancesEndOfPeriod,2349467000.0,期末現金及約當現金餘額,金可-KY,生技醫療業
2019-12-31,8406,AmortizationExpense,8748000.0,攤銷費用,金可-KY,生技醫療業
2019-12-31,8406,OtherNonCurrentLiabilitiesIncrease,45142000.0,其他流動資產(增加)減少,金可-KY,生技醫療業
2019-12-31,8406,TotalIncomeLossItems,868416000.0,收益費損項目合計,金可-KY,生技醫療業
2019-12-31,8406,InventoryIncrease,-112927000.0,存貨（增加）減少,金可-KY,生技醫療業
2019-12-31,8406,InterestExpense,253476000.0,利息費用,金可-KY,生技醫療業
2019-12-31,8406,CashReceivedThroughOperations,2646223000.0,營運產生之現金流入（流出）,金可-KY,生技醫療業
2019-12-31,8406,PayTheInterest,-253666000.0,支付之利息,金可-KY,生技醫療業
2019-12-31,8406,CashFlowsProvidedFromFinancingActivities,404507000.0,籌資活動之淨現金流入（流出）,金可-KY,生技醫療業
2019-12-31,8406,AmountDueToRelatedParties,64370000.0,應付帳款-關係人增加(減少),金可-KY,生技醫療業
2019-12-31,8406,DecreaseInShortTermLoans,-2164907000.0,短期借款減少,金可-KY,生技醫療業
2019-12-31,8406,ProceedsFromLongTermDebt,792600000.0,舉借長期借款,金可-KY,生技醫療業
2019-12-31,8406,AccountsPayable,53254000.0,應付帳款增加(減少),金可-KY,生技醫療業
2019-12-31,8406,RepaymentOfLongTermDebt,-288000000.0,償還長期借款,金可-KY,生技醫療業
2019-12-31,8406,RentalPrincipalRepayments,-49831000.0,租賃本金償還,金可-KY,生技醫療業
2019-12-31,8406,InterestIncome,-64266000.0,利息收入,金可-KY,生技醫療業
2019-12-31,8406,IncomeBeforeIncomeTaxFromContinuingOperations,1553701000.0,繼續營業單位稅前淨利（淨損）,金可-KY,生技醫療業
2020-03-31,8406,AccountsPayable,74324000.0,應付帳款增加(減少),金可-KY,生技醫療業
2020-03-31,8406,AmortizationExpense,1556000.0,攤銷費用,金可-KY,生技醫療業
2020-03-31,8406,CashFlowsProvidedFromFinancingActivities,113800000.0,籌資活動之淨現金流入（流出）,金可-KY,生技醫療業
2020-03-31,8406,CashProvidedByInvestingActivities,196938000.0,投資活動之淨現金流入（流出）,金可-KY,生技醫療業
2020-03-31,8406,Depreciation,212220000.0,折舊費用,金可-KY,生技醫療業
2020-03-31,8406,IncomeBeforeIncomeTaxFromContinuingOperations,103916000.0,繼續營業單位稅前淨利（淨損）,金可-KY,生技醫療業
2020-03-31,8406,InterestExpense,58717000.0,利息費用,金可-KY,生技醫療業
2020-03-31,8406,NetIncomeBeforeTax,103916000.0,本期稅前淨利（淨損）,金可-KY,生技醫療業
2020-03-31,8406,OtherNonCurrentLiabilitiesIncrease,65493000.0,其他流動資產(增加)減少,金可-KY,生技醫療業
2020-03-31,8406,ProceedsFromLongTermDebt,450000000.0,舉借長期借款,金可-KY,生技醫療業
2020-03-31,8406,RedemptionOfBonds,0.0,償還公司債,金可-KY,生技醫療業
2020-03-31,8406,TotalIncomeLossItems,352672000.0,收益費損項目合計,金可-KY,生技醫療業
2020-03-31,8406,CashBalancesBeginningOfPeriod,2349467000.0,期初現金及約當現金餘額,金可-KY,生技醫療業
2020-03-31,8406,CashBalancesEndOfPeriod,2191399000.0,期末現金及約當現金餘額,金可-KY,生技醫療業
2020-03-31,8406,RepaymentOfLongTermDebt,-180000000.0,償還長期借款,金可-KY,生技醫療業
2020-03-31,8406,InterestIncome,-9380000.0,利息收入,金可-KY,生技醫療業
2020-03-31,8406,PayTheInterest,-58510000.0,支付之利息,金可-KY,生技醫療業
2020-03-31,8406,CashReceivedThroughOperations,-103586000.0,營運產生之現金流入（流出）,金可-KY,生技醫療業
2020-03-31,8406,CashBalancesIncrease,-158068000.0,本期現金及約當現金增加（減少）數,金可-KY,生技醫療業
2020-03-31,8406,RentalPrincipalRepayments,-11486000.0,租賃本金償還,金可-KY,生技醫療業
2020-03-31,8406,AmountDueToRelatedParties,-4471000.0,應付帳款-關係人增加(減少),金可-KY,生技醫療業
2020-03-31,8406,PropertyAndPlantAndEquipment,-139975000.0,取得不動產、廠房及設備,金可-KY,生技醫療業
2020-03-31,8406,CashFlowsFromOperatingActivities,-182673000.0,營業活動之淨現金流入（流出）,金可-KY,生技醫療業
2020-03-31,8406,ReceivableIncrease,-161869000.0,應收帳款（增加）減少,金可-KY,生技醫療業
2020-03-31,8406,InventoryIncrease,-278432000.0,存貨（增加）減少,金可-KY,生技醫療業
2020-06-30,8406,AccountsPayable,35177000.0,應付帳款增加(減少),金可-KY,生技醫療業
2020-06-30,8406,AmortizationExpense,3099000.0,攤銷費用,金可-KY,生技醫療業
2020-06-30,8406,AmountDueToRelatedParties,2206000.0,應付帳款-關係人增加(減少),金可-KY,生技醫療業
2020-06-30,8406,CashReceivedThroughOperations,309813000.0,營運產生之現金流入（流出）,金可-KY,生技醫療業
2020-06-30,8406,Depreciation,424825000.0,折舊費用,金可-KY,生技醫療業
2020-06-30,8406,IncomeBeforeIncomeTaxFromContinuingOperations,352664000.0,繼續營業單位稅前淨利（淨損）,金可-KY,生技醫療業
2020-06-30,8406,InterestExpense,107221000.0,利息費用,金可-KY,生技醫療業
2020-06-30,8406,NetIncomeBeforeTax,352664000.0,本期稅前淨利（淨損）,金可-KY,生技醫療業
2020-06-30,8406,OtherNonCurrentLiabilitiesIncrease,16183000.0,其他流動資產(增加)減少,金可-KY,生技醫療業
2020-06-30,8406,ProceedsFromLongTermDebt,970000000.0,舉借長期借款,金可-KY,生技醫療業
2020-06-30,8406,TotalIncomeLossItems,562060000.0,收益費損項目合計,金可-KY,生技醫療業
2020-06-30,8406,CashBalancesBeginningOfPeriod,2349467000.0,期初現金及約當現金餘額,金可-KY,生技醫療業
2020-06-30,8406,CashBalancesEndOfPeriod,1672185000.0,期末現金及約當現金餘額,金可-KY,生技醫療業
2020-06-30,8406,CashFlowsProvidedFromFinancingActivities,-735201000.0,籌資活動之淨現金流入（流出）,金可-KY,生技醫療業
2020-06-30,8406,RentalPrincipalRepayments,-20051000.0,租賃本金償還,金可-KY,生技醫療業
2020-06-30,8406,DecreaseInShortTermLoans,-1277929000.0,短期借款減少,金可-KY,生技醫療業
2020-06-30,8406,InterestIncome,-30543000.0,利息收入,金可-KY,生技醫療業
2020-06-30,8406,InventoryIncrease,-358558000.0,存貨(增加)減少,金可-KY,生技醫療業
2020-06-30,8406,PayTheInterest,-107221000.0,支付之利息,金可-KY,生技醫療業
2020-06-30,8406,CashBalancesIncrease,-677282000.0,本期現金及約當現金增加（減少）數,金可-KY,生技醫療業
2020-06-30,8406,RepaymentOfLongTermDebt,-300000000.0,償還長期借款,金可-KY,生技醫療業
2020-06-30,8406,PropertyAndPlantAndEquipment,-291173000.0,取得不動產、廠房及設備,金可-KY,生技醫療業
2020-06-30,8406,ReceivableIncrease,-62651000.0,應收帳款（增加）減少,金可-KY,生技醫療業
2020-06-30,8406,CashProvidedByInvestingActivities,231349000.0,投資活動之淨現金流入(流出),金可-KY,生技醫療業
2020-06-30,8406,CashFlowsFromOperatingActivities,77285000.0,營業活動之淨現金流入（流出）,金可-KY,生技醫療業
2020-09-30,8406,AmortizationExpense,4623000.0,攤銷費用,金可-KY,生技醫療業
2020-09-30,8406,CashProvidedByInvestingActivities,438032000.0,投資活動之淨現金流入（流出）,金可-KY,生技醫療業
2020-09-30,8406,CashReceivedThroughOperations,958428000.0,營運產生之現金流入（流出）,金可-KY,生技醫療業
2020-09-30,8406,Depreciation,642445000.0,折舊費用,金可-KY,生技醫療業
2020-09-30,8406,IncomeBeforeIncomeTaxFromContinuingOperations,802669000.0,繼續營業單位稅前淨利（淨損）,金可-KY,生技醫療業
2020-09-30,8406,InterestExpense,147872000.0,利息費用,金可-KY,生技醫療業
2020-09-30,8406,NetIncomeBeforeTax,802669000.0,本期稅前淨利（淨損）,金可-KY,生技醫療業
2020-09-30,8406,OtherNonCurrentLiabilitiesIncrease,60164000.0,其他流動資產(增加)減少,金可-KY,生技醫療業
2020-09-30,8406,ProceedsFromLongTermDebt,970000000.0,舉借長期借款,金可-KY,生技醫療業
2020-09-30,8406,TotalIncomeLossItems,736984000.0,收益費損項目合計,金可-KY,生技醫療業
2020-09-30,8406,CashFlowsProvidedFromFinancingActivities,-1066346000.0,籌資活動之淨現金流入（流出）,金可-KY,生技醫療業
2020-09-30,8406,RentalPrincipalRepayments,-33194000.0,租賃本金償還,金可-KY,生技醫療業
2020-09-30,8406,DecreaseInShortTermLoans,-2361112000.0,短期借款減少,金可-KY,生技醫療業
2020-09-30,8406,InterestIncome,-95419000.0,利息收入,金可-KY,生技醫療業
2020-09-30,8406,InventoryIncrease,-461334000.0,存貨(增加)減少,金可-KY,生技醫療業
2020-09-30,8406,PayTheInterest,-147872000.0,支付之利息,金可-KY,生技醫療業
2020-09-30,8406,ReceivableIncrease,82117000.0,應收帳款(增加)減少,金可-KY,生技醫療業
2020-09-30,8406,CashBalancesIncrease,-148032000.0,本期現金及約當現金增加（減少）數,金可-KY,生技醫療業
2020-09-30,8406,CashBalancesBeginningOfPeriod,2349467000.0,期初現金及約當現金餘額,金可-KY,生技醫療業
2020-09-30,8406,RepaymentOfLongTermDebt,-300000000.0,償還長期借款,金可-KY,生技醫療業
2020-09-30,8406,CashBalancesEndOfPeriod,2201435000.0,期末現金及約當現金餘額,金可-KY,生技醫療業
2020-09-30,8406,AccountsPayable,-36367000.0,應付帳款增加(減少),金可-KY,生技醫療業
2020-09-30,8406,PropertyAndPlantAndEquipment,-391633000.0,取得不動產、廠房及設備,金可-KY,生技醫療業
2020-09-30,8406,AmountDueToRelatedParties,-2391000.0,應付帳款-關係人增加(減少),金可-KY,生技醫療業
2020-09-30,8406,CashFlowsFromOperatingActivities,708138000.0,營業活動之淨現金流入(流出),金可-KY,生技醫療業
2020-12-31,8406,NetIncomeBeforeTax,1256202000.0,本期稅前淨利（淨損）,金可-KY,生技醫療業
2020-12-31,8406,InterestExpense,183233000.0,利息費用,金可-KY,生技醫療業
2020-12-31,8406,CashBalancesEndOfPeriod,2863887000.0,期末現金及約當現金餘額,金可-KY,生技醫療業
2020-12-31,8406,CashBalancesBeginningOfPeriod,2349467000.0,期初現金及約當現金餘額,金可-KY,生技醫療業
2020-12-31,8406,CashBalancesIncrease,514420000.0,本期現金及約當現金增加（減少）數,金可-KY,生技醫療業
2020-12-31,8406,Depreciation,863720000.0,折舊費用,金可-KY,生技醫療業
2020-12-31,8406,OtherNonCurrentLiabilitiesIncrease,54734000.0,其他流動資產(增加)減少,金可-KY,生技醫療業
2020-12-31,8406,TotalIncomeLossItems,1012144000.0,收益費損項目合計,金可-KY,生技醫療業
2020-12-31,8406,AmortizationExpense,6191000.0,攤銷費用,金可-KY,生技醫療業
2020-12-31,8406,ProceedsFromLongTermDebt,1346000000.0,舉借長期借款,金可-KY,生技醫療業
2020-12-31,8406,AccountsPayable,32497000.0,應付帳款增加(減少),金可-KY,生技醫療業
2020-12-31,8406,IncomeBeforeIncomeTaxFromContinuingOperations,1256202000.0,繼續營業單位稅前淨利（淨損）,金可-KY,生技醫療業
2020-12-31,8406,CashFlowsProvidedFromFinancingActivities,-1153846000.0,籌資活動之淨現金流入（流出）,金可-KY,生技醫療業
2020-12-31,8406,RentalPrincipalRepayments,-47549000.0,租賃本金償還,金可-KY,生技醫療業
2020-12-31,8406,DecreaseInShortTermLoans,-27722306000.0,短期借款減少,金可-KY,生技醫療業
2020-12-31,8406,InterestIncome,-101047000.0,利息收入,金可-KY,生技醫療業
2020-12-31,8406,CashReceivedThroughOperations,1985087000.0,營運產生之現金流入（流出）,金可-KY,生技醫療業
2020-12-31,8406,InventoryIncrease,-420700000.0,存貨(增加)減少,金可-KY,生技醫療業
2020-12-31,8406,PayTheInterest,-177784000.0,支付之利息,金可-KY,生技醫療業
2020-12-31,8406,ReceivableIncrease,124917000.0,應收帳款(增加)減少,金可-KY,生技醫療業
2020-12-31,8406,RepaymentOfLongTermDebt,-580000000.0,償還長期借款,金可-KY,生技醫療業
2020-12-31,8406,PropertyAndPlantAndEquipment,-457987000.0,取得不動產、廠房及設備,金可-KY,生技醫療業
2020-12-31,8406,CashProvidedByInvestingActivities,155062000.0,投資活動之淨現金流入（流出）,金可-KY,生技醫療業
2020-12-31,8406,AmountDueToRelatedParties,-10345000.0,應付帳款-關係人增加(減少),金可-KY,生技醫療業
2020-12-31,8406,CashFlowsFromOperatingActivities,1699756000.0,營業活動之淨現金流入(流出),金可-KY,生技醫療業
2021-03-31,8406,RedemptionOfBonds,0.0,償還公司債,金可-KY,生技醫療業
2021-03-31,8406,CashBalancesBeginningOfPeriod,2863887000.0,期初現金及約當現金餘額,金可-KY,生技醫療業
2021-03-31,8406,CashBalancesEndOfPeriod,3210322000.0,期末現金及約當現金餘額,金可-KY,生技醫療業
2021-03-31,8406,CashBalancesIncrease,346435000.0,本期現金及約當現金增加（減少）數,金可-KY,生技醫療業
2021-03-31,8406,IncomeBeforeIncomeTaxFromContinuingOperations,341673000.0,繼續營業單位稅前淨利（淨損）,金可-KY,生技醫療業
2021-03-31,8406,NetIncomeBeforeTax,341673000.0,本期稅前淨利（淨損）,金可-KY,生技醫療業
2021-03-31,8406,CashFlowsFromOperatingActivities,118820000.0,營業活動之淨現金流入（流出）,金可-KY,生技醫療業
2021-03-31,8406,Depreciation,217616000.0,折舊費用,金可-KY,生技醫療業
2021-03-31,8406,AmortizationExpense,2722000.0,攤銷費用,金可-KY,生技醫療業
2021-03-31,8406,AmountDueToRelatedParties,8598000.0,應付帳款-關係人增加(減少),金可-KY,生技醫療業
2021-03-31,8406,InterestExpense,35636000.0,利息費用,金可-KY,生技醫療業
2021-03-31,8406,ReceivableIncrease,49501000.0,應收帳款（增加）減少,金可-KY,生技醫療業
2021-03-31,8406,CashFlowsProvidedFromFinancingActivities,241698000.0,籌資活動之淨現金流入（流出）,金可-KY,生技醫療業
2021-03-31,8406,ProceedsFromLongTermDebt,295360000.0,舉借長期借款,金可-KY,生技醫療業
2021-03-31,8406,TotalIncomeLossItems,291428000.0,收益費損項目合計,金可-KY,生技醫療業
2021-03-31,8406,CashReceivedThroughOperations,195616000.0,營運產生之現金流入（流出）,金可-KY,生技醫療業
2021-03-31,8406,PayTheInterest,-34186000.0,支付之利息,金可-KY,生技醫療業
2021-03-31,8406,CashProvidedByInvestingActivities,-42187000.0,投資活動之淨現金流入（流出）,金可-KY,生技醫療業
2021-03-31,8406,OtherNonCurrentLiabilitiesIncrease,-58000.0,其他流動資產(增加)減少,金可-KY,生技醫療業
2021-03-31,8406,PropertyAndPlantAndEquipment,-40438000.0,取得不動產、廠房及設備,金可-KY,生技醫療業
2021-03-31,8406,RepaymentOfLongTermDebt,-230000000.0,償還長期借款,金可-KY,生技醫療業
2021-03-31,8406,AccountsPayable,-192306000.0,應付帳款增加(減少),金可-KY,生技醫療業
2021-03-31,8406,RentalPrincipalRepayments,-15373000.0,租賃本金償還,金可-KY,生技醫療業
2021-03-31,8406,InventoryIncrease,-18660000.0,存貨（增加）減少,金可-KY,生技醫療業
2021-03-31,8406,InterestIncome,-9267000.0,利息收入,金可-KY,生技醫療業
2021-06-30,8406,CashBalancesEndOfPeriod,3724082000.0,期末現金及約當現金餘額,金可-KY,生技醫療業
2021-06-30,8406,CashBalancesIncrease,860195000.0,本期現金及約當現金增加（減少）數,金可-KY,生技醫療業
2021-06-30,8406,CashProvidedByInvestingActivities,28375000.0,投資活動之淨現金流入（流出）,金可-KY,生技醫療業
2021-06-30,8406,CashBalancesBeginningOfPeriod,2863887000.0,期初現金及約當現金餘額,金可-KY,生技醫療業
2021-06-30,8406,IncomeBeforeIncomeTaxFromContinuingOperations,783779000.0,繼續營業單位稅前淨利（淨損）,金可-KY,生技醫療業
2021-06-30,8406,ProceedsFromLongTermDebt,600360000.0,舉借長期借款,金可-KY,生技醫療業
2021-06-30,8406,NetIncomeBeforeTax,783779000.0,本期稅前淨利（淨損）,金可-KY,生技醫療業
2021-06-30,8406,CashFlowsFromOperatingActivities,963229000.0,營業活動之淨現金流入（流出）,金可-KY,生技醫療業
2021-06-30,8406,Depreciation,434678000.0,折舊費用,金可-KY,生技醫療業
2021-06-30,8406,AmortizationExpense,3150000.0,攤銷費用,金可-KY,生技醫療業
2021-06-30,8406,InterestExpense,73137000.0,利息費用,金可-KY,生技醫療業
2021-06-30,8406,ReceivableIncrease,114075000.0,應收帳款（增加）減少,金可-KY,生技醫療業
2021-06-30,8406,InventoryIncrease,84841000.0,存貨（增加）減少,金可-KY,生技醫療業
2021-06-30,8406,TotalIncomeLossItems,517259000.0,收益費損項目合計,金可-KY,生技醫療業
2021-06-30,8406,CashReceivedThroughOperations,1169816000.0,營運產生之現金流入（流出）,金可-KY,生技醫療業
2021-06-30,8406,OtherNonCurrentLiabilitiesIncrease,-6384000.0,其他流動資產(增加)減少,金可-KY,生技醫療業
2021-06-30,8406,PropertyAndPlantAndEquipment,-412012000.0,取得不動產、廠房及設備,金可-KY,生技醫療業
2021-06-30,8406,RentalPrincipalRepayments,-30466000.0,租賃本金償還,金可-KY,生技醫療業
2021-06-30,8406,PayTheInterest,-70302000.0,支付之利息,金可-KY,生技醫療業
2021-06-30,8406,AccountsPayable,-241185000.0,應付帳款增加(減少),金可-KY,生技醫療業
2021-06-30,8406,AmountDueToRelatedParties,-2516000.0,應付帳款-關係人增加(減少),金可-KY,生技醫療業
2021-06-30,8406,RepaymentOfLongTermDebt,-530000000.0,償還長期借款,金可-KY,生技醫療業
2021-06-30,8406,CashFlowsProvidedFromFinancingActivities,-77535000.0,籌資活動之淨現金流入（流出）,金可-KY,生技醫療業
2021-06-30,8406,InterestIncome,-43060000.0,利息收入,金可-KY,生技醫療業
2021-06-30,8406,DecreaseInShortTermLoans,-47127000.0,短期借款減少,金可-KY,生技醫療業
2021-09-30,8406,OtherNonCurrentLiabilitiesIncrease,-18307000.0,其他流動資產(增加)減少,金可-KY,生技醫療業
2021-09-30,8406,PropertyAndPlantAndEquipment,-950067000.0,取得不動產、廠房及設備,金可-KY,生技醫療業
2021-09-30,8406,CashBalancesEndOfPeriod,3012511000.0,期末現金及約當現金餘額,金可-KY,生技醫療業
2021-09-30,8406,CashBalancesIncrease,148624000.0,本期現金及約當現金增加（減少）數,金可-KY,生技醫療業
2021-09-30,8406,CashProvidedByInvestingActivities,-1506209000.0,投資活動之淨現金流入（流出）,金可-KY,生技醫療業
2021-09-30,8406,CashBalancesBeginningOfPeriod,2863887000.0,期初現金及約當現金餘額,金可-KY,生技醫療業
2021-09-30,8406,RentalPrincipalRepayments,-45821000.0,租賃本金償還,金可-KY,生技醫療業
2021-09-30,8406,PayTheInterest,-102722000.0,支付之利息,金可-KY,生技醫療業
2021-09-30,8406,IncomeBeforeIncomeTaxFromContinuingOperations,953463000.0,繼續營業單位稅前淨利（淨損）,金可-KY,生技醫療業
2021-09-30,8406,ProceedsFromLongTermDebt,800360000.0,舉借長期借款,金可-KY,生技醫療業
2021-09-30,8406,NetIncomeBeforeTax,953463000.0,本期稅前淨利（淨損）,金可-KY,生技醫療業
2021-09-30,8406,CashFlowsFromOperatingActivities,1654666000.0,營業活動之淨現金流入（流出）,金可-KY,生技醫療業
2021-09-30,8406,Depreciation,652052000.0,折舊費用,金可-KY,生技醫療業
2021-09-30,8406,AmortizationExpense,4681000.0,攤銷費用,金可-KY,生技醫療業
2021-09-30,8406,AccountsPayable,-174754000.0,應付帳款增加(減少),金可-KY,生技醫療業
2021-09-30,8406,AmountDueToRelatedParties,-54025000.0,應付帳款-關係人增加(減少),金可-KY,生技醫療業
2021-09-30,8406,RepaymentOfLongTermDebt,-795060000.0,償還長期借款,金可-KY,生技醫療業
2021-09-30,8406,InterestExpense,106881000.0,利息費用,金可-KY,生技醫療業
2021-09-30,8406,ReceivableIncrease,263605000.0,應收帳款（增加）減少,金可-KY,生技醫療業
2021-09-30,8406,InventoryIncrease,22834000.0,存貨（增加）減少,金可-KY,生技醫療業
2021-09-30,8406,CashFlowsProvidedFromFinancingActivities,-127109000.0,籌資活動之淨現金流入（流出）,金可-KY,生技醫療業
2021-09-30,8406,InterestIncome,-78858000.0,利息收入,金可-KY,生技醫療業
2021-09-30,8406,DecreaseInShortTermLoans,-26740156000.0,短期借款減少,金可-KY,生技醫療業
2021-09-30,8406,TotalIncomeLossItems,699462000.0,收益費損項目合計,金可-KY,生技醫療業
2021-09-30,8406,CashReceivedThroughOperations,1921197000.0,營運產生之現金流入（流出）,金可-KY,生技醫療業
2021-12-31,8406,OtherNonCurrentLiabilitiesIncrease,-11920000.0,其他流動資產(增加)減少,金可-KY,生技醫療業
2021-12-31,8406,PropertyAndPlantAndEquipment,-1274853000.0,取得不動產、廠房及設備,金可-KY,生技醫療業
2021-12-31,8406,CashBalancesEndOfPeriod,3552290000.0,期末現金及約當現金餘額,金可-KY,生技醫療業
2021-12-31,8406,CashBalancesIncrease,688403000.0,本期現金及約當現金增加（減少）數,金可-KY,生技醫療業
2021-12-31,8406,CashProvidedByInvestingActivities,-1911809000.0,投資活動之淨現金流入（流出）,金可-KY,生技醫療業
2021-12-31,8406,CashBalancesBeginningOfPeriod,2863887000.0,期初現金及約當現金餘額,金可-KY,生技醫療業
2021-12-31,8406,RentalPrincipalRepayments,-61826000.0,租賃本金償還,金可-KY,生技醫療業
2021-12-31,8406,PayTheInterest,-133503000.0,支付之利息,金可-KY,生技醫療業
2021-12-31,8406,IncomeBeforeIncomeTaxFromContinuingOperations,1095135000.0,繼續營業單位稅前淨利（淨損）,金可-KY,生技醫療業
2021-12-31,8406,ProceedsFromLongTermDebt,1000360000.0,舉借長期借款,金可-KY,生技醫療業
2021-12-31,8406,NetIncomeBeforeTax,1095135000.0,本期稅前淨利（淨損）,金可-KY,生技醫療業
2021-12-31,8406,CashFlowsFromOperatingActivities,2453008000.0,營業活動之淨現金流入（流出）,金可-KY,生技醫療業
2021-12-31,8406,Depreciation,873233000.0,折舊費用,金可-KY,生技醫療業
2021-12-31,8406,AmortizationExpense,6359000.0,攤銷費用,金可-KY,生技醫療業
2021-12-31,8406,AccountsPayable,-100079000.0,應付帳款增加(減少),金可-KY,生技醫療業
2021-12-31,8406,AmountDueToRelatedParties,-54025000.0,應付帳款-關係人增加(減少),金可-KY,生技醫療業
2021-12-31,8406,RepaymentOfLongTermDebt,-995060000.0,償還長期借款,金可-KY,生技醫療業
2021-12-31,8406,InterestExpense,139169000.0,利息費用,金可-KY,生技醫療業
2021-12-31,8406,ReceivableIncrease,408208000.0,應收帳款（增加）減少,金可-KY,生技醫療業
2021-12-31,8406,InventoryIncrease,64292000.0,存貨（增加）減少,金可-KY,生技醫療業
2021-12-31,8406,CashFlowsProvidedFromFinancingActivities,-245354000.0,籌資活動之淨現金流入（流出）,金可-KY,生技醫療業
2021-12-31,8406,InterestIncome,-86934000.0,利息收入,金可-KY,生技醫療業
2021-12-31,8406,DecreaseInShortTermLoans,-37863579000.0,短期借款減少,金可-KY,生技醫療業
2021-12-31,8406,TotalIncomeLossItems,929533000.0,收益費損項目合計,金可-KY,生技醫療業
2021-12-31,8406,CashReceivedThroughOperations,2753234000.0,營運產生之現金流入（流出）,金可-KY,生技醫療業
2019-03-31,1736,IncomeBeforeIncomeTax,65344000.0,稅前淨利(淨損),喬山,生技醫療業
2019-03-31,1736,NetIncome,26351000.0,本期淨利(淨損),喬山,生技醫療業
2019-03-31,1736,OperatingExpenses,2609527000.0,營業費用,喬山,生技醫療業
2019-03-31,1736,TAX,38993000.0,所得稅費用（利益）,喬山,生技醫療業
2019-03-31,1736,EPS,0.09,基本每股盈餘（元）,喬山,生技醫療業
2019-03-31,1736,PreTaxIncome,65344000.0,稅前淨利（淨損）,喬山,生技醫療業
2019-03-31,1736,IncomeFromContinuingOperations,26351000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2019-03-31,1736,IncomeAfterTaxes,26351000.0,本期淨利（淨損）,喬山,生技醫療業
2019-03-31,1736,TotalConsolidatedProfitForThePeriod,114102000.0,本期綜合損益總額,喬山,生技醫療業
2019-03-31,1736,Revenue,5336812000.0,營業收入,喬山,生技醫療業
2019-03-31,1736,CostOfGoodsSold,2695303000.0,營業成本,喬山,生技醫療業
2019-03-31,1736,GrossProfit,2641509000.0,營業毛利（毛損）淨額,喬山,生技醫療業
2019-03-31,1736,OperatingIncome,31982000.0,營業利益（損失）,喬山,生技醫療業
2019-03-31,1736,TotalNonoperatingIncomeAndExpense,33362000.0,營業外收入及支出,喬山,生技醫療業
2019-03-31,1736,OtherComprehensiveIncome,87751000.0,其他綜合損益（淨額）,喬山,生技醫療業
2019-03-31,1736,EquityAttributableToOwnersOfParent,25937000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2019-03-31,1736,NoncontrollingInterests,414000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2019-06-30,1736,IncomeBeforeIncomeTax,287736000.0,稅前淨利(淨損),喬山,生技醫療業
2019-06-30,1736,NetIncome,221839000.0,本期淨利(淨損),喬山,生技醫療業
2019-06-30,1736,OperatingExpenses,2654429000.0,營業費用,喬山,生技醫療業
2019-06-30,1736,TAX,65897000.0,所得稅費用（利益）,喬山,生技醫療業
2019-06-30,1736,EPS,0.73,基本每股盈餘（元）,喬山,生技醫療業
2019-06-30,1736,PreTaxIncome,287736000.0,稅前淨利（淨損）,喬山,生技醫療業
2019-06-30,1736,IncomeFromContinuingOperations,221839000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2019-06-30,1736,IncomeAfterTaxes,221839000.0,本期淨利（淨損）,喬山,生技醫療業
2019-06-30,1736,TotalConsolidatedProfitForThePeriod,241163000.0,本期綜合損益總額,喬山,生技醫療業
2019-06-30,1736,Revenue,5615217000.0,營業收入,喬山,生技醫療業
2019-06-30,1736,CostOfGoodsSold,2810843000.0,營業成本,喬山,生技醫療業
2019-06-30,1736,GrossProfit,2804374000.0,營業毛利（毛損）淨額,喬山,生技醫療業
2019-06-30,1736,OperatingIncome,149945000.0,營業利益（損失）,喬山,生技醫療業
2019-06-30,1736,TotalNonoperatingIncomeAndExpense,137791000.0,營業外收入及支出,喬山,生技醫療業
2019-06-30,1736,OtherComprehensiveIncome,19324000.0,其他綜合損益（淨額）,喬山,生技醫療業
2019-06-30,1736,EquityAttributableToOwnersOfParent,221556000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2019-06-30,1736,NoncontrollingInterests,283000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2019-09-30,1736,IncomeBeforeIncomeTax,438532000.0,稅前淨利(淨損),喬山,生技醫療業
2019-09-30,1736,NetIncome,341084000.0,本期淨利(淨損),喬山,生技醫療業
2019-09-30,1736,OperatingExpenses,2643616000.0,營業費用,喬山,生技醫療業
2019-09-30,1736,TAX,97448000.0,所得稅費用（利益）,喬山,生技醫療業
2019-09-30,1736,EPS,1.12,基本每股盈餘（元）,喬山,生技醫療業
2019-09-30,1736,PreTaxIncome,438532000.0,稅前淨利（淨損）,喬山,生技醫療業
2019-09-30,1736,IncomeFromContinuingOperations,341084000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2019-09-30,1736,IncomeAfterTaxes,341084000.0,本期淨利（淨損）,喬山,生技醫療業
2019-09-30,1736,TotalConsolidatedProfitForThePeriod,55957000.0,本期綜合損益總額,喬山,生技醫療業
2019-09-30,1736,Revenue,6159762000.0,營業收入,喬山,生技醫療業
2019-09-30,1736,CostOfGoodsSold,3073408000.0,營業成本,喬山,生技醫療業
2019-09-30,1736,GrossProfit,3086354000.0,營業毛利（毛損）淨額,喬山,生技醫療業
2019-09-30,1736,OperatingIncome,442738000.0,營業利益（損失）,喬山,生技醫療業
2019-09-30,1736,TotalNonoperatingIncomeAndExpense,-4206000.0,營業外收入及支出,喬山,生技醫療業
2019-09-30,1736,OtherComprehensiveIncome,-285127000.0,其他綜合損益（淨額）,喬山,生技醫療業
2019-09-30,1736,EquityAttributableToOwnersOfParent,341011000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2019-09-30,1736,NoncontrollingInterests,73000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2019-12-31,1736,IncomeBeforeIncomeTax,825590000.0,稅前淨利(淨損),喬山,生技醫療業
2019-12-31,1736,NetIncome,704747000.0,本期淨利(淨損),喬山,生技醫療業
2019-12-31,1736,OperatingExpenses,3030162000.0,營業費用,喬山,生技醫療業
2019-12-31,1736,TAX,120843000.0,所得稅費用（利益）,喬山,生技醫療業
2019-12-31,1736,EPS,2.32,基本每股盈餘（元）,喬山,生技醫療業
2019-12-31,1736,PreTaxIncome,825590000.0,稅前淨利（淨損）,喬山,生技醫療業
2019-12-31,1736,IncomeFromContinuingOperations,704747000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2019-12-31,1736,IncomeAfterTaxes,704747000.0,本期淨利（淨損）,喬山,生技醫療業
2019-12-31,1736,TotalConsolidatedProfitForThePeriod,520017000.0,本期綜合損益總額,喬山,生技醫療業
2019-12-31,1736,Revenue,8260770000.0,營業收入,喬山,生技醫療業
2019-12-31,1736,CostOfGoodsSold,4246140000.0,營業成本,喬山,生技醫療業
2019-12-31,1736,GrossProfit,4014630000.0,營業毛利（毛損）淨額,喬山,生技醫療業
2019-12-31,1736,OperatingIncome,984468000.0,營業利益（損失）,喬山,生技醫療業
2019-12-31,1736,TotalNonoperatingIncomeAndExpense,-158878000.0,營業外收入及支出,喬山,生技醫療業
2019-12-31,1736,OtherComprehensiveIncome,-184730000.0,其他綜合損益（淨額）,喬山,生技醫療業
2019-12-31,1736,EquityAttributableToOwnersOfParent,704027000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2019-12-31,1736,NoncontrollingInterests,720000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2020-03-31,1736,OperatingExpenses,2814255000.0,營業費用,喬山,生技醫療業
2020-03-31,1736,TAX,-49205000.0,所得稅費用（利益）,喬山,生技醫療業
2020-03-31,1736,EPS,-0.83,基本每股盈餘（元）,喬山,生技醫療業
2020-03-31,1736,PreTaxIncome,-283230000.0,稅前淨利（淨損）,喬山,生技醫療業
2020-03-31,1736,IncomeFromContinuingOperations,-234025000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2020-03-31,1736,IncomeAfterTaxes,-234025000.0,本期淨利（淨損）,喬山,生技醫療業
2020-03-31,1736,TotalConsolidatedProfitForThePeriod,-411412000.0,本期綜合損益總額,喬山,生技醫療業
2020-03-31,1736,Revenue,5534518000.0,營業收入,喬山,生技醫療業
2020-03-31,1736,CostOfGoodsSold,2926043000.0,營業成本,喬山,生技醫療業
2020-03-31,1736,GrossProfit,2608475000.0,營業毛利（毛損）淨額,喬山,生技醫療業
2020-03-31,1736,OperatingIncome,-205780000.0,營業利益（損失）,喬山,生技醫療業
2020-03-31,1736,TotalNonoperatingIncomeAndExpense,-77450000.0,營業外收入及支出,喬山,生技醫療業
2020-03-31,1736,OtherComprehensiveIncome,-177387000.0,其他綜合損益（淨額）,喬山,生技醫療業
2020-03-31,1736,EquityAttributableToOwnersOfParent,-252013000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2020-03-31,1736,NoncontrollingInterests,17988000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2020-06-30,1736,OperatingExpenses,2751287000.0,營業費用,喬山,生技醫療業
2020-06-30,1736,TAX,30978000.0,所得稅費用（利益）,喬山,生技醫療業
2020-06-30,1736,EPS,-0.03,基本每股盈餘（元）,喬山,生技醫療業
2020-06-30,1736,PreTaxIncome,18309000.0,稅前淨利（淨損）,喬山,生技醫療業
2020-06-30,1736,IncomeFromContinuingOperations,-12669000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2020-06-30,1736,IncomeAfterTaxes,-12669000.0,本期淨利（淨損）,喬山,生技醫療業
2020-06-30,1736,TotalConsolidatedProfitForThePeriod,-128376000.0,本期綜合損益總額,喬山,生技醫療業
2020-06-30,1736,Revenue,5629193000.0,營業收入,喬山,生技醫療業
2020-06-30,1736,CostOfGoodsSold,2997002000.0,營業成本,喬山,生技醫療業
2020-06-30,1736,GrossProfit,2632191000.0,營業毛利（毛損）淨額,喬山,生技醫療業
2020-06-30,1736,OperatingIncome,-119096000.0,營業利益（損失）,喬山,生技醫療業
2020-06-30,1736,TotalNonoperatingIncomeAndExpense,137405000.0,營業外收入及支出,喬山,生技醫療業
2020-06-30,1736,OtherComprehensiveIncome,-115707000.0,其他綜合損益（淨額）,喬山,生技醫療業
2020-06-30,1736,EquityAttributableToOwnersOfParent,-8830000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2020-06-30,1736,NoncontrollingInterests,-3839000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2020-09-30,1736,OperatingExpenses,3053754000.0,營業費用,喬山,生技醫療業
2020-09-30,1736,TAX,81982000.0,所得稅費用（利益）,喬山,生技醫療業
2020-09-30,1736,EPS,1.49,基本每股盈餘（元）,喬山,生技醫療業
2020-09-30,1736,PreTaxIncome,571006000.0,稅前淨利（淨損）,喬山,生技醫療業
2020-09-30,1736,IncomeFromContinuingOperations,489024000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2020-09-30,1736,IncomeAfterTaxes,489024000.0,本期淨利（淨損）,喬山,生技醫療業
2020-09-30,1736,TotalConsolidatedProfitForThePeriod,603304000.0,本期綜合損益總額,喬山,生技醫療業
2020-09-30,1736,Revenue,7476843000.0,營業收入,喬山,生技醫療業
2020-09-30,1736,CostOfGoodsSold,3867410000.0,營業成本,喬山,生技醫療業
2020-09-30,1736,GrossProfit,3609433000.0,營業毛利（毛損）淨額,喬山,生技醫療業
2020-09-30,1736,OperatingIncome,555679000.0,營業利益（損失）,喬山,生技醫療業
2020-09-30,1736,TotalNonoperatingIncomeAndExpense,15327000.0,營業外收入及支出,喬山,生技醫療業
2020-09-30,1736,OtherComprehensiveIncome,114280000.0,其他綜合損益（淨額）,喬山,生技醫療業
2020-09-30,1736,EquityAttributableToOwnersOfParent,451260000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2020-09-30,1736,NoncontrollingInterests,37764000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2020-12-31,1736,OperatingExpenses,3848102000.0,營業費用,喬山,生技醫療業
2020-12-31,1736,TAX,164223000.0,所得稅費用（利益）,喬山,生技醫療業
2020-12-31,1736,EPS,1.61,基本每股盈餘（元）,喬山,生技醫療業
2020-12-31,1736,PreTaxIncome,669247000.0,稅前淨利（淨損）,喬山,生技醫療業
2020-12-31,1736,IncomeFromContinuingOperations,505024000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2020-12-31,1736,IncomeAfterTaxes,505024000.0,本期淨利（淨損）,喬山,生技醫療業
2020-12-31,1736,TotalConsolidatedProfitForThePeriod,648022000.0,本期綜合損益總額,喬山,生技醫療業
2020-12-31,1736,Revenue,9726202000.0,營業收入,喬山,生技醫療業
2020-12-31,1736,CostOfGoodsSold,5178814000.0,營業成本,喬山,生技醫療業
2020-12-31,1736,GrossProfit,4547388000.0,營業毛利（毛損）淨額,喬山,生技醫療業
2020-12-31,1736,OperatingIncome,699286000.0,營業利益（損失）,喬山,生技醫療業
2020-12-31,1736,TotalNonoperatingIncomeAndExpense,-30039000.0,營業外收入及支出,喬山,生技醫療業
2020-12-31,1736,OtherComprehensiveIncome,142998000.0,其他綜合損益（淨額）,喬山,生技醫療業
2020-12-31,1736,EquityAttributableToOwnersOfParent,488876000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2020-12-31,1736,NoncontrollingInterests,16148000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2021-03-31,1736,OperatingExpenses,3475255000.0,營業費用,喬山,生技醫療業
2021-03-31,1736,TAX,54636000.0,所得稅費用（利益）,喬山,生技醫療業
2021-03-31,1736,EPS,0.22,基本每股盈餘（元）,喬山,生技醫療業
2021-03-31,1736,PreTaxIncome,145566000.0,稅前淨利（淨損）,喬山,生技醫療業
2021-03-31,1736,IncomeFromContinuingOperations,90930000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2021-03-31,1736,IncomeAfterTaxes,90930000.0,本期淨利（淨損）,喬山,生技醫療業
2021-03-31,1736,TotalConsolidatedProfitForThePeriod,-156496000.0,本期綜合損益總額,喬山,生技醫療業
2021-03-31,1736,Revenue,7269513000.0,營業收入,喬山,生技醫療業
2021-03-31,1736,CostOfGoodsSold,3715773000.0,營業成本,喬山,生技醫療業
2021-03-31,1736,OperatingIncome,78485000.0,營業利益（損失）,喬山,生技醫療業
2021-03-31,1736,TotalNonoperatingIncomeAndExpense,67081000.0,營業外收入及支出,喬山,生技醫療業
2021-03-31,1736,OtherComprehensiveIncome,-247426000.0,其他綜合損益（淨額）,喬山,生技醫療業
2021-03-31,1736,GrossProfit,3553740000.0,營業毛利（毛損）,喬山,生技醫療業
2021-03-31,1736,EquityAttributableToOwnersOfParent,67533000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2021-03-31,1736,NoncontrollingInterests,23397000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2021-03-31,1736,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-13033000.0,綜合損益總額歸屬於非控制權益,喬山,生技醫療業
2021-06-30,1736,OperatingExpenses,3093273000.0,營業費用,喬山,生技醫療業
2021-06-30,1736,TAX,47964000.0,所得稅費用（利益）,喬山,生技醫療業
2021-06-30,1736,PreTaxIncome,55989000.0,稅前淨利（淨損）,喬山,生技醫療業
2021-06-30,1736,IncomeFromContinuingOperations,8025000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2021-06-30,1736,IncomeAfterTaxes,8025000.0,本期淨利（淨損）,喬山,生技醫療業
2021-06-30,1736,TotalConsolidatedProfitForThePeriod,-133788000.0,本期綜合損益總額,喬山,生技醫療業
2021-06-30,1736,Revenue,6551785000.0,營業收入,喬山,生技醫療業
2021-06-30,1736,CostOfGoodsSold,3459629000.0,營業成本,喬山,生技醫療業
2021-06-30,1736,OperatingIncome,-1117000.0,營業利益（損失）,喬山,生技醫療業
2021-06-30,1736,TotalNonoperatingIncomeAndExpense,57106000.0,營業外收入及支出,喬山,生技醫療業
2021-06-30,1736,OtherComprehensiveIncome,-141813000.0,其他綜合損益（淨額）,喬山,生技醫療業
2021-06-30,1736,GrossProfit,3092156000.0,營業毛利（毛損）,喬山,生技醫療業
2021-06-30,1736,EquityAttributableToOwnersOfParent,3420000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2021-06-30,1736,NoncontrollingInterests,4605000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2021-06-30,1736,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-6412000.0,綜合損益總額歸屬於非控制權益,喬山,生技醫療業
2021-06-30,1736,EPS,0.01,基本每股盈餘（元）,喬山,生技醫療業
2021-09-30,1736,OperatingExpenses,3471904000.0,營業費用,喬山,生技醫療業
2021-09-30,1736,TAX,-107182000.0,所得稅費用（利益）,喬山,生技醫療業
2021-09-30,1736,EPS,-1.67,基本每股盈餘（元）,喬山,生技醫療業
2021-09-30,1736,PreTaxIncome,-605849000.0,稅前淨利（淨損）,喬山,生技醫療業
2021-09-30,1736,IncomeFromContinuingOperations,-498667000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2021-09-30,1736,IncomeAfterTaxes,-498667000.0,本期淨利（淨損）,喬山,生技醫療業
2021-09-30,1736,TotalConsolidatedProfitForThePeriod,-622845000.0,本期綜合損益總額,喬山,生技醫療業
2021-09-30,1736,Revenue,7217094000.0,營業收入,喬山,生技醫療業
2021-09-30,1736,CostOfGoodsSold,4300515000.0,營業成本,喬山,生技醫療業
2021-09-30,1736,OperatingIncome,-555325000.0,營業利益（損失）,喬山,生技醫療業
2021-09-30,1736,TotalNonoperatingIncomeAndExpense,-50524000.0,營業外收入及支出,喬山,生技醫療業
2021-09-30,1736,OtherComprehensiveIncome,-124178000.0,其他綜合損益（淨額）,喬山,生技醫療業
2021-09-30,1736,EquityAttributableToOwnersOfParent,-507310000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2021-09-30,1736,NoncontrollingInterests,8643000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2021-09-30,1736,GrossProfit,2916579000.0,營業毛利（毛損）,喬山,生技醫療業
2021-09-30,1736,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,2134000.0,綜合損益總額歸屬於非控制權益,喬山,生技醫療業
2021-12-31,1736,OperatingExpenses,3711636000.0,營業費用,喬山,生技醫療業
2021-12-31,1736,TAX,68913000.0,所得稅費用（利益）,喬山,生技醫療業
2021-12-31,1736,PreTaxIncome,567994000.0,稅前淨利（淨損）,喬山,生技醫療業
2021-12-31,1736,IncomeFromContinuingOperations,499081000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2021-12-31,1736,IncomeAfterTaxes,499081000.0,本期淨利（淨損）,喬山,生技醫療業
2021-12-31,1736,TotalConsolidatedProfitForThePeriod,370619000.0,本期綜合損益總額,喬山,生技醫療業
2021-12-31,1736,Revenue,9740936000.0,營業收入,喬山,生技醫療業
2021-12-31,1736,CostOfGoodsSold,5397155000.0,營業成本,喬山,生技醫療業
2021-12-31,1736,OperatingIncome,632145000.0,營業利益（損失）,喬山,生技醫療業
2021-12-31,1736,TotalNonoperatingIncomeAndExpense,-64151000.0,營業外收入及支出,喬山,生技醫療業
2021-12-31,1736,OtherComprehensiveIncome,-128462000.0,其他綜合損益（淨額）,喬山,生技醫療業
2021-12-31,1736,GrossProfit,4343781000.0,營業毛利（毛損）,喬山,生技醫療業
2021-12-31,1736,EquityAttributableToOwnersOfParent,474505000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2021-12-31,1736,NoncontrollingInterests,24576000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2021-12-31,1736,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,6078000.0,綜合損益總額歸屬於非控制權益,喬山,生技醫療業
2021-12-31,1736,EPS,1.57,基本每股盈餘（元）,喬山,生技醫療業
2022-03-31,1736,OperatingExpenses,3315249000.0,營業費用,喬山,生技醫療業
2022-03-31,1736,TAX,10253000.0,所得稅費用（利益）,喬山,生技醫療業
2022-03-31,1736,EPS,0.27,基本每股盈餘（元）,喬山,生技醫療業
2022-03-31,1736,PreTaxIncome,101150000.0,稅前淨利（淨損）,喬山,生技醫療業
2022-03-31,1736,IncomeFromContinuingOperations,90897000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2022-03-31,1736,IncomeAfterTaxes,90897000.0,本期淨利（淨損）,喬山,生技醫療業
2022-03-31,1736,TotalConsolidatedProfitForThePeriod,349552000.0,本期綜合損益總額,喬山,生技醫療業
2022-03-31,1736,Revenue,7526625000.0,營業收入,喬山,生技醫療業
2022-03-31,1736,CostOfGoodsSold,4386460000.0,營業成本,喬山,生技醫療業
2022-03-31,1736,OperatingIncome,-175084000.0,營業利益（損失）,喬山,生技醫療業
2022-03-31,1736,TotalNonoperatingIncomeAndExpense,276234000.0,營業外收入及支出,喬山,生技醫療業
2022-03-31,1736,OtherComprehensiveIncome,258655000.0,其他綜合損益（淨額）,喬山,生技醫療業
2022-03-31,1736,EquityAttributableToOwnersOfParent,82026000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2022-03-31,1736,NoncontrollingInterests,8871000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2022-03-31,1736,GrossProfit,3140165000.0,營業毛利（毛損）,喬山,生技醫療業
2022-03-31,1736,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-2578000.0,綜合損益總額歸屬於非控制權益,喬山,生技醫療業
2022-06-30,1736,OperatingExpenses,3386397000.0,營業費用,喬山,生技醫療業
2022-06-30,1736,TAX,-129206000.0,所得稅費用（利益）,喬山,生技醫療業
2022-06-30,1736,EPS,-1.35,基本每股盈餘（元）,喬山,生技醫療業
2022-06-30,1736,PreTaxIncome,-538085000.0,稅前淨利（淨損）,喬山,生技醫療業
2022-06-30,1736,IncomeFromContinuingOperations,-408879000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2022-06-30,1736,IncomeAfterTaxes,-408879000.0,本期淨利（淨損）,喬山,生技醫療業
2022-06-30,1736,TotalConsolidatedProfitForThePeriod,-616420000.0,本期綜合損益總額,喬山,生技醫療業
2022-06-30,1736,Revenue,6567106000.0,營業收入,喬山,生技醫療業
2022-06-30,1736,CostOfGoodsSold,3931360000.0,營業成本,喬山,生技醫療業
2022-06-30,1736,OperatingIncome,-750651000.0,營業利益（損失）,喬山,生技醫療業
2022-06-30,1736,TotalNonoperatingIncomeAndExpense,212566000.0,營業外收入及支出,喬山,生技醫療業
2022-06-30,1736,OtherComprehensiveIncome,-207541000.0,其他綜合損益（淨額）,喬山,生技醫療業
2022-06-30,1736,GrossProfit,2635746000.0,營業毛利（毛損）,喬山,生技醫療業
2022-06-30,1736,EquityAttributableToOwnersOfParent,-410280000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2022-06-30,1736,NoncontrollingInterests,1401000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2022-06-30,1736,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-33262000.0,綜合損益總額歸屬於非控制權益,喬山,生技醫療業
2022-09-30,1736,OperatingExpenses,3612834000.0,營業費用,喬山,生技醫療業
2022-09-30,1736,TAX,-6581000.0,所得稅費用（利益）,喬山,生技醫療業
2022-09-30,1736,PreTaxIncome,10293000.0,稅前淨利（淨損）,喬山,生技醫療業
2022-09-30,1736,IncomeFromContinuingOperations,16874000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2022-09-30,1736,IncomeAfterTaxes,16874000.0,本期淨利（淨損）,喬山,生技醫療業
2022-09-30,1736,TotalConsolidatedProfitForThePeriod,140977000.0,本期綜合損益總額,喬山,生技醫療業
2022-09-30,1736,Revenue,8028788000.0,營業收入,喬山,生技醫療業
2022-09-30,1736,CostOfGoodsSold,4531453000.0,營業成本,喬山,生技醫療業
2022-09-30,1736,OperatingIncome,-115499000.0,營業利益（損失）,喬山,生技醫療業
2022-09-30,1736,TotalNonoperatingIncomeAndExpense,125792000.0,營業外收入及支出,喬山,生技醫療業
2022-09-30,1736,OtherComprehensiveIncome,124103000.0,其他綜合損益（淨額）,喬山,生技醫療業
2022-09-30,1736,EquityAttributableToOwnersOfParent,223175000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2022-09-30,1736,NoncontrollingInterests,-206301000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2022-09-30,1736,GrossProfit,3497335000.0,營業毛利（毛損）,喬山,生技醫療業
2022-09-30,1736,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-194638000.0,綜合損益總額歸屬於非控制權益,喬山,生技醫療業
2022-09-30,1736,EPS,0.73,基本每股盈餘（元）,喬山,生技醫療業
2022-12-31,1736,OperatingExpenses,4506825000.0,營業費用,喬山,生技醫療業
2022-12-31,1736,TAX,204199000.0,所得稅費用（利益）,喬山,生技醫療業
2022-12-31,1736,EPS,1.77,基本每股盈餘（元）,喬山,生技醫療業
2022-12-31,1736,PreTaxIncome,730248000.0,稅前淨利（淨損）,喬山,生技醫療業
2022-12-31,1736,IncomeFromContinuingOperations,526049000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2022-12-31,1736,IncomeAfterTaxes,526049000.0,本期淨利（淨損）,喬山,生技醫療業
2022-12-31,1736,TotalConsolidatedProfitForThePeriod,770256000.0,本期綜合損益總額,喬山,生技醫療業
2022-12-31,1736,Revenue,11490428000.0,營業收入,喬山,生技醫療業
2022-12-31,1736,CostOfGoodsSold,6157303000.0,營業成本,喬山,生技醫療業
2022-12-31,1736,OperatingIncome,826300000.0,營業利益（損失）,喬山,生技醫療業
2022-12-31,1736,TotalNonoperatingIncomeAndExpense,-96052000.0,營業外收入及支出,喬山,生技醫療業
2022-12-31,1736,OtherComprehensiveIncome,244207000.0,其他綜合損益（淨額）,喬山,生技醫療業
2022-12-31,1736,GrossProfit,5333125000.0,營業毛利（毛損）,喬山,生技醫療業
2022-12-31,1736,EquityAttributableToOwnersOfParent,534103000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2022-12-31,1736,NoncontrollingInterests,-8054000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2022-12-31,1736,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,120142000.0,綜合損益總額歸屬於非控制權益,喬山,生技醫療業
2023-03-31,1736,OperatingExpenses,3860306000.0,營業費用,喬山,生技醫療業
2023-03-31,1736,TAX,-69509000.0,所得稅費用（利益）,喬山,生技醫療業
2023-03-31,1736,EPS,-2.14,基本每股盈餘（元）,喬山,生技醫療業
2023-03-31,1736,PreTaxIncome,-716463000.0,稅前淨利（淨損）,喬山,生技醫療業
2023-03-31,1736,IncomeFromContinuingOperations,-646954000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2023-03-31,1736,IncomeAfterTaxes,-646954000.0,本期淨利（淨損）,喬山,生技醫療業
2023-03-31,1736,TotalConsolidatedProfitForThePeriod,-643140000.0,本期綜合損益總額,喬山,生技醫療業
2023-03-31,1736,Revenue,7035347000.0,營業收入,喬山,生技醫療業
2023-03-31,1736,CostOfGoodsSold,3764938000.0,營業成本,喬山,生技醫療業
2023-03-31,1736,OperatingIncome,-589897000.0,營業利益（損失）,喬山,生技醫療業
2023-03-31,1736,TotalNonoperatingIncomeAndExpense,-126566000.0,營業外收入及支出,喬山,生技醫療業
2023-03-31,1736,OtherComprehensiveIncome,3814000.0,其他綜合損益（淨額）,喬山,生技醫療業
2023-03-31,1736,EquityAttributableToOwnersOfParent,-646761000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2023-03-31,1736,NoncontrollingInterests,-193000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2023-03-31,1736,GrossProfit,3270409000.0,營業毛利（毛損）,喬山,生技醫療業
2023-03-31,1736,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-225000.0,綜合損益總額歸屬於非控制權益,喬山,生技醫療業
2023-06-30,1736,OperatingExpenses,4002561000.0,營業費用,喬山,生技醫療業
2023-06-30,1736,TAX,150464000.0,所得稅費用（利益）,喬山,生技醫療業
2023-06-30,1736,EPS,1.11,基本每股盈餘（元）,喬山,生技醫療業
2023-06-30,1736,PreTaxIncome,483651000.0,稅前淨利（淨損）,喬山,生技醫療業
2023-06-30,1736,IncomeFromContinuingOperations,333187000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2023-06-30,1736,IncomeAfterTaxes,333187000.0,本期淨利（淨損）,喬山,生技醫療業
2023-06-30,1736,TotalConsolidatedProfitForThePeriod,257679000.0,本期綜合損益總額,喬山,生技醫療業
2023-06-30,1736,Revenue,8636292000.0,營業收入,喬山,生技醫療業
2023-06-30,1736,CostOfGoodsSold,4544710000.0,營業成本,喬山,生技醫療業
2023-06-30,1736,OperatingIncome,89021000.0,營業利益（損失）,喬山,生技醫療業
2023-06-30,1736,TotalNonoperatingIncomeAndExpense,394630000.0,營業外收入及支出,喬山,生技醫療業
2023-06-30,1736,OtherComprehensiveIncome,-75508000.0,其他綜合損益（淨額）,喬山,生技醫療業
2023-06-30,1736,EquityAttributableToOwnersOfParent,333334000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2023-06-30,1736,NoncontrollingInterests,-147000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2023-06-30,1736,GrossProfit,4091582000.0,營業毛利（毛損）,喬山,生技醫療業
2023-06-30,1736,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-288000.0,綜合損益總額歸屬於非控制權益,喬山,生技醫療業
2023-09-30,1736,OperatingExpenses,4241115000.0,營業費用,喬山,生技醫療業
2023-09-30,1736,TAX,191988000.0,所得稅費用（利益）,喬山,生技醫療業
2023-09-30,1736,EPS,1.22,基本每股盈餘（元）,喬山,生技醫療業
2023-09-30,1736,PreTaxIncome,561407000.0,稅前淨利（淨損）,喬山,生技醫療業
2023-09-30,1736,IncomeFromContinuingOperations,369419000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2023-09-30,1736,IncomeAfterTaxes,369419000.0,本期淨利（淨損）,喬山,生技醫療業
2023-09-30,1736,TotalConsolidatedProfitForThePeriod,567061000.0,本期綜合損益總額,喬山,生技醫療業
2023-09-30,1736,Revenue,9675946000.0,營業收入,喬山,生技醫療業
2023-09-30,1736,CostOfGoodsSold,4954903000.0,營業成本,喬山,生技醫療業
2023-09-30,1736,OperatingIncome,479928000.0,營業利益（損失）,喬山,生技醫療業
2023-09-30,1736,TotalNonoperatingIncomeAndExpense,81479000.0,營業外收入及支出,喬山,生技醫療業
2023-09-30,1736,OtherComprehensiveIncome,197642000.0,其他綜合損益（淨額）,喬山,生技醫療業
2023-09-30,1736,GrossProfit,4721043000.0,營業毛利（毛損）,喬山,生技醫療業
2023-09-30,1736,EquityAttributableToOwnersOfParent,369542000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2023-09-30,1736,NoncontrollingInterests,-123000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2023-09-30,1736,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-155000.0,綜合損益總額歸屬於非控制權益,喬山,生技醫療業
2023-12-31,1736,OperatingExpenses,5081013000.0,營業費用,喬山,生技醫療業
2023-12-31,1736,TAX,352102000.0,所得稅費用（利益）,喬山,生技醫療業
2023-12-31,1736,EPS,2.15,基本每股盈餘（元）,喬山,生技醫療業
2023-12-31,1736,PreTaxIncome,1005887000.0,稅前淨利（淨損）,喬山,生技醫療業
2023-12-31,1736,IncomeFromContinuingOperations,653785000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2023-12-31,1736,IncomeAfterTaxes,653785000.0,本期淨利（淨損）,喬山,生技醫療業
2023-12-31,1736,TotalConsolidatedProfitForThePeriod,167316000.0,本期綜合損益總額,喬山,生技醫療業
2023-12-31,1736,Revenue,12721978000.0,營業收入,喬山,生技醫療業
2023-12-31,1736,CostOfGoodsSold,6377702000.0,營業成本,喬山,生技醫療業
2023-12-31,1736,OperatingIncome,1263263000.0,營業利益（損失）,喬山,生技醫療業
2023-12-31,1736,TotalNonoperatingIncomeAndExpense,-257376000.0,營業外收入及支出,喬山,生技醫療業
2023-12-31,1736,OtherComprehensiveIncome,-486469000.0,其他綜合損益（淨額）,喬山,生技醫療業
2023-12-31,1736,EquityAttributableToOwnersOfParent,653713000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2023-12-31,1736,NoncontrollingInterests,72000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2023-12-31,1736,GrossProfit,6344276000.0,營業毛利（毛損）,喬山,生技醫療業
2023-12-31,1736,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,230000.0,綜合損益總額歸屬於非控制權益,喬山,生技醫療業
2024-03-31,1736,OperatingExpenses,4349544000.0,營業費用,喬山,生技醫療業
2024-03-31,1736,TAX,88123000.0,所得稅費用（利益）,喬山,生技醫療業
2024-03-31,1736,EPS,-0.46,基本每股盈餘（元）,喬山,生技醫療業
2024-03-31,1736,PreTaxIncome,-50058000.0,稅前淨利（淨損）,喬山,生技醫療業
2024-03-31,1736,IncomeFromContinuingOperations,-138181000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2024-03-31,1736,IncomeAfterTaxes,-138181000.0,本期淨利（淨損）,喬山,生技醫療業
2024-03-31,1736,TotalConsolidatedProfitForThePeriod,78271000.0,本期綜合損益總額,喬山,生技醫療業
2024-03-31,1736,Revenue,8026174000.0,營業收入,喬山,生技醫療業
2024-03-31,1736,CostOfGoodsSold,4008417000.0,營業成本,喬山,生技醫療業
2024-03-31,1736,OperatingIncome,-331787000.0,營業利益（損失）,喬山,生技醫療業
2024-03-31,1736,TotalNonoperatingIncomeAndExpense,281729000.0,營業外收入及支出,喬山,生技醫療業
2024-03-31,1736,OtherComprehensiveIncome,216452000.0,其他綜合損益（淨額）,喬山,生技醫療業
2024-03-31,1736,NoncontrollingInterests,-281000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2024-03-31,1736,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-712000.0,綜合損益總額歸屬於非控制權益,喬山,生技醫療業
2024-03-31,1736,GrossProfit,4017757000.0,營業毛利（毛損）,喬山,生技醫療業
2024-03-31,1736,EquityAttributableToOwnersOfParent,-137900000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2024-06-30,1736,OperatingExpenses,4832970000.0,營業費用,喬山,生技醫療業
2024-06-30,1736,TAX,180286000.0,所得稅費用（利益）,喬山,生技醫療業
2024-06-30,1736,EPS,0.97,基本每股盈餘（元）,喬山,生技醫療業
2024-06-30,1736,PreTaxIncome,472206000.0,稅前淨利（淨損）,喬山,生技醫療業
2024-06-30,1736,IncomeFromContinuingOperations,291920000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2024-06-30,1736,IncomeAfterTaxes,291920000.0,本期淨利（淨損）,喬山,生技醫療業
2024-06-30,1736,TotalConsolidatedProfitForThePeriod,279712000.0,本期綜合損益總額,喬山,生技醫療業
2024-06-30,1736,Revenue,10307812000.0,營業收入,喬山,生技醫療業
2024-06-30,1736,CostOfGoodsSold,5067184000.0,營業成本,喬山,生技醫療業
2024-06-30,1736,OperatingIncome,407658000.0,營業利益（損失）,喬山,生技醫療業
2024-06-30,1736,TotalNonoperatingIncomeAndExpense,64548000.0,營業外收入及支出,喬山,生技醫療業
2024-06-30,1736,OtherComprehensiveIncome,-12208000.0,其他綜合損益（淨額）,喬山,生技醫療業
2024-06-30,1736,NoncontrollingInterests,-169000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2024-06-30,1736,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-193000.0,綜合損益總額歸屬於非控制權益,喬山,生技醫療業
2024-06-30,1736,GrossProfit,5240628000.0,營業毛利（毛損）,喬山,生技醫療業
2024-06-30,1736,EquityAttributableToOwnersOfParent,292089000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2024-09-30,1736,OperatingExpenses,5257272000.0,營業費用,喬山,生技醫療業
2024-09-30,1736,TAX,272355000.0,所得稅費用（利益）,喬山,生技醫療業
2024-09-30,1736,EPS,1.57,基本每股盈餘（元）,喬山,生技醫療業
2024-09-30,1736,PreTaxIncome,747171000.0,稅前淨利（淨損）,喬山,生技醫療業
2024-09-30,1736,IncomeFromContinuingOperations,474816000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2024-09-30,1736,IncomeAfterTaxes,474816000.0,本期淨利（淨損）,喬山,生技醫療業
2024-09-30,1736,TotalConsolidatedProfitForThePeriod,616303000.0,本期綜合損益總額,喬山,生技醫療業
2024-09-30,1736,Revenue,12075058000.0,營業收入,喬山,生技醫療業
2024-09-30,1736,CostOfGoodsSold,5850857000.0,營業成本,喬山,生技醫療業
2024-09-30,1736,OperatingIncome,966929000.0,營業利益（損失）,喬山,生技醫療業
2024-09-30,1736,TotalNonoperatingIncomeAndExpense,-219758000.0,營業外收入及支出,喬山,生技醫療業
2024-09-30,1736,OtherComprehensiveIncome,141487000.0,其他綜合損益（淨額）,喬山,生技醫療業
2024-09-30,1736,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,609000.0,綜合損益總額歸屬於非控制權益,喬山,生技醫療業
2024-09-30,1736,NoncontrollingInterests,88000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2024-09-30,1736,EquityAttributableToOwnersOfParent,474728000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2024-09-30,1736,GrossProfit,6224201000.0,營業毛利（毛損）,喬山,生技醫療業
2024-12-31,1736,OperatingExpenses,6646296000.0,營業費用,喬山,生技醫療業
2024-12-31,1736,TAX,520917000.0,所得稅費用（利益）,喬山,生技醫療業
2024-12-31,1736,PreTaxIncome,2323015000.0,稅前淨利（淨損）,喬山,生技醫療業
2024-12-31,1736,IncomeFromContinuingOperations,1802098000.0,繼續營業單位本期淨利（淨損）,喬山,生技醫療業
2024-12-31,1736,IncomeAfterTaxes,1802098000.0,本期淨利（淨損）,喬山,生技醫療業
2024-12-31,1736,TotalConsolidatedProfitForThePeriod,1688956000.0,本期綜合損益總額,喬山,生技醫療業
2024-12-31,1736,Revenue,17376354000.0,營業收入,喬山,生技醫療業
2024-12-31,1736,CostOfGoodsSold,8581040000.0,營業成本,喬山,生技醫療業
2024-12-31,1736,OperatingIncome,2149018000.0,營業利益（損失）,喬山,生技醫療業
2024-12-31,1736,TotalNonoperatingIncomeAndExpense,173997000.0,營業外收入及支出,喬山,生技醫療業
2024-12-31,1736,OtherComprehensiveIncome,-113142000.0,其他綜合損益（淨額）,喬山,生技醫療業
2024-12-31,1736,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,631000.0,綜合損益總額歸屬於非控制權益,喬山,生技醫療業
2024-12-31,1736,NoncontrollingInterests,835000.0,淨利（淨損）歸屬於非控制權益,喬山,生技醫療業
2024-12-31,1736,EquityAttributableToOwnersOfParent,1801263000.0,淨利（淨損）歸屬於母公司業主,喬山,生技醫療業
2024-12-31,1736,GrossProfit,8795314000.0,營業毛利（毛損）,喬山,生技醫療業
2024-12-31,1736,EPS,5.94,基本每股盈餘（元）,喬山,生技醫療業
2019-03-31,1736,AccountsPayable_per,12.85,應付帳款,喬山,生技醫療業
2019-03-31,1736,AccountsReceivableNet,5965990000.0,應收帳款淨額,喬山,生技醫療業
2019-03-31,1736,AccountsReceivableNet_per,23.41,應收帳款淨額,喬山,生技醫療業
2019-03-31,1736,BondsPayable,0.0,應付公司債,喬山,生技醫療業
2019-03-31,1736,BondsPayable_per,0.0,應付公司債,喬山,生技醫療業
2019-03-31,1736,CapitalStock_per,11.93,股本合計,喬山,生技醫療業
2019-03-31,1736,CapitalSurplus,64971000.0,資本公積合計,喬山,生技醫療業
2019-03-31,1736,CapitalSurplus_per,0.25,資本公積合計,喬山,生技醫療業
2019-03-31,1736,CashAndCashEquivalents_per,15.81,現金及約當現金,喬山,生技醫療業
2019-03-31,1736,CurrentAssets_per,69.08,流動資產合計,喬山,生技醫療業
2019-03-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,7394000.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2019-03-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.03,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2019-03-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,3394000.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2019-03-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.01,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2019-03-31,1736,CurrentLiabilities_per,52.02,流動負債合計,喬山,生技醫療業
2019-03-31,1736,DeferredTaxAssets_per,4.93,遞延所得稅資產,喬山,生技醫療業
2019-03-31,1736,EquityAttributableToOwnersOfParent_per,33.54,歸屬於母公司業主之權益合計,喬山,生技醫療業
2019-03-31,1736,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,0.0,預收股款（權益項下）之約當發行股數,喬山,生技醫療業
2019-03-31,1736,IntangibleAssets,1219960000.0,無形資產,喬山,生技醫療業
2019-03-31,1736,IntangibleAssets_per,4.79,無形資產,喬山,生技醫療業
2019-03-31,1736,Inventories_per,24.8,存貨,喬山,生技醫療業
2019-03-31,1736,LegalReserve_per,5.0,法定盈餘公積,喬山,生技醫療業
2019-03-31,1736,LongtermBorrowings_per,7.3,長期借款,喬山,生技醫療業
2019-03-31,1736,NoncontrollingInterests,6344000.0,非控制權益,喬山,生技醫療業
2019-03-31,1736,NoncontrollingInterests_per,0.02,非控制權益,喬山,生技醫療業
2019-03-31,1736,NoncurrentAssets_per,30.92,非流動資產合計,喬山,生技醫療業
2019-03-31,1736,NoncurrentLiabilities_per,14.42,非流動負債合計,喬山,生技醫療業
2019-03-31,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,900000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2019-03-31,1736,OrdinaryShare_per,11.93,普通股股本,喬山,生技醫療業
2019-03-31,1736,OtherCurrentAssets,66140000.0,其他流動資產,喬山,生技醫療業
2019-03-31,1736,OtherCurrentAssets_per,0.26,其他流動資產,喬山,生技醫療業
2019-03-31,1736,OtherCurrentLiabilities,745666000.0,其他流動負債,喬山,生技醫療業
2019-03-31,1736,OtherCurrentLiabilities_per,2.93,其他流動負債,喬山,生技醫療業
2019-03-31,1736,OtherNoncurrentAssets,346805000.0,其他非流動資產,喬山,生技醫療業
2019-03-31,1736,OtherNoncurrentAssets_per,1.36,其他非流動資產,喬山,生技醫療業
2019-03-31,1736,OtherNoncurrentLiabilities,165055000.0,其他非流動負債,喬山,生技醫療業
2019-03-31,1736,OtherNoncurrentLiabilities_per,0.65,其他非流動負債,喬山,生技醫療業
2019-03-31,1736,OtherPayables_per,8.1,其他應付款,喬山,生技醫療業
2019-03-31,1736,OtherReceivable,459764000.0,其他應收款淨額,喬山,生技醫療業
2019-03-31,1736,OtherReceivable_per,1.8,其他應收款淨額,喬山,生技醫療業
2019-03-31,1736,PropertyPlantAndEquipment_per,12.15,不動產、廠房及設備,喬山,生技醫療業
2019-03-31,1736,RetainedEarnings_per,25.19,保留盈餘合計,喬山,生技醫療業
2019-03-31,1736,ShorttermBorrowings_per,21.68,短期借款,喬山,生技醫療業
2019-03-31,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2019-03-31,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2019-03-31,1736,CashAndCashEquivalents,4030827000.0,現金及約當現金,喬山,生技醫療業
2019-03-31,1736,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2019-03-31,1736,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2019-03-31,1736,BillsReceivableNet,75811000.0,應收票據淨額,喬山,生技醫療業
2019-03-31,1736,BillsReceivableNet_per,0.3,應收票據淨額,喬山,生技醫療業
2019-03-31,1736,Prepayments,609402000.0,預付款項,喬山,生技醫療業
2019-03-31,1736,Prepayments_per,2.39,預付款項,喬山,生技醫療業
2019-03-31,1736,Inventories,6320833000.0,存貨,喬山,生技醫療業
2019-03-31,1736,CurrentAssets,17607541000.0,流動資產合計,喬山,生技醫療業
2019-03-31,1736,PropertyPlantAndEquipment,3097574000.0,不動產、廠房及設備,喬山,生技醫療業
2019-03-31,1736,DeferredTaxAssets,1255568000.0,遞延所得稅資產,喬山,生技醫療業
2019-03-31,1736,NoncurrentAssets,7881488000.0,非流動資產合計,喬山,生技醫療業
2019-03-31,1736,TotalAssets,25489029000.0,資產總額,喬山,生技醫療業
2019-03-31,1736,ShorttermBorrowings,5525961000.0,短期借款,喬山,生技醫療業
2019-03-31,1736,AccountsPayable,3275151000.0,應付帳款,喬山,生技醫療業
2019-03-31,1736,OtherPayables,2064455000.0,其他應付款,喬山,生技醫療業
2019-03-31,1736,CurrentLiabilities,13258957000.0,流動負債合計,喬山,生技醫療業
2019-03-31,1736,LongtermBorrowings,1861273000.0,長期借款,喬山,生技醫療業
2019-03-31,1736,NoncurrentLiabilities,3675355000.0,非流動負債合計,喬山,生技醫療業
2019-03-31,1736,OrdinaryShare,3040166000.0,普通股股本,喬山,生技醫療業
2019-03-31,1736,CapitalStock,3040166000.0,股本合計,喬山,生技醫療業
2019-03-31,1736,LegalReserve,1273663000.0,法定盈餘公積,喬山,生技醫療業
2019-03-31,1736,RetainedEarnings,6420975000.0,保留盈餘合計,喬山,生技醫療業
2019-03-31,1736,EquityAttributableToOwnersOfParent,8548373000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2019-03-31,1736,TotalLiabilitiesEquity,25489029000.0,負債及權益總計,喬山,生技醫療業
2019-03-31,1736,RightOfUseAsset,1961581000.0,使用權資產,喬山,生技醫療業
2019-03-31,1736,RightOfUseAsset_per,7.7,使用權資產,喬山,生技醫療業
2019-03-31,1736,CurrentTaxLiabilities,387998000.0,本期所得稅負債,喬山,生技醫療業
2019-03-31,1736,CurrentTaxLiabilities_per,1.52,本期所得稅負債,喬山,生技醫療業
2019-03-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,4159903000.0,未分配盈餘,喬山,生技醫療業
2019-03-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,16.32,未分配盈餘,喬山,生技醫療業
2019-03-31,1736,OtherEquityInterest,-928791000.0,其他權益合計,喬山,生技醫療業
2019-03-31,1736,OtherEquityInterest_per,-3.64,其他權益合計,喬山,生技醫療業
2019-03-31,1736,Liabilities,16934312000.0,負債總,喬山,生技醫療業
2019-03-31,1736,Liabilities_per,66.44,負債總,喬山,生技醫療業
2019-03-31,1736,Equity,8554717000.0,權益總額,喬山,生技醫療業
2019-03-31,1736,Equity_per,33.56,權益總額,喬山,生技醫療業
2019-06-30,1736,AccountsPayable_per,11.76,應付帳款,喬山,生技醫療業
2019-06-30,1736,AccountsReceivableNet_per,23.02,應收帳款淨額,喬山,生技醫療業
2019-06-30,1736,BondsPayable,0.0,應付公司債,喬山,生技醫療業
2019-06-30,1736,BondsPayable_per,0.0,應付公司債,喬山,生技醫療業
2019-06-30,1736,CapitalStock_per,11.7,股本合計,喬山,生技醫療業
2019-06-30,1736,CapitalSurplus,54924000.0,資本公積合計,喬山,生技醫療業
2019-06-30,1736,CapitalSurplus_per,0.21,資本公積合計,喬山,生技醫療業
2019-06-30,1736,CashAndCashEquivalents_per,14.66,現金及約當現金,喬山,生技醫療業
2019-06-30,1736,CurrentAssets_per,69.15,流動資產合計,喬山,生技醫療業
2019-06-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,2040000.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2019-06-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.01,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2019-06-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,2265000.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2019-06-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.01,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2019-06-30,1736,CurrentLiabilities_per,54.35,流動負債合計,喬山,生技醫療業
2019-06-30,1736,DeferredTaxAssets_per,4.67,遞延所得稅資產,喬山,生技醫療業
2019-06-30,1736,EquityAttributableToOwnersOfParent_per,33.16,歸屬於母公司業主之權益合計,喬山,生技醫療業
2019-06-30,1736,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,0.0,預收股款（權益項下）之約當發行股數,喬山,生技醫療業
2019-06-30,1736,IntangibleAssets_per,4.72,無形資產,喬山,生技醫療業
2019-06-30,1736,Inventories_per,26.36,存貨,喬山,生技醫療業
2019-06-30,1736,LegalReserve_per,5.06,法定盈餘公積,喬山,生技醫療業
2019-06-30,1736,LongtermBorrowings_per,6.24,長期借款,喬山,生技醫療業
2019-06-30,1736,NoncontrollingInterests,6824000.0,非控制權益,喬山,生技醫療業
2019-06-30,1736,NoncontrollingInterests_per,0.03,非控制權益,喬山,生技醫療業
2019-06-30,1736,NoncurrentAssets_per,30.85,非流動資產合計,喬山,生技醫療業
2019-06-30,1736,NoncurrentLiabilities_per,12.46,非流動負債合計,喬山,生技醫療業
2019-06-30,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2019-06-30,1736,OrdinaryShare_per,11.7,普通股股本,喬山,生技醫療業
2019-06-30,1736,OtherCurrentAssets,113668000.0,其他流動資產,喬山,生技醫療業
2019-06-30,1736,OtherCurrentAssets_per,0.44,其他流動資產,喬山,生技醫療業
2019-06-30,1736,OtherCurrentLiabilities,881218000.0,其他流動負債,喬山,生技醫療業
2019-06-30,1736,OtherCurrentLiabilities_per,3.4,其他流動負債,喬山,生技醫療業
2019-06-30,1736,OtherNoncurrentAssets,386644000.0,其他非流動資產,喬山,生技醫療業
2019-06-30,1736,OtherNoncurrentAssets_per,1.49,其他非流動資產,喬山,生技醫療業
2019-06-30,1736,OtherNoncurrentLiabilities,172883000.0,其他非流動負債,喬山,生技醫療業
2019-06-30,1736,OtherNoncurrentLiabilities_per,0.67,其他非流動負債,喬山,生技醫療業
2019-06-30,1736,OtherPayables_per,8.8,其他應付款,喬山,生技醫療業
2019-06-30,1736,OtherReceivable,440333000.0,其他應收款淨額,喬山,生技醫療業
2019-06-30,1736,OtherReceivable_per,1.7,其他應收款淨額,喬山,生技醫療業
2019-06-30,1736,PropertyPlantAndEquipment_per,12.53,不動產、廠房及設備,喬山,生技醫療業
2019-06-30,1736,RetainedEarnings_per,24.75,保留盈餘合計,喬山,生技醫療業
2019-06-30,1736,ShorttermBorrowings_per,24.35,短期借款,喬山,生技醫療業
2019-06-30,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2019-06-30,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2019-06-30,1736,CashAndCashEquivalents,3801701000.0,現金及約當現金,喬山,生技醫療業
2019-06-30,1736,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2019-06-30,1736,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2019-06-30,1736,BillsReceivableNet,53486000.0,應收票據淨額,喬山,生技醫療業
2019-06-30,1736,BillsReceivableNet_per,0.21,應收票據淨額,喬山,生技醫療業
2019-06-30,1736,Prepayments,620707000.0,預付款項,喬山,生技醫療業
2019-06-30,1736,Prepayments_per,2.39,預付款項,喬山,生技醫療業
2019-06-30,1736,AccountsReceivableNet,5970754000.0,應收帳款淨額,喬山,生技醫療業
2019-06-30,1736,Inventories,6836786000.0,存貨,喬山,生技醫療業
2019-06-30,1736,CurrentAssets,17938932000.0,流動資產合計,喬山,生技醫療業
2019-06-30,1736,PropertyPlantAndEquipment,3251155000.0,不動產、廠房及設備,喬山,生技醫療業
2019-06-30,1736,IntangibleAssets,1224583000.0,無形資產,喬山,生技醫療業
2019-06-30,1736,DeferredTaxAssets,1211433000.0,遞延所得稅資產,喬山,生技醫療業
2019-06-30,1736,NoncurrentAssets,8002184000.0,非流動資產合計,喬山,生技醫療業
2019-06-30,1736,TotalAssets,25941116000.0,資產總額,喬山,生技醫療業
2019-06-30,1736,ShorttermBorrowings,6317819000.0,短期借款,喬山,生技醫療業
2019-06-30,1736,AccountsPayable,3049488000.0,應付帳款,喬山,生技醫療業
2019-06-30,1736,OtherPayables,2282744000.0,其他應付款,喬山,生技醫療業
2019-06-30,1736,CurrentLiabilities,14098441000.0,流動負債合計,喬山,生技醫療業
2019-06-30,1736,LongtermBorrowings,1617502000.0,長期借款,喬山,生技醫療業
2019-06-30,1736,NoncurrentLiabilities,3233424000.0,非流動負債合計,喬山,生技醫療業
2019-06-30,1736,OrdinaryShare,3036166000.0,普通股股本,喬山,生技醫療業
2019-06-30,1736,CapitalStock,3036166000.0,股本合計,喬山,生技醫療業
2019-06-30,1736,LegalReserve,1312641000.0,法定盈餘公積,喬山,生技醫療業
2019-06-30,1736,RetainedEarnings,6420804000.0,保留盈餘合計,喬山,生技醫療業
2019-06-30,1736,EquityAttributableToOwnersOfParent,8602427000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2019-06-30,1736,TotalLiabilitiesEquity,25941116000.0,負債及權益總計,喬山,生技醫療業
2019-06-30,1736,RightOfUseAsset,1928369000.0,使用權資產,喬山,生技醫療業
2019-06-30,1736,RightOfUseAsset_per,7.43,使用權資產,喬山,生技醫療業
2019-06-30,1736,CurrentTaxLiabilities,210404000.0,本期所得稅負債,喬山,生技醫療業
2019-06-30,1736,CurrentTaxLiabilities_per,0.81,本期所得稅負債,喬山,生技醫療業
2019-06-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,4091621000.0,未分配盈餘,喬山,生技醫療業
2019-06-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,15.77,未分配盈餘,喬山,生技醫療業
2019-06-30,1736,OtherEquityInterest,-909467000.0,其他權益合計,喬山,生技醫療業
2019-06-30,1736,OtherEquityInterest_per,-3.51,其他權益合計,喬山,生技醫療業
2019-06-30,1736,Liabilities,17331865000.0,負債總,喬山,生技醫療業
2019-06-30,1736,Liabilities_per,66.81,負債總,喬山,生技醫療業
2019-06-30,1736,Equity,8609251000.0,權益總額,喬山,生技醫療業
2019-06-30,1736,Equity_per,33.19,權益總額,喬山,生技醫療業
2019-09-30,1736,AccountsPayable_per,12.36,應付帳款,喬山,生技醫療業
2019-09-30,1736,AccountsReceivableNet_per,22.55,應收帳款淨額,喬山,生技醫療業
2019-09-30,1736,BondsPayable,2000000000.0,應付公司債,喬山,生技醫療業
2019-09-30,1736,BondsPayable_per,7.52,應付公司債,喬山,生技醫療業
2019-09-30,1736,CapitalStock_per,11.41,股本合計,喬山,生技醫療業
2019-09-30,1736,CapitalSurplus,54924000.0,資本公積合計,喬山,生技醫療業
2019-09-30,1736,CapitalSurplus_per,0.21,資本公積合計,喬山,生技醫療業
2019-09-30,1736,CashAndCashEquivalents_per,12.94,現金及約當現金,喬山,生技醫療業
2019-09-30,1736,CurrentAssets_per,68.62,流動資產合計,喬山,生技醫療業
2019-09-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,4109000.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2019-09-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.02,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2019-09-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,26636000.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2019-09-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.1,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2019-09-30,1736,CurrentLiabilities_per,50.47,流動負債合計,喬山,生技醫療業
2019-09-30,1736,DeferredTaxAssets_per,5.08,遞延所得稅資產,喬山,生技醫療業
2019-09-30,1736,EquityAttributableToOwnersOfParent_per,32.36,歸屬於母公司業主之權益合計,喬山,生技醫療業
2019-09-30,1736,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,0.0,預收股款（權益項下）之約當發行股數,喬山,生技醫療業
2019-09-30,1736,IntangibleAssets_per,4.58,無形資產,喬山,生技醫療業
2019-09-30,1736,Inventories_per,27.93,存貨,喬山,生技醫療業
2019-09-30,1736,LegalReserve_per,4.93,法定盈餘公積,喬山,生技醫療業
2019-09-30,1736,LongtermBorrowings,752385000.0,長期借款,喬山,生技醫療業
2019-09-30,1736,LongtermBorrowings_per,2.83,長期借款,喬山,生技醫療業
2019-09-30,1736,NoncontrollingInterests,6827000.0,非控制權益,喬山,生技醫療業
2019-09-30,1736,NoncontrollingInterests_per,0.03,非控制權益,喬山,生技醫療業
2019-09-30,1736,NoncurrentAssets_per,31.38,非流動資產合計,喬山,生技醫療業
2019-09-30,1736,NoncurrentLiabilities_per,17.15,非流動負債合計,喬山,生技醫療業
2019-09-30,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,600000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2019-09-30,1736,OrdinaryShare_per,11.41,普通股股本,喬山,生技醫療業
2019-09-30,1736,OtherCurrentAssets,52506000.0,其他流動資產,喬山,生技醫療業
2019-09-30,1736,OtherCurrentAssets_per,0.2,其他流動資產,喬山,生技醫療業
2019-09-30,1736,OtherCurrentLiabilities,518752000.0,其他流動負債,喬山,生技醫療業
2019-09-30,1736,OtherCurrentLiabilities_per,1.95,其他流動負債,喬山,生技醫療業
2019-09-30,1736,OtherNoncurrentAssets,417312000.0,其他非流動資產,喬山,生技醫療業
2019-09-30,1736,OtherNoncurrentAssets_per,1.57,其他非流動資產,喬山,生技醫療業
2019-09-30,1736,OtherNoncurrentLiabilities,168659000.0,其他非流動負債,喬山,生技醫療業
2019-09-30,1736,OtherNoncurrentLiabilities_per,0.63,其他非流動負債,喬山,生技醫療業
2019-09-30,1736,OtherPayables_per,8.16,其他應付款,喬山,生技醫療業
2019-09-30,1736,OtherReceivable,464957000.0,其他應收款淨額,喬山,生技醫療業
2019-09-30,1736,OtherReceivable_per,1.75,其他應收款淨額,喬山,生技醫療業
2019-09-30,1736,PropertyPlantAndEquipment,3290000000.0,不動產、廠房及設備,喬山,生技醫療業
2019-09-30,1736,PropertyPlantAndEquipment_per,12.36,不動產、廠房及設備,喬山,生技醫療業
2019-09-30,1736,RetainedEarnings_per,25.41,保留盈餘合計,喬山,生技醫療業
2019-09-30,1736,ShorttermBorrowings_per,21.76,短期借款,喬山,生技醫療業
2019-09-30,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2019-09-30,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2019-09-30,1736,CashAndCashEquivalents,3444732000.0,現金及約當現金,喬山,生技醫療業
2019-09-30,1736,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2019-09-30,1736,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2019-09-30,1736,BillsReceivableNet,63240000.0,應收票據淨額,喬山,生技醫療業
2019-09-30,1736,BillsReceivableNet_per,0.24,應收票據淨額,喬山,生技醫療業
2019-09-30,1736,Prepayments,680170000.0,預付款項,喬山,生技醫療業
2019-09-30,1736,Prepayments_per,2.56,預付款項,喬山,生技醫療業
2019-09-30,1736,AccountsReceivableNet,6001826000.0,應收帳款淨額,喬山,生技醫療業
2019-09-30,1736,Inventories,7433761000.0,存貨,喬山,生技醫療業
2019-09-30,1736,CurrentAssets,18262064000.0,流動資產合計,喬山,生技醫療業
2019-09-30,1736,IntangibleAssets,1217845000.0,無形資產,喬山,生技醫療業
2019-09-30,1736,DeferredTaxAssets,1350911000.0,遞延所得稅資產,喬山,生技醫療業
2019-09-30,1736,NoncurrentAssets,8350252000.0,非流動資產合計,喬山,生技醫療業
2019-09-30,1736,TotalAssets,26612316000.0,資產總額,喬山,生技醫療業
2019-09-30,1736,ShorttermBorrowings,5791667000.0,短期借款,喬山,生技醫療業
2019-09-30,1736,AccountsPayable,3288182000.0,應付帳款,喬山,生技醫療業
2019-09-30,1736,OtherPayables,2170286000.0,其他應付款,喬山,生技醫療業
2019-09-30,1736,CurrentLiabilities,13432204000.0,流動負債合計,喬山,生技醫療業
2019-09-30,1736,NoncurrentLiabilities,4562806000.0,非流動負債合計,喬山,生技醫療業
2019-09-30,1736,OrdinaryShare,3036166000.0,普通股股本,喬山,生技醫療業
2019-09-30,1736,CapitalStock,3036166000.0,股本合計,喬山,生技醫療業
2019-09-30,1736,LegalReserve,1312641000.0,法定盈餘公積,喬山,生技醫療業
2019-09-30,1736,RetainedEarnings,6761815000.0,保留盈餘合計,喬山,生技醫療業
2019-09-30,1736,EquityAttributableToOwnersOfParent,8610479000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2019-09-30,1736,TotalLiabilitiesEquity,26612316000.0,負債及權益總計,喬山,生技醫療業
2019-09-30,1736,RightOfUseAsset,2074184000.0,使用權資產,喬山,生技醫療業
2019-09-30,1736,RightOfUseAsset_per,7.79,使用權資產,喬山,生技醫療業
2019-09-30,1736,CurrentTaxLiabilities,262475000.0,本期所得稅負債,喬山,生技醫療業
2019-09-30,1736,CurrentTaxLiabilities_per,0.99,本期所得稅負債,喬山,生技醫療業
2019-09-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,4432632000.0,未分配盈餘,喬山,生技醫療業
2019-09-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,16.66,未分配盈餘,喬山,生技醫療業
2019-09-30,1736,OtherEquityInterest,-1194594000.0,其他權益合計,喬山,生技醫療業
2019-09-30,1736,OtherEquityInterest_per,-4.49,其他權益合計,喬山,生技醫療業
2019-09-30,1736,Liabilities,17995010000.0,負債總,喬山,生技醫療業
2019-09-30,1736,Liabilities_per,67.62,負債總,喬山,生技醫療業
2019-09-30,1736,Equity,8617306000.0,權益總額,喬山,生技醫療業
2019-09-30,1736,Equity_per,32.38,權益總額,喬山,生技醫療業
2019-12-31,1736,AccountsPayable_per,12.38,應付帳款,喬山,生技醫療業
2019-12-31,1736,AccountsReceivableNet_per,27.51,應收帳款淨額,喬山,生技醫療業
2019-12-31,1736,BondsPayable,2000000000.0,應付公司債,喬山,生技醫療業
2019-12-31,1736,BondsPayable_per,7.43,應付公司債,喬山,生技醫療業
2019-12-31,1736,CapitalStock_per,11.27,股本合計,喬山,生技醫療業
2019-12-31,1736,CapitalSurplus,54924000.0,資本公積合計,喬山,生技醫療業
2019-12-31,1736,CapitalSurplus_per,0.2,資本公積合計,喬山,生技醫療業
2019-12-31,1736,CashAndCashEquivalents_per,12.18,現金及約當現金,喬山,生技醫療業
2019-12-31,1736,CurrentAssets_per,68.17,流動資產合計,喬山,生技醫療業
2019-12-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,5216000.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2019-12-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.02,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2019-12-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,17129000.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2019-12-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.06,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2019-12-31,1736,CurrentLiabilities_per,48.82,流動負債合計,喬山,生技醫療業
2019-12-31,1736,DeferredTaxAssets_per,5.46,遞延所得稅資產,喬山,生技醫療業
2019-12-31,1736,EquityAttributableToOwnersOfParent_per,33.9,歸屬於母公司業主之權益合計,喬山,生技醫療業
2019-12-31,1736,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,0.0,預收股款（權益項下）之約當發行股數,喬山,生技醫療業
2019-12-31,1736,IntangibleAssets_per,4.58,無形資產,喬山,生技醫療業
2019-12-31,1736,Inventories_per,24.3,存貨,喬山,生技醫療業
2019-12-31,1736,LegalReserve_per,4.87,法定盈餘公積,喬山,生技醫療業
2019-12-31,1736,LongtermBorrowings,669032000.0,長期借款,喬山,生技醫療業
2019-12-31,1736,LongtermBorrowings_per,2.48,長期借款,喬山,生技醫療業
2019-12-31,1736,NoncontrollingInterests,7450000.0,非控制權益,喬山,生技醫療業
2019-12-31,1736,NoncontrollingInterests_per,0.03,非控制權益,喬山,生技醫療業
2019-12-31,1736,NoncurrentAssets_per,31.83,非流動資產合計,喬山,生技醫療業
2019-12-31,1736,NoncurrentLiabilities_per,17.25,非流動負債合計,喬山,生技醫療業
2019-12-31,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,600000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2019-12-31,1736,OrdinaryShare_per,11.27,普通股股本,喬山,生技醫療業
2019-12-31,1736,OtherCurrentAssets,65392000.0,其他流動資產,喬山,生技醫療業
2019-12-31,1736,OtherCurrentAssets_per,0.24,其他流動資產,喬山,生技醫療業
2019-12-31,1736,OtherCurrentLiabilities,579991000.0,其他流動負債,喬山,生技醫療業
2019-12-31,1736,OtherCurrentLiabilities_per,2.15,其他流動負債,喬山,生技醫療業
2019-12-31,1736,OtherNoncurrentAssets,473306000.0,其他非流動資產,喬山,生技醫療業
2019-12-31,1736,OtherNoncurrentAssets_per,1.76,其他非流動資產,喬山,生技醫療業
2019-12-31,1736,OtherNoncurrentLiabilities,259490000.0,其他非流動負債,喬山,生技醫療業
2019-12-31,1736,OtherNoncurrentLiabilities_per,0.96,其他非流動負債,喬山,生技醫療業
2019-12-31,1736,OtherPayables_per,8.88,其他應付款,喬山,生技醫療業
2019-12-31,1736,OtherReceivable,403635000.0,其他應收款淨額,喬山,生技醫療業
2019-12-31,1736,OtherReceivable_per,1.5,其他應收款淨額,喬山,生技醫療業
2019-12-31,1736,PropertyPlantAndEquipment,3261000000.0,不動產、廠房及設備,喬山,生技醫療業
2019-12-31,1736,PropertyPlantAndEquipment_per,12.11,不動產、廠房及設備,喬山,生技醫療業
2019-12-31,1736,RetainedEarnings_per,27.69,保留盈餘合計,喬山,生技醫療業
2019-12-31,1736,ShorttermBorrowings_per,19.33,短期借款,喬山,生技醫療業
2019-12-31,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2019-12-31,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2019-12-31,1736,CashAndCashEquivalents,3280481000.0,現金及約當現金,喬山,生技醫療業
2019-12-31,1736,AccountsReceivableNet,7411001000.0,應收帳款淨額,喬山,生技醫療業
2019-12-31,1736,Inventories,6544891000.0,存貨,喬山,生技醫療業
2019-12-31,1736,CurrentAssets,18361403000.0,流動資產合計,喬山,生技醫療業
2019-12-31,1736,IntangibleAssets,1234304000.0,無形資產,喬山,生技醫療業
2019-12-31,1736,DeferredTaxAssets,1471574000.0,遞延所得稅資產,喬山,生技醫療業
2019-12-31,1736,NoncurrentAssets,8573908000.0,非流動資產合計,喬山,生技醫療業
2019-12-31,1736,TotalAssets,26935311000.0,資產總額,喬山,生技醫療業
2019-12-31,1736,ShorttermBorrowings,5207681000.0,短期借款,喬山,生技醫療業
2019-12-31,1736,AccountsPayable,3335362000.0,應付帳款,喬山,生技醫療業
2019-12-31,1736,OtherPayables,2393089000.0,其他應付款,喬山,生技醫療業
2019-12-31,1736,CurrentLiabilities,13150648000.0,流動負債合計,喬山,生技醫療業
2019-12-31,1736,NoncurrentLiabilities,4647437000.0,非流動負債合計,喬山,生技醫療業
2019-12-31,1736,OrdinaryShare,3036166000.0,普通股股本,喬山,生技醫療業
2019-12-31,1736,CapitalStock,3036166000.0,股本合計,喬山,生技醫療業
2019-12-31,1736,LegalReserve,1312641000.0,法定盈餘公積,喬山,生技醫療業
2019-12-31,1736,RetainedEarnings,7457357000.0,保留盈餘合計,喬山,生技醫療業
2019-12-31,1736,EquityAttributableToOwnersOfParent,9129776000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2019-12-31,1736,TotalLiabilitiesEquity,26935311000.0,負債及權益總計,喬山,生技醫療業
2019-12-31,1736,BillsReceivableNet,53896000.0,應收票據淨額,喬山,生技醫療業
2019-12-31,1736,BillsReceivableNet_per,0.2,應收票據淨額,喬山,生技醫療業
2019-12-31,1736,Prepayments,521680000.0,預付款項,喬山,生技醫療業
2019-12-31,1736,Prepayments_per,1.94,預付款項,喬山,生技醫療業
2019-12-31,1736,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2019-12-31,1736,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2019-12-31,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,0.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2019-12-31,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2019-12-31,1736,RightOfUseAsset,2133724000.0,使用權資產,喬山,生技醫療業
2019-12-31,1736,RightOfUseAsset_per,7.92,使用權資產,喬山,生技醫療業
2019-12-31,1736,CurrentTaxLiabilities,358841000.0,本期所得稅負債,喬山,生技醫療業
2019-12-31,1736,CurrentTaxLiabilities_per,1.33,本期所得稅負債,喬山,生技醫療業
2019-12-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,5128174000.0,未分配盈餘,喬山,生技醫療業
2019-12-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,19.04,未分配盈餘,喬山,生技醫療業
2019-12-31,1736,OtherEquityInterest,-1370839000.0,其他權益合計,喬山,生技醫療業
2019-12-31,1736,OtherEquityInterest_per,-5.09,其他權益合計,喬山,生技醫療業
2019-12-31,1736,Liabilities,17798085000.0,負債總,喬山,生技醫療業
2019-12-31,1736,Liabilities_per,66.08,負債總,喬山,生技醫療業
2019-12-31,1736,Equity,9137226000.0,權益總額,喬山,生技醫療業
2019-12-31,1736,Equity_per,33.92,權益總額,喬山,生技醫療業
2020-03-31,1736,AccountsPayable_per,9.47,應付帳款,喬山,生技醫療業
2020-03-31,1736,AccountsReceivableNet_per,22.41,應收帳款淨額,喬山,生技醫療業
2020-03-31,1736,BondsPayable,2000000000.0,應付公司債,喬山,生技醫療業
2020-03-31,1736,BondsPayable_per,6.84,應付公司債,喬山,生技醫療業
2020-03-31,1736,CapitalStock_per,10.39,股本合計,喬山,生技醫療業
2020-03-31,1736,CapitalSurplus,54924000.0,資本公積合計,喬山,生技醫療業
2020-03-31,1736,CapitalSurplus_per,0.19,資本公積合計,喬山,生技醫療業
2020-03-31,1736,CashAndCashEquivalents_per,10.66,現金及約當現金,喬山,生技醫療業
2020-03-31,1736,CurrentAssets_per,60.72,流動資產合計,喬山,生技醫療業
2020-03-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,6357000.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2020-03-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.02,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2020-03-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,29382000.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2020-03-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.1,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2020-03-31,1736,CurrentLiabilities_per,48.32,流動負債合計,喬山,生技醫療業
2020-03-31,1736,DeferredTaxAssets_per,5.45,遞延所得稅資產,喬山,生技醫療業
2020-03-31,1736,EquityAttributableToOwnersOfParent_per,29.83,歸屬於母公司業主之權益合計,喬山,生技醫療業
2020-03-31,1736,IntangibleAssets,2354950000.0,無形資產,喬山,生技醫療業
2020-03-31,1736,IntangibleAssets_per,8.06,無形資產,喬山,生技醫療業
2020-03-31,1736,Inventories_per,23.77,存貨,喬山,生技醫療業
2020-03-31,1736,LegalReserve_per,4.49,法定盈餘公積,喬山,生技醫療業
2020-03-31,1736,LongtermBorrowings_per,6.32,長期借款,喬山,生技醫療業
2020-03-31,1736,NoncontrollingInterests,476504000.0,非控制權益,喬山,生技醫療業
2020-03-31,1736,NoncontrollingInterests_per,1.63,非控制權益,喬山,生技醫療業
2020-03-31,1736,NoncurrentAssets_per,39.28,非流動資產合計,喬山,生技醫療業
2020-03-31,1736,NoncurrentLiabilities_per,20.22,非流動負債合計,喬山,生技醫療業
2020-03-31,1736,OrdinaryShare_per,10.39,普通股股本,喬山,生技醫療業
2020-03-31,1736,OtherCurrentAssets,67624000.0,其他流動資產,喬山,生技醫療業
2020-03-31,1736,OtherCurrentAssets_per,0.23,其他流動資產,喬山,生技醫療業
2020-03-31,1736,OtherCurrentLiabilities,674720000.0,其他流動負債,喬山,生技醫療業
2020-03-31,1736,OtherCurrentLiabilities_per,2.31,其他流動負債,喬山,生技醫療業
2020-03-31,1736,OtherNoncurrentAssets_per,3.92,其他非流動資產,喬山,生技醫療業
2020-03-31,1736,OtherNoncurrentLiabilities,351348000.0,其他非流動負債,喬山,生技醫療業
2020-03-31,1736,OtherNoncurrentLiabilities_per,1.2,其他非流動負債,喬山,生技醫療業
2020-03-31,1736,OtherPayables_per,7.88,其他應付款,喬山,生技醫療業
2020-03-31,1736,OtherReceivable,368816000.0,其他應收款淨額,喬山,生技醫療業
2020-03-31,1736,OtherReceivable_per,1.26,其他應收款淨額,喬山,生技醫療業
2020-03-31,1736,PropertyPlantAndEquipment_per,13.62,不動產、廠房及設備,喬山,生技醫療業
2020-03-31,1736,RetainedEarnings_per,24.65,保留盈餘合計,喬山,生技醫療業
2020-03-31,1736,ShorttermBorrowings_per,22.68,短期借款,喬山,生技醫療業
2020-03-31,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2020-03-31,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2020-03-31,1736,CashAndCashEquivalents,3117597000.0,現金及約當現金,喬山,生技醫療業
2020-03-31,1736,AccountsReceivableNet,6550265000.0,應收帳款淨額,喬山,生技醫療業
2020-03-31,1736,Inventories,6949052000.0,存貨,喬山,生技醫療業
2020-03-31,1736,CurrentAssets,17750560000.0,流動資產合計,喬山,生技醫療業
2020-03-31,1736,PropertyPlantAndEquipment,3980765000.0,不動產、廠房及設備,喬山,生技醫療業
2020-03-31,1736,DeferredTaxAssets,1593638000.0,遞延所得稅資產,喬山,生技醫療業
2020-03-31,1736,OtherNoncurrentAssets,1146355000.0,其他非流動資產,喬山,生技醫療業
2020-03-31,1736,NoncurrentAssets,11484645000.0,非流動資產合計,喬山,生技醫療業
2020-03-31,1736,TotalAssets,29235205000.0,資產總額,喬山,生技醫療業
2020-03-31,1736,ShorttermBorrowings,6629639000.0,短期借款,喬山,生技醫療業
2020-03-31,1736,AccountsPayable,2767188000.0,應付帳款,喬山,生技醫療業
2020-03-31,1736,OtherPayables,2304796000.0,其他應付款,喬山,生技醫療業
2020-03-31,1736,CurrentLiabilities,14127066000.0,流動負債合計,喬山,生技醫療業
2020-03-31,1736,LongtermBorrowings,1846356000.0,長期借款,喬山,生技醫療業
2020-03-31,1736,NoncurrentLiabilities,5911476000.0,非流動負債合計,喬山,生技醫療業
2020-03-31,1736,OrdinaryShare,3036166000.0,普通股股本,喬山,生技醫療業
2020-03-31,1736,CapitalStock,3036166000.0,股本合計,喬山,生技醫療業
2020-03-31,1736,LegalReserve,1312641000.0,法定盈餘公積,喬山,生技醫療業
2020-03-31,1736,RetainedEarnings,7205344000.0,保留盈餘合計,喬山,生技醫療業
2020-03-31,1736,EquityAttributableToOwnersOfParent,8720159000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2020-03-31,1736,TotalLiabilitiesEquity,29235205000.0,負債及權益總計,喬山,生技醫療業
2020-03-31,1736,FinancialAssetsAtAmortizedCost,3824000.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2020-03-31,1736,FinancialAssetsAtAmortizedCost_per,0.01,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2020-03-31,1736,BillsReceivableNet,65694000.0,應收票據淨額,喬山,生技醫療業
2020-03-31,1736,BillsReceivableNet_per,0.22,應收票據淨額,喬山,生技醫療業
2020-03-31,1736,Prepayments,594719000.0,預付款項,喬山,生技醫療業
2020-03-31,1736,Prepayments_per,2.03,預付款項,喬山,生技醫療業
2020-03-31,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,0.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2020-03-31,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2020-03-31,1736,RightOfUseAsset,2361374000.0,使用權資產,喬山,生技醫療業
2020-03-31,1736,RightOfUseAsset_per,8.08,使用權資產,喬山,生技醫療業
2020-03-31,1736,CurrentTaxLiabilities,342384000.0,本期所得稅負債,喬山,生技醫療業
2020-03-31,1736,CurrentTaxLiabilities_per,1.17,本期所得稅負債,喬山,生技醫療業
2020-03-31,1736,Liabilities,20038542000.0,負債總額,喬山,生技醫療業
2020-03-31,1736,Liabilities_per,68.54,負債總額,喬山,生技醫療業
2020-03-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,4876161000.0,未分配盈餘,喬山,生技醫療業
2020-03-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,16.68,未分配盈餘,喬山,生技醫療業
2020-03-31,1736,OtherEquityInterest,-1528360000.0,其他權益合計,喬山,生技醫療業
2020-03-31,1736,OtherEquityInterest_per,-5.23,其他權益合計,喬山,生技醫療業
2020-03-31,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,642000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2020-03-31,1736,Equity,9196663000.0,權益總額,喬山,生技醫療業
2020-03-31,1736,Equity_per,31.46,權益總額,喬山,生技醫療業
2020-06-30,1736,AccountsPayable_per,9.18,應付帳款,喬山,生技醫療業
2020-06-30,1736,AccountsReceivableNet,6014240000.0,應收帳款淨額,喬山,生技醫療業
2020-06-30,1736,AccountsReceivableNet_per,20.96,應收帳款淨額,喬山,生技醫療業
2020-06-30,1736,BondsPayable,2000000000.0,應付公司債,喬山,生技醫療業
2020-06-30,1736,BondsPayable_per,6.97,應付公司債,喬山,生技醫療業
2020-06-30,1736,CapitalStock_per,10.58,股本合計,喬山,生技醫療業
2020-06-30,1736,CapitalSurplus,54924000.0,資本公積合計,喬山,生技醫療業
2020-06-30,1736,CapitalSurplus_per,0.19,資本公積合計,喬山,生技醫療業
2020-06-30,1736,CashAndCashEquivalents_per,11.53,現金及約當現金,喬山,生技醫療業
2020-06-30,1736,CurrentAssets_per,60.1,流動資產合計,喬山,生技醫療業
2020-06-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,224000.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2020-06-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2020-06-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,10397000.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2020-06-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.04,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2020-06-30,1736,CurrentLiabilities_per,49.59,流動負債合計,喬山,生技醫療業
2020-06-30,1736,DeferredTaxAssets_per,5.54,遞延所得稅資產,喬山,生技醫療業
2020-06-30,1736,EquityAttributableToOwnersOfParent_per,28.39,歸屬於母公司業主之權益合計,喬山,生技醫療業
2020-06-30,1736,IntangibleAssets_per,8.19,無形資產,喬山,生技醫療業
2020-06-30,1736,Inventories_per,23.91,存貨,喬山,生技醫療業
2020-06-30,1736,LegalReserve_per,5.03,法定盈餘公積,喬山,生技醫療業
2020-06-30,1736,LongtermBorrowings_per,6.41,長期借款,喬山,生技醫療業
2020-06-30,1736,NoncontrollingInterests,467330000.0,非控制權益,喬山,生技醫療業
2020-06-30,1736,NoncontrollingInterests_per,1.63,非控制權益,喬山,生技醫療業
2020-06-30,1736,NoncurrentAssets_per,39.9,非流動資產合計,喬山,生技醫療業
2020-06-30,1736,NoncurrentLiabilities_per,20.4,非流動負債合計,喬山,生技醫療業
2020-06-30,1736,OrdinaryShare_per,10.58,普通股股本,喬山,生技醫療業
2020-06-30,1736,OtherCurrentAssets,66290000.0,其他流動資產,喬山,生技醫療業
2020-06-30,1736,OtherCurrentAssets_per,0.23,其他流動資產,喬山,生技醫療業
2020-06-30,1736,OtherCurrentLiabilities,739370000.0,其他流動負債,喬山,生技醫療業
2020-06-30,1736,OtherCurrentLiabilities_per,2.58,其他流動負債,喬山,生技醫療業
2020-06-30,1736,OtherNoncurrentAssets_per,3.98,其他非流動資產,喬山,生技醫療業
2020-06-30,1736,OtherNoncurrentLiabilities,257988000.0,其他非流動負債,喬山,生技醫療業
2020-06-30,1736,OtherNoncurrentLiabilities_per,0.9,其他非流動負債,喬山,生技醫療業
2020-06-30,1736,OtherPayables_per,9.64,其他應付款,喬山,生技醫療業
2020-06-30,1736,OtherReceivable,285874000.0,其他應收款淨額,喬山,生技醫療業
2020-06-30,1736,OtherReceivable_per,1.0,其他應收款淨額,喬山,生技醫療業
2020-06-30,1736,PropertyPlantAndEquipment_per,13.88,不動產、廠房及設備,喬山,生技醫療業
2020-06-30,1736,RetainedEarnings,6772350000.0,保留盈餘合計,喬山,生技醫療業
2020-06-30,1736,RetainedEarnings_per,23.6,保留盈餘合計,喬山,生技醫療業
2020-06-30,1736,ShorttermBorrowings_per,22.24,短期借款,喬山,生技醫療業
2020-06-30,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2020-06-30,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2020-06-30,1736,CashAndCashEquivalents,3309249000.0,現金及約當現金,喬山,生技醫療業
2020-06-30,1736,Inventories,6859899000.0,存貨,喬山,生技醫療業
2020-06-30,1736,CurrentAssets,17243883000.0,流動資產合計,喬山,生技醫療業
2020-06-30,1736,PropertyPlantAndEquipment,3983323000.0,不動產、廠房及設備,喬山,生技醫療業
2020-06-30,1736,IntangibleAssets,2348485000.0,無形資產,喬山,生技醫療業
2020-06-30,1736,DeferredTaxAssets,1590503000.0,遞延所得稅資產,喬山,生技醫療業
2020-06-30,1736,OtherNoncurrentAssets,1142994000.0,其他非流動資產,喬山,生技醫療業
2020-06-30,1736,NoncurrentAssets,11446502000.0,非流動資產合計,喬山,生技醫療業
2020-06-30,1736,TotalAssets,28690385000.0,資產總額,喬山,生技醫療業
2020-06-30,1736,ShorttermBorrowings,6380748000.0,短期借款,喬山,生技醫療業
2020-06-30,1736,AccountsPayable,2634809000.0,應付帳款,喬山,生技醫療業
2020-06-30,1736,OtherPayables,2764428000.0,其他應付款,喬山,生技醫療業
2020-06-30,1736,CurrentLiabilities,14226841000.0,流動負債合計,喬山,生技醫療業
2020-06-30,1736,LongtermBorrowings,1837885000.0,長期借款,喬山,生技醫療業
2020-06-30,1736,NoncurrentLiabilities,5851626000.0,非流動負債合計,喬山,生技醫療業
2020-06-30,1736,OrdinaryShare,3036166000.0,普通股股本,喬山,生技醫療業
2020-06-30,1736,CapitalStock,3036166000.0,股本合計,喬山,生技醫療業
2020-06-30,1736,LegalReserve,1441895000.0,法定盈餘公積,喬山,生技醫療業
2020-06-30,1736,EquityAttributableToOwnersOfParent,8144588000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2020-06-30,1736,TotalLiabilitiesEquity,28690385000.0,負債及權益總計,喬山,生技醫療業
2020-06-30,1736,FinancialAssetsAtAmortizedCost,3774000.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2020-06-30,1736,FinancialAssetsAtAmortizedCost_per,0.01,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2020-06-30,1736,BillsReceivableNet,71633000.0,應收票據淨額,喬山,生技醫療業
2020-06-30,1736,BillsReceivableNet_per,0.25,應收票據淨額,喬山,生技醫療業
2020-06-30,1736,Prepayments,582046000.0,預付款項,喬山,生技醫療業
2020-06-30,1736,Prepayments_per,2.03,預付款項,喬山,生技醫療業
2020-06-30,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,0.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2020-06-30,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2020-06-30,1736,RightOfUseAsset,2334357000.0,使用權資產,喬山,生技醫療業
2020-06-30,1736,RightOfUseAsset_per,8.14,使用權資產,喬山,生技醫療業
2020-06-30,1736,CurrentTaxLiabilities,338882000.0,本期所得稅負債,喬山,生技醫療業
2020-06-30,1736,CurrentTaxLiabilities_per,1.18,本期所得稅負債,喬山,生技醫療業
2020-06-30,1736,Liabilities,20078467000.0,負債總額,喬山,生技醫療業
2020-06-30,1736,Liabilities_per,69.98,負債總額,喬山,生技醫療業
2020-06-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,3959617000.0,未分配盈餘,喬山,生技醫療業
2020-06-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,13.8,未分配盈餘,喬山,生技醫療業
2020-06-30,1736,OtherEquityInterest,-1638732000.0,其他權益合計,喬山,生技醫療業
2020-06-30,1736,OtherEquityInterest_per,-5.71,其他權益合計,喬山,生技醫療業
2020-06-30,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,1131000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2020-06-30,1736,Equity,8611918000.0,權益總額,喬山,生技醫療業
2020-06-30,1736,Equity_per,30.02,權益總額,喬山,生技醫療業
2020-09-30,1736,AccountsPayable_per,11.31,應付帳款,喬山,生技醫療業
2020-09-30,1736,AccountsReceivableNet_per,22.47,應收帳款淨額,喬山,生技醫療業
2020-09-30,1736,BondsPayable,2000000000.0,應付公司債,喬山,生技醫療業
2020-09-30,1736,BondsPayable_per,6.65,應付公司債,喬山,生技醫療業
2020-09-30,1736,CapitalStock_per,10.09,股本合計,喬山,生技醫療業
2020-09-30,1736,CapitalSurplus,55630000.0,資本公積合計,喬山,生技醫療業
2020-09-30,1736,CapitalSurplus_per,0.18,資本公積合計,喬山,生技醫療業
2020-09-30,1736,CashAndCashEquivalents_per,11.29,現金及約當現金,喬山,生技醫療業
2020-09-30,1736,CurrentAssets_per,62.38,流動資產合計,喬山,生技醫療業
2020-09-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,11236000.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2020-09-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.04,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2020-09-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,542000.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2020-09-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2020-09-30,1736,CurrentLiabilities_per,50.55,流動負債合計,喬山,生技醫療業
2020-09-30,1736,DeferredTaxAssets_per,5.2,遞延所得稅資產,喬山,生技醫療業
2020-09-30,1736,EquityAttributableToOwnersOfParent_per,28.97,歸屬於母公司業主之權益合計,喬山,生技醫療業
2020-09-30,1736,IntangibleAssets_per,7.73,無形資產,喬山,生技醫療業
2020-09-30,1736,Inventories_per,24.5,存貨,喬山,生技醫療業
2020-09-30,1736,LegalReserve_per,4.79,法定盈餘公積,喬山,生技醫療業
2020-09-30,1736,LongtermBorrowings_per,5.98,長期借款,喬山,生技醫療業
2020-09-30,1736,NoncontrollingInterests,505424000.0,非控制權益,喬山,生技醫療業
2020-09-30,1736,NoncontrollingInterests_per,1.68,非控制權益,喬山,生技醫療業
2020-09-30,1736,NoncurrentAssets_per,37.62,非流動資產合計,喬山,生技醫療業
2020-09-30,1736,NoncurrentLiabilities_per,18.8,非流動負債合計,喬山,生技醫療業
2020-09-30,1736,OrdinaryShare_per,10.09,普通股股本,喬山,生技醫療業
2020-09-30,1736,OtherCurrentAssets,79015000.0,其他流動資產,喬山,生技醫療業
2020-09-30,1736,OtherCurrentAssets_per,0.26,其他流動資產,喬山,生技醫療業
2020-09-30,1736,OtherCurrentLiabilities,921275000.0,其他流動負債,喬山,生技醫療業
2020-09-30,1736,OtherCurrentLiabilities_per,3.06,其他流動負債,喬山,生技醫療業
2020-09-30,1736,OtherNoncurrentAssets_per,3.99,其他非流動資產,喬山,生技醫療業
2020-09-30,1736,OtherNoncurrentLiabilities,260294000.0,其他非流動負債,喬山,生技醫療業
2020-09-30,1736,OtherNoncurrentLiabilities_per,0.86,其他非流動負債,喬山,生技醫療業
2020-09-30,1736,OtherPayables_per,9.39,其他應付款,喬山,生技醫療業
2020-09-30,1736,OtherReceivable,321302000.0,其他應收款淨額,喬山,生技醫療業
2020-09-30,1736,OtherReceivable_per,1.07,其他應收款淨額,喬山,生技醫療業
2020-09-30,1736,PropertyPlantAndEquipment_per,13.55,不動產、廠房及設備,喬山,生技醫療業
2020-09-30,1736,RetainedEarnings,7223610000.0,保留盈餘合計,喬山,生技醫療業
2020-09-30,1736,RetainedEarnings_per,24.01,保留盈餘合計,喬山,生技醫療業
2020-09-30,1736,ShorttermBorrowings_per,20.88,短期借款,喬山,生技醫療業
2020-09-30,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2020-09-30,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2020-09-30,1736,CashAndCashEquivalents,3397702000.0,現金及約當現金,喬山,生技醫療業
2020-09-30,1736,AccountsReceivableNet,6760928000.0,應收帳款淨額,喬山,生技醫療業
2020-09-30,1736,Inventories,7373009000.0,存貨,喬山,生技醫療業
2020-09-30,1736,CurrentAssets,18772538000.0,流動資產合計,喬山,生技醫療業
2020-09-30,1736,PropertyPlantAndEquipment,4077248000.0,不動產、廠房及設備,喬山,生技醫療業
2020-09-30,1736,IntangibleAssets,2326877000.0,無形資產,喬山,生技醫療業
2020-09-30,1736,DeferredTaxAssets,1563434000.0,遞延所得稅資產,喬山,生技醫療業
2020-09-30,1736,OtherNoncurrentAssets,1200935000.0,其他非流動資產,喬山,生技醫療業
2020-09-30,1736,NoncurrentAssets,11319397000.0,非流動資產合計,喬山,生技醫療業
2020-09-30,1736,TotalAssets,30091935000.0,資產總額,喬山,生技醫療業
2020-09-30,1736,ShorttermBorrowings,6282522000.0,短期借款,喬山,生技醫療業
2020-09-30,1736,AccountsPayable,3403681000.0,應付帳款,喬山,生技醫療業
2020-09-30,1736,OtherPayables,2825808000.0,其他應付款,喬山,生技醫療業
2020-09-30,1736,CurrentLiabilities,15212428000.0,流動負債合計,喬山,生技醫療業
2020-09-30,1736,LongtermBorrowings,1800986000.0,長期借款,喬山,生技醫療業
2020-09-30,1736,NoncurrentLiabilities,5657331000.0,非流動負債合計,喬山,生技醫療業
2020-09-30,1736,OrdinaryShare,3036166000.0,普通股股本,喬山,生技醫療業
2020-09-30,1736,CapitalStock,3036166000.0,股本合計,喬山,生技醫療業
2020-09-30,1736,LegalReserve,1441895000.0,法定盈餘公積,喬山,生技醫療業
2020-09-30,1736,EquityAttributableToOwnersOfParent,8716752000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2020-09-30,1736,TotalLiabilitiesEquity,30091935000.0,負債及權益總計,喬山,生技醫療業
2020-09-30,1736,FinancialAssetsAtAmortizedCost,16446000.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2020-09-30,1736,FinancialAssetsAtAmortizedCost_per,0.05,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2020-09-30,1736,BillsReceivableNet,72312000.0,應收票據淨額,喬山,生技醫療業
2020-09-30,1736,BillsReceivableNet_per,0.24,應收票據淨額,喬山,生技醫療業
2020-09-30,1736,Prepayments,661021000.0,預付款項,喬山,生技醫療業
2020-09-30,1736,Prepayments_per,2.2,預付款項,喬山,生技醫療業
2020-09-30,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,0.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2020-09-30,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2020-09-30,1736,RightOfUseAsset,2092237000.0,使用權資產,喬山,生技醫療業
2020-09-30,1736,RightOfUseAsset_per,6.95,使用權資產,喬山,生技醫療業
2020-09-30,1736,CurrentTaxLiabilities,447434000.0,本期所得稅負債,喬山,生技醫療業
2020-09-30,1736,CurrentTaxLiabilities_per,1.49,本期所得稅負債,喬山,生技醫療業
2020-09-30,1736,Liabilities,20869759000.0,負債總額,喬山,生技醫療業
2020-09-30,1736,Liabilities_per,69.35,負債總額,喬山,生技醫療業
2020-09-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,4410877000.0,未分配盈餘,喬山,生技醫療業
2020-09-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,14.66,未分配盈餘,喬山,生技醫療業
2020-09-30,1736,OtherEquityInterest,-1524782000.0,其他權益合計,喬山,生技醫療業
2020-09-30,1736,OtherEquityInterest_per,-5.07,其他權益合計,喬山,生技醫療業
2020-09-30,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,1028000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2020-09-30,1736,Equity,9222176000.0,權益總額,喬山,生技醫療業
2020-09-30,1736,Equity_per,30.65,權益總額,喬山,生技醫療業
2020-12-31,1736,CashAndCashEquivalents,3292801000.0,現金及約當現金,喬山,生技醫療業
2020-12-31,1736,CashAndCashEquivalents_per,10.56,現金及約當現金,喬山,生技醫療業
2020-12-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,15709000.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2020-12-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.05,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2020-12-31,1736,AccountsReceivableNet,6996248000.0,應收帳款淨額,喬山,生技醫療業
2020-12-31,1736,AccountsReceivableNet_per,22.43,應收帳款淨額,喬山,生技醫療業
2020-12-31,1736,Inventories,7945820000.0,存貨,喬山,生技醫療業
2020-12-31,1736,Inventories_per,25.48,存貨,喬山,生技醫療業
2020-12-31,1736,OtherCurrentAssets,54047000.0,其他流動資產,喬山,生技醫療業
2020-12-31,1736,OtherCurrentAssets_per,0.17,其他流動資產,喬山,生技醫療業
2020-12-31,1736,CurrentAssets,19574345000.0,流動資產合計,喬山,生技醫療業
2020-12-31,1736,CurrentAssets_per,62.76,流動資產合計,喬山,生技醫療業
2020-12-31,1736,PropertyPlantAndEquipment,3997692000.0,不動產、廠房及設備,喬山,生技醫療業
2020-12-31,1736,PropertyPlantAndEquipment_per,12.82,不動產、廠房及設備,喬山,生技醫療業
2020-12-31,1736,IntangibleAssets,2855047000.0,無形資產,喬山,生技醫療業
2020-12-31,1736,IntangibleAssets_per,9.15,無形資產,喬山,生技醫療業
2020-12-31,1736,DeferredTaxAssets,1445275000.0,遞延所得稅資產,喬山,生技醫療業
2020-12-31,1736,DeferredTaxAssets_per,4.63,遞延所得稅資產,喬山,生技醫療業
2020-12-31,1736,OtherNoncurrentAssets,1223543000.0,其他非流動資產,喬山,生技醫療業
2020-12-31,1736,OtherNoncurrentAssets_per,3.92,其他非流動資產,喬山,生技醫療業
2020-12-31,1736,NoncurrentAssets,11612744000.0,非流動資產合計,喬山,生技醫療業
2020-12-31,1736,NoncurrentAssets_per,37.24,非流動資產合計,喬山,生技醫療業
2020-12-31,1736,TotalAssets,31187089000.0,資產總額,喬山,生技醫療業
2020-12-31,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2020-12-31,1736,ShorttermBorrowings,6011150000.0,短期借款,喬山,生技醫療業
2020-12-31,1736,ShorttermBorrowings_per,19.27,短期借款,喬山,生技醫療業
2020-12-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,1657000.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2020-12-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.01,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2020-12-31,1736,AccountsPayable,4324359000.0,應付帳款,喬山,生技醫療業
2020-12-31,1736,AccountsPayable_per,13.87,應付帳款,喬山,生技醫療業
2020-12-31,1736,OtherPayables,2701405000.0,其他應付款,喬山,生技醫療業
2020-12-31,1736,OtherPayables_per,8.66,其他應付款,喬山,生技醫療業
2020-12-31,1736,OtherCurrentLiabilities,269656000.0,其他流動負債,喬山,生技醫療業
2020-12-31,1736,OtherCurrentLiabilities_per,0.86,其他流動負債,喬山,生技醫療業
2020-12-31,1736,CurrentLiabilities,15776500000.0,流動負債合計,喬山,生技醫療業
2020-12-31,1736,CurrentLiabilities_per,50.59,流動負債合計,喬山,生技醫療業
2020-12-31,1736,BondsPayable,2000000000.0,應付公司債,喬山,生技醫療業
2020-12-31,1736,BondsPayable_per,6.41,應付公司債,喬山,生技醫療業
2020-12-31,1736,LongtermBorrowings,1237150000.0,長期借款,喬山,生技醫療業
2020-12-31,1736,LongtermBorrowings_per,3.97,長期借款,喬山,生技醫療業
2020-12-31,1736,OtherNoncurrentLiabilities,295248000.0,其他非流動負債,喬山,生技醫療業
2020-12-31,1736,OtherNoncurrentLiabilities_per,0.95,其他非流動負債,喬山,生技醫療業
2020-12-31,1736,NoncurrentLiabilities,5128864000.0,非流動負債合計,喬山,生技醫療業
2020-12-31,1736,NoncurrentLiabilities_per,16.45,非流動負債合計,喬山,生技醫療業
2020-12-31,1736,OrdinaryShare,3036166000.0,普通股股本,喬山,生技醫療業
2020-12-31,1736,OrdinaryShare_per,9.74,普通股股本,喬山,生技醫療業
2020-12-31,1736,CapitalStock,3036166000.0,股本合計,喬山,生技醫療業
2020-12-31,1736,CapitalStock_per,9.74,股本合計,喬山,生技醫療業
2020-12-31,1736,CapitalSurplus,55630000.0,資本公積合計,喬山,生技醫療業
2020-12-31,1736,CapitalSurplus_per,0.18,資本公積合計,喬山,生技醫療業
2020-12-31,1736,LegalReserve,1441895000.0,法定盈餘公積,喬山,生技醫療業
2020-12-31,1736,LegalReserve_per,4.62,法定盈餘公積,喬山,生技醫療業
2020-12-31,1736,RetainedEarnings,7713232000.0,保留盈餘合計,喬山,生技醫療業
2020-12-31,1736,RetainedEarnings_per,24.73,保留盈餘合計,喬山,生技醫療業
2020-12-31,1736,EquityAttributableToOwnersOfParent,9345664000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2020-12-31,1736,EquityAttributableToOwnersOfParent_per,29.97,歸屬於母公司業主之權益合計,喬山,生技醫療業
2020-12-31,1736,NoncontrollingInterests,936061000.0,非控制權益,喬山,生技醫療業
2020-12-31,1736,NoncontrollingInterests_per,3.0,非控制權益,喬山,生技醫療業
2020-12-31,1736,TotalLiabilitiesEquity,31187089000.0,負債及權益總計,喬山,生技醫療業
2020-12-31,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2020-12-31,1736,OtherReceivable,364569000.0,其他應收款淨額,喬山,生技醫療業
2020-12-31,1736,OtherReceivable_per,1.17,其他應收款淨額,喬山,生技醫療業
2020-12-31,1736,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2020-12-31,1736,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2020-12-31,1736,BillsReceivableNet,65266000.0,應收票據淨額,喬山,生技醫療業
2020-12-31,1736,BillsReceivableNet_per,0.21,應收票據淨額,喬山,生技醫療業
2020-12-31,1736,Prepayments,823053000.0,預付款項,喬山,生技醫療業
2020-12-31,1736,Prepayments_per,2.64,預付款項,喬山,生技醫療業
2020-12-31,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,12423000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2020-12-31,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.04,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2020-12-31,1736,RightOfUseAsset,2031985000.0,使用權資產,喬山,生技醫療業
2020-12-31,1736,RightOfUseAsset_per,6.52,使用權資產,喬山,生技醫療業
2020-12-31,1736,CurrentTaxLiabilities,436573000.0,本期所得稅負債,喬山,生技醫療業
2020-12-31,1736,CurrentTaxLiabilities_per,1.4,本期所得稅負債,喬山,生技醫療業
2020-12-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,4900499000.0,未分配盈餘,喬山,生技醫療業
2020-12-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,15.71,未分配盈餘,喬山,生技醫療業
2020-12-31,1736,OtherEquityInterest,-1385492000.0,其他權益合計,喬山,生技醫療業
2020-12-31,1736,OtherEquityInterest_per,-4.44,其他權益合計,喬山,生技醫療業
2020-12-31,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,1028000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2020-12-31,1736,Equity,10281725000.0,權益總額,喬山,生技醫療業
2020-12-31,1736,Equity_per,32.97,權益總額,喬山,生技醫療業
2020-12-31,1736,Liabilities,20905364000.0,負債總額,喬山,生技醫療業
2020-12-31,1736,Liabilities_per,67.03,負債總額,喬山,生技醫療業
2021-03-31,1736,CashAndCashEquivalents,2891669000.0,現金及約當現金,喬山,生技醫療業
2021-03-31,1736,CashAndCashEquivalents_per,9.36,現金及約當現金,喬山,生技醫療業
2021-03-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,302000.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2021-03-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2021-03-31,1736,AccountsReceivableNet,6191775000.0,應收帳款淨額,喬山,生技醫療業
2021-03-31,1736,AccountsReceivableNet_per,20.04,應收帳款淨額,喬山,生技醫療業
2021-03-31,1736,Inventories,9118078000.0,存貨,喬山,生技醫療業
2021-03-31,1736,Inventories_per,29.52,存貨,喬山,生技醫療業
2021-03-31,1736,OtherCurrentAssets,59349000.0,其他流動資產,喬山,生技醫療業
2021-03-31,1736,OtherCurrentAssets_per,0.19,其他流動資產,喬山,生技醫療業
2021-03-31,1736,CurrentAssets,19436979000.0,流動資產合計,喬山,生技醫療業
2021-03-31,1736,CurrentAssets_per,62.92,流動資產合計,喬山,生技醫療業
2021-03-31,1736,PropertyPlantAndEquipment,3887597000.0,不動產、廠房及設備,喬山,生技醫療業
2021-03-31,1736,PropertyPlantAndEquipment_per,12.58,不動產、廠房及設備,喬山,生技醫療業
2021-03-31,1736,IntangibleAssets,2846659000.0,無形資產,喬山,生技醫療業
2021-03-31,1736,IntangibleAssets_per,9.22,無形資產,喬山,生技醫療業
2021-03-31,1736,DeferredTaxAssets,1467633000.0,遞延所得稅資產,喬山,生技醫療業
2021-03-31,1736,DeferredTaxAssets_per,4.75,遞延所得稅資產,喬山,生技醫療業
2021-03-31,1736,OtherNoncurrentAssets,1296681000.0,其他非流動資產,喬山,生技醫療業
2021-03-31,1736,OtherNoncurrentAssets_per,4.2,其他非流動資產,喬山,生技醫療業
2021-03-31,1736,NoncurrentAssets,11454334000.0,非流動資產合計,喬山,生技醫療業
2021-03-31,1736,NoncurrentAssets_per,37.08,非流動資產合計,喬山,生技醫療業
2021-03-31,1736,TotalAssets,30891313000.0,資產總額,喬山,生技醫療業
2021-03-31,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2021-03-31,1736,ShorttermBorrowings,6147924000.0,短期借款,喬山,生技醫療業
2021-03-31,1736,ShorttermBorrowings_per,19.9,短期借款,喬山,生技醫療業
2021-03-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2021-03-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2021-03-31,1736,AccountsPayable,4001203000.0,應付帳款,喬山,生技醫療業
2021-03-31,1736,AccountsPayable_per,12.95,應付帳款,喬山,生技醫療業
2021-03-31,1736,OtherPayables,2215379000.0,其他應付款,喬山,生技醫療業
2021-03-31,1736,OtherPayables_per,7.17,其他應付款,喬山,生技醫療業
2021-03-31,1736,OtherCurrentLiabilities,221460000.0,其他流動負債,喬山,生技醫療業
2021-03-31,1736,OtherCurrentLiabilities_per,0.72,其他流動負債,喬山,生技醫療業
2021-03-31,1736,CurrentLiabilities,15734277000.0,流動負債合計,喬山,生技醫療業
2021-03-31,1736,CurrentLiabilities_per,50.93,流動負債合計,喬山,生技醫療業
2021-03-31,1736,BondsPayable,2000000000.0,應付公司債,喬山,生技醫療業
2021-03-31,1736,BondsPayable_per,6.47,應付公司債,喬山,生技醫療業
2021-03-31,1736,LongtermBorrowings,1259366000.0,長期借款,喬山,生技醫療業
2021-03-31,1736,LongtermBorrowings_per,4.08,長期借款,喬山,生技醫療業
2021-03-31,1736,OtherNoncurrentLiabilities,258111000.0,其他非流動負債,喬山,生技醫療業
2021-03-31,1736,OtherNoncurrentLiabilities_per,0.84,其他非流動負債,喬山,生技醫療業
2021-03-31,1736,NoncurrentLiabilities,5055288000.0,非流動負債合計,喬山,生技醫療業
2021-03-31,1736,NoncurrentLiabilities_per,16.36,非流動負債合計,喬山,生技醫療業
2021-03-31,1736,OrdinaryShare,3036166000.0,普通股股本,喬山,生技醫療業
2021-03-31,1736,OrdinaryShare_per,9.83,普通股股本,喬山,生技醫療業
2021-03-31,1736,CapitalStock,3036166000.0,股本合計,喬山,生技醫療業
2021-03-31,1736,CapitalStock_per,9.83,股本合計,喬山,生技醫療業
2021-03-31,1736,CapitalSurplus,55630000.0,資本公積合計,喬山,生技醫療業
2021-03-31,1736,CapitalSurplus_per,0.18,資本公積合計,喬山,生技醫療業
2021-03-31,1736,LegalReserve,1441895000.0,法定盈餘公積,喬山,生技醫療業
2021-03-31,1736,LegalReserve_per,4.67,法定盈餘公積,喬山,生技醫療業
2021-03-31,1736,RetainedEarnings,7780765000.0,保留盈餘合計,喬山,生技醫療業
2021-03-31,1736,RetainedEarnings_per,25.19,保留盈餘合計,喬山,生技醫療業
2021-03-31,1736,EquityAttributableToOwnersOfParent,9202201000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2021-03-31,1736,EquityAttributableToOwnersOfParent_per,29.79,歸屬於母公司業主之權益合計,喬山,生技醫療業
2021-03-31,1736,NoncontrollingInterests,899547000.0,非控制權益,喬山,生技醫療業
2021-03-31,1736,NoncontrollingInterests_per,2.91,非控制權益,喬山,生技醫療業
2021-03-31,1736,TotalLiabilitiesEquity,30891313000.0,負債及權益總計,喬山,生技醫療業
2021-03-31,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2021-03-31,1736,OtherReceivable,299369000.0,其他應收款淨額,喬山,生技醫療業
2021-03-31,1736,OtherReceivable_per,0.97,其他應收款淨額,喬山,生技醫療業
2021-03-31,1736,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2021-03-31,1736,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2021-03-31,1736,BillsReceivableNet,63794000.0,應收票據淨額,喬山,生技醫療業
2021-03-31,1736,BillsReceivableNet_per,0.21,應收票據淨額,喬山,生技醫療業
2021-03-31,1736,Prepayments,763927000.0,預付款項,喬山,生技醫療業
2021-03-31,1736,Prepayments_per,2.47,預付款項,喬山,生技醫療業
2021-03-31,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,13433000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2021-03-31,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.04,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2021-03-31,1736,RightOfUseAsset,1898898000.0,使用權資產,喬山,生技醫療業
2021-03-31,1736,RightOfUseAsset_per,6.15,使用權資產,喬山,生技醫療業
2021-03-31,1736,CurrentTaxLiabilities,447333000.0,本期所得稅負債,喬山,生技醫療業
2021-03-31,1736,CurrentTaxLiabilities_per,1.45,本期所得稅負債,喬山,生技醫療業
2021-03-31,1736,Liabilities,20789565000.0,負債總額,喬山,生技醫療業
2021-03-31,1736,Liabilities_per,67.3,負債總額,喬山,生技醫療業
2021-03-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,4968032000.0,未分配盈餘,喬山,生技醫療業
2021-03-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,16.08,未分配盈餘,喬山,生技醫療業
2021-03-31,1736,OtherEquityInterest,-1596488000.0,其他權益合計,喬山,生技醫療業
2021-03-31,1736,OtherEquityInterest_per,-5.17,其他權益合計,喬山,生技醫療業
2021-03-31,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,1028000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2021-03-31,1736,Equity,10101748000.0,權益總額,喬山,生技醫療業
2021-03-31,1736,Equity_per,32.7,權益總額,喬山,生技醫療業
2021-06-30,1736,CashAndCashEquivalents,2605043000.0,現金及約當現金,喬山,生技醫療業
2021-06-30,1736,CashAndCashEquivalents_per,8.22,現金及約當現金,喬山,生技醫療業
2021-06-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2021-06-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2021-06-30,1736,AccountsReceivableNet,6379839000.0,應收帳款淨額,喬山,生技醫療業
2021-06-30,1736,AccountsReceivableNet_per,20.13,應收帳款淨額,喬山,生技醫療業
2021-06-30,1736,Inventories,9788427000.0,存貨,喬山,生技醫療業
2021-06-30,1736,Inventories_per,30.88,存貨,喬山,生技醫療業
2021-06-30,1736,OtherCurrentAssets,122135000.0,其他流動資產,喬山,生技醫療業
2021-06-30,1736,OtherCurrentAssets_per,0.39,其他流動資產,喬山,生技醫療業
2021-06-30,1736,CurrentAssets,20228866000.0,流動資產合計,喬山,生技醫療業
2021-06-30,1736,CurrentAssets_per,63.83,流動資產合計,喬山,生技醫療業
2021-06-30,1736,PropertyPlantAndEquipment,3893840000.0,不動產、廠房及設備,喬山,生技醫療業
2021-06-30,1736,PropertyPlantAndEquipment_per,12.29,不動產、廠房及設備,喬山,生技醫療業
2021-06-30,1736,IntangibleAssets,2810371000.0,無形資產,喬山,生技醫療業
2021-06-30,1736,IntangibleAssets_per,8.87,無形資產,喬山,生技醫療業
2021-06-30,1736,DeferredTaxAssets,1544502000.0,遞延所得稅資產,喬山,生技醫療業
2021-06-30,1736,DeferredTaxAssets_per,4.87,遞延所得稅資產,喬山,生技醫療業
2021-06-30,1736,OtherNoncurrentAssets,1311293000.0,其他非流動資產,喬山,生技醫療業
2021-06-30,1736,OtherNoncurrentAssets_per,4.14,其他非流動資產,喬山,生技醫療業
2021-06-30,1736,NoncurrentAssets,11464864000.0,非流動資產合計,喬山,生技醫療業
2021-06-30,1736,NoncurrentAssets_per,36.17,非流動資產合計,喬山,生技醫療業
2021-06-30,1736,TotalAssets,31693730000.0,資產總額,喬山,生技醫療業
2021-06-30,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2021-06-30,1736,ShorttermBorrowings,6808880000.0,短期借款,喬山,生技醫療業
2021-06-30,1736,ShorttermBorrowings_per,21.48,短期借款,喬山,生技醫療業
2021-06-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,141000.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2021-06-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2021-06-30,1736,AccountsPayable,3320445000.0,應付帳款,喬山,生技醫療業
2021-06-30,1736,AccountsPayable_per,10.48,應付帳款,喬山,生技醫療業
2021-06-30,1736,OtherPayables,2515610000.0,其他應付款,喬山,生技醫療業
2021-06-30,1736,OtherPayables_per,7.94,其他應付款,喬山,生技醫療業
2021-06-30,1736,OtherCurrentLiabilities,169603000.0,其他流動負債,喬山,生技醫療業
2021-06-30,1736,OtherCurrentLiabilities_per,0.54,其他流動負債,喬山,生技醫療業
2021-06-30,1736,CurrentLiabilities,17041281000.0,流動負債合計,喬山,生技醫療業
2021-06-30,1736,CurrentLiabilities_per,53.77,流動負債合計,喬山,生技醫療業
2021-06-30,1736,BondsPayable,2000000000.0,應付公司債,喬山,生技醫療業
2021-06-30,1736,BondsPayable_per,6.31,應付公司債,喬山,生技醫療業
2021-06-30,1736,LongtermBorrowings,1232038000.0,長期借款,喬山,生技醫療業
2021-06-30,1736,LongtermBorrowings_per,3.89,長期借款,喬山,生技醫療業
2021-06-30,1736,OtherNoncurrentLiabilities,239374000.0,其他非流動負債,喬山,生技醫療業
2021-06-30,1736,OtherNoncurrentLiabilities_per,0.76,其他非流動負債,喬山,生技醫療業
2021-06-30,1736,NoncurrentLiabilities,5019039000.0,非流動負債合計,喬山,生技醫療業
2021-06-30,1736,NoncurrentLiabilities_per,15.84,非流動負債合計,喬山,生技醫療業
2021-06-30,1736,OrdinaryShare,3036166000.0,普通股股本,喬山,生技醫療業
2021-06-30,1736,OrdinaryShare_per,9.58,普通股股本,喬山,生技醫療業
2021-06-30,1736,CapitalStock,3036166000.0,股本合計,喬山,生技醫療業
2021-06-30,1736,CapitalStock_per,9.58,股本合計,喬山,生技醫療業
2021-06-30,1736,CapitalSurplus,59979000.0,資本公積合計,喬山,生技醫療業
2021-06-30,1736,CapitalSurplus_per,0.19,資本公積合計,喬山,生技醫療業
2021-06-30,1736,LegalReserve,1509898000.0,法定盈餘公積,喬山,生技醫療業
2021-06-30,1736,LegalReserve_per,4.76,法定盈餘公積,喬山,生技醫療業
2021-06-30,1736,RetainedEarnings,7445286000.0,保留盈餘合計,喬山,生技醫療業
2021-06-30,1736,RetainedEarnings_per,23.49,保留盈餘合計,喬山,生技醫療業
2021-06-30,1736,EquityAttributableToOwnersOfParent,8740275000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2021-06-30,1736,EquityAttributableToOwnersOfParent_per,27.58,歸屬於母公司業主之權益合計,喬山,生技醫療業
2021-06-30,1736,NoncontrollingInterests,893135000.0,非控制權益,喬山,生技醫療業
2021-06-30,1736,NoncontrollingInterests_per,2.82,非控制權益,喬山,生技醫療業
2021-06-30,1736,TotalLiabilitiesEquity,31693730000.0,負債及權益總計,喬山,生技醫療業
2021-06-30,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2021-06-30,1736,OtherReceivable,273421000.0,其他應收款淨額,喬山,生技醫療業
2021-06-30,1736,OtherReceivable_per,0.86,其他應收款淨額,喬山,生技醫療業
2021-06-30,1736,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2021-06-30,1736,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2021-06-30,1736,BillsReceivableNet,45758000.0,應收票據淨額,喬山,生技醫療業
2021-06-30,1736,BillsReceivableNet_per,0.14,應收票據淨額,喬山,生技醫療業
2021-06-30,1736,Prepayments,981028000.0,預付款項,喬山,生技醫療業
2021-06-30,1736,Prepayments_per,3.1,預付款項,喬山,生技醫療業
2021-06-30,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,11191000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2021-06-30,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.04,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2021-06-30,1736,RightOfUseAsset,1851315000.0,使用權資產,喬山,生技醫療業
2021-06-30,1736,RightOfUseAsset_per,5.84,使用權資產,喬山,生技醫療業
2021-06-30,1736,CurrentTaxLiabilities,261046000.0,本期所得稅負債,喬山,生技醫療業
2021-06-30,1736,CurrentTaxLiabilities_per,0.82,本期所得稅負債,喬山,生技醫療業
2021-06-30,1736,Liabilities,22060320000.0,負債總額,喬山,生技醫療業
2021-06-30,1736,Liabilities_per,69.6,負債總額,喬山,生技醫療業
2021-06-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,4549896000.0,未分配盈餘,喬山,生技醫療業
2021-06-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,14.36,未分配盈餘,喬山,生技醫療業
2021-06-30,1736,OtherEquityInterest,-1727284000.0,其他權益合計,喬山,生技醫療業
2021-06-30,1736,OtherEquityInterest_per,-5.45,其他權益合計,喬山,生技醫療業
2021-06-30,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,1028000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2021-06-30,1736,Equity,9633410000.0,權益總額,喬山,生技醫療業
2021-06-30,1736,Equity_per,30.4,權益總額,喬山,生技醫療業
2021-09-30,1736,CashAndCashEquivalents,2577702000.0,現金及約當現金,喬山,生技醫療業
2021-09-30,1736,CashAndCashEquivalents_per,7.74,現金及約當現金,喬山,生技醫療業
2021-09-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2021-09-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2021-09-30,1736,AccountsReceivableNet,6668759000.0,應收帳款淨額,喬山,生技醫療業
2021-09-30,1736,AccountsReceivableNet_per,20.02,應收帳款淨額,喬山,生技醫療業
2021-09-30,1736,Inventories,10731891000.0,存貨,喬山,生技醫療業
2021-09-30,1736,Inventories_per,32.21,存貨,喬山,生技醫療業
2021-09-30,1736,OtherCurrentAssets,151056000.0,其他流動資產,喬山,生技醫療業
2021-09-30,1736,OtherCurrentAssets_per,0.45,其他流動資產,喬山,生技醫療業
2021-09-30,1736,CurrentAssets,21752829000.0,流動資產合計,喬山,生技醫療業
2021-09-30,1736,CurrentAssets_per,65.29,流動資產合計,喬山,生技醫療業
2021-09-30,1736,PropertyPlantAndEquipment,3902020000.0,不動產、廠房及設備,喬山,生技醫療業
2021-09-30,1736,PropertyPlantAndEquipment_per,11.71,不動產、廠房及設備,喬山,生技醫療業
2021-09-30,1736,IntangibleAssets,2808178000.0,無形資產,喬山,生技醫療業
2021-09-30,1736,IntangibleAssets_per,8.43,無形資產,喬山,生技醫療業
2021-09-30,1736,DeferredTaxAssets,1717177000.0,遞延所得稅資產,喬山,生技醫療業
2021-09-30,1736,DeferredTaxAssets_per,5.15,遞延所得稅資產,喬山,生技醫療業
2021-09-30,1736,OtherNoncurrentAssets,1363271000.0,其他非流動資產,喬山,生技醫療業
2021-09-30,1736,OtherNoncurrentAssets_per,4.09,其他非流動資產,喬山,生技醫療業
2021-09-30,1736,NoncurrentAssets,11562060000.0,非流動資產合計,喬山,生技醫療業
2021-09-30,1736,NoncurrentAssets_per,34.71,非流動資產合計,喬山,生技醫療業
2021-09-30,1736,TotalAssets,33314889000.0,資產總額,喬山,生技醫療業
2021-09-30,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2021-09-30,1736,ShorttermBorrowings,7976690000.0,短期借款,喬山,生技醫療業
2021-09-30,1736,ShorttermBorrowings_per,23.94,短期借款,喬山,生技醫療業
2021-09-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,910000.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2021-09-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2021-09-30,1736,AccountsPayable,3701051000.0,應付帳款,喬山,生技醫療業
2021-09-30,1736,AccountsPayable_per,11.11,應付帳款,喬山,生技醫療業
2021-09-30,1736,OtherPayables,2609823000.0,其他應付款,喬山,生技醫療業
2021-09-30,1736,OtherPayables_per,7.83,其他應付款,喬山,生技醫療業
2021-09-30,1736,OtherCurrentLiabilities,195895000.0,其他流動負債,喬山,生技醫療業
2021-09-30,1736,OtherCurrentLiabilities_per,0.59,其他流動負債,喬山,生技醫療業
2021-09-30,1736,CurrentLiabilities,19452922000.0,流動負債合計,喬山,生技醫療業
2021-09-30,1736,CurrentLiabilities_per,58.39,流動負債合計,喬山,生技醫療業
2021-09-30,1736,BondsPayable,2000000000.0,應付公司債,喬山,生技醫療業
2021-09-30,1736,BondsPayable_per,6.0,應付公司債,喬山,生技醫療業
2021-09-30,1736,LongtermBorrowings,1214019000.0,長期借款,喬山,生技醫療業
2021-09-30,1736,LongtermBorrowings_per,3.64,長期借款,喬山,生技醫療業
2021-09-30,1736,OtherNoncurrentLiabilities,249683000.0,其他非流動負債,喬山,生技醫療業
2021-09-30,1736,OtherNoncurrentLiabilities_per,0.75,其他非流動負債,喬山,生技醫療業
2021-09-30,1736,NoncurrentLiabilities,4851402000.0,非流動負債合計,喬山,生技醫療業
2021-09-30,1736,NoncurrentLiabilities_per,14.56,非流動負債合計,喬山,生技醫療業
2021-09-30,1736,OrdinaryShare,3036166000.0,普通股股本,喬山,生技醫療業
2021-09-30,1736,OrdinaryShare_per,9.11,普通股股本,喬山,生技醫療業
2021-09-30,1736,CapitalStock,3036166000.0,股本合計,喬山,生技醫療業
2021-09-30,1736,CapitalStock_per,9.11,股本合計,喬山,生技醫療業
2021-09-30,1736,CapitalSurplus,59979000.0,資本公積合計,喬山,生技醫療業
2021-09-30,1736,CapitalSurplus_per,0.18,資本公積合計,喬山,生技醫療業
2021-09-30,1736,LegalReserve,1509898000.0,法定盈餘公積,喬山,生技醫療業
2021-09-30,1736,LegalReserve_per,4.53,法定盈餘公積,喬山,生技醫療業
2021-09-30,1736,RetainedEarnings,6937976000.0,保留盈餘合計,喬山,生技醫療業
2021-09-30,1736,RetainedEarnings_per,20.83,保留盈餘合計,喬山,生技醫療業
2021-09-30,1736,EquityAttributableToOwnersOfParent,8115296000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2021-09-30,1736,EquityAttributableToOwnersOfParent_per,24.36,歸屬於母公司業主之權益合計,喬山,生技醫療業
2021-09-30,1736,NoncontrollingInterests,895269000.0,非控制權益,喬山,生技醫療業
2021-09-30,1736,NoncontrollingInterests_per,2.69,非控制權益,喬山,生技醫療業
2021-09-30,1736,TotalLiabilitiesEquity,33314889000.0,負債及權益總計,喬山,生技醫療業
2021-09-30,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2021-09-30,1736,OtherReceivable,393143000.0,其他應收款淨額,喬山,生技醫療業
2021-09-30,1736,OtherReceivable_per,1.18,其他應收款淨額,喬山,生技醫療業
2021-09-30,1736,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2021-09-30,1736,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2021-09-30,1736,BillsReceivableNet,44518000.0,應收票據淨額,喬山,生技醫療業
2021-09-30,1736,BillsReceivableNet_per,0.13,應收票據淨額,喬山,生技醫療業
2021-09-30,1736,Prepayments,1122686000.0,預付款項,喬山,生技醫療業
2021-09-30,1736,Prepayments_per,3.37,預付款項,喬山,生技醫療業
2021-09-30,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,10390000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2021-09-30,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.03,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2021-09-30,1736,RightOfUseAsset,1719332000.0,使用權資產,喬山,生技醫療業
2021-09-30,1736,RightOfUseAsset_per,5.16,使用權資產,喬山,生技醫療業
2021-09-30,1736,CurrentTaxLiabilities,301457000.0,本期所得稅負債,喬山,生技醫療業
2021-09-30,1736,CurrentTaxLiabilities_per,0.9,本期所得稅負債,喬山,生技醫療業
2021-09-30,1736,Liabilities,24304324000.0,負債總額,喬山,生技醫療業
2021-09-30,1736,Liabilities_per,72.95,負債總額,喬山,生技醫療業
2021-09-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,4042586000.0,未分配盈餘,喬山,生技醫療業
2021-09-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,12.13,未分配盈餘,喬山,生技醫療業
2021-09-30,1736,OtherEquityInterest,-1844953000.0,其他權益合計,喬山,生技醫療業
2021-09-30,1736,OtherEquityInterest_per,-5.54,其他權益合計,喬山,生技醫療業
2021-09-30,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,1028000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2021-09-30,1736,Equity,9010565000.0,權益總額,喬山,生技醫療業
2021-09-30,1736,Equity_per,27.05,權益總額,喬山,生技醫療業
2021-12-31,1736,CashAndCashEquivalents,2615077000.0,現金及約當現金,喬山,生技醫療業
2021-12-31,1736,CashAndCashEquivalents_per,7.42,現金及約當現金,喬山,生技醫療業
2021-12-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,8151000.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2021-12-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.02,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2021-12-31,1736,AccountsReceivableNet,7532245000.0,應收帳款淨額,喬山,生技醫療業
2021-12-31,1736,AccountsReceivableNet_per,21.36,應收帳款淨額,喬山,生技醫療業
2021-12-31,1736,Inventories,11674233000.0,存貨,喬山,生技醫療業
2021-12-31,1736,Inventories_per,33.11,存貨,喬山,生技醫療業
2021-12-31,1736,OtherCurrentAssets,97455000.0,其他流動資產,喬山,生技醫療業
2021-12-31,1736,OtherCurrentAssets_per,0.28,其他流動資產,喬山,生技醫療業
2021-12-31,1736,CurrentAssets,23461882000.0,流動資產合計,喬山,生技醫療業
2021-12-31,1736,CurrentAssets_per,66.53,流動資產合計,喬山,生技醫療業
2021-12-31,1736,PropertyPlantAndEquipment,4138726000.0,不動產、廠房及設備,喬山,生技醫療業
2021-12-31,1736,PropertyPlantAndEquipment_per,11.74,不動產、廠房及設備,喬山,生技醫療業
2021-12-31,1736,IntangibleAssets,2807002000.0,無形資產,喬山,生技醫療業
2021-12-31,1736,IntangibleAssets_per,7.96,無形資產,喬山,生技醫療業
2021-12-31,1736,DeferredTaxAssets,1893408000.0,遞延所得稅資產,喬山,生技醫療業
2021-12-31,1736,DeferredTaxAssets_per,5.37,遞延所得稅資產,喬山,生技醫療業
2021-12-31,1736,OtherNoncurrentAssets,1298354000.0,其他非流動資產,喬山,生技醫療業
2021-12-31,1736,OtherNoncurrentAssets_per,3.68,其他非流動資產,喬山,生技醫療業
2021-12-31,1736,NoncurrentAssets,11800694000.0,非流動資產合計,喬山,生技醫療業
2021-12-31,1736,NoncurrentAssets_per,33.47,非流動資產合計,喬山,生技醫療業
2021-12-31,1736,TotalAssets,35262576000.0,資產總額,喬山,生技醫療業
2021-12-31,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2021-12-31,1736,ShorttermBorrowings,7544264000.0,短期借款,喬山,生技醫療業
2021-12-31,1736,ShorttermBorrowings_per,21.39,短期借款,喬山,生技醫療業
2021-12-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2021-12-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2021-12-31,1736,AccountsPayable,4178687000.0,應付帳款,喬山,生技醫療業
2021-12-31,1736,AccountsPayable_per,11.85,應付帳款,喬山,生技醫療業
2021-12-31,1736,OtherPayables,3062444000.0,其他應付款,喬山,生技醫療業
2021-12-31,1736,OtherPayables_per,8.68,其他應付款,喬山,生技醫療業
2021-12-31,1736,OtherCurrentLiabilities,265042000.0,其他流動負債,喬山,生技醫療業
2021-12-31,1736,OtherCurrentLiabilities_per,0.75,其他流動負債,喬山,生技醫療業
2021-12-31,1736,CurrentLiabilities,21072476000.0,流動負債合計,喬山,生技醫療業
2021-12-31,1736,CurrentLiabilities_per,59.76,流動負債合計,喬山,生技醫療業
2021-12-31,1736,BondsPayable,2000000000.0,應付公司債,喬山,生技醫療業
2021-12-31,1736,BondsPayable_per,5.67,應付公司債,喬山,生技醫療業
2021-12-31,1736,LongtermBorrowings,1167433000.0,長期借款,喬山,生技醫療業
2021-12-31,1736,LongtermBorrowings_per,3.31,長期借款,喬山,生技醫療業
2021-12-31,1736,OtherNoncurrentLiabilities,257543000.0,其他非流動負債,喬山,生技醫療業
2021-12-31,1736,OtherNoncurrentLiabilities_per,0.73,其他非流動負債,喬山,生技醫療業
2021-12-31,1736,NoncurrentLiabilities,4808916000.0,非流動負債合計,喬山,生技醫療業
2021-12-31,1736,NoncurrentLiabilities_per,13.64,非流動負債合計,喬山,生技醫療業
2021-12-31,1736,OrdinaryShare,3036166000.0,普通股股本,喬山,生技醫療業
2021-12-31,1736,OrdinaryShare_per,8.61,普通股股本,喬山,生技醫療業
2021-12-31,1736,CapitalStock,3036166000.0,股本合計,喬山,生技醫療業
2021-12-31,1736,CapitalStock_per,8.61,股本合計,喬山,生技醫療業
2021-12-31,1736,CapitalSurplus,59979000.0,資本公積合計,喬山,生技醫療業
2021-12-31,1736,CapitalSurplus_per,0.17,資本公積合計,喬山,生技醫療業
2021-12-31,1736,LegalReserve,1509898000.0,法定盈餘公積,喬山,生技醫療業
2021-12-31,1736,LegalReserve_per,4.28,法定盈餘公積,喬山,生技醫療業
2021-12-31,1736,RetainedEarnings,7399573000.0,保留盈餘合計,喬山,生技醫療業
2021-12-31,1736,RetainedEarnings_per,20.98,保留盈餘合計,喬山,生技醫療業
2021-12-31,1736,EquityAttributableToOwnersOfParent,8479837000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2021-12-31,1736,EquityAttributableToOwnersOfParent_per,24.05,歸屬於母公司業主之權益合計,喬山,生技醫療業
2021-12-31,1736,NoncontrollingInterests,901347000.0,非控制權益,喬山,生技醫療業
2021-12-31,1736,NoncontrollingInterests_per,2.56,非控制權益,喬山,生技醫療業
2021-12-31,1736,TotalLiabilitiesEquity,35262576000.0,負債及權益總計,喬山,生技醫療業
2021-12-31,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2021-12-31,1736,OtherReceivable,493299000.0,其他應收款淨額,喬山,生技醫療業
2021-12-31,1736,OtherReceivable_per,1.4,其他應收款淨額,喬山,生技醫療業
2021-12-31,1736,BillsReceivableNet,76459000.0,應收票據淨額,喬山,生技醫療業
2021-12-31,1736,BillsReceivableNet_per,0.22,應收票據淨額,喬山,生技醫療業
2021-12-31,1736,Prepayments,908011000.0,預付款項,喬山,生技醫療業
2021-12-31,1736,Prepayments_per,2.57,預付款項,喬山,生技醫療業
2021-12-31,1736,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2021-12-31,1736,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2021-12-31,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,8494000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2021-12-31,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.02,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2021-12-31,1736,RightOfUseAsset,1614593000.0,使用權資產,喬山,生技醫療業
2021-12-31,1736,RightOfUseAsset_per,4.58,使用權資產,喬山,生技醫療業
2021-12-31,1736,CurrentTaxLiabilities,396582000.0,本期所得稅負債,喬山,生技醫療業
2021-12-31,1736,CurrentTaxLiabilities_per,1.12,本期所得稅負債,喬山,生技醫療業
2021-12-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,4504183000.0,未分配盈餘,喬山,生技醫療業
2021-12-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,12.77,未分配盈餘,喬山,生技醫療業
2021-12-31,1736,OtherEquityInterest,-1942009000.0,其他權益合計,喬山,生技醫療業
2021-12-31,1736,OtherEquityInterest_per,-5.51,其他權益合計,喬山,生技醫療業
2021-12-31,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,1028000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2021-12-31,1736,Liabilities,25881392000.0,負債總額,喬山,生技醫療業
2021-12-31,1736,Liabilities_per,73.4,負債總額,喬山,生技醫療業
2021-12-31,1736,Equity,9381184000.0,權益總額,喬山,生技醫療業
2021-12-31,1736,Equity_per,26.6,權益總額,喬山,生技醫療業
2022-03-31,1736,CashAndCashEquivalents,3869542000.0,現金及約當現金,喬山,生技醫療業
2022-03-31,1736,CashAndCashEquivalents_per,10.65,現金及約當現金,喬山,生技醫療業
2022-03-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2022-03-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2022-03-31,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,9979000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2022-03-31,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.03,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2022-03-31,1736,BillsReceivableNet,77253000.0,應收票據淨額,喬山,生技醫療業
2022-03-31,1736,BillsReceivableNet_per,0.21,應收票據淨額,喬山,生技醫療業
2022-03-31,1736,OtherReceivable,412112000.0,其他應收款淨額,喬山,生技醫療業
2022-03-31,1736,OtherReceivable_per,1.13,其他應收款淨額,喬山,生技醫療業
2022-03-31,1736,Prepayments,929728000.0,預付款項,喬山,生技醫療業
2022-03-31,1736,Prepayments_per,2.56,預付款項,喬山,生技醫療業
2022-03-31,1736,AccountsReceivableNet,6744001000.0,應收帳款淨額,喬山,生技醫療業
2022-03-31,1736,AccountsReceivableNet_per,18.57,應收帳款淨額,喬山,生技醫療業
2022-03-31,1736,Inventories,11698003000.0,存貨,喬山,生技醫療業
2022-03-31,1736,Inventories_per,32.21,存貨,喬山,生技醫療業
2022-03-31,1736,OtherCurrentAssets,101068000.0,其他流動資產,喬山,生技醫療業
2022-03-31,1736,OtherCurrentAssets_per,0.28,其他流動資產,喬山,生技醫療業
2022-03-31,1736,CurrentAssets,23877381000.0,流動資產合計,喬山,生技醫療業
2022-03-31,1736,CurrentAssets_per,65.74,流動資產合計,喬山,生技醫療業
2022-03-31,1736,PropertyPlantAndEquipment,4298791000.0,不動產、廠房及設備,喬山,生技醫療業
2022-03-31,1736,PropertyPlantAndEquipment_per,11.84,不動產、廠房及設備,喬山,生技醫療業
2022-03-31,1736,RightOfUseAsset,1974835000.0,使用權資產,喬山,生技醫療業
2022-03-31,1736,RightOfUseAsset_per,5.44,使用權資產,喬山,生技醫療業
2022-03-31,1736,IntangibleAssets,2826494000.0,無形資產,喬山,生技醫療業
2022-03-31,1736,IntangibleAssets_per,7.78,無形資產,喬山,生技醫療業
2022-03-31,1736,DeferredTaxAssets,1959327000.0,遞延所得稅資產,喬山,生技醫療業
2022-03-31,1736,DeferredTaxAssets_per,5.39,遞延所得稅資產,喬山,生技醫療業
2022-03-31,1736,OtherNoncurrentAssets,1335710000.0,其他非流動資產,喬山,生技醫療業
2022-03-31,1736,OtherNoncurrentAssets_per,3.68,其他非流動資產,喬山,生技醫療業
2022-03-31,1736,NoncurrentAssets,12444235000.0,非流動資產合計,喬山,生技醫療業
2022-03-31,1736,NoncurrentAssets_per,34.26,非流動資產合計,喬山,生技醫療業
2022-03-31,1736,TotalAssets,36321616000.0,資產總額,喬山,生技醫療業
2022-03-31,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2022-03-31,1736,ShorttermBorrowings,8692273000.0,短期借款,喬山,生技醫療業
2022-03-31,1736,ShorttermBorrowings_per,23.93,短期借款,喬山,生技醫療業
2022-03-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,64676000.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2022-03-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.18,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2022-03-31,1736,AccountsPayable,3520289000.0,應付帳款,喬山,生技醫療業
2022-03-31,1736,AccountsPayable_per,9.69,應付帳款,喬山,生技醫療業
2022-03-31,1736,OtherPayables,2612378000.0,其他應付款,喬山,生技醫療業
2022-03-31,1736,OtherPayables_per,7.19,其他應付款,喬山,生技醫療業
2022-03-31,1736,CurrentTaxLiabilities,383982000.0,本期所得稅負債,喬山,生技醫療業
2022-03-31,1736,CurrentTaxLiabilities_per,1.06,本期所得稅負債,喬山,生技醫療業
2022-03-31,1736,OtherCurrentLiabilities,1223197000.0,其他流動負債,喬山,生技醫療業
2022-03-31,1736,OtherCurrentLiabilities_per,3.37,其他流動負債,喬山,生技醫療業
2022-03-31,1736,CurrentLiabilities,22458242000.0,流動負債合計,喬山,生技醫療業
2022-03-31,1736,CurrentLiabilities_per,61.83,流動負債合計,喬山,生技醫療業
2022-03-31,1736,BondsPayable,2000000000.0,應付公司債,喬山,生技醫療業
2022-03-31,1736,BondsPayable_per,5.51,應付公司債,喬山,生技醫療業
2022-03-31,1736,LongtermBorrowings,268395000.0,長期借款,喬山,生技醫療業
2022-03-31,1736,LongtermBorrowings_per,0.74,長期借款,喬山,生技醫療業
2022-03-31,1736,OtherNoncurrentLiabilities,280302000.0,其他非流動負債,喬山,生技醫療業
2022-03-31,1736,OtherNoncurrentLiabilities_per,0.77,其他非流動負債,喬山,生技醫療業
2022-03-31,1736,NoncurrentLiabilities,4166521000.0,非流動負債合計,喬山,生技醫療業
2022-03-31,1736,NoncurrentLiabilities_per,11.47,非流動負債合計,喬山,生技醫療業
2022-03-31,1736,OrdinaryShare,3036166000.0,普通股股本,喬山,生技醫療業
2022-03-31,1736,OrdinaryShare_per,8.36,普通股股本,喬山,生技醫療業
2022-03-31,1736,CapitalStock,3036166000.0,股本合計,喬山,生技醫療業
2022-03-31,1736,CapitalStock_per,8.36,股本合計,喬山,生技醫療業
2022-03-31,1736,CapitalSurplus,59979000.0,資本公積合計,喬山,生技醫療業
2022-03-31,1736,CapitalSurplus_per,0.17,資本公積合計,喬山,生技醫療業
2022-03-31,1736,LegalReserve,1509898000.0,法定盈餘公積,喬山,生技醫療業
2022-03-31,1736,LegalReserve_per,4.16,法定盈餘公積,喬山,生技醫療業
2022-03-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,4586209000.0,未分配盈餘,喬山,生技醫療業
2022-03-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,12.63,未分配盈餘,喬山,生技醫療業
2022-03-31,1736,RetainedEarnings,7481599000.0,保留盈餘合計,喬山,生技醫療業
2022-03-31,1736,RetainedEarnings_per,20.6,保留盈餘合計,喬山,生技醫療業
2022-03-31,1736,OtherEquityInterest,-1671905000.0,其他權益合計,喬山,生技醫療業
2022-03-31,1736,OtherEquityInterest_per,-4.6,其他權益合計,喬山,生技醫療業
2022-03-31,1736,EquityAttributableToOwnersOfParent,8831967000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2022-03-31,1736,EquityAttributableToOwnersOfParent_per,24.32,歸屬於母公司業主之權益合計,喬山,生技醫療業
2022-03-31,1736,NoncontrollingInterests,864886000.0,非控制權益,喬山,生技醫療業
2022-03-31,1736,NoncontrollingInterests_per,2.38,非控制權益,喬山,生技醫療業
2022-03-31,1736,TotalLiabilitiesEquity,36321616000.0,負債及權益總計,喬山,生技醫療業
2022-03-31,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2022-03-31,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,1028000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2022-03-31,1736,Liabilities,26624763000.0,負債總額,喬山,生技醫療業
2022-03-31,1736,Liabilities_per,73.3,負債總額,喬山,生技醫療業
2022-03-31,1736,Equity,9696853000.0,權益總額,喬山,生技醫療業
2022-03-31,1736,Equity_per,26.7,權益總額,喬山,生技醫療業
2022-06-30,1736,CashAndCashEquivalents,3396235000.0,現金及約當現金,喬山,生技醫療業
2022-06-30,1736,CashAndCashEquivalents_per,9.72,現金及約當現金,喬山,生技醫療業
2022-06-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2022-06-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2022-06-30,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,9465000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2022-06-30,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.03,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2022-06-30,1736,FinancialAssetsAtAmortizedCost,1338000.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2022-06-30,1736,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2022-06-30,1736,BillsReceivableNet,64667000.0,應收票據淨額,喬山,生技醫療業
2022-06-30,1736,BillsReceivableNet_per,0.19,應收票據淨額,喬山,生技醫療業
2022-06-30,1736,OtherReceivable,458277000.0,其他應收款淨額,喬山,生技醫療業
2022-06-30,1736,OtherReceivable_per,1.31,其他應收款淨額,喬山,生技醫療業
2022-06-30,1736,Prepayments,981928000.0,預付款項,喬山,生技醫療業
2022-06-30,1736,Prepayments_per,2.81,預付款項,喬山,生技醫療業
2022-06-30,1736,AccountsReceivableNet,5673034000.0,應收帳款淨額,喬山,生技醫療業
2022-06-30,1736,AccountsReceivableNet_per,16.24,應收帳款淨額,喬山,生技醫療業
2022-06-30,1736,Inventories,11292256000.0,存貨,喬山,生技醫療業
2022-06-30,1736,Inventories_per,32.33,存貨,喬山,生技醫療業
2022-06-30,1736,OtherCurrentAssets,130319000.0,其他流動資產,喬山,生技醫療業
2022-06-30,1736,OtherCurrentAssets_per,0.37,其他流動資產,喬山,生技醫療業
2022-06-30,1736,CurrentAssets,22060703000.0,流動資產合計,喬山,生技醫療業
2022-06-30,1736,CurrentAssets_per,63.16,流動資產合計,喬山,生技醫療業
2022-06-30,1736,PropertyPlantAndEquipment,4328026000.0,不動產、廠房及設備,喬山,生技醫療業
2022-06-30,1736,PropertyPlantAndEquipment_per,12.39,不動產、廠房及設備,喬山,生技醫療業
2022-06-30,1736,RightOfUseAsset,2095624000.0,使用權資產,喬山,生技醫療業
2022-06-30,1736,RightOfUseAsset_per,6.0,使用權資產,喬山,生技醫療業
2022-06-30,1736,IntangibleAssets,2838845000.0,無形資產,喬山,生技醫療業
2022-06-30,1736,IntangibleAssets_per,8.13,無形資產,喬山,生技醫療業
2022-06-30,1736,DeferredTaxAssets,2220161000.0,遞延所得稅資產,喬山,生技醫療業
2022-06-30,1736,DeferredTaxAssets_per,6.36,遞延所得稅資產,喬山,生技醫療業
2022-06-30,1736,OtherNoncurrentAssets,1337789000.0,其他非流動資產,喬山,生技醫療業
2022-06-30,1736,OtherNoncurrentAssets_per,3.83,其他非流動資產,喬山,生技醫療業
2022-06-30,1736,NoncurrentAssets,12866039000.0,非流動資產合計,喬山,生技醫療業
2022-06-30,1736,NoncurrentAssets_per,36.84,非流動資產合計,喬山,生技醫療業
2022-06-30,1736,TotalAssets,34926742000.0,資產總額,喬山,生技醫療業
2022-06-30,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2022-06-30,1736,ShorttermBorrowings,8545007000.0,短期借款,喬山,生技醫療業
2022-06-30,1736,ShorttermBorrowings_per,24.47,短期借款,喬山,生技醫療業
2022-06-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,1204000.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2022-06-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2022-06-30,1736,AccountsPayable,2887932000.0,應付帳款,喬山,生技醫療業
2022-06-30,1736,AccountsPayable_per,8.27,應付帳款,喬山,生技醫療業
2022-06-30,1736,OtherPayables,2703431000.0,其他應付款,喬山,生技醫療業
2022-06-30,1736,OtherPayables_per,7.74,其他應付款,喬山,生技醫療業
2022-06-30,1736,CurrentTaxLiabilities,354471000.0,本期所得稅負債,喬山,生技醫療業
2022-06-30,1736,CurrentTaxLiabilities_per,1.01,本期所得稅負債,喬山,生技醫療業
2022-06-30,1736,OtherCurrentLiabilities,1153723000.0,其他流動負債,喬山,生技醫療業
2022-06-30,1736,OtherCurrentLiabilities_per,3.3,其他流動負債,喬山,生技醫療業
2022-06-30,1736,CurrentLiabilities,21505465000.0,流動負債合計,喬山,生技醫療業
2022-06-30,1736,CurrentLiabilities_per,61.57,流動負債合計,喬山,生技醫療業
2022-06-30,1736,BondsPayable,2000000000.0,應付公司債,喬山,生技醫療業
2022-06-30,1736,BondsPayable_per,5.73,應付公司債,喬山,生技醫療業
2022-06-30,1736,LongtermBorrowings,349922000.0,長期借款,喬山,生技醫療業
2022-06-30,1736,LongtermBorrowings_per,1.0,長期借款,喬山,生技醫療業
2022-06-30,1736,OtherNoncurrentLiabilities,285692000.0,其他非流動負債,喬山,生技醫療業
2022-06-30,1736,OtherNoncurrentLiabilities_per,0.82,其他非流動負債,喬山,生技醫療業
2022-06-30,1736,NoncurrentLiabilities,4492138000.0,非流動負債合計,喬山,生技醫療業
2022-06-30,1736,NoncurrentLiabilities_per,12.86,非流動負債合計,喬山,生技醫療業
2022-06-30,1736,OrdinaryShare,3036166000.0,普通股股本,喬山,生技醫療業
2022-06-30,1736,OrdinaryShare_per,8.69,普通股股本,喬山,生技醫療業
2022-06-30,1736,CapitalStock,3036166000.0,股本合計,喬山,生技醫療業
2022-06-30,1736,CapitalStock_per,8.69,股本合計,喬山,生技醫療業
2022-06-30,1736,CapitalSurplus,59979000.0,資本公積合計,喬山,生技醫療業
2022-06-30,1736,CapitalSurplus_per,0.17,資本公積合計,喬山,生技醫療業
2022-06-30,1736,LegalReserve,1512423000.0,法定盈餘公積,喬山,生技醫療業
2022-06-30,1736,LegalReserve_per,4.33,法定盈餘公積,喬山,生技醫療業
2022-06-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,3465593000.0,未分配盈餘,喬山,生技醫療業
2022-06-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,9.92,未分配盈餘,喬山,生技醫療業
2022-06-30,1736,RetainedEarnings,6920025000.0,保留盈餘合計,喬山,生技醫療業
2022-06-30,1736,RetainedEarnings_per,19.81,保留盈餘合計,喬山,生技醫療業
2022-06-30,1736,OtherEquityInterest,-1844783000.0,其他權益合計,喬山,生技醫療業
2022-06-30,1736,OtherEquityInterest_per,-5.28,其他權益合計,喬山,生技醫療業
2022-06-30,1736,EquityAttributableToOwnersOfParent,8097515000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2022-06-30,1736,EquityAttributableToOwnersOfParent_per,23.18,歸屬於母公司業主之權益合計,喬山,生技醫療業
2022-06-30,1736,NoncontrollingInterests,831624000.0,非控制權益,喬山,生技醫療業
2022-06-30,1736,NoncontrollingInterests_per,2.38,非控制權益,喬山,生技醫療業
2022-06-30,1736,TotalLiabilitiesEquity,34926742000.0,負債及權益總計,喬山,生技醫療業
2022-06-30,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2022-06-30,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,1028000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2022-06-30,1736,Equity,8929139000.0,權益總額,喬山,生技醫療業
2022-06-30,1736,Equity_per,25.57,權益總額,喬山,生技醫療業
2022-06-30,1736,Liabilities,25997603000.0,負債總額,喬山,生技醫療業
2022-06-30,1736,Liabilities_per,74.43,負債總額,喬山,生技醫療業
2022-09-30,1736,CashAndCashEquivalents,2650629000.0,現金及約當現金,喬山,生技醫療業
2022-09-30,1736,CashAndCashEquivalents_per,6.91,現金及約當現金,喬山,生技醫療業
2022-09-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2022-09-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2022-09-30,1736,BillsReceivableNet,90163000.0,應收票據淨額,喬山,生技醫療業
2022-09-30,1736,BillsReceivableNet_per,0.24,應收票據淨額,喬山,生技醫療業
2022-09-30,1736,OtherReceivable,803245000.0,其他應收款淨額,喬山,生技醫療業
2022-09-30,1736,OtherReceivable_per,2.1,其他應收款淨額,喬山,生技醫療業
2022-09-30,1736,Prepayments,987562000.0,預付款項,喬山,生技醫療業
2022-09-30,1736,Prepayments_per,2.58,預付款項,喬山,生技醫療業
2022-09-30,1736,AccountsReceivableNet,7222037000.0,應收帳款淨額,喬山,生技醫療業
2022-09-30,1736,AccountsReceivableNet_per,18.84,應收帳款淨額,喬山,生技醫療業
2022-09-30,1736,Inventories,12994705000.0,存貨,喬山,生技醫療業
2022-09-30,1736,Inventories_per,33.9,存貨,喬山,生技醫療業
2022-09-30,1736,OtherCurrentAssets,73997000.0,其他流動資產,喬山,生技醫療業
2022-09-30,1736,OtherCurrentAssets_per,0.19,其他流動資產,喬山,生技醫療業
2022-09-30,1736,CurrentAssets,24870124000.0,流動資產合計,喬山,生技醫療業
2022-09-30,1736,CurrentAssets_per,64.87,流動資產合計,喬山,生技醫療業
2022-09-30,1736,PropertyPlantAndEquipment,4478933000.0,不動產、廠房及設備,喬山,生技醫療業
2022-09-30,1736,PropertyPlantAndEquipment_per,11.68,不動產、廠房及設備,喬山,生技醫療業
2022-09-30,1736,IntangibleAssets,2890932000.0,無形資產,喬山,生技醫療業
2022-09-30,1736,IntangibleAssets_per,7.54,無形資產,喬山,生技醫療業
2022-09-30,1736,DeferredTaxAssets,2536681000.0,遞延所得稅資產,喬山,生技醫療業
2022-09-30,1736,DeferredTaxAssets_per,6.62,遞延所得稅資產,喬山,生技醫療業
2022-09-30,1736,OtherNoncurrentAssets,1355883000.0,其他非流動資產,喬山,生技醫療業
2022-09-30,1736,OtherNoncurrentAssets_per,3.54,其他非流動資產,喬山,生技醫療業
2022-09-30,1736,NoncurrentAssets,13466137000.0,非流動資產合計,喬山,生技醫療業
2022-09-30,1736,NoncurrentAssets_per,35.13,非流動資產合計,喬山,生技醫療業
2022-09-30,1736,TotalAssets,38336261000.0,資產總額,喬山,生技醫療業
2022-09-30,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2022-09-30,1736,ShorttermBorrowings,9172632000.0,短期借款,喬山,生技醫療業
2022-09-30,1736,ShorttermBorrowings_per,23.93,短期借款,喬山,生技醫療業
2022-09-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,18046000.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2022-09-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.05,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2022-09-30,1736,AccountsPayable,4893486000.0,應付帳款,喬山,生技醫療業
2022-09-30,1736,AccountsPayable_per,12.76,應付帳款,喬山,生技醫療業
2022-09-30,1736,OtherPayables,2878865000.0,其他應付款,喬山,生技醫療業
2022-09-30,1736,OtherPayables_per,7.51,其他應付款,喬山,生技醫療業
2022-09-30,1736,OtherCurrentLiabilities,1219831000.0,其他流動負債,喬山,生技醫療業
2022-09-30,1736,OtherCurrentLiabilities_per,3.18,其他流動負債,喬山,生技醫療業
2022-09-30,1736,CurrentLiabilities,24640665000.0,流動負債合計,喬山,生技醫療業
2022-09-30,1736,CurrentLiabilities_per,64.28,流動負債合計,喬山,生技醫療業
2022-09-30,1736,BondsPayable,2000000000.0,應付公司債,喬山,生技醫療業
2022-09-30,1736,BondsPayable_per,5.22,應付公司債,喬山,生技醫療業
2022-09-30,1736,LongtermBorrowings,419238000.0,長期借款,喬山,生技醫療業
2022-09-30,1736,LongtermBorrowings_per,1.09,長期借款,喬山,生技醫療業
2022-09-30,1736,OtherNoncurrentLiabilities,299822000.0,其他非流動負債,喬山,生技醫療業
2022-09-30,1736,OtherNoncurrentLiabilities_per,0.78,其他非流動負債,喬山,生技醫療業
2022-09-30,1736,NoncurrentLiabilities,4625480000.0,非流動負債合計,喬山,生技醫療業
2022-09-30,1736,NoncurrentLiabilities_per,12.07,非流動負債合計,喬山,生技醫療業
2022-09-30,1736,OrdinaryShare,3036166000.0,普通股股本,喬山,生技醫療業
2022-09-30,1736,OrdinaryShare_per,7.92,普通股股本,喬山,生技醫療業
2022-09-30,1736,CapitalStock,3036166000.0,股本合計,喬山,生技醫療業
2022-09-30,1736,CapitalStock_per,7.92,股本合計,喬山,生技醫療業
2022-09-30,1736,CapitalSurplus,59979000.0,資本公積合計,喬山,生技醫療業
2022-09-30,1736,CapitalSurplus_per,0.16,資本公積合計,喬山,生技醫療業
2022-09-30,1736,LegalReserve,1512423000.0,法定盈餘公積,喬山,生技醫療業
2022-09-30,1736,LegalReserve_per,3.95,法定盈餘公積,喬山,生技醫療業
2022-09-30,1736,RetainedEarnings,7143200000.0,保留盈餘合計,喬山,生技醫療業
2022-09-30,1736,RetainedEarnings_per,18.63,保留盈餘合計,喬山,生技醫療業
2022-09-30,1736,EquityAttributableToOwnersOfParent,8433130000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2022-09-30,1736,EquityAttributableToOwnersOfParent_per,22.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2022-09-30,1736,NoncontrollingInterests,636986000.0,非控制權益,喬山,生技醫療業
2022-09-30,1736,NoncontrollingInterests_per,1.66,非控制權益,喬山,生技醫療業
2022-09-30,1736,TotalLiabilitiesEquity,38336261000.0,負債及權益總計,喬山,生技醫療業
2022-09-30,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2022-09-30,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,9340000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2022-09-30,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.02,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2022-09-30,1736,RightOfUseAsset,2158085000.0,使用權資產,喬山,生技醫療業
2022-09-30,1736,RightOfUseAsset_per,5.63,使用權資產,喬山,生技醫療業
2022-09-30,1736,CurrentTaxLiabilities,490580000.0,本期所得稅負債,喬山,生技醫療業
2022-09-30,1736,CurrentTaxLiabilities_per,1.28,本期所得稅負債,喬山,生技醫療業
2022-09-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,3688768000.0,未分配盈餘,喬山,生技醫療業
2022-09-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,9.62,未分配盈餘,喬山,生技醫療業
2022-09-30,1736,OtherEquityInterest,-1732343000.0,其他權益合計,喬山,生技醫療業
2022-09-30,1736,OtherEquityInterest_per,-4.52,其他權益合計,喬山,生技醫療業
2022-09-30,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,1028000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2022-09-30,1736,Equity,9070116000.0,權益總額,喬山,生技醫療業
2022-09-30,1736,Equity_per,23.66,權益總額,喬山,生技醫療業
2022-09-30,1736,Liabilities,29266145000.0,負債總額,喬山,生技醫療業
2022-09-30,1736,Liabilities_per,76.34,負債總額,喬山,生技醫療業
2022-12-31,1736,CashAndCashEquivalents,3531554000.0,現金及約當現金,喬山,生技醫療業
2022-12-31,1736,CashAndCashEquivalents_per,9.09,現金及約當現金,喬山,生技醫療業
2022-12-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,8746000.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2022-12-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.02,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2022-12-31,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,7444000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2022-12-31,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.02,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2022-12-31,1736,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2022-12-31,1736,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2022-12-31,1736,BillsReceivableNet,85444000.0,應收票據淨額,喬山,生技醫療業
2022-12-31,1736,BillsReceivableNet_per,0.22,應收票據淨額,喬山,生技醫療業
2022-12-31,1736,OtherReceivable,1167768000.0,其他應收款淨額,喬山,生技醫療業
2022-12-31,1736,OtherReceivable_per,3.0,其他應收款淨額,喬山,生技醫療業
2022-12-31,1736,Prepayments,925837000.0,預付款項,喬山,生技醫療業
2022-12-31,1736,Prepayments_per,2.38,預付款項,喬山,生技醫療業
2022-12-31,1736,AccountsReceivableNet,8692416000.0,應收帳款淨額,喬山,生技醫療業
2022-12-31,1736,AccountsReceivableNet_per,22.37,應收帳款淨額,喬山,生技醫療業
2022-12-31,1736,Inventories,11808413000.0,存貨,喬山,生技醫療業
2022-12-31,1736,Inventories_per,30.38,存貨,喬山,生技醫療業
2022-12-31,1736,OtherCurrentAssets,155938000.0,其他流動資產,喬山,生技醫療業
2022-12-31,1736,OtherCurrentAssets_per,0.4,其他流動資產,喬山,生技醫療業
2022-12-31,1736,CurrentAssets,26419441000.0,流動資產合計,喬山,生技醫療業
2022-12-31,1736,CurrentAssets_per,67.98,流動資產合計,喬山,生技醫療業
2022-12-31,1736,PropertyPlantAndEquipment,4494351000.0,不動產、廠房及設備,喬山,生技醫療業
2022-12-31,1736,PropertyPlantAndEquipment_per,11.56,不動產、廠房及設備,喬山,生技醫療業
2022-12-31,1736,RightOfUseAsset,2209517000.0,使用權資產,喬山,生技醫療業
2022-12-31,1736,RightOfUseAsset_per,5.68,使用權資產,喬山,生技醫療業
2022-12-31,1736,IntangibleAssets,2857429000.0,無形資產,喬山,生技醫療業
2022-12-31,1736,IntangibleAssets_per,7.35,無形資產,喬山,生技醫療業
2022-12-31,1736,DeferredTaxAssets,2139856000.0,遞延所得稅資產,喬山,生技醫療業
2022-12-31,1736,DeferredTaxAssets_per,5.51,遞延所得稅資產,喬山,生技醫療業
2022-12-31,1736,OtherNoncurrentAssets,699706000.0,其他非流動資產,喬山,生技醫療業
2022-12-31,1736,OtherNoncurrentAssets_per,1.8,其他非流動資產,喬山,生技醫療業
2022-12-31,1736,NoncurrentAssets,12446503000.0,非流動資產合計,喬山,生技醫療業
2022-12-31,1736,NoncurrentAssets_per,32.02,非流動資產合計,喬山,生技醫療業
2022-12-31,1736,TotalAssets,38865944000.0,資產總額,喬山,生技醫療業
2022-12-31,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2022-12-31,1736,ShorttermBorrowings,12277783000.0,短期借款,喬山,生技醫療業
2022-12-31,1736,ShorttermBorrowings_per,31.59,短期借款,喬山,生技醫療業
2022-12-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,879000.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2022-12-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2022-12-31,1736,AccountsPayable,4290595000.0,應付帳款,喬山,生技醫療業
2022-12-31,1736,AccountsPayable_per,11.04,應付帳款,喬山,生技醫療業
2022-12-31,1736,OtherPayables,3567656000.0,其他應付款,喬山,生技醫療業
2022-12-31,1736,OtherPayables_per,9.18,其他應付款,喬山,生技醫療業
2022-12-31,1736,CurrentTaxLiabilities,708784000.0,本期所得稅負債,喬山,生技醫療業
2022-12-31,1736,CurrentTaxLiabilities_per,1.82,本期所得稅負債,喬山,生技醫療業
2022-12-31,1736,OtherCurrentLiabilities,1199365000.0,其他流動負債,喬山,生技醫療業
2022-12-31,1736,OtherCurrentLiabilities_per,3.09,其他流動負債,喬山,生技醫療業
2022-12-31,1736,CurrentLiabilities,24799590000.0,流動負債合計,喬山,生技醫療業
2022-12-31,1736,CurrentLiabilities_per,63.81,流動負債合計,喬山,生技醫療業
2022-12-31,1736,BondsPayable,2000000000.0,應付公司債,喬山,生技醫療業
2022-12-31,1736,BondsPayable_per,5.15,應付公司債,喬山,生技醫療業
2022-12-31,1736,LongtermBorrowings,446964000.0,長期借款,喬山,生技醫療業
2022-12-31,1736,LongtermBorrowings_per,1.15,長期借款,喬山,生技醫療業
2022-12-31,1736,OtherNoncurrentLiabilities,461805000.0,其他非流動負債,喬山,生技醫療業
2022-12-31,1736,OtherNoncurrentLiabilities_per,1.19,其他非流動負債,喬山,生技醫療業
2022-12-31,1736,NoncurrentLiabilities,4584074000.0,非流動負債合計,喬山,生技醫療業
2022-12-31,1736,NoncurrentLiabilities_per,11.79,非流動負債合計,喬山,生技醫療業
2022-12-31,1736,OrdinaryShare,3036166000.0,普通股股本,喬山,生技醫療業
2022-12-31,1736,OrdinaryShare_per,7.81,普通股股本,喬山,生技醫療業
2022-12-31,1736,CapitalStock,3036166000.0,股本合計,喬山,生技醫療業
2022-12-31,1736,CapitalStock_per,7.81,股本合計,喬山,生技醫療業
2022-12-31,1736,CapitalSurplus,431446000.0,資本公積合計,喬山,生技醫療業
2022-12-31,1736,CapitalSurplus_per,1.11,資本公積合計,喬山,生技醫療業
2022-12-31,1736,LegalReserve,1512422000.0,法定盈餘公積,喬山,生技醫療業
2022-12-31,1736,LegalReserve_per,3.89,法定盈餘公積,喬山,生技醫療業
2022-12-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,4226611000.0,未分配盈餘,喬山,生技醫療業
2022-12-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,10.87,未分配盈餘,喬山,生技醫療業
2022-12-31,1736,RetainedEarnings,7681042000.0,保留盈餘合計,喬山,生技醫療業
2022-12-31,1736,RetainedEarnings_per,19.76,保留盈餘合計,喬山,生技醫療業
2022-12-31,1736,OtherEquityInterest,-1620071000.0,其他權益合計,喬山,生技醫療業
2022-12-31,1736,OtherEquityInterest_per,-4.17,其他權益合計,喬山,生技醫療業
2022-12-31,1736,EquityAttributableToOwnersOfParent,9474971000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2022-12-31,1736,EquityAttributableToOwnersOfParent_per,24.38,歸屬於母公司業主之權益合計,喬山,生技醫療業
2022-12-31,1736,NoncontrollingInterests,7309000.0,非控制權益,喬山,生技醫療業
2022-12-31,1736,NoncontrollingInterests_per,0.02,非控制權益,喬山,生技醫療業
2022-12-31,1736,TotalLiabilitiesEquity,38865944000.0,負債及權益總計,喬山,生技醫療業
2022-12-31,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2022-12-31,1736,Equity,9482280000.0,權益總額,喬山,生技醫療業
2022-12-31,1736,Equity_per,24.4,權益總額,喬山,生技醫療業
2022-12-31,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,1028000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2022-12-31,1736,Liabilities,29383664000.0,負債總額,喬山,生技醫療業
2022-12-31,1736,Liabilities_per,75.6,負債總額,喬山,生技醫療業
2023-03-31,1736,CashAndCashEquivalents,2779264000.0,現金及約當現金,喬山,生技醫療業
2023-03-31,1736,CashAndCashEquivalents_per,7.79,現金及約當現金,喬山,生技醫療業
2023-03-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,2485000.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2023-03-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.01,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2023-03-31,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,7417000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2023-03-31,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.02,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2023-03-31,1736,BillsReceivableNet,82010000.0,應收票據淨額,喬山,生技醫療業
2023-03-31,1736,BillsReceivableNet_per,0.23,應收票據淨額,喬山,生技醫療業
2023-03-31,1736,OtherReceivable,305409000.0,其他應收款淨額,喬山,生技醫療業
2023-03-31,1736,OtherReceivable_per,0.86,其他應收款淨額,喬山,生技醫療業
2023-03-31,1736,Prepayments,955863000.0,預付款項,喬山,生技醫療業
2023-03-31,1736,Prepayments_per,2.68,預付款項,喬山,生技醫療業
2023-03-31,1736,AccountsReceivableNet,7639149000.0,應收帳款淨額,喬山,生技醫療業
2023-03-31,1736,AccountsReceivableNet_per,21.42,應收帳款淨額,喬山,生技醫療業
2023-03-31,1736,Inventories,11341393000.0,存貨,喬山,生技醫療業
2023-03-31,1736,Inventories_per,31.8,存貨,喬山,生技醫療業
2023-03-31,1736,OtherCurrentAssets,128893000.0,其他流動資產,喬山,生技醫療業
2023-03-31,1736,OtherCurrentAssets_per,0.36,其他流動資產,喬山,生技醫療業
2023-03-31,1736,CurrentAssets,23265114000.0,流動資產合計,喬山,生技醫療業
2023-03-31,1736,CurrentAssets_per,65.24,流動資產合計,喬山,生技醫療業
2023-03-31,1736,PropertyPlantAndEquipment,4439952000.0,不動產、廠房及設備,喬山,生技醫療業
2023-03-31,1736,PropertyPlantAndEquipment_per,12.45,不動產、廠房及設備,喬山,生技醫療業
2023-03-31,1736,RightOfUseAsset,2073076000.0,使用權資產,喬山,生技醫療業
2023-03-31,1736,RightOfUseAsset_per,5.81,使用權資產,喬山,生技醫療業
2023-03-31,1736,IntangibleAssets,2839236000.0,無形資產,喬山,生技醫療業
2023-03-31,1736,IntangibleAssets_per,7.96,無形資產,喬山,生技醫療業
2023-03-31,1736,DeferredTaxAssets,2226088000.0,遞延所得稅資產,喬山,生技醫療業
2023-03-31,1736,DeferredTaxAssets_per,6.24,遞延所得稅資產,喬山,生技醫療業
2023-03-31,1736,OtherNoncurrentAssets,771574000.0,其他非流動資產,喬山,生技醫療業
2023-03-31,1736,OtherNoncurrentAssets_per,2.16,其他非流動資產,喬山,生技醫療業
2023-03-31,1736,NoncurrentAssets,12395017000.0,非流動資產合計,喬山,生技醫療業
2023-03-31,1736,NoncurrentAssets_per,34.76,非流動資產合計,喬山,生技醫療業
2023-03-31,1736,TotalAssets,35660131000.0,資產總額,喬山,生技醫療業
2023-03-31,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2023-03-31,1736,ShorttermBorrowings,7568962000.0,短期借款,喬山,生技醫療業
2023-03-31,1736,ShorttermBorrowings_per,21.23,短期借款,喬山,生技醫療業
2023-03-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2023-03-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2023-03-31,1736,AccountsPayable,3035467000.0,應付帳款,喬山,生技醫療業
2023-03-31,1736,AccountsPayable_per,8.51,應付帳款,喬山,生技醫療業
2023-03-31,1736,OtherPayables,2527036000.0,其他應付款,喬山,生技醫療業
2023-03-31,1736,OtherPayables_per,7.09,其他應付款,喬山,生技醫療業
2023-03-31,1736,CurrentTaxLiabilities,554690000.0,本期所得稅負債,喬山,生技醫療業
2023-03-31,1736,CurrentTaxLiabilities_per,1.56,本期所得稅負債,喬山,生技醫療業
2023-03-31,1736,OtherCurrentLiabilities,253196000.0,其他流動負債,喬山,生技醫療業
2023-03-31,1736,OtherCurrentLiabilities_per,0.71,其他流動負債,喬山,生技醫療業
2023-03-31,1736,CurrentLiabilities,15839968000.0,流動負債合計,喬山,生技醫療業
2023-03-31,1736,CurrentLiabilities_per,44.42,流動負債合計,喬山,生技醫療業
2023-03-31,1736,BondsPayable,2000000000.0,應付公司債,喬山,生技醫療業
2023-03-31,1736,BondsPayable_per,5.61,應付公司債,喬山,生技醫療業
2023-03-31,1736,LongtermBorrowings,6797711000.0,長期借款,喬山,生技醫療業
2023-03-31,1736,LongtermBorrowings_per,19.06,長期借款,喬山,生技醫療業
2023-03-31,1736,OtherNoncurrentLiabilities,496411000.0,其他非流動負債,喬山,生技醫療業
2023-03-31,1736,OtherNoncurrentLiabilities_per,1.39,其他非流動負債,喬山,生技醫療業
2023-03-31,1736,NoncurrentLiabilities,10981023000.0,非流動負債合計,喬山,生技醫療業
2023-03-31,1736,NoncurrentLiabilities_per,30.79,非流動負債合計,喬山,生技醫療業
2023-03-31,1736,OrdinaryShare,3036166000.0,普通股股本,喬山,生技醫療業
2023-03-31,1736,OrdinaryShare_per,8.51,普通股股本,喬山,生技醫療業
2023-03-31,1736,CapitalStock,3036166000.0,股本合計,喬山,生技醫療業
2023-03-31,1736,CapitalStock_per,8.51,股本合計,喬山,生技醫療業
2023-03-31,1736,CapitalSurplus,431446000.0,資本公積合計,喬山,生技醫療業
2023-03-31,1736,CapitalSurplus_per,1.21,資本公積合計,喬山,生技醫療業
2023-03-31,1736,LegalReserve,1512422000.0,法定盈餘公積,喬山,生技醫療業
2023-03-31,1736,LegalReserve_per,4.24,法定盈餘公積,喬山,生技醫療業
2023-03-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,3579850000.0,未分配盈餘,喬山,生技醫療業
2023-03-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,10.04,未分配盈餘,喬山,生技醫療業
2023-03-31,1736,RetainedEarnings,7034281000.0,保留盈餘合計,喬山,生技醫療業
2023-03-31,1736,RetainedEarnings_per,19.73,保留盈餘合計,喬山,生技醫療業
2023-03-31,1736,OtherEquityInterest,-1616225000.0,其他權益合計,喬山,生技醫療業
2023-03-31,1736,OtherEquityInterest_per,-4.53,其他權益合計,喬山,生技醫療業
2023-03-31,1736,EquityAttributableToOwnersOfParent,8832056000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2023-03-31,1736,EquityAttributableToOwnersOfParent_per,24.77,歸屬於母公司業主之權益合計,喬山,生技醫療業
2023-03-31,1736,NoncontrollingInterests,7084000.0,非控制權益,喬山,生技醫療業
2023-03-31,1736,NoncontrollingInterests_per,0.02,非控制權益,喬山,生技醫療業
2023-03-31,1736,TotalLiabilitiesEquity,35660131000.0,負債及權益總計,喬山,生技醫療業
2023-03-31,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2023-03-31,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,695000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2023-03-31,1736,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2023-03-31,1736,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2023-03-31,1736,Liabilities,26820991000.0,負債總額,喬山,生技醫療業
2023-03-31,1736,Liabilities_per,75.21,負債總額,喬山,生技醫療業
2023-03-31,1736,Equity,8839140000.0,權益總額,喬山,生技醫療業
2023-03-31,1736,Equity_per,24.79,權益總額,喬山,生技醫療業
2023-06-30,1736,CashAndCashEquivalents,2315471000.0,現金及約當現金,喬山,生技醫療業
2023-06-30,1736,CashAndCashEquivalents_per,6.69,現金及約當現金,喬山,生技醫療業
2023-06-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,6918000.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2023-06-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.02,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2023-06-30,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,6952000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2023-06-30,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.02,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2023-06-30,1736,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2023-06-30,1736,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2023-06-30,1736,BillsReceivableNet,76722000.0,應收票據淨額,喬山,生技醫療業
2023-06-30,1736,BillsReceivableNet_per,0.22,應收票據淨額,喬山,生技醫療業
2023-06-30,1736,OtherReceivable,295292000.0,其他應收款淨額,喬山,生技醫療業
2023-06-30,1736,OtherReceivable_per,0.85,其他應收款淨額,喬山,生技醫療業
2023-06-30,1736,Prepayments,1035445000.0,預付款項,喬山,生技醫療業
2023-06-30,1736,Prepayments_per,2.99,預付款項,喬山,生技醫療業
2023-06-30,1736,AccountsReceivableNet,7847961000.0,應收帳款淨額,喬山,生技醫療業
2023-06-30,1736,AccountsReceivableNet_per,22.68,應收帳款淨額,喬山,生技醫療業
2023-06-30,1736,Inventories,10329252000.0,存貨,喬山,生技醫療業
2023-06-30,1736,Inventories_per,29.85,存貨,喬山,生技醫療業
2023-06-30,1736,OtherCurrentAssets,167694000.0,其他流動資產,喬山,生技醫療業
2023-06-30,1736,OtherCurrentAssets_per,0.48,其他流動資產,喬山,生技醫療業
2023-06-30,1736,CurrentAssets,22104668000.0,流動資產合計,喬山,生技醫療業
2023-06-30,1736,CurrentAssets_per,63.87,流動資產合計,喬山,生技醫療業
2023-06-30,1736,PropertyPlantAndEquipment,4448223000.0,不動產、廠房及設備,喬山,生技醫療業
2023-06-30,1736,PropertyPlantAndEquipment_per,12.85,不動產、廠房及設備,喬山,生技醫療業
2023-06-30,1736,RightOfUseAsset,2161346000.0,使用權資產,喬山,生技醫療業
2023-06-30,1736,RightOfUseAsset_per,6.24,使用權資產,喬山,生技醫療業
2023-06-30,1736,IntangibleAssets,2845902000.0,無形資產,喬山,生技醫療業
2023-06-30,1736,IntangibleAssets_per,8.22,無形資產,喬山,生技醫療業
2023-06-30,1736,DeferredTaxAssets,2227269000.0,遞延所得稅資產,喬山,生技醫療業
2023-06-30,1736,DeferredTaxAssets_per,6.44,遞延所得稅資產,喬山,生技醫療業
2023-06-30,1736,OtherNoncurrentAssets,779876000.0,其他非流動資產,喬山,生技醫療業
2023-06-30,1736,OtherNoncurrentAssets_per,2.25,其他非流動資產,喬山,生技醫療業
2023-06-30,1736,NoncurrentAssets,12504653000.0,非流動資產合計,喬山,生技醫療業
2023-06-30,1736,NoncurrentAssets_per,36.13,非流動資產合計,喬山,生技醫療業
2023-06-30,1736,TotalAssets,34609321000.0,資產總額,喬山,生技醫療業
2023-06-30,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2023-06-30,1736,ShorttermBorrowings,6763764000.0,短期借款,喬山,生技醫療業
2023-06-30,1736,ShorttermBorrowings_per,19.54,短期借款,喬山,生技醫療業
2023-06-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,2479000.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2023-06-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.01,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2023-06-30,1736,AccountsPayable,2793875000.0,應付帳款,喬山,生技醫療業
2023-06-30,1736,AccountsPayable_per,8.07,應付帳款,喬山,生技醫療業
2023-06-30,1736,OtherPayables,2753161000.0,其他應付款,喬山,生技醫療業
2023-06-30,1736,OtherPayables_per,7.95,其他應付款,喬山,生技醫療業
2023-06-30,1736,CurrentTaxLiabilities,397388000.0,本期所得稅負債,喬山,生技醫療業
2023-06-30,1736,CurrentTaxLiabilities_per,1.15,本期所得稅負債,喬山,生技醫療業
2023-06-30,1736,OtherCurrentLiabilities,309882000.0,其他流動負債,喬山,生技醫療業
2023-06-30,1736,OtherCurrentLiabilities_per,0.9,其他流動負債,喬山,生技醫療業
2023-06-30,1736,CurrentLiabilities,15063885000.0,流動負債合計,喬山,生技醫療業
2023-06-30,1736,CurrentLiabilities_per,43.53,流動負債合計,喬山,生技醫療業
2023-06-30,1736,BondsPayable,2000000000.0,應付公司債,喬山,生技醫療業
2023-06-30,1736,BondsPayable_per,5.78,應付公司債,喬山,生技醫療業
2023-06-30,1736,LongtermBorrowings,6535419000.0,長期借款,喬山,生技醫療業
2023-06-30,1736,LongtermBorrowings_per,18.88,長期借款,喬山,生技醫療業
2023-06-30,1736,OtherNoncurrentLiabilities,416280000.0,其他非流動負債,喬山,生技醫療業
2023-06-30,1736,OtherNoncurrentLiabilities_per,1.2,其他非流動負債,喬山,生技醫療業
2023-06-30,1736,NoncurrentLiabilities,10630370000.0,非流動負債合計,喬山,生技醫療業
2023-06-30,1736,NoncurrentLiabilities_per,30.72,非流動負債合計,喬山,生技醫療業
2023-06-30,1736,OrdinaryShare,3036166000.0,普通股股本,喬山,生技醫療業
2023-06-30,1736,OrdinaryShare_per,8.77,普通股股本,喬山,生技醫療業
2023-06-30,1736,CapitalStock,3036166000.0,股本合計,喬山,生技醫療業
2023-06-30,1736,CapitalStock_per,8.77,股本合計,喬山,生技醫療業
2023-06-30,1736,CapitalSurplus,431446000.0,資本公積合計,喬山,生技醫療業
2023-06-30,1736,CapitalSurplus_per,1.25,資本公積合計,喬山,生技醫療業
2023-06-30,1736,LegalReserve,1555699000.0,法定盈餘公積,喬山,生技醫療業
2023-06-30,1736,LegalReserve_per,4.5,法定盈餘公積,喬山,生技醫療業
2023-06-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,4010092000.0,未分配盈餘,喬山,生技醫療業
2023-06-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,11.59,未分配盈餘,喬山,生技醫療業
2023-06-30,1736,RetainedEarnings,7185862000.0,保留盈餘合計,喬山,生技醫療業
2023-06-30,1736,RetainedEarnings_per,20.76,保留盈餘合計,喬山,生技醫療業
2023-06-30,1736,OtherEquityInterest,-1691592000.0,其他權益合計,喬山,生技醫療業
2023-06-30,1736,OtherEquityInterest_per,-4.89,其他權益合計,喬山,生技醫療業
2023-06-30,1736,EquityAttributableToOwnersOfParent,8908270000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2023-06-30,1736,EquityAttributableToOwnersOfParent_per,25.74,歸屬於母公司業主之權益合計,喬山,生技醫療業
2023-06-30,1736,NoncontrollingInterests,6796000.0,非控制權益,喬山,生技醫療業
2023-06-30,1736,NoncontrollingInterests_per,0.02,非控制權益,喬山,生技醫療業
2023-06-30,1736,TotalLiabilitiesEquity,34609321000.0,負債及權益總計,喬山,生技醫療業
2023-06-30,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2023-06-30,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,695000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2023-06-30,1736,Liabilities,25694255000.0,負債總額,喬山,生技醫療業
2023-06-30,1736,Liabilities_per,74.24,負債總額,喬山,生技醫療業
2023-06-30,1736,Equity,8915066000.0,權益總額,喬山,生技醫療業
2023-06-30,1736,Equity_per,25.76,權益總額,喬山,生技醫療業
2023-09-30,1736,CashAndCashEquivalents,2216806000.0,現金及約當現金,喬山,生技醫療業
2023-09-30,1736,CashAndCashEquivalents_per,6.1,現金及約當現金,喬山,生技醫療業
2023-09-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,11088000.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2023-09-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.03,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2023-09-30,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,8386000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2023-09-30,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.02,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2023-09-30,1736,BillsReceivableNet,82502000.0,應收票據淨額,喬山,生技醫療業
2023-09-30,1736,BillsReceivableNet_per,0.23,應收票據淨額,喬山,生技醫療業
2023-09-30,1736,OtherReceivable,343001000.0,其他應收款淨額,喬山,生技醫療業
2023-09-30,1736,OtherReceivable_per,0.94,其他應收款淨額,喬山,生技醫療業
2023-09-30,1736,Prepayments,1087910000.0,預付款項,喬山,生技醫療業
2023-09-30,1736,Prepayments_per,2.99,預付款項,喬山,生技醫療業
2023-09-30,1736,AccountsReceivableNet,8664348000.0,應收帳款淨額,喬山,生技醫療業
2023-09-30,1736,AccountsReceivableNet_per,23.85,應收帳款淨額,喬山,生技醫療業
2023-09-30,1736,Inventories,10998685000.0,存貨,喬山,生技醫療業
2023-09-30,1736,Inventories_per,30.28,存貨,喬山,生技醫療業
2023-09-30,1736,OtherCurrentAssets,101770000.0,其他流動資產,喬山,生技醫療業
2023-09-30,1736,OtherCurrentAssets_per,0.28,其他流動資產,喬山,生技醫療業
2023-09-30,1736,CurrentAssets,23594299000.0,流動資產合計,喬山,生技醫療業
2023-09-30,1736,CurrentAssets_per,64.95,流動資產合計,喬山,生技醫療業
2023-09-30,1736,PropertyPlantAndEquipment,4488827000.0,不動產、廠房及設備,喬山,生技醫療業
2023-09-30,1736,PropertyPlantAndEquipment_per,12.36,不動產、廠房及設備,喬山,生技醫療業
2023-09-30,1736,RightOfUseAsset,2322360000.0,使用權資產,喬山,生技醫療業
2023-09-30,1736,RightOfUseAsset_per,6.39,使用權資產,喬山,生技醫療業
2023-09-30,1736,IntangibleAssets,2873086000.0,無形資產,喬山,生技醫療業
2023-09-30,1736,IntangibleAssets_per,7.91,無形資產,喬山,生技醫療業
2023-09-30,1736,DeferredTaxAssets,2244402000.0,遞延所得稅資產,喬山,生技醫療業
2023-09-30,1736,DeferredTaxAssets_per,6.18,遞延所得稅資產,喬山,生技醫療業
2023-09-30,1736,OtherNoncurrentAssets,760260000.0,其他非流動資產,喬山,生技醫療業
2023-09-30,1736,OtherNoncurrentAssets_per,2.09,其他非流動資產,喬山,生技醫療業
2023-09-30,1736,NoncurrentAssets,12732500000.0,非流動資產合計,喬山,生技醫療業
2023-09-30,1736,NoncurrentAssets_per,35.05,非流動資產合計,喬山,生技醫療業
2023-09-30,1736,TotalAssets,36326799000.0,資產總額,喬山,生技醫療業
2023-09-30,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2023-09-30,1736,ShorttermBorrowings,7030206000.0,短期借款,喬山,生技醫療業
2023-09-30,1736,ShorttermBorrowings_per,19.35,短期借款,喬山,生技醫療業
2023-09-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,21919000.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2023-09-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.06,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2023-09-30,1736,AccountsPayable,4376194000.0,應付帳款,喬山,生技醫療業
2023-09-30,1736,AccountsPayable_per,12.05,應付帳款,喬山,生技醫療業
2023-09-30,1736,OtherPayables,2873239000.0,其他應付款,喬山,生技醫療業
2023-09-30,1736,OtherPayables_per,7.91,其他應付款,喬山,生技醫療業
2023-09-30,1736,CurrentTaxLiabilities,367637000.0,本期所得稅負債,喬山,生技醫療業
2023-09-30,1736,CurrentTaxLiabilities_per,1.01,本期所得稅負債,喬山,生技醫療業
2023-09-30,1736,OtherCurrentLiabilities,2245822000.0,其他流動負債,喬山,生技醫療業
2023-09-30,1736,OtherCurrentLiabilities_per,6.18,其他流動負債,喬山,生技醫療業
2023-09-30,1736,CurrentLiabilities,18923195000.0,流動負債合計,喬山,生技醫療業
2023-09-30,1736,CurrentLiabilities_per,52.09,流動負債合計,喬山,生技醫療業
2023-09-30,1736,BondsPayable,0.0,應付公司債,喬山,生技醫療業
2023-09-30,1736,BondsPayable_per,0.0,應付公司債,喬山,生技醫療業
2023-09-30,1736,LongtermBorrowings,5579998000.0,長期借款,喬山,生技醫療業
2023-09-30,1736,LongtermBorrowings_per,15.36,長期借款,喬山,生技醫療業
2023-09-30,1736,OtherNoncurrentLiabilities,301020000.0,其他非流動負債,喬山,生技醫療業
2023-09-30,1736,OtherNoncurrentLiabilities_per,0.83,其他非流動負債,喬山,生技醫療業
2023-09-30,1736,NoncurrentLiabilities,7921477000.0,非流動負債合計,喬山,生技醫療業
2023-09-30,1736,NoncurrentLiabilities_per,21.81,非流動負債合計,喬山,生技醫療業
2023-09-30,1736,OrdinaryShare,3036166000.0,普通股股本,喬山,生技醫療業
2023-09-30,1736,OrdinaryShare_per,8.36,普通股股本,喬山,生技醫療業
2023-09-30,1736,CapitalStock,3036166000.0,股本合計,喬山,生技醫療業
2023-09-30,1736,CapitalStock_per,8.36,股本合計,喬山,生技醫療業
2023-09-30,1736,CapitalSurplus,431446000.0,資本公積合計,喬山,生技醫療業
2023-09-30,1736,CapitalSurplus_per,1.19,資本公積合計,喬山,生技醫療業
2023-09-30,1736,LegalReserve,1555699000.0,法定盈餘公積,喬山,生技醫療業
2023-09-30,1736,LegalReserve_per,4.28,法定盈餘公積,喬山,生技醫療業
2023-09-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,4379634000.0,未分配盈餘,喬山,生技醫療業
2023-09-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,12.06,未分配盈餘,喬山,生技醫療業
2023-09-30,1736,RetainedEarnings,7555404000.0,保留盈餘合計,喬山,生技醫療業
2023-09-30,1736,RetainedEarnings_per,20.8,保留盈餘合計,喬山,生技醫療業
2023-09-30,1736,OtherEquityInterest,-1493918000.0,其他權益合計,喬山,生技醫療業
2023-09-30,1736,OtherEquityInterest_per,-4.11,其他權益合計,喬山,生技醫療業
2023-09-30,1736,EquityAttributableToOwnersOfParent,9475486000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2023-09-30,1736,EquityAttributableToOwnersOfParent_per,26.08,歸屬於母公司業主之權益合計,喬山,生技醫療業
2023-09-30,1736,NoncontrollingInterests,6641000.0,非控制權益,喬山,生技醫療業
2023-09-30,1736,NoncontrollingInterests_per,0.02,非控制權益,喬山,生技醫療業
2023-09-30,1736,TotalLiabilitiesEquity,36326799000.0,負債及權益總計,喬山,生技醫療業
2023-09-30,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2023-09-30,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,695000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2023-09-30,1736,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2023-09-30,1736,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2023-09-30,1736,Liabilities,26844672000.0,負債總額,喬山,生技醫療業
2023-09-30,1736,Liabilities_per,73.9,負債總額,喬山,生技醫療業
2023-09-30,1736,Equity,9482127000.0,權益總額,喬山,生技醫療業
2023-09-30,1736,Equity_per,26.1,權益總額,喬山,生技醫療業
2023-12-31,1736,CashAndCashEquivalents,2341417000.0,現金及約當現金,喬山,生技醫療業
2023-12-31,1736,CashAndCashEquivalents_per,6.43,現金及約當現金,喬山,生技醫療業
2023-12-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,14162000.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2023-12-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.04,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2023-12-31,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,8707000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2023-12-31,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.02,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2023-12-31,1736,FinancialAssetsAtAmortizedCost,16597000.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2023-12-31,1736,FinancialAssetsAtAmortizedCost_per,0.05,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2023-12-31,1736,BillsReceivableNet,80421000.0,應收票據淨額,喬山,生技醫療業
2023-12-31,1736,BillsReceivableNet_per,0.22,應收票據淨額,喬山,生技醫療業
2023-12-31,1736,OtherReceivable,434611000.0,其他應收款淨額,喬山,生技醫療業
2023-12-31,1736,OtherReceivable_per,1.19,其他應收款淨額,喬山,生技醫療業
2023-12-31,1736,Prepayments,1066366000.0,預付款項,喬山,生技醫療業
2023-12-31,1736,Prepayments_per,2.93,預付款項,喬山,生技醫療業
2023-12-31,1736,AccountsReceivableNet,10482219000.0,應收帳款淨額,喬山,生技醫療業
2023-12-31,1736,AccountsReceivableNet_per,28.78,應收帳款淨額,喬山,生技醫療業
2023-12-31,1736,Inventories,9039224000.0,存貨,喬山,生技醫療業
2023-12-31,1736,Inventories_per,24.82,存貨,喬山,生技醫療業
2023-12-31,1736,OtherCurrentAssets,107588000.0,其他流動資產,喬山,生技醫療業
2023-12-31,1736,OtherCurrentAssets_per,0.3,其他流動資產,喬山,生技醫療業
2023-12-31,1736,CurrentAssets,23609864000.0,流動資產合計,喬山,生技醫療業
2023-12-31,1736,CurrentAssets_per,64.82,流動資產合計,喬山,生技醫療業
2023-12-31,1736,PropertyPlantAndEquipment,4580639000.0,不動產、廠房及設備,喬山,生技醫療業
2023-12-31,1736,PropertyPlantAndEquipment_per,12.58,不動產、廠房及設備,喬山,生技醫療業
2023-12-31,1736,RightOfUseAsset,2871402000.0,使用權資產,喬山,生技醫療業
2023-12-31,1736,RightOfUseAsset_per,7.88,使用權資產,喬山,生技醫療業
2023-12-31,1736,IntangibleAssets,2823009000.0,無形資產,喬山,生技醫療業
2023-12-31,1736,IntangibleAssets_per,7.75,無形資產,喬山,生技醫療業
2023-12-31,1736,DeferredTaxAssets,1656533000.0,遞延所得稅資產,喬山,生技醫療業
2023-12-31,1736,DeferredTaxAssets_per,4.55,遞延所得稅資產,喬山,生技醫療業
2023-12-31,1736,OtherNoncurrentAssets,836396000.0,其他非流動資產,喬山,生技醫療業
2023-12-31,1736,OtherNoncurrentAssets_per,2.3,其他非流動資產,喬山,生技醫療業
2023-12-31,1736,NoncurrentAssets,12811976000.0,非流動資產合計,喬山,生技醫療業
2023-12-31,1736,NoncurrentAssets_per,35.18,非流動資產合計,喬山,生技醫療業
2023-12-31,1736,TotalAssets,36421840000.0,資產總額,喬山,生技醫療業
2023-12-31,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2023-12-31,1736,ShorttermBorrowings,5029244000.0,短期借款,喬山,生技醫療業
2023-12-31,1736,ShorttermBorrowings_per,13.81,短期借款,喬山,生技醫療業
2023-12-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,19050000.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2023-12-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.05,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2023-12-31,1736,AccountsPayable,4088101000.0,應付帳款,喬山,生技醫療業
2023-12-31,1736,AccountsPayable_per,11.22,應付帳款,喬山,生技醫療業
2023-12-31,1736,OtherPayables,3762873000.0,其他應付款,喬山,生技醫療業
2023-12-31,1736,OtherPayables_per,10.33,其他應付款,喬山,生技醫療業
2023-12-31,1736,CurrentTaxLiabilities,628999000.0,本期所得稅負債,喬山,生技醫療業
2023-12-31,1736,CurrentTaxLiabilities_per,1.73,本期所得稅負債,喬山,生技醫療業
2023-12-31,1736,OtherCurrentLiabilities,2289643000.0,其他流動負債,喬山,生技醫療業
2023-12-31,1736,OtherCurrentLiabilities_per,6.29,其他流動負債,喬山,生技醫療業
2023-12-31,1736,CurrentLiabilities,18124321000.0,流動負債合計,喬山,生技醫療業
2023-12-31,1736,CurrentLiabilities_per,49.76,流動負債合計,喬山,生技醫療業
2023-12-31,1736,BondsPayable,0.0,應付公司債,喬山,生技醫療業
2023-12-31,1736,BondsPayable_per,0.0,應付公司債,喬山,生技醫療業
2023-12-31,1736,LongtermBorrowings,5959452000.0,長期借款,喬山,生技醫療業
2023-12-31,1736,LongtermBorrowings_per,16.36,長期借款,喬山,生技醫療業
2023-12-31,1736,OtherNoncurrentLiabilities,321655000.0,其他非流動負債,喬山,生技醫療業
2023-12-31,1736,OtherNoncurrentLiabilities_per,0.88,其他非流動負債,喬山,生技醫療業
2023-12-31,1736,NoncurrentLiabilities,8648076000.0,非流動負債合計,喬山,生技醫療業
2023-12-31,1736,NoncurrentLiabilities_per,23.74,非流動負債合計,喬山,生技醫療業
2023-12-31,1736,OrdinaryShare,3036166000.0,普通股股本,喬山,生技醫療業
2023-12-31,1736,OrdinaryShare_per,8.34,普通股股本,喬山,生技醫療業
2023-12-31,1736,CapitalStock,3036166000.0,股本合計,喬山,生技醫療業
2023-12-31,1736,CapitalStock_per,8.34,股本合計,喬山,生技醫療業
2023-12-31,1736,CapitalSurplus,431446000.0,資本公積合計,喬山,生技醫療業
2023-12-31,1736,CapitalSurplus_per,1.18,資本公積合計,喬山,生技醫療業
2023-12-31,1736,LegalReserve,1555699000.0,法定盈餘公積,喬山,生技醫療業
2023-12-31,1736,LegalReserve_per,4.27,法定盈餘公積,喬山,生技醫療業
2023-12-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,5031884000.0,未分配盈餘,喬山,生技醫療業
2023-12-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,13.82,未分配盈餘,喬山,生技醫療業
2023-12-31,1736,RetainedEarnings,8207654000.0,保留盈餘合計,喬山,生技醫療業
2023-12-31,1736,RetainedEarnings_per,22.53,保留盈餘合計,喬山,生技醫療業
2023-12-31,1736,OtherEquityInterest,-1979082000.0,其他權益合計,喬山,生技醫療業
2023-12-31,1736,OtherEquityInterest_per,-5.43,其他權益合計,喬山,生技醫療業
2023-12-31,1736,EquityAttributableToOwnersOfParent,9642572000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2023-12-31,1736,EquityAttributableToOwnersOfParent_per,26.47,歸屬於母公司業主之權益合計,喬山,生技醫療業
2023-12-31,1736,NoncontrollingInterests,6871000.0,非控制權益,喬山,生技醫療業
2023-12-31,1736,NoncontrollingInterests_per,0.02,非控制權益,喬山,生技醫療業
2023-12-31,1736,TotalLiabilitiesEquity,36421840000.0,負債及權益總計,喬山,生技醫療業
2023-12-31,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2023-12-31,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,695000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2023-12-31,1736,Equity,9649443000.0,權益總額,喬山,生技醫療業
2023-12-31,1736,Equity_per,26.49,權益總額,喬山,生技醫療業
2023-12-31,1736,Liabilities,26772397000.0,負債總額,喬山,生技醫療業
2023-12-31,1736,Liabilities_per,73.51,負債總額,喬山,生技醫療業
2024-03-31,1736,CashAndCashEquivalents,2438908000.0,現金及約當現金,喬山,生技醫療業
2024-03-31,1736,CashAndCashEquivalents_per,6.88,現金及約當現金,喬山,生技醫療業
2024-03-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,9060000.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2024-03-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.03,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2024-03-31,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,8119000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2024-03-31,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.02,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2024-03-31,1736,FinancialAssetsAtAmortizedCost,20033000.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2024-03-31,1736,FinancialAssetsAtAmortizedCost_per,0.06,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2024-03-31,1736,BillsReceivableNet,96132000.0,應收票據淨額,喬山,生技醫療業
2024-03-31,1736,BillsReceivableNet_per,0.27,應收票據淨額,喬山,生技醫療業
2024-03-31,1736,OtherReceivable,406690000.0,其他應收款淨額,喬山,生技醫療業
2024-03-31,1736,OtherReceivable_per,1.15,其他應收款淨額,喬山,生技醫療業
2024-03-31,1736,Prepayments,1015977000.0,預付款項,喬山,生技醫療業
2024-03-31,1736,Prepayments_per,2.86,預付款項,喬山,生技醫療業
2024-03-31,1736,AccountsReceivableNet,8714197000.0,應收帳款淨額,喬山,生技醫療業
2024-03-31,1736,AccountsReceivableNet_per,24.57,應收帳款淨額,喬山,生技醫療業
2024-03-31,1736,Inventories,9658728000.0,存貨,喬山,生技醫療業
2024-03-31,1736,Inventories_per,27.24,存貨,喬山,生技醫療業
2024-03-31,1736,OtherCurrentAssets,138954000.0,其他流動資產,喬山,生技醫療業
2024-03-31,1736,OtherCurrentAssets_per,0.39,其他流動資產,喬山,生技醫療業
2024-03-31,1736,CurrentAssets,22549333000.0,流動資產合計,喬山,生技醫療業
2024-03-31,1736,CurrentAssets_per,63.59,流動資產合計,喬山,生技醫療業
2024-03-31,1736,PropertyPlantAndEquipment,4620420000.0,不動產、廠房及設備,喬山,生技醫療業
2024-03-31,1736,PropertyPlantAndEquipment_per,13.03,不動產、廠房及設備,喬山,生技醫療業
2024-03-31,1736,RightOfUseAsset,2838795000.0,使用權資產,喬山,生技醫療業
2024-03-31,1736,RightOfUseAsset_per,8.0,使用權資產,喬山,生技醫療業
2024-03-31,1736,IntangibleAssets,2846157000.0,無形資產,喬山,生技醫療業
2024-03-31,1736,IntangibleAssets_per,8.03,無形資產,喬山,生技醫療業
2024-03-31,1736,DeferredTaxAssets,1686728000.0,遞延所得稅資產,喬山,生技醫療業
2024-03-31,1736,DeferredTaxAssets_per,4.76,遞延所得稅資產,喬山,生技醫療業
2024-03-31,1736,OtherNoncurrentAssets,879315000.0,其他非流動資產,喬山,生技醫療業
2024-03-31,1736,OtherNoncurrentAssets_per,2.48,其他非流動資產,喬山,生技醫療業
2024-03-31,1736,NoncurrentAssets,12913765000.0,非流動資產合計,喬山,生技醫療業
2024-03-31,1736,NoncurrentAssets_per,36.41,非流動資產合計,喬山,生技醫療業
2024-03-31,1736,TotalAssets,35463098000.0,資產總額,喬山,生技醫療業
2024-03-31,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2024-03-31,1736,ShorttermBorrowings,5217254000.0,短期借款,喬山,生技醫療業
2024-03-31,1736,ShorttermBorrowings_per,14.71,短期借款,喬山,生技醫療業
2024-03-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,10247000.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2024-03-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.03,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2024-03-31,1736,AccountsPayable,3794564000.0,應付帳款,喬山,生技醫療業
2024-03-31,1736,AccountsPayable_per,10.7,應付帳款,喬山,生技醫療業
2024-03-31,1736,OtherPayables,3481065000.0,其他應付款,喬山,生技醫療業
2024-03-31,1736,OtherPayables_per,9.82,其他應付款,喬山,生技醫療業
2024-03-31,1736,CurrentTaxLiabilities,537947000.0,本期所得稅負債,喬山,生技醫療業
2024-03-31,1736,CurrentTaxLiabilities_per,1.52,本期所得稅負債,喬山,生技醫療業
2024-03-31,1736,OtherCurrentLiabilities,2199216000.0,其他流動負債,喬山,生技醫療業
2024-03-31,1736,OtherCurrentLiabilities_per,6.2,其他流動負債,喬山,生技醫療業
2024-03-31,1736,CurrentLiabilities,17388495000.0,流動負債合計,喬山,生技醫療業
2024-03-31,1736,CurrentLiabilities_per,49.03,流動負債合計,喬山,生技醫療業
2024-03-31,1736,BondsPayable,0.0,應付公司債,喬山,生技醫療業
2024-03-31,1736,BondsPayable_per,0.0,應付公司債,喬山,生技醫療業
2024-03-31,1736,LongtermBorrowings,5893479000.0,長期借款,喬山,生技醫療業
2024-03-31,1736,LongtermBorrowings_per,16.62,長期借款,喬山,生技醫療業
2024-03-31,1736,OtherNoncurrentLiabilities,351970000.0,其他非流動負債,喬山,生技醫療業
2024-03-31,1736,OtherNoncurrentLiabilities_per,0.99,其他非流動負債,喬山,生技醫療業
2024-03-31,1736,NoncurrentLiabilities,8649811000.0,非流動負債合計,喬山,生技醫療業
2024-03-31,1736,NoncurrentLiabilities_per,24.39,非流動負債合計,喬山,生技醫療業
2024-03-31,1736,OrdinaryShare,3036166000.0,普通股股本,喬山,生技醫療業
2024-03-31,1736,OrdinaryShare_per,8.56,普通股股本,喬山,生技醫療業
2024-03-31,1736,CapitalStock,3036166000.0,股本合計,喬山,生技醫療業
2024-03-31,1736,CapitalStock_per,8.56,股本合計,喬山,生技醫療業
2024-03-31,1736,CapitalSurplus,431446000.0,資本公積合計,喬山,生技醫療業
2024-03-31,1736,CapitalSurplus_per,1.22,資本公積合計,喬山,生技醫療業
2024-03-31,1736,LegalReserve,1555699000.0,法定盈餘公積,喬山,生技醫療業
2024-03-31,1736,LegalReserve_per,4.39,法定盈餘公積,喬山,生技醫療業
2024-03-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,4591062000.0,未分配盈餘,喬山,生技醫療業
2024-03-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,12.95,未分配盈餘,喬山,生技醫療業
2024-03-31,1736,RetainedEarnings,7766832000.0,保留盈餘合計,喬山,生技醫療業
2024-03-31,1736,RetainedEarnings_per,21.9,保留盈餘合計,喬山,生技醫療業
2024-03-31,1736,OtherEquityInterest,-1762199000.0,其他權益合計,喬山,生技醫療業
2024-03-31,1736,OtherEquityInterest_per,-4.97,其他權益合計,喬山,生技醫療業
2024-03-31,1736,EquityAttributableToOwnersOfParent,9418633000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2024-03-31,1736,EquityAttributableToOwnersOfParent_per,26.56,歸屬於母公司業主之權益合計,喬山,生技醫療業
2024-03-31,1736,NoncontrollingInterests,6159000.0,非控制權益,喬山,生技醫療業
2024-03-31,1736,NoncontrollingInterests_per,0.02,非控制權益,喬山,生技醫療業
2024-03-31,1736,TotalLiabilitiesEquity,35463098000.0,負債及權益總計,喬山,生技醫療業
2024-03-31,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2024-03-31,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,695000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2024-03-31,1736,Liabilities,26038306000.0,負債總額,喬山,生技醫療業
2024-03-31,1736,Liabilities_per,73.42,負債總額,喬山,生技醫療業
2024-03-31,1736,Equity,9424792000.0,權益總額,喬山,生技醫療業
2024-03-31,1736,Equity_per,26.58,權益總額,喬山,生技醫療業
2024-06-30,1736,CashAndCashEquivalents,2499095000.0,現金及約當現金,喬山,生技醫療業
2024-06-30,1736,CashAndCashEquivalents_per,6.56,現金及約當現金,喬山,生技醫療業
2024-06-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2024-06-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2024-06-30,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,8813000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2024-06-30,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.02,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2024-06-30,1736,FinancialAssetsAtAmortizedCost,16500000.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2024-06-30,1736,FinancialAssetsAtAmortizedCost_per,0.04,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2024-06-30,1736,BillsReceivableNet,88413000.0,應收票據淨額,喬山,生技醫療業
2024-06-30,1736,BillsReceivableNet_per,0.23,應收票據淨額,喬山,生技醫療業
2024-06-30,1736,OtherReceivable,294027000.0,其他應收款淨額,喬山,生技醫療業
2024-06-30,1736,OtherReceivable_per,0.77,其他應收款淨額,喬山,生技醫療業
2024-06-30,1736,Prepayments,873896000.0,預付款項,喬山,生技醫療業
2024-06-30,1736,Prepayments_per,2.3,預付款項,喬山,生技醫療業
2024-06-30,1736,AccountsReceivableNet,9491960000.0,應收帳款淨額,喬山,生技醫療業
2024-06-30,1736,AccountsReceivableNet_per,24.93,應收帳款淨額,喬山,生技醫療業
2024-06-30,1736,Inventories,11665176000.0,存貨,喬山,生技醫療業
2024-06-30,1736,Inventories_per,30.64,存貨,喬山,生技醫療業
2024-06-30,1736,OtherCurrentAssets,101180000.0,其他流動資產,喬山,生技醫療業
2024-06-30,1736,OtherCurrentAssets_per,0.27,其他流動資產,喬山,生技醫療業
2024-06-30,1736,CurrentAssets,25074442000.0,流動資產合計,喬山,生技醫療業
2024-06-30,1736,CurrentAssets_per,65.86,流動資產合計,喬山,生技醫療業
2024-06-30,1736,PropertyPlantAndEquipment,4598620000.0,不動產、廠房及設備,喬山,生技醫療業
2024-06-30,1736,PropertyPlantAndEquipment_per,12.08,不動產、廠房及設備,喬山,生技醫療業
2024-06-30,1736,RightOfUseAsset,2799979000.0,使用權資產,喬山,生技醫療業
2024-06-30,1736,RightOfUseAsset_per,7.35,使用權資產,喬山,生技醫療業
2024-06-30,1736,IntangibleAssets,2854630000.0,無形資產,喬山,生技醫療業
2024-06-30,1736,IntangibleAssets_per,7.5,無形資產,喬山,生技醫療業
2024-06-30,1736,DeferredTaxAssets,1799657000.0,遞延所得稅資產,喬山,生技醫療業
2024-06-30,1736,DeferredTaxAssets_per,4.73,遞延所得稅資產,喬山,生技醫療業
2024-06-30,1736,OtherNoncurrentAssets,902180000.0,其他非流動資產,喬山,生技醫療業
2024-06-30,1736,OtherNoncurrentAssets_per,2.37,其他非流動資產,喬山,生技醫療業
2024-06-30,1736,NoncurrentAssets,12996448000.0,非流動資產合計,喬山,生技醫療業
2024-06-30,1736,NoncurrentAssets_per,34.14,非流動資產合計,喬山,生技醫療業
2024-06-30,1736,TotalAssets,38070890000.0,資產總額,喬山,生技醫療業
2024-06-30,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2024-06-30,1736,ShorttermBorrowings,6260135000.0,短期借款,喬山,生技醫療業
2024-06-30,1736,ShorttermBorrowings_per,16.44,短期借款,喬山,生技醫療業
2024-06-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,559000.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2024-06-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2024-06-30,1736,AccountsPayable,4624073000.0,應付帳款,喬山,生技醫療業
2024-06-30,1736,AccountsPayable_per,12.15,應付帳款,喬山,生技醫療業
2024-06-30,1736,OtherPayables,4083490000.0,其他應付款,喬山,生技醫療業
2024-06-30,1736,OtherPayables_per,10.73,其他應付款,喬山,生技醫療業
2024-06-30,1736,CurrentTaxLiabilities,465120000.0,本期所得稅負債,喬山,生技醫療業
2024-06-30,1736,CurrentTaxLiabilities_per,1.22,本期所得稅負債,喬山,生技醫療業
2024-06-30,1736,OtherCurrentLiabilities,2300107000.0,其他流動負債,喬山,生技醫療業
2024-06-30,1736,OtherCurrentLiabilities_per,6.04,其他流動負債,喬山,生技醫療業
2024-06-30,1736,CurrentLiabilities,20019165000.0,流動負債合計,喬山,生技醫療業
2024-06-30,1736,CurrentLiabilities_per,52.58,流動負債合計,喬山,生技醫療業
2024-06-30,1736,BondsPayable,0.0,應付公司債,喬山,生技醫療業
2024-06-30,1736,BondsPayable_per,0.0,應付公司債,喬山,生技醫療業
2024-06-30,1736,LongtermBorrowings,5582920000.0,長期借款,喬山,生技醫療業
2024-06-30,1736,LongtermBorrowings_per,14.66,長期借款,喬山,生技醫療業
2024-06-30,1736,OtherNoncurrentLiabilities,328902000.0,其他非流動負債,喬山,生技醫療業
2024-06-30,1736,OtherNoncurrentLiabilities_per,0.86,其他非流動負債,喬山,生技醫療業
2024-06-30,1736,NoncurrentLiabilities,8342560000.0,非流動負債合計,喬山,生技醫療業
2024-06-30,1736,NoncurrentLiabilities_per,21.91,非流動負債合計,喬山,生技醫療業
2024-06-30,1736,OrdinaryShare,3036166000.0,普通股股本,喬山,生技醫療業
2024-06-30,1736,OrdinaryShare_per,7.98,普通股股本,喬山,生技醫療業
2024-06-30,1736,CapitalStock,3036166000.0,股本合計,喬山,生技醫療業
2024-06-30,1736,CapitalStock_per,7.98,股本合計,喬山,生技醫療業
2024-06-30,1736,CapitalSurplus,436107000.0,資本公積合計,喬山,生技醫療業
2024-06-30,1736,CapitalSurplus_per,1.15,資本公積合計,喬山,生技醫療業
2024-06-30,1736,LegalReserve,1626536000.0,法定盈餘公積,喬山,生技醫療業
2024-06-30,1736,LegalReserve_per,4.27,法定盈餘公積,喬山,生技醫療業
2024-06-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,4453302000.0,未分配盈餘,喬山,生技醫療業
2024-06-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,11.7,未分配盈餘,喬山,生技醫療業
2024-06-30,1736,RetainedEarnings,8058921000.0,保留盈餘合計,喬山,生技醫療業
2024-06-30,1736,RetainedEarnings_per,21.17,保留盈餘合計,喬山,生技醫療業
2024-06-30,1736,OtherEquityInterest,-1774383000.0,其他權益合計,喬山,生技醫療業
2024-06-30,1736,OtherEquityInterest_per,-4.66,其他權益合計,喬山,生技醫療業
2024-06-30,1736,EquityAttributableToOwnersOfParent,9703199000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2024-06-30,1736,EquityAttributableToOwnersOfParent_per,25.49,歸屬於母公司業主之權益合計,喬山,生技醫療業
2024-06-30,1736,NoncontrollingInterests,5966000.0,非控制權益,喬山,生技醫療業
2024-06-30,1736,NoncontrollingInterests_per,0.02,非控制權益,喬山,生技醫療業
2024-06-30,1736,TotalLiabilitiesEquity,38070890000.0,負債及權益總計,喬山,生技醫療業
2024-06-30,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2024-06-30,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,695000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2024-06-30,1736,Liabilities,28361725000.0,負債總額,喬山,生技醫療業
2024-06-30,1736,Liabilities_per,74.5,負債總額,喬山,生技醫療業
2024-06-30,1736,Equity,9709165000.0,權益總額,喬山,生技醫療業
2024-06-30,1736,Equity_per,25.5,權益總額,喬山,生技醫療業
2024-09-30,1736,CashAndCashEquivalents,2000901000.0,現金及約當現金,喬山,生技醫療業
2024-09-30,1736,CashAndCashEquivalents_per,4.92,現金及約當現金,喬山,生技醫療業
2024-09-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2024-09-30,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2024-09-30,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,9927000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2024-09-30,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.02,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2024-09-30,1736,FinancialAssetsAtAmortizedCost,26563000.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2024-09-30,1736,FinancialAssetsAtAmortizedCost_per,0.07,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2024-09-30,1736,BillsReceivableNet,88514000.0,應收票據淨額,喬山,生技醫療業
2024-09-30,1736,BillsReceivableNet_per,0.22,應收票據淨額,喬山,生技醫療業
2024-09-30,1736,OtherReceivable,342561000.0,其他應收款淨額,喬山,生技醫療業
2024-09-30,1736,OtherReceivable_per,0.84,其他應收款淨額,喬山,生技醫療業
2024-09-30,1736,Prepayments,1079712000.0,預付款項,喬山,生技醫療業
2024-09-30,1736,Prepayments_per,2.65,預付款項,喬山,生技醫療業
2024-09-30,1736,AccountsReceivableNet,10842968000.0,應收帳款淨額,喬山,生技醫療業
2024-09-30,1736,AccountsReceivableNet_per,26.65,應收帳款淨額,喬山,生技醫療業
2024-09-30,1736,Inventories,12857171000.0,存貨,喬山,生技醫療業
2024-09-30,1736,Inventories_per,31.61,存貨,喬山,生技醫療業
2024-09-30,1736,OtherCurrentAssets,79636000.0,其他流動資產,喬山,生技醫療業
2024-09-30,1736,OtherCurrentAssets_per,0.2,其他流動資產,喬山,生技醫療業
2024-09-30,1736,CurrentAssets,27365791000.0,流動資產合計,喬山,生技醫療業
2024-09-30,1736,CurrentAssets_per,67.27,流動資產合計,喬山,生技醫療業
2024-09-30,1736,PropertyPlantAndEquipment,4652466000.0,不動產、廠房及設備,喬山,生技醫療業
2024-09-30,1736,PropertyPlantAndEquipment_per,11.44,不動產、廠房及設備,喬山,生技醫療業
2024-09-30,1736,RightOfUseAsset,2980204000.0,使用權資產,喬山,生技醫療業
2024-09-30,1736,RightOfUseAsset_per,7.33,使用權資產,喬山,生技醫療業
2024-09-30,1736,IntangibleAssets,2805932000.0,無形資產,喬山,生技醫療業
2024-09-30,1736,IntangibleAssets_per,6.9,無形資產,喬山,生技醫療業
2024-09-30,1736,DeferredTaxAssets,1689457000.0,遞延所得稅資產,喬山,生技醫療業
2024-09-30,1736,DeferredTaxAssets_per,4.15,遞延所得稅資產,喬山,生技醫療業
2024-09-30,1736,OtherNoncurrentAssets,1141171000.0,其他非流動資產,喬山,生技醫療業
2024-09-30,1736,OtherNoncurrentAssets_per,2.81,其他非流動資產,喬山,生技醫療業
2024-09-30,1736,NoncurrentAssets,13314973000.0,非流動資產合計,喬山,生技醫療業
2024-09-30,1736,NoncurrentAssets_per,32.73,非流動資產合計,喬山,生技醫療業
2024-09-30,1736,TotalAssets,40680764000.0,資產總額,喬山,生技醫療業
2024-09-30,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2024-09-30,1736,ShorttermBorrowings,6318878000.0,短期借款,喬山,生技醫療業
2024-09-30,1736,ShorttermBorrowings_per,15.53,短期借款,喬山,生技醫療業
2024-09-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,13033000.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2024-09-30,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.03,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2024-09-30,1736,AccountsPayable,5999739000.0,應付帳款,喬山,生技醫療業
2024-09-30,1736,AccountsPayable_per,14.75,應付帳款,喬山,生技醫療業
2024-09-30,1736,OtherPayables,3600788000.0,其他應付款,喬山,生技醫療業
2024-09-30,1736,OtherPayables_per,8.85,其他應付款,喬山,生技醫療業
2024-09-30,1736,CurrentTaxLiabilities,477512000.0,本期所得稅負債,喬山,生技醫療業
2024-09-30,1736,CurrentTaxLiabilities_per,1.17,本期所得稅負債,喬山,生技醫療業
2024-09-30,1736,OtherCurrentLiabilities,428489000.0,其他流動負債,喬山,生技醫療業
2024-09-30,1736,OtherCurrentLiabilities_per,1.05,其他流動負債,喬山,生技醫療業
2024-09-30,1736,CurrentLiabilities,19230428000.0,流動負債合計,喬山,生技醫療業
2024-09-30,1736,CurrentLiabilities_per,47.27,流動負債合計,喬山,生技醫療業
2024-09-30,1736,BondsPayable,3000000000.0,應付公司債,喬山,生技醫療業
2024-09-30,1736,BondsPayable_per,7.37,應付公司債,喬山,生技醫療業
2024-09-30,1736,LongtermBorrowings,5055678000.0,長期借款,喬山,生技醫療業
2024-09-30,1736,LongtermBorrowings_per,12.43,長期借款,喬山,生技醫療業
2024-09-30,1736,OtherNoncurrentLiabilities,297602000.0,其他非流動負債,喬山,生技醫療業
2024-09-30,1736,OtherNoncurrentLiabilities_per,0.73,其他非流動負債,喬山,生技醫療業
2024-09-30,1736,NoncurrentLiabilities,11094742000.0,非流動負債合計,喬山,生技醫療業
2024-09-30,1736,NoncurrentLiabilities_per,27.27,非流動負債合計,喬山,生技醫療業
2024-09-30,1736,OrdinaryShare,3033946000.0,普通股股本,喬山,生技醫療業
2024-09-30,1736,OrdinaryShare_per,7.46,普通股股本,喬山,生技醫療業
2024-09-30,1736,CapitalStock,3033946000.0,股本合計,喬山,生技醫療業
2024-09-30,1736,CapitalStock_per,7.46,股本合計,喬山,生技醫療業
2024-09-30,1736,CapitalSurplus,436067000.0,資本公積合計,喬山,生技醫療業
2024-09-30,1736,CapitalSurplus_per,1.07,資本公積合計,喬山,生技醫療業
2024-09-30,1736,LegalReserve,1626536000.0,法定盈餘公積,喬山,生技醫療業
2024-09-30,1736,LegalReserve_per,4.0,法定盈餘公積,喬山,生技醫療業
2024-09-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,4912584000.0,未分配盈餘,喬山,生技醫療業
2024-09-30,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,12.08,未分配盈餘,喬山,生技醫療業
2024-09-30,1736,RetainedEarnings,8518203000.0,保留盈餘合計,喬山,生技醫療業
2024-09-30,1736,RetainedEarnings_per,20.94,保留盈餘合計,喬山,生技醫療業
2024-09-30,1736,OtherEquityInterest,-1633417000.0,其他權益合計,喬山,生技醫療業
2024-09-30,1736,OtherEquityInterest_per,-4.02,其他權益合計,喬山,生技醫療業
2024-09-30,1736,EquityAttributableToOwnersOfParent,10349019000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2024-09-30,1736,EquityAttributableToOwnersOfParent_per,25.44,歸屬於母公司業主之權益合計,喬山,生技醫療業
2024-09-30,1736,NoncontrollingInterests,6575000.0,非控制權益,喬山,生技醫療業
2024-09-30,1736,NoncontrollingInterests_per,0.02,非控制權益,喬山,生技醫療業
2024-09-30,1736,TotalLiabilitiesEquity,40680764000.0,負債及權益總計,喬山,生技醫療業
2024-09-30,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2024-09-30,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,95000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2024-09-30,1736,Liabilities,30325170000.0,負債總額,喬山,生技醫療業
2024-09-30,1736,Liabilities_per,74.54,負債總額,喬山,生技醫療業
2024-09-30,1736,Equity,10355594000.0,權益總額,喬山,生技醫療業
2024-09-30,1736,Equity_per,25.46,權益總額,喬山,生技醫療業
2024-12-31,1736,CashAndCashEquivalents,2686730000.0,現金及約當現金,喬山,生技醫療業
2024-12-31,1736,CashAndCashEquivalents_per,6.16,現金及約當現金,喬山,生技醫療業
2024-12-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,8686000.0,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2024-12-31,1736,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.02,透過損益按公允價值衡量之金融資產－流動,喬山,生技醫療業
2024-12-31,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,7912000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2024-12-31,1736,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.02,透過其他綜合損益按公允價值衡量之金融資產－非流動,喬山,生技醫療業
2024-12-31,1736,FinancialAssetsAtAmortizedCost,11133000.0,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2024-12-31,1736,FinancialAssetsAtAmortizedCost_per,0.03,按攤銷後成本衡量之金融資產－流動,喬山,生技醫療業
2024-12-31,1736,BillsReceivableNet,44152000.0,應收票據淨額,喬山,生技醫療業
2024-12-31,1736,BillsReceivableNet_per,0.1,應收票據淨額,喬山,生技醫療業
2024-12-31,1736,OtherReceivable,434733000.0,其他應收款淨額,喬山,生技醫療業
2024-12-31,1736,OtherReceivable_per,1.0,其他應收款淨額,喬山,生技醫療業
2024-12-31,1736,Prepayments,2077241000.0,預付款項,喬山,生技醫療業
2024-12-31,1736,Prepayments_per,4.76,預付款項,喬山,生技醫療業
2024-12-31,1736,AccountsReceivableNet,13098043000.0,應收帳款淨額,喬山,生技醫療業
2024-12-31,1736,AccountsReceivableNet_per,30.03,應收帳款淨額,喬山,生技醫療業
2024-12-31,1736,Inventories,11800428000.0,存貨,喬山,生技醫療業
2024-12-31,1736,Inventories_per,27.06,存貨,喬山,生技醫療業
2024-12-31,1736,OtherCurrentAssets,111654000.0,其他流動資產,喬山,生技醫療業
2024-12-31,1736,OtherCurrentAssets_per,0.26,其他流動資產,喬山,生技醫療業
2024-12-31,1736,CurrentAssets,30307691000.0,流動資產合計,喬山,生技醫療業
2024-12-31,1736,CurrentAssets_per,69.49,流動資產合計,喬山,生技醫療業
2024-12-31,1736,PropertyPlantAndEquipment,4661018000.0,不動產、廠房及設備,喬山,生技醫療業
2024-12-31,1736,PropertyPlantAndEquipment_per,10.69,不動產、廠房及設備,喬山,生技醫療業
2024-12-31,1736,RightOfUseAsset,3134068000.0,使用權資產,喬山,生技醫療業
2024-12-31,1736,RightOfUseAsset_per,7.19,使用權資產,喬山,生技醫療業
2024-12-31,1736,IntangibleAssets,2825764000.0,無形資產,喬山,生技醫療業
2024-12-31,1736,IntangibleAssets_per,6.48,無形資產,喬山,生技醫療業
2024-12-31,1736,DeferredTaxAssets,1570740000.0,遞延所得稅資產,喬山,生技醫療業
2024-12-31,1736,DeferredTaxAssets_per,3.6,遞延所得稅資產,喬山,生技醫療業
2024-12-31,1736,OtherNoncurrentAssets,1074508000.0,其他非流動資產,喬山,生技醫療業
2024-12-31,1736,OtherNoncurrentAssets_per,2.46,其他非流動資產,喬山,生技醫療業
2024-12-31,1736,NoncurrentAssets,13307727000.0,非流動資產合計,喬山,生技醫療業
2024-12-31,1736,NoncurrentAssets_per,30.51,非流動資產合計,喬山,生技醫療業
2024-12-31,1736,TotalAssets,43615418000.0,資產總額,喬山,生技醫療業
2024-12-31,1736,TotalAssets_per,100.0,資產總額,喬山,生技醫療業
2024-12-31,1736,ShorttermBorrowings,6166733000.0,短期借款,喬山,生技醫療業
2024-12-31,1736,ShorttermBorrowings_per,14.14,短期借款,喬山,生技醫療業
2024-12-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2024-12-31,1736,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,喬山,生技醫療業
2024-12-31,1736,AccountsPayable,5750443000.0,應付帳款,喬山,生技醫療業
2024-12-31,1736,AccountsPayable_per,13.18,應付帳款,喬山,生技醫療業
2024-12-31,1736,OtherPayables,4706524000.0,其他應付款,喬山,生技醫療業
2024-12-31,1736,OtherPayables_per,10.79,其他應付款,喬山,生技醫療業
2024-12-31,1736,CurrentTaxLiabilities,751859000.0,本期所得稅負債,喬山,生技醫療業
2024-12-31,1736,CurrentTaxLiabilities_per,1.72,本期所得稅負債,喬山,生技醫療業
2024-12-31,1736,OtherCurrentLiabilities,555972000.0,其他流動負債,喬山,生技醫療業
2024-12-31,1736,OtherCurrentLiabilities_per,1.27,其他流動負債,喬山,生技醫療業
2024-12-31,1736,CurrentLiabilities,20789156000.0,流動負債合計,喬山,生技醫療業
2024-12-31,1736,CurrentLiabilities_per,47.66,流動負債合計,喬山,生技醫療業
2024-12-31,1736,BondsPayable,3000000000.0,應付公司債,喬山,生技醫療業
2024-12-31,1736,BondsPayable_per,6.88,應付公司債,喬山,生技醫療業
2024-12-31,1736,LongtermBorrowings,4359051000.0,長期借款,喬山,生技醫療業
2024-12-31,1736,LongtermBorrowings_per,9.99,長期借款,喬山,生技醫療業
2024-12-31,1736,OtherNoncurrentLiabilities,579342000.0,其他非流動負債,喬山,生技醫療業
2024-12-31,1736,OtherNoncurrentLiabilities_per,1.33,其他非流動負債,喬山,生技醫療業
2024-12-31,1736,NoncurrentLiabilities,10781712000.0,非流動負債合計,喬山,生技醫療業
2024-12-31,1736,NoncurrentLiabilities_per,24.72,非流動負債合計,喬山,生技醫療業
2024-12-31,1736,OrdinaryShare,3033946000.0,普通股股本,喬山,生技醫療業
2024-12-31,1736,OrdinaryShare_per,6.96,普通股股本,喬山,生技醫療業
2024-12-31,1736,CapitalStock,3033946000.0,股本合計,喬山,生技醫療業
2024-12-31,1736,CapitalStock_per,6.96,股本合計,喬山,生技醫療業
2024-12-31,1736,CapitalSurplus,436067000.0,資本公積合計,喬山,生技醫療業
2024-12-31,1736,CapitalSurplus_per,1.0,資本公積合計,喬山,生技醫療業
2024-12-31,1736,LegalReserve,1626536000.0,法定盈餘公積,喬山,生技醫療業
2024-12-31,1736,LegalReserve_per,3.73,法定盈餘公積,喬山,生技醫療業
2024-12-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit,6717817000.0,未分配盈餘,喬山,生技醫療業
2024-12-31,1736,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,15.4,未分配盈餘,喬山,生技醫療業
2024-12-31,1736,RetainedEarnings,10323436000.0,保留盈餘合計,喬山,生技醫療業
2024-12-31,1736,RetainedEarnings_per,23.67,保留盈餘合計,喬山,生技醫療業
2024-12-31,1736,OtherEquityInterest,-1750325000.0,其他權益合計,喬山,生技醫療業
2024-12-31,1736,OtherEquityInterest_per,-4.01,其他權益合計,喬山,生技醫療業
2024-12-31,1736,EquityAttributableToOwnersOfParent,12037344000.0,歸屬於母公司業主之權益合計,喬山,生技醫療業
2024-12-31,1736,EquityAttributableToOwnersOfParent_per,27.6,歸屬於母公司業主之權益合計,喬山,生技醫療業
2024-12-31,1736,NoncontrollingInterests,7206000.0,非控制權益,喬山,生技醫療業
2024-12-31,1736,NoncontrollingInterests_per,0.02,非控制權益,喬山,生技醫療業
2024-12-31,1736,TotalLiabilitiesEquity,43615418000.0,負債及權益總計,喬山,生技醫療業
2024-12-31,1736,TotalLiabilitiesEquity_per,100.0,負債及權益總計,喬山,生技醫療業
2024-12-31,1736,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,95000.0,母公司暨子公司所持有之母公司庫藏股股數,喬山,生技醫療業
2024-12-31,1736,Liabilities,31570868000.0,負債總額,喬山,生技醫療業
2024-12-31,1736,Liabilities_per,72.38,負債總額,喬山,生技醫療業
2024-12-31,1736,Equity,12044550000.0,權益總額,喬山,生技醫療業
2024-12-31,1736,Equity_per,27.62,權益總額,喬山,生技醫療業
2019-03-31,1736,ReceivableIncrease,1490196000.0,應收帳款(增加)減少,喬山,生技醫療業
2019-03-31,1736,PropertyAndPlantAndEquipment,-90911000.0,取得不動產、廠房及設備,喬山,生技醫療業
2019-03-31,1736,NetIncomeBeforeTax,65344000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2019-03-31,1736,TotalIncomeLossItems,129195000.0,收益費損項目合計,喬山,生技醫療業
2019-03-31,1736,CashFlowsFromOperatingActivities,243780000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2019-03-31,1736,CashBalancesEndOfPeriod,4030827000.0,期末現金及約當現金餘額,喬山,生技醫療業
2019-03-31,1736,InventoryIncrease,-809720000.0,存貨（增加）減少,喬山,生技醫療業
2019-03-31,1736,CashBalancesBeginningOfPeriod,3252486000.0,期初現金及約當現金餘額,喬山,生技醫療業
2019-03-31,1736,CashBalancesIncrease,778341000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2019-03-31,1736,CashReceivedThroughOperations,268806000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2019-03-31,1736,CashFlowsProvidedFromFinancingActivities,382020000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2019-03-31,1736,Depreciation,189348000.0,折舊費用,喬山,生技醫療業
2019-03-31,1736,OtherNonCurrentLiabilitiesIncrease,66847000.0,其他流動資產(增加)減少,喬山,生技醫療業
2019-03-31,1736,RentalPrincipalRepayments,-109600000.0,租賃本金償還,喬山,生技醫療業
2019-03-31,1736,AmortizationExpense,5116000.0,攤銷費用,喬山,生技醫療業
2019-03-31,1736,RepaymentOfLongTermDebt,-14626000.0,償還長期借款,喬山,生技醫療業
2019-03-31,1736,ProceedsFromLongTermDebt,6888000.0,舉借長期借款,喬山,生技醫療業
2019-03-31,1736,AccountsPayable,-205323000.0,應付帳款增加(減少),喬山,生技醫療業
2019-03-31,1736,DecreaseInShortTermLoans,-359363000.0,短期借款減少,喬山,生技醫療業
2019-03-31,1736,InterestExpense,40372000.0,利息費用,喬山,生技醫療業
2019-03-31,1736,InterestIncome,-66035000.0,利息收入,喬山,生技醫療業
2019-03-31,1736,PayTheInterest,-37165000.0,支付之利息,喬山,生技醫療業
2019-03-31,1736,IncomeBeforeIncomeTaxFromContinuingOperations,65344000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2019-03-31,1736,CashProvidedByInvestingActivities,53154000.0,投資活動之淨現金流入（流出）,喬山,生技醫療業
2019-06-30,1736,ReceivableIncrease,1485360000.0,應收帳款(增加)減少,喬山,生技醫療業
2019-06-30,1736,PropertyAndPlantAndEquipment,-298672000.0,取得不動產、廠房及設備,喬山,生技醫療業
2019-06-30,1736,NetIncomeBeforeTax,353080000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2019-06-30,1736,CashFlowsFromOperatingActivities,-339269000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2019-06-30,1736,CashBalancesEndOfPeriod,3801701000.0,期末現金及約當現金餘額,喬山,生技醫療業
2019-06-30,1736,InventoryIncrease,-1325673000.0,存貨（增加）減少,喬山,生技醫療業
2019-06-30,1736,CashBalancesBeginningOfPeriod,3252486000.0,期初現金及約當現金餘額,喬山,生技醫療業
2019-06-30,1736,CashBalancesIncrease,549215000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2019-06-30,1736,CashFlowsProvidedFromFinancingActivities,826450000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2019-06-30,1736,Depreciation,379366000.0,折舊費用,喬山,生技醫療業
2019-06-30,1736,OtherNonCurrentLiabilitiesIncrease,19319000.0,其他流動資產(增加)減少,喬山,生技醫療業
2019-06-30,1736,RentalPrincipalRepayments,-216484000.0,租賃本金償還,喬山,生技醫療業
2019-06-30,1736,AmortizationExpense,10316000.0,攤銷費用,喬山,生技醫療業
2019-06-30,1736,RepaymentOfLongTermDebt,-451430000.0,償還長期借款,喬山,生技醫療業
2019-06-30,1736,ProceedsFromLongTermDebt,112919000.0,舉借長期借款,喬山,生技醫療業
2019-06-30,1736,AccountsPayable,-430986000.0,應付帳款增加(減少),喬山,生技醫療業
2019-06-30,1736,DecreaseInShortTermLoans,-2255003000.0,短期借款減少,喬山,生技醫療業
2019-06-30,1736,IncomeBeforeIncomeTaxFromContinuingOperations,353080000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2019-06-30,1736,CashReceivedThroughOperations,-104061000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2019-06-30,1736,InterestIncome,-151113000.0,利息收入,喬山,生技醫療業
2019-06-30,1736,PayTheInterest,-69598000.0,支付之利息,喬山,生技醫療業
2019-06-30,1736,CashProvidedByInvestingActivities,-151432000.0,投資活動之淨現金流入（流出）,喬山,生技醫療業
2019-06-30,1736,TotalIncomeLossItems,274552000.0,收益費損項目合計,喬山,生技醫療業
2019-06-30,1736,InterestExpense,72802000.0,利息費用,喬山,生技醫療業
2019-09-30,1736,ReceivableIncrease,1420974000.0,應收帳款(增加)減少,喬山,生技醫療業
2019-09-30,1736,PropertyAndPlantAndEquipment,-520873000.0,取得不動產、廠房及設備,喬山,生技醫療業
2019-09-30,1736,NetIncomeBeforeTax,791612000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2019-09-30,1736,CashFlowsFromOperatingActivities,-62962000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2019-09-30,1736,CashBalancesEndOfPeriod,3444732000.0,期末現金及約當現金餘額,喬山,生技醫療業
2019-09-30,1736,InventoryIncrease,-1922648000.0,存貨（增加）減少,喬山,生技醫療業
2019-09-30,1736,CashBalancesBeginningOfPeriod,3252486000.0,期初現金及約當現金餘額,喬山,生技醫療業
2019-09-30,1736,CashBalancesIncrease,192246000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2019-09-30,1736,CashFlowsProvidedFromFinancingActivities,814567000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2019-09-30,1736,Depreciation,595295000.0,折舊費用,喬山,生技醫療業
2019-09-30,1736,OtherNonCurrentLiabilitiesIncrease,80481000.0,其他流動資產(增加)減少,喬山,生技醫療業
2019-09-30,1736,RentalPrincipalRepayments,-343139000.0,租賃本金償還,喬山,生技醫療業
2019-09-30,1736,AmortizationExpense,14971000.0,攤銷費用,喬山,生技醫療業
2019-09-30,1736,RepaymentOfLongTermDebt,-1552769000.0,償還長期借款,喬山,生技醫療業
2019-09-30,1736,ProceedsFromLongTermDebt,169575000.0,舉借長期借款,喬山,生技醫療業
2019-09-30,1736,AccountsPayable,-192292000.0,應付帳款增加(減少),喬山,生技醫療業
2019-09-30,1736,DecreaseInShortTermLoans,-5845223000.0,短期借款減少,喬山,生技醫療業
2019-09-30,1736,InterestIncome,-215313000.0,利息收入,喬山,生技醫療業
2019-09-30,1736,IncomeBeforeIncomeTaxFromContinuingOperations,791612000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2019-09-30,1736,CashReceivedThroughOperations,180445000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2019-09-30,1736,PayTheInterest,-105183000.0,支付之利息,喬山,生技醫療業
2019-09-30,1736,CashProvidedByInvestingActivities,-383032000.0,投資活動之淨現金流入（流出）,喬山,生技醫療業
2019-09-30,1736,TotalIncomeLossItems,536494000.0,收益費損項目合計,喬山,生技醫療業
2019-09-30,1736,InterestExpense,111181000.0,利息費用,喬山,生技醫療業
2019-12-31,1736,ReceivableIncrease,-59082000.0,應收帳款(增加)減少,喬山,生技醫療業
2019-12-31,1736,PropertyAndPlantAndEquipment,-647502000.0,取得不動產、廠房及設備,喬山,生技醫療業
2019-12-31,1736,NetIncomeBeforeTax,1617202000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2019-12-31,1736,CashFlowsFromOperatingActivities,943231000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2019-12-31,1736,CashBalancesEndOfPeriod,3280481000.0,期末現金及約當現金餘額,喬山,生技醫療業
2019-12-31,1736,InventoryIncrease,-1033778000.0,存貨（增加）減少,喬山,生技醫療業
2019-12-31,1736,CashBalancesBeginningOfPeriod,3252486000.0,期初現金及約當現金餘額,喬山,生技醫療業
2019-12-31,1736,CashBalancesIncrease,27995000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2019-12-31,1736,CashFlowsProvidedFromFinancingActivities,84011000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2019-12-31,1736,Depreciation,856661000.0,折舊費用,喬山,生技醫療業
2019-12-31,1736,OtherNonCurrentLiabilitiesIncrease,67595000.0,其他流動資產(增加)減少,喬山,生技醫療業
2019-12-31,1736,RentalPrincipalRepayments,-472681000.0,租賃本金償還,喬山,生技醫療業
2019-12-31,1736,AmortizationExpense,19873000.0,攤銷費用,喬山,生技醫療業
2019-12-31,1736,RepaymentOfLongTermDebt,-1659918000.0,償還長期借款,喬山,生技醫療業
2019-12-31,1736,ProceedsFromLongTermDebt,232071000.0,舉借長期借款,喬山,生技醫療業
2019-12-31,1736,AccountsPayable,-145112000.0,應付帳款增加(減少),喬山,生技醫療業
2019-12-31,1736,DecreaseInShortTermLoans,-8165831000.0,短期借款減少,喬山,生技醫療業
2019-12-31,1736,InterestIncome,-277977000.0,利息收入,喬山,生技醫療業
2019-12-31,1736,IncomeBeforeIncomeTaxFromContinuingOperations,1617202000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2019-12-31,1736,CashReceivedThroughOperations,1249965000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2019-12-31,1736,PayTheInterest,-150900000.0,支付之利息,喬山,生技醫療業
2019-12-31,1736,CashProvidedByInvestingActivities,-512578000.0,投資活動之淨現金流入（流出）,喬山,生技醫療業
2019-12-31,1736,TotalIncomeLossItems,836480000.0,收益費損項目合計,喬山,生技醫療業
2019-12-31,1736,InterestExpense,158022000.0,利息費用,喬山,生技醫療業
2020-03-31,1736,AmortizationExpense,7420000.0,攤銷費用,喬山,生技醫療業
2020-03-31,1736,Depreciation,231959000.0,折舊費用,喬山,生技醫療業
2020-03-31,1736,InterestExpense,45828000.0,利息費用,喬山,生技醫療業
2020-03-31,1736,InventoryIncrease,315957000.0,存貨（增加）減少,喬山,生技醫療業
2020-03-31,1736,OtherNonCurrentLiabilitiesIncrease,16704000.0,其他流動資產(增加)減少,喬山,生技醫療業
2020-03-31,1736,ProceedsFromLongTermDebt,1314232000.0,舉借長期借款,喬山,生技醫療業
2020-03-31,1736,CashBalancesBeginningOfPeriod,3280481000.0,期初現金及約當現金餘額,喬山,生技醫療業
2020-03-31,1736,CashBalancesEndOfPeriod,3117597000.0,期末現金及約當現金餘額,喬山,生技醫療業
2020-03-31,1736,ReceivableIncrease,1368656000.0,應收帳款(增加)減少,喬山,生技醫療業
2020-03-31,1736,CashFlowsProvidedFromFinancingActivities,1695341000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2020-03-31,1736,PropertyAndPlantAndEquipment,-187098000.0,取得不動產、廠房及設備,喬山,生技醫療業
2020-03-31,1736,NetIncomeBeforeTax,-283230000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2020-03-31,1736,CashProvidedByInvestingActivities,-1955212000.0,投資活動之淨現金流入(流出),喬山,生技醫療業
2020-03-31,1736,TotalIncomeLossItems,255142000.0,收益費損項目合計,喬山,生技醫療業
2020-03-31,1736,CashFlowsFromOperatingActivities,288967000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2020-03-31,1736,CashBalancesIncrease,-162884000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2020-03-31,1736,CashReceivedThroughOperations,386642000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2020-03-31,1736,RentalPrincipalRepayments,-149827000.0,租賃本金償還,喬山,生技醫療業
2020-03-31,1736,RepaymentOfLongTermDebt,-36986000.0,償還長期借款,喬山,生技醫療業
2020-03-31,1736,AccountsPayable,-753470000.0,應付帳款增加(減少),喬山,生技醫療業
2020-03-31,1736,DecreaseInShortTermLoans,-3683985000.0,短期借款減少,喬山,生技醫療業
2020-03-31,1736,InterestIncome,-50061000.0,利息收入,喬山,生技醫療業
2020-03-31,1736,PayTheInterest,-34419000.0,支付之利息,喬山,生技醫療業
2020-03-31,1736,IncomeBeforeIncomeTaxFromContinuingOperations,-283230000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2020-06-30,1736,AmortizationExpense,17014000.0,攤銷費用,喬山,生技醫療業
2020-06-30,1736,CashBalancesIncrease,28768000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2020-06-30,1736,Depreciation,452695000.0,折舊費用,喬山,生技醫療業
2020-06-30,1736,InterestExpense,79469000.0,利息費用,喬山,生技醫療業
2020-06-30,1736,InventoryIncrease,405110000.0,存貨（增加）減少,喬山,生技醫療業
2020-06-30,1736,OtherNonCurrentLiabilitiesIncrease,18038000.0,其他流動資產(增加)減少,喬山,生技醫療業
2020-06-30,1736,TotalIncomeLossItems,457764000.0,收益費損項目合計,喬山,生技醫療業
2020-06-30,1736,CashReceivedThroughOperations,1183002000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2020-06-30,1736,ProceedsFromLongTermDebt,1268468000.0,舉借長期借款,喬山,生技醫療業
2020-06-30,1736,CashBalancesBeginningOfPeriod,3280481000.0,期初現金及約當現金餘額,喬山,生技醫療業
2020-06-30,1736,CashBalancesEndOfPeriod,3309249000.0,期末現金及約當現金餘額,喬山,生技醫療業
2020-06-30,1736,ReceivableIncrease,1909946000.0,應收帳款(增加)減少,喬山,生技醫療業
2020-06-30,1736,CashFlowsProvidedFromFinancingActivities,1190012000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2020-06-30,1736,CashFlowsFromOperatingActivities,1126647000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2020-06-30,1736,InterestIncome,-96009000.0,利息收入,喬山,生技醫療業
2020-06-30,1736,DecreaseInShortTermLoans,-8745849000.0,短期借款減少,喬山,生技醫療業
2020-06-30,1736,RepaymentOfLongTermDebt,-89062000.0,償還長期借款,喬山,生技醫療業
2020-06-30,1736,RentalPrincipalRepayments,-298348000.0,租賃本金償還,喬山,生技醫療業
2020-06-30,1736,PayTheInterest,-39536000.0,支付之利息,喬山,生技醫療業
2020-06-30,1736,PropertyAndPlantAndEquipment,-304413000.0,取得不動產、廠房及設備,喬山,生技醫療業
2020-06-30,1736,IncomeBeforeIncomeTaxFromContinuingOperations,-264921000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2020-06-30,1736,NetIncomeBeforeTax,-264921000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2020-06-30,1736,AccountsPayable,-885849000.0,應付帳款增加(減少),喬山,生技醫療業
2020-06-30,1736,CashProvidedByInvestingActivities,-2081032000.0,投資活動之淨現金流入(流出),喬山,生技醫療業
2020-09-30,1736,AmortizationExpense,24474000.0,攤銷費用,喬山,生技醫療業
2020-09-30,1736,CashBalancesIncrease,117221000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2020-09-30,1736,Depreciation,679730000.0,折舊費用,喬山,生技醫療業
2020-09-30,1736,IncomeBeforeIncomeTaxFromContinuingOperations,306085000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2020-09-30,1736,InterestExpense,117686000.0,利息費用,喬山,生技醫療業
2020-09-30,1736,NetIncomeBeforeTax,306085000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2020-09-30,1736,OtherNonCurrentLiabilitiesIncrease,5313000.0,其他流動資產(增加)減少,喬山,生技醫療業
2020-09-30,1736,ReceivableIncrease,1135610000.0,應收帳款(增加)減少,喬山,生技醫療業
2020-09-30,1736,TotalIncomeLossItems,687714000.0,收益費損項目合計,喬山,生技醫療業
2020-09-30,1736,InventoryIncrease,-108000000.0,存貨（增加）減少,喬山,生技醫療業
2020-09-30,1736,InterestIncome,-151676000.0,利息收入,喬山,生技醫療業
2020-09-30,1736,DecreaseInShortTermLoans,-12536062000.0,短期借款減少,喬山,生技醫療業
2020-09-30,1736,ProceedsFromLongTermDebt,1297035000.0,舉借長期借款,喬山,生技醫療業
2020-09-30,1736,RepaymentOfLongTermDebt,-85513000.0,償還長期借款,喬山,生技醫療業
2020-09-30,1736,RentalPrincipalRepayments,-447826000.0,租賃本金償還,喬山,生技醫療業
2020-09-30,1736,PayTheInterest,-78628000.0,支付之利息,喬山,生技醫療業
2020-09-30,1736,CashBalancesBeginningOfPeriod,3280481000.0,期初現金及約當現金餘額,喬山,生技醫療業
2020-09-30,1736,CashBalancesEndOfPeriod,3397702000.0,期末現金及約當現金餘額,喬山,生技醫療業
2020-09-30,1736,PropertyAndPlantAndEquipment,-530855000.0,取得不動產、廠房及設備,喬山,生技醫療業
2020-09-30,1736,CashFlowsProvidedFromFinancingActivities,1028124000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2020-09-30,1736,AccountsPayable,-116977000.0,應付帳款增加(減少),喬山,生技醫療業
2020-09-30,1736,CashProvidedByInvestingActivities,-2332299000.0,投資活動之淨現金流入(流出),喬山,生技醫療業
2020-09-30,1736,CashFlowsFromOperatingActivities,1501895000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2020-09-30,1736,CashReceivedThroughOperations,1578752000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2020-12-31,1736,ReceivableIncrease,802270000.0,應收帳款(增加)減少,喬山,生技醫療業
2020-12-31,1736,NetIncomeBeforeTax,975332000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2020-12-31,1736,TotalIncomeLossItems,1001161000.0,收益費損項目合計,喬山,生技醫療業
2020-12-31,1736,CashFlowsFromOperatingActivities,2941790000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2020-12-31,1736,CashBalancesEndOfPeriod,3292801000.0,期末現金及約當現金餘額,喬山,生技醫療業
2020-12-31,1736,CashBalancesBeginningOfPeriod,3280481000.0,期初現金及約當現金餘額,喬山,生技醫療業
2020-12-31,1736,CashBalancesIncrease,12320000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2020-12-31,1736,CashReceivedThroughOperations,3093313000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2020-12-31,1736,Depreciation,912549000.0,折舊費用,喬山,生技醫療業
2020-12-31,1736,OtherNonCurrentLiabilitiesIncrease,21788000.0,其他流動資產(增加)減少,喬山,生技醫療業
2020-12-31,1736,AmortizationExpense,71458000.0,攤銷費用,喬山,生技醫療業
2020-12-31,1736,ProceedsFromLongTermDebt,1268346000.0,舉借長期借款,喬山,生技醫療業
2020-12-31,1736,AccountsPayable,803701000.0,應付帳款增加(減少),喬山,生技醫療業
2020-12-31,1736,InterestExpense,163228000.0,利息費用,喬山,生技醫療業
2020-12-31,1736,IncomeBeforeIncomeTaxFromContinuingOperations,975332000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2020-12-31,1736,PropertyAndPlantAndEquipment,-781490000.0,取得不動產、廠房及設備,喬山,生技醫療業
2020-12-31,1736,CashProvidedByInvestingActivities,-2583482000.0,投資活動之淨現金流入(流出),喬山,生技醫療業
2020-12-31,1736,InventoryIncrease,-666891000.0,存貨（增加）減少,喬山,生技醫療業
2020-12-31,1736,CashFlowsProvidedFromFinancingActivities,-417854000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2020-12-31,1736,RentalPrincipalRepayments,-567928000.0,租賃本金償還,喬山,生技醫療業
2020-12-31,1736,RepaymentOfLongTermDebt,-783480000.0,償還長期借款,喬山,生技醫療業
2020-12-31,1736,DecreaseInShortTermLoans,-16442202000.0,短期借款減少,喬山,生技醫療業
2020-12-31,1736,InterestIncome,-180441000.0,利息收入,喬山,生技醫療業
2020-12-31,1736,PayTheInterest,-109195000.0,支付之利息,喬山,生技醫療業
2021-03-31,1736,ReceivableIncrease,803130000.0,應收帳款(增加)減少,喬山,生技醫療業
2021-03-31,1736,NetIncomeBeforeTax,145566000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2021-03-31,1736,TotalIncomeLossItems,262983000.0,收益費損項目合計,喬山,生技醫療業
2021-03-31,1736,CashBalancesEndOfPeriod,2891669000.0,期末現金及約當現金餘額,喬山,生技醫療業
2021-03-31,1736,CashBalancesBeginningOfPeriod,3292801000.0,期初現金及約當現金餘額,喬山,生技醫療業
2021-03-31,1736,CashFlowsProvidedFromFinancingActivities,506928000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2021-03-31,1736,Depreciation,228991000.0,折舊費用,喬山,生技醫療業
2021-03-31,1736,AmortizationExpense,20196000.0,攤銷費用,喬山,生技醫療業
2021-03-31,1736,ProceedsFromLongTermDebt,724121000.0,舉借長期借款,喬山,生技醫療業
2021-03-31,1736,InterestExpense,35512000.0,利息費用,喬山,生技醫療業
2021-03-31,1736,IncomeBeforeIncomeTaxFromContinuingOperations,145566000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2021-03-31,1736,CashReceivedThroughOperations,-654049000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2021-03-31,1736,InventoryIncrease,-1172258000.0,存貨（增加）減少,喬山,生技醫療業
2021-03-31,1736,InterestIncome,-39574000.0,利息收入,喬山,生技醫療業
2021-03-31,1736,DecreaseInShortTermLoans,-2412725000.0,短期借款減少,喬山,生技醫療業
2021-03-31,1736,RepaymentOfLongTermDebt,-699157000.0,償還長期借款,喬山,生技醫療業
2021-03-31,1736,RentalPrincipalRepayments,-144513000.0,租賃本金償還,喬山,生技醫療業
2021-03-31,1736,OtherNonCurrentLiabilitiesIncrease,-5302000.0,其他流動資產(增加)減少,喬山,生技醫療業
2021-03-31,1736,PayTheInterest,-31712000.0,支付之利息,喬山,生技醫療業
2021-03-31,1736,CashBalancesIncrease,-401132000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2021-03-31,1736,PropertyAndPlantAndEquipment,-72504000.0,取得不動產、廠房及設備,喬山,生技醫療業
2021-03-31,1736,CashFlowsFromOperatingActivities,-646295000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2021-03-31,1736,AccountsPayable,-323156000.0,應付帳款增加(減少),喬山,生技醫療業
2021-03-31,1736,CashProvidedByInvestingActivities,-64299000.0,投資活動之淨現金流入（流出）,喬山,生技醫療業
2021-06-30,1736,ReceivableIncrease,588970000.0,應收帳款(增加)減少,喬山,生技醫療業
2021-06-30,1736,NetIncomeBeforeTax,201555000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2021-06-30,1736,TotalIncomeLossItems,544294000.0,收益費損項目合計,喬山,生技醫療業
2021-06-30,1736,CashBalancesEndOfPeriod,2605043000.0,期末現金及約當現金餘額,喬山,生技醫療業
2021-06-30,1736,CashBalancesBeginningOfPeriod,3292801000.0,期初現金及約當現金餘額,喬山,生技醫療業
2021-06-30,1736,CashFlowsProvidedFromFinancingActivities,2563180000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2021-06-30,1736,Depreciation,460466000.0,折舊費用,喬山,生技醫療業
2021-06-30,1736,AmortizationExpense,42334000.0,攤銷費用,喬山,生技醫療業
2021-06-30,1736,ProceedsFromLongTermDebt,729217000.0,舉借長期借款,喬山,生技醫療業
2021-06-30,1736,InterestExpense,69728000.0,利息費用,喬山,生技醫療業
2021-06-30,1736,IncomeBeforeIncomeTaxFromContinuingOperations,201555000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2021-06-30,1736,PropertyAndPlantAndEquipment,-206127000.0,取得不動產、廠房及設備,喬山,生技醫療業
2021-06-30,1736,CashFlowsFromOperatingActivities,-2612791000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2021-06-30,1736,InventoryIncrease,-1842607000.0,存貨（增加）減少,喬山,生技醫療業
2021-06-30,1736,CashBalancesIncrease,-687758000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2021-06-30,1736,CashReceivedThroughOperations,-2384639000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2021-06-30,1736,OtherNonCurrentLiabilitiesIncrease,-68088000.0,其他流動資產(增加)減少,喬山,生技醫療業
2021-06-30,1736,RentalPrincipalRepayments,-288921000.0,租賃本金償還,喬山,生技醫療業
2021-06-30,1736,RepaymentOfLongTermDebt,-701740000.0,償還長期借款,喬山,生技醫療業
2021-06-30,1736,AccountsPayable,-1003914000.0,應付帳款增加(減少),喬山,生技醫療業
2021-06-30,1736,DecreaseInShortTermLoans,-4199070000.0,短期借款減少,喬山,生技醫療業
2021-06-30,1736,InterestIncome,-78498000.0,利息收入,喬山,生技醫療業
2021-06-30,1736,PayTheInterest,-27027000.0,支付之利息,喬山,生技醫療業
2021-06-30,1736,CashProvidedByInvestingActivities,-200338000.0,投資活動之淨現金流入（流出）,喬山,生技醫療業
2021-09-30,1736,ReceivableIncrease,-63085000.0,應收帳款(增加)減少,喬山,生技醫療業
2021-09-30,1736,PropertyAndPlantAndEquipment,-341961000.0,取得不動產、廠房及設備,喬山,生技醫療業
2021-09-30,1736,NetIncomeBeforeTax,-404294000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2021-09-30,1736,TotalIncomeLossItems,1181444000.0,收益費損項目合計,喬山,生技醫療業
2021-09-30,1736,CashBalancesEndOfPeriod,2577702000.0,期末現金及約當現金餘額,喬山,生技醫療業
2021-09-30,1736,InventoryIncrease,-2786071000.0,存貨（增加）減少,喬山,生技醫療業
2021-09-30,1736,CashBalancesBeginningOfPeriod,3292801000.0,期初現金及約當現金餘額,喬山,生技醫療業
2021-09-30,1736,CashBalancesIncrease,-715099000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2021-09-30,1736,CashFlowsProvidedFromFinancingActivities,4195290000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2021-09-30,1736,Depreciation,701516000.0,折舊費用,喬山,生技醫療業
2021-09-30,1736,OtherNonCurrentLiabilitiesIncrease,-97009000.0,其他流動資產(增加)減少,喬山,生技醫療業
2021-09-30,1736,RentalPrincipalRepayments,-426094000.0,租賃本金償還,喬山,生技醫療業
2021-09-30,1736,AmortizationExpense,61062000.0,攤銷費用,喬山,生技醫療業
2021-09-30,1736,RepaymentOfLongTermDebt,-707717000.0,償還長期借款,喬山,生技醫療業
2021-09-30,1736,ProceedsFromLongTermDebt,628135000.0,舉借長期借款,喬山,生技醫療業
2021-09-30,1736,AccountsPayable,-623308000.0,應付帳款增加(減少),喬山,生技醫療業
2021-09-30,1736,DecreaseInShortTermLoans,-6287309000.0,短期借款減少,喬山,生技醫療業
2021-09-30,1736,InterestExpense,112339000.0,利息費用,喬山,生技醫療業
2021-09-30,1736,InterestIncome,-113100000.0,利息收入,喬山,生技醫療業
2021-09-30,1736,PayTheInterest,-69206000.0,支付之利息,喬山,生技醫療業
2021-09-30,1736,IncomeBeforeIncomeTaxFromContinuingOperations,-404294000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2021-09-30,1736,CashReceivedThroughOperations,-3792698000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2021-09-30,1736,CashProvidedByInvestingActivities,-349849000.0,投資活動之淨現金流入（流出）,喬山,生技醫療業
2021-09-30,1736,CashFlowsFromOperatingActivities,-4066085000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2021-12-31,1736,ReceivableIncrease,-897045000.0,應收帳款(增加)減少,喬山,生技醫療業
2021-12-31,1736,PropertyAndPlantAndEquipment,-692042000.0,取得不動產、廠房及設備,喬山,生技醫療業
2021-12-31,1736,NetIncomeBeforeTax,163700000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2021-12-31,1736,TotalIncomeLossItems,1441266000.0,收益費損項目合計,喬山,生技醫療業
2021-12-31,1736,CashFlowsFromOperatingActivities,-3537026000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2021-12-31,1736,CashBalancesEndOfPeriod,2615077000.0,期末現金及約當現金餘額,喬山,生技醫療業
2021-12-31,1736,InventoryIncrease,-3728413000.0,存貨（增加）減少,喬山,生技醫療業
2021-12-31,1736,CashBalancesBeginningOfPeriod,3292801000.0,期初現金及約當現金餘額,喬山,生技醫療業
2021-12-31,1736,CashBalancesIncrease,-677724000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2021-12-31,1736,CashReceivedThroughOperations,-3231777000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2021-12-31,1736,CashFlowsProvidedFromFinancingActivities,3983162000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2021-12-31,1736,Depreciation,959825000.0,折舊費用,喬山,生技醫療業
2021-12-31,1736,OtherNonCurrentLiabilitiesIncrease,-43408000.0,其他流動資產(增加)減少,喬山,生技醫療業
2021-12-31,1736,RentalPrincipalRepayments,-564411000.0,租賃本金償還,喬山,生技醫療業
2021-12-31,1736,AmortizationExpense,80400000.0,攤銷費用,喬山,生技醫療業
2021-12-31,1736,RepaymentOfLongTermDebt,-716018000.0,償還長期借款,喬山,生技醫療業
2021-12-31,1736,ProceedsFromLongTermDebt,593965000.0,舉借長期借款,喬山,生技醫療業
2021-12-31,1736,AccountsPayable,-145672000.0,應付帳款增加(減少),喬山,生技醫療業
2021-12-31,1736,DecreaseInShortTermLoans,-10574071000.0,短期借款減少,喬山,生技醫療業
2021-12-31,1736,InterestExpense,163482000.0,利息費用,喬山,生技醫療業
2021-12-31,1736,InterestIncome,-152413000.0,利息收入,喬山,生技醫療業
2021-12-31,1736,PayTheInterest,-115353000.0,支付之利息,喬山,生技醫療業
2021-12-31,1736,IncomeBeforeIncomeTaxFromContinuingOperations,163700000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2021-12-31,1736,CashProvidedByInvestingActivities,-721776000.0,投資活動之淨現金流入（流出）,喬山,生技醫療業
2022-03-31,1736,CashReceivedThroughOperations,108558000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2022-03-31,1736,InventoryIncrease,-23770000.0,存貨（增加）減少,喬山,生技醫療業
2022-03-31,1736,InterestIncome,-42384000.0,利息收入,喬山,生技醫療業
2022-03-31,1736,DecreaseInShortTermLoans,-7243041000.0,短期借款減少,喬山,生技醫療業
2022-03-31,1736,ProceedsFromLongTermDebt,1379568000.0,舉借長期借款,喬山,生技醫療業
2022-03-31,1736,RepaymentOfLongTermDebt,-1301830000.0,償還長期借款,喬山,生技醫療業
2022-03-31,1736,RentalPrincipalRepayments,-144515000.0,租賃本金償還,喬山,生技醫療業
2022-03-31,1736,OtherNonCurrentLiabilitiesIncrease,-3613000.0,其他流動資產(增加)減少,喬山,生技醫療業
2022-03-31,1736,PayTheInterest,-29821000.0,支付之利息,喬山,生技醫療業
2022-03-31,1736,CashBalancesIncrease,1254465000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2022-03-31,1736,CashBalancesBeginningOfPeriod,2615077000.0,期初現金及約當現金餘額,喬山,生技醫療業
2022-03-31,1736,CashBalancesEndOfPeriod,3869542000.0,期末現金及約當現金餘額,喬山,生技醫療業
2022-03-31,1736,CashProvidedByInvestingActivities,-162925000.0,投資活動之淨現金流入（流出）,喬山,生技醫療業
2022-03-31,1736,PropertyAndPlantAndEquipment,-166483000.0,取得不動產、廠房及設備,喬山,生技醫療業
2022-03-31,1736,CashFlowsProvidedFromFinancingActivities,1183886000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2022-03-31,1736,TotalIncomeLossItems,339554000.0,收益費損項目合計,喬山,生技醫療業
2022-03-31,1736,IncomeBeforeIncomeTaxFromContinuingOperations,101150000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2022-03-31,1736,NetIncomeBeforeTax,101150000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2022-03-31,1736,CashFlowsFromOperatingActivities,72776000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2022-03-31,1736,AmortizationExpense,20254000.0,攤銷費用,喬山,生技醫療業
2022-03-31,1736,Depreciation,255953000.0,折舊費用,喬山,生技醫療業
2022-03-31,1736,InterestExpense,43366000.0,利息費用,喬山,生技醫療業
2022-03-31,1736,ReceivableIncrease,777694000.0,應收帳款（增加）減少,喬山,生技醫療業
2022-03-31,1736,NetCashInflowFromOperatingActivities,72776000.0,營業活動之淨現金流入,喬山,生技醫療業
2022-03-31,1736,AccountsPayable,-658398000.0,應付帳款,喬山,生技醫療業
2022-06-30,1736,CashReceivedThroughOperations,363193000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2022-06-30,1736,InventoryIncrease,381977000.0,存貨（增加）減少,喬山,生技醫療業
2022-06-30,1736,InterestIncome,-76587000.0,利息收入,喬山,生技醫療業
2022-06-30,1736,DecreaseInShortTermLoans,-17690725000.0,短期借款減少,喬山,生技醫療業
2022-06-30,1736,ProceedsFromLongTermDebt,1479730000.0,舉借長期借款,喬山,生技醫療業
2022-06-30,1736,RepaymentOfLongTermDebt,-1380457000.0,償還長期借款,喬山,生技醫療業
2022-06-30,1736,RentalPrincipalRepayments,-319059000.0,租賃本金償還,喬山,生技醫療業
2022-06-30,1736,OtherNonCurrentLiabilitiesIncrease,-32864000.0,其他流動資產(增加)減少,喬山,生技醫療業
2022-06-30,1736,PayTheInterest,-69605000.0,支付之利息,喬山,生技醫療業
2022-06-30,1736,CashBalancesIncrease,781158000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2022-06-30,1736,CashBalancesBeginningOfPeriod,2615077000.0,期初現金及約當現金餘額,喬山,生技醫療業
2022-06-30,1736,CashBalancesEndOfPeriod,3396235000.0,期末現金及約當現金餘額,喬山,生技醫療業
2022-06-30,1736,CashProvidedByInvestingActivities,-276649000.0,投資活動之淨現金流入（流出）,喬山,生技醫療業
2022-06-30,1736,PropertyAndPlantAndEquipment,-283680000.0,取得不動產、廠房及設備,喬山,生技醫療業
2022-06-30,1736,CashFlowsProvidedFromFinancingActivities,815088000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2022-06-30,1736,TotalIncomeLossItems,599193000.0,收益費損項目合計,喬山,生技醫療業
2022-06-30,1736,IncomeBeforeIncomeTaxFromContinuingOperations,-436935000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2022-06-30,1736,NetIncomeBeforeTax,-436935000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2022-06-30,1736,CashFlowsFromOperatingActivities,273213000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2022-06-30,1736,AmortizationExpense,40560000.0,攤銷費用,喬山,生技醫療業
2022-06-30,1736,Depreciation,528005000.0,折舊費用,喬山,生技醫療業
2022-06-30,1736,InterestExpense,94255000.0,利息費用,喬山,生技醫療業
2022-06-30,1736,ReceivableIncrease,1843727000.0,應收帳款（增加）減少,喬山,生技醫療業
2022-06-30,1736,NetCashInflowFromOperatingActivities,273213000.0,營業活動之淨現金流入,喬山,生技醫療業
2022-06-30,1736,AccountsPayable,-1290755000.0,應付帳款,喬山,生技醫療業
2022-09-30,1736,PropertyAndPlantAndEquipment,-447341000.0,取得不動產、廠房及設備,喬山,生技醫療業
2022-09-30,1736,NetIncomeBeforeTax,-426642000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2022-09-30,1736,TotalIncomeLossItems,1005253000.0,收益費損項目合計,喬山,生技醫療業
2022-09-30,1736,CashFlowsFromOperatingActivities,-766655000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2022-09-30,1736,CashBalancesEndOfPeriod,2650629000.0,期末現金及約當現金餘額,喬山,生技醫療業
2022-09-30,1736,InventoryIncrease,-1320472000.0,存貨（增加）減少,喬山,生技醫療業
2022-09-30,1736,CashBalancesBeginningOfPeriod,2615077000.0,期初現金及約當現金餘額,喬山,生技醫療業
2022-09-30,1736,CashBalancesIncrease,35552000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2022-09-30,1736,CashReceivedThroughOperations,-608632000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2022-09-30,1736,CashFlowsProvidedFromFinancingActivities,1418746000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2022-09-30,1736,Depreciation,846121000.0,折舊費用,喬山,生技醫療業
2022-09-30,1736,OtherNonCurrentLiabilitiesIncrease,23458000.0,其他流動資產(增加)減少,喬山,生技醫療業
2022-09-30,1736,RentalPrincipalRepayments,-434711000.0,租賃本金償還,喬山,生技醫療業
2022-09-30,1736,AmortizationExpense,60950000.0,攤銷費用,喬山,生技醫療業
2022-09-30,1736,RepaymentOfLongTermDebt,-1385334000.0,償還長期借款,喬山,生技醫療業
2022-09-30,1736,ProceedsFromLongTermDebt,1568180000.0,舉借長期借款,喬山,生技醫療業
2022-09-30,1736,DecreaseInShortTermLoans,-27001295000.0,短期借款減少,喬山,生技醫療業
2022-09-30,1736,InterestExpense,172640000.0,利息費用,喬山,生技醫療業
2022-09-30,1736,InterestIncome,-119746000.0,利息收入,喬山,生技醫療業
2022-09-30,1736,PayTheInterest,-150263000.0,支付之利息,喬山,生技醫療業
2022-09-30,1736,IncomeBeforeIncomeTaxFromContinuingOperations,-426642000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2022-09-30,1736,CashProvidedByInvestingActivities,-440791000.0,投資活動之淨現金流入（流出）,喬山,生技醫療業
2022-09-30,1736,AccountsPayable,714799000.0,應付帳款,喬山,生技醫療業
2022-09-30,1736,NetCashInflowFromOperatingActivities,-766655000.0,營業活動之淨現金流入,喬山,生技醫療業
2022-09-30,1736,ReceivableIncrease,273492000.0,應收帳款（增加）減少,喬山,生技醫療業
2022-12-31,1736,PropertyAndPlantAndEquipment,-407775000.0,取得不動產、廠房及設備,喬山,生技醫療業
2022-12-31,1736,NetIncomeBeforeTax,303606000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2022-12-31,1736,TotalIncomeLossItems,1318817000.0,收益費損項目合計,喬山,生技醫療業
2022-12-31,1736,CashFlowsFromOperatingActivities,392453000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2022-12-31,1736,CashBalancesEndOfPeriod,3531554000.0,期末現金及約當現金餘額,喬山,生技醫療業
2022-12-31,1736,InventoryIncrease,-134180000.0,存貨（增加）減少,喬山,生技醫療業
2022-12-31,1736,CashBalancesBeginningOfPeriod,2615077000.0,期初現金及約當現金餘額,喬山,生技醫療業
2022-12-31,1736,CashBalancesIncrease,916477000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2022-12-31,1736,CashReceivedThroughOperations,639486000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2022-12-31,1736,CashFlowsProvidedFromFinancingActivities,846524000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2022-12-31,1736,Depreciation,1124453000.0,折舊費用,喬山,生技醫療業
2022-12-31,1736,OtherNonCurrentLiabilitiesIncrease,-58483000.0,其他流動資產(增加)減少,喬山,生技醫療業
2022-12-31,1736,RentalPrincipalRepayments,-582516000.0,租賃本金償還,喬山,生技醫療業
2022-12-31,1736,AmortizationExpense,82127000.0,攤銷費用,喬山,生技醫療業
2022-12-31,1736,RepaymentOfLongTermDebt,-1338156000.0,償還長期借款,喬山,生技醫療業
2022-12-31,1736,ProceedsFromLongTermDebt,1610985000.0,舉借長期借款,喬山,生技醫療業
2022-12-31,1736,DecreaseInShortTermLoans,-43254385000.0,短期借款減少,喬山,生技醫療業
2022-12-31,1736,InterestExpense,256180000.0,利息費用,喬山,生技醫療業
2022-12-31,1736,InterestIncome,-165172000.0,利息收入,喬山,生技醫療業
2022-12-31,1736,PayTheInterest,-222813000.0,支付之利息,喬山,生技醫療業
2022-12-31,1736,IncomeBeforeIncomeTaxFromContinuingOperations,303606000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2022-12-31,1736,AccountsPayable,111908000.0,應付帳款,喬山,生技醫療業
2022-12-31,1736,NetCashInflowFromOperatingActivities,392453000.0,營業活動之淨現金流入,喬山,生技醫療業
2022-12-31,1736,CashProvidedByInvestingActivities,-667728000.0,投資活動之淨現金流入（流出）,喬山,生技醫療業
2022-12-31,1736,ReceivableIncrease,-1193762000.0,應收帳款（增加）減少,喬山,生技醫療業
2023-03-31,1736,PropertyAndPlantAndEquipment,-55056000.0,取得不動產、廠房及設備,喬山,生技醫療業
2023-03-31,1736,NetIncomeBeforeTax,-716463000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2023-03-31,1736,TotalIncomeLossItems,424148000.0,收益費損項目合計,喬山,生技醫療業
2023-03-31,1736,CashFlowsFromOperatingActivities,-610920000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2023-03-31,1736,CashBalancesEndOfPeriod,2779264000.0,期末現金及約當現金餘額,喬山,生技醫療業
2023-03-31,1736,InventoryIncrease,467020000.0,存貨（增加）減少,喬山,生技醫療業
2023-03-31,1736,CashBalancesBeginningOfPeriod,3531554000.0,期初現金及約當現金餘額,喬山,生技醫療業
2023-03-31,1736,CashBalancesIncrease,-752290000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2023-03-31,1736,CashReceivedThroughOperations,-520652000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2023-03-31,1736,CashFlowsProvidedFromFinancingActivities,21888000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2023-03-31,1736,Depreciation,289595000.0,折舊費用,喬山,生技醫療業
2023-03-31,1736,OtherNonCurrentLiabilitiesIncrease,27045000.0,其他流動資產(增加)減少,喬山,生技醫療業
2023-03-31,1736,RentalPrincipalRepayments,-109362000.0,租賃本金償還,喬山,生技醫療業
2023-03-31,1736,AmortizationExpense,22333000.0,攤銷費用,喬山,生技醫療業
2023-03-31,1736,RepaymentOfLongTermDebt,-962453000.0,償還長期借款,喬山,生技醫療業
2023-03-31,1736,ProceedsFromLongTermDebt,6360666000.0,舉借長期借款,喬山,生技醫療業
2023-03-31,1736,DecreaseInShortTermLoans,-17334341000.0,短期借款減少,喬山,生技醫療業
2023-03-31,1736,InterestExpense,109227000.0,利息費用,喬山,生技醫療業
2023-03-31,1736,InterestIncome,-42786000.0,利息收入,喬山,生技醫療業
2023-03-31,1736,PayTheInterest,-96137000.0,支付之利息,喬山,生技醫療業
2023-03-31,1736,IncomeBeforeIncomeTaxFromContinuingOperations,-716463000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2023-03-31,1736,ReceivableIncrease,1015305000.0,應收帳款（增加）減少,喬山,生技醫療業
2023-03-31,1736,NetCashInflowFromOperatingActivities,-610920000.0,營業活動之淨現金流入,喬山,生技醫療業
2023-03-31,1736,AccountsPayable,-1255128000.0,應付帳款,喬山,生技醫療業
2023-03-31,1736,CashProvidedByInvestingActivities,-58335000.0,投資活動之淨現金流入（流出）,喬山,生技醫療業
2023-06-30,1736,PropertyAndPlantAndEquipment,-255529000.0,取得不動產、廠房及設備,喬山,生技醫療業
2023-06-30,1736,NetIncomeBeforeTax,-232812000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2023-06-30,1736,CashBalancesEndOfPeriod,2315471000.0,期末現金及約當現金餘額,喬山,生技醫療業
2023-06-30,1736,InventoryIncrease,1479161000.0,存貨（增加）減少,喬山,生技醫療業
2023-06-30,1736,CashBalancesBeginningOfPeriod,3531554000.0,期初現金及約當現金餘額,喬山,生技醫療業
2023-06-30,1736,CashBalancesIncrease,-1216083000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2023-06-30,1736,CashFlowsProvidedFromFinancingActivities,-1251373000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2023-06-30,1736,Depreciation,599422000.0,折舊費用,喬山,生技醫療業
2023-06-30,1736,OtherNonCurrentLiabilitiesIncrease,-11756000.0,其他流動資產(增加)減少,喬山,生技醫療業
2023-06-30,1736,RentalPrincipalRepayments,-349097000.0,租賃本金償還,喬山,生技醫療業
2023-06-30,1736,AmortizationExpense,54826000.0,攤銷費用,喬山,生技醫療業
2023-06-30,1736,RepaymentOfLongTermDebt,-6363200000.0,償還長期借款,喬山,生技醫療業
2023-06-30,1736,ProceedsFromLongTermDebt,11532581000.0,舉借長期借款,喬山,生技醫療業
2023-06-30,1736,DecreaseInShortTermLoans,-30563631000.0,短期借款減少,喬山,生技醫療業
2023-06-30,1736,InterestExpense,208487000.0,利息費用,喬山,生技醫療業
2023-06-30,1736,InterestIncome,-92275000.0,利息收入,喬山,生技醫療業
2023-06-30,1736,PayTheInterest,-190275000.0,支付之利息,喬山,生技醫療業
2023-06-30,1736,IncomeBeforeIncomeTaxFromContinuingOperations,-232812000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2023-06-30,1736,CashProvidedByInvestingActivities,-270660000.0,投資活動之淨現金流入（流出）,喬山,生技醫療業
2023-06-30,1736,AccountsPayable,-1496720000.0,應付帳款,喬山,生技醫療業
2023-06-30,1736,ReceivableIncrease,795883000.0,應收帳款（增加）減少,喬山,生技醫療業
2023-06-30,1736,CashReceivedThroughOperations,570175000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2023-06-30,1736,TotalIncomeLossItems,835181000.0,收益費損項目合計,喬山,生技醫療業
2023-06-30,1736,NetCashInflowFromOperatingActivities,346020000.0,營業活動之淨現金流入,喬山,生技醫療業
2023-06-30,1736,CashFlowsFromOperatingActivities,346020000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2023-09-30,1736,PropertyAndPlantAndEquipment,-391604000.0,取得不動產、廠房及設備,喬山,生技醫療業
2023-09-30,1736,NetIncomeBeforeTax,328595000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2023-09-30,1736,TotalIncomeLossItems,1322625000.0,收益費損項目合計,喬山,生技醫療業
2023-09-30,1736,CashFlowsFromOperatingActivities,1244450000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2023-09-30,1736,CashBalancesEndOfPeriod,2216806000.0,期末現金及約當現金餘額,喬山,生技醫療業
2023-09-30,1736,InventoryIncrease,809728000.0,存貨（增加）減少,喬山,生技醫療業
2023-09-30,1736,CashBalancesBeginningOfPeriod,3531554000.0,期初現金及約當現金餘額,喬山,生技醫療業
2023-09-30,1736,CashBalancesIncrease,-1314748000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2023-09-30,1736,CashReceivedThroughOperations,1689044000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2023-09-30,1736,CashFlowsProvidedFromFinancingActivities,-2066018000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2023-09-30,1736,Depreciation,961751000.0,折舊費用,喬山,生技醫療業
2023-09-30,1736,OtherNonCurrentLiabilitiesIncrease,54168000.0,其他流動資產(增加)減少,喬山,生技醫療業
2023-09-30,1736,RentalPrincipalRepayments,-540637000.0,租賃本金償還,喬山,生技醫療業
2023-09-30,1736,AmortizationExpense,77385000.0,攤銷費用,喬山,生技醫療業
2023-09-30,1736,RepaymentOfLongTermDebt,-8963997000.0,償還長期借款,喬山,生技醫療業
2023-09-30,1736,ProceedsFromLongTermDebt,13145803000.0,舉借長期借款,喬山,生技醫療業
2023-09-30,1736,DecreaseInShortTermLoans,-42604360000.0,短期借款減少,喬山,生技醫療業
2023-09-30,1736,InterestExpense,304376000.0,利息費用,喬山,生技醫療業
2023-09-30,1736,InterestIncome,-142956000.0,利息收入,喬山,生技醫療業
2023-09-30,1736,PayTheInterest,-298520000.0,支付之利息,喬山,生技醫療業
2023-09-30,1736,IncomeBeforeIncomeTaxFromContinuingOperations,328595000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2023-09-30,1736,NetCashInflowFromOperatingActivities,1244450000.0,營業活動之淨現金流入,喬山,生技醫療業
2023-09-30,1736,AccountsPayable,85599000.0,應付帳款,喬山,生技醫療業
2023-09-30,1736,CashProvidedByInvestingActivities,-411515000.0,投資活動之淨現金流入（流出）,喬山,生技醫療業
2023-09-30,1736,ReceivableIncrease,-43681000.0,應收帳款（增加）減少,喬山,生技醫療業
2023-09-30,1736,RedemptionOfBonds,0.0,償還公司債,喬山,生技醫療業
2023-12-31,1736,CashBalancesBeginningOfPeriod,3531554000.0,期初現金及約當現金餘額,喬山,生技醫療業
2023-12-31,1736,CashBalancesEndOfPeriod,2341417000.0,期末現金及約當現金餘額,喬山,生技醫療業
2023-12-31,1736,PayTheInterest,-407151000.0,支付之利息,喬山,生技醫療業
2023-12-31,1736,RentalPrincipalRepayments,-769217000.0,租賃本金償還,喬山,生技醫療業
2023-12-31,1736,Depreciation,1305774000.0,折舊費用,喬山,生技醫療業
2023-12-31,1736,ProceedsFromLongTermDebt,17840929000.0,舉借長期借款,喬山,生技醫療業
2023-12-31,1736,PropertyAndPlantAndEquipment,-649992000.0,取得不動產、廠房及設備,喬山,生技醫療業
2023-12-31,1736,InterestIncome,-194186000.0,利息收入,喬山,生技醫療業
2023-12-31,1736,TotalIncomeLossItems,1723755000.0,收益費損項目合計,喬山,生技醫療業
2023-12-31,1736,InterestExpense,377470000.0,利息費用,喬山,生技醫療業
2023-12-31,1736,NetCashInflowFromOperatingActivities,3842551000.0,營業活動之淨現金流入,喬山,生技醫療業
2023-12-31,1736,AccountsPayable,-202494000.0,應付帳款,喬山,生技醫療業
2023-12-31,1736,AmortizationExpense,92225000.0,攤銷費用,喬山,生技醫療業
2023-12-31,1736,RepaymentOfLongTermDebt,-13202472000.0,償還長期借款,喬山,生技醫療業
2023-12-31,1736,DecreaseInShortTermLoans,-47234038000.0,短期借款減少,喬山,生技醫療業
2023-12-31,1736,CashBalancesIncrease,-1190137000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2023-12-31,1736,CashProvidedByInvestingActivities,-680817000.0,投資活動之淨現金流入（流出）,喬山,生技醫療業
2023-12-31,1736,NetIncomeBeforeTax,1334482000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2023-12-31,1736,CashFlowsFromOperatingActivities,3842551000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2023-12-31,1736,CashFlowsProvidedFromFinancingActivities,-3871080000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2023-12-31,1736,CashReceivedThroughOperations,4200229000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2023-12-31,1736,InventoryIncrease,2769189000.0,存貨（增加）減少,喬山,生技醫療業
2023-12-31,1736,ReceivableIncrease,-1892216000.0,應收帳款（增加）減少,喬山,生技醫療業
2023-12-31,1736,IncomeBeforeIncomeTaxFromContinuingOperations,1334482000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2023-12-31,1736,RedemptionOfBonds,0.0,償還公司債,喬山,生技醫療業
2024-03-31,1736,CashBalancesIncrease,97491000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2024-03-31,1736,CashBalancesEndOfPeriod,2438908000.0,期末現金及約當現金餘額,喬山,生技醫療業
2024-03-31,1736,PropertyAndPlantAndEquipment,-165264000.0,取得不動產、廠房及設備,喬山,生技醫療業
2024-03-31,1736,PayTheInterest,-74787000.0,支付之利息,喬山,生技醫療業
2024-03-31,1736,CashBalancesBeginningOfPeriod,2341417000.0,期初現金及約當現金餘額,喬山,生技醫療業
2024-03-31,1736,RepaymentOfLongTermDebt,-4408845000.0,償還長期借款,喬山,生技醫療業
2024-03-31,1736,CashProvidedByInvestingActivities,-161442000.0,投資活動之淨現金流入（流出）,喬山,生技醫療業
2024-03-31,1736,IncomeBeforeIncomeTaxFromContinuingOperations,-50058000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2024-03-31,1736,DecreaseInShortTermLoans,-10000046000.0,短期借款減少,喬山,生技醫療業
2024-03-31,1736,InterestIncome,-79387000.0,利息收入,喬山,生技醫療業
2024-03-31,1736,CashFlowsProvidedFromFinancingActivities,-356689000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2024-03-31,1736,InventoryIncrease,-619504000.0,存貨（增加）減少,喬山,生技醫療業
2024-03-31,1736,ReceivableIncrease,1763951000.0,應收帳款（增加）減少,喬山,生技醫療業
2024-03-31,1736,TotalIncomeLossItems,403416000.0,收益費損項目合計,喬山,生技醫療業
2024-03-31,1736,InterestExpense,80107000.0,利息費用,喬山,生技醫療業
2024-03-31,1736,NetCashInflowFromOperatingActivities,494285000.0,營業活動之淨現金流入,喬山,生技醫療業
2024-03-31,1736,AccountsPayable,-293537000.0,應付帳款,喬山,生技醫療業
2024-03-31,1736,AmortizationExpense,29561000.0,攤銷費用,喬山,生技醫療業
2024-03-31,1736,Depreciation,380063000.0,折舊費用,喬山,生技醫療業
2024-03-31,1736,CashFlowsFromOperatingActivities,494285000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2024-03-31,1736,NetIncomeBeforeTax,-50058000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2024-03-31,1736,ProceedsFromLongTermDebt,4206171000.0,舉借長期借款,喬山,生技醫療業
2024-03-31,1736,CashReceivedThroughOperations,566584000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2024-03-31,1736,RentalPrincipalRepayments,-195685000.0,租賃本金償還,喬山,生技醫療業
2024-06-30,1736,Depreciation,761868000.0,折舊費用,喬山,生技醫療業
2024-06-30,1736,CashBalancesIncrease,157678000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2024-06-30,1736,TotalIncomeLossItems,844776000.0,收益費損項目合計,喬山,生技醫療業
2024-06-30,1736,PayTheInterest,-181875000.0,支付之利息,喬山,生技醫療業
2024-06-30,1736,CashBalancesEndOfPeriod,2499095000.0,期末現金及約當現金餘額,喬山,生技醫療業
2024-06-30,1736,CashProvidedByInvestingActivities,-311596000.0,投資活動之淨現金流入（流出）,喬山,生技醫療業
2024-06-30,1736,NetIncomeBeforeTax,422148000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2024-06-30,1736,PropertyAndPlantAndEquipment,-308113000.0,取得不動產、廠房及設備,喬山,生技醫療業
2024-06-30,1736,CashBalancesBeginningOfPeriod,2341417000.0,期初現金及約當現金餘額,喬山,生技醫療業
2024-06-30,1736,CashFlowsFromOperatingActivities,434981000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2024-06-30,1736,AmortizationExpense,45875000.0,攤銷費用,喬山,生技醫療業
2024-06-30,1736,RepaymentOfLongTermDebt,-8716691000.0,償還長期借款,喬山,生技醫療業
2024-06-30,1736,ProceedsFromLongTermDebt,8400000000.0,舉借長期借款,喬山,生技醫療業
2024-06-30,1736,AccountsPayable,535972000.0,應付帳款,喬山,生技醫療業
2024-06-30,1736,DecreaseInShortTermLoans,-18554717000.0,短期借款減少,喬山,生技醫療業
2024-06-30,1736,InterestIncome,-164904000.0,利息收入,喬山,生技醫療業
2024-06-30,1736,CashFlowsProvidedFromFinancingActivities,152854000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2024-06-30,1736,CashReceivedThroughOperations,715028000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2024-06-30,1736,NetCashInflowFromOperatingActivities,434981000.0,營業活動之淨現金流入,喬山,生技醫療業
2024-06-30,1736,InventoryIncrease,-2625952000.0,存貨（增加）減少,喬山,生技醫療業
2024-06-30,1736,ReceivableIncrease,967325000.0,應收帳款（增加）減少,喬山,生技醫療業
2024-06-30,1736,InterestExpense,191977000.0,利息費用,喬山,生技醫療業
2024-06-30,1736,RentalPrincipalRepayments,-695738000.0,租賃本金償還,喬山,生技醫療業
2024-06-30,1736,IncomeBeforeIncomeTaxFromContinuingOperations,422148000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2024-09-30,1736,PropertyAndPlantAndEquipment,-485025000.0,取得不動產、廠房及設備,喬山,生技醫療業
2024-09-30,1736,CashBalancesIncrease,-340516000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2024-09-30,1736,RedemptionOfBonds,-2000000000.0,償還公司債,喬山,生技醫療業
2024-09-30,1736,CashBalancesEndOfPeriod,2000901000.0,期末現金及約當現金餘額,喬山,生技醫療業
2024-09-30,1736,PayTheInterest,-293259000.0,支付之利息,喬山,生技醫療業
2024-09-30,1736,CashBalancesBeginningOfPeriod,2341417000.0,期初現金及約當現金餘額,喬山,生技醫療業
2024-09-30,1736,CashProvidedByInvestingActivities,-496718000.0,投資活動之淨現金流入（流出）,喬山,生技醫療業
2024-09-30,1736,IncomeBeforeIncomeTaxFromContinuingOperations,1169319000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2024-09-30,1736,RepaymentOfLongTermDebt,-14751840000.0,償還長期借款,喬山,生技醫療業
2024-09-30,1736,NetIncomeBeforeTax,1169319000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2024-09-30,1736,CashFlowsFromOperatingActivities,-521715000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2024-09-30,1736,Depreciation,1076602000.0,折舊費用,喬山,生技醫療業
2024-09-30,1736,AmortizationExpense,78867000.0,攤銷費用,喬山,生技醫療業
2024-09-30,1736,AccountsPayable,1911638000.0,應付帳款,喬山,生技醫療業
2024-09-30,1736,NetCashInflowFromOperatingActivities,-521715000.0,營業活動之淨現金流入,喬山,生技醫療業
2024-09-30,1736,RentalPrincipalRepayments,-565549000.0,租賃本金償還,喬山,生技醫療業
2024-09-30,1736,InterestExpense,296705000.0,利息費用,喬山,生技醫療業
2024-09-30,1736,ReceivableIncrease,-402857000.0,應收帳款（增加）減少,喬山,生技醫療業
2024-09-30,1736,InventoryIncrease,-3817947000.0,存貨（增加）減少,喬山,生技醫療業
2024-09-30,1736,CashReceivedThroughOperations,-130413000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2024-09-30,1736,CashFlowsProvidedFromFinancingActivities,576508000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2024-09-30,1736,DecreaseInShortTermLoans,-34700000000.0,短期借款減少,喬山,生技醫療業
2024-09-30,1736,ProceedsFromLongTermDebt,13976693000.0,舉借長期借款,喬山,生技醫療業
2024-09-30,1736,TotalIncomeLossItems,1241895000.0,收益費損項目合計,喬山,生技醫療業
2024-09-30,1736,InterestIncome,-233714000.0,利息收入,喬山,生技醫療業
2024-12-31,1736,PropertyAndPlantAndEquipment,-673776000.0,取得不動產、廠房及設備,喬山,生技醫療業
2024-12-31,1736,CashBalancesIncrease,345313000.0,本期現金及約當現金增加（減少）數,喬山,生技醫療業
2024-12-31,1736,RedemptionOfBonds,-2000000000.0,償還公司債,喬山,生技醫療業
2024-12-31,1736,CashBalancesEndOfPeriod,2686730000.0,期末現金及約當現金餘額,喬山,生技醫療業
2024-12-31,1736,PayTheInterest,-329744000.0,支付之利息,喬山,生技醫療業
2024-12-31,1736,CashBalancesBeginningOfPeriod,2341417000.0,期初現金及約當現金餘額,喬山,生技醫療業
2024-12-31,1736,CashProvidedByInvestingActivities,-670842000.0,投資活動之淨現金流入（流出）,喬山,生技醫療業
2024-12-31,1736,IncomeBeforeIncomeTaxFromContinuingOperations,3492334000.0,繼續營業單位稅前淨利（淨損）,喬山,生技醫療業
2024-12-31,1736,RepaymentOfLongTermDebt,-15445671000.0,償還長期借款,喬山,生技醫療業
2024-12-31,1736,NetIncomeBeforeTax,3492334000.0,本期稅前淨利（淨損）,喬山,生技醫療業
2024-12-31,1736,CashFlowsFromOperatingActivities,1053553000.0,營業活動之淨現金流入（流出）,喬山,生技醫療業
2024-12-31,1736,Depreciation,1418038000.0,折舊費用,喬山,生技醫療業
2024-12-31,1736,AmortizationExpense,103551000.0,攤銷費用,喬山,生技醫療業
2024-12-31,1736,AccountsPayable,1662342000.0,應付帳款,喬山,生技醫療業
2024-12-31,1736,NetCashInflowFromOperatingActivities,1053553000.0,營業活動之淨現金流入,喬山,生技醫療業
2024-12-31,1736,RentalPrincipalRepayments,-766902000.0,租賃本金償還,喬山,生技醫療業
2024-12-31,1736,InterestExpense,349802000.0,利息費用,喬山,生技醫療業
2024-12-31,1736,ReceivableIncrease,-2816181000.0,應收帳款（增加）減少,喬山,生技醫療業
2024-12-31,1736,InventoryIncrease,-2761204000.0,存貨（增加）減少,喬山,生技醫療業
2024-12-31,1736,CashReceivedThroughOperations,1621056000.0,營運產生之現金流入（流出）,喬山,生技醫療業
2024-12-31,1736,CashFlowsProvidedFromFinancingActivities,-114019000.0,籌資活動之淨現金流入（流出）,喬山,生技醫療業
2024-12-31,1736,DecreaseInShortTermLoans,-39914875000.0,短期借款減少,喬山,生技醫療業
2024-12-31,1736,ProceedsFromLongTermDebt,14165293000.0,舉借長期借款,喬山,生技醫療業
2024-12-31,1736,TotalIncomeLossItems,1750255000.0,收益費損項目合計,喬山,生技醫療業
2024-12-31,1736,InterestIncome,-311517000.0,利息收入,喬山,生技醫療業
2019-03-31,1598,IncomeBeforeIncomeTax,112937000.0,稅前淨利(淨損),岱宇,生技醫療業
2019-03-31,1598,NetIncome,83508000.0,本期淨利(淨損),岱宇,生技醫療業
2019-03-31,1598,OperatingExpenses,406888000.0,營業費用,岱宇,生技醫療業
2019-03-31,1598,TAX,29429000.0,所得稅費用（利益）,岱宇,生技醫療業
2019-03-31,1598,IncomeLossFromDiscontinuedOperation,0.0,停業單位損益,岱宇,生技醫療業
2019-03-31,1598,EPS,0.65,基本每股盈餘（元）,岱宇,生技醫療業
2019-03-31,1598,PreTaxIncome,112937000.0,稅前淨利（淨損）,岱宇,生技醫療業
2019-03-31,1598,IncomeFromContinuingOperations,83508000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2019-03-31,1598,IncomeAfterTaxes,83508000.0,本期淨利（淨損）,岱宇,生技醫療業
2019-03-31,1598,TotalConsolidatedProfitForThePeriod,116017000.0,本期綜合損益總額,岱宇,生技醫療業
2019-03-31,1598,Revenue,1782239000.0,營業收入,岱宇,生技醫療業
2019-03-31,1598,CostOfGoodsSold,1265553000.0,營業成本,岱宇,生技醫療業
2019-03-31,1598,GrossProfit,516686000.0,營業毛利（毛損）淨額,岱宇,生技醫療業
2019-03-31,1598,OTHNOE,13000.0,其他收益及費損淨額,岱宇,生技醫療業
2019-03-31,1598,OperatingIncome,109811000.0,營業利益（損失）,岱宇,生技醫療業
2019-03-31,1598,TotalNonoperatingIncomeAndExpense,3126000.0,營業外收入及支出,岱宇,生技醫療業
2019-03-31,1598,OtherComprehensiveIncome,32509000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2019-03-31,1598,EquityAttributableToOwnersOfParent,57411000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2019-03-31,1598,NoncontrollingInterests,26097000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2019-06-30,1598,IncomeBeforeIncomeTax,-29304000.0,稅前淨利(淨損),岱宇,生技醫療業
2019-06-30,1598,NetIncome,-14855000.0,本期淨利(淨損),岱宇,生技醫療業
2019-06-30,1598,OperatingExpenses,316114000.0,營業費用,岱宇,生技醫療業
2019-06-30,1598,TAX,-14449000.0,所得稅費用（利益）,岱宇,生技醫療業
2019-06-30,1598,EPS,-0.16,基本每股盈餘（元）,岱宇,生技醫療業
2019-06-30,1598,PreTaxIncome,-29304000.0,稅前淨利（淨損）,岱宇,生技醫療業
2019-06-30,1598,IncomeFromContinuingOperations,-14855000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2019-06-30,1598,IncomeAfterTaxes,-14855000.0,本期淨利（淨損）,岱宇,生技醫療業
2019-06-30,1598,TotalConsolidatedProfitForThePeriod,-19862000.0,本期綜合損益總額,岱宇,生技醫療業
2019-06-30,1598,Revenue,1104227000.0,營業收入,岱宇,生技醫療業
2019-06-30,1598,CostOfGoodsSold,833650000.0,營業成本,岱宇,生技醫療業
2019-06-30,1598,GrossProfit,270577000.0,營業毛利（毛損）淨額,岱宇,生技醫療業
2019-06-30,1598,OTHNOE,-214000.0,其他收益及費損淨額,岱宇,生技醫療業
2019-06-30,1598,OperatingIncome,-45751000.0,營業利益（損失）,岱宇,生技醫療業
2019-06-30,1598,TotalNonoperatingIncomeAndExpense,16447000.0,營業外收入及支出,岱宇,生技醫療業
2019-06-30,1598,OtherComprehensiveIncome,-5007000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2019-06-30,1598,EquityAttributableToOwnersOfParent,-11899000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2019-06-30,1598,NoncontrollingInterests,-2956000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2019-09-30,1598,IncomeBeforeIncomeTax,90239000.0,稅前淨利(淨損),岱宇,生技醫療業
2019-09-30,1598,NetIncome,68152000.0,本期淨利(淨損),岱宇,生技醫療業
2019-09-30,1598,OperatingExpenses,316625000.0,營業費用,岱宇,生技醫療業
2019-09-30,1598,TAX,22087000.0,所得稅費用（利益）,岱宇,生技醫療業
2019-09-30,1598,EPS,0.74,基本每股盈餘（元）,岱宇,生技醫療業
2019-09-30,1598,PreTaxIncome,90239000.0,稅前淨利（淨損）,岱宇,生技醫療業
2019-09-30,1598,IncomeFromContinuingOperations,68152000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2019-09-30,1598,IncomeAfterTaxes,68152000.0,本期淨利（淨損）,岱宇,生技醫療業
2019-09-30,1598,TotalConsolidatedProfitForThePeriod,12828000.0,本期綜合損益總額,岱宇,生技醫療業
2019-09-30,1598,Revenue,1285505000.0,營業收入,岱宇,生技醫療業
2019-09-30,1598,CostOfGoodsSold,871033000.0,營業成本,岱宇,生技醫療業
2019-09-30,1598,GrossProfit,414472000.0,營業毛利（毛損）淨額,岱宇,生技醫療業
2019-09-30,1598,OTHNOE,-398000.0,其他收益及費損淨額,岱宇,生技醫療業
2019-09-30,1598,OperatingIncome,97449000.0,營業利益（損失）,岱宇,生技醫療業
2019-09-30,1598,TotalNonoperatingIncomeAndExpense,-7210000.0,營業外收入及支出,岱宇,生技醫療業
2019-09-30,1598,OtherComprehensiveIncome,-55324000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2019-09-30,1598,EquityAttributableToOwnersOfParent,67398000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2019-09-30,1598,NoncontrollingInterests,754000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2019-12-31,1598,IncomeBeforeIncomeTax,104772000.0,稅前淨利(淨損),岱宇,生技醫療業
2019-12-31,1598,NetIncome,83290000.0,本期淨利(淨損),岱宇,生技醫療業
2019-12-31,1598,OperatingExpenses,337736000.0,營業費用,岱宇,生技醫療業
2019-12-31,1598,TAX,21482000.0,所得稅費用（利益）,岱宇,生技醫療業
2019-12-31,1598,EPS,0.82,基本每股盈餘（元）,岱宇,生技醫療業
2019-12-31,1598,PreTaxIncome,104772000.0,稅前淨利（淨損）,岱宇,生技醫療業
2019-12-31,1598,IncomeFromContinuingOperations,83290000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2019-12-31,1598,IncomeAfterTaxes,83290000.0,本期淨利（淨損）,岱宇,生技醫療業
2019-12-31,1598,TotalConsolidatedProfitForThePeriod,67665000.0,本期綜合損益總額,岱宇,生技醫療業
2019-12-31,1598,Revenue,1678557000.0,營業收入,岱宇,生技醫療業
2019-12-31,1598,CostOfGoodsSold,1163893000.0,營業成本,岱宇,生技醫療業
2019-12-31,1598,GrossProfit,514664000.0,營業毛利（毛損）淨額,岱宇,生技醫療業
2019-12-31,1598,OTHNOE,-10732000.0,其他收益及費損淨額,岱宇,生技醫療業
2019-12-31,1598,OperatingIncome,166196000.0,營業利益（損失）,岱宇,生技醫療業
2019-12-31,1598,TotalNonoperatingIncomeAndExpense,-61424000.0,營業外收入及支出,岱宇,生技醫療業
2019-12-31,1598,OtherComprehensiveIncome,-15625000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2019-12-31,1598,EquityAttributableToOwnersOfParent,76091000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2019-12-31,1598,NoncontrollingInterests,7199000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2020-03-31,1598,OperatingExpenses,463218000.0,營業費用,岱宇,生技醫療業
2020-03-31,1598,TAX,-790000.0,所得稅費用（利益）,岱宇,生技醫療業
2020-03-31,1598,EPS,0.01,基本每股盈餘（元）,岱宇,生技醫療業
2020-03-31,1598,PreTaxIncome,4321000.0,稅前淨利（淨損）,岱宇,生技醫療業
2020-03-31,1598,IncomeFromContinuingOperations,5111000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2020-03-31,1598,IncomeAfterTaxes,5111000.0,本期淨利（淨損）,岱宇,生技醫療業
2020-03-31,1598,TotalConsolidatedProfitForThePeriod,-14876000.0,本期綜合損益總額,岱宇,生技醫療業
2020-03-31,1598,Revenue,1647801000.0,營業收入,岱宇,生技醫療業
2020-03-31,1598,CostOfGoodsSold,1185779000.0,營業成本,岱宇,生技醫療業
2020-03-31,1598,GrossProfit,462022000.0,營業毛利（毛損）淨額,岱宇,生技醫療業
2020-03-31,1598,OTHNOE,43000.0,其他收益及費損淨額,岱宇,生技醫療業
2020-03-31,1598,OperatingIncome,-1153000.0,營業利益（損失）,岱宇,生技醫療業
2020-03-31,1598,TotalNonoperatingIncomeAndExpense,5474000.0,營業外收入及支出,岱宇,生技醫療業
2020-03-31,1598,OtherComprehensiveIncome,-19987000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2020-03-31,1598,EquityAttributableToOwnersOfParent,592000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2020-03-31,1598,NoncontrollingInterests,4519000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2020-06-30,1598,OperatingExpenses,837110000.0,營業費用,岱宇,生技醫療業
2020-06-30,1598,TAX,79429000.0,所得稅費用（利益）,岱宇,生技醫療業
2020-06-30,1598,EPS,1.77,基本每股盈餘（元）,岱宇,生技醫療業
2020-06-30,1598,PreTaxIncome,265887000.0,稅前淨利（淨損）,岱宇,生技醫療業
2020-06-30,1598,IncomeFromContinuingOperations,186458000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2020-06-30,1598,IncomeAfterTaxes,186458000.0,本期淨利（淨損）,岱宇,生技醫療業
2020-06-30,1598,TotalConsolidatedProfitForThePeriod,145203000.0,本期綜合損益總額,岱宇,生技醫療業
2020-06-30,1598,Revenue,2508224000.0,營業收入,岱宇,生技醫療業
2020-06-30,1598,CostOfGoodsSold,1376202000.0,營業成本,岱宇,生技醫療業
2020-06-30,1598,GrossProfit,1132022000.0,營業毛利（毛損）淨額,岱宇,生技醫療業
2020-06-30,1598,OTHNOE,35000.0,其他收益及費損淨額,岱宇,生技醫療業
2020-06-30,1598,OperatingIncome,294947000.0,營業利益（損失）,岱宇,生技醫療業
2020-06-30,1598,TotalNonoperatingIncomeAndExpense,-29060000.0,營業外收入及支出,岱宇,生技醫療業
2020-06-30,1598,OtherComprehensiveIncome,-41255000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2020-06-30,1598,EquityAttributableToOwnersOfParent,189180000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2020-06-30,1598,NoncontrollingInterests,-2722000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2020-09-30,1598,OperatingExpenses,976732000.0,營業費用,岱宇,生技醫療業
2020-09-30,1598,TAX,195365000.0,所得稅費用（利益）,岱宇,生技醫療業
2020-09-30,1598,EPS,3.84,基本每股盈餘（元）,岱宇,生技醫療業
2020-09-30,1598,PreTaxIncome,617037000.0,稅前淨利（淨損）,岱宇,生技醫療業
2020-09-30,1598,IncomeFromContinuingOperations,421672000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2020-09-30,1598,IncomeAfterTaxes,421672000.0,本期淨利（淨損）,岱宇,生技醫療業
2020-09-30,1598,TotalConsolidatedProfitForThePeriod,411930000.0,本期綜合損益總額,岱宇,生技醫療業
2020-09-30,1598,Revenue,3575476000.0,營業收入,岱宇,生技醫療業
2020-09-30,1598,CostOfGoodsSold,1904282000.0,營業成本,岱宇,生技醫療業
2020-09-30,1598,GrossProfit,1671194000.0,營業毛利（毛損）淨額,岱宇,生技醫療業
2020-09-30,1598,OTHNOE,-5820000.0,其他收益及費損淨額,岱宇,生技醫療業
2020-09-30,1598,OperatingIncome,688642000.0,營業利益（損失）,岱宇,生技醫療業
2020-09-30,1598,TotalNonoperatingIncomeAndExpense,-71605000.0,營業外收入及支出,岱宇,生技醫療業
2020-09-30,1598,OtherComprehensiveIncome,-9742000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2020-09-30,1598,EquityAttributableToOwnersOfParent,424523000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2020-09-30,1598,NoncontrollingInterests,-2851000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2020-12-31,1598,OperatingExpenses,1367513000.0,營業費用,岱宇,生技醫療業
2020-12-31,1598,TAX,62844000.0,所得稅費用（利益）,岱宇,生技醫療業
2020-12-31,1598,EPS,6.07,基本每股盈餘（元）,岱宇,生技醫療業
2020-12-31,1598,PreTaxIncome,767659000.0,稅前淨利（淨損）,岱宇,生技醫療業
2020-12-31,1598,IncomeFromContinuingOperations,704815000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2020-12-31,1598,IncomeAfterTaxes,704815000.0,本期淨利（淨損）,岱宇,生技醫療業
2020-12-31,1598,TotalConsolidatedProfitForThePeriod,714705000.0,本期綜合損益總額,岱宇,生技醫療業
2020-12-31,1598,Revenue,5392255000.0,營業收入,岱宇,生技醫療業
2020-12-31,1598,CostOfGoodsSold,3173174000.0,營業成本,岱宇,生技醫療業
2020-12-31,1598,GrossProfit,2219081000.0,營業毛利（毛損）淨額,岱宇,生技醫療業
2020-12-31,1598,OTHNOE,18906000.0,其他收益及費損淨額,岱宇,生技醫療業
2020-12-31,1598,OperatingIncome,870474000.0,營業利益（損失）,岱宇,生技醫療業
2020-12-31,1598,TotalNonoperatingIncomeAndExpense,-102815000.0,營業外收入及支出,岱宇,生技醫療業
2020-12-31,1598,OtherComprehensiveIncome,9890000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2020-12-31,1598,EquityAttributableToOwnersOfParent,706814000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2020-12-31,1598,NoncontrollingInterests,-1999000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2021-03-31,1598,OperatingExpenses,1047581000.0,營業費用,岱宇,生技醫療業
2021-03-31,1598,TAX,64896000.0,所得稅費用（利益）,岱宇,生技醫療業
2021-03-31,1598,EPS,2.1,基本每股盈餘（元）,岱宇,生技醫療業
2021-03-31,1598,PreTaxIncome,333088000.0,稅前淨利（淨損）,岱宇,生技醫療業
2021-03-31,1598,IncomeFromContinuingOperations,268192000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2021-03-31,1598,IncomeAfterTaxes,268192000.0,本期淨利（淨損）,岱宇,生技醫療業
2021-03-31,1598,TotalConsolidatedProfitForThePeriod,259573000.0,本期綜合損益總額,岱宇,生技醫療業
2021-03-31,1598,Revenue,3838107000.0,營業收入,岱宇,生技醫療業
2021-03-31,1598,CostOfGoodsSold,2454600000.0,營業成本,岱宇,生技醫療業
2021-03-31,1598,OTHNOE,165000.0,其他收益及費損淨額,岱宇,生技醫療業
2021-03-31,1598,OperatingIncome,336091000.0,營業利益（損失）,岱宇,生技醫療業
2021-03-31,1598,TotalNonoperatingIncomeAndExpense,-3003000.0,營業外收入及支出,岱宇,生技醫療業
2021-03-31,1598,OtherComprehensiveIncome,-8619000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2021-03-31,1598,GrossProfit,1383507000.0,營業毛利（毛損）,岱宇,生技醫療業
2021-03-31,1598,EquityAttributableToOwnersOfParent,264788000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2021-03-31,1598,NoncontrollingInterests,3404000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2021-03-31,1598,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,301000.0,綜合損益總額歸屬於非控制權益,岱宇,生技醫療業
2021-06-30,1598,OperatingExpenses,755807000.0,營業費用,岱宇,生技醫療業
2021-06-30,1598,TAX,14337000.0,所得稅費用（利益）,岱宇,生技醫療業
2021-06-30,1598,PreTaxIncome,55238000.0,稅前淨利（淨損）,岱宇,生技醫療業
2021-06-30,1598,IncomeFromContinuingOperations,40901000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2021-06-30,1598,IncomeAfterTaxes,40901000.0,本期淨利（淨損）,岱宇,生技醫療業
2021-06-30,1598,TotalConsolidatedProfitForThePeriod,1382000.0,本期綜合損益總額,岱宇,生技醫療業
2021-06-30,1598,Revenue,2774180000.0,營業收入,岱宇,生技醫療業
2021-06-30,1598,CostOfGoodsSold,1830054000.0,營業成本,岱宇,生技醫療業
2021-06-30,1598,OTHNOE,-2027000.0,其他收益及費損淨額,岱宇,生技醫療業
2021-06-30,1598,OperatingIncome,186292000.0,營業利益（損失）,岱宇,生技醫療業
2021-06-30,1598,TotalNonoperatingIncomeAndExpense,-131054000.0,營業外收入及支出,岱宇,生技醫療業
2021-06-30,1598,OtherComprehensiveIncome,-39519000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2021-06-30,1598,GrossProfit,944126000.0,營業毛利（毛損）,岱宇,生技醫療業
2021-06-30,1598,EquityAttributableToOwnersOfParent,50910000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2021-06-30,1598,NoncontrollingInterests,-10009000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2021-06-30,1598,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-11924000.0,綜合損益總額歸屬於非控制權益,岱宇,生技醫療業
2021-06-30,1598,EPS,0.39,基本每股盈餘（元）,岱宇,生技醫療業
2021-09-30,1598,OperatingExpenses,633571000.0,營業費用,岱宇,生技醫療業
2021-09-30,1598,TAX,41820000.0,所得稅費用（利益）,岱宇,生技醫療業
2021-09-30,1598,PreTaxIncome,149509000.0,稅前淨利（淨損）,岱宇,生技醫療業
2021-09-30,1598,IncomeFromContinuingOperations,107689000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2021-09-30,1598,IncomeAfterTaxes,107689000.0,本期淨利（淨損）,岱宇,生技醫療業
2021-09-30,1598,TotalConsolidatedProfitForThePeriod,99212000.0,本期綜合損益總額,岱宇,生技醫療業
2021-09-30,1598,Revenue,2436261000.0,營業收入,岱宇,生技醫療業
2021-09-30,1598,CostOfGoodsSold,1615886000.0,營業成本,岱宇,生技醫療業
2021-09-30,1598,OTHNOE,-164000.0,其他收益及費損淨額,岱宇,生技醫療業
2021-09-30,1598,OperatingIncome,186640000.0,營業利益（損失）,岱宇,生技醫療業
2021-09-30,1598,TotalNonoperatingIncomeAndExpense,-37131000.0,營業外收入及支出,岱宇,生技醫療業
2021-09-30,1598,OtherComprehensiveIncome,-8477000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2021-09-30,1598,GrossProfit,820375000.0,營業毛利（毛損）,岱宇,生技醫療業
2021-09-30,1598,EquityAttributableToOwnersOfParent,110683000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2021-09-30,1598,NoncontrollingInterests,-2994000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2021-09-30,1598,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-3198000.0,綜合損益總額歸屬於非控制權益,岱宇,生技醫療業
2021-09-30,1598,EPS,0.87,基本每股盈餘（元）,岱宇,生技醫療業
2021-12-31,1598,OperatingExpenses,831773000.0,營業費用,岱宇,生技醫療業
2021-12-31,1598,TAX,-16097000.0,所得稅費用（利益）,岱宇,生技醫療業
2021-12-31,1598,PreTaxIncome,11311000.0,稅前淨利（淨損）,岱宇,生技醫療業
2021-12-31,1598,IncomeFromContinuingOperations,27408000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2021-12-31,1598,IncomeAfterTaxes,27408000.0,本期淨利（淨損）,岱宇,生技醫療業
2021-12-31,1598,TotalConsolidatedProfitForThePeriod,20890000.0,本期綜合損益總額,岱宇,生技醫療業
2021-12-31,1598,Revenue,2693533000.0,營業收入,岱宇,生技醫療業
2021-12-31,1598,CostOfGoodsSold,1784139000.0,營業成本,岱宇,生技醫療業
2021-12-31,1598,OTHNOE,-814000.0,其他收益及費損淨額,岱宇,生技醫療業
2021-12-31,1598,OperatingIncome,76807000.0,營業利益（損失）,岱宇,生技醫療業
2021-12-31,1598,TotalNonoperatingIncomeAndExpense,-65496000.0,營業外收入及支出,岱宇,生技醫療業
2021-12-31,1598,OtherComprehensiveIncome,-6518000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2021-12-31,1598,EquityAttributableToOwnersOfParent,14467000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2021-12-31,1598,NoncontrollingInterests,12941000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2021-12-31,1598,GrossProfit,909394000.0,營業毛利（毛損）,岱宇,生技醫療業
2021-12-31,1598,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,16843000.0,綜合損益總額歸屬於非控制權益,岱宇,生技醫療業
2021-12-31,1598,EPS,0.12,基本每股盈餘（元）,岱宇,生技醫療業
2022-03-31,1598,OperatingExpenses,714885000.0,營業費用,岱宇,生技醫療業
2022-03-31,1598,TAX,13217000.0,所得稅費用（利益）,岱宇,生技醫療業
2022-03-31,1598,EPS,-0.34,基本每股盈餘（元）,岱宇,生技醫療業
2022-03-31,1598,PreTaxIncome,-29477000.0,稅前淨利（淨損）,岱宇,生技醫療業
2022-03-31,1598,IncomeFromContinuingOperations,-42694000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2022-03-31,1598,IncomeAfterTaxes,-42694000.0,本期淨利（淨損）,岱宇,生技醫療業
2022-03-31,1598,TotalConsolidatedProfitForThePeriod,51104000.0,本期綜合損益總額,岱宇,生技醫療業
2022-03-31,1598,Revenue,2260681000.0,營業收入,岱宇,生技醫療業
2022-03-31,1598,CostOfGoodsSold,1650703000.0,營業成本,岱宇,生技醫療業
2022-03-31,1598,OTHNOE,217000.0,其他收益及費損淨額,岱宇,生技醫療業
2022-03-31,1598,OperatingIncome,-104690000.0,營業利益（損失）,岱宇,生技醫療業
2022-03-31,1598,TotalNonoperatingIncomeAndExpense,75213000.0,營業外收入及支出,岱宇,生技醫療業
2022-03-31,1598,OtherComprehensiveIncome,93798000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2022-03-31,1598,EquityAttributableToOwnersOfParent,-43687000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2022-03-31,1598,NoncontrollingInterests,993000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2022-03-31,1598,GrossProfit,609978000.0,營業毛利（毛損）,岱宇,生技醫療業
2022-03-31,1598,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,15559000.0,綜合損益總額歸屬於非控制權益,岱宇,生技醫療業
2022-06-30,1598,OperatingExpenses,565984000.0,營業費用,岱宇,生技醫療業
2022-06-30,1598,TAX,-12992000.0,所得稅費用（利益）,岱宇,生技醫療業
2022-06-30,1598,PreTaxIncome,-85227000.0,稅前淨利（淨損）,岱宇,生技醫療業
2022-06-30,1598,IncomeFromContinuingOperations,-72235000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2022-06-30,1598,IncomeAfterTaxes,-72235000.0,本期淨利（淨損）,岱宇,生技醫療業
2022-06-30,1598,TotalConsolidatedProfitForThePeriod,-55775000.0,本期綜合損益總額,岱宇,生技醫療業
2022-06-30,1598,Revenue,1379277000.0,營業收入,岱宇,生技醫療業
2022-06-30,1598,CostOfGoodsSold,1046617000.0,營業成本,岱宇,生技醫療業
2022-06-30,1598,OTHNOE,-56000.0,其他收益及費損淨額,岱宇,生技醫療業
2022-06-30,1598,OperatingIncome,-233380000.0,營業利益（損失）,岱宇,生技醫療業
2022-06-30,1598,TotalNonoperatingIncomeAndExpense,148153000.0,營業外收入及支出,岱宇,生技醫療業
2022-06-30,1598,OtherComprehensiveIncome,16460000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2022-06-30,1598,GrossProfit,332660000.0,營業毛利（毛損）,岱宇,生技醫療業
2022-06-30,1598,EquityAttributableToOwnersOfParent,-61738000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2022-06-30,1598,NoncontrollingInterests,-10497000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2022-06-30,1598,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-20245000.0,綜合損益總額歸屬於非控制權益,岱宇,生技醫療業
2022-06-30,1598,EPS,-0.49,基本每股盈餘（元）,岱宇,生技醫療業
2022-09-30,1598,OperatingExpenses,549308000.0,營業費用,岱宇,生技醫療業
2022-09-30,1598,TAX,1078000.0,所得稅費用（利益）,岱宇,生技醫療業
2022-09-30,1598,EPS,0.6,基本每股盈餘（元）,岱宇,生技醫療業
2022-09-30,1598,PreTaxIncome,71621000.0,稅前淨利（淨損）,岱宇,生技醫療業
2022-09-30,1598,IncomeFromContinuingOperations,70543000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2022-09-30,1598,IncomeAfterTaxes,70543000.0,本期淨利（淨損）,岱宇,生技醫療業
2022-09-30,1598,TotalConsolidatedProfitForThePeriod,133330000.0,本期綜合損益總額,岱宇,生技醫療業
2022-09-30,1598,Revenue,1386397000.0,營業收入,岱宇,生技醫療業
2022-09-30,1598,CostOfGoodsSold,979735000.0,營業成本,岱宇,生技醫療業
2022-09-30,1598,OTHNOE,-28248000.0,其他收益及費損淨額,岱宇,生技醫療業
2022-09-30,1598,OperatingIncome,-170894000.0,營業利益（損失）,岱宇,生技醫療業
2022-09-30,1598,TotalNonoperatingIncomeAndExpense,242515000.0,營業外收入及支出,岱宇,生技醫療業
2022-09-30,1598,OtherComprehensiveIncome,62787000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2022-09-30,1598,EquityAttributableToOwnersOfParent,76690000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2022-09-30,1598,NoncontrollingInterests,-6147000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2022-09-30,1598,GrossProfit,406662000.0,營業毛利（毛損）,岱宇,生技醫療業
2022-09-30,1598,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-7003000.0,綜合損益總額歸屬於非控制權益,岱宇,生技醫療業
2022-12-31,1598,OperatingExpenses,611561000.0,營業費用,岱宇,生技醫療業
2022-12-31,1598,TAX,12319000.0,所得稅費用（利益）,岱宇,生技醫療業
2022-12-31,1598,EPS,-0.38,基本每股盈餘（元）,岱宇,生技醫療業
2022-12-31,1598,PreTaxIncome,-37978000.0,稅前淨利（淨損）,岱宇,生技醫療業
2022-12-31,1598,IncomeFromContinuingOperations,-50297000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2022-12-31,1598,IncomeAfterTaxes,-50297000.0,本期淨利（淨損）,岱宇,生技醫療業
2022-12-31,1598,TotalConsolidatedProfitForThePeriod,-109257000.0,本期綜合損益總額,岱宇,生技醫療業
2022-12-31,1598,Revenue,2096056000.0,營業收入,岱宇,生技醫療業
2022-12-31,1598,CostOfGoodsSold,1360201000.0,營業成本,岱宇,生技醫療業
2022-12-31,1598,OTHNOE,440000.0,其他收益及費損淨額,岱宇,生技醫療業
2022-12-31,1598,OperatingIncome,124734000.0,營業利益（損失）,岱宇,生技醫療業
2022-12-31,1598,TotalNonoperatingIncomeAndExpense,-162712000.0,營業外收入及支出,岱宇,生技醫療業
2022-12-31,1598,OtherComprehensiveIncome,-58960000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2022-12-31,1598,GrossProfit,735855000.0,營業毛利（毛損）,岱宇,生技醫療業
2022-12-31,1598,EquityAttributableToOwnersOfParent,-47394000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2022-12-31,1598,NoncontrollingInterests,-2903000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2022-12-31,1598,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-6751000.0,綜合損益總額歸屬於非控制權益,岱宇,生技醫療業
2023-03-31,1598,OperatingExpenses,763604000.0,營業費用,岱宇,生技醫療業
2023-03-31,1598,TAX,1896000.0,所得稅費用（利益）,岱宇,生技醫療業
2023-03-31,1598,EPS,-0.9,基本每股盈餘（元）,岱宇,生技醫療業
2023-03-31,1598,PreTaxIncome,-78105000.0,稅前淨利（淨損）,岱宇,生技醫療業
2023-03-31,1598,IncomeFromContinuingOperations,-80001000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2023-03-31,1598,IncomeAfterTaxes,-80001000.0,本期淨利（淨損）,岱宇,生技醫療業
2023-03-31,1598,TotalConsolidatedProfitForThePeriod,-82221000.0,本期綜合損益總額,岱宇,生技醫療業
2023-03-31,1598,Revenue,2245561000.0,營業收入,岱宇,生技醫療業
2023-03-31,1598,CostOfGoodsSold,1520847000.0,營業成本,岱宇,生技醫療業
2023-03-31,1598,OTHNOE,-6000.0,其他收益及費損淨額,岱宇,生技醫療業
2023-03-31,1598,OperatingIncome,-38896000.0,營業利益（損失）,岱宇,生技醫療業
2023-03-31,1598,TotalNonoperatingIncomeAndExpense,-39209000.0,營業外收入及支出,岱宇,生技醫療業
2023-03-31,1598,OtherComprehensiveIncome,-2220000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2023-03-31,1598,EquityAttributableToOwnersOfParent,-112560000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2023-03-31,1598,NoncontrollingInterests,32559000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2023-03-31,1598,GrossProfit,724714000.0,營業毛利（毛損）,岱宇,生技醫療業
2023-03-31,1598,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,36106000.0,綜合損益總額歸屬於非控制權益,岱宇,生技醫療業
2023-06-30,1598,OperatingExpenses,694307000.0,營業費用,岱宇,生技醫療業
2023-06-30,1598,TAX,-37953000.0,所得稅費用（利益）,岱宇,生技醫療業
2023-06-30,1598,PreTaxIncome,-89445000.0,稅前淨利（淨損）,岱宇,生技醫療業
2023-06-30,1598,IncomeFromContinuingOperations,-51492000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2023-06-30,1598,IncomeAfterTaxes,-51492000.0,本期淨利（淨損）,岱宇,生技醫療業
2023-06-30,1598,TotalConsolidatedProfitForThePeriod,-42284000.0,本期綜合損益總額,岱宇,生技醫療業
2023-06-30,1598,Revenue,1499737000.0,營業收入,岱宇,生技醫療業
2023-06-30,1598,CostOfGoodsSold,987809000.0,營業成本,岱宇,生技醫療業
2023-06-30,1598,OTHNOE,-180000.0,其他收益及費損淨額,岱宇,生技醫療業
2023-06-30,1598,OperatingIncome,-182559000.0,營業利益（損失）,岱宇,生技醫療業
2023-06-30,1598,TotalNonoperatingIncomeAndExpense,93114000.0,營業外收入及支出,岱宇,生技醫療業
2023-06-30,1598,OtherComprehensiveIncome,9208000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2023-06-30,1598,GrossProfit,511928000.0,營業毛利（毛損）,岱宇,生技醫療業
2023-06-30,1598,EquityAttributableToOwnersOfParent,-37098000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2023-06-30,1598,NoncontrollingInterests,-14394000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2023-06-30,1598,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-30867000.0,綜合損益總額歸屬於非控制權益,岱宇,生技醫療業
2023-06-30,1598,EPS,-0.28,基本每股盈餘（元）,岱宇,生技醫療業
2023-09-30,1598,OperatingExpenses,696958000.0,營業費用,岱宇,生技醫療業
2023-09-30,1598,TAX,-24147000.0,所得稅費用（利益）,岱宇,生技醫療業
2023-09-30,1598,PreTaxIncome,-28581000.0,稅前淨利（淨損）,岱宇,生技醫療業
2023-09-30,1598,IncomeFromContinuingOperations,-4434000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2023-09-30,1598,IncomeAfterTaxes,-4434000.0,本期淨利（淨損）,岱宇,生技醫療業
2023-09-30,1598,TotalConsolidatedProfitForThePeriod,83149000.0,本期綜合損益總額,岱宇,生技醫療業
2023-09-30,1598,Revenue,1665463000.0,營業收入,岱宇,生技醫療業
2023-09-30,1598,CostOfGoodsSold,1070159000.0,營業成本,岱宇,生技醫療業
2023-09-30,1598,OTHNOE,-51000.0,其他收益及費損淨額,岱宇,生技醫療業
2023-09-30,1598,OperatingIncome,-101705000.0,營業利益（損失）,岱宇,生技醫療業
2023-09-30,1598,TotalNonoperatingIncomeAndExpense,73124000.0,營業外收入及支出,岱宇,生技醫療業
2023-09-30,1598,OtherComprehensiveIncome,87583000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2023-09-30,1598,GrossProfit,595304000.0,營業毛利（毛損）,岱宇,生技醫療業
2023-09-30,1598,EquityAttributableToOwnersOfParent,24936000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2023-09-30,1598,NoncontrollingInterests,-29370000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2023-09-30,1598,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-17892000.0,綜合損益總額歸屬於非控制權益,岱宇,生技醫療業
2023-09-30,1598,EPS,0.26,基本每股盈餘（元）,岱宇,生技醫療業
2023-12-31,1598,OperatingExpenses,610639000.0,營業費用,岱宇,生技醫療業
2023-12-31,1598,TAX,1145000.0,所得稅費用（利益）,岱宇,生技醫療業
2023-12-31,1598,PreTaxIncome,26700000.0,稅前淨利（淨損）,岱宇,生技醫療業
2023-12-31,1598,IncomeFromContinuingOperations,25555000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2023-12-31,1598,IncomeAfterTaxes,25555000.0,本期淨利（淨損）,岱宇,生技醫療業
2023-12-31,1598,TotalConsolidatedProfitForThePeriod,-72321000.0,本期綜合損益總額,岱宇,生技醫療業
2023-12-31,1598,Revenue,2375710000.0,營業收入,岱宇,生技醫療業
2023-12-31,1598,CostOfGoodsSold,1540571000.0,營業成本,岱宇,生技醫療業
2023-12-31,1598,OTHNOE,-945000.0,其他收益及費損淨額,岱宇,生技醫療業
2023-12-31,1598,OperatingIncome,223555000.0,營業利益（損失）,岱宇,生技醫療業
2023-12-31,1598,TotalNonoperatingIncomeAndExpense,-196855000.0,營業外收入及支出,岱宇,生技醫療業
2023-12-31,1598,OtherComprehensiveIncome,-97876000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2023-12-31,1598,GrossProfit,835139000.0,營業毛利（毛損）,岱宇,生技醫療業
2023-12-31,1598,EquityAttributableToOwnersOfParent,1952000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2023-12-31,1598,NoncontrollingInterests,23603000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2023-12-31,1598,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,17529000.0,綜合損益總額歸屬於非控制權益,岱宇,生技醫療業
2023-12-31,1598,EPS,0.04,基本每股盈餘（元）,岱宇,生技醫療業
2024-03-31,1598,OperatingExpenses,667961000.0,營業費用,岱宇,生技醫療業
2024-03-31,1598,TAX,-1377000.0,所得稅費用（利益）,岱宇,生技醫療業
2024-03-31,1598,EPS,0.22,基本每股盈餘（元）,岱宇,生技醫療業
2024-03-31,1598,PreTaxIncome,26471000.0,稅前淨利（淨損）,岱宇,生技醫療業
2024-03-31,1598,IncomeFromContinuingOperations,27848000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2024-03-31,1598,IncomeAfterTaxes,27848000.0,本期淨利（淨損）,岱宇,生技醫療業
2024-03-31,1598,TotalConsolidatedProfitForThePeriod,109575000.0,本期綜合損益總額,岱宇,生技醫療業
2024-03-31,1598,Revenue,1764036000.0,營業收入,岱宇,生技醫療業
2024-03-31,1598,CostOfGoodsSold,1179145000.0,營業成本,岱宇,生技醫療業
2024-03-31,1598,OTHNOE,-291000.0,其他收益及費損淨額,岱宇,生技醫療業
2024-03-31,1598,OperatingIncome,-83361000.0,營業利益（損失）,岱宇,生技醫療業
2024-03-31,1598,TotalNonoperatingIncomeAndExpense,109832000.0,營業外收入及支出,岱宇,生技醫療業
2024-03-31,1598,OtherComprehensiveIncome,81727000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2024-03-31,1598,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-2212000.0,綜合損益總額歸屬於非控制權益,岱宇,生技醫療業
2024-03-31,1598,NoncontrollingInterests,-4868000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2024-03-31,1598,EquityAttributableToOwnersOfParent,32716000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2024-03-31,1598,GrossProfit,584891000.0,營業毛利（毛損）,岱宇,生技醫療業
2024-06-30,1598,OperatingExpenses,561071000.0,營業費用,岱宇,生技醫療業
2024-06-30,1598,TAX,-21143000.0,所得稅費用（利益）,岱宇,生技醫療業
2024-06-30,1598,EPS,-0.71,基本每股盈餘（元）,岱宇,生技醫療業
2024-06-30,1598,PreTaxIncome,-135834000.0,稅前淨利（淨損）,岱宇,生技醫療業
2024-06-30,1598,IncomeFromContinuingOperations,-114691000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2024-06-30,1598,IncomeAfterTaxes,-114691000.0,本期淨利（淨損）,岱宇,生技醫療業
2024-06-30,1598,TotalConsolidatedProfitForThePeriod,-76997000.0,本期綜合損益總額,岱宇,生技醫療業
2024-06-30,1598,Revenue,1499287000.0,營業收入,岱宇,生技醫療業
2024-06-30,1598,CostOfGoodsSold,985410000.0,營業成本,岱宇,生技醫療業
2024-06-30,1598,OperatingIncome,-46903000.0,營業利益（損失）,岱宇,生技醫療業
2024-06-30,1598,TotalNonoperatingIncomeAndExpense,-88931000.0,營業外收入及支出,岱宇,生技醫療業
2024-06-30,1598,OtherComprehensiveIncome,37694000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2024-06-30,1598,NoncontrollingInterests,-8523000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2024-06-30,1598,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-2336000.0,綜合損益總額歸屬於非控制權益,岱宇,生技醫療業
2024-06-30,1598,GrossProfit,513877000.0,營業毛利（毛損）,岱宇,生技醫療業
2024-06-30,1598,EquityAttributableToOwnersOfParent,-106168000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2024-09-30,1598,OperatingExpenses,611364000.0,營業費用,岱宇,生技醫療業
2024-09-30,1598,TAX,418000.0,所得稅費用（利益）,岱宇,生技醫療業
2024-09-30,1598,EPS,-0.81,基本每股盈餘（元）,岱宇,生技醫療業
2024-09-30,1598,PreTaxIncome,-137940000.0,稅前淨利（淨損）,岱宇,生技醫療業
2024-09-30,1598,IncomeFromContinuingOperations,-138358000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2024-09-30,1598,IncomeAfterTaxes,-138358000.0,本期淨利（淨損）,岱宇,生技醫療業
2024-09-30,1598,TotalConsolidatedProfitForThePeriod,-144801000.0,本期綜合損益總額,岱宇,生技醫療業
2024-09-30,1598,Revenue,1586368000.0,營業收入,岱宇,生技醫療業
2024-09-30,1598,CostOfGoodsSold,1045604000.0,營業成本,岱宇,生技醫療業
2024-09-30,1598,OperatingIncome,-70600000.0,營業利益（損失）,岱宇,生技醫療業
2024-09-30,1598,TotalNonoperatingIncomeAndExpense,-67340000.0,營業外收入及支出,岱宇,生技醫療業
2024-09-30,1598,OtherComprehensiveIncome,-6443000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2024-09-30,1598,NoncontrollingInterests,-6265000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2024-09-30,1598,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,2092000.0,綜合損益總額歸屬於非控制權益,岱宇,生技醫療業
2024-09-30,1598,GrossProfit,540764000.0,營業毛利（毛損）,岱宇,生技醫療業
2024-09-30,1598,EquityAttributableToOwnersOfParent,-132093000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2024-12-31,1598,OperatingExpenses,706981000.0,營業費用,岱宇,生技醫療業
2024-12-31,1598,TAX,31056000.0,所得稅費用（利益）,岱宇,生技醫療業
2024-12-31,1598,EPS,1.75,基本每股盈餘（元）,岱宇,生技醫療業
2024-12-31,1598,PreTaxIncome,326140000.0,稅前淨利（淨損）,岱宇,生技醫療業
2024-12-31,1598,IncomeFromContinuingOperations,295084000.0,繼續營業單位本期淨利（淨損）,岱宇,生技醫療業
2024-12-31,1598,IncomeAfterTaxes,295084000.0,本期淨利（淨損）,岱宇,生技醫療業
2024-12-31,1598,TotalConsolidatedProfitForThePeriod,293021000.0,本期綜合損益總額,岱宇,生技醫療業
2024-12-31,1598,Revenue,2367386000.0,營業收入,岱宇,生技醫療業
2024-12-31,1598,CostOfGoodsSold,1429667000.0,營業成本,岱宇,生技醫療業
2024-12-31,1598,OperatingIncome,230738000.0,營業利益（損失）,岱宇,生技醫療業
2024-12-31,1598,TotalNonoperatingIncomeAndExpense,95402000.0,營業外收入及支出,岱宇,生技醫療業
2024-12-31,1598,OtherComprehensiveIncome,-2063000.0,其他綜合損益（淨額）,岱宇,生技醫療業
2024-12-31,1598,NoncontrollingInterests,17587000.0,淨利（淨損）歸屬於非控制權益,岱宇,生技醫療業
2024-12-31,1598,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,11003000.0,綜合損益總額歸屬於非控制權益,岱宇,生技醫療業
2024-12-31,1598,GrossProfit,937719000.0,營業毛利（毛損）,岱宇,生技醫療業
2024-12-31,1598,EquityAttributableToOwnersOfParent,277497000.0,淨利（淨損）歸屬於母公司業主,岱宇,生技醫療業
2019-03-31,1598,AccountsPayable,722415000.0,應付帳款,岱宇,生技醫療業
2019-03-31,1598,AccountsPayable_per,10.36,應付帳款,岱宇,生技醫療業
2019-03-31,1598,AccountsPayableToRelatedParties,0.0,應付帳款－關係人,岱宇,生技醫療業
2019-03-31,1598,AccountsPayableToRelatedParties_per,0.0,應付帳款－關係人,岱宇,生技醫療業
2019-03-31,1598,AccountsReceivableDuefromRelatedPartiesNet,0.0,應收帳款－關係人淨額,岱宇,生技醫療業
2019-03-31,1598,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,岱宇,生技醫療業
2019-03-31,1598,AccountsReceivableNet_per,15.64,應收帳款淨額,岱宇,生技醫療業
2019-03-31,1598,BondsPayable,0.0,應付公司債,岱宇,生技醫療業
2019-03-31,1598,BondsPayable_per,0.0,應付公司債,岱宇,生技醫療業
2019-03-31,1598,CapitalStock,929502000.0,股本合計,岱宇,生技醫療業
2019-03-31,1598,CapitalStock_per,13.33,股本合計,岱宇,生技醫療業
2019-03-31,1598,CapitalSurplus,742399000.0,資本公積合計,岱宇,生技醫療業
2019-03-31,1598,CapitalSurplus_per,10.64,資本公積合計,岱宇,生技醫療業
2019-03-31,1598,CapitalSurplusAdditionalPaidInCapital,742399000.0,資本公積－發行溢價,岱宇,生技醫療業
2019-03-31,1598,CapitalSurplusAdditionalPaidInCapital_per,10.64,資本公積－發行溢價,岱宇,生技醫療業
2019-03-31,1598,CapitalSurplusDonatedAssetsReceived,0.0,資本公積－受贈資產,岱宇,生技醫療業
2019-03-31,1598,CapitalSurplusDonatedAssetsReceived_per,0.0,資本公積－受贈資產,岱宇,生技醫療業
2019-03-31,1598,CashAndCashEquivalents,605635000.0,現金及約當現金,岱宇,生技醫療業
2019-03-31,1598,CashAndCashEquivalents_per,8.68,現金及約當現金,岱宇,生技醫療業
2019-03-31,1598,CurrentAssets_per,43.76,流動資產合計,岱宇,生技醫療業
2019-03-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,835000.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2019-03-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.01,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2019-03-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,2386000.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2019-03-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.03,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2019-03-31,1598,CurrentIncomeTaxAssets,33783000.0,本期所得稅資產,岱宇,生技醫療業
2019-03-31,1598,CurrentIncomeTaxAssets_per,0.48,本期所得稅資產,岱宇,生技醫療業
2019-03-31,1598,CurrentLiabilities_per,52.13,流動負債合計,岱宇,生技醫療業
2019-03-31,1598,CurrentProvisions,14870000.0,負債準備－流動,岱宇,生技醫療業
2019-03-31,1598,CurrentProvisions_per,0.21,負債準備－流動,岱宇,生技醫療業
2019-03-31,1598,DeferredTaxAssets,155727000.0,遞延所得稅資產,岱宇,生技醫療業
2019-03-31,1598,DeferredTaxAssets_per,2.23,遞延所得稅資產,岱宇,生技醫療業
2019-03-31,1598,EquityAttributableToOwnersOfParent_per,26.22,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2019-03-31,1598,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,0.0,預收股款（權益項下）之約當發行股數,岱宇,生技醫療業
2019-03-31,1598,IntangibleAssets,488113000.0,無形資產,岱宇,生技醫療業
2019-03-31,1598,IntangibleAssets_per,7.0,無形資產,岱宇,生技醫療業
2019-03-31,1598,Inventories_per,15.08,存貨,岱宇,生技醫療業
2019-03-31,1598,LegalReserve,123174000.0,法定盈餘公積,岱宇,生技醫療業
2019-03-31,1598,LegalReserve_per,1.77,法定盈餘公積,岱宇,生技醫療業
2019-03-31,1598,LongtermBorrowings,641448000.0,長期借款,岱宇,生技醫療業
2019-03-31,1598,LongtermBorrowings_per,9.2,長期借款,岱宇,生技醫療業
2019-03-31,1598,NoncontrollingInterests,369531000.0,非控制權益,岱宇,生技醫療業
2019-03-31,1598,NoncontrollingInterests_per,5.3,非控制權益,岱宇,生技醫療業
2019-03-31,1598,NoncurrentAssets_per,56.24,非流動資產合計,岱宇,生技醫療業
2019-03-31,1598,NoncurrentLiabilities_per,16.35,非流動負債合計,岱宇,生技醫療業
2019-03-31,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,4000000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2019-03-31,1598,OrdinaryShare,929502000.0,普通股股本,岱宇,生技醫療業
2019-03-31,1598,OrdinaryShare_per,13.33,普通股股本,岱宇,生技醫療業
2019-03-31,1598,OtherCurrentAssets,144695000.0,其他流動資產,岱宇,生技醫療業
2019-03-31,1598,OtherCurrentAssets_per,2.07,其他流動資產,岱宇,生技醫療業
2019-03-31,1598,OtherNoncurrentAssets,19912000.0,其他非流動資產,岱宇,生技醫療業
2019-03-31,1598,OtherNoncurrentAssets_per,0.29,其他非流動資產,岱宇,生技醫療業
2019-03-31,1598,OtherNoncurrentLiabilities,218142000.0,其他非流動負債,岱宇,生技醫療業
2019-03-31,1598,OtherNoncurrentLiabilities_per,3.13,其他非流動負債,岱宇,生技醫療業
2019-03-31,1598,OtherPayables,286486000.0,其他應付款,岱宇,生技醫療業
2019-03-31,1598,OtherPayables_per,4.11,其他應付款,岱宇,生技醫療業
2019-03-31,1598,OtherReceivable,13866000.0,其他應收款淨額,岱宇,生技醫療業
2019-03-31,1598,OtherReceivable_per,0.2,其他應收款淨額,岱宇,生技醫療業
2019-03-31,1598,OtherReceivablesDueFromRelatedParties,0.0,其他應收款－關係人淨額,岱宇,生技醫療業
2019-03-31,1598,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,岱宇,生技醫療業
2019-03-31,1598,PropertyPlantAndEquipment_per,40.3,不動產、廠房及設備,岱宇,生技醫療業
2019-03-31,1598,RetainedEarnings,383248000.0,保留盈餘合計,岱宇,生技醫療業
2019-03-31,1598,RetainedEarnings_per,5.49,保留盈餘合計,岱宇,生技醫療業
2019-03-31,1598,ShorttermBorrowings,1522230000.0,短期借款,岱宇,生技醫療業
2019-03-31,1598,ShorttermBorrowings_per,21.82,短期借款,岱宇,生技醫療業
2019-03-31,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2019-03-31,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2019-03-31,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit,200816000.0,未分配盈餘,岱宇,生技醫療業
2019-03-31,1598,BillsReceivableNet,3204000.0,應收票據淨額,岱宇,生技醫療業
2019-03-31,1598,BillsReceivableNet_per,0.05,應收票據淨額,岱宇,生技醫療業
2019-03-31,1598,Prepayments,107869000.0,預付款項,岱宇,生技醫療業
2019-03-31,1598,Prepayments_per,1.55,預付款項,岱宇,生技醫療業
2019-03-31,1598,AccountsReceivableNet,1090641000.0,應收帳款淨額,岱宇,生技醫療業
2019-03-31,1598,Inventories,1051899000.0,存貨,岱宇,生技醫療業
2019-03-31,1598,CurrentAssets,3052427000.0,流動資產合計,岱宇,生技醫療業
2019-03-31,1598,PropertyPlantAndEquipment,2811109000.0,不動產、廠房及設備,岱宇,生技醫療業
2019-03-31,1598,NoncurrentAssets,3922612000.0,非流動資產合計,岱宇,生技醫療業
2019-03-31,1598,TotalAssets,6975039000.0,資產總額,岱宇,生技醫療業
2019-03-31,1598,CurrentLiabilities,3635827000.0,流動負債合計,岱宇,生技醫療業
2019-03-31,1598,NoncurrentLiabilities,1140672000.0,非流動負債合計,岱宇,生技醫療業
2019-03-31,1598,EquityAttributableToOwnersOfParent,1829009000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2019-03-31,1598,TotalLiabilitiesEquity,6975039000.0,負債及權益總計,岱宇,生技醫療業
2019-03-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome,0.0,透過其他綜合損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2019-03-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome_per,0.0,透過其他綜合損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2019-03-31,1598,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2019-03-31,1598,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2019-03-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,31319000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2019-03-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.45,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2019-03-31,1598,RightOfUseAsset,381081000.0,使用權資產,岱宇,生技醫療業
2019-03-31,1598,RightOfUseAsset_per,5.46,使用權資產,岱宇,生技醫療業
2019-03-31,1598,CurrentTaxLiabilities,62522000.0,本期所得稅負債,岱宇,生技醫療業
2019-03-31,1598,CurrentTaxLiabilities_per,0.9,本期所得稅負債,岱宇,生技醫療業
2019-03-31,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,2.88,未分配盈餘,岱宇,生技醫療業
2019-03-31,1598,OtherEquityInterest,-53800000.0,其他權益合計,岱宇,生技醫療業
2019-03-31,1598,OtherEquityInterest_per,-0.77,其他權益合計,岱宇,生技醫療業
2019-03-31,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2019-03-31,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2019-03-31,1598,FinancialAssetsAtAmortizedCostNonCurrent,0.0,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2019-03-31,1598,FinancialAssetsAtAmortizedCostNonCurrent_per,0.0,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2019-03-31,1598,InvestmentAccountedForUsingEquityMethod,0.0,採用權益法之投資,岱宇,生技醫療業
2019-03-31,1598,InvestmentAccountedForUsingEquityMethod_per,0.0,採用權益法之投資,岱宇,生技醫療業
2019-03-31,1598,OtherCurrentLiabilities,690661000.0,其他流動負債,岱宇,生技醫療業
2019-03-31,1598,OtherCurrentLiabilities_per,9.9,其他流動負債,岱宇,生技醫療業
2019-03-31,1598,Liabilities,4776499000.0,負債總,岱宇,生技醫療業
2019-03-31,1598,Liabilities_per,68.48,負債總,岱宇,生技醫療業
2019-03-31,1598,Equity,2198540000.0,權益總額,岱宇,生技醫療業
2019-03-31,1598,Equity_per,31.52,權益總額,岱宇,生技醫療業
2019-06-30,1598,AccountsPayable,523197000.0,應付帳款,岱宇,生技醫療業
2019-06-30,1598,AccountsPayable_per,8.02,應付帳款,岱宇,生技醫療業
2019-06-30,1598,AccountsReceivableNet,939454000.0,應收帳款淨額,岱宇,生技醫療業
2019-06-30,1598,AccountsReceivableNet_per,14.4,應收帳款淨額,岱宇,生技醫療業
2019-06-30,1598,BondsPayable,0.0,應付公司債,岱宇,生技醫療業
2019-06-30,1598,BondsPayable_per,0.0,應付公司債,岱宇,生技醫療業
2019-06-30,1598,CapitalStock,960635000.0,股本合計,岱宇,生技醫療業
2019-06-30,1598,CapitalStock_per,14.73,股本合計,岱宇,生技醫療業
2019-06-30,1598,CapitalSurplus,746400000.0,資本公積合計,岱宇,生技醫療業
2019-06-30,1598,CapitalSurplus_per,11.44,資本公積合計,岱宇,生技醫療業
2019-06-30,1598,CashAndCashEquivalents,367630000.0,現金及約當現金,岱宇,生技醫療業
2019-06-30,1598,CashAndCashEquivalents_per,5.64,現金及約當現金,岱宇,生技醫療業
2019-06-30,1598,CurrentAssets_per,40.65,流動資產合計,岱宇,生技醫療業
2019-06-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2019-06-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2019-06-30,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2019-06-30,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2019-06-30,1598,CurrentIncomeTaxAssets,23370000.0,本期所得稅資產,岱宇,生技醫療業
2019-06-30,1598,CurrentIncomeTaxAssets_per,0.36,本期所得稅資產,岱宇,生技醫療業
2019-06-30,1598,CurrentLiabilities_per,49.89,流動負債合計,岱宇,生技醫療業
2019-06-30,1598,CurrentProvisions,15535000.0,負債準備－流動,岱宇,生技醫療業
2019-06-30,1598,CurrentProvisions_per,0.24,負債準備－流動,岱宇,生技醫療業
2019-06-30,1598,DeferredTaxAssets,165693000.0,遞延所得稅資產,岱宇,生技醫療業
2019-06-30,1598,DeferredTaxAssets_per,2.54,遞延所得稅資產,岱宇,生技醫療業
2019-06-30,1598,EquityAttributableToOwnersOfParent_per,27.46,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2019-06-30,1598,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,0.0,預收股款（權益項下）之約當發行股數,岱宇,生技醫療業
2019-06-30,1598,IntangibleAssets,468592000.0,無形資產,岱宇,生技醫療業
2019-06-30,1598,IntangibleAssets_per,7.18,無形資產,岱宇,生技醫療業
2019-06-30,1598,Inventories_per,15.97,存貨,岱宇,生技醫療業
2019-06-30,1598,LegalReserve,133886000.0,法定盈餘公積,岱宇,生技醫療業
2019-06-30,1598,LegalReserve_per,2.05,法定盈餘公積,岱宇,生技醫療業
2019-06-30,1598,LongtermBorrowings,622488000.0,長期借款,岱宇,生技醫療業
2019-06-30,1598,LongtermBorrowings_per,9.54,長期借款,岱宇,生技醫療業
2019-06-30,1598,NoncontrollingInterests,360272000.0,非控制權益,岱宇,生技醫療業
2019-06-30,1598,NoncontrollingInterests_per,5.52,非控制權益,岱宇,生技醫療業
2019-06-30,1598,NoncurrentAssets,3871810000.0,非流動資產合計,岱宇,生技醫療業
2019-06-30,1598,NoncurrentAssets_per,59.35,非流動資產合計,岱宇,生技醫療業
2019-06-30,1598,NoncurrentLiabilities_per,17.12,非流動負債合計,岱宇,生技醫療業
2019-06-30,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,4000000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2019-06-30,1598,OrdinaryShare,929502000.0,普通股股本,岱宇,生技醫療業
2019-06-30,1598,OrdinaryShare_per,14.25,普通股股本,岱宇,生技醫療業
2019-06-30,1598,OtherCurrentAssets,141800000.0,其他流動資產,岱宇,生技醫療業
2019-06-30,1598,OtherCurrentAssets_per,2.17,其他流動資產,岱宇,生技醫療業
2019-06-30,1598,OtherNoncurrentAssets,22173000.0,其他非流動資產,岱宇,生技醫療業
2019-06-30,1598,OtherNoncurrentAssets_per,0.34,其他非流動資產,岱宇,生技醫療業
2019-06-30,1598,OtherNoncurrentLiabilities,212994000.0,其他非流動負債,岱宇,生技醫療業
2019-06-30,1598,OtherNoncurrentLiabilities_per,3.27,其他非流動負債,岱宇,生技醫療業
2019-06-30,1598,OtherPayables,289171000.0,其他應付款,岱宇,生技醫療業
2019-06-30,1598,OtherPayables_per,4.43,其他應付款,岱宇,生技醫療業
2019-06-30,1598,OtherReceivable,37223000.0,其他應收款淨額,岱宇,生技醫療業
2019-06-30,1598,OtherReceivable_per,0.57,其他應收款淨額,岱宇,生技醫療業
2019-06-30,1598,PropertyPlantAndEquipment_per,42.73,不動產、廠房及設備,岱宇,生技醫療業
2019-06-30,1598,RetainedEarnings,309083000.0,保留盈餘合計,岱宇,生技醫療業
2019-06-30,1598,RetainedEarnings_per,4.74,保留盈餘合計,岱宇,生技醫療業
2019-06-30,1598,ShorttermBorrowings_per,22.2,短期借款,岱宇,生技醫療業
2019-06-30,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2019-06-30,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2019-06-30,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit,96074000.0,未分配盈餘,岱宇,生技醫療業
2019-06-30,1598,BillsReceivableNet,2123000.0,應收票據淨額,岱宇,生技醫療業
2019-06-30,1598,BillsReceivableNet_per,0.03,應收票據淨額,岱宇,生技醫療業
2019-06-30,1598,Prepayments,98324000.0,預付款項,岱宇,生技醫療業
2019-06-30,1598,Prepayments_per,1.51,預付款項,岱宇,生技醫療業
2019-06-30,1598,Inventories,1041589000.0,存貨,岱宇,生技醫療業
2019-06-30,1598,CurrentAssets,2651513000.0,流動資產合計,岱宇,生技醫療業
2019-06-30,1598,PropertyPlantAndEquipment,2787458000.0,不動產、廠房及設備,岱宇,生技醫療業
2019-06-30,1598,TotalAssets,6523323000.0,資產總額,岱宇,生技醫療業
2019-06-30,1598,ShorttermBorrowings,1448209000.0,短期借款,岱宇,生技醫療業
2019-06-30,1598,CurrentLiabilities,3254771000.0,流動負債合計,岱宇,生技醫療業
2019-06-30,1598,NoncurrentLiabilities,1117006000.0,非流動負債合計,岱宇,生技醫療業
2019-06-30,1598,EquityAttributableToOwnersOfParent,1791274000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2019-06-30,1598,TotalLiabilitiesEquity,6523323000.0,負債及權益總計,岱宇,生技醫療業
2019-06-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,10571000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2019-06-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.16,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2019-06-30,1598,RightOfUseAsset,382659000.0,使用權資產,岱宇,生技醫療業
2019-06-30,1598,RightOfUseAsset_per,5.87,使用權資產,岱宇,生技醫療業
2019-06-30,1598,CurrentTaxLiabilities,17603000.0,本期所得稅負債,岱宇,生技醫療業
2019-06-30,1598,CurrentTaxLiabilities_per,0.27,本期所得稅負債,岱宇,生技醫療業
2019-06-30,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,1.47,未分配盈餘,岱宇,生技醫療業
2019-06-30,1598,OtherEquityInterest,-52504000.0,其他權益合計,岱宇,生技醫療業
2019-06-30,1598,OtherEquityInterest_per,-0.8,其他權益合計,岱宇,生技醫療業
2019-06-30,1598,OtherCurrentLiabilities,698228000.0,其他流動負債,岱宇,生技醫療業
2019-06-30,1598,OtherCurrentLiabilities_per,10.7,其他流動負債,岱宇,生技醫療業
2019-06-30,1598,Liabilities,4371777000.0,負債總,岱宇,生技醫療業
2019-06-30,1598,Liabilities_per,67.02,負債總,岱宇,生技醫療業
2019-06-30,1598,Equity,2151546000.0,權益總額,岱宇,生技醫療業
2019-06-30,1598,Equity_per,32.98,權益總額,岱宇,生技醫療業
2019-09-30,1598,AccountsPayable,733570000.0,應付帳款,岱宇,生技醫療業
2019-09-30,1598,AccountsPayable_per,10.45,應付帳款,岱宇,生技醫療業
2019-09-30,1598,AccountsReceivableNet,775953000.0,應收帳款淨額,岱宇,生技醫療業
2019-09-30,1598,AccountsReceivableNet_per,11.06,應收帳款淨額,岱宇,生技醫療業
2019-09-30,1598,BondsPayable,0.0,應付公司債,岱宇,生技醫療業
2019-09-30,1598,BondsPayable_per,0.0,應付公司債,岱宇,生技醫療業
2019-09-30,1598,CapitalStock,961009000.0,股本合計,岱宇,生技醫療業
2019-09-30,1598,CapitalStock_per,13.69,股本合計,岱宇,生技醫療業
2019-09-30,1598,CapitalSurplus,751509000.0,資本公積合計,岱宇,生技醫療業
2019-09-30,1598,CapitalSurplus_per,10.71,資本公積合計,岱宇,生技醫療業
2019-09-30,1598,CashAndCashEquivalents,690787000.0,現金及約當現金,岱宇,生技醫療業
2019-09-30,1598,CashAndCashEquivalents_per,9.84,現金及約當現金,岱宇,生技醫療業
2019-09-30,1598,CurrentAssets_per,45.57,流動資產合計,岱宇,生技醫療業
2019-09-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2019-09-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2019-09-30,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,6174000.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2019-09-30,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.09,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2019-09-30,1598,CurrentIncomeTaxAssets,7193000.0,本期所得稅資產,岱宇,生技醫療業
2019-09-30,1598,CurrentIncomeTaxAssets_per,0.1,本期所得稅資產,岱宇,生技醫療業
2019-09-30,1598,CurrentLiabilities_per,50.48,流動負債合計,岱宇,生技醫療業
2019-09-30,1598,CurrentProvisions,16155000.0,負債準備－流動,岱宇,生技醫療業
2019-09-30,1598,CurrentProvisions_per,0.23,負債準備－流動,岱宇,生技醫療業
2019-09-30,1598,DeferredTaxAssets,170809000.0,遞延所得稅資產,岱宇,生技醫療業
2019-09-30,1598,DeferredTaxAssets_per,2.43,遞延所得稅資產,岱宇,生技醫療業
2019-09-30,1598,EquityAttributableToOwnersOfParent_per,25.99,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2019-09-30,1598,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,37406.0,預收股款（權益項下）之約當發行股數,岱宇,生技醫療業
2019-09-30,1598,IntangibleAssets,448929000.0,無形資產,岱宇,生技醫療業
2019-09-30,1598,IntangibleAssets_per,6.4,無形資產,岱宇,生技醫療業
2019-09-30,1598,Inventories_per,17.63,存貨,岱宇,生技醫療業
2019-09-30,1598,LegalReserve,133886000.0,法定盈餘公積,岱宇,生技醫療業
2019-09-30,1598,LegalReserve_per,1.91,法定盈餘公積,岱宇,生技醫療業
2019-09-30,1598,LongtermBorrowings,815042000.0,長期借款,岱宇,生技醫療業
2019-09-30,1598,LongtermBorrowings_per,11.61,長期借款,岱宇,生技醫療業
2019-09-30,1598,NoncontrollingInterests,345501000.0,非控制權益,岱宇,生技醫療業
2019-09-30,1598,NoncontrollingInterests_per,4.92,非控制權益,岱宇,生技醫療業
2019-09-30,1598,NoncurrentAssets_per,54.43,非流動資產合計,岱宇,生技醫療業
2019-09-30,1598,NoncurrentLiabilities_per,18.6,非流動負債合計,岱宇,生技醫療業
2019-09-30,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,4000000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2019-09-30,1598,OrdinaryShare,960635000.0,普通股股本,岱宇,生技醫療業
2019-09-30,1598,OrdinaryShare_per,13.69,普通股股本,岱宇,生技醫療業
2019-09-30,1598,OtherCurrentAssets,359453000.0,其他流動資產,岱宇,生技醫療業
2019-09-30,1598,OtherCurrentAssets_per,5.12,其他流動資產,岱宇,生技醫療業
2019-09-30,1598,OtherNoncurrentAssets,16756000.0,其他非流動資產,岱宇,生技醫療業
2019-09-30,1598,OtherNoncurrentAssets_per,0.24,其他非流動資產,岱宇,生技醫療業
2019-09-30,1598,OtherNoncurrentLiabilities,204081000.0,其他非流動負債,岱宇,生技醫療業
2019-09-30,1598,OtherNoncurrentLiabilities_per,2.91,其他非流動負債,岱宇,生技醫療業
2019-09-30,1598,OtherPayables,254195000.0,其他應付款,岱宇,生技醫療業
2019-09-30,1598,OtherPayables_per,3.62,其他應付款,岱宇,生技醫療業
2019-09-30,1598,OtherReceivable,31847000.0,其他應收款淨額,岱宇,生技醫療業
2019-09-30,1598,OtherReceivable_per,0.45,其他應收款淨額,岱宇,生技醫療業
2019-09-30,1598,PropertyPlantAndEquipment_per,38.51,不動產、廠房及設備,岱宇,生技醫療業
2019-09-30,1598,RetainedEarnings,376481000.0,保留盈餘合計,岱宇,生技醫療業
2019-09-30,1598,RetainedEarnings_per,5.36,保留盈餘合計,岱宇,生技醫療業
2019-09-30,1598,ShorttermBorrowings,1424000000.0,短期借款,岱宇,生技醫療業
2019-09-30,1598,ShorttermBorrowings_per,20.29,短期借款,岱宇,生技醫療業
2019-09-30,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2019-09-30,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2019-09-30,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit,163472000.0,未分配盈餘,岱宇,生技醫療業
2019-09-30,1598,BillsReceivableNet,1398000.0,應收票據淨額,岱宇,生技醫療業
2019-09-30,1598,BillsReceivableNet_per,0.02,應收票據淨額,岱宇,生技醫療業
2019-09-30,1598,Prepayments,94304000.0,預付款項,岱宇,生技醫療業
2019-09-30,1598,Prepayments_per,1.34,預付款項,岱宇,生技醫療業
2019-09-30,1598,Inventories,1237254000.0,存貨,岱宇,生技醫療業
2019-09-30,1598,CurrentAssets,3198189000.0,流動資產合計,岱宇,生技醫療業
2019-09-30,1598,PropertyPlantAndEquipment,2702547000.0,不動產、廠房及設備,岱宇,生技醫療業
2019-09-30,1598,NoncurrentAssets,3820276000.0,非流動資產合計,岱宇,生技醫療業
2019-09-30,1598,TotalAssets,7018465000.0,資產總額,岱宇,生技醫療業
2019-09-30,1598,CurrentLiabilities,3543172000.0,流動負債合計,岱宇,生技醫療業
2019-09-30,1598,NoncurrentLiabilities,1305436000.0,非流動負債合計,岱宇,生技醫療業
2019-09-30,1598,EquityAttributableToOwnersOfParent,1824356000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2019-09-30,1598,TotalLiabilitiesEquity,7018465000.0,負債及權益總計,岱宇,生技醫療業
2019-09-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,41231000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2019-09-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.59,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2019-09-30,1598,InvestmentAccountedForUsingEquityMethod,0.0,採用權益法之投資,岱宇,生技醫療業
2019-09-30,1598,InvestmentAccountedForUsingEquityMethod_per,0.0,採用權益法之投資,岱宇,生技醫療業
2019-09-30,1598,RightOfUseAsset,379078000.0,使用權資產,岱宇,生技醫療業
2019-09-30,1598,RightOfUseAsset_per,5.4,使用權資產,岱宇,生技醫療業
2019-09-30,1598,CurrentTaxLiabilities,41659000.0,本期所得稅負債,岱宇,生技醫療業
2019-09-30,1598,CurrentTaxLiabilities_per,0.59,本期所得稅負債,岱宇,生技醫療業
2019-09-30,1598,OtherCurrentLiabilities,752658000.0,其他流動負債,岱宇,生技醫療業
2019-09-30,1598,OtherCurrentLiabilities_per,10.72,其他流動負債,岱宇,生技醫療業
2019-09-30,1598,Liabilities,4848608000.0,負債總額,岱宇,生技醫療業
2019-09-30,1598,Liabilities_per,69.08,負債總額,岱宇,生技醫療業
2019-09-30,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,2.33,未分配盈餘,岱宇,生技醫療業
2019-09-30,1598,OtherEquityInterest,-92303000.0,其他權益合計,岱宇,生技醫療業
2019-09-30,1598,OtherEquityInterest_per,-1.32,其他權益合計,岱宇,生技醫療業
2019-09-30,1598,Equity,7018465000.0,權益總計,岱宇,生技醫療業
2019-09-30,1598,Equity_per,100.0,權益總計,岱宇,生技醫療業
2019-12-31,1598,AccountsPayable,780661000.0,應付帳款,岱宇,生技醫療業
2019-12-31,1598,AccountsPayable_per,10.7,應付帳款,岱宇,生技醫療業
2019-12-31,1598,AccountsReceivableNet_per,13.84,應收帳款淨額,岱宇,生技醫療業
2019-12-31,1598,BondsPayable,0.0,應付公司債,岱宇,生技醫療業
2019-12-31,1598,BondsPayable_per,0.0,應付公司債,岱宇,生技醫療業
2019-12-31,1598,CapitalStock,961009000.0,股本合計,岱宇,生技醫療業
2019-12-31,1598,CapitalStock_per,13.17,股本合計,岱宇,生技醫療業
2019-12-31,1598,CapitalSurplus,758304000.0,資本公積合計,岱宇,生技醫療業
2019-12-31,1598,CapitalSurplus_per,10.39,資本公積合計,岱宇,生技醫療業
2019-12-31,1598,CashAndCashEquivalents,826213000.0,現金及約當現金,岱宇,生技醫療業
2019-12-31,1598,CashAndCashEquivalents_per,11.33,現金及約當現金,岱宇,生技醫療業
2019-12-31,1598,CurrentAssets_per,48.66,流動資產合計,岱宇,生技醫療業
2019-12-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2019-12-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2019-12-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,3043000.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2019-12-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.04,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2019-12-31,1598,CurrentIncomeTaxAssets,1282000.0,本期所得稅資產,岱宇,生技醫療業
2019-12-31,1598,CurrentIncomeTaxAssets_per,0.02,本期所得稅資產,岱宇,生技醫療業
2019-12-31,1598,CurrentLiabilities_per,52.39,流動負債合計,岱宇,生技醫療業
2019-12-31,1598,CurrentProvisions,15835000.0,負債準備－流動,岱宇,生技醫療業
2019-12-31,1598,CurrentProvisions_per,0.22,負債準備－流動,岱宇,生技醫療業
2019-12-31,1598,DeferredTaxAssets,181176000.0,遞延所得稅資產,岱宇,生技醫療業
2019-12-31,1598,DeferredTaxAssets_per,2.48,遞延所得稅資產,岱宇,生技醫療業
2019-12-31,1598,EquityAttributableToOwnersOfParent_per,25.96,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2019-12-31,1598,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,0.0,預收股款（權益項下）之約當發行股數,岱宇,生技醫療業
2019-12-31,1598,IntangibleAssets,416321000.0,無形資產,岱宇,生技醫療業
2019-12-31,1598,IntangibleAssets_per,5.71,無形資產,岱宇,生技醫療業
2019-12-31,1598,Inventories_per,16.49,存貨,岱宇,生技醫療業
2019-12-31,1598,LegalReserve,133886000.0,法定盈餘公積,岱宇,生技醫療業
2019-12-31,1598,LegalReserve_per,1.84,法定盈餘公積,岱宇,生技醫療業
2019-12-31,1598,LongtermBorrowings,785594000.0,長期借款,岱宇,生技醫療業
2019-12-31,1598,LongtermBorrowings_per,10.77,長期借款,岱宇,生技醫療業
2019-12-31,1598,NoncontrollingInterests,350172000.0,非控制權益,岱宇,生技醫療業
2019-12-31,1598,NoncontrollingInterests_per,4.8,非控制權益,岱宇,生技醫療業
2019-12-31,1598,NoncurrentAssets_per,51.34,非流動資產合計,岱宇,生技醫療業
2019-12-31,1598,NoncurrentLiabilities_per,16.84,非流動負債合計,岱宇,生技醫療業
2019-12-31,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,4000000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2019-12-31,1598,OrdinaryShare,961009000.0,普通股股本,岱宇,生技醫療業
2019-12-31,1598,OrdinaryShare_per,13.17,普通股股本,岱宇,生技醫療業
2019-12-31,1598,OtherCurrentAssets,360476000.0,其他流動資產,岱宇,生技醫療業
2019-12-31,1598,OtherCurrentAssets_per,4.94,其他流動資產,岱宇,生技醫療業
2019-12-31,1598,OtherCurrentLiabilities,788120000.0,其他流動負債,岱宇,生技醫療業
2019-12-31,1598,OtherCurrentLiabilities_per,10.8,其他流動負債,岱宇,生技醫療業
2019-12-31,1598,OtherNoncurrentAssets,16088000.0,其他非流動資產,岱宇,生技醫療業
2019-12-31,1598,OtherNoncurrentAssets_per,0.22,其他非流動資產,岱宇,生技醫療業
2019-12-31,1598,OtherNoncurrentLiabilities,158544000.0,其他非流動負債,岱宇,生技醫療業
2019-12-31,1598,OtherNoncurrentLiabilities_per,2.17,其他非流動負債,岱宇,生技醫療業
2019-12-31,1598,OtherPayables,324232000.0,其他應付款,岱宇,生技醫療業
2019-12-31,1598,OtherPayables_per,4.44,其他應付款,岱宇,生技醫療業
2019-12-31,1598,OtherReceivable,44531000.0,其他應收款淨額,岱宇,生技醫療業
2019-12-31,1598,OtherReceivable_per,0.61,其他應收款淨額,岱宇,生技醫療業
2019-12-31,1598,PropertyPlantAndEquipment,2656050000.0,不動產、廠房及設備,岱宇,生技醫療業
2019-12-31,1598,PropertyPlantAndEquipment_per,36.41,不動產、廠房及設備,岱宇,生技醫療業
2019-12-31,1598,RetainedEarnings,452985000.0,保留盈餘合計,岱宇,生技醫療業
2019-12-31,1598,RetainedEarnings_per,6.21,保留盈餘合計,岱宇,生技醫療業
2019-12-31,1598,ShorttermBorrowings,1513300000.0,短期借款,岱宇,生技醫療業
2019-12-31,1598,ShorttermBorrowings_per,20.74,短期借款,岱宇,生技醫療業
2019-12-31,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2019-12-31,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2019-12-31,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit,239976000.0,未分配盈餘,岱宇,生技醫療業
2019-12-31,1598,AccountsReceivableNet,1009492000.0,應收帳款淨額,岱宇,生技醫療業
2019-12-31,1598,Inventories,1202977000.0,存貨,岱宇,生技醫療業
2019-12-31,1598,CurrentAssets,3550149000.0,流動資產合計,岱宇,生技醫療業
2019-12-31,1598,NoncurrentAssets,3745152000.0,非流動資產合計,岱宇,生技醫療業
2019-12-31,1598,TotalAssets,7295301000.0,資產總額,岱宇,生技醫療業
2019-12-31,1598,CurrentLiabilities,3822171000.0,流動負債合計,岱宇,生技醫療業
2019-12-31,1598,NoncurrentLiabilities,1228813000.0,非流動負債合計,岱宇,生技醫療業
2019-12-31,1598,EquityAttributableToOwnersOfParent,1894145000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2019-12-31,1598,TotalLiabilitiesEquity,7295301000.0,負債及權益總計,岱宇,生技醫療業
2019-12-31,1598,BillsReceivableNet,1501000.0,應收票據淨額,岱宇,生技醫療業
2019-12-31,1598,BillsReceivableNet_per,0.02,應收票據淨額,岱宇,生技醫療業
2019-12-31,1598,Prepayments,103677000.0,預付款項,岱宇,生技醫療業
2019-12-31,1598,Prepayments_per,1.42,預付款項,岱宇,生技醫療業
2019-12-31,1598,InvestmentAccountedForUsingEquityMethod,0.0,採用權益法之投資,岱宇,生技醫療業
2019-12-31,1598,InvestmentAccountedForUsingEquityMethod_per,0.0,採用權益法之投資,岱宇,生技醫療業
2019-12-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,42984000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2019-12-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.59,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2019-12-31,1598,RightOfUseAsset,372771000.0,使用權資產,岱宇,生技醫療業
2019-12-31,1598,RightOfUseAsset_per,5.11,使用權資產,岱宇,生技醫療業
2019-12-31,1598,CurrentTaxLiabilities,56348000.0,本期所得稅負債,岱宇,生技醫療業
2019-12-31,1598,CurrentTaxLiabilities_per,0.77,本期所得稅負債,岱宇,生技醫療業
2019-12-31,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,3.29,未分配盈餘,岱宇,生技醫療業
2019-12-31,1598,OtherEquityInterest,-105813000.0,其他權益合計,岱宇,生技醫療業
2019-12-31,1598,OtherEquityInterest_per,-1.45,其他權益合計,岱宇,生技醫療業
2019-12-31,1598,Liabilities,5050984000.0,負債總,岱宇,生技醫療業
2019-12-31,1598,Liabilities_per,69.24,負債總,岱宇,生技醫療業
2019-12-31,1598,Equity,2244317000.0,權益總額,岱宇,生技醫療業
2019-12-31,1598,Equity_per,30.76,權益總額,岱宇,生技醫療業
2020-03-31,1598,AccountsPayable,556623000.0,應付帳款,岱宇,生技醫療業
2020-03-31,1598,CashAndCashEquivalents,625864000.0,現金及約當現金,岱宇,生技醫療業
2020-03-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2020-03-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2020-03-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,1397000.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2020-03-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.02,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2020-03-31,1598,CurrentIncomeTaxAssets,178000.0,本期所得稅資產,岱宇,生技醫療業
2020-03-31,1598,CurrentIncomeTaxAssets_per,0.0,本期所得稅資產,岱宇,生技醫療業
2020-03-31,1598,CurrentProvisions,14602000.0,負債準備－流動,岱宇,生技醫療業
2020-03-31,1598,CurrentProvisions_per,0.18,負債準備－流動,岱宇,生技醫療業
2020-03-31,1598,DeferredTaxAssets,193022000.0,遞延所得稅資產,岱宇,生技醫療業
2020-03-31,1598,DeferredTaxAssets_per,2.33,遞延所得稅資產,岱宇,生技醫療業
2020-03-31,1598,LegalReserve,133886000.0,法定盈餘公積,岱宇,生技醫療業
2020-03-31,1598,LongtermBorrowings,911889000.0,長期借款,岱宇,生技醫療業
2020-03-31,1598,NoncontrollingInterests,349092000.0,非控制權益,岱宇,生技醫療業
2020-03-31,1598,OtherCurrentLiabilities,792293000.0,其他流動負債,岱宇,生技醫療業
2020-03-31,1598,OtherNoncurrentAssets,32061000.0,其他非流動資產,岱宇,生技醫療業
2020-03-31,1598,OtherNoncurrentAssets_per,0.39,其他非流動資產,岱宇,生技醫療業
2020-03-31,1598,OtherNoncurrentLiabilities,157200000.0,其他非流動負債,岱宇,生技醫療業
2020-03-31,1598,OtherNoncurrentLiabilities_per,1.9,其他非流動負債,岱宇,生技醫療業
2020-03-31,1598,OtherPayables,764988000.0,其他應付款,岱宇,生技醫療業
2020-03-31,1598,OtherReceivable,31735000.0,其他應收款淨額,岱宇,生技醫療業
2020-03-31,1598,OtherReceivable_per,0.38,其他應收款淨額,岱宇,生技醫療業
2020-03-31,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2020-03-31,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2020-03-31,1598,AccountsReceivableNet,1257551000.0,應收帳款淨額,岱宇,生技醫療業
2020-03-31,1598,Inventories,1128359000.0,存貨,岱宇,生技醫療業
2020-03-31,1598,CurrentAssets,3543365000.0,流動資產合計,岱宇,生技醫療業
2020-03-31,1598,PropertyPlantAndEquipment,2637027000.0,不動產、廠房及設備,岱宇,生技醫療業
2020-03-31,1598,ShorttermBorrowings,1619397000.0,短期借款,岱宇,生技醫療業
2020-03-31,1598,CurrentLiabilities,4058054000.0,流動負債合計,岱宇,生技醫療業
2020-03-31,1598,BondsPayable,0.0,應付公司債,岱宇,生技醫療業
2020-03-31,1598,BondsPayable_per,0.0,應付公司債,岱宇,生技醫療業
2020-03-31,1598,OrdinaryShare,1151009000.0,普通股股本,岱宇,生技醫療業
2020-03-31,1598,CapitalStock,1151009000.0,股本合計,岱宇,生技醫療業
2020-03-31,1598,CapitalSurplus,1308607000.0,資本公積合計,岱宇,生技醫療業
2020-03-31,1598,FinancialAssetsAtAmortizedCost,314832000.0,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2020-03-31,1598,FinancialAssetsAtAmortizedCost_per,3.8,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2020-03-31,1598,BillsReceivableNet,972000.0,應收票據淨額,岱宇,生技醫療業
2020-03-31,1598,BillsReceivableNet_per,0.01,應收票據淨額,岱宇,生技醫療業
2020-03-31,1598,Prepayments,155825000.0,預付款項,岱宇,生技醫療業
2020-03-31,1598,Prepayments_per,1.88,預付款項,岱宇,生技醫療業
2020-03-31,1598,CashAndCashEquivalents_per,7.55,現金及約當現金,岱宇,生技醫療業
2020-03-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,51930000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2020-03-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.63,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2020-03-31,1598,AccountsReceivableNet_per,15.16,應收帳款淨額,岱宇,生技醫療業
2020-03-31,1598,Inventories_per,13.6,存貨,岱宇,生技醫療業
2020-03-31,1598,OtherCurrentAssets,28049000.0,其他流動資產,岱宇,生技醫療業
2020-03-31,1598,OtherCurrentAssets_per,0.34,其他流動資產,岱宇,生技醫療業
2020-03-31,1598,CurrentAssets_per,42.72,流動資產合計,岱宇,生技醫療業
2020-03-31,1598,InvestmentAccountedForUsingEquityMethod,0.0,採用權益法之投資,岱宇,生技醫療業
2020-03-31,1598,InvestmentAccountedForUsingEquityMethod_per,0.0,採用權益法之投資,岱宇,生技醫療業
2020-03-31,1598,PropertyPlantAndEquipment_per,31.79,不動產、廠房及設備,岱宇,生技醫療業
2020-03-31,1598,RightOfUseAsset,359833000.0,使用權資產,岱宇,生技醫療業
2020-03-31,1598,RightOfUseAsset_per,4.34,使用權資產,岱宇,生技醫療業
2020-03-31,1598,IntangibleAssets,1418936000.0,無形資產,岱宇,生技醫療業
2020-03-31,1598,IntangibleAssets_per,17.11,無形資產,岱宇,生技醫療業
2020-03-31,1598,NoncurrentAssets,4751319000.0,非流動資產合計,岱宇,生技醫療業
2020-03-31,1598,NoncurrentAssets_per,57.28,非流動資產合計,岱宇,生技醫療業
2020-03-31,1598,TotalAssets,8294684000.0,資產總額,岱宇,生技醫療業
2020-03-31,1598,ShorttermBorrowings_per,19.52,短期借款,岱宇,生技醫療業
2020-03-31,1598,AccountsPayable_per,6.71,應付帳款,岱宇,生技醫療業
2020-03-31,1598,OtherPayables_per,9.22,其他應付款,岱宇,生技醫療業
2020-03-31,1598,CurrentTaxLiabilities,58465000.0,本期所得稅負債,岱宇,生技醫療業
2020-03-31,1598,CurrentTaxLiabilities_per,0.7,本期所得稅負債,岱宇,生技醫療業
2020-03-31,1598,OtherCurrentLiabilities_per,9.55,其他流動負債,岱宇,生技醫療業
2020-03-31,1598,CurrentLiabilities_per,48.92,流動負債合計,岱宇,生技醫療業
2020-03-31,1598,LongtermBorrowings_per,10.99,長期借款,岱宇,生技醫療業
2020-03-31,1598,NoncurrentLiabilities,1532898000.0,非流動負債合計,岱宇,生技醫療業
2020-03-31,1598,NoncurrentLiabilities_per,18.48,非流動負債合計,岱宇,生技醫療業
2020-03-31,1598,Liabilities,5590952000.0,負債總額,岱宇,生技醫療業
2020-03-31,1598,Liabilities_per,67.4,負債總額,岱宇,生技醫療業
2020-03-31,1598,OrdinaryShare_per,13.88,普通股股本,岱宇,生技醫療業
2020-03-31,1598,CapitalStock_per,13.88,股本合計,岱宇,生技醫療業
2020-03-31,1598,CapitalSurplus_per,15.78,資本公積合計,岱宇,生技醫療業
2020-03-31,1598,LegalReserve_per,1.61,法定盈餘公積,岱宇,生技醫療業
2020-03-31,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit,114426000.0,未分配盈餘,岱宇,生技醫療業
2020-03-31,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,1.38,未分配盈餘,岱宇,生技醫療業
2020-03-31,1598,RetainedEarnings,327435000.0,保留盈餘合計,岱宇,生技醫療業
2020-03-31,1598,RetainedEarnings_per,3.95,保留盈餘合計,岱宇,生技醫療業
2020-03-31,1598,OtherEquityInterest,-120210000.0,其他權益合計,岱宇,生技醫療業
2020-03-31,1598,OtherEquityInterest_per,-1.45,其他權益合計,岱宇,生技醫療業
2020-03-31,1598,EquityAttributableToOwnersOfParent,2354640000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2020-03-31,1598,EquityAttributableToOwnersOfParent_per,28.39,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2020-03-31,1598,NoncontrollingInterests_per,4.21,非控制權益,岱宇,生技醫療業
2020-03-31,1598,TotalLiabilitiesEquity,8294684000.0,負債及權益總計,岱宇,生技醫療業
2020-03-31,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,8068000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2020-03-31,1598,Equity,2703732000.0,權益總額,岱宇,生技醫療業
2020-03-31,1598,Equity_per,32.6,權益總額,岱宇,生技醫療業
2020-06-30,1598,CapitalStock,1209820000.0,股本合計,岱宇,生技醫療業
2020-06-30,1598,CashAndCashEquivalents,1284240000.0,現金及約當現金,岱宇,生技醫療業
2020-06-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,480000.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2020-06-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.01,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2020-06-30,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,3041000.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2020-06-30,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.03,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2020-06-30,1598,CurrentIncomeTaxAssets,1267000.0,本期所得稅資產,岱宇,生技醫療業
2020-06-30,1598,CurrentIncomeTaxAssets_per,0.01,本期所得稅資產,岱宇,生技醫療業
2020-06-30,1598,CurrentProvisions,17178000.0,負債準備－流動,岱宇,生技醫療業
2020-06-30,1598,CurrentProvisions_per,0.18,負債準備－流動,岱宇,生技醫療業
2020-06-30,1598,DeferredTaxAssets,229729000.0,遞延所得稅資產,岱宇,生技醫療業
2020-06-30,1598,LegalReserve,152827000.0,法定盈餘公積,岱宇,生技醫療業
2020-06-30,1598,LongtermBorrowings,874068000.0,長期借款,岱宇,生技醫療業
2020-06-30,1598,NoncontrollingInterests,341473000.0,非控制權益,岱宇,生技醫療業
2020-06-30,1598,OtherCurrentLiabilities,591884000.0,其他流動負債,岱宇,生技醫療業
2020-06-30,1598,OtherNoncurrentAssets,29833000.0,其他非流動資產,岱宇,生技醫療業
2020-06-30,1598,OtherNoncurrentAssets_per,0.31,其他非流動資產,岱宇,生技醫療業
2020-06-30,1598,OtherNoncurrentLiabilities,151921000.0,其他非流動負債,岱宇,生技醫療業
2020-06-30,1598,OtherPayables,919570000.0,其他應付款,岱宇,生技醫療業
2020-06-30,1598,OtherReceivable,52902000.0,其他應收款淨額,岱宇,生技醫療業
2020-06-30,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2020-06-30,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2020-06-30,1598,AccountsReceivableNet,1296258000.0,應收帳款淨額,岱宇,生技醫療業
2020-06-30,1598,Inventories,1627699000.0,存貨,岱宇,生技醫療業
2020-06-30,1598,CurrentAssets,4816423000.0,流動資產合計,岱宇,生技醫療業
2020-06-30,1598,PropertyPlantAndEquipment,2604726000.0,不動產、廠房及設備,岱宇,生技醫療業
2020-06-30,1598,ShorttermBorrowings,1507085000.0,短期借款,岱宇,生技醫療業
2020-06-30,1598,AccountsPayable,1239088000.0,應付帳款,岱宇,生技醫療業
2020-06-30,1598,CurrentLiabilities,4942764000.0,流動負債合計,岱宇,生技醫療業
2020-06-30,1598,BondsPayable,0.0,應付公司債,岱宇,生技醫療業
2020-06-30,1598,BondsPayable_per,0.0,應付公司債,岱宇,生技醫療業
2020-06-30,1598,OrdinaryShare,1151009000.0,普通股股本,岱宇,生技醫療業
2020-06-30,1598,CapitalSurplus,1477248000.0,資本公積合計,岱宇,生技醫療業
2020-06-30,1598,FinancialAssetsAtAmortizedCost,329433000.0,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2020-06-30,1598,FinancialAssetsAtAmortizedCost_per,3.47,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2020-06-30,1598,BillsReceivableNet,2531000.0,應收票據淨額,岱宇,生技醫療業
2020-06-30,1598,BillsReceivableNet_per,0.03,應收票據淨額,岱宇,生技醫療業
2020-06-30,1598,Prepayments,187011000.0,預付款項,岱宇,生技醫療業
2020-06-30,1598,CashAndCashEquivalents_per,13.52,現金及約當現金,岱宇,生技醫療業
2020-06-30,1598,OtherReceivable_per,0.56,其他應收款淨額,岱宇,生技醫療業
2020-06-30,1598,Prepayments_per,1.97,預付款項,岱宇,生技醫療業
2020-06-30,1598,AccountsReceivableNet_per,13.64,應收帳款淨額,岱宇,生技醫療業
2020-06-30,1598,Inventories_per,17.13,存貨,岱宇,生技醫療業
2020-06-30,1598,OtherCurrentAssets,34602000.0,其他流動資產,岱宇,生技醫療業
2020-06-30,1598,OtherCurrentAssets_per,0.36,其他流動資產,岱宇,生技醫療業
2020-06-30,1598,CurrentAssets_per,50.69,流動資產合計,岱宇,生技醫療業
2020-06-30,1598,InvestmentAccountedForUsingEquityMethod,0.0,採用權益法之投資,岱宇,生技醫療業
2020-06-30,1598,InvestmentAccountedForUsingEquityMethod_per,0.0,採用權益法之投資,岱宇,生技醫療業
2020-06-30,1598,PropertyPlantAndEquipment_per,27.41,不動產、廠房及設備,岱宇,生技醫療業
2020-06-30,1598,IntangibleAssets,1367620000.0,無形資產,岱宇,生技醫療業
2020-06-30,1598,IntangibleAssets_per,14.39,無形資產,岱宇,生技醫療業
2020-06-30,1598,DeferredTaxAssets_per,2.42,遞延所得稅資產,岱宇,生技醫療業
2020-06-30,1598,NoncurrentAssets,4685683000.0,非流動資產合計,岱宇,生技醫療業
2020-06-30,1598,NoncurrentAssets_per,49.31,非流動資產合計,岱宇,生技醫療業
2020-06-30,1598,TotalAssets,9502106000.0,資產總額,岱宇,生技醫療業
2020-06-30,1598,ShorttermBorrowings_per,15.86,短期借款,岱宇,生技醫療業
2020-06-30,1598,AccountsPayable_per,13.04,應付帳款,岱宇,生技醫療業
2020-06-30,1598,OtherPayables_per,9.68,其他應付款,岱宇,生技醫療業
2020-06-30,1598,OtherCurrentLiabilities_per,6.23,其他流動負債,岱宇,生技醫療業
2020-06-30,1598,CurrentLiabilities_per,52.02,流動負債合計,岱宇,生技醫療業
2020-06-30,1598,LongtermBorrowings_per,9.2,長期借款,岱宇,生技醫療業
2020-06-30,1598,OtherNoncurrentLiabilities_per,1.6,其他非流動負債,岱宇,生技醫療業
2020-06-30,1598,NoncurrentLiabilities,1497360000.0,非流動負債合計,岱宇,生技醫療業
2020-06-30,1598,NoncurrentLiabilities_per,15.76,非流動負債合計,岱宇,生技醫療業
2020-06-30,1598,OrdinaryShare_per,12.11,普通股股本,岱宇,生技醫療業
2020-06-30,1598,CapitalStock_per,12.73,股本合計,岱宇,生技醫療業
2020-06-30,1598,CapitalSurplus_per,15.55,資本公積合計,岱宇,生技醫療業
2020-06-30,1598,LegalReserve_per,1.61,法定盈餘公積,岱宇,生技醫療業
2020-06-30,1598,RetainedEarnings,517880000.0,保留盈餘合計,岱宇,生技醫療業
2020-06-30,1598,RetainedEarnings_per,5.45,保留盈餘合計,岱宇,生技醫療業
2020-06-30,1598,EquityAttributableToOwnersOfParent,2720509000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2020-06-30,1598,EquityAttributableToOwnersOfParent_per,28.63,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2020-06-30,1598,NoncontrollingInterests_per,3.59,非控制權益,岱宇,生技醫療業
2020-06-30,1598,TotalLiabilitiesEquity,9502106000.0,負債及權益總計,岱宇,生技醫療業
2020-06-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,51765000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2020-06-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.54,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2020-06-30,1598,RightOfUseAsset,344855000.0,使用權資產,岱宇,生技醫療業
2020-06-30,1598,CurrentTaxLiabilities,110082000.0,本期所得稅負債,岱宇,生技醫療業
2020-06-30,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,8565000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2020-06-30,1598,RightOfUseAsset_per,3.63,使用權資產,岱宇,生技醫療業
2020-06-30,1598,CurrentTaxLiabilities_per,1.16,本期所得稅負債,岱宇,生技醫療業
2020-06-30,1598,Liabilities,6440124000.0,負債總額,岱宇,生技醫療業
2020-06-30,1598,Liabilities_per,67.78,負債總額,岱宇,生技醫療業
2020-06-30,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit,259241000.0,未分配盈餘,岱宇,生技醫療業
2020-06-30,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,2.73,未分配盈餘,岱宇,生技醫療業
2020-06-30,1598,OtherEquityInterest,-156549000.0,其他權益合計,岱宇,生技醫療業
2020-06-30,1598,OtherEquityInterest_per,-1.65,其他權益合計,岱宇,生技醫療業
2020-06-30,1598,Equity,3061982000.0,權益總額,岱宇,生技醫療業
2020-06-30,1598,Equity_per,32.22,權益總額,岱宇,生技醫療業
2020-09-30,1598,BondsPayable,584043000.0,應付公司債,岱宇,生技醫療業
2020-09-30,1598,CapitalSurplus,1811140000.0,資本公積合計,岱宇,生技醫療業
2020-09-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,5172000.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2020-09-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.05,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2020-09-30,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,5543000.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2020-09-30,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.05,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2020-09-30,1598,CurrentIncomeTaxAssets,2855000.0,本期所得稅資產,岱宇,生技醫療業
2020-09-30,1598,CurrentIncomeTaxAssets_per,0.03,本期所得稅資產,岱宇,生技醫療業
2020-09-30,1598,CurrentProvisions,18118000.0,負債準備－流動,岱宇,生技醫療業
2020-09-30,1598,CurrentProvisions_per,0.16,負債準備－流動,岱宇,生技醫療業
2020-09-30,1598,DeferredTaxAssets,288391000.0,遞延所得稅資產,岱宇,生技醫療業
2020-09-30,1598,DeferredTaxAssets_per,2.59,遞延所得稅資產,岱宇,生技醫療業
2020-09-30,1598,LegalReserve,152827000.0,法定盈餘公積,岱宇,生技醫療業
2020-09-30,1598,LegalReserve_per,1.37,法定盈餘公積,岱宇,生技醫療業
2020-09-30,1598,LongtermBorrowings,829850000.0,長期借款,岱宇,生技醫療業
2020-09-30,1598,NoncontrollingInterests,347174000.0,非控制權益,岱宇,生技醫療業
2020-09-30,1598,OrdinaryShare,1209820000.0,普通股股本,岱宇,生技醫療業
2020-09-30,1598,OtherCurrentLiabilities,214318000.0,其他流動負債,岱宇,生技醫療業
2020-09-30,1598,OtherNoncurrentAssets,105243000.0,其他非流動資產,岱宇,生技醫療業
2020-09-30,1598,OtherNoncurrentLiabilities,128157000.0,其他非流動負債,岱宇,生技醫療業
2020-09-30,1598,OtherNoncurrentLiabilities_per,1.15,其他非流動負債,岱宇,生技醫療業
2020-09-30,1598,OtherPayables,813467000.0,其他應付款,岱宇,生技醫療業
2020-09-30,1598,OtherReceivable,78886000.0,其他應收款淨額,岱宇,生技醫療業
2020-09-30,1598,OtherReceivable_per,0.71,其他應收款淨額,岱宇,生技醫療業
2020-09-30,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2020-09-30,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2020-09-30,1598,CashAndCashEquivalents,1259177000.0,現金及約當現金,岱宇,生技醫療業
2020-09-30,1598,AccountsReceivableNet,1821832000.0,應收帳款淨額,岱宇,生技醫療業
2020-09-30,1598,Inventories,2668939000.0,存貨,岱宇,生技醫療業
2020-09-30,1598,CurrentAssets,6350417000.0,流動資產合計,岱宇,生技醫療業
2020-09-30,1598,PropertyPlantAndEquipment,2593996000.0,不動產、廠房及設備,岱宇,生技醫療業
2020-09-30,1598,ShorttermBorrowings,1023557000.0,短期借款,岱宇,生技醫療業
2020-09-30,1598,AccountsPayable,2075489000.0,應付帳款,岱宇,生技醫療業
2020-09-30,1598,CurrentLiabilities,5098521000.0,流動負債合計,岱宇,生技醫療業
2020-09-30,1598,CapitalStock,1311496000.0,股本合計,岱宇,生技醫療業
2020-09-30,1598,FinancialAssetsAtAmortizedCost,282096000.0,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2020-09-30,1598,FinancialAssetsAtAmortizedCost_per,2.54,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2020-09-30,1598,BillsReceivableNet,2741000.0,應收票據淨額,岱宇,生技醫療業
2020-09-30,1598,BillsReceivableNet_per,0.02,應收票據淨額,岱宇,生技醫療業
2020-09-30,1598,Prepayments,200977000.0,預付款項,岱宇,生技醫療業
2020-09-30,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2020-09-30,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2020-09-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,51966000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2020-09-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.47,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2020-09-30,1598,InvestmentAccountedForUsingEquityMethod,5123000.0,採用權益法之投資,岱宇,生技醫療業
2020-09-30,1598,InvestmentAccountedForUsingEquityMethod_per,0.05,採用權益法之投資,岱宇,生技醫療業
2020-09-30,1598,RightOfUseAsset,342740000.0,使用權資產,岱宇,生技醫療業
2020-09-30,1598,CurrentTaxLiabilities,271532000.0,本期所得稅負債,岱宇,生技醫療業
2020-09-30,1598,OtherEquityInterest_per,-1.57,其他權益合計,岱宇,生技醫療業
2020-09-30,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,7122000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2020-09-30,1598,CashAndCashEquivalents_per,11.32,現金及約當現金,岱宇,生技醫療業
2020-09-30,1598,Prepayments_per,1.81,預付款項,岱宇,生技醫療業
2020-09-30,1598,AccountsReceivableNet_per,16.38,應收帳款淨額,岱宇,生技醫療業
2020-09-30,1598,Inventories_per,23.99,存貨,岱宇,生技醫療業
2020-09-30,1598,OtherCurrentAssets,27742000.0,其他流動資產,岱宇,生技醫療業
2020-09-30,1598,OtherCurrentAssets_per,0.25,其他流動資產,岱宇,生技醫療業
2020-09-30,1598,CurrentAssets_per,57.09,流動資產合計,岱宇,生技醫療業
2020-09-30,1598,PropertyPlantAndEquipment_per,23.32,不動產、廠房及設備,岱宇,生技醫療業
2020-09-30,1598,RightOfUseAsset_per,3.08,使用權資產,岱宇,生技醫療業
2020-09-30,1598,IntangibleAssets,1328198000.0,無形資產,岱宇,生技醫療業
2020-09-30,1598,IntangibleAssets_per,11.94,無形資產,岱宇,生技醫療業
2020-09-30,1598,OtherNoncurrentAssets_per,0.95,其他非流動資產,岱宇,生技醫療業
2020-09-30,1598,NoncurrentAssets,4772653000.0,非流動資產合計,岱宇,生技醫療業
2020-09-30,1598,NoncurrentAssets_per,42.91,非流動資產合計,岱宇,生技醫療業
2020-09-30,1598,TotalAssets,11123070000.0,資產總額,岱宇,生技醫療業
2020-09-30,1598,ShorttermBorrowings_per,9.2,短期借款,岱宇,生技醫療業
2020-09-30,1598,AccountsPayable_per,18.66,應付帳款,岱宇,生技醫療業
2020-09-30,1598,OtherPayables_per,7.31,其他應付款,岱宇,生技醫療業
2020-09-30,1598,CurrentTaxLiabilities_per,2.44,本期所得稅負債,岱宇,生技醫療業
2020-09-30,1598,OtherCurrentLiabilities_per,1.93,其他流動負債,岱宇,生技醫療業
2020-09-30,1598,CurrentLiabilities_per,45.84,流動負債合計,岱宇,生技醫療業
2020-09-30,1598,BondsPayable_per,5.25,應付公司債,岱宇,生技醫療業
2020-09-30,1598,LongtermBorrowings_per,7.46,長期借款,岱宇,生技醫療業
2020-09-30,1598,NoncurrentLiabilities,2060406000.0,非流動負債合計,岱宇,生技醫療業
2020-09-30,1598,NoncurrentLiabilities_per,18.52,非流動負債合計,岱宇,生技醫療業
2020-09-30,1598,Liabilities,7158927000.0,負債總額,岱宇,生技醫療業
2020-09-30,1598,Liabilities_per,64.36,負債總額,岱宇,生技醫療業
2020-09-30,1598,OrdinaryShare_per,10.88,普通股股本,岱宇,生技醫療業
2020-09-30,1598,CapitalStock_per,11.79,股本合計,岱宇,生技醫療業
2020-09-30,1598,CapitalSurplus_per,16.28,資本公積合計,岱宇,生技醫療業
2020-09-30,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit,683163000.0,未分配盈餘,岱宇,生技醫療業
2020-09-30,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,6.14,未分配盈餘,岱宇,生技醫療業
2020-09-30,1598,RetainedEarnings,941802000.0,保留盈餘合計,岱宇,生技醫療業
2020-09-30,1598,RetainedEarnings_per,8.47,保留盈餘合計,岱宇,生技醫療業
2020-09-30,1598,OtherEquityInterest,-174818000.0,其他權益合計,岱宇,生技醫療業
2020-09-30,1598,EquityAttributableToOwnersOfParent,3616969000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2020-09-30,1598,EquityAttributableToOwnersOfParent_per,32.52,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2020-09-30,1598,NoncontrollingInterests_per,3.12,非控制權益,岱宇,生技醫療業
2020-09-30,1598,Equity,3964143000.0,權益總額,岱宇,生技醫療業
2020-09-30,1598,Equity_per,35.64,權益總額,岱宇,生技醫療業
2020-09-30,1598,TotalLiabilitiesEquity,11123070000.0,負債及權益總計,岱宇,生技醫療業
2020-12-31,1598,CashAndCashEquivalents,1542324000.0,現金及約當現金,岱宇,生技醫療業
2020-12-31,1598,CashAndCashEquivalents_per,11.64,現金及約當現金,岱宇,生技醫療業
2020-12-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,2593000.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2020-12-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.02,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2020-12-31,1598,AccountsReceivableNet,3050265000.0,應收帳款淨額,岱宇,生技醫療業
2020-12-31,1598,AccountsReceivableNet_per,23.02,應收帳款淨額,岱宇,生技醫療業
2020-12-31,1598,Inventories,3141741000.0,存貨,岱宇,生技醫療業
2020-12-31,1598,Inventories_per,23.71,存貨,岱宇,生技醫療業
2020-12-31,1598,CurrentAssets,8255861000.0,流動資產合計,岱宇,生技醫療業
2020-12-31,1598,CurrentAssets_per,62.3,流動資產合計,岱宇,生技醫療業
2020-12-31,1598,PropertyPlantAndEquipment,2877597000.0,不動產、廠房及設備,岱宇,生技醫療業
2020-12-31,1598,PropertyPlantAndEquipment_per,21.71,不動產、廠房及設備,岱宇,生技醫療業
2020-12-31,1598,IntangibleAssets,1238670000.0,無形資產,岱宇,生技醫療業
2020-12-31,1598,IntangibleAssets_per,9.35,無形資產,岱宇,生技醫療業
2020-12-31,1598,DeferredTaxAssets,330238000.0,遞延所得稅資產,岱宇,生技醫療業
2020-12-31,1598,DeferredTaxAssets_per,2.49,遞延所得稅資產,岱宇,生技醫療業
2020-12-31,1598,OtherNoncurrentAssets,85767000.0,其他非流動資產,岱宇,生技醫療業
2020-12-31,1598,OtherNoncurrentAssets_per,0.65,其他非流動資產,岱宇,生技醫療業
2020-12-31,1598,NoncurrentAssets,4996127000.0,非流動資產合計,岱宇,生技醫療業
2020-12-31,1598,NoncurrentAssets_per,37.7,非流動資產合計,岱宇,生技醫療業
2020-12-31,1598,TotalAssets,13251988000.0,資產總額,岱宇,生技醫療業
2020-12-31,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2020-12-31,1598,ShorttermBorrowings,1573781000.0,短期借款,岱宇,生技醫療業
2020-12-31,1598,ShorttermBorrowings_per,11.88,短期借款,岱宇,生技醫療業
2020-12-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,1685000.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2020-12-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.01,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2020-12-31,1598,AccountsPayable,2438687000.0,應付帳款,岱宇,生技醫療業
2020-12-31,1598,AccountsPayable_per,18.4,應付帳款,岱宇,生技醫療業
2020-12-31,1598,OtherPayables,1075723000.0,其他應付款,岱宇,生技醫療業
2020-12-31,1598,OtherPayables_per,8.12,其他應付款,岱宇,生技醫療業
2020-12-31,1598,CurrentProvisions,18359000.0,負債準備－流動,岱宇,生技醫療業
2020-12-31,1598,CurrentProvisions_per,0.14,負債準備－流動,岱宇,生技醫療業
2020-12-31,1598,OtherCurrentLiabilities,223830000.0,其他流動負債,岱宇,生技醫療業
2020-12-31,1598,OtherCurrentLiabilities_per,1.69,其他流動負債,岱宇,生技醫療業
2020-12-31,1598,CurrentLiabilities,6608905000.0,流動負債合計,岱宇,生技醫療業
2020-12-31,1598,CurrentLiabilities_per,49.87,流動負債合計,岱宇,生技醫療業
2020-12-31,1598,BondsPayable,462372000.0,應付公司債,岱宇,生技醫療業
2020-12-31,1598,BondsPayable_per,3.49,應付公司債,岱宇,生技醫療業
2020-12-31,1598,LongtermBorrowings,790621000.0,長期借款,岱宇,生技醫療業
2020-12-31,1598,LongtermBorrowings_per,5.97,長期借款,岱宇,生技醫療業
2020-12-31,1598,OtherNoncurrentLiabilities,49014000.0,其他非流動負債,岱宇,生技醫療業
2020-12-31,1598,OtherNoncurrentLiabilities_per,0.37,其他非流動負債,岱宇,生技醫療業
2020-12-31,1598,NoncurrentLiabilities,1773221000.0,非流動負債合計,岱宇,生技醫療業
2020-12-31,1598,NoncurrentLiabilities_per,13.38,非流動負債合計,岱宇,生技醫療業
2020-12-31,1598,OrdinaryShare,1311496000.0,普通股股本,岱宇,生技醫療業
2020-12-31,1598,OrdinaryShare_per,9.9,普通股股本,岱宇,生技醫療業
2020-12-31,1598,CapitalStock,1326523000.0,股本合計,岱宇,生技醫療業
2020-12-31,1598,CapitalStock_per,10.01,股本合計,岱宇,生技醫療業
2020-12-31,1598,CapitalSurplus,1986005000.0,資本公積合計,岱宇,生技醫療業
2020-12-31,1598,CapitalSurplus_per,14.99,資本公積合計,岱宇,生技醫療業
2020-12-31,1598,LegalReserve,152827000.0,法定盈餘公積,岱宇,生技醫療業
2020-12-31,1598,LegalReserve_per,1.15,法定盈餘公積,岱宇,生技醫療業
2020-12-31,1598,RetainedEarnings,1648927000.0,保留盈餘合計,岱宇,生技醫療業
2020-12-31,1598,RetainedEarnings_per,12.44,保留盈餘合計,岱宇,生技醫療業
2020-12-31,1598,EquityAttributableToOwnersOfParent,4513176000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2020-12-31,1598,EquityAttributableToOwnersOfParent_per,34.06,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2020-12-31,1598,NoncontrollingInterests,356686000.0,非控制權益,岱宇,生技醫療業
2020-12-31,1598,NoncontrollingInterests_per,2.69,非控制權益,岱宇,生技醫療業
2020-12-31,1598,TotalLiabilitiesEquity,13251988000.0,負債及權益總計,岱宇,生技醫療業
2020-12-31,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2020-12-31,1598,OtherReceivable,86259000.0,其他應收款淨額,岱宇,生技醫療業
2020-12-31,1598,OtherReceivable_per,0.65,其他應收款淨額,岱宇,生技醫療業
2020-12-31,1598,CurrentIncomeTaxAssets,17980000.0,本期所得稅資產,岱宇,生技醫療業
2020-12-31,1598,CurrentIncomeTaxAssets_per,0.14,本期所得稅資產,岱宇,生技醫療業
2020-12-31,1598,FinancialAssetsAtAmortizedCost,208931000.0,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2020-12-31,1598,FinancialAssetsAtAmortizedCost_per,1.58,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2020-12-31,1598,BillsReceivableNet,2020000.0,應收票據淨額,岱宇,生技醫療業
2020-12-31,1598,BillsReceivableNet_per,0.02,應收票據淨額,岱宇,生技醫療業
2020-12-31,1598,Prepayments,183385000.0,預付款項,岱宇,生技醫療業
2020-12-31,1598,Prepayments_per,1.38,預付款項,岱宇,生技醫療業
2020-12-31,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2020-12-31,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2020-12-31,1598,OtherCurrentAssets,20363000.0,其他流動資產,岱宇,生技醫療業
2020-12-31,1598,OtherCurrentAssets_per,0.15,其他流動資產,岱宇,生技醫療業
2020-12-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,51165000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2020-12-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.39,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2020-12-31,1598,InvestmentAccountedForUsingEquityMethod,5252000.0,採用權益法之投資,岱宇,生技醫療業
2020-12-31,1598,InvestmentAccountedForUsingEquityMethod_per,0.04,採用權益法之投資,岱宇,生技醫療業
2020-12-31,1598,RightOfUseAsset,350377000.0,使用權資產,岱宇,生技醫療業
2020-12-31,1598,RightOfUseAsset_per,2.64,使用權資產,岱宇,生技醫療業
2020-12-31,1598,CurrentTaxLiabilities,401093000.0,本期所得稅負債,岱宇,生技醫療業
2020-12-31,1598,CurrentTaxLiabilities_per,3.03,本期所得稅負債,岱宇,生技醫療業
2020-12-31,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit,1390288000.0,未分配盈餘,岱宇,生技醫療業
2020-12-31,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,10.49,未分配盈餘,岱宇,生技醫療業
2020-12-31,1598,OtherEquityInterest,-175628000.0,其他權益合計,岱宇,生技醫療業
2020-12-31,1598,OtherEquityInterest_per,-1.33,其他權益合計,岱宇,生技醫療業
2020-12-31,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,7122000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2020-12-31,1598,Equity,4869862000.0,權益總額,岱宇,生技醫療業
2020-12-31,1598,Equity_per,36.75,權益總額,岱宇,生技醫療業
2020-12-31,1598,Liabilities,8382126000.0,負債總額,岱宇,生技醫療業
2020-12-31,1598,Liabilities_per,63.25,負債總額,岱宇,生技醫療業
2021-03-31,1598,CashAndCashEquivalents,1541677000.0,現金及約當現金,岱宇,生技醫療業
2021-03-31,1598,CashAndCashEquivalents_per,11.85,現金及約當現金,岱宇,生技醫療業
2021-03-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,2446000.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2021-03-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.02,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2021-03-31,1598,AccountsReceivableNet,2474866000.0,應收帳款淨額,岱宇,生技醫療業
2021-03-31,1598,AccountsReceivableNet_per,19.02,應收帳款淨額,岱宇,生技醫療業
2021-03-31,1598,Inventories,3505558000.0,存貨,岱宇,生技醫療業
2021-03-31,1598,Inventories_per,26.95,存貨,岱宇,生技醫療業
2021-03-31,1598,OtherCurrentAssets,18873000.0,其他流動資產,岱宇,生技醫療業
2021-03-31,1598,OtherCurrentAssets_per,0.15,其他流動資產,岱宇,生技醫療業
2021-03-31,1598,CurrentAssets,7990726000.0,流動資產合計,岱宇,生技醫療業
2021-03-31,1598,CurrentAssets_per,61.42,流動資產合計,岱宇,生技醫療業
2021-03-31,1598,PropertyPlantAndEquipment,2848304000.0,不動產、廠房及設備,岱宇,生技醫療業
2021-03-31,1598,PropertyPlantAndEquipment_per,21.89,不動產、廠房及設備,岱宇,生技醫療業
2021-03-31,1598,IntangibleAssets,1230372000.0,無形資產,岱宇,生技醫療業
2021-03-31,1598,IntangibleAssets_per,9.46,無形資產,岱宇,生技醫療業
2021-03-31,1598,DeferredTaxAssets,387474000.0,遞延所得稅資產,岱宇,生技醫療業
2021-03-31,1598,DeferredTaxAssets_per,2.98,遞延所得稅資產,岱宇,生技醫療業
2021-03-31,1598,OtherNoncurrentAssets,98877000.0,其他非流動資產,岱宇,生技醫療業
2021-03-31,1598,OtherNoncurrentAssets_per,0.76,其他非流動資產,岱宇,生技醫療業
2021-03-31,1598,NoncurrentAssets,5019025000.0,非流動資產合計,岱宇,生技醫療業
2021-03-31,1598,NoncurrentAssets_per,38.58,非流動資產合計,岱宇,生技醫療業
2021-03-31,1598,TotalAssets,13009751000.0,資產總額,岱宇,生技醫療業
2021-03-31,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2021-03-31,1598,ShorttermBorrowings,1874403000.0,短期借款,岱宇,生技醫療業
2021-03-31,1598,ShorttermBorrowings_per,14.41,短期借款,岱宇,生技醫療業
2021-03-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,1121000.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2021-03-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.01,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2021-03-31,1598,AccountsPayable,2016120000.0,應付帳款,岱宇,生技醫療業
2021-03-31,1598,AccountsPayable_per,15.5,應付帳款,岱宇,生技醫療業
2021-03-31,1598,OtherPayables,1707521000.0,其他應付款,岱宇,生技醫療業
2021-03-31,1598,OtherPayables_per,13.12,其他應付款,岱宇,生技醫療業
2021-03-31,1598,CurrentProvisions,18863000.0,負債準備－流動,岱宇,生技醫療業
2021-03-31,1598,CurrentProvisions_per,0.14,負債準備－流動,岱宇,生技醫療業
2021-03-31,1598,OtherCurrentLiabilities,222377000.0,其他流動負債,岱宇,生技醫療業
2021-03-31,1598,OtherCurrentLiabilities_per,1.71,其他流動負債,岱宇,生技醫療業
2021-03-31,1598,CurrentLiabilities,7050619000.0,流動負債合計,岱宇,生技醫療業
2021-03-31,1598,CurrentLiabilities_per,54.19,流動負債合計,岱宇,生技醫療業
2021-03-31,1598,BondsPayable,414747000.0,應付公司債,岱宇,生技醫療業
2021-03-31,1598,BondsPayable_per,3.19,應付公司債,岱宇,生技醫療業
2021-03-31,1598,LongtermBorrowings,751083000.0,長期借款,岱宇,生技醫療業
2021-03-31,1598,LongtermBorrowings_per,5.77,長期借款,岱宇,生技醫療業
2021-03-31,1598,OtherNoncurrentLiabilities,58655000.0,其他非流動負債,岱宇,生技醫療業
2021-03-31,1598,OtherNoncurrentLiabilities_per,0.45,其他非流動負債,岱宇,生技醫療業
2021-03-31,1598,NoncurrentLiabilities,1701194000.0,非流動負債合計,岱宇,生技醫療業
2021-03-31,1598,NoncurrentLiabilities_per,13.08,非流動負債合計,岱宇,生技醫療業
2021-03-31,1598,OrdinaryShare,1326523000.0,普通股股本,岱宇,生技醫療業
2021-03-31,1598,OrdinaryShare_per,10.2,普通股股本,岱宇,生技醫療業
2021-03-31,1598,CapitalStock,1334442000.0,股本合計,岱宇,生技醫療業
2021-03-31,1598,CapitalStock_per,10.26,股本合計,岱宇,生技醫療業
2021-03-31,1598,CapitalSurplus,2030983000.0,資本公積合計,岱宇,生技醫療業
2021-03-31,1598,CapitalSurplus_per,15.61,資本公積合計,岱宇,生技醫療業
2021-03-31,1598,LegalReserve,152827000.0,法定盈餘公積,岱宇,生技醫療業
2021-03-31,1598,LegalReserve_per,1.17,法定盈餘公積,岱宇,生技醫療業
2021-03-31,1598,RetainedEarnings,960688000.0,保留盈餘合計,岱宇,生技醫療業
2021-03-31,1598,RetainedEarnings_per,7.38,保留盈餘合計,岱宇,生技醫療業
2021-03-31,1598,EquityAttributableToOwnersOfParent,3900951000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2021-03-31,1598,EquityAttributableToOwnersOfParent_per,29.98,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2021-03-31,1598,NoncontrollingInterests,356987000.0,非控制權益,岱宇,生技醫療業
2021-03-31,1598,NoncontrollingInterests_per,2.74,非控制權益,岱宇,生技醫療業
2021-03-31,1598,TotalLiabilitiesEquity,13009751000.0,負債及權益總計,岱宇,生技醫療業
2021-03-31,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2021-03-31,1598,OtherReceivable,49858000.0,其他應收款淨額,岱宇,生技醫療業
2021-03-31,1598,OtherReceivable_per,0.38,其他應收款淨額,岱宇,生技醫療業
2021-03-31,1598,CurrentIncomeTaxAssets,26918000.0,本期所得稅資產,岱宇,生技醫療業
2021-03-31,1598,CurrentIncomeTaxAssets_per,0.21,本期所得稅資產,岱宇,生技醫療業
2021-03-31,1598,FinancialAssetsAtAmortizedCost,208999000.0,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2021-03-31,1598,FinancialAssetsAtAmortizedCost_per,1.61,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2021-03-31,1598,BillsReceivableNet,1370000.0,應收票據淨額,岱宇,生技醫療業
2021-03-31,1598,BillsReceivableNet_per,0.01,應收票據淨額,岱宇,生技醫療業
2021-03-31,1598,Prepayments,160161000.0,預付款項,岱宇,生技醫療業
2021-03-31,1598,Prepayments_per,1.23,預付款項,岱宇,生技醫療業
2021-03-31,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2021-03-31,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2021-03-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,51089000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2021-03-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.39,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2021-03-31,1598,InvestmentAccountedForUsingEquityMethod,5213000.0,採用權益法之投資,岱宇,生技醫療業
2021-03-31,1598,InvestmentAccountedForUsingEquityMethod_per,0.04,採用權益法之投資,岱宇,生技醫療業
2021-03-31,1598,RightOfUseAsset,341732000.0,使用權資產,岱宇,生技醫療業
2021-03-31,1598,RightOfUseAsset_per,2.63,使用權資產,岱宇,生技醫療業
2021-03-31,1598,CurrentTaxLiabilities,495687000.0,本期所得稅負債,岱宇,生技醫療業
2021-03-31,1598,CurrentTaxLiabilities_per,3.81,本期所得稅負債,岱宇,生技醫療業
2021-03-31,1598,Liabilities,8751813000.0,負債總額,岱宇,生技醫療業
2021-03-31,1598,Liabilities_per,67.27,負債總額,岱宇,生技醫療業
2021-03-31,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit,702049000.0,未分配盈餘,岱宇,生技醫療業
2021-03-31,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,5.4,未分配盈餘,岱宇,生技醫療業
2021-03-31,1598,OtherEquityInterest,-181144000.0,其他權益合計,岱宇,生技醫療業
2021-03-31,1598,OtherEquityInterest_per,-1.39,其他權益合計,岱宇,生技醫療業
2021-03-31,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,6374000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2021-03-31,1598,Equity,4257938000.0,權益總額,岱宇,生技醫療業
2021-03-31,1598,Equity_per,32.73,權益總額,岱宇,生技醫療業
2021-06-30,1598,CashAndCashEquivalents,1091551000.0,現金及約當現金,岱宇,生技醫療業
2021-06-30,1598,CashAndCashEquivalents_per,9.01,現金及約當現金,岱宇,生技醫療業
2021-06-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,2644000.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2021-06-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.02,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2021-06-30,1598,AccountsReceivableNet,2016131000.0,應收帳款淨額,岱宇,生技醫療業
2021-06-30,1598,AccountsReceivableNet_per,16.64,應收帳款淨額,岱宇,生技醫療業
2021-06-30,1598,Inventories,3592469000.0,存貨,岱宇,生技醫療業
2021-06-30,1598,Inventories_per,29.65,存貨,岱宇,生技醫療業
2021-06-30,1598,OtherCurrentAssets,19361000.0,其他流動資產,岱宇,生技醫療業
2021-06-30,1598,OtherCurrentAssets_per,0.16,其他流動資產,岱宇,生技醫療業
2021-06-30,1598,CurrentAssets,7192435000.0,流動資產合計,岱宇,生技醫療業
2021-06-30,1598,CurrentAssets_per,59.36,流動資產合計,岱宇,生技醫療業
2021-06-30,1598,PropertyPlantAndEquipment,2793308000.0,不動產、廠房及設備,岱宇,生技醫療業
2021-06-30,1598,PropertyPlantAndEquipment_per,23.05,不動產、廠房及設備,岱宇,生技醫療業
2021-06-30,1598,IntangibleAssets,1186564000.0,無形資產,岱宇,生技醫療業
2021-06-30,1598,IntangibleAssets_per,9.79,無形資產,岱宇,生技醫療業
2021-06-30,1598,DeferredTaxAssets,410254000.0,遞延所得稅資產,岱宇,生技醫療業
2021-06-30,1598,DeferredTaxAssets_per,3.39,遞延所得稅資產,岱宇,生技醫療業
2021-06-30,1598,OtherNoncurrentAssets,78779000.0,其他非流動資產,岱宇,生技醫療業
2021-06-30,1598,OtherNoncurrentAssets_per,0.65,其他非流動資產,岱宇,生技醫療業
2021-06-30,1598,NoncurrentAssets,4924109000.0,非流動資產合計,岱宇,生技醫療業
2021-06-30,1598,NoncurrentAssets_per,40.64,非流動資產合計,岱宇,生技醫療業
2021-06-30,1598,TotalAssets,12116544000.0,資產總額,岱宇,生技醫療業
2021-06-30,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2021-06-30,1598,ShorttermBorrowings,1348817000.0,短期借款,岱宇,生技醫療業
2021-06-30,1598,ShorttermBorrowings_per,11.13,短期借款,岱宇,生技醫療業
2021-06-30,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,1846000.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2021-06-30,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.02,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2021-06-30,1598,AccountsPayable,1815917000.0,應付帳款,岱宇,生技醫療業
2021-06-30,1598,AccountsPayable_per,14.99,應付帳款,岱宇,生技醫療業
2021-06-30,1598,OtherPayables,1441795000.0,其他應付款,岱宇,生技醫療業
2021-06-30,1598,OtherPayables_per,11.9,其他應付款,岱宇,生技醫療業
2021-06-30,1598,CurrentProvisions,17653000.0,負債準備－流動,岱宇,生技醫療業
2021-06-30,1598,CurrentProvisions_per,0.15,負債準備－流動,岱宇,生技醫療業
2021-06-30,1598,OtherCurrentLiabilities,223553000.0,其他流動負債,岱宇,生技醫療業
2021-06-30,1598,OtherCurrentLiabilities_per,1.85,其他流動負債,岱宇,生技醫療業
2021-06-30,1598,CurrentLiabilities,5193547000.0,流動負債合計,岱宇,生技醫療業
2021-06-30,1598,CurrentLiabilities_per,42.86,流動負債合計,岱宇,生技醫療業
2021-06-30,1598,BondsPayable,1369828000.0,應付公司債,岱宇,生技醫療業
2021-06-30,1598,BondsPayable_per,11.31,應付公司債,岱宇,生技醫療業
2021-06-30,1598,LongtermBorrowings,710732000.0,長期借款,岱宇,生技醫療業
2021-06-30,1598,LongtermBorrowings_per,5.87,長期借款,岱宇,生技醫療業
2021-06-30,1598,OtherNoncurrentLiabilities,57908000.0,其他非流動負債,岱宇,生技醫療業
2021-06-30,1598,OtherNoncurrentLiabilities_per,0.48,其他非流動負債,岱宇,生技醫療業
2021-06-30,1598,NoncurrentLiabilities,2602560000.0,非流動負債合計,岱宇,生技醫療業
2021-06-30,1598,NoncurrentLiabilities_per,21.48,非流動負債合計,岱宇,生技醫療業
2021-06-30,1598,OrdinaryShare,1334442000.0,普通股股本,岱宇,生技醫療業
2021-06-30,1598,OrdinaryShare_per,11.01,普通股股本,岱宇,生技醫療業
2021-06-30,1598,CapitalStock,1339822000.0,股本合計,岱宇,生技醫療業
2021-06-30,1598,CapitalStock_per,11.06,股本合計,岱宇,生技醫療業
2021-06-30,1598,CapitalSurplus,2086720000.0,資本公積合計,岱宇,生技醫療業
2021-06-30,1598,CapitalSurplus_per,17.22,資本公積合計,岱宇,生技醫療業
2021-06-30,1598,LegalReserve,152827000.0,法定盈餘公積,岱宇,生技醫療業
2021-06-30,1598,LegalReserve_per,1.26,法定盈餘公積,岱宇,生技醫療業
2021-06-30,1598,RetainedEarnings,1011598000.0,保留盈餘合計,岱宇,生技醫療業
2021-06-30,1598,RetainedEarnings_per,8.35,保留盈餘合計,岱宇,生技醫療業
2021-06-30,1598,EquityAttributableToOwnersOfParent,3975374000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2021-06-30,1598,EquityAttributableToOwnersOfParent_per,32.81,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2021-06-30,1598,NoncontrollingInterests,345063000.0,非控制權益,岱宇,生技醫療業
2021-06-30,1598,NoncontrollingInterests_per,2.85,非控制權益,岱宇,生技醫療業
2021-06-30,1598,TotalLiabilitiesEquity,12116544000.0,負債及權益總計,岱宇,生技醫療業
2021-06-30,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2021-06-30,1598,OtherReceivable,38183000.0,其他應收款淨額,岱宇,生技醫療業
2021-06-30,1598,OtherReceivable_per,0.32,其他應收款淨額,岱宇,生技醫療業
2021-06-30,1598,CurrentIncomeTaxAssets,37028000.0,本期所得稅資產,岱宇,生技醫療業
2021-06-30,1598,CurrentIncomeTaxAssets_per,0.31,本期所得稅資產,岱宇,生技醫療業
2021-06-30,1598,FinancialAssetsAtAmortizedCost,237720000.0,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2021-06-30,1598,FinancialAssetsAtAmortizedCost_per,1.96,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2021-06-30,1598,BillsReceivableNet,6467000.0,應收票據淨額,岱宇,生技醫療業
2021-06-30,1598,BillsReceivableNet_per,0.05,應收票據淨額,岱宇,生技醫療業
2021-06-30,1598,Prepayments,150881000.0,預付款項,岱宇,生技醫療業
2021-06-30,1598,Prepayments_per,1.25,預付款項,岱宇,生技醫療業
2021-06-30,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2021-06-30,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2021-06-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,56409000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2021-06-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.47,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2021-06-30,1598,FinancialAssetsAtAmortizedCostNonCurrent,0.0,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2021-06-30,1598,FinancialAssetsAtAmortizedCostNonCurrent_per,0.0,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2021-06-30,1598,InvestmentAccountedForUsingEquityMethod,4540000.0,採用權益法之投資,岱宇,生技醫療業
2021-06-30,1598,InvestmentAccountedForUsingEquityMethod_per,0.04,採用權益法之投資,岱宇,生技醫療業
2021-06-30,1598,RightOfUseAsset,339395000.0,使用權資產,岱宇,生技醫療業
2021-06-30,1598,RightOfUseAsset_per,2.8,使用權資產,岱宇,生技醫療業
2021-06-30,1598,CurrentTaxLiabilities,189896000.0,本期所得稅負債,岱宇,生技醫療業
2021-06-30,1598,CurrentTaxLiabilities_per,1.57,本期所得稅負債,岱宇,生技醫療業
2021-06-30,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit,752959000.0,未分配盈餘,岱宇,生技醫療業
2021-06-30,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,6.21,未分配盈餘,岱宇,生技醫療業
2021-06-30,1598,OtherEquityInterest,-218748000.0,其他權益合計,岱宇,生技醫療業
2021-06-30,1598,OtherEquityInterest_per,-1.81,其他權益合計,岱宇,生技醫療業
2021-06-30,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,6374000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2021-06-30,1598,Equity,4320437000.0,權益總額,岱宇,生技醫療業
2021-06-30,1598,Equity_per,35.66,權益總額,岱宇,生技醫療業
2021-06-30,1598,Liabilities,7796107000.0,負債總額,岱宇,生技醫療業
2021-06-30,1598,Liabilities_per,64.34,負債總額,岱宇,生技醫療業
2021-09-30,1598,CashAndCashEquivalents,938206000.0,現金及約當現金,岱宇,生技醫療業
2021-09-30,1598,CashAndCashEquivalents_per,7.64,現金及約當現金,岱宇,生技醫療業
2021-09-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,156000.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2021-09-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2021-09-30,1598,AccountsReceivableNet,2023362000.0,應收帳款淨額,岱宇,生技醫療業
2021-09-30,1598,AccountsReceivableNet_per,16.47,應收帳款淨額,岱宇,生技醫療業
2021-09-30,1598,Inventories,3660768000.0,存貨,岱宇,生技醫療業
2021-09-30,1598,Inventories_per,29.8,存貨,岱宇,生技醫療業
2021-09-30,1598,OtherCurrentAssets,21312000.0,其他流動資產,岱宇,生技醫療業
2021-09-30,1598,OtherCurrentAssets_per,0.17,其他流動資產,岱宇,生技醫療業
2021-09-30,1598,CurrentAssets,7130480000.0,流動資產合計,岱宇,生技醫療業
2021-09-30,1598,CurrentAssets_per,58.04,流動資產合計,岱宇,生技醫療業
2021-09-30,1598,PropertyPlantAndEquipment,2831128000.0,不動產、廠房及設備,岱宇,生技醫療業
2021-09-30,1598,PropertyPlantAndEquipment_per,23.04,不動產、廠房及設備,岱宇,生技醫療業
2021-09-30,1598,IntangibleAssets,1228503000.0,無形資產,岱宇,生技醫療業
2021-09-30,1598,IntangibleAssets_per,10.0,無形資產,岱宇,生技醫療業
2021-09-30,1598,DeferredTaxAssets,402410000.0,遞延所得稅資產,岱宇,生技醫療業
2021-09-30,1598,DeferredTaxAssets_per,3.28,遞延所得稅資產,岱宇,生技醫療業
2021-09-30,1598,OtherNoncurrentAssets,75058000.0,其他非流動資產,岱宇,生技醫療業
2021-09-30,1598,OtherNoncurrentAssets_per,0.61,其他非流動資產,岱宇,生技醫療業
2021-09-30,1598,NoncurrentAssets_per,41.96,非流動資產合計,岱宇,生技醫療業
2021-09-30,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2021-09-30,1598,ShorttermBorrowings,2820225000.0,短期借款,岱宇,生技醫療業
2021-09-30,1598,ShorttermBorrowings_per,22.95,短期借款,岱宇,生技醫療業
2021-09-30,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,9465000.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2021-09-30,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.08,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2021-09-30,1598,AccountsPayable,1539456000.0,應付帳款,岱宇,生技醫療業
2021-09-30,1598,AccountsPayable_per,12.53,應付帳款,岱宇,生技醫療業
2021-09-30,1598,OtherPayables,399183000.0,其他應付款,岱宇,生技醫療業
2021-09-30,1598,OtherPayables_per,3.25,其他應付款,岱宇,生技醫療業
2021-09-30,1598,CurrentProvisions,19280000.0,負債準備－流動,岱宇,生技醫療業
2021-09-30,1598,CurrentProvisions_per,0.16,負債準備－流動,岱宇,生技醫療業
2021-09-30,1598,OtherCurrentLiabilities,230524000.0,其他流動負債,岱宇,生技醫療業
2021-09-30,1598,OtherCurrentLiabilities_per,1.88,其他流動負債,岱宇,生技醫療業
2021-09-30,1598,CurrentLiabilities,5154406000.0,流動負債合計,岱宇,生技醫療業
2021-09-30,1598,CurrentLiabilities_per,41.95,流動負債合計,岱宇,生技醫療業
2021-09-30,1598,BondsPayable,1374706000.0,應付公司債,岱宇,生技醫療業
2021-09-30,1598,BondsPayable_per,11.19,應付公司債,岱宇,生技醫療業
2021-09-30,1598,LongtermBorrowings,669715000.0,長期借款,岱宇,生技醫療業
2021-09-30,1598,LongtermBorrowings_per,5.45,長期借款,岱宇,生技醫療業
2021-09-30,1598,OtherNoncurrentLiabilities,140719000.0,其他非流動負債,岱宇,生技醫療業
2021-09-30,1598,OtherNoncurrentLiabilities_per,1.15,其他非流動負債,岱宇,生技醫療業
2021-09-30,1598,NoncurrentLiabilities,2654924000.0,非流動負債合計,岱宇,生技醫療業
2021-09-30,1598,NoncurrentLiabilities_per,21.61,非流動負債合計,岱宇,生技醫療業
2021-09-30,1598,OrdinaryShare,1339822000.0,普通股股本,岱宇,生技醫療業
2021-09-30,1598,OrdinaryShare_per,10.91,普通股股本,岱宇,生技醫療業
2021-09-30,1598,CapitalStock,1339822000.0,股本合計,岱宇,生技醫療業
2021-09-30,1598,CapitalStock_per,10.91,股本合計,岱宇,生技醫療業
2021-09-30,1598,CapitalSurplus,2111368000.0,資本公積合計,岱宇,生技醫療業
2021-09-30,1598,LegalReserve,284853000.0,法定盈餘公積,岱宇,生技醫療業
2021-09-30,1598,LegalReserve_per,2.32,法定盈餘公積,岱宇,生技醫療業
2021-09-30,1598,RetainedEarnings_per,9.13,保留盈餘合計,岱宇,生技醫療業
2021-09-30,1598,NoncontrollingInterests,341865000.0,非控制權益,岱宇,生技醫療業
2021-09-30,1598,NoncontrollingInterests_per,2.78,非控制權益,岱宇,生技醫療業
2021-09-30,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2021-09-30,1598,OtherReceivable,28912000.0,其他應收款淨額,岱宇,生技醫療業
2021-09-30,1598,OtherReceivable_per,0.24,其他應收款淨額,岱宇,生技醫療業
2021-09-30,1598,CurrentIncomeTaxAssets,57715000.0,本期所得稅資產,岱宇,生技醫療業
2021-09-30,1598,CurrentIncomeTaxAssets_per,0.47,本期所得稅資產,岱宇,生技醫療業
2021-09-30,1598,FinancialAssetsAtAmortizedCost,237694000.0,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2021-09-30,1598,FinancialAssetsAtAmortizedCost_per,1.93,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2021-09-30,1598,BillsReceivableNet,1006000.0,應收票據淨額,岱宇,生技醫療業
2021-09-30,1598,BillsReceivableNet_per,0.01,應收票據淨額,岱宇,生技醫療業
2021-09-30,1598,Prepayments,161349000.0,預付款項,岱宇,生技醫療業
2021-09-30,1598,Prepayments_per,1.31,預付款項,岱宇,生技醫療業
2021-09-30,1598,FinancialAssetsAtAmortizedCostNonCurrent,0.0,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2021-09-30,1598,FinancialAssetsAtAmortizedCostNonCurrent_per,0.0,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2021-09-30,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,138750000.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2021-09-30,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.13,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2021-09-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,63900000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2021-09-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.52,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2021-09-30,1598,InvestmentAccountedForUsingEquityMethod_per,0.25,採用權益法之投資,岱宇,生技醫療業
2021-09-30,1598,RightOfUseAsset,330816000.0,使用權資產,岱宇,生技醫療業
2021-09-30,1598,RightOfUseAsset_per,2.69,使用權資產,岱宇,生技醫療業
2021-09-30,1598,CurrentTaxLiabilities,36823000.0,本期所得稅負債,岱宇,生技醫療業
2021-09-30,1598,CurrentTaxLiabilities_per,0.3,本期所得稅負債,岱宇,生技醫療業
2021-09-30,1598,Liabilities,7809330000.0,負債總額,岱宇,生技醫療業
2021-09-30,1598,Liabilities_per,63.56,負債總額,岱宇,生技醫療業
2021-09-30,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,5.39,未分配盈餘,岱宇,生技醫療業
2021-09-30,1598,OtherEquityInterest,-227021000.0,其他權益合計,岱宇,生技醫療業
2021-09-30,1598,OtherEquityInterest_per,-1.85,其他權益合計,岱宇,生技醫療業
2021-09-30,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,5525000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2021-09-30,1598,InvestmentAccountedForUsingEquityMethod,31019000.0,採用權益法之投資,岱宇,生技醫療業
2021-09-30,1598,NoncurrentAssets,5155590000.0,非流動資產合計,岱宇,生技醫療業
2021-09-30,1598,TotalAssets,12286070000.0,資產總額,岱宇,生技醫療業
2021-09-30,1598,CapitalSurplus_per,17.19,資本公積合計,岱宇,生技醫療業
2021-09-30,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit,661743000.0,未分配盈餘,岱宇,生技醫療業
2021-09-30,1598,RetainedEarnings,1122224000.0,保留盈餘合計,岱宇,生技醫療業
2021-09-30,1598,EquityAttributableToOwnersOfParent,4134875000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2021-09-30,1598,EquityAttributableToOwnersOfParent_per,33.65,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2021-09-30,1598,TotalLiabilitiesEquity,12286070000.0,負債及權益總計,岱宇,生技醫療業
2021-09-30,1598,Equity,4476797000.0,權益總額,岱宇,生技醫療業
2021-09-30,1598,Equity_per,36.44,權益總額,岱宇,生技醫療業
2021-12-31,1598,CashAndCashEquivalents,1212636000.0,現金及約當現金,岱宇,生技醫療業
2021-12-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2021-12-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2021-12-31,1598,AccountsReceivableNet,1647028000.0,應收帳款淨額,岱宇,生技醫療業
2021-12-31,1598,Inventories,3531206000.0,存貨,岱宇,生技醫療業
2021-12-31,1598,OtherCurrentAssets,22631000.0,其他流動資產,岱宇,生技醫療業
2021-12-31,1598,OtherCurrentAssets_per,0.19,其他流動資產,岱宇,生技醫療業
2021-12-31,1598,CurrentAssets,6967059000.0,流動資產合計,岱宇,生技醫療業
2021-12-31,1598,DeferredTaxAssets,383136000.0,遞延所得稅資產,岱宇,生技醫療業
2021-12-31,1598,OtherNoncurrentAssets,31941000.0,其他非流動資產,岱宇,生技醫療業
2021-12-31,1598,OtherNoncurrentAssets_per,0.26,其他非流動資產,岱宇,生技醫療業
2021-12-31,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2021-12-31,1598,ShorttermBorrowings,2866075000.0,短期借款,岱宇,生技醫療業
2021-12-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,14135000.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2021-12-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.12,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2021-12-31,1598,AccountsPayable,1338034000.0,應付帳款,岱宇,生技醫療業
2021-12-31,1598,CurrentProvisions,19343000.0,負債準備－流動,岱宇,生技醫療業
2021-12-31,1598,CurrentProvisions_per,0.16,負債準備－流動,岱宇,生技醫療業
2021-12-31,1598,OtherCurrentLiabilities,309373000.0,其他流動負債,岱宇,生技醫療業
2021-12-31,1598,OtherCurrentLiabilities_per,2.54,其他流動負債,岱宇,生技醫療業
2021-12-31,1598,BondsPayable,1379436000.0,應付公司債,岱宇,生技醫療業
2021-12-31,1598,LongtermBorrowings,557615000.0,長期借款,岱宇,生技醫療業
2021-12-31,1598,OtherNoncurrentLiabilities,129110000.0,其他非流動負債,岱宇,生技醫療業
2021-12-31,1598,OtherNoncurrentLiabilities_per,1.06,其他非流動負債,岱宇,生技醫療業
2021-12-31,1598,OrdinaryShare,1339822000.0,普通股股本,岱宇,生技醫療業
2021-12-31,1598,CapitalStock,1340222000.0,股本合計,岱宇,生技醫療業
2021-12-31,1598,CapitalSurplus,2115925000.0,資本公積合計,岱宇,生技醫療業
2021-12-31,1598,LegalReserve,284853000.0,法定盈餘公積,岱宇,生技醫療業
2021-12-31,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2021-12-31,1598,OtherReceivable,68090000.0,其他應收款淨額,岱宇,生技醫療業
2021-12-31,1598,OtherReceivable_per,0.56,其他應收款淨額,岱宇,生技醫療業
2021-12-31,1598,CurrentIncomeTaxAssets,35596000.0,本期所得稅資產,岱宇,生技醫療業
2021-12-31,1598,CurrentIncomeTaxAssets_per,0.29,本期所得稅資產,岱宇,生技醫療業
2021-12-31,1598,FinancialAssetsAtAmortizedCost,292394000.0,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2021-12-31,1598,FinancialAssetsAtAmortizedCost_per,2.4,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2021-12-31,1598,BillsReceivableNet,1490000.0,應收票據淨額,岱宇,生技醫療業
2021-12-31,1598,BillsReceivableNet_per,0.01,應收票據淨額,岱宇,生技醫療業
2021-12-31,1598,Prepayments,155988000.0,預付款項,岱宇,生技醫療業
2021-12-31,1598,Prepayments_per,1.28,預付款項,岱宇,生技醫療業
2021-12-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,58785000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2021-12-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.48,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2021-12-31,1598,FinancialAssetsAtAmortizedCostNonCurrent,0.0,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2021-12-31,1598,FinancialAssetsAtAmortizedCostNonCurrent_per,0.0,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2021-12-31,1598,OtherReceivablesDueFromRelatedParties,0.0,其他應收款－關係人淨額,岱宇,生技醫療業
2021-12-31,1598,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,岱宇,生技醫療業
2021-12-31,1598,InvestmentAccountedForUsingEquityMethod_per,0.24,採用權益法之投資,岱宇,生技醫療業
2021-12-31,1598,RightOfUseAsset,328889000.0,使用權資產,岱宇,生技醫療業
2021-12-31,1598,RightOfUseAsset_per,2.7,使用權資產,岱宇,生技醫療業
2021-12-31,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,8013000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2021-12-31,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,139035000.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2021-12-31,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.14,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2021-12-31,1598,CashAndCashEquivalents_per,9.96,現金及約當現金,岱宇,生技醫療業
2021-12-31,1598,AccountsReceivableNet_per,13.53,應收帳款淨額,岱宇,生技醫療業
2021-12-31,1598,Inventories_per,29.0,存貨,岱宇,生技醫療業
2021-12-31,1598,CurrentAssets_per,57.22,流動資產合計,岱宇,生技醫療業
2021-12-31,1598,InvestmentAccountedForUsingEquityMethod,29706000.0,採用權益法之投資,岱宇,生技醫療業
2021-12-31,1598,PropertyPlantAndEquipment,2913174000.0,不動產、廠房及設備,岱宇,生技醫療業
2021-12-31,1598,PropertyPlantAndEquipment_per,23.92,不動產、廠房及設備,岱宇,生技醫療業
2021-12-31,1598,IntangibleAssets,1271421000.0,無形資產,岱宇,生技醫療業
2021-12-31,1598,IntangibleAssets_per,10.44,無形資產,岱宇,生技醫療業
2021-12-31,1598,DeferredTaxAssets_per,3.15,遞延所得稅資產,岱宇,生技醫療業
2021-12-31,1598,NoncurrentAssets,5209568000.0,非流動資產合計,岱宇,生技醫療業
2021-12-31,1598,NoncurrentAssets_per,42.78,非流動資產合計,岱宇,生技醫療業
2021-12-31,1598,TotalAssets,12176627000.0,資產總額,岱宇,生技醫療業
2021-12-31,1598,ShorttermBorrowings_per,23.54,短期借款,岱宇,生技醫療業
2021-12-31,1598,AccountsPayable_per,10.99,應付帳款,岱宇,生技醫療業
2021-12-31,1598,OtherPayables,650538000.0,其他應付款,岱宇,生技醫療業
2021-12-31,1598,OtherPayables_per,5.34,其他應付款,岱宇,生技醫療業
2021-12-31,1598,CurrentTaxLiabilities,27907000.0,本期所得稅負債,岱宇,生技醫療業
2021-12-31,1598,CurrentTaxLiabilities_per,0.23,本期所得稅負債,岱宇,生技醫療業
2021-12-31,1598,CurrentLiabilities,5298005000.0,流動負債合計,岱宇,生技醫療業
2021-12-31,1598,CurrentLiabilities_per,43.51,流動負債合計,岱宇,生技醫療業
2021-12-31,1598,BondsPayable_per,11.33,應付公司債,岱宇,生技醫療業
2021-12-31,1598,LongtermBorrowings_per,4.58,長期借款,岱宇,生技醫療業
2021-12-31,1598,NoncurrentLiabilities,2509183000.0,非流動負債合計,岱宇,生技醫療業
2021-12-31,1598,NoncurrentLiabilities_per,20.61,非流動負債合計,岱宇,生技醫療業
2021-12-31,1598,Liabilities,7807188000.0,負債總額,岱宇,生技醫療業
2021-12-31,1598,Liabilities_per,64.12,負債總額,岱宇,生技醫療業
2021-12-31,1598,OrdinaryShare_per,11.0,普通股股本,岱宇,生技醫療業
2021-12-31,1598,CapitalStock_per,11.01,股本合計,岱宇,生技醫療業
2021-12-31,1598,CapitalSurplus_per,17.38,資本公積合計,岱宇,生技醫療業
2021-12-31,1598,LegalReserve_per,2.34,法定盈餘公積,岱宇,生技醫療業
2021-12-31,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit,676913000.0,未分配盈餘,岱宇,生技醫療業
2021-12-31,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,5.56,未分配盈餘,岱宇,生技醫療業
2021-12-31,1598,RetainedEarnings,1137394000.0,保留盈餘合計,岱宇,生技醫療業
2021-12-31,1598,RetainedEarnings_per,9.34,保留盈餘合計,岱宇,生技醫療業
2021-12-31,1598,OtherEquityInterest,-238087000.0,其他權益合計,岱宇,生技醫療業
2021-12-31,1598,OtherEquityInterest_per,-1.96,其他權益合計,岱宇,生技醫療業
2021-12-31,1598,EquityAttributableToOwnersOfParent,3986850000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2021-12-31,1598,EquityAttributableToOwnersOfParent_per,32.74,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2021-12-31,1598,NoncontrollingInterests,382589000.0,非控制權益,岱宇,生技醫療業
2021-12-31,1598,NoncontrollingInterests_per,3.14,非控制權益,岱宇,生技醫療業
2021-12-31,1598,Equity,4369439000.0,權益總額,岱宇,生技醫療業
2021-12-31,1598,Equity_per,35.88,權益總額,岱宇,生技醫療業
2021-12-31,1598,TotalLiabilitiesEquity,12176627000.0,負債及權益總計,岱宇,生技醫療業
2022-03-31,1598,CashAndCashEquivalents,967535000.0,現金及約當現金,岱宇,生技醫療業
2022-03-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,8246000.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2022-03-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.07,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2022-03-31,1598,AccountsReceivableNet,1655415000.0,應收帳款淨額,岱宇,生技醫療業
2022-03-31,1598,Inventories,3014934000.0,存貨,岱宇,生技醫療業
2022-03-31,1598,OtherCurrentAssets,25573000.0,其他流動資產,岱宇,生技醫療業
2022-03-31,1598,CurrentAssets,6014644000.0,流動資產合計,岱宇,生技醫療業
2022-03-31,1598,DeferredTaxAssets,395287000.0,遞延所得稅資產,岱宇,生技醫療業
2022-03-31,1598,OtherNoncurrentAssets,24710000.0,其他非流動資產,岱宇,生技醫療業
2022-03-31,1598,OtherNoncurrentAssets_per,0.22,其他非流動資產,岱宇,生技醫療業
2022-03-31,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2022-03-31,1598,ShorttermBorrowings,2450143000.0,短期借款,岱宇,生技醫療業
2022-03-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,18505000.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2022-03-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.16,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2022-03-31,1598,AccountsPayable,864043000.0,應付帳款,岱宇,生技醫療業
2022-03-31,1598,CurrentProvisions,25108000.0,負債準備－流動,岱宇,生技醫療業
2022-03-31,1598,CurrentProvisions_per,0.22,負債準備－流動,岱宇,生技醫療業
2022-03-31,1598,OtherCurrentLiabilities,300321000.0,其他流動負債,岱宇,生技醫療業
2022-03-31,1598,OtherCurrentLiabilities_per,2.64,其他流動負債,岱宇,生技醫療業
2022-03-31,1598,BondsPayable,1384184000.0,應付公司債,岱宇,生技醫療業
2022-03-31,1598,LongtermBorrowings,523290000.0,長期借款,岱宇,生技醫療業
2022-03-31,1598,OtherNoncurrentLiabilities,129063000.0,其他非流動負債,岱宇,生技醫療業
2022-03-31,1598,OrdinaryShare,1339822000.0,普通股股本,岱宇,生技醫療業
2022-03-31,1598,CapitalStock,1341147000.0,股本合計,岱宇,生技醫療業
2022-03-31,1598,CapitalSurplus,2129887000.0,資本公積合計,岱宇,生技醫療業
2022-03-31,1598,LegalReserve,284853000.0,法定盈餘公積,岱宇,生技醫療業
2022-03-31,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2022-03-31,1598,OtherReceivable,27103000.0,其他應收款淨額,岱宇,生技醫療業
2022-03-31,1598,OtherReceivable_per,0.24,其他應收款淨額,岱宇,生技醫療業
2022-03-31,1598,CurrentIncomeTaxAssets,35733000.0,本期所得稅資產,岱宇,生技醫療業
2022-03-31,1598,CurrentIncomeTaxAssets_per,0.31,本期所得稅資產,岱宇,生技醫療業
2022-03-31,1598,FinancialAssetsAtAmortizedCost,154877000.0,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2022-03-31,1598,FinancialAssetsAtAmortizedCost_per,1.36,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2022-03-31,1598,BillsReceivableNet,1483000.0,應收票據淨額,岱宇,生技醫療業
2022-03-31,1598,BillsReceivableNet_per,0.01,應收票據淨額,岱宇,生技醫療業
2022-03-31,1598,Prepayments,123745000.0,預付款項,岱宇,生技醫療業
2022-03-31,1598,Prepayments_per,1.09,預付款項,岱宇,生技醫療業
2022-03-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,70696000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2022-03-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.62,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2022-03-31,1598,FinancialAssetsAtAmortizedCostNonCurrent,0.0,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2022-03-31,1598,FinancialAssetsAtAmortizedCostNonCurrent_per,0.0,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2022-03-31,1598,OtherReceivablesDueFromRelatedParties,0.0,其他應收款－關係人淨額,岱宇,生技醫療業
2022-03-31,1598,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,岱宇,生技醫療業
2022-03-31,1598,RightOfUseAsset,333282000.0,使用權資產,岱宇,生技醫療業
2022-03-31,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,7114000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2022-03-31,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,143814000.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2022-03-31,1598,CashAndCashEquivalents_per,8.52,現金及約當現金,岱宇,生技醫療業
2022-03-31,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.27,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2022-03-31,1598,AccountsReceivableNet_per,14.58,應收帳款淨額,岱宇,生技醫療業
2022-03-31,1598,Inventories_per,26.55,存貨,岱宇,生技醫療業
2022-03-31,1598,OtherCurrentAssets_per,0.23,其他流動資產,岱宇,生技醫療業
2022-03-31,1598,CurrentAssets_per,52.97,流動資產合計,岱宇,生技醫療業
2022-03-31,1598,InvestmentAccountedForUsingEquityMethod,31408000.0,採用權益法之投資,岱宇,生技醫療業
2022-03-31,1598,InvestmentAccountedForUsingEquityMethod_per,0.28,採用權益法之投資,岱宇,生技醫療業
2022-03-31,1598,PropertyPlantAndEquipment,2999392000.0,不動產、廠房及設備,岱宇,生技醫療業
2022-03-31,1598,PropertyPlantAndEquipment_per,26.42,不動產、廠房及設備,岱宇,生技醫療業
2022-03-31,1598,RightOfUseAsset_per,2.94,使用權資產,岱宇,生技醫療業
2022-03-31,1598,IntangibleAssets,1293459000.0,無形資產,岱宇,生技醫療業
2022-03-31,1598,IntangibleAssets_per,11.39,無形資產,岱宇,生技醫療業
2022-03-31,1598,DeferredTaxAssets_per,3.48,遞延所得稅資產,岱宇,生技醫療業
2022-03-31,1598,NoncurrentAssets,5340198000.0,非流動資產合計,岱宇,生技醫療業
2022-03-31,1598,NoncurrentAssets_per,47.03,非流動資產合計,岱宇,生技醫療業
2022-03-31,1598,TotalAssets,11354842000.0,資產總額,岱宇,生技醫療業
2022-03-31,1598,ShorttermBorrowings_per,21.58,短期借款,岱宇,生技醫療業
2022-03-31,1598,AccountsPayable_per,7.61,應付帳款,岱宇,生技醫療業
2022-03-31,1598,OtherPayables,965520000.0,其他應付款,岱宇,生技醫療業
2022-03-31,1598,OtherPayables_per,8.5,其他應付款,岱宇,生技醫療業
2022-03-31,1598,CurrentTaxLiabilities,43672000.0,本期所得稅負債,岱宇,生技醫療業
2022-03-31,1598,CurrentTaxLiabilities_per,0.38,本期所得稅負債,岱宇,生技醫療業
2022-03-31,1598,CurrentLiabilities,4711152000.0,流動負債合計,岱宇,生技醫療業
2022-03-31,1598,CurrentLiabilities_per,41.49,流動負債合計,岱宇,生技醫療業
2022-03-31,1598,BondsPayable_per,12.19,應付公司債,岱宇,生技醫療業
2022-03-31,1598,LongtermBorrowings_per,4.61,長期借款,岱宇,生技醫療業
2022-03-31,1598,OtherNoncurrentLiabilities_per,1.14,其他非流動負債,岱宇,生技醫療業
2022-03-31,1598,NoncurrentLiabilities,2485948000.0,非流動負債合計,岱宇,生技醫療業
2022-03-31,1598,NoncurrentLiabilities_per,21.89,非流動負債合計,岱宇,生技醫療業
2022-03-31,1598,Liabilities,7197100000.0,負債總額,岱宇,生技醫療業
2022-03-31,1598,Liabilities_per,63.38,負債總額,岱宇,生技醫療業
2022-03-31,1598,OrdinaryShare_per,11.8,普通股股本,岱宇,生技醫療業
2022-03-31,1598,CapitalStock_per,11.81,股本合計,岱宇,生技醫療業
2022-03-31,1598,CapitalSurplus_per,18.76,資本公積合計,岱宇,生技醫療業
2022-03-31,1598,LegalReserve_per,2.51,法定盈餘公積,岱宇,生技醫療業
2022-03-31,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit,315724000.0,未分配盈餘,岱宇,生技醫療業
2022-03-31,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,2.78,未分配盈餘,岱宇,生技醫療業
2022-03-31,1598,RetainedEarnings,776205000.0,保留盈餘合計,岱宇,生技醫療業
2022-03-31,1598,RetainedEarnings_per,6.84,保留盈餘合計,岱宇,生技醫療業
2022-03-31,1598,OtherEquityInterest,-158855000.0,其他權益合計,岱宇,生技醫療業
2022-03-31,1598,OtherEquityInterest_per,-1.4,其他權益合計,岱宇,生技醫療業
2022-03-31,1598,EquityAttributableToOwnersOfParent,3758509000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2022-03-31,1598,EquityAttributableToOwnersOfParent_per,33.1,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2022-03-31,1598,NoncontrollingInterests,399233000.0,非控制權益,岱宇,生技醫療業
2022-03-31,1598,NoncontrollingInterests_per,3.52,非控制權益,岱宇,生技醫療業
2022-03-31,1598,Equity,4157742000.0,權益總額,岱宇,生技醫療業
2022-03-31,1598,Equity_per,36.62,權益總額,岱宇,生技醫療業
2022-03-31,1598,TotalLiabilitiesEquity,11354842000.0,負債及權益總計,岱宇,生技醫療業
2022-06-30,1598,CashAndCashEquivalents,783409000.0,現金及約當現金,岱宇,生技醫療業
2022-06-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,19620000.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2022-06-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.18,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2022-06-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,70634000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2022-06-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.66,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2022-06-30,1598,FinancialAssetsAtAmortizedCost,155890000.0,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2022-06-30,1598,FinancialAssetsAtAmortizedCost_per,1.46,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2022-06-30,1598,FinancialAssetsAtAmortizedCostNonCurrent,22290000.0,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2022-06-30,1598,FinancialAssetsAtAmortizedCostNonCurrent_per,0.21,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2022-06-30,1598,BillsReceivableNet,2914000.0,應收票據淨額,岱宇,生技醫療業
2022-06-30,1598,BillsReceivableNet_per,0.03,應收票據淨額,岱宇,生技醫療業
2022-06-30,1598,OtherReceivable,38904000.0,其他應收款淨額,岱宇,生技醫療業
2022-06-30,1598,OtherReceivable_per,0.36,其他應收款淨額,岱宇,生技醫療業
2022-06-30,1598,Prepayments,133541000.0,預付款項,岱宇,生技醫療業
2022-06-30,1598,Prepayments_per,1.25,預付款項,岱宇,生技醫療業
2022-06-30,1598,AccountsReceivableNet,1330774000.0,應收帳款淨額,岱宇,生技醫療業
2022-06-30,1598,OtherReceivablesDueFromRelatedParties,0.0,其他應收款－關係人淨額,岱宇,生技醫療業
2022-06-30,1598,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,岱宇,生技醫療業
2022-06-30,1598,Inventories,2797527000.0,存貨,岱宇,生技醫療業
2022-06-30,1598,OtherCurrentAssets,7244000.0,其他流動資產,岱宇,生技醫療業
2022-06-30,1598,OtherCurrentAssets_per,0.07,其他流動資產,岱宇,生技醫療業
2022-06-30,1598,CurrentAssets,5277413000.0,流動資產合計,岱宇,生技醫療業
2022-06-30,1598,RightOfUseAsset,322884000.0,使用權資產,岱宇,生技醫療業
2022-06-30,1598,RightOfUseAsset_per,3.02,使用權資產,岱宇,生技醫療業
2022-06-30,1598,DeferredTaxAssets,423118000.0,遞延所得稅資產,岱宇,生技醫療業
2022-06-30,1598,OtherNoncurrentAssets,27050000.0,其他非流動資產,岱宇,生技醫療業
2022-06-30,1598,OtherNoncurrentAssets_per,0.25,其他非流動資產,岱宇,生技醫療業
2022-06-30,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2022-06-30,1598,ShorttermBorrowings,2337417000.0,短期借款,岱宇,生技醫療業
2022-06-30,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,26639000.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2022-06-30,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.25,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2022-06-30,1598,AccountsPayable,686212000.0,應付帳款,岱宇,生技醫療業
2022-06-30,1598,CurrentProvisions,20758000.0,負債準備－流動,岱宇,生技醫療業
2022-06-30,1598,CurrentProvisions_per,0.19,負債準備－流動,岱宇,生技醫療業
2022-06-30,1598,OtherCurrentLiabilities,1282819000.0,其他流動負債,岱宇,生技醫療業
2022-06-30,1598,BondsPayable,419612000.0,應付公司債,岱宇,生技醫療業
2022-06-30,1598,LongtermBorrowings,427328000.0,長期借款,岱宇,生技醫療業
2022-06-30,1598,OtherNoncurrentLiabilities,128573000.0,其他非流動負債,岱宇,生技醫療業
2022-06-30,1598,OtherNoncurrentLiabilities_per,1.2,其他非流動負債,岱宇,生技醫療業
2022-06-30,1598,OrdinaryShare,1341147000.0,普通股股本,岱宇,生技醫療業
2022-06-30,1598,CapitalStock,1341147000.0,股本合計,岱宇,生技醫療業
2022-06-30,1598,CapitalSurplus,2134231000.0,資本公積合計,岱宇,生技醫療業
2022-06-30,1598,LegalReserve,329002000.0,法定盈餘公積,岱宇,生技醫療業
2022-06-30,1598,OtherEquityInterest_per,-1.24,其他權益合計,岱宇,生技醫療業
2022-06-30,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2022-06-30,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,7953000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2022-06-30,1598,CurrentIncomeTaxAssets,7590000.0,本期所得稅資產,岱宇,生技醫療業
2022-06-30,1598,CurrentIncomeTaxAssets_per,0.07,本期所得稅資產,岱宇,生技醫療業
2022-06-30,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,149315000.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2022-06-30,1598,CashAndCashEquivalents_per,7.33,現金及約當現金,岱宇,生技醫療業
2022-06-30,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.4,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2022-06-30,1598,AccountsReceivableNet_per,12.46,應收帳款淨額,岱宇,生技醫療業
2022-06-30,1598,Inventories_per,26.19,存貨,岱宇,生技醫療業
2022-06-30,1598,CurrentAssets_per,49.4,流動資產合計,岱宇,生技醫療業
2022-06-30,1598,InvestmentAccountedForUsingEquityMethod,27652000.0,採用權益法之投資,岱宇,生技醫療業
2022-06-30,1598,InvestmentAccountedForUsingEquityMethod_per,0.26,採用權益法之投資,岱宇,生技醫療業
2022-06-30,1598,PropertyPlantAndEquipment,3001938000.0,不動產、廠房及設備,岱宇,生技醫療業
2022-06-30,1598,PropertyPlantAndEquipment_per,28.1,不動產、廠房及設備,岱宇,生技醫療業
2022-06-30,1598,IntangibleAssets,1307877000.0,無形資產,岱宇,生技醫療業
2022-06-30,1598,IntangibleAssets_per,12.24,無形資產,岱宇,生技醫療業
2022-06-30,1598,DeferredTaxAssets_per,3.96,遞延所得稅資產,岱宇,生技醫療業
2022-06-30,1598,NoncurrentAssets,5404655000.0,非流動資產合計,岱宇,生技醫療業
2022-06-30,1598,NoncurrentAssets_per,50.6,非流動資產合計,岱宇,生技醫療業
2022-06-30,1598,TotalAssets,10682068000.0,資產總額,岱宇,生技醫療業
2022-06-30,1598,ShorttermBorrowings_per,21.88,短期借款,岱宇,生技醫療業
2022-06-30,1598,AccountsPayable_per,6.42,應付帳款,岱宇,生技醫療業
2022-06-30,1598,OtherPayables,735902000.0,其他應付款,岱宇,生技醫療業
2022-06-30,1598,OtherPayables_per,6.89,其他應付款,岱宇,生技醫療業
2022-06-30,1598,CurrentTaxLiabilities,21832000.0,本期所得稅負債,岱宇,生技醫療業
2022-06-30,1598,CurrentTaxLiabilities_per,0.2,本期所得稅負債,岱宇,生技醫療業
2022-06-30,1598,OtherCurrentLiabilities_per,12.01,其他流動負債,岱宇,生技醫療業
2022-06-30,1598,CurrentLiabilities,5165211000.0,流動負債合計,岱宇,生技醫療業
2022-06-30,1598,CurrentLiabilities_per,48.35,流動負債合計,岱宇,生技醫療業
2022-06-30,1598,BondsPayable_per,3.93,應付公司債,岱宇,生技醫療業
2022-06-30,1598,LongtermBorrowings_per,4.0,長期借款,岱宇,生技醫療業
2022-06-30,1598,NoncurrentLiabilities,1444882000.0,非流動負債合計,岱宇,生技醫療業
2022-06-30,1598,NoncurrentLiabilities_per,13.53,非流動負債合計,岱宇,生技醫療業
2022-06-30,1598,Liabilities,6610093000.0,負債總額,岱宇,生技醫療業
2022-06-30,1598,Liabilities_per,61.88,負債總額,岱宇,生技醫療業
2022-06-30,1598,OrdinaryShare_per,12.56,普通股股本,岱宇,生技醫療業
2022-06-30,1598,CapitalStock_per,12.56,股本合計,岱宇,生技醫療業
2022-06-30,1598,CapitalSurplus_per,19.98,資本公積合計,岱宇,生技醫療業
2022-06-30,1598,LegalReserve_per,3.08,法定盈餘公積,岱宇,生技醫療業
2022-06-30,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit,147378000.0,未分配盈餘,岱宇,生技醫療業
2022-06-30,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,1.38,未分配盈餘,岱宇,生技醫療業
2022-06-30,1598,RetainedEarnings,714467000.0,保留盈餘合計,岱宇,生技醫療業
2022-06-30,1598,RetainedEarnings_per,6.69,保留盈餘合計,岱宇,生技醫療業
2022-06-30,1598,OtherEquityInterest,-132647000.0,其他權益合計,岱宇,生技醫療業
2022-06-30,1598,EquityAttributableToOwnersOfParent,3691900000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2022-06-30,1598,EquityAttributableToOwnersOfParent_per,34.56,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2022-06-30,1598,NoncontrollingInterests,380075000.0,非控制權益,岱宇,生技醫療業
2022-06-30,1598,NoncontrollingInterests_per,3.56,非控制權益,岱宇,生技醫療業
2022-06-30,1598,Equity,4071975000.0,權益總額,岱宇,生技醫療業
2022-06-30,1598,Equity_per,38.12,權益總額,岱宇,生技醫療業
2022-06-30,1598,TotalLiabilitiesEquity,10682068000.0,負債及權益總計,岱宇,生技醫療業
2022-09-30,1598,CashAndCashEquivalents,746784000.0,現金及約當現金,岱宇,生技醫療業
2022-09-30,1598,CashAndCashEquivalents_per,6.87,現金及約當現金,岱宇,生技醫療業
2022-09-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,34733000.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2022-09-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.32,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2022-09-30,1598,FinancialAssetsAtAmortizedCost,157829000.0,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2022-09-30,1598,FinancialAssetsAtAmortizedCost_per,1.45,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2022-09-30,1598,BillsReceivableNet,872000.0,應收票據淨額,岱宇,生技醫療業
2022-09-30,1598,BillsReceivableNet_per,0.01,應收票據淨額,岱宇,生技醫療業
2022-09-30,1598,OtherReceivable,31610000.0,其他應收款淨額,岱宇,生技醫療業
2022-09-30,1598,OtherReceivable_per,0.29,其他應收款淨額,岱宇,生技醫療業
2022-09-30,1598,Prepayments,135491000.0,預付款項,岱宇,生技醫療業
2022-09-30,1598,Prepayments_per,1.25,預付款項,岱宇,生技醫療業
2022-09-30,1598,AccountsReceivableNet,1162631000.0,應收帳款淨額,岱宇,生技醫療業
2022-09-30,1598,AccountsReceivableNet_per,10.7,應收帳款淨額,岱宇,生技醫療業
2022-09-30,1598,Inventories,2967231000.0,存貨,岱宇,生技醫療業
2022-09-30,1598,Inventories_per,27.31,存貨,岱宇,生技醫療業
2022-09-30,1598,OtherCurrentAssets,10170000.0,其他流動資產,岱宇,生技醫療業
2022-09-30,1598,OtherCurrentAssets_per,0.09,其他流動資產,岱宇,生技醫療業
2022-09-30,1598,CurrentAssets,5255347000.0,流動資產合計,岱宇,生技醫療業
2022-09-30,1598,CurrentAssets_per,48.38,流動資產合計,岱宇,生技醫療業
2022-09-30,1598,PropertyPlantAndEquipment,3059995000.0,不動產、廠房及設備,岱宇,生技醫療業
2022-09-30,1598,PropertyPlantAndEquipment_per,28.17,不動產、廠房及設備,岱宇,生技醫療業
2022-09-30,1598,IntangibleAssets,1371551000.0,無形資產,岱宇,生技醫療業
2022-09-30,1598,IntangibleAssets_per,12.63,無形資產,岱宇,生技醫療業
2022-09-30,1598,DeferredTaxAssets,462375000.0,遞延所得稅資產,岱宇,生技醫療業
2022-09-30,1598,DeferredTaxAssets_per,4.26,遞延所得稅資產,岱宇,生技醫療業
2022-09-30,1598,OtherNoncurrentAssets,74184000.0,其他非流動資產,岱宇,生技醫療業
2022-09-30,1598,OtherNoncurrentAssets_per,0.68,其他非流動資產,岱宇,生技醫療業
2022-09-30,1598,NoncurrentAssets,5608316000.0,非流動資產合計,岱宇,生技醫療業
2022-09-30,1598,NoncurrentAssets_per,51.62,非流動資產合計,岱宇,生技醫療業
2022-09-30,1598,TotalAssets,10863663000.0,資產總額,岱宇,生技醫療業
2022-09-30,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2022-09-30,1598,ShorttermBorrowings,2180186000.0,短期借款,岱宇,生技醫療業
2022-09-30,1598,ShorttermBorrowings_per,20.07,短期借款,岱宇,生技醫療業
2022-09-30,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,27905000.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2022-09-30,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.26,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2022-09-30,1598,AccountsPayable,782053000.0,應付帳款,岱宇,生技醫療業
2022-09-30,1598,AccountsPayable_per,7.2,應付帳款,岱宇,生技醫療業
2022-09-30,1598,OtherPayables,459170000.0,其他應付款,岱宇,生技醫療業
2022-09-30,1598,OtherPayables_per,4.23,其他應付款,岱宇,生技醫療業
2022-09-30,1598,CurrentProvisions,21394000.0,負債準備－流動,岱宇,生技醫療業
2022-09-30,1598,CurrentProvisions_per,0.2,負債準備－流動,岱宇,生技醫療業
2022-09-30,1598,OtherCurrentLiabilities,1683795000.0,其他流動負債,岱宇,生技醫療業
2022-09-30,1598,OtherCurrentLiabilities_per,15.5,其他流動負債,岱宇,生技醫療業
2022-09-30,1598,CurrentLiabilities,5241205000.0,流動負債合計,岱宇,生技醫療業
2022-09-30,1598,CurrentLiabilities_per,48.25,流動負債合計,岱宇,生技醫療業
2022-09-30,1598,BondsPayable,0.0,應付公司債,岱宇,生技醫療業
2022-09-30,1598,BondsPayable_per,0.0,應付公司債,岱宇,生技醫療業
2022-09-30,1598,LongtermBorrowings,821364000.0,長期借款,岱宇,生技醫療業
2022-09-30,1598,LongtermBorrowings_per,7.56,長期借款,岱宇,生技醫療業
2022-09-30,1598,OtherNoncurrentLiabilities,117307000.0,其他非流動負債,岱宇,生技醫療業
2022-09-30,1598,OtherNoncurrentLiabilities_per,1.08,其他非流動負債,岱宇,生技醫療業
2022-09-30,1598,NoncurrentLiabilities,1460871000.0,非流動負債合計,岱宇,生技醫療業
2022-09-30,1598,NoncurrentLiabilities_per,13.45,非流動負債合計,岱宇,生技醫療業
2022-09-30,1598,OrdinaryShare,1341147000.0,普通股股本,岱宇,生技醫療業
2022-09-30,1598,OrdinaryShare_per,12.35,普通股股本,岱宇,生技醫療業
2022-09-30,1598,CapitalStock,1341147000.0,股本合計,岱宇,生技醫療業
2022-09-30,1598,CapitalStock_per,12.35,股本合計,岱宇,生技醫療業
2022-09-30,1598,CapitalSurplus,2138575000.0,資本公積合計,岱宇,生技醫療業
2022-09-30,1598,CapitalSurplus_per,19.69,資本公積合計,岱宇,生技醫療業
2022-09-30,1598,LegalReserve,329002000.0,法定盈餘公積,岱宇,生技醫療業
2022-09-30,1598,LegalReserve_per,3.03,法定盈餘公積,岱宇,生技醫療業
2022-09-30,1598,RetainedEarnings,790651000.0,保留盈餘合計,岱宇,生技醫療業
2022-09-30,1598,RetainedEarnings_per,7.28,保留盈餘合計,岱宇,生技醫療業
2022-09-30,1598,EquityAttributableToOwnersOfParent,3775085000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2022-09-30,1598,EquityAttributableToOwnersOfParent_per,34.75,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2022-09-30,1598,NoncontrollingInterests,386502000.0,非控制權益,岱宇,生技醫療業
2022-09-30,1598,NoncontrollingInterests_per,3.56,非控制權益,岱宇,生技醫療業
2022-09-30,1598,TotalLiabilitiesEquity,10863663000.0,負債及權益總計,岱宇,生技醫療業
2022-09-30,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2022-09-30,1598,CurrentIncomeTaxAssets,7996000.0,本期所得稅資產,岱宇,生技醫療業
2022-09-30,1598,CurrentIncomeTaxAssets_per,0.07,本期所得稅資產,岱宇,生技醫療業
2022-09-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,70665000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2022-09-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.65,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2022-09-30,1598,FinancialAssetsAtAmortizedCostNonCurrent,31750000.0,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2022-09-30,1598,FinancialAssetsAtAmortizedCostNonCurrent_per,0.29,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2022-09-30,1598,OtherReceivablesDueFromRelatedParties,0.0,其他應收款－關係人淨額,岱宇,生技醫療業
2022-09-30,1598,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,岱宇,生技醫療業
2022-09-30,1598,InvestmentAccountedForUsingEquityMethod,21792000.0,採用權益法之投資,岱宇,生技醫療業
2022-09-30,1598,InvestmentAccountedForUsingEquityMethod_per,0.2,採用權益法之投資,岱宇,生技醫療業
2022-09-30,1598,RightOfUseAsset,318270000.0,使用權資產,岱宇,生技醫療業
2022-09-30,1598,RightOfUseAsset_per,2.93,使用權資產,岱宇,生技醫療業
2022-09-30,1598,CurrentTaxLiabilities,20253000.0,本期所得稅負債,岱宇,生技醫療業
2022-09-30,1598,CurrentTaxLiabilities_per,0.19,本期所得稅負債,岱宇,生技醫療業
2022-09-30,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit,223562000.0,未分配盈餘,岱宇,生技醫療業
2022-09-30,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,2.06,未分配盈餘,岱宇,生技醫療業
2022-09-30,1598,OtherEquityInterest,-68998000.0,其他權益合計,岱宇,生技醫療業
2022-09-30,1598,OtherEquityInterest_per,-0.64,其他權益合計,岱宇,生技醫療業
2022-09-30,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,9452000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2022-09-30,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,159514000.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2022-09-30,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.47,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2022-09-30,1598,Liabilities,6702076000.0,負債總額,岱宇,生技醫療業
2022-09-30,1598,Liabilities_per,61.69,負債總額,岱宇,生技醫療業
2022-09-30,1598,Equity,4161587000.0,權益總額,岱宇,生技醫療業
2022-09-30,1598,Equity_per,38.31,權益總額,岱宇,生技醫療業
2022-12-31,1598,CashAndCashEquivalents,1120781000.0,現金及約當現金,岱宇,生技醫療業
2022-12-31,1598,CashAndCashEquivalents_per,9.37,現金及約當現金,岱宇,生技醫療業
2022-12-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,3739000.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2022-12-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.03,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2022-12-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,65697000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2022-12-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.55,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2022-12-31,1598,FinancialAssetsAtAmortizedCost,240578000.0,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2022-12-31,1598,FinancialAssetsAtAmortizedCost_per,2.01,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2022-12-31,1598,FinancialAssetsAtAmortizedCostNonCurrent,30710000.0,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2022-12-31,1598,FinancialAssetsAtAmortizedCostNonCurrent_per,0.26,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2022-12-31,1598,BillsReceivableNet,940000.0,應收票據淨額,岱宇,生技醫療業
2022-12-31,1598,BillsReceivableNet_per,0.01,應收票據淨額,岱宇,生技醫療業
2022-12-31,1598,OtherReceivable,65176000.0,其他應收款淨額,岱宇,生技醫療業
2022-12-31,1598,OtherReceivable_per,0.54,其他應收款淨額,岱宇,生技醫療業
2022-12-31,1598,Prepayments,214900000.0,預付款項,岱宇,生技醫療業
2022-12-31,1598,Prepayments_per,1.8,預付款項,岱宇,生技醫療業
2022-12-31,1598,AccountsReceivableNet,1095392000.0,應收帳款淨額,岱宇,生技醫療業
2022-12-31,1598,AccountsReceivableNet_per,9.16,應收帳款淨額,岱宇,生技醫療業
2022-12-31,1598,OtherReceivablesDueFromRelatedParties,24909000.0,其他應收款－關係人淨額,岱宇,生技醫療業
2022-12-31,1598,OtherReceivablesDueFromRelatedParties_per,0.21,其他應收款－關係人淨額,岱宇,生技醫療業
2022-12-31,1598,Inventories,2989456000.0,存貨,岱宇,生技醫療業
2022-12-31,1598,Inventories_per,24.99,存貨,岱宇,生技醫療業
2022-12-31,1598,OtherCurrentAssets,10618000.0,其他流動資產,岱宇,生技醫療業
2022-12-31,1598,OtherCurrentAssets_per,0.09,其他流動資產,岱宇,生技醫療業
2022-12-31,1598,CurrentAssets,5818100000.0,流動資產合計,岱宇,生技醫療業
2022-12-31,1598,CurrentAssets_per,48.63,流動資產合計,岱宇,生技醫療業
2022-12-31,1598,InvestmentAccountedForUsingEquityMethod,6823000.0,採用權益法之投資,岱宇,生技醫療業
2022-12-31,1598,InvestmentAccountedForUsingEquityMethod_per,0.06,採用權益法之投資,岱宇,生技醫療業
2022-12-31,1598,PropertyPlantAndEquipment,3691829000.0,不動產、廠房及設備,岱宇,生技醫療業
2022-12-31,1598,PropertyPlantAndEquipment_per,30.86,不動產、廠房及設備,岱宇,生技醫療業
2022-12-31,1598,RightOfUseAsset,311457000.0,使用權資產,岱宇,生技醫療業
2022-12-31,1598,RightOfUseAsset_per,2.6,使用權資產,岱宇,生技醫療業
2022-12-31,1598,IntangibleAssets,1355244000.0,無形資產,岱宇,生技醫療業
2022-12-31,1598,IntangibleAssets_per,11.33,無形資產,岱宇,生技醫療業
2022-12-31,1598,DeferredTaxAssets,453080000.0,遞延所得稅資產,岱宇,生技醫療業
2022-12-31,1598,DeferredTaxAssets_per,3.79,遞延所得稅資產,岱宇,生技醫療業
2022-12-31,1598,OtherNoncurrentAssets,56041000.0,其他非流動資產,岱宇,生技醫療業
2022-12-31,1598,OtherNoncurrentAssets_per,0.47,其他非流動資產,岱宇,生技醫療業
2022-12-31,1598,NoncurrentAssets,6146499000.0,非流動資產合計,岱宇,生技醫療業
2022-12-31,1598,NoncurrentAssets_per,51.37,非流動資產合計,岱宇,生技醫療業
2022-12-31,1598,TotalAssets,11964599000.0,資產總額,岱宇,生技醫療業
2022-12-31,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2022-12-31,1598,ShorttermBorrowings,2390915000.0,短期借款,岱宇,生技醫療業
2022-12-31,1598,ShorttermBorrowings_per,19.98,短期借款,岱宇,生技醫療業
2022-12-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,25305000.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2022-12-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.21,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2022-12-31,1598,AccountsPayable,1015770000.0,應付帳款,岱宇,生技醫療業
2022-12-31,1598,AccountsPayable_per,8.49,應付帳款,岱宇,生技醫療業
2022-12-31,1598,OtherPayables,497800000.0,其他應付款,岱宇,生技醫療業
2022-12-31,1598,OtherPayables_per,4.16,其他應付款,岱宇,生技醫療業
2022-12-31,1598,CurrentTaxLiabilities,10696000.0,本期所得稅負債,岱宇,生技醫療業
2022-12-31,1598,CurrentTaxLiabilities_per,0.09,本期所得稅負債,岱宇,生技醫療業
2022-12-31,1598,CurrentProvisions,13927000.0,負債準備－流動,岱宇,生技醫療業
2022-12-31,1598,CurrentProvisions_per,0.12,負債準備－流動,岱宇,生技醫療業
2022-12-31,1598,OtherCurrentLiabilities,1658513000.0,其他流動負債,岱宇,生技醫療業
2022-12-31,1598,OtherCurrentLiabilities_per,13.86,其他流動負債,岱宇,生技醫療業
2022-12-31,1598,CurrentLiabilities,5853132000.0,流動負債合計,岱宇,生技醫療業
2022-12-31,1598,CurrentLiabilities_per,48.92,流動負債合計,岱宇,生技醫療業
2022-12-31,1598,BondsPayable,0.0,應付公司債,岱宇,生技醫療業
2022-12-31,1598,BondsPayable_per,0.0,應付公司債,岱宇,生技醫療業
2022-12-31,1598,LongtermBorrowings,1483762000.0,長期借款,岱宇,生技醫療業
2022-12-31,1598,LongtermBorrowings_per,12.4,長期借款,岱宇,生技醫療業
2022-12-31,1598,OtherNoncurrentLiabilities,102700000.0,其他非流動負債,岱宇,生技醫療業
2022-12-31,1598,OtherNoncurrentLiabilities_per,0.86,其他非流動負債,岱宇,生技醫療業
2022-12-31,1598,NoncurrentLiabilities,2047507000.0,非流動負債合計,岱宇,生技醫療業
2022-12-31,1598,NoncurrentLiabilities_per,17.11,非流動負債合計,岱宇,生技醫療業
2022-12-31,1598,OrdinaryShare,1341147000.0,普通股股本,岱宇,生技醫療業
2022-12-31,1598,OrdinaryShare_per,11.21,普通股股本,岱宇,生技醫療業
2022-12-31,1598,CapitalStock,1341147000.0,股本合計,岱宇,生技醫療業
2022-12-31,1598,CapitalStock_per,11.21,股本合計,岱宇,生技醫療業
2022-12-31,1598,CapitalSurplus,2142919000.0,資本公積合計,岱宇,生技醫療業
2022-12-31,1598,CapitalSurplus_per,17.91,資本公積合計,岱宇,生技醫療業
2022-12-31,1598,LegalReserve,329002000.0,法定盈餘公積,岱宇,生技醫療業
2022-12-31,1598,LegalReserve_per,2.75,法定盈餘公積,岱宇,生技醫療業
2022-12-31,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit,170420000.0,未分配盈餘,岱宇,生技醫療業
2022-12-31,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,1.42,未分配盈餘,岱宇,生技醫療業
2022-12-31,1598,RetainedEarnings,737509000.0,保留盈餘合計,岱宇,生技醫療業
2022-12-31,1598,RetainedEarnings_per,6.16,保留盈餘合計,岱宇,生技醫療業
2022-12-31,1598,OtherEquityInterest,-126177000.0,其他權益合計,岱宇,生技醫療業
2022-12-31,1598,OtherEquityInterest_per,-1.05,其他權益合計,岱宇,生技醫療業
2022-12-31,1598,EquityAttributableToOwnersOfParent,3669108000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2022-12-31,1598,EquityAttributableToOwnersOfParent_per,30.67,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2022-12-31,1598,NoncontrollingInterests,394852000.0,非控制權益,岱宇,生技醫療業
2022-12-31,1598,NoncontrollingInterests_per,3.3,非控制權益,岱宇,生技醫療業
2022-12-31,1598,TotalLiabilitiesEquity,11964599000.0,負債及權益總計,岱宇,生技醫療業
2022-12-31,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2022-12-31,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,9452000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2022-12-31,1598,CurrentIncomeTaxAssets,51611000.0,本期所得稅資產,岱宇,生技醫療業
2022-12-31,1598,CurrentIncomeTaxAssets_per,0.43,本期所得稅資產,岱宇,生技醫療業
2022-12-31,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,147071000.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2022-12-31,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.23,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2022-12-31,1598,Equity,4063960000.0,權益總額,岱宇,生技醫療業
2022-12-31,1598,Equity_per,33.97,權益總額,岱宇,生技醫療業
2022-12-31,1598,Liabilities,7900639000.0,負債總額,岱宇,生技醫療業
2022-12-31,1598,Liabilities_per,66.03,負債總額,岱宇,生技醫療業
2023-03-31,1598,CashAndCashEquivalents,1035549000.0,現金及約當現金,岱宇,生技醫療業
2023-03-31,1598,CashAndCashEquivalents_per,8.93,現金及約當現金,岱宇,生技醫療業
2023-03-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,17949000.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2023-03-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.15,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2023-03-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,65718000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2023-03-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.57,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2023-03-31,1598,FinancialAssetsAtAmortizedCost,216850000.0,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2023-03-31,1598,FinancialAssetsAtAmortizedCost_per,1.87,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2023-03-31,1598,FinancialAssetsAtAmortizedCostNonCurrent,13703000.0,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2023-03-31,1598,FinancialAssetsAtAmortizedCostNonCurrent_per,0.12,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2023-03-31,1598,BillsReceivableNet,1867000.0,應收票據淨額,岱宇,生技醫療業
2023-03-31,1598,BillsReceivableNet_per,0.02,應收票據淨額,岱宇,生技醫療業
2023-03-31,1598,OtherReceivable,35641000.0,其他應收款淨額,岱宇,生技醫療業
2023-03-31,1598,OtherReceivable_per,0.31,其他應收款淨額,岱宇,生技醫療業
2023-03-31,1598,Prepayments,204442000.0,預付款項,岱宇,生技醫療業
2023-03-31,1598,Prepayments_per,1.76,預付款項,岱宇,生技醫療業
2023-03-31,1598,AccountsReceivableNet,1244392000.0,應收帳款淨額,岱宇,生技醫療業
2023-03-31,1598,AccountsReceivableNet_per,10.73,應收帳款淨額,岱宇,生技醫療業
2023-03-31,1598,OtherReceivablesDueFromRelatedParties,0.0,其他應收款－關係人淨額,岱宇,生技醫療業
2023-03-31,1598,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,岱宇,生技醫療業
2023-03-31,1598,Inventories,2616825000.0,存貨,岱宇,生技醫療業
2023-03-31,1598,Inventories_per,22.57,存貨,岱宇,生技醫療業
2023-03-31,1598,OtherCurrentAssets,10534000.0,其他流動資產,岱宇,生技醫療業
2023-03-31,1598,OtherCurrentAssets_per,0.09,其他流動資產,岱宇,生技醫療業
2023-03-31,1598,CurrentAssets,5427393000.0,流動資產合計,岱宇,生技醫療業
2023-03-31,1598,CurrentAssets_per,46.81,流動資產合計,岱宇,生技醫療業
2023-03-31,1598,InvestmentAccountedForUsingEquityMethod,6673000.0,採用權益法之投資,岱宇,生技醫療業
2023-03-31,1598,InvestmentAccountedForUsingEquityMethod_per,0.06,採用權益法之投資,岱宇,生技醫療業
2023-03-31,1598,PropertyPlantAndEquipment,3738564000.0,不動產、廠房及設備,岱宇,生技醫療業
2023-03-31,1598,PropertyPlantAndEquipment_per,32.25,不動產、廠房及設備,岱宇,生技醫療業
2023-03-31,1598,RightOfUseAsset,306720000.0,使用權資產,岱宇,生技醫療業
2023-03-31,1598,RightOfUseAsset_per,2.65,使用權資產,岱宇,生技醫療業
2023-03-31,1598,IntangibleAssets,1330117000.0,無形資產,岱宇,生技醫療業
2023-03-31,1598,IntangibleAssets_per,11.47,無形資產,岱宇,生技醫療業
2023-03-31,1598,DeferredTaxAssets,481220000.0,遞延所得稅資產,岱宇,生技醫療業
2023-03-31,1598,DeferredTaxAssets_per,4.15,遞延所得稅資產,岱宇,生技醫療業
2023-03-31,1598,OtherNoncurrentAssets,45209000.0,其他非流動資產,岱宇,生技醫療業
2023-03-31,1598,OtherNoncurrentAssets_per,0.39,其他非流動資產,岱宇,生技醫療業
2023-03-31,1598,NoncurrentAssets,6166317000.0,非流動資產合計,岱宇,生技醫療業
2023-03-31,1598,NoncurrentAssets_per,53.19,非流動資產合計,岱宇,生技醫療業
2023-03-31,1598,TotalAssets,11593710000.0,資產總額,岱宇,生技醫療業
2023-03-31,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2023-03-31,1598,ShorttermBorrowings,2090873000.0,短期借款,岱宇,生技醫療業
2023-03-31,1598,ShorttermBorrowings_per,18.03,短期借款,岱宇,生技醫療業
2023-03-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,22005000.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2023-03-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.19,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2023-03-31,1598,AccountsPayable,940558000.0,應付帳款,岱宇,生技醫療業
2023-03-31,1598,AccountsPayable_per,8.11,應付帳款,岱宇,生技醫療業
2023-03-31,1598,OtherPayables,486264000.0,其他應付款,岱宇,生技醫療業
2023-03-31,1598,OtherPayables_per,4.19,其他應付款,岱宇,生技醫療業
2023-03-31,1598,CurrentTaxLiabilities,16790000.0,本期所得稅負債,岱宇,生技醫療業
2023-03-31,1598,CurrentTaxLiabilities_per,0.14,本期所得稅負債,岱宇,生技醫療業
2023-03-31,1598,CurrentProvisions,14106000.0,負債準備－流動,岱宇,生技醫療業
2023-03-31,1598,CurrentProvisions_per,0.12,負債準備－流動,岱宇,生技醫療業
2023-03-31,1598,OtherCurrentLiabilities,1677325000.0,其他流動負債,岱宇,生技醫療業
2023-03-31,1598,OtherCurrentLiabilities_per,14.47,其他流動負債,岱宇,生技醫療業
2023-03-31,1598,CurrentLiabilities,5472138000.0,流動負債合計,岱宇,生技醫療業
2023-03-31,1598,CurrentLiabilities_per,47.2,流動負債合計,岱宇,生技醫療業
2023-03-31,1598,BondsPayable,0.0,應付公司債,岱宇,生技醫療業
2023-03-31,1598,BondsPayable_per,0.0,應付公司債,岱宇,生技醫療業
2023-03-31,1598,LongtermBorrowings,1596255000.0,長期借款,岱宇,生技醫療業
2023-03-31,1598,LongtermBorrowings_per,13.77,長期借款,岱宇,生技醫療業
2023-03-31,1598,OtherNoncurrentLiabilities,101807000.0,其他非流動負債,岱宇,生技醫療業
2023-03-31,1598,OtherNoncurrentLiabilities_per,0.88,其他非流動負債,岱宇,生技醫療業
2023-03-31,1598,NoncurrentLiabilities,2163712000.0,非流動負債合計,岱宇,生技醫療業
2023-03-31,1598,NoncurrentLiabilities_per,18.66,非流動負債合計,岱宇,生技醫療業
2023-03-31,1598,OrdinaryShare,1341147000.0,普通股股本,岱宇,生技醫療業
2023-03-31,1598,OrdinaryShare_per,11.57,普通股股本,岱宇,生技醫療業
2023-03-31,1598,CapitalStock,1346097000.0,股本合計,岱宇,生技醫療業
2023-03-31,1598,CapitalStock_per,11.61,股本合計,岱宇,生技醫療業
2023-03-31,1598,CapitalSurplus,2163341000.0,資本公積合計,岱宇,生技醫療業
2023-03-31,1598,CapitalSurplus_per,18.66,資本公積合計,岱宇,生技醫療業
2023-03-31,1598,LegalReserve,329002000.0,法定盈餘公積,岱宇,生技醫療業
2023-03-31,1598,LegalReserve_per,2.84,法定盈餘公積,岱宇,生技醫療業
2023-03-31,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit,-4953000.0,未分配盈餘,岱宇,生技醫療業
2023-03-31,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-0.04,未分配盈餘,岱宇,生技醫療業
2023-03-31,1598,RetainedEarnings,562136000.0,保留盈餘合計,岱宇,生技醫療業
2023-03-31,1598,RetainedEarnings_per,4.85,保留盈餘合計,岱宇,生技醫療業
2023-03-31,1598,OtherEquityInterest,-131944000.0,其他權益合計,岱宇,生技醫療業
2023-03-31,1598,OtherEquityInterest_per,-1.14,其他權益合計,岱宇,生技醫療業
2023-03-31,1598,EquityAttributableToOwnersOfParent,3530940000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2023-03-31,1598,EquityAttributableToOwnersOfParent_per,30.46,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2023-03-31,1598,NoncontrollingInterests,426920000.0,非控制權益,岱宇,生技醫療業
2023-03-31,1598,NoncontrollingInterests_per,3.68,非控制權益,岱宇,生技醫療業
2023-03-31,1598,TotalLiabilitiesEquity,11593710000.0,負債及權益總計,岱宇,生技醫療業
2023-03-31,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2023-03-31,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,8963000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2023-03-31,1598,CurrentIncomeTaxAssets,43344000.0,本期所得稅資產,岱宇,生技醫療業
2023-03-31,1598,CurrentIncomeTaxAssets_per,0.37,本期所得稅資產,岱宇,生技醫療業
2023-03-31,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,152250000.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2023-03-31,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.31,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2023-03-31,1598,Equity,3957860000.0,權益總額,岱宇,生技醫療業
2023-03-31,1598,Equity_per,34.14,權益總額,岱宇,生技醫療業
2023-03-31,1598,Liabilities,7635850000.0,負債總額,岱宇,生技醫療業
2023-03-31,1598,Liabilities_per,65.86,負債總額,岱宇,生技醫療業
2023-06-30,1598,CashAndCashEquivalents,1851873000.0,現金及約當現金,岱宇,生技醫療業
2023-06-30,1598,CashAndCashEquivalents_per,15.02,現金及約當現金,岱宇,生技醫療業
2023-06-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,19066000.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2023-06-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.15,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2023-06-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,65587000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2023-06-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.53,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2023-06-30,1598,FinancialAssetsAtAmortizedCost,210629000.0,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2023-06-30,1598,FinancialAssetsAtAmortizedCost_per,1.71,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2023-06-30,1598,FinancialAssetsAtAmortizedCostNonCurrent,14013000.0,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2023-06-30,1598,FinancialAssetsAtAmortizedCostNonCurrent_per,0.11,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2023-06-30,1598,BillsReceivableNet,992000.0,應收票據淨額,岱宇,生技醫療業
2023-06-30,1598,BillsReceivableNet_per,0.01,應收票據淨額,岱宇,生技醫療業
2023-06-30,1598,OtherReceivable,13975000.0,其他應收款淨額,岱宇,生技醫療業
2023-06-30,1598,OtherReceivable_per,0.11,其他應收款淨額,岱宇,生技醫療業
2023-06-30,1598,Prepayments,218050000.0,預付款項,岱宇,生技醫療業
2023-06-30,1598,Prepayments_per,1.77,預付款項,岱宇,生技醫療業
2023-06-30,1598,AccountsReceivableNet,955276000.0,應收帳款淨額,岱宇,生技醫療業
2023-06-30,1598,AccountsReceivableNet_per,7.75,應收帳款淨額,岱宇,生技醫療業
2023-06-30,1598,OtherReceivablesDueFromRelatedParties,0.0,其他應收款－關係人淨額,岱宇,生技醫療業
2023-06-30,1598,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,岱宇,生技醫療業
2023-06-30,1598,Inventories,2725752000.0,存貨,岱宇,生技醫療業
2023-06-30,1598,Inventories_per,22.11,存貨,岱宇,生技醫療業
2023-06-30,1598,OtherCurrentAssets,14204000.0,其他流動資產,岱宇,生技醫療業
2023-06-30,1598,OtherCurrentAssets_per,0.12,其他流動資產,岱宇,生技醫療業
2023-06-30,1598,CurrentAssets,6081101000.0,流動資產合計,岱宇,生技醫療業
2023-06-30,1598,CurrentAssets_per,49.32,流動資產合計,岱宇,生技醫療業
2023-06-30,1598,InvestmentAccountedForUsingEquityMethod,6490000.0,採用權益法之投資,岱宇,生技醫療業
2023-06-30,1598,InvestmentAccountedForUsingEquityMethod_per,0.05,採用權益法之投資,岱宇,生技醫療業
2023-06-30,1598,PropertyPlantAndEquipment,3744548000.0,不動產、廠房及設備,岱宇,生技醫療業
2023-06-30,1598,PropertyPlantAndEquipment_per,30.37,不動產、廠房及設備,岱宇,生技醫療業
2023-06-30,1598,RightOfUseAsset,298338000.0,使用權資產,岱宇,生技醫療業
2023-06-30,1598,RightOfUseAsset_per,2.42,使用權資產,岱宇,生技醫療業
2023-06-30,1598,IntangibleAssets,1359239000.0,無形資產,岱宇,生技醫療業
2023-06-30,1598,IntangibleAssets_per,11.02,無形資產,岱宇,生技醫療業
2023-06-30,1598,DeferredTaxAssets,539447000.0,遞延所得稅資產,岱宇,生技醫療業
2023-06-30,1598,DeferredTaxAssets_per,4.38,遞延所得稅資產,岱宇,生技醫療業
2023-06-30,1598,OtherNoncurrentAssets,39143000.0,其他非流動資產,岱宇,生技醫療業
2023-06-30,1598,OtherNoncurrentAssets_per,0.32,其他非流動資產,岱宇,生技醫療業
2023-06-30,1598,NoncurrentAssets,6247914000.0,非流動資產合計,岱宇,生技醫療業
2023-06-30,1598,NoncurrentAssets_per,50.68,非流動資產合計,岱宇,生技醫療業
2023-06-30,1598,TotalAssets,12329015000.0,資產總額,岱宇,生技醫療業
2023-06-30,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2023-06-30,1598,ShorttermBorrowings,1891633000.0,短期借款,岱宇,生技醫療業
2023-06-30,1598,ShorttermBorrowings_per,15.34,短期借款,岱宇,生技醫療業
2023-06-30,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2023-06-30,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2023-06-30,1598,AccountsPayable,994122000.0,應付帳款,岱宇,生技醫療業
2023-06-30,1598,AccountsPayable_per,8.06,應付帳款,岱宇,生技醫療業
2023-06-30,1598,OtherPayables,1481990000.0,其他應付款,岱宇,生技醫療業
2023-06-30,1598,OtherPayables_per,12.02,其他應付款,岱宇,生技醫療業
2023-06-30,1598,CurrentTaxLiabilities,44673000.0,本期所得稅負債,岱宇,生技醫療業
2023-06-30,1598,CurrentTaxLiabilities_per,0.36,本期所得稅負債,岱宇,生技醫療業
2023-06-30,1598,CurrentProvisions,14521000.0,負債準備－流動,岱宇,生技醫療業
2023-06-30,1598,CurrentProvisions_per,0.12,負債準備－流動,岱宇,生技醫療業
2023-06-30,1598,OtherCurrentLiabilities,661742000.0,其他流動負債,岱宇,生技醫療業
2023-06-30,1598,OtherCurrentLiabilities_per,5.37,其他流動負債,岱宇,生技醫療業
2023-06-30,1598,CurrentLiabilities,5345627000.0,流動負債合計,岱宇,生技醫療業
2023-06-30,1598,CurrentLiabilities_per,43.36,流動負債合計,岱宇,生技醫療業
2023-06-30,1598,BondsPayable,0.0,應付公司債,岱宇,生技醫療業
2023-06-30,1598,BondsPayable_per,0.0,應付公司債,岱宇,生技醫療業
2023-06-30,1598,LongtermBorrowings,1646796000.0,長期借款,岱宇,生技醫療業
2023-06-30,1598,LongtermBorrowings_per,13.36,長期借款,岱宇,生技醫療業
2023-06-30,1598,OtherNoncurrentLiabilities,112102000.0,其他非流動負債,岱宇,生技醫療業
2023-06-30,1598,OtherNoncurrentLiabilities_per,0.91,其他非流動負債,岱宇,生技醫療業
2023-06-30,1598,NoncurrentLiabilities,2223034000.0,非流動負債合計,岱宇,生技醫療業
2023-06-30,1598,NoncurrentLiabilities_per,18.03,非流動負債合計,岱宇,生技醫療業
2023-06-30,1598,OrdinaryShare,1596097000.0,普通股股本,岱宇,生技醫療業
2023-06-30,1598,OrdinaryShare_per,12.95,普通股股本,岱宇,生技醫療業
2023-06-30,1598,CapitalStock,1596097000.0,股本合計,岱宇,生技醫療業
2023-06-30,1598,CapitalStock_per,12.95,股本合計,岱宇,生技醫療業
2023-06-30,1598,CapitalSurplus,2758037000.0,資本公積合計,岱宇,生技醫療業
2023-06-30,1598,CapitalSurplus_per,22.37,資本公積合計,岱宇,生技醫療業
2023-06-30,1598,LegalReserve,329002000.0,法定盈餘公積,岱宇,生技醫療業
2023-06-30,1598,LegalReserve_per,2.67,法定盈餘公積,岱宇,生技醫療業
2023-06-30,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit,69859000.0,未分配盈餘,岱宇,生技醫療業
2023-06-30,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,0.57,未分配盈餘,岱宇,生技醫療業
2023-06-30,1598,RetainedEarnings,525038000.0,保留盈餘合計,岱宇,生技醫療業
2023-06-30,1598,RetainedEarnings_per,4.26,保留盈餘合計,岱宇,生技醫療業
2023-06-30,1598,OtherEquityInterest,-106263000.0,其他權益合計,岱宇,生技醫療業
2023-06-30,1598,OtherEquityInterest_per,-0.86,其他權益合計,岱宇,生技醫療業
2023-06-30,1598,EquityAttributableToOwnersOfParent,4364219000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2023-06-30,1598,EquityAttributableToOwnersOfParent_per,35.4,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2023-06-30,1598,NoncontrollingInterests,396135000.0,非控制權益,岱宇,生技醫療業
2023-06-30,1598,NoncontrollingInterests_per,3.21,非控制權益,岱宇,生技醫療業
2023-06-30,1598,TotalLiabilitiesEquity,12329015000.0,負債及權益總計,岱宇,生技醫療業
2023-06-30,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2023-06-30,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,8963000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2023-06-30,1598,CurrentIncomeTaxAssets,71284000.0,本期所得稅資產,岱宇,生技醫療業
2023-06-30,1598,CurrentIncomeTaxAssets_per,0.58,本期所得稅資產,岱宇,生技醫療業
2023-06-30,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,155700000.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2023-06-30,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.26,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2023-06-30,1598,Equity,4760354000.0,權益總額,岱宇,生技醫療業
2023-06-30,1598,Equity_per,38.61,權益總額,岱宇,生技醫療業
2023-06-30,1598,Liabilities,7568661000.0,負債總額,岱宇,生技醫療業
2023-06-30,1598,Liabilities_per,61.39,負債總額,岱宇,生技醫療業
2023-09-30,1598,CashAndCashEquivalents,854642000.0,現金及約當現金,岱宇,生技醫療業
2023-09-30,1598,CashAndCashEquivalents_per,7.42,現金及約當現金,岱宇,生技醫療業
2023-09-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,16848000.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2023-09-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.15,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2023-09-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,65703000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2023-09-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.57,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2023-09-30,1598,FinancialAssetsAtAmortizedCost,86523000.0,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2023-09-30,1598,FinancialAssetsAtAmortizedCost_per,0.75,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2023-09-30,1598,FinancialAssetsAtAmortizedCostNonCurrent,6454000.0,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2023-09-30,1598,FinancialAssetsAtAmortizedCostNonCurrent_per,0.06,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2023-09-30,1598,BillsReceivableNet,2112000.0,應收票據淨額,岱宇,生技醫療業
2023-09-30,1598,BillsReceivableNet_per,0.02,應收票據淨額,岱宇,生技醫療業
2023-09-30,1598,OtherReceivable,33486000.0,其他應收款淨額,岱宇,生技醫療業
2023-09-30,1598,OtherReceivable_per,0.29,其他應收款淨額,岱宇,生技醫療業
2023-09-30,1598,Prepayments,263063000.0,預付款項,岱宇,生技醫療業
2023-09-30,1598,Prepayments_per,2.28,預付款項,岱宇,生技醫療業
2023-09-30,1598,AccountsReceivableNet,879355000.0,應收帳款淨額,岱宇,生技醫療業
2023-09-30,1598,AccountsReceivableNet_per,7.64,應收帳款淨額,岱宇,生技醫療業
2023-09-30,1598,OtherReceivablesDueFromRelatedParties,0.0,其他應收款－關係人淨額,岱宇,生技醫療業
2023-09-30,1598,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,岱宇,生技醫療業
2023-09-30,1598,Inventories,2898540000.0,存貨,岱宇,生技醫療業
2023-09-30,1598,Inventories_per,25.17,存貨,岱宇,生技醫療業
2023-09-30,1598,OtherCurrentAssets,23599000.0,其他流動資產,岱宇,生技醫療業
2023-09-30,1598,OtherCurrentAssets_per,0.2,其他流動資產,岱宇,生技醫療業
2023-09-30,1598,CurrentAssets,5136731000.0,流動資產合計,岱宇,生技醫療業
2023-09-30,1598,CurrentAssets_per,44.61,流動資產合計,岱宇,生技醫療業
2023-09-30,1598,InvestmentAccountedForUsingEquityMethod,6535000.0,採用權益法之投資,岱宇,生技醫療業
2023-09-30,1598,InvestmentAccountedForUsingEquityMethod_per,0.06,採用權益法之投資,岱宇,生技醫療業
2023-09-30,1598,PropertyPlantAndEquipment,3801762000.0,不動產、廠房及設備,岱宇,生技醫療業
2023-09-30,1598,PropertyPlantAndEquipment_per,33.02,不動產、廠房及設備,岱宇,生技醫療業
2023-09-30,1598,RightOfUseAsset,297775000.0,使用權資產,岱宇,生技醫療業
2023-09-30,1598,RightOfUseAsset_per,2.59,使用權資產,岱宇,生技醫療業
2023-09-30,1598,IntangibleAssets,1382578000.0,無形資產,岱宇,生技醫療業
2023-09-30,1598,IntangibleAssets_per,12.01,無形資產,岱宇,生技醫療業
2023-09-30,1598,DeferredTaxAssets,603811000.0,遞延所得稅資產,岱宇,生技醫療業
2023-09-30,1598,DeferredTaxAssets_per,5.24,遞延所得稅資產,岱宇,生技醫療業
2023-09-30,1598,OtherNoncurrentAssets,33225000.0,其他非流動資產,岱宇,生技醫療業
2023-09-30,1598,OtherNoncurrentAssets_per,0.29,其他非流動資產,岱宇,生技醫療業
2023-09-30,1598,NoncurrentAssets,6377471000.0,非流動資產合計,岱宇,生技醫療業
2023-09-30,1598,NoncurrentAssets_per,55.39,非流動資產合計,岱宇,生技醫療業
2023-09-30,1598,TotalAssets,11514202000.0,資產總額,岱宇,生技醫療業
2023-09-30,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2023-09-30,1598,ShorttermBorrowings,1918617000.0,短期借款,岱宇,生技醫療業
2023-09-30,1598,ShorttermBorrowings_per,16.66,短期借款,岱宇,生技醫療業
2023-09-30,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2023-09-30,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2023-09-30,1598,AccountsPayable,1038846000.0,應付帳款,岱宇,生技醫療業
2023-09-30,1598,AccountsPayable_per,9.02,應付帳款,岱宇,生技醫療業
2023-09-30,1598,OtherPayables,435486000.0,其他應付款,岱宇,生技醫療業
2023-09-30,1598,OtherPayables_per,3.78,其他應付款,岱宇,生技醫療業
2023-09-30,1598,CurrentTaxLiabilities,80975000.0,本期所得稅負債,岱宇,生技醫療業
2023-09-30,1598,CurrentTaxLiabilities_per,0.7,本期所得稅負債,岱宇,生技醫療業
2023-09-30,1598,CurrentProvisions,14797000.0,負債準備－流動,岱宇,生技醫療業
2023-09-30,1598,CurrentProvisions_per,0.13,負債準備－流動,岱宇,生技醫療業
2023-09-30,1598,OtherCurrentLiabilities,343195000.0,其他流動負債,岱宇,生技醫療業
2023-09-30,1598,OtherCurrentLiabilities_per,2.98,其他流動負債,岱宇,生技醫療業
2023-09-30,1598,CurrentLiabilities,4099628000.0,流動負債合計,岱宇,生技醫療業
2023-09-30,1598,CurrentLiabilities_per,35.6,流動負債合計,岱宇,生技醫療業
2023-09-30,1598,LongtermBorrowings,1988916000.0,長期借款,岱宇,生技醫療業
2023-09-30,1598,LongtermBorrowings_per,17.27,長期借款,岱宇,生技醫療業
2023-09-30,1598,OtherNoncurrentLiabilities,111513000.0,其他非流動負債,岱宇,生技醫療業
2023-09-30,1598,OtherNoncurrentLiabilities_per,0.97,其他非流動負債,岱宇,生技醫療業
2023-09-30,1598,NoncurrentLiabilities,2572182000.0,非流動負債合計,岱宇,生技醫療業
2023-09-30,1598,NoncurrentLiabilities_per,22.34,非流動負債合計,岱宇,生技醫療業
2023-09-30,1598,OrdinaryShare,1596097000.0,普通股股本,岱宇,生技醫療業
2023-09-30,1598,OrdinaryShare_per,13.86,普通股股本,岱宇,生技醫療業
2023-09-30,1598,CapitalStock,1596097000.0,股本合計,岱宇,生技醫療業
2023-09-30,1598,CapitalStock_per,13.86,股本合計,岱宇,生技醫療業
2023-09-30,1598,CapitalSurplus,2755171000.0,資本公積合計,岱宇,生技醫療業
2023-09-30,1598,CapitalSurplus_per,23.93,資本公積合計,岱宇,生技醫療業
2023-09-30,1598,LegalReserve,329002000.0,法定盈餘公積,岱宇,生技醫療業
2023-09-30,1598,LegalReserve_per,2.86,法定盈餘公積,岱宇,生技醫療業
2023-09-30,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit,94795000.0,未分配盈餘,岱宇,生技醫療業
2023-09-30,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,0.82,未分配盈餘,岱宇,生技醫療業
2023-09-30,1598,RetainedEarnings,549974000.0,保留盈餘合計,岱宇,生技醫療業
2023-09-30,1598,RetainedEarnings_per,4.78,保留盈餘合計,岱宇,生技醫療業
2023-09-30,1598,OtherEquityInterest,-30158000.0,其他權益合計,岱宇,生技醫療業
2023-09-30,1598,OtherEquityInterest_per,-0.26,其他權益合計,岱宇,生技醫療業
2023-09-30,1598,EquityAttributableToOwnersOfParent,4462394000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2023-09-30,1598,EquityAttributableToOwnersOfParent_per,38.76,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2023-09-30,1598,NoncontrollingInterests,379998000.0,非控制權益,岱宇,生技醫療業
2023-09-30,1598,NoncontrollingInterests_per,3.3,非控制權益,岱宇,生技醫療業
2023-09-30,1598,TotalLiabilitiesEquity,11514202000.0,負債及權益總計,岱宇,生技醫療業
2023-09-30,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2023-09-30,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,8963000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2023-09-30,1598,CurrentIncomeTaxAssets,78563000.0,本期所得稅資產,岱宇,生技醫療業
2023-09-30,1598,CurrentIncomeTaxAssets_per,0.68,本期所得稅資產,岱宇,生技醫療業
2023-09-30,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,154542000.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2023-09-30,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.34,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2023-09-30,1598,Equity,4842392000.0,權益總額,岱宇,生技醫療業
2023-09-30,1598,Equity_per,42.06,權益總額,岱宇,生技醫療業
2023-09-30,1598,Liabilities,6671810000.0,負債總額,岱宇,生技醫療業
2023-09-30,1598,Liabilities_per,57.94,負債總額,岱宇,生技醫療業
2023-12-31,1598,CashAndCashEquivalents,1158512000.0,現金及約當現金,岱宇,生技醫療業
2023-12-31,1598,CashAndCashEquivalents_per,10.26,現金及約當現金,岱宇,生技醫療業
2023-12-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,16555000.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2023-12-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.15,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2023-12-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,50970000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2023-12-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.45,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2023-12-31,1598,FinancialAssetsAtAmortizedCost,83095000.0,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2023-12-31,1598,FinancialAssetsAtAmortizedCost_per,0.74,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2023-12-31,1598,FinancialAssetsAtAmortizedCostNonCurrent,6141000.0,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2023-12-31,1598,FinancialAssetsAtAmortizedCostNonCurrent_per,0.05,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2023-12-31,1598,BillsReceivableNet,984000.0,應收票據淨額,岱宇,生技醫療業
2023-12-31,1598,BillsReceivableNet_per,0.01,應收票據淨額,岱宇,生技醫療業
2023-12-31,1598,OtherReceivable,15099000.0,其他應收款淨額,岱宇,生技醫療業
2023-12-31,1598,OtherReceivable_per,0.13,其他應收款淨額,岱宇,生技醫療業
2023-12-31,1598,Prepayments,187734000.0,預付款項,岱宇,生技醫療業
2023-12-31,1598,Prepayments_per,1.66,預付款項,岱宇,生技醫療業
2023-12-31,1598,AccountsReceivableNet,1071044000.0,應收帳款淨額,岱宇,生技醫療業
2023-12-31,1598,AccountsReceivableNet_per,9.49,應收帳款淨額,岱宇,生技醫療業
2023-12-31,1598,OtherReceivablesDueFromRelatedParties,0.0,其他應收款－關係人淨額,岱宇,生技醫療業
2023-12-31,1598,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,岱宇,生技醫療業
2023-12-31,1598,Inventories,2474495000.0,存貨,岱宇,生技醫療業
2023-12-31,1598,Inventories_per,21.92,存貨,岱宇,生技醫療業
2023-12-31,1598,OtherCurrentAssets,12395000.0,其他流動資產,岱宇,生技醫療業
2023-12-31,1598,OtherCurrentAssets_per,0.11,其他流動資產,岱宇,生技醫療業
2023-12-31,1598,CurrentAssets,5113911000.0,流動資產合計,岱宇,生技醫療業
2023-12-31,1598,CurrentAssets_per,45.3,流動資產合計,岱宇,生技醫療業
2023-12-31,1598,InvestmentAccountedForUsingEquityMethod,6368000.0,採用權益法之投資,岱宇,生技醫療業
2023-12-31,1598,InvestmentAccountedForUsingEquityMethod_per,0.06,採用權益法之投資,岱宇,生技醫療業
2023-12-31,1598,PropertyPlantAndEquipment,3755859000.0,不動產、廠房及設備,岱宇,生技醫療業
2023-12-31,1598,PropertyPlantAndEquipment_per,33.27,不動產、廠房及設備,岱宇,生技醫療業
2023-12-31,1598,RightOfUseAsset,286306000.0,使用權資產,岱宇,生技醫療業
2023-12-31,1598,RightOfUseAsset_per,2.54,使用權資產,岱宇,生技醫療業
2023-12-31,1598,IntangibleAssets,1315161000.0,無形資產,岱宇,生技醫療業
2023-12-31,1598,IntangibleAssets_per,11.65,無形資產,岱宇,生技醫療業
2023-12-31,1598,DeferredTaxAssets,493769000.0,遞延所得稅資產,岱宇,生技醫療業
2023-12-31,1598,DeferredTaxAssets_per,4.37,遞延所得稅資產,岱宇,生技醫療業
2023-12-31,1598,OtherNoncurrentAssets,117307000.0,其他非流動資產,岱宇,生技醫療業
2023-12-31,1598,OtherNoncurrentAssets_per,1.04,其他非流動資產,岱宇,生技醫療業
2023-12-31,1598,NoncurrentAssets,6175263000.0,非流動資產合計,岱宇,生技醫療業
2023-12-31,1598,NoncurrentAssets_per,54.7,非流動資產合計,岱宇,生技醫療業
2023-12-31,1598,TotalAssets,11289174000.0,資產總額,岱宇,生技醫療業
2023-12-31,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2023-12-31,1598,ShorttermBorrowings,2118015000.0,短期借款,岱宇,生技醫療業
2023-12-31,1598,ShorttermBorrowings_per,18.76,短期借款,岱宇,生技醫療業
2023-12-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2023-12-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2023-12-31,1598,AccountsPayable,941012000.0,應付帳款,岱宇,生技醫療業
2023-12-31,1598,AccountsPayable_per,8.34,應付帳款,岱宇,生技醫療業
2023-12-31,1598,OtherPayables,457690000.0,其他應付款,岱宇,生技醫療業
2023-12-31,1598,OtherPayables_per,4.05,其他應付款,岱宇,生技醫療業
2023-12-31,1598,CurrentTaxLiabilities,7066000.0,本期所得稅負債,岱宇,生技醫療業
2023-12-31,1598,CurrentTaxLiabilities_per,0.06,本期所得稅負債,岱宇,生技醫療業
2023-12-31,1598,CurrentProvisions,12044000.0,負債準備－流動,岱宇,生技醫療業
2023-12-31,1598,CurrentProvisions_per,0.11,負債準備－流動,岱宇,生技醫療業
2023-12-31,1598,OtherCurrentLiabilities,336219000.0,其他流動負債,岱宇,生技醫療業
2023-12-31,1598,OtherCurrentLiabilities_per,2.98,其他流動負債,岱宇,生技醫療業
2023-12-31,1598,CurrentLiabilities,4081683000.0,流動負債合計,岱宇,生技醫療業
2023-12-31,1598,CurrentLiabilities_per,36.16,流動負債合計,岱宇,生技醫療業
2023-12-31,1598,LongtermBorrowings,1918802000.0,長期借款,岱宇,生技醫療業
2023-12-31,1598,LongtermBorrowings_per,17.0,長期借款,岱宇,生技醫療業
2023-12-31,1598,OtherNoncurrentLiabilities,79560000.0,其他非流動負債,岱宇,生技醫療業
2023-12-31,1598,OtherNoncurrentLiabilities_per,0.7,其他非流動負債,岱宇,生技醫療業
2023-12-31,1598,NoncurrentLiabilities,2435814000.0,非流動負債合計,岱宇,生技醫療業
2023-12-31,1598,NoncurrentLiabilities_per,21.58,非流動負債合計,岱宇,生技醫療業
2023-12-31,1598,OrdinaryShare,1596097000.0,普通股股本,岱宇,生技醫療業
2023-12-31,1598,OrdinaryShare_per,14.14,普通股股本,岱宇,生技醫療業
2023-12-31,1598,CapitalStock,1596097000.0,股本合計,岱宇,生技醫療業
2023-12-31,1598,CapitalStock_per,14.14,股本合計,岱宇,生技醫療業
2023-12-31,1598,CapitalSurplus,2756721000.0,資本公積合計,岱宇,生技醫療業
2023-12-31,1598,CapitalSurplus_per,24.42,資本公積合計,岱宇,生技醫療業
2023-12-31,1598,LegalReserve,329002000.0,法定盈餘公積,岱宇,生技醫療業
2023-12-31,1598,LegalReserve_per,2.91,法定盈餘公積,岱宇,生技醫療業
2023-12-31,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit,100471000.0,未分配盈餘,岱宇,生技醫療業
2023-12-31,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,0.89,未分配盈餘,岱宇,生技醫療業
2023-12-31,1598,RetainedEarnings,555650000.0,保留盈餘合計,岱宇,生技醫療業
2023-12-31,1598,RetainedEarnings_per,4.92,保留盈餘合計,岱宇,生技醫療業
2023-12-31,1598,OtherEquityInterest,-125684000.0,其他權益合計,岱宇,生技醫療業
2023-12-31,1598,OtherEquityInterest_per,-1.11,其他權益合計,岱宇,生技醫療業
2023-12-31,1598,EquityAttributableToOwnersOfParent,4374094000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2023-12-31,1598,EquityAttributableToOwnersOfParent_per,38.75,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2023-12-31,1598,NoncontrollingInterests,397583000.0,非控制權益,岱宇,生技醫療業
2023-12-31,1598,NoncontrollingInterests_per,3.52,非控制權益,岱宇,生技醫療業
2023-12-31,1598,TotalLiabilitiesEquity,11289174000.0,負債及權益總計,岱宇,生技醫療業
2023-12-31,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2023-12-31,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,8963000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2023-12-31,1598,CurrentIncomeTaxAssets,93998000.0,本期所得稅資產,岱宇,生技醫療業
2023-12-31,1598,CurrentIncomeTaxAssets_per,0.83,本期所得稅資產,岱宇,生技醫療業
2023-12-31,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,118124000.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2023-12-31,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.05,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2023-12-31,1598,Equity,4771677000.0,權益總額,岱宇,生技醫療業
2023-12-31,1598,Equity_per,42.27,權益總額,岱宇,生技醫療業
2023-12-31,1598,Liabilities,6517497000.0,負債總額,岱宇,生技醫療業
2023-12-31,1598,Liabilities_per,57.73,負債總額,岱宇,生技醫療業
2024-03-31,1598,CashAndCashEquivalents,1047219000.0,現金及約當現金,岱宇,生技醫療業
2024-03-31,1598,CashAndCashEquivalents_per,9.41,現金及約當現金,岱宇,生技醫療業
2024-03-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,40472000.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2024-03-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.36,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2024-03-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,52770000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2024-03-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.47,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2024-03-31,1598,FinancialAssetsAtAmortizedCost,77933000.0,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2024-03-31,1598,FinancialAssetsAtAmortizedCost_per,0.7,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2024-03-31,1598,FinancialAssetsAtAmortizedCostNonCurrent,30400000.0,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2024-03-31,1598,FinancialAssetsAtAmortizedCostNonCurrent_per,0.27,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2024-03-31,1598,BillsReceivableNet,2775000.0,應收票據淨額,岱宇,生技醫療業
2024-03-31,1598,BillsReceivableNet_per,0.02,應收票據淨額,岱宇,生技醫療業
2024-03-31,1598,OtherReceivable,13273000.0,其他應收款淨額,岱宇,生技醫療業
2024-03-31,1598,OtherReceivable_per,0.12,其他應收款淨額,岱宇,生技醫療業
2024-03-31,1598,Prepayments,218744000.0,預付款項,岱宇,生技醫療業
2024-03-31,1598,Prepayments_per,1.97,預付款項,岱宇,生技醫療業
2024-03-31,1598,AccountsReceivableNet,916076000.0,應收帳款淨額,岱宇,生技醫療業
2024-03-31,1598,AccountsReceivableNet_per,8.24,應收帳款淨額,岱宇,生技醫療業
2024-03-31,1598,Inventories,2354692000.0,存貨,岱宇,生技醫療業
2024-03-31,1598,Inventories_per,21.17,存貨,岱宇,生技醫療業
2024-03-31,1598,OtherCurrentAssets,9761000.0,其他流動資產,岱宇,生技醫療業
2024-03-31,1598,OtherCurrentAssets_per,0.09,其他流動資產,岱宇,生技醫療業
2024-03-31,1598,CurrentAssets,4765081000.0,流動資產合計,岱宇,生技醫療業
2024-03-31,1598,CurrentAssets_per,42.84,流動資產合計,岱宇,生技醫療業
2024-03-31,1598,InvestmentAccountedForUsingEquityMethod,6334000.0,採用權益法之投資,岱宇,生技醫療業
2024-03-31,1598,InvestmentAccountedForUsingEquityMethod_per,0.06,採用權益法之投資,岱宇,生技醫療業
2024-03-31,1598,PropertyPlantAndEquipment,3915305000.0,不動產、廠房及設備,岱宇,生技醫療業
2024-03-31,1598,PropertyPlantAndEquipment_per,35.2,不動產、廠房及設備,岱宇,生技醫療業
2024-03-31,1598,RightOfUseAsset,293737000.0,使用權資產,岱宇,生技醫療業
2024-03-31,1598,RightOfUseAsset_per,2.64,使用權資產,岱宇,生技醫療業
2024-03-31,1598,IntangibleAssets,1343149000.0,無形資產,岱宇,生技醫療業
2024-03-31,1598,IntangibleAssets_per,12.08,無形資產,岱宇,生技醫療業
2024-03-31,1598,DeferredTaxAssets,516990000.0,遞延所得稅資產,岱宇,生技醫療業
2024-03-31,1598,DeferredTaxAssets_per,4.65,遞延所得稅資產,岱宇,生技醫療業
2024-03-31,1598,OtherNoncurrentAssets,51564000.0,其他非流動資產,岱宇,生技醫療業
2024-03-31,1598,OtherNoncurrentAssets_per,0.46,其他非流動資產,岱宇,生技醫療業
2024-03-31,1598,NoncurrentAssets,6358221000.0,非流動資產合計,岱宇,生技醫療業
2024-03-31,1598,NoncurrentAssets_per,57.16,非流動資產合計,岱宇,生技醫療業
2024-03-31,1598,TotalAssets,11123302000.0,資產總額,岱宇,生技醫療業
2024-03-31,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2024-03-31,1598,ShorttermBorrowings,1923120000.0,短期借款,岱宇,生技醫療業
2024-03-31,1598,ShorttermBorrowings_per,17.29,短期借款,岱宇,生技醫療業
2024-03-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,2665000.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2024-03-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.02,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2024-03-31,1598,AccountsPayable,845908000.0,應付帳款,岱宇,生技醫療業
2024-03-31,1598,AccountsPayable_per,7.6,應付帳款,岱宇,生技醫療業
2024-03-31,1598,OtherPayables,457214000.0,其他應付款,岱宇,生技醫療業
2024-03-31,1598,OtherPayables_per,4.11,其他應付款,岱宇,生技醫療業
2024-03-31,1598,CurrentTaxLiabilities,24266000.0,本期所得稅負債,岱宇,生技醫療業
2024-03-31,1598,CurrentTaxLiabilities_per,0.22,本期所得稅負債,岱宇,生技醫療業
2024-03-31,1598,CurrentProvisions,12766000.0,負債準備－流動,岱宇,生技醫療業
2024-03-31,1598,CurrentProvisions_per,0.11,負債準備－流動,岱宇,生技醫療業
2024-03-31,1598,OtherCurrentLiabilities,317624000.0,其他流動負債,岱宇,生技醫療業
2024-03-31,1598,OtherCurrentLiabilities_per,2.86,其他流動負債,岱宇,生技醫療業
2024-03-31,1598,CurrentLiabilities,3780683000.0,流動負債合計,岱宇,生技醫療業
2024-03-31,1598,CurrentLiabilities_per,33.99,流動負債合計,岱宇,生技醫療業
2024-03-31,1598,LongtermBorrowings,1922678000.0,長期借款,岱宇,生技醫療業
2024-03-31,1598,LongtermBorrowings_per,17.29,長期借款,岱宇,生技醫療業
2024-03-31,1598,OtherNoncurrentLiabilities,80400000.0,其他非流動負債,岱宇,生技醫療業
2024-03-31,1598,OtherNoncurrentLiabilities_per,0.72,其他非流動負債,岱宇,生技醫療業
2024-03-31,1598,NoncurrentLiabilities,2460677000.0,非流動負債合計,岱宇,生技醫療業
2024-03-31,1598,NoncurrentLiabilities_per,22.12,非流動負債合計,岱宇,生技醫療業
2024-03-31,1598,OrdinaryShare,1596097000.0,普通股股本,岱宇,生技醫療業
2024-03-31,1598,OrdinaryShare_per,14.35,普通股股本,岱宇,生技醫療業
2024-03-31,1598,CapitalStock,1596097000.0,股本合計,岱宇,生技醫療業
2024-03-31,1598,CapitalStock_per,14.35,股本合計,岱宇,生技醫療業
2024-03-31,1598,CapitalSurplus,2757513000.0,資本公積合計,岱宇,生技醫療業
2024-03-31,1598,CapitalSurplus_per,24.79,資本公積合計,岱宇,生技醫療業
2024-03-31,1598,LegalReserve,329002000.0,法定盈餘公積,岱宇,生技醫療業
2024-03-31,1598,LegalReserve_per,2.96,法定盈餘公積,岱宇,生技醫療業
2024-03-31,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit,133187000.0,未分配盈餘,岱宇,生技醫療業
2024-03-31,1598,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,1.2,未分配盈餘,岱宇,生技醫療業
2024-03-31,1598,RetainedEarnings,588366000.0,保留盈餘合計,岱宇,生技醫療業
2024-03-31,1598,RetainedEarnings_per,5.29,保留盈餘合計,岱宇,生技醫療業
2024-03-31,1598,OtherEquityInterest,-46613000.0,其他權益合計,岱宇,生技醫療業
2024-03-31,1598,OtherEquityInterest_per,-0.42,其他權益合計,岱宇,生技醫療業
2024-03-31,1598,EquityAttributableToOwnersOfParent,4486673000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2024-03-31,1598,EquityAttributableToOwnersOfParent_per,40.34,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2024-03-31,1598,NoncontrollingInterests,395269000.0,非控制權益,岱宇,生技醫療業
2024-03-31,1598,NoncontrollingInterests_per,3.55,非控制權益,岱宇,生技醫療業
2024-03-31,1598,TotalLiabilitiesEquity,11123302000.0,負債及權益總計,岱宇,生技醫療業
2024-03-31,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2024-03-31,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,8963000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2024-03-31,1598,CurrentIncomeTaxAssets,84136000.0,本期所得稅資產,岱宇,生技醫療業
2024-03-31,1598,CurrentIncomeTaxAssets_per,0.76,本期所得稅資產,岱宇,生技醫療業
2024-03-31,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,123106000.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2024-03-31,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.11,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2024-03-31,1598,BondsPayable,0.0,應付公司債,岱宇,生技醫療業
2024-03-31,1598,BondsPayable_per,0.0,應付公司債,岱宇,生技醫療業
2024-03-31,1598,Liabilities,6241360000.0,負債總額,岱宇,生技醫療業
2024-03-31,1598,Liabilities_per,56.11,負債總額,岱宇,生技醫療業
2024-03-31,1598,Equity,4881942000.0,權益總額,岱宇,生技醫療業
2024-03-31,1598,Equity_per,43.89,權益總額,岱宇,生技醫療業
2024-06-30,1598,CashAndCashEquivalents,1038127000.0,現金及約當現金,岱宇,生技醫療業
2024-06-30,1598,CashAndCashEquivalents_per,9.36,現金及約當現金,岱宇,生技醫療業
2024-06-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,42222000.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2024-06-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.38,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2024-06-30,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2024-06-30,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2024-06-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,55210000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2024-06-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.5,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2024-06-30,1598,FinancialAssetsAtAmortizedCost,18957000.0,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2024-06-30,1598,FinancialAssetsAtAmortizedCost_per,0.17,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2024-06-30,1598,FinancialAssetsAtAmortizedCostNonCurrent,30828000.0,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2024-06-30,1598,FinancialAssetsAtAmortizedCostNonCurrent_per,0.28,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2024-06-30,1598,BillsReceivableNet,2970000.0,應收票據淨額,岱宇,生技醫療業
2024-06-30,1598,BillsReceivableNet_per,0.03,應收票據淨額,岱宇,生技醫療業
2024-06-30,1598,OtherReceivable,49337000.0,其他應收款淨額,岱宇,生技醫療業
2024-06-30,1598,OtherReceivable_per,0.44,其他應收款淨額,岱宇,生技醫療業
2024-06-30,1598,Prepayments,250277000.0,預付款項,岱宇,生技醫療業
2024-06-30,1598,Prepayments_per,2.26,預付款項,岱宇,生技醫療業
2024-06-30,1598,AccountsReceivableNet,792085000.0,應收帳款淨額,岱宇,生技醫療業
2024-06-30,1598,AccountsReceivableNet_per,7.14,應收帳款淨額,岱宇,生技醫療業
2024-06-30,1598,Inventories,2496071000.0,存貨,岱宇,生技醫療業
2024-06-30,1598,Inventories_per,22.51,存貨,岱宇,生技醫療業
2024-06-30,1598,OtherCurrentAssets,36439000.0,其他流動資產,岱宇,生技醫療業
2024-06-30,1598,OtherCurrentAssets_per,0.33,其他流動資產,岱宇,生技醫療業
2024-06-30,1598,CurrentAssets,4808970000.0,流動資產合計,岱宇,生技醫療業
2024-06-30,1598,CurrentAssets_per,43.37,流動資產合計,岱宇,生技醫療業
2024-06-30,1598,InvestmentAccountedForUsingEquityMethod,6269000.0,採用權益法之投資,岱宇,生技醫療業
2024-06-30,1598,InvestmentAccountedForUsingEquityMethod_per,0.06,採用權益法之投資,岱宇,生技醫療業
2024-06-30,1598,PropertyPlantAndEquipment,3944533000.0,不動產、廠房及設備,岱宇,生技醫療業
2024-06-30,1598,PropertyPlantAndEquipment_per,35.58,不動產、廠房及設備,岱宇,生技醫療業
2024-06-30,1598,RightOfUseAsset,323889000.0,使用權資產,岱宇,生技醫療業
2024-06-30,1598,RightOfUseAsset_per,2.92,使用權資產,岱宇,生技醫療業
2024-06-30,1598,IntangibleAssets,1345171000.0,無形資產,岱宇,生技醫療業
2024-06-30,1598,IntangibleAssets_per,12.13,無形資產,岱宇,生技醫療業
2024-06-30,1598,DeferredTaxAssets,504393000.0,遞延所得稅資產,岱宇,生技醫療業
2024-06-30,1598,DeferredTaxAssets_per,4.55,遞延所得稅資產,岱宇,生技醫療業
2024-06-30,1598,OtherNoncurrentAssets,46541000.0,其他非流動資產,岱宇,生技醫療業
2024-06-30,1598,OtherNoncurrentAssets_per,0.42,其他非流動資產,岱宇,生技醫療業
2024-06-30,1598,NoncurrentAssets,6278264000.0,非流動資產合計,岱宇,生技醫療業
2024-06-30,1598,NoncurrentAssets_per,56.63,非流動資產合計,岱宇,生技醫療業
2024-06-30,1598,TotalAssets,11087234000.0,資產總額,岱宇,生技醫療業
2024-06-30,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2024-06-30,1598,ShorttermBorrowings,1907270000.0,短期借款,岱宇,生技醫療業
2024-06-30,1598,ShorttermBorrowings_per,17.2,短期借款,岱宇,生技醫療業
2024-06-30,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,88000.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2024-06-30,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2024-06-30,1598,AccountsPayable,855566000.0,應付帳款,岱宇,生技醫療業
2024-06-30,1598,AccountsPayable_per,7.72,應付帳款,岱宇,生技醫療業
2024-06-30,1598,OtherPayables,547283000.0,其他應付款,岱宇,生技醫療業
2024-06-30,1598,OtherPayables_per,4.94,其他應付款,岱宇,生技醫療業
2024-06-30,1598,CurrentTaxLiabilities,6198000.0,本期所得稅負債,岱宇,生技醫療業
2024-06-30,1598,CurrentTaxLiabilities_per,0.06,本期所得稅負債,岱宇,生技醫療業
2024-06-30,1598,CurrentProvisions,13994000.0,負債準備－流動,岱宇,生技醫療業
2024-06-30,1598,CurrentProvisions_per,0.13,負債準備－流動,岱宇,生技醫療業
2024-06-30,1598,OtherCurrentLiabilities,304120000.0,其他流動負債,岱宇,生技醫療業
2024-06-30,1598,OtherCurrentLiabilities_per,2.74,其他流動負債,岱宇,生技醫療業
2024-06-30,1598,CurrentLiabilities,3849640000.0,流動負債合計,岱宇,生技醫療業
2024-06-30,1598,CurrentLiabilities_per,34.72,流動負債合計,岱宇,生技醫療業
2024-06-30,1598,LongtermBorrowings,1882878000.0,長期借款,岱宇,生技醫療業
2024-06-30,1598,LongtermBorrowings_per,16.98,長期借款,岱宇,生技醫療業
2024-06-30,1598,OtherNoncurrentLiabilities,78146000.0,其他非流動負債,岱宇,生技醫療業
2024-06-30,1598,OtherNoncurrentLiabilities_per,0.7,其他非流動負債,岱宇,生技醫療業
2024-06-30,1598,NoncurrentLiabilities,2435383000.0,非流動負債合計,岱宇,生技醫療業
2024-06-30,1598,NoncurrentLiabilities_per,21.97,非流動負債合計,岱宇,生技醫療業
2024-06-30,1598,OrdinaryShare,1596097000.0,普通股股本,岱宇,生技醫療業
2024-06-30,1598,OrdinaryShare_per,14.4,普通股股本,岱宇,生技醫療業
2024-06-30,1598,CapitalStock,1671420000.0,股本合計,岱宇,生技醫療業
2024-06-30,1598,CapitalStock_per,15.08,股本合計,岱宇,生技醫療業
2024-06-30,1598,CapitalSurplus,2682875000.0,資本公積合計,岱宇,生技醫療業
2024-06-30,1598,CapitalSurplus_per,24.2,資本公積合計,岱宇,生技醫療業
2024-06-30,1598,RetainedEarnings,482198000.0,保留盈餘合計,岱宇,生技醫療業
2024-06-30,1598,RetainedEarnings_per,4.35,保留盈餘合計,岱宇,生技醫療業
2024-06-30,1598,OtherEquityInterest,-15106000.0,其他權益合計,岱宇,生技醫療業
2024-06-30,1598,OtherEquityInterest_per,-0.14,其他權益合計,岱宇,生技醫療業
2024-06-30,1598,EquityAttributableToOwnersOfParent,4412697000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2024-06-30,1598,EquityAttributableToOwnersOfParent_per,39.8,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2024-06-30,1598,NoncontrollingInterests,389514000.0,非控制權益,岱宇,生技醫療業
2024-06-30,1598,NoncontrollingInterests_per,3.51,非控制權益,岱宇,生技醫療業
2024-06-30,1598,TotalLiabilitiesEquity,11087234000.0,負債及權益總計,岱宇,生技醫療業
2024-06-30,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2024-06-30,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,8963000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2024-06-30,1598,CurrentIncomeTaxAssets,82485000.0,本期所得稅資產,岱宇,生技醫療業
2024-06-30,1598,CurrentIncomeTaxAssets_per,0.74,本期所得稅資產,岱宇,生技醫療業
2024-06-30,1598,Liabilities,6285023000.0,負債總額,岱宇,生技醫療業
2024-06-30,1598,Liabilities_per,56.69,負債總額,岱宇,生技醫療業
2024-06-30,1598,Equity,4802211000.0,權益總額,岱宇,生技醫療業
2024-06-30,1598,Equity_per,43.31,權益總額,岱宇,生技醫療業
2024-09-30,1598,CashAndCashEquivalents,846105000.0,現金及約當現金,岱宇,生技醫療業
2024-09-30,1598,CashAndCashEquivalents_per,7.89,現金及約當現金,岱宇,生技醫療業
2024-09-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,44049000.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2024-09-30,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.41,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2024-09-30,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2024-09-30,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2024-09-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,55273000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2024-09-30,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.52,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2024-09-30,1598,FinancialAssetsAtAmortizedCost,10844000.0,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2024-09-30,1598,FinancialAssetsAtAmortizedCost_per,0.1,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2024-09-30,1598,FinancialAssetsAtAmortizedCostNonCurrent,37980000.0,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2024-09-30,1598,FinancialAssetsAtAmortizedCostNonCurrent_per,0.35,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2024-09-30,1598,BillsReceivableNet,2929000.0,應收票據淨額,岱宇,生技醫療業
2024-09-30,1598,BillsReceivableNet_per,0.03,應收票據淨額,岱宇,生技醫療業
2024-09-30,1598,OtherReceivable,14969000.0,其他應收款淨額,岱宇,生技醫療業
2024-09-30,1598,OtherReceivable_per,0.14,其他應收款淨額,岱宇,生技醫療業
2024-09-30,1598,Prepayments,267473000.0,預付款項,岱宇,生技醫療業
2024-09-30,1598,Prepayments_per,2.49,預付款項,岱宇,生技醫療業
2024-09-30,1598,AccountsReceivableNet,870428000.0,應收帳款淨額,岱宇,生技醫療業
2024-09-30,1598,AccountsReceivableNet_per,8.11,應收帳款淨額,岱宇,生技醫療業
2024-09-30,1598,Inventories,2399933000.0,存貨,岱宇,生技醫療業
2024-09-30,1598,Inventories_per,22.37,存貨,岱宇,生技醫療業
2024-09-30,1598,OtherCurrentAssets,17602000.0,其他流動資產,岱宇,生技醫療業
2024-09-30,1598,OtherCurrentAssets_per,0.16,其他流動資產,岱宇,生技醫療業
2024-09-30,1598,CurrentAssets,4514506000.0,流動資產合計,岱宇,生技醫療業
2024-09-30,1598,CurrentAssets_per,42.08,流動資產合計,岱宇,生技醫療業
2024-09-30,1598,InvestmentAccountedForUsingEquityMethod,6240000.0,採用權益法之投資,岱宇,生技醫療業
2024-09-30,1598,InvestmentAccountedForUsingEquityMethod_per,0.06,採用權益法之投資,岱宇,生技醫療業
2024-09-30,1598,PropertyPlantAndEquipment,3935622000.0,不動產、廠房及設備,岱宇,生技醫療業
2024-09-30,1598,PropertyPlantAndEquipment_per,36.69,不動產、廠房及設備,岱宇,生技醫療業
2024-09-30,1598,RightOfUseAsset,321057000.0,使用權資產,岱宇,生技醫療業
2024-09-30,1598,RightOfUseAsset_per,2.99,使用權資產,岱宇,生技醫療業
2024-09-30,1598,IntangibleAssets,1304379000.0,無形資產,岱宇,生技醫療業
2024-09-30,1598,IntangibleAssets_per,12.16,無形資產,岱宇,生技醫療業
2024-09-30,1598,DeferredTaxAssets,495151000.0,遞延所得稅資產,岱宇,生技醫療業
2024-09-30,1598,DeferredTaxAssets_per,4.62,遞延所得稅資產,岱宇,生技醫療業
2024-09-30,1598,OtherNoncurrentAssets,38124000.0,其他非流動資產,岱宇,生技醫療業
2024-09-30,1598,OtherNoncurrentAssets_per,0.36,其他非流動資產,岱宇,生技醫療業
2024-09-30,1598,NoncurrentAssets,6212630000.0,非流動資產合計,岱宇,生技醫療業
2024-09-30,1598,NoncurrentAssets_per,57.92,非流動資產合計,岱宇,生技醫療業
2024-09-30,1598,TotalAssets,10727136000.0,資產總額,岱宇,生技醫療業
2024-09-30,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2024-09-30,1598,ShorttermBorrowings,1860108000.0,短期借款,岱宇,生技醫療業
2024-09-30,1598,ShorttermBorrowings_per,17.34,短期借款,岱宇,生技醫療業
2024-09-30,1598,AccountsPayable,963953000.0,應付帳款,岱宇,生技醫療業
2024-09-30,1598,AccountsPayable_per,8.99,應付帳款,岱宇,生技醫療業
2024-09-30,1598,OtherPayables,390906000.0,其他應付款,岱宇,生技醫療業
2024-09-30,1598,OtherPayables_per,3.64,其他應付款,岱宇,生技醫療業
2024-09-30,1598,CurrentTaxLiabilities,3415000.0,本期所得稅負債,岱宇,生技醫療業
2024-09-30,1598,CurrentTaxLiabilities_per,0.03,本期所得稅負債,岱宇,生技醫療業
2024-09-30,1598,CurrentProvisions,13290000.0,負債準備－流動,岱宇,生技醫療業
2024-09-30,1598,CurrentProvisions_per,0.12,負債準備－流動,岱宇,生技醫療業
2024-09-30,1598,OtherCurrentLiabilities,273803000.0,其他流動負債,岱宇,生技醫療業
2024-09-30,1598,OtherCurrentLiabilities_per,2.55,其他流動負債,岱宇,生技醫療業
2024-09-30,1598,CurrentLiabilities,3655942000.0,流動負債合計,岱宇,生技醫療業
2024-09-30,1598,CurrentLiabilities_per,34.08,流動負債合計,岱宇,生技醫療業
2024-09-30,1598,LongtermBorrowings,1894619000.0,長期借款,岱宇,生技醫療業
2024-09-30,1598,LongtermBorrowings_per,17.66,長期借款,岱宇,生技醫療業
2024-09-30,1598,OtherNoncurrentLiabilities,59107000.0,其他非流動負債,岱宇,生技醫療業
2024-09-30,1598,OtherNoncurrentLiabilities_per,0.55,其他非流動負債,岱宇,生技醫療業
2024-09-30,1598,NoncurrentLiabilities,2413095000.0,非流動負債合計,岱宇,生技醫療業
2024-09-30,1598,NoncurrentLiabilities_per,22.5,非流動負債合計,岱宇,生技醫療業
2024-09-30,1598,OrdinaryShare,1671420000.0,普通股股本,岱宇,生技醫療業
2024-09-30,1598,OrdinaryShare_per,15.58,普通股股本,岱宇,生技醫療業
2024-09-30,1598,CapitalStock,1671420000.0,股本合計,岱宇,生技醫療業
2024-09-30,1598,CapitalStock_per,15.58,股本合計,岱宇,生技醫療業
2024-09-30,1598,CapitalSurplus,2683557000.0,資本公積合計,岱宇,生技醫療業
2024-09-30,1598,CapitalSurplus_per,25.02,資本公積合計,岱宇,生技醫療業
2024-09-30,1598,RetainedEarnings,350105000.0,保留盈餘合計,岱宇,生技醫療業
2024-09-30,1598,RetainedEarnings_per,3.26,保留盈餘合計,岱宇,生技醫療業
2024-09-30,1598,OtherEquityInterest,-29906000.0,其他權益合計,岱宇,生技醫療業
2024-09-30,1598,OtherEquityInterest_per,-0.28,其他權益合計,岱宇,生技醫療業
2024-09-30,1598,EquityAttributableToOwnersOfParent,4266486000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2024-09-30,1598,EquityAttributableToOwnersOfParent_per,39.77,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2024-09-30,1598,NoncontrollingInterests,391613000.0,非控制權益,岱宇,生技醫療業
2024-09-30,1598,NoncontrollingInterests_per,3.65,非控制權益,岱宇,生技醫療業
2024-09-30,1598,TotalLiabilitiesEquity,10727136000.0,負債及權益總計,岱宇,生技醫療業
2024-09-30,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2024-09-30,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,8963000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2024-09-30,1598,CurrentIncomeTaxAssets,40174000.0,本期所得稅資產,岱宇,生技醫療業
2024-09-30,1598,CurrentIncomeTaxAssets_per,0.37,本期所得稅資產,岱宇,生技醫療業
2024-09-30,1598,Liabilities,6069037000.0,負債總額,岱宇,生技醫療業
2024-09-30,1598,Liabilities_per,56.58,負債總額,岱宇,生技醫療業
2024-09-30,1598,Equity,4658099000.0,權益總額,岱宇,生技醫療業
2024-09-30,1598,Equity_per,43.42,權益總額,岱宇,生技醫療業
2024-12-31,1598,CashAndCashEquivalents,1159244000.0,現金及約當現金,岱宇,生技醫療業
2024-12-31,1598,CashAndCashEquivalents_per,10.42,現金及約當現金,岱宇,生技醫療業
2024-12-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,43117000.0,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2024-12-31,1598,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.39,透過損益按公允價值衡量之金融資產－流動,岱宇,生技醫療業
2024-12-31,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2024-12-31,1598,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2024-12-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,36813000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2024-12-31,1598,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.33,透過其他綜合損益按公允價值衡量之金融資產－非流動,岱宇,生技醫療業
2024-12-31,1598,FinancialAssetsAtAmortizedCost,14532000.0,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2024-12-31,1598,FinancialAssetsAtAmortizedCost_per,0.13,按攤銷後成本衡量之金融資產－流動,岱宇,生技醫療業
2024-12-31,1598,FinancialAssetsAtAmortizedCostNonCurrent,32785000.0,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2024-12-31,1598,FinancialAssetsAtAmortizedCostNonCurrent_per,0.29,按攤銷後成本衡量之金融資產－非流動,岱宇,生技醫療業
2024-12-31,1598,BillsReceivableNet,1892000.0,應收票據淨額,岱宇,生技醫療業
2024-12-31,1598,BillsReceivableNet_per,0.02,應收票據淨額,岱宇,生技醫療業
2024-12-31,1598,OtherReceivable,17808000.0,其他應收款淨額,岱宇,生技醫療業
2024-12-31,1598,OtherReceivable_per,0.16,其他應收款淨額,岱宇,生技醫療業
2024-12-31,1598,Prepayments,237280000.0,預付款項,岱宇,生技醫療業
2024-12-31,1598,Prepayments_per,2.13,預付款項,岱宇,生技醫療業
2024-12-31,1598,AccountsReceivableNet,1208714000.0,應收帳款淨額,岱宇,生技醫療業
2024-12-31,1598,AccountsReceivableNet_per,10.87,應收帳款淨額,岱宇,生技醫療業
2024-12-31,1598,Inventories,2250910000.0,存貨,岱宇,生技醫療業
2024-12-31,1598,Inventories_per,20.24,存貨,岱宇,生技醫療業
2024-12-31,1598,OtherCurrentAssets,44649000.0,其他流動資產,岱宇,生技醫療業
2024-12-31,1598,OtherCurrentAssets_per,0.4,其他流動資產,岱宇,生技醫療業
2024-12-31,1598,CurrentAssets,5016004000.0,流動資產合計,岱宇,生技醫療業
2024-12-31,1598,CurrentAssets_per,45.09,流動資產合計,岱宇,生技醫療業
2024-12-31,1598,InvestmentAccountedForUsingEquityMethod,6136000.0,採用權益法之投資,岱宇,生技醫療業
2024-12-31,1598,InvestmentAccountedForUsingEquityMethod_per,0.06,採用權益法之投資,岱宇,生技醫療業
2024-12-31,1598,PropertyPlantAndEquipment,3934280000.0,不動產、廠房及設備,岱宇,生技醫療業
2024-12-31,1598,PropertyPlantAndEquipment_per,35.37,不動產、廠房及設備,岱宇,生技醫療業
2024-12-31,1598,RightOfUseAsset,317520000.0,使用權資產,岱宇,生技醫療業
2024-12-31,1598,RightOfUseAsset_per,2.85,使用權資產,岱宇,生技醫療業
2024-12-31,1598,IntangibleAssets,1318107000.0,無形資產,岱宇,生技醫療業
2024-12-31,1598,IntangibleAssets_per,11.85,無形資產,岱宇,生技醫療業
2024-12-31,1598,DeferredTaxAssets,407007000.0,遞延所得稅資產,岱宇,生技醫療業
2024-12-31,1598,DeferredTaxAssets_per,3.66,遞延所得稅資產,岱宇,生技醫療業
2024-12-31,1598,OtherNoncurrentAssets,33694000.0,其他非流動資產,岱宇,生技醫療業
2024-12-31,1598,OtherNoncurrentAssets_per,0.3,其他非流動資產,岱宇,生技醫療業
2024-12-31,1598,NoncurrentAssets,6107794000.0,非流動資產合計,岱宇,生技醫療業
2024-12-31,1598,NoncurrentAssets_per,54.91,非流動資產合計,岱宇,生技醫療業
2024-12-31,1598,TotalAssets,11123798000.0,資產總額,岱宇,生技醫療業
2024-12-31,1598,TotalAssets_per,100.0,資產總額,岱宇,生技醫療業
2024-12-31,1598,ShorttermBorrowings,1953595000.0,短期借款,岱宇,生技醫療業
2024-12-31,1598,ShorttermBorrowings_per,17.56,短期借款,岱宇,生技醫療業
2024-12-31,1598,AccountsPayable,1096460000.0,應付帳款,岱宇,生技醫療業
2024-12-31,1598,AccountsPayable_per,9.86,應付帳款,岱宇,生技醫療業
2024-12-31,1598,OtherPayables,394248000.0,其他應付款,岱宇,生技醫療業
2024-12-31,1598,OtherPayables_per,3.54,其他應付款,岱宇,生技醫療業
2024-12-31,1598,CurrentTaxLiabilities,55354000.0,本期所得稅負債,岱宇,生技醫療業
2024-12-31,1598,CurrentTaxLiabilities_per,0.5,本期所得稅負債,岱宇,生技醫療業
2024-12-31,1598,CurrentProvisions,13338000.0,負債準備－流動,岱宇,生技醫療業
2024-12-31,1598,CurrentProvisions_per,0.12,負債準備－流動,岱宇,生技醫療業
2024-12-31,1598,OtherCurrentLiabilities,297048000.0,其他流動負債,岱宇,生技醫療業
2024-12-31,1598,OtherCurrentLiabilities_per,2.67,其他流動負債,岱宇,生技醫療業
2024-12-31,1598,CurrentLiabilities,3932853000.0,流動負債合計,岱宇,生技醫療業
2024-12-31,1598,CurrentLiabilities_per,35.36,流動負債合計,岱宇,生技醫療業
2024-12-31,1598,LongtermBorrowings,1830671000.0,長期借款,岱宇,生技醫療業
2024-12-31,1598,LongtermBorrowings_per,16.46,長期借款,岱宇,生技醫療業
2024-12-31,1598,OtherNoncurrentLiabilities,56510000.0,其他非流動負債,岱宇,生技醫療業
2024-12-31,1598,OtherNoncurrentLiabilities_per,0.51,其他非流動負債,岱宇,生技醫療業
2024-12-31,1598,NoncurrentLiabilities,2239364000.0,非流動負債合計,岱宇,生技醫療業
2024-12-31,1598,NoncurrentLiabilities_per,20.13,非流動負債合計,岱宇,生技醫療業
2024-12-31,1598,OrdinaryShare,1671420000.0,普通股股本,岱宇,生技醫療業
2024-12-31,1598,OrdinaryShare_per,15.03,普通股股本,岱宇,生技醫療業
2024-12-31,1598,CapitalStock,1671420000.0,股本合計,岱宇,生技醫療業
2024-12-31,1598,CapitalStock_per,15.03,股本合計,岱宇,生技醫療業
2024-12-31,1598,CapitalSurplus,2684014000.0,資本公積合計,岱宇,生技醫療業
2024-12-31,1598,CapitalSurplus_per,24.13,資本公積合計,岱宇,生技醫療業
2024-12-31,1598,RetainedEarnings,628320000.0,保留盈餘合計,岱宇,生技醫療業
2024-12-31,1598,RetainedEarnings_per,5.65,保留盈餘合計,岱宇,生技醫療業
2024-12-31,1598,OtherEquityInterest,-26103000.0,其他權益合計,岱宇,生技醫療業
2024-12-31,1598,OtherEquityInterest_per,-0.23,其他權益合計,岱宇,生技醫療業
2024-12-31,1598,EquityAttributableToOwnersOfParent,4548961000.0,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2024-12-31,1598,EquityAttributableToOwnersOfParent_per,40.89,歸屬於母公司業主之權益合計,岱宇,生技醫療業
2024-12-31,1598,NoncontrollingInterests,402620000.0,非控制權益,岱宇,生技醫療業
2024-12-31,1598,NoncontrollingInterests_per,3.62,非控制權益,岱宇,生技醫療業
2024-12-31,1598,TotalLiabilitiesEquity,11123798000.0,負債及權益總計,岱宇,生技醫療業
2024-12-31,1598,TotalLiabilitiesEquity_per,100.0,負債及權益總計,岱宇,生技醫療業
2024-12-31,1598,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,8963000.0,母公司暨子公司所持有之母公司庫藏股股數,岱宇,生技醫療業
2024-12-31,1598,CurrentIncomeTaxAssets,37858000.0,本期所得稅資產,岱宇,生技醫療業
2024-12-31,1598,CurrentIncomeTaxAssets_per,0.34,本期所得稅資產,岱宇,生技醫療業
2024-12-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2024-12-31,1598,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,岱宇,生技醫療業
2024-12-31,1598,BondsPayable,0.0,應付公司債,岱宇,生技醫療業
2024-12-31,1598,BondsPayable_per,0.0,應付公司債,岱宇,生技醫療業
2024-12-31,1598,Equity,4951581000.0,權益總額,岱宇,生技醫療業
2024-12-31,1598,Equity_per,44.51,權益總額,岱宇,生技醫療業
2024-12-31,1598,Liabilities,6172217000.0,負債總額,岱宇,生技醫療業
2024-12-31,1598,Liabilities_per,55.49,負債總額,岱宇,生技醫療業
2019-03-31,1598,ProceedsFromLongTermDebt,0.0,舉借長期借款,岱宇,生技醫療業
2019-03-31,1598,ReceivableIncrease,-161174000.0,應收帳款（增加）減少,岱宇,生技醫療業
2019-03-31,1598,PropertyAndPlantAndEquipment,-29570000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2019-03-31,1598,NetIncomeBeforeTax,112937000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2019-03-31,1598,CashProvidedByInvestingActivities,103380000.0,投資活動之淨現金流入(流出),岱宇,生技醫療業
2019-03-31,1598,InterestExpense,16108000.0,利息費用,岱宇,生技醫療業
2019-03-31,1598,CashFlowsFromOperatingActivities,63663000.0,營業活動之淨現金流入（流出）,岱宇,生技醫療業
2019-03-31,1598,CashBalancesEndOfPeriod,605635000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2019-03-31,1598,CashBalancesBeginningOfPeriod,595597000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2019-03-31,1598,CashBalancesIncrease,10038000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2019-03-31,1598,InventoryIncrease,170461000.0,存貨(增加)減少,岱宇,生技醫療業
2019-03-31,1598,CashFlowsProvidedFromFinancingActivities,-157358000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2019-03-31,1598,Depreciation,45310000.0,折舊費用,岱宇,生技醫療業
2019-03-31,1598,OtherNonCurrentLiabilitiesIncrease,-4834000.0,其他流動資產(增加)減少,岱宇,生技醫療業
2019-03-31,1598,TotalIncomeLossItems,91959000.0,收益費損項目合計,岱宇,生技醫療業
2019-03-31,1598,RentalPrincipalRepayments,-3805000.0,租賃本金償還,岱宇,生技醫療業
2019-03-31,1598,AmortizationExpense,24819000.0,攤銷費用,岱宇,生技醫療業
2019-03-31,1598,RepaymentOfLongTermDebt,-15606000.0,償還長期借款,岱宇,生技醫療業
2019-03-31,1598,DecreaseInShortTermLoans,-1199060000.0,短期借款減少,岱宇,生技醫療業
2019-03-31,1598,AccountsPayable,-19214000.0,應付帳款增加(減少),岱宇,生技醫療業
2019-03-31,1598,InterestIncome,-1674000.0,利息收入,岱宇,生技醫療業
2019-03-31,1598,DecreaseInDepositDeposit,159000.0,存出保證金減少,岱宇,生技醫療業
2019-03-31,1598,CashReceivedThroughOperations,73352000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2019-03-31,1598,PayTheInterest,-12776000.0,支付之利息,岱宇,生技醫療業
2019-03-31,1598,IncomeBeforeIncomeTaxFromContinuingOperations,112937000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2019-06-30,1598,ProceedsFromLongTermDebt,0.0,舉借長期借款,岱宇,生技醫療業
2019-06-30,1598,PropertyAndPlantAndEquipment,-42560000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2019-06-30,1598,NetIncomeBeforeTax,83633000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2019-06-30,1598,InterestExpense,30168000.0,利息費用,岱宇,生技醫療業
2019-06-30,1598,CashBalancesEndOfPeriod,367630000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2019-06-30,1598,CashBalancesBeginningOfPeriod,595597000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2019-06-30,1598,CashBalancesIncrease,-227967000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2019-06-30,1598,InventoryIncrease,196203000.0,存貨(增加)減少,岱宇,生技醫療業
2019-06-30,1598,Depreciation,91429000.0,折舊費用,岱宇,生技醫療業
2019-06-30,1598,OtherNonCurrentLiabilitiesIncrease,-5171000.0,其他流動資產(增加)減少,岱宇,生技醫療業
2019-06-30,1598,TotalIncomeLossItems,157087000.0,收益費損項目合計,岱宇,生技醫療業
2019-06-30,1598,AmortizationExpense,48678000.0,攤銷費用,岱宇,生技醫療業
2019-06-30,1598,RepaymentOfLongTermDebt,-34160000.0,償還長期借款,岱宇,生技醫療業
2019-06-30,1598,AccountsPayable,-225549000.0,應付帳款增加(減少),岱宇,生技醫療業
2019-06-30,1598,InterestIncome,-3763000.0,利息收入,岱宇,生技醫療業
2019-06-30,1598,DecreaseInDepositDeposit,1085000.0,存出保證金減少,岱宇,生技醫療業
2019-06-30,1598,CashReceivedThroughOperations,-31560000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2019-06-30,1598,PayTheInterest,-25895000.0,支付之利息,岱宇,生技醫療業
2019-06-30,1598,IncomeBeforeIncomeTaxFromContinuingOperations,83633000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2019-06-30,1598,CashFlowsProvidedFromFinancingActivities,-251978000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2019-06-30,1598,RentalPrincipalRepayments,-8944000.0,租賃本金償還,岱宇,生技醫療業
2019-06-30,1598,DecreaseInShortTermLoans,-208308000.0,短期借款減少,岱宇,生技醫療業
2019-06-30,1598,ReceivableIncrease,-4005000.0,應收帳款(增加)減少,岱宇,生技醫療業
2019-06-30,1598,CashProvidedByInvestingActivities,107191000.0,投資活動之淨現金流入（流出）,岱宇,生技醫療業
2019-06-30,1598,CashFlowsFromOperatingActivities,-87749000.0,營業活動之淨現金流入(流出),岱宇,生技醫療業
2019-09-30,1598,RedemptionOfBonds,0.0,償還公司債,岱宇,生技醫療業
2019-09-30,1598,OtherNonCurrentLiabilitiesIncrease,-7145000.0,其他流動資產(增加)減少,岱宇,生技醫療業
2019-09-30,1598,PropertyAndPlantAndEquipment,-49448000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2019-09-30,1598,CashBalancesEndOfPeriod,690787000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2019-09-30,1598,CashBalancesIncrease,95190000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2019-09-30,1598,CashProvidedByInvestingActivities,-155260000.0,投資活動之淨現金流入（流出）,岱宇,生技醫療業
2019-09-30,1598,CashBalancesBeginningOfPeriod,595597000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2019-09-30,1598,RentalPrincipalRepayments,-18156000.0,租賃本金償還,岱宇,生技醫療業
2019-09-30,1598,PayTheInterest,-37603000.0,支付之利息,岱宇,生技醫療業
2019-09-30,1598,IncomeBeforeIncomeTaxFromContinuingOperations,173872000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2019-09-30,1598,ProceedsFromLongTermDebt,470000000.0,舉借長期借款,岱宇,生技醫療業
2019-09-30,1598,NetIncomeBeforeTax,173872000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2019-09-30,1598,CashFlowsFromOperatingActivities,303380000.0,營業活動之淨現金流入（流出）,岱宇,生技醫療業
2019-09-30,1598,Depreciation,138704000.0,折舊費用,岱宇,生技醫療業
2019-09-30,1598,AmortizationExpense,70700000.0,攤銷費用,岱宇,生技醫療業
2019-09-30,1598,AccountsPayable,-10770000.0,應付帳款增加(減少),岱宇,生技醫療業
2019-09-30,1598,DecreaseInDepositDeposit,1642000.0,存出保證金減少,岱宇,生技醫療業
2019-09-30,1598,RepaymentOfLongTermDebt,-259746000.0,償還長期借款,岱宇,生技醫療業
2019-09-30,1598,InterestExpense,43822000.0,利息費用,岱宇,生技醫療業
2019-09-30,1598,ReceivableIncrease,151870000.0,應收帳款（增加）減少,岱宇,生技醫療業
2019-09-30,1598,InventoryIncrease,-8898000.0,存貨（增加）減少,岱宇,生技醫療業
2019-09-30,1598,CashFlowsProvidedFromFinancingActivities,-56148000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2019-09-30,1598,InterestIncome,-7155000.0,利息收入,岱宇,生技醫療業
2019-09-30,1598,DecreaseInShortTermLoans,-3655505000.0,短期借款減少,岱宇,生技醫療業
2019-09-30,1598,TotalIncomeLossItems,240144000.0,收益費損項目合計,岱宇,生技醫療業
2019-09-30,1598,CashReceivedThroughOperations,359147000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2019-12-31,1598,RedemptionOfBonds,0.0,償還公司債,岱宇,生技醫療業
2019-12-31,1598,OtherNonCurrentLiabilitiesIncrease,-11621000.0,其他流動資產(增加)減少,岱宇,生技醫療業
2019-12-31,1598,PropertyAndPlantAndEquipment,-60861000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2019-12-31,1598,CashBalancesEndOfPeriod,826213000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2019-12-31,1598,CashBalancesIncrease,230616000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2019-12-31,1598,CashProvidedByInvestingActivities,-204768000.0,投資活動之淨現金流入（流出）,岱宇,生技醫療業
2019-12-31,1598,CashBalancesBeginningOfPeriod,595597000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2019-12-31,1598,RentalPrincipalRepayments,-21310000.0,租賃本金償還,岱宇,生技醫療業
2019-12-31,1598,PayTheInterest,-51155000.0,支付之利息,岱宇,生技醫療業
2019-12-31,1598,IncomeBeforeIncomeTaxFromContinuingOperations,278644000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2019-12-31,1598,ProceedsFromLongTermDebt,470000000.0,舉借長期借款,岱宇,生技醫療業
2019-12-31,1598,NetIncomeBeforeTax,278644000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2019-12-31,1598,Depreciation,188246000.0,折舊費用,岱宇,生技醫療業
2019-12-31,1598,AmortizationExpense,92592000.0,攤銷費用,岱宇,生技醫療業
2019-12-31,1598,AccountsPayable,29543000.0,應付帳款增加(減少),岱宇,生技醫療業
2019-12-31,1598,DecreaseInDepositDeposit,-962000.0,存出保證金減少,岱宇,生技醫療業
2019-12-31,1598,RepaymentOfLongTermDebt,-288725000.0,償還長期借款,岱宇,生技醫療業
2019-12-31,1598,InterestExpense,59424000.0,利息費用,岱宇,生技醫療業
2019-12-31,1598,InventoryIncrease,19531000.0,存貨（增加）減少,岱宇,生技醫療業
2019-12-31,1598,CashFlowsProvidedFromFinancingActivities,27679000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2019-12-31,1598,InterestIncome,-9807000.0,利息收入,岱宇,生技醫療業
2019-12-31,1598,TotalIncomeLossItems,388675000.0,收益費損項目合計,岱宇,生技醫療業
2019-12-31,1598,CashReceivedThroughOperations,488322000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2019-12-31,1598,DecreaseInShortTermLoans,-133393000.0,短期借款減少,岱宇,生技醫療業
2019-12-31,1598,ReceivableIncrease,-99988000.0,應收帳款(增加)減少,岱宇,生技醫療業
2019-12-31,1598,CashFlowsFromOperatingActivities,411747000.0,營業活動之淨現金流入(流出),岱宇,生技醫療業
2020-03-31,1598,CashBalancesBeginningOfPeriod,826213000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2020-03-31,1598,CashBalancesEndOfPeriod,625864000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2020-03-31,1598,CashFlowsProvidedFromFinancingActivities,389620000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2020-03-31,1598,CashReceivedThroughOperations,98813000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2020-03-31,1598,DecreaseInDepositDeposit,4028000.0,存出保證金減少,岱宇,生技醫療業
2020-03-31,1598,Depreciation,48498000.0,折舊費用,岱宇,生技醫療業
2020-03-31,1598,InterestExpense,15606000.0,利息費用,岱宇,生技醫療業
2020-03-31,1598,OtherNonCurrentLiabilitiesIncrease,223000.0,其他流動資產(增加)減少,岱宇,生技醫療業
2020-03-31,1598,ProceedsFromLongTermDebt,200000000.0,舉借長期借款,岱宇,生技醫療業
2020-03-31,1598,InventoryIncrease,354620000.0,存貨(增加)減少,岱宇,生技醫療業
2020-03-31,1598,ReceivableIncrease,299611000.0,應收帳款(增加)減少,岱宇,生技醫療業
2020-03-31,1598,TotalIncomeLossItems,80538000.0,收益費損項目合計,岱宇,生技醫療業
2020-03-31,1598,IncomeBeforeIncomeTaxFromContinuingOperations,1428000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2020-03-31,1598,NetIncomeBeforeTax,1428000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2020-03-31,1598,AmortizationExpense,27717000.0,攤銷費用,岱宇,生技醫療業
2020-03-31,1598,CashFlowsFromOperatingActivities,79082000.0,營業活動之淨現金流入(流出),岱宇,生技醫療業
2020-03-31,1598,RentalPrincipalRepayments,-6340000.0,租賃本金償還,岱宇,生技醫療業
2020-03-31,1598,DecreaseInShortTermLoans,-371370000.0,短期借款減少,岱宇,生技醫療業
2020-03-31,1598,InterestIncome,-1421000.0,利息收入,岱宇,生技醫療業
2020-03-31,1598,PayTheInterest,-14595000.0,支付之利息,岱宇,生技醫療業
2020-03-31,1598,CashBalancesIncrease,-200349000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2020-03-31,1598,RepaymentOfLongTermDebt,-31508000.0,償還長期借款,岱宇,生技醫療業
2020-03-31,1598,AccountsPayable,-376647000.0,應付帳款增加(減少),岱宇,生技醫療業
2020-03-31,1598,PropertyAndPlantAndEquipment,-5947000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2020-03-31,1598,CashProvidedByInvestingActivities,-672218000.0,投資活動之淨現金流入（流出）,岱宇,生技醫療業
2020-06-30,1598,AccountsPayable,318147000.0,應付帳款增加(減少),岱宇,生技醫療業
2020-06-30,1598,CashBalancesBeginningOfPeriod,826213000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2020-06-30,1598,CashBalancesEndOfPeriod,1284240000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2020-06-30,1598,CashBalancesIncrease,458027000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2020-06-30,1598,CashFlowsProvidedFromFinancingActivities,224454000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2020-06-30,1598,DecreaseInDepositDeposit,4289000.0,存出保證金減少,岱宇,生技醫療業
2020-06-30,1598,Depreciation,97415000.0,折舊費用,岱宇,生技醫療業
2020-06-30,1598,InterestExpense,30827000.0,利息費用,岱宇,生技醫療業
2020-06-30,1598,ProceedsFromLongTermDebt,200000000.0,舉借長期借款,岱宇,生技醫療業
2020-06-30,1598,CashReceivedThroughOperations,1152916000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2020-06-30,1598,RentalPrincipalRepayments,-11418000.0,租賃本金償還,岱宇,生技醫療業
2020-06-30,1598,DecreaseInShortTermLoans,-479275000.0,短期借款減少,岱宇,生技醫療業
2020-06-30,1598,InterestIncome,-2277000.0,利息收入,岱宇,生技醫療業
2020-06-30,1598,OtherNonCurrentLiabilitiesIncrease,-6333000.0,其他流動資產(增加)減少,岱宇,生技醫療業
2020-06-30,1598,PayTheInterest,-27893000.0,支付之利息,岱宇,生技醫療業
2020-06-30,1598,RepaymentOfLongTermDebt,-69626000.0,償還長期借款,岱宇,生技醫療業
2020-06-30,1598,PropertyAndPlantAndEquipment,-19930000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2020-06-30,1598,CashProvidedByInvestingActivities,-825288000.0,投資活動之淨現金流入（流出）,岱宇,生技醫療業
2020-06-30,1598,IncomeBeforeIncomeTaxFromContinuingOperations,270208000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2020-06-30,1598,NetIncomeBeforeTax,270208000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2020-06-30,1598,CashFlowsFromOperatingActivities,1066628000.0,營業活動之淨現金流入（流出）,岱宇,生技醫療業
2020-06-30,1598,AmortizationExpense,58898000.0,攤銷費用,岱宇,生技醫療業
2020-06-30,1598,ReceivableIncrease,233209000.0,應收帳款（增加）減少,岱宇,生技醫療業
2020-06-30,1598,InventoryIncrease,-89424000.0,存貨（增加）減少,岱宇,生技醫療業
2020-06-30,1598,TotalIncomeLossItems,144685000.0,收益費損項目合計,岱宇,生技醫療業
2020-09-30,1598,CashBalancesBeginningOfPeriod,826213000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2020-09-30,1598,CashBalancesIncrease,432964000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2020-09-30,1598,CashFlowsProvidedFromFinancingActivities,224659000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2020-09-30,1598,Depreciation,146533000.0,折舊費用,岱宇,生技醫療業
2020-09-30,1598,InterestExpense,43801000.0,利息費用,岱宇,生技醫療業
2020-09-30,1598,OtherNonCurrentLiabilitiesIncrease,527000.0,其他流動資產(增加)減少,岱宇,生技醫療業
2020-09-30,1598,ProceedsFromLongTermDebt,200000000.0,舉借長期借款,岱宇,生技醫療業
2020-09-30,1598,CashReceivedThroughOperations,1360597000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2020-09-30,1598,InventoryIncrease,-1172463000.0,存貨（增加）減少,岱宇,生技醫療業
2020-09-30,1598,InterestIncome,-2513000.0,利息收入,岱宇,生技醫療業
2020-09-30,1598,DecreaseInShortTermLoans,-967299000.0,短期借款減少,岱宇,生技醫療業
2020-09-30,1598,RepaymentOfLongTermDebt,-107495000.0,償還長期借款,岱宇,生技醫療業
2020-09-30,1598,RentalPrincipalRepayments,-16132000.0,租賃本金償還,岱宇,生技醫療業
2020-09-30,1598,ReceivableIncrease,-329288000.0,應收帳款(增加)減少,岱宇,生技醫療業
2020-09-30,1598,CashBalancesEndOfPeriod,1259177000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2020-09-30,1598,CashProvidedByInvestingActivities,-990804000.0,投資活動之淨現金流入（流出）,岱宇,生技醫療業
2020-09-30,1598,PropertyAndPlantAndEquipment,-52203000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2020-09-30,1598,RedemptionOfBonds,-100000.0,償還公司債,岱宇,生技醫療業
2020-09-30,1598,PayTheInterest,-39206000.0,支付之利息,岱宇,生技醫療業
2020-09-30,1598,IncomeBeforeIncomeTaxFromContinuingOperations,886672000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2020-09-30,1598,TotalIncomeLossItems,354718000.0,收益費損項目合計,岱宇,生技醫療業
2020-09-30,1598,AmortizationExpense,92467000.0,攤銷費用,岱宇,生技醫療業
2020-09-30,1598,NetIncomeBeforeTax,886672000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2020-09-30,1598,DecreaseInDepositDeposit,-42926000.0,存出保證金減少,岱宇,生技醫療業
2020-09-30,1598,CashFlowsFromOperatingActivities,1218326000.0,營業活動之淨現金流入(流出),岱宇,生技醫療業
2020-09-30,1598,AccountsPayable,1179353000.0,應付帳款增加(減少),岱宇,生技醫療業
2020-12-31,1598,CashBalancesIncrease,716111000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2020-12-31,1598,CashBalancesBeginningOfPeriod,826213000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2020-12-31,1598,CashFlowsFromOperatingActivities,1277086000.0,營業活動之淨現金流入(流出),岱宇,生技醫療業
2020-12-31,1598,Depreciation,199252000.0,折舊費用,岱宇,生技醫療業
2020-12-31,1598,NetIncomeBeforeTax,1654904000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2020-12-31,1598,CashBalancesEndOfPeriod,1542324000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2020-12-31,1598,AmortizationExpense,124398000.0,攤銷費用,岱宇,生技醫療業
2020-12-31,1598,OtherNonCurrentLiabilitiesIncrease,7703000.0,其他流動資產(增加)減少,岱宇,生技醫療業
2020-12-31,1598,TotalIncomeLossItems,601013000.0,收益費損項目合計,岱宇,生技醫療業
2020-12-31,1598,InterestExpense,56116000.0,利息費用,岱宇,生技醫療業
2020-12-31,1598,CashReceivedThroughOperations,1465236000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2020-12-31,1598,CashFlowsProvidedFromFinancingActivities,663390000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2020-12-31,1598,ProceedsFromLongTermDebt,200000000.0,舉借長期借款,岱宇,生技醫療業
2020-12-31,1598,AccountsPayable,1575672000.0,應付帳款增加(減少),岱宇,生技醫療業
2020-12-31,1598,IncomeBeforeIncomeTaxFromContinuingOperations,1654904000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2020-12-31,1598,ReceivableIncrease,-1627374000.0,應收帳款（增加）減少,岱宇,生技醫療業
2020-12-31,1598,CashProvidedByInvestingActivities,-1195741000.0,投資活動之淨現金流入(流出),岱宇,生技醫療業
2020-12-31,1598,PropertyAndPlantAndEquipment,-96792000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2020-12-31,1598,RedemptionOfBonds,-100000.0,償還公司債,岱宇,生技醫療業
2020-12-31,1598,InventoryIncrease,-1686436000.0,存貨（增加）減少,岱宇,生技醫療業
2020-12-31,1598,PayTheInterest,-48088000.0,支付之利息,岱宇,生技醫療業
2020-12-31,1598,DecreaseInDepositDeposit,-43123000.0,存出保證金減少,岱宇,生技醫療業
2020-12-31,1598,DecreaseInShortTermLoans,-453384000.0,短期借款減少,岱宇,生技醫療業
2020-12-31,1598,RepaymentOfLongTermDebt,-145956000.0,償還長期借款,岱宇,生技醫療業
2020-12-31,1598,RentalPrincipalRepayments,-24375000.0,租賃本金償還,岱宇,生技醫療業
2020-12-31,1598,InterestIncome,-2819000.0,利息收入,岱宇,生技醫療業
2021-03-31,1598,CashBalancesEndOfPeriod,1541677000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2021-03-31,1598,CashBalancesBeginningOfPeriod,1542324000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2021-03-31,1598,IncomeBeforeIncomeTaxFromContinuingOperations,333088000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2021-03-31,1598,ProceedsFromLongTermDebt,0.0,舉借長期借款,岱宇,生技醫療業
2021-03-31,1598,NetIncomeBeforeTax,333088000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2021-03-31,1598,Depreciation,50138000.0,折舊費用,岱宇,生技醫療業
2021-03-31,1598,AmortizationExpense,21960000.0,攤銷費用,岱宇,生技醫療業
2021-03-31,1598,DecreaseInDepositDeposit,4098000.0,存出保證金減少,岱宇,生技醫療業
2021-03-31,1598,InterestExpense,13967000.0,利息費用,岱宇,生技醫療業
2021-03-31,1598,CashFlowsProvidedFromFinancingActivities,291021000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2021-03-31,1598,DecreaseInShortTermLoans,0.0,短期借款減少,岱宇,生技醫療業
2021-03-31,1598,TotalIncomeLossItems,109775000.0,收益費損項目合計,岱宇,生技醫療業
2021-03-31,1598,InterestIncome,-491000.0,利息收入,岱宇,生技醫療業
2021-03-31,1598,OtherNonCurrentLiabilitiesIncrease,-2385000.0,其他流動資產(增加)減少,岱宇,生技醫療業
2021-03-31,1598,CashReceivedThroughOperations,-117050000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2021-03-31,1598,PayTheInterest,-12491000.0,支付之利息,岱宇,生技醫療業
2021-03-31,1598,CashBalancesIncrease,-647000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2021-03-31,1598,RepaymentOfLongTermDebt,-39949000.0,償還長期借款,岱宇,生技醫療業
2021-03-31,1598,AccountsPayable,-419088000.0,應付帳款增加(減少),岱宇,生技醫療業
2021-03-31,1598,PropertyAndPlantAndEquipment,-15995000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2021-03-31,1598,CashFlowsFromOperatingActivities,-158248000.0,營業活動之淨現金流入（流出）,岱宇,生技醫療業
2021-03-31,1598,RentalPrincipalRepayments,-5006000.0,租賃本金償還,岱宇,生技醫療業
2021-03-31,1598,InventoryIncrease,-373538000.0,存貨(增加)減少,岱宇,生技醫療業
2021-03-31,1598,ReceivableIncrease,556981000.0,應收帳款(增加)減少,岱宇,生技醫療業
2021-03-31,1598,CashProvidedByInvestingActivities,-129623000.0,投資活動之淨現金流入(流出),岱宇,生技醫療業
2021-06-30,1598,CashBalancesEndOfPeriod,1091551000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2021-06-30,1598,CashBalancesBeginningOfPeriod,1542324000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2021-06-30,1598,IncomeBeforeIncomeTaxFromContinuingOperations,388326000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2021-06-30,1598,ProceedsFromLongTermDebt,0.0,舉借長期借款,岱宇,生技醫療業
2021-06-30,1598,NetIncomeBeforeTax,388326000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2021-06-30,1598,Depreciation,100212000.0,折舊費用,岱宇,生技醫療業
2021-06-30,1598,AmortizationExpense,44565000.0,攤銷費用,岱宇,生技醫療業
2021-06-30,1598,DecreaseInDepositDeposit,425000.0,存出保證金減少,岱宇,生技醫療業
2021-06-30,1598,InterestExpense,28812000.0,利息費用,岱宇,生技醫療業
2021-06-30,1598,CashFlowsProvidedFromFinancingActivities,741075000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2021-06-30,1598,TotalIncomeLossItems,307785000.0,收益費損項目合計,岱宇,生技醫療業
2021-06-30,1598,OtherNonCurrentLiabilitiesIncrease,-2873000.0,其他流動資產(增加)減少,岱宇,生技醫療業
2021-06-30,1598,PropertyAndPlantAndEquipment,-26047000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2021-06-30,1598,CashBalancesIncrease,-450773000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2021-06-30,1598,CashProvidedByInvestingActivities,-156398000.0,投資活動之淨現金流入（流出）,岱宇,生技醫療業
2021-06-30,1598,RentalPrincipalRepayments,-10352000.0,租賃本金償還,岱宇,生技醫療業
2021-06-30,1598,PayTheInterest,-26421000.0,支付之利息,岱宇,生技醫療業
2021-06-30,1598,CashFlowsFromOperatingActivities,-1015041000.0,營業活動之淨現金流入（流出）,岱宇,生技醫療業
2021-06-30,1598,AccountsPayable,-590730000.0,應付帳款增加(減少),岱宇,生技醫療業
2021-06-30,1598,RepaymentOfLongTermDebt,-79929000.0,償還長期借款,岱宇,生技醫療業
2021-06-30,1598,InterestIncome,-938000.0,利息收入,岱宇,生技醫療業
2021-06-30,1598,DecreaseInShortTermLoans,-217066000.0,短期借款減少,岱宇,生技醫療業
2021-06-30,1598,CashReceivedThroughOperations,-593690000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2021-06-30,1598,InventoryIncrease,-538024000.0,存貨(增加)減少,岱宇,生技醫療業
2021-06-30,1598,ReceivableIncrease,966902000.0,應收帳款(增加)減少,岱宇,生技醫療業
2021-09-30,1598,CashBalancesIncrease,-604118000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2021-09-30,1598,CashBalancesBeginningOfPeriod,1542324000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2021-09-30,1598,CashFlowsFromOperatingActivities,-1393073000.0,營業活動之淨現金流入(流出),岱宇,生技醫療業
2021-09-30,1598,Depreciation,151849000.0,折舊費用,岱宇,生技醫療業
2021-09-30,1598,PropertyAndPlantAndEquipment,-109281000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2021-09-30,1598,RedemptionOfBonds,0.0,償還公司債,岱宇,生技醫療業
2021-09-30,1598,CashBalancesEndOfPeriod,938206000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2021-09-30,1598,AmortizationExpense,62984000.0,攤銷費用,岱宇,生技醫療業
2021-09-30,1598,OtherNonCurrentLiabilitiesIncrease,-4689000.0,其他流動資產(增加)減少,岱宇,生技醫療業
2021-09-30,1598,InterestExpense,48441000.0,利息費用,岱宇,生技醫療業
2021-09-30,1598,CashReceivedThroughOperations,-759107000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2021-09-30,1598,PayTheInterest,-42009000.0,支付之利息,岱宇,生技醫療業
2021-09-30,1598,CashFlowsProvidedFromFinancingActivities,1240515000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2021-09-30,1598,DecreaseInDepositDeposit,423000.0,存出保證金減少,岱宇,生技醫療業
2021-09-30,1598,DecreaseInShortTermLoans,1253714000.0,短期借款減少,岱宇,生技醫療業
2021-09-30,1598,ProceedsFromLongTermDebt,0.0,舉借長期借款,岱宇,生技醫療業
2021-09-30,1598,AccountsPayable,-860485000.0,應付帳款增加(減少),岱宇,生技醫療業
2021-09-30,1598,RepaymentOfLongTermDebt,-119446000.0,償還長期借款,岱宇,生技醫療業
2021-09-30,1598,RentalPrincipalRepayments,-14498000.0,租賃本金償還,岱宇,生技醫療業
2021-09-30,1598,InterestIncome,-1130000.0,利息收入,岱宇,生技醫療業
2021-09-30,1598,InventoryIncrease,-625570000.0,存貨(增加)減少,岱宇,生技醫療業
2021-09-30,1598,ReceivableIncrease,942729000.0,應收帳款(增加)減少,岱宇,生技醫療業
2021-09-30,1598,TotalIncomeLossItems,467036000.0,收益費損項目合計,岱宇,生技醫療業
2021-09-30,1598,IncomeBeforeIncomeTaxFromContinuingOperations,537778000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2021-09-30,1598,NetIncomeBeforeTax,537778000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2021-09-30,1598,CashProvidedByInvestingActivities,-430577000.0,投資活動之淨現金流入（流出）,岱宇,生技醫療業
2021-12-31,1598,CashReceivedThroughOperations,-153586000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2021-12-31,1598,InventoryIncrease,-371807000.0,存貨（增加）減少,岱宇,生技醫療業
2021-12-31,1598,InterestIncome,-1444000.0,利息收入,岱宇,生技醫療業
2021-12-31,1598,DecreaseInShortTermLoans,0.0,短期借款減少,岱宇,生技醫療業
2021-12-31,1598,ProceedsFromLongTermDebt,0.0,舉借長期借款,岱宇,生技醫療業
2021-12-31,1598,RepaymentOfLongTermDebt,-158886000.0,償還長期借款,岱宇,生技醫療業
2021-12-31,1598,RentalPrincipalRepayments,-20503000.0,租賃本金償還,岱宇,生技醫療業
2021-12-31,1598,OtherNonCurrentLiabilitiesIncrease,-3008000.0,其他流動資產(增加)減少,岱宇,生技醫療業
2021-12-31,1598,PayTheInterest,-57775000.0,支付之利息,岱宇,生技醫療業
2021-12-31,1598,CashBalancesIncrease,-329688000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2021-12-31,1598,CashBalancesBeginningOfPeriod,1542324000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2021-12-31,1598,CashBalancesEndOfPeriod,1212636000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2021-12-31,1598,CashProvidedByInvestingActivities,-603489000.0,投資活動之淨現金流入（流出）,岱宇,生技醫療業
2021-12-31,1598,PropertyAndPlantAndEquipment,-225170000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2021-12-31,1598,ReceivableIncrease,1313017000.0,應收帳款(增加)減少,岱宇,生技醫療業
2021-12-31,1598,CashFlowsProvidedFromFinancingActivities,1075889000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2021-12-31,1598,TotalIncomeLossItems,600484000.0,收益費損項目合計,岱宇,生技醫療業
2021-12-31,1598,IncomeBeforeIncomeTaxFromContinuingOperations,548463000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2021-12-31,1598,NetIncomeBeforeTax,548463000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2021-12-31,1598,CashFlowsFromOperatingActivities,-781464000.0,營業活動之淨現金流入（流出）,岱宇,生技醫療業
2021-12-31,1598,AmortizationExpense,81736000.0,攤銷費用,岱宇,生技醫療業
2021-12-31,1598,AccountsPayable,-1113088000.0,應付帳款增加(減少),岱宇,生技醫療業
2021-12-31,1598,Depreciation,202595000.0,折舊費用,岱宇,生技醫療業
2021-12-31,1598,InterestExpense,68509000.0,利息費用,岱宇,生技醫療業
2022-03-31,1598,CashBalancesBeginningOfPeriod,1212636000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2022-03-31,1598,PropertyAndPlantAndEquipment,-48809000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2022-03-31,1598,PayTheInterest,-16615000.0,支付之利息,岱宇,生技醫療業
2022-03-31,1598,CashProvidedByInvestingActivities,80868000.0,投資活動之淨現金流入（流出）,岱宇,生技醫療業
2022-03-31,1598,CashBalancesEndOfPeriod,967535000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2022-03-31,1598,OtherNonCurrentLiabilitiesIncrease,-6707000.0,其他流動資產(增加)減少,岱宇,生技醫療業
2022-03-31,1598,CashBalancesIncrease,-245101000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2022-03-31,1598,RepaymentOfLongTermDebt,-41078000.0,償還長期借款,岱宇,生技醫療業
2022-03-31,1598,CashFlowsFromOperatingActivities,110005000.0,營業活動之淨現金流入（流出）,岱宇,生技醫療業
2022-03-31,1598,DecreaseInDepositDeposit,4418000.0,存出保證金減少,岱宇,生技醫療業
2022-03-31,1598,InterestExpense,19960000.0,利息費用,岱宇,生技醫療業
2022-03-31,1598,CashFlowsProvidedFromFinancingActivities,-449615000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2022-03-31,1598,CashReceivedThroughOperations,126581000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2022-03-31,1598,InterestIncome,-161000.0,利息收入,岱宇,生技醫療業
2022-03-31,1598,RentalPrincipalRepayments,-4267000.0,租賃本金償還,岱宇,生技醫療業
2022-03-31,1598,ProceedsFromLongTermDebt,0.0,舉借長期借款,岱宇,生技醫療業
2022-03-31,1598,TotalIncomeLossItems,50088000.0,收益費損項目合計,岱宇,生技醫療業
2022-03-31,1598,IncomeBeforeIncomeTaxFromContinuingOperations,-30960000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2022-03-31,1598,NetIncomeBeforeTax,-30960000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2022-03-31,1598,AmortizationExpense,20055000.0,攤銷費用,岱宇,生技醫療業
2022-03-31,1598,Depreciation,47087000.0,折舊費用,岱宇,生技醫療業
2022-03-31,1598,InventoryIncrease,606844000.0,存貨（增加）減少,岱宇,生技醫療業
2022-03-31,1598,ReceivableIncrease,32150000.0,應收帳款（增加）減少,岱宇,生技醫療業
2022-03-31,1598,NetCashInflowFromOperatingActivities,110005000.0,營業活動之淨現金流入,岱宇,生技醫療業
2022-03-31,1598,AccountsPayable,-496688000.0,應付帳款,岱宇,生技醫療業
2022-06-30,1598,CashFlowsProvidedFromFinancingActivities,-681214000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2022-06-30,1598,ProceedsFromLongTermDebt,0.0,舉借長期借款,岱宇,生技醫療業
2022-06-30,1598,RentalPrincipalRepayments,-10257000.0,租賃本金償還,岱宇,生技醫療業
2022-06-30,1598,DecreaseInShortTermLoans,-584202000.0,短期借款減少,岱宇,生技醫療業
2022-06-30,1598,InterestIncome,-439000.0,利息收入,岱宇,生技醫療業
2022-06-30,1598,OtherNonCurrentLiabilitiesIncrease,11667000.0,其他流動資產(增加)減少,岱宇,生技醫療業
2022-06-30,1598,CashReceivedThroughOperations,305291000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2022-06-30,1598,PayTheInterest,-30236000.0,支付之利息,岱宇,生技醫療業
2022-06-30,1598,CashBalancesIncrease,-429227000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2022-06-30,1598,TotalIncomeLossItems,85367000.0,收益費損項目合計,岱宇,生技醫療業
2022-06-30,1598,InterestExpense,40283000.0,利息費用,岱宇,生技醫療業
2022-06-30,1598,CashBalancesBeginningOfPeriod,1212636000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2022-06-30,1598,RepaymentOfLongTermDebt,-81128000.0,償還長期借款,岱宇,生技醫療業
2022-06-30,1598,CashBalancesEndOfPeriod,783409000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2022-06-30,1598,IncomeBeforeIncomeTaxFromContinuingOperations,-117728000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2022-06-30,1598,PropertyAndPlantAndEquipment,-126086000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2022-06-30,1598,NetIncomeBeforeTax,-117728000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2022-06-30,1598,AmortizationExpense,40160000.0,攤銷費用,岱宇,生技醫療業
2022-06-30,1598,CashProvidedByInvestingActivities,-54802000.0,投資活動之淨現金流入（流出）,岱宇,生技醫療業
2022-06-30,1598,Depreciation,91015000.0,折舊費用,岱宇,生技醫療業
2022-06-30,1598,DecreaseInDepositDeposit,1363000.0,存出保證金減少,岱宇,生技醫療業
2022-06-30,1598,InventoryIncrease,867246000.0,存貨（增加）減少,岱宇,生技醫療業
2022-06-30,1598,ReceivableIncrease,384467000.0,應收帳款（增加）減少,岱宇,生技醫療業
2022-06-30,1598,CashFlowsFromOperatingActivities,272278000.0,營業活動之淨現金流入（流出）,岱宇,生技醫療業
2022-06-30,1598,NetCashInflowFromOperatingActivities,272278000.0,營業活動之淨現金流入,岱宇,生技醫療業
2022-06-30,1598,AccountsPayable,-697856000.0,應付帳款,岱宇,生技醫療業
2022-09-30,1598,OtherNonCurrentLiabilitiesIncrease,8747000.0,其他流動資產(增加)減少,岱宇,生技醫療業
2022-09-30,1598,PropertyAndPlantAndEquipment,-159331000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2022-09-30,1598,CashBalancesEndOfPeriod,746784000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2022-09-30,1598,CashBalancesIncrease,-465852000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2022-09-30,1598,CashProvidedByInvestingActivities,-179832000.0,投資活動之淨現金流入（流出）,岱宇,生技醫療業
2022-09-30,1598,CashBalancesBeginningOfPeriod,1212636000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2022-09-30,1598,RentalPrincipalRepayments,-14699000.0,租賃本金償還,岱宇,生技醫療業
2022-09-30,1598,PayTheInterest,-48514000.0,支付之利息,岱宇,生技醫療業
2022-09-30,1598,IncomeBeforeIncomeTaxFromContinuingOperations,-43083000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2022-09-30,1598,ProceedsFromLongTermDebt,400000000.0,舉借長期借款,岱宇,生技醫療業
2022-09-30,1598,NetIncomeBeforeTax,-43083000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2022-09-30,1598,Depreciation,134167000.0,折舊費用,岱宇,生技醫療業
2022-09-30,1598,AmortizationExpense,59994000.0,攤銷費用,岱宇,生技醫療業
2022-09-30,1598,DecreaseInDepositDeposit,-16083000.0,存出保證金減少,岱宇,生技醫療業
2022-09-30,1598,RepaymentOfLongTermDebt,-121164000.0,償還長期借款,岱宇,生技醫療業
2022-09-30,1598,InterestExpense,62589000.0,利息費用,岱宇,生技醫療業
2022-09-30,1598,InventoryIncrease,947012000.0,存貨（增加）減少,岱宇,生技醫療業
2022-09-30,1598,CashFlowsProvidedFromFinancingActivities,-849522000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2022-09-30,1598,InterestIncome,-746000.0,利息收入,岱宇,生技醫療業
2022-09-30,1598,DecreaseInShortTermLoans,-729844000.0,短期借款減少,岱宇,生技醫療業
2022-09-30,1598,TotalIncomeLossItems,-76687000.0,收益費損項目合計,岱宇,生技醫療業
2022-09-30,1598,CashReceivedThroughOperations,517940000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2022-09-30,1598,ReceivableIncrease,605538000.0,應收帳款(增加)減少,岱宇,生技醫療業
2022-09-30,1598,RedemptionOfBonds,0.0,償還公司債,岱宇,生技醫療業
2022-09-30,1598,CashFlowsFromOperatingActivities,463250000.0,營業活動之淨現金流入(流出),岱宇,生技醫療業
2022-09-30,1598,NetCashInflowFromOperatingActivities,463250000.0,營業活動之淨現金流入,岱宇,生技醫療業
2022-09-30,1598,AccountsPayable,-738730000.0,應付帳款,岱宇,生技醫療業
2022-12-31,1598,PropertyAndPlantAndEquipment,-355560000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2022-12-31,1598,NetIncomeBeforeTax,-81061000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2022-12-31,1598,TotalIncomeLossItems,209057000.0,收益費損項目合計,岱宇,生技醫療業
2022-12-31,1598,CashFlowsFromOperatingActivities,626766000.0,營業活動之淨現金流入（流出）,岱宇,生技醫療業
2022-12-31,1598,CashBalancesEndOfPeriod,1120781000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2022-12-31,1598,InventoryIncrease,768900000.0,存貨（增加）減少,岱宇,生技醫療業
2022-12-31,1598,CashBalancesBeginningOfPeriod,1212636000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2022-12-31,1598,CashBalancesIncrease,-91855000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2022-12-31,1598,CashReceivedThroughOperations,810339000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2022-12-31,1598,CashFlowsProvidedFromFinancingActivities,-355281000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2022-12-31,1598,Depreciation,173448000.0,折舊費用,岱宇,生技醫療業
2022-12-31,1598,OtherNonCurrentLiabilitiesIncrease,8126000.0,其他流動資產(增加)減少,岱宇,生技醫療業
2022-12-31,1598,RentalPrincipalRepayments,-25962000.0,租賃本金償還,岱宇,生技醫療業
2022-12-31,1598,AmortizationExpense,80321000.0,攤銷費用,岱宇,生技醫療業
2022-12-31,1598,RepaymentOfLongTermDebt,-166873000.0,償還長期借款,岱宇,生技醫療業
2022-12-31,1598,ProceedsFromLongTermDebt,723145000.0,舉借長期借款,岱宇,生技醫療業
2022-12-31,1598,DecreaseInShortTermLoans,-502054000.0,短期借款減少,岱宇,生技醫療業
2022-12-31,1598,InterestExpense,84529000.0,利息費用,岱宇,生技醫療業
2022-12-31,1598,InterestIncome,-2275000.0,利息收入,岱宇,生技醫療業
2022-12-31,1598,PayTheInterest,-65346000.0,支付之利息,岱宇,生技醫療業
2022-12-31,1598,IncomeBeforeIncomeTaxFromContinuingOperations,-81061000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2022-12-31,1598,ReceivableIncrease,601778000.0,應收帳款（增加）減少,岱宇,生技醫療業
2022-12-31,1598,RedemptionOfBonds,0.0,償還公司債,岱宇,生技醫療業
2022-12-31,1598,NetCashInflowFromOperatingActivities,626766000.0,營業活動之淨現金流入,岱宇,生技醫療業
2022-12-31,1598,CashProvidedByInvestingActivities,-436620000.0,投資活動之淨現金流入（流出）,岱宇,生技醫療業
2022-12-31,1598,AccountsPayable,-476108000.0,應付帳款,岱宇,生技醫療業
2023-03-31,1598,ReceivableIncrease,-113586000.0,應收帳款（增加）減少,岱宇,生技醫療業
2023-03-31,1598,PropertyAndPlantAndEquipment,-81348000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2023-03-31,1598,NetIncomeBeforeTax,-78105000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2023-03-31,1598,InterestExpense,26312000.0,利息費用,岱宇,生技醫療業
2023-03-31,1598,CashFlowsFromOperatingActivities,106407000.0,營業活動之淨現金流入（流出）,岱宇,生技醫療業
2023-03-31,1598,CashBalancesEndOfPeriod,1035549000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2023-03-31,1598,CashBalancesBeginningOfPeriod,1120781000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2023-03-31,1598,CashBalancesIncrease,-85232000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2023-03-31,1598,CashFlowsProvidedFromFinancingActivities,-146765000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2023-03-31,1598,Depreciation,45374000.0,折舊費用,岱宇,生技醫療業
2023-03-31,1598,OtherNonCurrentLiabilitiesIncrease,-3854000.0,其他流動資產(增加)減少,岱宇,生技醫療業
2023-03-31,1598,TotalIncomeLossItems,85769000.0,收益費損項目合計,岱宇,生技醫療業
2023-03-31,1598,RentalPrincipalRepayments,-3276000.0,租賃本金償還,岱宇,生技醫療業
2023-03-31,1598,AmortizationExpense,20055000.0,攤銷費用,岱宇,生技醫療業
2023-03-31,1598,RepaymentOfLongTermDebt,-42714000.0,償還長期借款,岱宇,生技醫療業
2023-03-31,1598,ProceedsFromLongTermDebt,169851000.0,舉借長期借款,岱宇,生技醫療業
2023-03-31,1598,InterestIncome,-2593000.0,利息收入,岱宇,生技醫療業
2023-03-31,1598,DecreaseInDepositDeposit,11348000.0,存出保證金減少,岱宇,生技醫療業
2023-03-31,1598,CashReceivedThroughOperations,133130000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2023-03-31,1598,PayTheInterest,-22106000.0,支付之利息,岱宇,生技醫療業
2023-03-31,1598,IncomeBeforeIncomeTaxFromContinuingOperations,-78105000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2023-03-31,1598,DecreaseInShortTermLoans,-301147000.0,短期借款減少,岱宇,生技醫療業
2023-03-31,1598,InventoryIncrease,333438000.0,存貨（增加）減少,岱宇,生技醫療業
2023-03-31,1598,CashProvidedByInvestingActivities,-48785000.0,投資活動之淨現金流入（流出）,岱宇,生技醫療業
2023-03-31,1598,NetCashInflowFromOperatingActivities,106407000.0,營業活動之淨現金流入,岱宇,生技醫療業
2023-03-31,1598,AccountsPayable,-66518000.0,應付帳款,岱宇,生技醫療業
2023-06-30,1598,OtherNonCurrentLiabilitiesIncrease,-7603000.0,其他流動資產(增加)減少,岱宇,生技醫療業
2023-06-30,1598,PropertyAndPlantAndEquipment,-127835000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2023-06-30,1598,CashBalancesEndOfPeriod,1851873000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2023-06-30,1598,CashBalancesIncrease,731092000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2023-06-30,1598,CashProvidedByInvestingActivities,-98967000.0,投資活動之淨現金流入（流出）,岱宇,生技醫療業
2023-06-30,1598,CashBalancesBeginningOfPeriod,1120781000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2023-06-30,1598,RentalPrincipalRepayments,-13008000.0,租賃本金償還,岱宇,生技醫療業
2023-06-30,1598,PayTheInterest,-69005000.0,支付之利息,岱宇,生技醫療業
2023-06-30,1598,IncomeBeforeIncomeTaxFromContinuingOperations,-167550000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2023-06-30,1598,ProceedsFromLongTermDebt,272276000.0,舉借長期借款,岱宇,生技醫療業
2023-06-30,1598,NetIncomeBeforeTax,-167550000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2023-06-30,1598,CashFlowsFromOperatingActivities,314361000.0,營業活動之淨現金流入（流出）,岱宇,生技醫療業
2023-06-30,1598,Depreciation,91512000.0,折舊費用,岱宇,生技醫療業
2023-06-30,1598,AmortizationExpense,40944000.0,攤銷費用,岱宇,生技醫療業
2023-06-30,1598,DecreaseInDepositDeposit,12492000.0,存出保證金減少,岱宇,生技醫療業
2023-06-30,1598,RepaymentOfLongTermDebt,-121122000.0,償還長期借款,岱宇,生技醫療業
2023-06-30,1598,InterestExpense,52712000.0,利息費用,岱宇,生技醫療業
2023-06-30,1598,ReceivableIncrease,184637000.0,應收帳款（增加）減少,岱宇,生技醫療業
2023-06-30,1598,InventoryIncrease,245598000.0,存貨（增加）減少,岱宇,生技醫療業
2023-06-30,1598,CashFlowsProvidedFromFinancingActivities,499112000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2023-06-30,1598,InterestIncome,-6500000.0,利息收入,岱宇,生技醫療業
2023-06-30,1598,DecreaseInShortTermLoans,-494494000.0,短期借款減少,岱宇,生技醫療業
2023-06-30,1598,TotalIncomeLossItems,161935000.0,收益費損項目合計,岱宇,生技醫療業
2023-06-30,1598,CashReceivedThroughOperations,406571000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2023-06-30,1598,AccountsPayable,-29011000.0,應付帳款,岱宇,生技醫療業
2023-06-30,1598,NetCashInflowFromOperatingActivities,314361000.0,營業活動之淨現金流入,岱宇,生技醫療業
2023-09-30,1598,CashBalancesIncrease,-266139000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2023-09-30,1598,CashBalancesBeginningOfPeriod,1120781000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2023-09-30,1598,ReceivableIncrease,209633000.0,應收帳款（增加）減少,岱宇,生技醫療業
2023-09-30,1598,Depreciation,138835000.0,折舊費用,岱宇,生技醫療業
2023-09-30,1598,PropertyAndPlantAndEquipment,-187069000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2023-09-30,1598,NetIncomeBeforeTax,-196131000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2023-09-30,1598,RedemptionOfBonds,-1407553000.0,償還公司債,岱宇,生技醫療業
2023-09-30,1598,CashBalancesEndOfPeriod,854642000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2023-09-30,1598,AmortizationExpense,61792000.0,攤銷費用,岱宇,生技醫療業
2023-09-30,1598,OtherNonCurrentLiabilitiesIncrease,-17009000.0,其他流動資產(增加)減少,岱宇,生技醫療業
2023-09-30,1598,TotalIncomeLossItems,245837000.0,收益費損項目合計,岱宇,生技醫療業
2023-09-30,1598,InventoryIncrease,156427000.0,存貨（增加）減少,岱宇,生技醫療業
2023-09-30,1598,InterestExpense,74911000.0,利息費用,岱宇,生技醫療業
2023-09-30,1598,CashReceivedThroughOperations,376148000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2023-09-30,1598,PayTheInterest,-90655000.0,支付之利息,岱宇,生技醫療業
2023-09-30,1598,CashFlowsProvidedFromFinancingActivities,-532971000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2023-09-30,1598,DecreaseInDepositDeposit,18472000.0,存出保證金減少,岱宇,生技醫療業
2023-09-30,1598,ProceedsFromLongTermDebt,765513000.0,舉借長期借款,岱宇,生技醫療業
2023-09-30,1598,RepaymentOfLongTermDebt,-161874000.0,償還長期借款,岱宇,生技醫療業
2023-09-30,1598,RentalPrincipalRepayments,-16949000.0,租賃本金償還,岱宇,生技醫療業
2023-09-30,1598,InterestIncome,-9328000.0,利息收入,岱宇,生技醫療業
2023-09-30,1598,IncomeBeforeIncomeTaxFromContinuingOperations,-196131000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2023-09-30,1598,NetCashInflowFromOperatingActivities,258850000.0,營業活動之淨現金流入,岱宇,生技醫療業
2023-09-30,1598,AccountsPayable,-3852000.0,應付帳款,岱宇,生技醫療業
2023-09-30,1598,DecreaseInShortTermLoans,-6733232000.0,短期借款減少,岱宇,生技醫療業
2023-09-30,1598,CashProvidedByInvestingActivities,-27977000.0,投資活動之淨現金流入（流出）,岱宇,生技醫療業
2023-09-30,1598,CashFlowsFromOperatingActivities,258850000.0,營業活動之淨現金流入（流出）,岱宇,生技醫療業
2023-12-31,1598,PropertyAndPlantAndEquipment,-218197000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2023-12-31,1598,CashBalancesIncrease,37731000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2023-12-31,1598,RedemptionOfBonds,-1407553000.0,償還公司債,岱宇,生技醫療業
2023-12-31,1598,CashBalancesEndOfPeriod,1158512000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2023-12-31,1598,PayTheInterest,-113647000.0,支付之利息,岱宇,生技醫療業
2023-12-31,1598,CashBalancesBeginningOfPeriod,1120781000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2023-12-31,1598,CashProvidedByInvestingActivities,-166508000.0,投資活動之淨現金流入（流出）,岱宇,生技醫療業
2023-12-31,1598,IncomeBeforeIncomeTaxFromContinuingOperations,-169431000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2023-12-31,1598,RepaymentOfLongTermDebt,-223637000.0,償還長期借款,岱宇,生技醫療業
2023-12-31,1598,NetIncomeBeforeTax,-169431000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2023-12-31,1598,CashFlowsFromOperatingActivities,616610000.0,營業活動之淨現金流入（流出）,岱宇,生技醫療業
2023-12-31,1598,Depreciation,183356000.0,折舊費用,岱宇,生技醫療業
2023-12-31,1598,AmortizationExpense,82791000.0,攤銷費用,岱宇,生技醫療業
2023-12-31,1598,AccountsPayable,-78231000.0,應付帳款,岱宇,生技醫療業
2023-12-31,1598,NetCashInflowFromOperatingActivities,616610000.0,營業活動之淨現金流入,岱宇,生技醫療業
2023-12-31,1598,RentalPrincipalRepayments,-20781000.0,租賃本金償還,岱宇,生技醫療業
2023-12-31,1598,InterestExpense,97894000.0,利息費用,岱宇,生技醫療業
2023-12-31,1598,ReceivableIncrease,29729000.0,應收帳款（增加）減少,岱宇,生技醫療業
2023-12-31,1598,InventoryIncrease,582662000.0,存貨（增加）減少,岱宇,生技醫療業
2023-12-31,1598,CashReceivedThroughOperations,758293000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2023-12-31,1598,CashFlowsProvidedFromFinancingActivities,-397456000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2023-12-31,1598,DecreaseInShortTermLoans,-300981000.0,短期借款減少,岱宇,生技醫療業
2023-12-31,1598,ProceedsFromLongTermDebt,765513000.0,舉借長期借款,岱宇,生技醫療業
2023-12-31,1598,TotalIncomeLossItems,374637000.0,收益費損項目合計,岱宇,生技醫療業
2023-12-31,1598,InterestIncome,-13404000.0,利息收入,岱宇,生技醫療業
2023-12-31,1598,DecreaseInDepositDeposit,-41752000.0,存出保證金減少,岱宇,生技醫療業
2024-03-31,1598,CashProvidedByInvestingActivities,-110561000.0,投資活動之淨現金流入（流出）,岱宇,生技醫療業
2024-03-31,1598,PayTheInterest,-22843000.0,支付之利息,岱宇,生技醫療業
2024-03-31,1598,PropertyAndPlantAndEquipment,-124166000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2024-03-31,1598,CashBalancesBeginningOfPeriod,1158512000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2024-03-31,1598,RentalPrincipalRepayments,-7215000.0,租賃本金償還,岱宇,生技醫療業
2024-03-31,1598,CashBalancesIncrease,-111293000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2024-03-31,1598,CashBalancesEndOfPeriod,1047219000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2024-03-31,1598,IncomeBeforeIncomeTaxFromContinuingOperations,26471000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2024-03-31,1598,ProceedsFromLongTermDebt,62196000.0,舉借長期借款,岱宇,生技醫療業
2024-03-31,1598,NetIncomeBeforeTax,26471000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2024-03-31,1598,CashFlowsFromOperatingActivities,173276000.0,營業活動之淨現金流入（流出）,岱宇,生技醫療業
2024-03-31,1598,Depreciation,42923000.0,折舊費用,岱宇,生技醫療業
2024-03-31,1598,AmortizationExpense,20390000.0,攤銷費用,岱宇,生技醫療業
2024-03-31,1598,AccountsPayable,-116018000.0,應付帳款,岱宇,生技醫療業
2024-03-31,1598,NetCashInflowFromOperatingActivities,173276000.0,營業活動之淨現金流入,岱宇,生技醫療業
2024-03-31,1598,RepaymentOfLongTermDebt,-76304000.0,償還長期借款,岱宇,生技醫療業
2024-03-31,1598,DecreaseInDepositDeposit,36332000.0,存出保證金減少,岱宇,生技醫療業
2024-03-31,1598,TotalIncomeLossItems,-17074000.0,收益費損項目合計,岱宇,生技醫療業
2024-03-31,1598,ReceivableIncrease,184071000.0,應收帳款（增加）減少,岱宇,生技醫療業
2024-03-31,1598,InventoryIncrease,182783000.0,存貨（增加）減少,岱宇,生技醫療業
2024-03-31,1598,CashFlowsProvidedFromFinancingActivities,-217763000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2024-03-31,1598,InterestIncome,-3167000.0,利息收入,岱宇,生技醫療業
2024-03-31,1598,InterestExpense,22485000.0,利息費用,岱宇,生技醫療業
2024-03-31,1598,CashReceivedThroughOperations,178374000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2024-03-31,1598,DecreaseInShortTermLoans,-1732445000.0,短期借款減少,岱宇,生技醫療業
2024-06-30,1598,CashProvidedByInvestingActivities,-156168000.0,投資活動之淨現金流入（流出）,岱宇,生技醫療業
2024-06-30,1598,PayTheInterest,-46848000.0,支付之利息,岱宇,生技醫療業
2024-06-30,1598,PropertyAndPlantAndEquipment,-217393000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2024-06-30,1598,CashBalancesBeginningOfPeriod,1158512000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2024-06-30,1598,RentalPrincipalRepayments,-6654000.0,租賃本金償還,岱宇,生技醫療業
2024-06-30,1598,CashBalancesIncrease,-120385000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2024-06-30,1598,CashBalancesEndOfPeriod,1038127000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2024-06-30,1598,IncomeBeforeIncomeTaxFromContinuingOperations,-109363000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2024-06-30,1598,ProceedsFromLongTermDebt,92801000.0,舉借長期借款,岱宇,生技醫療業
2024-06-30,1598,NetIncomeBeforeTax,-109363000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2024-06-30,1598,CashFlowsFromOperatingActivities,288289000.0,營業活動之淨現金流入（流出）,岱宇,生技醫療業
2024-06-30,1598,Depreciation,89627000.0,折舊費用,岱宇,生技醫療業
2024-06-30,1598,AmortizationExpense,41186000.0,攤銷費用,岱宇,生技醫療業
2024-06-30,1598,AccountsPayable,-118955000.0,應付帳款,岱宇,生技醫療業
2024-06-30,1598,NetCashInflowFromOperatingActivities,288289000.0,營業活動之淨現金流入,岱宇,生技醫療業
2024-06-30,1598,RepaymentOfLongTermDebt,-155899000.0,償還長期借款,岱宇,生技醫療業
2024-06-30,1598,DecreaseInDepositDeposit,43909000.0,存出保證金減少,岱宇,生技醫療業
2024-06-30,1598,TotalIncomeLossItems,163232000.0,收益費損項目合計,岱宇,生技醫療業
2024-06-30,1598,ReceivableIncrease,343985000.0,應收帳款（增加）減少,岱宇,生技醫療業
2024-06-30,1598,InventoryIncrease,43152000.0,存貨（增加）減少,岱宇,生技醫療業
2024-06-30,1598,CashFlowsProvidedFromFinancingActivities,-286305000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2024-06-30,1598,InterestIncome,-4340000.0,利息收入,岱宇,生技醫療業
2024-06-30,1598,DecreaseInShortTermLoans,-3396408000.0,短期借款減少,岱宇,生技醫療業
2024-06-30,1598,InterestExpense,46584000.0,利息費用,岱宇,生技醫療業
2024-06-30,1598,CashReceivedThroughOperations,315358000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2024-09-30,1598,Depreciation,138620000.0,折舊費用,岱宇,生技醫療業
2024-09-30,1598,CashBalancesBeginningOfPeriod,1158512000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2024-09-30,1598,TotalIncomeLossItems,329844000.0,收益費損項目合計,岱宇,生技醫療業
2024-09-30,1598,CashFlowsFromOperatingActivities,238022000.0,營業活動之淨現金流入（流出）,岱宇,生技醫療業
2024-09-30,1598,CashBalancesIncrease,-312407000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2024-09-30,1598,PropertyAndPlantAndEquipment,-253356000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2024-09-30,1598,NetIncomeBeforeTax,-247303000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2024-09-30,1598,RedemptionOfBonds,-1200000.0,償還公司債,岱宇,生技醫療業
2024-09-30,1598,CashBalancesEndOfPeriod,846105000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2024-09-30,1598,CashProvidedByInvestingActivities,-211840000.0,投資活動之淨現金流入（流出）,岱宇,生技醫療業
2024-09-30,1598,RentalPrincipalRepayments,-13653000.0,租賃本金償還,岱宇,生技醫療業
2024-09-30,1598,AmortizationExpense,64250000.0,攤銷費用,岱宇,生技醫療業
2024-09-30,1598,InterestExpense,72825000.0,利息費用,岱宇,生技醫療業
2024-09-30,1598,RepaymentOfLongTermDebt,-241315000.0,償還長期借款,岱宇,生技醫療業
2024-09-30,1598,AccountsPayable,-4067000.0,應付帳款,岱宇,生技醫療業
2024-09-30,1598,ProceedsFromLongTermDebt,156901000.0,舉借長期借款,岱宇,生技醫療業
2024-09-30,1598,DecreaseInShortTermLoans,-4642006000.0,短期借款減少,岱宇,生技醫療業
2024-09-30,1598,NetCashInflowFromOperatingActivities,238022000.0,營業活動之淨現金流入,岱宇,生技醫療業
2024-09-30,1598,InterestIncome,-9942000.0,利息收入,岱宇,生技醫療業
2024-09-30,1598,CashFlowsProvidedFromFinancingActivities,-363860000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2024-09-30,1598,CashReceivedThroughOperations,235631000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2024-09-30,1598,InventoryIncrease,110324000.0,存貨（增加）減少,岱宇,生技醫療業
2024-09-30,1598,DecreaseInDepositDeposit,50366000.0,存出保證金減少,岱宇,生技醫療業
2024-09-30,1598,ReceivableIncrease,260210000.0,應收帳款（增加）減少,岱宇,生技醫療業
2024-09-30,1598,PayTheInterest,-73204000.0,支付之利息,岱宇,生技醫療業
2024-09-30,1598,IncomeBeforeIncomeTaxFromContinuingOperations,-247303000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2024-12-31,1598,Depreciation,192914000.0,折舊費用,岱宇,生技醫療業
2024-12-31,1598,CashBalancesBeginningOfPeriod,1158512000.0,期初現金及約當現金餘額,岱宇,生技醫療業
2024-12-31,1598,TotalIncomeLossItems,312304000.0,收益費損項目合計,岱宇,生技醫療業
2024-12-31,1598,CashFlowsFromOperatingActivities,492260000.0,營業活動之淨現金流入（流出）,岱宇,生技醫療業
2024-12-31,1598,CashBalancesIncrease,732000.0,本期現金及約當現金增加（減少）數,岱宇,生技醫療業
2024-12-31,1598,PropertyAndPlantAndEquipment,-288908000.0,取得不動產、廠房及設備,岱宇,生技醫療業
2024-12-31,1598,NetIncomeBeforeTax,78837000.0,本期稅前淨利（淨損）,岱宇,生技醫療業
2024-12-31,1598,RedemptionOfBonds,-1200000.0,償還公司債,岱宇,生技醫療業
2024-12-31,1598,CashBalancesEndOfPeriod,1159244000.0,期末現金及約當現金餘額,岱宇,生技醫療業
2024-12-31,1598,CashProvidedByInvestingActivities,-217256000.0,投資活動之淨現金流入（流出）,岱宇,生技醫療業
2024-12-31,1598,RentalPrincipalRepayments,-19225000.0,租賃本金償還,岱宇,生技醫療業
2024-12-31,1598,AmortizationExpense,85425000.0,攤銷費用,岱宇,生技醫療業
2024-12-31,1598,InterestExpense,97664000.0,利息費用,岱宇,生技醫療業
2024-12-31,1598,RepaymentOfLongTermDebt,-1510993000.0,償還長期借款,岱宇,生技醫療業
2024-12-31,1598,AccountsPayable,113044000.0,應付帳款,岱宇,生技醫療業
2024-12-31,1598,ProceedsFromLongTermDebt,1387722000.0,舉借長期借款,岱宇,生技醫療業
2024-12-31,1598,DecreaseInShortTermLoans,-6758467000.0,短期借款減少,岱宇,生技醫療業
2024-12-31,1598,NetCashInflowFromOperatingActivities,492260000.0,營業活動之淨現金流入,岱宇,生技醫療業
2024-12-31,1598,InterestIncome,-13731000.0,利息收入,岱宇,生技醫療業
2024-12-31,1598,CashFlowsProvidedFromFinancingActivities,-314410000.0,籌資活動之淨現金流入（流出）,岱宇,生技醫療業
2024-12-31,1598,CashReceivedThroughOperations,506021000.0,營運產生之現金流入（流出）,岱宇,生技醫療業
2024-12-31,1598,InventoryIncrease,328898000.0,存貨（增加）減少,岱宇,生技醫療業
2024-12-31,1598,DecreaseInDepositDeposit,54697000.0,存出保證金減少,岱宇,生技醫療業
2024-12-31,1598,ReceivableIncrease,-51230000.0,應收帳款（增加）減少,岱宇,生技醫療業
2024-12-31,1598,PayTheInterest,-98000000.0,支付之利息,岱宇,生技醫療業
2024-12-31,1598,IncomeBeforeIncomeTaxFromContinuingOperations,78837000.0,繼續營業單位稅前淨利（淨損）,岱宇,生技醫療業
2019-03-31,1593,IncomeBeforeIncomeTax,30425000.0,稅前淨利(淨損),祺驊,生技醫療業
2019-03-31,1593,NetIncome,25790000.0,本期淨利(淨損),祺驊,生技醫療業
2019-03-31,1593,PreTaxIncome,30425000.0,稅前淨利（淨損）,祺驊,生技醫療業
2019-03-31,1593,TAX,4635000.0,所得稅費用（利益）,祺驊,生技醫療業
2019-03-31,1593,IncomeFromContinuingOperations,25790000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2019-03-31,1593,IncomeAfterTaxes,25790000.0,本期淨利（淨損）,祺驊,生技醫療業
2019-03-31,1593,TotalConsolidatedProfitForThePeriod,25960000.0,本期綜合損益總額,祺驊,生技醫療業
2019-03-31,1593,EPS,0.81,基本每股盈餘（元）,祺驊,生技醫療業
2019-03-31,1593,Revenue,187389000.0,營業收入,祺驊,生技醫療業
2019-03-31,1593,CostOfGoodsSold,131393000.0,營業成本,祺驊,生技醫療業
2019-03-31,1593,GrossProfit,55996000.0,營業毛利（毛損）淨額,祺驊,生技醫療業
2019-03-31,1593,OperatingExpenses,32548000.0,營業費用,祺驊,生技醫療業
2019-03-31,1593,OperatingIncome,23448000.0,營業利益（損失）,祺驊,生技醫療業
2019-03-31,1593,TotalNonoperatingIncomeAndExpense,6977000.0,營業外收入及支出,祺驊,生技醫療業
2019-03-31,1593,OtherComprehensiveIncome,170000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2019-03-31,1593,EquityAttributableToOwnersOfParent,25753000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2019-03-31,1593,NoncontrollingInterests,37000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2019-06-30,1593,IncomeBeforeIncomeTax,29447000.0,稅前淨利(淨損),祺驊,生技醫療業
2019-06-30,1593,NetIncome,24925000.0,本期淨利(淨損),祺驊,生技醫療業
2019-06-30,1593,PreTaxIncome,29447000.0,稅前淨利（淨損）,祺驊,生技醫療業
2019-06-30,1593,TAX,4522000.0,所得稅費用（利益）,祺驊,生技醫療業
2019-06-30,1593,IncomeFromContinuingOperations,24925000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2019-06-30,1593,IncomeAfterTaxes,24925000.0,本期淨利（淨損）,祺驊,生技醫療業
2019-06-30,1593,TotalConsolidatedProfitForThePeriod,24740000.0,本期綜合損益總額,祺驊,生技醫療業
2019-06-30,1593,EPS,0.77,基本每股盈餘（元）,祺驊,生技醫療業
2019-06-30,1593,Revenue,198574000.0,營業收入,祺驊,生技醫療業
2019-06-30,1593,CostOfGoodsSold,140957000.0,營業成本,祺驊,生技醫療業
2019-06-30,1593,GrossProfit,57617000.0,營業毛利（毛損）淨額,祺驊,生技醫療業
2019-06-30,1593,OperatingExpenses,34119000.0,營業費用,祺驊,生技醫療業
2019-06-30,1593,OperatingIncome,23498000.0,營業利益（損失）,祺驊,生技醫療業
2019-06-30,1593,TotalNonoperatingIncomeAndExpense,5949000.0,營業外收入及支出,祺驊,生技醫療業
2019-06-30,1593,OtherComprehensiveIncome,-185000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2019-06-30,1593,EquityAttributableToOwnersOfParent,24652000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2019-06-30,1593,NoncontrollingInterests,273000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2019-09-30,1593,IncomeBeforeIncomeTax,43685000.0,稅前淨利(淨損),祺驊,生技醫療業
2019-09-30,1593,NetIncome,36437000.0,本期淨利(淨損),祺驊,生技醫療業
2019-09-30,1593,PreTaxIncome,43685000.0,稅前淨利（淨損）,祺驊,生技醫療業
2019-09-30,1593,TAX,7248000.0,所得稅費用（利益）,祺驊,生技醫療業
2019-09-30,1593,IncomeFromContinuingOperations,36437000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2019-09-30,1593,IncomeAfterTaxes,36437000.0,本期淨利（淨損）,祺驊,生技醫療業
2019-09-30,1593,TotalConsolidatedProfitForThePeriod,34301000.0,本期綜合損益總額,祺驊,生技醫療業
2019-09-30,1593,EPS,1.13,基本每股盈餘（元）,祺驊,生技醫療業
2019-09-30,1593,Revenue,216918000.0,營業收入,祺驊,生技醫療業
2019-09-30,1593,CostOfGoodsSold,145326000.0,營業成本,祺驊,生技醫療業
2019-09-30,1593,GrossProfit,71592000.0,營業毛利（毛損）淨額,祺驊,生技醫療業
2019-09-30,1593,OperatingExpenses,34261000.0,營業費用,祺驊,生技醫療業
2019-09-30,1593,OperatingIncome,37331000.0,營業利益（損失）,祺驊,生技醫療業
2019-09-30,1593,TotalNonoperatingIncomeAndExpense,6354000.0,營業外收入及支出,祺驊,生技醫療業
2019-09-30,1593,OtherComprehensiveIncome,-2136000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2019-09-30,1593,EquityAttributableToOwnersOfParent,36226000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2019-09-30,1593,NoncontrollingInterests,211000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2019-12-31,1593,IncomeBeforeIncomeTax,40249000.0,稅前淨利(淨損),祺驊,生技醫療業
2019-12-31,1593,NetIncome,33039000.0,本期淨利(淨損),祺驊,生技醫療業
2019-12-31,1593,PreTaxIncome,40249000.0,稅前淨利（淨損）,祺驊,生技醫療業
2019-12-31,1593,TAX,7210000.0,所得稅費用（利益）,祺驊,生技醫療業
2019-12-31,1593,IncomeFromContinuingOperations,33039000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2019-12-31,1593,IncomeAfterTaxes,33039000.0,本期淨利（淨損）,祺驊,生技醫療業
2019-12-31,1593,TotalConsolidatedProfitForThePeriod,20404000.0,本期綜合損益總額,祺驊,生技醫療業
2019-12-31,1593,EPS,1.03,基本每股盈餘（元）,祺驊,生技醫療業
2019-12-31,1593,Revenue,211635000.0,營業收入,祺驊,生技醫療業
2019-12-31,1593,CostOfGoodsSold,144565000.0,營業成本,祺驊,生技醫療業
2019-12-31,1593,GrossProfit,67070000.0,營業毛利（毛損）淨額,祺驊,生技醫療業
2019-12-31,1593,OperatingExpenses,35496000.0,營業費用,祺驊,生技醫療業
2019-12-31,1593,OperatingIncome,31574000.0,營業利益（損失）,祺驊,生技醫療業
2019-12-31,1593,TotalNonoperatingIncomeAndExpense,8675000.0,營業外收入及支出,祺驊,生技醫療業
2019-12-31,1593,OtherComprehensiveIncome,-12635000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2019-12-31,1593,EquityAttributableToOwnersOfParent,32766000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2019-12-31,1593,NoncontrollingInterests,273000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2020-03-31,1593,PreTaxIncome,23420000.0,稅前淨利（淨損）,祺驊,生技醫療業
2020-03-31,1593,TAX,3271000.0,所得稅費用（利益）,祺驊,生技醫療業
2020-03-31,1593,IncomeFromContinuingOperations,20149000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2020-03-31,1593,IncomeAfterTaxes,20149000.0,本期淨利（淨損）,祺驊,生技醫療業
2020-03-31,1593,TotalConsolidatedProfitForThePeriod,12278000.0,本期綜合損益總額,祺驊,生技醫療業
2020-03-31,1593,EPS,0.63,基本每股盈餘（元）,祺驊,生技醫療業
2020-03-31,1593,Revenue,155358000.0,營業收入,祺驊,生技醫療業
2020-03-31,1593,CostOfGoodsSold,108395000.0,營業成本,祺驊,生技醫療業
2020-03-31,1593,GrossProfit,46963000.0,營業毛利（毛損）淨額,祺驊,生技醫療業
2020-03-31,1593,OperatingExpenses,30833000.0,營業費用,祺驊,生技醫療業
2020-03-31,1593,OperatingIncome,16130000.0,營業利益（損失）,祺驊,生技醫療業
2020-03-31,1593,TotalNonoperatingIncomeAndExpense,7290000.0,營業外收入及支出,祺驊,生技醫療業
2020-03-31,1593,OtherComprehensiveIncome,-7871000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2020-03-31,1593,EquityAttributableToOwnersOfParent,20003000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2020-03-31,1593,NoncontrollingInterests,146000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2020-06-30,1593,PreTaxIncome,32793000.0,稅前淨利（淨損）,祺驊,生技醫療業
2020-06-30,1593,TAX,3533000.0,所得稅費用（利益）,祺驊,生技醫療業
2020-06-30,1593,IncomeFromContinuingOperations,29260000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2020-06-30,1593,IncomeAfterTaxes,29260000.0,本期淨利（淨損）,祺驊,生技醫療業
2020-06-30,1593,TotalConsolidatedProfitForThePeriod,26561000.0,本期綜合損益總額,祺驊,生技醫療業
2020-06-30,1593,EPS,0.91,基本每股盈餘（元）,祺驊,生技醫療業
2020-06-30,1593,Revenue,188211000.0,營業收入,祺驊,生技醫療業
2020-06-30,1593,CostOfGoodsSold,136842000.0,營業成本,祺驊,生技醫療業
2020-06-30,1593,GrossProfit,51369000.0,營業毛利（毛損）淨額,祺驊,生技醫療業
2020-06-30,1593,OperatingExpenses,30652000.0,營業費用,祺驊,生技醫療業
2020-06-30,1593,OperatingIncome,20717000.0,營業利益（損失）,祺驊,生技醫療業
2020-06-30,1593,TotalNonoperatingIncomeAndExpense,12076000.0,營業外收入及支出,祺驊,生技醫療業
2020-06-30,1593,OtherComprehensiveIncome,-2699000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2020-06-30,1593,EquityAttributableToOwnersOfParent,29236000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2020-06-30,1593,NoncontrollingInterests,24000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2020-09-30,1593,PreTaxIncome,50441000.0,稅前淨利（淨損）,祺驊,生技醫療業
2020-09-30,1593,TAX,7284000.0,所得稅費用（利益）,祺驊,生技醫療業
2020-09-30,1593,IncomeFromContinuingOperations,43157000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2020-09-30,1593,IncomeAfterTaxes,43157000.0,本期淨利（淨損）,祺驊,生技醫療業
2020-09-30,1593,TotalConsolidatedProfitForThePeriod,38740000.0,本期綜合損益總額,祺驊,生技醫療業
2020-09-30,1593,EPS,1.34,基本每股盈餘（元）,祺驊,生技醫療業
2020-09-30,1593,Revenue,244139000.0,營業收入,祺驊,生技醫療業
2020-09-30,1593,CostOfGoodsSold,172235000.0,營業成本,祺驊,生技醫療業
2020-09-30,1593,GrossProfit,71904000.0,營業毛利（毛損）淨額,祺驊,生技醫療業
2020-09-30,1593,OperatingExpenses,32678000.0,營業費用,祺驊,生技醫療業
2020-09-30,1593,OperatingIncome,39226000.0,營業利益（損失）,祺驊,生技醫療業
2020-09-30,1593,TotalNonoperatingIncomeAndExpense,11215000.0,營業外收入及支出,祺驊,生技醫療業
2020-09-30,1593,OtherComprehensiveIncome,-4417000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2020-09-30,1593,EquityAttributableToOwnersOfParent,42673000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2020-09-30,1593,NoncontrollingInterests,484000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2020-12-31,1593,PreTaxIncome,59659000.0,稅前淨利（淨損）,祺驊,生技醫療業
2020-12-31,1593,TAX,7927000.0,所得稅費用（利益）,祺驊,生技醫療業
2020-12-31,1593,IncomeFromContinuingOperations,51732000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2020-12-31,1593,IncomeAfterTaxes,51732000.0,本期淨利（淨損）,祺驊,生技醫療業
2020-12-31,1593,TotalConsolidatedProfitForThePeriod,44906000.0,本期綜合損益總額,祺驊,生技醫療業
2020-12-31,1593,EPS,1.61,基本每股盈餘（元）,祺驊,生技醫療業
2020-12-31,1593,Revenue,280938000.0,營業收入,祺驊,生技醫療業
2020-12-31,1593,CostOfGoodsSold,202437000.0,營業成本,祺驊,生技醫療業
2020-12-31,1593,GrossProfit,78501000.0,營業毛利（毛損）淨額,祺驊,生技醫療業
2020-12-31,1593,OperatingExpenses,37343000.0,營業費用,祺驊,生技醫療業
2020-12-31,1593,OperatingIncome,41158000.0,營業利益（損失）,祺驊,生技醫療業
2020-12-31,1593,TotalNonoperatingIncomeAndExpense,18501000.0,營業外收入及支出,祺驊,生技醫療業
2020-12-31,1593,OtherComprehensiveIncome,-6826000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2020-12-31,1593,EquityAttributableToOwnersOfParent,51572000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2020-12-31,1593,NoncontrollingInterests,160000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2021-03-31,1593,PreTaxIncome,40397000.0,稅前淨利（淨損）,祺驊,生技醫療業
2021-03-31,1593,TAX,6526000.0,所得稅費用（利益）,祺驊,生技醫療業
2021-03-31,1593,IncomeFromContinuingOperations,33871000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2021-03-31,1593,IncomeAfterTaxes,33871000.0,本期淨利（淨損）,祺驊,生技醫療業
2021-03-31,1593,TotalConsolidatedProfitForThePeriod,29347000.0,本期綜合損益總額,祺驊,生技醫療業
2021-03-31,1593,EPS,0.99,基本每股盈餘（元）,祺驊,生技醫療業
2021-03-31,1593,Revenue,266671000.0,營業收入,祺驊,生技醫療業
2021-03-31,1593,CostOfGoodsSold,198628000.0,營業成本,祺驊,生技醫療業
2021-03-31,1593,OperatingExpenses,35575000.0,營業費用,祺驊,生技醫療業
2021-03-31,1593,OperatingIncome,32468000.0,營業利益（損失）,祺驊,生技醫療業
2021-03-31,1593,TotalNonoperatingIncomeAndExpense,7929000.0,營業外收入及支出,祺驊,生技醫療業
2021-03-31,1593,OtherComprehensiveIncome,-4524000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2021-03-31,1593,EquityAttributableToOwnersOfParent,33765000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2021-03-31,1593,NoncontrollingInterests,106000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2021-03-31,1593,GrossProfit,68043000.0,營業毛利（毛損）,祺驊,生技醫療業
2021-03-31,1593,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,106000.0,綜合損益總額歸屬於非控制權益,祺驊,生技醫療業
2021-06-30,1593,PreTaxIncome,55925000.0,稅前淨利（淨損）,祺驊,生技醫療業
2021-06-30,1593,TAX,9235000.0,所得稅費用（利益）,祺驊,生技醫療業
2021-06-30,1593,IncomeFromContinuingOperations,46690000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2021-06-30,1593,IncomeAfterTaxes,46690000.0,本期淨利（淨損）,祺驊,生技醫療業
2021-06-30,1593,TotalConsolidatedProfitForThePeriod,39068000.0,本期綜合損益總額,祺驊,生技醫療業
2021-06-30,1593,Revenue,338869000.0,營業收入,祺驊,生技醫療業
2021-06-30,1593,CostOfGoodsSold,250237000.0,營業成本,祺驊,生技醫療業
2021-06-30,1593,OperatingExpenses,38563000.0,營業費用,祺驊,生技醫療業
2021-06-30,1593,OperatingIncome,50069000.0,營業利益（損失）,祺驊,生技醫療業
2021-06-30,1593,TotalNonoperatingIncomeAndExpense,5856000.0,營業外收入及支出,祺驊,生技醫療業
2021-06-30,1593,OtherComprehensiveIncome,-7622000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2021-06-30,1593,GrossProfit,88632000.0,營業毛利（毛損）,祺驊,生技醫療業
2021-06-30,1593,EquityAttributableToOwnersOfParent,46560000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2021-06-30,1593,NoncontrollingInterests,130000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2021-06-30,1593,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,130000.0,綜合損益總額歸屬於非控制權益,祺驊,生技醫療業
2021-06-30,1593,EPS,1.33,基本每股盈餘（元）,祺驊,生技醫療業
2021-09-30,1593,PreTaxIncome,56361000.0,稅前淨利（淨損）,祺驊,生技醫療業
2021-09-30,1593,TAX,10281000.0,所得稅費用（利益）,祺驊,生技醫療業
2021-09-30,1593,IncomeFromContinuingOperations,46080000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2021-09-30,1593,IncomeAfterTaxes,46080000.0,本期淨利（淨損）,祺驊,生技醫療業
2021-09-30,1593,TotalConsolidatedProfitForThePeriod,49065000.0,本期綜合損益總額,祺驊,生技醫療業
2021-09-30,1593,Revenue,316550000.0,營業收入,祺驊,生技醫療業
2021-09-30,1593,CostOfGoodsSold,225376000.0,營業成本,祺驊,生技醫療業
2021-09-30,1593,OperatingExpenses,41214000.0,營業費用,祺驊,生技醫療業
2021-09-30,1593,OperatingIncome,49960000.0,營業利益（損失）,祺驊,生技醫療業
2021-09-30,1593,TotalNonoperatingIncomeAndExpense,6401000.0,營業外收入及支出,祺驊,生技醫療業
2021-09-30,1593,OtherComprehensiveIncome,2985000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2021-09-30,1593,GrossProfit,91174000.0,營業毛利（毛損）,祺驊,生技醫療業
2021-09-30,1593,EquityAttributableToOwnersOfParent,45907000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2021-09-30,1593,NoncontrollingInterests,173000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2021-09-30,1593,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,173000.0,綜合損益總額歸屬於非控制權益,祺驊,生技醫療業
2021-09-30,1593,EPS,1.3,基本每股盈餘（元）,祺驊,生技醫療業
2021-12-31,1593,PreTaxIncome,53189000.0,稅前淨利（淨損）,祺驊,生技醫療業
2021-12-31,1593,TAX,7527000.0,所得稅費用（利益）,祺驊,生技醫療業
2021-12-31,1593,IncomeFromContinuingOperations,45662000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2021-12-31,1593,IncomeAfterTaxes,45662000.0,本期淨利（淨損）,祺驊,生技醫療業
2021-12-31,1593,TotalConsolidatedProfitForThePeriod,61841000.0,本期綜合損益總額,祺驊,生技醫療業
2021-12-31,1593,Revenue,255387000.0,營業收入,祺驊,生技醫療業
2021-12-31,1593,CostOfGoodsSold,174949000.0,營業成本,祺驊,生技醫療業
2021-12-31,1593,OperatingExpenses,38978000.0,營業費用,祺驊,生技醫療業
2021-12-31,1593,OperatingIncome,41460000.0,營業利益（損失）,祺驊,生技醫療業
2021-12-31,1593,TotalNonoperatingIncomeAndExpense,11729000.0,營業外收入及支出,祺驊,生技醫療業
2021-12-31,1593,OtherComprehensiveIncome,16179000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2021-12-31,1593,EquityAttributableToOwnersOfParent,45079000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2021-12-31,1593,NoncontrollingInterests,583000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2021-12-31,1593,GrossProfit,80438000.0,營業毛利（毛損）,祺驊,生技醫療業
2021-12-31,1593,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,583000.0,綜合損益總額歸屬於非控制權益,祺驊,生技醫療業
2021-12-31,1593,EPS,1.28,基本每股盈餘（元）,祺驊,生技醫療業
2022-03-31,1593,PreTaxIncome,16709000.0,稅前淨利（淨損）,祺驊,生技醫療業
2022-03-31,1593,TAX,3982000.0,所得稅費用（利益）,祺驊,生技醫療業
2022-03-31,1593,IncomeFromContinuingOperations,12727000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2022-03-31,1593,IncomeAfterTaxes,12727000.0,本期淨利（淨損）,祺驊,生技醫療業
2022-03-31,1593,TotalConsolidatedProfitForThePeriod,30580000.0,本期綜合損益總額,祺驊,生技醫療業
2022-03-31,1593,EPS,0.34,基本每股盈餘（元）,祺驊,生技醫療業
2022-03-31,1593,Revenue,170649000.0,營業收入,祺驊,生技醫療業
2022-03-31,1593,CostOfGoodsSold,129753000.0,營業成本,祺驊,生技醫療業
2022-03-31,1593,OperatingExpenses,35247000.0,營業費用,祺驊,生技醫療業
2022-03-31,1593,OperatingIncome,5649000.0,營業利益（損失）,祺驊,生技醫療業
2022-03-31,1593,TotalNonoperatingIncomeAndExpense,11060000.0,營業外收入及支出,祺驊,生技醫療業
2022-03-31,1593,OtherComprehensiveIncome,17853000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2022-03-31,1593,EquityAttributableToOwnersOfParent,12103000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2022-03-31,1593,NoncontrollingInterests,624000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2022-03-31,1593,GrossProfit,40896000.0,營業毛利（毛損）,祺驊,生技醫療業
2022-03-31,1593,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,624000.0,綜合損益總額歸屬於非控制權益,祺驊,生技醫療業
2022-06-30,1593,PreTaxIncome,18093000.0,稅前淨利（淨損）,祺驊,生技醫療業
2022-06-30,1593,TAX,772000.0,所得稅費用（利益）,祺驊,生技醫療業
2022-06-30,1593,IncomeFromContinuingOperations,17321000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2022-06-30,1593,IncomeAfterTaxes,17321000.0,本期淨利（淨損）,祺驊,生技醫療業
2022-06-30,1593,TotalConsolidatedProfitForThePeriod,17876000.0,本期綜合損益總額,祺驊,生技醫療業
2022-06-30,1593,Revenue,123037000.0,營業收入,祺驊,生技醫療業
2022-06-30,1593,CostOfGoodsSold,95522000.0,營業成本,祺驊,生技醫療業
2022-06-30,1593,OperatingExpenses,33498000.0,營業費用,祺驊,生技醫療業
2022-06-30,1593,OperatingIncome,-5983000.0,營業利益（損失）,祺驊,生技醫療業
2022-06-30,1593,TotalNonoperatingIncomeAndExpense,24076000.0,營業外收入及支出,祺驊,生技醫療業
2022-06-30,1593,OtherComprehensiveIncome,555000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2022-06-30,1593,GrossProfit,27515000.0,營業毛利（毛損）,祺驊,生技醫療業
2022-06-30,1593,EquityAttributableToOwnersOfParent,16917000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2022-06-30,1593,NoncontrollingInterests,404000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2022-06-30,1593,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,404000.0,綜合損益總額歸屬於非控制權益,祺驊,生技醫療業
2022-06-30,1593,EPS,0.48,基本每股盈餘（元）,祺驊,生技醫療業
2022-09-30,1593,PreTaxIncome,131529000.0,稅前淨利（淨損）,祺驊,生技醫療業
2022-09-30,1593,TAX,5733000.0,所得稅費用（利益）,祺驊,生技醫療業
2022-09-30,1593,IncomeFromContinuingOperations,125796000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2022-09-30,1593,IncomeAfterTaxes,125796000.0,本期淨利（淨損）,祺驊,生技醫療業
2022-09-30,1593,TotalConsolidatedProfitForThePeriod,123975000.0,本期綜合損益總額,祺驊,生技醫療業
2022-09-30,1593,EPS,3.47,基本每股盈餘（元）,祺驊,生技醫療業
2022-09-30,1593,Revenue,227736000.0,營業收入,祺驊,生技醫療業
2022-09-30,1593,CostOfGoodsSold,158694000.0,營業成本,祺驊,生技醫療業
2022-09-30,1593,OperatingExpenses,50079000.0,營業費用,祺驊,生技醫療業
2022-09-30,1593,OperatingIncome,18963000.0,營業利益（損失）,祺驊,生技醫療業
2022-09-30,1593,TotalNonoperatingIncomeAndExpense,112566000.0,營業外收入及支出,祺驊,生技醫療業
2022-09-30,1593,OtherComprehensiveIncome,-1821000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2022-09-30,1593,GrossProfit,69042000.0,營業毛利（毛損）,祺驊,生技醫療業
2022-09-30,1593,EquityAttributableToOwnersOfParent,123159000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2022-09-30,1593,NoncontrollingInterests,2637000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2022-09-30,1593,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,2637000.0,綜合損益總額歸屬於非控制權益,祺驊,生技醫療業
2022-12-31,1593,PreTaxIncome,53936000.0,稅前淨利（淨損）,祺驊,生技醫療業
2022-12-31,1593,TAX,10751000.0,所得稅費用（利益）,祺驊,生技醫療業
2022-12-31,1593,IncomeFromContinuingOperations,43185000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2022-12-31,1593,IncomeAfterTaxes,43185000.0,本期淨利（淨損）,祺驊,生技醫療業
2022-12-31,1593,TotalConsolidatedProfitForThePeriod,31426000.0,本期綜合損益總額,祺驊,生技醫療業
2022-12-31,1593,Revenue,353468000.0,營業收入,祺驊,生技醫療業
2022-12-31,1593,CostOfGoodsSold,238202000.0,營業成本,祺驊,生技醫療業
2022-12-31,1593,OperatingExpenses,61123000.0,營業費用,祺驊,生技醫療業
2022-12-31,1593,OperatingIncome,54143000.0,營業利益（損失）,祺驊,生技醫療業
2022-12-31,1593,TotalNonoperatingIncomeAndExpense,-207000.0,營業外收入及支出,祺驊,生技醫療業
2022-12-31,1593,OtherComprehensiveIncome,-11759000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2022-12-31,1593,GrossProfit,115266000.0,營業毛利（毛損）,祺驊,生技醫療業
2022-12-31,1593,EquityAttributableToOwnersOfParent,36117000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2022-12-31,1593,NoncontrollingInterests,7068000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2022-12-31,1593,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,7068000.0,綜合損益總額歸屬於非控制權益,祺驊,生技醫療業
2022-12-31,1593,EPS,0.95,基本每股盈餘（元）,祺驊,生技醫療業
2023-03-31,1593,PreTaxIncome,16720000.0,稅前淨利（淨損）,祺驊,生技醫療業
2023-03-31,1593,TAX,1696000.0,所得稅費用（利益）,祺驊,生技醫療業
2023-03-31,1593,IncomeFromContinuingOperations,15024000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2023-03-31,1593,IncomeAfterTaxes,15024000.0,本期淨利（淨損）,祺驊,生技醫療業
2023-03-31,1593,TotalConsolidatedProfitForThePeriod,23840000.0,本期綜合損益總額,祺驊,生技醫療業
2023-03-31,1593,EPS,0.26,基本每股盈餘（元）,祺驊,生技醫療業
2023-03-31,1593,Revenue,237909000.0,營業收入,祺驊,生技醫療業
2023-03-31,1593,CostOfGoodsSold,166583000.0,營業成本,祺驊,生技醫療業
2023-03-31,1593,OperatingExpenses,53838000.0,營業費用,祺驊,生技醫療業
2023-03-31,1593,OperatingIncome,17488000.0,營業利益（損失）,祺驊,生技醫療業
2023-03-31,1593,TotalNonoperatingIncomeAndExpense,-768000.0,營業外收入及支出,祺驊,生技醫療業
2023-03-31,1593,OtherComprehensiveIncome,8816000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2023-03-31,1593,EquityAttributableToOwnersOfParent,9615000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2023-03-31,1593,NoncontrollingInterests,5409000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2023-03-31,1593,GrossProfit,71326000.0,營業毛利（毛損）,祺驊,生技醫療業
2023-03-31,1593,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,5409000.0,綜合損益總額歸屬於非控制權益,祺驊,生技醫療業
2023-06-30,1593,PreTaxIncome,40814000.0,稅前淨利（淨損）,祺驊,生技醫療業
2023-06-30,1593,TAX,9101000.0,所得稅費用（利益）,祺驊,生技醫療業
2023-06-30,1593,IncomeFromContinuingOperations,31713000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2023-06-30,1593,IncomeAfterTaxes,31713000.0,本期淨利（淨損）,祺驊,生技醫療業
2023-06-30,1593,TotalConsolidatedProfitForThePeriod,39638000.0,本期綜合損益總額,祺驊,生技醫療業
2023-06-30,1593,EPS,0.6,基本每股盈餘（元）,祺驊,生技醫療業
2023-06-30,1593,Revenue,276515000.0,營業收入,祺驊,生技醫療業
2023-06-30,1593,CostOfGoodsSold,185828000.0,營業成本,祺驊,生技醫療業
2023-06-30,1593,OperatingExpenses,58572000.0,營業費用,祺驊,生技醫療業
2023-06-30,1593,OperatingIncome,32115000.0,營業利益（損失）,祺驊,生技醫療業
2023-06-30,1593,TotalNonoperatingIncomeAndExpense,8699000.0,營業外收入及支出,祺驊,生技醫療業
2023-06-30,1593,OtherComprehensiveIncome,7925000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2023-06-30,1593,GrossProfit,90687000.0,營業毛利（毛損）,祺驊,生技醫療業
2023-06-30,1593,EquityAttributableToOwnersOfParent,22446000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2023-06-30,1593,NoncontrollingInterests,9267000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2023-06-30,1593,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,9267000.0,綜合損益總額歸屬於非控制權益,祺驊,生技醫療業
2023-09-30,1593,PreTaxIncome,27073000.0,稅前淨利（淨損）,祺驊,生技醫療業
2023-09-30,1593,TAX,11759000.0,所得稅費用（利益）,祺驊,生技醫療業
2023-09-30,1593,IncomeFromContinuingOperations,15314000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2023-09-30,1593,IncomeAfterTaxes,15314000.0,本期淨利（淨損）,祺驊,生技醫療業
2023-09-30,1593,TotalConsolidatedProfitForThePeriod,25091000.0,本期綜合損益總額,祺驊,生技醫療業
2023-09-30,1593,Revenue,267939000.0,營業收入,祺驊,生技醫療業
2023-09-30,1593,CostOfGoodsSold,182872000.0,營業成本,祺驊,生技醫療業
2023-09-30,1593,OperatingExpenses,64093000.0,營業費用,祺驊,生技醫療業
2023-09-30,1593,OperatingIncome,20974000.0,營業利益（損失）,祺驊,生技醫療業
2023-09-30,1593,TotalNonoperatingIncomeAndExpense,6099000.0,營業外收入及支出,祺驊,生技醫療業
2023-09-30,1593,OtherComprehensiveIncome,9777000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2023-09-30,1593,EquityAttributableToOwnersOfParent,8366000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2023-09-30,1593,NoncontrollingInterests,6948000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2023-09-30,1593,GrossProfit,85067000.0,營業毛利（毛損）,祺驊,生技醫療業
2023-09-30,1593,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,6948000.0,綜合損益總額歸屬於非控制權益,祺驊,生技醫療業
2023-09-30,1593,EPS,0.21,基本每股盈餘（元）,祺驊,生技醫療業
2023-12-31,1593,PreTaxIncome,20972000.0,稅前淨利（淨損）,祺驊,生技醫療業
2023-12-31,1593,TAX,3556000.0,所得稅費用（利益）,祺驊,生技醫療業
2023-12-31,1593,IncomeFromContinuingOperations,17416000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2023-12-31,1593,IncomeAfterTaxes,17416000.0,本期淨利（淨損）,祺驊,生技醫療業
2023-12-31,1593,TotalConsolidatedProfitForThePeriod,-14304000.0,本期綜合損益總額,祺驊,生技醫療業
2023-12-31,1593,Revenue,283071000.0,營業收入,祺驊,生技醫療業
2023-12-31,1593,CostOfGoodsSold,198435000.0,營業成本,祺驊,生技醫療業
2023-12-31,1593,OperatingExpenses,65044000.0,營業費用,祺驊,生技醫療業
2023-12-31,1593,OperatingIncome,19592000.0,營業利益（損失）,祺驊,生技醫療業
2023-12-31,1593,TotalNonoperatingIncomeAndExpense,1380000.0,營業外收入及支出,祺驊,生技醫療業
2023-12-31,1593,OtherComprehensiveIncome,-31720000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2023-12-31,1593,GrossProfit,84636000.0,營業毛利（毛損）,祺驊,生技醫療業
2023-12-31,1593,EquityAttributableToOwnersOfParent,10359000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2023-12-31,1593,NoncontrollingInterests,7057000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2023-12-31,1593,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,7057000.0,綜合損益總額歸屬於非控制權益,祺驊,生技醫療業
2023-12-31,1593,EPS,0.21,基本每股盈餘（元）,祺驊,生技醫療業
2024-03-31,1593,PreTaxIncome,14766000.0,稅前淨利（淨損）,祺驊,生技醫療業
2024-03-31,1593,TAX,10138000.0,所得稅費用（利益）,祺驊,生技醫療業
2024-03-31,1593,IncomeFromContinuingOperations,4628000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2024-03-31,1593,IncomeAfterTaxes,4628000.0,本期淨利（淨損）,祺驊,生技醫療業
2024-03-31,1593,TotalConsolidatedProfitForThePeriod,19923000.0,本期綜合損益總額,祺驊,生技醫療業
2024-03-31,1593,EPS,0.0,基本每股盈餘（元）,祺驊,生技醫療業
2024-03-31,1593,Revenue,242939000.0,營業收入,祺驊,生技醫療業
2024-03-31,1593,CostOfGoodsSold,169810000.0,營業成本,祺驊,生技醫療業
2024-03-31,1593,OperatingExpenses,68626000.0,營業費用,祺驊,生技醫療業
2024-03-31,1593,OperatingIncome,4503000.0,營業利益（損失）,祺驊,生技醫療業
2024-03-31,1593,TotalNonoperatingIncomeAndExpense,10263000.0,營業外收入及支出,祺驊,生技醫療業
2024-03-31,1593,OtherComprehensiveIncome,15295000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2024-03-31,1593,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,4501000.0,綜合損益總額歸屬於非控制權益,祺驊,生技醫療業
2024-03-31,1593,NoncontrollingInterests,4501000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2024-03-31,1593,EquityAttributableToOwnersOfParent,127000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2024-03-31,1593,GrossProfit,73129000.0,營業毛利（毛損）,祺驊,生技醫療業
2024-06-30,1593,PreTaxIncome,30084000.0,稅前淨利（淨損）,祺驊,生技醫療業
2024-06-30,1593,TAX,5749000.0,所得稅費用（利益）,祺驊,生技醫療業
2024-06-30,1593,IncomeFromContinuingOperations,24335000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2024-06-30,1593,IncomeAfterTaxes,24335000.0,本期淨利（淨損）,祺驊,生技醫療業
2024-06-30,1593,TotalConsolidatedProfitForThePeriod,26946000.0,本期綜合損益總額,祺驊,生技醫療業
2024-06-30,1593,EPS,0.43,基本每股盈餘（元）,祺驊,生技醫療業
2024-06-30,1593,Revenue,262574000.0,營業收入,祺驊,生技醫療業
2024-06-30,1593,CostOfGoodsSold,179801000.0,營業成本,祺驊,生技醫療業
2024-06-30,1593,OperatingExpenses,63867000.0,營業費用,祺驊,生技醫療業
2024-06-30,1593,OperatingIncome,18906000.0,營業利益（損失）,祺驊,生技醫療業
2024-06-30,1593,TotalNonoperatingIncomeAndExpense,11178000.0,營業外收入及支出,祺驊,生技醫療業
2024-06-30,1593,OtherComprehensiveIncome,2611000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2024-06-30,1593,NoncontrollingInterests,7407000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2024-06-30,1593,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,7407000.0,綜合損益總額歸屬於非控制權益,祺驊,生技醫療業
2024-06-30,1593,GrossProfit,82773000.0,營業毛利（毛損）,祺驊,生技醫療業
2024-06-30,1593,EquityAttributableToOwnersOfParent,16928000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2024-09-30,1593,PreTaxIncome,40304000.0,稅前淨利（淨損）,祺驊,生技醫療業
2024-09-30,1593,TAX,8369000.0,所得稅費用（利益）,祺驊,生技醫療業
2024-09-30,1593,IncomeFromContinuingOperations,31935000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2024-09-30,1593,IncomeAfterTaxes,31935000.0,本期淨利（淨損）,祺驊,生技醫療業
2024-09-30,1593,TotalConsolidatedProfitForThePeriod,25038000.0,本期綜合損益總額,祺驊,生技醫療業
2024-09-30,1593,Revenue,290435000.0,營業收入,祺驊,生技醫療業
2024-09-30,1593,CostOfGoodsSold,191378000.0,營業成本,祺驊,生技醫療業
2024-09-30,1593,OperatingExpenses,64156000.0,營業費用,祺驊,生技醫療業
2024-09-30,1593,OperatingIncome,34901000.0,營業利益（損失）,祺驊,生技醫療業
2024-09-30,1593,TotalNonoperatingIncomeAndExpense,5403000.0,營業外收入及支出,祺驊,生技醫療業
2024-09-30,1593,OtherComprehensiveIncome,-6897000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2024-09-30,1593,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,8904000.0,綜合損益總額歸屬於非控制權益,祺驊,生技醫療業
2024-09-30,1593,NoncontrollingInterests,8904000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2024-09-30,1593,EquityAttributableToOwnersOfParent,23031000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2024-09-30,1593,GrossProfit,99057000.0,營業毛利（毛損）,祺驊,生技醫療業
2024-09-30,1593,EPS,0.58,基本每股盈餘（元）,祺驊,生技醫療業
2024-12-31,1593,PreTaxIncome,47754000.0,稅前淨利（淨損）,祺驊,生技醫療業
2024-12-31,1593,TAX,12959000.0,所得稅費用（利益）,祺驊,生技醫療業
2024-12-31,1593,IncomeFromContinuingOperations,34795000.0,繼續營業單位本期淨利（淨損）,祺驊,生技醫療業
2024-12-31,1593,IncomeAfterTaxes,34795000.0,本期淨利（淨損）,祺驊,生技醫療業
2024-12-31,1593,TotalConsolidatedProfitForThePeriod,40358000.0,本期綜合損益總額,祺驊,生技醫療業
2024-12-31,1593,EPS,0.69,基本每股盈餘（元）,祺驊,生技醫療業
2024-12-31,1593,Revenue,323268000.0,營業收入,祺驊,生技醫療業
2024-12-31,1593,CostOfGoodsSold,221258000.0,營業成本,祺驊,生技醫療業
2024-12-31,1593,OperatingExpenses,65247000.0,營業費用,祺驊,生技醫療業
2024-12-31,1593,OperatingIncome,36763000.0,營業利益（損失）,祺驊,生技醫療業
2024-12-31,1593,TotalNonoperatingIncomeAndExpense,10991000.0,營業外收入及支出,祺驊,生技醫療業
2024-12-31,1593,OtherComprehensiveIncome,5563000.0,其他綜合損益（淨額）,祺驊,生技醫療業
2024-12-31,1593,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,7252000.0,綜合損益總額歸屬於非控制權益,祺驊,生技醫療業
2024-12-31,1593,NoncontrollingInterests,7252000.0,淨利（淨損）歸屬於非控制權益,祺驊,生技醫療業
2024-12-31,1593,EquityAttributableToOwnersOfParent,27543000.0,淨利（淨損）歸屬於母公司業主,祺驊,生技醫療業
2024-12-31,1593,GrossProfit,102010000.0,營業毛利（毛損）,祺驊,生技醫療業
2019-03-31,1593,AccountsPayable,92943000.0,應付帳款,祺驊,生技醫療業
2019-03-31,1593,AccountsPayable_per,8.42,應付帳款,祺驊,生技醫療業
2019-03-31,1593,AccountsPayableToRelatedParties,9691000.0,應付帳款－關係人,祺驊,生技醫療業
2019-03-31,1593,AccountsPayableToRelatedParties_per,0.88,應付帳款－關係人,祺驊,生技醫療業
2019-03-31,1593,AccountsReceivableDuefromRelatedPartiesNet,8000.0,應收帳款－關係人淨額,祺驊,生技醫療業
2019-03-31,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2019-03-31,1593,AccountsReceivableNet,154207000.0,應收帳款淨額,祺驊,生技醫療業
2019-03-31,1593,AccountsReceivableNet_per,13.96,應收帳款淨額,祺驊,生技醫療業
2019-03-31,1593,CapitalStock,319484000.0,股本合計,祺驊,生技醫療業
2019-03-31,1593,CapitalStock_per,28.93,股本合計,祺驊,生技醫療業
2019-03-31,1593,CapitalSurplus,285787000.0,資本公積合計,祺驊,生技醫療業
2019-03-31,1593,CapitalSurplus_per,25.88,資本公積合計,祺驊,生技醫療業
2019-03-31,1593,CashAndCashEquivalents,187179000.0,現金及約當現金,祺驊,生技醫療業
2019-03-31,1593,CashAndCashEquivalents_per,16.95,現金及約當現金,祺驊,生技醫療業
2019-03-31,1593,CurrentAssets,735139000.0,流動資產合計,祺驊,生技醫療業
2019-03-31,1593,CurrentAssets_per,66.56,流動資產合計,祺驊,生技醫療業
2019-03-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,37898000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2019-03-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,3.43,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2019-03-31,1593,CurrentLiabilities,170214000.0,流動負債合計,祺驊,生技醫療業
2019-03-31,1593,CurrentLiabilities_per,15.41,流動負債合計,祺驊,生技醫療業
2019-03-31,1593,DeferredTaxAssets,9323000.0,遞延所得稅資產,祺驊,生技醫療業
2019-03-31,1593,DeferredTaxAssets_per,0.84,遞延所得稅資產,祺驊,生技醫療業
2019-03-31,1593,EquityAttributableToOwnersOfParent,918301000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2019-03-31,1593,EquityAttributableToOwnersOfParent_per,83.15,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2019-03-31,1593,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,0.0,預收股款（權益項下）之約當發行股數,祺驊,生技醫療業
2019-03-31,1593,IntangibleAssets,3930000.0,無形資產,祺驊,生技醫療業
2019-03-31,1593,IntangibleAssets_per,0.36,無形資產,祺驊,生技醫療業
2019-03-31,1593,Inventories,153917000.0,存貨,祺驊,生技醫療業
2019-03-31,1593,Inventories_per,13.94,存貨,祺驊,生技醫療業
2019-03-31,1593,LegalReserve,90340000.0,法定盈餘公積,祺驊,生技醫療業
2019-03-31,1593,LegalReserve_per,8.18,法定盈餘公積,祺驊,生技醫療業
2019-03-31,1593,LongtermBorrowings,0.0,長期借款,祺驊,生技醫療業
2019-03-31,1593,LongtermBorrowings_per,0.0,長期借款,祺驊,生技醫療業
2019-03-31,1593,NoncontrollingInterests,6520000.0,非控制權益,祺驊,生技醫療業
2019-03-31,1593,NoncontrollingInterests_per,0.59,非控制權益,祺驊,生技醫療業
2019-03-31,1593,NoncurrentAssets,369310000.0,非流動資產合計,祺驊,生技醫療業
2019-03-31,1593,NoncurrentAssets_per,33.44,非流動資產合計,祺驊,生技醫療業
2019-03-31,1593,NoncurrentLiabilities,9414000.0,非流動負債合計,祺驊,生技醫療業
2019-03-31,1593,NoncurrentLiabilities_per,0.85,非流動負債合計,祺驊,生技醫療業
2019-03-31,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2019-03-31,1593,OrdinaryShare,319484000.0,普通股股本,祺驊,生技醫療業
2019-03-31,1593,OrdinaryShare_per,28.93,普通股股本,祺驊,生技醫療業
2019-03-31,1593,OtherCurrentAssets,14973000.0,其他流動資產,祺驊,生技醫療業
2019-03-31,1593,OtherCurrentAssets_per,1.36,其他流動資產,祺驊,生技醫療業
2019-03-31,1593,OtherCurrentLiabilities,14965000.0,其他流動負債,祺驊,生技醫療業
2019-03-31,1593,OtherCurrentLiabilities_per,1.35,其他流動負債,祺驊,生技醫療業
2019-03-31,1593,OtherNoncurrentAssets,3398000.0,其他非流動資產,祺驊,生技醫療業
2019-03-31,1593,OtherNoncurrentAssets_per,0.31,其他非流動資產,祺驊,生技醫療業
2019-03-31,1593,OtherNoncurrentLiabilities,6887000.0,其他非流動負債,祺驊,生技醫療業
2019-03-31,1593,OtherNoncurrentLiabilities_per,0.62,其他非流動負債,祺驊,生技醫療業
2019-03-31,1593,OtherPayables,35789000.0,其他應付款,祺驊,生技醫療業
2019-03-31,1593,OtherPayables_per,3.24,其他應付款,祺驊,生技醫療業
2019-03-31,1593,PropertyPlantAndEquipment,233793000.0,不動產、廠房及設備,祺驊,生技醫療業
2019-03-31,1593,PropertyPlantAndEquipment_per,21.17,不動產、廠房及設備,祺驊,生技醫療業
2019-03-31,1593,RetainedEarnings,331520000.0,保留盈餘合計,祺驊,生技醫療業
2019-03-31,1593,RetainedEarnings_per,30.02,保留盈餘合計,祺驊,生技醫療業
2019-03-31,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2019-03-31,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2019-03-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,202216000.0,未分配盈餘,祺驊,生技醫療業
2019-03-31,1593,FinancialAssetsAtAmortizedCost,186957000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2019-03-31,1593,FinancialAssetsAtAmortizedCost_per,16.93,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2019-03-31,1593,TotalAssets,1104449000.0,資產總額,祺驊,生技醫療業
2019-03-31,1593,TotalLiabilitiesEquity,1104449000.0,負債及權益總計,祺驊,生技醫療業
2019-03-31,1593,Prepayments,0.0,預付款項,祺驊,生技醫療業
2019-03-31,1593,Prepayments_per,0.0,預付款項,祺驊,生技醫療業
2019-03-31,1593,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,11442000.0,透過損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2019-03-31,1593,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.04,透過損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2019-03-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,22003000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2019-03-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,1.99,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2019-03-31,1593,InvestmentAccountedForUsingEquityMethod,53834000.0,採用權益法之投資,祺驊,生技醫療業
2019-03-31,1593,InvestmentAccountedForUsingEquityMethod_per,4.87,採用權益法之投資,祺驊,生技醫療業
2019-03-31,1593,RightOfUseAsset,23800000.0,使用權資產,祺驊,生技醫療業
2019-03-31,1593,RightOfUseAsset_per,2.15,使用權資產,祺驊,生技醫療業
2019-03-31,1593,CurrentTaxLiabilities,13449000.0,本期所得稅負債,祺驊,生技醫療業
2019-03-31,1593,CurrentTaxLiabilities_per,1.22,本期所得稅負債,祺驊,生技醫療業
2019-03-31,1593,Liabilities,179628000.0,負債總,祺驊,生技醫療業
2019-03-31,1593,Liabilities_per,16.26,負債總額,祺驊,生技醫療業
2019-03-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,18.31,未分配盈餘,祺驊,生技醫療業
2019-03-31,1593,OtherEquityInterest,-18490000.0,其他權益合計,祺驊,生技醫療業
2019-03-31,1593,OtherEquityInterest_per,-1.67,其他權益合計,祺驊,生技醫療業
2019-03-31,1593,Equity,1104449000.0,權益總計,祺驊,生技醫療業
2019-03-31,1593,Equity_per,100.0,權益總計,祺驊,生技醫療業
2019-06-30,1593,AccountsPayable,87689000.0,應付帳款,祺驊,生技醫療業
2019-06-30,1593,AccountsPayable_per,7.92,應付帳款,祺驊,生技醫療業
2019-06-30,1593,AccountsPayableToRelatedParties,9400000.0,應付帳款－關係人,祺驊,生技醫療業
2019-06-30,1593,AccountsPayableToRelatedParties_per,0.85,應付帳款－關係人,祺驊,生技醫療業
2019-06-30,1593,AccountsReceivableDuefromRelatedPartiesNet,29000.0,應收帳款－關係人淨額,祺驊,生技醫療業
2019-06-30,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2019-06-30,1593,AccountsReceivableNet,164244000.0,應收帳款淨額,祺驊,生技醫療業
2019-06-30,1593,AccountsReceivableNet_per,14.83,應收帳款淨額,祺驊,生技醫療業
2019-06-30,1593,CapitalStock,319484000.0,股本合計,祺驊,生技醫療業
2019-06-30,1593,CapitalStock_per,28.85,股本合計,祺驊,生技醫療業
2019-06-30,1593,CapitalSurplus,285787000.0,資本公積合計,祺驊,生技醫療業
2019-06-30,1593,CapitalSurplus_per,25.81,資本公積合計,祺驊,生技醫療業
2019-06-30,1593,CashAndCashEquivalents,264100000.0,現金及約當現金,祺驊,生技醫療業
2019-06-30,1593,CashAndCashEquivalents_per,23.85,現金及約當現金,祺驊,生技醫療業
2019-06-30,1593,CurrentAssets,753646000.0,流動資產合計,祺驊,生技醫療業
2019-06-30,1593,CurrentAssets_per,68.05,流動資產合計,祺驊,生技醫療業
2019-06-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,37771000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2019-06-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,3.41,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2019-06-30,1593,CurrentLiabilities,277338000.0,流動負債合計,祺驊,生技醫療業
2019-06-30,1593,CurrentLiabilities_per,25.04,流動負債合計,祺驊,生技醫療業
2019-06-30,1593,DeferredTaxAssets,9382000.0,遞延所得稅資產,祺驊,生技醫療業
2019-06-30,1593,DeferredTaxAssets_per,0.85,遞延所得稅資產,祺驊,生技醫療業
2019-06-30,1593,EquityAttributableToOwnersOfParent,814974000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2019-06-30,1593,EquityAttributableToOwnersOfParent_per,73.59,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2019-06-30,1593,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,0.0,預收股款（權益項下）之約當發行股數,祺驊,生技醫療業
2019-06-30,1593,IntangibleAssets,3953000.0,無形資產,祺驊,生技醫療業
2019-06-30,1593,IntangibleAssets_per,0.36,無形資產,祺驊,生技醫療業
2019-06-30,1593,Inventories,135356000.0,存貨,祺驊,生技醫療業
2019-06-30,1593,Inventories_per,12.22,存貨,祺驊,生技醫療業
2019-06-30,1593,LegalReserve,102369000.0,法定盈餘公積,祺驊,生技醫療業
2019-06-30,1593,LegalReserve_per,9.24,法定盈餘公積,祺驊,生技醫療業
2019-06-30,1593,LongtermBorrowings,0.0,長期借款,祺驊,生技醫療業
2019-06-30,1593,LongtermBorrowings_per,0.0,長期借款,祺驊,生技醫療業
2019-06-30,1593,NoncontrollingInterests,6793000.0,非控制權益,祺驊,生技醫療業
2019-06-30,1593,NoncontrollingInterests_per,0.61,非控制權益,祺驊,生技醫療業
2019-06-30,1593,NoncurrentAssets,353765000.0,非流動資產合計,祺驊,生技醫療業
2019-06-30,1593,NoncurrentAssets_per,31.95,非流動資產合計,祺驊,生技醫療業
2019-06-30,1593,NoncurrentLiabilities,8306000.0,非流動負債合計,祺驊,生技醫療業
2019-06-30,1593,NoncurrentLiabilities_per,0.75,非流動負債合計,祺驊,生技醫療業
2019-06-30,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2019-06-30,1593,OrdinaryShare,319484000.0,普通股股本,祺驊,生技醫療業
2019-06-30,1593,OrdinaryShare_per,28.85,普通股股本,祺驊,生技醫療業
2019-06-30,1593,OtherCurrentAssets,18887000.0,其他流動資產,祺驊,生技醫療業
2019-06-30,1593,OtherCurrentAssets_per,1.71,其他流動資產,祺驊,生技醫療業
2019-06-30,1593,OtherCurrentLiabilities,10021000.0,其他流動負債,祺驊,生技醫療業
2019-06-30,1593,OtherCurrentLiabilities_per,0.9,其他流動負債,祺驊,生技醫療業
2019-06-30,1593,OtherNoncurrentAssets,8171000.0,其他非流動資產,祺驊,生技醫療業
2019-06-30,1593,OtherNoncurrentAssets_per,0.74,其他非流動資產,祺驊,生技醫療業
2019-06-30,1593,OtherNoncurrentLiabilities,6609000.0,其他非流動負債,祺驊,生技醫療業
2019-06-30,1593,OtherNoncurrentLiabilities_per,0.6,其他非流動負債,祺驊,生技醫療業
2019-06-30,1593,OtherPayables,158671000.0,其他應付款,祺驊,生技醫療業
2019-06-30,1593,OtherPayables_per,14.33,其他應付款,祺驊,生技醫療業
2019-06-30,1593,PropertyPlantAndEquipment,231761000.0,不動產、廠房及設備,祺驊,生技醫療業
2019-06-30,1593,PropertyPlantAndEquipment_per,20.93,不動產、廠房及設備,祺驊,生技醫療業
2019-06-30,1593,RetainedEarnings,228378000.0,保留盈餘合計,祺驊,生技醫療業
2019-06-30,1593,RetainedEarnings_per,20.62,保留盈餘合計,祺驊,生技醫療業
2019-06-30,1593,ShorttermBorrowings,0.0,短期借款,祺驊,生技醫療業
2019-06-30,1593,ShorttermBorrowings_per,0.0,短期借款,祺驊,生技醫療業
2019-06-30,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2019-06-30,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2019-06-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,107349000.0,未分配盈餘,祺驊,生技醫療業
2019-06-30,1593,FinancialAssetsAtAmortizedCost,133259000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2019-06-30,1593,FinancialAssetsAtAmortizedCost_per,12.03,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2019-06-30,1593,TotalAssets,1107411000.0,資產總額,祺驊,生技醫療業
2019-06-30,1593,TotalLiabilitiesEquity,1107411000.0,負債及權益總計,祺驊,生技醫療業
2019-06-30,1593,Prepayments,0.0,預付款項,祺驊,生技醫療業
2019-06-30,1593,Prepayments_per,0.0,預付款項,祺驊,生技醫療業
2019-06-30,1593,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,4518000.0,透過損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2019-06-30,1593,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.41,透過損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2019-06-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,21286000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2019-06-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,1.92,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2019-06-30,1593,InvestmentAccountedForUsingEquityMethod,44026000.0,採用權益法之投資,祺驊,生技醫療業
2019-06-30,1593,InvestmentAccountedForUsingEquityMethod_per,3.98,採用權益法之投資,祺驊,生技醫療業
2019-06-30,1593,RightOfUseAsset,22896000.0,使用權資產,祺驊,生技醫療業
2019-06-30,1593,RightOfUseAsset_per,2.07,使用權資產,祺驊,生技醫療業
2019-06-30,1593,CurrentTaxLiabilities,8228000.0,本期所得稅負債,祺驊,生技醫療業
2019-06-30,1593,CurrentTaxLiabilities_per,0.74,本期所得稅負債,祺驊,生技醫療業
2019-06-30,1593,Liabilities,285644000.0,負債總,祺驊,生技醫療業
2019-06-30,1593,Liabilities_per,25.79,負債總額,祺驊,生技醫療業
2019-06-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,9.69,未分配盈餘,祺驊,生技醫療業
2019-06-30,1593,OtherEquityInterest,-18675000.0,其他權益合計,祺驊,生技醫療業
2019-06-30,1593,OtherEquityInterest_per,-1.69,其他權益合計,祺驊,生技醫療業
2019-06-30,1593,Equity,1107411000.0,權益總計,祺驊,生技醫療業
2019-06-30,1593,Equity_per,100.0,權益總計,祺驊,生技醫療業
2019-09-30,1593,AccountsPayable,93350000.0,應付帳款,祺驊,生技醫療業
2019-09-30,1593,AccountsPayable_per,9.08,應付帳款,祺驊,生技醫療業
2019-09-30,1593,AccountsPayableToRelatedParties,10913000.0,應付帳款－關係人,祺驊,生技醫療業
2019-09-30,1593,AccountsPayableToRelatedParties_per,1.06,應付帳款－關係人,祺驊,生技醫療業
2019-09-30,1593,AccountsReceivableDuefromRelatedPartiesNet,9000.0,應收帳款－關係人淨額,祺驊,生技醫療業
2019-09-30,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2019-09-30,1593,AccountsReceivableNet,188118000.0,應收帳款淨額,祺驊,生技醫療業
2019-09-30,1593,AccountsReceivableNet_per,18.29,應收帳款淨額,祺驊,生技醫療業
2019-09-30,1593,CapitalStock,319484000.0,股本合計,祺驊,生技醫療業
2019-09-30,1593,CapitalStock_per,31.06,股本合計,祺驊,生技醫療業
2019-09-30,1593,CapitalSurplus,285787000.0,資本公積合計,祺驊,生技醫療業
2019-09-30,1593,CapitalSurplus_per,27.78,資本公積合計,祺驊,生技醫療業
2019-09-30,1593,CashAndCashEquivalents,154598000.0,現金及約當現金,祺驊,生技醫療業
2019-09-30,1593,CashAndCashEquivalents_per,15.03,現金及約當現金,祺驊,生技醫療業
2019-09-30,1593,CurrentAssets,670490000.0,流動資產合計,祺驊,生技醫療業
2019-09-30,1593,CurrentAssets_per,65.18,流動資產合計,祺驊,生技醫療業
2019-09-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,45817000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2019-09-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,4.45,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2019-09-30,1593,CurrentLiabilities,165377000.0,流動負債合計,祺驊,生技醫療業
2019-09-30,1593,CurrentLiabilities_per,16.08,流動負債合計,祺驊,生技醫療業
2019-09-30,1593,DeferredTaxAssets,8492000.0,遞延所得稅資產,祺驊,生技醫療業
2019-09-30,1593,DeferredTaxAssets_per,0.83,遞延所得稅資產,祺驊,生技醫療業
2019-09-30,1593,EquityAttributableToOwnersOfParent,849064000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2019-09-30,1593,EquityAttributableToOwnersOfParent_per,82.55,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2019-09-30,1593,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,0.0,預收股款（權益項下）之約當發行股數,祺驊,生技醫療業
2019-09-30,1593,IntangibleAssets,3951000.0,無形資產,祺驊,生技醫療業
2019-09-30,1593,IntangibleAssets_per,0.38,無形資產,祺驊,生技醫療業
2019-09-30,1593,Inventories,130894000.0,存貨,祺驊,生技醫療業
2019-09-30,1593,Inventories_per,12.73,存貨,祺驊,生技醫療業
2019-09-30,1593,LegalReserve,102369000.0,法定盈餘公積,祺驊,生技醫療業
2019-09-30,1593,LegalReserve_per,9.95,法定盈餘公積,祺驊,生技醫療業
2019-09-30,1593,LongtermBorrowings,0.0,長期借款,祺驊,生技醫療業
2019-09-30,1593,LongtermBorrowings_per,0.0,長期借款,祺驊,生技醫療業
2019-09-30,1593,NoncontrollingInterests,7004000.0,非控制權益,祺驊,生技醫療業
2019-09-30,1593,NoncontrollingInterests_per,0.68,非控制權益,祺驊,生技醫療業
2019-09-30,1593,NoncurrentAssets,358109000.0,非流動資產合計,祺驊,生技醫療業
2019-09-30,1593,NoncurrentAssets_per,34.82,非流動資產合計,祺驊,生技醫療業
2019-09-30,1593,NoncurrentLiabilities,7154000.0,非流動負債合計,祺驊,生技醫療業
2019-09-30,1593,NoncurrentLiabilities_per,0.7,非流動負債合計,祺驊,生技醫療業
2019-09-30,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2019-09-30,1593,OrdinaryShare,319484000.0,普通股股本,祺驊,生技醫療業
2019-09-30,1593,OrdinaryShare_per,31.06,普通股股本,祺驊,生技醫療業
2019-09-30,1593,OtherCurrentAssets,15516000.0,其他流動資產,祺驊,生技醫療業
2019-09-30,1593,OtherCurrentAssets_per,1.51,其他流動資產,祺驊,生技醫療業
2019-09-30,1593,OtherCurrentLiabilities,15007000.0,其他流動負債,祺驊,生技醫療業
2019-09-30,1593,OtherCurrentLiabilities_per,1.46,其他流動負債,祺驊,生技醫療業
2019-09-30,1593,OtherNoncurrentAssets,7781000.0,其他非流動資產,祺驊,生技醫療業
2019-09-30,1593,OtherNoncurrentAssets_per,0.76,其他非流動資產,祺驊,生技醫療業
2019-09-30,1593,OtherNoncurrentLiabilities,6319000.0,其他非流動負債,祺驊,生技醫療業
2019-09-30,1593,OtherNoncurrentLiabilities_per,0.61,其他非流動負債,祺驊,生技醫療業
2019-09-30,1593,OtherPayables,38528000.0,其他應付款,祺驊,生技醫療業
2019-09-30,1593,OtherPayables_per,3.75,其他應付款,祺驊,生技醫療業
2019-09-30,1593,PropertyPlantAndEquipment,237455000.0,不動產、廠房及設備,祺驊,生技醫療業
2019-09-30,1593,PropertyPlantAndEquipment_per,23.09,不動產、廠房及設備,祺驊,生技醫療業
2019-09-30,1593,RetainedEarnings,264604000.0,保留盈餘合計,祺驊,生技醫療業
2019-09-30,1593,RetainedEarnings_per,25.72,保留盈餘合計,祺驊,生技醫療業
2019-09-30,1593,ShorttermBorrowings,0.0,短期借款,祺驊,生技醫療業
2019-09-30,1593,ShorttermBorrowings_per,0.0,短期借款,祺驊,生技醫療業
2019-09-30,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2019-09-30,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2019-09-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,143575000.0,未分配盈餘,祺驊,生技醫療業
2019-09-30,1593,FinancialAssetsAtAmortizedCost,135538000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2019-09-30,1593,FinancialAssetsAtAmortizedCost_per,13.18,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2019-09-30,1593,Prepayments,0.0,預付款項,祺驊,生技醫療業
2019-09-30,1593,Prepayments_per,0.0,預付款項,祺驊,生技醫療業
2019-09-30,1593,TotalAssets,1028599000.0,資產總額,祺驊,生技醫療業
2019-09-30,1593,TotalLiabilitiesEquity,1028599000.0,負債及權益總計,祺驊,生技醫療業
2019-09-30,1593,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2019-09-30,1593,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2019-09-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,22500000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2019-09-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,2.19,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2019-09-30,1593,InvestmentAccountedForUsingEquityMethod,48373000.0,採用權益法之投資,祺驊,生技醫療業
2019-09-30,1593,InvestmentAccountedForUsingEquityMethod_per,4.7,採用權益法之投資,祺驊,生技醫療業
2019-09-30,1593,RightOfUseAsset,21799000.0,使用權資產,祺驊,生技醫療業
2019-09-30,1593,RightOfUseAsset_per,2.12,使用權資產,祺驊,生技醫療業
2019-09-30,1593,CurrentTaxLiabilities,4350000.0,本期所得稅負債,祺驊,生技醫療業
2019-09-30,1593,CurrentTaxLiabilities_per,0.42,本期所得稅負債,祺驊,生技醫療業
2019-09-30,1593,Liabilities,172531000.0,負債總,祺驊,生技醫療業
2019-09-30,1593,Liabilities_per,16.77,負債總額,祺驊,生技醫療業
2019-09-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,13.96,未分配盈餘,祺驊,生技醫療業
2019-09-30,1593,OtherEquityInterest,-20811000.0,其他權益合計,祺驊,生技醫療業
2019-09-30,1593,OtherEquityInterest_per,-2.02,其他權益合計,祺驊,生技醫療業
2019-09-30,1593,Equity,1028599000.0,權益總計,祺驊,生技醫療業
2019-09-30,1593,Equity_per,100.0,權益總計,祺驊,生技醫療業
2019-12-31,1593,AccountsPayable,86682000.0,應付帳款,祺驊,生技醫療業
2019-12-31,1593,AccountsPayable_per,8.23,應付帳款,祺驊,生技醫療業
2019-12-31,1593,AccountsPayableToRelatedParties,10243000.0,應付帳款－關係人,祺驊,生技醫療業
2019-12-31,1593,AccountsPayableToRelatedParties_per,0.97,應付帳款－關係人,祺驊,生技醫療業
2019-12-31,1593,AccountsReceivableDuefromRelatedPartiesNet,4000.0,應收帳款－關係人淨額,祺驊,生技醫療業
2019-12-31,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2019-12-31,1593,AccountsReceivableNet,185711000.0,應收帳款淨額,祺驊,生技醫療業
2019-12-31,1593,AccountsReceivableNet_per,17.63,應收帳款淨額,祺驊,生技醫療業
2019-12-31,1593,CapitalStock,319484000.0,股本合計,祺驊,生技醫療業
2019-12-31,1593,CapitalStock_per,30.33,股本合計,祺驊,生技醫療業
2019-12-31,1593,CapitalSurplus,285787000.0,資本公積合計,祺驊,生技醫療業
2019-12-31,1593,CapitalSurplus_per,27.13,資本公積合計,祺驊,生技醫療業
2019-12-31,1593,CashAndCashEquivalents,182615000.0,現金及約當現金,祺驊,生技醫療業
2019-12-31,1593,CashAndCashEquivalents_per,17.34,現金及約當現金,祺驊,生技醫療業
2019-12-31,1593,CurrentAssets,698418000.0,流動資產合計,祺驊,生技醫療業
2019-12-31,1593,CurrentAssets_per,66.3,流動資產合計,祺驊,生技醫療業
2019-12-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,45209000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2019-12-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,4.29,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2019-12-31,1593,CurrentLiabilities,170401000.0,流動負債合計,祺驊,生技醫療業
2019-12-31,1593,CurrentLiabilities_per,16.18,流動負債合計,祺驊,生技醫療業
2019-12-31,1593,DeferredTaxAssets,8474000.0,遞延所得稅資產,祺驊,生技醫療業
2019-12-31,1593,DeferredTaxAssets_per,0.8,遞延所得稅資產,祺驊,生技醫療業
2019-12-31,1593,EquityAttributableToOwnersOfParent,869195000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2019-12-31,1593,EquityAttributableToOwnersOfParent_per,82.51,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2019-12-31,1593,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,0.0,預收股款（權益項下）之約當發行股數,祺驊,生技醫療業
2019-12-31,1593,IntangibleAssets,3847000.0,無形資產,祺驊,生技醫療業
2019-12-31,1593,IntangibleAssets_per,0.37,無形資產,祺驊,生技醫療業
2019-12-31,1593,Inventories,118427000.0,存貨,祺驊,生技醫療業
2019-12-31,1593,Inventories_per,11.24,存貨,祺驊,生技醫療業
2019-12-31,1593,LegalReserve,102369000.0,法定盈餘公積,祺驊,生技醫療業
2019-12-31,1593,LegalReserve_per,9.72,法定盈餘公積,祺驊,生技醫療業
2019-12-31,1593,LongtermBorrowings,67000.0,長期借款,祺驊,生技醫療業
2019-12-31,1593,LongtermBorrowings_per,0.01,長期借款,祺驊,生技醫療業
2019-12-31,1593,NoncontrollingInterests,7277000.0,非控制權益,祺驊,生技醫療業
2019-12-31,1593,NoncontrollingInterests_per,0.69,非控制權益,祺驊,生技醫療業
2019-12-31,1593,NoncurrentAssets,354969000.0,非流動資產合計,祺驊,生技醫療業
2019-12-31,1593,NoncurrentAssets_per,33.7,非流動資產合計,祺驊,生技醫療業
2019-12-31,1593,NoncurrentLiabilities,6514000.0,非流動負債合計,祺驊,生技醫療業
2019-12-31,1593,NoncurrentLiabilities_per,0.62,非流動負債合計,祺驊,生技醫療業
2019-12-31,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2019-12-31,1593,OrdinaryShare,319484000.0,普通股股本,祺驊,生技醫療業
2019-12-31,1593,OrdinaryShare_per,30.33,普通股股本,祺驊,生技醫療業
2019-12-31,1593,OtherCurrentAssets,13767000.0,其他流動資產,祺驊,生技醫療業
2019-12-31,1593,OtherCurrentAssets_per,1.31,其他流動資產,祺驊,生技醫療業
2019-12-31,1593,OtherCurrentLiabilities,14841000.0,其他流動負債,祺驊,生技醫療業
2019-12-31,1593,OtherCurrentLiabilities_per,1.41,其他流動負債,祺驊,生技醫療業
2019-12-31,1593,OtherNoncurrentAssets,6703000.0,其他非流動資產,祺驊,生技醫療業
2019-12-31,1593,OtherNoncurrentAssets_per,0.64,其他非流動資產,祺驊,生技醫療業
2019-12-31,1593,OtherNoncurrentLiabilities,6400000.0,其他非流動負債,祺驊,生技醫療業
2019-12-31,1593,OtherNoncurrentLiabilities_per,0.61,其他非流動負債,祺驊,生技醫療業
2019-12-31,1593,OtherPayables,45213000.0,其他應付款,祺驊,生技醫療業
2019-12-31,1593,OtherPayables_per,4.29,其他應付款,祺驊,生技醫療業
2019-12-31,1593,PropertyPlantAndEquipment,234732000.0,不動產、廠房及設備,祺驊,生技醫療業
2019-12-31,1593,PropertyPlantAndEquipment_per,22.28,不動產、廠房及設備,祺驊,生技醫療業
2019-12-31,1593,RetainedEarnings,296993000.0,保留盈餘合計,祺驊,生技醫療業
2019-12-31,1593,RetainedEarnings_per,28.19,保留盈餘合計,祺驊,生技醫療業
2019-12-31,1593,ShorttermBorrowings,0.0,短期借款,祺驊,生技醫療業
2019-12-31,1593,ShorttermBorrowings_per,0.0,短期借款,祺驊,生技醫療業
2019-12-31,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2019-12-31,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2019-12-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,175964000.0,未分配盈餘,祺驊,生技醫療業
2019-12-31,1593,TotalAssets,1053387000.0,資產總額,祺驊,生技醫療業
2019-12-31,1593,BondsPayable,0.0,應付公司債,祺驊,生技醫療業
2019-12-31,1593,BondsPayable_per,0.0,應付公司債,祺驊,生技醫療業
2019-12-31,1593,TotalLiabilitiesEquity,1053387000.0,負債及權益總計,祺驊,生技醫療業
2019-12-31,1593,FinancialAssetsAtAmortizedCost,152685000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2019-12-31,1593,FinancialAssetsAtAmortizedCost_per,14.49,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2019-12-31,1593,Prepayments,0.0,預付款項,祺驊,生技醫療業
2019-12-31,1593,Prepayments_per,0.0,預付款項,祺驊,生技醫療業
2019-12-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,21776000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2019-12-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,2.07,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2019-12-31,1593,InvestmentAccountedForUsingEquityMethod,51512000.0,採用權益法之投資,祺驊,生技醫療業
2019-12-31,1593,InvestmentAccountedForUsingEquityMethod_per,4.89,採用權益法之投資,祺驊,生技醫療業
2019-12-31,1593,RightOfUseAsset,20182000.0,使用權資產,祺驊,生技醫療業
2019-12-31,1593,RightOfUseAsset_per,1.92,使用權資產,祺驊,生技醫療業
2019-12-31,1593,CurrentTaxLiabilities,10267000.0,本期所得稅負債,祺驊,生技醫療業
2019-12-31,1593,CurrentTaxLiabilities_per,0.97,本期所得稅負債,祺驊,生技醫療業
2019-12-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,16.7,未分配盈餘,祺驊,生技醫療業
2019-12-31,1593,OtherEquityInterest,-33069000.0,其他權益合計,祺驊,生技醫療業
2019-12-31,1593,OtherEquityInterest_per,-3.14,其他權益合計,祺驊,生技醫療業
2019-12-31,1593,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2019-12-31,1593,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2019-12-31,1593,Liabilities,176915000.0,負債總,祺驊,生技醫療業
2019-12-31,1593,Liabilities_per,16.79,負債總額,祺驊,生技醫療業
2019-12-31,1593,Equity,1053387000.0,權益總計,祺驊,生技醫療業
2019-12-31,1593,Equity_per,100.0,權益總計,祺驊,生技醫療業
2020-03-31,1593,AccountsPayable,85379000.0,應付帳款,祺驊,生技醫療業
2020-03-31,1593,AccountsPayable_per,8.15,應付帳款,祺驊,生技醫療業
2020-03-31,1593,AccountsPayableToRelatedParties,9269000.0,應付帳款－關係人,祺驊,生技醫療業
2020-03-31,1593,AccountsPayableToRelatedParties_per,0.88,應付帳款－關係人,祺驊,生技醫療業
2020-03-31,1593,AccountsReceivableDuefromRelatedPartiesNet,16000.0,應收帳款－關係人淨額,祺驊,生技醫療業
2020-03-31,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2020-03-31,1593,AccountsReceivableNet,148162000.0,應收帳款淨額,祺驊,生技醫療業
2020-03-31,1593,AccountsReceivableNet_per,14.14,應收帳款淨額,祺驊,生技醫療業
2020-03-31,1593,CapitalStock,319484000.0,股本合計,祺驊,生技醫療業
2020-03-31,1593,CapitalStock_per,30.5,股本合計,祺驊,生技醫療業
2020-03-31,1593,CapitalSurplus,285787000.0,資本公積合計,祺驊,生技醫療業
2020-03-31,1593,CapitalSurplus_per,27.28,資本公積合計,祺驊,生技醫療業
2020-03-31,1593,CashAndCashEquivalents,186093000.0,現金及約當現金,祺驊,生技醫療業
2020-03-31,1593,CashAndCashEquivalents_per,17.76,現金及約當現金,祺驊,生技醫療業
2020-03-31,1593,CurrentAssets,685353000.0,流動資產合計,祺驊,生技醫療業
2020-03-31,1593,CurrentAssets_per,65.42,流動資產合計,祺驊,生技醫療業
2020-03-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,48675000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2020-03-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,4.65,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2020-03-31,1593,CurrentLiabilities,152735000.0,流動負債合計,祺驊,生技醫療業
2020-03-31,1593,CurrentLiabilities_per,14.58,流動負債合計,祺驊,生技醫療業
2020-03-31,1593,DeferredTaxAssets,8259000.0,遞延所得稅資產,祺驊,生技醫療業
2020-03-31,1593,DeferredTaxAssets_per,0.79,遞延所得稅資產,祺驊,生技醫療業
2020-03-31,1593,EquityAttributableToOwnersOfParent,881327000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2020-03-31,1593,EquityAttributableToOwnersOfParent_per,84.12,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2020-03-31,1593,IntangibleAssets,3871000.0,無形資產,祺驊,生技醫療業
2020-03-31,1593,IntangibleAssets_per,0.37,無形資產,祺驊,生技醫療業
2020-03-31,1593,Inventories,125722000.0,存貨,祺驊,生技醫療業
2020-03-31,1593,Inventories_per,12.0,存貨,祺驊,生技醫療業
2020-03-31,1593,LegalReserve,102369000.0,法定盈餘公積,祺驊,生技醫療業
2020-03-31,1593,LegalReserve_per,9.77,法定盈餘公積,祺驊,生技醫療業
2020-03-31,1593,LongtermBorrowings,0.0,長期借款,祺驊,生技醫療業
2020-03-31,1593,LongtermBorrowings_per,0.0,長期借款,祺驊,生技醫療業
2020-03-31,1593,NoncontrollingInterests,7423000.0,非控制權益,祺驊,生技醫療業
2020-03-31,1593,NoncontrollingInterests_per,0.71,非控制權益,祺驊,生技醫療業
2020-03-31,1593,NoncurrentAssets,362289000.0,非流動資產合計,祺驊,生技醫療業
2020-03-31,1593,NoncurrentAssets_per,34.58,非流動資產合計,祺驊,生技醫療業
2020-03-31,1593,NoncurrentLiabilities,6157000.0,非流動負債合計,祺驊,生技醫療業
2020-03-31,1593,NoncurrentLiabilities_per,0.59,非流動負債合計,祺驊,生技醫療業
2020-03-31,1593,OrdinaryShare,319484000.0,普通股股本,祺驊,生技醫療業
2020-03-31,1593,OrdinaryShare_per,30.5,普通股股本,祺驊,生技醫療業
2020-03-31,1593,OtherCurrentAssets,20270000.0,其他流動資產,祺驊,生技醫療業
2020-03-31,1593,OtherCurrentAssets_per,1.93,其他流動資產,祺驊,生技醫療業
2020-03-31,1593,OtherCurrentLiabilities,12625000.0,其他流動負債,祺驊,生技醫療業
2020-03-31,1593,OtherCurrentLiabilities_per,1.21,其他流動負債,祺驊,生技醫療業
2020-03-31,1593,OtherNoncurrentAssets,5691000.0,其他非流動資產,祺驊,生技醫療業
2020-03-31,1593,OtherNoncurrentAssets_per,0.54,其他非流動資產,祺驊,生技醫療業
2020-03-31,1593,OtherNoncurrentLiabilities,6079000.0,其他非流動負債,祺驊,生技醫療業
2020-03-31,1593,OtherNoncurrentLiabilities_per,0.58,其他非流動負債,祺驊,生技醫療業
2020-03-31,1593,OtherPayables,31948000.0,其他應付款,祺驊,生技醫療業
2020-03-31,1593,OtherPayables_per,3.05,其他應付款,祺驊,生技醫療業
2020-03-31,1593,PropertyPlantAndEquipment,230664000.0,不動產、廠房及設備,祺驊,生技醫療業
2020-03-31,1593,PropertyPlantAndEquipment_per,22.02,不動產、廠房及設備,祺驊,生技醫療業
2020-03-31,1593,RetainedEarnings,316996000.0,保留盈餘合計,祺驊,生技醫療業
2020-03-31,1593,RetainedEarnings_per,30.26,保留盈餘合計,祺驊,生技醫療業
2020-03-31,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2020-03-31,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2020-03-31,1593,TotalAssets,1047642000.0,資產總額,祺驊,生技醫療業
2020-03-31,1593,BondsPayable,0.0,應付公司債,祺驊,生技醫療業
2020-03-31,1593,BondsPayable_per,0.0,應付公司債,祺驊,生技醫療業
2020-03-31,1593,TotalLiabilitiesEquity,1047642000.0,負債及權益總計,祺驊,生技醫療業
2020-03-31,1593,FinancialAssetsAtAmortizedCost,156415000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2020-03-31,1593,FinancialAssetsAtAmortizedCost_per,14.93,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2020-03-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,18722000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2020-03-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,1.79,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2020-03-31,1593,InvestmentAccountedForUsingEquityMethod,68360000.0,採用權益法之投資,祺驊,生技醫療業
2020-03-31,1593,InvestmentAccountedForUsingEquityMethod_per,6.53,採用權益法之投資,祺驊,生技醫療業
2020-03-31,1593,RightOfUseAsset,18993000.0,使用權資產,祺驊,生技醫療業
2020-03-31,1593,RightOfUseAsset_per,1.81,使用權資產,祺驊,生技醫療業
2020-03-31,1593,CurrentTaxLiabilities,11174000.0,本期所得稅負債,祺驊,生技醫療業
2020-03-31,1593,CurrentTaxLiabilities_per,1.07,本期所得稅負債,祺驊,生技醫療業
2020-03-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,195967000.0,未分配盈餘,祺驊,生技醫療業
2020-03-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,18.71,未分配盈餘,祺驊,生技醫療業
2020-03-31,1593,OtherEquityInterest,-40940000.0,其他權益合計,祺驊,生技醫療業
2020-03-31,1593,OtherEquityInterest_per,-3.91,其他權益合計,祺驊,生技醫療業
2020-03-31,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2020-03-31,1593,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2020-03-31,1593,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2020-03-31,1593,Equity,888750000.0,權益總額,祺驊,生技醫療業
2020-03-31,1593,Equity_per,84.83,權益總額,祺驊,生技醫療業
2020-03-31,1593,Liabilities,158892000.0,負債總額,祺驊,生技醫療業
2020-03-31,1593,Liabilities_per,15.17,負債總額,祺驊,生技醫療業
2020-06-30,1593,AccountsPayable,102967000.0,應付帳款,祺驊,生技醫療業
2020-06-30,1593,AccountsPayable_per,9.1,應付帳款,祺驊,生技醫療業
2020-06-30,1593,AccountsPayableToRelatedParties,10479000.0,應付帳款－關係人,祺驊,生技醫療業
2020-06-30,1593,AccountsPayableToRelatedParties_per,0.93,應付帳款－關係人,祺驊,生技醫療業
2020-06-30,1593,AccountsReceivableDuefromRelatedPartiesNet,33000.0,應收帳款－關係人淨額,祺驊,生技醫療業
2020-06-30,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2020-06-30,1593,AccountsReceivableNet,168190000.0,應收帳款淨額,祺驊,生技醫療業
2020-06-30,1593,AccountsReceivableNet_per,14.86,應收帳款淨額,祺驊,生技醫療業
2020-06-30,1593,CapitalStock,319484000.0,股本合計,祺驊,生技醫療業
2020-06-30,1593,CapitalStock_per,28.23,股本合計,祺驊,生技醫療業
2020-06-30,1593,CapitalSurplus,285787000.0,資本公積合計,祺驊,生技醫療業
2020-06-30,1593,CapitalSurplus_per,25.26,資本公積合計,祺驊,生技醫療業
2020-06-30,1593,CashAndCashEquivalents,247181000.0,現金及約當現金,祺驊,生技醫療業
2020-06-30,1593,CashAndCashEquivalents_per,21.84,現金及約當現金,祺驊,生技醫療業
2020-06-30,1593,CurrentAssets,785443000.0,流動資產合計,祺驊,生技醫療業
2020-06-30,1593,CurrentAssets_per,69.41,流動資產合計,祺驊,生技醫療業
2020-06-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,57172000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2020-06-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,5.05,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2020-06-30,1593,CurrentLiabilities,313184000.0,流動負債合計,祺驊,生技醫療業
2020-06-30,1593,CurrentLiabilities_per,27.68,流動負債合計,祺驊,生技醫療業
2020-06-30,1593,DeferredTaxAssets,7272000.0,遞延所得稅資產,祺驊,生技醫療業
2020-06-30,1593,DeferredTaxAssets_per,0.64,遞延所得稅資產,祺驊,生技醫療業
2020-06-30,1593,EquityAttributableToOwnersOfParent,805629000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2020-06-30,1593,EquityAttributableToOwnersOfParent_per,71.2,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2020-06-30,1593,IntangibleAssets,3813000.0,無形資產,祺驊,生技醫療業
2020-06-30,1593,IntangibleAssets_per,0.34,無形資產,祺驊,生技醫療業
2020-06-30,1593,Inventories,139835000.0,存貨,祺驊,生技醫療業
2020-06-30,1593,Inventories_per,12.36,存貨,祺驊,生技醫療業
2020-06-30,1593,LegalReserve,114309000.0,法定盈餘公積,祺驊,生技醫療業
2020-06-30,1593,LegalReserve_per,10.1,法定盈餘公積,祺驊,生技醫療業
2020-06-30,1593,LongtermBorrowings,0.0,長期借款,祺驊,生技醫療業
2020-06-30,1593,LongtermBorrowings_per,0.0,長期借款,祺驊,生技醫療業
2020-06-30,1593,NoncontrollingInterests,6950000.0,非控制權益,祺驊,生技醫療業
2020-06-30,1593,NoncontrollingInterests_per,0.61,非控制權益,祺驊,生技醫療業
2020-06-30,1593,NoncurrentAssets,346103000.0,非流動資產合計,祺驊,生技醫療業
2020-06-30,1593,NoncurrentAssets_per,30.59,非流動資產合計,祺驊,生技醫療業
2020-06-30,1593,NoncurrentLiabilities,5783000.0,非流動負債合計,祺驊,生技醫療業
2020-06-30,1593,NoncurrentLiabilities_per,0.51,非流動負債合計,祺驊,生技醫療業
2020-06-30,1593,OrdinaryShare,319484000.0,普通股股本,祺驊,生技醫療業
2020-06-30,1593,OrdinaryShare_per,28.23,普通股股本,祺驊,生技醫療業
2020-06-30,1593,OtherCurrentAssets,13781000.0,其他流動資產,祺驊,生技醫療業
2020-06-30,1593,OtherCurrentAssets_per,1.22,其他流動資產,祺驊,生技醫療業
2020-06-30,1593,OtherCurrentLiabilities,11483000.0,其他流動負債,祺驊,生技醫療業
2020-06-30,1593,OtherCurrentLiabilities_per,1.01,其他流動負債,祺驊,生技醫療業
2020-06-30,1593,OtherNoncurrentAssets,4972000.0,其他非流動資產,祺驊,生技醫療業
2020-06-30,1593,OtherNoncurrentAssets_per,0.44,其他非流動資產,祺驊,生技醫療業
2020-06-30,1593,OtherNoncurrentLiabilities,5783000.0,其他非流動負債,祺驊,生技醫療業
2020-06-30,1593,OtherNoncurrentLiabilities_per,0.51,其他非流動負債,祺驊,生技醫療業
2020-06-30,1593,OtherPayables,131420000.0,其他應付款,祺驊,生技醫療業
2020-06-30,1593,OtherPayables_per,11.61,其他應付款,祺驊,生技醫療業
2020-06-30,1593,PropertyPlantAndEquipment,228338000.0,不動產、廠房及設備,祺驊,生技醫療業
2020-06-30,1593,PropertyPlantAndEquipment_per,20.18,不動產、廠房及設備,祺驊,生技醫療業
2020-06-30,1593,RetainedEarnings,243997000.0,保留盈餘合計,祺驊,生技醫療業
2020-06-30,1593,RetainedEarnings_per,21.56,保留盈餘合計,祺驊,生技醫療業
2020-06-30,1593,ShorttermBorrowings,50000000.0,短期借款,祺驊,生技醫療業
2020-06-30,1593,ShorttermBorrowings_per,4.42,短期借款,祺驊,生技醫療業
2020-06-30,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2020-06-30,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2020-06-30,1593,TotalAssets,1131546000.0,資產總額,祺驊,生技醫療業
2020-06-30,1593,BondsPayable,0.0,應付公司債,祺驊,生技醫療業
2020-06-30,1593,BondsPayable_per,0.0,應付公司債,祺驊,生技醫療業
2020-06-30,1593,TotalLiabilitiesEquity,1131546000.0,負債及權益總計,祺驊,生技醫療業
2020-06-30,1593,FinancialAssetsAtAmortizedCost,159251000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2020-06-30,1593,FinancialAssetsAtAmortizedCost_per,14.07,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2020-06-30,1593,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2020-06-30,1593,NonCurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2020-06-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,17895000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2020-06-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,1.58,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2020-06-30,1593,InvestmentAccountedForUsingEquityMethod,57949000.0,採用權益法之投資,祺驊,生技醫療業
2020-06-30,1593,InvestmentAccountedForUsingEquityMethod_per,5.12,採用權益法之投資,祺驊,生技醫療業
2020-06-30,1593,RightOfUseAsset,18150000.0,使用權資產,祺驊,生技醫療業
2020-06-30,1593,RightOfUseAsset_per,1.6,使用權資產,祺驊,生技醫療業
2020-06-30,1593,CurrentTaxLiabilities,5295000.0,本期所得稅負債,祺驊,生技醫療業
2020-06-30,1593,CurrentTaxLiabilities_per,0.47,本期所得稅負債,祺驊,生技醫療業
2020-06-30,1593,Liabilities,318967000.0,負債總額,祺驊,生技醫療業
2020-06-30,1593,Liabilities_per,28.19,負債總額,祺驊,生技醫療業
2020-06-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,96618000.0,未分配盈餘,祺驊,生技醫療業
2020-06-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,8.54,未分配盈餘,祺驊,生技醫療業
2020-06-30,1593,OtherEquityInterest,-43639000.0,其他權益合計,祺驊,生技醫療業
2020-06-30,1593,OtherEquityInterest_per,-3.86,其他權益合計,祺驊,生技醫療業
2020-06-30,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2020-06-30,1593,Equity,812579000.0,權益總額,祺驊,生技醫療業
2020-06-30,1593,Equity_per,71.81,權益總額,祺驊,生技醫療業
2020-09-30,1593,AccountsPayable,127774000.0,應付帳款,祺驊,生技醫療業
2020-09-30,1593,AccountsPayable_per,11.15,應付帳款,祺驊,生技醫療業
2020-09-30,1593,AccountsPayableToRelatedParties,3521000.0,應付帳款－關係人,祺驊,生技醫療業
2020-09-30,1593,AccountsPayableToRelatedParties_per,0.31,應付帳款－關係人,祺驊,生技醫療業
2020-09-30,1593,AccountsReceivableDuefromRelatedPartiesNet,138000.0,應收帳款－關係人淨額,祺驊,生技醫療業
2020-09-30,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.01,應收帳款－關係人淨額,祺驊,生技醫療業
2020-09-30,1593,AccountsReceivableNet,216339000.0,應收帳款淨額,祺驊,生技醫療業
2020-09-30,1593,AccountsReceivableNet_per,18.89,應收帳款淨額,祺驊,生技醫療業
2020-09-30,1593,CapitalStock,319484000.0,股本合計,祺驊,生技醫療業
2020-09-30,1593,CapitalStock_per,27.89,股本合計,祺驊,生技醫療業
2020-09-30,1593,CapitalSurplus,285787000.0,資本公積合計,祺驊,生技醫療業
2020-09-30,1593,CapitalSurplus_per,24.95,資本公積合計,祺驊,生技醫療業
2020-09-30,1593,CashAndCashEquivalents,216292000.0,現金及約當現金,祺驊,生技醫療業
2020-09-30,1593,CashAndCashEquivalents_per,18.88,現金及約當現金,祺驊,生技醫療業
2020-09-30,1593,CurrentAssets,797865000.0,流動資產合計,祺驊,生技醫療業
2020-09-30,1593,CurrentAssets_per,69.65,流動資產合計,祺驊,生技醫療業
2020-09-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,29271000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2020-09-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,2.56,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2020-09-30,1593,CurrentLiabilities,289091000.0,流動負債合計,祺驊,生技醫療業
2020-09-30,1593,CurrentLiabilities_per,25.24,流動負債合計,祺驊,生技醫療業
2020-09-30,1593,DeferredTaxAssets,7310000.0,遞延所得稅資產,祺驊,生技醫療業
2020-09-30,1593,DeferredTaxAssets_per,0.64,遞延所得稅資產,祺驊,生技醫療業
2020-09-30,1593,EquityAttributableToOwnersOfParent,843885000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2020-09-30,1593,EquityAttributableToOwnersOfParent_per,73.67,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2020-09-30,1593,IntangibleAssets,3761000.0,無形資產,祺驊,生技醫療業
2020-09-30,1593,IntangibleAssets_per,0.33,無形資產,祺驊,生技醫療業
2020-09-30,1593,Inventories,154939000.0,存貨,祺驊,生技醫療業
2020-09-30,1593,Inventories_per,13.53,存貨,祺驊,生技醫療業
2020-09-30,1593,LegalReserve,114309000.0,法定盈餘公積,祺驊,生技醫療業
2020-09-30,1593,LegalReserve_per,9.98,法定盈餘公積,祺驊,生技醫療業
2020-09-30,1593,LongtermBorrowings,0.0,長期借款,祺驊,生技醫療業
2020-09-30,1593,LongtermBorrowings_per,0.0,長期借款,祺驊,生技醫療業
2020-09-30,1593,NoncontrollingInterests,7434000.0,非控制權益,祺驊,生技醫療業
2020-09-30,1593,NoncontrollingInterests_per,0.65,非控制權益,祺驊,生技醫療業
2020-09-30,1593,NoncurrentAssets,347650000.0,非流動資產合計,祺驊,生技醫療業
2020-09-30,1593,NoncurrentAssets_per,30.35,非流動資產合計,祺驊,生技醫療業
2020-09-30,1593,NoncurrentLiabilities,5105000.0,非流動負債合計,祺驊,生技醫療業
2020-09-30,1593,NoncurrentLiabilities_per,0.45,非流動負債合計,祺驊,生技醫療業
2020-09-30,1593,OrdinaryShare,319484000.0,普通股股本,祺驊,生技醫療業
2020-09-30,1593,OrdinaryShare_per,27.89,普通股股本,祺驊,生技醫療業
2020-09-30,1593,OtherCurrentAssets,23016000.0,其他流動資產,祺驊,生技醫療業
2020-09-30,1593,OtherCurrentAssets_per,2.01,其他流動資產,祺驊,生技醫療業
2020-09-30,1593,OtherCurrentLiabilities,10176000.0,其他流動負債,祺驊,生技醫療業
2020-09-30,1593,OtherCurrentLiabilities_per,0.89,其他流動負債,祺驊,生技醫療業
2020-09-30,1593,OtherNoncurrentAssets,4786000.0,其他非流動資產,祺驊,生技醫療業
2020-09-30,1593,OtherNoncurrentAssets_per,0.42,其他非流動資產,祺驊,生技醫療業
2020-09-30,1593,OtherNoncurrentLiabilities,5091000.0,其他非流動負債,祺驊,生技醫療業
2020-09-30,1593,OtherNoncurrentLiabilities_per,0.44,其他非流動負債,祺驊,生技醫療業
2020-09-30,1593,OtherPayables,39836000.0,其他應付款,祺驊,生技醫療業
2020-09-30,1593,OtherPayables_per,3.48,其他應付款,祺驊,生技醫療業
2020-09-30,1593,PropertyPlantAndEquipment,225498000.0,不動產、廠房及設備,祺驊,生技醫療業
2020-09-30,1593,PropertyPlantAndEquipment_per,19.69,不動產、廠房及設備,祺驊,生技醫療業
2020-09-30,1593,RetainedEarnings,286670000.0,保留盈餘合計,祺驊,生技醫療業
2020-09-30,1593,RetainedEarnings_per,25.03,保留盈餘合計,祺驊,生技醫療業
2020-09-30,1593,ShorttermBorrowings,95000000.0,短期借款,祺驊,生技醫療業
2020-09-30,1593,ShorttermBorrowings_per,8.29,短期借款,祺驊,生技醫療業
2020-09-30,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2020-09-30,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2020-09-30,1593,TotalAssets,1145515000.0,資產總額,祺驊,生技醫療業
2020-09-30,1593,BondsPayable,0.0,應付公司債,祺驊,生技醫療業
2020-09-30,1593,BondsPayable_per,0.0,應付公司債,祺驊,生技醫療業
2020-09-30,1593,TotalLiabilitiesEquity,1145515000.0,負債及權益總計,祺驊,生技醫療業
2020-09-30,1593,FinancialAssetsAtAmortizedCost,157870000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2020-09-30,1593,FinancialAssetsAtAmortizedCost_per,13.78,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2020-09-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,17201000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2020-09-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,1.5,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2020-09-30,1593,InvestmentAccountedForUsingEquityMethod,64386000.0,採用權益法之投資,祺驊,生技醫療業
2020-09-30,1593,InvestmentAccountedForUsingEquityMethod_per,5.62,採用權益法之投資,祺驊,生技醫療業
2020-09-30,1593,RightOfUseAsset,17009000.0,使用權資產,祺驊,生技醫療業
2020-09-30,1593,RightOfUseAsset_per,1.48,使用權資產,祺驊,生技醫療業
2020-09-30,1593,CurrentTaxLiabilities,11993000.0,本期所得稅負債,祺驊,生技醫療業
2020-09-30,1593,CurrentTaxLiabilities_per,1.05,本期所得稅負債,祺驊,生技醫療業
2020-09-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,139291000.0,未分配盈餘,祺驊,生技醫療業
2020-09-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,12.16,未分配盈餘,祺驊,生技醫療業
2020-09-30,1593,OtherEquityInterest,-48056000.0,其他權益合計,祺驊,生技醫療業
2020-09-30,1593,OtherEquityInterest_per,-4.2,其他權益合計,祺驊,生技醫療業
2020-09-30,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2020-09-30,1593,Equity,851319000.0,權益總額,祺驊,生技醫療業
2020-09-30,1593,Equity_per,74.32,權益總額,祺驊,生技醫療業
2020-09-30,1593,Liabilities,294196000.0,負債總額,祺驊,生技醫療業
2020-09-30,1593,Liabilities_per,25.68,負債總額,祺驊,生技醫療業
2020-12-31,1593,CashAndCashEquivalents,343682000.0,現金及約當現金,祺驊,生技醫療業
2020-12-31,1593,CashAndCashEquivalents_per,25.64,現金及約當現金,祺驊,生技醫療業
2020-12-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,24154000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2020-12-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.8,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2020-12-31,1593,AccountsReceivableNet,237887000.0,應收帳款淨額,祺驊,生技醫療業
2020-12-31,1593,AccountsReceivableNet_per,17.75,應收帳款淨額,祺驊,生技醫療業
2020-12-31,1593,AccountsReceivableDuefromRelatedPartiesNet,2000.0,應收帳款－關係人淨額,祺驊,生技醫療業
2020-12-31,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2020-12-31,1593,Inventories,160035000.0,存貨,祺驊,生技醫療業
2020-12-31,1593,Inventories_per,11.94,存貨,祺驊,生技醫療業
2020-12-31,1593,OtherCurrentAssets,30556000.0,其他流動資產,祺驊,生技醫療業
2020-12-31,1593,OtherCurrentAssets_per,2.28,其他流動資產,祺驊,生技醫療業
2020-12-31,1593,CurrentAssets,953466000.0,流動資產合計,祺驊,生技醫療業
2020-12-31,1593,CurrentAssets_per,71.14,流動資產合計,祺驊,生技醫療業
2020-12-31,1593,PropertyPlantAndEquipment,237290000.0,不動產、廠房及設備,祺驊,生技醫療業
2020-12-31,1593,PropertyPlantAndEquipment_per,17.71,不動產、廠房及設備,祺驊,生技醫療業
2020-12-31,1593,IntangibleAssets,3700000.0,無形資產,祺驊,生技醫療業
2020-12-31,1593,IntangibleAssets_per,0.28,無形資產,祺驊,生技醫療業
2020-12-31,1593,DeferredTaxAssets,6843000.0,遞延所得稅資產,祺驊,生技醫療業
2020-12-31,1593,DeferredTaxAssets_per,0.51,遞延所得稅資產,祺驊,生技醫療業
2020-12-31,1593,OtherNoncurrentAssets,7421000.0,其他非流動資產,祺驊,生技醫療業
2020-12-31,1593,OtherNoncurrentAssets_per,0.55,其他非流動資產,祺驊,生技醫療業
2020-12-31,1593,NoncurrentAssets,386765000.0,非流動資產合計,祺驊,生技醫療業
2020-12-31,1593,NoncurrentAssets_per,28.86,非流動資產合計,祺驊,生技醫療業
2020-12-31,1593,TotalAssets,1340231000.0,資產總額,祺驊,生技醫療業
2020-12-31,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2020-12-31,1593,AccountsPayable,152985000.0,應付帳款,祺驊,生技醫療業
2020-12-31,1593,AccountsPayable_per,11.41,應付帳款,祺驊,生技醫療業
2020-12-31,1593,AccountsPayableToRelatedParties,1134000.0,應付帳款－關係人,祺驊,生技醫療業
2020-12-31,1593,AccountsPayableToRelatedParties_per,0.08,應付帳款－關係人,祺驊,生技醫療業
2020-12-31,1593,OtherPayables,52488000.0,其他應付款,祺驊,生技醫療業
2020-12-31,1593,OtherPayables_per,3.92,其他應付款,祺驊,生技醫療業
2020-12-31,1593,OtherCurrentLiabilities,13051000.0,其他流動負債,祺驊,生技醫療業
2020-12-31,1593,OtherCurrentLiabilities_per,0.97,其他流動負債,祺驊,生技醫療業
2020-12-31,1593,CurrentLiabilities,237958000.0,流動負債合計,祺驊,生技醫療業
2020-12-31,1593,CurrentLiabilities_per,17.75,流動負債合計,祺驊,生技醫療業
2020-12-31,1593,BondsPayable,95346000.0,應付公司債,祺驊,生技醫療業
2020-12-31,1593,BondsPayable_per,7.11,應付公司債,祺驊,生技醫療業
2020-12-31,1593,LongtermBorrowings,0.0,長期借款,祺驊,生技醫療業
2020-12-31,1593,LongtermBorrowings_per,0.0,長期借款,祺驊,生技醫療業
2020-12-31,1593,OtherNoncurrentLiabilities,5987000.0,其他非流動負債,祺驊,生技醫療業
2020-12-31,1593,OtherNoncurrentLiabilities_per,0.45,其他非流動負債,祺驊,生技醫療業
2020-12-31,1593,NoncurrentLiabilities,101424000.0,非流動負債合計,祺驊,生技醫療業
2020-12-31,1593,NoncurrentLiabilities_per,7.57,非流動負債合計,祺驊,生技醫療業
2020-12-31,1593,OrdinaryShare,339484000.0,普通股股本,祺驊,生技醫療業
2020-12-31,1593,OrdinaryShare_per,25.33,普通股股本,祺驊,生技醫療業
2020-12-31,1593,CapitalStock,339484000.0,股本合計,祺驊,生技醫療業
2020-12-31,1593,CapitalStock_per,25.33,股本合計,祺驊,生技醫療業
2020-12-31,1593,CapitalSurplus,370411000.0,資本公積合計,祺驊,生技醫療業
2020-12-31,1593,CapitalSurplus_per,27.64,資本公積合計,祺驊,生技醫療業
2020-12-31,1593,LegalReserve,114309000.0,法定盈餘公積,祺驊,生技醫療業
2020-12-31,1593,LegalReserve_per,8.53,法定盈餘公積,祺驊,生技醫療業
2020-12-31,1593,RetainedEarnings,337042000.0,保留盈餘合計,祺驊,生技醫療業
2020-12-31,1593,RetainedEarnings_per,25.15,保留盈餘合計,祺驊,生技醫療業
2020-12-31,1593,EquityAttributableToOwnersOfParent,993255000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2020-12-31,1593,EquityAttributableToOwnersOfParent_per,74.11,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2020-12-31,1593,NoncontrollingInterests,7594000.0,非控制權益,祺驊,生技醫療業
2020-12-31,1593,NoncontrollingInterests_per,0.57,非控制權益,祺驊,生技醫療業
2020-12-31,1593,TotalLiabilitiesEquity,1340231000.0,負債及權益總計,祺驊,生技醫療業
2020-12-31,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2020-12-31,1593,ShorttermBorrowings,0.0,短期借款,祺驊,生技醫療業
2020-12-31,1593,ShorttermBorrowings_per,0.0,短期借款,祺驊,生技醫療業
2020-12-31,1593,FinancialAssetsAtAmortizedCost,157150000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2020-12-31,1593,FinancialAssetsAtAmortizedCost_per,11.73,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2020-12-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,36166000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2020-12-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,2.7,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2020-12-31,1593,InvestmentAccountedForUsingEquityMethod,71870000.0,採用權益法之投資,祺驊,生技醫療業
2020-12-31,1593,InvestmentAccountedForUsingEquityMethod_per,5.36,採用權益法之投資,祺驊,生技醫療業
2020-12-31,1593,RightOfUseAsset,15790000.0,使用權資產,祺驊,生技醫療業
2020-12-31,1593,RightOfUseAsset_per,1.18,使用權資產,祺驊,生技醫療業
2020-12-31,1593,CurrentTaxLiabilities,18300000.0,本期所得稅負債,祺驊,生技醫療業
2020-12-31,1593,CurrentTaxLiabilities_per,1.37,本期所得稅負債,祺驊,生技醫療業
2020-12-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,189663000.0,未分配盈餘,祺驊,生技醫療業
2020-12-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,14.15,未分配盈餘,祺驊,生技醫療業
2020-12-31,1593,OtherEquityInterest,-53682000.0,其他權益合計,祺驊,生技醫療業
2020-12-31,1593,OtherEquityInterest_per,-4.01,其他權益合計,祺驊,生技醫療業
2020-12-31,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2020-12-31,1593,Equity,1000849000.0,權益總額,祺驊,生技醫療業
2020-12-31,1593,Equity_per,74.68,權益總額,祺驊,生技醫療業
2020-12-31,1593,Liabilities,339382000.0,負債總額,祺驊,生技醫療業
2020-12-31,1593,Liabilities_per,25.32,負債總額,祺驊,生技醫療業
2021-03-31,1593,CashAndCashEquivalents,304960000.0,現金及約當現金,祺驊,生技醫療業
2021-03-31,1593,CashAndCashEquivalents_per,22.09,現金及約當現金,祺驊,生技醫療業
2021-03-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,33969000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2021-03-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,2.46,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2021-03-31,1593,AccountsReceivableNet,269939000.0,應收帳款淨額,祺驊,生技醫療業
2021-03-31,1593,AccountsReceivableNet_per,19.55,應收帳款淨額,祺驊,生技醫療業
2021-03-31,1593,AccountsReceivableDuefromRelatedPartiesNet,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2021-03-31,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2021-03-31,1593,Inventories,181309000.0,存貨,祺驊,生技醫療業
2021-03-31,1593,Inventories_per,13.13,存貨,祺驊,生技醫療業
2021-03-31,1593,OtherCurrentAssets,27395000.0,其他流動資產,祺驊,生技醫療業
2021-03-31,1593,OtherCurrentAssets_per,1.98,其他流動資產,祺驊,生技醫療業
2021-03-31,1593,CurrentAssets,978647000.0,流動資產合計,祺驊,生技醫療業
2021-03-31,1593,CurrentAssets_per,70.89,流動資產合計,祺驊,生技醫療業
2021-03-31,1593,PropertyPlantAndEquipment,247410000.0,不動產、廠房及設備,祺驊,生技醫療業
2021-03-31,1593,PropertyPlantAndEquipment_per,17.92,不動產、廠房及設備,祺驊,生技醫療業
2021-03-31,1593,IntangibleAssets,3705000.0,無形資產,祺驊,生技醫療業
2021-03-31,1593,IntangibleAssets_per,0.27,無形資產,祺驊,生技醫療業
2021-03-31,1593,DeferredTaxAssets,7180000.0,遞延所得稅資產,祺驊,生技醫療業
2021-03-31,1593,DeferredTaxAssets_per,0.52,遞延所得稅資產,祺驊,生技醫療業
2021-03-31,1593,OtherNoncurrentAssets,6716000.0,其他非流動資產,祺驊,生技醫療業
2021-03-31,1593,OtherNoncurrentAssets_per,0.49,其他非流動資產,祺驊,生技醫療業
2021-03-31,1593,NoncurrentAssets,401849000.0,非流動資產合計,祺驊,生技醫療業
2021-03-31,1593,NoncurrentAssets_per,29.11,非流動資產合計,祺驊,生技醫療業
2021-03-31,1593,TotalAssets,1380496000.0,資產總額,祺驊,生技醫療業
2021-03-31,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2021-03-31,1593,AccountsPayable,171342000.0,應付帳款,祺驊,生技醫療業
2021-03-31,1593,AccountsPayable_per,12.41,應付帳款,祺驊,生技醫療業
2021-03-31,1593,AccountsPayableToRelatedParties,826000.0,應付帳款－關係人,祺驊,生技醫療業
2021-03-31,1593,AccountsPayableToRelatedParties_per,0.06,應付帳款－關係人,祺驊,生技醫療業
2021-03-31,1593,OtherPayables,33010000.0,其他應付款,祺驊,生技醫療業
2021-03-31,1593,OtherPayables_per,2.39,其他應付款,祺驊,生技醫療業
2021-03-31,1593,OtherCurrentLiabilities,17355000.0,其他流動負債,祺驊,生技醫療業
2021-03-31,1593,OtherCurrentLiabilities_per,1.26,其他流動負債,祺驊,生技醫療業
2021-03-31,1593,CurrentLiabilities,247649000.0,流動負債合計,祺驊,生技醫療業
2021-03-31,1593,CurrentLiabilities_per,17.94,流動負債合計,祺驊,生技醫療業
2021-03-31,1593,BondsPayable,17896000.0,應付公司債,祺驊,生技醫療業
2021-03-31,1593,BondsPayable_per,1.3,應付公司債,祺驊,生技醫療業
2021-03-31,1593,OtherNoncurrentLiabilities,5657000.0,其他非流動負債,祺驊,生技醫療業
2021-03-31,1593,OtherNoncurrentLiabilities_per,0.41,其他非流動負債,祺驊,生技醫療業
2021-03-31,1593,NoncurrentLiabilities,24873000.0,非流動負債合計,祺驊,生技醫療業
2021-03-31,1593,NoncurrentLiabilities_per,1.8,非流動負債合計,祺驊,生技醫療業
2021-03-31,1593,OrdinaryShare,352148000.0,普通股股本,祺驊,生技醫療業
2021-03-31,1593,OrdinaryShare_per,25.51,普通股股本,祺驊,生技醫療業
2021-03-31,1593,CapitalStock,352148000.0,股本合計,祺驊,生技醫療業
2021-03-31,1593,CapitalStock_per,25.51,股本合計,祺驊,生技醫療業
2021-03-31,1593,CapitalSurplus,435525000.0,資本公積合計,祺驊,生技醫療業
2021-03-31,1593,CapitalSurplus_per,31.55,資本公積合計,祺驊,生技醫療業
2021-03-31,1593,LegalReserve,114309000.0,法定盈餘公積,祺驊,生技醫療業
2021-03-31,1593,LegalReserve_per,8.28,法定盈餘公積,祺驊,生技醫療業
2021-03-31,1593,RetainedEarnings,370807000.0,保留盈餘合計,祺驊,生技醫療業
2021-03-31,1593,RetainedEarnings_per,26.86,保留盈餘合計,祺驊,生技醫療業
2021-03-31,1593,EquityAttributableToOwnersOfParent,1100274000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2021-03-31,1593,EquityAttributableToOwnersOfParent_per,79.7,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2021-03-31,1593,NoncontrollingInterests,7700000.0,非控制權益,祺驊,生技醫療業
2021-03-31,1593,NoncontrollingInterests_per,0.56,非控制權益,祺驊,生技醫療業
2021-03-31,1593,TotalLiabilitiesEquity,1380496000.0,負債及權益總計,祺驊,生技醫療業
2021-03-31,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2021-03-31,1593,OtherReceivablesDueFromRelatedParties,0.0,其他應收款－關係人淨額,祺驊,生技醫療業
2021-03-31,1593,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,祺驊,生技醫療業
2021-03-31,1593,ShorttermBorrowings,0.0,短期借款,祺驊,生技醫療業
2021-03-31,1593,ShorttermBorrowings_per,0.0,短期借款,祺驊,生技醫療業
2021-03-31,1593,LongtermBorrowings,0.0,長期借款,祺驊,生技醫療業
2021-03-31,1593,LongtermBorrowings_per,0.0,長期借款,祺驊,生技醫療業
2021-03-31,1593,FinancialAssetsAtAmortizedCost,161075000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2021-03-31,1593,FinancialAssetsAtAmortizedCost_per,11.67,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2021-03-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,31665000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2021-03-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,2.29,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2021-03-31,1593,InvestmentAccountedForUsingEquityMethod,79261000.0,採用權益法之投資,祺驊,生技醫療業
2021-03-31,1593,InvestmentAccountedForUsingEquityMethod_per,5.74,採用權益法之投資,祺驊,生技醫療業
2021-03-31,1593,RightOfUseAsset,18241000.0,使用權資產,祺驊,生技醫療業
2021-03-31,1593,RightOfUseAsset_per,1.32,使用權資產,祺驊,生技醫療業
2021-03-31,1593,CurrentTaxLiabilities,23375000.0,本期所得稅負債,祺驊,生技醫療業
2021-03-31,1593,CurrentTaxLiabilities_per,1.69,本期所得稅負債,祺驊,生技醫療業
2021-03-31,1593,Liabilities,272522000.0,負債總額,祺驊,生技醫療業
2021-03-31,1593,Liabilities_per,19.74,負債總額,祺驊,生技醫療業
2021-03-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,223428000.0,未分配盈餘,祺驊,生技醫療業
2021-03-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,16.18,未分配盈餘,祺驊,生技醫療業
2021-03-31,1593,OtherEquityInterest,-58206000.0,其他權益合計,祺驊,生技醫療業
2021-03-31,1593,OtherEquityInterest_per,-4.22,其他權益合計,祺驊,生技醫療業
2021-03-31,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2021-03-31,1593,Equity,1107974000.0,權益總額,祺驊,生技醫療業
2021-03-31,1593,Equity_per,80.26,權益總額,祺驊,生技醫療業
2021-06-30,1593,CashAndCashEquivalents,317762000.0,現金及約當現金,祺驊,生技醫療業
2021-06-30,1593,CashAndCashEquivalents_per,22.25,現金及約當現金,祺驊,生技醫療業
2021-06-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,42538000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2021-06-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,2.98,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2021-06-30,1593,AccountsReceivableNet,282549000.0,應收帳款淨額,祺驊,生技醫療業
2021-06-30,1593,AccountsReceivableNet_per,19.78,應收帳款淨額,祺驊,生技醫療業
2021-06-30,1593,AccountsReceivableDuefromRelatedPartiesNet,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2021-06-30,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2021-06-30,1593,Inventories,171706000.0,存貨,祺驊,生技醫療業
2021-06-30,1593,Inventories_per,12.02,存貨,祺驊,生技醫療業
2021-06-30,1593,OtherCurrentAssets,26984000.0,其他流動資產,祺驊,生技醫療業
2021-06-30,1593,OtherCurrentAssets_per,1.89,其他流動資產,祺驊,生技醫療業
2021-06-30,1593,CurrentAssets,983502000.0,流動資產合計,祺驊,生技醫療業
2021-06-30,1593,CurrentAssets_per,68.86,流動資產合計,祺驊,生技醫療業
2021-06-30,1593,PropertyPlantAndEquipment,257499000.0,不動產、廠房及設備,祺驊,生技醫療業
2021-06-30,1593,PropertyPlantAndEquipment_per,18.03,不動產、廠房及設備,祺驊,生技醫療業
2021-06-30,1593,IntangibleAssets,3639000.0,無形資產,祺驊,生技醫療業
2021-06-30,1593,IntangibleAssets_per,0.25,無形資產,祺驊,生技醫療業
2021-06-30,1593,DeferredTaxAssets,7214000.0,遞延所得稅資產,祺驊,生技醫療業
2021-06-30,1593,DeferredTaxAssets_per,0.51,遞延所得稅資產,祺驊,生技醫療業
2021-06-30,1593,OtherNoncurrentAssets,59241000.0,其他非流動資產,祺驊,生技醫療業
2021-06-30,1593,OtherNoncurrentAssets_per,4.15,其他非流動資產,祺驊,生技醫療業
2021-06-30,1593,NoncurrentAssets,444864000.0,非流動資產合計,祺驊,生技醫療業
2021-06-30,1593,NoncurrentAssets_per,31.14,非流動資產合計,祺驊,生技醫療業
2021-06-30,1593,TotalAssets,1428366000.0,資產總額,祺驊,生技醫療業
2021-06-30,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2021-06-30,1593,ShorttermBorrowings,3000000.0,短期借款,祺驊,生技醫療業
2021-06-30,1593,ShorttermBorrowings_per,0.21,短期借款,祺驊,生技醫療業
2021-06-30,1593,AccountsPayable,180570000.0,應付帳款,祺驊,生技醫療業
2021-06-30,1593,AccountsPayable_per,12.64,應付帳款,祺驊,生技醫療業
2021-06-30,1593,AccountsPayableToRelatedParties,1030000.0,應付帳款－關係人,祺驊,生技醫療業
2021-06-30,1593,AccountsPayableToRelatedParties_per,0.07,應付帳款－關係人,祺驊,生技醫療業
2021-06-30,1593,OtherPayables,38333000.0,其他應付款,祺驊,生技醫療業
2021-06-30,1593,OtherPayables_per,2.68,其他應付款,祺驊,生技醫療業
2021-06-30,1593,OtherCurrentLiabilities,16969000.0,其他流動負債,祺驊,生技醫療業
2021-06-30,1593,OtherCurrentLiabilities_per,1.19,其他流動負債,祺驊,生技醫療業
2021-06-30,1593,CurrentLiabilities,257316000.0,流動負債合計,祺驊,生技醫療業
2021-06-30,1593,CurrentLiabilities_per,18.01,流動負債合計,祺驊,生技醫療業
2021-06-30,1593,BondsPayable,17684000.0,應付公司債,祺驊,生技醫療業
2021-06-30,1593,BondsPayable_per,1.24,應付公司債,祺驊,生技醫療業
2021-06-30,1593,OtherNoncurrentLiabilities,5296000.0,其他非流動負債,祺驊,生技醫療業
2021-06-30,1593,OtherNoncurrentLiabilities_per,0.37,其他非流動負債,祺驊,生技醫療業
2021-06-30,1593,NoncurrentLiabilities,24327000.0,非流動負債合計,祺驊,生技醫療業
2021-06-30,1593,NoncurrentLiabilities_per,1.7,非流動負債合計,祺驊,生技醫療業
2021-06-30,1593,OrdinaryShare,352194000.0,普通股股本,祺驊,生技醫療業
2021-06-30,1593,OrdinaryShare_per,24.66,普通股股本,祺驊,生技醫療業
2021-06-30,1593,CapitalStock,352194000.0,股本合計,祺驊,生技醫療業
2021-06-30,1593,CapitalStock_per,24.66,股本合計,祺驊,生技醫療業
2021-06-30,1593,CapitalSurplus,435739000.0,資本公積合計,祺驊,生技醫療業
2021-06-30,1593,CapitalSurplus_per,30.51,資本公積合計,祺驊,生技醫療業
2021-06-30,1593,LegalReserve,114309000.0,法定盈餘公積,祺驊,生技醫療業
2021-06-30,1593,LegalReserve_per,8.0,法定盈餘公積,祺驊,生技醫療業
2021-06-30,1593,RetainedEarnings,417367000.0,保留盈餘合計,祺驊,生技醫療業
2021-06-30,1593,RetainedEarnings_per,29.22,保留盈餘合計,祺驊,生技醫療業
2021-06-30,1593,EquityAttributableToOwnersOfParent,1139472000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2021-06-30,1593,EquityAttributableToOwnersOfParent_per,79.77,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2021-06-30,1593,NoncontrollingInterests,7251000.0,非控制權益,祺驊,生技醫療業
2021-06-30,1593,NoncontrollingInterests_per,0.51,非控制權益,祺驊,生技醫療業
2021-06-30,1593,TotalLiabilitiesEquity,1428366000.0,負債及權益總計,祺驊,生技醫療業
2021-06-30,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2021-06-30,1593,FinancialAssetsAtAmortizedCost,141963000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2021-06-30,1593,FinancialAssetsAtAmortizedCost_per,9.94,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2021-06-30,1593,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,祺驊,生技醫療業
2021-06-30,1593,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,祺驊,生技醫療業
2021-06-30,1593,LongtermBorrowings,0.0,長期借款,祺驊,生技醫療業
2021-06-30,1593,LongtermBorrowings_per,0.0,長期借款,祺驊,生技醫療業
2021-06-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,29885000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2021-06-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,2.09,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2021-06-30,1593,InvestmentAccountedForUsingEquityMethod,62315000.0,採用權益法之投資,祺驊,生技醫療業
2021-06-30,1593,InvestmentAccountedForUsingEquityMethod_per,4.36,採用權益法之投資,祺驊,生技醫療業
2021-06-30,1593,RightOfUseAsset,17415000.0,使用權資產,祺驊,生技醫療業
2021-06-30,1593,RightOfUseAsset_per,1.22,使用權資產,祺驊,生技醫療業
2021-06-30,1593,CurrentTaxLiabilities,15664000.0,本期所得稅負債,祺驊,生技醫療業
2021-06-30,1593,CurrentTaxLiabilities_per,1.1,本期所得稅負債,祺驊,生技醫療業
2021-06-30,1593,Liabilities,281643000.0,負債總額,祺驊,生技醫療業
2021-06-30,1593,Liabilities_per,19.72,負債總額,祺驊,生技醫療業
2021-06-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,269988000.0,未分配盈餘,祺驊,生技醫療業
2021-06-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,18.9,未分配盈餘,祺驊,生技醫療業
2021-06-30,1593,OtherEquityInterest,-65828000.0,其他權益合計,祺驊,生技醫療業
2021-06-30,1593,OtherEquityInterest_per,-4.61,其他權益合計,祺驊,生技醫療業
2021-06-30,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2021-06-30,1593,Equity,1146723000.0,權益總額,祺驊,生技醫療業
2021-06-30,1593,Equity_per,80.28,權益總額,祺驊,生技醫療業
2021-09-30,1593,CashAndCashEquivalents,244827000.0,現金及約當現金,祺驊,生技醫療業
2021-09-30,1593,CashAndCashEquivalents_per,14.58,現金及約當現金,祺驊,生技醫療業
2021-09-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,38561000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2021-09-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,2.3,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2021-09-30,1593,AccountsReceivableNet,275062000.0,應收帳款淨額,祺驊,生技醫療業
2021-09-30,1593,AccountsReceivableNet_per,16.38,應收帳款淨額,祺驊,生技醫療業
2021-09-30,1593,AccountsReceivableDuefromRelatedPartiesNet,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2021-09-30,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2021-09-30,1593,Inventories,191494000.0,存貨,祺驊,生技醫療業
2021-09-30,1593,Inventories_per,11.4,存貨,祺驊,生技醫療業
2021-09-30,1593,OtherCurrentAssets,23917000.0,其他流動資產,祺驊,生技醫療業
2021-09-30,1593,OtherCurrentAssets_per,1.42,其他流動資產,祺驊,生技醫療業
2021-09-30,1593,CurrentAssets,875566000.0,流動資產合計,祺驊,生技醫療業
2021-09-30,1593,CurrentAssets_per,52.14,流動資產合計,祺驊,生技醫療業
2021-09-30,1593,PropertyPlantAndEquipment,656911000.0,不動產、廠房及設備,祺驊,生技醫療業
2021-09-30,1593,PropertyPlantAndEquipment_per,39.12,不動產、廠房及設備,祺驊,生技醫療業
2021-09-30,1593,IntangibleAssets,3638000.0,無形資產,祺驊,生技醫療業
2021-09-30,1593,IntangibleAssets_per,0.22,無形資產,祺驊,生技醫療業
2021-09-30,1593,DeferredTaxAssets,7665000.0,遞延所得稅資產,祺驊,生技醫療業
2021-09-30,1593,DeferredTaxAssets_per,0.46,遞延所得稅資產,祺驊,生技醫療業
2021-09-30,1593,OtherNoncurrentAssets,6933000.0,其他非流動資產,祺驊,生技醫療業
2021-09-30,1593,OtherNoncurrentAssets_per,0.41,其他非流動資產,祺驊,生技醫療業
2021-09-30,1593,NoncurrentAssets,803843000.0,非流動資產合計,祺驊,生技醫療業
2021-09-30,1593,NoncurrentAssets_per,47.86,非流動資產合計,祺驊,生技醫療業
2021-09-30,1593,TotalAssets,1679409000.0,資產總額,祺驊,生技醫療業
2021-09-30,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2021-09-30,1593,ShorttermBorrowings,38000000.0,短期借款,祺驊,生技醫療業
2021-09-30,1593,ShorttermBorrowings_per,2.26,短期借款,祺驊,生技醫療業
2021-09-30,1593,AccountsPayable,174567000.0,應付帳款,祺驊,生技醫療業
2021-09-30,1593,AccountsPayable_per,10.39,應付帳款,祺驊,生技醫療業
2021-09-30,1593,AccountsPayableToRelatedParties,3089000.0,應付帳款－關係人,祺驊,生技醫療業
2021-09-30,1593,AccountsPayableToRelatedParties_per,0.18,應付帳款－關係人,祺驊,生技醫療業
2021-09-30,1593,OtherPayables,44674000.0,其他應付款,祺驊,生技醫療業
2021-09-30,1593,OtherPayables_per,2.66,其他應付款,祺驊,生技醫療業
2021-09-30,1593,OtherCurrentLiabilities,22527000.0,其他流動負債,祺驊,生技醫療業
2021-09-30,1593,OtherCurrentLiabilities_per,1.34,其他流動負債,祺驊,生技醫療業
2021-09-30,1593,CurrentLiabilities,312175000.0,流動負債合計,祺驊,生技醫療業
2021-09-30,1593,CurrentLiabilities_per,18.59,流動負債合計,祺驊,生技醫療業
2021-09-30,1593,BondsPayable,17277000.0,應付公司債,祺驊,生技醫療業
2021-09-30,1593,BondsPayable_per,1.03,應付公司債,祺驊,生技醫療業
2021-09-30,1593,LongtermBorrowings,268000000.0,長期借款,祺驊,生技醫療業
2021-09-30,1593,LongtermBorrowings_per,15.96,長期借款,祺驊,生技醫療業
2021-09-30,1593,OtherNoncurrentLiabilities,4953000.0,其他非流動負債,祺驊,生技醫療業
2021-09-30,1593,OtherNoncurrentLiabilities_per,0.29,其他非流動負債,祺驊,生技醫療業
2021-09-30,1593,NoncurrentLiabilities,297187000.0,非流動負債合計,祺驊,生技醫療業
2021-09-30,1593,NoncurrentLiabilities_per,17.7,非流動負債合計,祺驊,生技醫療業
2021-09-30,1593,OrdinaryShare,352275000.0,普通股股本,祺驊,生技醫療業
2021-09-30,1593,OrdinaryShare_per,20.98,普通股股本,祺驊,生技醫療業
2021-09-30,1593,CapitalStock,352275000.0,股本合計,祺驊,生技醫療業
2021-09-30,1593,CapitalStock_per,20.98,股本合計,祺驊,生技醫療業
2021-09-30,1593,CapitalSurplus,436141000.0,資本公積合計,祺驊,生技醫療業
2021-09-30,1593,CapitalSurplus_per,25.97,資本公積合計,祺驊,生技醫療業
2021-09-30,1593,LegalReserve,126476000.0,法定盈餘公積,祺驊,生技醫療業
2021-09-30,1593,LegalReserve_per,7.53,法定盈餘公積,祺驊,生技醫療業
2021-09-30,1593,RetainedEarnings,337050000.0,保留盈餘合計,祺驊,生技醫療業
2021-09-30,1593,RetainedEarnings_per,20.07,保留盈餘合計,祺驊,生技醫療業
2021-09-30,1593,EquityAttributableToOwnersOfParent,1062623000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2021-09-30,1593,EquityAttributableToOwnersOfParent_per,63.27,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2021-09-30,1593,NoncontrollingInterests,7424000.0,非控制權益,祺驊,生技醫療業
2021-09-30,1593,NoncontrollingInterests_per,0.44,非控制權益,祺驊,生技醫療業
2021-09-30,1593,TotalLiabilitiesEquity,1679409000.0,負債及權益總計,祺驊,生技醫療業
2021-09-30,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2021-09-30,1593,FinancialAssetsAtAmortizedCost,101705000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2021-09-30,1593,FinancialAssetsAtAmortizedCost_per,6.06,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2021-09-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,31603000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2021-09-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,1.88,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2021-09-30,1593,InvestmentAccountedForUsingEquityMethod,64837000.0,採用權益法之投資,祺驊,生技醫療業
2021-09-30,1593,InvestmentAccountedForUsingEquityMethod_per,3.86,採用權益法之投資,祺驊,生技醫療業
2021-09-30,1593,RightOfUseAsset,24615000.0,使用權資產,祺驊,生技醫療業
2021-09-30,1593,RightOfUseAsset_per,1.47,使用權資產,祺驊,生技醫療業
2021-09-30,1593,CurrentTaxLiabilities,25523000.0,本期所得稅負債,祺驊,生技醫療業
2021-09-30,1593,CurrentTaxLiabilities_per,1.52,本期所得稅負債,祺驊,生技醫療業
2021-09-30,1593,Liabilities,609362000.0,負債總額,祺驊,生技醫療業
2021-09-30,1593,Liabilities_per,36.28,負債總額,祺驊,生技醫療業
2021-09-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,156890000.0,未分配盈餘,祺驊,生技醫療業
2021-09-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,9.34,未分配盈餘,祺驊,生技醫療業
2021-09-30,1593,OtherEquityInterest,-62843000.0,其他權益合計,祺驊,生技醫療業
2021-09-30,1593,OtherEquityInterest_per,-3.74,其他權益合計,祺驊,生技醫療業
2021-09-30,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2021-09-30,1593,Equity,1070047000.0,權益總額,祺驊,生技醫療業
2021-09-30,1593,Equity_per,63.72,權益總額,祺驊,生技醫療業
2021-12-31,1593,CashAndCashEquivalents,201466000.0,現金及約當現金,祺驊,生技醫療業
2021-12-31,1593,CashAndCashEquivalents_per,12.21,現金及約當現金,祺驊,生技醫療業
2021-12-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,39065000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2021-12-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,2.37,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2021-12-31,1593,AccountsReceivableNet,247306000.0,應收帳款淨額,祺驊,生技醫療業
2021-12-31,1593,AccountsReceivableNet_per,14.98,應收帳款淨額,祺驊,生技醫療業
2021-12-31,1593,AccountsReceivableDuefromRelatedPartiesNet,22000.0,應收帳款－關係人淨額,祺驊,生技醫療業
2021-12-31,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2021-12-31,1593,Inventories,177054000.0,存貨,祺驊,生技醫療業
2021-12-31,1593,Inventories_per,10.73,存貨,祺驊,生技醫療業
2021-12-31,1593,OtherCurrentAssets,28752000.0,其他流動資產,祺驊,生技醫療業
2021-12-31,1593,OtherCurrentAssets_per,1.74,其他流動資產,祺驊,生技醫療業
2021-12-31,1593,CurrentAssets,764735000.0,流動資產合計,祺驊,生技醫療業
2021-12-31,1593,CurrentAssets_per,46.34,流動資產合計,祺驊,生技醫療業
2021-12-31,1593,PropertyPlantAndEquipment,697850000.0,不動產、廠房及設備,祺驊,生技醫療業
2021-12-31,1593,PropertyPlantAndEquipment_per,42.28,不動產、廠房及設備,祺驊,生技醫療業
2021-12-31,1593,IntangibleAssets,3621000.0,無形資產,祺驊,生技醫療業
2021-12-31,1593,IntangibleAssets_per,0.22,無形資產,祺驊,生技醫療業
2021-12-31,1593,DeferredTaxAssets,7637000.0,遞延所得稅資產,祺驊,生技醫療業
2021-12-31,1593,DeferredTaxAssets_per,0.46,遞延所得稅資產,祺驊,生技醫療業
2021-12-31,1593,OtherNoncurrentAssets,20646000.0,其他非流動資產,祺驊,生技醫療業
2021-12-31,1593,OtherNoncurrentAssets_per,1.25,其他非流動資產,祺驊,生技醫療業
2021-12-31,1593,NoncurrentAssets,885673000.0,非流動資產合計,祺驊,生技醫療業
2021-12-31,1593,NoncurrentAssets_per,53.66,非流動資產合計,祺驊,生技醫療業
2021-12-31,1593,TotalAssets,1650408000.0,資產總額,祺驊,生技醫療業
2021-12-31,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2021-12-31,1593,ShorttermBorrowings,5000000.0,短期借款,祺驊,生技醫療業
2021-12-31,1593,ShorttermBorrowings_per,0.3,短期借款,祺驊,生技醫療業
2021-12-31,1593,AccountsPayable,108257000.0,應付帳款,祺驊,生技醫療業
2021-12-31,1593,AccountsPayable_per,6.56,應付帳款,祺驊,生技醫療業
2021-12-31,1593,AccountsPayableToRelatedParties,4587000.0,應付帳款－關係人,祺驊,生技醫療業
2021-12-31,1593,AccountsPayableToRelatedParties_per,0.28,應付帳款－關係人,祺驊,生技醫療業
2021-12-31,1593,OtherPayables,53785000.0,其他應付款,祺驊,生技醫療業
2021-12-31,1593,OtherPayables_per,3.26,其他應付款,祺驊,生技醫療業
2021-12-31,1593,LongtermBorrowings,268000000.0,長期借款,祺驊,生技醫療業
2021-12-31,1593,LongtermBorrowings_per,16.24,長期借款,祺驊,生技醫療業
2021-12-31,1593,OtherNoncurrentLiabilities,4749000.0,其他非流動負債,祺驊,生技醫療業
2021-12-31,1593,OtherNoncurrentLiabilities_per,0.29,其他非流動負債,祺驊,生技醫療業
2021-12-31,1593,OrdinaryShare,352275000.0,普通股股本,祺驊,生技醫療業
2021-12-31,1593,OrdinaryShare_per,21.34,普通股股本,祺驊,生技醫療業
2021-12-31,1593,CapitalStock,352275000.0,股本合計,祺驊,生技醫療業
2021-12-31,1593,CapitalStock_per,21.34,股本合計,祺驊,生技醫療業
2021-12-31,1593,CapitalSurplus,436141000.0,資本公積合計,祺驊,生技醫療業
2021-12-31,1593,CapitalSurplus_per,26.43,資本公積合計,祺驊,生技醫療業
2021-12-31,1593,LegalReserve,126476000.0,法定盈餘公積,祺驊,生技醫療業
2021-12-31,1593,LegalReserve_per,7.66,法定盈餘公積,祺驊,生技醫療業
2021-12-31,1593,RetainedEarnings,382007000.0,保留盈餘合計,祺驊,生技醫療業
2021-12-31,1593,RetainedEarnings_per,23.15,保留盈餘合計,祺驊,生技醫療業
2021-12-31,1593,EquityAttributableToOwnersOfParent,1123881000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2021-12-31,1593,EquityAttributableToOwnersOfParent_per,68.1,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2021-12-31,1593,NoncontrollingInterests,8007000.0,非控制權益,祺驊,生技醫療業
2021-12-31,1593,NoncontrollingInterests_per,0.49,非控制權益,祺驊,生技醫療業
2021-12-31,1593,TotalLiabilitiesEquity,1650408000.0,負債及權益總計,祺驊,生技醫療業
2021-12-31,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2021-12-31,1593,OtherReceivablesDueFromRelatedParties,0.0,其他應收款－關係人淨額,祺驊,生技醫療業
2021-12-31,1593,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,祺驊,生技醫療業
2021-12-31,1593,FinancialAssetsAtAmortizedCost,71070000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2021-12-31,1593,FinancialAssetsAtAmortizedCost_per,4.31,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2021-12-31,1593,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,祺驊,生技醫療業
2021-12-31,1593,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,祺驊,生技醫療業
2021-12-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,53682000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2021-12-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,3.25,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2021-12-31,1593,InvestmentAccountedForUsingEquityMethod,70821000.0,採用權益法之投資,祺驊,生技醫療業
2021-12-31,1593,InvestmentAccountedForUsingEquityMethod_per,4.29,採用權益法之投資,祺驊,生技醫療業
2021-12-31,1593,RightOfUseAsset,23790000.0,使用權資產,祺驊,生技醫療業
2021-12-31,1593,RightOfUseAsset_per,1.44,使用權資產,祺驊,生技醫療業
2021-12-31,1593,CurrentTaxLiabilities,31404000.0,本期所得稅負債,祺驊,生技醫療業
2021-12-31,1593,CurrentTaxLiabilities_per,1.9,本期所得稅負債,祺驊,生技醫療業
2021-12-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,201847000.0,未分配盈餘,祺驊,生技醫療業
2021-12-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,12.23,未分配盈餘,祺驊,生技醫療業
2021-12-31,1593,OtherEquityInterest,-46542000.0,其他權益合計,祺驊,生技醫療業
2021-12-31,1593,OtherEquityInterest_per,-2.82,其他權益合計,祺驊,生技醫療業
2021-12-31,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2021-12-31,1593,Equity,1131888000.0,權益總額,祺驊,生技醫療業
2021-12-31,1593,Equity_per,68.58,權益總額,祺驊,生技醫療業
2021-12-31,1593,Liabilities,518520000.0,負債總額,祺驊,生技醫療業
2021-12-31,1593,Liabilities_per,31.42,負債總額,祺驊,生技醫療業
2021-12-31,1593,OtherCurrentLiabilities,14766000.0,其他流動負債,祺驊,生技醫療業
2021-12-31,1593,OtherCurrentLiabilities_per,0.89,其他流動負債,祺驊,生技醫療業
2021-12-31,1593,CurrentLiabilities,221669000.0,流動負債合計,祺驊,生技醫療業
2021-12-31,1593,CurrentLiabilities_per,13.43,流動負債合計,祺驊,生技醫療業
2021-12-31,1593,BondsPayable,17351000.0,應付公司債,祺驊,生技醫療業
2021-12-31,1593,BondsPayable_per,1.05,應付公司債,祺驊,生技醫療業
2021-12-31,1593,NoncurrentLiabilities,296851000.0,非流動負債合計,祺驊,生技醫療業
2021-12-31,1593,NoncurrentLiabilities_per,17.99,非流動負債合計,祺驊,生技醫療業
2022-03-31,1593,CashAndCashEquivalents,270549000.0,現金及約當現金,祺驊,生技醫療業
2022-03-31,1593,CashAndCashEquivalents_per,16.5,現金及約當現金,祺驊,生技醫療業
2022-03-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,22962000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2022-03-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.4,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2022-03-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,55879000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2022-03-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,3.41,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2022-03-31,1593,FinancialAssetsAtAmortizedCost,39231000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2022-03-31,1593,FinancialAssetsAtAmortizedCost_per,2.39,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2022-03-31,1593,AccountsReceivableNet,175868000.0,應收帳款淨額,祺驊,生技醫療業
2022-03-31,1593,AccountsReceivableNet_per,10.73,應收帳款淨額,祺驊,生技醫療業
2022-03-31,1593,AccountsReceivableDuefromRelatedPartiesNet,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2022-03-31,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2022-03-31,1593,OtherReceivablesDueFromRelatedParties,20211000.0,其他應收款－關係人淨額,祺驊,生技醫療業
2022-03-31,1593,OtherReceivablesDueFromRelatedParties_per,1.23,其他應收款－關係人淨額,祺驊,生技醫療業
2022-03-31,1593,Inventories,170572000.0,存貨,祺驊,生技醫療業
2022-03-31,1593,Inventories_per,10.4,存貨,祺驊,生技醫療業
2022-03-31,1593,OtherCurrentAssets,32105000.0,其他流動資產,祺驊,生技醫療業
2022-03-31,1593,OtherCurrentAssets_per,1.96,其他流動資產,祺驊,生技醫療業
2022-03-31,1593,CurrentAssets,731498000.0,流動資產合計,祺驊,生技醫療業
2022-03-31,1593,CurrentAssets_per,44.61,流動資產合計,祺驊,生技醫療業
2022-03-31,1593,InvestmentAccountedForUsingEquityMethod,53513000.0,採用權益法之投資,祺驊,生技醫療業
2022-03-31,1593,InvestmentAccountedForUsingEquityMethod_per,3.26,採用權益法之投資,祺驊,生技醫療業
2022-03-31,1593,PropertyPlantAndEquipment,713575000.0,不動產、廠房及設備,祺驊,生技醫療業
2022-03-31,1593,PropertyPlantAndEquipment_per,43.52,不動產、廠房及設備,祺驊,生技醫療業
2022-03-31,1593,RightOfUseAsset,23453000.0,使用權資產,祺驊,生技醫療業
2022-03-31,1593,RightOfUseAsset_per,1.43,使用權資產,祺驊,生技醫療業
2022-03-31,1593,IntangibleAssets,3714000.0,無形資產,祺驊,生技醫療業
2022-03-31,1593,IntangibleAssets_per,0.23,無形資產,祺驊,生技醫療業
2022-03-31,1593,DeferredTaxAssets,7466000.0,遞延所得稅資產,祺驊,生技醫療業
2022-03-31,1593,DeferredTaxAssets_per,0.46,遞延所得稅資產,祺驊,生技醫療業
2022-03-31,1593,OtherNoncurrentAssets,42957000.0,其他非流動資產,祺驊,生技醫療業
2022-03-31,1593,OtherNoncurrentAssets_per,2.62,其他非流動資產,祺驊,生技醫療業
2022-03-31,1593,NoncurrentAssets,908169000.0,非流動資產合計,祺驊,生技醫療業
2022-03-31,1593,NoncurrentAssets_per,55.39,非流動資產合計,祺驊,生技醫療業
2022-03-31,1593,TotalAssets,1639667000.0,資產總額,祺驊,生技醫療業
2022-03-31,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2022-03-31,1593,ShorttermBorrowings,5000000.0,短期借款,祺驊,生技醫療業
2022-03-31,1593,ShorttermBorrowings_per,0.3,短期借款,祺驊,生技醫療業
2022-03-31,1593,AccountsPayable,82046000.0,應付帳款,祺驊,生技醫療業
2022-03-31,1593,AccountsPayable_per,5.0,應付帳款,祺驊,生技醫療業
2022-03-31,1593,AccountsPayableToRelatedParties,4577000.0,應付帳款－關係人,祺驊,生技醫療業
2022-03-31,1593,AccountsPayableToRelatedParties_per,0.28,應付帳款－關係人,祺驊,生技醫療業
2022-03-31,1593,OtherPayables,37213000.0,其他應付款,祺驊,生技醫療業
2022-03-31,1593,OtherPayables_per,2.27,其他應付款,祺驊,生技醫療業
2022-03-31,1593,CurrentTaxLiabilities,34349000.0,本期所得稅負債,祺驊,生技醫療業
2022-03-31,1593,CurrentTaxLiabilities_per,2.09,本期所得稅負債,祺驊,生技醫療業
2022-03-31,1593,OtherCurrentLiabilities,16411000.0,其他流動負債,祺驊,生技醫療業
2022-03-31,1593,OtherCurrentLiabilities_per,1.0,其他流動負債,祺驊,生技醫療業
2022-03-31,1593,CurrentLiabilities,180632000.0,流動負債合計,祺驊,生技醫療業
2022-03-31,1593,CurrentLiabilities_per,11.02,流動負債合計,祺驊,生技醫療業
2022-03-31,1593,BondsPayable,17423000.0,應付公司債,祺驊,生技醫療業
2022-03-31,1593,BondsPayable_per,1.06,應付公司債,祺驊,生技醫療業
2022-03-31,1593,LongtermBorrowings,268000000.0,長期借款,祺驊,生技醫療業
2022-03-31,1593,LongtermBorrowings_per,16.34,長期借款,祺驊,生技醫療業
2022-03-31,1593,OtherNoncurrentLiabilities,4405000.0,其他非流動負債,祺驊,生技醫療業
2022-03-31,1593,OtherNoncurrentLiabilities_per,0.27,其他非流動負債,祺驊,生技醫療業
2022-03-31,1593,NoncurrentLiabilities,296567000.0,非流動負債合計,祺驊,生技醫療業
2022-03-31,1593,NoncurrentLiabilities_per,18.09,非流動負債合計,祺驊,生技醫療業
2022-03-31,1593,OrdinaryShare,352275000.0,普通股股本,祺驊,生技醫療業
2022-03-31,1593,OrdinaryShare_per,21.48,普通股股本,祺驊,生技醫療業
2022-03-31,1593,CapitalStock,352275000.0,股本合計,祺驊,生技醫療業
2022-03-31,1593,CapitalStock_per,21.48,股本合計,祺驊,生技醫療業
2022-03-31,1593,CapitalSurplus,436141000.0,資本公積合計,祺驊,生技醫療業
2022-03-31,1593,CapitalSurplus_per,26.6,資本公積合計,祺驊,生技醫療業
2022-03-31,1593,LegalReserve,126476000.0,法定盈餘公積,祺驊,生技醫療業
2022-03-31,1593,LegalReserve_per,7.71,法定盈餘公積,祺驊,生技醫療業
2022-03-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,213950000.0,未分配盈餘,祺驊,生技醫療業
2022-03-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,13.05,未分配盈餘,祺驊,生技醫療業
2022-03-31,1593,RetainedEarnings,394110000.0,保留盈餘合計,祺驊,生技醫療業
2022-03-31,1593,RetainedEarnings_per,24.04,保留盈餘合計,祺驊,生技醫療業
2022-03-31,1593,OtherEquityInterest,-28689000.0,其他權益合計,祺驊,生技醫療業
2022-03-31,1593,OtherEquityInterest_per,-1.75,其他權益合計,祺驊,生技醫療業
2022-03-31,1593,EquityAttributableToOwnersOfParent,1153837000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2022-03-31,1593,EquityAttributableToOwnersOfParent_per,70.37,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2022-03-31,1593,NoncontrollingInterests,8631000.0,非控制權益,祺驊,生技醫療業
2022-03-31,1593,NoncontrollingInterests_per,0.53,非控制權益,祺驊,生技醫療業
2022-03-31,1593,TotalLiabilitiesEquity,1639667000.0,負債及權益總計,祺驊,生技醫療業
2022-03-31,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2022-03-31,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2022-03-31,1593,Equity,1162468000.0,權益總額,祺驊,生技醫療業
2022-03-31,1593,Equity_per,70.9,權益總額,祺驊,生技醫療業
2022-03-31,1593,Liabilities,477199000.0,負債總額,祺驊,生技醫療業
2022-03-31,1593,Liabilities_per,29.1,負債總額,祺驊,生技醫療業
2022-06-30,1593,BondsPayable,0.0,應付公司債,祺驊,生技醫療業
2022-06-30,1593,BondsPayable_per,0.0,應付公司債,祺驊,生技醫療業
2022-06-30,1593,CashAndCashEquivalents,215834000.0,現金及約當現金,祺驊,生技醫療業
2022-06-30,1593,CashAndCashEquivalents_per,13.39,現金及約當現金,祺驊,生技醫療業
2022-06-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,49425000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2022-06-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,3.07,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2022-06-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,52531000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2022-06-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,3.26,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2022-06-30,1593,FinancialAssetsAtAmortizedCost,46690000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2022-06-30,1593,FinancialAssetsAtAmortizedCost_per,2.9,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2022-06-30,1593,AccountsReceivableNet,107865000.0,應收帳款淨額,祺驊,生技醫療業
2022-06-30,1593,AccountsReceivableNet_per,6.69,應收帳款淨額,祺驊,生技醫療業
2022-06-30,1593,AccountsReceivableDuefromRelatedPartiesNet,38000.0,應收帳款－關係人淨額,祺驊,生技醫療業
2022-06-30,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2022-06-30,1593,OtherReceivablesDueFromRelatedParties,318000.0,其他應收款－關係人淨額,祺驊,生技醫療業
2022-06-30,1593,OtherReceivablesDueFromRelatedParties_per,0.02,其他應收款－關係人淨額,祺驊,生技醫療業
2022-06-30,1593,Inventories,180551000.0,存貨,祺驊,生技醫療業
2022-06-30,1593,Inventories_per,11.2,存貨,祺驊,生技醫療業
2022-06-30,1593,CurrentAssets,631848000.0,流動資產合計,祺驊,生技醫療業
2022-06-30,1593,CurrentAssets_per,39.21,流動資產合計,祺驊,生技醫療業
2022-06-30,1593,InvestmentAccountedForUsingEquityMethod,59177000.0,採用權益法之投資,祺驊,生技醫療業
2022-06-30,1593,InvestmentAccountedForUsingEquityMethod_per,3.67,採用權益法之投資,祺驊,生技醫療業
2022-06-30,1593,PropertyPlantAndEquipment,752604000.0,不動產、廠房及設備,祺驊,生技醫療業
2022-06-30,1593,PropertyPlantAndEquipment_per,46.71,不動產、廠房及設備,祺驊,生技醫療業
2022-06-30,1593,RightOfUseAsset,22943000.0,使用權資產,祺驊,生技醫療業
2022-06-30,1593,RightOfUseAsset_per,1.42,使用權資產,祺驊,生技醫療業
2022-06-30,1593,IntangibleAssets,3822000.0,無形資產,祺驊,生技醫療業
2022-06-30,1593,IntangibleAssets_per,0.24,無形資產,祺驊,生技醫療業
2022-06-30,1593,DeferredTaxAssets,7158000.0,遞延所得稅資產,祺驊,生技醫療業
2022-06-30,1593,DeferredTaxAssets_per,0.44,遞延所得稅資產,祺驊,生技醫療業
2022-06-30,1593,OtherNoncurrentAssets,81270000.0,其他非流動資產,祺驊,生技醫療業
2022-06-30,1593,OtherNoncurrentAssets_per,5.04,其他非流動資產,祺驊,生技醫療業
2022-06-30,1593,NoncurrentAssets,979505000.0,非流動資產合計,祺驊,生技醫療業
2022-06-30,1593,NoncurrentAssets_per,60.79,非流動資產合計,祺驊,生技醫療業
2022-06-30,1593,TotalAssets,1611353000.0,資產總額,祺驊,生技醫療業
2022-06-30,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2022-06-30,1593,ShorttermBorrowings,4000000.0,短期借款,祺驊,生技醫療業
2022-06-30,1593,ShorttermBorrowings_per,0.25,短期借款,祺驊,生技醫療業
2022-06-30,1593,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,39000.0,透過損益按公允價值衡量之金融負債－流動,祺驊,生技醫療業
2022-06-30,1593,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,祺驊,生技醫療業
2022-06-30,1593,AccountsPayable,69642000.0,應付帳款,祺驊,生技醫療業
2022-06-30,1593,AccountsPayable_per,4.32,應付帳款,祺驊,生技醫療業
2022-06-30,1593,AccountsPayableToRelatedParties,299000.0,應付帳款－關係人,祺驊,生技醫療業
2022-06-30,1593,AccountsPayableToRelatedParties_per,0.02,應付帳款－關係人,祺驊,生技醫療業
2022-06-30,1593,OtherPayables,171950000.0,其他應付款,祺驊,生技醫療業
2022-06-30,1593,OtherPayables_per,10.67,其他應付款,祺驊,生技醫療業
2022-06-30,1593,CurrentTaxLiabilities,4253000.0,本期所得稅負債,祺驊,生技醫療業
2022-06-30,1593,CurrentTaxLiabilities_per,0.26,本期所得稅負債,祺驊,生技醫療業
2022-06-30,1593,OtherCurrentLiabilities,35497000.0,其他流動負債,祺驊,生技醫療業
2022-06-30,1593,OtherCurrentLiabilities_per,2.2,其他流動負債,祺驊,生技醫療業
2022-06-30,1593,CurrentLiabilities,286730000.0,流動負債合計,祺驊,生技醫療業
2022-06-30,1593,CurrentLiabilities_per,17.79,流動負債合計,祺驊,生技醫療業
2022-06-30,1593,LongtermBorrowings,268000000.0,長期借款,祺驊,生技醫療業
2022-06-30,1593,LongtermBorrowings_per,16.63,長期借款,祺驊,生技醫療業
2022-06-30,1593,OtherNoncurrentLiabilities,4081000.0,其他非流動負債,祺驊,生技醫療業
2022-06-30,1593,OtherNoncurrentLiabilities_per,0.25,其他非流動負債,祺驊,生技醫療業
2022-06-30,1593,NoncurrentLiabilities,278544000.0,非流動負債合計,祺驊,生技醫療業
2022-06-30,1593,NoncurrentLiabilities_per,17.29,非流動負債合計,祺驊,生技醫療業
2022-06-30,1593,OrdinaryShare,352275000.0,普通股股本,祺驊,生技醫療業
2022-06-30,1593,OrdinaryShare_per,21.86,普通股股本,祺驊,生技醫療業
2022-06-30,1593,CapitalStock,352275000.0,股本合計,祺驊,生技醫療業
2022-06-30,1593,CapitalStock_per,21.86,股本合計,祺驊,生技醫療業
2022-06-30,1593,CapitalSurplus,436141000.0,資本公積合計,祺驊,生技醫療業
2022-06-30,1593,CapitalSurplus_per,27.07,資本公積合計,祺驊,生技醫療業
2022-06-30,1593,LegalReserve,143595000.0,法定盈餘公積,祺驊,生技醫療業
2022-06-30,1593,LegalReserve_per,8.91,法定盈餘公積,祺驊,生技醫療業
2022-06-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,87025000.0,未分配盈餘,祺驊,生技醫療業
2022-06-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,5.4,未分配盈餘,祺驊,生技醫療業
2022-06-30,1593,RetainedEarnings,277162000.0,保留盈餘合計,祺驊,生技醫療業
2022-06-30,1593,RetainedEarnings_per,17.2,保留盈餘合計,祺驊,生技醫療業
2022-06-30,1593,OtherEquityInterest,-28134000.0,其他權益合計,祺驊,生技醫療業
2022-06-30,1593,OtherEquityInterest_per,-1.75,其他權益合計,祺驊,生技醫療業
2022-06-30,1593,EquityAttributableToOwnersOfParent,1037444000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2022-06-30,1593,EquityAttributableToOwnersOfParent_per,64.38,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2022-06-30,1593,NoncontrollingInterests,8635000.0,非控制權益,祺驊,生技醫療業
2022-06-30,1593,NoncontrollingInterests_per,0.54,非控制權益,祺驊,生技醫療業
2022-06-30,1593,TotalLiabilitiesEquity,1611353000.0,負債及權益總計,祺驊,生技醫療業
2022-06-30,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2022-06-30,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2022-06-30,1593,Liabilities,565274000.0,負債總額,祺驊,生技醫療業
2022-06-30,1593,Liabilities_per,35.08,負債總額,祺驊,生技醫療業
2022-06-30,1593,Equity,1046079000.0,權益總額,祺驊,生技醫療業
2022-06-30,1593,Equity_per,64.92,權益總額,祺驊,生技醫療業
2022-06-30,1593,OtherCurrentAssets,31445000.0,其他流動資產,祺驊,生技醫療業
2022-06-30,1593,OtherCurrentAssets_per,1.95,其他流動資產,祺驊,生技醫療業
2022-09-30,1593,CashAndCashEquivalents,270815000.0,現金及約當現金,祺驊,生技醫療業
2022-09-30,1593,CashAndCashEquivalents_per,13.17,現金及約當現金,祺驊,生技醫療業
2022-09-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,56870000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2022-09-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,2.76,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2022-09-30,1593,FinancialAssetsAtAmortizedCost,65481000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2022-09-30,1593,FinancialAssetsAtAmortizedCost_per,3.18,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2022-09-30,1593,AccountsReceivableNet,176487000.0,應收帳款淨額,祺驊,生技醫療業
2022-09-30,1593,AccountsReceivableNet_per,8.58,應收帳款淨額,祺驊,生技醫療業
2022-09-30,1593,AccountsReceivableDuefromRelatedPartiesNet,150000.0,應收帳款－關係人淨額,祺驊,生技醫療業
2022-09-30,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.01,應收帳款－關係人淨額,祺驊,生技醫療業
2022-09-30,1593,Inventories,201693000.0,存貨,祺驊,生技醫療業
2022-09-30,1593,Inventories_per,9.81,存貨,祺驊,生技醫療業
2022-09-30,1593,OtherCurrentAssets,47815000.0,其他流動資產,祺驊,生技醫療業
2022-09-30,1593,OtherCurrentAssets_per,2.32,其他流動資產,祺驊,生技醫療業
2022-09-30,1593,CurrentAssets,819311000.0,流動資產合計,祺驊,生技醫療業
2022-09-30,1593,CurrentAssets_per,39.83,流動資產合計,祺驊,生技醫療業
2022-09-30,1593,PropertyPlantAndEquipment,866069000.0,不動產、廠房及設備,祺驊,生技醫療業
2022-09-30,1593,PropertyPlantAndEquipment_per,42.11,不動產、廠房及設備,祺驊,生技醫療業
2022-09-30,1593,IntangibleAssets,234970000.0,無形資產,祺驊,生技醫療業
2022-09-30,1593,IntangibleAssets_per,11.42,無形資產,祺驊,生技醫療業
2022-09-30,1593,DeferredTaxAssets,6742000.0,遞延所得稅資產,祺驊,生技醫療業
2022-09-30,1593,DeferredTaxAssets_per,0.33,遞延所得稅資產,祺驊,生技醫療業
2022-09-30,1593,OtherNoncurrentAssets,50027000.0,其他非流動資產,祺驊,生技醫療業
2022-09-30,1593,OtherNoncurrentAssets_per,2.43,其他非流動資產,祺驊,生技醫療業
2022-09-30,1593,NoncurrentAssets,1237554000.0,非流動資產合計,祺驊,生技醫療業
2022-09-30,1593,NoncurrentAssets_per,60.17,非流動資產合計,祺驊,生技醫療業
2022-09-30,1593,TotalAssets,2056865000.0,資產總額,祺驊,生技醫療業
2022-09-30,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2022-09-30,1593,ShorttermBorrowings,154000000.0,短期借款,祺驊,生技醫療業
2022-09-30,1593,ShorttermBorrowings_per,7.49,短期借款,祺驊,生技醫療業
2022-09-30,1593,AccountsPayable,87248000.0,應付帳款,祺驊,生技醫療業
2022-09-30,1593,AccountsPayable_per,4.24,應付帳款,祺驊,生技醫療業
2022-09-30,1593,AccountsPayableToRelatedParties,2670000.0,應付帳款－關係人,祺驊,生技醫療業
2022-09-30,1593,AccountsPayableToRelatedParties_per,0.13,應付帳款－關係人,祺驊,生技醫療業
2022-09-30,1593,OtherPayables,77790000.0,其他應付款,祺驊,生技醫療業
2022-09-30,1593,OtherPayables_per,3.78,其他應付款,祺驊,生技醫療業
2022-09-30,1593,OtherCurrentLiabilities,56112000.0,其他流動負債,祺驊,生技醫療業
2022-09-30,1593,OtherCurrentLiabilities_per,2.73,其他流動負債,祺驊,生技醫療業
2022-09-30,1593,CurrentLiabilities,408180000.0,流動負債合計,祺驊,生技醫療業
2022-09-30,1593,CurrentLiabilities_per,19.84,流動負債合計,祺驊,生技醫療業
2022-09-30,1593,BondsPayable,0.0,應付公司債,祺驊,生技醫療業
2022-09-30,1593,BondsPayable_per,0.0,應付公司債,祺驊,生技醫療業
2022-09-30,1593,LongtermBorrowings,265701000.0,長期借款,祺驊,生技醫療業
2022-09-30,1593,LongtermBorrowings_per,12.92,長期借款,祺驊,生技醫療業
2022-09-30,1593,OtherNoncurrentLiabilities,27215000.0,其他非流動負債,祺驊,生技醫療業
2022-09-30,1593,OtherNoncurrentLiabilities_per,1.32,其他非流動負債,祺驊,生技醫療業
2022-09-30,1593,NoncurrentLiabilities,299679000.0,非流動負債合計,祺驊,生技醫療業
2022-09-30,1593,NoncurrentLiabilities_per,14.57,非流動負債合計,祺驊,生技醫療業
2022-09-30,1593,OrdinaryShare,372275000.0,普通股股本,祺驊,生技醫療業
2022-09-30,1593,OrdinaryShare_per,18.1,普通股股本,祺驊,生技醫療業
2022-09-30,1593,CapitalStock,372382000.0,股本合計,祺驊,生技醫療業
2022-09-30,1593,CapitalStock_per,18.1,股本合計,祺驊,生技醫療業
2022-09-30,1593,CapitalSurplus,566423000.0,資本公積合計,祺驊,生技醫療業
2022-09-30,1593,CapitalSurplus_per,27.54,資本公積合計,祺驊,生技醫療業
2022-09-30,1593,LegalReserve,143595000.0,法定盈餘公積,祺驊,生技醫療業
2022-09-30,1593,LegalReserve_per,6.98,法定盈餘公積,祺驊,生技醫療業
2022-09-30,1593,RetainedEarnings,400321000.0,保留盈餘合計,祺驊,生技醫療業
2022-09-30,1593,RetainedEarnings_per,19.46,保留盈餘合計,祺驊,生技醫療業
2022-09-30,1593,EquityAttributableToOwnersOfParent,1309171000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2022-09-30,1593,EquityAttributableToOwnersOfParent_per,63.65,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2022-09-30,1593,NoncontrollingInterests,39835000.0,非控制權益,祺驊,生技醫療業
2022-09-30,1593,NoncontrollingInterests_per,1.94,非控制權益,祺驊,生技醫療業
2022-09-30,1593,TotalLiabilitiesEquity,2056865000.0,負債及權益總計,祺驊,生技醫療業
2022-09-30,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2022-09-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,34339000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2022-09-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,1.67,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2022-09-30,1593,OtherReceivablesDueFromRelatedParties,0.0,其他應收款－關係人淨額,祺驊,生技醫療業
2022-09-30,1593,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,祺驊,生技醫療業
2022-09-30,1593,InvestmentAccountedForUsingEquityMethod,15298000.0,採用權益法之投資,祺驊,生技醫療業
2022-09-30,1593,InvestmentAccountedForUsingEquityMethod_per,0.74,採用權益法之投資,祺驊,生技醫療業
2022-09-30,1593,RightOfUseAsset,30109000.0,使用權資產,祺驊,生技醫療業
2022-09-30,1593,RightOfUseAsset_per,1.46,使用權資產,祺驊,生技醫療業
2022-09-30,1593,CurrentTaxLiabilities,22595000.0,本期所得稅負債,祺驊,生技醫療業
2022-09-30,1593,CurrentTaxLiabilities_per,1.1,本期所得稅負債,祺驊,生技醫療業
2022-09-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,210184000.0,未分配盈餘,祺驊,生技醫療業
2022-09-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,10.22,未分配盈餘,祺驊,生技醫療業
2022-09-30,1593,OtherEquityInterest,-29955000.0,其他權益合計,祺驊,生技醫療業
2022-09-30,1593,OtherEquityInterest_per,-1.46,其他權益合計,祺驊,生技醫療業
2022-09-30,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2022-09-30,1593,Equity,1349006000.0,權益總額,祺驊,生技醫療業
2022-09-30,1593,Equity_per,65.59,權益總額,祺驊,生技醫療業
2022-09-30,1593,Liabilities,707859000.0,負債總額,祺驊,生技醫療業
2022-09-30,1593,Liabilities_per,34.41,負債總額,祺驊,生技醫療業
2022-12-31,1593,BondsPayable,0.0,應付公司債,祺驊,生技醫療業
2022-12-31,1593,BondsPayable_per,0.0,應付公司債,祺驊,生技醫療業
2022-12-31,1593,CashAndCashEquivalents,331929000.0,現金及約當現金,祺驊,生技醫療業
2022-12-31,1593,CashAndCashEquivalents_per,15.75,現金及約當現金,祺驊,生技醫療業
2022-12-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,38689000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2022-12-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.84,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2022-12-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,34897000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2022-12-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,1.66,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2022-12-31,1593,FinancialAssetsAtAmortizedCost,87122000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2022-12-31,1593,FinancialAssetsAtAmortizedCost_per,4.13,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2022-12-31,1593,AccountsReceivableNet,191688000.0,應收帳款淨額,祺驊,生技醫療業
2022-12-31,1593,AccountsReceivableNet_per,9.1,應收帳款淨額,祺驊,生技醫療業
2022-12-31,1593,AccountsReceivableDuefromRelatedPartiesNet,190000.0,應收帳款－關係人淨額,祺驊,生技醫療業
2022-12-31,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.01,應收帳款－關係人淨額,祺驊,生技醫療業
2022-12-31,1593,OtherReceivablesDueFromRelatedParties,1000.0,其他應收款－關係人淨額,祺驊,生技醫療業
2022-12-31,1593,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,祺驊,生技醫療業
2022-12-31,1593,Inventories,179636000.0,存貨,祺驊,生技醫療業
2022-12-31,1593,Inventories_per,8.52,存貨,祺驊,生技醫療業
2022-12-31,1593,OtherCurrentAssets_per,1.83,其他流動資產,祺驊,生技醫療業
2022-12-31,1593,CurrentAssets,867810000.0,流動資產合計,祺驊,生技醫療業
2022-12-31,1593,CurrentAssets_per,41.18,流動資產合計,祺驊,生技醫療業
2022-12-31,1593,InvestmentAccountedForUsingEquityMethod,15703000.0,採用權益法之投資,祺驊,生技醫療業
2022-12-31,1593,InvestmentAccountedForUsingEquityMethod_per,0.75,採用權益法之投資,祺驊,生技醫療業
2022-12-31,1593,PropertyPlantAndEquipment,875895000.0,不動產、廠房及設備,祺驊,生技醫療業
2022-12-31,1593,PropertyPlantAndEquipment_per,41.57,不動產、廠房及設備,祺驊,生技醫療業
2022-12-31,1593,RightOfUseAsset,28251000.0,使用權資產,祺驊,生技醫療業
2022-12-31,1593,RightOfUseAsset_per,1.34,使用權資產,祺驊,生技醫療業
2022-12-31,1593,IntangibleAssets,243063000.0,無形資產,祺驊,生技醫療業
2022-12-31,1593,IntangibleAssets_per,11.53,無形資產,祺驊,生技醫療業
2022-12-31,1593,DeferredTaxAssets,7832000.0,遞延所得稅資產,祺驊,生技醫療業
2022-12-31,1593,DeferredTaxAssets_per,0.37,遞延所得稅資產,祺驊,生技醫療業
2022-12-31,1593,OtherNoncurrentAssets,33823000.0,其他非流動資產,祺驊,生技醫療業
2022-12-31,1593,OtherNoncurrentAssets_per,1.61,其他非流動資產,祺驊,生技醫療業
2022-12-31,1593,NoncurrentAssets,1239464000.0,非流動資產合計,祺驊,生技醫療業
2022-12-31,1593,NoncurrentAssets_per,58.82,非流動資產合計,祺驊,生技醫療業
2022-12-31,1593,TotalAssets,2107274000.0,資產總額,祺驊,生技醫療業
2022-12-31,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2022-12-31,1593,ShorttermBorrowings,152000000.0,短期借款,祺驊,生技醫療業
2022-12-31,1593,ShorttermBorrowings_per,7.21,短期借款,祺驊,生技醫療業
2022-12-31,1593,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,祺驊,生技醫療業
2022-12-31,1593,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,祺驊,生技醫療業
2022-12-31,1593,AccountsPayable,83155000.0,應付帳款,祺驊,生技醫療業
2022-12-31,1593,AccountsPayable_per,3.95,應付帳款,祺驊,生技醫療業
2022-12-31,1593,AccountsPayableToRelatedParties,7288000.0,應付帳款－關係人,祺驊,生技醫療業
2022-12-31,1593,AccountsPayableToRelatedParties_per,0.35,應付帳款－關係人,祺驊,生技醫療業
2022-12-31,1593,OtherPayables,94628000.0,其他應付款,祺驊,生技醫療業
2022-12-31,1593,OtherPayables_per,4.49,其他應付款,祺驊,生技醫療業
2022-12-31,1593,CurrentTaxLiabilities,34651000.0,本期所得稅負債,祺驊,生技醫療業
2022-12-31,1593,CurrentTaxLiabilities_per,1.64,本期所得稅負債,祺驊,生技醫療業
2022-12-31,1593,OtherCurrentLiabilities,54564000.0,其他流動負債,祺驊,生技醫療業
2022-12-31,1593,OtherCurrentLiabilities_per,2.59,其他流動負債,祺驊,生技醫療業
2022-12-31,1593,CurrentLiabilities,431483000.0,流動負債合計,祺驊,生技醫療業
2022-12-31,1593,CurrentLiabilities_per,20.48,流動負債合計,祺驊,生技醫療業
2022-12-31,1593,LongtermBorrowings,261083000.0,長期借款,祺驊,生技醫療業
2022-12-31,1593,LongtermBorrowings_per,12.39,長期借款,祺驊,生技醫療業
2022-12-31,1593,OtherNoncurrentLiabilities,25549000.0,其他非流動負債,祺驊,生技醫療業
2022-12-31,1593,OtherNoncurrentLiabilities_per,1.21,其他非流動負債,祺驊,生技醫療業
2022-12-31,1593,NoncurrentLiabilities,294376000.0,非流動負債合計,祺驊,生技醫療業
2022-12-31,1593,NoncurrentLiabilities_per,13.97,非流動負債合計,祺驊,生技醫療業
2022-12-31,1593,OrdinaryShare,372560000.0,普通股股本,祺驊,生技醫療業
2022-12-31,1593,OrdinaryShare_per,17.68,普通股股本,祺驊,生技醫療業
2022-12-31,1593,CapitalStock,372560000.0,股本合計,祺驊,生技醫療業
2022-12-31,1593,CapitalStock_per,17.68,股本合計,祺驊,生技醫療業
2022-12-31,1593,CapitalSurplus,567228000.0,資本公積合計,祺驊,生技醫療業
2022-12-31,1593,CapitalSurplus_per,26.92,資本公積合計,祺驊,生技醫療業
2022-12-31,1593,LegalReserve,143595000.0,法定盈餘公積,祺驊,生技醫療業
2022-12-31,1593,LegalReserve_per,6.81,法定盈餘公積,祺驊,生技醫療業
2022-12-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,247926000.0,未分配盈餘,祺驊,生技醫療業
2022-12-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,11.77,未分配盈餘,祺驊,生技醫療業
2022-12-31,1593,RetainedEarnings,438063000.0,保留盈餘合計,祺驊,生技醫療業
2022-12-31,1593,RetainedEarnings_per,20.79,保留盈餘合計,祺驊,生技醫療業
2022-12-31,1593,OtherEquityInterest,-43339000.0,其他權益合計,祺驊,生技醫療業
2022-12-31,1593,OtherEquityInterest_per,-2.06,其他權益合計,祺驊,生技醫療業
2022-12-31,1593,EquityAttributableToOwnersOfParent,1334512000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2022-12-31,1593,EquityAttributableToOwnersOfParent_per,63.33,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2022-12-31,1593,NoncontrollingInterests,46903000.0,非控制權益,祺驊,生技醫療業
2022-12-31,1593,NoncontrollingInterests_per,2.23,非控制權益,祺驊,生技醫療業
2022-12-31,1593,TotalLiabilitiesEquity,2107274000.0,負債及權益總計,祺驊,生技醫療業
2022-12-31,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2022-12-31,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2022-12-31,1593,Equity,1381415000.0,權益總額,祺驊,生技醫療業
2022-12-31,1593,Equity_per,65.55,權益總額,祺驊,生技醫療業
2022-12-31,1593,Liabilities,725859000.0,負債總額,祺驊,生技醫療業
2022-12-31,1593,Liabilities_per,34.45,負債總額,祺驊,生技醫療業
2022-12-31,1593,OtherCurrentAssets,38555000.0,其他流動資產,祺驊,生技醫療業
2023-03-31,1593,CashAndCashEquivalents,317783000.0,現金及約當現金,祺驊,生技醫療業
2023-03-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,69302000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2023-03-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,3.34,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2023-03-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,41054000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2023-03-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,1.98,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2023-03-31,1593,FinancialAssetsAtAmortizedCost,89311000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2023-03-31,1593,FinancialAssetsAtAmortizedCost_per,4.3,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2023-03-31,1593,AccountsReceivableNet,139841000.0,應收帳款淨額,祺驊,生技醫療業
2023-03-31,1593,AccountsReceivableNet_per,6.74,應收帳款淨額,祺驊,生技醫療業
2023-03-31,1593,AccountsReceivableDuefromRelatedPartiesNet,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2023-03-31,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2023-03-31,1593,OtherReceivablesDueFromRelatedParties,458000.0,其他應收款－關係人淨額,祺驊,生技醫療業
2023-03-31,1593,OtherReceivablesDueFromRelatedParties_per,0.02,其他應收款－關係人淨額,祺驊,生技醫療業
2023-03-31,1593,Inventories,172946000.0,存貨,祺驊,生技醫療業
2023-03-31,1593,OtherCurrentAssets,40459000.0,其他流動資產,祺驊,生技醫療業
2023-03-31,1593,OtherCurrentAssets_per,1.95,其他流動資產,祺驊,生技醫療業
2023-03-31,1593,CurrentAssets,830100000.0,流動資產合計,祺驊,生技醫療業
2023-03-31,1593,InvestmentAccountedForUsingEquityMethod,16288000.0,採用權益法之投資,祺驊,生技醫療業
2023-03-31,1593,PropertyPlantAndEquipment,872939000.0,不動產、廠房及設備,祺驊,生技醫療業
2023-03-31,1593,RightOfUseAsset,29046000.0,使用權資產,祺驊,生技醫療業
2023-03-31,1593,RightOfUseAsset_per,1.4,使用權資產,祺驊,生技醫療業
2023-03-31,1593,DeferredTaxAssets,10380000.0,遞延所得稅資產,祺驊,生技醫療業
2023-03-31,1593,DeferredTaxAssets_per,0.5,遞延所得稅資產,祺驊,生技醫療業
2023-03-31,1593,OtherNoncurrentAssets,33736000.0,其他非流動資產,祺驊,生技醫療業
2023-03-31,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2023-03-31,1593,ShorttermBorrowings,154000000.0,短期借款,祺驊,生技醫療業
2023-03-31,1593,ShorttermBorrowings_per,7.42,短期借款,祺驊,生技醫療業
2023-03-31,1593,AccountsPayable,57650000.0,應付帳款,祺驊,生技醫療業
2023-03-31,1593,AccountsPayable_per,2.78,應付帳款,祺驊,生技醫療業
2023-03-31,1593,AccountsPayableToRelatedParties,2617000.0,應付帳款－關係人,祺驊,生技醫療業
2023-03-31,1593,AccountsPayableToRelatedParties_per,0.13,應付帳款－關係人,祺驊,生技醫療業
2023-03-31,1593,OtherPayables_per,7.47,其他應付款,祺驊,生技醫療業
2023-03-31,1593,CurrentTaxLiabilities,38595000.0,本期所得稅負債,祺驊,生技醫療業
2023-03-31,1593,CurrentTaxLiabilities_per,1.86,本期所得稅負債,祺驊,生技醫療業
2023-03-31,1593,OtherCurrentLiabilities,48749000.0,其他流動負債,祺驊,生技醫療業
2023-03-31,1593,OtherCurrentLiabilities_per,2.35,其他流動負債,祺驊,生技醫療業
2023-03-31,1593,BondsPayable,0.0,應付公司債,祺驊,生技醫療業
2023-03-31,1593,BondsPayable_per,0.0,應付公司債,祺驊,生技醫療業
2023-03-31,1593,LongtermBorrowings,256446000.0,長期借款,祺驊,生技醫療業
2023-03-31,1593,OtherNoncurrentLiabilities,24755000.0,其他非流動負債,祺驊,生技醫療業
2023-03-31,1593,OtherNoncurrentLiabilities_per,1.19,其他非流動負債,祺驊,生技醫療業
2023-03-31,1593,NoncurrentLiabilities,289609000.0,非流動負債合計,祺驊,生技醫療業
2023-03-31,1593,OrdinaryShare,372560000.0,普通股股本,祺驊,生技醫療業
2023-03-31,1593,CapitalStock,375443000.0,股本合計,祺驊,生技醫療業
2023-03-31,1593,CapitalSurplus,580378000.0,資本公積合計,祺驊,生技醫療業
2023-03-31,1593,LegalReserve,143595000.0,法定盈餘公積,祺驊,生技醫療業
2023-03-31,1593,LegalReserve_per,6.92,法定盈餘公積,祺驊,生技醫療業
2023-03-31,1593,OtherEquityInterest,-34523000.0,其他權益合計,祺驊,生技醫療業
2023-03-31,1593,OtherEquityInterest_per,-1.66,其他權益合計,祺驊,生技醫療業
2023-03-31,1593,NoncontrollingInterests,52312000.0,非控制權益,祺驊,生技醫療業
2023-03-31,1593,NoncontrollingInterests_per,2.52,非控制權益,祺驊,生技醫療業
2023-03-31,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2023-03-31,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2023-03-31,1593,CashAndCashEquivalents_per,15.31,現金及約當現金,祺驊,生技醫療業
2023-03-31,1593,Inventories_per,8.33,存貨,祺驊,生技醫療業
2023-03-31,1593,CurrentAssets_per,39.98,流動資產合計,祺驊,生技醫療業
2023-03-31,1593,InvestmentAccountedForUsingEquityMethod_per,0.78,採用權益法之投資,祺驊,生技醫療業
2023-03-31,1593,PropertyPlantAndEquipment_per,42.05,不動產、廠房及設備,祺驊,生技醫療業
2023-03-31,1593,IntangibleAssets,242621000.0,無形資產,祺驊,生技醫療業
2023-03-31,1593,IntangibleAssets_per,11.69,無形資產,祺驊,生技醫療業
2023-03-31,1593,OtherNoncurrentAssets_per,1.62,其他非流動資產,祺驊,生技醫療業
2023-03-31,1593,NoncurrentAssets,1246064000.0,非流動資產合計,祺驊,生技醫療業
2023-03-31,1593,NoncurrentAssets_per,60.02,非流動資產合計,祺驊,生技醫療業
2023-03-31,1593,TotalAssets,2076164000.0,資產總額,祺驊,生技醫療業
2023-03-31,1593,OtherPayables,155167000.0,其他應付款,祺驊,生技醫療業
2023-03-31,1593,CurrentLiabilities,462271000.0,流動負債合計,祺驊,生技醫療業
2023-03-31,1593,CurrentLiabilities_per,22.27,流動負債合計,祺驊,生技醫療業
2023-03-31,1593,LongtermBorrowings_per,12.35,長期借款,祺驊,生技醫療業
2023-03-31,1593,NoncurrentLiabilities_per,13.95,非流動負債合計,祺驊,生技醫療業
2023-03-31,1593,Liabilities,751880000.0,負債總額,祺驊,生技醫療業
2023-03-31,1593,Liabilities_per,36.21,負債總額,祺驊,生技醫療業
2023-03-31,1593,OrdinaryShare_per,17.94,普通股股本,祺驊,生技醫療業
2023-03-31,1593,CapitalStock_per,18.08,股本合計,祺驊,生技醫療業
2023-03-31,1593,CapitalSurplus_per,27.95,資本公積合計,祺驊,生技醫療業
2023-03-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,160537000.0,未分配盈餘,祺驊,生技醫療業
2023-03-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,7.73,未分配盈餘,祺驊,生技醫療業
2023-03-31,1593,RetainedEarnings,350674000.0,保留盈餘合計,祺驊,生技醫療業
2023-03-31,1593,RetainedEarnings_per,16.89,保留盈餘合計,祺驊,生技醫療業
2023-03-31,1593,EquityAttributableToOwnersOfParent,1271972000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2023-03-31,1593,EquityAttributableToOwnersOfParent_per,61.27,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2023-03-31,1593,Equity,1324284000.0,權益總額,祺驊,生技醫療業
2023-03-31,1593,Equity_per,63.79,權益總額,祺驊,生技醫療業
2023-03-31,1593,TotalLiabilitiesEquity,2076164000.0,負債及權益總計,祺驊,生技醫療業
2023-06-30,1593,CashAndCashEquivalents,367751000.0,現金及約當現金,祺驊,生技醫療業
2023-06-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,60518000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2023-06-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,46896000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2023-06-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,2.26,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2023-06-30,1593,FinancialAssetsAtAmortizedCost,71125000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2023-06-30,1593,AccountsReceivableNet,119718000.0,應收帳款淨額,祺驊,生技醫療業
2023-06-30,1593,AccountsReceivableDuefromRelatedPartiesNet,13000.0,應收帳款－關係人淨額,祺驊,生技醫療業
2023-06-30,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2023-06-30,1593,OtherReceivablesDueFromRelatedParties,0.0,其他應收款－關係人淨額,祺驊,生技醫療業
2023-06-30,1593,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,祺驊,生技醫療業
2023-06-30,1593,Inventories,166288000.0,存貨,祺驊,生技醫療業
2023-06-30,1593,OtherCurrentAssets,42227000.0,其他流動資產,祺驊,生技醫療業
2023-06-30,1593,CurrentAssets,827640000.0,流動資產合計,祺驊,生技醫療業
2023-06-30,1593,InvestmentAccountedForUsingEquityMethod,18652000.0,採用權益法之投資,祺驊,生技醫療業
2023-06-30,1593,InvestmentAccountedForUsingEquityMethod_per,0.9,採用權益法之投資,祺驊,生技醫療業
2023-06-30,1593,PropertyPlantAndEquipment,870776000.0,不動產、廠房及設備,祺驊,生技醫療業
2023-06-30,1593,RightOfUseAsset,29440000.0,使用權資產,祺驊,生技醫療業
2023-06-30,1593,RightOfUseAsset_per,1.42,使用權資產,祺驊,生技醫療業
2023-06-30,1593,DeferredTaxAssets,9960000.0,遞延所得稅資產,祺驊,生技醫療業
2023-06-30,1593,DeferredTaxAssets_per,0.48,遞延所得稅資產,祺驊,生技醫療業
2023-06-30,1593,OtherNoncurrentAssets,33643000.0,其他非流動資產,祺驊,生技醫療業
2023-06-30,1593,OtherNoncurrentAssets_per,1.62,其他非流動資產,祺驊,生技醫療業
2023-06-30,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2023-06-30,1593,ShorttermBorrowings,154000000.0,短期借款,祺驊,生技醫療業
2023-06-30,1593,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,祺驊,生技醫療業
2023-06-30,1593,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,祺驊,生技醫療業
2023-06-30,1593,AccountsPayable,63556000.0,應付帳款,祺驊,生技醫療業
2023-06-30,1593,AccountsPayable_per,3.06,應付帳款,祺驊,生技醫療業
2023-06-30,1593,AccountsPayableToRelatedParties,2067000.0,應付帳款－關係人,祺驊,生技醫療業
2023-06-30,1593,AccountsPayableToRelatedParties_per,0.1,應付帳款－關係人,祺驊,生技醫療業
2023-06-30,1593,OtherPayables_per,7.64,其他應付款,祺驊,生技醫療業
2023-06-30,1593,CurrentTaxLiabilities,14409000.0,本期所得稅負債,祺驊,生技醫療業
2023-06-30,1593,CurrentTaxLiabilities_per,0.69,本期所得稅負債,祺驊,生技醫療業
2023-06-30,1593,OtherCurrentLiabilities,44784000.0,其他流動負債,祺驊,生技醫療業
2023-06-30,1593,OtherCurrentLiabilities_per,2.16,其他流動負債,祺驊,生技醫療業
2023-06-30,1593,LongtermBorrowings,252225000.0,長期借款,祺驊,生技醫療業
2023-06-30,1593,OtherNoncurrentLiabilities,24447000.0,其他非流動負債,祺驊,生技醫療業
2023-06-30,1593,OtherNoncurrentLiabilities_per,1.18,其他非流動負債,祺驊,生技醫療業
2023-06-30,1593,NoncurrentLiabilities,284274000.0,非流動負債合計,祺驊,生技醫療業
2023-06-30,1593,OrdinaryShare,375443000.0,普通股股本,祺驊,生技醫療業
2023-06-30,1593,CapitalStock,397829000.0,股本合計,祺驊,生技醫療業
2023-06-30,1593,CapitalSurplus,580378000.0,資本公積合計,祺驊,生技醫療業
2023-06-30,1593,LegalReserve,162587000.0,法定盈餘公積,祺驊,生技醫療業
2023-06-30,1593,OtherEquityInterest,-26598000.0,其他權益合計,祺驊,生技醫療業
2023-06-30,1593,OtherEquityInterest_per,-1.28,其他權益合計,祺驊,生技醫療業
2023-06-30,1593,NoncontrollingInterests,47539000.0,非控制權益,祺驊,生技醫療業
2023-06-30,1593,NoncontrollingInterests_per,2.29,非控制權益,祺驊,生技醫療業
2023-06-30,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2023-06-30,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2023-06-30,1593,CashAndCashEquivalents_per,17.7,現金及約當現金,祺驊,生技醫療業
2023-06-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,2.91,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2023-06-30,1593,FinancialAssetsAtAmortizedCost_per,3.42,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2023-06-30,1593,AccountsReceivableNet_per,5.76,應收帳款淨額,祺驊,生技醫療業
2023-06-30,1593,Inventories_per,8.0,存貨,祺驊,生技醫療業
2023-06-30,1593,OtherCurrentAssets_per,2.03,其他流動資產,祺驊,生技醫療業
2023-06-30,1593,CurrentAssets_per,39.83,流動資產合計,祺驊,生技醫療業
2023-06-30,1593,PropertyPlantAndEquipment_per,41.9,不動產、廠房及設備,祺驊,生技醫療業
2023-06-30,1593,IntangibleAssets,241048000.0,無形資產,祺驊,生技醫療業
2023-06-30,1593,IntangibleAssets_per,11.6,無形資產,祺驊,生技醫療業
2023-06-30,1593,NoncurrentAssets,1250415000.0,非流動資產合計,祺驊,生技醫療業
2023-06-30,1593,NoncurrentAssets_per,60.17,非流動資產合計,祺驊,生技醫療業
2023-06-30,1593,TotalAssets,2078055000.0,資產總額,祺驊,生技醫療業
2023-06-30,1593,ShorttermBorrowings_per,7.41,短期借款,祺驊,生技醫療業
2023-06-30,1593,OtherPayables,158660000.0,其他應付款,祺驊,生技醫療業
2023-06-30,1593,CurrentLiabilities,443899000.0,流動負債合計,祺驊,生技醫療業
2023-06-30,1593,CurrentLiabilities_per,21.36,流動負債合計,祺驊,生技醫療業
2023-06-30,1593,LongtermBorrowings_per,12.14,長期借款,祺驊,生技醫療業
2023-06-30,1593,NoncurrentLiabilities_per,13.68,非流動負債合計,祺驊,生技醫療業
2023-06-30,1593,Liabilities,728173000.0,負債總額,祺驊,生技醫療業
2023-06-30,1593,Liabilities_per,35.04,負債總額,祺驊,生技醫療業
2023-06-30,1593,OrdinaryShare_per,18.07,普通股股本,祺驊,生技醫療業
2023-06-30,1593,CapitalStock_per,19.14,股本合計,祺驊,生技醫療業
2023-06-30,1593,CapitalSurplus_per,27.93,資本公積合計,祺驊,生技醫療業
2023-06-30,1593,LegalReserve_per,7.82,法定盈餘公積,祺驊,生技醫療業
2023-06-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,144808000.0,未分配盈餘,祺驊,生技醫療業
2023-06-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,6.97,未分配盈餘,祺驊,生技醫療業
2023-06-30,1593,RetainedEarnings,350734000.0,保留盈餘合計,祺驊,生技醫療業
2023-06-30,1593,RetainedEarnings_per,16.88,保留盈餘合計,祺驊,生技醫療業
2023-06-30,1593,EquityAttributableToOwnersOfParent,1302343000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2023-06-30,1593,EquityAttributableToOwnersOfParent_per,62.67,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2023-06-30,1593,Equity,1349882000.0,權益總額,祺驊,生技醫療業
2023-06-30,1593,Equity_per,64.96,權益總額,祺驊,生技醫療業
2023-06-30,1593,TotalLiabilitiesEquity,2078055000.0,負債及權益總計,祺驊,生技醫療業
2023-09-30,1593,CashAndCashEquivalents,288342000.0,現金及約當現金,祺驊,生技醫療業
2023-09-30,1593,CashAndCashEquivalents_per,14.1,現金及約當現金,祺驊,生技醫療業
2023-09-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,68653000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2023-09-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,3.36,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2023-09-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,45893000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2023-09-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,2.24,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2023-09-30,1593,FinancialAssetsAtAmortizedCost,95952000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2023-09-30,1593,FinancialAssetsAtAmortizedCost_per,4.69,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2023-09-30,1593,AccountsReceivableNet,144369000.0,應收帳款淨額,祺驊,生技醫療業
2023-09-30,1593,AccountsReceivableNet_per,7.06,應收帳款淨額,祺驊,生技醫療業
2023-09-30,1593,AccountsReceivableDuefromRelatedPartiesNet,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2023-09-30,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2023-09-30,1593,OtherReceivablesDueFromRelatedParties,0.0,其他應收款－關係人淨額,祺驊,生技醫療業
2023-09-30,1593,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,祺驊,生技醫療業
2023-09-30,1593,Inventories,169415000.0,存貨,祺驊,生技醫療業
2023-09-30,1593,Inventories_per,8.28,存貨,祺驊,生技醫療業
2023-09-30,1593,OtherCurrentAssets,34567000.0,其他流動資產,祺驊,生技醫療業
2023-09-30,1593,OtherCurrentAssets_per,1.69,其他流動資產,祺驊,生技醫療業
2023-09-30,1593,CurrentAssets,801298000.0,流動資產合計,祺驊,生技醫療業
2023-09-30,1593,CurrentAssets_per,39.17,流動資產合計,祺驊,生技醫療業
2023-09-30,1593,InvestmentAccountedForUsingEquityMethod,19718000.0,採用權益法之投資,祺驊,生技醫療業
2023-09-30,1593,InvestmentAccountedForUsingEquityMethod_per,0.96,採用權益法之投資,祺驊,生技醫療業
2023-09-30,1593,PropertyPlantAndEquipment,872303000.0,不動產、廠房及設備,祺驊,生技醫療業
2023-09-30,1593,PropertyPlantAndEquipment_per,42.64,不動產、廠房及設備,祺驊,生技醫療業
2023-09-30,1593,RightOfUseAsset,27568000.0,使用權資產,祺驊,生技醫療業
2023-09-30,1593,RightOfUseAsset_per,1.35,使用權資產,祺驊,生技醫療業
2023-09-30,1593,IntangibleAssets,233560000.0,無形資產,祺驊,生技醫療業
2023-09-30,1593,IntangibleAssets_per,11.42,無形資產,祺驊,生技醫療業
2023-09-30,1593,DeferredTaxAssets,9945000.0,遞延所得稅資產,祺驊,生技醫療業
2023-09-30,1593,DeferredTaxAssets_per,0.49,遞延所得稅資產,祺驊,生技醫療業
2023-09-30,1593,OtherNoncurrentAssets,35215000.0,其他非流動資產,祺驊,生技醫療業
2023-09-30,1593,OtherNoncurrentAssets_per,1.72,其他非流動資產,祺驊,生技醫療業
2023-09-30,1593,NoncurrentAssets,1244202000.0,非流動資產合計,祺驊,生技醫療業
2023-09-30,1593,NoncurrentAssets_per,60.83,非流動資產合計,祺驊,生技醫療業
2023-09-30,1593,TotalAssets,2045500000.0,資產總額,祺驊,生技醫療業
2023-09-30,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2023-09-30,1593,ShorttermBorrowings,169000000.0,短期借款,祺驊,生技醫療業
2023-09-30,1593,ShorttermBorrowings_per,8.26,短期借款,祺驊,生技醫療業
2023-09-30,1593,AccountsPayable,75310000.0,應付帳款,祺驊,生技醫療業
2023-09-30,1593,AccountsPayable_per,3.68,應付帳款,祺驊,生技醫療業
2023-09-30,1593,AccountsPayableToRelatedParties,5279000.0,應付帳款－關係人,祺驊,生技醫療業
2023-09-30,1593,AccountsPayableToRelatedParties_per,0.26,應付帳款－關係人,祺驊,生技醫療業
2023-09-30,1593,OtherPayables,65601000.0,其他應付款,祺驊,生技醫療業
2023-09-30,1593,OtherPayables_per,3.21,其他應付款,祺驊,生技醫療業
2023-09-30,1593,CurrentTaxLiabilities,25978000.0,本期所得稅負債,祺驊,生技醫療業
2023-09-30,1593,CurrentTaxLiabilities_per,1.27,本期所得稅負債,祺驊,生技醫療業
2023-09-30,1593,OtherCurrentLiabilities,38689000.0,其他流動負債,祺驊,生技醫療業
2023-09-30,1593,OtherCurrentLiabilities_per,1.89,其他流動負債,祺驊,生技醫療業
2023-09-30,1593,CurrentLiabilities,385109000.0,流動負債合計,祺驊,生技醫療業
2023-09-30,1593,CurrentLiabilities_per,18.83,流動負債合計,祺驊,生技醫療業
2023-09-30,1593,BondsPayable,0.0,應付公司債,祺驊,生技醫療業
2023-09-30,1593,BondsPayable_per,0.0,應付公司債,祺驊,生技醫療業
2023-09-30,1593,LongtermBorrowings,247612000.0,長期借款,祺驊,生技醫療業
2023-09-30,1593,LongtermBorrowings_per,12.11,長期借款,祺驊,生技醫療業
2023-09-30,1593,OtherNoncurrentLiabilities,30778000.0,其他非流動負債,祺驊,生技醫療業
2023-09-30,1593,OtherNoncurrentLiabilities_per,1.5,其他非流動負債,祺驊,生技醫療業
2023-09-30,1593,NoncurrentLiabilities,285418000.0,非流動負債合計,祺驊,生技醫療業
2023-09-30,1593,NoncurrentLiabilities_per,13.95,非流動負債合計,祺驊,生技醫療業
2023-09-30,1593,OrdinaryShare,397829000.0,普通股股本,祺驊,生技醫療業
2023-09-30,1593,OrdinaryShare_per,19.45,普通股股本,祺驊,生技醫療業
2023-09-30,1593,CapitalStock,397829000.0,股本合計,祺驊,生技醫療業
2023-09-30,1593,CapitalStock_per,19.45,股本合計,祺驊,生技醫療業
2023-09-30,1593,CapitalSurplus,580378000.0,資本公積合計,祺驊,生技醫療業
2023-09-30,1593,CapitalSurplus_per,28.37,資本公積合計,祺驊,生技醫療業
2023-09-30,1593,LegalReserve,162587000.0,法定盈餘公積,祺驊,生技醫療業
2023-09-30,1593,LegalReserve_per,7.95,法定盈餘公積,祺驊,生技醫療業
2023-09-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,153174000.0,未分配盈餘,祺驊,生技醫療業
2023-09-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,7.49,未分配盈餘,祺驊,生技醫療業
2023-09-30,1593,RetainedEarnings,359100000.0,保留盈餘合計,祺驊,生技醫療業
2023-09-30,1593,RetainedEarnings_per,17.56,保留盈餘合計,祺驊,生技醫療業
2023-09-30,1593,OtherEquityInterest,-16821000.0,其他權益合計,祺驊,生技醫療業
2023-09-30,1593,OtherEquityInterest_per,-0.82,其他權益合計,祺驊,生技醫療業
2023-09-30,1593,EquityAttributableToOwnersOfParent,1320486000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2023-09-30,1593,EquityAttributableToOwnersOfParent_per,64.56,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2023-09-30,1593,NoncontrollingInterests,54487000.0,非控制權益,祺驊,生技醫療業
2023-09-30,1593,NoncontrollingInterests_per,2.66,非控制權益,祺驊,生技醫療業
2023-09-30,1593,TotalLiabilitiesEquity,2045500000.0,負債及權益總計,祺驊,生技醫療業
2023-09-30,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2023-09-30,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2023-09-30,1593,Liabilities,670527000.0,負債總額,祺驊,生技醫療業
2023-09-30,1593,Liabilities_per,32.78,負債總額,祺驊,生技醫療業
2023-09-30,1593,Equity,1374973000.0,權益總額,祺驊,生技醫療業
2023-09-30,1593,Equity_per,67.22,權益總額,祺驊,生技醫療業
2023-12-31,1593,CashAndCashEquivalents,350563000.0,現金及約當現金,祺驊,生技醫療業
2023-12-31,1593,CashAndCashEquivalents_per,17.36,現金及約當現金,祺驊,生技醫療業
2023-12-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,37516000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2023-12-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.86,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2023-12-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,38963000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2023-12-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,1.93,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2023-12-31,1593,FinancialAssetsAtAmortizedCost,103733000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2023-12-31,1593,FinancialAssetsAtAmortizedCost_per,5.14,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2023-12-31,1593,AccountsReceivableNet,108413000.0,應收帳款淨額,祺驊,生技醫療業
2023-12-31,1593,AccountsReceivableNet_per,5.37,應收帳款淨額,祺驊,生技醫療業
2023-12-31,1593,AccountsReceivableDuefromRelatedPartiesNet,6000.0,應收帳款－關係人淨額,祺驊,生技醫療業
2023-12-31,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2023-12-31,1593,OtherReceivablesDueFromRelatedParties,3000.0,其他應收款－關係人淨額,祺驊,生技醫療業
2023-12-31,1593,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,祺驊,生技醫療業
2023-12-31,1593,Inventories,155943000.0,存貨,祺驊,生技醫療業
2023-12-31,1593,Inventories_per,7.72,存貨,祺驊,生技醫療業
2023-12-31,1593,OtherCurrentAssets,40013000.0,其他流動資產,祺驊,生技醫療業
2023-12-31,1593,OtherCurrentAssets_per,1.98,其他流動資產,祺驊,生技醫療業
2023-12-31,1593,CurrentAssets,796190000.0,流動資產合計,祺驊,生技醫療業
2023-12-31,1593,CurrentAssets_per,39.42,流動資產合計,祺驊,生技醫療業
2023-12-31,1593,InvestmentAccountedForUsingEquityMethod,20823000.0,採用權益法之投資,祺驊,生技醫療業
2023-12-31,1593,InvestmentAccountedForUsingEquityMethod_per,1.03,採用權益法之投資,祺驊,生技醫療業
2023-12-31,1593,PropertyPlantAndEquipment,859117000.0,不動產、廠房及設備,祺驊,生技醫療業
2023-12-31,1593,PropertyPlantAndEquipment_per,42.54,不動產、廠房及設備,祺驊,生技醫療業
2023-12-31,1593,RightOfUseAsset,25320000.0,使用權資產,祺驊,生技醫療業
2023-12-31,1593,RightOfUseAsset_per,1.25,使用權資產,祺驊,生技醫療業
2023-12-31,1593,IntangibleAssets,239447000.0,無形資產,祺驊,生技醫療業
2023-12-31,1593,IntangibleAssets_per,11.86,無形資產,祺驊,生技醫療業
2023-12-31,1593,DeferredTaxAssets,10443000.0,遞延所得稅資產,祺驊,生技醫療業
2023-12-31,1593,DeferredTaxAssets_per,0.52,遞延所得稅資產,祺驊,生技醫療業
2023-12-31,1593,OtherNoncurrentAssets,29259000.0,其他非流動資產,祺驊,生技醫療業
2023-12-31,1593,OtherNoncurrentAssets_per,1.45,其他非流動資產,祺驊,生技醫療業
2023-12-31,1593,NoncurrentAssets,1223372000.0,非流動資產合計,祺驊,生技醫療業
2023-12-31,1593,NoncurrentAssets_per,60.58,非流動資產合計,祺驊,生技醫療業
2023-12-31,1593,TotalAssets,2019562000.0,資產總額,祺驊,生技醫療業
2023-12-31,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2023-12-31,1593,ShorttermBorrowings,169000000.0,短期借款,祺驊,生技醫療業
2023-12-31,1593,ShorttermBorrowings_per,8.37,短期借款,祺驊,生技醫療業
2023-12-31,1593,AccountsPayable,55696000.0,應付帳款,祺驊,生技醫療業
2023-12-31,1593,AccountsPayable_per,2.76,應付帳款,祺驊,生技醫療業
2023-12-31,1593,AccountsPayableToRelatedParties,6375000.0,應付帳款－關係人,祺驊,生技醫療業
2023-12-31,1593,AccountsPayableToRelatedParties_per,0.32,應付帳款－關係人,祺驊,生技醫療業
2023-12-31,1593,OtherPayables,77132000.0,其他應付款,祺驊,生技醫療業
2023-12-31,1593,OtherPayables_per,3.82,其他應付款,祺驊,生技醫療業
2023-12-31,1593,CurrentTaxLiabilities,30097000.0,本期所得稅負債,祺驊,生技醫療業
2023-12-31,1593,CurrentTaxLiabilities_per,1.49,本期所得稅負債,祺驊,生技醫療業
2023-12-31,1593,OtherCurrentLiabilities,37425000.0,其他流動負債,祺驊,生技醫療業
2023-12-31,1593,OtherCurrentLiabilities_per,1.85,其他流動負債,祺驊,生技醫療業
2023-12-31,1593,CurrentLiabilities,380437000.0,流動負債合計,祺驊,生技醫療業
2023-12-31,1593,CurrentLiabilities_per,18.84,流動負債合計,祺驊,生技醫療業
2023-12-31,1593,BondsPayable,0.0,應付公司債,祺驊,生技醫療業
2023-12-31,1593,BondsPayable_per,0.0,應付公司債,祺驊,生技醫療業
2023-12-31,1593,LongtermBorrowings,242976000.0,長期借款,祺驊,生技醫療業
2023-12-31,1593,LongtermBorrowings_per,12.03,長期借款,祺驊,生技醫療業
2023-12-31,1593,OtherNoncurrentLiabilities,29266000.0,其他非流動負債,祺驊,生技醫療業
2023-12-31,1593,OtherNoncurrentLiabilities_per,1.45,其他非流動負債,祺驊,生技醫療業
2023-12-31,1593,NoncurrentLiabilities,278356000.0,非流動負債合計,祺驊,生技醫療業
2023-12-31,1593,NoncurrentLiabilities_per,13.78,非流動負債合計,祺驊,生技醫療業
2023-12-31,1593,OrdinaryShare,397829000.0,普通股股本,祺驊,生技醫療業
2023-12-31,1593,OrdinaryShare_per,19.7,普通股股本,祺驊,生技醫療業
2023-12-31,1593,CapitalStock,397848000.0,股本合計,祺驊,生技醫療業
2023-12-31,1593,CapitalStock_per,19.7,股本合計,祺驊,生技醫療業
2023-12-31,1593,CapitalSurplus,580459000.0,資本公積合計,祺驊,生技醫療業
2023-12-31,1593,CapitalSurplus_per,28.74,資本公積合計,祺驊,生技醫療業
2023-12-31,1593,LegalReserve,162587000.0,法定盈餘公積,祺驊,生技醫療業
2023-12-31,1593,LegalReserve_per,8.05,法定盈餘公積,祺驊,生技醫療業
2023-12-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,164148000.0,未分配盈餘,祺驊,生技醫療業
2023-12-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,8.13,未分配盈餘,祺驊,生技醫療業
2023-12-31,1593,RetainedEarnings,370074000.0,保留盈餘合計,祺驊,生技醫療業
2023-12-31,1593,RetainedEarnings_per,18.32,保留盈餘合計,祺驊,生技醫療業
2023-12-31,1593,OtherEquityInterest,-49156000.0,其他權益合計,祺驊,生技醫療業
2023-12-31,1593,OtherEquityInterest_per,-2.43,其他權益合計,祺驊,生技醫療業
2023-12-31,1593,EquityAttributableToOwnersOfParent,1299225000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2023-12-31,1593,EquityAttributableToOwnersOfParent_per,64.33,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2023-12-31,1593,NoncontrollingInterests,61544000.0,非控制權益,祺驊,生技醫療業
2023-12-31,1593,NoncontrollingInterests_per,3.05,非控制權益,祺驊,生技醫療業
2023-12-31,1593,TotalLiabilitiesEquity,2019562000.0,負債及權益總計,祺驊,生技醫療業
2023-12-31,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2023-12-31,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2023-12-31,1593,CurrentIncomeTaxAssets,0.0,本期所得稅資產,祺驊,生技醫療業
2023-12-31,1593,CurrentIncomeTaxAssets_per,0.0,本期所得稅資產,祺驊,生技醫療業
2023-12-31,1593,Equity,1360769000.0,權益總額,祺驊,生技醫療業
2023-12-31,1593,Equity_per,67.38,權益總額,祺驊,生技醫療業
2023-12-31,1593,Liabilities,658793000.0,負債總額,祺驊,生技醫療業
2023-12-31,1593,Liabilities_per,32.62,負債總額,祺驊,生技醫療業
2024-03-31,1593,CashAndCashEquivalents,316647000.0,現金及約當現金,祺驊,生技醫療業
2024-03-31,1593,CashAndCashEquivalents_per,15.84,現金及約當現金,祺驊,生技醫療業
2024-03-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,39965000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2024-03-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,2.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2024-03-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,39624000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2024-03-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,1.98,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2024-03-31,1593,FinancialAssetsAtAmortizedCost,124185000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2024-03-31,1593,FinancialAssetsAtAmortizedCost_per,6.21,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2024-03-31,1593,AccountsReceivableNet,108251000.0,應收帳款淨額,祺驊,生技醫療業
2024-03-31,1593,AccountsReceivableNet_per,5.41,應收帳款淨額,祺驊,生技醫療業
2024-03-31,1593,AccountsReceivableDuefromRelatedPartiesNet,1000.0,應收帳款－關係人淨額,祺驊,生技醫療業
2024-03-31,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2024-03-31,1593,OtherReceivablesDueFromRelatedParties,0.0,其他應收款－關係人淨額,祺驊,生技醫療業
2024-03-31,1593,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,祺驊,生技醫療業
2024-03-31,1593,Inventories,151778000.0,存貨,祺驊,生技醫療業
2024-03-31,1593,Inventories_per,7.59,存貨,祺驊,生技醫療業
2024-03-31,1593,OtherCurrentAssets,36476000.0,其他流動資產,祺驊,生技醫療業
2024-03-31,1593,OtherCurrentAssets_per,1.82,其他流動資產,祺驊,生技醫療業
2024-03-31,1593,CurrentAssets,777303000.0,流動資產合計,祺驊,生技醫療業
2024-03-31,1593,CurrentAssets_per,38.88,流動資產合計,祺驊,生技醫療業
2024-03-31,1593,InvestmentAccountedForUsingEquityMethod,20338000.0,採用權益法之投資,祺驊,生技醫療業
2024-03-31,1593,InvestmentAccountedForUsingEquityMethod_per,1.02,採用權益法之投資,祺驊,生技醫療業
2024-03-31,1593,PropertyPlantAndEquipment,740944000.0,不動產、廠房及設備,祺驊,生技醫療業
2024-03-31,1593,PropertyPlantAndEquipment_per,37.06,不動產、廠房及設備,祺驊,生技醫療業
2024-03-31,1593,RightOfUseAsset,24356000.0,使用權資產,祺驊,生技醫療業
2024-03-31,1593,RightOfUseAsset_per,1.22,使用權資產,祺驊,生技醫療業
2024-03-31,1593,IntangibleAssets,238031000.0,無形資產,祺驊,生技醫療業
2024-03-31,1593,IntangibleAssets_per,11.9,無形資產,祺驊,生技醫療業
2024-03-31,1593,DeferredTaxAssets,10056000.0,遞延所得稅資產,祺驊,生技醫療業
2024-03-31,1593,DeferredTaxAssets_per,0.5,遞延所得稅資產,祺驊,生技醫療業
2024-03-31,1593,OtherNoncurrentAssets,7119000.0,其他非流動資產,祺驊,生技醫療業
2024-03-31,1593,OtherNoncurrentAssets_per,0.36,其他非流動資產,祺驊,生技醫療業
2024-03-31,1593,NoncurrentAssets,1222161000.0,非流動資產合計,祺驊,生技醫療業
2024-03-31,1593,NoncurrentAssets_per,61.12,非流動資產合計,祺驊,生技醫療業
2024-03-31,1593,TotalAssets,1999464000.0,資產總額,祺驊,生技醫療業
2024-03-31,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2024-03-31,1593,ShorttermBorrowings,154000000.0,短期借款,祺驊,生技醫療業
2024-03-31,1593,ShorttermBorrowings_per,7.7,短期借款,祺驊,生技醫療業
2024-03-31,1593,AccountsPayable,44345000.0,應付帳款,祺驊,生技醫療業
2024-03-31,1593,AccountsPayable_per,2.22,應付帳款,祺驊,生技醫療業
2024-03-31,1593,AccountsPayableToRelatedParties,6011000.0,應付帳款－關係人,祺驊,生技醫療業
2024-03-31,1593,AccountsPayableToRelatedParties_per,0.3,應付帳款－關係人,祺驊,生技醫療業
2024-03-31,1593,OtherPayables,112976000.0,其他應付款,祺驊,生技醫療業
2024-03-31,1593,OtherPayables_per,5.65,其他應付款,祺驊,生技醫療業
2024-03-31,1593,CurrentTaxLiabilities,35965000.0,本期所得稅負債,祺驊,生技醫療業
2024-03-31,1593,CurrentTaxLiabilities_per,1.8,本期所得稅負債,祺驊,生技醫療業
2024-03-31,1593,OtherCurrentLiabilities,31747000.0,其他流動負債,祺驊,生技醫療業
2024-03-31,1593,OtherCurrentLiabilities_per,1.59,其他流動負債,祺驊,生技醫療業
2024-03-31,1593,CurrentLiabilities,389212000.0,流動負債合計,祺驊,生技醫療業
2024-03-31,1593,CurrentLiabilities_per,19.47,流動負債合計,祺驊,生技醫療業
2024-03-31,1593,LongtermBorrowings,238317000.0,長期借款,祺驊,生技醫療業
2024-03-31,1593,LongtermBorrowings_per,11.92,長期借款,祺驊,生技醫療業
2024-03-31,1593,OtherNoncurrentLiabilities,28976000.0,其他非流動負債,祺驊,生技醫療業
2024-03-31,1593,OtherNoncurrentLiabilities_per,1.45,其他非流動負債,祺驊,生技醫療業
2024-03-31,1593,NoncurrentLiabilities,272822000.0,非流動負債合計,祺驊,生技醫療業
2024-03-31,1593,NoncurrentLiabilities_per,13.64,非流動負債合計,祺驊,生技醫療業
2024-03-31,1593,OrdinaryShare,397848000.0,普通股股本,祺驊,生技醫療業
2024-03-31,1593,OrdinaryShare_per,19.9,普通股股本,祺驊,生技醫療業
2024-03-31,1593,CapitalStock,397848000.0,股本合計,祺驊,生技醫療業
2024-03-31,1593,CapitalStock_per,19.9,股本合計,祺驊,生技醫療業
2024-03-31,1593,CapitalSurplus,578145000.0,資本公積合計,祺驊,生技醫療業
2024-03-31,1593,CapitalSurplus_per,28.91,資本公積合計,祺驊,生技醫療業
2024-03-31,1593,LegalReserve,162587000.0,法定盈餘公積,祺驊,生技醫療業
2024-03-31,1593,LegalReserve_per,8.13,法定盈餘公積,祺驊,生技醫療業
2024-03-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,112555000.0,未分配盈餘,祺驊,生技醫療業
2024-03-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,5.63,未分配盈餘,祺驊,生技醫療業
2024-03-31,1593,RetainedEarnings,318481000.0,保留盈餘合計,祺驊,生技醫療業
2024-03-31,1593,RetainedEarnings_per,15.93,保留盈餘合計,祺驊,生技醫療業
2024-03-31,1593,OtherEquityInterest,-33861000.0,其他權益合計,祺驊,生技醫療業
2024-03-31,1593,OtherEquityInterest_per,-1.69,其他權益合計,祺驊,生技醫療業
2024-03-31,1593,EquityAttributableToOwnersOfParent,1260613000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2024-03-31,1593,EquityAttributableToOwnersOfParent_per,63.05,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2024-03-31,1593,NoncontrollingInterests,76817000.0,非控制權益,祺驊,生技醫療業
2024-03-31,1593,NoncontrollingInterests_per,3.84,非控制權益,祺驊,生技醫療業
2024-03-31,1593,TotalLiabilitiesEquity,1999464000.0,負債及權益總計,祺驊,生技醫療業
2024-03-31,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2024-03-31,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2024-03-31,1593,FinancialAssetsAtAmortizedCostNonCurrent,0.0,按攤銷後成本衡量之金融資產－非流動,祺驊,生技醫療業
2024-03-31,1593,FinancialAssetsAtAmortizedCostNonCurrent_per,0.0,按攤銷後成本衡量之金融資產－非流動,祺驊,生技醫療業
2024-03-31,1593,CurrentIncomeTaxAssets,0.0,本期所得稅資產,祺驊,生技醫療業
2024-03-31,1593,CurrentIncomeTaxAssets_per,0.0,本期所得稅資產,祺驊,生技醫療業
2024-03-31,1593,Liabilities,662034000.0,負債總額,祺驊,生技醫療業
2024-03-31,1593,Liabilities_per,33.11,負債總額,祺驊,生技醫療業
2024-03-31,1593,Equity,1337430000.0,權益總額,祺驊,生技醫療業
2024-03-31,1593,Equity_per,66.89,權益總額,祺驊,生技醫療業
2024-06-30,1593,CashAndCashEquivalents,313819000.0,現金及約當現金,祺驊,生技醫療業
2024-06-30,1593,CashAndCashEquivalents_per,15.71,現金及約當現金,祺驊,生技醫療業
2024-06-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,21279000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2024-06-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.07,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2024-06-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,43539000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2024-06-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,2.18,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2024-06-30,1593,FinancialAssetsAtAmortizedCost,124641000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2024-06-30,1593,FinancialAssetsAtAmortizedCost_per,6.24,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2024-06-30,1593,AccountsReceivableNet,131562000.0,應收帳款淨額,祺驊,生技醫療業
2024-06-30,1593,AccountsReceivableNet_per,6.59,應收帳款淨額,祺驊,生技醫療業
2024-06-30,1593,AccountsReceivableDuefromRelatedPartiesNet,28000.0,應收帳款－關係人淨額,祺驊,生技醫療業
2024-06-30,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2024-06-30,1593,OtherReceivablesDueFromRelatedParties,0.0,其他應收款－關係人淨額,祺驊,生技醫療業
2024-06-30,1593,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,祺驊,生技醫療業
2024-06-30,1593,Inventories,145621000.0,存貨,祺驊,生技醫療業
2024-06-30,1593,Inventories_per,7.29,存貨,祺驊,生技醫療業
2024-06-30,1593,OtherCurrentAssets,44340000.0,其他流動資產,祺驊,生技醫療業
2024-06-30,1593,OtherCurrentAssets_per,2.22,其他流動資產,祺驊,生技醫療業
2024-06-30,1593,CurrentAssets,781290000.0,流動資產合計,祺驊,生技醫療業
2024-06-30,1593,CurrentAssets_per,39.11,流動資產合計,祺驊,生技醫療業
2024-06-30,1593,InvestmentAccountedForUsingEquityMethod,20960000.0,採用權益法之投資,祺驊,生技醫療業
2024-06-30,1593,InvestmentAccountedForUsingEquityMethod_per,1.05,採用權益法之投資,祺驊,生技醫療業
2024-06-30,1593,PropertyPlantAndEquipment,735225000.0,不動產、廠房及設備,祺驊,生技醫療業
2024-06-30,1593,PropertyPlantAndEquipment_per,36.8,不動產、廠房及設備,祺驊,生技醫療業
2024-06-30,1593,RightOfUseAsset,24559000.0,使用權資產,祺驊,生技醫療業
2024-06-30,1593,RightOfUseAsset_per,1.23,使用權資產,祺驊,生技醫療業
2024-06-30,1593,IntangibleAssets,235827000.0,無形資產,祺驊,生技醫療業
2024-06-30,1593,IntangibleAssets_per,11.8,無形資產,祺驊,生技醫療業
2024-06-30,1593,DeferredTaxAssets,10224000.0,遞延所得稅資產,祺驊,生技醫療業
2024-06-30,1593,DeferredTaxAssets_per,0.51,遞延所得稅資產,祺驊,生技醫療業
2024-06-30,1593,OtherNoncurrentAssets,7128000.0,其他非流動資產,祺驊,生技醫療業
2024-06-30,1593,OtherNoncurrentAssets_per,0.36,其他非流動資產,祺驊,生技醫療業
2024-06-30,1593,NoncurrentAssets,1216502000.0,非流動資產合計,祺驊,生技醫療業
2024-06-30,1593,NoncurrentAssets_per,60.89,非流動資產合計,祺驊,生技醫療業
2024-06-30,1593,TotalAssets,1997792000.0,資產總額,祺驊,生技醫療業
2024-06-30,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2024-06-30,1593,ShorttermBorrowings,164000000.0,短期借款,祺驊,生技醫療業
2024-06-30,1593,ShorttermBorrowings_per,8.21,短期借款,祺驊,生技醫療業
2024-06-30,1593,AccountsPayable,55041000.0,應付帳款,祺驊,生技醫療業
2024-06-30,1593,AccountsPayable_per,2.76,應付帳款,祺驊,生技醫療業
2024-06-30,1593,AccountsPayableToRelatedParties,2437000.0,應付帳款－關係人,祺驊,生技醫療業
2024-06-30,1593,AccountsPayableToRelatedParties_per,0.12,應付帳款－關係人,祺驊,生技醫療業
2024-06-30,1593,OtherPayables,112664000.0,其他應付款,祺驊,生技醫療業
2024-06-30,1593,OtherPayables_per,5.64,其他應付款,祺驊,生技醫療業
2024-06-30,1593,CurrentTaxLiabilities,11738000.0,本期所得稅負債,祺驊,生技醫療業
2024-06-30,1593,CurrentTaxLiabilities_per,0.59,本期所得稅負債,祺驊,生技醫療業
2024-06-30,1593,OtherCurrentLiabilities,32489000.0,其他流動負債,祺驊,生技醫療業
2024-06-30,1593,OtherCurrentLiabilities_per,1.63,其他流動負債,祺驊,生技醫療業
2024-06-30,1593,CurrentLiabilities,383422000.0,流動負債合計,祺驊,生技醫療業
2024-06-30,1593,CurrentLiabilities_per,19.19,流動負債合計,祺驊,生技醫療業
2024-06-30,1593,LongtermBorrowings,233788000.0,長期借款,祺驊,生技醫療業
2024-06-30,1593,LongtermBorrowings_per,11.7,長期借款,祺驊,生技醫療業
2024-06-30,1593,OtherNoncurrentLiabilities,29194000.0,其他非流動負債,祺驊,生技醫療業
2024-06-30,1593,OtherNoncurrentLiabilities_per,1.46,其他非流動負債,祺驊,生技醫療業
2024-06-30,1593,NoncurrentLiabilities,268001000.0,非流動負債合計,祺驊,生技醫療業
2024-06-30,1593,NoncurrentLiabilities_per,13.41,非流動負債合計,祺驊,生技醫療業
2024-06-30,1593,OrdinaryShare,397848000.0,普通股股本,祺驊,生技醫療業
2024-06-30,1593,OrdinaryShare_per,19.91,普通股股本,祺驊,生技醫療業
2024-06-30,1593,CapitalStock,397848000.0,股本合計,祺驊,生技醫療業
2024-06-30,1593,CapitalStock_per,19.91,股本合計,祺驊,生技醫療業
2024-06-30,1593,CapitalSurplus,579245000.0,資本公積合計,祺驊,生技醫療業
2024-06-30,1593,CapitalSurplus_per,28.99,資本公積合計,祺驊,生技醫療業
2024-06-30,1593,LegalReserve,167727000.0,法定盈餘公積,祺驊,生技醫療業
2024-06-30,1593,LegalReserve_per,8.4,法定盈餘公積,祺驊,生技醫療業
2024-06-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,118526000.0,未分配盈餘,祺驊,生技醫療業
2024-06-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,5.93,未分配盈餘,祺驊,生技醫療業
2024-06-30,1593,RetainedEarnings,335409000.0,保留盈餘合計,祺驊,生技醫療業
2024-06-30,1593,RetainedEarnings_per,16.79,保留盈餘合計,祺驊,生技醫療業
2024-06-30,1593,OtherEquityInterest,-31250000.0,其他權益合計,祺驊,生技醫療業
2024-06-30,1593,OtherEquityInterest_per,-1.56,其他權益合計,祺驊,生技醫療業
2024-06-30,1593,EquityAttributableToOwnersOfParent,1281252000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2024-06-30,1593,EquityAttributableToOwnersOfParent_per,64.13,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2024-06-30,1593,NoncontrollingInterests,65117000.0,非控制權益,祺驊,生技醫療業
2024-06-30,1593,NoncontrollingInterests_per,3.26,非控制權益,祺驊,生技醫療業
2024-06-30,1593,TotalLiabilitiesEquity,1997792000.0,負債及權益總計,祺驊,生技醫療業
2024-06-30,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2024-06-30,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2024-06-30,1593,Liabilities,651423000.0,負債總額,祺驊,生技醫療業
2024-06-30,1593,Liabilities_per,32.61,負債總額,祺驊,生技醫療業
2024-06-30,1593,Equity,1346369000.0,權益總額,祺驊,生技醫療業
2024-06-30,1593,Equity_per,67.39,權益總額,祺驊,生技醫療業
2024-06-30,1593,FinancialAssetsAtAmortizedCostNonCurrent,0.0,按攤銷後成本衡量之金融資產－非流動,祺驊,生技醫療業
2024-06-30,1593,FinancialAssetsAtAmortizedCostNonCurrent_per,0.0,按攤銷後成本衡量之金融資產－非流動,祺驊,生技醫療業
2024-06-30,1593,CurrentIncomeTaxAssets,0.0,本期所得稅資產,祺驊,生技醫療業
2024-06-30,1593,CurrentIncomeTaxAssets_per,0.0,本期所得稅資產,祺驊,生技醫療業
2024-09-30,1593,CashAndCashEquivalents,293218000.0,現金及約當現金,祺驊,生技醫療業
2024-09-30,1593,CashAndCashEquivalents_per,14.63,現金及約當現金,祺驊,生技醫療業
2024-09-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,41067000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2024-09-30,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,2.05,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2024-09-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,35999000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2024-09-30,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,1.8,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2024-09-30,1593,FinancialAssetsAtAmortizedCost,143644000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2024-09-30,1593,FinancialAssetsAtAmortizedCost_per,7.17,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2024-09-30,1593,AccountsReceivableNet,134722000.0,應收帳款淨額,祺驊,生技醫療業
2024-09-30,1593,AccountsReceivableNet_per,6.72,應收帳款淨額,祺驊,生技醫療業
2024-09-30,1593,AccountsReceivableDuefromRelatedPartiesNet,37000.0,應收帳款－關係人淨額,祺驊,生技醫療業
2024-09-30,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2024-09-30,1593,OtherReceivablesDueFromRelatedParties,0.0,其他應收款－關係人淨額,祺驊,生技醫療業
2024-09-30,1593,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,祺驊,生技醫療業
2024-09-30,1593,Inventories,148525000.0,存貨,祺驊,生技醫療業
2024-09-30,1593,Inventories_per,7.41,存貨,祺驊,生技醫療業
2024-09-30,1593,OtherCurrentAssets,43469000.0,其他流動資產,祺驊,生技醫療業
2024-09-30,1593,OtherCurrentAssets_per,2.17,其他流動資產,祺驊,生技醫療業
2024-09-30,1593,CurrentAssets,804682000.0,流動資產合計,祺驊,生技醫療業
2024-09-30,1593,CurrentAssets_per,40.15,流動資產合計,祺驊,生技醫療業
2024-09-30,1593,InvestmentAccountedForUsingEquityMethod,19982000.0,採用權益法之投資,祺驊,生技醫療業
2024-09-30,1593,InvestmentAccountedForUsingEquityMethod_per,1.0,採用權益法之投資,祺驊,生技醫療業
2024-09-30,1593,PropertyPlantAndEquipment,731259000.0,不動產、廠房及設備,祺驊,生技醫療業
2024-09-30,1593,PropertyPlantAndEquipment_per,36.48,不動產、廠房及設備,祺驊,生技醫療業
2024-09-30,1593,RightOfUseAsset,23261000.0,使用權資產,祺驊,生技醫療業
2024-09-30,1593,RightOfUseAsset_per,1.16,使用權資產,祺驊,生技醫療業
2024-09-30,1593,IntangibleAssets,233901000.0,無形資產,祺驊,生技醫療業
2024-09-30,1593,IntangibleAssets_per,11.67,無形資產,祺驊,生技醫療業
2024-09-30,1593,DeferredTaxAssets,10091000.0,遞延所得稅資產,祺驊,生技醫療業
2024-09-30,1593,DeferredTaxAssets_per,0.5,遞延所得稅資產,祺驊,生技醫療業
2024-09-30,1593,OtherNoncurrentAssets,6908000.0,其他非流動資產,祺驊,生技醫療業
2024-09-30,1593,OtherNoncurrentAssets_per,0.34,其他非流動資產,祺驊,生技醫療業
2024-09-30,1593,NoncurrentAssets,1199677000.0,非流動資產合計,祺驊,生技醫療業
2024-09-30,1593,NoncurrentAssets_per,59.85,非流動資產合計,祺驊,生技醫療業
2024-09-30,1593,TotalAssets,2004359000.0,資產總額,祺驊,生技醫療業
2024-09-30,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2024-09-30,1593,ShorttermBorrowings,199000000.0,短期借款,祺驊,生技醫療業
2024-09-30,1593,ShorttermBorrowings_per,9.93,短期借款,祺驊,生技醫療業
2024-09-30,1593,AccountsPayable,62042000.0,應付帳款,祺驊,生技醫療業
2024-09-30,1593,AccountsPayable_per,3.1,應付帳款,祺驊,生技醫療業
2024-09-30,1593,AccountsPayableToRelatedParties,5603000.0,應付帳款－關係人,祺驊,生技醫療業
2024-09-30,1593,AccountsPayableToRelatedParties_per,0.28,應付帳款－關係人,祺驊,生技醫療業
2024-09-30,1593,OtherPayables,58988000.0,其他應付款,祺驊,生技醫療業
2024-09-30,1593,OtherPayables_per,2.94,其他應付款,祺驊,生技醫療業
2024-09-30,1593,CurrentTaxLiabilities,6848000.0,本期所得稅負債,祺驊,生技醫療業
2024-09-30,1593,CurrentTaxLiabilities_per,0.34,本期所得稅負債,祺驊,生技醫療業
2024-09-30,1593,OtherCurrentLiabilities,32479000.0,其他流動負債,祺驊,生技醫療業
2024-09-30,1593,OtherCurrentLiabilities_per,1.62,其他流動負債,祺驊,生技醫療業
2024-09-30,1593,CurrentLiabilities,369026000.0,流動負債合計,祺驊,生技醫療業
2024-09-30,1593,CurrentLiabilities_per,18.41,流動負債合計,祺驊,生技醫療業
2024-09-30,1593,LongtermBorrowings,229112000.0,長期借款,祺驊,生技醫療業
2024-09-30,1593,LongtermBorrowings_per,11.43,長期借款,祺驊,生技醫療業
2024-09-30,1593,OtherNoncurrentLiabilities,29069000.0,其他非流動負債,祺驊,生技醫療業
2024-09-30,1593,OtherNoncurrentLiabilities_per,1.45,其他非流動負債,祺驊,生技醫療業
2024-09-30,1593,NoncurrentLiabilities,262870000.0,非流動負債合計,祺驊,生技醫療業
2024-09-30,1593,NoncurrentLiabilities_per,13.11,非流動負債合計,祺驊,生技醫療業
2024-09-30,1593,OrdinaryShare,397848000.0,普通股股本,祺驊,生技醫療業
2024-09-30,1593,OrdinaryShare_per,19.85,普通股股本,祺驊,生技醫療業
2024-09-30,1593,CapitalStock,397848000.0,股本合計,祺驊,生技醫療業
2024-09-30,1593,CapitalStock_per,19.85,股本合計,祺驊,生技醫療業
2024-09-30,1593,CapitalSurplus,579961000.0,資本公積合計,祺驊,生技醫療業
2024-09-30,1593,CapitalSurplus_per,28.93,資本公積合計,祺驊,生技醫療業
2024-09-30,1593,LegalReserve,167727000.0,法定盈餘公積,祺驊,生技醫療業
2024-09-30,1593,LegalReserve_per,8.37,法定盈餘公積,祺驊,生技醫療業
2024-09-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,141557000.0,未分配盈餘,祺驊,生技醫療業
2024-09-30,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,7.06,未分配盈餘,祺驊,生技醫療業
2024-09-30,1593,RetainedEarnings,358440000.0,保留盈餘合計,祺驊,生技醫療業
2024-09-30,1593,RetainedEarnings_per,17.88,保留盈餘合計,祺驊,生技醫療業
2024-09-30,1593,OtherEquityInterest,-38147000.0,其他權益合計,祺驊,生技醫療業
2024-09-30,1593,OtherEquityInterest_per,-1.9,其他權益合計,祺驊,生技醫療業
2024-09-30,1593,EquityAttributableToOwnersOfParent,1298102000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2024-09-30,1593,EquityAttributableToOwnersOfParent_per,64.76,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2024-09-30,1593,NoncontrollingInterests,74361000.0,非控制權益,祺驊,生技醫療業
2024-09-30,1593,NoncontrollingInterests_per,3.71,非控制權益,祺驊,生技醫療業
2024-09-30,1593,TotalLiabilitiesEquity,2004359000.0,負債及權益總計,祺驊,生技醫療業
2024-09-30,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2024-09-30,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2024-09-30,1593,Liabilities,631896000.0,負債總額,祺驊,生技醫療業
2024-09-30,1593,Liabilities_per,31.53,負債總額,祺驊,生技醫療業
2024-09-30,1593,Equity,1372463000.0,權益總額,祺驊,生技醫療業
2024-09-30,1593,Equity_per,68.47,權益總額,祺驊,生技醫療業
2024-12-31,1593,CashAndCashEquivalents,313124000.0,現金及約當現金,祺驊,生技醫療業
2024-12-31,1593,CashAndCashEquivalents_per,15.22,現金及約當現金,祺驊,生技醫療業
2024-12-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,46201000.0,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2024-12-31,1593,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,2.25,透過損益按公允價值衡量之金融資產－流動,祺驊,生技醫療業
2024-12-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,33580000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2024-12-31,1593,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,1.63,透過其他綜合損益按公允價值衡量之金融資產－非流動,祺驊,生技醫療業
2024-12-31,1593,FinancialAssetsAtAmortizedCost,161755000.0,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2024-12-31,1593,FinancialAssetsAtAmortizedCost_per,7.86,按攤銷後成本衡量之金融資產－流動,祺驊,生技醫療業
2024-12-31,1593,AccountsReceivableNet,145695000.0,應收帳款淨額,祺驊,生技醫療業
2024-12-31,1593,AccountsReceivableNet_per,7.08,應收帳款淨額,祺驊,生技醫療業
2024-12-31,1593,AccountsReceivableDuefromRelatedPartiesNet,4000.0,應收帳款－關係人淨額,祺驊,生技醫療業
2024-12-31,1593,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,祺驊,生技醫療業
2024-12-31,1593,OtherReceivablesDueFromRelatedParties,0.0,其他應收款－關係人淨額,祺驊,生技醫療業
2024-12-31,1593,OtherReceivablesDueFromRelatedParties_per,0.0,其他應收款－關係人淨額,祺驊,生技醫療業
2024-12-31,1593,Inventories,156668000.0,存貨,祺驊,生技醫療業
2024-12-31,1593,Inventories_per,7.62,存貨,祺驊,生技醫療業
2024-12-31,1593,OtherCurrentAssets,32852000.0,其他流動資產,祺驊,生技醫療業
2024-12-31,1593,OtherCurrentAssets_per,1.6,其他流動資產,祺驊,生技醫療業
2024-12-31,1593,CurrentAssets,856931000.0,流動資產合計,祺驊,生技醫療業
2024-12-31,1593,CurrentAssets_per,41.66,流動資產合計,祺驊,生技醫療業
2024-12-31,1593,InvestmentAccountedForUsingEquityMethod,21872000.0,採用權益法之投資,祺驊,生技醫療業
2024-12-31,1593,InvestmentAccountedForUsingEquityMethod_per,1.06,採用權益法之投資,祺驊,生技醫療業
2024-12-31,1593,PropertyPlantAndEquipment,726206000.0,不動產、廠房及設備,祺驊,生技醫療業
2024-12-31,1593,PropertyPlantAndEquipment_per,35.3,不動產、廠房及設備,祺驊,生技醫療業
2024-12-31,1593,RightOfUseAsset,28510000.0,使用權資產,祺驊,生技醫療業
2024-12-31,1593,RightOfUseAsset_per,1.39,使用權資產,祺驊,生技醫療業
2024-12-31,1593,IntangibleAssets,233134000.0,無形資產,祺驊,生技醫療業
2024-12-31,1593,IntangibleAssets_per,11.33,無形資產,祺驊,生技醫療業
2024-12-31,1593,DeferredTaxAssets,9922000.0,遞延所得稅資產,祺驊,生技醫療業
2024-12-31,1593,DeferredTaxAssets_per,0.48,遞延所得稅資產,祺驊,生技醫療業
2024-12-31,1593,OtherNoncurrentAssets,9606000.0,其他非流動資產,祺驊,生技醫療業
2024-12-31,1593,OtherNoncurrentAssets_per,0.47,其他非流動資產,祺驊,生技醫療業
2024-12-31,1593,NoncurrentAssets,1200111000.0,非流動資產合計,祺驊,生技醫療業
2024-12-31,1593,NoncurrentAssets_per,58.34,非流動資產合計,祺驊,生技醫療業
2024-12-31,1593,TotalAssets,2057042000.0,資產總額,祺驊,生技醫療業
2024-12-31,1593,TotalAssets_per,100.0,資產總額,祺驊,生技醫療業
2024-12-31,1593,ShorttermBorrowings,164000000.0,短期借款,祺驊,生技醫療業
2024-12-31,1593,ShorttermBorrowings_per,7.97,短期借款,祺驊,生技醫療業
2024-12-31,1593,AccountsPayable,80774000.0,應付帳款,祺驊,生技醫療業
2024-12-31,1593,AccountsPayable_per,3.93,應付帳款,祺驊,生技醫療業
2024-12-31,1593,AccountsPayableToRelatedParties,6524000.0,應付帳款－關係人,祺驊,生技醫療業
2024-12-31,1593,AccountsPayableToRelatedParties_per,0.32,應付帳款－關係人,祺驊,生技醫療業
2024-12-31,1593,OtherPayables,74708000.0,其他應付款,祺驊,生技醫療業
2024-12-31,1593,OtherPayables_per,3.63,其他應付款,祺驊,生技醫療業
2024-12-31,1593,CurrentTaxLiabilities,14515000.0,本期所得稅負債,祺驊,生技醫療業
2024-12-31,1593,CurrentTaxLiabilities_per,0.71,本期所得稅負債,祺驊,生技醫療業
2024-12-31,1593,OtherCurrentLiabilities,34967000.0,其他流動負債,祺驊,生技醫療業
2024-12-31,1593,OtherCurrentLiabilities_per,1.7,其他流動負債,祺驊,生技醫療業
2024-12-31,1593,CurrentLiabilities,385103000.0,流動負債合計,祺驊,生技醫療業
2024-12-31,1593,CurrentLiabilities_per,18.72,流動負債合計,祺驊,生技醫療業
2024-12-31,1593,LongtermBorrowings,224410000.0,長期借款,祺驊,生技醫療業
2024-12-31,1593,LongtermBorrowings_per,10.91,長期借款,祺驊,生技醫療業
2024-12-31,1593,OtherNoncurrentLiabilities,29015000.0,其他非流動負債,祺驊,生技醫療業
2024-12-31,1593,OtherNoncurrentLiabilities_per,1.41,其他非流動負債,祺驊,生技醫療業
2024-12-31,1593,NoncurrentLiabilities,258060000.0,非流動負債合計,祺驊,生技醫療業
2024-12-31,1593,NoncurrentLiabilities_per,12.55,非流動負債合計,祺驊,生技醫療業
2024-12-31,1593,OrdinaryShare,397848000.0,普通股股本,祺驊,生技醫療業
2024-12-31,1593,OrdinaryShare_per,19.34,普通股股本,祺驊,生技醫療業
2024-12-31,1593,CapitalStock,397848000.0,股本合計,祺驊,生技醫療業
2024-12-31,1593,CapitalStock_per,19.34,股本合計,祺驊,生技醫療業
2024-12-31,1593,CapitalSurplus,580678000.0,資本公積合計,祺驊,生技醫療業
2024-12-31,1593,CapitalSurplus_per,28.23,資本公積合計,祺驊,生技醫療業
2024-12-31,1593,LegalReserve,167727000.0,法定盈餘公積,祺驊,生技醫療業
2024-12-31,1593,LegalReserve_per,8.15,法定盈餘公積,祺驊,生技醫療業
2024-12-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit,170237000.0,未分配盈餘,祺驊,生技醫療業
2024-12-31,1593,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,8.28,未分配盈餘,祺驊,生技醫療業
2024-12-31,1593,RetainedEarnings,387120000.0,保留盈餘合計,祺驊,生技醫療業
2024-12-31,1593,RetainedEarnings_per,18.82,保留盈餘合計,祺驊,生技醫療業
2024-12-31,1593,OtherEquityInterest,-33721000.0,其他權益合計,祺驊,生技醫療業
2024-12-31,1593,OtherEquityInterest_per,-1.64,其他權益合計,祺驊,生技醫療業
2024-12-31,1593,EquityAttributableToOwnersOfParent,1331925000.0,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2024-12-31,1593,EquityAttributableToOwnersOfParent_per,64.75,歸屬於母公司業主之權益合計,祺驊,生技醫療業
2024-12-31,1593,NoncontrollingInterests,81954000.0,非控制權益,祺驊,生技醫療業
2024-12-31,1593,NoncontrollingInterests_per,3.98,非控制權益,祺驊,生技醫療業
2024-12-31,1593,TotalLiabilitiesEquity,2057042000.0,負債及權益總計,祺驊,生技醫療業
2024-12-31,1593,TotalLiabilitiesEquity_per,100.0,負債及權益總計,祺驊,生技醫療業
2024-12-31,1593,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,祺驊,生技醫療業
2024-12-31,1593,CurrentIncomeTaxAssets,632000.0,本期所得稅資產,祺驊,生技醫療業
2024-12-31,1593,CurrentIncomeTaxAssets_per,0.03,本期所得稅資產,祺驊,生技醫療業
2024-12-31,1593,FinancialAssetsAtAmortizedCostNonCurrent,0.0,按攤銷後成本衡量之金融資產－非流動,祺驊,生技醫療業
2024-12-31,1593,FinancialAssetsAtAmortizedCostNonCurrent_per,0.0,按攤銷後成本衡量之金融資產－非流動,祺驊,生技醫療業
2024-12-31,1593,Equity,1413879000.0,權益總額,祺驊,生技醫療業
2024-12-31,1593,Equity_per,68.73,權益總額,祺驊,生技醫療業
2024-12-31,1593,Liabilities,643163000.0,負債總額,祺驊,生技醫療業
2024-12-31,1593,Liabilities_per,31.27,負債總額,祺驊,生技醫療業
2019-03-31,1593,RepaymentOfLongTermDebt,0.0,償還長期借款,祺驊,生技醫療業
2019-03-31,1593,CashBalancesBeginningOfPeriod,171089000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2019-03-31,1593,TotalIncomeLossItems,937000.0,收益費損項目合計,祺驊,生技醫療業
2019-03-31,1593,CashBalancesIncrease,16090000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2019-03-31,1593,CashProvidedByInvestingActivities,-5224000.0,投資活動之淨現金流入(流出),祺驊,生技醫療業
2019-03-31,1593,NetIncomeBeforeTax,30425000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2019-03-31,1593,PropertyAndPlantAndEquipment,-2778000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2019-03-31,1593,CashBalancesEndOfPeriod,187179000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2019-03-31,1593,OtherNonCurrentLiabilitiesIncrease,-5126000.0,其他流動資產(增加)減少,祺驊,生技醫療業
2019-03-31,1593,Depreciation,4850000.0,折舊費用,祺驊,生技醫療業
2019-03-31,1593,InterestExpense,75000.0,利息費用,祺驊,生技醫療業
2019-03-31,1593,RentalPrincipalRepayments,-899000.0,租賃本金償還,祺驊,生技醫療業
2019-03-31,1593,AmortizationExpense,725000.0,攤銷費用,祺驊,生技醫療業
2019-03-31,1593,InterestIncome,-1321000.0,利息收入,祺驊,生技醫療業
2019-03-31,1593,CashReceivedThroughOperations,19178000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2019-03-31,1593,AccountsPayable,-15929000.0,應付帳款增加(減少),祺驊,生技醫療業
2019-03-31,1593,InventoryIncrease,-5576000.0,存貨(增加)減少,祺驊,生技醫療業
2019-03-31,1593,CashFlowsProvidedFromFinancingActivities,-899000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2019-03-31,1593,ReceivableIncrease,20644000.0,應收帳款(增加)減少,祺驊,生技醫療業
2019-03-31,1593,AmountDueToRelatedParties,-1035000.0,應付帳款-關係人增加(減少),祺驊,生技醫療業
2019-03-31,1593,PayTheInterest,0.0,支付之利息,祺驊,生技醫療業
2019-03-31,1593,IncomeBeforeIncomeTaxFromContinuingOperations,30425000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2019-03-31,1593,CashFlowsFromOperatingActivities,20400000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2019-06-30,1593,DecreaseInDepositDeposit,0.0,存出保證金減少,祺驊,生技醫療業
2019-06-30,1593,RepaymentOfLongTermDebt,0.0,償還長期借款,祺驊,生技醫療業
2019-06-30,1593,CashBalancesBeginningOfPeriod,171089000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2019-06-30,1593,TotalIncomeLossItems,2318000.0,收益費損項目合計,祺驊,生技醫療業
2019-06-30,1593,CashBalancesIncrease,93011000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2019-06-30,1593,NetIncomeBeforeTax,59872000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2019-06-30,1593,PropertyAndPlantAndEquipment,-3030000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2019-06-30,1593,CashBalancesEndOfPeriod,264100000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2019-06-30,1593,OtherNonCurrentLiabilitiesIncrease,-10835000.0,其他流動資產(增加)減少,祺驊,生技醫療業
2019-06-30,1593,Depreciation,9762000.0,折舊費用,祺驊,生技醫療業
2019-06-30,1593,InterestExpense,141000.0,利息費用,祺驊,生技醫療業
2019-06-30,1593,RentalPrincipalRepayments,-1635000.0,租賃本金償還,祺驊,生技醫療業
2019-06-30,1593,AmortizationExpense,1635000.0,攤銷費用,祺驊,生技醫療業
2019-06-30,1593,InterestIncome,-2861000.0,利息收入,祺驊,生技醫療業
2019-06-30,1593,CashReceivedThroughOperations,31780000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2019-06-30,1593,AccountsPayable,-21183000.0,應付帳款增加(減少),祺驊,生技醫療業
2019-06-30,1593,CashFlowsProvidedFromFinancingActivities,-1635000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2019-06-30,1593,AmountDueToRelatedParties,-1326000.0,應付帳款-關係人增加(減少),祺驊,生技醫療業
2019-06-30,1593,PayTheInterest,-141000.0,支付之利息,祺驊,生技醫療業
2019-06-30,1593,IncomeBeforeIncomeTaxFromContinuingOperations,59872000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2019-06-30,1593,InventoryIncrease,12985000.0,存貨（增加）減少,祺驊,生技醫療業
2019-06-30,1593,ReceivableIncrease,10094000.0,應收帳款（增加）減少,祺驊,生技醫療業
2019-06-30,1593,CashProvidedByInvestingActivities,65752000.0,投資活動之淨現金流入（流出）,祺驊,生技醫療業
2019-06-30,1593,CashFlowsFromOperatingActivities,26614000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2019-09-30,1593,RepaymentOfLongTermDebt,0.0,償還長期借款,祺驊,生技醫療業
2019-09-30,1593,CashBalancesBeginningOfPeriod,171089000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2019-09-30,1593,PropertyAndPlantAndEquipment,-13881000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2019-09-30,1593,PayTheInterest,-195000.0,支付之利息,祺驊,生技醫療業
2019-09-30,1593,CashProvidedByInvestingActivities,48153000.0,投資活動之淨現金流入（流出）,祺驊,生技醫療業
2019-09-30,1593,CashBalancesEndOfPeriod,154598000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2019-09-30,1593,OtherNonCurrentLiabilitiesIncrease,-7492000.0,其他流動資產(增加)減少,祺驊,生技醫療業
2019-09-30,1593,CashBalancesIncrease,-16491000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2019-09-30,1593,IncomeBeforeIncomeTaxFromContinuingOperations,103557000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2019-09-30,1593,InterestIncome,-5610000.0,利息收入,祺驊,生技醫療業
2019-09-30,1593,NetIncomeBeforeTax,103557000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2019-09-30,1593,CashFlowsFromOperatingActivities,65214000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2019-09-30,1593,Depreciation,14704000.0,折舊費用,祺驊,生技醫療業
2019-09-30,1593,AmortizationExpense,2544000.0,攤銷費用,祺驊,生技醫療業
2019-09-30,1593,AccountsPayable,-15522000.0,應付帳款增加(減少),祺驊,生技醫療業
2019-09-30,1593,AmountDueToRelatedParties,187000.0,應付帳款-關係人增加(減少),祺驊,生技醫療業
2019-09-30,1593,DecreaseInDepositDeposit,8000.0,存出保證金減少,祺驊,生技醫療業
2019-09-30,1593,InterestExpense,195000.0,利息費用,祺驊,生技醫療業
2019-09-30,1593,TotalIncomeLossItems,1187000.0,收益費損項目合計,祺驊,生技醫療業
2019-09-30,1593,ReceivableIncrease,-13840000.0,應收帳款（增加）減少,祺驊,生技醫療業
2019-09-30,1593,CashFlowsProvidedFromFinancingActivities,-130190000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2019-09-30,1593,CashReceivedThroughOperations,77895000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2019-09-30,1593,RentalPrincipalRepayments,-2396000.0,租賃本金償還,祺驊,生技醫療業
2019-09-30,1593,InventoryIncrease,17447000.0,存貨（增加）減少,祺驊,生技醫療業
2019-12-31,1593,RepaymentOfLongTermDebt,0.0,償還長期借款,祺驊,生技醫療業
2019-12-31,1593,CashBalancesBeginningOfPeriod,171089000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2019-12-31,1593,PropertyAndPlantAndEquipment,-16891000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2019-12-31,1593,PayTheInterest,-238000.0,支付之利息,祺驊,生技醫療業
2019-12-31,1593,CashProvidedByInvestingActivities,28977000.0,投資活動之淨現金流入（流出）,祺驊,生技醫療業
2019-12-31,1593,CashBalancesEndOfPeriod,182615000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2019-12-31,1593,OtherNonCurrentLiabilitiesIncrease,208000.0,其他流動資產(增加)減少,祺驊,生技醫療業
2019-12-31,1593,CashBalancesIncrease,11526000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2019-12-31,1593,IncomeBeforeIncomeTaxFromContinuingOperations,143806000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2019-12-31,1593,ProceedsFromLongTermDebt,100000.0,舉借長期借款,祺驊,生技醫療業
2019-12-31,1593,NetIncomeBeforeTax,143806000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2019-12-31,1593,CashFlowsFromOperatingActivities,121340000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2019-12-31,1593,Depreciation,19759000.0,折舊費用,祺驊,生技醫療業
2019-12-31,1593,AccountsPayable,-22190000.0,應付帳款增加(減少),祺驊,生技醫療業
2019-12-31,1593,AmountDueToRelatedParties,-483000.0,應付帳款-關係人增加(減少),祺驊,生技醫療業
2019-12-31,1593,DecreaseInDepositDeposit,16000.0,存出保證金減少,祺驊,生技醫療業
2019-12-31,1593,InterestExpense,238000.0,利息費用,祺驊,生技醫療業
2019-12-31,1593,TotalIncomeLossItems,-3407000.0,收益費損項目合計,祺驊,生技醫療業
2019-12-31,1593,CashFlowsProvidedFromFinancingActivities,-130843000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2019-12-31,1593,CashReceivedThroughOperations,133878000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2019-12-31,1593,InterestIncome,-13206000.0,利息收入,祺驊,生技醫療業
2019-12-31,1593,RentalPrincipalRepayments,-3149000.0,租賃本金償還,祺驊,生技醫療業
2019-12-31,1593,InventoryIncrease,29914000.0,存貨(增加)減少,祺驊,生技醫療業
2019-12-31,1593,ReceivableIncrease,-11698000.0,應收帳款(增加)減少,祺驊,生技醫療業
2020-03-31,1593,AmortizationExpense,794000.0,攤銷費用,祺驊,生技醫療業
2020-03-31,1593,CashBalancesBeginningOfPeriod,182615000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2020-03-31,1593,CashBalancesEndOfPeriod,186093000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2020-03-31,1593,CashBalancesIncrease,3478000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2020-03-31,1593,CashFlowsFromOperatingActivities,27680000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2020-03-31,1593,CashReceivedThroughOperations,25756000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2020-03-31,1593,Depreciation,5039000.0,折舊費用,祺驊,生技醫療業
2020-03-31,1593,IncomeBeforeIncomeTaxFromContinuingOperations,23420000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2020-03-31,1593,InterestExpense,35000.0,利息費用,祺驊,生技醫療業
2020-03-31,1593,NetIncomeBeforeTax,23420000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2020-03-31,1593,PayTheInterest,0.0,支付之利息,祺驊,生技醫療業
2020-03-31,1593,TotalIncomeLossItems,615000.0,收益費損項目合計,祺驊,生技醫療業
2020-03-31,1593,DecreaseInDepositDeposit,3000.0,存出保證金減少,祺驊,生技醫療業
2020-03-31,1593,CashFlowsProvidedFromFinancingActivities,-925000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2020-03-31,1593,RentalPrincipalRepayments,-825000.0,租賃本金償還,祺驊,生技醫療業
2020-03-31,1593,OtherNonCurrentLiabilitiesIncrease,-9891000.0,其他流動資產(增加)減少,祺驊,生技醫療業
2020-03-31,1593,InterestIncome,-658000.0,利息收入,祺驊,生技醫療業
2020-03-31,1593,AmountDueToRelatedParties,-974000.0,應付帳款-關係人增加(減少),祺驊,生技醫療業
2020-03-31,1593,AccountsPayable,-1303000.0,應付帳款增加(減少),祺驊,生技醫療業
2020-03-31,1593,PropertyAndPlantAndEquipment,-84000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2020-03-31,1593,RepaymentOfLongTermDebt,-100000.0,償還長期借款,祺驊,生技醫療業
2020-03-31,1593,CashProvidedByInvestingActivities,-19655000.0,投資活動之淨現金流入（流出）,祺驊,生技醫療業
2020-03-31,1593,ReceivableIncrease,37296000.0,應收帳款（增加）減少,祺驊,生技醫療業
2020-03-31,1593,InventoryIncrease,-7295000.0,存貨（增加）減少,祺驊,生技醫療業
2020-06-30,1593,AccountsPayable,16285000.0,應付帳款增加(減少),祺驊,生技醫療業
2020-06-30,1593,AmortizationExpense,1597000.0,攤銷費用,祺驊,生技醫療業
2020-06-30,1593,AmountDueToRelatedParties,236000.0,應付帳款-關係人增加(減少),祺驊,生技醫療業
2020-06-30,1593,CashBalancesBeginningOfPeriod,182615000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2020-06-30,1593,CashBalancesEndOfPeriod,247181000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2020-06-30,1593,CashBalancesIncrease,64566000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2020-06-30,1593,CashFlowsFromOperatingActivities,37346000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2020-06-30,1593,CashFlowsProvidedFromFinancingActivities,48368000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2020-06-30,1593,CashReceivedThroughOperations,40627000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2020-06-30,1593,DecreaseInDepositDeposit,10000.0,存出保證金減少,祺驊,生技醫療業
2020-06-30,1593,Depreciation,9969000.0,折舊費用,祺驊,生技醫療業
2020-06-30,1593,IncomeBeforeIncomeTaxFromContinuingOperations,56213000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2020-06-30,1593,InterestExpense,99000.0,利息費用,祺驊,生技醫療業
2020-06-30,1593,NetIncomeBeforeTax,56213000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2020-06-30,1593,ReceivableIncrease,17772000.0,應收帳款（增加）減少,祺驊,生技醫療業
2020-06-30,1593,InterestIncome,-1579000.0,利息收入,祺驊,生技醫療業
2020-06-30,1593,RepaymentOfLongTermDebt,-100000.0,償還長期借款,祺驊,生技醫療業
2020-06-30,1593,RentalPrincipalRepayments,-1532000.0,租賃本金償還,祺驊,生技醫療業
2020-06-30,1593,OtherNonCurrentLiabilitiesIncrease,-5747000.0,其他流動資產(增加)減少,祺驊,生技醫療業
2020-06-30,1593,PayTheInterest,-99000.0,支付之利息,祺驊,生技醫療業
2020-06-30,1593,PropertyAndPlantAndEquipment,-1390000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2020-06-30,1593,TotalIncomeLossItems,-1473000.0,收益費損項目合計,祺驊,生技醫療業
2020-06-30,1593,CashProvidedByInvestingActivities,-16217000.0,投資活動之淨現金流入(流出),祺驊,生技醫療業
2020-06-30,1593,InventoryIncrease,-21408000.0,存貨（增加）減少,祺驊,生技醫療業
2020-09-30,1593,AccountsPayable,41092000.0,應付帳款增加(減少),祺驊,生技醫療業
2020-09-30,1593,CashBalancesBeginningOfPeriod,182615000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2020-09-30,1593,CashBalancesEndOfPeriod,216292000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2020-09-30,1593,CashBalancesIncrease,33677000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2020-09-30,1593,CashFlowsFromOperatingActivities,39425000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2020-09-30,1593,CashReceivedThroughOperations,40485000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2020-09-30,1593,DecreaseInDepositDeposit,2000.0,存出保證金減少,祺驊,生技醫療業
2020-09-30,1593,Depreciation,14883000.0,折舊費用,祺驊,生技醫療業
2020-09-30,1593,IncomeBeforeIncomeTaxFromContinuingOperations,106654000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2020-09-30,1593,InterestExpense,299000.0,利息費用,祺驊,生技醫療業
2020-09-30,1593,NetIncomeBeforeTax,106654000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2020-09-30,1593,ReceivableIncrease,-28635000.0,應收帳款（增加）減少,祺驊,生技醫療業
2020-09-30,1593,InterestIncome,-4862000.0,利息收入,祺驊,生技醫療業
2020-09-30,1593,RepaymentOfLongTermDebt,-100000.0,償還長期借款,祺驊,生技醫療業
2020-09-30,1593,RentalPrincipalRepayments,-2346000.0,租賃本金償還,祺驊,生技醫療業
2020-09-30,1593,OtherNonCurrentLiabilitiesIncrease,-14880000.0,其他流動資產(增加)減少,祺驊,生技醫療業
2020-09-30,1593,PayTheInterest,-299000.0,支付之利息,祺驊,生技醫療業
2020-09-30,1593,PropertyAndPlantAndEquipment,-3600000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2020-09-30,1593,CashFlowsProvidedFromFinancingActivities,-10178000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2020-09-30,1593,AmountDueToRelatedParties,-6722000.0,應付帳款-關係人增加(減少),祺驊,生技醫療業
2020-09-30,1593,TotalIncomeLossItems,-7958000.0,收益費損項目合計,祺驊,生技醫療業
2020-09-30,1593,CashProvidedByInvestingActivities,12811000.0,投資活動之淨現金流入(流出),祺驊,生技醫療業
2020-09-30,1593,InventoryIncrease,-36512000.0,存貨（增加）減少,祺驊,生技醫療業
2020-09-30,1593,AmortizationExpense,2403000.0,攤銷費用,祺驊,生技醫療業
2020-12-31,1593,NetIncomeBeforeTax,166313000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2020-12-31,1593,InterestExpense,738000.0,利息費用,祺驊,生技醫療業
2020-12-31,1593,CashBalancesEndOfPeriod,343682000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2020-12-31,1593,CashBalancesBeginningOfPeriod,182615000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2020-12-31,1593,CashBalancesIncrease,161067000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2020-12-31,1593,CashFlowsProvidedFromFinancingActivities,93898000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2020-12-31,1593,Depreciation,19809000.0,折舊費用,祺驊,生技醫療業
2020-12-31,1593,AccountsPayable,66303000.0,應付帳款增加(減少),祺驊,生技醫療業
2020-12-31,1593,ProceedsFromLongTermDebt,0.0,舉借長期借款,祺驊,生技醫療業
2020-12-31,1593,DecreaseInDepositDeposit,0.0,存出保證金減少,祺驊,生技醫療業
2020-12-31,1593,CashReceivedThroughOperations,98259000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2020-12-31,1593,IncomeBeforeIncomeTaxFromContinuingOperations,166313000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2020-12-31,1593,RentalPrincipalRepayments,-3205000.0,租賃本金償還,祺驊,生技醫療業
2020-12-31,1593,InterestIncome,-14452000.0,利息收入,祺驊,生技醫療業
2020-12-31,1593,OtherNonCurrentLiabilitiesIncrease,-16207000.0,其他流動資產(增加)減少,祺驊,生技醫療業
2020-12-31,1593,InventoryIncrease,-41608000.0,存貨(增加)減少,祺驊,生技醫療業
2020-12-31,1593,PayTheInterest,-443000.0,支付之利息,祺驊,生技醫療業
2020-12-31,1593,TotalIncomeLossItems,-18406000.0,收益費損項目合計,祺驊,生技醫療業
2020-12-31,1593,RepaymentOfLongTermDebt,-100000.0,償還長期借款,祺驊,生技醫療業
2020-12-31,1593,PropertyAndPlantAndEquipment,-20201000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2020-12-31,1593,AmortizationExpense,0.0,攤銷費用,祺驊,生技醫療業
2020-12-31,1593,AmountDueToRelatedParties,-9109000.0,應付帳款-關係人增加(減少),祺驊,生技醫療業
2020-12-31,1593,ReceivableIncrease,-51016000.0,應收帳款（增加）減少,祺驊,生技醫療業
2020-12-31,1593,CashProvidedByInvestingActivities,-19482000.0,投資活動之淨現金流入(流出),祺驊,生技醫療業
2020-12-31,1593,CashFlowsFromOperatingActivities,99358000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2021-03-31,1593,CashBalancesBeginningOfPeriod,343682000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2021-03-31,1593,CashBalancesEndOfPeriod,304960000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2021-03-31,1593,RentalPrincipalRepayments,0.0,租賃本金償還,祺驊,生技醫療業
2021-03-31,1593,IncomeBeforeIncomeTaxFromContinuingOperations,40397000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2021-03-31,1593,NetIncomeBeforeTax,40397000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2021-03-31,1593,Depreciation,4612000.0,折舊費用,祺驊,生技醫療業
2021-03-31,1593,AmortizationExpense,724000.0,攤銷費用,祺驊,生技醫療業
2021-03-31,1593,AccountsPayable,18357000.0,應付帳款增加(減少),祺驊,生技醫療業
2021-03-31,1593,DecreaseInDepositDeposit,166000.0,存出保證金減少,祺驊,生技醫療業
2021-03-31,1593,InterestExpense,383000.0,利息費用,祺驊,生技醫療業
2021-03-31,1593,CashFlowsProvidedFromFinancingActivities,0.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2021-03-31,1593,RepaymentOfLongTermDebt,0.0,償還長期借款,祺驊,生技醫療業
2021-03-31,1593,CashReceivedThroughOperations,-13703000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2021-03-31,1593,OtherNonCurrentLiabilitiesIncrease,-535000.0,其他流動資產(增加)減少,祺驊,生技醫療業
2021-03-31,1593,PayTheInterest,-36000.0,支付之利息,祺驊,生技醫療業
2021-03-31,1593,CashBalancesIncrease,-38722000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2021-03-31,1593,InterestIncome,-725000.0,利息收入,祺驊,生技醫療業
2021-03-31,1593,AmountDueToRelatedParties,-308000.0,應付帳款-關係人增加(減少),祺驊,生技醫療業
2021-03-31,1593,PropertyAndPlantAndEquipment,-13713000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2021-03-31,1593,InventoryIncrease,-23692000.0,存貨(增加)減少,祺驊,生技醫療業
2021-03-31,1593,ReceivableIncrease,-31711000.0,應收帳款(增加)減少,祺驊,生技醫療業
2021-03-31,1593,TotalIncomeLossItems,-378000.0,收益費損項目合計,祺驊,生技醫療業
2021-03-31,1593,CashFlowsFromOperatingActivities,-11179000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2021-03-31,1593,CashProvidedByInvestingActivities,-27558000.0,投資活動之淨現金流入(流出),祺驊,生技醫療業
2021-06-30,1593,NetIncomeBeforeTax,96322000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2021-06-30,1593,DecreaseInDepositDeposit,166000.0,存出保證金減少,祺驊,生技醫療業
2021-06-30,1593,CashFlowsFromOperatingActivities,36717000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2021-06-30,1593,CashBalancesEndOfPeriod,317762000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2021-06-30,1593,CashBalancesBeginningOfPeriod,343682000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2021-06-30,1593,CashFlowsProvidedFromFinancingActivities,3000000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2021-06-30,1593,Depreciation,8858000.0,折舊費用,祺驊,生技醫療業
2021-06-30,1593,InterestExpense,455000.0,利息費用,祺驊,生技醫療業
2021-06-30,1593,RentalPrincipalRepayments,0.0,租賃本金償還,祺驊,生技醫療業
2021-06-30,1593,AmortizationExpense,1463000.0,攤銷費用,祺驊,生技醫療業
2021-06-30,1593,RepaymentOfLongTermDebt,0.0,償還長期借款,祺驊,生技醫療業
2021-06-30,1593,AccountsPayable,27585000.0,應付帳款增加(減少),祺驊,生技醫療業
2021-06-30,1593,CashReceivedThroughOperations,48041000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2021-06-30,1593,IncomeBeforeIncomeTaxFromContinuingOperations,96322000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2021-06-30,1593,TotalIncomeLossItems,-2332000.0,收益費損項目合計,祺驊,生技醫療業
2021-06-30,1593,PropertyAndPlantAndEquipment,-27282000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2021-06-30,1593,CashProvidedByInvestingActivities,-60828000.0,投資活動之淨現金流入(流出),祺驊,生技醫療業
2021-06-30,1593,CashBalancesIncrease,-25920000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2021-06-30,1593,OtherNonCurrentLiabilitiesIncrease,-2445000.0,其他流動資產(增加)減少,祺驊,生技醫療業
2021-06-30,1593,InterestIncome,-1376000.0,利息收入,祺驊,生技醫療業
2021-06-30,1593,AmountDueToRelatedParties,-104000.0,應付帳款-關係人增加(減少),祺驊,生技醫療業
2021-06-30,1593,PayTheInterest,-7000.0,支付之利息,祺驊,生技醫療業
2021-06-30,1593,InventoryIncrease,-14204000.0,存貨(增加)減少,祺驊,生技醫療業
2021-06-30,1593,ReceivableIncrease,-43601000.0,應收帳款(增加)減少,祺驊,生技醫療業
2021-09-30,1593,TotalIncomeLossItems,2783000.0,收益費損項目合計,祺驊,生技醫療業
2021-09-30,1593,PropertyAndPlantAndEquipment,-431801000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2021-09-30,1593,NetIncomeBeforeTax,152683000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2021-09-30,1593,DecreaseInDepositDeposit,165000.0,存出保證金減少,祺驊,生技醫療業
2021-09-30,1593,CashFlowsFromOperatingActivities,94745000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2021-09-30,1593,CashBalancesEndOfPeriod,244827000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2021-09-30,1593,ReceivableIncrease,-38379000.0,應收帳款（增加）減少,祺驊,生技醫療業
2021-09-30,1593,CashBalancesBeginningOfPeriod,343682000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2021-09-30,1593,CashBalancesIncrease,-98855000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2021-09-30,1593,InventoryIncrease,-36743000.0,存貨（增加）減少,祺驊,生技醫療業
2021-09-30,1593,CashFlowsProvidedFromFinancingActivities,178980000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2021-09-30,1593,Depreciation,13822000.0,折舊費用,祺驊,生技醫療業
2021-09-30,1593,OtherNonCurrentLiabilitiesIncrease,4229000.0,其他流動資產(增加)減少,祺驊,生技醫療業
2021-09-30,1593,InterestExpense,900000.0,利息費用,祺驊,生技醫療業
2021-09-30,1593,RentalPrincipalRepayments,-217000.0,租賃本金償還,祺驊,生技醫療業
2021-09-30,1593,RepaymentOfLongTermDebt,268000000.0,償還長期借款,祺驊,生技醫療業
2021-09-30,1593,InterestIncome,-4386000.0,利息收入,祺驊,生技醫療業
2021-09-30,1593,AccountsPayable,21582000.0,應付帳款增加(減少),祺驊,生技醫療業
2021-09-30,1593,CashReceivedThroughOperations,108445000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2021-09-30,1593,AmountDueToRelatedParties,1955000.0,應付帳款-關係人增加(減少),祺驊,生技醫療業
2021-09-30,1593,PayTheInterest,-750000.0,支付之利息,祺驊,生技醫療業
2021-09-30,1593,IncomeBeforeIncomeTaxFromContinuingOperations,152683000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2021-09-30,1593,CashProvidedByInvestingActivities,-370549000.0,投資活動之淨現金流入（流出）,祺驊,生技醫療業
2021-09-30,1593,AmortizationExpense,2262000.0,攤銷費用,祺驊,生技醫療業
2021-12-31,1593,OtherNonCurrentLiabilitiesIncrease,-1099000.0,其他流動資產(增加)減少,祺驊,生技醫療業
2021-12-31,1593,PropertyAndPlantAndEquipment,-476816000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2021-12-31,1593,CashBalancesEndOfPeriod,201466000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2021-12-31,1593,CashBalancesIncrease,-142216000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2021-12-31,1593,CashProvidedByInvestingActivities,-405585000.0,投資活動之淨現金流入（流出）,祺驊,生技醫療業
2021-12-31,1593,CashBalancesBeginningOfPeriod,343682000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2021-12-31,1593,RentalPrincipalRepayments,-353000.0,租賃本金償還,祺驊,生技醫療業
2021-12-31,1593,PayTheInterest,-1208000.0,支付之利息,祺驊,生技醫療業
2021-12-31,1593,IncomeBeforeIncomeTaxFromContinuingOperations,205872000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2021-12-31,1593,ProceedsFromLongTermDebt,268000000.0,舉借長期借款,祺驊,生技醫療業
2021-12-31,1593,NetIncomeBeforeTax,205872000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2021-12-31,1593,CashFlowsFromOperatingActivities,119336000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2021-12-31,1593,Depreciation,19177000.0,折舊費用,祺驊,生技醫療業
2021-12-31,1593,AccountsPayable,-44728000.0,應付帳款增加(減少),祺驊,生技醫療業
2021-12-31,1593,AmountDueToRelatedParties,3453000.0,應付帳款-關係人增加(減少),祺驊,生技醫療業
2021-12-31,1593,RepaymentOfLongTermDebt,0.0,償還長期借款,祺驊,生技醫療業
2021-12-31,1593,DecreaseInDepositDeposit,164000.0,存出保證金減少,祺驊,生技醫療業
2021-12-31,1593,ReceivableIncrease,-13049000.0,應收帳款（增加）減少,祺驊,生技醫療業
2021-12-31,1593,CashFlowsProvidedFromFinancingActivities,145844000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2021-12-31,1593,CashReceivedThroughOperations,129270000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2021-12-31,1593,InterestIncome,-9779000.0,利息收入,祺驊,生技醫療業
2021-12-31,1593,InterestExpense,1880000.0,利息費用,祺驊,生技醫療業
2021-12-31,1593,InventoryIncrease,-22414000.0,存貨（增加）減少,祺驊,生技醫療業
2021-12-31,1593,TotalIncomeLossItems,1064000.0,收益費損項目合計,祺驊,生技醫療業
2021-12-31,1593,AmortizationExpense,2970000.0,攤銷費用,祺驊,生技醫療業
2022-03-31,1593,DecreaseInDepositDeposit,0.0,存出保證金減少,祺驊,生技醫療業
2022-03-31,1593,InventoryIncrease,5689000.0,存貨（增加）減少,祺驊,生技醫療業
2022-03-31,1593,ReceivableIncrease,70607000.0,應收帳款（增加）減少,祺驊,生技醫療業
2022-03-31,1593,CashReceivedThroughOperations,47620000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2022-03-31,1593,InterestIncome,-842000.0,利息收入,祺驊,生技醫療業
2022-03-31,1593,RentalPrincipalRepayments,-178000.0,租賃本金償還,祺驊,生技醫療業
2022-03-31,1593,TotalIncomeLossItems,2340000.0,收益費損項目合計,祺驊,生技醫療業
2022-03-31,1593,OtherNonCurrentLiabilitiesIncrease,-6222000.0,其他流動資產(增加)減少,祺驊,生技醫療業
2022-03-31,1593,CashBalancesIncrease,69083000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2022-03-31,1593,CashBalancesBeginningOfPeriod,201466000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2022-03-31,1593,CashBalancesEndOfPeriod,270549000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2022-03-31,1593,CashProvidedByInvestingActivities,10566000.0,投資活動之淨現金流入（流出）,祺驊,生技醫療業
2022-03-31,1593,PropertyAndPlantAndEquipment,-16310000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2022-03-31,1593,PayTheInterest,-849000.0,支付之利息,祺驊,生技醫療業
2022-03-31,1593,InterestExpense,937000.0,利息費用,祺驊,生技醫療業
2022-03-31,1593,CashFlowsProvidedFromFinancingActivities,-178000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2022-03-31,1593,AmountDueToRelatedParties,-10000.0,應付帳款-關係人增加(減少),祺驊,生技醫療業
2022-03-31,1593,IncomeBeforeIncomeTaxFromContinuingOperations,16709000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2022-03-31,1593,Depreciation,5722000.0,折舊費用,祺驊,生技醫療業
2022-03-31,1593,NetIncomeBeforeTax,16709000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2022-03-31,1593,AmortizationExpense,709000.0,攤銷費用,祺驊,生技醫療業
2022-03-31,1593,AccountsPayable,-26211000.0,應付帳款,祺驊,生技醫療業
2022-03-31,1593,NetCashInflowFromOperatingActivities,49766000.0,營業活動之淨現金流入,祺驊,生技醫療業
2022-03-31,1593,CashFlowsFromOperatingActivities,49766000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2022-06-30,1593,InventoryIncrease,-3501000.0,存貨（增加）減少,祺驊,生技醫療業
2022-06-30,1593,ReceivableIncrease,137351000.0,應收帳款（增加）減少,祺驊,生技醫療業
2022-06-30,1593,CashReceivedThroughOperations,89901000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2022-06-30,1593,InterestIncome,-2105000.0,利息收入,祺驊,生技醫療業
2022-06-30,1593,RentalPrincipalRepayments,-356000.0,租賃本金償還,祺驊,生技醫療業
2022-06-30,1593,OtherNonCurrentLiabilitiesIncrease,-6144000.0,其他流動資產(增加)減少,祺驊,生技醫療業
2022-06-30,1593,PayTheInterest,-1804000.0,支付之利息,祺驊,生技醫療業
2022-06-30,1593,CashBalancesIncrease,14368000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2022-06-30,1593,CashBalancesBeginningOfPeriod,201466000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2022-06-30,1593,CashBalancesEndOfPeriod,215834000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2022-06-30,1593,CashProvidedByInvestingActivities,-56030000.0,投資活動之淨現金流入（流出）,祺驊,生技醫療業
2022-06-30,1593,PropertyAndPlantAndEquipment,-50287000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2022-06-30,1593,OtherInvestingActivities,0.0,其他投資活動,祺驊,生技醫療業
2022-06-30,1593,TotalIncomeLossItems,-9394000.0,收益費損項目合計,祺驊,生技醫療業
2022-06-30,1593,InterestExpense,1982000.0,利息費用,祺驊,生技醫療業
2022-06-30,1593,CashFlowsProvidedFromFinancingActivities,-1756000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2022-06-30,1593,DecreaseInDepositDeposit,43000.0,存出保證金減少,祺驊,生技醫療業
2022-06-30,1593,IncomeBeforeIncomeTaxFromContinuingOperations,34802000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2022-06-30,1593,NetIncomeBeforeTax,34802000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2022-06-30,1593,CashFlowsFromOperatingActivities,62297000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2022-06-30,1593,AmortizationExpense,1236000.0,攤銷費用,祺驊,生技醫療業
2022-06-30,1593,Depreciation,11212000.0,折舊費用,祺驊,生技醫療業
2022-06-30,1593,AmountDueToRelatedParties,-4288000.0,應付帳款-關係人增加(減少),祺驊,生技醫療業
2022-06-30,1593,NetCashInflowFromOperatingActivities,62297000.0,營業活動之淨現金流入,祺驊,生技醫療業
2022-06-30,1593,AccountsPayable,-38615000.0,應付帳款,祺驊,生技醫療業
2022-09-30,1593,PropertyAndPlantAndEquipment,-73190000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2022-09-30,1593,NetIncomeBeforeTax,166331000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2022-09-30,1593,DecreaseInDepositDeposit,42000.0,存出保證金減少,祺驊,生技醫療業
2022-09-30,1593,CashFlowsFromOperatingActivities,50131000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2022-09-30,1593,CashBalancesEndOfPeriod,270815000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2022-09-30,1593,ReceivableIncrease,80366000.0,應收帳款（增加）減少,祺驊,生技醫療業
2022-09-30,1593,CashBalancesBeginningOfPeriod,201466000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2022-09-30,1593,CashBalancesIncrease,69349000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2022-09-30,1593,CashFlowsProvidedFromFinancingActivities,13408000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2022-09-30,1593,Depreciation,17213000.0,折舊費用,祺驊,生技醫療業
2022-09-30,1593,OtherNonCurrentLiabilitiesIncrease,-13647000.0,其他流動資產(增加)減少,祺驊,生技醫療業
2022-09-30,1593,InterestExpense,3195000.0,利息費用,祺驊,生技醫療業
2022-09-30,1593,RentalPrincipalRepayments,-887000.0,租賃本金償還,祺驊,生技醫療業
2022-09-30,1593,AmortizationExpense,2129000.0,攤銷費用,祺驊,生技醫療業
2022-09-30,1593,RepaymentOfLongTermDebt,0.0,償還長期借款,祺驊,生技醫療業
2022-09-30,1593,InterestIncome,-2729000.0,利息收入,祺驊,生技醫療業
2022-09-30,1593,CashReceivedThroughOperations,78113000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2022-09-30,1593,AmountDueToRelatedParties,-1917000.0,應付帳款-關係人增加(減少),祺驊,生技醫療業
2022-09-30,1593,PayTheInterest,-2925000.0,支付之利息,祺驊,生技醫療業
2022-09-30,1593,IncomeBeforeIncomeTaxFromContinuingOperations,166331000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2022-09-30,1593,InventoryIncrease,-1480000.0,存貨（增加）減少,祺驊,生技醫療業
2022-09-30,1593,CashProvidedByInvestingActivities,-12195000.0,投資活動之淨現金流入（流出）,祺驊,生技醫療業
2022-09-30,1593,TotalIncomeLossItems,-104224000.0,收益費損項目合計,祺驊,生技醫療業
2022-09-30,1593,NetCashInflowFromOperatingActivities,50131000.0,營業活動之淨現金流入,祺驊,生技醫療業
2022-09-30,1593,AccountsPayable,-37747000.0,應付帳款,祺驊,生技醫療業
2022-12-31,1593,TotalIncomeLossItems,-94618000.0,收益費損項目合計,祺驊,生技醫療業
2022-12-31,1593,PropertyAndPlantAndEquipment,-178468000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2022-12-31,1593,NetIncomeBeforeTax,220267000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2022-12-31,1593,DecreaseInDepositDeposit,38000.0,存出保證金減少,祺驊,生技醫療業
2022-12-31,1593,CashFlowsFromOperatingActivities,136800000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2022-12-31,1593,CashBalancesEndOfPeriod,331929000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2022-12-31,1593,ReceivableIncrease,66807000.0,應收帳款（增加）減少,祺驊,生技醫療業
2022-12-31,1593,CashBalancesBeginningOfPeriod,201466000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2022-12-31,1593,CashBalancesIncrease,130463000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2022-12-31,1593,InventoryIncrease,17443000.0,存貨（增加）減少,祺驊,生技醫療業
2022-12-31,1593,CashFlowsProvidedFromFinancingActivities,10453000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2022-12-31,1593,Depreciation,24826000.0,折舊費用,祺驊,生技醫療業
2022-12-31,1593,OtherNonCurrentLiabilitiesIncrease,-1163000.0,其他流動資產(增加)減少,祺驊,生技醫療業
2022-12-31,1593,InterestExpense,5181000.0,利息費用,祺驊,生技醫療業
2022-12-31,1593,RentalPrincipalRepayments,-2122000.0,租賃本金償還,祺驊,生技醫療業
2022-12-31,1593,AmortizationExpense,4627000.0,攤銷費用,祺驊,生技醫療業
2022-12-31,1593,ProceedsFromLongTermDebt,0.0,舉借長期借款,祺驊,生技醫療業
2022-12-31,1593,InterestIncome,-6229000.0,利息收入,祺驊,生技醫療業
2022-12-31,1593,CashReceivedThroughOperations,167098000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2022-12-31,1593,AmountDueToRelatedParties,2701000.0,應付帳款-關係人增加(減少),祺驊,生技醫療業
2022-12-31,1593,PayTheInterest,-4808000.0,支付之利息,祺驊,生技醫療業
2022-12-31,1593,IncomeBeforeIncomeTaxFromContinuingOperations,220267000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2022-12-31,1593,RepaymentOfLongTermDebt,0.0,償還長期借款,祺驊,生技醫療業
2022-12-31,1593,NetCashInflowFromOperatingActivities,136800000.0,營業活動之淨現金流入,祺驊,生技醫療業
2022-12-31,1593,AccountsPayable,-41840000.0,應付帳款,祺驊,生技醫療業
2022-12-31,1593,CashProvidedByInvestingActivities,-29807000.0,投資活動之淨現金流入（流出）,祺驊,生技醫療業
2023-03-31,1593,CashBalancesBeginningOfPeriod,331929000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2023-03-31,1593,CashBalancesIncrease,-14146000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2023-03-31,1593,PropertyAndPlantAndEquipment,-2759000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2023-03-31,1593,CashBalancesEndOfPeriod,317783000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2023-03-31,1593,OtherNonCurrentLiabilitiesIncrease,-3469000.0,其他流動資產(增加)減少,祺驊,生技醫療業
2023-03-31,1593,Depreciation,7808000.0,折舊費用,祺驊,生技醫療業
2023-03-31,1593,InterestExpense,2016000.0,利息費用,祺驊,生技醫療業
2023-03-31,1593,RentalPrincipalRepayments,-1293000.0,租賃本金償還,祺驊,生技醫療業
2023-03-31,1593,InterestIncome,-870000.0,利息收入,祺驊,生技醫療業
2023-03-31,1593,CashReceivedThroughOperations,21163000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2023-03-31,1593,CashFlowsProvidedFromFinancingActivities,227000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2023-03-31,1593,AmountDueToRelatedParties,-4671000.0,應付帳款-關係人增加(減少),祺驊,生技醫療業
2023-03-31,1593,PayTheInterest,-1924000.0,支付之利息,祺驊,生技醫療業
2023-03-31,1593,InventoryIncrease,2334000.0,存貨（增加）減少,祺驊,生技醫療業
2023-03-31,1593,ReceivableIncrease,52219000.0,應收帳款（增加）減少,祺驊,生技醫療業
2023-03-31,1593,DecreaseInDepositDeposit,0.0,存出保證金減少,祺驊,生技醫療業
2023-03-31,1593,NetCashInflowFromOperatingActivities,20872000.0,營業活動之淨現金流入,祺驊,生技醫療業
2023-03-31,1593,AccountsPayable,-25505000.0,應付帳款,祺驊,生技醫療業
2023-03-31,1593,CashFlowsFromOperatingActivities,20872000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2023-03-31,1593,CashProvidedByInvestingActivities,-36578000.0,投資活動之淨現金流入（流出）,祺驊,生技醫療業
2023-03-31,1593,RepaymentOfLongTermDebt,0.0,償還長期借款,祺驊,生技醫療業
2023-03-31,1593,TotalIncomeLossItems,15571000.0,收益費損項目合計,祺驊,生技醫療業
2023-03-31,1593,IncomeBeforeIncomeTaxFromContinuingOperations,15289000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2023-03-31,1593,NetIncomeBeforeTax,15289000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2023-03-31,1593,AmortizationExpense,3366000.0,攤銷費用,祺驊,生技醫療業
2023-06-30,1593,OtherInvestingActivities,1014000.0,其他投資活動,祺驊,生技醫療業
2023-06-30,1593,PropertyAndPlantAndEquipment,-1565000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2023-06-30,1593,DecreaseInDepositDeposit,-142000.0,存出保證金減少,祺驊,生技醫療業
2023-06-30,1593,CashFlowsFromOperatingActivities,61016000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2023-06-30,1593,ReceivableIncrease,71222000.0,應收帳款（增加）減少,祺驊,生技醫療業
2023-06-30,1593,CashBalancesEndOfPeriod,367751000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2023-06-30,1593,CashBalancesBeginningOfPeriod,331929000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2023-06-30,1593,InventoryIncrease,9789000.0,存貨（增加）減少,祺驊,生技醫療業
2023-06-30,1593,CashFlowsProvidedFromFinancingActivities,-15266000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2023-06-30,1593,Depreciation,15586000.0,折舊費用,祺驊,生技醫療業
2023-06-30,1593,PayTheInterest,-4031000.0,支付之利息,祺驊,生技醫療業
2023-06-30,1593,InterestExpense,4104000.0,利息費用,祺驊,生技醫療業
2023-06-30,1593,OtherNonCurrentLiabilitiesIncrease,-5825000.0,其他流動資產(增加)減少,祺驊,生技醫療業
2023-06-30,1593,RentalPrincipalRepayments,-2746000.0,租賃本金償還,祺驊,生技醫療業
2023-06-30,1593,InterestIncome,-2360000.0,利息收入,祺驊,生技醫療業
2023-06-30,1593,CashReceivedThroughOperations,93443000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2023-06-30,1593,AmountDueToRelatedParties,-5221000.0,應付帳款-關係人增加(減少),祺驊,生技醫療業
2023-06-30,1593,CashBalancesIncrease,35822000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2023-06-30,1593,CashProvidedByInvestingActivities,-9989000.0,投資活動之淨現金流入（流出）,祺驊,生技醫療業
2023-06-30,1593,NetCashInflowFromOperatingActivities,61016000.0,營業活動之淨現金流入,祺驊,生技醫療業
2023-06-30,1593,AccountsPayable,-19599000.0,應付帳款,祺驊,生技醫療業
2023-06-30,1593,DecreaseInShortTermLoans,0.0,短期借款減少,祺驊,生技醫療業
2023-06-30,1593,TotalIncomeLossItems,24574000.0,收益費損項目合計,祺驊,生技醫療業
2023-06-30,1593,IncomeBeforeIncomeTaxFromContinuingOperations,54517000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2023-06-30,1593,NetIncomeBeforeTax,54517000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2023-06-30,1593,RepaymentOfLongTermDebt,0.0,償還長期借款,祺驊,生技醫療業
2023-06-30,1593,AmortizationExpense,7321000.0,攤銷費用,祺驊,生技醫療業
2023-09-30,1593,TotalIncomeLossItems,42384000.0,收益費損項目合計,祺驊,生技醫療業
2023-09-30,1593,PropertyAndPlantAndEquipment,-15319000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2023-09-30,1593,NetIncomeBeforeTax,84607000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2023-09-30,1593,DecreaseInDepositDeposit,80000.0,存出保證金減少,祺驊,生技醫療業
2023-09-30,1593,CashFlowsFromOperatingActivities,97373000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2023-09-30,1593,CashBalancesEndOfPeriod,288342000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2023-09-30,1593,ReceivableIncrease,46091000.0,應收帳款（增加）減少,祺驊,生技醫療業
2023-09-30,1593,CashBalancesBeginningOfPeriod,331929000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2023-09-30,1593,CashBalancesIncrease,-43587000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2023-09-30,1593,InventoryIncrease,3500000.0,存貨（增加）減少,祺驊,生技醫療業
2023-09-30,1593,CashFlowsProvidedFromFinancingActivities,-93289000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2023-09-30,1593,Depreciation,24657000.0,折舊費用,祺驊,生技醫療業
2023-09-30,1593,OtherNonCurrentLiabilitiesIncrease,1433000.0,其他流動資產(增加)減少,祺驊,生技醫療業
2023-09-30,1593,InterestExpense,6234000.0,利息費用,祺驊,生技醫療業
2023-09-30,1593,RentalPrincipalRepayments,-4080000.0,租賃本金償還,祺驊,生技醫療業
2023-09-30,1593,AmortizationExpense,12662000.0,攤銷費用,祺驊,生技醫療業
2023-09-30,1593,RepaymentOfLongTermDebt,-1316000.0,償還長期借款,祺驊,生技醫療業
2023-09-30,1593,InterestIncome,-3133000.0,利息收入,祺驊,生技醫療業
2023-09-30,1593,CashReceivedThroughOperations,131206000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2023-09-30,1593,AmountDueToRelatedParties,-2009000.0,應付帳款-關係人增加(減少),祺驊,生技醫療業
2023-09-30,1593,PayTheInterest,-6148000.0,支付之利息,祺驊,生技醫療業
2023-09-30,1593,IncomeBeforeIncomeTaxFromContinuingOperations,84607000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2023-09-30,1593,NetCashInflowFromOperatingActivities,97373000.0,營業活動之淨現金流入,祺驊,生技醫療業
2023-09-30,1593,AccountsPayable,-7845000.0,應付帳款,祺驊,生技醫療業
2023-09-30,1593,CashProvidedByInvestingActivities,-54925000.0,投資活動之淨現金流入（流出）,祺驊,生技醫療業
2023-12-31,1593,InterestExpense,8737000.0,利息費用,祺驊,生技醫療業
2023-12-31,1593,CashBalancesEndOfPeriod,350563000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2023-12-31,1593,AmortizationExpense,15895000.0,攤銷費用,祺驊,生技醫療業
2023-12-31,1593,CashBalancesBeginningOfPeriod,331929000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2023-12-31,1593,PayTheInterest,-8673000.0,支付之利息,祺驊,生技醫療業
2023-12-31,1593,RentalPrincipalRepayments,-5307000.0,租賃本金償還,祺驊,生技醫療業
2023-12-31,1593,DecreaseInDepositDeposit,0.0,存出保證金減少,祺驊,生技醫療業
2023-12-31,1593,RepaymentOfLongTermDebt,-5858000.0,償還長期借款,祺驊,生技醫療業
2023-12-31,1593,NetCashInflowFromOperatingActivities,162977000.0,營業活動之淨現金流入,祺驊,生技醫療業
2023-12-31,1593,InterestIncome,-7291000.0,利息收入,祺驊,生技醫療業
2023-12-31,1593,PropertyAndPlantAndEquipment,-20386000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2023-12-31,1593,TotalIncomeLossItems,52791000.0,收益費損項目合計,祺驊,生技醫療業
2023-12-31,1593,AccountsPayable,-27459000.0,應付帳款,祺驊,生技醫療業
2023-12-31,1593,Depreciation,33264000.0,折舊費用,祺驊,生技醫療業
2023-12-31,1593,CashBalancesIncrease,18634000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2023-12-31,1593,CashProvidedByInvestingActivities,-39958000.0,投資活動之淨現金流入（流出）,祺驊,生技醫療業
2023-12-31,1593,IncomeBeforeIncomeTaxFromContinuingOperations,105579000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2023-12-31,1593,CashReceivedThroughOperations,197720000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2023-12-31,1593,CashFlowsProvidedFromFinancingActivities,-99663000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2023-12-31,1593,ReceivableIncrease,83682000.0,應收帳款（增加）減少,祺驊,生技醫療業
2023-12-31,1593,CashFlowsFromOperatingActivities,162977000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2023-12-31,1593,NetIncomeBeforeTax,105579000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2023-12-31,1593,InventoryIncrease,13727000.0,存貨（增加）減少,祺驊,生技醫療業
2023-12-31,1593,DecreaseInShortTermLoans,0.0,短期借款減少,祺驊,生技醫療業
2024-03-31,1593,CashBalancesIncrease,-33916000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2024-03-31,1593,CashBalancesEndOfPeriod,316647000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2024-03-31,1593,PropertyAndPlantAndEquipment,-1978000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2024-03-31,1593,PayTheInterest,-2003000.0,支付之利息,祺驊,生技醫療業
2024-03-31,1593,CashBalancesBeginningOfPeriod,350563000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2024-03-31,1593,RentalPrincipalRepayments,-1256000.0,租賃本金償還,祺驊,生技醫療業
2024-03-31,1593,CashProvidedByInvestingActivities,-24163000.0,投資活動之淨現金流入（流出）,祺驊,生技醫療業
2024-03-31,1593,IncomeBeforeIncomeTaxFromContinuingOperations,14766000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2024-03-31,1593,InterestIncome,-916000.0,利息收入,祺驊,生技醫療業
2024-03-31,1593,CashReceivedThroughOperations,-5566000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2024-03-31,1593,CashFlowsProvidedFromFinancingActivities,-8328000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2024-03-31,1593,ReceivableIncrease,-65000.0,應收帳款（增加）減少,祺驊,生技醫療業
2024-03-31,1593,TotalIncomeLossItems,22151000.0,收益費損項目合計,祺驊,生技醫療業
2024-03-31,1593,InterestExpense,2003000.0,利息費用,祺驊,生技醫療業
2024-03-31,1593,DecreaseInDepositDeposit,9000.0,存出保證金減少,祺驊,生技醫療業
2024-03-31,1593,NetCashInflowFromOperatingActivities,-8500000.0,營業活動之淨現金流入,祺驊,生技醫療業
2024-03-31,1593,AccountsPayable,-11351000.0,應付帳款,祺驊,生技醫療業
2024-03-31,1593,AmortizationExpense,3195000.0,攤銷費用,祺驊,生技醫療業
2024-03-31,1593,Depreciation,9037000.0,折舊費用,祺驊,生技醫療業
2024-03-31,1593,CashFlowsFromOperatingActivities,-8500000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2024-03-31,1593,NetIncomeBeforeTax,14766000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2024-03-31,1593,RepaymentOfLongTermDebt,-4564000.0,償還長期借款,祺驊,生技醫療業
2024-03-31,1593,InventoryIncrease,3296000.0,存貨（增加）減少,祺驊,生技醫療業
2024-06-30,1593,PropertyAndPlantAndEquipment,-3149000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2024-06-30,1593,CashBalancesIncrease,-36744000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2024-06-30,1593,OtherInvestingActivities,1524000.0,其他投資活動,祺驊,生技醫療業
2024-06-30,1593,CashBalancesEndOfPeriod,313819000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2024-06-30,1593,PayTheInterest,-4035000.0,支付之利息,祺驊,生技醫療業
2024-06-30,1593,CashBalancesBeginningOfPeriod,350563000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2024-06-30,1593,CashProvidedByInvestingActivities,-5845000.0,投資活動之淨現金流入（流出）,祺驊,生技醫療業
2024-06-30,1593,IncomeBeforeIncomeTaxFromContinuingOperations,44850000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2024-06-30,1593,RepaymentOfLongTermDebt,-9130000.0,償還長期借款,祺驊,生技醫療業
2024-06-30,1593,NetIncomeBeforeTax,44850000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2024-06-30,1593,CashFlowsFromOperatingActivities,-14717000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2024-06-30,1593,Depreciation,18087000.0,折舊費用,祺驊,生技醫療業
2024-06-30,1593,AmortizationExpense,6387000.0,攤銷費用,祺驊,生技醫療業
2024-06-30,1593,AccountsPayable,-655000.0,應付帳款,祺驊,生技醫療業
2024-06-30,1593,NetCashInflowFromOperatingActivities,-14717000.0,營業活動之淨現金流入,祺驊,生技醫療業
2024-06-30,1593,RentalPrincipalRepayments,-2512000.0,租賃本金償還,祺驊,生技醫療業
2024-06-30,1593,DecreaseInDepositDeposit,-89000.0,存出保證金減少,祺驊,生技醫療業
2024-06-30,1593,TotalIncomeLossItems,35623000.0,收益費損項目合計,祺驊,生技醫療業
2024-06-30,1593,ReceivableIncrease,-22337000.0,應收帳款（增加）減少,祺驊,生技醫療業
2024-06-30,1593,InventoryIncrease,6929000.0,存貨（增加）減少,祺驊,生技醫療業
2024-06-30,1593,CashFlowsProvidedFromFinancingActivities,-23434000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2024-06-30,1593,InterestIncome,-2418000.0,利息收入,祺驊,生技醫療業
2024-06-30,1593,DecreaseInShortTermLoans,-5000000.0,短期借款減少,祺驊,生技醫療業
2024-06-30,1593,InterestExpense,4031000.0,利息費用,祺驊,生技醫療業
2024-06-30,1593,CashReceivedThroughOperations,18651000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2024-09-30,1593,CashBalancesIncrease,-57345000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2024-09-30,1593,CashBalancesEndOfPeriod,293218000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2024-09-30,1593,PropertyAndPlantAndEquipment,-3707000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2024-09-30,1593,PayTheInterest,-6112000.0,支付之利息,祺驊,生技醫療業
2024-09-30,1593,CashBalancesBeginningOfPeriod,350563000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2024-09-30,1593,RentalPrincipalRepayments,-3774000.0,租賃本金償還,祺驊,生技醫療業
2024-09-30,1593,CashProvidedByInvestingActivities,-44917000.0,投資活動之淨現金流入（流出）,祺驊,生技醫療業
2024-09-30,1593,IncomeBeforeIncomeTaxFromContinuingOperations,85154000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2024-09-30,1593,InterestIncome,-4757000.0,利息收入,祺驊,生技醫療業
2024-09-30,1593,CashReceivedThroughOperations,86542000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2024-09-30,1593,CashFlowsProvidedFromFinancingActivities,-58052000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2024-09-30,1593,ReceivableIncrease,-25617000.0,應收帳款（增加）減少,祺驊,生技醫療業
2024-09-30,1593,TotalIncomeLossItems,52022000.0,收益費損項目合計,祺驊,生技醫療業
2024-09-30,1593,InterestExpense,6108000.0,利息費用,祺驊,生技醫療業
2024-09-30,1593,DecreaseInDepositDeposit,-428000.0,存出保證金減少,祺驊,生技醫療業
2024-09-30,1593,NetCashInflowFromOperatingActivities,39616000.0,營業活動之淨現金流入,祺驊,生技醫療業
2024-09-30,1593,AccountsPayable,6346000.0,應付帳款,祺驊,生技醫療業
2024-09-30,1593,AmortizationExpense,9429000.0,攤銷費用,祺驊,生技醫療業
2024-09-30,1593,Depreciation,27505000.0,折舊費用,祺驊,生技醫療業
2024-09-30,1593,CashFlowsFromOperatingActivities,39616000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2024-09-30,1593,NetIncomeBeforeTax,85154000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2024-09-30,1593,RepaymentOfLongTermDebt,-13705000.0,償還長期借款,祺驊,生技醫療業
2024-09-30,1593,InventoryIncrease,1399000.0,存貨（增加）減少,祺驊,生技醫療業
2024-12-31,1593,CashBalancesIncrease,-37439000.0,本期現金及約當現金增加（減少）數,祺驊,生技醫療業
2024-12-31,1593,CashBalancesEndOfPeriod,313124000.0,期末現金及約當現金餘額,祺驊,生技醫療業
2024-12-31,1593,PropertyAndPlantAndEquipment,-4986000.0,取得不動產、廠房及設備,祺驊,生技醫療業
2024-12-31,1593,PayTheInterest,-8610000.0,支付之利息,祺驊,生技醫療業
2024-12-31,1593,CashBalancesBeginningOfPeriod,350563000.0,期初現金及約當現金餘額,祺驊,生技醫療業
2024-12-31,1593,RentalPrincipalRepayments,-5298000.0,租賃本金償還,祺驊,生技醫療業
2024-12-31,1593,CashProvidedByInvestingActivities,-71574000.0,投資活動之淨現金流入（流出）,祺驊,生技醫療業
2024-12-31,1593,IncomeBeforeIncomeTaxFromContinuingOperations,132908000.0,繼續營業單位稅前淨利（淨損）,祺驊,生技醫療業
2024-12-31,1593,DecreaseInShortTermLoans,-5000000.0,短期借款減少,祺驊,生技醫療業
2024-12-31,1593,InterestIncome,-9183000.0,利息收入,祺驊,生技醫療業
2024-12-31,1593,CashFlowsProvidedFromFinancingActivities,-99230000.0,籌資活動之淨現金流入（流出）,祺驊,生技醫療業
2024-12-31,1593,InventoryIncrease,-6764000.0,存貨（增加）減少,祺驊,生技醫療業
2024-12-31,1593,ReceivableIncrease,-32424000.0,應收帳款（增加）減少,祺驊,生技醫療業
2024-12-31,1593,TotalIncomeLossItems,61647000.0,收益費損項目合計,祺驊,生技醫療業
2024-12-31,1593,InterestExpense,8614000.0,利息費用,祺驊,生技醫療業
2024-12-31,1593,NetCashInflowFromOperatingActivities,127006000.0,營業活動之淨現金流入,祺驊,生技醫療業
2024-12-31,1593,AccountsPayable,25078000.0,應付帳款,祺驊,生技醫療業
2024-12-31,1593,AmortizationExpense,12595000.0,攤銷費用,祺驊,生技醫療業
2024-12-31,1593,Depreciation,37133000.0,折舊費用,祺驊,生技醫療業
2024-12-31,1593,CashFlowsFromOperatingActivities,127006000.0,營業活動之淨現金流入（流出）,祺驊,生技醫療業
2024-12-31,1593,NetIncomeBeforeTax,132908000.0,本期稅前淨利（淨損）,祺驊,生技醫療業
2024-12-31,1593,RepaymentOfLongTermDebt,-18305000.0,償還長期借款,祺驊,生技醫療業
2024-12-31,1593,CashReceivedThroughOperations,178850000.0,營運產生之現金流入（流出）,祺驊,生技醫療業
2019-03-31,4154,IncomeBeforeIncomeTax,-301000.0,稅前淨利(淨損),樂威科-KY,生技醫療業
2019-03-31,4154,NetIncome,-1297000.0,本期淨利(淨損),樂威科-KY,生技醫療業
2019-03-31,4154,PreTaxIncome,-301000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2019-03-31,4154,TAX,996000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2019-03-31,4154,IncomeFromContinuingOperations,-1297000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2019-03-31,4154,IncomeAfterTaxes,-1297000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2019-03-31,4154,TotalConsolidatedProfitForThePeriod,3891000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2019-03-31,4154,EPS,-0.03,基本每股盈餘（元）,樂威科-KY,生技醫療業
2019-03-31,4154,Revenue,174124000.0,營業收入,樂威科-KY,生技醫療業
2019-03-31,4154,CostOfGoodsSold,83083000.0,營業成本,樂威科-KY,生技醫療業
2019-03-31,4154,GrossProfit,91041000.0,營業毛利（毛損）淨額,樂威科-KY,生技醫療業
2019-03-31,4154,OperatingExpenses,89954000.0,營業費用,樂威科-KY,生技醫療業
2019-03-31,4154,OperatingIncome,1087000.0,營業利益（損失）,樂威科-KY,生技醫療業
2019-03-31,4154,TotalNonoperatingIncomeAndExpense,-1388000.0,營業外收入及支出,樂威科-KY,生技醫療業
2019-03-31,4154,OtherComprehensiveIncome,5188000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2019-03-31,4154,EquityAttributableToOwnersOfParent,-762000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2019-03-31,4154,NoncontrollingInterests,-535000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2019-06-30,4154,IncomeBeforeIncomeTax,-22717000.0,稅前淨利(淨損),樂威科-KY,生技醫療業
2019-06-30,4154,NetIncome,-23701000.0,本期淨利(淨損),樂威科-KY,生技醫療業
2019-06-30,4154,PreTaxIncome,-22717000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2019-06-30,4154,TAX,984000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2019-06-30,4154,IncomeFromContinuingOperations,-23701000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2019-06-30,4154,IncomeAfterTaxes,-23701000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2019-06-30,4154,TotalConsolidatedProfitForThePeriod,-24231000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2019-06-30,4154,EPS,-0.97,基本每股盈餘（元）,樂威科-KY,生技醫療業
2019-06-30,4154,Revenue,157817000.0,營業收入,樂威科-KY,生技醫療業
2019-06-30,4154,CostOfGoodsSold,90607000.0,營業成本,樂威科-KY,生技醫療業
2019-06-30,4154,GrossProfit,67210000.0,營業毛利（毛損）淨額,樂威科-KY,生技醫療業
2019-06-30,4154,OperatingExpenses,89704000.0,營業費用,樂威科-KY,生技醫療業
2019-06-30,4154,OperatingIncome,-22494000.0,營業利益（損失）,樂威科-KY,生技醫療業
2019-06-30,4154,TotalNonoperatingIncomeAndExpense,-223000.0,營業外收入及支出,樂威科-KY,生技醫療業
2019-06-30,4154,OtherComprehensiveIncome,-530000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2019-06-30,4154,EquityAttributableToOwnersOfParent,-23462000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2019-06-30,4154,NoncontrollingInterests,-239000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2019-09-30,4154,IncomeBeforeIncomeTax,-10896000.0,稅前淨利(淨損),樂威科-KY,生技醫療業
2019-09-30,4154,NetIncome,-10314000.0,本期淨利(淨損),樂威科-KY,生技醫療業
2019-09-30,4154,PreTaxIncome,-10896000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2019-09-30,4154,TAX,-582000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2019-09-30,4154,IncomeFromContinuingOperations,-10314000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2019-09-30,4154,IncomeAfterTaxes,-10314000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2019-09-30,4154,TotalConsolidatedProfitForThePeriod,-15663000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2019-09-30,4154,EPS,-0.41,基本每股盈餘（元）,樂威科-KY,生技醫療業
2019-09-30,4154,Revenue,167582000.0,營業收入,樂威科-KY,生技醫療業
2019-09-30,4154,CostOfGoodsSold,70366000.0,營業成本,樂威科-KY,生技醫療業
2019-09-30,4154,GrossProfit,97216000.0,營業毛利（毛損）淨額,樂威科-KY,生技醫療業
2019-09-30,4154,OperatingExpenses,104827000.0,營業費用,樂威科-KY,生技醫療業
2019-09-30,4154,OperatingIncome,-7611000.0,營業利益（損失）,樂威科-KY,生技醫療業
2019-09-30,4154,TotalNonoperatingIncomeAndExpense,-3285000.0,營業外收入及支出,樂威科-KY,生技醫療業
2019-09-30,4154,OtherComprehensiveIncome,-5349000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2019-09-30,4154,EquityAttributableToOwnersOfParent,-10048000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2019-09-30,4154,NoncontrollingInterests,-266000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2019-12-31,4154,IncomeBeforeIncomeTax,-19239000.0,稅前淨利(淨損),樂威科-KY,生技醫療業
2019-12-31,4154,NetIncome,-19894000.0,本期淨利(淨損),樂威科-KY,生技醫療業
2019-12-31,4154,PreTaxIncome,-19239000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2019-12-31,4154,TAX,655000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2019-12-31,4154,IncomeFromContinuingOperations,-19894000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2019-12-31,4154,IncomeAfterTaxes,-19894000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2019-12-31,4154,TotalConsolidatedProfitForThePeriod,-21892000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2019-12-31,4154,EPS,-0.82,基本每股盈餘（元）,樂威科-KY,生技醫療業
2019-12-31,4154,Revenue,213099000.0,營業收入,樂威科-KY,生技醫療業
2019-12-31,4154,CostOfGoodsSold,124949000.0,營業成本,樂威科-KY,生技醫療業
2019-12-31,4154,GrossProfit,88150000.0,營業毛利（毛損）淨額,樂威科-KY,生技醫療業
2019-12-31,4154,OperatingExpenses,104588000.0,營業費用,樂威科-KY,生技醫療業
2019-12-31,4154,OperatingIncome,-16438000.0,營業利益（損失）,樂威科-KY,生技醫療業
2019-12-31,4154,TotalNonoperatingIncomeAndExpense,-2801000.0,營業外收入及支出,樂威科-KY,生技醫療業
2019-12-31,4154,OtherComprehensiveIncome,-1998000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2019-12-31,4154,EquityAttributableToOwnersOfParent,-19867000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2019-12-31,4154,NoncontrollingInterests,-27000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2020-03-31,4154,PreTaxIncome,24158000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2020-03-31,4154,TAX,674000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2020-03-31,4154,IncomeFromContinuingOperations,23484000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2020-03-31,4154,IncomeAfterTaxes,23484000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2020-03-31,4154,TotalConsolidatedProfitForThePeriod,20219000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2020-03-31,4154,EPS,1.12,基本每股盈餘（元）,樂威科-KY,生技醫療業
2020-03-31,4154,Revenue,163028000.0,營業收入,樂威科-KY,生技醫療業
2020-03-31,4154,CostOfGoodsSold,78405000.0,營業成本,樂威科-KY,生技醫療業
2020-03-31,4154,GrossProfit,84623000.0,營業毛利（毛損）淨額,樂威科-KY,生技醫療業
2020-03-31,4154,OperatingExpenses,62207000.0,營業費用,樂威科-KY,生技醫療業
2020-03-31,4154,OperatingIncome,22416000.0,營業利益（損失）,樂威科-KY,生技醫療業
2020-03-31,4154,TotalNonoperatingIncomeAndExpense,1742000.0,營業外收入及支出,樂威科-KY,生技醫療業
2020-03-31,4154,OtherComprehensiveIncome,-3265000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2020-03-31,4154,EquityAttributableToOwnersOfParent,27163000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2020-03-31,4154,NoncontrollingInterests,-3679000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2020-06-30,4154,PreTaxIncome,-6848000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2020-06-30,4154,TAX,581000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2020-06-30,4154,IncomeFromContinuingOperations,-7429000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2020-06-30,4154,IncomeAfterTaxes,-7429000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2020-06-30,4154,TotalConsolidatedProfitForThePeriod,-7862000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2020-06-30,4154,EPS,-0.26,基本每股盈餘（元）,樂威科-KY,生技醫療業
2020-06-30,4154,Revenue,124762000.0,營業收入,樂威科-KY,生技醫療業
2020-06-30,4154,CostOfGoodsSold,84444000.0,營業成本,樂威科-KY,生技醫療業
2020-06-30,4154,GrossProfit,40318000.0,營業毛利（毛損）淨額,樂威科-KY,生技醫療業
2020-06-30,4154,OperatingExpenses,45535000.0,營業費用,樂威科-KY,生技醫療業
2020-06-30,4154,OperatingIncome,-5217000.0,營業利益（損失）,樂威科-KY,生技醫療業
2020-06-30,4154,TotalNonoperatingIncomeAndExpense,-1631000.0,營業外收入及支出,樂威科-KY,生技醫療業
2020-06-30,4154,OtherComprehensiveIncome,-433000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2020-06-30,4154,EquityAttributableToOwnersOfParent,-6187000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2020-06-30,4154,NoncontrollingInterests,-1242000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2020-09-30,4154,PreTaxIncome,-22443000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2020-09-30,4154,TAX,588000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2020-09-30,4154,IncomeFromContinuingOperations,-23031000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2020-09-30,4154,IncomeAfterTaxes,-23031000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2020-09-30,4154,TotalConsolidatedProfitForThePeriod,-25937000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2020-09-30,4154,EPS,-0.91,基本每股盈餘（元）,樂威科-KY,生技醫療業
2020-09-30,4154,Revenue,130223000.0,營業收入,樂威科-KY,生技醫療業
2020-09-30,4154,CostOfGoodsSold,98607000.0,營業成本,樂威科-KY,生技醫療業
2020-09-30,4154,GrossProfit,31616000.0,營業毛利（毛損）淨額,樂威科-KY,生技醫療業
2020-09-30,4154,OperatingExpenses,55982000.0,營業費用,樂威科-KY,生技醫療業
2020-09-30,4154,OperatingIncome,-24366000.0,營業利益（損失）,樂威科-KY,生技醫療業
2020-09-30,4154,TotalNonoperatingIncomeAndExpense,1923000.0,營業外收入及支出,樂威科-KY,生技醫療業
2020-09-30,4154,OtherComprehensiveIncome,-2906000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2020-09-30,4154,EquityAttributableToOwnersOfParent,-22126000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2020-09-30,4154,NoncontrollingInterests,-905000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2020-12-31,4154,PreTaxIncome,-24481000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2020-12-31,4154,TAX,123000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2020-12-31,4154,IncomeFromContinuingOperations,-24604000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2020-12-31,4154,IncomeAfterTaxes,-24604000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2020-12-31,4154,TotalConsolidatedProfitForThePeriod,-20067000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2020-12-31,4154,EPS,-1.11,基本每股盈餘（元）,樂威科-KY,生技醫療業
2020-12-31,4154,Revenue,132214000.0,營業收入,樂威科-KY,生技醫療業
2020-12-31,4154,CostOfGoodsSold,98105000.0,營業成本,樂威科-KY,生技醫療業
2020-12-31,4154,GrossProfit,34109000.0,營業毛利（毛損）淨額,樂威科-KY,生技醫療業
2020-12-31,4154,OperatingExpenses,61850000.0,營業費用,樂威科-KY,生技醫療業
2020-12-31,4154,OperatingIncome,-27741000.0,營業利益（損失）,樂威科-KY,生技醫療業
2020-12-31,4154,TotalNonoperatingIncomeAndExpense,3260000.0,營業外收入及支出,樂威科-KY,生技醫療業
2020-12-31,4154,OtherComprehensiveIncome,4537000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2020-12-31,4154,EquityAttributableToOwnersOfParent,-26991000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2020-12-31,4154,NoncontrollingInterests,2387000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2021-03-31,4154,PreTaxIncome,-31714000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2021-03-31,4154,TAX,-273000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2021-03-31,4154,IncomeFromContinuingOperations,-31441000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2021-03-31,4154,IncomeAfterTaxes,-31441000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2021-03-31,4154,TotalConsolidatedProfitForThePeriod,-39384000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2021-03-31,4154,Revenue,110385000.0,營業收入,樂威科-KY,生技醫療業
2021-03-31,4154,CostOfGoodsSold,102711000.0,營業成本,樂威科-KY,生技醫療業
2021-03-31,4154,OperatingExpenses,39358000.0,營業費用,樂威科-KY,生技醫療業
2021-03-31,4154,OperatingIncome,-31684000.0,營業利益（損失）,樂威科-KY,生技醫療業
2021-03-31,4154,TotalNonoperatingIncomeAndExpense,-30000.0,營業外收入及支出,樂威科-KY,生技醫療業
2021-03-31,4154,OtherComprehensiveIncome,-7943000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2021-03-31,4154,EquityAttributableToOwnersOfParent,-22900000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2021-03-31,4154,NoncontrollingInterests,-8541000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2021-03-31,4154,EPS,-0.81,基本每股盈餘（元）,樂威科-KY,生技醫療業
2021-03-31,4154,GrossProfit,7674000.0,營業毛利（毛損）,樂威科-KY,生技醫療業
2021-03-31,4154,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-10712000.0,綜合損益總額歸屬於非控制權益,樂威科-KY,生技醫療業
2021-06-30,4154,PreTaxIncome,-14498000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2021-06-30,4154,TAX,45000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2021-06-30,4154,IncomeFromContinuingOperations,-14543000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2021-06-30,4154,IncomeAfterTaxes,-14543000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2021-06-30,4154,TotalConsolidatedProfitForThePeriod,-25610000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2021-06-30,4154,Revenue,97402000.0,營業收入,樂威科-KY,生技醫療業
2021-06-30,4154,CostOfGoodsSold,82122000.0,營業成本,樂威科-KY,生技醫療業
2021-06-30,4154,OperatingExpenses,28707000.0,營業費用,樂威科-KY,生技醫療業
2021-06-30,4154,OperatingIncome,-13427000.0,營業利益（損失）,樂威科-KY,生技醫療業
2021-06-30,4154,TotalNonoperatingIncomeAndExpense,-1071000.0,營業外收入及支出,樂威科-KY,生技醫療業
2021-06-30,4154,OtherComprehensiveIncome,-11067000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2021-06-30,4154,GrossProfit,15280000.0,營業毛利（毛損）,樂威科-KY,生技醫療業
2021-06-30,4154,EPS,-0.52,基本每股盈餘（元）,樂威科-KY,生技醫療業
2021-06-30,4154,EquityAttributableToOwnersOfParent,-16032000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2021-06-30,4154,NoncontrollingInterests,1489000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2021-06-30,4154,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-1480000.0,綜合損益總額歸屬於非控制權益,樂威科-KY,生技醫療業
2021-09-30,4154,PreTaxIncome,-21464000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2021-09-30,4154,TAX,275000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2021-09-30,4154,IncomeFromContinuingOperations,-21739000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2021-09-30,4154,IncomeAfterTaxes,-21739000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2021-09-30,4154,TotalConsolidatedProfitForThePeriod,-36058000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2021-09-30,4154,Revenue,124920000.0,營業收入,樂威科-KY,生技醫療業
2021-09-30,4154,CostOfGoodsSold,110733000.0,營業成本,樂威科-KY,生技醫療業
2021-09-30,4154,OperatingExpenses,29005000.0,營業費用,樂威科-KY,生技醫療業
2021-09-30,4154,OperatingIncome,-14818000.0,營業利益（損失）,樂威科-KY,生技醫療業
2021-09-30,4154,TotalNonoperatingIncomeAndExpense,-6646000.0,營業外收入及支出,樂威科-KY,生技醫療業
2021-09-30,4154,OtherComprehensiveIncome,-14319000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2021-09-30,4154,EquityAttributableToOwnersOfParent,-19582000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2021-09-30,4154,NoncontrollingInterests,-2157000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2021-09-30,4154,GrossProfit,14187000.0,營業毛利（毛損）,樂威科-KY,生技醫療業
2021-09-30,4154,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-5061000.0,綜合損益總額歸屬於非控制權益,樂威科-KY,生技醫療業
2021-09-30,4154,EPS,-0.6,基本每股盈餘（元）,樂威科-KY,生技醫療業
2021-12-31,4154,PreTaxIncome,-18640000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2021-12-31,4154,TAX,-562000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2021-12-31,4154,IncomeFromContinuingOperations,-18078000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2021-12-31,4154,IncomeAfterTaxes,-18078000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2021-12-31,4154,TotalConsolidatedProfitForThePeriod,-14920000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2021-12-31,4154,Revenue,68005000.0,營業收入,樂威科-KY,生技醫療業
2021-12-31,4154,CostOfGoodsSold,87116000.0,營業成本,樂威科-KY,生技醫療業
2021-12-31,4154,OperatingExpenses,21681000.0,營業費用,樂威科-KY,生技醫療業
2021-12-31,4154,OperatingIncome,-40792000.0,營業利益（損失）,樂威科-KY,生技醫療業
2021-12-31,4154,TotalNonoperatingIncomeAndExpense,22152000.0,營業外收入及支出,樂威科-KY,生技醫療業
2021-12-31,4154,OtherComprehensiveIncome,3158000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2021-12-31,4154,GrossProfit,-19111000.0,營業毛利（毛損）,樂威科-KY,生技醫療業
2021-12-31,4154,EquityAttributableToOwnersOfParent,-10358000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2021-12-31,4154,NoncontrollingInterests,-7720000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2021-12-31,4154,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-7141000.0,綜合損益總額歸屬於非控制權益,樂威科-KY,生技醫療業
2021-12-31,4154,EPS,-0.25,基本每股盈餘（元）,樂威科-KY,生技醫療業
2022-03-31,4154,PreTaxIncome,-3544000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2022-03-31,4154,TAX,1824000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2022-03-31,4154,IncomeFromContinuingOperations,-5368000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2022-03-31,4154,IncomeAfterTaxes,-5368000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2022-03-31,4154,TotalConsolidatedProfitForThePeriod,11352000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2022-03-31,4154,EPS,-0.11,基本每股盈餘（元）,樂威科-KY,生技醫療業
2022-03-31,4154,Revenue,98403000.0,營業收入,樂威科-KY,生技醫療業
2022-03-31,4154,CostOfGoodsSold,85641000.0,營業成本,樂威科-KY,生技醫療業
2022-03-31,4154,OperatingExpenses,15340000.0,營業費用,樂威科-KY,生技醫療業
2022-03-31,4154,OperatingIncome,-2578000.0,營業利益（損失）,樂威科-KY,生技醫療業
2022-03-31,4154,TotalNonoperatingIncomeAndExpense,-966000.0,營業外收入及支出,樂威科-KY,生技醫療業
2022-03-31,4154,OtherComprehensiveIncome,16720000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2022-03-31,4154,EquityAttributableToOwnersOfParent,-3924000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2022-03-31,4154,NoncontrollingInterests,-1444000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2022-03-31,4154,GrossProfit,12762000.0,營業毛利（毛損）,樂威科-KY,生技醫療業
2022-03-31,4154,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,639000.0,綜合損益總額歸屬於非控制權益,樂威科-KY,生技醫療業
2022-06-30,4154,PreTaxIncome,1044000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2022-06-30,4154,TAX,-785000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2022-06-30,4154,IncomeFromContinuingOperations,1829000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2022-06-30,4154,IncomeAfterTaxes,1829000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2022-06-30,4154,TotalConsolidatedProfitForThePeriod,-3470000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2022-06-30,4154,EPS,0.03,基本每股盈餘（元）,樂威科-KY,生技醫療業
2022-06-30,4154,Revenue,133267000.0,營業收入,樂威科-KY,生技醫療業
2022-06-30,4154,CostOfGoodsSold,108195000.0,營業成本,樂威科-KY,生技醫療業
2022-06-30,4154,OperatingExpenses,17815000.0,營業費用,樂威科-KY,生技醫療業
2022-06-30,4154,OperatingIncome,7257000.0,營業利益（損失）,樂威科-KY,生技醫療業
2022-06-30,4154,TotalNonoperatingIncomeAndExpense,-6213000.0,營業外收入及支出,樂威科-KY,生技醫療業
2022-06-30,4154,OtherComprehensiveIncome,-5299000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2022-06-30,4154,GrossProfit,25072000.0,營業毛利（毛損）,樂威科-KY,生技醫療業
2022-06-30,4154,EquityAttributableToOwnersOfParent,972000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2022-06-30,4154,NoncontrollingInterests,857000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2022-06-30,4154,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-36000.0,綜合損益總額歸屬於非控制權益,樂威科-KY,生技醫療業
2022-09-30,4154,PreTaxIncome,-19687000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2022-09-30,4154,TAX,-448000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2022-09-30,4154,IncomeFromContinuingOperations,-19239000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2022-09-30,4154,IncomeAfterTaxes,-19239000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2022-09-30,4154,TotalConsolidatedProfitForThePeriod,-18610000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2022-09-30,4154,EPS,-0.45,基本每股盈餘（元）,樂威科-KY,生技醫療業
2022-09-30,4154,Revenue,98649000.0,營業收入,樂威科-KY,生技醫療業
2022-09-30,4154,CostOfGoodsSold,92868000.0,營業成本,樂威科-KY,生技醫療業
2022-09-30,4154,OperatingExpenses,18416000.0,營業費用,樂威科-KY,生技醫療業
2022-09-30,4154,OperatingIncome,-12635000.0,營業利益（損失）,樂威科-KY,生技醫療業
2022-09-30,4154,TotalNonoperatingIncomeAndExpense,-7052000.0,營業外收入及支出,樂威科-KY,生技醫療業
2022-09-30,4154,OtherComprehensiveIncome,629000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2022-09-30,4154,GrossProfit,5781000.0,營業毛利（毛損）,樂威科-KY,生技醫療業
2022-09-30,4154,EquityAttributableToOwnersOfParent,-15929000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2022-09-30,4154,NoncontrollingInterests,-3310000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2022-09-30,4154,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-3268000.0,綜合損益總額歸屬於非控制權益,樂威科-KY,生技醫療業
2022-12-31,4154,PreTaxIncome,-20504000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2022-12-31,4154,TAX,-2253000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2022-12-31,4154,IncomeFromContinuingOperations,-18251000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2022-12-31,4154,IncomeAfterTaxes,-18251000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2022-12-31,4154,TotalConsolidatedProfitForThePeriod,-6353000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2022-12-31,4154,Revenue,109241000.0,營業收入,樂威科-KY,生技醫療業
2022-12-31,4154,CostOfGoodsSold,111688000.0,營業成本,樂威科-KY,生技醫療業
2022-12-31,4154,OperatingExpenses,25670000.0,營業費用,樂威科-KY,生技醫療業
2022-12-31,4154,OperatingIncome,-28117000.0,營業利益（損失）,樂威科-KY,生技醫療業
2022-12-31,4154,TotalNonoperatingIncomeAndExpense,7613000.0,營業外收入及支出,樂威科-KY,生技醫療業
2022-12-31,4154,OtherComprehensiveIncome,11898000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2022-12-31,4154,EquityAttributableToOwnersOfParent,-16059000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2022-12-31,4154,NoncontrollingInterests,-2192000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2022-12-31,4154,GrossProfit,-2447000.0,營業毛利（毛損）,樂威科-KY,生技醫療業
2022-12-31,4154,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,237000.0,綜合損益總額歸屬於非控制權益,樂威科-KY,生技醫療業
2022-12-31,4154,EPS,-0.45,基本每股盈餘（元）,樂威科-KY,生技醫療業
2023-03-31,4154,PreTaxIncome,-11683000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2023-03-31,4154,TAX,-759000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2023-03-31,4154,IncomeFromContinuingOperations,-10924000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2023-03-31,4154,IncomeAfterTaxes,-10924000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2023-03-31,4154,TotalConsolidatedProfitForThePeriod,-10021000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2023-03-31,4154,EPS,-0.28,基本每股盈餘（元）,樂威科-KY,生技醫療業
2023-03-31,4154,Revenue,110872000.0,營業收入,樂威科-KY,生技醫療業
2023-03-31,4154,CostOfGoodsSold,100353000.0,營業成本,樂威科-KY,生技醫療業
2023-03-31,4154,OperatingExpenses,17328000.0,營業費用,樂威科-KY,生技醫療業
2023-03-31,4154,OperatingIncome,-6809000.0,營業利益（損失）,樂威科-KY,生技醫療業
2023-03-31,4154,TotalNonoperatingIncomeAndExpense,-4874000.0,營業外收入及支出,樂威科-KY,生技醫療業
2023-03-31,4154,OtherComprehensiveIncome,903000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2023-03-31,4154,EquityAttributableToOwnersOfParent,-9948000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2023-03-31,4154,NoncontrollingInterests,-976000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2023-03-31,4154,GrossProfit,10519000.0,營業毛利（毛損）,樂威科-KY,生技醫療業
2023-03-31,4154,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-829000.0,綜合損益總額歸屬於非控制權益,樂威科-KY,生技醫療業
2023-06-30,4154,PreTaxIncome,-41284000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2023-06-30,4154,TAX,672000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2023-06-30,4154,IncomeFromContinuingOperations,-41956000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2023-06-30,4154,IncomeAfterTaxes,-41956000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2023-06-30,4154,TotalConsolidatedProfitForThePeriod,-46748000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2023-06-30,4154,EPS,-0.96,基本每股盈餘（元）,樂威科-KY,生技醫療業
2023-06-30,4154,Revenue,80403000.0,營業收入,樂威科-KY,生技醫療業
2023-06-30,4154,CostOfGoodsSold,93615000.0,營業成本,樂威科-KY,生技醫療業
2023-06-30,4154,OperatingExpenses,16192000.0,營業費用,樂威科-KY,生技醫療業
2023-06-30,4154,OperatingIncome,-29404000.0,營業利益（損失）,樂威科-KY,生技醫療業
2023-06-30,4154,TotalNonoperatingIncomeAndExpense,-11880000.0,營業外收入及支出,樂威科-KY,生技醫療業
2023-06-30,4154,OtherComprehensiveIncome,-4792000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2023-06-30,4154,GrossProfit,-13212000.0,營業毛利（毛損）,樂威科-KY,生技醫療業
2023-06-30,4154,EquityAttributableToOwnersOfParent,-34202000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2023-06-30,4154,NoncontrollingInterests,-7754000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2023-06-30,4154,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-8360000.0,綜合損益總額歸屬於非控制權益,樂威科-KY,生技醫療業
2023-09-30,4154,PreTaxIncome,-43765000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2023-09-30,4154,TAX,-328000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2023-09-30,4154,IncomeFromContinuingOperations,-43437000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2023-09-30,4154,IncomeAfterTaxes,-43437000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2023-09-30,4154,TotalConsolidatedProfitForThePeriod,-37218000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2023-09-30,4154,EPS,-1.03,基本每股盈餘（元）,樂威科-KY,生技醫療業
2023-09-30,4154,Revenue,54640000.0,營業收入,樂威科-KY,生技醫療業
2023-09-30,4154,CostOfGoodsSold,71315000.0,營業成本,樂威科-KY,生技醫療業
2023-09-30,4154,OperatingExpenses,14138000.0,營業費用,樂威科-KY,生技醫療業
2023-09-30,4154,OperatingIncome,-30813000.0,營業利益（損失）,樂威科-KY,生技醫療業
2023-09-30,4154,TotalNonoperatingIncomeAndExpense,-12952000.0,營業外收入及支出,樂威科-KY,生技醫療業
2023-09-30,4154,OtherComprehensiveIncome,6219000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2023-09-30,4154,EquityAttributableToOwnersOfParent,-37029000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2023-09-30,4154,NoncontrollingInterests,-6408000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2023-09-30,4154,GrossProfit,-16675000.0,營業毛利（毛損）,樂威科-KY,生技醫療業
2023-09-30,4154,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-5302000.0,綜合損益總額歸屬於非控制權益,樂威科-KY,生技醫療業
2023-12-31,4154,PreTaxIncome,-27857000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2023-12-31,4154,TAX,3446000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2023-12-31,4154,IncomeFromContinuingOperations,-31303000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2023-12-31,4154,IncomeAfterTaxes,-31303000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2023-12-31,4154,TotalConsolidatedProfitForThePeriod,-28190000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2023-12-31,4154,Revenue,33427000.0,營業收入,樂威科-KY,生技醫療業
2023-12-31,4154,CostOfGoodsSold,57490000.0,營業成本,樂威科-KY,生技醫療業
2023-12-31,4154,OperatingExpenses,13789000.0,營業費用,樂威科-KY,生技醫療業
2023-12-31,4154,OperatingIncome,-37852000.0,營業利益（損失）,樂威科-KY,生技醫療業
2023-12-31,4154,TotalNonoperatingIncomeAndExpense,9995000.0,營業外收入及支出,樂威科-KY,生技醫療業
2023-12-31,4154,OtherComprehensiveIncome,3113000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2023-12-31,4154,GrossProfit,-24063000.0,營業毛利（毛損）,樂威科-KY,生技醫療業
2023-12-31,4154,EquityAttributableToOwnersOfParent,-27644000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2023-12-31,4154,NoncontrollingInterests,-3659000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2023-12-31,4154,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-3929000.0,綜合損益總額歸屬於非控制權益,樂威科-KY,生技醫療業
2023-12-31,4154,EPS,-0.78,基本每股盈餘（元）,樂威科-KY,生技醫療業
2024-03-31,4154,PreTaxIncome,-36988000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2024-03-31,4154,TAX,258000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2024-03-31,4154,IncomeFromContinuingOperations,-37246000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2024-03-31,4154,IncomeAfterTaxes,-37246000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2024-03-31,4154,TotalConsolidatedProfitForThePeriod,-37983000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2024-03-31,4154,EPS,-0.89,基本每股盈餘（元）,樂威科-KY,生技醫療業
2024-03-31,4154,Revenue,6958000.0,營業收入,樂威科-KY,生技醫療業
2024-03-31,4154,CostOfGoodsSold,22447000.0,營業成本,樂威科-KY,生技醫療業
2024-03-31,4154,OperatingExpenses,13684000.0,營業費用,樂威科-KY,生技醫療業
2024-03-31,4154,OperatingIncome,-29173000.0,營業利益（損失）,樂威科-KY,生技醫療業
2024-03-31,4154,TotalNonoperatingIncomeAndExpense,-7815000.0,營業外收入及支出,樂威科-KY,生技醫療業
2024-03-31,4154,OtherComprehensiveIncome,-737000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2024-03-31,4154,NoncontrollingInterests,-5620000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2024-03-31,4154,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-6123000.0,綜合損益總額歸屬於非控制權益,樂威科-KY,生技醫療業
2024-03-31,4154,GrossProfit,-15489000.0,營業毛利（毛損）,樂威科-KY,生技醫療業
2024-03-31,4154,EquityAttributableToOwnersOfParent,-31626000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2024-06-30,4154,PreTaxIncome,-30120000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2024-06-30,4154,TAX,14000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2024-06-30,4154,IncomeFromContinuingOperations,-30134000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2024-06-30,4154,IncomeAfterTaxes,-30134000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2024-06-30,4154,TotalConsolidatedProfitForThePeriod,-28502000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2024-06-30,4154,EPS,-1.44,基本每股盈餘（元）,樂威科-KY,生技醫療業
2024-06-30,4154,Revenue,14586000.0,營業收入,樂威科-KY,生技醫療業
2024-06-30,4154,CostOfGoodsSold,29623000.0,營業成本,樂威科-KY,生技醫療業
2024-06-30,4154,OperatingExpenses,11790000.0,營業費用,樂威科-KY,生技醫療業
2024-06-30,4154,OperatingIncome,-26827000.0,營業利益（損失）,樂威科-KY,生技醫療業
2024-06-30,4154,TotalNonoperatingIncomeAndExpense,-3293000.0,營業外收入及支出,樂威科-KY,生技醫療業
2024-06-30,4154,OtherComprehensiveIncome,1632000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2024-06-30,4154,NoncontrollingInterests,-4331000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2024-06-30,4154,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-4251000.0,綜合損益總額歸屬於非控制權益,樂威科-KY,生技醫療業
2024-06-30,4154,GrossProfit,-15037000.0,營業毛利（毛損）,樂威科-KY,生技醫療業
2024-06-30,4154,EquityAttributableToOwnersOfParent,-25803000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2024-09-30,4154,PreTaxIncome,-24462000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2024-09-30,4154,TAX,-579000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2024-09-30,4154,IncomeFromContinuingOperations,-23883000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2024-09-30,4154,IncomeAfterTaxes,-23883000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2024-09-30,4154,TotalConsolidatedProfitForThePeriod,-2870000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2024-09-30,4154,Revenue,10129000.0,營業收入,樂威科-KY,生技醫療業
2024-09-30,4154,CostOfGoodsSold,17710000.0,營業成本,樂威科-KY,生技醫療業
2024-09-30,4154,OperatingExpenses,10028000.0,營業費用,樂威科-KY,生技醫療業
2024-09-30,4154,OperatingIncome,-17609000.0,營業利益（損失）,樂威科-KY,生技醫療業
2024-09-30,4154,TotalNonoperatingIncomeAndExpense,-6853000.0,營業外收入及支出,樂威科-KY,生技醫療業
2024-09-30,4154,OtherComprehensiveIncome,21013000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2024-09-30,4154,NoncontrollingInterests,-1145000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2024-09-30,4154,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,1004000.0,綜合損益總額歸屬於非控制權益,樂威科-KY,生技醫療業
2024-09-30,4154,GrossProfit,-7581000.0,營業毛利（毛損）,樂威科-KY,生技醫療業
2024-09-30,4154,EquityAttributableToOwnersOfParent,-22738000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2024-09-30,4154,EPS,-0.91,基本每股盈餘（元）,樂威科-KY,生技醫療業
2024-12-31,4154,PreTaxIncome,-51559000.0,稅前淨利（淨損）,樂威科-KY,生技醫療業
2024-12-31,4154,TAX,-753000.0,所得稅費用（利益）,樂威科-KY,生技醫療業
2024-12-31,4154,IncomeFromContinuingOperations,-50806000.0,繼續營業單位本期淨利（淨損）,樂威科-KY,生技醫療業
2024-12-31,4154,IncomeAfterTaxes,-50806000.0,本期淨利（淨損）,樂威科-KY,生技醫療業
2024-12-31,4154,TotalConsolidatedProfitForThePeriod,-38821000.0,本期綜合損益總額,樂威科-KY,生技醫療業
2024-12-31,4154,Revenue,9695000.0,營業收入,樂威科-KY,生技醫療業
2024-12-31,4154,CostOfGoodsSold,20670000.0,營業成本,樂威科-KY,生技醫療業
2024-12-31,4154,OperatingExpenses,11232000.0,營業費用,樂威科-KY,生技醫療業
2024-12-31,4154,OperatingIncome,-22207000.0,營業利益（損失）,樂威科-KY,生技醫療業
2024-12-31,4154,TotalNonoperatingIncomeAndExpense,-29352000.0,營業外收入及支出,樂威科-KY,生技醫療業
2024-12-31,4154,OtherComprehensiveIncome,11985000.0,其他綜合損益（淨額）,樂威科-KY,生技醫療業
2024-12-31,4154,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,-6789000.0,綜合損益總額歸屬於非控制權益,樂威科-KY,生技醫療業
2024-12-31,4154,NoncontrollingInterests,-6184000.0,淨利（淨損）歸屬於非控制權益,樂威科-KY,生技醫療業
2024-12-31,4154,EquityAttributableToOwnersOfParent,-44622000.0,淨利（淨損）歸屬於母公司業主,樂威科-KY,生技醫療業
2024-12-31,4154,GrossProfit,-10975000.0,營業毛利（毛損）,樂威科-KY,生技醫療業
2024-12-31,4154,EPS,-1.51,基本每股盈餘（元）,樂威科-KY,生技醫療業
2019-03-31,4154,AccountsPayable,33282000.0,應付帳款,樂威科-KY,生技醫療業
2019-03-31,4154,AccountsPayable_per,6.6,應付帳款,樂威科-KY,生技醫療業
2019-03-31,4154,AccountsPayableToRelatedParties,0.0,應付帳款－關係人,樂威科-KY,生技醫療業
2019-03-31,4154,AccountsPayableToRelatedParties_per,0.0,應付帳款－關係人,樂威科-KY,生技醫療業
2019-03-31,4154,AccountsReceivableDuefromRelatedPartiesNet,19695000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2019-03-31,4154,AccountsReceivableDuefromRelatedPartiesNet_per,3.91,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2019-03-31,4154,CapitalStock,243260000.0,股本合計,樂威科-KY,生技醫療業
2019-03-31,4154,CapitalStock_per,48.24,股本合計,樂威科-KY,生技醫療業
2019-03-31,4154,CapitalSurplus,120887000.0,資本公積合計,樂威科-KY,生技醫療業
2019-03-31,4154,CapitalSurplus_per,23.97,資本公積合計,樂威科-KY,生技醫療業
2019-03-31,4154,CashAndCashEquivalents,149727000.0,現金及約當現金,樂威科-KY,生技醫療業
2019-03-31,4154,CashAndCashEquivalents_per,29.69,現金及約當現金,樂威科-KY,生技醫療業
2019-03-31,4154,CurrentAssets,398048000.0,流動資產合計,樂威科-KY,生技醫療業
2019-03-31,4154,CurrentAssets_per,78.94,流動資產合計,樂威科-KY,生技醫療業
2019-03-31,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2019-03-31,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2019-03-31,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2019-03-31,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2019-03-31,4154,CurrentIncomeTaxAssets,5944000.0,本期所得稅資產,樂威科-KY,生技醫療業
2019-03-31,4154,CurrentIncomeTaxAssets_per,1.18,本期所得稅資產,樂威科-KY,生技醫療業
2019-03-31,4154,CurrentLiabilities,180212000.0,流動負債合計,樂威科-KY,生技醫療業
2019-03-31,4154,CurrentLiabilities_per,35.74,流動負債合計,樂威科-KY,生技醫療業
2019-03-31,4154,EquityAttributableToOwnersOfParent,269034000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2019-03-31,4154,EquityAttributableToOwnersOfParent_per,53.35,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2019-03-31,4154,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,0.0,預收股款（權益項下）之約當發行股數,樂威科-KY,生技醫療業
2019-03-31,4154,IntangibleAssets,15092000.0,無形資產,樂威科-KY,生技醫療業
2019-03-31,4154,IntangibleAssets_per,2.99,無形資產,樂威科-KY,生技醫療業
2019-03-31,4154,Inventories,88720000.0,存貨,樂威科-KY,生技醫療業
2019-03-31,4154,Inventories_per,17.59,存貨,樂威科-KY,生技醫療業
2019-03-31,4154,LongtermBorrowings,1084000.0,長期借款,樂威科-KY,生技醫療業
2019-03-31,4154,LongtermBorrowings_per,0.21,長期借款,樂威科-KY,生技醫療業
2019-03-31,4154,NoncontrollingInterests,25471000.0,非控制權益,樂威科-KY,生技醫療業
2019-03-31,4154,NoncontrollingInterests_per,5.05,非控制權益,樂威科-KY,生技醫療業
2019-03-31,4154,NoncurrentAssets,106220000.0,非流動資產合計,樂威科-KY,生技醫療業
2019-03-31,4154,NoncurrentAssets_per,21.06,非流動資產合計,樂威科-KY,生技醫療業
2019-03-31,4154,NoncurrentLiabilities,29551000.0,非流動負債合計,樂威科-KY,生技醫療業
2019-03-31,4154,NoncurrentLiabilities_per,5.86,非流動負債合計,樂威科-KY,生技醫療業
2019-03-31,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2019-03-31,4154,OrdinaryShare,243260000.0,普通股股本,樂威科-KY,生技醫療業
2019-03-31,4154,OrdinaryShare_per,48.24,普通股股本,樂威科-KY,生技醫療業
2019-03-31,4154,OtherCurrentAssets,19526000.0,其他流動資產,樂威科-KY,生技醫療業
2019-03-31,4154,OtherCurrentAssets_per,3.87,其他流動資產,樂威科-KY,生技醫療業
2019-03-31,4154,OtherCurrentLiabilities,15405000.0,其他流動負債,樂威科-KY,生技醫療業
2019-03-31,4154,OtherCurrentLiabilities_per,3.05,其他流動負債,樂威科-KY,生技醫療業
2019-03-31,4154,OtherNoncurrentAssets,6709000.0,其他非流動資產,樂威科-KY,生技醫療業
2019-03-31,4154,OtherNoncurrentAssets_per,1.33,其他非流動資產,樂威科-KY,生技醫療業
2019-03-31,4154,OtherNoncurrentLiabilities,8000.0,其他非流動負債,樂威科-KY,生技醫療業
2019-03-31,4154,OtherNoncurrentLiabilities_per,0.0,其他非流動負債,樂威科-KY,生技醫療業
2019-03-31,4154,OtherPayables,44383000.0,其他應付款,樂威科-KY,生技醫療業
2019-03-31,4154,OtherPayables_per,8.8,其他應付款,樂威科-KY,生技醫療業
2019-03-31,4154,PropertyPlantAndEquipment,34178000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2019-03-31,4154,PropertyPlantAndEquipment_per,6.78,不動產、廠房及設備,樂威科-KY,生技醫療業
2019-03-31,4154,ShorttermBorrowings,31915000.0,短期借款,樂威科-KY,生技醫療業
2019-03-31,4154,ShorttermBorrowings_per,6.33,短期借款,樂威科-KY,生技醫療業
2019-03-31,4154,TotalAssets,504268000.0,資產總額,樂威科-KY,生技醫療業
2019-03-31,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2019-03-31,4154,TotalLiabilitiesEquity,504268000.0,負債及權益總計,樂威科-KY,生技醫療業
2019-03-31,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2019-03-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-67178000.0,未分配盈餘,樂威科-KY,生技醫療業
2019-03-31,4154,AccountsReceivableNet,114436000.0,應收帳款淨額,樂威科-KY,生技醫療業
2019-03-31,4154,AccountsReceivableNet_per,22.69,應收帳款淨額,樂威科-KY,生技醫療業
2019-03-31,4154,FinancialAssetsAtAmortizedCostNonCurrent,2925000.0,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2019-03-31,4154,FinancialAssetsAtAmortizedCostNonCurrent_per,0.58,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2019-03-31,4154,RightOfUseAsset,47316000.0,使用權資產,樂威科-KY,生技醫療業
2019-03-31,4154,RightOfUseAsset_per,9.38,使用權資產,樂威科-KY,生技醫療業
2019-03-31,4154,Liabilities,209763000.0,負債總,樂威科-KY,生技醫療業
2019-03-31,4154,Liabilities_per,41.6,負債總額,樂威科-KY,生技醫療業
2019-03-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-13.32,未分配盈餘,樂威科-KY,生技醫療業
2019-03-31,4154,RetainedEarnings,-67178000.0,保留盈餘合計,樂威科-KY,生技醫療業
2019-03-31,4154,RetainedEarnings_per,-13.32,保留盈餘合計,樂威科-KY,生技醫療業
2019-03-31,4154,OtherEquityInterest,-27935000.0,其他權益合計,樂威科-KY,生技醫療業
2019-03-31,4154,OtherEquityInterest_per,-5.54,其他權益合計,樂威科-KY,生技醫療業
2019-03-31,4154,Equity,504268000.0,權益總計,樂威科-KY,生技醫療業
2019-03-31,4154,Equity_per,100.0,權益總計,樂威科-KY,生技醫療業
2019-06-30,4154,AccountsPayable,36478000.0,應付帳款,樂威科-KY,生技醫療業
2019-06-30,4154,AccountsPayable_per,7.06,應付帳款,樂威科-KY,生技醫療業
2019-06-30,4154,AccountsPayableToRelatedParties,43795000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2019-06-30,4154,AccountsPayableToRelatedParties_per,8.48,應付帳款－關係人,樂威科-KY,生技醫療業
2019-06-30,4154,AccountsReceivableDuefromRelatedPartiesNet,33990000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2019-06-30,4154,AccountsReceivableDuefromRelatedPartiesNet_per,6.58,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2019-06-30,4154,AccountsReceivableNet,112567000.0,應收帳款淨額,樂威科-KY,生技醫療業
2019-06-30,4154,AccountsReceivableNet_per,21.8,應收帳款淨額,樂威科-KY,生技醫療業
2019-06-30,4154,CapitalStock,243260000.0,股本合計,樂威科-KY,生技醫療業
2019-06-30,4154,CapitalStock_per,47.11,股本合計,樂威科-KY,生技醫療業
2019-06-30,4154,CapitalSurplus,120887000.0,資本公積合計,樂威科-KY,生技醫療業
2019-06-30,4154,CapitalSurplus_per,23.41,資本公積合計,樂威科-KY,生技醫療業
2019-06-30,4154,CashAndCashEquivalents,142336000.0,現金及約當現金,樂威科-KY,生技醫療業
2019-06-30,4154,CashAndCashEquivalents_per,27.56,現金及約當現金,樂威科-KY,生技醫療業
2019-06-30,4154,CurrentAssets,396578000.0,流動資產合計,樂威科-KY,生技醫療業
2019-06-30,4154,CurrentAssets_per,76.8,流動資產合計,樂威科-KY,生技醫療業
2019-06-30,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2019-06-30,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2019-06-30,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2019-06-30,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2019-06-30,4154,CurrentIncomeTaxAssets,4126000.0,本期所得稅資產,樂威科-KY,生技醫療業
2019-06-30,4154,CurrentIncomeTaxAssets_per,0.8,本期所得稅資產,樂威科-KY,生技醫療業
2019-06-30,4154,CurrentLiabilities,206748000.0,流動負債合計,樂威科-KY,生技醫療業
2019-06-30,4154,CurrentLiabilities_per,40.04,流動負債合計,樂威科-KY,生技醫療業
2019-06-30,4154,EquityAttributableToOwnersOfParent,244969000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2019-06-30,4154,EquityAttributableToOwnersOfParent_per,47.44,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2019-06-30,4154,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,0.0,預收股款（權益項下）之約當發行股數,樂威科-KY,生技醫療業
2019-06-30,4154,IntangibleAssets,14403000.0,無形資產,樂威科-KY,生技醫療業
2019-06-30,4154,IntangibleAssets_per,2.79,無形資產,樂威科-KY,生技醫療業
2019-06-30,4154,Inventories,86609000.0,存貨,樂威科-KY,生技醫療業
2019-06-30,4154,Inventories_per,16.77,存貨,樂威科-KY,生技醫療業
2019-06-30,4154,LongtermBorrowings,920000.0,長期借款,樂威科-KY,生技醫療業
2019-06-30,4154,LongtermBorrowings_per,0.18,長期借款,樂威科-KY,生技醫療業
2019-06-30,4154,NoncontrollingInterests,25305000.0,非控制權益,樂威科-KY,生技醫療業
2019-06-30,4154,NoncontrollingInterests_per,4.9,非控制權益,樂威科-KY,生技醫療業
2019-06-30,4154,NoncurrentAssets,119801000.0,非流動資產合計,樂威科-KY,生技醫療業
2019-06-30,4154,NoncurrentAssets_per,23.2,非流動資產合計,樂威科-KY,生技醫療業
2019-06-30,4154,NoncurrentLiabilities,39357000.0,非流動負債合計,樂威科-KY,生技醫療業
2019-06-30,4154,NoncurrentLiabilities_per,7.62,非流動負債合計,樂威科-KY,生技醫療業
2019-06-30,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2019-06-30,4154,OrdinaryShare,243260000.0,普通股股本,樂威科-KY,生技醫療業
2019-06-30,4154,OrdinaryShare_per,47.11,普通股股本,樂威科-KY,生技醫療業
2019-06-30,4154,OtherCurrentAssets,16950000.0,其他流動資產,樂威科-KY,生技醫療業
2019-06-30,4154,OtherCurrentAssets_per,3.28,其他流動資產,樂威科-KY,生技醫療業
2019-06-30,4154,OtherCurrentLiabilities,5787000.0,其他流動負債,樂威科-KY,生技醫療業
2019-06-30,4154,OtherCurrentLiabilities_per,1.12,其他流動負債,樂威科-KY,生技醫療業
2019-06-30,4154,OtherNoncurrentAssets,7166000.0,其他非流動資產,樂威科-KY,生技醫療業
2019-06-30,4154,OtherNoncurrentAssets_per,1.39,其他非流動資產,樂威科-KY,生技醫療業
2019-06-30,4154,OtherNoncurrentLiabilities,8000.0,其他非流動負債,樂威科-KY,生技醫療業
2019-06-30,4154,OtherNoncurrentLiabilities_per,0.0,其他非流動負債,樂威科-KY,生技醫療業
2019-06-30,4154,OtherPayables,47908000.0,其他應付款,樂威科-KY,生技醫療業
2019-06-30,4154,OtherPayables_per,9.28,其他應付款,樂威科-KY,生技醫療業
2019-06-30,4154,PropertyPlantAndEquipment,36416000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2019-06-30,4154,PropertyPlantAndEquipment_per,7.05,不動產、廠房及設備,樂威科-KY,生技醫療業
2019-06-30,4154,ShorttermBorrowings,9754000.0,短期借款,樂威科-KY,生技醫療業
2019-06-30,4154,ShorttermBorrowings_per,1.89,短期借款,樂威科-KY,生技醫療業
2019-06-30,4154,TotalAssets,516379000.0,資產總額,樂威科-KY,生技醫療業
2019-06-30,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2019-06-30,4154,TotalLiabilitiesEquity,516379000.0,負債及權益總計,樂威科-KY,生技醫療業
2019-06-30,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2019-06-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-90640000.0,未分配盈餘,樂威科-KY,生技醫療業
2019-06-30,4154,FinancialAssetsAtAmortizedCostNonCurrent,2930000.0,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2019-06-30,4154,FinancialAssetsAtAmortizedCostNonCurrent_per,0.57,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2019-06-30,4154,RightOfUseAsset,58886000.0,使用權資產,樂威科-KY,生技醫療業
2019-06-30,4154,RightOfUseAsset_per,11.4,使用權資產,樂威科-KY,生技醫療業
2019-06-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-17.55,未分配盈餘,樂威科-KY,生技醫療業
2019-06-30,4154,RetainedEarnings,-90640000.0,保留盈餘合計,樂威科-KY,生技醫療業
2019-06-30,4154,RetainedEarnings_per,-17.55,保留盈餘合計,樂威科-KY,生技醫療業
2019-06-30,4154,OtherEquityInterest,-28538000.0,其他權益合計,樂威科-KY,生技醫療業
2019-06-30,4154,OtherEquityInterest_per,-5.53,其他權益合計,樂威科-KY,生技醫療業
2019-06-30,4154,Liabilities_per,47.66,負債總,樂威科-KY,生技醫療業
2019-06-30,4154,Liabilities,246105000.0,負債總額,樂威科-KY,生技醫療業
2019-06-30,4154,Equity,270274000.0,權益總額,樂威科-KY,生技醫療業
2019-06-30,4154,Equity_per,52.34,權益總額,樂威科-KY,生技醫療業
2019-09-30,4154,AccountsPayable,44840000.0,應付帳款,樂威科-KY,生技醫療業
2019-09-30,4154,AccountsPayable_per,9.0,應付帳款,樂威科-KY,生技醫療業
2019-09-30,4154,AccountsPayableToRelatedParties,36007000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2019-09-30,4154,AccountsPayableToRelatedParties_per,7.23,應付帳款－關係人,樂威科-KY,生技醫療業
2019-09-30,4154,AccountsReceivableDuefromRelatedPartiesNet,5774000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2019-09-30,4154,AccountsReceivableDuefromRelatedPartiesNet_per,1.16,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2019-09-30,4154,AccountsReceivableNet,107967000.0,應收帳款淨額,樂威科-KY,生技醫療業
2019-09-30,4154,AccountsReceivableNet_per,21.67,應收帳款淨額,樂威科-KY,生技醫療業
2019-09-30,4154,CapitalStock,243260000.0,股本合計,樂威科-KY,生技醫療業
2019-09-30,4154,CapitalStock_per,48.84,股本合計,樂威科-KY,生技醫療業
2019-09-30,4154,CapitalSurplus,120887000.0,資本公積合計,樂威科-KY,生技醫療業
2019-09-30,4154,CapitalSurplus_per,24.27,資本公積合計,樂威科-KY,生技醫療業
2019-09-30,4154,CashAndCashEquivalents,142002000.0,現金及約當現金,樂威科-KY,生技醫療業
2019-09-30,4154,CashAndCashEquivalents_per,28.51,現金及約當現金,樂威科-KY,生技醫療業
2019-09-30,4154,CurrentAssets,390733000.0,流動資產合計,樂威科-KY,生技醫療業
2019-09-30,4154,CurrentAssets_per,78.44,流動資產合計,樂威科-KY,生技醫療業
2019-09-30,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2019-09-30,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2019-09-30,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2019-09-30,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2019-09-30,4154,CurrentIncomeTaxAssets,5639000.0,本期所得稅資產,樂威科-KY,生技醫療業
2019-09-30,4154,CurrentIncomeTaxAssets_per,1.13,本期所得稅資產,樂威科-KY,生技醫療業
2019-09-30,4154,CurrentLiabilities,212172000.0,流動負債合計,樂威科-KY,生技醫療業
2019-09-30,4154,CurrentLiabilities_per,42.59,流動負債合計,樂威科-KY,生技醫療業
2019-09-30,4154,EquityAttributableToOwnersOfParent,230139000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2019-09-30,4154,EquityAttributableToOwnersOfParent_per,46.2,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2019-09-30,4154,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,0.0,預收股款（權益項下）之約當發行股數,樂威科-KY,生技醫療業
2019-09-30,4154,IntangibleAssets,12790000.0,無形資產,樂威科-KY,生技醫療業
2019-09-30,4154,IntangibleAssets_per,2.57,無形資產,樂威科-KY,生技醫療業
2019-09-30,4154,Inventories,114576000.0,存貨,樂威科-KY,生技醫療業
2019-09-30,4154,Inventories_per,23.0,存貨,樂威科-KY,生技醫療業
2019-09-30,4154,LongtermBorrowings,755000.0,長期借款,樂威科-KY,生技醫療業
2019-09-30,4154,LongtermBorrowings_per,0.15,長期借款,樂威科-KY,生技醫療業
2019-09-30,4154,NoncontrollingInterests,24472000.0,非控制權益,樂威科-KY,生技醫療業
2019-09-30,4154,NoncontrollingInterests_per,4.91,非控制權益,樂威科-KY,生技醫療業
2019-09-30,4154,NoncurrentAssets,107390000.0,非流動資產合計,樂威科-KY,生技醫療業
2019-09-30,4154,NoncurrentAssets_per,21.56,非流動資產合計,樂威科-KY,生技醫療業
2019-09-30,4154,NoncurrentLiabilities,31340000.0,非流動負債合計,樂威科-KY,生技醫療業
2019-09-30,4154,NoncurrentLiabilities_per,6.29,非流動負債合計,樂威科-KY,生技醫療業
2019-09-30,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2019-09-30,4154,OrdinaryShare,243260000.0,普通股股本,樂威科-KY,生技醫療業
2019-09-30,4154,OrdinaryShare_per,48.84,普通股股本,樂威科-KY,生技醫療業
2019-09-30,4154,OtherCurrentAssets,14775000.0,其他流動資產,樂威科-KY,生技醫療業
2019-09-30,4154,OtherCurrentAssets_per,2.97,其他流動資產,樂威科-KY,生技醫療業
2019-09-30,4154,OtherCurrentLiabilities,5251000.0,其他流動負債,樂威科-KY,生技醫療業
2019-09-30,4154,OtherCurrentLiabilities_per,1.05,其他流動負債,樂威科-KY,生技醫療業
2019-09-30,4154,OtherNoncurrentAssets,7003000.0,其他非流動資產,樂威科-KY,生技醫療業
2019-09-30,4154,OtherNoncurrentAssets_per,1.41,其他非流動資產,樂威科-KY,生技醫療業
2019-09-30,4154,OtherNoncurrentLiabilities,67000.0,其他非流動負債,樂威科-KY,生技醫療業
2019-09-30,4154,OtherNoncurrentLiabilities_per,0.01,其他非流動負債,樂威科-KY,生技醫療業
2019-09-30,4154,OtherPayables,49730000.0,其他應付款,樂威科-KY,生技醫療業
2019-09-30,4154,OtherPayables_per,9.98,其他應付款,樂威科-KY,生技醫療業
2019-09-30,4154,PropertyPlantAndEquipment,36339000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2019-09-30,4154,PropertyPlantAndEquipment_per,7.3,不動產、廠房及設備,樂威科-KY,生技醫療業
2019-09-30,4154,ShorttermBorrowings,27910000.0,短期借款,樂威科-KY,生技醫療業
2019-09-30,4154,ShorttermBorrowings_per,5.6,短期借款,樂威科-KY,生技醫療業
2019-09-30,4154,TotalAssets,498123000.0,資產總額,樂威科-KY,生技醫療業
2019-09-30,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2019-09-30,4154,TotalLiabilitiesEquity,498123000.0,負債及權益總計,樂威科-KY,生技醫療業
2019-09-30,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2019-09-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-100688000.0,未分配盈餘,樂威科-KY,生技醫療業
2019-09-30,4154,BillsReceivableNet,0.0,應收票據淨額,樂威科-KY,生技醫療業
2019-09-30,4154,BillsReceivableNet_per,0.0,應收票據淨額,樂威科-KY,生技醫療業
2019-09-30,4154,FinancialAssetsAtAmortizedCostNonCurrent,2899000.0,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2019-09-30,4154,FinancialAssetsAtAmortizedCostNonCurrent_per,0.58,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2019-09-30,4154,RightOfUseAsset,48359000.0,使用權資產,樂威科-KY,生技醫療業
2019-09-30,4154,RightOfUseAsset_per,9.71,使用權資產,樂威科-KY,生技醫療業
2019-09-30,4154,Liabilities,243512000.0,負債總,樂威科-KY,生技醫療業
2019-09-30,4154,Liabilities_per,48.89,負債總額,樂威科-KY,生技醫療業
2019-09-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-20.21,未分配盈餘,樂威科-KY,生技醫療業
2019-09-30,4154,RetainedEarnings,-100688000.0,保留盈餘合計,樂威科-KY,生技醫療業
2019-09-30,4154,RetainedEarnings_per,-20.21,保留盈餘合計,樂威科-KY,生技醫療業
2019-09-30,4154,OtherEquityInterest,-33320000.0,其他權益合計,樂威科-KY,生技醫療業
2019-09-30,4154,OtherEquityInterest_per,-6.69,其他權益合計,樂威科-KY,生技醫療業
2019-09-30,4154,Equity,498123000.0,權益總計,樂威科-KY,生技醫療業
2019-09-30,4154,Equity_per,100.0,權益總計,樂威科-KY,生技醫療業
2019-12-31,4154,AccountsPayable,57795000.0,應付帳款,樂威科-KY,生技醫療業
2019-12-31,4154,AccountsPayable_per,10.11,應付帳款,樂威科-KY,生技醫療業
2019-12-31,4154,AccountsPayableToRelatedParties,43980000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2019-12-31,4154,AccountsPayableToRelatedParties_per,7.69,應付帳款－關係人,樂威科-KY,生技醫療業
2019-12-31,4154,AccountsReceivableDuefromRelatedPartiesNet,24856000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2019-12-31,4154,AccountsReceivableDuefromRelatedPartiesNet_per,4.35,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2019-12-31,4154,AccountsReceivableNet,67454000.0,應收帳款淨額,樂威科-KY,生技醫療業
2019-12-31,4154,AccountsReceivableNet_per,11.8,應收帳款淨額,樂威科-KY,生技醫療業
2019-12-31,4154,CapitalStock,243260000.0,股本合計,樂威科-KY,生技醫療業
2019-12-31,4154,CapitalStock_per,42.55,股本合計,樂威科-KY,生技醫療業
2019-12-31,4154,CapitalSurplus,54471000.0,資本公積合計,樂威科-KY,生技醫療業
2019-12-31,4154,CapitalSurplus_per,9.53,資本公積合計,樂威科-KY,生技醫療業
2019-12-31,4154,CashAndCashEquivalents,141725000.0,現金及約當現金,樂威科-KY,生技醫療業
2019-12-31,4154,CashAndCashEquivalents_per,24.79,現金及約當現金,樂威科-KY,生技醫療業
2019-12-31,4154,CurrentAssets,510188000.0,流動資產合計,樂威科-KY,生技醫療業
2019-12-31,4154,CurrentAssets_per,89.24,流動資產合計,樂威科-KY,生技醫療業
2019-12-31,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2019-12-31,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2019-12-31,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2019-12-31,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2019-12-31,4154,CurrentIncomeTaxAssets,1914000.0,本期所得稅資產,樂威科-KY,生技醫療業
2019-12-31,4154,CurrentIncomeTaxAssets_per,0.33,本期所得稅資產,樂威科-KY,生技醫療業
2019-12-31,4154,CurrentLiabilities,294047000.0,流動負債合計,樂威科-KY,生技醫療業
2019-12-31,4154,CurrentLiabilities_per,51.44,流動負債合計,樂威科-KY,生技醫療業
2019-12-31,4154,EquityAttributableToOwnersOfParent,208957000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2019-12-31,4154,EquityAttributableToOwnersOfParent_per,36.55,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2019-12-31,4154,EquivalentIssueSharesOfAdvanceReceiptsForOrdinaryShare,0.0,預收股款（權益項下）之約當發行股數,樂威科-KY,生技醫療業
2019-12-31,4154,IntangibleAssets,861000.0,無形資產,樂威科-KY,生技醫療業
2019-12-31,4154,IntangibleAssets_per,0.15,無形資產,樂威科-KY,生技醫療業
2019-12-31,4154,Inventories,52151000.0,存貨,樂威科-KY,生技醫療業
2019-12-31,4154,Inventories_per,9.12,存貨,樂威科-KY,生技醫療業
2019-12-31,4154,LongtermBorrowings,321000.0,長期借款,樂威科-KY,生技醫療業
2019-12-31,4154,LongtermBorrowings_per,0.06,長期借款,樂威科-KY,生技醫療業
2019-12-31,4154,NoncontrollingInterests,41272000.0,非控制權益,樂威科-KY,生技醫療業
2019-12-31,4154,NoncontrollingInterests_per,7.22,非控制權益,樂威科-KY,生技醫療業
2019-12-31,4154,NoncurrentAssets,61491000.0,非流動資產合計,樂威科-KY,生技醫療業
2019-12-31,4154,NoncurrentAssets_per,10.76,非流動資產合計,樂威科-KY,生技醫療業
2019-12-31,4154,NoncurrentLiabilities,27403000.0,非流動負債合計,樂威科-KY,生技醫療業
2019-12-31,4154,NoncurrentLiabilities_per,4.79,非流動負債合計,樂威科-KY,生技醫療業
2019-12-31,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2019-12-31,4154,OrdinaryShare,243260000.0,普通股股本,樂威科-KY,生技醫療業
2019-12-31,4154,OrdinaryShare_per,42.55,普通股股本,樂威科-KY,生技醫療業
2019-12-31,4154,OtherCurrentAssets,11969000.0,其他流動資產,樂威科-KY,生技醫療業
2019-12-31,4154,OtherCurrentAssets_per,2.09,其他流動資產,樂威科-KY,生技醫療業
2019-12-31,4154,OtherCurrentLiabilities,2159000.0,其他流動負債,樂威科-KY,生技醫療業
2019-12-31,4154,OtherCurrentLiabilities_per,0.38,其他流動負債,樂威科-KY,生技醫療業
2019-12-31,4154,OtherNoncurrentAssets,4468000.0,其他非流動資產,樂威科-KY,生技醫療業
2019-12-31,4154,OtherNoncurrentAssets_per,0.78,其他非流動資產,樂威科-KY,生技醫療業
2019-12-31,4154,OtherNoncurrentLiabilities,8000.0,其他非流動負債,樂威科-KY,生技醫療業
2019-12-31,4154,OtherNoncurrentLiabilities_per,0.0,其他非流動負債,樂威科-KY,生技醫療業
2019-12-31,4154,OtherPayables,36096000.0,其他應付款,樂威科-KY,生技醫療業
2019-12-31,4154,OtherPayables_per,6.31,其他應付款,樂威科-KY,生技醫療業
2019-12-31,4154,PropertyPlantAndEquipment,16377000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2019-12-31,4154,PropertyPlantAndEquipment_per,2.86,不動產、廠房及設備,樂威科-KY,生技醫療業
2019-12-31,4154,ShorttermBorrowings,21120000.0,短期借款,樂威科-KY,生技醫療業
2019-12-31,4154,ShorttermBorrowings_per,3.69,短期借款,樂威科-KY,生技醫療業
2019-12-31,4154,TotalAssets,571679000.0,資產總額,樂威科-KY,生技醫療業
2019-12-31,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2019-12-31,4154,TotalLiabilitiesEquity,571679000.0,負債及權益總計,樂威科-KY,生技醫療業
2019-12-31,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2019-12-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-54139000.0,未分配盈餘,樂威科-KY,生技醫療業
2019-12-31,4154,BillsReceivableNet,0.0,應收票據淨額,樂威科-KY,生技醫療業
2019-12-31,4154,BillsReceivableNet_per,0.0,應收票據淨額,樂威科-KY,生技醫療業
2019-12-31,4154,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2019-12-31,4154,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2019-12-31,4154,FinancialAssetsAtAmortizedCostNonCurrent,2937000.0,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2019-12-31,4154,FinancialAssetsAtAmortizedCostNonCurrent_per,0.51,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2019-12-31,4154,RightOfUseAsset,36848000.0,使用權資產,樂威科-KY,生技醫療業
2019-12-31,4154,RightOfUseAsset_per,6.45,使用權資產,樂威科-KY,生技醫療業
2019-12-31,4154,CurrentTaxLiabilities,0.0,本期所得稅負債,樂威科-KY,生技醫療業
2019-12-31,4154,CurrentTaxLiabilities_per,0.0,本期所得稅負債,樂威科-KY,生技醫療業
2019-12-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-9.47,未分配盈餘,樂威科-KY,生技醫療業
2019-12-31,4154,RetainedEarnings,-54139000.0,保留盈餘合計,樂威科-KY,生技醫療業
2019-12-31,4154,RetainedEarnings_per,-9.47,保留盈餘合計,樂威科-KY,生技醫療業
2019-12-31,4154,OtherEquityInterest,-34635000.0,其他權益合計,樂威科-KY,生技醫療業
2019-12-31,4154,OtherEquityInterest_per,-6.06,其他權益合計,樂威科-KY,生技醫療業
2019-12-31,4154,Liabilities,321450000.0,負債總,樂威科-KY,生技醫療業
2019-12-31,4154,Liabilities_per,56.23,負債總額,樂威科-KY,生技醫療業
2019-12-31,4154,Equity,571679000.0,權益總計,樂威科-KY,生技醫療業
2019-12-31,4154,Equity_per,100.0,權益總計,樂威科-KY,生技醫療業
2020-03-31,4154,AccountsPayable,44828000.0,應付帳款,樂威科-KY,生技醫療業
2020-03-31,4154,AccountsPayable_per,9.09,應付帳款,樂威科-KY,生技醫療業
2020-03-31,4154,AccountsPayableToRelatedParties,32777000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2020-03-31,4154,AccountsPayableToRelatedParties_per,6.65,應付帳款－關係人,樂威科-KY,生技醫療業
2020-03-31,4154,AccountsReceivableDuefromRelatedPartiesNet,81232000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2020-03-31,4154,AccountsReceivableDuefromRelatedPartiesNet_per,16.47,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2020-03-31,4154,AccountsReceivableNet,75331000.0,應收帳款淨額,樂威科-KY,生技醫療業
2020-03-31,4154,AccountsReceivableNet_per,15.28,應收帳款淨額,樂威科-KY,生技醫療業
2020-03-31,4154,CapitalStock,243260000.0,股本合計,樂威科-KY,生技醫療業
2020-03-31,4154,CapitalStock_per,49.33,股本合計,樂威科-KY,生技醫療業
2020-03-31,4154,CapitalSurplus,54471000.0,資本公積合計,樂威科-KY,生技醫療業
2020-03-31,4154,CapitalSurplus_per,11.05,資本公積合計,樂威科-KY,生技醫療業
2020-03-31,4154,CashAndCashEquivalents,209431000.0,現金及約當現金,樂威科-KY,生技醫療業
2020-03-31,4154,CashAndCashEquivalents_per,42.47,現金及約當現金,樂威科-KY,生技醫療業
2020-03-31,4154,CurrentAssets,431033000.0,流動資產合計,樂威科-KY,生技醫療業
2020-03-31,4154,CurrentAssets_per,87.41,流動資產合計,樂威科-KY,生技醫療業
2020-03-31,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,63000.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2020-03-31,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.01,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2020-03-31,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2020-03-31,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2020-03-31,4154,CurrentIncomeTaxAssets,1833000.0,本期所得稅資產,樂威科-KY,生技醫療業
2020-03-31,4154,CurrentIncomeTaxAssets_per,0.37,本期所得稅資產,樂威科-KY,生技醫療業
2020-03-31,4154,CurrentLiabilities,173744000.0,流動負債合計,樂威科-KY,生技醫療業
2020-03-31,4154,CurrentLiabilities_per,35.23,流動負債合計,樂威科-KY,生技醫療業
2020-03-31,4154,EquityAttributableToOwnersOfParent,233018000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2020-03-31,4154,EquityAttributableToOwnersOfParent_per,47.26,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2020-03-31,4154,IntangibleAssets,802000.0,無形資產,樂威科-KY,生技醫療業
2020-03-31,4154,IntangibleAssets_per,0.16,無形資產,樂威科-KY,生技醫療業
2020-03-31,4154,Inventories,50859000.0,存貨,樂威科-KY,生技醫療業
2020-03-31,4154,Inventories_per,10.31,存貨,樂威科-KY,生技醫療業
2020-03-31,4154,LongtermBorrowings,231000.0,長期借款,樂威科-KY,生技醫療業
2020-03-31,4154,LongtermBorrowings_per,0.05,長期借款,樂威科-KY,生技醫療業
2020-03-31,4154,NoncontrollingInterests,62116000.0,非控制權益,樂威科-KY,生技醫療業
2020-03-31,4154,NoncontrollingInterests_per,12.6,非控制權益,樂威科-KY,生技醫療業
2020-03-31,4154,NoncurrentAssets,62072000.0,非流動資產合計,樂威科-KY,生技醫療業
2020-03-31,4154,NoncurrentAssets_per,12.59,非流動資產合計,樂威科-KY,生技醫療業
2020-03-31,4154,NoncurrentLiabilities,24227000.0,非流動負債合計,樂威科-KY,生技醫療業
2020-03-31,4154,NoncurrentLiabilities_per,4.91,非流動負債合計,樂威科-KY,生技醫療業
2020-03-31,4154,OrdinaryShare,243260000.0,普通股股本,樂威科-KY,生技醫療業
2020-03-31,4154,OrdinaryShare_per,49.33,普通股股本,樂威科-KY,生技醫療業
2020-03-31,4154,OtherCurrentAssets,12284000.0,其他流動資產,樂威科-KY,生技醫療業
2020-03-31,4154,OtherCurrentAssets_per,2.49,其他流動資產,樂威科-KY,生技醫療業
2020-03-31,4154,OtherCurrentLiabilities,7130000.0,其他流動負債,樂威科-KY,生技醫療業
2020-03-31,4154,OtherCurrentLiabilities_per,1.45,其他流動負債,樂威科-KY,生技醫療業
2020-03-31,4154,OtherNoncurrentAssets,9463000.0,其他非流動資產,樂威科-KY,生技醫療業
2020-03-31,4154,OtherNoncurrentAssets_per,1.92,其他非流動資產,樂威科-KY,生技醫療業
2020-03-31,4154,OtherNoncurrentLiabilities,8000.0,其他非流動負債,樂威科-KY,生技醫療業
2020-03-31,4154,OtherNoncurrentLiabilities_per,0.0,其他非流動負債,樂威科-KY,生技醫療業
2020-03-31,4154,OtherPayables,29865000.0,其他應付款,樂威科-KY,生技醫療業
2020-03-31,4154,OtherPayables_per,6.06,其他應付款,樂威科-KY,生技醫療業
2020-03-31,4154,PropertyPlantAndEquipment,15215000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2020-03-31,4154,PropertyPlantAndEquipment_per,3.09,不動產、廠房及設備,樂威科-KY,生技醫療業
2020-03-31,4154,ShorttermBorrowings,18686000.0,短期借款,樂威科-KY,生技醫療業
2020-03-31,4154,ShorttermBorrowings_per,3.79,短期借款,樂威科-KY,生技醫療業
2020-03-31,4154,TotalAssets,493105000.0,資產總額,樂威科-KY,生技醫療業
2020-03-31,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2020-03-31,4154,TotalLiabilitiesEquity,493105000.0,負債及權益總計,樂威科-KY,生技醫療業
2020-03-31,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2020-03-31,4154,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2020-03-31,4154,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2020-03-31,4154,BillsReceivableNet,0.0,應收票據淨額,樂威科-KY,生技醫療業
2020-03-31,4154,BillsReceivableNet_per,0.0,應收票據淨額,樂威科-KY,生技醫療業
2020-03-31,4154,FinancialAssetsAtAmortizedCostNonCurrent,2813000.0,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2020-03-31,4154,FinancialAssetsAtAmortizedCostNonCurrent_per,0.57,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2020-03-31,4154,RightOfUseAsset,33779000.0,使用權資產,樂威科-KY,生技醫療業
2020-03-31,4154,RightOfUseAsset_per,6.85,使用權資產,樂威科-KY,生技醫療業
2020-03-31,4154,CurrentTaxLiabilities,0.0,本期所得稅負債,樂威科-KY,生技醫療業
2020-03-31,4154,CurrentTaxLiabilities_per,0.0,本期所得稅負債,樂威科-KY,生技醫療業
2020-03-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-26976000.0,未分配盈餘,樂威科-KY,生技醫療業
2020-03-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-5.47,未分配盈餘,樂威科-KY,生技醫療業
2020-03-31,4154,RetainedEarnings,-26976000.0,保留盈餘合計,樂威科-KY,生技醫療業
2020-03-31,4154,RetainedEarnings_per,-5.47,保留盈餘合計,樂威科-KY,生技醫療業
2020-03-31,4154,OtherEquityInterest,-37737000.0,其他權益合計,樂威科-KY,生技醫療業
2020-03-31,4154,OtherEquityInterest_per,-7.65,其他權益合計,樂威科-KY,生技醫療業
2020-03-31,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2020-03-31,4154,Equity,295134000.0,權益總額,樂威科-KY,生技醫療業
2020-03-31,4154,Equity_per,59.85,權益總額,樂威科-KY,生技醫療業
2020-03-31,4154,Liabilities,197971000.0,負債總額,樂威科-KY,生技醫療業
2020-03-31,4154,Liabilities_per,40.15,負債總額,樂威科-KY,生技醫療業
2020-06-30,4154,AccountsPayable,43645000.0,應付帳款,樂威科-KY,生技醫療業
2020-06-30,4154,AccountsPayable_per,8.78,應付帳款,樂威科-KY,生技醫療業
2020-06-30,4154,AccountsPayableToRelatedParties,33510000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2020-06-30,4154,AccountsPayableToRelatedParties_per,6.74,應付帳款－關係人,樂威科-KY,生技醫療業
2020-06-30,4154,AccountsReceivableDuefromRelatedPartiesNet,106654000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2020-06-30,4154,AccountsReceivableDuefromRelatedPartiesNet_per,21.45,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2020-06-30,4154,AccountsReceivableNet,50008000.0,應收帳款淨額,樂威科-KY,生技醫療業
2020-06-30,4154,AccountsReceivableNet_per,10.06,應收帳款淨額,樂威科-KY,生技醫療業
2020-06-30,4154,CapitalStock,243260000.0,股本合計,樂威科-KY,生技醫療業
2020-06-30,4154,CapitalStock_per,48.93,股本合計,樂威科-KY,生技醫療業
2020-06-30,4154,CapitalSurplus,332000.0,資本公積合計,樂威科-KY,生技醫療業
2020-06-30,4154,CapitalSurplus_per,0.07,資本公積合計,樂威科-KY,生技醫療業
2020-06-30,4154,CashAndCashEquivalents,194521000.0,現金及約當現金,樂威科-KY,生技醫療業
2020-06-30,4154,CashAndCashEquivalents_per,39.12,現金及約當現金,樂威科-KY,生技醫療業
2020-06-30,4154,CurrentAssets,410550000.0,流動資產合計,樂威科-KY,生技醫療業
2020-06-30,4154,CurrentAssets_per,82.57,流動資產合計,樂威科-KY,生技醫療業
2020-06-30,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,68000.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2020-06-30,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.01,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2020-06-30,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2020-06-30,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2020-06-30,4154,CurrentIncomeTaxAssets,1797000.0,本期所得稅資產,樂威科-KY,生技醫療業
2020-06-30,4154,CurrentIncomeTaxAssets_per,0.36,本期所得稅資產,樂威科-KY,生技醫療業
2020-06-30,4154,CurrentLiabilities,184735000.0,流動負債合計,樂威科-KY,生技醫療業
2020-06-30,4154,CurrentLiabilities_per,37.16,流動負債合計,樂威科-KY,生技醫療業
2020-06-30,4154,EquityAttributableToOwnersOfParent,225614000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2020-06-30,4154,EquityAttributableToOwnersOfParent_per,45.38,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2020-06-30,4154,IntangibleAssets,1190000.0,無形資產,樂威科-KY,生技醫療業
2020-06-30,4154,IntangibleAssets_per,0.24,無形資產,樂威科-KY,生技醫療業
2020-06-30,4154,Inventories,39395000.0,存貨,樂威科-KY,生技醫療業
2020-06-30,4154,Inventories_per,7.92,存貨,樂威科-KY,生技醫療業
2020-06-30,4154,LongtermBorrowings,153000.0,長期借款,樂威科-KY,生技醫療業
2020-06-30,4154,LongtermBorrowings_per,0.03,長期借款,樂威科-KY,生技醫療業
2020-06-30,4154,NoncontrollingInterests,56134000.0,非控制權益,樂威科-KY,生技醫療業
2020-06-30,4154,NoncontrollingInterests_per,11.29,非控制權益,樂威科-KY,生技醫療業
2020-06-30,4154,NoncurrentAssets,86635000.0,非流動資產合計,樂威科-KY,生技醫療業
2020-06-30,4154,NoncurrentAssets_per,17.43,非流動資產合計,樂威科-KY,生技醫療業
2020-06-30,4154,NoncurrentLiabilities,30702000.0,非流動負債合計,樂威科-KY,生技醫療業
2020-06-30,4154,NoncurrentLiabilities_per,6.18,非流動負債合計,樂威科-KY,生技醫療業
2020-06-30,4154,OrdinaryShare,243260000.0,普通股股本,樂威科-KY,生技醫療業
2020-06-30,4154,OrdinaryShare_per,48.93,普通股股本,樂威科-KY,生技醫療業
2020-06-30,4154,OtherCurrentAssets,18107000.0,其他流動資產,樂威科-KY,生技醫療業
2020-06-30,4154,OtherCurrentAssets_per,3.64,其他流動資產,樂威科-KY,生技醫療業
2020-06-30,4154,OtherCurrentLiabilities,14758000.0,其他流動負債,樂威科-KY,生技醫療業
2020-06-30,4154,OtherCurrentLiabilities_per,2.97,其他流動負債,樂威科-KY,生技醫療業
2020-06-30,4154,OtherNoncurrentAssets,25745000.0,其他非流動資產,樂威科-KY,生技醫療業
2020-06-30,4154,OtherNoncurrentAssets_per,5.18,其他非流動資產,樂威科-KY,生技醫療業
2020-06-30,4154,OtherNoncurrentLiabilities,0.0,其他非流動負債,樂威科-KY,生技醫療業
2020-06-30,4154,OtherNoncurrentLiabilities_per,0.0,其他非流動負債,樂威科-KY,生技醫療業
2020-06-30,4154,OtherPayables,29891000.0,其他應付款,樂威科-KY,生技醫療業
2020-06-30,4154,OtherPayables_per,6.01,其他應付款,樂威科-KY,生技醫療業
2020-06-30,4154,PropertyPlantAndEquipment,14715000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2020-06-30,4154,PropertyPlantAndEquipment_per,2.96,不動產、廠房及設備,樂威科-KY,生技醫療業
2020-06-30,4154,RetainedEarnings,20976000.0,保留盈餘合計,樂威科-KY,生技醫療業
2020-06-30,4154,RetainedEarnings_per,4.22,保留盈餘合計,樂威科-KY,生技醫療業
2020-06-30,4154,ShorttermBorrowings,25082000.0,短期借款,樂威科-KY,生技醫療業
2020-06-30,4154,ShorttermBorrowings_per,5.04,短期借款,樂威科-KY,生技醫療業
2020-06-30,4154,TotalAssets,497185000.0,資產總額,樂威科-KY,生技醫療業
2020-06-30,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2020-06-30,4154,TotalLiabilitiesEquity,497185000.0,負債及權益總計,樂威科-KY,生技醫療業
2020-06-30,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2020-06-30,4154,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2020-06-30,4154,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2020-06-30,4154,CurrentTaxLiabilities,0.0,本期所得稅負債,樂威科-KY,生技醫療業
2020-06-30,4154,CurrentTaxLiabilities_per,0.0,本期所得稅負債,樂威科-KY,生技醫療業
2020-06-30,4154,FinancialAssetsAtAmortizedCostNonCurrent,2779000.0,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2020-06-30,4154,FinancialAssetsAtAmortizedCostNonCurrent_per,0.56,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2020-06-30,4154,RightOfUseAsset,42206000.0,使用權資產,樂威科-KY,生技醫療業
2020-06-30,4154,RightOfUseAsset_per,8.49,使用權資產,樂威科-KY,生技醫療業
2020-06-30,4154,Liabilities,215437000.0,負債總額,樂威科-KY,生技醫療業
2020-06-30,4154,Liabilities_per,43.33,負債總額,樂威科-KY,生技醫療業
2020-06-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,20976000.0,未分配盈餘,樂威科-KY,生技醫療業
2020-06-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,4.22,未分配盈餘,樂威科-KY,生技醫療業
2020-06-30,4154,OtherEquityInterest,-38954000.0,其他權益合計,樂威科-KY,生技醫療業
2020-06-30,4154,OtherEquityInterest_per,-7.83,其他權益合計,樂威科-KY,生技醫療業
2020-06-30,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2020-06-30,4154,Equity,281748000.0,權益總額,樂威科-KY,生技醫療業
2020-06-30,4154,Equity_per,56.67,權益總額,樂威科-KY,生技醫療業
2020-09-30,4154,AccountsPayable,41516000.0,應付帳款,樂威科-KY,生技醫療業
2020-09-30,4154,AccountsPayable_per,7.73,應付帳款,樂威科-KY,生技醫療業
2020-09-30,4154,AccountsPayableToRelatedParties,46996000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2020-09-30,4154,AccountsPayableToRelatedParties_per,8.75,應付帳款－關係人,樂威科-KY,生技醫療業
2020-09-30,4154,AccountsReceivableDuefromRelatedPartiesNet,108571000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2020-09-30,4154,AccountsReceivableDuefromRelatedPartiesNet_per,20.21,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2020-09-30,4154,AccountsReceivableNet,58486000.0,應收帳款淨額,樂威科-KY,生技醫療業
2020-09-30,4154,AccountsReceivableNet_per,10.89,應收帳款淨額,樂威科-KY,生技醫療業
2020-09-30,4154,CapitalStock,243260000.0,股本合計,樂威科-KY,生技醫療業
2020-09-30,4154,CapitalStock_per,45.29,股本合計,樂威科-KY,生技醫療業
2020-09-30,4154,CapitalSurplus,333000.0,資本公積合計,樂威科-KY,生技醫療業
2020-09-30,4154,CapitalSurplus_per,0.06,資本公積合計,樂威科-KY,生技醫療業
2020-09-30,4154,CashAndCashEquivalents,195466000.0,現金及約當現金,樂威科-KY,生技醫療業
2020-09-30,4154,CashAndCashEquivalents_per,36.39,現金及約當現金,樂威科-KY,生技醫療業
2020-09-30,4154,CurrentAssets,407335000.0,流動資產合計,樂威科-KY,生技醫療業
2020-09-30,4154,CurrentAssets_per,75.83,流動資產合計,樂威科-KY,生技醫療業
2020-09-30,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2020-09-30,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2020-09-30,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,20000.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2020-09-30,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2020-09-30,4154,CurrentIncomeTaxAssets,1823000.0,本期所得稅資產,樂威科-KY,生技醫療業
2020-09-30,4154,CurrentIncomeTaxAssets_per,0.34,本期所得稅資產,樂威科-KY,生技醫療業
2020-09-30,4154,CurrentLiabilities,231984000.0,流動負債合計,樂威科-KY,生技醫療業
2020-09-30,4154,CurrentLiabilities_per,43.19,流動負債合計,樂威科-KY,生技醫療業
2020-09-30,4154,EquityAttributableToOwnersOfParent,203759000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2020-09-30,4154,EquityAttributableToOwnersOfParent_per,37.93,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2020-09-30,4154,IntangibleAssets,1160000.0,無形資產,樂威科-KY,生技醫療業
2020-09-30,4154,IntangibleAssets_per,0.22,無形資產,樂威科-KY,生技醫療業
2020-09-30,4154,Inventories,26355000.0,存貨,樂威科-KY,生技醫療業
2020-09-30,4154,Inventories_per,4.91,存貨,樂威科-KY,生技醫療業
2020-09-30,4154,LongtermBorrowings,78000.0,長期借款,樂威科-KY,生技醫療業
2020-09-30,4154,LongtermBorrowings_per,0.01,長期借款,樂威科-KY,生技醫療業
2020-09-30,4154,NoncontrollingInterests,74370000.0,非控制權益,樂威科-KY,生技醫療業
2020-09-30,4154,NoncontrollingInterests_per,13.84,非控制權益,樂威科-KY,生技醫療業
2020-09-30,4154,NoncurrentAssets,129834000.0,非流動資產合計,樂威科-KY,生技醫療業
2020-09-30,4154,NoncurrentAssets_per,24.17,非流動資產合計,樂威科-KY,生技醫療業
2020-09-30,4154,NoncurrentLiabilities,27056000.0,非流動負債合計,樂威科-KY,生技醫療業
2020-09-30,4154,NoncurrentLiabilities_per,5.04,非流動負債合計,樂威科-KY,生技醫療業
2020-09-30,4154,OrdinaryShare,243260000.0,普通股股本,樂威科-KY,生技醫療業
2020-09-30,4154,OrdinaryShare_per,45.29,普通股股本,樂威科-KY,生技醫療業
2020-09-30,4154,OtherCurrentAssets,16540000.0,其他流動資產,樂威科-KY,生技醫療業
2020-09-30,4154,OtherCurrentAssets_per,3.08,其他流動資產,樂威科-KY,生技醫療業
2020-09-30,4154,OtherCurrentLiabilities,11849000.0,其他流動負債,樂威科-KY,生技醫療業
2020-09-30,4154,OtherCurrentLiabilities_per,2.21,其他流動負債,樂威科-KY,生技醫療業
2020-09-30,4154,OtherNoncurrentAssets,50349000.0,其他非流動資產,樂威科-KY,生技醫療業
2020-09-30,4154,OtherNoncurrentAssets_per,9.37,其他非流動資產,樂威科-KY,生技醫療業
2020-09-30,4154,OtherNoncurrentLiabilities,0.0,其他非流動負債,樂威科-KY,生技醫療業
2020-09-30,4154,OtherNoncurrentLiabilities_per,0.0,其他非流動負債,樂威科-KY,生技醫療業
2020-09-30,4154,OtherPayables,37875000.0,其他應付款,樂威科-KY,生技醫療業
2020-09-30,4154,OtherPayables_per,7.05,其他應付款,樂威科-KY,生技醫療業
2020-09-30,4154,PropertyPlantAndEquipment,36542000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2020-09-30,4154,PropertyPlantAndEquipment_per,6.8,不動產、廠房及設備,樂威科-KY,生技醫療業
2020-09-30,4154,ShorttermBorrowings,3940000.0,短期借款,樂威科-KY,生技醫療業
2020-09-30,4154,ShorttermBorrowings_per,0.73,短期借款,樂威科-KY,生技醫療業
2020-09-30,4154,TotalAssets,537169000.0,資產總額,樂威科-KY,生技醫療業
2020-09-30,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2020-09-30,4154,TotalLiabilitiesEquity,537169000.0,負債及權益總計,樂威科-KY,生技醫療業
2020-09-30,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2020-09-30,4154,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2020-09-30,4154,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2020-09-30,4154,BillsReceivableNet,94000.0,應收票據淨額,樂威科-KY,生技醫療業
2020-09-30,4154,BillsReceivableNet_per,0.02,應收票據淨額,樂威科-KY,生技醫療業
2020-09-30,4154,FinancialAssetsAtAmortizedCostNonCurrent,2819000.0,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2020-09-30,4154,FinancialAssetsAtAmortizedCostNonCurrent_per,0.52,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2020-09-30,4154,RightOfUseAsset,38964000.0,使用權資產,樂威科-KY,生技醫療業
2020-09-30,4154,RightOfUseAsset_per,7.25,使用權資產,樂威科-KY,生技醫療業
2020-09-30,4154,CurrentTaxLiabilities,0.0,本期所得稅負債,樂威科-KY,生技醫療業
2020-09-30,4154,CurrentTaxLiabilities_per,0.0,本期所得稅負債,樂威科-KY,生技醫療業
2020-09-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-1182000.0,未分配盈餘,樂威科-KY,生技醫療業
2020-09-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-0.22,未分配盈餘,樂威科-KY,生技醫療業
2020-09-30,4154,RetainedEarnings,-1182000.0,保留盈餘合計,樂威科-KY,生技醫療業
2020-09-30,4154,RetainedEarnings_per,-0.22,保留盈餘合計,樂威科-KY,生技醫療業
2020-09-30,4154,OtherEquityInterest,-38652000.0,其他權益合計,樂威科-KY,生技醫療業
2020-09-30,4154,OtherEquityInterest_per,-7.2,其他權益合計,樂威科-KY,生技醫療業
2020-09-30,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2020-09-30,4154,Equity,278129000.0,權益總額,樂威科-KY,生技醫療業
2020-09-30,4154,Equity_per,51.78,權益總額,樂威科-KY,生技醫療業
2020-09-30,4154,Liabilities,259040000.0,負債總額,樂威科-KY,生技醫療業
2020-09-30,4154,Liabilities_per,48.22,負債總額,樂威科-KY,生技醫療業
2020-12-31,4154,CashAndCashEquivalents,148799000.0,現金及約當現金,樂威科-KY,生技醫療業
2020-12-31,4154,CashAndCashEquivalents_per,28.47,現金及約當現金,樂威科-KY,生技醫療業
2020-12-31,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2020-12-31,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2020-12-31,4154,AccountsReceivableNet,36492000.0,應收帳款淨額,樂威科-KY,生技醫療業
2020-12-31,4154,AccountsReceivableNet_per,6.98,應收帳款淨額,樂威科-KY,生技醫療業
2020-12-31,4154,AccountsReceivableDuefromRelatedPartiesNet,126319000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2020-12-31,4154,AccountsReceivableDuefromRelatedPartiesNet_per,24.17,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2020-12-31,4154,Inventories,19524000.0,存貨,樂威科-KY,生技醫療業
2020-12-31,4154,Inventories_per,3.74,存貨,樂威科-KY,生技醫療業
2020-12-31,4154,OtherCurrentAssets,16543000.0,其他流動資產,樂威科-KY,生技醫療業
2020-12-31,4154,OtherCurrentAssets_per,3.17,其他流動資產,樂威科-KY,生技醫療業
2020-12-31,4154,CurrentAssets,353924000.0,流動資產合計,樂威科-KY,生技醫療業
2020-12-31,4154,CurrentAssets_per,67.72,流動資產合計,樂威科-KY,生技醫療業
2020-12-31,4154,PropertyPlantAndEquipment,47526000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2020-12-31,4154,PropertyPlantAndEquipment_per,9.09,不動產、廠房及設備,樂威科-KY,生技醫療業
2020-12-31,4154,IntangibleAssets,3540000.0,無形資產,樂威科-KY,生技醫療業
2020-12-31,4154,IntangibleAssets_per,0.68,無形資產,樂威科-KY,生技醫療業
2020-12-31,4154,OtherNoncurrentAssets,79680000.0,其他非流動資產,樂威科-KY,生技醫療業
2020-12-31,4154,OtherNoncurrentAssets_per,15.25,其他非流動資產,樂威科-KY,生技醫療業
2020-12-31,4154,NoncurrentAssets,168688000.0,非流動資產合計,樂威科-KY,生技醫療業
2020-12-31,4154,NoncurrentAssets_per,32.28,非流動資產合計,樂威科-KY,生技醫療業
2020-12-31,4154,TotalAssets,522612000.0,資產總額,樂威科-KY,生技醫療業
2020-12-31,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2020-12-31,4154,ShorttermBorrowings,11849000.0,短期借款,樂威科-KY,生技醫療業
2020-12-31,4154,ShorttermBorrowings_per,2.27,短期借款,樂威科-KY,生技醫療業
2020-12-31,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,7000.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2020-12-31,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2020-12-31,4154,AccountsPayable,56863000.0,應付帳款,樂威科-KY,生技醫療業
2020-12-31,4154,AccountsPayable_per,10.88,應付帳款,樂威科-KY,生技醫療業
2020-12-31,4154,AccountsPayableToRelatedParties,36979000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2020-12-31,4154,AccountsPayableToRelatedParties_per,7.08,應付帳款－關係人,樂威科-KY,生技醫療業
2020-12-31,4154,OtherPayables,39676000.0,其他應付款,樂威科-KY,生技醫療業
2020-12-31,4154,OtherPayables_per,7.59,其他應付款,樂威科-KY,生技醫療業
2020-12-31,4154,OtherCurrentLiabilities,3609000.0,其他流動負債,樂威科-KY,生技醫療業
2020-12-31,4154,OtherCurrentLiabilities_per,0.69,其他流動負債,樂威科-KY,生技醫療業
2020-12-31,4154,CurrentLiabilities,241566000.0,流動負債合計,樂威科-KY,生技醫療業
2020-12-31,4154,CurrentLiabilities_per,46.22,流動負債合計,樂威科-KY,生技醫療業
2020-12-31,4154,LongtermBorrowings,0.0,長期借款,樂威科-KY,生技醫療業
2020-12-31,4154,LongtermBorrowings_per,0.0,長期借款,樂威科-KY,生技醫療業
2020-12-31,4154,OtherNoncurrentLiabilities,0.0,其他非流動負債,樂威科-KY,生技醫療業
2020-12-31,4154,OtherNoncurrentLiabilities_per,0.0,其他非流動負債,樂威科-KY,生技醫療業
2020-12-31,4154,NoncurrentLiabilities,23080000.0,非流動負債合計,樂威科-KY,生技醫療業
2020-12-31,4154,NoncurrentLiabilities_per,4.42,非流動負債合計,樂威科-KY,生技醫療業
2020-12-31,4154,OrdinaryShare,243260000.0,普通股股本,樂威科-KY,生技醫療業
2020-12-31,4154,OrdinaryShare_per,46.55,普通股股本,樂威科-KY,生技醫療業
2020-12-31,4154,CapitalStock,243260000.0,股本合計,樂威科-KY,生技醫療業
2020-12-31,4154,CapitalStock_per,46.55,股本合計,樂威科-KY,生技醫療業
2020-12-31,4154,CapitalSurplus,333000.0,資本公積合計,樂威科-KY,生技醫療業
2020-12-31,4154,CapitalSurplus_per,0.06,資本公積合計,樂威科-KY,生技醫療業
2020-12-31,4154,EquityAttributableToOwnersOfParent,179521000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2020-12-31,4154,EquityAttributableToOwnersOfParent_per,34.35,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2020-12-31,4154,NoncontrollingInterests,78445000.0,非控制權益,樂威科-KY,生技醫療業
2020-12-31,4154,NoncontrollingInterests_per,15.01,非控制權益,樂威科-KY,生技醫療業
2020-12-31,4154,TotalLiabilitiesEquity,522612000.0,負債及權益總計,樂威科-KY,生技醫療業
2020-12-31,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2020-12-31,4154,CurrentIncomeTaxAssets,3445000.0,本期所得稅資產,樂威科-KY,生技醫療業
2020-12-31,4154,CurrentIncomeTaxAssets_per,0.66,本期所得稅資產,樂威科-KY,生技醫療業
2020-12-31,4154,DeferredTaxAssets,0.0,遞延所得稅資產,樂威科-KY,生技醫療業
2020-12-31,4154,DeferredTaxAssets_per,0.0,遞延所得稅資產,樂威科-KY,生技醫療業
2020-12-31,4154,FinancialAssetsAtAmortizedCost,2802000.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2020-12-31,4154,FinancialAssetsAtAmortizedCost_per,0.54,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2020-12-31,4154,BillsReceivableNet,0.0,應收票據淨額,樂威科-KY,生技醫療業
2020-12-31,4154,BillsReceivableNet_per,0.0,應收票據淨額,樂威科-KY,生技醫療業
2020-12-31,4154,FinancialAssetsAtAmortizedCostNonCurrent,2882000.0,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2020-12-31,4154,FinancialAssetsAtAmortizedCostNonCurrent_per,0.55,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2020-12-31,4154,RightOfUseAsset,35060000.0,使用權資產,樂威科-KY,生技醫療業
2020-12-31,4154,RightOfUseAsset_per,6.71,使用權資產,樂威科-KY,生技醫療業
2020-12-31,4154,CurrentTaxLiabilities,1174000.0,本期所得稅負債,樂威科-KY,生技醫療業
2020-12-31,4154,CurrentTaxLiabilities_per,0.22,本期所得稅負債,樂威科-KY,生技醫療業
2020-12-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-28173000.0,未分配盈餘,樂威科-KY,生技醫療業
2020-12-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-5.39,未分配盈餘,樂威科-KY,生技醫療業
2020-12-31,4154,RetainedEarnings,-28173000.0,保留盈餘合計,樂威科-KY,生技醫療業
2020-12-31,4154,RetainedEarnings_per,-5.39,保留盈餘合計,樂威科-KY,生技醫療業
2020-12-31,4154,OtherEquityInterest,-35899000.0,其他權益合計,樂威科-KY,生技醫療業
2020-12-31,4154,OtherEquityInterest_per,-6.87,其他權益合計,樂威科-KY,生技醫療業
2020-12-31,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2020-12-31,4154,Equity,257966000.0,權益總額,樂威科-KY,生技醫療業
2020-12-31,4154,Equity_per,49.36,權益總額,樂威科-KY,生技醫療業
2020-12-31,4154,Liabilities,264646000.0,負債總額,樂威科-KY,生技醫療業
2020-12-31,4154,Liabilities_per,50.64,負債總額,樂威科-KY,生技醫療業
2021-03-31,4154,CashAndCashEquivalents,251596000.0,現金及約當現金,樂威科-KY,生技醫療業
2021-03-31,4154,CashAndCashEquivalents_per,40.86,現金及約當現金,樂威科-KY,生技醫療業
2021-03-31,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2021-03-31,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2021-03-31,4154,AccountsReceivableNet,20677000.0,應收帳款淨額,樂威科-KY,生技醫療業
2021-03-31,4154,AccountsReceivableNet_per,3.36,應收帳款淨額,樂威科-KY,生技醫療業
2021-03-31,4154,AccountsReceivableDuefromRelatedPartiesNet,74496000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2021-03-31,4154,AccountsReceivableDuefromRelatedPartiesNet_per,12.1,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2021-03-31,4154,Inventories,47657000.0,存貨,樂威科-KY,生技醫療業
2021-03-31,4154,Inventories_per,7.74,存貨,樂威科-KY,生技醫療業
2021-03-31,4154,OtherCurrentAssets,17306000.0,其他流動資產,樂威科-KY,生技醫療業
2021-03-31,4154,OtherCurrentAssets_per,2.81,其他流動資產,樂威科-KY,生技醫療業
2021-03-31,4154,CurrentAssets,421224000.0,流動資產合計,樂威科-KY,生技醫療業
2021-03-31,4154,CurrentAssets_per,68.41,流動資產合計,樂威科-KY,生技醫療業
2021-03-31,4154,PropertyPlantAndEquipment,71609000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2021-03-31,4154,PropertyPlantAndEquipment_per,11.63,不動產、廠房及設備,樂威科-KY,生技醫療業
2021-03-31,4154,IntangibleAssets,3372000.0,無形資產,樂威科-KY,生技醫療業
2021-03-31,4154,IntangibleAssets_per,0.55,無形資產,樂威科-KY,生技醫療業
2021-03-31,4154,OtherNoncurrentAssets,79921000.0,其他非流動資產,樂威科-KY,生技醫療業
2021-03-31,4154,OtherNoncurrentAssets_per,12.98,其他非流動資產,樂威科-KY,生技醫療業
2021-03-31,4154,NoncurrentAssets,194467000.0,非流動資產合計,樂威科-KY,生技醫療業
2021-03-31,4154,NoncurrentAssets_per,31.59,非流動資產合計,樂威科-KY,生技醫療業
2021-03-31,4154,TotalAssets,615691000.0,資產總額,樂威科-KY,生技醫療業
2021-03-31,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2021-03-31,4154,ShorttermBorrowings,22411000.0,短期借款,樂威科-KY,生技醫療業
2021-03-31,4154,ShorttermBorrowings_per,3.64,短期借款,樂威科-KY,生技醫療業
2021-03-31,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2021-03-31,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2021-03-31,4154,AccountsPayable,61367000.0,應付帳款,樂威科-KY,生技醫療業
2021-03-31,4154,AccountsPayable_per,9.97,應付帳款,樂威科-KY,生技醫療業
2021-03-31,4154,AccountsPayableToRelatedParties,57305000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2021-03-31,4154,AccountsPayableToRelatedParties_per,9.31,應付帳款－關係人,樂威科-KY,生技醫療業
2021-03-31,4154,OtherPayables,38309000.0,其他應付款,樂威科-KY,生技醫療業
2021-03-31,4154,OtherPayables_per,6.22,其他應付款,樂威科-KY,生技醫療業
2021-03-31,4154,OtherCurrentLiabilities,1714000.0,其他流動負債,樂威科-KY,生技醫療業
2021-03-31,4154,OtherCurrentLiabilities_per,0.28,其他流動負債,樂威科-KY,生技醫療業
2021-03-31,4154,CurrentLiabilities,209718000.0,流動負債合計,樂威科-KY,生技醫療業
2021-03-31,4154,CurrentLiabilities_per,34.06,流動負債合計,樂威科-KY,生技醫療業
2021-03-31,4154,LongtermBorrowings,0.0,長期借款,樂威科-KY,生技醫療業
2021-03-31,4154,LongtermBorrowings_per,0.0,長期借款,樂威科-KY,生技醫療業
2021-03-31,4154,OtherNoncurrentLiabilities,0.0,其他非流動負債,樂威科-KY,生技醫療業
2021-03-31,4154,OtherNoncurrentLiabilities_per,0.0,其他非流動負債,樂威科-KY,生技醫療業
2021-03-31,4154,NoncurrentLiabilities,24465000.0,非流動負債合計,樂威科-KY,生技醫療業
2021-03-31,4154,NoncurrentLiabilities_per,3.97,非流動負債合計,樂威科-KY,生技醫療業
2021-03-31,4154,OrdinaryShare,303155000.0,普通股股本,樂威科-KY,生技醫療業
2021-03-31,4154,OrdinaryShare_per,49.24,普通股股本,樂威科-KY,生技醫療業
2021-03-31,4154,CapitalStock,303155000.0,股本合計,樂威科-KY,生技醫療業
2021-03-31,4154,CapitalStock_per,49.24,股本合計,樂威科-KY,生技醫療業
2021-03-31,4154,CapitalSurplus,76998000.0,資本公積合計,樂威科-KY,生技醫療業
2021-03-31,4154,CapitalSurplus_per,12.51,資本公積合計,樂威科-KY,生技醫療業
2021-03-31,4154,EquityAttributableToOwnersOfParent,286936000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2021-03-31,4154,EquityAttributableToOwnersOfParent_per,46.6,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2021-03-31,4154,NoncontrollingInterests,94572000.0,非控制權益,樂威科-KY,生技醫療業
2021-03-31,4154,NoncontrollingInterests_per,15.36,非控制權益,樂威科-KY,生技醫療業
2021-03-31,4154,TotalLiabilitiesEquity,615691000.0,負債及權益總計,樂威科-KY,生技醫療業
2021-03-31,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2021-03-31,4154,CurrentIncomeTaxAssets,3389000.0,本期所得稅資產,樂威科-KY,生技醫療業
2021-03-31,4154,CurrentIncomeTaxAssets_per,0.55,本期所得稅資產,樂威科-KY,生技醫療業
2021-03-31,4154,DeferredTaxAssets,0.0,遞延所得稅資產,樂威科-KY,生技醫療業
2021-03-31,4154,DeferredTaxAssets_per,0.0,遞延所得稅資產,樂威科-KY,生技醫療業
2021-03-31,4154,FinancialAssetsAtAmortizedCost,6103000.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2021-03-31,4154,FinancialAssetsAtAmortizedCost_per,0.99,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2021-03-31,4154,BillsReceivableNet,0.0,應收票據淨額,樂威科-KY,生技醫療業
2021-03-31,4154,BillsReceivableNet_per,0.0,應收票據淨額,樂威科-KY,生技醫療業
2021-03-31,4154,FinancialAssetsAtAmortizedCostNonCurrent,2836000.0,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2021-03-31,4154,FinancialAssetsAtAmortizedCostNonCurrent_per,0.46,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2021-03-31,4154,RightOfUseAsset,36729000.0,使用權資產,樂威科-KY,生技醫療業
2021-03-31,4154,RightOfUseAsset_per,5.97,使用權資產,樂威科-KY,生技醫療業
2021-03-31,4154,CurrentTaxLiabilities,207000.0,本期所得稅負債,樂威科-KY,生技醫療業
2021-03-31,4154,CurrentTaxLiabilities_per,0.03,本期所得稅負債,樂威科-KY,生技醫療業
2021-03-31,4154,Liabilities,234183000.0,負債總額,樂威科-KY,生技醫療業
2021-03-31,4154,Liabilities_per,38.04,負債總額,樂威科-KY,生技醫療業
2021-03-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-51546000.0,未分配盈餘,樂威科-KY,生技醫療業
2021-03-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-8.37,未分配盈餘,樂威科-KY,生技醫療業
2021-03-31,4154,RetainedEarnings,-51546000.0,保留盈餘合計,樂威科-KY,生技醫療業
2021-03-31,4154,RetainedEarnings_per,-8.37,保留盈餘合計,樂威科-KY,生技醫療業
2021-03-31,4154,OtherEquityInterest,-41671000.0,其他權益合計,樂威科-KY,生技醫療業
2021-03-31,4154,OtherEquityInterest_per,-6.77,其他權益合計,樂威科-KY,生技醫療業
2021-03-31,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2021-03-31,4154,Equity,381508000.0,權益總額,樂威科-KY,生技醫療業
2021-03-31,4154,Equity_per,61.96,權益總額,樂威科-KY,生技醫療業
2021-06-30,4154,CashAndCashEquivalents,212363000.0,現金及約當現金,樂威科-KY,生技醫療業
2021-06-30,4154,CashAndCashEquivalents_per,33.35,現金及約當現金,樂威科-KY,生技醫療業
2021-06-30,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2021-06-30,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2021-06-30,4154,AccountsReceivableNet,10005000.0,應收帳款淨額,樂威科-KY,生技醫療業
2021-06-30,4154,AccountsReceivableNet_per,1.57,應收帳款淨額,樂威科-KY,生技醫療業
2021-06-30,4154,AccountsReceivableDuefromRelatedPartiesNet,97938000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2021-06-30,4154,AccountsReceivableDuefromRelatedPartiesNet_per,15.38,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2021-06-30,4154,Inventories,44713000.0,存貨,樂威科-KY,生技醫療業
2021-06-30,4154,Inventories_per,7.02,存貨,樂威科-KY,生技醫療業
2021-06-30,4154,OtherCurrentAssets,17008000.0,其他流動資產,樂威科-KY,生技醫療業
2021-06-30,4154,OtherCurrentAssets_per,2.67,其他流動資產,樂威科-KY,生技醫療業
2021-06-30,4154,CurrentAssets,397624000.0,流動資產合計,樂威科-KY,生技醫療業
2021-06-30,4154,CurrentAssets_per,62.44,流動資產合計,樂威科-KY,生技醫療業
2021-06-30,4154,PropertyPlantAndEquipment,115044000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2021-06-30,4154,PropertyPlantAndEquipment_per,18.07,不動產、廠房及設備,樂威科-KY,生技醫療業
2021-06-30,4154,IntangibleAssets,3155000.0,無形資產,樂威科-KY,生技醫療業
2021-06-30,4154,IntangibleAssets_per,0.5,無形資產,樂威科-KY,生技醫療業
2021-06-30,4154,OtherNoncurrentAssets,82066000.0,其他非流動資產,樂威科-KY,生技醫療業
2021-06-30,4154,OtherNoncurrentAssets_per,12.89,其他非流動資產,樂威科-KY,生技醫療業
2021-06-30,4154,NoncurrentAssets,239209000.0,非流動資產合計,樂威科-KY,生技醫療業
2021-06-30,4154,NoncurrentAssets_per,37.56,非流動資產合計,樂威科-KY,生技醫療業
2021-06-30,4154,TotalAssets,636833000.0,資產總額,樂威科-KY,生技醫療業
2021-06-30,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2021-06-30,4154,ShorttermBorrowings,53902000.0,短期借款,樂威科-KY,生技醫療業
2021-06-30,4154,ShorttermBorrowings_per,8.46,短期借款,樂威科-KY,生技醫療業
2021-06-30,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2021-06-30,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2021-06-30,4154,AccountsPayable,26888000.0,應付帳款,樂威科-KY,生技醫療業
2021-06-30,4154,AccountsPayable_per,4.22,應付帳款,樂威科-KY,生技醫療業
2021-06-30,4154,AccountsPayableToRelatedParties,86010000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2021-06-30,4154,AccountsPayableToRelatedParties_per,13.51,應付帳款－關係人,樂威科-KY,生技醫療業
2021-06-30,4154,OtherPayables,24732000.0,其他應付款,樂威科-KY,生技醫療業
2021-06-30,4154,OtherPayables_per,3.88,其他應付款,樂威科-KY,生技醫療業
2021-06-30,4154,OtherCurrentLiabilities,5302000.0,其他流動負債,樂威科-KY,生技醫療業
2021-06-30,4154,OtherCurrentLiabilities_per,0.83,其他流動負債,樂威科-KY,生技醫療業
2021-06-30,4154,CurrentLiabilities,253231000.0,流動負債合計,樂威科-KY,生技醫療業
2021-06-30,4154,CurrentLiabilities_per,39.76,流動負債合計,樂威科-KY,生技醫療業
2021-06-30,4154,LongtermBorrowings,5000000.0,長期借款,樂威科-KY,生技醫療業
2021-06-30,4154,LongtermBorrowings_per,0.79,長期借款,樂威科-KY,生技醫療業
2021-06-30,4154,OtherNoncurrentLiabilities,647000.0,其他非流動負債,樂威科-KY,生技醫療業
2021-06-30,4154,OtherNoncurrentLiabilities_per,0.1,其他非流動負債,樂威科-KY,生技醫療業
2021-06-30,4154,NoncurrentLiabilities,27704000.0,非流動負債合計,樂威科-KY,生技醫療業
2021-06-30,4154,NoncurrentLiabilities_per,4.35,非流動負債合計,樂威科-KY,生技醫療業
2021-06-30,4154,OrdinaryShare,303155000.0,普通股股本,樂威科-KY,生技醫療業
2021-06-30,4154,OrdinaryShare_per,47.6,普通股股本,樂威科-KY,生技醫療業
2021-06-30,4154,CapitalStock,303155000.0,股本合計,樂威科-KY,生技醫療業
2021-06-30,4154,CapitalStock_per,47.6,股本合計,樂威科-KY,生技醫療業
2021-06-30,4154,CapitalSurplus,76665000.0,資本公積合計,樂威科-KY,生技醫療業
2021-06-30,4154,CapitalSurplus_per,12.04,資本公積合計,樂威科-KY,生技醫療業
2021-06-30,4154,EquityAttributableToOwnersOfParent,262806000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2021-06-30,4154,EquityAttributableToOwnersOfParent_per,41.27,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2021-06-30,4154,NoncontrollingInterests,93092000.0,非控制權益,樂威科-KY,生技醫療業
2021-06-30,4154,NoncontrollingInterests_per,14.62,非控制權益,樂威科-KY,生技醫療業
2021-06-30,4154,TotalLiabilitiesEquity,636833000.0,負債及權益總計,樂威科-KY,生技醫療業
2021-06-30,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2021-06-30,4154,CurrentIncomeTaxAssets,4308000.0,本期所得稅資產,樂威科-KY,生技醫療業
2021-06-30,4154,CurrentIncomeTaxAssets_per,0.68,本期所得稅資產,樂威科-KY,生技醫療業
2021-06-30,4154,FinancialAssetsAtAmortizedCost,11289000.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2021-06-30,4154,FinancialAssetsAtAmortizedCost_per,1.77,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2021-06-30,4154,BillsReceivableNet,0.0,應收票據淨額,樂威科-KY,生技醫療業
2021-06-30,4154,BillsReceivableNet_per,0.0,應收票據淨額,樂威科-KY,生技醫療業
2021-06-30,4154,DeferredTaxAssets,0.0,遞延所得稅資產,樂威科-KY,生技醫療業
2021-06-30,4154,DeferredTaxAssets_per,0.0,遞延所得稅資產,樂威科-KY,生技醫療業
2021-06-30,4154,FinancialAssetsAtAmortizedCostNonCurrent,5905000.0,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2021-06-30,4154,FinancialAssetsAtAmortizedCostNonCurrent_per,0.93,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2021-06-30,4154,RightOfUseAsset,33039000.0,使用權資產,樂威科-KY,生技醫療業
2021-06-30,4154,RightOfUseAsset_per,5.19,使用權資產,樂威科-KY,生技醫療業
2021-06-30,4154,CurrentTaxLiabilities,449000.0,本期所得稅負債,樂威科-KY,生技醫療業
2021-06-30,4154,CurrentTaxLiabilities_per,0.07,本期所得稅負債,樂威科-KY,生技醫療業
2021-06-30,4154,Liabilities,280935000.0,負債總額,樂威科-KY,生技醫療業
2021-06-30,4154,Liabilities_per,44.11,負債總額,樂威科-KY,生技醫療業
2021-06-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-67245000.0,未分配盈餘,樂威科-KY,生技醫療業
2021-06-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-10.56,未分配盈餘,樂威科-KY,生技醫療業
2021-06-30,4154,RetainedEarnings,-67245000.0,保留盈餘合計,樂威科-KY,生技醫療業
2021-06-30,4154,RetainedEarnings_per,-10.56,保留盈餘合計,樂威科-KY,生技醫療業
2021-06-30,4154,OtherEquityInterest,-49769000.0,其他權益合計,樂威科-KY,生技醫療業
2021-06-30,4154,OtherEquityInterest_per,-7.82,其他權益合計,樂威科-KY,生技醫療業
2021-06-30,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2021-06-30,4154,Equity,355898000.0,權益總額,樂威科-KY,生技醫療業
2021-06-30,4154,Equity_per,55.89,權益總額,樂威科-KY,生技醫療業
2021-09-30,4154,CashAndCashEquivalents,203763000.0,現金及約當現金,樂威科-KY,生技醫療業
2021-09-30,4154,CashAndCashEquivalents_per,27.23,現金及約當現金,樂威科-KY,生技醫療業
2021-09-30,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2021-09-30,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2021-09-30,4154,AccountsReceivableNet,23429000.0,應收帳款淨額,樂威科-KY,生技醫療業
2021-09-30,4154,AccountsReceivableNet_per,3.13,應收帳款淨額,樂威科-KY,生技醫療業
2021-09-30,4154,AccountsReceivableDuefromRelatedPartiesNet,99810000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2021-09-30,4154,AccountsReceivableDuefromRelatedPartiesNet_per,13.34,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2021-09-30,4154,Inventories,74735000.0,存貨,樂威科-KY,生技醫療業
2021-09-30,4154,Inventories_per,9.99,存貨,樂威科-KY,生技醫療業
2021-09-30,4154,OtherCurrentAssets,19524000.0,其他流動資產,樂威科-KY,生技醫療業
2021-09-30,4154,OtherCurrentAssets_per,2.61,其他流動資產,樂威科-KY,生技醫療業
2021-09-30,4154,CurrentAssets,437232000.0,流動資產合計,樂威科-KY,生技醫療業
2021-09-30,4154,CurrentAssets_per,58.42,流動資產合計,樂威科-KY,生技醫療業
2021-09-30,4154,PropertyPlantAndEquipment,265438000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2021-09-30,4154,PropertyPlantAndEquipment_per,35.47,不動產、廠房及設備,樂威科-KY,生技醫療業
2021-09-30,4154,IntangibleAssets,4637000.0,無形資產,樂威科-KY,生技醫療業
2021-09-30,4154,IntangibleAssets_per,0.62,無形資產,樂威科-KY,生技醫療業
2021-09-30,4154,OtherNoncurrentAssets,2242000.0,其他非流動資產,樂威科-KY,生技醫療業
2021-09-30,4154,OtherNoncurrentAssets_per,0.3,其他非流動資產,樂威科-KY,生技醫療業
2021-09-30,4154,NoncurrentAssets,311147000.0,非流動資產合計,樂威科-KY,生技醫療業
2021-09-30,4154,NoncurrentAssets_per,41.58,非流動資產合計,樂威科-KY,生技醫療業
2021-09-30,4154,TotalAssets,748379000.0,資產總額,樂威科-KY,生技醫療業
2021-09-30,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2021-09-30,4154,ShorttermBorrowings,52552000.0,短期借款,樂威科-KY,生技醫療業
2021-09-30,4154,ShorttermBorrowings_per,7.02,短期借款,樂威科-KY,生技醫療業
2021-09-30,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2021-09-30,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2021-09-30,4154,AccountsPayable,32436000.0,應付帳款,樂威科-KY,生技醫療業
2021-09-30,4154,AccountsPayable_per,4.33,應付帳款,樂威科-KY,生技醫療業
2021-09-30,4154,AccountsPayableToRelatedParties,155371000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2021-09-30,4154,AccountsPayableToRelatedParties_per,20.76,應付帳款－關係人,樂威科-KY,生技醫療業
2021-09-30,4154,OtherPayables,20526000.0,其他應付款,樂威科-KY,生技醫療業
2021-09-30,4154,OtherPayables_per,2.74,其他應付款,樂威科-KY,生技醫療業
2021-09-30,4154,OtherCurrentLiabilities,21210000.0,其他流動負債,樂威科-KY,生技醫療業
2021-09-30,4154,OtherCurrentLiabilities_per,2.83,其他流動負債,樂威科-KY,生技醫療業
2021-09-30,4154,CurrentLiabilities,307839000.0,流動負債合計,樂威科-KY,生技醫療業
2021-09-30,4154,CurrentLiabilities_per,41.13,流動負債合計,樂威科-KY,生技醫療業
2021-09-30,4154,LongtermBorrowings,9167000.0,長期借款,樂威科-KY,生技醫療業
2021-09-30,4154,LongtermBorrowings_per,1.22,長期借款,樂威科-KY,生技醫療業
2021-09-30,4154,OtherNoncurrentLiabilities,0.0,其他非流動負債,樂威科-KY,生技醫療業
2021-09-30,4154,OtherNoncurrentLiabilities_per,0.0,其他非流動負債,樂威科-KY,生技醫療業
2021-09-30,4154,NoncurrentLiabilities,27863000.0,非流動負債合計,樂威科-KY,生技醫療業
2021-09-30,4154,NoncurrentLiabilities_per,3.72,非流動負債合計,樂威科-KY,生技醫療業
2021-09-30,4154,OrdinaryShare,357200000.0,普通股股本,樂威科-KY,生技醫療業
2021-09-30,4154,OrdinaryShare_per,47.73,普通股股本,樂威科-KY,生技醫療業
2021-09-30,4154,CapitalStock,357200000.0,股本合計,樂威科-KY,生技醫療業
2021-09-30,4154,CapitalStock_per,47.73,股本合計,樂威科-KY,生技醫療業
2021-09-30,4154,CapitalSurplus,133952000.0,資本公積合計,樂威科-KY,生技醫療業
2021-09-30,4154,CapitalSurplus_per,17.9,資本公積合計,樂威科-KY,生技醫療業
2021-09-30,4154,EquityAttributableToOwnersOfParent,339120000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2021-09-30,4154,EquityAttributableToOwnersOfParent_per,45.31,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2021-09-30,4154,NoncontrollingInterests,73557000.0,非控制權益,樂威科-KY,生技醫療業
2021-09-30,4154,NoncontrollingInterests_per,9.83,非控制權益,樂威科-KY,生技醫療業
2021-09-30,4154,TotalLiabilitiesEquity,748379000.0,負債及權益總計,樂威科-KY,生技醫療業
2021-09-30,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2021-09-30,4154,CurrentIncomeTaxAssets,4752000.0,本期所得稅資產,樂威科-KY,生技醫療業
2021-09-30,4154,CurrentIncomeTaxAssets_per,0.63,本期所得稅資產,樂威科-KY,生技醫療業
2021-09-30,4154,FinancialAssetsAtAmortizedCost,11219000.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2021-09-30,4154,FinancialAssetsAtAmortizedCost_per,1.5,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2021-09-30,4154,BillsReceivableNet,0.0,應收票據淨額,樂威科-KY,生技醫療業
2021-09-30,4154,BillsReceivableNet_per,0.0,應收票據淨額,樂威科-KY,生技醫療業
2021-09-30,4154,DeferredTaxAssets,0.0,遞延所得稅資產,樂威科-KY,生技醫療業
2021-09-30,4154,DeferredTaxAssets_per,0.0,遞延所得稅資產,樂威科-KY,生技醫療業
2021-09-30,4154,FinancialAssetsAtAmortizedCostNonCurrent,11972000.0,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2021-09-30,4154,FinancialAssetsAtAmortizedCostNonCurrent_per,1.6,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2021-09-30,4154,RightOfUseAsset,26858000.0,使用權資產,樂威科-KY,生技醫療業
2021-09-30,4154,RightOfUseAsset_per,3.59,使用權資產,樂威科-KY,生技醫療業
2021-09-30,4154,CurrentTaxLiabilities,596000.0,本期所得稅負債,樂威科-KY,生技醫療業
2021-09-30,4154,CurrentTaxLiabilities_per,0.08,本期所得稅負債,樂威科-KY,生技醫療業
2021-09-30,4154,Liabilities,335702000.0,負債總額,樂威科-KY,生技醫療業
2021-09-30,4154,Liabilities_per,44.86,負債總額,樂威科-KY,生技醫療業
2021-09-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-90848000.0,未分配盈餘,樂威科-KY,生技醫療業
2021-09-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-12.14,未分配盈餘,樂威科-KY,生技醫療業
2021-09-30,4154,RetainedEarnings,-90848000.0,保留盈餘合計,樂威科-KY,生技醫療業
2021-09-30,4154,RetainedEarnings_per,-12.14,保留盈餘合計,樂威科-KY,生技醫療業
2021-09-30,4154,OtherEquityInterest,-61184000.0,其他權益合計,樂威科-KY,生技醫療業
2021-09-30,4154,OtherEquityInterest_per,-8.18,其他權益合計,樂威科-KY,生技醫療業
2021-09-30,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2021-09-30,4154,Equity,412677000.0,權益總額,樂威科-KY,生技醫療業
2021-09-30,4154,Equity_per,55.14,權益總額,樂威科-KY,生技醫療業
2021-12-31,4154,CashAndCashEquivalents,198544000.0,現金及約當現金,樂威科-KY,生技醫療業
2021-12-31,4154,CashAndCashEquivalents_per,29.32,現金及約當現金,樂威科-KY,生技醫療業
2021-12-31,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2021-12-31,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2021-12-31,4154,AccountsReceivableNet,12849000.0,應收帳款淨額,樂威科-KY,生技醫療業
2021-12-31,4154,AccountsReceivableNet_per,1.9,應收帳款淨額,樂威科-KY,生技醫療業
2021-12-31,4154,AccountsReceivableDuefromRelatedPartiesNet,50800000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2021-12-31,4154,AccountsReceivableDuefromRelatedPartiesNet_per,7.5,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2021-12-31,4154,Inventories,65220000.0,存貨,樂威科-KY,生技醫療業
2021-12-31,4154,Inventories_per,9.63,存貨,樂威科-KY,生技醫療業
2021-12-31,4154,OtherCurrentAssets,18025000.0,其他流動資產,樂威科-KY,生技醫療業
2021-12-31,4154,OtherCurrentAssets_per,2.66,其他流動資產,樂威科-KY,生技醫療業
2021-12-31,4154,CurrentAssets,364376000.0,流動資產合計,樂威科-KY,生技醫療業
2021-12-31,4154,CurrentAssets_per,53.8,流動資產合計,樂威科-KY,生技醫療業
2021-12-31,4154,PropertyPlantAndEquipment,268893000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2021-12-31,4154,PropertyPlantAndEquipment_per,39.7,不動產、廠房及設備,樂威科-KY,生技醫療業
2021-12-31,4154,IntangibleAssets,3625000.0,無形資產,樂威科-KY,生技醫療業
2021-12-31,4154,IntangibleAssets_per,0.54,無形資產,樂威科-KY,生技醫療業
2021-12-31,4154,DeferredTaxAssets,343000.0,遞延所得稅資產,樂威科-KY,生技醫療業
2021-12-31,4154,DeferredTaxAssets_per,0.05,遞延所得稅資產,樂威科-KY,生技醫療業
2021-12-31,4154,OtherNoncurrentAssets,14165000.0,其他非流動資產,樂威科-KY,生技醫療業
2021-12-31,4154,OtherNoncurrentAssets_per,2.09,其他非流動資產,樂威科-KY,生技醫療業
2021-12-31,4154,NoncurrentAssets,312901000.0,非流動資產合計,樂威科-KY,生技醫療業
2021-12-31,4154,NoncurrentAssets_per,46.2,非流動資產合計,樂威科-KY,生技醫療業
2021-12-31,4154,TotalAssets,677277000.0,資產總額,樂威科-KY,生技醫療業
2021-12-31,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2021-12-31,4154,ShorttermBorrowings,39682000.0,短期借款,樂威科-KY,生技醫療業
2021-12-31,4154,ShorttermBorrowings_per,5.86,短期借款,樂威科-KY,生技醫療業
2021-12-31,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2021-12-31,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2021-12-31,4154,AccountsPayable,8533000.0,應付帳款,樂威科-KY,生技醫療業
2021-12-31,4154,AccountsPayable_per,1.26,應付帳款,樂威科-KY,生技醫療業
2021-12-31,4154,AccountsPayableToRelatedParties,150792000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2021-12-31,4154,AccountsPayableToRelatedParties_per,22.26,應付帳款－關係人,樂威科-KY,生技醫療業
2021-12-31,4154,OtherPayables,29453000.0,其他應付款,樂威科-KY,生技醫療業
2021-12-31,4154,OtherPayables_per,4.35,其他應付款,樂威科-KY,生技醫療業
2021-12-31,4154,OtherCurrentLiabilities,28508000.0,其他流動負債,樂威科-KY,生技醫療業
2021-12-31,4154,OtherCurrentLiabilities_per,4.21,其他流動負債,樂威科-KY,生技醫療業
2021-12-31,4154,CurrentLiabilities,263491000.0,流動負債合計,樂威科-KY,生技醫療業
2021-12-31,4154,CurrentLiabilities_per,38.9,流動負債合計,樂威科-KY,生技醫療業
2021-12-31,4154,LongtermBorrowings,1667000.0,長期借款,樂威科-KY,生技醫療業
2021-12-31,4154,LongtermBorrowings_per,0.25,長期借款,樂威科-KY,生技醫療業
2021-12-31,4154,OtherNoncurrentLiabilities,0.0,其他非流動負債,樂威科-KY,生技醫療業
2021-12-31,4154,OtherNoncurrentLiabilities_per,0.0,其他非流動負債,樂威科-KY,生技醫療業
2021-12-31,4154,NoncurrentLiabilities,16029000.0,非流動負債合計,樂威科-KY,生技醫療業
2021-12-31,4154,NoncurrentLiabilities_per,2.37,非流動負債合計,樂威科-KY,生技醫療業
2021-12-31,4154,OrdinaryShare,357200000.0,普通股股本,樂威科-KY,生技醫療業
2021-12-31,4154,OrdinaryShare_per,52.74,普通股股本,樂威科-KY,生技醫療業
2021-12-31,4154,CapitalStock,357200000.0,股本合計,樂威科-KY,生技醫療業
2021-12-31,4154,CapitalStock_per,52.74,股本合計,樂威科-KY,生技醫療業
2021-12-31,4154,CapitalSurplus,133952000.0,資本公積合計,樂威科-KY,生技醫療業
2021-12-31,4154,CapitalSurplus_per,19.78,資本公積合計,樂威科-KY,生技醫療業
2021-12-31,4154,EquityAttributableToOwnersOfParent,331341000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2021-12-31,4154,EquityAttributableToOwnersOfParent_per,48.92,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2021-12-31,4154,NoncontrollingInterests,66416000.0,非控制權益,樂威科-KY,生技醫療業
2021-12-31,4154,NoncontrollingInterests_per,9.81,非控制權益,樂威科-KY,生技醫療業
2021-12-31,4154,TotalLiabilitiesEquity,677277000.0,負債及權益總計,樂威科-KY,生技醫療業
2021-12-31,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2021-12-31,4154,CurrentIncomeTaxAssets,4751000.0,本期所得稅資產,樂威科-KY,生技醫療業
2021-12-31,4154,CurrentIncomeTaxAssets_per,0.7,本期所得稅資產,樂威科-KY,生技醫療業
2021-12-31,4154,FinancialAssetsAtAmortizedCost,14187000.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2021-12-31,4154,FinancialAssetsAtAmortizedCost_per,2.09,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2021-12-31,4154,BillsReceivableNet,0.0,應收票據淨額,樂威科-KY,生技醫療業
2021-12-31,4154,BillsReceivableNet_per,0.0,應收票據淨額,樂威科-KY,生技醫療業
2021-12-31,4154,FinancialAssetsAtAmortizedCostNonCurrent,6042000.0,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2021-12-31,4154,FinancialAssetsAtAmortizedCostNonCurrent_per,0.89,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2021-12-31,4154,RightOfUseAsset,19833000.0,使用權資產,樂威科-KY,生技醫療業
2021-12-31,4154,RightOfUseAsset_per,2.93,使用權資產,樂威科-KY,生技醫療業
2021-12-31,4154,CurrentTaxLiabilities,298000.0,本期所得稅負債,樂威科-KY,生技醫療業
2021-12-31,4154,CurrentTaxLiabilities_per,0.04,本期所得稅負債,樂威科-KY,生技醫療業
2021-12-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-101206000.0,未分配盈餘,樂威科-KY,生技醫療業
2021-12-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-14.94,未分配盈餘,樂威科-KY,生技醫療業
2021-12-31,4154,RetainedEarnings,-101206000.0,保留盈餘合計,樂威科-KY,生技醫療業
2021-12-31,4154,RetainedEarnings_per,-14.94,保留盈餘合計,樂威科-KY,生技醫療業
2021-12-31,4154,OtherEquityInterest,-58605000.0,其他權益合計,樂威科-KY,生技醫療業
2021-12-31,4154,OtherEquityInterest_per,-8.65,其他權益合計,樂威科-KY,生技醫療業
2021-12-31,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2021-12-31,4154,Liabilities,279520000.0,負債總額,樂威科-KY,生技醫療業
2021-12-31,4154,Liabilities_per,41.27,負債總額,樂威科-KY,生技醫療業
2021-12-31,4154,Equity,397757000.0,權益總額,樂威科-KY,生技醫療業
2021-12-31,4154,Equity_per,58.73,權益總額,樂威科-KY,生技醫療業
2022-03-31,4154,CashAndCashEquivalents,258200000.0,現金及約當現金,樂威科-KY,生技醫療業
2022-03-31,4154,CashAndCashEquivalents_per,33.8,現金及約當現金,樂威科-KY,生技醫療業
2022-03-31,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2022-03-31,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2022-03-31,4154,FinancialAssetsAtAmortizedCost,20873000.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2022-03-31,4154,FinancialAssetsAtAmortizedCost_per,2.73,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2022-03-31,4154,BillsReceivableNet,0.0,應收票據淨額,樂威科-KY,生技醫療業
2022-03-31,4154,BillsReceivableNet_per,0.0,應收票據淨額,樂威科-KY,生技醫療業
2022-03-31,4154,AccountsReceivableNet,13441000.0,應收帳款淨額,樂威科-KY,生技醫療業
2022-03-31,4154,AccountsReceivableNet_per,1.76,應收帳款淨額,樂威科-KY,生技醫療業
2022-03-31,4154,AccountsReceivableDuefromRelatedPartiesNet,52928000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2022-03-31,4154,AccountsReceivableDuefromRelatedPartiesNet_per,6.93,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2022-03-31,4154,Inventories,61979000.0,存貨,樂威科-KY,生技醫療業
2022-03-31,4154,Inventories_per,8.11,存貨,樂威科-KY,生技醫療業
2022-03-31,4154,OtherCurrentAssets,18500000.0,其他流動資產,樂威科-KY,生技醫療業
2022-03-31,4154,OtherCurrentAssets_per,2.42,其他流動資產,樂威科-KY,生技醫療業
2022-03-31,4154,CurrentAssets,430984000.0,流動資產合計,樂威科-KY,生技醫療業
2022-03-31,4154,CurrentAssets_per,56.41,流動資產合計,樂威科-KY,生技醫療業
2022-03-31,4154,PropertyPlantAndEquipment,289734000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2022-03-31,4154,PropertyPlantAndEquipment_per,37.92,不動產、廠房及設備,樂威科-KY,生技醫療業
2022-03-31,4154,RightOfUseAsset,18279000.0,使用權資產,樂威科-KY,生技醫療業
2022-03-31,4154,RightOfUseAsset_per,2.39,使用權資產,樂威科-KY,生技醫療業
2022-03-31,4154,IntangibleAssets,3334000.0,無形資產,樂威科-KY,生技醫療業
2022-03-31,4154,IntangibleAssets_per,0.44,無形資產,樂威科-KY,生技醫療業
2022-03-31,4154,DeferredTaxAssets,343000.0,遞延所得稅資產,樂威科-KY,生技醫療業
2022-03-31,4154,DeferredTaxAssets_per,0.04,遞延所得稅資產,樂威科-KY,生技醫療業
2022-03-31,4154,OtherNoncurrentAssets,21296000.0,其他非流動資產,樂威科-KY,生技醫療業
2022-03-31,4154,OtherNoncurrentAssets_per,2.79,其他非流動資產,樂威科-KY,生技醫療業
2022-03-31,4154,NoncurrentAssets,332986000.0,非流動資產合計,樂威科-KY,生技醫療業
2022-03-31,4154,NoncurrentAssets_per,43.59,非流動資產合計,樂威科-KY,生技醫療業
2022-03-31,4154,TotalAssets,763970000.0,資產總額,樂威科-KY,生技醫療業
2022-03-31,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2022-03-31,4154,ShorttermBorrowings,131394000.0,短期借款,樂威科-KY,生技醫療業
2022-03-31,4154,ShorttermBorrowings_per,17.2,短期借款,樂威科-KY,生技醫療業
2022-03-31,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2022-03-31,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2022-03-31,4154,AccountsPayable,6692000.0,應付帳款,樂威科-KY,生技醫療業
2022-03-31,4154,AccountsPayable_per,0.88,應付帳款,樂威科-KY,生技醫療業
2022-03-31,4154,AccountsPayableToRelatedParties,156986000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2022-03-31,4154,AccountsPayableToRelatedParties_per,20.55,應付帳款－關係人,樂威科-KY,生技醫療業
2022-03-31,4154,OtherPayables_per,3.43,其他應付款,樂威科-KY,生技醫療業
2022-03-31,4154,CurrentTaxLiabilities,2122000.0,本期所得稅負債,樂威科-KY,生技醫療業
2022-03-31,4154,CurrentTaxLiabilities_per,0.28,本期所得稅負債,樂威科-KY,生技醫療業
2022-03-31,4154,OtherCurrentLiabilities,24413000.0,其他流動負債,樂威科-KY,生技醫療業
2022-03-31,4154,OtherCurrentLiabilities_per,3.2,其他流動負債,樂威科-KY,生技醫療業
2022-03-31,4154,CurrentLiabilities,354264000.0,流動負債合計,樂威科-KY,生技醫療業
2022-03-31,4154,CurrentLiabilities_per,46.37,流動負債合計,樂威科-KY,生技醫療業
2022-03-31,4154,LongtermBorrowings,0.0,長期借款,樂威科-KY,生技醫療業
2022-03-31,4154,LongtermBorrowings_per,0.0,長期借款,樂威科-KY,生技醫療業
2022-03-31,4154,OtherNoncurrentLiabilities,0.0,其他非流動負債,樂威科-KY,生技醫療業
2022-03-31,4154,OtherNoncurrentLiabilities_per,0.0,其他非流動負債,樂威科-KY,生技醫療業
2022-03-31,4154,NoncurrentLiabilities,12777000.0,非流動負債合計,樂威科-KY,生技醫療業
2022-03-31,4154,NoncurrentLiabilities_per,1.67,非流動負債合計,樂威科-KY,生技醫療業
2022-03-31,4154,OrdinaryShare,357200000.0,普通股股本,樂威科-KY,生技醫療業
2022-03-31,4154,OrdinaryShare_per,46.76,普通股股本,樂威科-KY,生技醫療業
2022-03-31,4154,CapitalStock,357200000.0,股本合計,樂威科-KY,生技醫療業
2022-03-31,4154,CapitalStock_per,46.76,股本合計,樂威科-KY,生技醫療業
2022-03-31,4154,CapitalSurplus,134385000.0,資本公積合計,樂威科-KY,生技醫療業
2022-03-31,4154,CapitalSurplus_per,17.59,資本公積合計,樂威科-KY,生技醫療業
2022-03-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-105130000.0,未分配盈餘,樂威科-KY,生技醫療業
2022-03-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-13.76,未分配盈餘,樂威科-KY,生技醫療業
2022-03-31,4154,RetainedEarnings,-105130000.0,保留盈餘合計,樂威科-KY,生技醫療業
2022-03-31,4154,RetainedEarnings_per,-13.76,保留盈餘合計,樂威科-KY,生技醫療業
2022-03-31,4154,OtherEquityInterest,-43968000.0,其他權益合計,樂威科-KY,生技醫療業
2022-03-31,4154,OtherEquityInterest_per,-5.76,其他權益合計,樂威科-KY,生技醫療業
2022-03-31,4154,EquityAttributableToOwnersOfParent,342487000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2022-03-31,4154,EquityAttributableToOwnersOfParent_per,44.83,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2022-03-31,4154,NoncontrollingInterests,54442000.0,非控制權益,樂威科-KY,生技醫療業
2022-03-31,4154,NoncontrollingInterests_per,7.13,非控制權益,樂威科-KY,生技醫療業
2022-03-31,4154,TotalLiabilitiesEquity,763970000.0,負債及權益總計,樂威科-KY,生技醫療業
2022-03-31,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2022-03-31,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2022-03-31,4154,CurrentIncomeTaxAssets,5063000.0,本期所得稅資產,樂威科-KY,生技醫療業
2022-03-31,4154,CurrentIncomeTaxAssets_per,0.66,本期所得稅資產,樂威科-KY,生技醫療業
2022-03-31,4154,FinancialAssetsAtAmortizedCostNonCurrent,0.0,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2022-03-31,4154,FinancialAssetsAtAmortizedCostNonCurrent_per,0.0,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2022-03-31,4154,Equity,396929000.0,權益總額,樂威科-KY,生技醫療業
2022-03-31,4154,Equity_per,51.96,權益總額,樂威科-KY,生技醫療業
2022-03-31,4154,Liabilities,367041000.0,負債總額,樂威科-KY,生技醫療業
2022-03-31,4154,Liabilities_per,48.04,負債總額,樂威科-KY,生技醫療業
2022-03-31,4154,OtherPayables,26209000.0,其他應付款,樂威科-KY,生技醫療業
2022-06-30,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2022-06-30,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2022-06-30,4154,BillsReceivableNet,0.0,應收票據淨額,樂威科-KY,生技醫療業
2022-06-30,4154,BillsReceivableNet_per,0.0,應收票據淨額,樂威科-KY,生技醫療業
2022-06-30,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2022-06-30,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2022-06-30,4154,LongtermBorrowings,0.0,長期借款,樂威科-KY,生技醫療業
2022-06-30,4154,LongtermBorrowings_per,0.0,長期借款,樂威科-KY,生技醫療業
2022-06-30,4154,OtherNoncurrentLiabilities,0.0,其他非流動負債,樂威科-KY,生技醫療業
2022-06-30,4154,OtherNoncurrentLiabilities_per,0.0,其他非流動負債,樂威科-KY,生技醫療業
2022-06-30,4154,CashAndCashEquivalents,275847000.0,現金及約當現金,樂威科-KY,生技醫療業
2022-06-30,4154,CashAndCashEquivalents_per,32.34,現金及約當現金,樂威科-KY,生技醫療業
2022-06-30,4154,FinancialAssetsAtAmortizedCost,29211000.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2022-06-30,4154,FinancialAssetsAtAmortizedCost_per,3.42,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2022-06-30,4154,AccountsReceivableNet,22301000.0,應收帳款淨額,樂威科-KY,生技醫療業
2022-06-30,4154,AccountsReceivableNet_per,2.61,應收帳款淨額,樂威科-KY,生技醫療業
2022-06-30,4154,AccountsReceivableDuefromRelatedPartiesNet,60967000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2022-06-30,4154,AccountsReceivableDuefromRelatedPartiesNet_per,7.15,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2022-06-30,4154,Inventories,89603000.0,存貨,樂威科-KY,生技醫療業
2022-06-30,4154,Inventories_per,10.5,存貨,樂威科-KY,生技醫療業
2022-06-30,4154,OtherCurrentAssets,25927000.0,其他流動資產,樂威科-KY,生技醫療業
2022-06-30,4154,OtherCurrentAssets_per,3.04,其他流動資產,樂威科-KY,生技醫療業
2022-06-30,4154,CurrentAssets,509058000.0,流動資產合計,樂威科-KY,生技醫療業
2022-06-30,4154,CurrentAssets_per,59.68,流動資產合計,樂威科-KY,生技醫療業
2022-06-30,4154,PropertyPlantAndEquipment,309870000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2022-06-30,4154,PropertyPlantAndEquipment_per,36.33,不動產、廠房及設備,樂威科-KY,生技醫療業
2022-06-30,4154,RightOfUseAsset,16725000.0,使用權資產,樂威科-KY,生技醫療業
2022-06-30,4154,RightOfUseAsset_per,1.96,使用權資產,樂威科-KY,生技醫療業
2022-06-30,4154,IntangibleAssets,3460000.0,無形資產,樂威科-KY,生技醫療業
2022-06-30,4154,IntangibleAssets_per,0.41,無形資產,樂威科-KY,生技醫療業
2022-06-30,4154,DeferredTaxAssets,501000.0,遞延所得稅資產,樂威科-KY,生技醫療業
2022-06-30,4154,DeferredTaxAssets_per,0.06,遞延所得稅資產,樂威科-KY,生技醫療業
2022-06-30,4154,OtherNoncurrentAssets,13425000.0,其他非流動資產,樂威科-KY,生技醫療業
2022-06-30,4154,OtherNoncurrentAssets_per,1.57,其他非流動資產,樂威科-KY,生技醫療業
2022-06-30,4154,NoncurrentAssets,343981000.0,非流動資產合計,樂威科-KY,生技醫療業
2022-06-30,4154,NoncurrentAssets_per,40.32,非流動資產合計,樂威科-KY,生技醫療業
2022-06-30,4154,TotalAssets,853039000.0,資產總額,樂威科-KY,生技醫療業
2022-06-30,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2022-06-30,4154,ShorttermBorrowings,191021000.0,短期借款,樂威科-KY,生技醫療業
2022-06-30,4154,ShorttermBorrowings_per,22.39,短期借款,樂威科-KY,生技醫療業
2022-06-30,4154,AccountsPayable,6152000.0,應付帳款,樂威科-KY,生技醫療業
2022-06-30,4154,AccountsPayable_per,0.72,應付帳款,樂威科-KY,生技醫療業
2022-06-30,4154,AccountsPayableToRelatedParties,200722000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2022-06-30,4154,AccountsPayableToRelatedParties_per,23.53,應付帳款－關係人,樂威科-KY,生技醫療業
2022-06-30,4154,OtherPayables,26003000.0,其他應付款,樂威科-KY,生技醫療業
2022-06-30,4154,OtherPayables_per,3.05,其他應付款,樂威科-KY,生技醫療業
2022-06-30,4154,CurrentTaxLiabilities,1173000.0,本期所得稅負債,樂威科-KY,生技醫療業
2022-06-30,4154,CurrentTaxLiabilities_per,0.14,本期所得稅負債,樂威科-KY,生技醫療業
2022-06-30,4154,OtherCurrentLiabilities,17040000.0,其他流動負債,樂威科-KY,生技醫療業
2022-06-30,4154,OtherCurrentLiabilities_per,2.0,其他流動負債,樂威科-KY,生技醫療業
2022-06-30,4154,CurrentLiabilities,448427000.0,流動負債合計,樂威科-KY,生技醫療業
2022-06-30,4154,CurrentLiabilities_per,52.57,流動負債合計,樂威科-KY,生技醫療業
2022-06-30,4154,NoncurrentLiabilities,11153000.0,非流動負債合計,樂威科-KY,生技醫療業
2022-06-30,4154,NoncurrentLiabilities_per,1.31,非流動負債合計,樂威科-KY,生技醫療業
2022-06-30,4154,OrdinaryShare,357200000.0,普通股股本,樂威科-KY,生技醫療業
2022-06-30,4154,OrdinaryShare_per,41.87,普通股股本,樂威科-KY,生技醫療業
2022-06-30,4154,CapitalStock,357200000.0,股本合計,樂威科-KY,生技醫療業
2022-06-30,4154,CapitalStock_per,41.87,股本合計,樂威科-KY,生技醫療業
2022-06-30,4154,CapitalSurplus,33179000.0,資本公積合計,樂威科-KY,生技醫療業
2022-06-30,4154,CapitalSurplus_per,3.89,資本公積合計,樂威科-KY,生技醫療業
2022-06-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-2952000.0,未分配盈餘,樂威科-KY,生技醫療業
2022-06-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-0.35,未分配盈餘,樂威科-KY,生技醫療業
2022-06-30,4154,RetainedEarnings,-2952000.0,保留盈餘合計,樂威科-KY,生技醫療業
2022-06-30,4154,RetainedEarnings_per,-0.35,保留盈餘合計,樂威科-KY,生技醫療業
2022-06-30,4154,OtherEquityInterest,-48374000.0,其他權益合計,樂威科-KY,生技醫療業
2022-06-30,4154,OtherEquityInterest_per,-5.67,其他權益合計,樂威科-KY,生技醫療業
2022-06-30,4154,EquityAttributableToOwnersOfParent,339053000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2022-06-30,4154,EquityAttributableToOwnersOfParent_per,39.75,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2022-06-30,4154,NoncontrollingInterests,54406000.0,非控制權益,樂威科-KY,生技醫療業
2022-06-30,4154,NoncontrollingInterests_per,6.38,非控制權益,樂威科-KY,生技醫療業
2022-06-30,4154,TotalLiabilitiesEquity,853039000.0,負債及權益總計,樂威科-KY,生技醫療業
2022-06-30,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2022-06-30,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2022-06-30,4154,CurrentIncomeTaxAssets,5202000.0,本期所得稅資產,樂威科-KY,生技醫療業
2022-06-30,4154,CurrentIncomeTaxAssets_per,0.61,本期所得稅資產,樂威科-KY,生技醫療業
2022-06-30,4154,FinancialAssetsAtAmortizedCostNonCurrent,0.0,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2022-06-30,4154,FinancialAssetsAtAmortizedCostNonCurrent_per,0.0,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2022-06-30,4154,Liabilities,459580000.0,負債總額,樂威科-KY,生技醫療業
2022-06-30,4154,Liabilities_per,53.88,負債總額,樂威科-KY,生技醫療業
2022-06-30,4154,Equity,393459000.0,權益總額,樂威科-KY,生技醫療業
2022-06-30,4154,Equity_per,46.12,權益總額,樂威科-KY,生技醫療業
2022-09-30,4154,CashAndCashEquivalents,242639000.0,現金及約當現金,樂威科-KY,生技醫療業
2022-09-30,4154,CashAndCashEquivalents_per,29.13,現金及約當現金,樂威科-KY,生技醫療業
2022-09-30,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2022-09-30,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2022-09-30,4154,FinancialAssetsAtAmortizedCost,30528000.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2022-09-30,4154,FinancialAssetsAtAmortizedCost_per,3.67,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2022-09-30,4154,BillsReceivableNet,0.0,應收票據淨額,樂威科-KY,生技醫療業
2022-09-30,4154,BillsReceivableNet_per,0.0,應收票據淨額,樂威科-KY,生技醫療業
2022-09-30,4154,AccountsReceivableNet,14811000.0,應收帳款淨額,樂威科-KY,生技醫療業
2022-09-30,4154,AccountsReceivableNet_per,1.78,應收帳款淨額,樂威科-KY,生技醫療業
2022-09-30,4154,AccountsReceivableDuefromRelatedPartiesNet,64793000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2022-09-30,4154,AccountsReceivableDuefromRelatedPartiesNet_per,7.78,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2022-09-30,4154,Inventories,106332000.0,存貨,樂威科-KY,生技醫療業
2022-09-30,4154,Inventories_per,12.77,存貨,樂威科-KY,生技醫療業
2022-09-30,4154,OtherCurrentAssets,20110000.0,其他流動資產,樂威科-KY,生技醫療業
2022-09-30,4154,OtherCurrentAssets_per,2.41,其他流動資產,樂威科-KY,生技醫療業
2022-09-30,4154,CurrentAssets,484496000.0,流動資產合計,樂威科-KY,生技醫療業
2022-09-30,4154,CurrentAssets_per,58.17,流動資產合計,樂威科-KY,生技醫療業
2022-09-30,4154,PropertyPlantAndEquipment,317987000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2022-09-30,4154,PropertyPlantAndEquipment_per,38.18,不動產、廠房及設備,樂威科-KY,生技醫療業
2022-09-30,4154,IntangibleAssets,3896000.0,無形資產,樂威科-KY,生技醫療業
2022-09-30,4154,IntangibleAssets_per,0.47,無形資產,樂威科-KY,生技醫療業
2022-09-30,4154,DeferredTaxAssets,501000.0,遞延所得稅資產,樂威科-KY,生技醫療業
2022-09-30,4154,DeferredTaxAssets_per,0.06,遞延所得稅資產,樂威科-KY,生技醫療業
2022-09-30,4154,OtherNoncurrentAssets,10851000.0,其他非流動資產,樂威科-KY,生技醫療業
2022-09-30,4154,OtherNoncurrentAssets_per,1.3,其他非流動資產,樂威科-KY,生技醫療業
2022-09-30,4154,NoncurrentAssets,348407000.0,非流動資產合計,樂威科-KY,生技醫療業
2022-09-30,4154,NoncurrentAssets_per,41.83,非流動資產合計,樂威科-KY,生技醫療業
2022-09-30,4154,TotalAssets,832903000.0,資產總額,樂威科-KY,生技醫療業
2022-09-30,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2022-09-30,4154,ShorttermBorrowings,178221000.0,短期借款,樂威科-KY,生技醫療業
2022-09-30,4154,ShorttermBorrowings_per,21.4,短期借款,樂威科-KY,生技醫療業
2022-09-30,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2022-09-30,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2022-09-30,4154,AccountsPayable,2738000.0,應付帳款,樂威科-KY,生技醫療業
2022-09-30,4154,AccountsPayable_per,0.33,應付帳款,樂威科-KY,生技醫療業
2022-09-30,4154,AccountsPayableToRelatedParties,227569000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2022-09-30,4154,AccountsPayableToRelatedParties_per,27.32,應付帳款－關係人,樂威科-KY,生技醫療業
2022-09-30,4154,OtherPayables,23355000.0,其他應付款,樂威科-KY,生技醫療業
2022-09-30,4154,OtherPayables_per,2.8,其他應付款,樂威科-KY,生技醫療業
2022-09-30,4154,OtherCurrentLiabilities,9466000.0,其他流動負債,樂威科-KY,生技醫療業
2022-09-30,4154,OtherCurrentLiabilities_per,1.14,其他流動負債,樂威科-KY,生技醫療業
2022-09-30,4154,CurrentLiabilities,448509000.0,流動負債合計,樂威科-KY,生技醫療業
2022-09-30,4154,CurrentLiabilities_per,53.85,流動負債合計,樂威科-KY,生技醫療業
2022-09-30,4154,LongtermBorrowings,0.0,長期借款,樂威科-KY,生技醫療業
2022-09-30,4154,LongtermBorrowings_per,0.0,長期借款,樂威科-KY,生技醫療業
2022-09-30,4154,OtherNoncurrentLiabilities,0.0,其他非流動負債,樂威科-KY,生技醫療業
2022-09-30,4154,OtherNoncurrentLiabilities_per,0.0,其他非流動負債,樂威科-KY,生技醫療業
2022-09-30,4154,NoncurrentLiabilities,9545000.0,非流動負債合計,樂威科-KY,生技醫療業
2022-09-30,4154,NoncurrentLiabilities_per,1.15,非流動負債合計,樂威科-KY,生技醫療業
2022-09-30,4154,OrdinaryShare,357200000.0,普通股股本,樂威科-KY,生技醫療業
2022-09-30,4154,OrdinaryShare_per,42.89,普通股股本,樂威科-KY,生技醫療業
2022-09-30,4154,CapitalStock,357200000.0,股本合計,樂威科-KY,生技醫療業
2022-09-30,4154,CapitalStock_per,42.89,股本合計,樂威科-KY,生技醫療業
2022-09-30,4154,CapitalSurplus,33179000.0,資本公積合計,樂威科-KY,生技醫療業
2022-09-30,4154,CapitalSurplus_per,3.98,資本公積合計,樂威科-KY,生技醫療業
2022-09-30,4154,EquityAttributableToOwnersOfParent,323711000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2022-09-30,4154,EquityAttributableToOwnersOfParent_per,38.87,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2022-09-30,4154,NoncontrollingInterests,51138000.0,非控制權益,樂威科-KY,生技醫療業
2022-09-30,4154,NoncontrollingInterests_per,6.14,非控制權益,樂威科-KY,生技醫療業
2022-09-30,4154,TotalLiabilitiesEquity,832903000.0,負債及權益總計,樂威科-KY,生技醫療業
2022-09-30,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2022-09-30,4154,CurrentIncomeTaxAssets,5283000.0,本期所得稅資產,樂威科-KY,生技醫療業
2022-09-30,4154,CurrentIncomeTaxAssets_per,0.63,本期所得稅資產,樂威科-KY,生技醫療業
2022-09-30,4154,RightOfUseAsset,15172000.0,使用權資產,樂威科-KY,生技醫療業
2022-09-30,4154,RightOfUseAsset_per,1.82,使用權資產,樂威科-KY,生技醫療業
2022-09-30,4154,CurrentTaxLiabilities,559000.0,本期所得稅負債,樂威科-KY,生技醫療業
2022-09-30,4154,CurrentTaxLiabilities_per,0.07,本期所得稅負債,樂威科-KY,生技醫療業
2022-09-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-18881000.0,未分配盈餘,樂威科-KY,生技醫療業
2022-09-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-2.27,未分配盈餘,樂威科-KY,生技醫療業
2022-09-30,4154,RetainedEarnings,-18881000.0,保留盈餘合計,樂威科-KY,生技醫療業
2022-09-30,4154,RetainedEarnings_per,-2.27,保留盈餘合計,樂威科-KY,生技醫療業
2022-09-30,4154,OtherEquityInterest,-47787000.0,其他權益合計,樂威科-KY,生技醫療業
2022-09-30,4154,OtherEquityInterest_per,-5.74,其他權益合計,樂威科-KY,生技醫療業
2022-09-30,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2022-09-30,4154,FinancialAssetsAtAmortizedCostNonCurrent,0.0,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2022-09-30,4154,FinancialAssetsAtAmortizedCostNonCurrent_per,0.0,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2022-09-30,4154,Equity,374849000.0,權益總額,樂威科-KY,生技醫療業
2022-09-30,4154,Equity_per,45.01,權益總額,樂威科-KY,生技醫療業
2022-09-30,4154,Liabilities,458054000.0,負債總額,樂威科-KY,生技醫療業
2022-09-30,4154,Liabilities_per,54.99,負債總額,樂威科-KY,生技醫療業
2022-12-31,4154,FinancialAssetsAtAmortizedCostNonCurrent,0.0,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2022-12-31,4154,FinancialAssetsAtAmortizedCostNonCurrent_per,0.0,按攤銷後成本衡量之金融資產－非流動,樂威科-KY,生技醫療業
2022-12-31,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2022-12-31,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2022-12-31,4154,BillsReceivableNet,0.0,應收票據淨額,樂威科-KY,生技醫療業
2022-12-31,4154,BillsReceivableNet_per,0.0,應收票據淨額,樂威科-KY,生技醫療業
2022-12-31,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2022-12-31,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2022-12-31,4154,LongtermBorrowings,0.0,長期借款,樂威科-KY,生技醫療業
2022-12-31,4154,LongtermBorrowings_per,0.0,長期借款,樂威科-KY,生技醫療業
2022-12-31,4154,OtherNoncurrentLiabilities,0.0,其他非流動負債,樂威科-KY,生技醫療業
2022-12-31,4154,OtherNoncurrentLiabilities_per,0.0,其他非流動負債,樂威科-KY,生技醫療業
2022-12-31,4154,CashAndCashEquivalents,196494000.0,現金及約當現金,樂威科-KY,生技醫療業
2022-12-31,4154,CashAndCashEquivalents_per,23.23,現金及約當現金,樂威科-KY,生技醫療業
2022-12-31,4154,FinancialAssetsAtAmortizedCost,30410000.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2022-12-31,4154,FinancialAssetsAtAmortizedCost_per,3.6,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2022-12-31,4154,AccountsReceivableNet,11544000.0,應收帳款淨額,樂威科-KY,生技醫療業
2022-12-31,4154,AccountsReceivableNet_per,1.36,應收帳款淨額,樂威科-KY,生技醫療業
2022-12-31,4154,AccountsReceivableDuefromRelatedPartiesNet,77485000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2022-12-31,4154,AccountsReceivableDuefromRelatedPartiesNet_per,9.16,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2022-12-31,4154,Inventories,144031000.0,存貨,樂威科-KY,生技醫療業
2022-12-31,4154,Inventories_per,17.03,存貨,樂威科-KY,生技醫療業
2022-12-31,4154,OtherCurrentAssets,10362000.0,其他流動資產,樂威科-KY,生技醫療業
2022-12-31,4154,OtherCurrentAssets_per,1.23,其他流動資產,樂威科-KY,生技醫療業
2022-12-31,4154,CurrentAssets,475940000.0,流動資產合計,樂威科-KY,生技醫療業
2022-12-31,4154,CurrentAssets_per,56.27,流動資產合計,樂威科-KY,生技醫療業
2022-12-31,4154,PropertyPlantAndEquipment,349930000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2022-12-31,4154,PropertyPlantAndEquipment_per,41.37,不動產、廠房及設備,樂威科-KY,生技醫療業
2022-12-31,4154,RightOfUseAsset,9661000.0,使用權資產,樂威科-KY,生技醫療業
2022-12-31,4154,RightOfUseAsset_per,1.14,使用權資產,樂威科-KY,生技醫療業
2022-12-31,4154,IntangibleAssets,3592000.0,無形資產,樂威科-KY,生技醫療業
2022-12-31,4154,IntangibleAssets_per,0.42,無形資產,樂威科-KY,生技醫療業
2022-12-31,4154,DeferredTaxAssets,2031000.0,遞延所得稅資產,樂威科-KY,生技醫療業
2022-12-31,4154,DeferredTaxAssets_per,0.24,遞延所得稅資產,樂威科-KY,生技醫療業
2022-12-31,4154,OtherNoncurrentAssets,4662000.0,其他非流動資產,樂威科-KY,生技醫療業
2022-12-31,4154,OtherNoncurrentAssets_per,0.55,其他非流動資產,樂威科-KY,生技醫療業
2022-12-31,4154,NoncurrentAssets,369876000.0,非流動資產合計,樂威科-KY,生技醫療業
2022-12-31,4154,NoncurrentAssets_per,43.73,非流動資產合計,樂威科-KY,生技醫療業
2022-12-31,4154,TotalAssets,845816000.0,資產總額,樂威科-KY,生技醫療業
2022-12-31,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2022-12-31,4154,ShorttermBorrowings,195714000.0,短期借款,樂威科-KY,生技醫療業
2022-12-31,4154,ShorttermBorrowings_per,23.14,短期借款,樂威科-KY,生技醫療業
2022-12-31,4154,AccountsPayable,5130000.0,應付帳款,樂威科-KY,生技醫療業
2022-12-31,4154,AccountsPayable_per,0.61,應付帳款,樂威科-KY,生技醫療業
2022-12-31,4154,AccountsPayableToRelatedParties,241681000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2022-12-31,4154,AccountsPayableToRelatedParties_per,28.57,應付帳款－關係人,樂威科-KY,生技醫療業
2022-12-31,4154,OtherPayables,22382000.0,其他應付款,樂威科-KY,生技醫療業
2022-12-31,4154,OtherPayables_per,2.65,其他應付款,樂威科-KY,生技醫療業
2022-12-31,4154,CurrentTaxLiabilities,0.0,本期所得稅負債,樂威科-KY,生技醫療業
2022-12-31,4154,CurrentTaxLiabilities_per,0.0,本期所得稅負債,樂威科-KY,生技醫療業
2022-12-31,4154,OtherCurrentLiabilities,1983000.0,其他流動負債,樂威科-KY,生技醫療業
2022-12-31,4154,OtherCurrentLiabilities_per,0.23,其他流動負債,樂威科-KY,生技醫療業
2022-12-31,4154,CurrentLiabilities,471379000.0,流動負債合計,樂威科-KY,生技醫療業
2022-12-31,4154,CurrentLiabilities_per,55.73,流動負債合計,樂威科-KY,生技醫療業
2022-12-31,4154,NoncurrentLiabilities,5941000.0,非流動負債合計,樂威科-KY,生技醫療業
2022-12-31,4154,NoncurrentLiabilities_per,0.7,非流動負債合計,樂威科-KY,生技醫療業
2022-12-31,4154,OrdinaryShare,357200000.0,普通股股本,樂威科-KY,生技醫療業
2022-12-31,4154,OrdinaryShare_per,42.23,普通股股本,樂威科-KY,生技醫療業
2022-12-31,4154,CapitalStock,357200000.0,股本合計,樂威科-KY,生技醫療業
2022-12-31,4154,CapitalStock_per,42.23,股本合計,樂威科-KY,生技醫療業
2022-12-31,4154,CapitalSurplus,33179000.0,資本公積合計,樂威科-KY,生技醫療業
2022-12-31,4154,CapitalSurplus_per,3.92,資本公積合計,樂威科-KY,生技醫療業
2022-12-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-34940000.0,未分配盈餘,樂威科-KY,生技醫療業
2022-12-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-4.13,未分配盈餘,樂威科-KY,生技醫療業
2022-12-31,4154,RetainedEarnings,-34940000.0,保留盈餘合計,樂威科-KY,生技醫療業
2022-12-31,4154,RetainedEarnings_per,-4.13,保留盈餘合計,樂威科-KY,生技醫療業
2022-12-31,4154,OtherEquityInterest,-38318000.0,其他權益合計,樂威科-KY,生技醫療業
2022-12-31,4154,OtherEquityInterest_per,-4.53,其他權益合計,樂威科-KY,生技醫療業
2022-12-31,4154,EquityAttributableToOwnersOfParent,317121000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2022-12-31,4154,EquityAttributableToOwnersOfParent_per,37.49,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2022-12-31,4154,NoncontrollingInterests,51375000.0,非控制權益,樂威科-KY,生技醫療業
2022-12-31,4154,NoncontrollingInterests_per,6.07,非控制權益,樂威科-KY,生技醫療業
2022-12-31,4154,TotalLiabilitiesEquity,845816000.0,負債及權益總計,樂威科-KY,生技醫療業
2022-12-31,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2022-12-31,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2022-12-31,4154,CurrentIncomeTaxAssets,5614000.0,本期所得稅資產,樂威科-KY,生技醫療業
2022-12-31,4154,CurrentIncomeTaxAssets_per,0.66,本期所得稅資產,樂威科-KY,生技醫療業
2022-12-31,4154,Liabilities,477320000.0,負債總額,樂威科-KY,生技醫療業
2022-12-31,4154,Liabilities_per,56.43,負債總額,樂威科-KY,生技醫療業
2022-12-31,4154,Equity,368496000.0,權益總額,樂威科-KY,生技醫療業
2022-12-31,4154,Equity_per,43.57,權益總額,樂威科-KY,生技醫療業
2023-03-31,4154,CashAndCashEquivalents,175267000.0,現金及約當現金,樂威科-KY,生技醫療業
2023-03-31,4154,CashAndCashEquivalents_per,21.67,現金及約當現金,樂威科-KY,生技醫療業
2023-03-31,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2023-03-31,4154,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,樂威科-KY,生技醫療業
2023-03-31,4154,FinancialAssetsAtAmortizedCost,30404000.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2023-03-31,4154,FinancialAssetsAtAmortizedCost_per,3.76,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2023-03-31,4154,BillsReceivableNet,0.0,應收票據淨額,樂威科-KY,生技醫療業
2023-03-31,4154,BillsReceivableNet_per,0.0,應收票據淨額,樂威科-KY,生技醫療業
2023-03-31,4154,AccountsReceivableNet,13001000.0,應收帳款淨額,樂威科-KY,生技醫療業
2023-03-31,4154,AccountsReceivableNet_per,1.61,應收帳款淨額,樂威科-KY,生技醫療業
2023-03-31,4154,AccountsReceivableDuefromRelatedPartiesNet,76481000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2023-03-31,4154,AccountsReceivableDuefromRelatedPartiesNet_per,9.46,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2023-03-31,4154,Inventories,140972000.0,存貨,樂威科-KY,生技醫療業
2023-03-31,4154,Inventories_per,17.43,存貨,樂威科-KY,生技醫療業
2023-03-31,4154,OtherCurrentAssets,11704000.0,其他流動資產,樂威科-KY,生技醫療業
2023-03-31,4154,OtherCurrentAssets_per,1.45,其他流動資產,樂威科-KY,生技醫療業
2023-03-31,4154,CurrentAssets,453378000.0,流動資產合計,樂威科-KY,生技醫療業
2023-03-31,4154,CurrentAssets_per,56.06,流動資產合計,樂威科-KY,生技醫療業
2023-03-31,4154,PropertyPlantAndEquipment,336666000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2023-03-31,4154,PropertyPlantAndEquipment_per,41.63,不動產、廠房及設備,樂威科-KY,生技醫療業
2023-03-31,4154,RightOfUseAsset,7813000.0,使用權資產,樂威科-KY,生技醫療業
2023-03-31,4154,RightOfUseAsset_per,0.97,使用權資產,樂威科-KY,生技醫療業
2023-03-31,4154,IntangibleAssets,3128000.0,無形資產,樂威科-KY,生技醫療業
2023-03-31,4154,IntangibleAssets_per,0.39,無形資產,樂威科-KY,生技醫療業
2023-03-31,4154,DeferredTaxAssets,2790000.0,遞延所得稅資產,樂威科-KY,生技醫療業
2023-03-31,4154,DeferredTaxAssets_per,0.34,遞延所得稅資產,樂威科-KY,生技醫療業
2023-03-31,4154,OtherNoncurrentAssets,5024000.0,其他非流動資產,樂威科-KY,生技醫療業
2023-03-31,4154,OtherNoncurrentAssets_per,0.62,其他非流動資產,樂威科-KY,生技醫療業
2023-03-31,4154,NoncurrentAssets,355421000.0,非流動資產合計,樂威科-KY,生技醫療業
2023-03-31,4154,NoncurrentAssets_per,43.94,非流動資產合計,樂威科-KY,生技醫療業
2023-03-31,4154,TotalAssets,808799000.0,資產總額,樂威科-KY,生技醫療業
2023-03-31,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2023-03-31,4154,ShorttermBorrowings,211076000.0,短期借款,樂威科-KY,生技醫療業
2023-03-31,4154,ShorttermBorrowings_per,26.1,短期借款,樂威科-KY,生技醫療業
2023-03-31,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2023-03-31,4154,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,樂威科-KY,生技醫療業
2023-03-31,4154,AccountsPayable,1072000.0,應付帳款,樂威科-KY,生技醫療業
2023-03-31,4154,AccountsPayable_per,0.13,應付帳款,樂威科-KY,生技醫療業
2023-03-31,4154,AccountsPayableToRelatedParties,208104000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2023-03-31,4154,AccountsPayableToRelatedParties_per,25.73,應付帳款－關係人,樂威科-KY,生技醫療業
2023-03-31,4154,OtherPayables,21869000.0,其他應付款,樂威科-KY,生技醫療業
2023-03-31,4154,OtherPayables_per,2.7,其他應付款,樂威科-KY,生技醫療業
2023-03-31,4154,CurrentTaxLiabilities,0.0,本期所得稅負債,樂威科-KY,生技醫療業
2023-03-31,4154,CurrentTaxLiabilities_per,0.0,本期所得稅負債,樂威科-KY,生技醫療業
2023-03-31,4154,OtherCurrentLiabilities,306000.0,其他流動負債,樂威科-KY,生技醫療業
2023-03-31,4154,OtherCurrentLiabilities_per,0.04,其他流動負債,樂威科-KY,生技醫療業
2023-03-31,4154,CurrentLiabilities,445162000.0,流動負債合計,樂威科-KY,生技醫療業
2023-03-31,4154,CurrentLiabilities_per,55.04,流動負債合計,樂威科-KY,生技醫療業
2023-03-31,4154,LongtermBorrowings,0.0,長期借款,樂威科-KY,生技醫療業
2023-03-31,4154,LongtermBorrowings_per,0.0,長期借款,樂威科-KY,生技醫療業
2023-03-31,4154,OtherNoncurrentLiabilities,0.0,其他非流動負債,樂威科-KY,生技醫療業
2023-03-31,4154,OtherNoncurrentLiabilities_per,0.0,其他非流動負債,樂威科-KY,生技醫療業
2023-03-31,4154,NoncurrentLiabilities,5162000.0,非流動負債合計,樂威科-KY,生技醫療業
2023-03-31,4154,NoncurrentLiabilities_per,0.64,非流動負債合計,樂威科-KY,生技醫療業
2023-03-31,4154,OrdinaryShare,357200000.0,普通股股本,樂威科-KY,生技醫療業
2023-03-31,4154,OrdinaryShare_per,44.16,普通股股本,樂威科-KY,生技醫療業
2023-03-31,4154,CapitalStock,357200000.0,股本合計,樂威科-KY,生技醫療業
2023-03-31,4154,CapitalStock_per,44.16,股本合計,樂威科-KY,生技醫療業
2023-03-31,4154,CapitalSurplus,33179000.0,資本公積合計,樂威科-KY,生技醫療業
2023-03-31,4154,CapitalSurplus_per,4.1,資本公積合計,樂威科-KY,生技醫療業
2023-03-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-44888000.0,未分配盈餘,樂威科-KY,生技醫療業
2023-03-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-5.55,未分配盈餘,樂威科-KY,生技醫療業
2023-03-31,4154,RetainedEarnings,-44888000.0,保留盈餘合計,樂威科-KY,生技醫療業
2023-03-31,4154,RetainedEarnings_per,-5.55,保留盈餘合計,樂威科-KY,生技醫療業
2023-03-31,4154,OtherEquityInterest,-37562000.0,其他權益合計,樂威科-KY,生技醫療業
2023-03-31,4154,OtherEquityInterest_per,-4.64,其他權益合計,樂威科-KY,生技醫療業
2023-03-31,4154,EquityAttributableToOwnersOfParent,307929000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2023-03-31,4154,EquityAttributableToOwnersOfParent_per,38.07,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2023-03-31,4154,NoncontrollingInterests,50546000.0,非控制權益,樂威科-KY,生技醫療業
2023-03-31,4154,NoncontrollingInterests_per,6.25,非控制權益,樂威科-KY,生技醫療業
2023-03-31,4154,TotalLiabilitiesEquity,808799000.0,負債及權益總計,樂威科-KY,生技醫療業
2023-03-31,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2023-03-31,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2023-03-31,4154,CurrentIncomeTaxAssets,5549000.0,本期所得稅資產,樂威科-KY,生技醫療業
2023-03-31,4154,CurrentIncomeTaxAssets_per,0.69,本期所得稅資產,樂威科-KY,生技醫療業
2023-03-31,4154,Liabilities,450324000.0,負債總額,樂威科-KY,生技醫療業
2023-03-31,4154,Liabilities_per,55.68,負債總額,樂威科-KY,生技醫療業
2023-03-31,4154,Equity,358475000.0,權益總額,樂威科-KY,生技醫療業
2023-03-31,4154,Equity_per,44.32,權益總額,樂威科-KY,生技醫療業
2023-06-30,4154,CashAndCashEquivalents,157536000.0,現金及約當現金,樂威科-KY,生技醫療業
2023-06-30,4154,CashAndCashEquivalents_per,22.18,現金及約當現金,樂威科-KY,生技醫療業
2023-06-30,4154,FinancialAssetsAtAmortizedCost,21656000.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2023-06-30,4154,FinancialAssetsAtAmortizedCost_per,3.05,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2023-06-30,4154,AccountsReceivableNet,9626000.0,應收帳款淨額,樂威科-KY,生技醫療業
2023-06-30,4154,AccountsReceivableNet_per,1.36,應收帳款淨額,樂威科-KY,生技醫療業
2023-06-30,4154,AccountsReceivableDuefromRelatedPartiesNet,65456000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2023-06-30,4154,AccountsReceivableDuefromRelatedPartiesNet_per,9.22,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2023-06-30,4154,Inventories,105868000.0,存貨,樂威科-KY,生技醫療業
2023-06-30,4154,Inventories_per,14.91,存貨,樂威科-KY,生技醫療業
2023-06-30,4154,OtherCurrentAssets,7523000.0,其他流動資產,樂威科-KY,生技醫療業
2023-06-30,4154,OtherCurrentAssets_per,1.06,其他流動資產,樂威科-KY,生技醫療業
2023-06-30,4154,CurrentAssets,373042000.0,流動資產合計,樂威科-KY,生技醫療業
2023-06-30,4154,CurrentAssets_per,52.53,流動資產合計,樂威科-KY,生技醫療業
2023-06-30,4154,PropertyPlantAndEquipment,321007000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2023-06-30,4154,PropertyPlantAndEquipment_per,45.2,不動產、廠房及設備,樂威科-KY,生技醫療業
2023-06-30,4154,RightOfUseAsset,7103000.0,使用權資產,樂威科-KY,生技醫療業
2023-06-30,4154,RightOfUseAsset_per,1.0,使用權資產,樂威科-KY,生技醫療業
2023-06-30,4154,IntangibleAssets,2631000.0,無形資產,樂威科-KY,生技醫療業
2023-06-30,4154,IntangibleAssets_per,0.37,無形資產,樂威科-KY,生技醫療業
2023-06-30,4154,DeferredTaxAssets,2508000.0,遞延所得稅資產,樂威科-KY,生技醫療業
2023-06-30,4154,DeferredTaxAssets_per,0.35,遞延所得稅資產,樂威科-KY,生技醫療業
2023-06-30,4154,OtherNoncurrentAssets,3912000.0,其他非流動資產,樂威科-KY,生技醫療業
2023-06-30,4154,OtherNoncurrentAssets_per,0.55,其他非流動資產,樂威科-KY,生技醫療業
2023-06-30,4154,NoncurrentAssets,337161000.0,非流動資產合計,樂威科-KY,生技醫療業
2023-06-30,4154,NoncurrentAssets_per,47.47,非流動資產合計,樂威科-KY,生技醫療業
2023-06-30,4154,TotalAssets,710203000.0,資產總額,樂威科-KY,生技醫療業
2023-06-30,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2023-06-30,4154,ShorttermBorrowings,184592000.0,短期借款,樂威科-KY,生技醫療業
2023-06-30,4154,ShorttermBorrowings_per,25.99,短期借款,樂威科-KY,生技醫療業
2023-06-30,4154,AccountsPayable,2724000.0,應付帳款,樂威科-KY,生技醫療業
2023-06-30,4154,AccountsPayable_per,0.38,應付帳款,樂威科-KY,生技醫療業
2023-06-30,4154,AccountsPayableToRelatedParties,188815000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2023-06-30,4154,AccountsPayableToRelatedParties_per,26.59,應付帳款－關係人,樂威科-KY,生技醫療業
2023-06-30,4154,OtherPayables,15434000.0,其他應付款,樂威科-KY,生技醫療業
2023-06-30,4154,OtherPayables_per,2.17,其他應付款,樂威科-KY,生技醫療業
2023-06-30,4154,CurrentTaxLiabilities,0.0,本期所得稅負債,樂威科-KY,生技醫療業
2023-06-30,4154,CurrentTaxLiabilities_per,0.0,本期所得稅負債,樂威科-KY,生技醫療業
2023-06-30,4154,OtherCurrentLiabilities,227000.0,其他流動負債,樂威科-KY,生技醫療業
2023-06-30,4154,OtherCurrentLiabilities_per,0.03,其他流動負債,樂威科-KY,生技醫療業
2023-06-30,4154,CurrentLiabilities,398097000.0,流動負債合計,樂威科-KY,生技醫療業
2023-06-30,4154,CurrentLiabilities_per,56.05,流動負債合計,樂威科-KY,生技醫療業
2023-06-30,4154,NoncurrentLiabilities,4854000.0,非流動負債合計,樂威科-KY,生技醫療業
2023-06-30,4154,NoncurrentLiabilities_per,0.68,非流動負債合計,樂威科-KY,生技醫療業
2023-06-30,4154,OrdinaryShare,357200000.0,普通股股本,樂威科-KY,生技醫療業
2023-06-30,4154,OrdinaryShare_per,50.3,普通股股本,樂威科-KY,生技醫療業
2023-06-30,4154,CapitalStock,357200000.0,股本合計,樂威科-KY,生技醫療業
2023-06-30,4154,CapitalStock_per,50.3,股本合計,樂威科-KY,生技醫療業
2023-06-30,4154,CapitalSurplus,0.0,資本公積合計,樂威科-KY,生技醫療業
2023-06-30,4154,CapitalSurplus_per,0.0,資本公積合計,樂威科-KY,生技醫療業
2023-06-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-45911000.0,未分配盈餘,樂威科-KY,生技醫療業
2023-06-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-6.46,未分配盈餘,樂威科-KY,生技醫療業
2023-06-30,4154,RetainedEarnings,-45911000.0,保留盈餘合計,樂威科-KY,生技醫療業
2023-06-30,4154,RetainedEarnings_per,-6.46,保留盈餘合計,樂威科-KY,生技醫療業
2023-06-30,4154,OtherEquityInterest,-41748000.0,其他權益合計,樂威科-KY,生技醫療業
2023-06-30,4154,OtherEquityInterest_per,-5.88,其他權益合計,樂威科-KY,生技醫療業
2023-06-30,4154,EquityAttributableToOwnersOfParent,269541000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2023-06-30,4154,EquityAttributableToOwnersOfParent_per,37.95,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2023-06-30,4154,NoncontrollingInterests,37711000.0,非控制權益,樂威科-KY,生技醫療業
2023-06-30,4154,NoncontrollingInterests_per,5.31,非控制權益,樂威科-KY,生技醫療業
2023-06-30,4154,TotalLiabilitiesEquity,710203000.0,負債及權益總計,樂威科-KY,生技醫療業
2023-06-30,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2023-06-30,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2023-06-30,4154,CurrentIncomeTaxAssets,5377000.0,本期所得稅資產,樂威科-KY,生技醫療業
2023-06-30,4154,CurrentIncomeTaxAssets_per,0.76,本期所得稅資產,樂威科-KY,生技醫療業
2023-06-30,4154,InvestmentAccountedForUsingEquityMethod,0.0,採用權益法之投資,樂威科-KY,生技醫療業
2023-06-30,4154,InvestmentAccountedForUsingEquityMethod_per,0.0,採用權益法之投資,樂威科-KY,生技醫療業
2023-06-30,4154,Equity,307252000.0,權益總額,樂威科-KY,生技醫療業
2023-06-30,4154,Equity_per,43.26,權益總額,樂威科-KY,生技醫療業
2023-06-30,4154,Liabilities,402951000.0,負債總額,樂威科-KY,生技醫療業
2023-06-30,4154,Liabilities_per,56.74,負債總額,樂威科-KY,生技醫療業
2023-09-30,4154,CashAndCashEquivalents,221722000.0,現金及約當現金,樂威科-KY,生技醫療業
2023-09-30,4154,CashAndCashEquivalents_per,32.64,現金及約當現金,樂威科-KY,生技醫療業
2023-09-30,4154,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2023-09-30,4154,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2023-09-30,4154,AccountsReceivableNet,5683000.0,應收帳款淨額,樂威科-KY,生技醫療業
2023-09-30,4154,AccountsReceivableNet_per,0.84,應收帳款淨額,樂威科-KY,生技醫療業
2023-09-30,4154,AccountsReceivableDuefromRelatedPartiesNet,46626000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2023-09-30,4154,AccountsReceivableDuefromRelatedPartiesNet_per,6.86,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2023-09-30,4154,Inventories,74910000.0,存貨,樂威科-KY,生技醫療業
2023-09-30,4154,Inventories_per,11.03,存貨,樂威科-KY,生技醫療業
2023-09-30,4154,OtherCurrentAssets,5114000.0,其他流動資產,樂威科-KY,生技醫療業
2023-09-30,4154,OtherCurrentAssets_per,0.75,其他流動資產,樂威科-KY,生技醫療業
2023-09-30,4154,CurrentAssets,354312000.0,流動資產合計,樂威科-KY,生技醫療業
2023-09-30,4154,CurrentAssets_per,52.16,流動資產合計,樂威科-KY,生技醫療業
2023-09-30,4154,PropertyPlantAndEquipment,310879000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2023-09-30,4154,PropertyPlantAndEquipment_per,45.77,不動產、廠房及設備,樂威科-KY,生技醫療業
2023-09-30,4154,RightOfUseAsset,6392000.0,使用權資產,樂威科-KY,生技醫療業
2023-09-30,4154,RightOfUseAsset_per,0.94,使用權資產,樂威科-KY,生技醫療業
2023-09-30,4154,IntangibleAssets,2166000.0,無形資產,樂威科-KY,生技醫療業
2023-09-30,4154,IntangibleAssets_per,0.32,無形資產,樂威科-KY,生技醫療業
2023-09-30,4154,DeferredTaxAssets,3288000.0,遞延所得稅資產,樂威科-KY,生技醫療業
2023-09-30,4154,DeferredTaxAssets_per,0.48,遞延所得稅資產,樂威科-KY,生技醫療業
2023-09-30,4154,OtherNoncurrentAssets,2200000.0,其他非流動資產,樂威科-KY,生技醫療業
2023-09-30,4154,OtherNoncurrentAssets_per,0.32,其他非流動資產,樂威科-KY,生技醫療業
2023-09-30,4154,NoncurrentAssets,324925000.0,非流動資產合計,樂威科-KY,生技醫療業
2023-09-30,4154,NoncurrentAssets_per,47.84,非流動資產合計,樂威科-KY,生技醫療業
2023-09-30,4154,TotalAssets,679237000.0,資產總額,樂威科-KY,生技醫療業
2023-09-30,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2023-09-30,4154,ShorttermBorrowings,66794000.0,短期借款,樂威科-KY,生技醫療業
2023-09-30,4154,ShorttermBorrowings_per,9.83,短期借款,樂威科-KY,生技醫療業
2023-09-30,4154,AccountsPayable,5232000.0,應付帳款,樂威科-KY,生技醫療業
2023-09-30,4154,AccountsPayable_per,0.77,應付帳款,樂威科-KY,生技醫療業
2023-09-30,4154,AccountsPayableToRelatedParties,195821000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2023-09-30,4154,AccountsPayableToRelatedParties_per,28.83,應付帳款－關係人,樂威科-KY,生技醫療業
2023-09-30,4154,OtherPayables,14326000.0,其他應付款,樂威科-KY,生技醫療業
2023-09-30,4154,OtherPayables_per,2.11,其他應付款,樂威科-KY,生技醫療業
2023-09-30,4154,CurrentTaxLiabilities,0.0,本期所得稅負債,樂威科-KY,生技醫療業
2023-09-30,4154,CurrentTaxLiabilities_per,0.0,本期所得稅負債,樂威科-KY,生技醫療業
2023-09-30,4154,OtherCurrentLiabilities,157000.0,其他流動負債,樂威科-KY,生技醫療業
2023-09-30,4154,OtherCurrentLiabilities_per,0.02,其他流動負債,樂威科-KY,生技醫療業
2023-09-30,4154,CurrentLiabilities,404603000.0,流動負債合計,樂威科-KY,生技醫療業
2023-09-30,4154,CurrentLiabilities_per,59.57,流動負債合計,樂威科-KY,生技醫療業
2023-09-30,4154,NoncurrentLiabilities,4600000.0,非流動負債合計,樂威科-KY,生技醫療業
2023-09-30,4154,NoncurrentLiabilities_per,0.68,非流動負債合計,樂威科-KY,生技醫療業
2023-09-30,4154,OrdinaryShare,357200000.0,普通股股本,樂威科-KY,生技醫療業
2023-09-30,4154,OrdinaryShare_per,52.59,普通股股本,樂威科-KY,生技醫療業
2023-09-30,4154,CapitalStock,357200000.0,股本合計,樂威科-KY,生技醫療業
2023-09-30,4154,CapitalStock_per,52.59,股本合計,樂威科-KY,生技醫療業
2023-09-30,4154,CapitalSurplus,0.0,資本公積合計,樂威科-KY,生技醫療業
2023-09-30,4154,CapitalSurplus_per,0.0,資本公積合計,樂威科-KY,生技醫療業
2023-09-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-82940000.0,未分配盈餘,樂威科-KY,生技醫療業
2023-09-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-12.21,未分配盈餘,樂威科-KY,生技醫療業
2023-09-30,4154,RetainedEarnings,-82940000.0,保留盈餘合計,樂威科-KY,生技醫療業
2023-09-30,4154,RetainedEarnings_per,-12.21,保留盈餘合計,樂威科-KY,生技醫療業
2023-09-30,4154,OtherEquityInterest,-36635000.0,其他權益合計,樂威科-KY,生技醫療業
2023-09-30,4154,OtherEquityInterest_per,-5.39,其他權益合計,樂威科-KY,生技醫療業
2023-09-30,4154,EquityAttributableToOwnersOfParent,237625000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2023-09-30,4154,EquityAttributableToOwnersOfParent_per,34.98,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2023-09-30,4154,NoncontrollingInterests,32409000.0,非控制權益,樂威科-KY,生技醫療業
2023-09-30,4154,NoncontrollingInterests_per,4.77,非控制權益,樂威科-KY,生技醫療業
2023-09-30,4154,TotalLiabilitiesEquity,679237000.0,負債及權益總計,樂威科-KY,生技醫療業
2023-09-30,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2023-09-30,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2023-09-30,4154,CurrentIncomeTaxAssets,257000.0,本期所得稅資產,樂威科-KY,生技醫療業
2023-09-30,4154,CurrentIncomeTaxAssets_per,0.04,本期所得稅資產,樂威科-KY,生技醫療業
2023-09-30,4154,InvestmentAccountedForUsingEquityMethod,0.0,採用權益法之投資,樂威科-KY,生技醫療業
2023-09-30,4154,InvestmentAccountedForUsingEquityMethod_per,0.0,採用權益法之投資,樂威科-KY,生技醫療業
2023-09-30,4154,CapitalSurplusAdditionalPaidInCapital,0.0,資本公積－發行溢價,樂威科-KY,生技醫療業
2023-09-30,4154,CapitalSurplusAdditionalPaidInCapital_per,0.0,資本公積－發行溢價,樂威科-KY,生技醫療業
2023-09-30,4154,Equity,270034000.0,權益總額,樂威科-KY,生技醫療業
2023-09-30,4154,Equity_per,39.76,權益總額,樂威科-KY,生技醫療業
2023-09-30,4154,Liabilities,409203000.0,負債總額,樂威科-KY,生技醫療業
2023-09-30,4154,Liabilities_per,60.24,負債總額,樂威科-KY,生技醫療業
2023-12-31,4154,CashAndCashEquivalents,119708000.0,現金及約當現金,樂威科-KY,生技醫療業
2023-12-31,4154,CashAndCashEquivalents_per,24.65,現金及約當現金,樂威科-KY,生技醫療業
2023-12-31,4154,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2023-12-31,4154,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2023-12-31,4154,AccountsReceivableNet,3674000.0,應收帳款淨額,樂威科-KY,生技醫療業
2023-12-31,4154,AccountsReceivableNet_per,0.76,應收帳款淨額,樂威科-KY,生技醫療業
2023-12-31,4154,AccountsReceivableDuefromRelatedPartiesNet,13185000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2023-12-31,4154,AccountsReceivableDuefromRelatedPartiesNet_per,2.71,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2023-12-31,4154,Inventories,44017000.0,存貨,樂威科-KY,生技醫療業
2023-12-31,4154,Inventories_per,9.06,存貨,樂威科-KY,生技醫療業
2023-12-31,4154,OtherCurrentAssets,4772000.0,其他流動資產,樂威科-KY,生技醫療業
2023-12-31,4154,OtherCurrentAssets_per,0.98,其他流動資產,樂威科-KY,生技醫療業
2023-12-31,4154,CurrentAssets,253248000.0,流動資產合計,樂威科-KY,生技醫療業
2023-12-31,4154,CurrentAssets_per,52.15,流動資產合計,樂威科-KY,生技醫療業
2023-12-31,4154,PropertyPlantAndEquipment,222326000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2023-12-31,4154,PropertyPlantAndEquipment_per,45.78,不動產、廠房及設備,樂威科-KY,生技醫療業
2023-12-31,4154,RightOfUseAsset,5682000.0,使用權資產,樂威科-KY,生技醫療業
2023-12-31,4154,RightOfUseAsset_per,1.17,使用權資產,樂威科-KY,生技醫療業
2023-12-31,4154,IntangibleAssets,2279000.0,無形資產,樂威科-KY,生技醫療業
2023-12-31,4154,IntangibleAssets_per,0.47,無形資產,樂威科-KY,生技醫療業
2023-12-31,4154,DeferredTaxAssets,5000.0,遞延所得稅資產,樂威科-KY,生技醫療業
2023-12-31,4154,DeferredTaxAssets_per,0.0,遞延所得稅資產,樂威科-KY,生技醫療業
2023-12-31,4154,OtherNoncurrentAssets,2115000.0,其他非流動資產,樂威科-KY,生技醫療業
2023-12-31,4154,OtherNoncurrentAssets_per,0.44,其他非流動資產,樂威科-KY,生技醫療業
2023-12-31,4154,NoncurrentAssets,232407000.0,非流動資產合計,樂威科-KY,生技醫療業
2023-12-31,4154,NoncurrentAssets_per,47.85,非流動資產合計,樂威科-KY,生技醫療業
2023-12-31,4154,TotalAssets,485655000.0,資產總額,樂威科-KY,生技醫療業
2023-12-31,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2023-12-31,4154,ShorttermBorrowings,0.0,短期借款,樂威科-KY,生技醫療業
2023-12-31,4154,ShorttermBorrowings_per,0.0,短期借款,樂威科-KY,生技醫療業
2023-12-31,4154,AccountsPayable,5956000.0,應付帳款,樂威科-KY,生技醫療業
2023-12-31,4154,AccountsPayable_per,1.23,應付帳款,樂威科-KY,生技醫療業
2023-12-31,4154,AccountsPayableToRelatedParties,127572000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2023-12-31,4154,AccountsPayableToRelatedParties_per,26.27,應付帳款－關係人,樂威科-KY,生技醫療業
2023-12-31,4154,OtherPayables,10656000.0,其他應付款,樂威科-KY,生技醫療業
2023-12-31,4154,OtherPayables_per,2.19,其他應付款,樂威科-KY,生技醫療業
2023-12-31,4154,CurrentTaxLiabilities,29000.0,本期所得稅負債,樂威科-KY,生技醫療業
2023-12-31,4154,CurrentTaxLiabilities_per,0.01,本期所得稅負債,樂威科-KY,生技醫療業
2023-12-31,4154,OtherCurrentLiabilities,69235000.0,其他流動負債,樂威科-KY,生技醫療業
2023-12-31,4154,OtherCurrentLiabilities_per,14.26,其他流動負債,樂威科-KY,生技醫療業
2023-12-31,4154,CurrentLiabilities,238950000.0,流動負債合計,樂威科-KY,生技醫療業
2023-12-31,4154,CurrentLiabilities_per,49.2,流動負債合計,樂威科-KY,生技醫療業
2023-12-31,4154,NoncurrentLiabilities,3968000.0,非流動負債合計,樂威科-KY,生技醫療業
2023-12-31,4154,NoncurrentLiabilities_per,0.82,非流動負債合計,樂威科-KY,生技醫療業
2023-12-31,4154,OrdinaryShare,357200000.0,普通股股本,樂威科-KY,生技醫療業
2023-12-31,4154,OrdinaryShare_per,73.55,普通股股本,樂威科-KY,生技醫療業
2023-12-31,4154,CapitalStock,357200000.0,股本合計,樂威科-KY,生技醫療業
2023-12-31,4154,CapitalStock_per,73.55,股本合計,樂威科-KY,生技醫療業
2023-12-31,4154,CapitalSurplus,0.0,資本公積合計,樂威科-KY,生技醫療業
2023-12-31,4154,CapitalSurplus_per,0.0,資本公積合計,樂威科-KY,生技醫療業
2023-12-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-110584000.0,未分配盈餘,樂威科-KY,生技醫療業
2023-12-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-22.77,未分配盈餘,樂威科-KY,生技醫療業
2023-12-31,4154,RetainedEarnings,-110584000.0,保留盈餘合計,樂威科-KY,生技醫療業
2023-12-31,4154,RetainedEarnings_per,-22.77,保留盈餘合計,樂威科-KY,生技醫療業
2023-12-31,4154,OtherEquityInterest,-33252000.0,其他權益合計,樂威科-KY,生技醫療業
2023-12-31,4154,OtherEquityInterest_per,-6.85,其他權益合計,樂威科-KY,生技醫療業
2023-12-31,4154,EquityAttributableToOwnersOfParent,213364000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2023-12-31,4154,EquityAttributableToOwnersOfParent_per,43.93,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2023-12-31,4154,NoncontrollingInterests,29373000.0,非控制權益,樂威科-KY,生技醫療業
2023-12-31,4154,NoncontrollingInterests_per,6.05,非控制權益,樂威科-KY,生技醫療業
2023-12-31,4154,TotalLiabilitiesEquity,485655000.0,負債及權益總計,樂威科-KY,生技醫療業
2023-12-31,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2023-12-31,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2023-12-31,4154,CurrentIncomeTaxAssets,263000.0,本期所得稅資產,樂威科-KY,生技醫療業
2023-12-31,4154,CurrentIncomeTaxAssets_per,0.05,本期所得稅資產,樂威科-KY,生技醫療業
2023-12-31,4154,InvestmentAccountedForUsingEquityMethod,0.0,採用權益法之投資,樂威科-KY,生技醫療業
2023-12-31,4154,InvestmentAccountedForUsingEquityMethod_per,0.0,採用權益法之投資,樂威科-KY,生技醫療業
2023-12-31,4154,CapitalSurplusAdditionalPaidInCapital,0.0,資本公積－發行溢價,樂威科-KY,生技醫療業
2023-12-31,4154,CapitalSurplusAdditionalPaidInCapital_per,0.0,資本公積－發行溢價,樂威科-KY,生技醫療業
2023-12-31,4154,OtherNoncurrentLiabilities,0.0,其他非流動負債,樂威科-KY,生技醫療業
2023-12-31,4154,OtherNoncurrentLiabilities_per,0.0,其他非流動負債,樂威科-KY,生技醫療業
2023-12-31,4154,Equity,242737000.0,權益總額,樂威科-KY,生技醫療業
2023-12-31,4154,Equity_per,49.98,權益總額,樂威科-KY,生技醫療業
2023-12-31,4154,Liabilities,242918000.0,負債總額,樂威科-KY,生技醫療業
2023-12-31,4154,Liabilities_per,50.02,負債總額,樂威科-KY,生技醫療業
2024-03-31,4154,CashAndCashEquivalents,110266000.0,現金及約當現金,樂威科-KY,生技醫療業
2024-03-31,4154,CashAndCashEquivalents_per,24.75,現金及約當現金,樂威科-KY,生技醫療業
2024-03-31,4154,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2024-03-31,4154,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2024-03-31,4154,AccountsReceivableNet,4665000.0,應收帳款淨額,樂威科-KY,生技醫療業
2024-03-31,4154,AccountsReceivableNet_per,1.05,應收帳款淨額,樂威科-KY,生技醫療業
2024-03-31,4154,AccountsReceivableDuefromRelatedPartiesNet,54000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2024-03-31,4154,AccountsReceivableDuefromRelatedPartiesNet_per,0.01,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2024-03-31,4154,Inventories,39774000.0,存貨,樂威科-KY,生技醫療業
2024-03-31,4154,Inventories_per,8.93,存貨,樂威科-KY,生技醫療業
2024-03-31,4154,OtherCurrentAssets,6311000.0,其他流動資產,樂威科-KY,生技醫療業
2024-03-31,4154,OtherCurrentAssets_per,1.42,其他流動資產,樂威科-KY,生技醫療業
2024-03-31,4154,CurrentAssets,227702000.0,流動資產合計,樂威科-KY,生技醫療業
2024-03-31,4154,CurrentAssets_per,51.12,流動資產合計,樂威科-KY,生技醫療業
2024-03-31,4154,PropertyPlantAndEquipment,208957000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2024-03-31,4154,PropertyPlantAndEquipment_per,46.91,不動產、廠房及設備,樂威科-KY,生技醫療業
2024-03-31,4154,RightOfUseAsset,4972000.0,使用權資產,樂威科-KY,生技醫療業
2024-03-31,4154,RightOfUseAsset_per,1.12,使用權資產,樂威科-KY,生技醫療業
2024-03-31,4154,IntangibleAssets,1292000.0,無形資產,樂威科-KY,生技醫療業
2024-03-31,4154,IntangibleAssets_per,0.29,無形資產,樂威科-KY,生技醫療業
2024-03-31,4154,DeferredTaxAssets,0.0,遞延所得稅資產,樂威科-KY,生技醫療業
2024-03-31,4154,DeferredTaxAssets_per,0.0,遞延所得稅資產,樂威科-KY,生技醫療業
2024-03-31,4154,OtherNoncurrentAssets,2530000.0,其他非流動資產,樂威科-KY,生技醫療業
2024-03-31,4154,OtherNoncurrentAssets_per,0.57,其他非流動資產,樂威科-KY,生技醫療業
2024-03-31,4154,NoncurrentAssets,217751000.0,非流動資產合計,樂威科-KY,生技醫療業
2024-03-31,4154,NoncurrentAssets_per,48.88,非流動資產合計,樂威科-KY,生技醫療業
2024-03-31,4154,TotalAssets,445453000.0,資產總額,樂威科-KY,生技醫療業
2024-03-31,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2024-03-31,4154,ShorttermBorrowings,0.0,短期借款,樂威科-KY,生技醫療業
2024-03-31,4154,ShorttermBorrowings_per,0.0,短期借款,樂威科-KY,生技醫療業
2024-03-31,4154,AccountsPayable,2351000.0,應付帳款,樂威科-KY,生技醫療業
2024-03-31,4154,AccountsPayable_per,0.53,應付帳款,樂威科-KY,生技醫療業
2024-03-31,4154,AccountsPayableToRelatedParties,128940000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2024-03-31,4154,AccountsPayableToRelatedParties_per,28.95,應付帳款－關係人,樂威科-KY,生技醫療業
2024-03-31,4154,OtherPayables,11863000.0,其他應付款,樂威科-KY,生技醫療業
2024-03-31,4154,OtherPayables_per,2.66,其他應付款,樂威科-KY,生技醫療業
2024-03-31,4154,CurrentTaxLiabilities,55000.0,本期所得稅負債,樂威科-KY,生技醫療業
2024-03-31,4154,CurrentTaxLiabilities_per,0.01,本期所得稅負債,樂威科-KY,生技醫療業
2024-03-31,4154,OtherCurrentLiabilities,68539000.0,其他流動負債,樂威科-KY,生技醫療業
2024-03-31,4154,OtherCurrentLiabilities_per,15.39,其他流動負債,樂威科-KY,生技醫療業
2024-03-31,4154,CurrentLiabilities,237250000.0,流動負債合計,樂威科-KY,生技醫療業
2024-03-31,4154,CurrentLiabilities_per,53.26,流動負債合計,樂威科-KY,生技醫療業
2024-03-31,4154,NoncurrentLiabilities,3449000.0,非流動負債合計,樂威科-KY,生技醫療業
2024-03-31,4154,NoncurrentLiabilities_per,0.77,非流動負債合計,樂威科-KY,生技醫療業
2024-03-31,4154,OrdinaryShare,357200000.0,普通股股本,樂威科-KY,生技醫療業
2024-03-31,4154,OrdinaryShare_per,80.19,普通股股本,樂威科-KY,生技醫療業
2024-03-31,4154,CapitalStock,357200000.0,股本合計,樂威科-KY,生技醫療業
2024-03-31,4154,CapitalStock_per,80.19,股本合計,樂威科-KY,生技醫療業
2024-03-31,4154,CapitalSurplus,0.0,資本公積合計,樂威科-KY,生技醫療業
2024-03-31,4154,CapitalSurplus_per,0.0,資本公積合計,樂威科-KY,生技醫療業
2024-03-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-142210000.0,未分配盈餘,樂威科-KY,生技醫療業
2024-03-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-31.92,未分配盈餘,樂威科-KY,生技醫療業
2024-03-31,4154,RetainedEarnings,-142210000.0,保留盈餘合計,樂威科-KY,生技醫療業
2024-03-31,4154,RetainedEarnings_per,-31.92,保留盈餘合計,樂威科-KY,生技醫療業
2024-03-31,4154,OtherEquityInterest,-33486000.0,其他權益合計,樂威科-KY,生技醫療業
2024-03-31,4154,OtherEquityInterest_per,-7.52,其他權益合計,樂威科-KY,生技醫療業
2024-03-31,4154,EquityAttributableToOwnersOfParent,181504000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2024-03-31,4154,EquityAttributableToOwnersOfParent_per,40.75,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2024-03-31,4154,NoncontrollingInterests,23250000.0,非控制權益,樂威科-KY,生技醫療業
2024-03-31,4154,NoncontrollingInterests_per,5.22,非控制權益,樂威科-KY,生技醫療業
2024-03-31,4154,TotalLiabilitiesEquity,445453000.0,負債及權益總計,樂威科-KY,生技醫療業
2024-03-31,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2024-03-31,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2024-03-31,4154,CurrentIncomeTaxAssets,332000.0,本期所得稅資產,樂威科-KY,生技醫療業
2024-03-31,4154,CurrentIncomeTaxAssets_per,0.07,本期所得稅資產,樂威科-KY,生技醫療業
2024-03-31,4154,InvestmentAccountedForUsingEquityMethod,0.0,採用權益法之投資,樂威科-KY,生技醫療業
2024-03-31,4154,InvestmentAccountedForUsingEquityMethod_per,0.0,採用權益法之投資,樂威科-KY,生技醫療業
2024-03-31,4154,OtherNoncurrentLiabilities,0.0,其他非流動負債,樂威科-KY,生技醫療業
2024-03-31,4154,OtherNoncurrentLiabilities_per,0.0,其他非流動負債,樂威科-KY,生技醫療業
2024-03-31,4154,CapitalSurplusAdditionalPaidInCapital,0.0,資本公積－發行溢價,樂威科-KY,生技醫療業
2024-03-31,4154,CapitalSurplusAdditionalPaidInCapital_per,0.0,資本公積－發行溢價,樂威科-KY,生技醫療業
2024-03-31,4154,Equity,204754000.0,權益總額,樂威科-KY,生技醫療業
2024-03-31,4154,Equity_per,45.97,權益總額,樂威科-KY,生技醫療業
2024-03-31,4154,Liabilities,240699000.0,負債總額,樂威科-KY,生技醫療業
2024-03-31,4154,Liabilities_per,54.03,負債總額,樂威科-KY,生技醫療業
2024-06-30,4154,CashAndCashEquivalents,97748000.0,現金及約當現金,樂威科-KY,生技醫療業
2024-06-30,4154,CashAndCashEquivalents_per,23.09,現金及約當現金,樂威科-KY,生技醫療業
2024-06-30,4154,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2024-06-30,4154,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2024-06-30,4154,AccountsReceivableNet,2486000.0,應收帳款淨額,樂威科-KY,生技醫療業
2024-06-30,4154,AccountsReceivableNet_per,0.59,應收帳款淨額,樂威科-KY,生技醫療業
2024-06-30,4154,AccountsReceivableDuefromRelatedPartiesNet,6272000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2024-06-30,4154,AccountsReceivableDuefromRelatedPartiesNet_per,1.48,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2024-06-30,4154,Inventories,27466000.0,存貨,樂威科-KY,生技醫療業
2024-06-30,4154,Inventories_per,6.49,存貨,樂威科-KY,生技醫療業
2024-06-30,4154,OtherCurrentAssets,7100000.0,其他流動資產,樂威科-KY,生技醫療業
2024-06-30,4154,OtherCurrentAssets_per,1.68,其他流動資產,樂威科-KY,生技醫療業
2024-06-30,4154,CurrentAssets,208006000.0,流動資產合計,樂威科-KY,生技醫療業
2024-06-30,4154,CurrentAssets_per,49.13,流動資產合計,樂威科-KY,生技醫療業
2024-06-30,4154,InvestmentAccountedForUsingEquityMethod,6824000.0,採用權益法之投資,樂威科-KY,生技醫療業
2024-06-30,4154,InvestmentAccountedForUsingEquityMethod_per,1.61,採用權益法之投資,樂威科-KY,生技醫療業
2024-06-30,4154,PropertyPlantAndEquipment,201081000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2024-06-30,4154,PropertyPlantAndEquipment_per,47.49,不動產、廠房及設備,樂威科-KY,生技醫療業
2024-06-30,4154,RightOfUseAsset,4262000.0,使用權資產,樂威科-KY,生技醫療業
2024-06-30,4154,RightOfUseAsset_per,1.01,使用權資產,樂威科-KY,生技醫療業
2024-06-30,4154,IntangibleAssets,861000.0,無形資產,樂威科-KY,生技醫療業
2024-06-30,4154,IntangibleAssets_per,0.2,無形資產,樂威科-KY,生技醫療業
2024-06-30,4154,DeferredTaxAssets,0.0,遞延所得稅資產,樂威科-KY,生技醫療業
2024-06-30,4154,DeferredTaxAssets_per,0.0,遞延所得稅資產,樂威科-KY,生技醫療業
2024-06-30,4154,OtherNoncurrentAssets,2359000.0,其他非流動資產,樂威科-KY,生技醫療業
2024-06-30,4154,OtherNoncurrentAssets_per,0.56,其他非流動資產,樂威科-KY,生技醫療業
2024-06-30,4154,NoncurrentAssets,215387000.0,非流動資產合計,樂威科-KY,生技醫療業
2024-06-30,4154,NoncurrentAssets_per,50.87,非流動資產合計,樂威科-KY,生技醫療業
2024-06-30,4154,TotalAssets,423393000.0,資產總額,樂威科-KY,生技醫療業
2024-06-30,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2024-06-30,4154,ShorttermBorrowings,8058000.0,短期借款,樂威科-KY,生技醫療業
2024-06-30,4154,ShorttermBorrowings_per,1.9,短期借款,樂威科-KY,生技醫療業
2024-06-30,4154,AccountsPayable,1887000.0,應付帳款,樂威科-KY,生技醫療業
2024-06-30,4154,AccountsPayable_per,0.45,應付帳款,樂威科-KY,生技醫療業
2024-06-30,4154,AccountsPayableToRelatedParties,129548000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2024-06-30,4154,AccountsPayableToRelatedParties_per,30.6,應付帳款－關係人,樂威科-KY,生技醫療業
2024-06-30,4154,OtherPayables,8986000.0,其他應付款,樂威科-KY,生技醫療業
2024-06-30,4154,OtherPayables_per,2.12,其他應付款,樂威科-KY,生技醫療業
2024-06-30,4154,CurrentTaxLiabilities,0.0,本期所得稅負債,樂威科-KY,生技醫療業
2024-06-30,4154,CurrentTaxLiabilities_per,0.0,本期所得稅負債,樂威科-KY,生技醫療業
2024-06-30,4154,OtherCurrentLiabilities,68050000.0,其他流動負債,樂威科-KY,生技醫療業
2024-06-30,4154,OtherCurrentLiabilities_per,16.07,其他流動負債,樂威科-KY,生技醫療業
2024-06-30,4154,CurrentLiabilities,244408000.0,流動負債合計,樂威科-KY,生技醫療業
2024-06-30,4154,CurrentLiabilities_per,57.73,流動負債合計,樂威科-KY,生技醫療業
2024-06-30,4154,NoncurrentLiabilities,2733000.0,非流動負債合計,樂威科-KY,生技醫療業
2024-06-30,4154,NoncurrentLiabilities_per,0.65,非流動負債合計,樂威科-KY,生技醫療業
2024-06-30,4154,OrdinaryShare,246616000.0,普通股股本,樂威科-KY,生技醫療業
2024-06-30,4154,OrdinaryShare_per,58.25,普通股股本,樂威科-KY,生技醫療業
2024-06-30,4154,CapitalStock,246616000.0,股本合計,樂威科-KY,生技醫療業
2024-06-30,4154,CapitalStock_per,58.25,股本合計,樂威科-KY,生技醫療業
2024-06-30,4154,CapitalSurplus,0.0,資本公積合計,樂威科-KY,生技醫療業
2024-06-30,4154,CapitalSurplus_per,0.0,資本公積合計,樂威科-KY,生技醫療業
2024-06-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-57429000.0,未分配盈餘,樂威科-KY,生技醫療業
2024-06-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-13.56,未分配盈餘,樂威科-KY,生技醫療業
2024-06-30,4154,RetainedEarnings,-57429000.0,保留盈餘合計,樂威科-KY,生技醫療業
2024-06-30,4154,RetainedEarnings_per,-13.56,保留盈餘合計,樂威科-KY,生技醫療業
2024-06-30,4154,OtherEquityInterest,-31934000.0,其他權益合計,樂威科-KY,生技醫療業
2024-06-30,4154,OtherEquityInterest_per,-7.54,其他權益合計,樂威科-KY,生技醫療業
2024-06-30,4154,EquityAttributableToOwnersOfParent,157253000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2024-06-30,4154,EquityAttributableToOwnersOfParent_per,37.14,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2024-06-30,4154,NoncontrollingInterests,18999000.0,非控制權益,樂威科-KY,生技醫療業
2024-06-30,4154,NoncontrollingInterests_per,4.49,非控制權益,樂威科-KY,生技醫療業
2024-06-30,4154,TotalLiabilitiesEquity,423393000.0,負債及權益總計,樂威科-KY,生技醫療業
2024-06-30,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2024-06-30,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2024-06-30,4154,CurrentIncomeTaxAssets,432000.0,本期所得稅資產,樂威科-KY,生技醫療業
2024-06-30,4154,CurrentIncomeTaxAssets_per,0.1,本期所得稅資產,樂威科-KY,生技醫療業
2024-06-30,4154,Liabilities,247141000.0,負債總額,樂威科-KY,生技醫療業
2024-06-30,4154,Liabilities_per,58.37,負債總額,樂威科-KY,生技醫療業
2024-06-30,4154,Equity,176252000.0,權益總額,樂威科-KY,生技醫療業
2024-06-30,4154,Equity_per,41.63,權益總額,樂威科-KY,生技醫療業
2024-09-30,4154,CashAndCashEquivalents,172456000.0,現金及約當現金,樂威科-KY,生技醫療業
2024-09-30,4154,CashAndCashEquivalents_per,34.38,現金及約當現金,樂威科-KY,生技醫療業
2024-09-30,4154,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2024-09-30,4154,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2024-09-30,4154,AccountsReceivableNet,2203000.0,應收帳款淨額,樂威科-KY,生技醫療業
2024-09-30,4154,AccountsReceivableNet_per,0.44,應收帳款淨額,樂威科-KY,生技醫療業
2024-09-30,4154,AccountsReceivableDuefromRelatedPartiesNet,6526000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2024-09-30,4154,AccountsReceivableDuefromRelatedPartiesNet_per,1.3,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2024-09-30,4154,Inventories,26882000.0,存貨,樂威科-KY,生技醫療業
2024-09-30,4154,Inventories_per,5.36,存貨,樂威科-KY,生技醫療業
2024-09-30,4154,OtherCurrentAssets,4384000.0,其他流動資產,樂威科-KY,生技醫療業
2024-09-30,4154,OtherCurrentAssets_per,0.87,其他流動資產,樂威科-KY,生技醫療業
2024-09-30,4154,CurrentAssets,286767000.0,流動資產合計,樂威科-KY,生技醫療業
2024-09-30,4154,CurrentAssets_per,57.17,流動資產合計,樂威科-KY,生技醫療業
2024-09-30,4154,InvestmentAccountedForUsingEquityMethod,5806000.0,採用權益法之投資,樂威科-KY,生技醫療業
2024-09-30,4154,InvestmentAccountedForUsingEquityMethod_per,1.16,採用權益法之投資,樂威科-KY,生技醫療業
2024-09-30,4154,PropertyPlantAndEquipment,197317000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2024-09-30,4154,PropertyPlantAndEquipment_per,39.34,不動產、廠房及設備,樂威科-KY,生技醫療業
2024-09-30,4154,RightOfUseAsset,4363000.0,使用權資產,樂威科-KY,生技醫療業
2024-09-30,4154,RightOfUseAsset_per,0.87,使用權資產,樂威科-KY,生技醫療業
2024-09-30,4154,IntangibleAssets,5186000.0,無形資產,樂威科-KY,生技醫療業
2024-09-30,4154,IntangibleAssets_per,1.03,無形資產,樂威科-KY,生技醫療業
2024-09-30,4154,DeferredTaxAssets,0.0,遞延所得稅資產,樂威科-KY,生技醫療業
2024-09-30,4154,DeferredTaxAssets_per,0.0,遞延所得稅資產,樂威科-KY,生技醫療業
2024-09-30,4154,OtherNoncurrentAssets,2187000.0,其他非流動資產,樂威科-KY,生技醫療業
2024-09-30,4154,OtherNoncurrentAssets_per,0.44,其他非流動資產,樂威科-KY,生技醫療業
2024-09-30,4154,NoncurrentAssets,214859000.0,非流動資產合計,樂威科-KY,生技醫療業
2024-09-30,4154,NoncurrentAssets_per,42.83,非流動資產合計,樂威科-KY,生技醫療業
2024-09-30,4154,TotalAssets,501626000.0,資產總額,樂威科-KY,生技醫療業
2024-09-30,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2024-09-30,4154,ShorttermBorrowings,0.0,短期借款,樂威科-KY,生技醫療業
2024-09-30,4154,ShorttermBorrowings_per,0.0,短期借款,樂威科-KY,生技醫療業
2024-09-30,4154,AccountsPayable,1453000.0,應付帳款,樂威科-KY,生技醫療業
2024-09-30,4154,AccountsPayable_per,0.29,應付帳款,樂威科-KY,生技醫療業
2024-09-30,4154,AccountsPayableToRelatedParties,115720000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2024-09-30,4154,AccountsPayableToRelatedParties_per,23.07,應付帳款－關係人,樂威科-KY,生技醫療業
2024-09-30,4154,OtherPayables,10492000.0,其他應付款,樂威科-KY,生技醫療業
2024-09-30,4154,OtherPayables_per,2.09,其他應付款,樂威科-KY,生技醫療業
2024-09-30,4154,CurrentTaxLiabilities,0.0,本期所得稅負債,樂威科-KY,生技醫療業
2024-09-30,4154,CurrentTaxLiabilities_per,0.0,本期所得稅負債,樂威科-KY,生技醫療業
2024-09-30,4154,OtherCurrentLiabilities,76148000.0,其他流動負債,樂威科-KY,生技醫療業
2024-09-30,4154,OtherCurrentLiabilities_per,15.18,其他流動負債,樂威科-KY,生技醫療業
2024-09-30,4154,CurrentLiabilities,224844000.0,流動負債合計,樂威科-KY,生技醫療業
2024-09-30,4154,CurrentLiabilities_per,44.82,流動負債合計,樂威科-KY,生技醫療業
2024-09-30,4154,NoncurrentLiabilities,3511000.0,非流動負債合計,樂威科-KY,生技醫療業
2024-09-30,4154,NoncurrentLiabilities_per,0.7,非流動負債合計,樂威科-KY,生技醫療業
2024-09-30,4154,OrdinaryShare,308276000.0,普通股股本,樂威科-KY,生技醫療業
2024-09-30,4154,OrdinaryShare_per,61.46,普通股股本,樂威科-KY,生技醫療業
2024-09-30,4154,CapitalStock,308276000.0,股本合計,樂威科-KY,生技醫療業
2024-09-30,4154,CapitalStock_per,61.46,股本合計,樂威科-KY,生技醫療業
2024-09-30,4154,CapitalSurplusAdditionalPaidInCapital,38229000.0,資本公積－發行溢價,樂威科-KY,生技醫療業
2024-09-30,4154,CapitalSurplusAdditionalPaidInCapital_per,7.62,資本公積－發行溢價,樂威科-KY,生技醫療業
2024-09-30,4154,CapitalSurplus,38229000.0,資本公積合計,樂威科-KY,生技醫療業
2024-09-30,4154,CapitalSurplus_per,7.62,資本公積合計,樂威科-KY,生技醫療業
2024-09-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-80167000.0,未分配盈餘,樂威科-KY,生技醫療業
2024-09-30,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-15.98,未分配盈餘,樂威科-KY,生技醫療業
2024-09-30,4154,RetainedEarnings,-80167000.0,保留盈餘合計,樂威科-KY,生技醫療業
2024-09-30,4154,RetainedEarnings_per,-15.98,保留盈餘合計,樂威科-KY,生技醫療業
2024-09-30,4154,OtherEquityInterest,-13070000.0,其他權益合計,樂威科-KY,生技醫療業
2024-09-30,4154,OtherEquityInterest_per,-2.61,其他權益合計,樂威科-KY,生技醫療業
2024-09-30,4154,EquityAttributableToOwnersOfParent,253268000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2024-09-30,4154,EquityAttributableToOwnersOfParent_per,50.49,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2024-09-30,4154,NoncontrollingInterests,20003000.0,非控制權益,樂威科-KY,生技醫療業
2024-09-30,4154,NoncontrollingInterests_per,3.99,非控制權益,樂威科-KY,生技醫療業
2024-09-30,4154,TotalLiabilitiesEquity,501626000.0,負債及權益總計,樂威科-KY,生技醫療業
2024-09-30,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2024-09-30,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2024-09-30,4154,CurrentIncomeTaxAssets,307000.0,本期所得稅資產,樂威科-KY,生技醫療業
2024-09-30,4154,CurrentIncomeTaxAssets_per,0.06,本期所得稅資產,樂威科-KY,生技醫療業
2024-09-30,4154,Equity,273271000.0,權益總額,樂威科-KY,生技醫療業
2024-09-30,4154,Equity_per,54.48,權益總額,樂威科-KY,生技醫療業
2024-09-30,4154,Liabilities,228355000.0,負債總額,樂威科-KY,生技醫療業
2024-09-30,4154,Liabilities_per,45.52,負債總額,樂威科-KY,生技醫療業
2024-12-31,4154,CashAndCashEquivalents,163439000.0,現金及約當現金,樂威科-KY,生技醫療業
2024-12-31,4154,CashAndCashEquivalents_per,35.69,現金及約當現金,樂威科-KY,生技醫療業
2024-12-31,4154,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2024-12-31,4154,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,樂威科-KY,生技醫療業
2024-12-31,4154,AccountsReceivableNet,2892000.0,應收帳款淨額,樂威科-KY,生技醫療業
2024-12-31,4154,AccountsReceivableNet_per,0.63,應收帳款淨額,樂威科-KY,生技醫療業
2024-12-31,4154,AccountsReceivableDuefromRelatedPartiesNet,5297000.0,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2024-12-31,4154,AccountsReceivableDuefromRelatedPartiesNet_per,1.16,應收帳款－關係人淨額,樂威科-KY,生技醫療業
2024-12-31,4154,Inventories,19359000.0,存貨,樂威科-KY,生技醫療業
2024-12-31,4154,Inventories_per,4.23,存貨,樂威科-KY,生技醫療業
2024-12-31,4154,OtherCurrentAssets,4780000.0,其他流動資產,樂威科-KY,生技醫療業
2024-12-31,4154,OtherCurrentAssets_per,1.04,其他流動資產,樂威科-KY,生技醫療業
2024-12-31,4154,CurrentAssets,196069000.0,流動資產合計,樂威科-KY,生技醫療業
2024-12-31,4154,CurrentAssets_per,42.82,流動資產合計,樂威科-KY,生技醫療業
2024-12-31,4154,InvestmentAccountedForUsingEquityMethod,4164000.0,採用權益法之投資,樂威科-KY,生技醫療業
2024-12-31,4154,InvestmentAccountedForUsingEquityMethod_per,0.91,採用權益法之投資,樂威科-KY,生技醫療業
2024-12-31,4154,PropertyPlantAndEquipment,247431000.0,不動產、廠房及設備,樂威科-KY,生技醫療業
2024-12-31,4154,PropertyPlantAndEquipment_per,54.04,不動產、廠房及設備,樂威科-KY,生技醫療業
2024-12-31,4154,RightOfUseAsset,3953000.0,使用權資產,樂威科-KY,生技醫療業
2024-12-31,4154,RightOfUseAsset_per,0.86,使用權資產,樂威科-KY,生技醫療業
2024-12-31,4154,IntangibleAssets,4802000.0,無形資產,樂威科-KY,生技醫療業
2024-12-31,4154,IntangibleAssets_per,1.05,無形資產,樂威科-KY,生技醫療業
2024-12-31,4154,DeferredTaxAssets,59000.0,遞延所得稅資產,樂威科-KY,生技醫療業
2024-12-31,4154,DeferredTaxAssets_per,0.01,遞延所得稅資產,樂威科-KY,生技醫療業
2024-12-31,4154,OtherNoncurrentAssets,1411000.0,其他非流動資產,樂威科-KY,生技醫療業
2024-12-31,4154,OtherNoncurrentAssets_per,0.31,其他非流動資產,樂威科-KY,生技醫療業
2024-12-31,4154,NoncurrentAssets,261820000.0,非流動資產合計,樂威科-KY,生技醫療業
2024-12-31,4154,NoncurrentAssets_per,57.18,非流動資產合計,樂威科-KY,生技醫療業
2024-12-31,4154,TotalAssets,457889000.0,資產總額,樂威科-KY,生技醫療業
2024-12-31,4154,TotalAssets_per,100.0,資產總額,樂威科-KY,生技醫療業
2024-12-31,4154,ShorttermBorrowings,0.0,短期借款,樂威科-KY,生技醫療業
2024-12-31,4154,ShorttermBorrowings_per,0.0,短期借款,樂威科-KY,生技醫療業
2024-12-31,4154,AccountsPayable,2379000.0,應付帳款,樂威科-KY,生技醫療業
2024-12-31,4154,AccountsPayable_per,0.52,應付帳款,樂威科-KY,生技醫療業
2024-12-31,4154,AccountsPayableToRelatedParties,118833000.0,應付帳款－關係人,樂威科-KY,生技醫療業
2024-12-31,4154,AccountsPayableToRelatedParties_per,25.95,應付帳款－關係人,樂威科-KY,生技醫療業
2024-12-31,4154,OtherPayables,7328000.0,其他應付款,樂威科-KY,生技醫療業
2024-12-31,4154,OtherPayables_per,1.6,其他應付款,樂威科-KY,生技醫療業
2024-12-31,4154,CurrentTaxLiabilities,0.0,本期所得稅負債,樂威科-KY,生技醫療業
2024-12-31,4154,CurrentTaxLiabilities_per,0.0,本期所得稅負債,樂威科-KY,生技醫療業
2024-12-31,4154,OtherCurrentLiabilities,602000.0,其他流動負債,樂威科-KY,生技醫療業
2024-12-31,4154,OtherCurrentLiabilities_per,0.13,其他流動負債,樂威科-KY,生技醫療業
2024-12-31,4154,CurrentLiabilities,143058000.0,流動負債合計,樂威科-KY,生技醫療業
2024-12-31,4154,CurrentLiabilities_per,31.24,流動負債合計,樂威科-KY,生技醫療業
2024-12-31,4154,OtherNoncurrentLiabilities,77970000.0,其他非流動負債,樂威科-KY,生技醫療業
2024-12-31,4154,OtherNoncurrentLiabilities_per,17.03,其他非流動負債,樂威科-KY,生技醫療業
2024-12-31,4154,NoncurrentLiabilities,80381000.0,非流動負債合計,樂威科-KY,生技醫療業
2024-12-31,4154,NoncurrentLiabilities_per,17.55,非流動負債合計,樂威科-KY,生技醫療業
2024-12-31,4154,OrdinaryShare,308276000.0,普通股股本,樂威科-KY,生技醫療業
2024-12-31,4154,OrdinaryShare_per,67.33,普通股股本,樂威科-KY,生技醫療業
2024-12-31,4154,CapitalStock,308276000.0,股本合計,樂威科-KY,生技醫療業
2024-12-31,4154,CapitalStock_per,67.33,股本合計,樂威科-KY,生技醫療業
2024-12-31,4154,CapitalSurplusAdditionalPaidInCapital,38229000.0,資本公積－發行溢價,樂威科-KY,生技醫療業
2024-12-31,4154,CapitalSurplusAdditionalPaidInCapital_per,8.35,資本公積－發行溢價,樂威科-KY,生技醫療業
2024-12-31,4154,CapitalSurplus,38229000.0,資本公積合計,樂威科-KY,生技醫療業
2024-12-31,4154,CapitalSurplus_per,8.35,資本公積合計,樂威科-KY,生技醫療業
2024-12-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit,-124789000.0,未分配盈餘,樂威科-KY,生技醫療業
2024-12-31,4154,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-27.25,未分配盈餘,樂威科-KY,生技醫療業
2024-12-31,4154,RetainedEarnings,-124789000.0,保留盈餘合計,樂威科-KY,生技醫療業
2024-12-31,4154,RetainedEarnings_per,-27.25,保留盈餘合計,樂威科-KY,生技醫療業
2024-12-31,4154,OtherEquityInterest,-480000.0,其他權益合計,樂威科-KY,生技醫療業
2024-12-31,4154,OtherEquityInterest_per,-0.1,其他權益合計,樂威科-KY,生技醫療業
2024-12-31,4154,EquityAttributableToOwnersOfParent,221236000.0,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2024-12-31,4154,EquityAttributableToOwnersOfParent_per,48.32,歸屬於母公司業主之權益合計,樂威科-KY,生技醫療業
2024-12-31,4154,NoncontrollingInterests,13214000.0,非控制權益,樂威科-KY,生技醫療業
2024-12-31,4154,NoncontrollingInterests_per,2.89,非控制權益,樂威科-KY,生技醫療業
2024-12-31,4154,TotalLiabilitiesEquity,457889000.0,負債及權益總計,樂威科-KY,生技醫療業
2024-12-31,4154,TotalLiabilitiesEquity_per,100.0,負債及權益總計,樂威科-KY,生技醫療業
2024-12-31,4154,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,樂威科-KY,生技醫療業
2024-12-31,4154,CurrentIncomeTaxAssets,302000.0,本期所得稅資產,樂威科-KY,生技醫療業
2024-12-31,4154,CurrentIncomeTaxAssets_per,0.07,本期所得稅資產,樂威科-KY,生技醫療業
2024-12-31,4154,Equity,234450000.0,權益總額,樂威科-KY,生技醫療業
2024-12-31,4154,Equity_per,51.2,權益總額,樂威科-KY,生技醫療業
2024-12-31,4154,Liabilities,223439000.0,負債總額,樂威科-KY,生技醫療業
2024-12-31,4154,Liabilities_per,48.8,負債總額,樂威科-KY,生技醫療業
2019-03-31,4154,ReceivableIncrease,-46213000.0,應收帳款（增加）減少,樂威科-KY,生技醫療業
2019-03-31,4154,PropertyAndPlantAndEquipment,-247000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2019-03-31,4154,NetIncomeBeforeTax,-301000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2019-03-31,4154,CashProvidedByInvestingActivities,-88000.0,投資活動之淨現金流入(流出),樂威科-KY,生技醫療業
2019-03-31,4154,InterestExpense,1396000.0,利息費用,樂威科-KY,生技醫療業
2019-03-31,4154,CashFlowsFromOperatingActivities,-25837000.0,營業活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2019-03-31,4154,CashBalancesEndOfPeriod,149727000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2019-03-31,4154,CashBalancesBeginningOfPeriod,181605000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2019-03-31,4154,CashBalancesIncrease,-31878000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2019-03-31,4154,InventoryIncrease,10392000.0,存貨(增加)減少,樂威科-KY,生技醫療業
2019-03-31,4154,CashFlowsProvidedFromFinancingActivities,-8981000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2019-03-31,4154,Depreciation,7035000.0,折舊費用,樂威科-KY,生技醫療業
2019-03-31,4154,OtherNonCurrentLiabilitiesIncrease,1707000.0,其他流動資產(增加)減少,樂威科-KY,生技醫療業
2019-03-31,4154,TotalIncomeLossItems,8185000.0,收益費損項目合計,樂威科-KY,生技醫療業
2019-03-31,4154,RentalPrincipalRepayments,-4235000.0,租賃本金償還,樂威科-KY,生技醫療業
2019-03-31,4154,AmortizationExpense,797000.0,攤銷費用,樂威科-KY,生技醫療業
2019-03-31,4154,RepaymentOfLongTermDebt,-114000.0,償還長期借款,樂威科-KY,生技醫療業
2019-03-31,4154,DecreaseInShortTermLoans,-10037000.0,短期借款減少,樂威科-KY,生技醫療業
2019-03-31,4154,AccountsPayable,-4893000.0,應付帳款增加(減少),樂威科-KY,生技醫療業
2019-03-31,4154,InterestIncome,-46000.0,利息收入,樂威科-KY,生技醫療業
2019-03-31,4154,DecreaseInDepositDeposit,159000.0,存出保證金減少,樂威科-KY,生技醫療業
2019-03-31,4154,CashReceivedThroughOperations,-24272000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2019-03-31,4154,PayTheInterest,-1304000.0,支付之利息,樂威科-KY,生技醫療業
2019-03-31,4154,IncomeBeforeIncomeTaxFromContinuingOperations,-301000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2019-06-30,4154,PropertyAndPlantAndEquipment,-5333000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2019-06-30,4154,NetIncomeBeforeTax,-23018000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2019-06-30,4154,InterestExpense,2766000.0,利息費用,樂威科-KY,生技醫療業
2019-06-30,4154,CashFlowsFromOperatingActivities,1497000.0,營業活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2019-06-30,4154,CashBalancesEndOfPeriod,142336000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2019-06-30,4154,CashBalancesBeginningOfPeriod,181605000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2019-06-30,4154,CashBalancesIncrease,-39269000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2019-06-30,4154,InventoryIncrease,11488000.0,存貨(增加)減少,樂威科-KY,生技醫療業
2019-06-30,4154,CashFlowsProvidedFromFinancingActivities,-38101000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2019-06-30,4154,Depreciation,15203000.0,折舊費用,樂威科-KY,生技醫療業
2019-06-30,4154,OtherNonCurrentLiabilitiesIncrease,-866000.0,其他流動資產(增加)減少,樂威科-KY,生技醫療業
2019-06-30,4154,TotalIncomeLossItems,19156000.0,收益費損項目合計,樂威科-KY,生技醫療業
2019-06-30,4154,RentalPrincipalRepayments,-9550000.0,租賃本金償還,樂威科-KY,生技醫療業
2019-06-30,4154,AmortizationExpense,1595000.0,攤銷費用,樂威科-KY,生技醫療業
2019-06-30,4154,RepaymentOfLongTermDebt,-319000.0,償還長期借款,樂威科-KY,生技醫療業
2019-06-30,4154,DecreaseInShortTermLoans,-32343000.0,短期借款減少,樂威科-KY,生技醫療業
2019-06-30,4154,AccountsPayable,43306000.0,應付帳款增加(減少),樂威科-KY,生技醫療業
2019-06-30,4154,InterestIncome,-267000.0,利息收入,樂威科-KY,生技醫療業
2019-06-30,4154,CashReceivedThroughOperations,2018000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2019-06-30,4154,PayTheInterest,-2598000.0,支付之利息,樂威科-KY,生技醫療業
2019-06-30,4154,IncomeBeforeIncomeTaxFromContinuingOperations,-23018000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2019-06-30,4154,ReceivableIncrease,-59307000.0,應收帳款(增加)減少,樂威科-KY,生技醫療業
2019-06-30,4154,CashProvidedByInvestingActivities,-5675000.0,投資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2019-06-30,4154,DecreaseInDepositDeposit,-342000.0,存出保證金減少,樂威科-KY,生技醫療業
2019-09-30,4154,DecreaseInShortTermLoans,13721000.0,短期借款減少,樂威科-KY,生技醫療業
2019-09-30,4154,CashBalancesBeginningOfPeriod,181605000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2019-09-30,4154,PropertyAndPlantAndEquipment,-9352000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2019-09-30,4154,PayTheInterest,-3413000.0,支付之利息,樂威科-KY,生技醫療業
2019-09-30,4154,CashProvidedByInvestingActivities,-9716000.0,投資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2019-09-30,4154,CashBalancesEndOfPeriod,142002000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2019-09-30,4154,OtherNonCurrentLiabilitiesIncrease,3868000.0,其他流動資產(增加)減少,樂威科-KY,生技醫療業
2019-09-30,4154,CashBalancesIncrease,-39603000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2019-09-30,4154,IncomeBeforeIncomeTaxFromContinuingOperations,-33914000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2019-09-30,4154,RepaymentOfLongTermDebt,-455000.0,償還長期借款,樂威科-KY,生技醫療業
2019-09-30,4154,NetIncomeBeforeTax,-33914000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2019-09-30,4154,CashFlowsFromOperatingActivities,-3983000.0,營業活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2019-09-30,4154,Depreciation,23066000.0,折舊費用,樂威科-KY,生技醫療業
2019-09-30,4154,AmortizationExpense,2944000.0,攤銷費用,樂威科-KY,生技醫療業
2019-09-30,4154,AccountsPayable,44372000.0,應付帳款增加(減少),樂威科-KY,生技醫療業
2019-09-30,4154,DecreaseInDepositDeposit,0.0,存出保證金減少,樂威科-KY,生技醫療業
2019-09-30,4154,InterestExpense,3666000.0,利息費用,樂威科-KY,生技醫療業
2019-09-30,4154,TotalIncomeLossItems,30533000.0,收益費損項目合計,樂威科-KY,生技醫療業
2019-09-30,4154,ReceivableIncrease,-30264000.0,應收帳款（增加）減少,樂威科-KY,生技醫療業
2019-09-30,4154,InventoryIncrease,-16725000.0,存貨（增加）減少,樂威科-KY,生技醫療業
2019-09-30,4154,CashFlowsProvidedFromFinancingActivities,-25466000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2019-09-30,4154,CashReceivedThroughOperations,-2562000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2019-09-30,4154,InterestIncome,-361000.0,利息收入,樂威科-KY,生技醫療業
2019-09-30,4154,RentalPrincipalRepayments,-14654000.0,租賃本金償還,樂威科-KY,生技醫療業
2019-12-31,4154,PropertyAndPlantAndEquipment,-12061000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2019-12-31,4154,NetIncomeBeforeTax,-53153000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2019-12-31,4154,InterestExpense,5121000.0,利息費用,樂威科-KY,生技醫療業
2019-12-31,4154,CashFlowsFromOperatingActivities,30493000.0,營業活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2019-12-31,4154,CashBalancesEndOfPeriod,172648000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2019-12-31,4154,CashBalancesBeginningOfPeriod,181605000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2019-12-31,4154,CashBalancesIncrease,-8957000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2019-12-31,4154,InventoryIncrease,2288000.0,存貨(增加)減少,樂威科-KY,生技醫療業
2019-12-31,4154,CashFlowsProvidedFromFinancingActivities,-21691000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2019-12-31,4154,Depreciation,32772000.0,折舊費用,樂威科-KY,生技醫療業
2019-12-31,4154,OtherNonCurrentLiabilitiesIncrease,1609000.0,其他流動資產(增加)減少,樂威科-KY,生技醫療業
2019-12-31,4154,TotalIncomeLossItems,41726000.0,收益費損項目合計,樂威科-KY,生技醫療業
2019-12-31,4154,RentalPrincipalRepayments,-20245000.0,租賃本金償還,樂威科-KY,生技醫療業
2019-12-31,4154,AmortizationExpense,4284000.0,攤銷費用,樂威科-KY,生技醫療業
2019-12-31,4154,RepaymentOfLongTermDebt,-589000.0,償還長期借款,樂威科-KY,生技醫療業
2019-12-31,4154,DecreaseInShortTermLoans,-20296000.0,短期借款減少,樂威科-KY,生技醫療業
2019-12-31,4154,AccountsPayable,74594000.0,應付帳款增加(減少),樂威科-KY,生技醫療業
2019-12-31,4154,InterestIncome,-774000.0,利息收入,樂威科-KY,生技醫療業
2019-12-31,4154,DecreaseInDepositDeposit,0.0,存出保證金減少,樂威科-KY,生技醫療業
2019-12-31,4154,CashReceivedThroughOperations,29235000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2019-12-31,4154,PayTheInterest,-4780000.0,支付之利息,樂威科-KY,生技醫療業
2019-12-31,4154,IncomeBeforeIncomeTaxFromContinuingOperations,-53153000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2019-12-31,4154,ReceivableIncrease,-39460000.0,應收帳款（增加）減少,樂威科-KY,生技醫療業
2019-12-31,4154,CashProvidedByInvestingActivities,-15661000.0,投資活動之淨現金流入(流出),樂威科-KY,生技醫療業
2020-03-31,4154,AmortizationExpense,20000.0,攤銷費用,樂威科-KY,生技醫療業
2020-03-31,4154,CashBalancesBeginningOfPeriod,172648000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2020-03-31,4154,CashBalancesEndOfPeriod,209431000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2020-03-31,4154,CashBalancesIncrease,36783000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2020-03-31,4154,CashFlowsProvidedFromFinancingActivities,22984000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2020-03-31,4154,DecreaseInDepositDeposit,0.0,存出保證金減少,樂威科-KY,生技醫療業
2020-03-31,4154,Depreciation,4397000.0,折舊費用,樂威科-KY,生技醫療業
2020-03-31,4154,IncomeBeforeIncomeTaxFromContinuingOperations,24158000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2020-03-31,4154,InterestExpense,1036000.0,利息費用,樂威科-KY,生技醫療業
2020-03-31,4154,NetIncomeBeforeTax,24158000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2020-03-31,4154,OtherNonCurrentLiabilitiesIncrease,0.0,其他流動資產(增加)減少,樂威科-KY,生技醫療業
2020-03-31,4154,CashProvidedByInvestingActivities,26050000.0,投資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2020-03-31,4154,InventoryIncrease,-152000.0,存貨(增加)減少,樂威科-KY,生技醫療業
2020-03-31,4154,ReceivableIncrease,-18146000.0,應收帳款(增加)減少,樂威科-KY,生技醫療業
2020-03-31,4154,CashReceivedThroughOperations,-13580000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2020-03-31,4154,InterestIncome,-147000.0,利息收入,樂威科-KY,生技醫療業
2020-03-31,4154,DecreaseInShortTermLoans,-1499000.0,短期借款減少,樂威科-KY,生技醫療業
2020-03-31,4154,RepaymentOfLongTermDebt,-87000.0,償還長期借款,樂威科-KY,生技醫療業
2020-03-31,4154,RentalPrincipalRepayments,-3919000.0,租賃本金償還,樂威科-KY,生技醫療業
2020-03-31,4154,PayTheInterest,-934000.0,支付之利息,樂威科-KY,生技醫療業
2020-03-31,4154,PropertyAndPlantAndEquipment,-680000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2020-03-31,4154,TotalIncomeLossItems,-838000.0,收益費損項目合計,樂威科-KY,生技醫療業
2020-03-31,4154,CashFlowsFromOperatingActivities,-13446000.0,營業活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2020-03-31,4154,AccountsPayable,-19341000.0,應付帳款增加(減少),樂威科-KY,生技醫療業
2020-06-30,4154,AmortizationExpense,52000.0,攤銷費用,樂威科-KY,生技醫療業
2020-06-30,4154,CashBalancesBeginningOfPeriod,172648000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2020-06-30,4154,CashBalancesEndOfPeriod,194521000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2020-06-30,4154,CashBalancesIncrease,21873000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2020-06-30,4154,CashFlowsProvidedFromFinancingActivities,20615000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2020-06-30,4154,DecreaseInShortTermLoans,0.0,短期借款減少,樂威科-KY,生技醫療業
2020-06-30,4154,Depreciation,8955000.0,折舊費用,樂威科-KY,生技醫療業
2020-06-30,4154,IncomeBeforeIncomeTaxFromContinuingOperations,17310000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2020-06-30,4154,InterestExpense,1721000.0,利息費用,樂威科-KY,生技醫療業
2020-06-30,4154,InventoryIncrease,11381000.0,存貨(增加)減少,樂威科-KY,生技醫療業
2020-06-30,4154,NetIncomeBeforeTax,17310000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2020-06-30,4154,TotalIncomeLossItems,1094000.0,收益費損項目合計,樂威科-KY,生技醫療業
2020-06-30,4154,ProceedsFromLongTermDebt,0.0,舉借長期借款,樂威科-KY,生技醫療業
2020-06-30,4154,RentalPrincipalRepayments,-7021000.0,租賃本金償還,樂威科-KY,生技醫療業
2020-06-30,4154,InterestIncome,-253000.0,利息收入,樂威科-KY,生技醫療業
2020-06-30,4154,OtherNonCurrentLiabilitiesIncrease,-5105000.0,其他流動資產(增加)減少,樂威科-KY,生技醫療業
2020-06-30,4154,CashReceivedThroughOperations,-9128000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2020-06-30,4154,PayTheInterest,-1459000.0,支付之利息,樂威科-KY,生技醫療業
2020-06-30,4154,RepaymentOfLongTermDebt,-172000.0,償還長期借款,樂威科-KY,生技醫療業
2020-06-30,4154,AccountsPayable,-18942000.0,應付帳款增加(減少),樂威科-KY,生技醫療業
2020-06-30,4154,PropertyAndPlantAndEquipment,-1848000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2020-06-30,4154,ReceivableIncrease,-17976000.0,應收帳款（增加）減少,樂威科-KY,生技醫療業
2020-06-30,4154,CashProvidedByInvestingActivities,7766000.0,投資活動之淨現金流入(流出),樂威科-KY,生技醫療業
2020-06-30,4154,CashFlowsFromOperatingActivities,-10133000.0,營業活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2020-06-30,4154,DecreaseInDepositDeposit,-644000.0,存出保證金減少,樂威科-KY,生技醫療業
2020-09-30,4154,AmortizationExpense,93000.0,攤銷費用,樂威科-KY,生技醫療業
2020-09-30,4154,CashBalancesBeginningOfPeriod,172648000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2020-09-30,4154,CashBalancesEndOfPeriod,195466000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2020-09-30,4154,CashBalancesIncrease,22818000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2020-09-30,4154,CashFlowsProvidedFromFinancingActivities,66326000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2020-09-30,4154,CashReceivedThroughOperations,5537000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2020-09-30,4154,Depreciation,13817000.0,折舊費用,樂威科-KY,生技醫療業
2020-09-30,4154,InterestExpense,2504000.0,利息費用,樂威科-KY,生技醫療業
2020-09-30,4154,TotalIncomeLossItems,14068000.0,收益費損項目合計,樂威科-KY,生技醫療業
2020-09-30,4154,ProceedsFromLongTermDebt,0.0,舉借長期借款,樂威科-KY,生技醫療業
2020-09-30,4154,RentalPrincipalRepayments,-10412000.0,租賃本金償還,樂威科-KY,生技醫療業
2020-09-30,4154,DecreaseInShortTermLoans,-16340000.0,短期借款減少,樂威科-KY,生技醫療業
2020-09-30,4154,InterestIncome,-266000.0,利息收入,樂威科-KY,生技醫療業
2020-09-30,4154,OtherNonCurrentLiabilitiesIncrease,-3704000.0,其他流動資產(增加)減少,樂威科-KY,生技醫療業
2020-09-30,4154,InventoryIncrease,24099000.0,存貨(增加)減少,樂威科-KY,生技醫療業
2020-09-30,4154,PayTheInterest,-2163000.0,支付之利息,樂威科-KY,生技醫療業
2020-09-30,4154,ReceivableIncrease,-28953000.0,應收帳款(增加)減少,樂威科-KY,生技醫療業
2020-09-30,4154,RepaymentOfLongTermDebt,-236000.0,償還長期借款,樂威科-KY,生技醫療業
2020-09-30,4154,IncomeBeforeIncomeTaxFromContinuingOperations,-5133000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2020-09-30,4154,AccountsPayable,-6339000.0,應付帳款增加(減少),樂威科-KY,生技醫療業
2020-09-30,4154,PropertyAndPlantAndEquipment,-25686000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2020-09-30,4154,NetIncomeBeforeTax,-5133000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2020-09-30,4154,CashProvidedByInvestingActivities,-40370000.0,投資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2020-09-30,4154,DecreaseInDepositDeposit,0.0,存出保證金減少,樂威科-KY,生技醫療業
2020-09-30,4154,CashFlowsFromOperatingActivities,3961000.0,營業活動之淨現金流入(流出),樂威科-KY,生技醫療業
2020-12-31,4154,InterestExpense,2973000.0,利息費用,樂威科-KY,生技醫療業
2020-12-31,4154,CashBalancesEndOfPeriod,148799000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2020-12-31,4154,CashBalancesBeginningOfPeriod,172648000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2020-12-31,4154,InventoryIncrease,31550000.0,存貨(增加)減少,樂威科-KY,生技醫療業
2020-12-31,4154,CashFlowsProvidedFromFinancingActivities,74499000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2020-12-31,4154,Depreciation,19489000.0,折舊費用,樂威科-KY,生技醫療業
2020-12-31,4154,TotalIncomeLossItems,20784000.0,收益費損項目合計,樂威科-KY,生技醫療業
2020-12-31,4154,AmortizationExpense,295000.0,攤銷費用,樂威科-KY,生技醫療業
2020-12-31,4154,DecreaseInDepositDeposit,0.0,存出保證金減少,樂威科-KY,生技醫療業
2020-12-31,4154,ProceedsFromLongTermDebt,0.0,舉借長期借款,樂威科-KY,生技醫療業
2020-12-31,4154,ReceivableIncrease,-24027000.0,應收帳款（增加）減少,樂威科-KY,生技醫療業
2020-12-31,4154,PropertyAndPlantAndEquipment,-39011000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2020-12-31,4154,NetIncomeBeforeTax,-29614000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2020-12-31,4154,CashProvidedByInvestingActivities,-88614000.0,投資活動之淨現金流入(流出),樂威科-KY,生技醫療業
2020-12-31,4154,CashFlowsFromOperatingActivities,-6337000.0,營業活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2020-12-31,4154,CashBalancesIncrease,-23849000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2020-12-31,4154,OtherNonCurrentLiabilitiesIncrease,-2007000.0,其他流動資產(增加)減少,樂威科-KY,生技醫療業
2020-12-31,4154,RentalPrincipalRepayments,-14435000.0,租賃本金償還,樂威科-KY,生技醫療業
2020-12-31,4154,RepaymentOfLongTermDebt,-320000.0,償還長期借款,樂威科-KY,生技醫療業
2020-12-31,4154,DecreaseInShortTermLoans,-8347000.0,短期借款減少,樂威科-KY,生技醫療業
2020-12-31,4154,AccountsPayable,-1366000.0,應付帳款增加(減少),樂威科-KY,生技醫療業
2020-12-31,4154,InterestIncome,-399000.0,利息收入,樂威科-KY,生技醫療業
2020-12-31,4154,CashReceivedThroughOperations,-4318000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2020-12-31,4154,PayTheInterest,-2519000.0,支付之利息,樂威科-KY,生技醫療業
2020-12-31,4154,IncomeBeforeIncomeTaxFromContinuingOperations,-29614000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2021-03-31,4154,InterestExpense,834000.0,利息費用,樂威科-KY,生技醫療業
2021-03-31,4154,CashFlowsFromOperatingActivities,21251000.0,營業活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2021-03-31,4154,CashBalancesEndOfPeriod,251596000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2021-03-31,4154,CashBalancesBeginningOfPeriod,148799000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2021-03-31,4154,CashBalancesIncrease,102797000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2021-03-31,4154,CashFlowsProvidedFromFinancingActivities,105559000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2021-03-31,4154,Depreciation,5520000.0,折舊費用,樂威科-KY,生技醫療業
2021-03-31,4154,OtherNonCurrentLiabilitiesIncrease,1047000.0,其他流動資產(增加)減少,樂威科-KY,生技醫療業
2021-03-31,4154,TotalIncomeLossItems,4666000.0,收益費損項目合計,樂威科-KY,生技醫療業
2021-03-31,4154,AmortizationExpense,202000.0,攤銷費用,樂威科-KY,生技醫療業
2021-03-31,4154,DecreaseInShortTermLoans,0.0,短期借款減少,樂威科-KY,生技醫療業
2021-03-31,4154,AccountsPayable,22621000.0,應付帳款增加(減少),樂威科-KY,生技醫療業
2021-03-31,4154,DecreaseInDepositDeposit,657000.0,存出保證金減少,樂威科-KY,生技醫療業
2021-03-31,4154,CashReceivedThroughOperations,21856000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2021-03-31,4154,InventoryIncrease,-27045000.0,存貨(增加)減少,樂威科-KY,生技醫療業
2021-03-31,4154,InterestIncome,-33000.0,利息收入,樂威科-KY,生技醫療業
2021-03-31,4154,RepaymentOfLongTermDebt,-84000.0,償還長期借款,樂威科-KY,生技醫療業
2021-03-31,4154,RentalPrincipalRepayments,-3864000.0,租賃本金償還,樂威科-KY,生技醫療業
2021-03-31,4154,PayTheInterest,-1235000.0,支付之利息,樂威科-KY,生技醫療業
2021-03-31,4154,PropertyAndPlantAndEquipment,-13485000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2021-03-31,4154,IncomeBeforeIncomeTaxFromContinuingOperations,-31714000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2021-03-31,4154,NetIncomeBeforeTax,-31714000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2021-03-31,4154,ReceivableIncrease,68960000.0,應收帳款(增加)減少,樂威科-KY,生技醫療業
2021-03-31,4154,CashProvidedByInvestingActivities,-20461000.0,投資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2021-06-30,4154,OtherNonCurrentLiabilitiesIncrease,845000.0,其他流動資產(增加)減少,樂威科-KY,生技醫療業
2021-06-30,4154,CashBalancesEndOfPeriod,212363000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2021-06-30,4154,CashBalancesIncrease,63564000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2021-06-30,4154,CashBalancesBeginningOfPeriod,148799000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2021-06-30,4154,ProceedsFromLongTermDebt,9852000.0,舉借長期借款,樂威科-KY,生技醫療業
2021-06-30,4154,Depreciation,11830000.0,折舊費用,樂威科-KY,生技醫療業
2021-06-30,4154,AmortizationExpense,404000.0,攤銷費用,樂威科-KY,生技醫療業
2021-06-30,4154,AccountsPayable,23003000.0,應付帳款增加(減少),樂威科-KY,生技醫療業
2021-06-30,4154,DecreaseInDepositDeposit,1320000.0,存出保證金減少,樂威科-KY,生技醫療業
2021-06-30,4154,RepaymentOfLongTermDebt,0.0,償還長期借款,樂威科-KY,生技醫療業
2021-06-30,4154,InterestExpense,1367000.0,利息費用,樂威科-KY,生技醫療業
2021-06-30,4154,CashFlowsProvidedFromFinancingActivities,143540000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2021-06-30,4154,DecreaseInShortTermLoans,0.0,短期借款減少,樂威科-KY,生技醫療業
2021-06-30,4154,TotalIncomeLossItems,18542000.0,收益費損項目合計,樂威科-KY,生技醫療業
2021-06-30,4154,PropertyAndPlantAndEquipment,-39195000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2021-06-30,4154,CashProvidedByInvestingActivities,-64296000.0,投資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2021-06-30,4154,RentalPrincipalRepayments,-7430000.0,租賃本金償還,樂威科-KY,生技醫療業
2021-06-30,4154,PayTheInterest,-1251000.0,支付之利息,樂威科-KY,生技醫療業
2021-06-30,4154,IncomeBeforeIncomeTaxFromContinuingOperations,-46212000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2021-06-30,4154,NetIncomeBeforeTax,-46212000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2021-06-30,4154,InterestIncome,-185000.0,利息收入,樂威科-KY,生技醫療業
2021-06-30,4154,CashReceivedThroughOperations,-6587000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2021-06-30,4154,InventoryIncrease,-32703000.0,存貨(增加)減少,樂威科-KY,生技醫療業
2021-06-30,4154,ReceivableIncrease,52805000.0,應收帳款(增加)減少,樂威科-KY,生技醫療業
2021-06-30,4154,CashFlowsFromOperatingActivities,-7920000.0,營業活動之淨現金流入(流出),樂威科-KY,生技醫療業
2021-09-30,4154,OtherNonCurrentLiabilitiesIncrease,-9306000.0,其他流動資產(增加)減少,樂威科-KY,生技醫療業
2021-09-30,4154,PropertyAndPlantAndEquipment,-167003000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2021-09-30,4154,CashBalancesEndOfPeriod,203763000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2021-09-30,4154,CashBalancesIncrease,54964000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2021-09-30,4154,CashProvidedByInvestingActivities,-196503000.0,投資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2021-09-30,4154,CashBalancesBeginningOfPeriod,148799000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2021-09-30,4154,RentalPrincipalRepayments,-11021000.0,租賃本金償還,樂威科-KY,生技醫療業
2021-09-30,4154,PayTheInterest,-2732000.0,支付之利息,樂威科-KY,生技醫療業
2021-09-30,4154,IncomeBeforeIncomeTaxFromContinuingOperations,-67676000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2021-09-30,4154,ProceedsFromLongTermDebt,29778000.0,舉借長期借款,樂威科-KY,生技醫療業
2021-09-30,4154,NetIncomeBeforeTax,-67676000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2021-09-30,4154,CashFlowsFromOperatingActivities,5157000.0,營業活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2021-09-30,4154,Depreciation,19488000.0,折舊費用,樂威科-KY,生技醫療業
2021-09-30,4154,AmortizationExpense,707000.0,攤銷費用,樂威科-KY,生技醫療業
2021-09-30,4154,AccountsPayable,104306000.0,應付帳款增加(減少),樂威科-KY,生技醫療業
2021-09-30,4154,DecreaseInDepositDeposit,3928000.0,存出保證金減少,樂威科-KY,生技醫療業
2021-09-30,4154,RepaymentOfLongTermDebt,0.0,償還長期借款,樂威科-KY,生技醫療業
2021-09-30,4154,InterestExpense,1898000.0,利息費用,樂威科-KY,生技醫療業
2021-09-30,4154,CashFlowsProvidedFromFinancingActivities,254065000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2021-09-30,4154,InterestIncome,-319000.0,利息收入,樂威科-KY,生技醫療業
2021-09-30,4154,DecreaseInShortTermLoans,0.0,短期借款減少,樂威科-KY,生技醫療業
2021-09-30,4154,TotalIncomeLossItems,24440000.0,收益費損項目合計,樂威科-KY,生技醫療業
2021-09-30,4154,CashReceivedThroughOperations,6973000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2021-09-30,4154,InventoryIncrease,-66863000.0,存貨(增加)減少,樂威科-KY,生技醫療業
2021-09-30,4154,ReceivableIncrease,36027000.0,應收帳款(增加)減少,樂威科-KY,生技醫療業
2021-12-31,4154,OtherNonCurrentLiabilitiesIncrease,-8886000.0,其他流動資產(增加)減少,樂威科-KY,生技醫療業
2021-12-31,4154,PropertyAndPlantAndEquipment,-174968000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2021-12-31,4154,CashBalancesEndOfPeriod,198544000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2021-12-31,4154,CashBalancesIncrease,49745000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2021-12-31,4154,CashProvidedByInvestingActivities,-190534000.0,投資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2021-12-31,4154,CashBalancesBeginningOfPeriod,148799000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2021-12-31,4154,RentalPrincipalRepayments,-13014000.0,租賃本金償還,樂威科-KY,生技醫療業
2021-12-31,4154,PayTheInterest,-3207000.0,支付之利息,樂威科-KY,生技醫療業
2021-12-31,4154,IncomeBeforeIncomeTaxFromContinuingOperations,-86316000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2021-12-31,4154,ProceedsFromLongTermDebt,29704000.0,舉借長期借款,樂威科-KY,生技醫療業
2021-12-31,4154,NetIncomeBeforeTax,-86316000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2021-12-31,4154,Depreciation,27390000.0,折舊費用,樂威科-KY,生技醫療業
2021-12-31,4154,AmortizationExpense,1025000.0,攤銷費用,樂威科-KY,生技醫療業
2021-12-31,4154,AccountsPayable,72988000.0,應付帳款增加(減少),樂威科-KY,生技醫療業
2021-12-31,4154,DecreaseInDepositDeposit,2601000.0,存出保證金減少,樂威科-KY,生技醫療業
2021-12-31,4154,RepaymentOfLongTermDebt,0.0,償還長期借款,樂威科-KY,生技醫療業
2021-12-31,4154,InterestExpense,2379000.0,利息費用,樂威科-KY,生技醫療業
2021-12-31,4154,CashFlowsProvidedFromFinancingActivities,238653000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2021-12-31,4154,InterestIncome,-418000.0,利息收入,樂威科-KY,生技醫療業
2021-12-31,4154,DecreaseInShortTermLoans,0.0,短期借款減少,樂威科-KY,生技醫療業
2021-12-31,4154,TotalIncomeLossItems,8913000.0,收益費損項目合計,樂威科-KY,生技醫療業
2021-12-31,4154,CashReceivedThroughOperations,7072000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2021-12-31,4154,InventoryIncrease,-53359000.0,存貨(增加)減少,樂威科-KY,生技醫療業
2021-12-31,4154,ReceivableIncrease,95588000.0,應收帳款(增加)減少,樂威科-KY,生技醫療業
2021-12-31,4154,CashFlowsFromOperatingActivities,5306000.0,營業活動之淨現金流入(流出),樂威科-KY,生技醫療業
2022-03-31,4154,CashReceivedThroughOperations,13094000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2022-03-31,4154,InterestIncome,-37000.0,利息收入,樂威科-KY,生技醫療業
2022-03-31,4154,DecreaseInShortTermLoans,0.0,短期借款減少,樂威科-KY,生技醫療業
2022-03-31,4154,RepaymentOfLongTermDebt,-5833000.0,償還長期借款,樂威科-KY,生技醫療業
2022-03-31,4154,RentalPrincipalRepayments,-1540000.0,租賃本金償還,樂威科-KY,生技醫療業
2022-03-31,4154,OtherNonCurrentLiabilitiesIncrease,-3676000.0,其他流動資產(增加)減少,樂威科-KY,生技醫療業
2022-03-31,4154,PayTheInterest,0.0,支付之利息,樂威科-KY,生技醫療業
2022-03-31,4154,CashBalancesIncrease,59656000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2022-03-31,4154,CashBalancesBeginningOfPeriod,198544000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2022-03-31,4154,CashBalancesEndOfPeriod,258200000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2022-03-31,4154,CashProvidedByInvestingActivities,-26020000.0,投資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2022-03-31,4154,PropertyAndPlantAndEquipment,-19534000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2022-03-31,4154,TotalIncomeLossItems,11733000.0,收益費損項目合計,樂威科-KY,生技醫療業
2022-03-31,4154,CashFlowsProvidedFromFinancingActivities,71598000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2022-03-31,4154,InterestExpense,571000.0,利息費用,樂威科-KY,生技醫療業
2022-03-31,4154,IncomeBeforeIncomeTaxFromContinuingOperations,-3544000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2022-03-31,4154,NetIncomeBeforeTax,-3544000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2022-03-31,4154,CashFlowsFromOperatingActivities,12944000.0,營業活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2022-03-31,4154,AmortizationExpense,357000.0,攤銷費用,樂威科-KY,生技醫療業
2022-03-31,4154,Depreciation,7273000.0,折舊費用,樂威科-KY,生技醫療業
2022-03-31,4154,DecreaseInDepositDeposit,1532000.0,存出保證金減少,樂威科-KY,生技醫療業
2022-03-31,4154,InventoryIncrease,5845000.0,存貨（增加）減少,樂威科-KY,生技醫療業
2022-03-31,4154,ReceivableIncrease,-2414000.0,應收帳款（增加）減少,樂威科-KY,生技醫療業
2022-03-31,4154,NetCashInflowFromOperatingActivities,12944000.0,營業活動之淨現金流入,樂威科-KY,生技醫療業
2022-03-31,4154,AccountsPayable,703000.0,應付帳款,樂威科-KY,生技醫療業
2022-06-30,4154,CashFlowsProvidedFromFinancingActivities,121562000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2022-06-30,4154,ProceedsFromLongTermDebt,0.0,舉借長期借款,樂威科-KY,生技醫療業
2022-06-30,4154,RentalPrincipalRepayments,-3090000.0,租賃本金償還,樂威科-KY,生技醫療業
2022-06-30,4154,DecreaseInShortTermLoans,0.0,短期借款減少,樂威科-KY,生技醫療業
2022-06-30,4154,InterestIncome,-122000.0,利息收入,樂威科-KY,生技醫療業
2022-06-30,4154,OtherNonCurrentLiabilitiesIncrease,-2380000.0,其他流動資產(增加)減少,樂威科-KY,生技醫療業
2022-06-30,4154,CashReceivedThroughOperations,15532000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2022-06-30,4154,PayTheInterest,0.0,支付之利息,樂威科-KY,生技醫療業
2022-06-30,4154,CashBalancesIncrease,77303000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2022-06-30,4154,TotalIncomeLossItems,18911000.0,收益費損項目合計,樂威科-KY,生技醫療業
2022-06-30,4154,InterestExpense,1714000.0,利息費用,樂威科-KY,生技醫療業
2022-06-30,4154,CashBalancesBeginningOfPeriod,198544000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2022-06-30,4154,RepaymentOfLongTermDebt,-13333000.0,償還長期借款,樂威科-KY,生技醫療業
2022-06-30,4154,CashBalancesEndOfPeriod,275847000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2022-06-30,4154,IncomeBeforeIncomeTaxFromContinuingOperations,-2500000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2022-06-30,4154,PropertyAndPlantAndEquipment,-53164000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2022-06-30,4154,NetIncomeBeforeTax,-2500000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2022-06-30,4154,AmortizationExpense,708000.0,攤銷費用,樂威科-KY,生技醫療業
2022-06-30,4154,CashProvidedByInvestingActivities,-63102000.0,投資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2022-06-30,4154,Depreciation,15574000.0,折舊費用,樂威科-KY,生技醫療業
2022-06-30,4154,DecreaseInDepositDeposit,1546000.0,存出保證金減少,樂威科-KY,生技醫療業
2022-06-30,4154,InventoryIncrease,-23957000.0,存貨（增加）減少,樂威科-KY,生技醫療業
2022-06-30,4154,ReceivableIncrease,-19232000.0,應收帳款（增加）減少,樂威科-KY,生技醫療業
2022-06-30,4154,CashFlowsFromOperatingActivities,15116000.0,營業活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2022-06-30,4154,NetCashInflowFromOperatingActivities,15116000.0,營業活動之淨現金流入,樂威科-KY,生技醫療業
2022-06-30,4154,AccountsPayable,46363000.0,應付帳款,樂威科-KY,生技醫療業
2022-09-30,4154,PropertyAndPlantAndEquipment,-72522000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2022-09-30,4154,NetIncomeBeforeTax,-22187000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2022-09-30,4154,InterestExpense,3043000.0,利息費用,樂威科-KY,生技醫療業
2022-09-30,4154,CashFlowsFromOperatingActivities,27886000.0,營業活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2022-09-30,4154,CashBalancesEndOfPeriod,242639000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2022-09-30,4154,CashBalancesBeginningOfPeriod,198544000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2022-09-30,4154,CashBalancesIncrease,44095000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2022-09-30,4154,CashFlowsProvidedFromFinancingActivities,98146000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2022-09-30,4154,Depreciation,25276000.0,折舊費用,樂威科-KY,生技醫療業
2022-09-30,4154,OtherNonCurrentLiabilitiesIncrease,-3948000.0,其他流動資產(增加)減少,樂威科-KY,生技醫療業
2022-09-30,4154,TotalIncomeLossItems,33114000.0,收益費損項目合計,樂威科-KY,生技醫療業
2022-09-30,4154,RentalPrincipalRepayments,-4652000.0,租賃本金償還,樂威科-KY,生技醫療業
2022-09-30,4154,AmortizationExpense,1158000.0,攤銷費用,樂威科-KY,生技醫療業
2022-09-30,4154,RepaymentOfLongTermDebt,-20833000.0,償還長期借款,樂威科-KY,生技醫療業
2022-09-30,4154,ProceedsFromLongTermDebt,0.0,舉借長期借款,樂威科-KY,生技醫療業
2022-09-30,4154,InterestIncome,-217000.0,利息收入,樂威科-KY,生技醫療業
2022-09-30,4154,DecreaseInDepositDeposit,348000.0,存出保證金減少,樂威科-KY,生技醫療業
2022-09-30,4154,CashReceivedThroughOperations,28374000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2022-09-30,4154,PayTheInterest,-3004000.0,支付之利息,樂威科-KY,生技醫療業
2022-09-30,4154,IncomeBeforeIncomeTaxFromContinuingOperations,-22187000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2022-09-30,4154,NetCashInflowFromOperatingActivities,27886000.0,營業活動之淨現金流入,樂威科-KY,生技醫療業
2022-09-30,4154,AccountsPayable,69723000.0,應付帳款,樂威科-KY,生技醫療業
2022-09-30,4154,InventoryIncrease,-40713000.0,存貨（增加）減少,樂威科-KY,生技醫療業
2022-09-30,4154,ReceivableIncrease,-15601000.0,應收帳款（增加）減少,樂威科-KY,生技醫療業
2022-09-30,4154,CashProvidedByInvestingActivities,-83793000.0,投資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2022-12-31,4154,OtherNonCurrentLiabilitiesIncrease,-5164000.0,其他流動資產(增加)減少,樂威科-KY,生技醫療業
2022-12-31,4154,PropertyAndPlantAndEquipment,-96968000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2022-12-31,4154,CashBalancesEndOfPeriod,196494000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2022-12-31,4154,CashBalancesIncrease,-2050000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2022-12-31,4154,CashProvidedByInvestingActivities,-104514000.0,投資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2022-12-31,4154,CashBalancesBeginningOfPeriod,198544000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2022-12-31,4154,RentalPrincipalRepayments,-5781000.0,租賃本金償還,樂威科-KY,生技醫療業
2022-12-31,4154,PayTheInterest,-4095000.0,支付之利息,樂威科-KY,生技醫療業
2022-12-31,4154,IncomeBeforeIncomeTaxFromContinuingOperations,-42691000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2022-12-31,4154,ProceedsFromLongTermDebt,0.0,舉借長期借款,樂威科-KY,生技醫療業
2022-12-31,4154,NetIncomeBeforeTax,-42691000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2022-12-31,4154,CashFlowsFromOperatingActivities,-7465000.0,營業活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2022-12-31,4154,Depreciation,35117000.0,折舊費用,樂威科-KY,生技醫療業
2022-12-31,4154,AmortizationExpense,1617000.0,攤銷費用,樂威科-KY,生技醫療業
2022-12-31,4154,DecreaseInDepositDeposit,0.0,存出保證金減少,樂威科-KY,生技醫療業
2022-12-31,4154,RepaymentOfLongTermDebt,-28333000.0,償還長期借款,樂威科-KY,生技醫療業
2022-12-31,4154,InterestExpense,4654000.0,利息費用,樂威科-KY,生技醫療業
2022-12-31,4154,ReceivableIncrease,-24494000.0,應收帳款（增加）減少,樂威科-KY,生技醫療業
2022-12-31,4154,InventoryIncrease,-55333000.0,存貨（增加）減少,樂威科-KY,生技醫療業
2022-12-31,4154,CashFlowsProvidedFromFinancingActivities,101169000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2022-12-31,4154,InterestIncome,-503000.0,利息收入,樂威科-KY,生技醫療業
2022-12-31,4154,DecreaseInShortTermLoans,0.0,短期借款減少,樂威科-KY,生技醫療業
2022-12-31,4154,TotalIncomeLossItems,40100000.0,收益費損項目合計,樂威科-KY,生技醫療業
2022-12-31,4154,CashReceivedThroughOperations,-7025000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2022-12-31,4154,NetCashInflowFromOperatingActivities,-7465000.0,營業活動之淨現金流入,樂威科-KY,生技醫療業
2022-12-31,4154,AccountsPayable,77047000.0,應付帳款,樂威科-KY,生技醫療業
2023-03-31,4154,ReceivableIncrease,-511000.0,應收帳款（增加）減少,樂威科-KY,生技醫療業
2023-03-31,4154,PropertyAndPlantAndEquipment,-865000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2023-03-31,4154,NetIncomeBeforeTax,-11683000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2023-03-31,4154,InterestExpense,2229000.0,利息費用,樂威科-KY,生技醫療業
2023-03-31,4154,CashFlowsFromOperatingActivities,-25205000.0,營業活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2023-03-31,4154,CashBalancesEndOfPeriod,175267000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2023-03-31,4154,CashBalancesBeginningOfPeriod,196494000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2023-03-31,4154,CashBalancesIncrease,-21227000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2023-03-31,4154,CashFlowsProvidedFromFinancingActivities,10338000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2023-03-31,4154,Depreciation,11057000.0,折舊費用,樂威科-KY,生技醫療業
2023-03-31,4154,OtherNonCurrentLiabilitiesIncrease,-1536000.0,其他流動資產(增加)減少,樂威科-KY,生技醫療業
2023-03-31,4154,TotalIncomeLossItems,28766000.0,收益費損項目合計,樂威科-KY,生技醫療業
2023-03-31,4154,RentalPrincipalRepayments,-939000.0,租賃本金償還,樂威科-KY,生技醫療業
2023-03-31,4154,AmortizationExpense,472000.0,攤銷費用,樂威科-KY,生技醫療業
2023-03-31,4154,RepaymentOfLongTermDebt,-1667000.0,償還長期借款,樂威科-KY,生技醫療業
2023-03-31,4154,DecreaseInShortTermLoans,0.0,短期借款減少,樂威科-KY,生技醫療業
2023-03-31,4154,InterestIncome,-207000.0,利息收入,樂威科-KY,生技醫療業
2023-03-31,4154,DecreaseInDepositDeposit,679000.0,存出保證金減少,樂威科-KY,生技醫療業
2023-03-31,4154,CashReceivedThroughOperations,-25402000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2023-03-31,4154,IncomeBeforeIncomeTaxFromContinuingOperations,-11683000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2023-03-31,4154,InventoryIncrease,-5560000.0,存貨（增加）減少,樂威科-KY,生技醫療業
2023-03-31,4154,NetCashInflowFromOperatingActivities,-25205000.0,營業活動之淨現金流入,樂威科-KY,生技醫療業
2023-03-31,4154,AccountsPayable,-38326000.0,應付帳款,樂威科-KY,生技醫療業
2023-03-31,4154,CashProvidedByInvestingActivities,-5695000.0,投資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2023-03-31,4154,PayTheInterest,-2073000.0,支付之利息,樂威科-KY,生技醫療業
2023-06-30,4154,OtherNonCurrentLiabilitiesIncrease,-2464000.0,其他流動資產(增加)減少,樂威科-KY,生技醫療業
2023-06-30,4154,PropertyAndPlantAndEquipment,-3599000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2023-06-30,4154,CashBalancesEndOfPeriod,157536000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2023-06-30,4154,CashBalancesIncrease,-38958000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2023-06-30,4154,CashProvidedByInvestingActivities,5733000.0,投資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2023-06-30,4154,CashBalancesBeginningOfPeriod,196494000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2023-06-30,4154,RentalPrincipalRepayments,-1699000.0,租賃本金償還,樂威科-KY,生技醫療業
2023-06-30,4154,PayTheInterest,0.0,支付之利息,樂威科-KY,生技醫療業
2023-06-30,4154,IncomeBeforeIncomeTaxFromContinuingOperations,-52967000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2023-06-30,4154,ProceedsFromLongTermDebt,0.0,舉借長期借款,樂威科-KY,生技醫療業
2023-06-30,4154,NetIncomeBeforeTax,-52967000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2023-06-30,4154,CashFlowsFromOperatingActivities,-28107000.0,營業活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2023-06-30,4154,Depreciation,22111000.0,折舊費用,樂威科-KY,生技醫療業
2023-06-30,4154,AmortizationExpense,942000.0,攤銷費用,樂威科-KY,生技醫療業
2023-06-30,4154,DecreaseInDepositDeposit,578000.0,存出保證金減少,樂威科-KY,生技醫療業
2023-06-30,4154,RepaymentOfLongTermDebt,-1667000.0,償還長期借款,樂威科-KY,生技醫療業
2023-06-30,4154,InterestExpense,4636000.0,利息費用,樂威科-KY,生技醫療業
2023-06-30,4154,ReceivableIncrease,13946000.0,應收帳款（增加）減少,樂威科-KY,生技醫療業
2023-06-30,4154,InventoryIncrease,25714000.0,存貨（增加）減少,樂威科-KY,生技醫療業
2023-06-30,4154,CashFlowsProvidedFromFinancingActivities,-18459000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2023-06-30,4154,InterestIncome,-689000.0,利息收入,樂威科-KY,生技醫療業
2023-06-30,4154,DecreaseInShortTermLoans,0.0,短期借款減少,樂威科-KY,生技醫療業
2023-06-30,4154,TotalIncomeLossItems,41863000.0,收益費損項目合計,樂威科-KY,生技醫療業
2023-06-30,4154,CashReceivedThroughOperations,-28760000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2023-06-30,4154,AccountsPayable,-52916000.0,應付帳款,樂威科-KY,生技醫療業
2023-06-30,4154,NetCashInflowFromOperatingActivities,-28107000.0,營業活動之淨現金流入,樂威科-KY,生技醫療業
2023-09-30,4154,CashBalancesBeginningOfPeriod,196494000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2023-09-30,4154,PropertyAndPlantAndEquipment,-6934000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2023-09-30,4154,PayTheInterest,-6218000.0,支付之利息,樂威科-KY,生技醫療業
2023-09-30,4154,CashProvidedByInvestingActivities,27858000.0,投資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2023-09-30,4154,CashBalancesEndOfPeriod,221722000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2023-09-30,4154,OtherNonCurrentLiabilitiesIncrease,-646000.0,其他流動資產(增加)減少,樂威科-KY,生技醫療業
2023-09-30,4154,CashBalancesIncrease,25228000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2023-09-30,4154,IncomeBeforeIncomeTaxFromContinuingOperations,-96732000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2023-09-30,4154,RepaymentOfLongTermDebt,-1667000.0,償還長期借款,樂威科-KY,生技醫療業
2023-09-30,4154,NetIncomeBeforeTax,-96732000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2023-09-30,4154,CashFlowsFromOperatingActivities,9057000.0,營業活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2023-09-30,4154,Depreciation,33107000.0,折舊費用,樂威科-KY,生技醫療業
2023-09-30,4154,AmortizationExpense,1416000.0,攤銷費用,樂威科-KY,生技醫療業
2023-09-30,4154,DecreaseInDepositDeposit,1651000.0,存出保證金減少,樂威科-KY,生技醫療業
2023-09-30,4154,InterestExpense,6803000.0,利息費用,樂威科-KY,生技醫療業
2023-09-30,4154,TotalIncomeLossItems,67657000.0,收益費損項目合計,樂威科-KY,生技醫療業
2023-09-30,4154,ReceivableIncrease,36720000.0,應收帳款（增加）減少,樂威科-KY,生技醫療業
2023-09-30,4154,InventoryIncrease,49244000.0,存貨（增加）減少,樂威科-KY,生技醫療業
2023-09-30,4154,CashFlowsProvidedFromFinancingActivities,-18651000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2023-09-30,4154,CashReceivedThroughOperations,3078000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2023-09-30,4154,InterestIncome,-895000.0,利息收入,樂威科-KY,生技醫療業
2023-09-30,4154,RentalPrincipalRepayments,-2163000.0,租賃本金償還,樂威科-KY,生技醫療業
2023-09-30,4154,NetCashInflowFromOperatingActivities,9057000.0,營業活動之淨現金流入,樂威科-KY,生技醫療業
2023-09-30,4154,AccountsPayable,-47129000.0,應付帳款,樂威科-KY,生技醫療業
2023-09-30,4154,DecreaseInShortTermLoans,-128227000.0,短期借款減少,樂威科-KY,生技醫療業
2023-12-31,4154,InterestExpense,8326000.0,利息費用,樂威科-KY,生技醫療業
2023-12-31,4154,CashBalancesEndOfPeriod,119708000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2023-12-31,4154,AmortizationExpense,1931000.0,攤銷費用,樂威科-KY,生技醫療業
2023-12-31,4154,CashBalancesBeginningOfPeriod,196494000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2023-12-31,4154,PayTheInterest,-6271000.0,支付之利息,樂威科-KY,生技醫療業
2023-12-31,4154,RentalPrincipalRepayments,-3218000.0,租賃本金償還,樂威科-KY,生技醫療業
2023-12-31,4154,DecreaseInDepositDeposit,1768000.0,存出保證金減少,樂威科-KY,生技醫療業
2023-12-31,4154,RepaymentOfLongTermDebt,-1667000.0,償還長期借款,樂威科-KY,生技醫療業
2023-12-31,4154,NetCashInflowFromOperatingActivities,56399000.0,營業活動之淨現金流入,樂威科-KY,生技醫療業
2023-12-31,4154,InterestIncome,-1407000.0,利息收入,樂威科-KY,生技醫療業
2023-12-31,4154,PropertyAndPlantAndEquipment,-7783000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2023-12-31,4154,TotalIncomeLossItems,88410000.0,收益費損項目合計,樂威科-KY,生技醫療業
2023-12-31,4154,AccountsPayable,-114621000.0,應付帳款,樂威科-KY,生技醫療業
2023-12-31,4154,Depreciation,43766000.0,折舊費用,樂威科-KY,生技醫療業
2023-12-31,4154,CashBalancesIncrease,-76786000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2023-12-31,4154,CashProvidedByInvestingActivities,49083000.0,投資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2023-12-31,4154,IncomeBeforeIncomeTaxFromContinuingOperations,-124589000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2023-12-31,4154,CashReceivedThroughOperations,49746000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2023-12-31,4154,CashFlowsProvidedFromFinancingActivities,-184750000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2023-12-31,4154,ReceivableIncrease,72169000.0,應收帳款（增加）減少,樂威科-KY,生技醫療業
2023-12-31,4154,CashFlowsFromOperatingActivities,56399000.0,營業活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2023-12-31,4154,NetIncomeBeforeTax,-124589000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2023-12-31,4154,InventoryIncrease,70847000.0,存貨（增加）減少,樂威科-KY,生技醫療業
2024-03-31,4154,CashBalancesIncrease,-9442000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2024-03-31,4154,CashBalancesEndOfPeriod,110266000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2024-03-31,4154,PropertyAndPlantAndEquipment,-1517000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2024-03-31,4154,PayTheInterest,-615000.0,支付之利息,樂威科-KY,生技醫療業
2024-03-31,4154,CashBalancesBeginningOfPeriod,119708000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2024-03-31,4154,RentalPrincipalRepayments,-759000.0,租賃本金償還,樂威科-KY,生技醫療業
2024-03-31,4154,CashProvidedByInvestingActivities,-1568000.0,投資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2024-03-31,4154,IncomeBeforeIncomeTaxFromContinuingOperations,-36988000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2024-03-31,4154,InterestIncome,-47000.0,利息收入,樂威科-KY,生技醫療業
2024-03-31,4154,CashReceivedThroughOperations,-9959000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2024-03-31,4154,CashFlowsProvidedFromFinancingActivities,1093000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2024-03-31,4154,ReceivableIncrease,12140000.0,應收帳款（增加）減少,樂威科-KY,生技醫療業
2024-03-31,4154,TotalIncomeLossItems,21662000.0,收益費損項目合計,樂威科-KY,生技醫療業
2024-03-31,4154,InterestExpense,1205000.0,利息費用,樂威科-KY,生技醫療業
2024-03-31,4154,DecreaseInDepositDeposit,0.0,存出保證金減少,樂威科-KY,生技醫療業
2024-03-31,4154,NetCashInflowFromOperatingActivities,-9882000.0,營業活動之淨現金流入,樂威科-KY,生技醫療業
2024-03-31,4154,AccountsPayable,-2157000.0,應付帳款,樂威科-KY,生技醫療業
2024-03-31,4154,AmortizationExpense,968000.0,攤銷費用,樂威科-KY,生技醫療業
2024-03-31,4154,Depreciation,9889000.0,折舊費用,樂威科-KY,生技醫療業
2024-03-31,4154,CashFlowsFromOperatingActivities,-9882000.0,營業活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2024-03-31,4154,NetIncomeBeforeTax,-36988000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2024-03-31,4154,RepaymentOfLongTermDebt,0.0,償還長期借款,樂威科-KY,生技醫療業
2024-03-31,4154,InventoryIncrease,-1492000.0,存貨（增加）減少,樂威科-KY,生技醫療業
2024-06-30,4154,CashProvidedByInvestingActivities,-14059000.0,投資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2024-06-30,4154,PayTheInterest,0.0,支付之利息,樂威科-KY,生技醫療業
2024-06-30,4154,PropertyAndPlantAndEquipment,-4045000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2024-06-30,4154,CashBalancesBeginningOfPeriod,119708000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2024-06-30,4154,RentalPrincipalRepayments,-1519000.0,租賃本金償還,樂威科-KY,生技醫療業
2024-06-30,4154,CashBalancesIncrease,-21960000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2024-06-30,4154,CashBalancesEndOfPeriod,97748000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2024-06-30,4154,IncomeBeforeIncomeTaxFromContinuingOperations,-67108000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2024-06-30,4154,ProceedsFromLongTermDebt,0.0,舉借長期借款,樂威科-KY,生技醫療業
2024-06-30,4154,NetIncomeBeforeTax,-67108000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2024-06-30,4154,Depreciation,18561000.0,折舊費用,樂威科-KY,生技醫療業
2024-06-30,4154,AmortizationExpense,1402000.0,攤銷費用,樂威科-KY,生技醫療業
2024-06-30,4154,AccountsPayable,-657000.0,應付帳款,樂威科-KY,生技醫療業
2024-06-30,4154,RepaymentOfLongTermDebt,0.0,償還長期借款,樂威科-KY,生技醫療業
2024-06-30,4154,DecreaseInDepositDeposit,0.0,存出保證金減少,樂威科-KY,生技醫療業
2024-06-30,4154,TotalIncomeLossItems,39600000.0,收益費損項目合計,樂威科-KY,生技醫療業
2024-06-30,4154,ReceivableIncrease,8092000.0,應收帳款（增加）減少,樂威科-KY,生技醫療業
2024-06-30,4154,InventoryIncrease,4986000.0,存貨（增加）減少,樂威科-KY,生技醫療業
2024-06-30,4154,InterestIncome,-788000.0,利息收入,樂威科-KY,生技醫療業
2024-06-30,4154,DecreaseInShortTermLoans,0.0,短期借款減少,樂威科-KY,生技醫療業
2024-06-30,4154,InterestExpense,2540000.0,利息費用,樂威科-KY,生技醫療業
2024-06-30,4154,CashFlowsFromOperatingActivities,-18889000.0,營業活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2024-06-30,4154,NetCashInflowFromOperatingActivities,-18889000.0,營業活動之淨現金流入,樂威科-KY,生技醫療業
2024-06-30,4154,CashFlowsProvidedFromFinancingActivities,9239000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2024-06-30,4154,CashReceivedThroughOperations,-19580000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2024-09-30,4154,Depreciation,27508000.0,折舊費用,樂威科-KY,生技醫療業
2024-09-30,4154,CashBalancesIncrease,52748000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2024-09-30,4154,InterestExpense,3790000.0,利息費用,樂威科-KY,生技醫療業
2024-09-30,4154,PayTheInterest,-245000.0,支付之利息,樂威科-KY,生技醫療業
2024-09-30,4154,CashBalancesEndOfPeriod,172456000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2024-09-30,4154,CashProvidedByInvestingActivities,-11224000.0,投資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2024-09-30,4154,NetIncomeBeforeTax,-91570000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2024-09-30,4154,PropertyAndPlantAndEquipment,-6391000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2024-09-30,4154,CashBalancesBeginningOfPeriod,119708000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2024-09-30,4154,CashFlowsFromOperatingActivities,-27957000.0,營業活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2024-09-30,4154,AmortizationExpense,1885000.0,攤銷費用,樂威科-KY,生技醫療業
2024-09-30,4154,RepaymentOfLongTermDebt,0.0,償還長期借款,樂威科-KY,生技醫療業
2024-09-30,4154,DecreaseInShortTermLoans,0.0,短期借款減少,樂威科-KY,生技醫療業
2024-09-30,4154,AccountsPayable,-14979000.0,應付帳款,樂威科-KY,生技醫療業
2024-09-30,4154,InterestIncome,-863000.0,利息收入,樂威科-KY,生技醫療業
2024-09-30,4154,CashReceivedThroughOperations,-28797000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2024-09-30,4154,CashFlowsProvidedFromFinancingActivities,90865000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2024-09-30,4154,InventoryIncrease,8161000.0,存貨（增加）減少,樂威科-KY,生技醫療業
2024-09-30,4154,NetCashInflowFromOperatingActivities,-27957000.0,營業活動之淨現金流入,樂威科-KY,生技醫療業
2024-09-30,4154,ReceivableIncrease,8120000.0,應收帳款（增加）減少,樂威科-KY,生技醫療業
2024-09-30,4154,TotalIncomeLossItems,57137000.0,收益費損項目合計,樂威科-KY,生技醫療業
2024-09-30,4154,DecreaseInDepositDeposit,-799000.0,存出保證金減少,樂威科-KY,生技醫療業
2024-09-30,4154,RentalPrincipalRepayments,-2342000.0,租賃本金償還,樂威科-KY,生技醫療業
2024-09-30,4154,IncomeBeforeIncomeTaxFromContinuingOperations,-91570000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2024-12-31,4154,CashBalancesIncrease,43731000.0,本期現金及約當現金增加（減少）數,樂威科-KY,生技醫療業
2024-12-31,4154,CashBalancesEndOfPeriod,163439000.0,期末現金及約當現金餘額,樂威科-KY,生技醫療業
2024-12-31,4154,PropertyAndPlantAndEquipment,-6486000.0,取得不動產、廠房及設備,樂威科-KY,生技醫療業
2024-12-31,4154,PayTheInterest,-1601000.0,支付之利息,樂威科-KY,生技醫療業
2024-12-31,4154,CashBalancesBeginningOfPeriod,119708000.0,期初現金及約當現金餘額,樂威科-KY,生技醫療業
2024-12-31,4154,RentalPrincipalRepayments,-2505000.0,租賃本金償還,樂威科-KY,生技醫療業
2024-12-31,4154,CashProvidedByInvestingActivities,-8124000.0,投資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2024-12-31,4154,IncomeBeforeIncomeTaxFromContinuingOperations,-143129000.0,繼續營業單位稅前淨利（淨損）,樂威科-KY,生技醫療業
2024-12-31,4154,InterestIncome,-1457000.0,利息收入,樂威科-KY,生技醫療業
2024-12-31,4154,CashReceivedThroughOperations,-39512000.0,營運產生之現金流入（流出）,樂威科-KY,生技醫療業
2024-12-31,4154,CashFlowsProvidedFromFinancingActivities,87636000.0,籌資活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2024-12-31,4154,ReceivableIncrease,9017000.0,應收帳款（增加）減少,樂威科-KY,生技醫療業
2024-12-31,4154,TotalIncomeLossItems,112622000.0,收益費損項目合計,樂威科-KY,生技醫療業
2024-12-31,4154,InterestExpense,4925000.0,利息費用,樂威科-KY,生技醫療業
2024-12-31,4154,DecreaseInDepositDeposit,777000.0,存出保證金減少,樂威科-KY,生技醫療業
2024-12-31,4154,NetCashInflowFromOperatingActivities,-38072000.0,營業活動之淨現金流入,樂威科-KY,生技醫療業
2024-12-31,4154,AccountsPayable,-17275000.0,應付帳款,樂威科-KY,生技醫療業
2024-12-31,4154,AmortizationExpense,2265000.0,攤銷費用,樂威科-KY,生技醫療業
2024-12-31,4154,Depreciation,34365000.0,折舊費用,樂威科-KY,生技醫療業
2024-12-31,4154,CashFlowsFromOperatingActivities,-38072000.0,營業活動之淨現金流入（流出）,樂威科-KY,生技醫療業
2024-12-31,4154,NetIncomeBeforeTax,-143129000.0,本期稅前淨利（淨損）,樂威科-KY,生技醫療業
2024-12-31,4154,RepaymentOfLongTermDebt,0.0,償還長期借款,樂威科-KY,生技醫療業
2024-12-31,4154,InventoryIncrease,5543000.0,存貨（增加）減少,樂威科-KY,生技醫療業
2019-06-30,6562,OperatingExpenses,162431000.0,營業費用,聯亞藥,生技醫療業
2019-06-30,6562,TAX,0.0,所得稅費用（利益）,聯亞藥,生技醫療業
2019-06-30,6562,EPS,-0.76,基本每股盈餘（元）,聯亞藥,生技醫療業
2019-06-30,6562,PreTaxIncome,-113128000.0,稅前淨利（淨損）,聯亞藥,生技醫療業
2019-06-30,6562,IncomeFromContinuingOperations,-113128000.0,繼續營業單位本期淨利（淨損）,聯亞藥,生技醫療業
2019-06-30,6562,IncomeAfterTaxes,-113128000.0,本期淨利（淨損）,聯亞藥,生技醫療業
2019-06-30,6562,TotalConsolidatedProfitForThePeriod,-111315000.0,本期綜合損益總額,聯亞藥,生技醫療業
2019-06-30,6562,Revenue,226380000.0,營業收入,聯亞藥,生技醫療業
2019-06-30,6562,CostOfGoodsSold,170269000.0,營業成本,聯亞藥,生技醫療業
2019-06-30,6562,GrossProfit,56111000.0,營業毛利（毛損）淨額,聯亞藥,生技醫療業
2019-06-30,6562,OperatingIncome,-106320000.0,營業利益（損失）,聯亞藥,生技醫療業
2019-06-30,6562,TotalNonoperatingIncomeAndExpense,-6808000.0,營業外收入及支出,聯亞藥,生技醫療業
2019-06-30,6562,OtherComprehensiveIncome,1813000.0,其他綜合損益（淨額）,聯亞藥,生技醫療業
2019-06-30,6562,EquityAttributableToOwnersOfParent,-107918000.0,淨利（淨損）歸屬於母公司業主,聯亞藥,生技醫療業
2019-06-30,6562,NoncontrollingInterests,-5210000.0,淨利（淨損）歸屬於非控制權益,聯亞藥,生技醫療業
2019-12-31,6562,OperatingExpenses,183483000.0,營業費用,聯亞藥,生技醫療業
2019-12-31,6562,TAX,0.0,所得稅費用（利益）,聯亞藥,生技醫療業
2019-12-31,6562,EPS,-0.95,基本每股盈餘（元）,聯亞藥,生技醫療業
2019-12-31,6562,PreTaxIncome,-142278000.0,稅前淨利（淨損）,聯亞藥,生技醫療業
2019-12-31,6562,IncomeFromContinuingOperations,-142278000.0,繼續營業單位本期淨利（淨損）,聯亞藥,生技醫療業
2019-12-31,6562,IncomeAfterTaxes,-142278000.0,本期淨利（淨損）,聯亞藥,生技醫療業
2019-12-31,6562,TotalConsolidatedProfitForThePeriod,-141531000.0,本期綜合損益總額,聯亞藥,生技醫療業
2019-12-31,6562,Revenue,235693000.0,營業收入,聯亞藥,生技醫療業
2019-12-31,6562,CostOfGoodsSold,184065000.0,營業成本,聯亞藥,生技醫療業
2019-12-31,6562,GrossProfit,51628000.0,營業毛利（毛損）淨額,聯亞藥,生技醫療業
2019-12-31,6562,OperatingIncome,-131855000.0,營業利益（損失）,聯亞藥,生技醫療業
2019-12-31,6562,TotalNonoperatingIncomeAndExpense,-10423000.0,營業外收入及支出,聯亞藥,生技醫療業
2019-12-31,6562,OtherComprehensiveIncome,747000.0,其他綜合損益（淨額）,聯亞藥,生技醫療業
2019-12-31,6562,EquityAttributableToOwnersOfParent,-133962000.0,淨利（淨損）歸屬於母公司業主,聯亞藥,生技醫療業
2019-12-31,6562,NoncontrollingInterests,-8316000.0,淨利（淨損）歸屬於非控制權益,聯亞藥,生技醫療業
2020-06-30,6562,OperatingExpenses,135172000.0,營業費用,聯亞藥,生技醫療業
2020-06-30,6562,TAX,0.0,所得稅費用（利益）,聯亞藥,生技醫療業
2020-06-30,6562,EPS,-0.63,基本每股盈餘（元）,聯亞藥,生技醫療業
2020-06-30,6562,PreTaxIncome,-95455000.0,稅前淨利（淨損）,聯亞藥,生技醫療業
2020-06-30,6562,IncomeFromContinuingOperations,-95455000.0,繼續營業單位本期淨利（淨損）,聯亞藥,生技醫療業
2020-06-30,6562,IncomeAfterTaxes,-95455000.0,本期淨利（淨損）,聯亞藥,生技醫療業
2020-06-30,6562,TotalConsolidatedProfitForThePeriod,-80071000.0,本期綜合損益總額,聯亞藥,生技醫療業
2020-06-30,6562,Revenue,210626000.0,營業收入,聯亞藥,生技醫療業
2020-06-30,6562,CostOfGoodsSold,164458000.0,營業成本,聯亞藥,生技醫療業
2020-06-30,6562,GrossProfit,46168000.0,營業毛利（毛損）淨額,聯亞藥,生技醫療業
2020-06-30,6562,OperatingIncome,-89004000.0,營業利益（損失）,聯亞藥,生技醫療業
2020-06-30,6562,TotalNonoperatingIncomeAndExpense,-6451000.0,營業外收入及支出,聯亞藥,生技醫療業
2020-06-30,6562,OtherComprehensiveIncome,15384000.0,其他綜合損益（淨額）,聯亞藥,生技醫療業
2020-06-30,6562,EquityAttributableToOwnersOfParent,-89323000.0,淨利（淨損）歸屬於母公司業主,聯亞藥,生技醫療業
2020-06-30,6562,NoncontrollingInterests,-6132000.0,淨利（淨損）歸屬於非控制權益,聯亞藥,生技醫療業
2020-12-31,6562,OperatingExpenses,152962000.0,營業費用,聯亞藥,生技醫療業
2020-12-31,6562,TAX,1371000.0,所得稅費用（利益）,聯亞藥,生技醫療業
2020-12-31,6562,EPS,-0.23,基本每股盈餘（元）,聯亞藥,生技醫療業
2020-12-31,6562,PreTaxIncome,5196000.0,稅前淨利（淨損）,聯亞藥,生技醫療業
2020-12-31,6562,IncomeFromContinuingOperations,3825000.0,繼續營業單位本期淨利（淨損）,聯亞藥,生技醫療業
2020-12-31,6562,IncomeAfterTaxes,3825000.0,本期淨利（淨損）,聯亞藥,生技醫療業
2020-12-31,6562,TotalConsolidatedProfitForThePeriod,-17228000.0,本期綜合損益總額,聯亞藥,生技醫療業
2020-12-31,6562,Revenue,247836000.0,營業收入,聯亞藥,生技醫療業
2020-12-31,6562,CostOfGoodsSold,159688000.0,營業成本,聯亞藥,生技醫療業
2020-12-31,6562,GrossProfit,88148000.0,營業毛利（毛損）淨額,聯亞藥,生技醫療業
2020-12-31,6562,OperatingIncome,-64814000.0,營業利益（損失）,聯亞藥,生技醫療業
2020-12-31,6562,TotalNonoperatingIncomeAndExpense,70010000.0,營業外收入及支出,聯亞藥,生技醫療業
2020-12-31,6562,OtherComprehensiveIncome,-21053000.0,其他綜合損益（淨額）,聯亞藥,生技醫療業
2020-12-31,6562,EquityAttributableToOwnersOfParent,15098000.0,淨利（淨損）歸屬於母公司業主,聯亞藥,生技醫療業
2020-12-31,6562,NoncontrollingInterests,-11273000.0,淨利（淨損）歸屬於非控制權益,聯亞藥,生技醫療業
2021-06-30,6562,OperatingExpenses,129232000.0,營業費用,聯亞藥,生技醫療業
2021-06-30,6562,TAX,0.0,所得稅費用（利益）,聯亞藥,生技醫療業
2021-06-30,6562,EPS,-0.43,基本每股盈餘（元）,聯亞藥,生技醫療業
2021-06-30,6562,PreTaxIncome,-39218000.0,稅前淨利（淨損）,聯亞藥,生技醫療業
2021-06-30,6562,IncomeFromContinuingOperations,-39218000.0,繼續營業單位本期淨利（淨損）,聯亞藥,生技醫療業
2021-06-30,6562,IncomeAfterTaxes,-39218000.0,本期淨利（淨損）,聯亞藥,生技醫療業
2021-06-30,6562,TotalConsolidatedProfitForThePeriod,-33026000.0,本期綜合損益總額,聯亞藥,生技醫療業
2021-06-30,6562,OperatingIncome,-30201000.0,營業利益（損失）,聯亞藥,生技醫療業
2021-06-30,6562,TotalNonoperatingIncomeAndExpense,-9017000.0,營業外收入及支出,聯亞藥,生技醫療業
2021-06-30,6562,OtherComprehensiveIncome,6192000.0,其他綜合損益（淨額）,聯亞藥,生技醫療業
2021-06-30,6562,Revenue,277328000.0,營業收入,聯亞藥,生技醫療業
2021-06-30,6562,CostOfGoodsSold,178297000.0,營業成本,聯亞藥,生技醫療業
2021-06-30,6562,EquityAttributableToOwnersOfParent,-39218000.0,淨利（淨損）歸屬於母公司業主,聯亞藥,生技醫療業
2021-06-30,6562,NoncontrollingInterests,0.0,淨利（淨損）歸屬於非控制權益,聯亞藥,生技醫療業
2021-06-30,6562,GrossProfit,99031000.0,營業毛利（毛損）,聯亞藥,生技醫療業
2021-06-30,6562,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,0.0,綜合損益總額歸屬於非控制權益,聯亞藥,生技醫療業
2021-12-31,6562,TAX,1396000.0,所得稅費用（利益）,聯亞藥,生技醫療業
2021-12-31,6562,OperatingExpenses,100621000.0,營業費用,聯亞藥,生技醫療業
2021-12-31,6562,EPS,0.66,基本每股盈餘（元）,聯亞藥,生技醫療業
2021-12-31,6562,PreTaxIncome,62978000.0,稅前淨利（淨損）,聯亞藥,生技醫療業
2021-12-31,6562,IncomeFromContinuingOperations,61582000.0,繼續營業單位本期淨利（淨損）,聯亞藥,生技醫療業
2021-12-31,6562,IncomeAfterTaxes,61582000.0,本期淨利（淨損）,聯亞藥,生技醫療業
2021-12-31,6562,TotalConsolidatedProfitForThePeriod,54121000.0,本期綜合損益總額,聯亞藥,生技醫療業
2021-12-31,6562,Revenue,366958000.0,營業收入,聯亞藥,生技醫療業
2021-12-31,6562,CostOfGoodsSold,190029000.0,營業成本,聯亞藥,生技醫療業
2021-12-31,6562,OperatingIncome,76308000.0,營業利益（損失）,聯亞藥,生技醫療業
2021-12-31,6562,TotalNonoperatingIncomeAndExpense,-13330000.0,營業外收入及支出,聯亞藥,生技醫療業
2021-12-31,6562,OtherComprehensiveIncome,-7461000.0,其他綜合損益（淨額）,聯亞藥,生技醫療業
2021-12-31,6562,EquityAttributableToOwnersOfParent,61582000.0,淨利（淨損）歸屬於母公司業主,聯亞藥,生技醫療業
2021-12-31,6562,NoncontrollingInterests,0.0,淨利（淨損）歸屬於非控制權益,聯亞藥,生技醫療業
2021-12-31,6562,GrossProfit,176929000.0,營業毛利（毛損）,聯亞藥,生技醫療業
2021-12-31,6562,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,0.0,綜合損益總額歸屬於非控制權益,聯亞藥,生技醫療業
2022-06-30,6562,OperatingExpenses,119077000.0,營業費用,聯亞藥,生技醫療業
2022-06-30,6562,TAX,3844000.0,所得稅費用（利益）,聯亞藥,生技醫療業
2022-06-30,6562,EPS,0.18,基本每股盈餘（元）,聯亞藥,生技醫療業
2022-06-30,6562,PreTaxIncome,23186000.0,稅前淨利（淨損）,聯亞藥,生技醫療業
2022-06-30,6562,IncomeFromContinuingOperations,19342000.0,繼續營業單位本期淨利（淨損）,聯亞藥,生技醫療業
2022-06-30,6562,IncomeAfterTaxes,19342000.0,本期淨利（淨損）,聯亞藥,生技醫療業
2022-06-30,6562,TotalConsolidatedProfitForThePeriod,-3132000.0,本期綜合損益總額,聯亞藥,生技醫療業
2022-06-30,6562,Revenue,319019000.0,營業收入,聯亞藥,生技醫療業
2022-06-30,6562,CostOfGoodsSold,186020000.0,營業成本,聯亞藥,生技醫療業
2022-06-30,6562,OperatingIncome,13922000.0,營業利益（損失）,聯亞藥,生技醫療業
2022-06-30,6562,TotalNonoperatingIncomeAndExpense,9264000.0,營業外收入及支出,聯亞藥,生技醫療業
2022-06-30,6562,OtherComprehensiveIncome,-22474000.0,其他綜合損益（淨額）,聯亞藥,生技醫療業
2022-06-30,6562,EquityAttributableToOwnersOfParent,19342000.0,淨利（淨損）歸屬於母公司業主,聯亞藥,生技醫療業
2022-06-30,6562,NoncontrollingInterests,0.0,淨利（淨損）歸屬於非控制權益,聯亞藥,生技醫療業
2022-06-30,6562,GrossProfit,132999000.0,營業毛利（毛損）,聯亞藥,生技醫療業
2022-06-30,6562,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,0.0,綜合損益總額歸屬於非控制權益,聯亞藥,生技醫療業
2022-12-31,6562,OperatingExpenses,124852000.0,營業費用,聯亞藥,生技醫療業
2022-12-31,6562,TAX,3212000.0,所得稅費用（利益）,聯亞藥,生技醫療業
2022-12-31,6562,EPS,0.25,基本每股盈餘（元）,聯亞藥,生技醫療業
2022-12-31,6562,PreTaxIncome,31078000.0,稅前淨利（淨損）,聯亞藥,生技醫療業
2022-12-31,6562,IncomeFromContinuingOperations,27866000.0,繼續營業單位本期淨利（淨損）,聯亞藥,生技醫療業
2022-12-31,6562,IncomeAfterTaxes,27866000.0,本期淨利（淨損）,聯亞藥,生技醫療業
2022-12-31,6562,TotalConsolidatedProfitForThePeriod,-90330000.0,本期綜合損益總額,聯亞藥,生技醫療業
2022-12-31,6562,Revenue,314803000.0,營業收入,聯亞藥,生技醫療業
2022-12-31,6562,CostOfGoodsSold,166558000.0,營業成本,聯亞藥,生技醫療業
2022-12-31,6562,OperatingIncome,23393000.0,營業利益（損失）,聯亞藥,生技醫療業
2022-12-31,6562,TotalNonoperatingIncomeAndExpense,7685000.0,營業外收入及支出,聯亞藥,生技醫療業
2022-12-31,6562,OtherComprehensiveIncome,-118196000.0,其他綜合損益（淨額）,聯亞藥,生技醫療業
2022-12-31,6562,EquityAttributableToOwnersOfParent,27866000.0,淨利（淨損）歸屬於母公司業主,聯亞藥,生技醫療業
2022-12-31,6562,NoncontrollingInterests,0.0,淨利（淨損）歸屬於非控制權益,聯亞藥,生技醫療業
2022-12-31,6562,GrossProfit,148245000.0,營業毛利（毛損）,聯亞藥,生技醫療業
2022-12-31,6562,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,0.0,綜合損益總額歸屬於非控制權益,聯亞藥,生技醫療業
2023-06-30,6562,OperatingExpenses,95735000.0,營業費用,聯亞藥,生技醫療業
2023-06-30,6562,TAX,704000.0,所得稅費用（利益）,聯亞藥,生技醫療業
2023-06-30,6562,EPS,0.12,基本每股盈餘（元）,聯亞藥,生技醫療業
2023-06-30,6562,PreTaxIncome,14544000.0,稅前淨利（淨損）,聯亞藥,生技醫療業
2023-06-30,6562,IncomeFromContinuingOperations,13840000.0,繼續營業單位本期淨利（淨損）,聯亞藥,生技醫療業
2023-06-30,6562,IncomeAfterTaxes,13840000.0,本期淨利（淨損）,聯亞藥,生技醫療業
2023-06-30,6562,TotalConsolidatedProfitForThePeriod,658000.0,本期綜合損益總額,聯亞藥,生技醫療業
2023-06-30,6562,Revenue,335731000.0,營業收入,聯亞藥,生技醫療業
2023-06-30,6562,CostOfGoodsSold,226814000.0,營業成本,聯亞藥,生技醫療業
2023-06-30,6562,OperatingIncome,13182000.0,營業利益（損失）,聯亞藥,生技醫療業
2023-06-30,6562,TotalNonoperatingIncomeAndExpense,1362000.0,營業外收入及支出,聯亞藥,生技醫療業
2023-06-30,6562,OtherComprehensiveIncome,-13182000.0,其他綜合損益（淨額）,聯亞藥,生技醫療業
2023-06-30,6562,GrossProfit,108917000.0,營業毛利（毛損）,聯亞藥,生技醫療業
2023-06-30,6562,EquityAttributableToOwnersOfParent,13840000.0,淨利（淨損）歸屬於母公司業主,聯亞藥,生技醫療業
2023-06-30,6562,NoncontrollingInterests,0.0,淨利（淨損）歸屬於非控制權益,聯亞藥,生技醫療業
2023-06-30,6562,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,0.0,綜合損益總額歸屬於非控制權益,聯亞藥,生技醫療業
2023-12-31,6562,OperatingExpenses,95933000.0,營業費用,聯亞藥,生技醫療業
2023-12-31,6562,TAX,1089000.0,所得稅費用（利益）,聯亞藥,生技醫療業
2023-12-31,6562,EPS,-0.11,基本每股盈餘（元）,聯亞藥,生技醫療業
2023-12-31,6562,PreTaxIncome,-11948000.0,稅前淨利（淨損）,聯亞藥,生技醫療業
2023-12-31,6562,IncomeFromContinuingOperations,-13037000.0,繼續營業單位本期淨利（淨損）,聯亞藥,生技醫療業
2023-12-31,6562,IncomeAfterTaxes,-13037000.0,本期淨利（淨損）,聯亞藥,生技醫療業
2023-12-31,6562,TotalConsolidatedProfitForThePeriod,-13034000.0,本期綜合損益總額,聯亞藥,生技醫療業
2023-12-31,6562,Revenue,312894000.0,營業收入,聯亞藥,生技醫療業
2023-12-31,6562,CostOfGoodsSold,224690000.0,營業成本,聯亞藥,生技醫療業
2023-12-31,6562,OperatingIncome,-7729000.0,營業利益（損失）,聯亞藥,生技醫療業
2023-12-31,6562,TotalNonoperatingIncomeAndExpense,-4219000.0,營業外收入及支出,聯亞藥,生技醫療業
2023-12-31,6562,OtherComprehensiveIncome,3000.0,其他綜合損益（淨額）,聯亞藥,生技醫療業
2023-12-31,6562,GrossProfit,88204000.0,營業毛利（毛損）,聯亞藥,生技醫療業
2023-12-31,6562,EquityAttributableToOwnersOfParent,-13037000.0,淨利（淨損）歸屬於母公司業主,聯亞藥,生技醫療業
2023-12-31,6562,NoncontrollingInterests,0.0,淨利（淨損）歸屬於非控制權益,聯亞藥,生技醫療業
2023-12-31,6562,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,0.0,綜合損益總額歸屬於非控制權益,聯亞藥,生技醫療業
2024-06-30,6562,PreTaxIncome,-3437000.0,稅前淨利（淨損）,聯亞藥,生技醫療業
2024-06-30,6562,TAX,115000.0,所得稅費用（利益）,聯亞藥,生技醫療業
2024-06-30,6562,IncomeFromContinuingOperations,-3552000.0,繼續營業單位本期淨利（淨損）,聯亞藥,生技醫療業
2024-06-30,6562,IncomeAfterTaxes,-3552000.0,本期淨利（淨損）,聯亞藥,生技醫療業
2024-06-30,6562,TotalConsolidatedProfitForThePeriod,-3358000.0,本期綜合損益總額,聯亞藥,生技醫療業
2024-06-30,6562,EPS,-0.03,基本每股盈餘（元）,聯亞藥,生技醫療業
2024-06-30,6562,Revenue,261343000.0,營業收入,聯亞藥,生技醫療業
2024-06-30,6562,CostOfGoodsSold,205036000.0,營業成本,聯亞藥,生技醫療業
2024-06-30,6562,OperatingExpenses,96500000.0,營業費用,聯亞藥,生技醫療業
2024-06-30,6562,OperatingIncome,-40193000.0,營業利益（損失）,聯亞藥,生技醫療業
2024-06-30,6562,TotalNonoperatingIncomeAndExpense,36756000.0,營業外收入及支出,聯亞藥,生技醫療業
2024-06-30,6562,OtherComprehensiveIncome,194000.0,其他綜合損益（淨額）,聯亞藥,生技醫療業
2024-06-30,6562,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,0.0,綜合損益總額歸屬於非控制權益,聯亞藥,生技醫療業
2024-06-30,6562,NoncontrollingInterests,0.0,淨利（淨損）歸屬於非控制權益,聯亞藥,生技醫療業
2024-06-30,6562,GrossProfit,56307000.0,營業毛利（毛損）,聯亞藥,生技醫療業
2024-06-30,6562,EquityAttributableToOwnersOfParent,-3552000.0,淨利（淨損）歸屬於母公司業主,聯亞藥,生技醫療業
2024-12-31,6562,OperatingExpenses,124780000.0,營業費用,聯亞藥,生技醫療業
2024-12-31,6562,TAX,-1228000.0,所得稅費用（利益）,聯亞藥,生技醫療業
2024-12-31,6562,EPS,-1.45,基本每股盈餘（元）,聯亞藥,生技醫療業
2024-12-31,6562,PreTaxIncome,-172192000.0,稅前淨利（淨損）,聯亞藥,生技醫療業
2024-12-31,6562,IncomeFromContinuingOperations,-170964000.0,繼續營業單位本期淨利（淨損）,聯亞藥,生技醫療業
2024-12-31,6562,IncomeAfterTaxes,-170964000.0,本期淨利（淨損）,聯亞藥,生技醫療業
2024-12-31,6562,TotalConsolidatedProfitForThePeriod,-170951000.0,本期綜合損益總額,聯亞藥,生技醫療業
2024-12-31,6562,Revenue,277485000.0,營業收入,聯亞藥,生技醫療業
2024-12-31,6562,CostOfGoodsSold,225908000.0,營業成本,聯亞藥,生技醫療業
2024-12-31,6562,OperatingIncome,-73203000.0,營業利益（損失）,聯亞藥,生技醫療業
2024-12-31,6562,TotalNonoperatingIncomeAndExpense,-98989000.0,營業外收入及支出,聯亞藥,生技醫療業
2024-12-31,6562,OtherComprehensiveIncome,13000.0,其他綜合損益（淨額）,聯亞藥,生技醫療業
2024-12-31,6562,GrossProfit,51577000.0,營業毛利（毛損）,聯亞藥,生技醫療業
2024-12-31,6562,EquityAttributableToOwnersOfParent,-170964000.0,淨利（淨損）歸屬於母公司業主,聯亞藥,生技醫療業
2019-06-30,6562,CashAndCashEquivalents,76529000.0,現金及約當現金,聯亞藥,生技醫療業
2019-06-30,6562,CashAndCashEquivalents_per,2.69,現金及約當現金,聯亞藥,生技醫療業
2019-06-30,6562,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,150335000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,聯亞藥,生技醫療業
2019-06-30,6562,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,5.29,透過其他綜合損益按公允價值衡量之金融資產－非流動,聯亞藥,生技醫療業
2019-06-30,6562,FinancialAssetsAtAmortizedCost,520529000.0,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2019-06-30,6562,FinancialAssetsAtAmortizedCost_per,18.3,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2019-06-30,6562,BillsReceivableNet,2054000.0,應收票據淨額,聯亞藥,生技醫療業
2019-06-30,6562,BillsReceivableNet_per,0.07,應收票據淨額,聯亞藥,生技醫療業
2019-06-30,6562,OtherReceivable,32777000.0,其他應收款淨額,聯亞藥,生技醫療業
2019-06-30,6562,OtherReceivable_per,1.15,其他應收款淨額,聯亞藥,生技醫療業
2019-06-30,6562,AccountsReceivableNet,74887000.0,應收帳款淨額,聯亞藥,生技醫療業
2019-06-30,6562,AccountsReceivableNet_per,2.63,應收帳款淨額,聯亞藥,生技醫療業
2019-06-30,6562,AccountsReceivableDuefromRelatedPartiesNet,20870000.0,應收帳款－關係人淨額,聯亞藥,生技醫療業
2019-06-30,6562,AccountsReceivableDuefromRelatedPartiesNet_per,0.73,應收帳款－關係人淨額,聯亞藥,生技醫療業
2019-06-30,6562,OtherReceivablesDueFromRelatedParties,4654000.0,其他應收款－關係人淨額,聯亞藥,生技醫療業
2019-06-30,6562,OtherReceivablesDueFromRelatedParties_per,0.16,其他應收款－關係人淨額,聯亞藥,生技醫療業
2019-06-30,6562,Inventories,81180000.0,存貨,聯亞藥,生技醫療業
2019-06-30,6562,Inventories_per,2.85,存貨,聯亞藥,生技醫療業
2019-06-30,6562,OtherCurrentAssets,103304000.0,其他流動資產,聯亞藥,生技醫療業
2019-06-30,6562,OtherCurrentAssets_per,3.63,其他流動資產,聯亞藥,生技醫療業
2019-06-30,6562,CurrentAssets,916784000.0,流動資產合計,聯亞藥,生技醫療業
2019-06-30,6562,CurrentAssets_per,32.23,流動資產合計,聯亞藥,生技醫療業
2019-06-30,6562,PropertyPlantAndEquipment,455519000.0,不動產、廠房及設備,聯亞藥,生技醫療業
2019-06-30,6562,PropertyPlantAndEquipment_per,16.02,不動產、廠房及設備,聯亞藥,生技醫療業
2019-06-30,6562,RightOfUseAsset,523423000.0,使用權資產,聯亞藥,生技醫療業
2019-06-30,6562,RightOfUseAsset_per,18.4,使用權資產,聯亞藥,生技醫療業
2019-06-30,6562,IntangibleAssets,305344000.0,無形資產,聯亞藥,生技醫療業
2019-06-30,6562,IntangibleAssets_per,10.74,無形資產,聯亞藥,生技醫療業
2019-06-30,6562,DeferredTaxAssets,0.0,遞延所得稅資產,聯亞藥,生技醫療業
2019-06-30,6562,DeferredTaxAssets_per,0.0,遞延所得稅資產,聯亞藥,生技醫療業
2019-06-30,6562,OtherNoncurrentAssets,492894000.0,其他非流動資產,聯亞藥,生技醫療業
2019-06-30,6562,OtherNoncurrentAssets_per,17.33,其他非流動資產,聯亞藥,生技醫療業
2019-06-30,6562,NoncurrentAssets,1927515000.0,非流動資產合計,聯亞藥,生技醫療業
2019-06-30,6562,NoncurrentAssets_per,67.77,非流動資產合計,聯亞藥,生技醫療業
2019-06-30,6562,TotalAssets,2844299000.0,資產總額,聯亞藥,生技醫療業
2019-06-30,6562,TotalAssets_per,100.0,資產總額,聯亞藥,生技醫療業
2019-06-30,6562,ShorttermBorrowings,29634000.0,短期借款,聯亞藥,生技醫療業
2019-06-30,6562,ShorttermBorrowings_per,1.04,短期借款,聯亞藥,生技醫療業
2019-06-30,6562,AccountsPayable,30732000.0,應付帳款,聯亞藥,生技醫療業
2019-06-30,6562,AccountsPayable_per,1.08,應付帳款,聯亞藥,生技醫療業
2019-06-30,6562,OtherPayables,140359000.0,其他應付款,聯亞藥,生技醫療業
2019-06-30,6562,OtherPayables_per,4.93,其他應付款,聯亞藥,生技醫療業
2019-06-30,6562,OtherCurrentLiabilities,136211000.0,其他流動負債,聯亞藥,生技醫療業
2019-06-30,6562,OtherCurrentLiabilities_per,4.79,其他流動負債,聯亞藥,生技醫療業
2019-06-30,6562,CurrentLiabilities,401874000.0,流動負債合計,聯亞藥,生技醫療業
2019-06-30,6562,CurrentLiabilities_per,14.13,流動負債合計,聯亞藥,生技醫療業
2019-06-30,6562,LongtermBorrowings,1150204000.0,長期借款,聯亞藥,生技醫療業
2019-06-30,6562,LongtermBorrowings_per,40.44,長期借款,聯亞藥,生技醫療業
2019-06-30,6562,OtherNoncurrentLiabilities,140852000.0,其他非流動負債,聯亞藥,生技醫療業
2019-06-30,6562,OtherNoncurrentLiabilities_per,4.95,其他非流動負債,聯亞藥,生技醫療業
2019-06-30,6562,NoncurrentLiabilities,1786164000.0,非流動負債合計,聯亞藥,生技醫療業
2019-06-30,6562,NoncurrentLiabilities_per,62.8,非流動負債合計,聯亞藥,生技醫療業
2019-06-30,6562,Liabilities,2188038000.0,負債總額,聯亞藥,生技醫療業
2019-06-30,6562,Liabilities_per,76.93,負債總額,聯亞藥,生技醫療業
2019-06-30,6562,OrdinaryShare,1424471000.0,普通股股本,聯亞藥,生技醫療業
2019-06-30,6562,OrdinaryShare_per,50.08,普通股股本,聯亞藥,生技醫療業
2019-06-30,6562,CapitalStock,1424471000.0,股本合計,聯亞藥,生技醫療業
2019-06-30,6562,CapitalStock_per,50.08,股本合計,聯亞藥,生技醫療業
2019-06-30,6562,CapitalSurplusAdditionalPaidInCapital,23996000.0,資本公積－發行溢價,聯亞藥,生技醫療業
2019-06-30,6562,CapitalSurplusAdditionalPaidInCapital_per,0.84,資本公積－發行溢價,聯亞藥,生技醫療業
2019-06-30,6562,CapitalSurplus,96530000.0,資本公積合計,聯亞藥,生技醫療業
2019-06-30,6562,CapitalSurplus_per,3.39,資本公積合計,聯亞藥,生技醫療業
2019-06-30,6562,LegalReserve,1586000.0,法定盈餘公積,聯亞藥,生技醫療業
2019-06-30,6562,LegalReserve_per,0.06,法定盈餘公積,聯亞藥,生技醫療業
2019-06-30,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit,-737555000.0,未分配盈餘,聯亞藥,生技醫療業
2019-06-30,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-25.93,未分配盈餘,聯亞藥,生技醫療業
2019-06-30,6562,RetainedEarnings,-735969000.0,保留盈餘合計,聯亞藥,生技醫療業
2019-06-30,6562,RetainedEarnings_per,-25.88,保留盈餘合計,聯亞藥,生技醫療業
2019-06-30,6562,OtherEquityInterest,-150642000.0,其他權益合計,聯亞藥,生技醫療業
2019-06-30,6562,OtherEquityInterest_per,-5.3,其他權益合計,聯亞藥,生技醫療業
2019-06-30,6562,EquityAttributableToOwnersOfParent,634390000.0,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2019-06-30,6562,EquityAttributableToOwnersOfParent_per,22.3,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2019-06-30,6562,NoncontrollingInterests,21871000.0,非控制權益,聯亞藥,生技醫療業
2019-06-30,6562,NoncontrollingInterests_per,0.77,非控制權益,聯亞藥,生技醫療業
2019-06-30,6562,Equity,2844299000.0,權益總計,聯亞藥,生技醫療業
2019-06-30,6562,Equity_per,100.0,權益總計,聯亞藥,生技醫療業
2019-06-30,6562,TotalLiabilitiesEquity,2844299000.0,負債及權益總計,聯亞藥,生技醫療業
2019-06-30,6562,TotalLiabilitiesEquity_per,100.0,負債及權益總計,聯亞藥,生技醫療業
2019-06-30,6562,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,聯亞藥,生技醫療業
2019-12-31,6562,CashAndCashEquivalents,73143000.0,現金及約當現金,聯亞藥,生技醫療業
2019-12-31,6562,CashAndCashEquivalents_per,2.72,現金及約當現金,聯亞藥,生技醫療業
2019-12-31,6562,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,154073000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,聯亞藥,生技醫療業
2019-12-31,6562,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,5.72,透過其他綜合損益按公允價值衡量之金融資產－非流動,聯亞藥,生技醫療業
2019-12-31,6562,FinancialAssetsAtAmortizedCost,219999000.0,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2019-12-31,6562,FinancialAssetsAtAmortizedCost_per,8.17,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2019-12-31,6562,BillsReceivableNet,1571000.0,應收票據淨額,聯亞藥,生技醫療業
2019-12-31,6562,BillsReceivableNet_per,0.06,應收票據淨額,聯亞藥,生技醫療業
2019-12-31,6562,OtherReceivable,10590000.0,其他應收款淨額,聯亞藥,生技醫療業
2019-12-31,6562,OtherReceivable_per,0.39,其他應收款淨額,聯亞藥,生技醫療業
2019-12-31,6562,AccountsReceivableNet,66294000.0,應收帳款淨額,聯亞藥,生技醫療業
2019-12-31,6562,AccountsReceivableNet_per,2.46,應收帳款淨額,聯亞藥,生技醫療業
2019-12-31,6562,AccountsReceivableDuefromRelatedPartiesNet,3281000.0,應收帳款－關係人淨額,聯亞藥,生技醫療業
2019-12-31,6562,AccountsReceivableDuefromRelatedPartiesNet_per,0.12,應收帳款－關係人淨額,聯亞藥,生技醫療業
2019-12-31,6562,OtherReceivablesDueFromRelatedParties,3732000.0,其他應收款－關係人淨額,聯亞藥,生技醫療業
2019-12-31,6562,OtherReceivablesDueFromRelatedParties_per,0.14,其他應收款－關係人淨額,聯亞藥,生技醫療業
2019-12-31,6562,Inventories,73343000.0,存貨,聯亞藥,生技醫療業
2019-12-31,6562,Inventories_per,2.72,存貨,聯亞藥,生技醫療業
2019-12-31,6562,OtherCurrentAssets,143850000.0,其他流動資產,聯亞藥,生技醫療業
2019-12-31,6562,OtherCurrentAssets_per,5.34,其他流動資產,聯亞藥,生技醫療業
2019-12-31,6562,CurrentAssets,595803000.0,流動資產合計,聯亞藥,生技醫療業
2019-12-31,6562,CurrentAssets_per,22.13,流動資產合計,聯亞藥,生技醫療業
2019-12-31,6562,PropertyPlantAndEquipment,507762000.0,不動產、廠房及設備,聯亞藥,生技醫療業
2019-12-31,6562,PropertyPlantAndEquipment_per,18.86,不動產、廠房及設備,聯亞藥,生技醫療業
2019-12-31,6562,RightOfUseAsset,554151000.0,使用權資產,聯亞藥,生技醫療業
2019-12-31,6562,RightOfUseAsset_per,20.58,使用權資產,聯亞藥,生技醫療業
2019-12-31,6562,IntangibleAssets,272600000.0,無形資產,聯亞藥,生技醫療業
2019-12-31,6562,IntangibleAssets_per,10.13,無形資產,聯亞藥,生技醫療業
2019-12-31,6562,OtherNoncurrentAssets,607669000.0,其他非流動資產,聯亞藥,生技醫療業
2019-12-31,6562,OtherNoncurrentAssets_per,22.57,其他非流動資產,聯亞藥,生技醫療業
2019-12-31,6562,NoncurrentAssets,2096255000.0,非流動資產合計,聯亞藥,生技醫療業
2019-12-31,6562,NoncurrentAssets_per,77.87,非流動資產合計,聯亞藥,生技醫療業
2019-12-31,6562,TotalAssets,2692058000.0,資產總額,聯亞藥,生技醫療業
2019-12-31,6562,TotalAssets_per,100.0,資產總額,聯亞藥,生技醫療業
2019-12-31,6562,ShorttermBorrowings,64381000.0,短期借款,聯亞藥,生技醫療業
2019-12-31,6562,ShorttermBorrowings_per,2.39,短期借款,聯亞藥,生技醫療業
2019-12-31,6562,AccountsPayable,24414000.0,應付帳款,聯亞藥,生技醫療業
2019-12-31,6562,AccountsPayable_per,0.91,應付帳款,聯亞藥,生技醫療業
2019-12-31,6562,OtherPayables,130737000.0,其他應付款,聯亞藥,生技醫療業
2019-12-31,6562,OtherPayables_per,4.86,其他應付款,聯亞藥,生技醫療業
2019-12-31,6562,OtherCurrentLiabilities,66696000.0,其他流動負債,聯亞藥,生技醫療業
2019-12-31,6562,OtherCurrentLiabilities_per,2.48,其他流動負債,聯亞藥,生技醫療業
2019-12-31,6562,CurrentLiabilities,357311000.0,流動負債合計,聯亞藥,生技醫療業
2019-12-31,6562,CurrentLiabilities_per,13.27,流動負債合計,聯亞藥,生技醫療業
2019-12-31,6562,LongtermBorrowings,1179733000.0,長期借款,聯亞藥,生技醫療業
2019-12-31,6562,LongtermBorrowings_per,43.82,長期借款,聯亞藥,生技醫療業
2019-12-31,6562,OtherNoncurrentLiabilities,104437000.0,其他非流動負債,聯亞藥,生技醫療業
2019-12-31,6562,OtherNoncurrentLiabilities_per,3.88,其他非流動負債,聯亞藥,生技醫療業
2019-12-31,6562,NoncurrentLiabilities,1808950000.0,非流動負債合計,聯亞藥,生技醫療業
2019-12-31,6562,NoncurrentLiabilities_per,67.2,非流動負債合計,聯亞藥,生技醫療業
2019-12-31,6562,OrdinaryShare,1423581000.0,普通股股本,聯亞藥,生技醫療業
2019-12-31,6562,OrdinaryShare_per,52.88,普通股股本,聯亞藥,生技醫療業
2019-12-31,6562,CapitalStock,1423581000.0,股本合計,聯亞藥,生技醫療業
2019-12-31,6562,CapitalStock_per,52.88,股本合計,聯亞藥,生技醫療業
2019-12-31,6562,CapitalSurplusAdditionalPaidInCapital,23996000.0,資本公積－發行溢價,聯亞藥,生技醫療業
2019-12-31,6562,CapitalSurplusAdditionalPaidInCapital_per,0.89,資本公積－發行溢價,聯亞藥,生技醫療業
2019-12-31,6562,CapitalSurplus,102293000.0,資本公積合計,聯亞藥,生技醫療業
2019-12-31,6562,CapitalSurplus_per,3.8,資本公積合計,聯亞藥,生技醫療業
2019-12-31,6562,LegalReserve,1586000.0,法定盈餘公積,聯亞藥,生技醫療業
2019-12-31,6562,LegalReserve_per,0.06,法定盈餘公積,聯亞藥,生技醫療業
2019-12-31,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit,-869411000.0,未分配盈餘,聯亞藥,生技醫療業
2019-12-31,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-32.3,未分配盈餘,聯亞藥,生技醫療業
2019-12-31,6562,RetainedEarnings,-867825000.0,保留盈餘合計,聯亞藥,生技醫療業
2019-12-31,6562,RetainedEarnings_per,-32.24,保留盈餘合計,聯亞藥,生技醫療業
2019-12-31,6562,OtherEquityInterest,-147842000.0,其他權益合計,聯亞藥,生技醫療業
2019-12-31,6562,OtherEquityInterest_per,-5.49,其他權益合計,聯亞藥,生技醫療業
2019-12-31,6562,EquityAttributableToOwnersOfParent,510207000.0,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2019-12-31,6562,EquityAttributableToOwnersOfParent_per,18.95,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2019-12-31,6562,NoncontrollingInterests,15590000.0,非控制權益,聯亞藥,生技醫療業
2019-12-31,6562,NoncontrollingInterests_per,0.58,非控制權益,聯亞藥,生技醫療業
2019-12-31,6562,TotalLiabilitiesEquity,2692058000.0,負債及權益總計,聯亞藥,生技醫療業
2019-12-31,6562,TotalLiabilitiesEquity_per,100.0,負債及權益總計,聯亞藥,生技醫療業
2019-12-31,6562,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,聯亞藥,生技醫療業
2019-12-31,6562,Liabilities,2166261000.0,負債總額,聯亞藥,生技醫療業
2019-12-31,6562,Liabilities_per,80.47,負債總額,聯亞藥,生技醫療業
2019-12-31,6562,Equity,2692058000.0,權益總計,聯亞藥,生技醫療業
2019-12-31,6562,Equity_per,100.0,權益總計,聯亞藥,生技醫療業
2020-06-30,6562,CashAndCashEquivalents,127529000.0,現金及約當現金,聯亞藥,生技醫療業
2020-06-30,6562,CashAndCashEquivalents_per,4.8,現金及約當現金,聯亞藥,生技醫療業
2020-06-30,6562,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,170600000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,聯亞藥,生技醫療業
2020-06-30,6562,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,6.42,透過其他綜合損益按公允價值衡量之金融資產－非流動,聯亞藥,生技醫療業
2020-06-30,6562,FinancialAssetsAtAmortizedCost,163761000.0,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2020-06-30,6562,FinancialAssetsAtAmortizedCost_per,6.16,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2020-06-30,6562,BillsReceivableNet,11000.0,應收票據淨額,聯亞藥,生技醫療業
2020-06-30,6562,BillsReceivableNet_per,0.0,應收票據淨額,聯亞藥,生技醫療業
2020-06-30,6562,OtherReceivable,10788000.0,其他應收款淨額,聯亞藥,生技醫療業
2020-06-30,6562,OtherReceivable_per,0.41,其他應收款淨額,聯亞藥,生技醫療業
2020-06-30,6562,AccountsReceivableNet,83938000.0,應收帳款淨額,聯亞藥,生技醫療業
2020-06-30,6562,AccountsReceivableNet_per,3.16,應收帳款淨額,聯亞藥,生技醫療業
2020-06-30,6562,AccountsReceivableDuefromRelatedPartiesNet,2824000.0,應收帳款－關係人淨額,聯亞藥,生技醫療業
2020-06-30,6562,AccountsReceivableDuefromRelatedPartiesNet_per,0.11,應收帳款－關係人淨額,聯亞藥,生技醫療業
2020-06-30,6562,OtherReceivablesDueFromRelatedParties,3934000.0,其他應收款－關係人淨額,聯亞藥,生技醫療業
2020-06-30,6562,OtherReceivablesDueFromRelatedParties_per,0.15,其他應收款－關係人淨額,聯亞藥,生技醫療業
2020-06-30,6562,Inventories,67144000.0,存貨,聯亞藥,生技醫療業
2020-06-30,6562,Inventories_per,2.53,存貨,聯亞藥,生技醫療業
2020-06-30,6562,OtherCurrentAssets,109955000.0,其他流動資產,聯亞藥,生技醫療業
2020-06-30,6562,OtherCurrentAssets_per,4.14,其他流動資產,聯亞藥,生技醫療業
2020-06-30,6562,CurrentAssets,569884000.0,流動資產合計,聯亞藥,生技醫療業
2020-06-30,6562,CurrentAssets_per,21.45,流動資產合計,聯亞藥,生技醫療業
2020-06-30,6562,PropertyPlantAndEquipment,1078377000.0,不動產、廠房及設備,聯亞藥,生技醫療業
2020-06-30,6562,PropertyPlantAndEquipment_per,40.59,不動產、廠房及設備,聯亞藥,生技醫療業
2020-06-30,6562,RightOfUseAsset,534759000.0,使用權資產,聯亞藥,生技醫療業
2020-06-30,6562,RightOfUseAsset_per,20.13,使用權資產,聯亞藥,生技醫療業
2020-06-30,6562,IntangibleAssets,263188000.0,無形資產,聯亞藥,生技醫療業
2020-06-30,6562,IntangibleAssets_per,9.91,無形資產,聯亞藥,生技醫療業
2020-06-30,6562,OtherNoncurrentAssets,40229000.0,其他非流動資產,聯亞藥,生技醫療業
2020-06-30,6562,OtherNoncurrentAssets_per,1.51,其他非流動資產,聯亞藥,生技醫療業
2020-06-30,6562,NoncurrentAssets,2087153000.0,非流動資產合計,聯亞藥,生技醫療業
2020-06-30,6562,NoncurrentAssets_per,78.55,非流動資產合計,聯亞藥,生技醫療業
2020-06-30,6562,TotalAssets,2657037000.0,資產總額,聯亞藥,生技醫療業
2020-06-30,6562,TotalAssets_per,100.0,資產總額,聯亞藥,生技醫療業
2020-06-30,6562,ShorttermBorrowings,53779000.0,短期借款,聯亞藥,生技醫療業
2020-06-30,6562,ShorttermBorrowings_per,2.02,短期借款,聯亞藥,生技醫療業
2020-06-30,6562,AccountsPayable,29586000.0,應付帳款,聯亞藥,生技醫療業
2020-06-30,6562,AccountsPayable_per,1.11,應付帳款,聯亞藥,生技醫療業
2020-06-30,6562,OtherPayables,115284000.0,其他應付款,聯亞藥,生技醫療業
2020-06-30,6562,OtherPayables_per,4.34,其他應付款,聯亞藥,生技醫療業
2020-06-30,6562,OtherCurrentLiabilities,91195000.0,其他流動負債,聯亞藥,生技醫療業
2020-06-30,6562,OtherCurrentLiabilities_per,3.43,其他流動負債,聯亞藥,生技醫療業
2020-06-30,6562,CurrentLiabilities,366826000.0,流動負債合計,聯亞藥,生技醫療業
2020-06-30,6562,CurrentLiabilities_per,13.81,流動負債合計,聯亞藥,生技醫療業
2020-06-30,6562,LongtermBorrowings,1132898000.0,長期借款,聯亞藥,生技醫療業
2020-06-30,6562,LongtermBorrowings_per,42.64,長期借款,聯亞藥,生技醫療業
2020-06-30,6562,OtherNoncurrentLiabilities,101583000.0,其他非流動負債,聯亞藥,生技醫療業
2020-06-30,6562,OtherNoncurrentLiabilities_per,3.82,其他非流動負債,聯亞藥,生技醫療業
2020-06-30,6562,NoncurrentLiabilities,1742455000.0,非流動負債合計,聯亞藥,生技醫療業
2020-06-30,6562,NoncurrentLiabilities_per,65.58,非流動負債合計,聯亞藥,生技醫療業
2020-06-30,6562,OrdinaryShare,1523081000.0,普通股股本,聯亞藥,生技醫療業
2020-06-30,6562,OrdinaryShare_per,57.32,普通股股本,聯亞藥,生技醫療業
2020-06-30,6562,CapitalStock,1523081000.0,股本合計,聯亞藥,生技醫療業
2020-06-30,6562,CapitalStock_per,57.32,股本合計,聯亞藥,生技醫療業
2020-06-30,6562,CapitalSurplusAdditionalPaidInCapital,24886000.0,資本公積－發行溢價,聯亞藥,生技醫療業
2020-06-30,6562,CapitalSurplusAdditionalPaidInCapital_per,0.94,資本公積－發行溢價,聯亞藥,生技醫療業
2020-06-30,6562,CapitalSurplus,101678000.0,資本公積合計,聯亞藥,生技醫療業
2020-06-30,6562,CapitalSurplus_per,3.83,資本公積合計,聯亞藥,生技醫療業
2020-06-30,6562,LegalReserve,1586000.0,法定盈餘公積,聯亞藥,生技醫療業
2020-06-30,6562,LegalReserve_per,0.06,法定盈餘公積,聯亞藥,生技醫療業
2020-06-30,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit,-958734000.0,未分配盈餘,聯亞藥,生技醫療業
2020-06-30,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-36.08,未分配盈餘,聯亞藥,生技醫療業
2020-06-30,6562,RetainedEarnings,-957148000.0,保留盈餘合計,聯亞藥,生技醫療業
2020-06-30,6562,RetainedEarnings_per,-36.02,保留盈餘合計,聯亞藥,生技醫療業
2020-06-30,6562,OtherEquityInterest,-129394000.0,其他權益合計,聯亞藥,生技醫療業
2020-06-30,6562,OtherEquityInterest_per,-4.87,其他權益合計,聯亞藥,生技醫療業
2020-06-30,6562,EquityAttributableToOwnersOfParent,538217000.0,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2020-06-30,6562,EquityAttributableToOwnersOfParent_per,20.26,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2020-06-30,6562,NoncontrollingInterests,9539000.0,非控制權益,聯亞藥,生技醫療業
2020-06-30,6562,NoncontrollingInterests_per,0.36,非控制權益,聯亞藥,生技醫療業
2020-06-30,6562,TotalLiabilitiesEquity,2657037000.0,負債及權益總計,聯亞藥,生技醫療業
2020-06-30,6562,TotalLiabilitiesEquity_per,100.0,負債及權益總計,聯亞藥,生技醫療業
2020-06-30,6562,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,聯亞藥,生技醫療業
2020-06-30,6562,Equity,547756000.0,權益總額,聯亞藥,生技醫療業
2020-06-30,6562,Equity_per,20.62,權益總額,聯亞藥,生技醫療業
2020-06-30,6562,Liabilities,2109281000.0,負債總額,聯亞藥,生技醫療業
2020-06-30,6562,Liabilities_per,79.38,負債總額,聯亞藥,生技醫療業
2020-12-31,6562,CashAndCashEquivalents,140224000.0,現金及約當現金,聯亞藥,生技醫療業
2020-12-31,6562,CashAndCashEquivalents_per,9.12,現金及約當現金,聯亞藥,生技醫療業
2020-12-31,6562,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,156308000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,聯亞藥,生技醫療業
2020-12-31,6562,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,10.17,透過其他綜合損益按公允價值衡量之金融資產－非流動,聯亞藥,生技醫療業
2020-12-31,6562,FinancialAssetsAtAmortizedCost,6835000.0,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2020-12-31,6562,FinancialAssetsAtAmortizedCost_per,0.44,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2020-12-31,6562,BillsReceivableNet,9000.0,應收票據淨額,聯亞藥,生技醫療業
2020-12-31,6562,BillsReceivableNet_per,0.0,應收票據淨額,聯亞藥,生技醫療業
2020-12-31,6562,OtherReceivable,17133000.0,其他應收款淨額,聯亞藥,生技醫療業
2020-12-31,6562,OtherReceivable_per,1.11,其他應收款淨額,聯亞藥,生技醫療業
2020-12-31,6562,AccountsReceivableNet,87286000.0,應收帳款淨額,聯亞藥,生技醫療業
2020-12-31,6562,AccountsReceivableNet_per,5.68,應收帳款淨額,聯亞藥,生技醫療業
2020-12-31,6562,AccountsReceivableDuefromRelatedPartiesNet,7652000.0,應收帳款－關係人淨額,聯亞藥,生技醫療業
2020-12-31,6562,AccountsReceivableDuefromRelatedPartiesNet_per,0.5,應收帳款－關係人淨額,聯亞藥,生技醫療業
2020-12-31,6562,OtherReceivablesDueFromRelatedParties,3805000.0,其他應收款－關係人淨額,聯亞藥,生技醫療業
2020-12-31,6562,OtherReceivablesDueFromRelatedParties_per,0.25,其他應收款－關係人淨額,聯亞藥,生技醫療業
2020-12-31,6562,Inventories,70183000.0,存貨,聯亞藥,生技醫療業
2020-12-31,6562,Inventories_per,4.56,存貨,聯亞藥,生技醫療業
2020-12-31,6562,OtherCurrentAssets,26583000.0,其他流動資產,聯亞藥,生技醫療業
2020-12-31,6562,OtherCurrentAssets_per,1.73,其他流動資產,聯亞藥,生技醫療業
2020-12-31,6562,CurrentAssets,359710000.0,流動資產合計,聯亞藥,生技醫療業
2020-12-31,6562,CurrentAssets_per,23.4,流動資產合計,聯亞藥,生技醫療業
2020-12-31,6562,PropertyPlantAndEquipment,211754000.0,不動產、廠房及設備,聯亞藥,生技醫療業
2020-12-31,6562,PropertyPlantAndEquipment_per,13.77,不動產、廠房及設備,聯亞藥,生技醫療業
2020-12-31,6562,RightOfUseAsset,515365000.0,使用權資產,聯亞藥,生技醫療業
2020-12-31,6562,RightOfUseAsset_per,33.52,使用權資產,聯亞藥,生技醫療業
2020-12-31,6562,IntangibleAssets,246862000.0,無形資產,聯亞藥,生技醫療業
2020-12-31,6562,IntangibleAssets_per,16.06,無形資產,聯亞藥,生技醫療業
2020-12-31,6562,OtherNoncurrentAssets,47480000.0,其他非流動資產,聯亞藥,生技醫療業
2020-12-31,6562,OtherNoncurrentAssets_per,3.09,其他非流動資產,聯亞藥,生技醫療業
2020-12-31,6562,NoncurrentAssets,1177769000.0,非流動資產合計,聯亞藥,生技醫療業
2020-12-31,6562,NoncurrentAssets_per,76.6,非流動資產合計,聯亞藥,生技醫療業
2020-12-31,6562,TotalAssets,1537479000.0,資產總額,聯亞藥,生技醫療業
2020-12-31,6562,TotalAssets_per,100.0,資產總額,聯亞藥,生技醫療業
2020-12-31,6562,ShorttermBorrowings,17276000.0,短期借款,聯亞藥,生技醫療業
2020-12-31,6562,ShorttermBorrowings_per,1.12,短期借款,聯亞藥,生技醫療業
2020-12-31,6562,AccountsPayable,31452000.0,應付帳款,聯亞藥,生技醫療業
2020-12-31,6562,AccountsPayable_per,2.05,應付帳款,聯亞藥,生技醫療業
2020-12-31,6562,OtherPayables,80356000.0,其他應付款,聯亞藥,生技醫療業
2020-12-31,6562,OtherPayables_per,5.23,其他應付款,聯亞藥,生技醫療業
2020-12-31,6562,OtherCurrentLiabilities,146670000.0,其他流動負債,聯亞藥,生技醫療業
2020-12-31,6562,OtherCurrentLiabilities_per,9.54,其他流動負債,聯亞藥,生技醫療業
2020-12-31,6562,CurrentLiabilities,340227000.0,流動負債合計,聯亞藥,生技醫療業
2020-12-31,6562,CurrentLiabilities_per,22.13,流動負債合計,聯亞藥,生技醫療業
2020-12-31,6562,LongtermBorrowings,246607000.0,長期借款,聯亞藥,生技醫療業
2020-12-31,6562,LongtermBorrowings_per,16.04,長期借款,聯亞藥,生技醫療業
2020-12-31,6562,OtherNoncurrentLiabilities,709000.0,其他非流動負債,聯亞藥,生技醫療業
2020-12-31,6562,OtherNoncurrentLiabilities_per,0.05,其他非流動負債,聯亞藥,生技醫療業
2020-12-31,6562,NoncurrentLiabilities,738385000.0,非流動負債合計,聯亞藥,生技醫療業
2020-12-31,6562,NoncurrentLiabilities_per,48.03,非流動負債合計,聯亞藥,生技醫療業
2020-12-31,6562,OrdinaryShare,913548000.0,普通股股本,聯亞藥,生技醫療業
2020-12-31,6562,OrdinaryShare_per,59.42,普通股股本,聯亞藥,生技醫療業
2020-12-31,6562,CapitalStock,913548000.0,股本合計,聯亞藥,生技醫療業
2020-12-31,6562,CapitalStock_per,59.42,股本合計,聯亞藥,生技醫療業
2020-12-31,6562,CapitalSurplusAdditionalPaidInCapital,24886000.0,資本公積－發行溢價,聯亞藥,生技醫療業
2020-12-31,6562,CapitalSurplusAdditionalPaidInCapital_per,1.62,資本公積－發行溢價,聯亞藥,生技醫療業
2020-12-31,6562,CapitalSurplus,26920000.0,資本公積合計,聯亞藥,生技醫療業
2020-12-31,6562,CapitalSurplus_per,1.75,資本公積合計,聯亞藥,生技醫療業
2020-12-31,6562,LegalReserve,1586000.0,法定盈餘公積,聯亞藥,生技醫療業
2020-12-31,6562,LegalReserve_per,0.1,法定盈餘公積,聯亞藥,生技醫療業
2020-12-31,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit,-333866000.0,未分配盈餘,聯亞藥,生技醫療業
2020-12-31,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-21.72,未分配盈餘,聯亞藥,生技醫療業
2020-12-31,6562,RetainedEarnings,-332280000.0,保留盈餘合計,聯亞藥,生技醫療業
2020-12-31,6562,RetainedEarnings_per,-21.61,保留盈餘合計,聯亞藥,生技醫療業
2020-12-31,6562,OtherEquityInterest,-149321000.0,其他權益合計,聯亞藥,生技醫療業
2020-12-31,6562,OtherEquityInterest_per,-9.71,其他權益合計,聯亞藥,生技醫療業
2020-12-31,6562,EquityAttributableToOwnersOfParent,458867000.0,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2020-12-31,6562,EquityAttributableToOwnersOfParent_per,29.85,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2020-12-31,6562,NoncontrollingInterests,0.0,非控制權益,聯亞藥,生技醫療業
2020-12-31,6562,NoncontrollingInterests_per,0.0,非控制權益,聯亞藥,生技醫療業
2020-12-31,6562,TotalLiabilitiesEquity,1537479000.0,負債及權益總計,聯亞藥,生技醫療業
2020-12-31,6562,TotalLiabilitiesEquity_per,100.0,負債及權益總計,聯亞藥,生技醫療業
2020-12-31,6562,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,聯亞藥,生技醫療業
2020-12-31,6562,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,聯亞藥,生技醫療業
2020-12-31,6562,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,聯亞藥,生技醫療業
2020-12-31,6562,Liabilities,1078612000.0,負債總額,聯亞藥,生技醫療業
2020-12-31,6562,Liabilities_per,70.15,負債總額,聯亞藥,生技醫療業
2020-12-31,6562,Equity,458867000.0,權益總額,聯亞藥,生技醫療業
2020-12-31,6562,Equity_per,29.85,權益總額,聯亞藥,生技醫療業
2021-06-30,6562,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,聯亞藥,生技醫療業
2021-06-30,6562,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,聯亞藥,生技醫療業
2021-06-30,6562,CashAndCashEquivalents,497270000.0,現金及約當現金,聯亞藥,生技醫療業
2021-06-30,6562,CashAndCashEquivalents_per,24.75,現金及約當現金,聯亞藥,生技醫療業
2021-06-30,6562,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,162505000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,聯亞藥,生技醫療業
2021-06-30,6562,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,8.09,透過其他綜合損益按公允價值衡量之金融資產－非流動,聯亞藥,生技醫療業
2021-06-30,6562,FinancialAssetsAtAmortizedCost,41010000.0,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2021-06-30,6562,FinancialAssetsAtAmortizedCost_per,2.04,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2021-06-30,6562,BillsReceivableNet,1767000.0,應收票據淨額,聯亞藥,生技醫療業
2021-06-30,6562,BillsReceivableNet_per,0.09,應收票據淨額,聯亞藥,生技醫療業
2021-06-30,6562,OtherReceivable,1155000.0,其他應收款淨額,聯亞藥,生技醫療業
2021-06-30,6562,OtherReceivable_per,0.06,其他應收款淨額,聯亞藥,生技醫療業
2021-06-30,6562,AccountsReceivableNet,111455000.0,應收帳款淨額,聯亞藥,生技醫療業
2021-06-30,6562,AccountsReceivableNet_per,5.55,應收帳款淨額,聯亞藥,生技醫療業
2021-06-30,6562,AccountsReceivableDuefromRelatedPartiesNet,9640000.0,應收帳款－關係人淨額,聯亞藥,生技醫療業
2021-06-30,6562,AccountsReceivableDuefromRelatedPartiesNet_per,0.48,應收帳款－關係人淨額,聯亞藥,生技醫療業
2021-06-30,6562,OtherReceivablesDueFromRelatedParties,15465000.0,其他應收款－關係人淨額,聯亞藥,生技醫療業
2021-06-30,6562,OtherReceivablesDueFromRelatedParties_per,0.77,其他應收款－關係人淨額,聯亞藥,生技醫療業
2021-06-30,6562,Inventories,110322000.0,存貨,聯亞藥,生技醫療業
2021-06-30,6562,Inventories_per,5.49,存貨,聯亞藥,生技醫療業
2021-06-30,6562,OtherCurrentAssets,42702000.0,其他流動資產,聯亞藥,生技醫療業
2021-06-30,6562,OtherCurrentAssets_per,2.13,其他流動資產,聯亞藥,生技醫療業
2021-06-30,6562,CurrentAssets,830786000.0,流動資產合計,聯亞藥,生技醫療業
2021-06-30,6562,CurrentAssets_per,41.35,流動資產合計,聯亞藥,生技醫療業
2021-06-30,6562,PropertyPlantAndEquipment,208620000.0,不動產、廠房及設備,聯亞藥,生技醫療業
2021-06-30,6562,PropertyPlantAndEquipment_per,10.38,不動產、廠房及設備,聯亞藥,生技醫療業
2021-06-30,6562,RightOfUseAsset,497679000.0,使用權資產,聯亞藥,生技醫療業
2021-06-30,6562,RightOfUseAsset_per,24.77,使用權資產,聯亞藥,生技醫療業
2021-06-30,6562,IntangibleAssets,245204000.0,無形資產,聯亞藥,生技醫療業
2021-06-30,6562,IntangibleAssets_per,12.2,無形資產,聯亞藥,生技醫療業
2021-06-30,6562,OtherNoncurrentAssets,64521000.0,其他非流動資產,聯亞藥,生技醫療業
2021-06-30,6562,OtherNoncurrentAssets_per,3.21,其他非流動資產,聯亞藥,生技醫療業
2021-06-30,6562,NoncurrentAssets,1178529000.0,非流動資產合計,聯亞藥,生技醫療業
2021-06-30,6562,NoncurrentAssets_per,58.65,非流動資產合計,聯亞藥,生技醫療業
2021-06-30,6562,TotalAssets,2009315000.0,資產總額,聯亞藥,生技醫療業
2021-06-30,6562,TotalAssets_per,100.0,資產總額,聯亞藥,生技醫療業
2021-06-30,6562,ShorttermBorrowings,30593000.0,短期借款,聯亞藥,生技醫療業
2021-06-30,6562,ShorttermBorrowings_per,1.52,短期借款,聯亞藥,生技醫療業
2021-06-30,6562,AccountsPayable,58371000.0,應付帳款,聯亞藥,生技醫療業
2021-06-30,6562,AccountsPayable_per,2.91,應付帳款,聯亞藥,生技醫療業
2021-06-30,6562,OtherPayables,97313000.0,其他應付款,聯亞藥,生技醫療業
2021-06-30,6562,OtherPayables_per,4.84,其他應付款,聯亞藥,生技醫療業
2021-06-30,6562,OtherCurrentLiabilities,189780000.0,其他流動負債,聯亞藥,生技醫療業
2021-06-30,6562,OtherCurrentLiabilities_per,9.45,其他流動負債,聯亞藥,生技醫療業
2021-06-30,6562,CurrentLiabilities,531777000.0,流動負債合計,聯亞藥,生技醫療業
2021-06-30,6562,CurrentLiabilities_per,26.47,流動負債合計,聯亞藥,生技醫療業
2021-06-30,6562,LongtermBorrowings,155688000.0,長期借款,聯亞藥,生技醫療業
2021-06-30,6562,LongtermBorrowings_per,7.75,長期借款,聯亞藥,生技醫療業
2021-06-30,6562,OtherNoncurrentLiabilities,705000.0,其他非流動負債,聯亞藥,生技醫療業
2021-06-30,6562,OtherNoncurrentLiabilities_per,0.04,其他非流動負債,聯亞藥,生技醫療業
2021-06-30,6562,NoncurrentLiabilities,630773000.0,非流動負債合計,聯亞藥,生技醫療業
2021-06-30,6562,NoncurrentLiabilities_per,31.39,非流動負債合計,聯亞藥,生技醫療業
2021-06-30,6562,Liabilities,1162550000.0,負債總額,聯亞藥,生技醫療業
2021-06-30,6562,Liabilities_per,57.86,負債總額,聯亞藥,生技醫療業
2021-06-30,6562,OrdinaryShare,1053548000.0,普通股股本,聯亞藥,生技醫療業
2021-06-30,6562,OrdinaryShare_per,52.43,普通股股本,聯亞藥,生技醫療業
2021-06-30,6562,CapitalStock,1053548000.0,股本合計,聯亞藥,生技醫療業
2021-06-30,6562,CapitalStock_per,52.43,股本合計,聯亞藥,生技醫療業
2021-06-30,6562,CapitalSurplusAdditionalPaidInCapital,305732000.0,資本公積－發行溢價,聯亞藥,生技醫療業
2021-06-30,6562,CapitalSurplusAdditionalPaidInCapital_per,15.22,資本公積－發行溢價,聯亞藥,生技醫療業
2021-06-30,6562,CapitalSurplus,306920000.0,資本公積合計,聯亞藥,生技醫療業
2021-06-30,6562,CapitalSurplus_per,15.27,資本公積合計,聯亞藥,生技醫療業
2021-06-30,6562,LegalReserve,1586000.0,法定盈餘公積,聯亞藥,生技醫療業
2021-06-30,6562,LegalReserve_per,0.08,法定盈餘公積,聯亞藥,生技醫療業
2021-06-30,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit,-373165000.0,未分配盈餘,聯亞藥,生技醫療業
2021-06-30,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-18.57,未分配盈餘,聯亞藥,生技醫療業
2021-06-30,6562,RetainedEarnings,-371579000.0,保留盈餘合計,聯亞藥,生技醫療業
2021-06-30,6562,RetainedEarnings_per,-18.49,保留盈餘合計,聯亞藥,生技醫療業
2021-06-30,6562,OtherEquityInterest,-142124000.0,其他權益合計,聯亞藥,生技醫療業
2021-06-30,6562,OtherEquityInterest_per,-7.07,其他權益合計,聯亞藥,生技醫療業
2021-06-30,6562,EquityAttributableToOwnersOfParent,846765000.0,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2021-06-30,6562,EquityAttributableToOwnersOfParent_per,42.14,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2021-06-30,6562,NoncontrollingInterests,0.0,非控制權益,聯亞藥,生技醫療業
2021-06-30,6562,NoncontrollingInterests_per,0.0,非控制權益,聯亞藥,生技醫療業
2021-06-30,6562,TotalLiabilitiesEquity,2009315000.0,負債及權益總計,聯亞藥,生技醫療業
2021-06-30,6562,TotalLiabilitiesEquity_per,100.0,負債及權益總計,聯亞藥,生技醫療業
2021-06-30,6562,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,聯亞藥,生技醫療業
2021-06-30,6562,Equity,846765000.0,權益總額,聯亞藥,生技醫療業
2021-06-30,6562,Equity_per,42.14,權益總額,聯亞藥,生技醫療業
2021-12-31,6562,CashAndCashEquivalents,298706000.0,現金及約當現金,聯亞藥,生技醫療業
2021-12-31,6562,CashAndCashEquivalents_per,15.7,現金及約當現金,聯亞藥,生技醫療業
2021-12-31,6562,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,154963000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,聯亞藥,生技醫療業
2021-12-31,6562,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,8.14,透過其他綜合損益按公允價值衡量之金融資產－非流動,聯亞藥,生技醫療業
2021-12-31,6562,FinancialAssetsAtAmortizedCost,58454000.0,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2021-12-31,6562,FinancialAssetsAtAmortizedCost_per,3.07,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2021-12-31,6562,BillsReceivableNet,1102000.0,應收票據淨額,聯亞藥,生技醫療業
2021-12-31,6562,BillsReceivableNet_per,0.06,應收票據淨額,聯亞藥,生技醫療業
2021-12-31,6562,OtherReceivable,4242000.0,其他應收款淨額,聯亞藥,生技醫療業
2021-12-31,6562,OtherReceivable_per,0.22,其他應收款淨額,聯亞藥,生技醫療業
2021-12-31,6562,AccountsReceivableNet,119897000.0,應收帳款淨額,聯亞藥,生技醫療業
2021-12-31,6562,AccountsReceivableNet_per,6.3,應收帳款淨額,聯亞藥,生技醫療業
2021-12-31,6562,AccountsReceivableDuefromRelatedPartiesNet,26489000.0,應收帳款－關係人淨額,聯亞藥,生技醫療業
2021-12-31,6562,AccountsReceivableDuefromRelatedPartiesNet_per,1.39,應收帳款－關係人淨額,聯亞藥,生技醫療業
2021-12-31,6562,OtherReceivablesDueFromRelatedParties,1382000.0,其他應收款－關係人淨額,聯亞藥,生技醫療業
2021-12-31,6562,OtherReceivablesDueFromRelatedParties_per,0.07,其他應收款－關係人淨額,聯亞藥,生技醫療業
2021-12-31,6562,Inventories,105200000.0,存貨,聯亞藥,生技醫療業
2021-12-31,6562,Inventories_per,5.53,存貨,聯亞藥,生技醫療業
2021-12-31,6562,OtherCurrentAssets,59174000.0,其他流動資產,聯亞藥,生技醫療業
2021-12-31,6562,OtherCurrentAssets_per,3.11,其他流動資產,聯亞藥,生技醫療業
2021-12-31,6562,CurrentAssets,712484000.0,流動資產合計,聯亞藥,生技醫療業
2021-12-31,6562,CurrentAssets_per,37.45,流動資產合計,聯亞藥,生技醫療業
2021-12-31,6562,PropertyPlantAndEquipment,209565000.0,不動產、廠房及設備,聯亞藥,生技醫療業
2021-12-31,6562,PropertyPlantAndEquipment_per,11.01,不動產、廠房及設備,聯亞藥,生技醫療業
2021-12-31,6562,RightOfUseAsset,478284000.0,使用權資產,聯亞藥,生技醫療業
2021-12-31,6562,RightOfUseAsset_per,25.14,使用權資產,聯亞藥,生技醫療業
2021-12-31,6562,IntangibleAssets,242604000.0,無形資產,聯亞藥,生技醫療業
2021-12-31,6562,IntangibleAssets_per,12.75,無形資產,聯亞藥,生技醫療業
2021-12-31,6562,OtherNoncurrentAssets,104702000.0,其他非流動資產,聯亞藥,生技醫療業
2021-12-31,6562,OtherNoncurrentAssets_per,5.5,其他非流動資產,聯亞藥,生技醫療業
2021-12-31,6562,NoncurrentAssets,1190118000.0,非流動資產合計,聯亞藥,生技醫療業
2021-12-31,6562,NoncurrentAssets_per,62.55,非流動資產合計,聯亞藥,生技醫療業
2021-12-31,6562,TotalAssets,1902602000.0,資產總額,聯亞藥,生技醫療業
2021-12-31,6562,TotalAssets_per,100.0,資產總額,聯亞藥,生技醫療業
2021-12-31,6562,ShorttermBorrowings,33560000.0,短期借款,聯亞藥,生技醫療業
2021-12-31,6562,ShorttermBorrowings_per,1.76,短期借款,聯亞藥,生技醫療業
2021-12-31,6562,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,307000.0,透過損益按公允價值衡量之金融負債－流動,聯亞藥,生技醫療業
2021-12-31,6562,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.02,透過損益按公允價值衡量之金融負債－流動,聯亞藥,生技醫療業
2021-12-31,6562,AccountsPayable,29747000.0,應付帳款,聯亞藥,生技醫療業
2021-12-31,6562,AccountsPayable_per,1.56,應付帳款,聯亞藥,生技醫療業
2021-12-31,6562,OtherPayables,94597000.0,其他應付款,聯亞藥,生技醫療業
2021-12-31,6562,OtherPayables_per,4.97,其他應付款,聯亞藥,生技醫療業
2021-12-31,6562,OtherCurrentLiabilities,165494000.0,其他流動負債,聯亞藥,生技醫療業
2021-12-31,6562,OtherCurrentLiabilities_per,8.7,其他流動負債,聯亞藥,生技醫療業
2021-12-31,6562,CurrentLiabilities,450742000.0,流動負債合計,聯亞藥,生技醫療業
2021-12-31,6562,CurrentLiabilities_per,23.69,流動負債合計,聯亞藥,生技醫療業
2021-12-31,6562,LongtermBorrowings,93226000.0,長期借款,聯亞藥,生技醫療業
2021-12-31,6562,LongtermBorrowings_per,4.9,長期借款,聯亞藥,生技醫療業
2021-12-31,6562,OtherNoncurrentLiabilities,543000.0,其他非流動負債,聯亞藥,生技醫療業
2021-12-31,6562,OtherNoncurrentLiabilities_per,0.03,其他非流動負債,聯亞藥,生技醫療業
2021-12-31,6562,NoncurrentLiabilities,550395000.0,非流動負債合計,聯亞藥,生技醫療業
2021-12-31,6562,NoncurrentLiabilities_per,28.93,非流動負債合計,聯亞藥,生技醫療業
2021-12-31,6562,OrdinaryShare,1053485000.0,普通股股本,聯亞藥,生技醫療業
2021-12-31,6562,OrdinaryShare_per,55.37,普通股股本,聯亞藥,生技醫療業
2021-12-31,6562,CapitalStock,1053485000.0,股本合計,聯亞藥,生技醫療業
2021-12-31,6562,CapitalStock_per,55.37,股本合計,聯亞藥,生技醫療業
2021-12-31,6562,CapitalSurplusAdditionalPaidInCapital,305732000.0,資本公積－發行溢價,聯亞藥,生技醫療業
2021-12-31,6562,CapitalSurplusAdditionalPaidInCapital_per,16.07,資本公積－發行溢價,聯亞藥,生技醫療業
2021-12-31,6562,CapitalSurplus,306884000.0,資本公積合計,聯亞藥,生技醫療業
2021-12-31,6562,CapitalSurplus_per,16.13,資本公積合計,聯亞藥,生技醫療業
2021-12-31,6562,LegalReserve,1586000.0,法定盈餘公積,聯亞藥,生技醫療業
2021-12-31,6562,LegalReserve_per,0.08,法定盈餘公積,聯亞藥,生技醫療業
2021-12-31,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit,-311615000.0,未分配盈餘,聯亞藥,生技醫療業
2021-12-31,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-16.38,未分配盈餘,聯亞藥,生技醫療業
2021-12-31,6562,RetainedEarnings,-310029000.0,保留盈餘合計,聯亞藥,生技醫療業
2021-12-31,6562,RetainedEarnings_per,-16.3,保留盈餘合計,聯亞藥,生技醫療業
2021-12-31,6562,OtherEquityInterest,-148875000.0,其他權益合計,聯亞藥,生技醫療業
2021-12-31,6562,OtherEquityInterest_per,-7.82,其他權益合計,聯亞藥,生技醫療業
2021-12-31,6562,EquityAttributableToOwnersOfParent,901465000.0,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2021-12-31,6562,EquityAttributableToOwnersOfParent_per,47.38,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2021-12-31,6562,NoncontrollingInterests,0.0,非控制權益,聯亞藥,生技醫療業
2021-12-31,6562,NoncontrollingInterests_per,0.0,非控制權益,聯亞藥,生技醫療業
2021-12-31,6562,TotalLiabilitiesEquity,1902602000.0,負債及權益總計,聯亞藥,生技醫療業
2021-12-31,6562,TotalLiabilitiesEquity_per,100.0,負債及權益總計,聯亞藥,生技醫療業
2021-12-31,6562,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,聯亞藥,生技醫療業
2021-12-31,6562,CurrentIncomeTaxAssets,0.0,本期所得稅資產,聯亞藥,生技醫療業
2021-12-31,6562,CurrentIncomeTaxAssets_per,0.0,本期所得稅資產,聯亞藥,生技醫療業
2021-12-31,6562,Liabilities,1001137000.0,負債總額,聯亞藥,生技醫療業
2021-12-31,6562,Liabilities_per,52.62,負債總額,聯亞藥,生技醫療業
2021-12-31,6562,Equity,901465000.0,權益總額,聯亞藥,生技醫療業
2021-12-31,6562,Equity_per,47.38,權益總額,聯亞藥,生技醫療業
2022-06-30,6562,CashAndCashEquivalents,407277000.0,現金及約當現金,聯亞藥,生技醫療業
2022-06-30,6562,CashAndCashEquivalents_per,20.52,現金及約當現金,聯亞藥,生技醫療業
2022-06-30,6562,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,132367000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,聯亞藥,生技醫療業
2022-06-30,6562,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,6.67,透過其他綜合損益按公允價值衡量之金融資產－非流動,聯亞藥,生技醫療業
2022-06-30,6562,FinancialAssetsAtAmortizedCost,12194000.0,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2022-06-30,6562,FinancialAssetsAtAmortizedCost_per,0.61,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2022-06-30,6562,BillsReceivableNet,0.0,應收票據淨額,聯亞藥,生技醫療業
2022-06-30,6562,BillsReceivableNet_per,0.0,應收票據淨額,聯亞藥,生技醫療業
2022-06-30,6562,OtherReceivable,4326000.0,其他應收款淨額,聯亞藥,生技醫療業
2022-06-30,6562,OtherReceivable_per,0.22,其他應收款淨額,聯亞藥,生技醫療業
2022-06-30,6562,AccountsReceivableNet,165211000.0,應收帳款淨額,聯亞藥,生技醫療業
2022-06-30,6562,AccountsReceivableNet_per,8.32,應收帳款淨額,聯亞藥,生技醫療業
2022-06-30,6562,AccountsReceivableDuefromRelatedPartiesNet,89000.0,應收帳款－關係人淨額,聯亞藥,生技醫療業
2022-06-30,6562,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,聯亞藥,生技醫療業
2022-06-30,6562,OtherReceivablesDueFromRelatedParties,28897000.0,其他應收款－關係人淨額,聯亞藥,生技醫療業
2022-06-30,6562,OtherReceivablesDueFromRelatedParties_per,1.46,其他應收款－關係人淨額,聯亞藥,生技醫療業
2022-06-30,6562,Inventories,86264000.0,存貨,聯亞藥,生技醫療業
2022-06-30,6562,Inventories_per,4.35,存貨,聯亞藥,生技醫療業
2022-06-30,6562,OtherCurrentAssets,48563000.0,其他流動資產,聯亞藥,生技醫療業
2022-06-30,6562,OtherCurrentAssets_per,2.45,其他流動資產,聯亞藥,生技醫療業
2022-06-30,6562,CurrentAssets,762391000.0,流動資產合計,聯亞藥,生技醫療業
2022-06-30,6562,CurrentAssets_per,38.41,流動資產合計,聯亞藥,生技醫療業
2022-06-30,6562,PropertyPlantAndEquipment,240096000.0,不動產、廠房及設備,聯亞藥,生技醫療業
2022-06-30,6562,PropertyPlantAndEquipment_per,12.1,不動產、廠房及設備,聯亞藥,生技醫療業
2022-06-30,6562,RightOfUseAsset,458889000.0,使用權資產,聯亞藥,生技醫療業
2022-06-30,6562,RightOfUseAsset_per,23.12,使用權資產,聯亞藥,生技醫療業
2022-06-30,6562,IntangibleAssets,243582000.0,無形資產,聯亞藥,生技醫療業
2022-06-30,6562,IntangibleAssets_per,12.27,無形資產,聯亞藥,生技醫療業
2022-06-30,6562,OtherNoncurrentAssets,147585000.0,其他非流動資產,聯亞藥,生技醫療業
2022-06-30,6562,OtherNoncurrentAssets_per,7.44,其他非流動資產,聯亞藥,生技醫療業
2022-06-30,6562,NoncurrentAssets,1222519000.0,非流動資產合計,聯亞藥,生技醫療業
2022-06-30,6562,NoncurrentAssets_per,61.59,非流動資產合計,聯亞藥,生技醫療業
2022-06-30,6562,TotalAssets,1984910000.0,資產總額,聯亞藥,生技醫療業
2022-06-30,6562,TotalAssets_per,100.0,資產總額,聯亞藥,生技醫療業
2022-06-30,6562,ShorttermBorrowings,59476000.0,短期借款,聯亞藥,生技醫療業
2022-06-30,6562,ShorttermBorrowings_per,3.0,短期借款,聯亞藥,生技醫療業
2022-06-30,6562,AccountsPayable,36225000.0,應付帳款,聯亞藥,生技醫療業
2022-06-30,6562,AccountsPayable_per,1.83,應付帳款,聯亞藥,生技醫療業
2022-06-30,6562,OtherPayables,61747000.0,其他應付款,聯亞藥,生技醫療業
2022-06-30,6562,OtherPayables_per,3.11,其他應付款,聯亞藥,生技醫療業
2022-06-30,6562,OtherCurrentLiabilities,33285000.0,其他流動負債,聯亞藥,生技醫療業
2022-06-30,6562,OtherCurrentLiabilities_per,1.68,其他流動負債,聯亞藥,生技醫療業
2022-06-30,6562,CurrentLiabilities,321413000.0,流動負債合計,聯亞藥,生技醫療業
2022-06-30,6562,CurrentLiabilities_per,16.19,流動負債合計,聯亞藥,生技醫療業
2022-06-30,6562,LongtermBorrowings,13333000.0,長期借款,聯亞藥,生技醫療業
2022-06-30,6562,LongtermBorrowings_per,0.67,長期借款,聯亞藥,生技醫療業
2022-06-30,6562,OtherNoncurrentLiabilities,543000.0,其他非流動負債,聯亞藥,生技醫療業
2022-06-30,6562,OtherNoncurrentLiabilities_per,0.03,其他非流動負債,聯亞藥,生技醫療業
2022-06-30,6562,NoncurrentLiabilities,452915000.0,非流動負債合計,聯亞藥,生技醫療業
2022-06-30,6562,NoncurrentLiabilities_per,22.82,非流動負債合計,聯亞藥,生技醫療業
2022-06-30,6562,OrdinaryShare,1113485000.0,普通股股本,聯亞藥,生技醫療業
2022-06-30,6562,OrdinaryShare_per,56.1,普通股股本,聯亞藥,生技醫療業
2022-06-30,6562,CapitalStock,1113485000.0,股本合計,聯亞藥,生技醫療業
2022-06-30,6562,CapitalStock_per,56.1,股本合計,聯亞藥,生技醫療業
2022-06-30,6562,CapitalSurplusAdditionalPaidInCapital,248147000.0,資本公積－發行溢價,聯亞藥,生技醫療業
2022-06-30,6562,CapitalSurplusAdditionalPaidInCapital_per,12.5,資本公積－發行溢價,聯亞藥,生技醫療業
2022-06-30,6562,CapitalSurplus,248723000.0,資本公積合計,聯亞藥,生技醫療業
2022-06-30,6562,CapitalSurplus_per,12.53,資本公積合計,聯亞藥,生技醫療業
2022-06-30,6562,LegalReserve,0.0,法定盈餘公積,聯亞藥,生技醫療業
2022-06-30,6562,LegalReserve_per,0.0,法定盈餘公積,聯亞藥,生技醫療業
2022-06-30,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit,19289000.0,未分配盈餘,聯亞藥,生技醫療業
2022-06-30,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,0.97,未分配盈餘,聯亞藥,生技醫療業
2022-06-30,6562,RetainedEarnings,19289000.0,保留盈餘合計,聯亞藥,生技醫療業
2022-06-30,6562,RetainedEarnings_per,0.97,保留盈餘合計,聯亞藥,生技醫療業
2022-06-30,6562,OtherEquityInterest,-170915000.0,其他權益合計,聯亞藥,生技醫療業
2022-06-30,6562,OtherEquityInterest_per,-8.61,其他權益合計,聯亞藥,生技醫療業
2022-06-30,6562,EquityAttributableToOwnersOfParent,1210582000.0,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2022-06-30,6562,EquityAttributableToOwnersOfParent_per,60.99,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2022-06-30,6562,TotalLiabilitiesEquity,1984910000.0,負債及權益總計,聯亞藥,生技醫療業
2022-06-30,6562,TotalLiabilitiesEquity_per,100.0,負債及權益總計,聯亞藥,生技醫療業
2022-06-30,6562,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,聯亞藥,生技醫療業
2022-06-30,6562,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,聯亞藥,生技醫療業
2022-06-30,6562,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,聯亞藥,生技醫療業
2022-06-30,6562,Liabilities,774328000.0,負債總額,聯亞藥,生技醫療業
2022-06-30,6562,Liabilities_per,39.01,負債總額,聯亞藥,生技醫療業
2022-06-30,6562,Equity,1210582000.0,權益總額,聯亞藥,生技醫療業
2022-06-30,6562,Equity_per,60.99,權益總額,聯亞藥,生技醫療業
2022-12-31,6562,CashAndCashEquivalents,395335000.0,現金及約當現金,聯亞藥,生技醫療業
2022-12-31,6562,CashAndCashEquivalents_per,21.08,現金及約當現金,聯亞藥,生技醫療業
2022-12-31,6562,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,13050000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,聯亞藥,生技醫療業
2022-12-31,6562,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.7,透過其他綜合損益按公允價值衡量之金融資產－非流動,聯亞藥,生技醫療業
2022-12-31,6562,FinancialAssetsAtAmortizedCost,16047000.0,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2022-12-31,6562,FinancialAssetsAtAmortizedCost_per,0.86,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2022-12-31,6562,BillsReceivableNet,5241000.0,應收票據淨額,聯亞藥,生技醫療業
2022-12-31,6562,BillsReceivableNet_per,0.28,應收票據淨額,聯亞藥,生技醫療業
2022-12-31,6562,OtherReceivable,4854000.0,其他應收款淨額,聯亞藥,生技醫療業
2022-12-31,6562,OtherReceivable_per,0.26,其他應收款淨額,聯亞藥,生技醫療業
2022-12-31,6562,AccountsReceivableNet,97201000.0,應收帳款淨額,聯亞藥,生技醫療業
2022-12-31,6562,AccountsReceivableNet_per,5.18,應收帳款淨額,聯亞藥,生技醫療業
2022-12-31,6562,AccountsReceivableDuefromRelatedPartiesNet,1300000.0,應收帳款－關係人淨額,聯亞藥,生技醫療業
2022-12-31,6562,AccountsReceivableDuefromRelatedPartiesNet_per,0.07,應收帳款－關係人淨額,聯亞藥,生技醫療業
2022-12-31,6562,OtherReceivablesDueFromRelatedParties,28150000.0,其他應收款－關係人淨額,聯亞藥,生技醫療業
2022-12-31,6562,OtherReceivablesDueFromRelatedParties_per,1.5,其他應收款－關係人淨額,聯亞藥,生技醫療業
2022-12-31,6562,Inventories,106309000.0,存貨,聯亞藥,生技醫療業
2022-12-31,6562,Inventories_per,5.67,存貨,聯亞藥,生技醫療業
2022-12-31,6562,OtherCurrentAssets,53695000.0,其他流動資產,聯亞藥,生技醫療業
2022-12-31,6562,OtherCurrentAssets_per,2.86,其他流動資產,聯亞藥,生技醫療業
2022-12-31,6562,CurrentAssets,721926000.0,流動資產合計,聯亞藥,生技醫療業
2022-12-31,6562,CurrentAssets_per,38.49,流動資產合計,聯亞藥,生技醫療業
2022-12-31,6562,PropertyPlantAndEquipment,398429000.0,不動產、廠房及設備,聯亞藥,生技醫療業
2022-12-31,6562,PropertyPlantAndEquipment_per,21.24,不動產、廠房及設備,聯亞藥,生技醫療業
2022-12-31,6562,RightOfUseAsset,438085000.0,使用權資產,聯亞藥,生技醫療業
2022-12-31,6562,RightOfUseAsset_per,23.36,使用權資產,聯亞藥,生技醫療業
2022-12-31,6562,IntangibleAssets,240780000.0,無形資產,聯亞藥,生技醫療業
2022-12-31,6562,IntangibleAssets_per,12.84,無形資產,聯亞藥,生技醫療業
2022-12-31,6562,OtherNoncurrentAssets,63370000.0,其他非流動資產,聯亞藥,生技醫療業
2022-12-31,6562,OtherNoncurrentAssets_per,3.38,其他非流動資產,聯亞藥,生技醫療業
2022-12-31,6562,NoncurrentAssets,1153714000.0,非流動資產合計,聯亞藥,生技醫療業
2022-12-31,6562,NoncurrentAssets_per,61.51,非流動資產合計,聯亞藥,生技醫療業
2022-12-31,6562,TotalAssets,1875640000.0,資產總額,聯亞藥,生技醫療業
2022-12-31,6562,TotalAssets_per,100.0,資產總額,聯亞藥,生技醫療業
2022-12-31,6562,ShorttermBorrowings,42194000.0,短期借款,聯亞藥,生技醫療業
2022-12-31,6562,ShorttermBorrowings_per,2.25,短期借款,聯亞藥,生技醫療業
2022-12-31,6562,AccountsPayable,29431000.0,應付帳款,聯亞藥,生技醫療業
2022-12-31,6562,AccountsPayable_per,1.57,應付帳款,聯亞藥,生技醫療業
2022-12-31,6562,OtherPayables,99038000.0,其他應付款,聯亞藥,生技醫療業
2022-12-31,6562,OtherPayables_per,5.28,其他應付款,聯亞藥,生技醫療業
2022-12-31,6562,OtherCurrentLiabilities,25550000.0,其他流動負債,聯亞藥,生技醫療業
2022-12-31,6562,OtherCurrentLiabilities_per,1.36,其他流動負債,聯亞藥,生技醫療業
2022-12-31,6562,CurrentLiabilities,316140000.0,流動負債合計,聯亞藥,生技醫療業
2022-12-31,6562,CurrentLiabilities_per,16.86,流動負債合計,聯亞藥,生技醫療業
2022-12-31,6562,LongtermBorrowings,8333000.0,長期借款,聯亞藥,生技醫療業
2022-12-31,6562,LongtermBorrowings_per,0.44,長期借款,聯亞藥,生技醫療業
2022-12-31,6562,NoncurrentLiabilities,441495000.0,非流動負債合計,聯亞藥,生技醫療業
2022-12-31,6562,NoncurrentLiabilities_per,23.54,非流動負債合計,聯亞藥,生技醫療業
2022-12-31,6562,OrdinaryShare,1113455000.0,普通股股本,聯亞藥,生技醫療業
2022-12-31,6562,OrdinaryShare_per,59.36,普通股股本,聯亞藥,生技醫療業
2022-12-31,6562,CapitalStock,1113455000.0,股本合計,聯亞藥,生技醫療業
2022-12-31,6562,CapitalStock_per,59.36,股本合計,聯亞藥,生技醫療業
2022-12-31,6562,CapitalSurplusAdditionalPaidInCapital,248147000.0,資本公積－發行溢價,聯亞藥,生技醫療業
2022-12-31,6562,CapitalSurplusAdditionalPaidInCapital_per,13.23,資本公積－發行溢價,聯亞藥,生技醫療業
2022-12-31,6562,CapitalSurplus,248706000.0,資本公積合計,聯亞藥,生技醫療業
2022-12-31,6562,CapitalSurplus_per,13.26,資本公積合計,聯亞藥,生技醫療業
2022-12-31,6562,LegalReserve,0.0,法定盈餘公積,聯亞藥,生技醫療業
2022-12-31,6562,LegalReserve_per,0.0,法定盈餘公積,聯亞藥,生技醫療業
2022-12-31,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit,48299000.0,未分配盈餘,聯亞藥,生技醫療業
2022-12-31,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,2.58,未分配盈餘,聯亞藥,生技醫療業
2022-12-31,6562,RetainedEarnings,48299000.0,保留盈餘合計,聯亞藥,生技醫療業
2022-12-31,6562,RetainedEarnings_per,2.58,保留盈餘合計,聯亞藥,生技醫療業
2022-12-31,6562,OtherEquityInterest,-290271000.0,其他權益合計,聯亞藥,生技醫療業
2022-12-31,6562,OtherEquityInterest_per,-15.48,其他權益合計,聯亞藥,生技醫療業
2022-12-31,6562,EquityAttributableToOwnersOfParent,1118005000.0,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2022-12-31,6562,EquityAttributableToOwnersOfParent_per,59.61,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2022-12-31,6562,TotalLiabilitiesEquity,1875640000.0,負債及權益總計,聯亞藥,生技醫療業
2022-12-31,6562,TotalLiabilitiesEquity_per,100.0,負債及權益總計,聯亞藥,生技醫療業
2022-12-31,6562,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,45000.0,母公司暨子公司所持有之母公司庫藏股股數,聯亞藥,生技醫療業
2022-12-31,6562,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融負債－流動,聯亞藥,生技醫療業
2022-12-31,6562,CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融負債－流動,聯亞藥,生技醫療業
2022-12-31,6562,OtherNoncurrentLiabilities,0.0,其他非流動負債,聯亞藥,生技醫療業
2022-12-31,6562,OtherNoncurrentLiabilities_per,0.0,其他非流動負債,聯亞藥,生技醫療業
2022-12-31,6562,NoncontrollingInterests,0.0,非控制權益,聯亞藥,生技醫療業
2022-12-31,6562,NoncontrollingInterests_per,0.0,非控制權益,聯亞藥,生技醫療業
2022-12-31,6562,CurrentIncomeTaxAssets,0.0,本期所得稅資產,聯亞藥,生技醫療業
2022-12-31,6562,CurrentIncomeTaxAssets_per,0.0,本期所得稅資產,聯亞藥,生技醫療業
2022-12-31,6562,Liabilities,757635000.0,負債總額,聯亞藥,生技醫療業
2022-12-31,6562,Liabilities_per,40.39,負債總額,聯亞藥,生技醫療業
2022-12-31,6562,Equity,1118005000.0,權益總額,聯亞藥,生技醫療業
2022-12-31,6562,Equity_per,59.61,權益總額,聯亞藥,生技醫療業
2023-06-30,6562,CashAndCashEquivalents,319640000.0,現金及約當現金,聯亞藥,生技醫療業
2023-06-30,6562,CashAndCashEquivalents_per,18.33,現金及約當現金,聯亞藥,生技醫療業
2023-06-30,6562,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,0.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,聯亞藥,生技醫療業
2023-06-30,6562,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,聯亞藥,生技醫療業
2023-06-30,6562,FinancialAssetsAtAmortizedCost,14517000.0,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2023-06-30,6562,FinancialAssetsAtAmortizedCost_per,0.83,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2023-06-30,6562,BillsReceivableNet,2721000.0,應收票據淨額,聯亞藥,生技醫療業
2023-06-30,6562,BillsReceivableNet_per,0.16,應收票據淨額,聯亞藥,生技醫療業
2023-06-30,6562,OtherReceivable,2997000.0,其他應收款淨額,聯亞藥,生技醫療業
2023-06-30,6562,OtherReceivable_per,0.17,其他應收款淨額,聯亞藥,生技醫療業
2023-06-30,6562,AccountsReceivableNet,91972000.0,應收帳款淨額,聯亞藥,生技醫療業
2023-06-30,6562,AccountsReceivableNet_per,5.28,應收帳款淨額,聯亞藥,生技醫療業
2023-06-30,6562,AccountsReceivableDuefromRelatedPartiesNet,1300000.0,應收帳款－關係人淨額,聯亞藥,生技醫療業
2023-06-30,6562,AccountsReceivableDuefromRelatedPartiesNet_per,0.07,應收帳款－關係人淨額,聯亞藥,生技醫療業
2023-06-30,6562,OtherReceivablesDueFromRelatedParties,11976000.0,其他應收款－關係人淨額,聯亞藥,生技醫療業
2023-06-30,6562,OtherReceivablesDueFromRelatedParties_per,0.69,其他應收款－關係人淨額,聯亞藥,生技醫療業
2023-06-30,6562,Inventories,85086000.0,存貨,聯亞藥,生技醫療業
2023-06-30,6562,Inventories_per,4.88,存貨,聯亞藥,生技醫療業
2023-06-30,6562,OtherCurrentAssets,40607000.0,其他流動資產,聯亞藥,生技醫療業
2023-06-30,6562,OtherCurrentAssets_per,2.33,其他流動資產,聯亞藥,生技醫療業
2023-06-30,6562,CurrentAssets,589099000.0,流動資產合計,聯亞藥,生技醫療業
2023-06-30,6562,CurrentAssets_per,33.79,流動資產合計,聯亞藥,生技醫療業
2023-06-30,6562,PropertyPlantAndEquipment,453520000.0,不動產、廠房及設備,聯亞藥,生技醫療業
2023-06-30,6562,PropertyPlantAndEquipment_per,26.01,不動產、廠房及設備,聯亞藥,生技醫療業
2023-06-30,6562,RightOfUseAsset,414959000.0,使用權資產,聯亞藥,生技醫療業
2023-06-30,6562,RightOfUseAsset_per,23.8,使用權資產,聯亞藥,生技醫療業
2023-06-30,6562,IntangibleAssets,243606000.0,無形資產,聯亞藥,生技醫療業
2023-06-30,6562,IntangibleAssets_per,13.97,無形資產,聯亞藥,生技醫療業
2023-06-30,6562,OtherNoncurrentAssets,42187000.0,其他非流動資產,聯亞藥,生技醫療業
2023-06-30,6562,OtherNoncurrentAssets_per,2.42,其他非流動資產,聯亞藥,生技醫療業
2023-06-30,6562,NoncurrentAssets,1154272000.0,非流動資產合計,聯亞藥,生技醫療業
2023-06-30,6562,NoncurrentAssets_per,66.21,非流動資產合計,聯亞藥,生技醫療業
2023-06-30,6562,TotalAssets,1743371000.0,資產總額,聯亞藥,生技醫療業
2023-06-30,6562,TotalAssets_per,100.0,資產總額,聯亞藥,生技醫療業
2023-06-30,6562,ShorttermBorrowings,29304000.0,短期借款,聯亞藥,生技醫療業
2023-06-30,6562,ShorttermBorrowings_per,1.68,短期借款,聯亞藥,生技醫療業
2023-06-30,6562,AccountsPayable,28921000.0,應付帳款,聯亞藥,生技醫療業
2023-06-30,6562,AccountsPayable_per,1.66,應付帳款,聯亞藥,生技醫療業
2023-06-30,6562,OtherPayables,62953000.0,其他應付款,聯亞藥,生技醫療業
2023-06-30,6562,OtherPayables_per,3.61,其他應付款,聯亞藥,生技醫療業
2023-06-30,6562,OtherCurrentLiabilities,23187000.0,其他流動負債,聯亞藥,生技醫療業
2023-06-30,6562,OtherCurrentLiabilities_per,1.33,其他流動負債,聯亞藥,生技醫療業
2023-06-30,6562,CurrentLiabilities,219615000.0,流動負債合計,聯亞藥,生技醫療業
2023-06-30,6562,CurrentLiabilities_per,12.6,流動負債合計,聯亞藥,生技醫療業
2023-06-30,6562,LongtermBorrowings,3333000.0,長期借款,聯亞藥,生技醫療業
2023-06-30,6562,LongtermBorrowings_per,0.19,長期借款,聯亞藥,生技醫療業
2023-06-30,6562,OtherNoncurrentLiabilities,0.0,其他非流動負債,聯亞藥,生技醫療業
2023-06-30,6562,OtherNoncurrentLiabilities_per,0.0,其他非流動負債,聯亞藥,生技醫療業
2023-06-30,6562,NoncurrentLiabilities,406209000.0,非流動負債合計,聯亞藥,生技醫療業
2023-06-30,6562,NoncurrentLiabilities_per,23.3,非流動負債合計,聯亞藥,生技醫療業
2023-06-30,6562,OrdinaryShare,1113433000.0,普通股股本,聯亞藥,生技醫療業
2023-06-30,6562,OrdinaryShare_per,63.87,普通股股本,聯亞藥,生技醫療業
2023-06-30,6562,CapitalStock,1156902000.0,股本合計,聯亞藥,生技醫療業
2023-06-30,6562,CapitalStock_per,66.36,股本合計,聯亞藥,生技醫療業
2023-06-30,6562,CapitalSurplusAdditionalPaidInCapital,205225000.0,資本公積－發行溢價,聯亞藥,生技醫療業
2023-06-30,6562,CapitalSurplusAdditionalPaidInCapital_per,11.77,資本公積－發行溢價,聯亞藥,生技醫療業
2023-06-30,6562,CapitalSurplus,205225000.0,資本公積合計,聯亞藥,生技醫療業
2023-06-30,6562,CapitalSurplus_per,11.77,資本公積合計,聯亞藥,生技醫療業
2023-06-30,6562,LegalReserve,4830000.0,法定盈餘公積,聯亞藥,生技醫療業
2023-06-30,6562,LegalReserve_per,0.28,法定盈餘公積,聯亞藥,生技醫療業
2023-06-30,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit,13826000.0,未分配盈餘,聯亞藥,生技醫療業
2023-06-30,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,0.79,未分配盈餘,聯亞藥,生技醫療業
2023-06-30,6562,RetainedEarnings,62125000.0,保留盈餘合計,聯亞藥,生技醫療業
2023-06-30,6562,RetainedEarnings_per,3.56,保留盈餘合計,聯亞藥,生技醫療業
2023-06-30,6562,OtherEquityInterest,-303312000.0,其他權益合計,聯亞藥,生技醫療業
2023-06-30,6562,OtherEquityInterest_per,-17.4,其他權益合計,聯亞藥,生技醫療業
2023-06-30,6562,EquityAttributableToOwnersOfParent,1117547000.0,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2023-06-30,6562,EquityAttributableToOwnersOfParent_per,64.1,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2023-06-30,6562,TotalLiabilitiesEquity,1743371000.0,負債及權益總計,聯亞藥,生技醫療業
2023-06-30,6562,TotalLiabilitiesEquity_per,100.0,負債及權益總計,聯亞藥,生技醫療業
2023-06-30,6562,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,70000.0,母公司暨子公司所持有之母公司庫藏股股數,聯亞藥,生技醫療業
2023-06-30,6562,Liabilities,625824000.0,負債總額,聯亞藥,生技醫療業
2023-06-30,6562,Liabilities_per,35.9,負債總額,聯亞藥,生技醫療業
2023-06-30,6562,Equity,1117547000.0,權益總額,聯亞藥,生技醫療業
2023-06-30,6562,Equity_per,64.1,權益總額,聯亞藥,生技醫療業
2023-12-31,6562,CashAndCashEquivalents,340299000.0,現金及約當現金,聯亞藥,生技醫療業
2023-12-31,6562,CashAndCashEquivalents_per,18.53,現金及約當現金,聯亞藥,生技醫療業
2023-12-31,6562,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,0.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,聯亞藥,生技醫療業
2023-12-31,6562,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,聯亞藥,生技醫療業
2023-12-31,6562,FinancialAssetsAtAmortizedCost,35672000.0,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2023-12-31,6562,FinancialAssetsAtAmortizedCost_per,1.94,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2023-12-31,6562,BillsReceivableNet,6760000.0,應收票據淨額,聯亞藥,生技醫療業
2023-12-31,6562,BillsReceivableNet_per,0.37,應收票據淨額,聯亞藥,生技醫療業
2023-12-31,6562,OtherReceivable,1175000.0,其他應收款淨額,聯亞藥,生技醫療業
2023-12-31,6562,OtherReceivable_per,0.06,其他應收款淨額,聯亞藥,生技醫療業
2023-12-31,6562,AccountsReceivableNet,118860000.0,應收帳款淨額,聯亞藥,生技醫療業
2023-12-31,6562,AccountsReceivableNet_per,6.47,應收帳款淨額,聯亞藥,生技醫療業
2023-12-31,6562,AccountsReceivableDuefromRelatedPartiesNet,2133000.0,應收帳款－關係人淨額,聯亞藥,生技醫療業
2023-12-31,6562,AccountsReceivableDuefromRelatedPartiesNet_per,0.12,應收帳款－關係人淨額,聯亞藥,生技醫療業
2023-12-31,6562,OtherReceivablesDueFromRelatedParties,12164000.0,其他應收款－關係人淨額,聯亞藥,生技醫療業
2023-12-31,6562,OtherReceivablesDueFromRelatedParties_per,0.66,其他應收款－關係人淨額,聯亞藥,生技醫療業
2023-12-31,6562,Inventories,95625000.0,存貨,聯亞藥,生技醫療業
2023-12-31,6562,Inventories_per,5.21,存貨,聯亞藥,生技醫療業
2023-12-31,6562,OtherCurrentAssets,55138000.0,其他流動資產,聯亞藥,生技醫療業
2023-12-31,6562,OtherCurrentAssets_per,3.0,其他流動資產,聯亞藥,生技醫療業
2023-12-31,6562,CurrentAssets,680376000.0,流動資產合計,聯亞藥,生技醫療業
2023-12-31,6562,CurrentAssets_per,37.05,流動資產合計,聯亞藥,生技醫療業
2023-12-31,6562,PropertyPlantAndEquipment,468341000.0,不動產、廠房及設備,聯亞藥,生技醫療業
2023-12-31,6562,PropertyPlantAndEquipment_per,25.5,不動產、廠房及設備,聯亞藥,生技醫療業
2023-12-31,6562,RightOfUseAsset,392149000.0,使用權資產,聯亞藥,生技醫療業
2023-12-31,6562,RightOfUseAsset_per,21.35,使用權資產,聯亞藥,生技醫療業
2023-12-31,6562,IntangibleAssets,247425000.0,無形資產,聯亞藥,生技醫療業
2023-12-31,6562,IntangibleAssets_per,13.47,無形資產,聯亞藥,生技醫療業
2023-12-31,6562,OtherNoncurrentAssets,48061000.0,其他非流動資產,聯亞藥,生技醫療業
2023-12-31,6562,OtherNoncurrentAssets_per,2.62,其他非流動資產,聯亞藥,生技醫療業
2023-12-31,6562,NoncurrentAssets,1155976000.0,非流動資產合計,聯亞藥,生技醫療業
2023-12-31,6562,NoncurrentAssets_per,62.95,非流動資產合計,聯亞藥,生技醫療業
2023-12-31,6562,TotalAssets,1836352000.0,資產總額,聯亞藥,生技醫療業
2023-12-31,6562,TotalAssets_per,100.0,資產總額,聯亞藥,生技醫療業
2023-12-31,6562,ShorttermBorrowings,37457000.0,短期借款,聯亞藥,生技醫療業
2023-12-31,6562,ShorttermBorrowings_per,2.04,短期借款,聯亞藥,生技醫療業
2023-12-31,6562,AccountsPayable,28477000.0,應付帳款,聯亞藥,生技醫療業
2023-12-31,6562,AccountsPayable_per,1.55,應付帳款,聯亞藥,生技醫療業
2023-12-31,6562,OtherPayables,80869000.0,其他應付款,聯亞藥,生技醫療業
2023-12-31,6562,OtherPayables_per,4.4,其他應付款,聯亞藥,生技醫療業
2023-12-31,6562,OtherCurrentLiabilities,7770000.0,其他流動負債,聯亞藥,生技醫療業
2023-12-31,6562,OtherCurrentLiabilities_per,0.42,其他流動負債,聯亞藥,生技醫療業
2023-12-31,6562,CurrentLiabilities,218706000.0,流動負債合計,聯亞藥,生技醫療業
2023-12-31,6562,CurrentLiabilities_per,11.91,流動負債合計,聯亞藥,生技醫療業
2023-12-31,6562,LongtermBorrowings,55000000.0,長期借款,聯亞藥,生技醫療業
2023-12-31,6562,LongtermBorrowings_per,3.0,長期借款,聯亞藥,生技醫療業
2023-12-31,6562,NoncurrentLiabilities,448133000.0,非流動負債合計,聯亞藥,生技醫療業
2023-12-31,6562,NoncurrentLiabilities_per,24.4,非流動負債合計,聯亞藥,生技醫療業
2023-12-31,6562,OrdinaryShare,1181902000.0,普通股股本,聯亞藥,生技醫療業
2023-12-31,6562,OrdinaryShare_per,64.36,普通股股本,聯亞藥,生技醫療業
2023-12-31,6562,CapitalStock,1181902000.0,股本合計,聯亞藥,生技醫療業
2023-12-31,6562,CapitalStock_per,64.36,股本合計,聯亞藥,生技醫療業
2023-12-31,6562,CapitalSurplusAdditionalPaidInCapital,245225000.0,資本公積－發行溢價,聯亞藥,生技醫療業
2023-12-31,6562,CapitalSurplusAdditionalPaidInCapital_per,13.35,資本公積－發行溢價,聯亞藥,生技醫療業
2023-12-31,6562,CapitalSurplus,245225000.0,資本公積合計,聯亞藥,生技醫療業
2023-12-31,6562,CapitalSurplus_per,13.35,資本公積合計,聯亞藥,生技醫療業
2023-12-31,6562,LegalReserve,4830000.0,法定盈餘公積,聯亞藥,生技醫療業
2023-12-31,6562,LegalReserve_per,0.26,法定盈餘公積,聯亞藥,生技醫療業
2023-12-31,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit,791000.0,未分配盈餘,聯亞藥,生技醫療業
2023-12-31,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,0.04,未分配盈餘,聯亞藥,生技醫療業
2023-12-31,6562,RetainedEarnings,49090000.0,保留盈餘合計,聯亞藥,生技醫療業
2023-12-31,6562,RetainedEarnings_per,2.67,保留盈餘合計,聯亞藥,生技醫療業
2023-12-31,6562,OtherEquityInterest,-303311000.0,其他權益合計,聯亞藥,生技醫療業
2023-12-31,6562,OtherEquityInterest_per,-16.52,其他權益合計,聯亞藥,生技醫療業
2023-12-31,6562,EquityAttributableToOwnersOfParent,1169513000.0,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2023-12-31,6562,EquityAttributableToOwnersOfParent_per,63.69,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2023-12-31,6562,TotalLiabilitiesEquity,1836352000.0,負債及權益總計,聯亞藥,生技醫療業
2023-12-31,6562,TotalLiabilitiesEquity_per,100.0,負債及權益總計,聯亞藥,生技醫療業
2023-12-31,6562,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,70000.0,母公司暨子公司所持有之母公司庫藏股股數,聯亞藥,生技醫療業
2023-12-31,6562,Equity,1169513000.0,權益總額,聯亞藥,生技醫療業
2023-12-31,6562,Equity_per,63.69,權益總額,聯亞藥,生技醫療業
2023-12-31,6562,Liabilities,666839000.0,負債總額,聯亞藥,生技醫療業
2023-12-31,6562,Liabilities_per,36.31,負債總額,聯亞藥,生技醫療業
2024-06-30,6562,CashAndCashEquivalents,288630000.0,現金及約當現金,聯亞藥,生技醫療業
2024-06-30,6562,CashAndCashEquivalents_per,15.79,現金及約當現金,聯亞藥,生技醫療業
2024-06-30,6562,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,0.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,聯亞藥,生技醫療業
2024-06-30,6562,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,聯亞藥,生技醫療業
2024-06-30,6562,FinancialAssetsAtAmortizedCost,32780000.0,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2024-06-30,6562,FinancialAssetsAtAmortizedCost_per,1.79,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2024-06-30,6562,BillsReceivableNet,2572000.0,應收票據淨額,聯亞藥,生技醫療業
2024-06-30,6562,BillsReceivableNet_per,0.14,應收票據淨額,聯亞藥,生技醫療業
2024-06-30,6562,OtherReceivable,15177000.0,其他應收款淨額,聯亞藥,生技醫療業
2024-06-30,6562,OtherReceivable_per,0.83,其他應收款淨額,聯亞藥,生技醫療業
2024-06-30,6562,AccountsReceivableNet,104520000.0,應收帳款淨額,聯亞藥,生技醫療業
2024-06-30,6562,AccountsReceivableNet_per,5.72,應收帳款淨額,聯亞藥,生技醫療業
2024-06-30,6562,AccountsReceivableDuefromRelatedPartiesNet,4468000.0,應收帳款－關係人淨額,聯亞藥,生技醫療業
2024-06-30,6562,AccountsReceivableDuefromRelatedPartiesNet_per,0.24,應收帳款－關係人淨額,聯亞藥,生技醫療業
2024-06-30,6562,OtherReceivablesDueFromRelatedParties,17571000.0,其他應收款－關係人淨額,聯亞藥,生技醫療業
2024-06-30,6562,OtherReceivablesDueFromRelatedParties_per,0.96,其他應收款－關係人淨額,聯亞藥,生技醫療業
2024-06-30,6562,Inventories,144299000.0,存貨,聯亞藥,生技醫療業
2024-06-30,6562,Inventories_per,7.89,存貨,聯亞藥,生技醫療業
2024-06-30,6562,OtherCurrentAssets,59507000.0,其他流動資產,聯亞藥,生技醫療業
2024-06-30,6562,OtherCurrentAssets_per,3.25,其他流動資產,聯亞藥,生技醫療業
2024-06-30,6562,CurrentAssets,691838000.0,流動資產合計,聯亞藥,生技醫療業
2024-06-30,6562,CurrentAssets_per,37.84,流動資產合計,聯亞藥,生技醫療業
2024-06-30,6562,PropertyPlantAndEquipment,477007000.0,不動產、廠房及設備,聯亞藥,生技醫療業
2024-06-30,6562,PropertyPlantAndEquipment_per,26.09,不動產、廠房及設備,聯亞藥,生技醫療業
2024-06-30,6562,RightOfUseAsset,372091000.0,使用權資產,聯亞藥,生技醫療業
2024-06-30,6562,RightOfUseAsset_per,20.35,使用權資產,聯亞藥,生技醫療業
2024-06-30,6562,IntangibleAssets,242396000.0,無形資產,聯亞藥,生技醫療業
2024-06-30,6562,IntangibleAssets_per,13.26,無形資產,聯亞藥,生技醫療業
2024-06-30,6562,OtherNoncurrentAssets,44920000.0,其他非流動資產,聯亞藥,生技醫療業
2024-06-30,6562,OtherNoncurrentAssets_per,2.46,其他非流動資產,聯亞藥,生技醫療業
2024-06-30,6562,NoncurrentAssets,1136414000.0,非流動資產合計,聯亞藥,生技醫療業
2024-06-30,6562,NoncurrentAssets_per,62.16,非流動資產合計,聯亞藥,生技醫療業
2024-06-30,6562,TotalAssets,1828252000.0,資產總額,聯亞藥,生技醫療業
2024-06-30,6562,TotalAssets_per,100.0,資產總額,聯亞藥,生技醫療業
2024-06-30,6562,ShorttermBorrowings,30000000.0,短期借款,聯亞藥,生技醫療業
2024-06-30,6562,ShorttermBorrowings_per,1.64,短期借款,聯亞藥,生技醫療業
2024-06-30,6562,AccountsPayable,55129000.0,應付帳款,聯亞藥,生技醫療業
2024-06-30,6562,AccountsPayable_per,3.02,應付帳款,聯亞藥,生技醫療業
2024-06-30,6562,OtherPayables,74160000.0,其他應付款,聯亞藥,生技醫療業
2024-06-30,6562,OtherPayables_per,4.06,其他應付款,聯亞藥,生技醫療業
2024-06-30,6562,OtherCurrentLiabilities,16160000.0,其他流動負債,聯亞藥,生技醫療業
2024-06-30,6562,OtherCurrentLiabilities_per,0.88,其他流動負債,聯亞藥,生技醫療業
2024-06-30,6562,CurrentLiabilities,243346000.0,流動負債合計,聯亞藥,生技醫療業
2024-06-30,6562,CurrentLiabilities_per,13.31,流動負債合計,聯亞藥,生技醫療業
2024-06-30,6562,LongtermBorrowings,48125000.0,長期借款,聯亞藥,生技醫療業
2024-06-30,6562,LongtermBorrowings_per,2.63,長期借款,聯亞藥,生技醫療業
2024-06-30,6562,NoncurrentLiabilities,418751000.0,非流動負債合計,聯亞藥,生技醫療業
2024-06-30,6562,NoncurrentLiabilities_per,22.9,非流動負債合計,聯亞藥,生技醫療業
2024-06-30,6562,OrdinaryShare,1181902000.0,普通股股本,聯亞藥,生技醫療業
2024-06-30,6562,OrdinaryShare_per,64.65,普通股股本,聯亞藥,生技醫療業
2024-06-30,6562,CapitalStock,1181902000.0,股本合計,聯亞藥,生技醫療業
2024-06-30,6562,CapitalStock_per,64.65,股本合計,聯亞藥,生技醫療業
2024-06-30,6562,CapitalSurplusAdditionalPaidInCapital,245225000.0,資本公積－發行溢價,聯亞藥,生技醫療業
2024-06-30,6562,CapitalSurplusAdditionalPaidInCapital_per,13.41,資本公積－發行溢價,聯亞藥,生技醫療業
2024-06-30,6562,CapitalSurplus,245225000.0,資本公積合計,聯亞藥,生技醫療業
2024-06-30,6562,CapitalSurplus_per,13.41,資本公積合計,聯亞藥,生技醫療業
2024-06-30,6562,LegalReserve,4909000.0,法定盈餘公積,聯亞藥,生技醫療業
2024-06-30,6562,LegalReserve_per,0.27,法定盈餘公積,聯亞藥,生技醫療業
2024-06-30,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit,-3552000.0,未分配盈餘,聯亞藥,生技醫療業
2024-06-30,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-0.19,未分配盈餘,聯亞藥,生技醫療業
2024-06-30,6562,RetainedEarnings,45538000.0,保留盈餘合計,聯亞藥,生技醫療業
2024-06-30,6562,RetainedEarnings_per,2.49,保留盈餘合計,聯亞藥,生技醫療業
2024-06-30,6562,OtherEquityInterest,-303117000.0,其他權益合計,聯亞藥,生技醫療業
2024-06-30,6562,OtherEquityInterest_per,-16.58,其他權益合計,聯亞藥,生技醫療業
2024-06-30,6562,EquityAttributableToOwnersOfParent,1166155000.0,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2024-06-30,6562,EquityAttributableToOwnersOfParent_per,63.79,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2024-06-30,6562,TotalLiabilitiesEquity,1828252000.0,負債及權益總計,聯亞藥,生技醫療業
2024-06-30,6562,TotalLiabilitiesEquity_per,100.0,負債及權益總計,聯亞藥,生技醫療業
2024-06-30,6562,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,70000.0,母公司暨子公司所持有之母公司庫藏股股數,聯亞藥,生技醫療業
2024-06-30,6562,Liabilities,662097000.0,負債總額,聯亞藥,生技醫療業
2024-06-30,6562,Liabilities_per,36.21,負債總額,聯亞藥,生技醫療業
2024-06-30,6562,Equity,1166155000.0,權益總額,聯亞藥,生技醫療業
2024-06-30,6562,Equity_per,63.79,權益總額,聯亞藥,生技醫療業
2024-12-31,6562,CashAndCashEquivalents,233880000.0,現金及約當現金,聯亞藥,生技醫療業
2024-12-31,6562,CashAndCashEquivalents_per,14.13,現金及約當現金,聯亞藥,生技醫療業
2024-12-31,6562,FinancialAssetsAtAmortizedCost,2860000.0,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2024-12-31,6562,FinancialAssetsAtAmortizedCost_per,0.17,按攤銷後成本衡量之金融資產－流動,聯亞藥,生技醫療業
2024-12-31,6562,BillsReceivableNet,3466000.0,應收票據淨額,聯亞藥,生技醫療業
2024-12-31,6562,BillsReceivableNet_per,0.21,應收票據淨額,聯亞藥,生技醫療業
2024-12-31,6562,OtherReceivable,39514000.0,其他應收款淨額,聯亞藥,生技醫療業
2024-12-31,6562,OtherReceivable_per,2.39,其他應收款淨額,聯亞藥,生技醫療業
2024-12-31,6562,AccountsReceivableNet,115677000.0,應收帳款淨額,聯亞藥,生技醫療業
2024-12-31,6562,AccountsReceivableNet_per,6.99,應收帳款淨額,聯亞藥,生技醫療業
2024-12-31,6562,AccountsReceivableDuefromRelatedPartiesNet,0.0,應收帳款－關係人淨額,聯亞藥,生技醫療業
2024-12-31,6562,AccountsReceivableDuefromRelatedPartiesNet_per,0.0,應收帳款－關係人淨額,聯亞藥,生技醫療業
2024-12-31,6562,OtherReceivablesDueFromRelatedParties,3452000.0,其他應收款－關係人淨額,聯亞藥,生技醫療業
2024-12-31,6562,OtherReceivablesDueFromRelatedParties_per,0.21,其他應收款－關係人淨額,聯亞藥,生技醫療業
2024-12-31,6562,Inventories,167190000.0,存貨,聯亞藥,生技醫療業
2024-12-31,6562,Inventories_per,10.1,存貨,聯亞藥,生技醫療業
2024-12-31,6562,OtherCurrentAssets,57546000.0,其他流動資產,聯亞藥,生技醫療業
2024-12-31,6562,OtherCurrentAssets_per,3.48,其他流動資產,聯亞藥,生技醫療業
2024-12-31,6562,CurrentAssets,645070000.0,流動資產合計,聯亞藥,生技醫療業
2024-12-31,6562,CurrentAssets_per,38.97,流動資產合計,聯亞藥,生技醫療業
2024-12-31,6562,PropertyPlantAndEquipment,465414000.0,不動產、廠房及設備,聯亞藥,生技醫療業
2024-12-31,6562,PropertyPlantAndEquipment_per,28.12,不動產、廠房及設備,聯亞藥,生技醫療業
2024-12-31,6562,RightOfUseAsset,361542000.0,使用權資產,聯亞藥,生技醫療業
2024-12-31,6562,RightOfUseAsset_per,21.84,使用權資產,聯亞藥,生技醫療業
2024-12-31,6562,IntangibleAssets,145075000.0,無形資產,聯亞藥,生技醫療業
2024-12-31,6562,IntangibleAssets_per,8.76,無形資產,聯亞藥,生技醫療業
2024-12-31,6562,OtherNoncurrentAssets,38271000.0,其他非流動資產,聯亞藥,生技醫療業
2024-12-31,6562,OtherNoncurrentAssets_per,2.31,其他非流動資產,聯亞藥,生技醫療業
2024-12-31,6562,NoncurrentAssets,1010302000.0,非流動資產合計,聯亞藥,生技醫療業
2024-12-31,6562,NoncurrentAssets_per,61.03,非流動資產合計,聯亞藥,生技醫療業
2024-12-31,6562,TotalAssets,1655372000.0,資產總額,聯亞藥,生技醫療業
2024-12-31,6562,TotalAssets_per,100.0,資產總額,聯亞藥,生技醫療業
2024-12-31,6562,ShorttermBorrowings,45292000.0,短期借款,聯亞藥,生技醫療業
2024-12-31,6562,ShorttermBorrowings_per,2.74,短期借款,聯亞藥,生技醫療業
2024-12-31,6562,AccountsPayable,29103000.0,應付帳款,聯亞藥,生技醫療業
2024-12-31,6562,AccountsPayable_per,1.76,應付帳款,聯亞藥,生技醫療業
2024-12-31,6562,OtherPayables,68306000.0,其他應付款,聯亞藥,生技醫療業
2024-12-31,6562,OtherPayables_per,4.13,其他應付款,聯亞藥,生技醫療業
2024-12-31,6562,OtherCurrentLiabilities,44957000.0,其他流動負債,聯亞藥,生技醫療業
2024-12-31,6562,OtherCurrentLiabilities_per,2.72,其他流動負債,聯亞藥,生技醫療業
2024-12-31,6562,CurrentLiabilities,265174000.0,流動負債合計,聯亞藥,生技醫療業
2024-12-31,6562,CurrentLiabilities_per,16.02,流動負債合計,聯亞藥,生技醫療業
2024-12-31,6562,LongtermBorrowings,41250000.0,長期借款,聯亞藥,生技醫療業
2024-12-31,6562,LongtermBorrowings_per,2.49,長期借款,聯亞藥,生技醫療業
2024-12-31,6562,NoncurrentLiabilities,394994000.0,非流動負債合計,聯亞藥,生技醫療業
2024-12-31,6562,NoncurrentLiabilities_per,23.86,非流動負債合計,聯亞藥,生技醫療業
2024-12-31,6562,OrdinaryShare,1181902000.0,普通股股本,聯亞藥,生技醫療業
2024-12-31,6562,OrdinaryShare_per,71.4,普通股股本,聯亞藥,生技醫療業
2024-12-31,6562,CapitalStock,1181902000.0,股本合計,聯亞藥,生技醫療業
2024-12-31,6562,CapitalStock_per,71.4,股本合計,聯亞藥,生技醫療業
2024-12-31,6562,CapitalSurplusAdditionalPaidInCapital,245225000.0,資本公積－發行溢價,聯亞藥,生技醫療業
2024-12-31,6562,CapitalSurplusAdditionalPaidInCapital_per,14.81,資本公積－發行溢價,聯亞藥,生技醫療業
2024-12-31,6562,CapitalSurplus,245225000.0,資本公積合計,聯亞藥,生技醫療業
2024-12-31,6562,CapitalSurplus_per,14.81,資本公積合計,聯亞藥,生技醫療業
2024-12-31,6562,LegalReserve,4909000.0,法定盈餘公積,聯亞藥,生技醫療業
2024-12-31,6562,LegalReserve_per,0.3,法定盈餘公積,聯亞藥,生技醫療業
2024-12-31,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit,-174516000.0,未分配盈餘,聯亞藥,生技醫療業
2024-12-31,6562,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,-10.54,未分配盈餘,聯亞藥,生技醫療業
2024-12-31,6562,RetainedEarnings,-125426000.0,保留盈餘合計,聯亞藥,生技醫療業
2024-12-31,6562,RetainedEarnings_per,-7.58,保留盈餘合計,聯亞藥,生技醫療業
2024-12-31,6562,OtherEquityInterest,-303104000.0,其他權益合計,聯亞藥,生技醫療業
2024-12-31,6562,OtherEquityInterest_per,-18.31,其他權益合計,聯亞藥,生技醫療業
2024-12-31,6562,EquityAttributableToOwnersOfParent,995204000.0,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2024-12-31,6562,EquityAttributableToOwnersOfParent_per,60.12,歸屬於母公司業主之權益合計,聯亞藥,生技醫療業
2024-12-31,6562,TotalLiabilitiesEquity,1655372000.0,負債及權益總計,聯亞藥,生技醫療業
2024-12-31,6562,TotalLiabilitiesEquity_per,100.0,負債及權益總計,聯亞藥,生技醫療業
2024-12-31,6562,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,70000.0,母公司暨子公司所持有之母公司庫藏股股數,聯亞藥,生技醫療業
2024-12-31,6562,Equity,995204000.0,權益總額,聯亞藥,生技醫療業
2024-12-31,6562,Equity_per,60.12,權益總額,聯亞藥,生技醫療業
2024-12-31,6562,Liabilities,660168000.0,負債總額,聯亞藥,生技醫療業
2024-12-31,6562,Liabilities_per,39.88,負債總額,聯亞藥,生技醫療業
2022-06-30,6562,InventoryIncrease,18936000.0,存貨（增加）減少,聯亞藥,生技醫療業
2022-06-30,6562,PropertyAndPlantAndEquipment,-92108000.0,取得不動產、廠房及設備,聯亞藥,生技醫療業
2022-06-30,6562,CashProvidedByInvestingActivities,-47696000.0,投資活動之淨現金流入（流出）,聯亞藥,生技醫療業
2022-06-30,6562,CashBalancesEndOfPeriod,407277000.0,期末現金及約當現金餘額,聯亞藥,生技醫療業
2022-06-30,6562,CashBalancesBeginningOfPeriod,298706000.0,期初現金及約當現金餘額,聯亞藥,生技醫療業
2022-06-30,6562,CashBalancesIncrease,108571000.0,本期現金及約當現金增加（減少）數,聯亞藥,生技醫療業
2022-06-30,6562,PayTheInterest,-7125000.0,支付之利息,聯亞藥,生技醫療業
2022-06-30,6562,RentalPrincipalRepayments,-17604000.0,租賃本金償還,聯亞藥,生技醫療業
2022-06-30,6562,RepaymentOfLongTermDebt,-215741000.0,償還長期借款,聯亞藥,生技醫療業
2022-06-30,6562,DecreaseInShortTermLoans,-46411000.0,短期借款減少,聯亞藥,生技醫療業
2022-06-30,6562,InterestIncome,-164000.0,利息收入,聯亞藥,生技醫療業
2022-06-30,6562,CashReceivedThroughOperations,74381000.0,營運產生之現金流入（流出）,聯亞藥,生技醫療業
2022-06-30,6562,ReceivableIncrease,-45847000.0,應收帳款（增加）減少,聯亞藥,生技醫療業
2022-06-30,6562,TotalIncomeLossItems,57539000.0,收益費損項目合計,聯亞藥,生技醫療業
2022-06-30,6562,InterestExpense,6914000.0,利息費用,聯亞藥,生技醫療業
2022-06-30,6562,CashFlowsProvidedFromFinancingActivities,92571000.0,籌資活動之淨現金流入（流出）,聯亞藥,生技醫療業
2022-06-30,6562,Depreciation,36765000.0,折舊費用,聯亞藥,生技醫療業
2022-06-30,6562,IncomeBeforeIncomeTaxFromContinuingOperations,23186000.0,繼續營業單位稅前淨利（淨損）,聯亞藥,生技醫療業
2022-06-30,6562,DecreaseInDepositDeposit,250000.0,存出保證金減少,聯亞藥,生技醫療業
2022-06-30,6562,NetCashInflowFromOperatingActivities,63574000.0,營業活動之淨現金流入,聯亞藥,生技醫療業
2022-06-30,6562,AmortizationExpense,2240000.0,攤銷費用,聯亞藥,生技醫療業
2022-06-30,6562,NetIncomeBeforeTax,23186000.0,本期稅前淨利（淨損）,聯亞藥,生技醫療業
2022-06-30,6562,CashFlowsFromOperatingActivities,63574000.0,營業活動之淨現金流入（流出）,聯亞藥,生技醫療業
2022-06-30,6562,AccountsPayable,6478000.0,應付帳款,聯亞藥,生技醫療業
2022-12-31,6562,CashFlowsProvidedFromFinancingActivities,42475000.0,籌資活動之淨現金流入（流出）,聯亞藥,生技醫療業
2022-12-31,6562,DecreaseInShortTermLoans,-124019000.0,短期借款減少,聯亞藥,生技醫療業
2022-12-31,6562,InterestIncome,-1388000.0,利息收入,聯亞藥,生技醫療業
2022-12-31,6562,RentalPrincipalRepayments,-35701000.0,租賃本金償還,聯亞藥,生技醫療業
2022-12-31,6562,CashReceivedThroughOperations,200242000.0,營運產生之現金流入（流出）,聯亞藥,生技醫療業
2022-12-31,6562,InventoryIncrease,-1109000.0,存貨（增加）減少,聯亞藥,生技醫療業
2022-12-31,6562,PayTheInterest,-11909000.0,支付之利息,聯亞藥,生技醫療業
2022-12-31,6562,ReceivableIncrease,22725000.0,應收帳款（增加）減少,聯亞藥,生技醫療業
2022-12-31,6562,TotalIncomeLossItems,103213000.0,收益費損項目合計,聯亞藥,生技醫療業
2022-12-31,6562,CashBalancesIncrease,96629000.0,本期現金及約當現金增加（減少）數,聯亞藥,生技醫療業
2022-12-31,6562,InterestExpense,11684000.0,利息費用,聯亞藥,生技醫療業
2022-12-31,6562,RepaymentOfLongTermDebt,-228274000.0,償還長期借款,聯亞藥,生技醫療業
2022-12-31,6562,CashBalancesBeginningOfPeriod,298706000.0,期初現金及約當現金餘額,聯亞藥,生技醫療業
2022-12-31,6562,DecreaseInDepositDeposit,250000.0,存出保證金減少,聯亞藥,生技醫療業
2022-12-31,6562,CashProvidedByInvestingActivities,-128539000.0,投資活動之淨現金流入（流出）,聯亞藥,生技醫療業
2022-12-31,6562,IncomeBeforeIncomeTaxFromContinuingOperations,54264000.0,繼續營業單位稅前淨利（淨損）,聯亞藥,生技醫療業
2022-12-31,6562,PropertyAndPlantAndEquipment,-160228000.0,取得不動產、廠房及設備,聯亞藥,生技醫療業
2022-12-31,6562,NetIncomeBeforeTax,54264000.0,本期稅前淨利（淨損）,聯亞藥,生技醫療業
2022-12-31,6562,CashFlowsFromOperatingActivities,182606000.0,營業活動之淨現金流入（流出）,聯亞藥,生技醫療業
2022-12-31,6562,NetCashInflowFromOperatingActivities,182606000.0,營業活動之淨現金流入,聯亞藥,生技醫療業
2022-12-31,6562,Depreciation,74817000.0,折舊費用,聯亞藥,生技醫療業
2022-12-31,6562,ProceedsFromLongTermDebt,0.0,舉借長期借款,聯亞藥,生技醫療業
2022-12-31,6562,AmortizationExpense,4320000.0,攤銷費用,聯亞藥,生技醫療業
2022-12-31,6562,CashBalancesEndOfPeriod,395335000.0,期末現金及約當現金餘額,聯亞藥,生技醫療業
2022-12-31,6562,AccountsPayable,-316000.0,應付帳款,聯亞藥,生技醫療業
2023-06-30,6562,Depreciation,38932000.0,折舊費用,聯亞藥,生技醫療業
2023-06-30,6562,CashBalancesIncrease,-75695000.0,本期現金及約當現金增加（減少）數,聯亞藥,生技醫療業
2023-06-30,6562,InterestExpense,5321000.0,利息費用,聯亞藥,生技醫療業
2023-06-30,6562,PayTheInterest,-5333000.0,支付之利息,聯亞藥,生技醫療業
2023-06-30,6562,CashBalancesEndOfPeriod,319640000.0,期末現金及約當現金餘額,聯亞藥,生技醫療業
2023-06-30,6562,CashProvidedByInvestingActivities,-63426000.0,投資活動之淨現金流入（流出）,聯亞藥,生技醫療業
2023-06-30,6562,NetIncomeBeforeTax,14544000.0,本期稅前淨利（淨損）,聯亞藥,生技醫療業
2023-06-30,6562,PropertyAndPlantAndEquipment,-65479000.0,取得不動產、廠房及設備,聯亞藥,生技醫療業
2023-06-30,6562,CashBalancesBeginningOfPeriod,395335000.0,期初現金及約當現金餘額,聯亞藥,生技醫療業
2023-06-30,6562,CashFlowsFromOperatingActivities,28632000.0,營業活動之淨現金流入（流出）,聯亞藥,生技醫療業
2023-06-30,6562,AmortizationExpense,2193000.0,攤銷費用,聯亞藥,生技醫療業
2023-06-30,6562,RepaymentOfLongTermDebt,-5000000.0,償還長期借款,聯亞藥,生技醫療業
2023-06-30,6562,DecreaseInShortTermLoans,-42194000.0,短期借款減少,聯亞藥,生技醫療業
2023-06-30,6562,AccountsPayable,-510000.0,應付帳款,聯亞藥,生技醫療業
2023-06-30,6562,InterestIncome,-2240000.0,利息收入,聯亞藥,生技醫療業
2023-06-30,6562,CashReceivedThroughOperations,32488000.0,營運產生之現金流入（流出）,聯亞藥,生技醫療業
2023-06-30,6562,CashFlowsProvidedFromFinancingActivities,-40769000.0,籌資活動之淨現金流入（流出）,聯亞藥,生技醫療業
2023-06-30,6562,InventoryIncrease,21223000.0,存貨（增加）減少,聯亞藥,生技醫療業
2023-06-30,6562,NetCashInflowFromOperatingActivities,28632000.0,營業活動之淨現金流入,聯亞藥,生技醫療業
2023-06-30,6562,ReceivableIncrease,5266000.0,應收帳款（增加）減少,聯亞藥,生技醫療業
2023-06-30,6562,TotalIncomeLossItems,44298000.0,收益費損項目合計,聯亞藥,生技醫療業
2023-06-30,6562,DecreaseInDepositDeposit,0.0,存出保證金減少,聯亞藥,生技醫療業
2023-06-30,6562,RentalPrincipalRepayments,-21670000.0,租賃本金償還,聯亞藥,生技醫療業
2023-06-30,6562,IncomeBeforeIncomeTaxFromContinuingOperations,14544000.0,繼續營業單位稅前淨利（淨損）,聯亞藥,生技醫療業
2023-12-31,6562,CashProvidedByInvestingActivities,-140051000.0,投資活動之淨現金流入（流出）,聯亞藥,生技醫療業
2023-12-31,6562,PayTheInterest,-10799000.0,支付之利息,聯亞藥,生技醫療業
2023-12-31,6562,PropertyAndPlantAndEquipment,-120829000.0,取得不動產、廠房及設備,聯亞藥,生技醫療業
2023-12-31,6562,CashBalancesBeginningOfPeriod,395335000.0,期初現金及約當現金餘額,聯亞藥,生技醫療業
2023-12-31,6562,RentalPrincipalRepayments,-17515000.0,租賃本金償還,聯亞藥,生技醫療業
2023-12-31,6562,CashBalancesIncrease,-55036000.0,本期現金及約當現金增加（減少）數,聯亞藥,生技醫療業
2023-12-31,6562,CashBalancesEndOfPeriod,340299000.0,期末現金及約當現金餘額,聯亞藥,生技醫療業
2023-12-31,6562,IncomeBeforeIncomeTaxFromContinuingOperations,2596000.0,繼續營業單位稅前淨利（淨損）,聯亞藥,生技醫療業
2023-12-31,6562,ProceedsFromLongTermDebt,55000000.0,舉借長期借款,聯亞藥,生技醫療業
2023-12-31,6562,NetIncomeBeforeTax,2596000.0,本期稅前淨利（淨損）,聯亞藥,生技醫療業
2023-12-31,6562,CashFlowsFromOperatingActivities,6940000.0,營業活動之淨現金流入（流出）,聯亞藥,生技醫療業
2023-12-31,6562,Depreciation,87262000.0,折舊費用,聯亞藥,生技醫療業
2023-12-31,6562,AmortizationExpense,4133000.0,攤銷費用,聯亞藥,生技醫療業
2023-12-31,6562,AccountsPayable,-954000.0,應付帳款,聯亞藥,生技醫療業
2023-12-31,6562,NetCashInflowFromOperatingActivities,6940000.0,營業活動之淨現金流入,聯亞藥,生技醫療業
2023-12-31,6562,RepaymentOfLongTermDebt,-18333000.0,償還長期借款,聯亞藥,生技醫療業
2023-12-31,6562,DecreaseInDepositDeposit,0.0,存出保證金減少,聯亞藥,生技醫療業
2023-12-31,6562,TotalIncomeLossItems,100205000.0,收益費損項目合計,聯亞藥,生技醫療業
2023-12-31,6562,ReceivableIncrease,-21430000.0,應收帳款（增加）減少,聯亞藥,生技醫療業
2023-12-31,6562,InventoryIncrease,10684000.0,存貨（增加）減少,聯亞藥,生技醫療業
2023-12-31,6562,CashFlowsProvidedFromFinancingActivities,78206000.0,籌資活動之淨現金流入（流出）,聯亞藥,生技醫療業
2023-12-31,6562,InterestIncome,-4901000.0,利息收入,聯亞藥,生技醫療業
2023-12-31,6562,DecreaseInShortTermLoans,-114738000.0,短期借款減少,聯亞藥,生技醫療業
2023-12-31,6562,InterestExpense,10845000.0,利息費用,聯亞藥,生技醫療業
2023-12-31,6562,CashReceivedThroughOperations,14764000.0,營運產生之現金流入（流出）,聯亞藥,生技醫療業
2024-06-30,6562,CashBalancesIncrease,-51669000.0,本期現金及約當現金增加（減少）數,聯亞藥,生技醫療業
2024-06-30,6562,CashBalancesEndOfPeriod,288630000.0,期末現金及約當現金餘額,聯亞藥,生技醫療業
2024-06-30,6562,PropertyAndPlantAndEquipment,-24802000.0,取得不動產、廠房及設備,聯亞藥,生技醫療業
2024-06-30,6562,PayTheInterest,-6320000.0,支付之利息,聯亞藥,生技醫療業
2024-06-30,6562,CashBalancesBeginningOfPeriod,340299000.0,期初現金及約當現金餘額,聯亞藥,生技醫療業
2024-06-30,6562,RentalPrincipalRepayments,-18784000.0,租賃本金償還,聯亞藥,生技醫療業
2024-06-30,6562,CashProvidedByInvestingActivities,-5469000.0,投資活動之淨現金流入（流出）,聯亞藥,生技醫療業
2024-06-30,6562,IncomeBeforeIncomeTaxFromContinuingOperations,-3437000.0,繼續營業單位稅前淨利（淨損）,聯亞藥,生技醫療業
2024-06-30,6562,DecreaseInShortTermLoans,-159139000.0,短期借款減少,聯亞藥,生技醫療業
2024-06-30,6562,InterestIncome,-3409000.0,利息收入,聯亞藥,生技醫療業
2024-06-30,6562,CashFlowsProvidedFromFinancingActivities,-26241000.0,籌資活動之淨現金流入（流出）,聯亞藥,生技醫療業
2024-06-30,6562,InventoryIncrease,-48674000.0,存貨（增加）減少,聯亞藥,生技醫療業
2024-06-30,6562,ReceivableIncrease,13906000.0,應收帳款（增加）減少,聯亞藥,生技醫療業
2024-06-30,6562,TotalIncomeLossItems,26859000.0,收益費損項目合計,聯亞藥,生技醫療業
2024-06-30,6562,InterestExpense,6318000.0,利息費用,聯亞藥,生技醫療業
2024-06-30,6562,NetCashInflowFromOperatingActivities,-20153000.0,營業活動之淨現金流入,聯亞藥,生技醫療業
2024-06-30,6562,AccountsPayable,26652000.0,應付帳款,聯亞藥,生技醫療業
2024-06-30,6562,AmortizationExpense,2288000.0,攤銷費用,聯亞藥,生技醫療業
2024-06-30,6562,Depreciation,52595000.0,折舊費用,聯亞藥,生技醫療業
2024-06-30,6562,CashFlowsFromOperatingActivities,-20153000.0,營業活動之淨現金流入（流出）,聯亞藥,生技醫療業
2024-06-30,6562,NetIncomeBeforeTax,-3437000.0,本期稅前淨利（淨損）,聯亞藥,生技醫療業
2024-06-30,6562,RepaymentOfLongTermDebt,0.0,償還長期借款,聯亞藥,生技醫療業
2024-06-30,6562,CashReceivedThroughOperations,-17004000.0,營運產生之現金流入（流出）,聯亞藥,生技醫療業
2024-12-31,6562,CashProvidedByInvestingActivities,-16297000.0,投資活動之淨現金流入（流出）,聯亞藥,生技醫療業
2024-12-31,6562,PayTheInterest,-12106000.0,支付之利息,聯亞藥,生技醫療業
2024-12-31,6562,PropertyAndPlantAndEquipment,-66213000.0,取得不動產、廠房及設備,聯亞藥,生技醫療業
2024-12-31,6562,CashBalancesBeginningOfPeriod,340299000.0,期初現金及約當現金餘額,聯亞藥,生技醫療業
2024-12-31,6562,RentalPrincipalRepayments,-38017000.0,租賃本金償還,聯亞藥,生技醫療業
2024-12-31,6562,CashBalancesIncrease,-106419000.0,本期現金及約當現金增加（減少）數,聯亞藥,生技醫療業
2024-12-31,6562,CashBalancesEndOfPeriod,233880000.0,期末現金及約當現金餘額,聯亞藥,生技醫療業
2024-12-31,6562,IncomeBeforeIncomeTaxFromContinuingOperations,-175629000.0,繼續營業單位稅前淨利（淨損）,聯亞藥,生技醫療業
2024-12-31,6562,ProceedsFromLongTermDebt,0.0,舉借長期借款,聯亞藥,生技醫療業
2024-12-31,6562,NetIncomeBeforeTax,-175629000.0,本期稅前淨利（淨損）,聯亞藥,生技醫療業
2024-12-31,6562,CashFlowsFromOperatingActivities,-60147000.0,營業活動之淨現金流入（流出）,聯亞藥,生技醫療業
2024-12-31,6562,Depreciation,107479000.0,折舊費用,聯亞藥,生技醫療業
2024-12-31,6562,AmortizationExpense,4329000.0,攤銷費用,聯亞藥,生技醫療業
2024-12-31,6562,AccountsPayable,626000.0,應付帳款,聯亞藥,生技醫療業
2024-12-31,6562,NetCashInflowFromOperatingActivities,-60147000.0,營業活動之淨現金流入,聯亞藥,生技醫療業
2024-12-31,6562,RepaymentOfLongTermDebt,0.0,償還長期借款,聯亞藥,生技醫療業
2024-12-31,6562,DecreaseInDepositDeposit,1000000.0,存出保證金減少,聯亞藥,生技醫療業
2024-12-31,6562,TotalIncomeLossItems,194806000.0,收益費損項目合計,聯亞藥,生技醫療業
2024-12-31,6562,ReceivableIncrease,3112000.0,應收帳款（增加）減少,聯亞藥,生技醫療業
2024-12-31,6562,InventoryIncrease,-71565000.0,存貨（增加）減少,聯亞藥,生技醫療業
2024-12-31,6562,CashFlowsProvidedFromFinancingActivities,-30182000.0,籌資活動之淨現金流入（流出）,聯亞藥,生技醫療業
2024-12-31,6562,InterestIncome,-5154000.0,利息收入,聯亞藥,生技醫療業
2024-12-31,6562,DecreaseInShortTermLoans,-257139000.0,短期借款減少,聯亞藥,生技醫療業
2024-12-31,6562,InterestExpense,12119000.0,利息費用,聯亞藥,生技醫療業
2024-12-31,6562,CashReceivedThroughOperations,-52863000.0,營運產生之現金流入（流出）,聯亞藥,生技醫療業
2019-06-30,1716,IncomeBeforeIncomeTax,510884000.0,稅前淨利(淨損),永信,生技醫療業
2019-06-30,1716,NetIncome,407089000.0,本期淨利(淨損),永信,生技醫療業
2019-06-30,1716,OperatingExpenses,770667000.0,營業費用,永信,生技醫療業
2019-06-30,1716,TAX,103795000.0,所得稅費用（利益）,永信,生技醫療業
2019-06-30,1716,EPS,2.41,基本每股盈餘（元）,永信,生技醫療業
2019-06-30,1716,PreTaxIncome,510884000.0,稅前淨利（淨損）,永信,生技醫療業
2019-06-30,1716,IncomeFromContinuingOperations,407089000.0,繼續營業單位本期淨利（淨損）,永信,生技醫療業
2019-06-30,1716,IncomeAfterTaxes,407089000.0,本期淨利（淨損）,永信,生技醫療業
2019-06-30,1716,TotalConsolidatedProfitForThePeriod,411291000.0,本期綜合損益總額,永信,生技醫療業
2019-06-30,1716,Revenue,2617842000.0,營業收入,永信,生技醫療業
2019-06-30,1716,CostOfGoodsSold,1380479000.0,營業成本,永信,生技醫療業
2019-06-30,1716,GrossProfit,1237363000.0,營業毛利（毛損）淨額,永信,生技醫療業
2019-06-30,1716,OperatingIncome,466696000.0,營業利益（損失）,永信,生技醫療業
2019-06-30,1716,TotalNonoperatingIncomeAndExpense,44188000.0,營業外收入及支出,永信,生技醫療業
2019-06-30,1716,OtherComprehensiveIncome,4202000.0,其他綜合損益（淨額）,永信,生技醫療業
2019-06-30,1716,EquityAttributableToOwnersOfParent,406828000.0,淨利（淨損）歸屬於母公司業主,永信,生技醫療業
2019-06-30,1716,NoncontrollingInterests,261000.0,淨利（淨損）歸屬於非控制權益,永信,生技醫療業
2019-12-31,1716,IncomeBeforeIncomeTax,517749000.0,稅前淨利(淨損),永信,生技醫療業
2019-12-31,1716,NetIncome,412073000.0,本期淨利(淨損),永信,生技醫療業
2019-12-31,1716,OperatingExpenses,840849000.0,營業費用,永信,生技醫療業
2019-12-31,1716,TAX,105676000.0,所得稅費用（利益）,永信,生技醫療業
2019-12-31,1716,EPS,2.43,基本每股盈餘（元）,永信,生技醫療業
2019-12-31,1716,PreTaxIncome,517749000.0,稅前淨利（淨損）,永信,生技醫療業
2019-12-31,1716,IncomeFromContinuingOperations,412073000.0,繼續營業單位本期淨利（淨損）,永信,生技醫療業
2019-12-31,1716,IncomeAfterTaxes,412073000.0,本期淨利（淨損）,永信,生技醫療業
2019-12-31,1716,TotalConsolidatedProfitForThePeriod,425703000.0,本期綜合損益總額,永信,生技醫療業
2019-12-31,1716,Revenue,2891952000.0,營業收入,永信,生技醫療業
2019-12-31,1716,CostOfGoodsSold,1561870000.0,營業成本,永信,生技醫療業
2019-12-31,1716,GrossProfit,1330082000.0,營業毛利（毛損）淨額,永信,生技醫療業
2019-12-31,1716,OperatingIncome,489233000.0,營業利益（損失）,永信,生技醫療業
2019-12-31,1716,TotalNonoperatingIncomeAndExpense,28516000.0,營業外收入及支出,永信,生技醫療業
2019-12-31,1716,OtherComprehensiveIncome,13630000.0,其他綜合損益（淨額）,永信,生技醫療業
2019-12-31,1716,EquityAttributableToOwnersOfParent,411877000.0,淨利（淨損）歸屬於母公司業主,永信,生技醫療業
2019-12-31,1716,NoncontrollingInterests,196000.0,淨利（淨損）歸屬於非控制權益,永信,生技醫療業
2020-06-30,1716,OperatingExpenses,768917000.0,營業費用,永信,生技醫療業
2020-06-30,1716,TAX,97807000.0,所得稅費用（利益）,永信,生技醫療業
2020-06-30,1716,EPS,8.86,基本每股盈餘（元）,永信,生技醫療業
2020-06-30,1716,PreTaxIncome,484740000.0,稅前淨利（淨損）,永信,生技醫療業
2020-06-30,1716,IncomeFromContinuingOperations,386933000.0,繼續營業單位本期淨利（淨損）,永信,生技醫療業
2020-06-30,1716,IncomeAfterTaxes,386933000.0,本期淨利（淨損）,永信,生技醫療業
2020-06-30,1716,TotalConsolidatedProfitForThePeriod,434641000.0,本期綜合損益總額,永信,生技醫療業
2020-06-30,1716,Revenue,2737524000.0,營業收入,永信,生技醫療業
2020-06-30,1716,CostOfGoodsSold,1488464000.0,營業成本,永信,生技醫療業
2020-06-30,1716,GrossProfit,1249060000.0,營業毛利（毛損）淨額,永信,生技醫療業
2020-06-30,1716,OperatingIncome,480143000.0,營業利益（損失）,永信,生技醫療業
2020-06-30,1716,TotalNonoperatingIncomeAndExpense,4597000.0,營業外收入及支出,永信,生技醫療業
2020-06-30,1716,OtherComprehensiveIncome,47708000.0,其他綜合損益（淨額）,永信,生技醫療業
2020-06-30,1716,EquityAttributableToOwnersOfParent,386789000.0,淨利（淨損）歸屬於母公司業主,永信,生技醫療業
2020-06-30,1716,NoncontrollingInterests,144000.0,淨利（淨損）歸屬於非控制權益,永信,生技醫療業
2020-12-31,1716,OperatingExpenses,718444000.0,營業費用,永信,生技醫療業
2020-12-31,1716,TAX,79429000.0,所得稅費用（利益）,永信,生技醫療業
2020-12-31,1716,EPS,-3.09,基本每股盈餘（元）,永信,生技醫療業
2020-12-31,1716,PreTaxIncome,437400000.0,稅前淨利（淨損）,永信,生技醫療業
2020-12-31,1716,IncomeFromContinuingOperations,357971000.0,繼續營業單位本期淨利（淨損）,永信,生技醫療業
2020-12-31,1716,IncomeAfterTaxes,357971000.0,本期淨利（淨損）,永信,生技醫療業
2020-12-31,1716,TotalConsolidatedProfitForThePeriod,283252000.0,本期綜合損益總額,永信,生技醫療業
2020-12-31,1716,Revenue,2444856000.0,營業收入,永信,生技醫療業
2020-12-31,1716,CostOfGoodsSold,1315226000.0,營業成本,永信,生技醫療業
2020-12-31,1716,GrossProfit,1129630000.0,營業毛利（毛損）淨額,永信,生技醫療業
2020-12-31,1716,OperatingIncome,411186000.0,營業利益（損失）,永信,生技醫療業
2020-12-31,1716,TotalNonoperatingIncomeAndExpense,26214000.0,營業外收入及支出,永信,生技醫療業
2020-12-31,1716,OtherComprehensiveIncome,-74719000.0,其他綜合損益（淨額）,永信,生技醫療業
2020-12-31,1716,EquityAttributableToOwnersOfParent,357577000.0,淨利（淨損）歸屬於母公司業主,永信,生技醫療業
2020-12-31,1716,NoncontrollingInterests,394000.0,淨利（淨損）歸屬於非控制權益,永信,生技醫療業
2021-06-30,1716,OperatingExpenses,653401000.0,營業費用,永信,生技醫療業
2021-06-30,1716,TAX,75662000.0,所得稅費用（利益）,永信,生技醫療業
2021-06-30,1716,EPS,4.32,基本每股盈餘（元）,永信,生技醫療業
2021-06-30,1716,PreTaxIncome,363852000.0,稅前淨利（淨損）,永信,生技醫療業
2021-06-30,1716,IncomeFromContinuingOperations,288190000.0,繼續營業單位本期淨利（淨損）,永信,生技醫療業
2021-06-30,1716,IncomeAfterTaxes,288190000.0,本期淨利（淨損）,永信,生技醫療業
2021-06-30,1716,TotalConsolidatedProfitForThePeriod,290191000.0,本期綜合損益總額,永信,生技醫療業
2021-06-30,1716,Revenue,2076159000.0,營業收入,永信,生技醫療業
2021-06-30,1716,CostOfGoodsSold,1061723000.0,營業成本,永信,生技醫療業
2021-06-30,1716,OperatingIncome,361035000.0,營業利益（損失）,永信,生技醫療業
2021-06-30,1716,TotalNonoperatingIncomeAndExpense,2817000.0,營業外收入及支出,永信,生技醫療業
2021-06-30,1716,OtherComprehensiveIncome,2001000.0,其他綜合損益（淨額）,永信,生技醫療業
2021-06-30,1716,EquityAttributableToOwnersOfParent,288020000.0,淨利（淨損）歸屬於母公司業主,永信,生技醫療業
2021-06-30,1716,NoncontrollingInterests,170000.0,淨利（淨損）歸屬於非控制權益,永信,生技醫療業
2021-06-30,1716,GrossProfit,1014436000.0,營業毛利（毛損）,永信,生技醫療業
2021-06-30,1716,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,170000.0,綜合損益總額歸屬於非控制權益,永信,生技醫療業
2021-12-31,1716,OperatingExpenses,686623000.0,營業費用,永信,生技醫療業
2021-12-31,1716,TAX,74897000.0,所得稅費用（利益）,永信,生技醫療業
2021-12-31,1716,PreTaxIncome,357129000.0,稅前淨利（淨損）,永信,生技醫療業
2021-12-31,1716,IncomeFromContinuingOperations,282232000.0,繼續營業單位本期淨利（淨損）,永信,生技醫療業
2021-12-31,1716,IncomeAfterTaxes,282232000.0,本期淨利（淨損）,永信,生技醫療業
2021-12-31,1716,TotalConsolidatedProfitForThePeriod,290691000.0,本期綜合損益總額,永信,生技醫療業
2021-12-31,1716,Revenue,2160914000.0,營業收入,永信,生技醫療業
2021-12-31,1716,CostOfGoodsSold,1117271000.0,營業成本,永信,生技醫療業
2021-12-31,1716,OperatingIncome,357020000.0,營業利益（損失）,永信,生技醫療業
2021-12-31,1716,TotalNonoperatingIncomeAndExpense,109000.0,營業外收入及支出,永信,生技醫療業
2021-12-31,1716,OtherComprehensiveIncome,8459000.0,其他綜合損益（淨額）,永信,生技醫療業
2021-12-31,1716,GrossProfit,1043643000.0,營業毛利（毛損）,永信,生技醫療業
2021-12-31,1716,EquityAttributableToOwnersOfParent,282209000.0,淨利（淨損）歸屬於母公司業主,永信,生技醫療業
2021-12-31,1716,NoncontrollingInterests,23000.0,淨利（淨損）歸屬於非控制權益,永信,生技醫療業
2021-12-31,1716,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,23000.0,綜合損益總額歸屬於非控制權益,永信,生技醫療業
2021-12-31,1716,EPS,2.52,基本每股盈餘（元）,永信,生技醫療業
2022-06-30,1716,OperatingExpenses,665917000.0,營業費用,永信,生技醫療業
2022-06-30,1716,TAX,63025000.0,所得稅費用（利益）,永信,生技醫療業
2022-06-30,1716,EPS,3.65,基本每股盈餘（元）,永信,生技醫療業
2022-06-30,1716,PreTaxIncome,367569000.0,稅前淨利（淨損）,永信,生技醫療業
2022-06-30,1716,IncomeFromContinuingOperations,304544000.0,繼續營業單位本期淨利（淨損）,永信,生技醫療業
2022-06-30,1716,IncomeAfterTaxes,304544000.0,本期淨利（淨損）,永信,生技醫療業
2022-06-30,1716,TotalConsolidatedProfitForThePeriod,307708000.0,本期綜合損益總額,永信,生技醫療業
2022-06-30,1716,Revenue,2166347000.0,營業收入,永信,生技醫療業
2022-06-30,1716,CostOfGoodsSold,1137067000.0,營業成本,永信,生技醫療業
2022-06-30,1716,OperatingIncome,363363000.0,營業利益（損失）,永信,生技醫療業
2022-06-30,1716,TotalNonoperatingIncomeAndExpense,4206000.0,營業外收入及支出,永信,生技醫療業
2022-06-30,1716,OtherComprehensiveIncome,3164000.0,其他綜合損益（淨額）,永信,生技醫療業
2022-06-30,1716,EquityAttributableToOwnersOfParent,304338000.0,淨利（淨損）歸屬於母公司業主,永信,生技醫療業
2022-06-30,1716,NoncontrollingInterests,206000.0,淨利（淨損）歸屬於非控制權益,永信,生技醫療業
2022-06-30,1716,GrossProfit,1029280000.0,營業毛利（毛損）,永信,生技醫療業
2022-06-30,1716,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,206000.0,綜合損益總額歸屬於非控制權益,永信,生技醫療業
2022-12-31,1716,OperatingExpenses,717263000.0,營業費用,永信,生技醫療業
2022-12-31,1716,TAX,58903000.0,所得稅費用（利益）,永信,生技醫療業
2022-12-31,1716,EPS,1.94,基本每股盈餘（元）,永信,生技醫療業
2022-12-31,1716,PreTaxIncome,275226000.0,稅前淨利（淨損）,永信,生技醫療業
2022-12-31,1716,IncomeFromContinuingOperations,216323000.0,繼續營業單位本期淨利（淨損）,永信,生技醫療業
2022-12-31,1716,IncomeAfterTaxes,216323000.0,本期淨利（淨損）,永信,生技醫療業
2022-12-31,1716,TotalConsolidatedProfitForThePeriod,186777000.0,本期綜合損益總額,永信,生技醫療業
2022-12-31,1716,Revenue,2299659000.0,營業收入,永信,生技醫療業
2022-12-31,1716,CostOfGoodsSold,1308609000.0,營業成本,永信,生技醫療業
2022-12-31,1716,OperatingIncome,273787000.0,營業利益（損失）,永信,生技醫療業
2022-12-31,1716,TotalNonoperatingIncomeAndExpense,1439000.0,營業外收入及支出,永信,生技醫療業
2022-12-31,1716,OtherComprehensiveIncome,-29546000.0,其他綜合損益（淨額）,永信,生技醫療業
2022-12-31,1716,GrossProfit,991050000.0,營業毛利（毛損）,永信,生技醫療業
2022-12-31,1716,EquityAttributableToOwnersOfParent,216175000.0,淨利（淨損）歸屬於母公司業主,永信,生技醫療業
2022-12-31,1716,NoncontrollingInterests,148000.0,淨利（淨損）歸屬於非控制權益,永信,生技醫療業
2022-12-31,1716,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,148000.0,綜合損益總額歸屬於非控制權益,永信,生技醫療業
2023-06-30,1716,OperatingExpenses,735340000.0,營業費用,永信,生技醫療業
2023-06-30,1716,TAX,79750000.0,所得稅費用（利益）,永信,生技醫療業
2023-06-30,1716,EPS,3.23,基本每股盈餘（元）,永信,生技醫療業
2023-06-30,1716,PreTaxIncome,380813000.0,稅前淨利（淨損）,永信,生技醫療業
2023-06-30,1716,IncomeFromContinuingOperations,301063000.0,繼續營業單位本期淨利（淨損）,永信,生技醫療業
2023-06-30,1716,IncomeAfterTaxes,301063000.0,本期淨利（淨損）,永信,生技醫療業
2023-06-30,1716,TotalConsolidatedProfitForThePeriod,323150000.0,本期綜合損益總額,永信,生技醫療業
2023-06-30,1716,Revenue,2266060000.0,營業收入,永信,生技醫療業
2023-06-30,1716,CostOfGoodsSold,1154207000.0,營業成本,永信,生技醫療業
2023-06-30,1716,OperatingIncome,376513000.0,營業利益（損失）,永信,生技醫療業
2023-06-30,1716,TotalNonoperatingIncomeAndExpense,4300000.0,營業外收入及支出,永信,生技醫療業
2023-06-30,1716,OtherComprehensiveIncome,22087000.0,其他綜合損益（淨額）,永信,生技醫療業
2023-06-30,1716,GrossProfit,1111853000.0,營業毛利（毛損）,永信,生技醫療業
2023-06-30,1716,EquityAttributableToOwnersOfParent,300892000.0,淨利（淨損）歸屬於母公司業主,永信,生技醫療業
2023-06-30,1716,NoncontrollingInterests,171000.0,淨利（淨損）歸屬於非控制權益,永信,生技醫療業
2023-06-30,1716,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,171000.0,綜合損益總額歸屬於非控制權益,永信,生技醫療業
2023-12-31,1716,OperatingExpenses,753541000.0,營業費用,永信,生技醫療業
2023-12-31,1716,TAX,85711000.0,所得稅費用（利益）,永信,生技醫療業
2023-12-31,1716,EPS,3.48,基本每股盈餘（元）,永信,生技醫療業
2023-12-31,1716,PreTaxIncome,443587000.0,稅前淨利（淨損）,永信,生技醫療業
2023-12-31,1716,IncomeFromContinuingOperations,357876000.0,繼續營業單位本期淨利（淨損）,永信,生技醫療業
2023-12-31,1716,IncomeAfterTaxes,357876000.0,本期淨利（淨損）,永信,生技醫療業
2023-12-31,1716,TotalConsolidatedProfitForThePeriod,355897000.0,本期綜合損益總額,永信,生技醫療業
2023-12-31,1716,Revenue,2467840000.0,營業收入,永信,生技醫療業
2023-12-31,1716,CostOfGoodsSold,1278392000.0,營業成本,永信,生技醫療業
2023-12-31,1716,OperatingIncome,435907000.0,營業利益（損失）,永信,生技醫療業
2023-12-31,1716,TotalNonoperatingIncomeAndExpense,7680000.0,營業外收入及支出,永信,生技醫療業
2023-12-31,1716,OtherComprehensiveIncome,-1979000.0,其他綜合損益（淨額）,永信,生技醫療業
2023-12-31,1716,GrossProfit,1189448000.0,營業毛利（毛損）,永信,生技醫療業
2023-12-31,1716,EquityAttributableToOwnersOfParent,357545000.0,淨利（淨損）歸屬於母公司業主,永信,生技醫療業
2023-12-31,1716,NoncontrollingInterests,331000.0,淨利（淨損）歸屬於非控制權益,永信,生技醫療業
2023-12-31,1716,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,331000.0,綜合損益總額歸屬於非控制權益,永信,生技醫療業
2024-06-30,1716,PreTaxIncome,405738000.0,稅前淨利（淨損）,永信,生技醫療業
2024-06-30,1716,TAX,83720000.0,所得稅費用（利益）,永信,生技醫療業
2024-06-30,1716,IncomeFromContinuingOperations,322018000.0,繼續營業單位本期淨利（淨損）,永信,生技醫療業
2024-06-30,1716,IncomeAfterTaxes,322018000.0,本期淨利（淨損）,永信,生技醫療業
2024-06-30,1716,TotalConsolidatedProfitForThePeriod,336212000.0,本期綜合損益總額,永信,生技醫療業
2024-06-30,1716,EPS,3.28,基本每股盈餘（元）,永信,生技醫療業
2024-06-30,1716,Revenue,2371798000.0,營業收入,永信,生技醫療業
2024-06-30,1716,CostOfGoodsSold,1247750000.0,營業成本,永信,生技醫療業
2024-06-30,1716,OperatingExpenses,728493000.0,營業費用,永信,生技醫療業
2024-06-30,1716,OperatingIncome,395555000.0,營業利益（損失）,永信,生技醫療業
2024-06-30,1716,TotalNonoperatingIncomeAndExpense,10183000.0,營業外收入及支出,永信,生技醫療業
2024-06-30,1716,OtherComprehensiveIncome,14194000.0,其他綜合損益（淨額）,永信,生技醫療業
2024-06-30,1716,NoncontrollingInterests,386000.0,淨利（淨損）歸屬於非控制權益,永信,生技醫療業
2024-06-30,1716,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,386000.0,綜合損益總額歸屬於非控制權益,永信,生技醫療業
2024-06-30,1716,EquityAttributableToOwnersOfParent,321632000.0,淨利（淨損）歸屬於母公司業主,永信,生技醫療業
2024-06-30,1716,GrossProfit,1124048000.0,營業毛利（毛損）,永信,生技醫療業
2024-12-31,1716,OperatingExpenses,789614000.0,營業費用,永信,生技醫療業
2024-12-31,1716,TAX,85530000.0,所得稅費用（利益）,永信,生技醫療業
2024-12-31,1716,EPS,3.07,基本每股盈餘（元）,永信,生技醫療業
2024-12-31,1716,PreTaxIncome,455011000.0,稅前淨利（淨損）,永信,生技醫療業
2024-12-31,1716,IncomeFromContinuingOperations,369481000.0,繼續營業單位本期淨利（淨損）,永信,生技醫療業
2024-12-31,1716,IncomeAfterTaxes,369481000.0,本期淨利（淨損）,永信,生技醫療業
2024-12-31,1716,TotalConsolidatedProfitForThePeriod,367732000.0,本期綜合損益總額,永信,生技醫療業
2024-12-31,1716,Revenue,2602830000.0,營業收入,永信,生技醫療業
2024-12-31,1716,CostOfGoodsSold,1362792000.0,營業成本,永信,生技醫療業
2024-12-31,1716,OperatingIncome,450424000.0,營業利益（損失）,永信,生技醫療業
2024-12-31,1716,TotalNonoperatingIncomeAndExpense,4587000.0,營業外收入及支出,永信,生技醫療業
2024-12-31,1716,OtherComprehensiveIncome,-1749000.0,其他綜合損益（淨額）,永信,生技醫療業
2024-12-31,1716,NoncontrollingInterests,112000.0,淨利（淨損）歸屬於非控制權益,永信,生技醫療業
2024-12-31,1716,ComprehensiveIncomeConsolidatedNetIncomeAttributedNonControllingInterest,112000.0,綜合損益總額歸屬於非控制權益,永信,生技醫療業
2024-12-31,1716,EquityAttributableToOwnersOfParent,369369000.0,淨利（淨損）歸屬於母公司業主,永信,生技醫療業
2024-12-31,1716,GrossProfit,1240038000.0,營業毛利（毛損）,永信,生技醫療業
2019-06-30,1716,AccountsPayableToRelatedParties,18194000.0,應付帳款－關係人,永信,生技醫療業
2019-06-30,1716,AccountsPayableToRelatedParties_per,0.24,應付帳款－關係人,永信,生技醫療業
2019-06-30,1716,AccountsReceivableDuefromRelatedPartiesNet,54545000.0,應收帳款－關係人淨額,永信,生技醫療業
2019-06-30,1716,AccountsReceivableDuefromRelatedPartiesNet_per,0.71,應收帳款－關係人淨額,永信,生技醫療業
2019-06-30,1716,AccountsReceivableNet,892147000.0,應收帳款淨額,永信,生技醫療業
2019-06-30,1716,AccountsReceivableNet_per,11.67,應收帳款淨額,永信,生技醫療業
2019-06-30,1716,CapitalStock_per,22.11,股本合計,永信,生技醫療業
2019-06-30,1716,CapitalSurplus,530000.0,資本公積合計,永信,生技醫療業
2019-06-30,1716,CapitalSurplus_per,0.01,資本公積合計,永信,生技醫療業
2019-06-30,1716,CashAndCashEquivalents,614594000.0,現金及約當現金,永信,生技醫療業
2019-06-30,1716,CashAndCashEquivalents_per,8.04,現金及約當現金,永信,生技醫療業
2019-06-30,1716,CurrentAssets_per,49.59,流動資產合計,永信,生技醫療業
2019-06-30,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2019-06-30,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2019-06-30,1716,CurrentLiabilities_per,42.54,流動負債合計,永信,生技醫療業
2019-06-30,1716,DeferredTaxAssets,54532000.0,遞延所得稅資產,永信,生技醫療業
2019-06-30,1716,DeferredTaxAssets_per,0.71,遞延所得稅資產,永信,生技醫療業
2019-06-30,1716,EquityAttributableToOwnersOfParent_per,52.88,歸屬於母公司業主之權益合計,永信,生技醫療業
2019-06-30,1716,IntangibleAssets,28261000.0,無形資產,永信,生技醫療業
2019-06-30,1716,IntangibleAssets_per,0.37,無形資產,永信,生技醫療業
2019-06-30,1716,Inventories_per,22.99,存貨,永信,生技醫療業
2019-06-30,1716,LegalReserve,1502370000.0,法定盈餘公積,永信,生技醫療業
2019-06-30,1716,LegalReserve_per,19.65,法定盈餘公積,永信,生技醫療業
2019-06-30,1716,LongtermBorrowings,70000000.0,長期借款,永信,生技醫療業
2019-06-30,1716,LongtermBorrowings_per,0.92,長期借款,永信,生技醫療業
2019-06-30,1716,NoncontrollingInterests,3797000.0,非控制權益,永信,生技醫療業
2019-06-30,1716,NoncontrollingInterests_per,0.05,非控制權益,永信,生技醫療業
2019-06-30,1716,NoncurrentAssets_per,50.41,非流動資產合計,永信,生技醫療業
2019-06-30,1716,NoncurrentLiabilities,346740000.0,非流動負債合計,永信,生技醫療業
2019-06-30,1716,NoncurrentLiabilities_per,4.53,非流動負債合計,永信,生技醫療業
2019-06-30,1716,OrdinaryShare_per,22.11,普通股股本,永信,生技醫療業
2019-06-30,1716,OtherEquityInterest,3318000.0,其他權益合計,永信,生技醫療業
2019-06-30,1716,OtherEquityInterest_per,0.04,其他權益合計,永信,生技醫療業
2019-06-30,1716,OtherPayables_per,17.29,其他應付款,永信,生技醫療業
2019-06-30,1716,OtherReceivable,2373000.0,其他應收款淨額,永信,生技醫療業
2019-06-30,1716,OtherReceivable_per,0.03,其他應收款淨額,永信,生技醫療業
2019-06-30,1716,RetainedEarnings_per,30.71,保留盈餘合計,永信,生技醫療業
2019-06-30,1716,ShorttermBorrowings,1335000000.0,短期借款,永信,生技醫療業
2019-06-30,1716,ShorttermBorrowings_per,17.46,短期借款,永信,生技醫療業
2019-06-30,1716,TotalAssets_per,100.0,資產總額,永信,生技醫療業
2019-06-30,1716,TotalLiabilitiesEquity_per,100.0,負債及權益總計,永信,生技醫療業
2019-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome,1958000.0,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2019-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome_per,0.03,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2019-06-30,1716,FinancialAssetsAtAmortizedCost,0.0,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2019-06-30,1716,FinancialAssetsAtAmortizedCost_per,0.0,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2019-06-30,1716,BillsReceivableNet,303443000.0,應收票據淨額,永信,生技醫療業
2019-06-30,1716,BillsReceivableNet_per,3.97,應收票據淨額,永信,生技醫療業
2019-06-30,1716,Inventories,1758475000.0,存貨,永信,生技醫療業
2019-06-30,1716,CurrentAssets,3792524000.0,流動資產合計,永信,生技醫療業
2019-06-30,1716,NoncurrentAssets,3854813000.0,非流動資產合計,永信,生技醫療業
2019-06-30,1716,TotalAssets,7647337000.0,資產總額,永信,生技醫療業
2019-06-30,1716,OtherPayables,1322362000.0,其他應付款,永信,生技醫療業
2019-06-30,1716,CurrentLiabilities,3253055000.0,流動負債合計,永信,生技醫療業
2019-06-30,1716,OrdinaryShare,1691098000.0,普通股股本,永信,生技醫療業
2019-06-30,1716,CapitalStock,1691098000.0,股本合計,永信,生技醫療業
2019-06-30,1716,RetainedEarnings,2348799000.0,保留盈餘合計,永信,生技醫療業
2019-06-30,1716,EquityAttributableToOwnersOfParent,4043745000.0,歸屬於母公司業主之權益合計,永信,生技醫療業
2019-06-30,1716,TotalLiabilitiesEquity,7647337000.0,負債及權益總計,永信,生技醫療業
2019-06-30,1716,CapitalSurplusDonatedAssetsReceived,530000.0,資本公積－受贈資產,永信,生技醫療業
2019-06-30,1716,CapitalSurplusDonatedAssetsReceived_per,0.01,資本公積－受贈資產,永信,生技醫療業
2019-06-30,1716,OtherCurrentAssets,164989000.0,其他流動資產,永信,生技醫療業
2019-06-30,1716,OtherCurrentAssets_per,2.16,其他流動資產,永信,生技醫療業
2019-06-30,1716,PropertyPlantAndEquipment,3367693000.0,不動產、廠房及設備,永信,生技醫療業
2019-06-30,1716,PropertyPlantAndEquipment_per,44.04,不動產、廠房及設備,永信,生技醫療業
2019-06-30,1716,RightOfUseAsset,21844000.0,使用權資產,永信,生技醫療業
2019-06-30,1716,RightOfUseAsset_per,0.29,使用權資產,永信,生技醫療業
2019-06-30,1716,OtherNoncurrentAssets,109525000.0,其他非流動資產,永信,生技醫療業
2019-06-30,1716,OtherNoncurrentAssets_per,1.43,其他非流動資產,永信,生技醫療業
2019-06-30,1716,AccountsPayable,371286000.0,應付帳款,永信,生技醫療業
2019-06-30,1716,AccountsPayable_per,4.86,應付帳款,永信,生技醫療業
2019-06-30,1716,OtherCurrentLiabilities,69606000.0,其他流動負債,永信,生技醫療業
2019-06-30,1716,OtherCurrentLiabilities_per,0.91,其他流動負債,永信,生技醫療業
2019-06-30,1716,OtherNoncurrentLiabilities,163233000.0,其他非流動負債,永信,生技醫療業
2019-06-30,1716,OtherNoncurrentLiabilities_per,2.13,其他非流動負債,永信,生技醫療業
2019-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,47916000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2019-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.63,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2019-06-30,1716,InvestmentAccountedForUsingEquityMethod,208540000.0,採用權益法之投資,永信,生技醫療業
2019-06-30,1716,InvestmentAccountedForUsingEquityMethod_per,2.73,採用權益法之投資,永信,生技醫療業
2019-06-30,1716,CurrentTaxLiabilities,117245000.0,本期所得稅負債,永信,生技醫療業
2019-06-30,1716,CurrentTaxLiabilities_per,1.53,本期所得稅負債,永信,生技醫療業
2019-06-30,1716,Liabilities,3599795000.0,負債總額,永信,生技醫療業
2019-06-30,1716,Liabilities_per,47.07,負債總額,永信,生技醫療業
2019-06-30,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit,444221000.0,未分配盈餘,永信,生技醫療業
2019-06-30,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,5.81,未分配盈餘,永信,生技醫療業
2019-06-30,1716,Equity,7647337000.0,權益總計,永信,生技醫療業
2019-06-30,1716,Equity_per,100.0,權益總計,永信,生技醫療業
2019-06-30,1716,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,永信,生技醫療業
2019-12-31,1716,AccountsPayableToRelatedParties,19643000.0,應付帳款－關係人,永信,生技醫療業
2019-12-31,1716,AccountsPayableToRelatedParties_per,0.24,應付帳款－關係人,永信,生技醫療業
2019-12-31,1716,AccountsReceivableDuefromRelatedPartiesNet,91281000.0,應收帳款－關係人淨額,永信,生技醫療業
2019-12-31,1716,AccountsReceivableDuefromRelatedPartiesNet_per,1.13,應收帳款－關係人淨額,永信,生技醫療業
2019-12-31,1716,AccountsReceivableNet,924989000.0,應收帳款淨額,永信,生技醫療業
2019-12-31,1716,AccountsReceivableNet_per,11.44,應收帳款淨額,永信,生技醫療業
2019-12-31,1716,CapitalStock_per,20.91,股本合計,永信,生技醫療業
2019-12-31,1716,CapitalSurplus,530000.0,資本公積合計,永信,生技醫療業
2019-12-31,1716,CapitalSurplus_per,0.01,資本公積合計,永信,生技醫療業
2019-12-31,1716,CashAndCashEquivalents,627290000.0,現金及約當現金,永信,生技醫療業
2019-12-31,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,0.0,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2019-12-31,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.0,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2019-12-31,1716,IntangibleAssets,23502000.0,無形資產,永信,生技醫療業
2019-12-31,1716,IntangibleAssets_per,0.29,無形資產,永信,生技醫療業
2019-12-31,1716,Inventories_per,22.06,存貨,永信,生技醫療業
2019-12-31,1716,LongtermBorrowings,295000000.0,長期借款,永信,生技醫療業
2019-12-31,1716,LongtermBorrowings_per,3.65,長期借款,永信,生技醫療業
2019-12-31,1716,NoncontrollingInterests,3993000.0,非控制權益,永信,生技醫療業
2019-12-31,1716,NoncontrollingInterests_per,0.05,非控制權益,永信,生技醫療業
2019-12-31,1716,OrdinaryShare_per,20.91,普通股股本,永信,生技醫療業
2019-12-31,1716,OtherCurrentLiabilities,70918000.0,其他流動負債,永信,生技醫療業
2019-12-31,1716,OtherCurrentLiabilities_per,0.88,其他流動負債,永信,生技醫療業
2019-12-31,1716,OtherEquityInterest,15062000.0,其他權益合計,永信,生技醫療業
2019-12-31,1716,OtherEquityInterest_per,0.19,其他權益合計,永信,生技醫療業
2019-12-31,1716,OtherPayables,674134000.0,其他應付款,永信,生技醫療業
2019-12-31,1716,OtherReceivable,38551000.0,其他應收款淨額,永信,生技醫療業
2019-12-31,1716,OtherReceivable_per,0.48,其他應收款淨額,永信,生技醫療業
2019-12-31,1716,ShorttermBorrowings,1785000000.0,短期借款,永信,生技醫療業
2019-12-31,1716,ShorttermBorrowings_per,22.07,短期借款,永信,生技醫療業
2019-12-31,1716,TotalAssets_per,100.0,資產總額,永信,生技醫療業
2019-12-31,1716,TotalLiabilitiesEquity_per,100.0,負債及權益總計,永信,生技醫療業
2019-12-31,1716,Inventories,1784055000.0,存貨,永信,生技醫療業
2019-12-31,1716,PropertyPlantAndEquipment,3671055000.0,不動產、廠房及設備,永信,生技醫療業
2019-12-31,1716,CurrentLiabilities,3047198000.0,流動負債合計,永信,生技醫療業
2019-12-31,1716,OrdinaryShare,1691098000.0,普通股股本,永信,生技醫療業
2019-12-31,1716,CapitalStock,1691098000.0,股本合計,永信,生技醫療業
2019-12-31,1716,LegalReserve,1502369000.0,法定盈餘公積,永信,生技醫療業
2019-12-31,1716,RetainedEarnings,2762562000.0,保留盈餘合計,永信,生技醫療業
2019-12-31,1716,EquityAttributableToOwnersOfParent,4469252000.0,歸屬於母公司業主之權益合計,永信,生技醫療業
2019-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome,1958000.0,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2019-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome_per,0.02,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2019-12-31,1716,FinancialAssetsAtAmortizedCost,7000000.0,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2019-12-31,1716,FinancialAssetsAtAmortizedCost_per,0.09,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2019-12-31,1716,BillsReceivableNet,212085000.0,應收票據淨額,永信,生技醫療業
2019-12-31,1716,BillsReceivableNet_per,2.62,應收票據淨額,永信,生技醫療業
2019-12-31,1716,CapitalSurplusDonatedAssetsReceived,530000.0,資本公積－受贈資產,永信,生技醫療業
2019-12-31,1716,CapitalSurplusDonatedAssetsReceived_per,0.01,資本公積－受贈資產,永信,生技醫療業
2019-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,59660000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2019-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.74,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2019-12-31,1716,InvestmentAccountedForUsingEquityMethod,197547000.0,採用權益法之投資,永信,生技醫療業
2019-12-31,1716,InvestmentAccountedForUsingEquityMethod_per,2.44,採用權益法之投資,永信,生技醫療業
2019-12-31,1716,RightOfUseAsset,18336000.0,使用權資產,永信,生技醫療業
2019-12-31,1716,RightOfUseAsset_per,0.23,使用權資產,永信,生技醫療業
2019-12-31,1716,CurrentTaxLiabilities,122177000.0,本期所得稅負債,永信,生技醫療業
2019-12-31,1716,CurrentTaxLiabilities_per,1.51,本期所得稅負債,永信,生技醫療業
2019-12-31,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit,857985000.0,未分配盈餘,永信,生技醫療業
2019-12-31,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,10.61,未分配盈餘,永信,生技醫療業
2019-12-31,1716,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,永信,生技醫療業
2019-12-31,1716,CashAndCashEquivalents_per,7.76,現金及約當現金,永信,生技醫療業
2019-12-31,1716,CurrentAssets,3867230000.0,流動資產合計,永信,生技醫療業
2019-12-31,1716,CurrentAssets_per,47.82,流動資產合計,永信,生技醫療業
2019-12-31,1716,PropertyPlantAndEquipment_per,45.39,不動產、廠房及設備,永信,生技醫療業
2019-12-31,1716,DeferredTaxAssets,62811000.0,遞延所得稅資產,永信,生技醫療業
2019-12-31,1716,DeferredTaxAssets_per,0.78,遞延所得稅資產,永信,生技醫療業
2019-12-31,1716,OtherNoncurrentAssets,171188000.0,其他非流動資產,永信,生技醫療業
2019-12-31,1716,OtherNoncurrentAssets_per,2.12,其他非流動資產,永信,生技醫療業
2019-12-31,1716,NoncurrentAssets,4220351000.0,非流動資產合計,永信,生技醫療業
2019-12-31,1716,NoncurrentAssets_per,52.18,非流動資產合計,永信,生技醫療業
2019-12-31,1716,TotalAssets,8087581000.0,資產總額,永信,生技醫療業
2019-12-31,1716,OtherPayables_per,8.34,其他應付款,永信,生技醫療業
2019-12-31,1716,CurrentLiabilities_per,37.68,流動負債合計,永信,生技醫療業
2019-12-31,1716,OtherNoncurrentLiabilities,152624000.0,其他非流動負債,永信,生技醫療業
2019-12-31,1716,OtherNoncurrentLiabilities_per,1.89,其他非流動負債,永信,生技醫療業
2019-12-31,1716,NoncurrentLiabilities,567138000.0,非流動負債合計,永信,生技醫療業
2019-12-31,1716,NoncurrentLiabilities_per,7.01,非流動負債合計,永信,生技醫療業
2019-12-31,1716,LegalReserve_per,18.58,法定盈餘公積,永信,生技醫療業
2019-12-31,1716,RetainedEarnings_per,34.16,保留盈餘合計,永信,生技醫療業
2019-12-31,1716,EquityAttributableToOwnersOfParent_per,55.26,歸屬於母公司業主之權益合計,永信,生技醫療業
2019-12-31,1716,TotalLiabilitiesEquity,8087581000.0,負債及權益總計,永信,生技醫療業
2019-12-31,1716,OtherCurrentAssets,180021000.0,其他流動資產,永信,生技醫療業
2019-12-31,1716,OtherCurrentAssets_per,2.23,其他流動資產,永信,生技醫療業
2019-12-31,1716,AccountsPayable,358773000.0,應付帳款,永信,生技醫療業
2019-12-31,1716,AccountsPayable_per,4.44,應付帳款,永信,生技醫療業
2019-12-31,1716,Liabilities,3614336000.0,負債總,永信,生技醫療業
2019-12-31,1716,Liabilities_per,44.69,負債總,永信,生技醫療業
2019-12-31,1716,Equity,4473245000.0,權益總額,永信,生技醫療業
2019-12-31,1716,Equity_per,100.0,權益總計,永信,生技醫療業
2020-06-30,1716,AccountsPayable,437498000.0,應付帳款,永信,生技醫療業
2020-06-30,1716,AccountsPayable_per,5.39,應付帳款,永信,生技醫療業
2020-06-30,1716,AccountsPayableToRelatedParties,24896000.0,應付帳款－關係人,永信,生技醫療業
2020-06-30,1716,AccountsPayableToRelatedParties_per,0.31,應付帳款－關係人,永信,生技醫療業
2020-06-30,1716,AccountsReceivableDuefromRelatedPartiesNet,73936000.0,應收帳款－關係人淨額,永信,生技醫療業
2020-06-30,1716,AccountsReceivableDuefromRelatedPartiesNet_per,0.91,應收帳款－關係人淨額,永信,生技醫療業
2020-06-30,1716,AccountsReceivableNet,834338000.0,應收帳款淨額,永信,生技醫療業
2020-06-30,1716,AccountsReceivableNet_per,10.28,應收帳款淨額,永信,生技醫療業
2020-06-30,1716,CapitalStock_per,23.68,股本合計,永信,生技醫療業
2020-06-30,1716,CapitalSurplus,530000.0,資本公積合計,永信,生技醫療業
2020-06-30,1716,CapitalSurplus_per,0.01,資本公積合計,永信,生技醫療業
2020-06-30,1716,CashAndCashEquivalents,550990000.0,現金及約當現金,永信,生技醫療業
2020-06-30,1716,CashAndCashEquivalents_per,6.79,現金及約當現金,永信,生技醫療業
2020-06-30,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,23868000.0,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2020-06-30,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.29,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2020-06-30,1716,CurrentLiabilities_per,39.09,流動負債合計,永信,生技醫療業
2020-06-30,1716,DeferredTaxAssets,68742000.0,遞延所得稅資產,永信,生技醫療業
2020-06-30,1716,DeferredTaxAssets_per,0.85,遞延所得稅資產,永信,生技醫療業
2020-06-30,1716,EquityAttributableToOwnersOfParent_per,54.16,歸屬於母公司業主之權益合計,永信,生技醫療業
2020-06-30,1716,IntangibleAssets,30745000.0,無形資產,永信,生技醫療業
2020-06-30,1716,IntangibleAssets_per,0.38,無形資產,永信,生技醫療業
2020-06-30,1716,Inventories_per,24.05,存貨,永信,生技醫療業
2020-06-30,1716,LegalReserve,1584240000.0,法定盈餘公積,永信,生技醫療業
2020-06-30,1716,LegalReserve_per,19.52,法定盈餘公積,永信,生技醫療業
2020-06-30,1716,LongtermBorrowings,95000000.0,長期借款,永信,生技醫療業
2020-06-30,1716,LongtermBorrowings_per,1.17,長期借款,永信,生技醫療業
2020-06-30,1716,NoncontrollingInterests,4137000.0,非控制權益,永信,生技醫療業
2020-06-30,1716,NoncontrollingInterests_per,0.05,非控制權益,永信,生技醫療業
2020-06-30,1716,NoncurrentLiabilities,543775000.0,非流動負債合計,永信,生技醫療業
2020-06-30,1716,NoncurrentLiabilities_per,6.7,非流動負債合計,永信,生技醫療業
2020-06-30,1716,OrdinaryShare_per,20.84,普通股股本,永信,生技醫療業
2020-06-30,1716,OtherCurrentLiabilities,58336000.0,其他流動負債,永信,生技醫療業
2020-06-30,1716,OtherCurrentLiabilities_per,0.72,其他流動負債,永信,生技醫療業
2020-06-30,1716,OtherEquityInterest,62770000.0,其他權益合計,永信,生技醫療業
2020-06-30,1716,OtherEquityInterest_per,0.77,其他權益合計,永信,生技醫療業
2020-06-30,1716,OtherPayables_per,13.77,其他應付款,永信,生技醫療業
2020-06-30,1716,OtherReceivable,4617000.0,其他應收款淨額,永信,生技醫療業
2020-06-30,1716,OtherReceivable_per,0.06,其他應收款淨額,永信,生技醫療業
2020-06-30,1716,PropertyPlantAndEquipment_per,45.36,不動產、廠房及設備,永信,生技醫療業
2020-06-30,1716,RetainedEarnings_per,29.7,保留盈餘合計,永信,生技醫療業
2020-06-30,1716,ShorttermBorrowings,1380000000.0,短期借款,永信,生技醫療業
2020-06-30,1716,ShorttermBorrowings_per,17.01,短期借款,永信,生技醫療業
2020-06-30,1716,TotalAssets_per,100.0,資產總額,永信,生技醫療業
2020-06-30,1716,TotalLiabilitiesEquity_per,100.0,負債及權益總計,永信,生技醫療業
2020-06-30,1716,Inventories,1951508000.0,存貨,永信,生技醫療業
2020-06-30,1716,PropertyPlantAndEquipment,3680824000.0,不動產、廠房及設備,永信,生技醫療業
2020-06-30,1716,TotalAssets,8114294000.0,資產總額,永信,生技醫療業
2020-06-30,1716,OtherPayables,1117297000.0,其他應付款,永信,生技醫療業
2020-06-30,1716,CurrentLiabilities,3171654000.0,流動負債合計,永信,生技醫療業
2020-06-30,1716,OrdinaryShare,1691098000.0,普通股股本,永信,生技醫療業
2020-06-30,1716,CapitalStock,1921087000.0,股本合計,永信,生技醫療業
2020-06-30,1716,RetainedEarnings,2410341000.0,保留盈餘合計,永信,生技醫療業
2020-06-30,1716,EquityAttributableToOwnersOfParent,4394728000.0,歸屬於母公司業主之權益合計,永信,生技醫療業
2020-06-30,1716,TotalLiabilitiesEquity,8114294000.0,負債及權益總計,永信,生技醫療業
2020-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome,1958000.0,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2020-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome_per,0.02,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2020-06-30,1716,FinancialAssetsAtAmortizedCost,7000000.0,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2020-06-30,1716,FinancialAssetsAtAmortizedCost_per,0.09,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2020-06-30,1716,BillsReceivableNet,243660000.0,應收票據淨額,永信,生技醫療業
2020-06-30,1716,BillsReceivableNet_per,3.0,應收票據淨額,永信,生技醫療業
2020-06-30,1716,OtherCurrentAssets,136929000.0,其他流動資產,永信,生技醫療業
2020-06-30,1716,OtherCurrentAssets_per,1.69,其他流動資產,永信,生技醫療業
2020-06-30,1716,CurrentAssets,3828804000.0,流動資產合計,永信,生技醫療業
2020-06-30,1716,CurrentAssets_per,47.19,流動資產合計,永信,生技醫療業
2020-06-30,1716,OtherNoncurrentAssets,168123000.0,其他非流動資產,永信,生技醫療業
2020-06-30,1716,OtherNoncurrentAssets_per,2.07,其他非流動資產,永信,生技醫療業
2020-06-30,1716,NoncurrentAssets,4285490000.0,非流動資產合計,永信,生技醫療業
2020-06-30,1716,NoncurrentAssets_per,52.81,非流動資產合計,永信,生技醫療業
2020-06-30,1716,OtherNoncurrentLiabilities,96489000.0,其他非流動負債,永信,生技醫療業
2020-06-30,1716,OtherNoncurrentLiabilities_per,1.19,其他非流動負債,永信,生技醫療業
2020-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,107368000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2020-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,1.32,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2020-06-30,1716,InvestmentAccountedForUsingEquityMethod,199218000.0,採用權益法之投資,永信,生技醫療業
2020-06-30,1716,InvestmentAccountedForUsingEquityMethod_per,2.46,採用權益法之投資,永信,生技醫療業
2020-06-30,1716,RightOfUseAsset,14468000.0,使用權資產,永信,生技醫療業
2020-06-30,1716,RightOfUseAsset_per,0.18,使用權資產,永信,生技醫療業
2020-06-30,1716,CurrentTaxLiabilities,135224000.0,本期所得稅負債,永信,生技醫療業
2020-06-30,1716,CurrentTaxLiabilities_per,1.67,本期所得稅負債,永信,生技醫療業
2020-06-30,1716,Liabilities,3715429000.0,負債總額,永信,生技醫療業
2020-06-30,1716,Liabilities_per,45.79,負債總額,永信,生技醫療業
2020-06-30,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit,423893000.0,未分配盈餘,永信,生技醫療業
2020-06-30,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,5.22,未分配盈餘,永信,生技醫療業
2020-06-30,1716,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,永信,生技醫療業
2020-06-30,1716,Equity,4398865000.0,權益總額,永信,生技醫療業
2020-06-30,1716,Equity_per,54.21,權益總額,永信,生技醫療業
2020-12-31,1716,CashAndCashEquivalents,873424000.0,現金及約當現金,永信,生技醫療業
2020-12-31,1716,CashAndCashEquivalents_per,12.87,現金及約當現金,永信,生技醫療業
2020-12-31,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,23868000.0,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2020-12-31,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.35,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2020-12-31,1716,AccountsReceivableNet,684499000.0,應收帳款淨額,永信,生技醫療業
2020-12-31,1716,AccountsReceivableNet_per,10.09,應收帳款淨額,永信,生技醫療業
2020-12-31,1716,AccountsReceivableDuefromRelatedPartiesNet,134491000.0,應收帳款－關係人淨額,永信,生技醫療業
2020-12-31,1716,AccountsReceivableDuefromRelatedPartiesNet_per,1.98,應收帳款－關係人淨額,永信,生技醫療業
2020-12-31,1716,Inventories,1851148000.0,存貨,永信,生技醫療業
2020-12-31,1716,Inventories_per,27.27,存貨,永信,生技醫療業
2020-12-31,1716,OtherCurrentAssets,102949000.0,其他流動資產,永信,生技醫療業
2020-12-31,1716,OtherCurrentAssets_per,1.52,其他流動資產,永信,生技醫療業
2020-12-31,1716,CurrentAssets,3843309000.0,流動資產合計,永信,生技醫療業
2020-12-31,1716,CurrentAssets_per,56.63,流動資產合計,永信,生技醫療業
2020-12-31,1716,PropertyPlantAndEquipment,2396972000.0,不動產、廠房及設備,永信,生技醫療業
2020-12-31,1716,PropertyPlantAndEquipment_per,35.32,不動產、廠房及設備,永信,生技醫療業
2020-12-31,1716,IntangibleAssets,57935000.0,無形資產,永信,生技醫療業
2020-12-31,1716,IntangibleAssets_per,0.85,無形資產,永信,生技醫療業
2020-12-31,1716,DeferredTaxAssets,77206000.0,遞延所得稅資產,永信,生技醫療業
2020-12-31,1716,DeferredTaxAssets_per,1.14,遞延所得稅資產,永信,生技醫療業
2020-12-31,1716,OtherNoncurrentAssets,93565000.0,其他非流動資產,永信,生技醫療業
2020-12-31,1716,OtherNoncurrentAssets_per,1.38,其他非流動資產,永信,生技醫療業
2020-12-31,1716,NoncurrentAssets,2943687000.0,非流動資產合計,永信,生技醫療業
2020-12-31,1716,NoncurrentAssets_per,43.37,非流動資產合計,永信,生技醫療業
2020-12-31,1716,TotalAssets,6786996000.0,資產總額,永信,生技醫療業
2020-12-31,1716,TotalAssets_per,100.0,資產總額,永信,生技醫療業
2020-12-31,1716,ShorttermBorrowings,1450000000.0,短期借款,永信,生技醫療業
2020-12-31,1716,ShorttermBorrowings_per,21.36,短期借款,永信,生技醫療業
2020-12-31,1716,AccountsPayable,384069000.0,應付帳款,永信,生技醫療業
2020-12-31,1716,AccountsPayable_per,5.66,應付帳款,永信,生技醫療業
2020-12-31,1716,AccountsPayableToRelatedParties,15420000.0,應付帳款－關係人,永信,生技醫療業
2020-12-31,1716,AccountsPayableToRelatedParties_per,0.23,應付帳款－關係人,永信,生技醫療業
2020-12-31,1716,OtherPayables,604079000.0,其他應付款,永信,生技醫療業
2020-12-31,1716,OtherPayables_per,8.9,其他應付款,永信,生技醫療業
2020-12-31,1716,OtherCurrentLiabilities,50622000.0,其他流動負債,永信,生技醫療業
2020-12-31,1716,OtherCurrentLiabilities_per,0.75,其他流動負債,永信,生技醫療業
2020-12-31,1716,CurrentLiabilities,2622088000.0,流動負債合計,永信,生技醫療業
2020-12-31,1716,CurrentLiabilities_per,38.63,流動負債合計,永信,生技醫療業
2020-12-31,1716,LongtermBorrowings,300000000.0,長期借款,永信,生技醫療業
2020-12-31,1716,LongtermBorrowings_per,4.42,長期借款,永信,生技醫療業
2020-12-31,1716,OtherNoncurrentLiabilities,105047000.0,其他非流動負債,永信,生技醫療業
2020-12-31,1716,OtherNoncurrentLiabilities_per,1.55,其他非流動負債,永信,生技醫療業
2020-12-31,1716,NoncurrentLiabilities,738454000.0,非流動負債合計,永信,生技醫療業
2020-12-31,1716,NoncurrentLiabilities_per,10.88,非流動負債合計,永信,生技醫療業
2020-12-31,1716,OrdinaryShare,666484000.0,普通股股本,永信,生技醫療業
2020-12-31,1716,OrdinaryShare_per,9.82,普通股股本,永信,生技醫療業
2020-12-31,1716,CapitalStock,666484000.0,股本合計,永信,生技醫療業
2020-12-31,1716,CapitalStock_per,9.82,股本合計,永信,生技醫療業
2020-12-31,1716,CapitalSurplus,530000.0,資本公積合計,永信,生技醫療業
2020-12-31,1716,CapitalSurplus_per,0.01,資本公積合計,永信,生技醫療業
2020-12-31,1716,LegalReserve,1584240000.0,法定盈餘公積,永信,生技醫療業
2020-12-31,1716,LegalReserve_per,23.34,法定盈餘公積,永信,生技醫療業
2020-12-31,1716,RetainedEarnings,2753180000.0,保留盈餘合計,永信,生技醫療業
2020-12-31,1716,RetainedEarnings_per,40.57,保留盈餘合計,永信,生技醫療業
2020-12-31,1716,OtherEquityInterest,2789000.0,其他權益合計,永信,生技醫療業
2020-12-31,1716,OtherEquityInterest_per,0.04,其他權益合計,永信,生技醫療業
2020-12-31,1716,EquityAttributableToOwnersOfParent,3422983000.0,歸屬於母公司業主之權益合計,永信,生技醫療業
2020-12-31,1716,EquityAttributableToOwnersOfParent_per,50.43,歸屬於母公司業主之權益合計,永信,生技醫療業
2020-12-31,1716,NoncontrollingInterests,3471000.0,非控制權益,永信,生技醫療業
2020-12-31,1716,NoncontrollingInterests_per,0.05,非控制權益,永信,生技醫療業
2020-12-31,1716,TotalLiabilitiesEquity,6786996000.0,負債及權益總計,永信,生技醫療業
2020-12-31,1716,TotalLiabilitiesEquity_per,100.0,負債及權益總計,永信,生技醫療業
2020-12-31,1716,OtherReceivable,11964000.0,其他應收款淨額,永信,生技醫療業
2020-12-31,1716,OtherReceivable_per,0.18,其他應收款淨額,永信,生技醫療業
2020-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome,1958000.0,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2020-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome_per,0.03,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2020-12-31,1716,FinancialAssetsAtAmortizedCost,2000000.0,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2020-12-31,1716,FinancialAssetsAtAmortizedCost_per,0.03,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2020-12-31,1716,BillsReceivableNet,157008000.0,應收票據淨額,永信,生技醫療業
2020-12-31,1716,BillsReceivableNet_per,2.31,應收票據淨額,永信,生技醫療業
2020-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,42809000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2020-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.63,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2020-12-31,1716,InvestmentAccountedForUsingEquityMethod,195451000.0,採用權益法之投資,永信,生技醫療業
2020-12-31,1716,InvestmentAccountedForUsingEquityMethod_per,2.88,採用權益法之投資,永信,生技醫療業
2020-12-31,1716,RightOfUseAsset,11505000.0,使用權資產,永信,生技醫療業
2020-12-31,1716,RightOfUseAsset_per,0.17,使用權資產,永信,生技醫療業
2020-12-31,1716,CurrentTaxLiabilities,104448000.0,本期所得稅負債,永信,生技醫療業
2020-12-31,1716,CurrentTaxLiabilities_per,1.54,本期所得稅負債,永信,生技醫療業
2020-12-31,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit,766732000.0,未分配盈餘,永信,生技醫療業
2020-12-31,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,11.3,未分配盈餘,永信,生技醫療業
2020-12-31,1716,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,永信,生技醫療業
2020-12-31,1716,Equity,3426454000.0,權益總額,永信,生技醫療業
2020-12-31,1716,Equity_per,50.49,權益總額,永信,生技醫療業
2020-12-31,1716,Liabilities,3360542000.0,負債總額,永信,生技醫療業
2020-12-31,1716,Liabilities_per,49.51,負債總額,永信,生技醫療業
2021-06-30,1716,CashAndCashEquivalents,622571000.0,現金及約當現金,永信,生技醫療業
2021-06-30,1716,CashAndCashEquivalents_per,9.57,現金及約當現金,永信,生技醫療業
2021-06-30,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,63482000.0,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2021-06-30,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,0.98,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2021-06-30,1716,AccountsReceivableNet,691933000.0,應收帳款淨額,永信,生技醫療業
2021-06-30,1716,AccountsReceivableNet_per,10.64,應收帳款淨額,永信,生技醫療業
2021-06-30,1716,AccountsReceivableDuefromRelatedPartiesNet,105736000.0,應收帳款－關係人淨額,永信,生技醫療業
2021-06-30,1716,AccountsReceivableDuefromRelatedPartiesNet_per,1.63,應收帳款－關係人淨額,永信,生技醫療業
2021-06-30,1716,Inventories,2068729000.0,存貨,永信,生技醫療業
2021-06-30,1716,Inventories_per,31.81,存貨,永信,生技醫療業
2021-06-30,1716,OtherCurrentAssets,145946000.0,其他流動資產,永信,生技醫療業
2021-06-30,1716,OtherCurrentAssets_per,2.24,其他流動資產,永信,生技醫療業
2021-06-30,1716,CurrentAssets,3849045000.0,流動資產合計,永信,生技醫療業
2021-06-30,1716,CurrentAssets_per,59.18,流動資產合計,永信,生技醫療業
2021-06-30,1716,PropertyPlantAndEquipment,2339875000.0,不動產、廠房及設備,永信,生技醫療業
2021-06-30,1716,PropertyPlantAndEquipment_per,35.97,不動產、廠房及設備,永信,生技醫療業
2021-06-30,1716,IntangibleAssets,48503000.0,無形資產,永信,生技醫療業
2021-06-30,1716,IntangibleAssets_per,0.75,無形資產,永信,生技醫療業
2021-06-30,1716,DeferredTaxAssets,74306000.0,遞延所得稅資產,永信,生技醫療業
2021-06-30,1716,DeferredTaxAssets_per,1.14,遞延所得稅資產,永信,生技醫療業
2021-06-30,1716,OtherNoncurrentAssets,67063000.0,其他非流動資產,永信,生技醫療業
2021-06-30,1716,OtherNoncurrentAssets_per,1.03,其他非流動資產,永信,生技醫療業
2021-06-30,1716,NoncurrentAssets,2655284000.0,非流動資產合計,永信,生技醫療業
2021-06-30,1716,NoncurrentAssets_per,40.82,非流動資產合計,永信,生技醫療業
2021-06-30,1716,TotalAssets,6504329000.0,資產總額,永信,生技醫療業
2021-06-30,1716,TotalAssets_per,100.0,資產總額,永信,生技醫療業
2021-06-30,1716,ShorttermBorrowings,1250000000.0,短期借款,永信,生技醫療業
2021-06-30,1716,ShorttermBorrowings_per,19.22,短期借款,永信,生技醫療業
2021-06-30,1716,AccountsPayable,409794000.0,應付帳款,永信,生技醫療業
2021-06-30,1716,AccountsPayable_per,6.3,應付帳款,永信,生技醫療業
2021-06-30,1716,AccountsPayableToRelatedParties,19213000.0,應付帳款－關係人,永信,生技醫療業
2021-06-30,1716,AccountsPayableToRelatedParties_per,0.3,應付帳款－關係人,永信,生技醫療業
2021-06-30,1716,OtherPayables,1016819000.0,其他應付款,永信,生技醫療業
2021-06-30,1716,OtherPayables_per,15.63,其他應付款,永信,生技醫療業
2021-06-30,1716,OtherCurrentLiabilities,37335000.0,其他流動負債,永信,生技醫療業
2021-06-30,1716,OtherCurrentLiabilities_per,0.57,其他流動負債,永信,生技醫療業
2021-06-30,1716,CurrentLiabilities,2852577000.0,流動負債合計,永信,生技醫療業
2021-06-30,1716,CurrentLiabilities_per,43.86,流動負債合計,永信,生技醫療業
2021-06-30,1716,LongtermBorrowings,0.0,長期借款,永信,生技醫療業
2021-06-30,1716,LongtermBorrowings_per,0.0,長期借款,永信,生技醫療業
2021-06-30,1716,OtherNoncurrentLiabilities,86472000.0,其他非流動負債,永信,生技醫療業
2021-06-30,1716,OtherNoncurrentLiabilities_per,1.33,其他非流動負債,永信,生技醫療業
2021-06-30,1716,NoncurrentLiabilities,424973000.0,非流動負債合計,永信,生技醫療業
2021-06-30,1716,NoncurrentLiabilities_per,6.53,非流動負債合計,永信,生技醫療業
2021-06-30,1716,OrdinaryShare,666484000.0,普通股股本,永信,生技醫療業
2021-06-30,1716,OrdinaryShare_per,10.25,普通股股本,永信,生技醫療業
2021-06-30,1716,CapitalStock,833772000.0,股本合計,永信,生技醫療業
2021-06-30,1716,CapitalStock_per,12.82,股本合計,永信,生技醫療業
2021-06-30,1716,CapitalSurplus,530000.0,資本公積合計,永信,生技醫療業
2021-06-30,1716,CapitalSurplus_per,0.01,資本公積合計,永信,生技醫療業
2021-06-30,1716,LegalReserve,1657203000.0,法定盈餘公積,永信,生技醫療業
2021-06-30,1716,LegalReserve_per,25.48,法定盈餘公積,永信,生技醫療業
2021-06-30,1716,RetainedEarnings,2384046000.0,保留盈餘合計,永信,生技醫療業
2021-06-30,1716,RetainedEarnings_per,36.65,保留盈餘合計,永信,生技醫療業
2021-06-30,1716,OtherEquityInterest,4790000.0,其他權益合計,永信,生技醫療業
2021-06-30,1716,OtherEquityInterest_per,0.07,其他權益合計,永信,生技醫療業
2021-06-30,1716,EquityAttributableToOwnersOfParent,3223138000.0,歸屬於母公司業主之權益合計,永信,生技醫療業
2021-06-30,1716,EquityAttributableToOwnersOfParent_per,49.55,歸屬於母公司業主之權益合計,永信,生技醫療業
2021-06-30,1716,NoncontrollingInterests,3641000.0,非控制權益,永信,生技醫療業
2021-06-30,1716,NoncontrollingInterests_per,0.06,非控制權益,永信,生技醫療業
2021-06-30,1716,TotalLiabilitiesEquity,6504329000.0,負債及權益總計,永信,生技醫療業
2021-06-30,1716,TotalLiabilitiesEquity_per,100.0,負債及權益總計,永信,生技醫療業
2021-06-30,1716,OtherReceivable,3556000.0,其他應收款淨額,永信,生技醫療業
2021-06-30,1716,OtherReceivable_per,0.05,其他應收款淨額,永信,生技醫療業
2021-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome,1958000.0,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2021-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome_per,0.03,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2021-06-30,1716,FinancialAssetsAtAmortizedCost,2000000.0,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2021-06-30,1716,FinancialAssetsAtAmortizedCost_per,0.03,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2021-06-30,1716,BillsReceivableNet,143134000.0,應收票據淨額,永信,生技醫療業
2021-06-30,1716,BillsReceivableNet_per,2.2,應收票據淨額,永信,生技醫療業
2021-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,44810000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2021-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.69,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2021-06-30,1716,InvestmentAccountedForUsingEquityMethod,3563000.0,採用權益法之投資,永信,生技醫療業
2021-06-30,1716,InvestmentAccountedForUsingEquityMethod_per,0.05,採用權益法之投資,永信,生技醫療業
2021-06-30,1716,RightOfUseAsset,9478000.0,使用權資產,永信,生技醫療業
2021-06-30,1716,RightOfUseAsset_per,0.15,使用權資產,永信,生技醫療業
2021-06-30,1716,CurrentTaxLiabilities,103219000.0,本期所得稅負債,永信,生技醫療業
2021-06-30,1716,CurrentTaxLiabilities_per,1.59,本期所得稅負債,永信,生技醫療業
2021-06-30,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit,324635000.0,未分配盈餘,永信,生技醫療業
2021-06-30,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,4.99,未分配盈餘,永信,生技醫療業
2021-06-30,1716,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,永信,生技醫療業
2021-06-30,1716,Equity,3226779000.0,權益總額,永信,生技醫療業
2021-06-30,1716,Equity_per,49.61,權益總額,永信,生技醫療業
2021-06-30,1716,Liabilities,3277550000.0,負債總額,永信,生技醫療業
2021-06-30,1716,Liabilities_per,50.39,負債總額,永信,生技醫療業
2021-12-31,1716,CashAndCashEquivalents,436601000.0,現金及約當現金,永信,生技醫療業
2021-12-31,1716,CashAndCashEquivalents_per,6.9,現金及約當現金,永信,生技醫療業
2021-12-31,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,63482000.0,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2021-12-31,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.0,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2021-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome,1958000.0,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2021-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome_per,0.03,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2021-12-31,1716,FinancialAssetsAtAmortizedCost,2000000.0,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2021-12-31,1716,FinancialAssetsAtAmortizedCost_per,0.03,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2021-12-31,1716,BillsReceivableNet,173129000.0,應收票據淨額,永信,生技醫療業
2021-12-31,1716,BillsReceivableNet_per,2.74,應收票據淨額,永信,生技醫療業
2021-12-31,1716,OtherReceivable,8433000.0,其他應收款淨額,永信,生技醫療業
2021-12-31,1716,OtherReceivable_per,0.13,其他應收款淨額,永信,生技醫療業
2021-12-31,1716,AccountsReceivableNet,712684000.0,應收帳款淨額,永信,生技醫療業
2021-12-31,1716,AccountsReceivableNet_per,11.27,應收帳款淨額,永信,生技醫療業
2021-12-31,1716,AccountsReceivableDuefromRelatedPartiesNet,108520000.0,應收帳款－關係人淨額,永信,生技醫療業
2021-12-31,1716,AccountsReceivableDuefromRelatedPartiesNet_per,1.72,應收帳款－關係人淨額,永信,生技醫療業
2021-12-31,1716,Inventories,2115684000.0,存貨,永信,生技醫療業
2021-12-31,1716,Inventories_per,33.44,存貨,永信,生技醫療業
2021-12-31,1716,OtherCurrentAssets,101644000.0,其他流動資產,永信,生技醫療業
2021-12-31,1716,OtherCurrentAssets_per,1.61,其他流動資產,永信,生技醫療業
2021-12-31,1716,CurrentAssets,3724135000.0,流動資產合計,永信,生技醫療業
2021-12-31,1716,CurrentAssets_per,58.87,流動資產合計,永信,生技醫療業
2021-12-31,1716,PropertyPlantAndEquipment,2277854000.0,不動產、廠房及設備,永信,生技醫療業
2021-12-31,1716,PropertyPlantAndEquipment_per,36.01,不動產、廠房及設備,永信,生技醫療業
2021-12-31,1716,IntangibleAssets,38421000.0,無形資產,永信,生技醫療業
2021-12-31,1716,IntangibleAssets_per,0.61,無形資產,永信,生技醫療業
2021-12-31,1716,DeferredTaxAssets,75867000.0,遞延所得稅資產,永信,生技醫療業
2021-12-31,1716,DeferredTaxAssets_per,1.2,遞延所得稅資產,永信,生技醫療業
2021-12-31,1716,OtherNoncurrentAssets,93963000.0,其他非流動資產,永信,生技醫療業
2021-12-31,1716,OtherNoncurrentAssets_per,1.49,其他非流動資產,永信,生技醫療業
2021-12-31,1716,NoncurrentAssets,2602216000.0,非流動資產合計,永信,生技醫療業
2021-12-31,1716,NoncurrentAssets_per,41.13,非流動資產合計,永信,生技醫療業
2021-12-31,1716,TotalAssets,6326351000.0,資產總額,永信,生技醫療業
2021-12-31,1716,TotalAssets_per,100.0,資產總額,永信,生技醫療業
2021-12-31,1716,ShorttermBorrowings,1200000000.0,短期借款,永信,生技醫療業
2021-12-31,1716,ShorttermBorrowings_per,18.97,短期借款,永信,生技醫療業
2021-12-31,1716,AccountsPayable,316078000.0,應付帳款,永信,生技醫療業
2021-12-31,1716,AccountsPayable_per,5.0,應付帳款,永信,生技醫療業
2021-12-31,1716,AccountsPayableToRelatedParties,31629000.0,應付帳款－關係人,永信,生技醫療業
2021-12-31,1716,AccountsPayableToRelatedParties_per,0.5,應付帳款－關係人,永信,生技醫療業
2021-12-31,1716,OtherPayables,518496000.0,其他應付款,永信,生技醫療業
2021-12-31,1716,OtherPayables_per,8.2,其他應付款,永信,生技醫療業
2021-12-31,1716,OtherCurrentLiabilities,49781000.0,其他流動負債,永信,生技醫療業
2021-12-31,1716,OtherCurrentLiabilities_per,0.79,其他流動負債,永信,生技醫療業
2021-12-31,1716,CurrentLiabilities,2224839000.0,流動負債合計,永信,生技醫療業
2021-12-31,1716,CurrentLiabilities_per,35.17,流動負債合計,永信,生技醫療業
2021-12-31,1716,LongtermBorrowings,87000000.0,長期借款,永信,生技醫療業
2021-12-31,1716,LongtermBorrowings_per,1.38,長期借款,永信,生技醫療業
2021-12-31,1716,OtherNoncurrentLiabilities,58986000.0,其他非流動負債,永信,生技醫療業
2021-12-31,1716,OtherNoncurrentLiabilities_per,0.93,其他非流動負債,永信,生技醫療業
2021-12-31,1716,NoncurrentLiabilities,584519000.0,非流動負債合計,永信,生技醫療業
2021-12-31,1716,NoncurrentLiabilities_per,9.24,非流動負債合計,永信,生技醫療業
2021-12-31,1716,OrdinaryShare,833772000.0,普通股股本,永信,生技醫療業
2021-12-31,1716,OrdinaryShare_per,13.18,普通股股本,永信,生技醫療業
2021-12-31,1716,CapitalStock,833772000.0,股本合計,永信,生技醫療業
2021-12-31,1716,CapitalStock_per,13.18,股本合計,永信,生技醫療業
2021-12-31,1716,CapitalSurplus,530000.0,資本公積合計,永信,生技醫療業
2021-12-31,1716,CapitalSurplus_per,0.01,資本公積合計,永信,生技醫療業
2021-12-31,1716,LegalReserve,1657203000.0,法定盈餘公積,永信,生技醫療業
2021-12-31,1716,LegalReserve_per,26.2,法定盈餘公積,永信,生技醫療業
2021-12-31,1716,RetainedEarnings,2677925000.0,保留盈餘合計,永信,生技醫療業
2021-12-31,1716,RetainedEarnings_per,42.33,保留盈餘合計,永信,生技醫療業
2021-12-31,1716,OtherEquityInterest,1579000.0,其他權益合計,永信,生技醫療業
2021-12-31,1716,OtherEquityInterest_per,0.02,其他權益合計,永信,生技醫療業
2021-12-31,1716,EquityAttributableToOwnersOfParent,3513806000.0,歸屬於母公司業主之權益合計,永信,生技醫療業
2021-12-31,1716,EquityAttributableToOwnersOfParent_per,55.54,歸屬於母公司業主之權益合計,永信,生技醫療業
2021-12-31,1716,NoncontrollingInterests,3187000.0,非控制權益,永信,生技醫療業
2021-12-31,1716,NoncontrollingInterests_per,0.05,非控制權益,永信,生技醫療業
2021-12-31,1716,TotalLiabilitiesEquity,6326351000.0,負債及權益總計,永信,生技醫療業
2021-12-31,1716,TotalLiabilitiesEquity_per,100.0,負債及權益總計,永信,生技醫療業
2021-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,41599000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2021-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.66,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2021-12-31,1716,InvestmentAccountedForUsingEquityMethod,0.0,採用權益法之投資,永信,生技醫療業
2021-12-31,1716,InvestmentAccountedForUsingEquityMethod_per,0.0,採用權益法之投資,永信,生技醫療業
2021-12-31,1716,RightOfUseAsset,7200000.0,使用權資產,永信,生技醫療業
2021-12-31,1716,RightOfUseAsset_per,0.11,使用權資產,永信,生技醫療業
2021-12-31,1716,CurrentTaxLiabilities,94963000.0,本期所得稅負債,永信,生技醫療業
2021-12-31,1716,CurrentTaxLiabilities_per,1.5,本期所得稅負債,永信,生技醫療業
2021-12-31,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit,618514000.0,未分配盈餘,永信,生技醫療業
2021-12-31,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,9.78,未分配盈餘,永信,生技醫療業
2021-12-31,1716,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,永信,生技醫療業
2021-12-31,1716,Liabilities,2809358000.0,負債總額,永信,生技醫療業
2021-12-31,1716,Liabilities_per,44.41,負債總額,永信,生技醫療業
2021-12-31,1716,Equity,3516993000.0,權益總額,永信,生技醫療業
2021-12-31,1716,Equity_per,55.59,權益總額,永信,生技醫療業
2022-06-30,1716,CashAndCashEquivalents,332311000.0,現金及約當現金,永信,生技醫療業
2022-06-30,1716,CashAndCashEquivalents_per,5.4,現金及約當現金,永信,生技醫療業
2022-06-30,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,63482000.0,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2022-06-30,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.03,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2022-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome,1958000.0,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2022-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome_per,0.03,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2022-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,44763000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2022-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.73,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2022-06-30,1716,FinancialAssetsAtAmortizedCost,2000000.0,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2022-06-30,1716,FinancialAssetsAtAmortizedCost_per,0.03,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2022-06-30,1716,BillsReceivableNet,149423000.0,應收票據淨額,永信,生技醫療業
2022-06-30,1716,BillsReceivableNet_per,2.43,應收票據淨額,永信,生技醫療業
2022-06-30,1716,OtherReceivable,3466000.0,其他應收款淨額,永信,生技醫療業
2022-06-30,1716,OtherReceivable_per,0.06,其他應收款淨額,永信,生技醫療業
2022-06-30,1716,AccountsReceivableNet,755414000.0,應收帳款淨額,永信,生技醫療業
2022-06-30,1716,AccountsReceivableNet_per,12.27,應收帳款淨額,永信,生技醫療業
2022-06-30,1716,AccountsReceivableDuefromRelatedPartiesNet,128577000.0,應收帳款－關係人淨額,永信,生技醫療業
2022-06-30,1716,AccountsReceivableDuefromRelatedPartiesNet_per,2.09,應收帳款－關係人淨額,永信,生技醫療業
2022-06-30,1716,Inventories,2028816000.0,存貨,永信,生技醫療業
2022-06-30,1716,Inventories_per,32.95,存貨,永信,生技醫療業
2022-06-30,1716,OtherCurrentAssets,141711000.0,其他流動資產,永信,生技醫療業
2022-06-30,1716,OtherCurrentAssets_per,2.3,其他流動資產,永信,生技醫療業
2022-06-30,1716,CurrentAssets,3607158000.0,流動資產合計,永信,生技醫療業
2022-06-30,1716,CurrentAssets_per,58.58,流動資產合計,永信,生技醫療業
2022-06-30,1716,PropertyPlantAndEquipment,2247887000.0,不動產、廠房及設備,永信,生技醫療業
2022-06-30,1716,PropertyPlantAndEquipment_per,36.51,不動產、廠房及設備,永信,生技醫療業
2022-06-30,1716,RightOfUseAsset,7855000.0,使用權資產,永信,生技醫療業
2022-06-30,1716,RightOfUseAsset_per,0.13,使用權資產,永信,生技醫療業
2022-06-30,1716,IntangibleAssets,28424000.0,無形資產,永信,生技醫療業
2022-06-30,1716,IntangibleAssets_per,0.46,無形資產,永信,生技醫療業
2022-06-30,1716,DeferredTaxAssets,75466000.0,遞延所得稅資產,永信,生技醫療業
2022-06-30,1716,DeferredTaxAssets_per,1.23,遞延所得稅資產,永信,生技醫療業
2022-06-30,1716,OtherNoncurrentAssets,79135000.0,其他非流動資產,永信,生技醫療業
2022-06-30,1716,OtherNoncurrentAssets_per,1.29,其他非流動資產,永信,生技醫療業
2022-06-30,1716,NoncurrentAssets,2550306000.0,非流動資產合計,永信,生技醫療業
2022-06-30,1716,NoncurrentAssets_per,41.42,非流動資產合計,永信,生技醫療業
2022-06-30,1716,TotalAssets,6157464000.0,資產總額,永信,生技醫療業
2022-06-30,1716,TotalAssets_per,100.0,資產總額,永信,生技醫療業
2022-06-30,1716,ShorttermBorrowings,1150000000.0,短期借款,永信,生技醫療業
2022-06-30,1716,ShorttermBorrowings_per,18.68,短期借款,永信,生技醫療業
2022-06-30,1716,AccountsPayable,349860000.0,應付帳款,永信,生技醫療業
2022-06-30,1716,AccountsPayable_per,5.68,應付帳款,永信,生技醫療業
2022-06-30,1716,AccountsPayableToRelatedParties,29471000.0,應付帳款－關係人,永信,生技醫療業
2022-06-30,1716,AccountsPayableToRelatedParties_per,0.48,應付帳款－關係人,永信,生技醫療業
2022-06-30,1716,OtherPayables,508418000.0,其他應付款,永信,生技醫療業
2022-06-30,1716,OtherPayables_per,8.26,其他應付款,永信,生技醫療業
2022-06-30,1716,CurrentTaxLiabilities,86862000.0,本期所得稅負債,永信,生技醫療業
2022-06-30,1716,CurrentTaxLiabilities_per,1.41,本期所得稅負債,永信,生技醫療業
2022-06-30,1716,OtherCurrentLiabilities,44338000.0,其他流動負債,永信,生技醫療業
2022-06-30,1716,OtherCurrentLiabilities_per,0.72,其他流動負債,永信,生技醫療業
2022-06-30,1716,CurrentLiabilities,2183902000.0,流動負債合計,永信,生技醫療業
2022-06-30,1716,CurrentLiabilities_per,35.47,流動負債合計,永信,生技醫療業
2022-06-30,1716,LongtermBorrowings,87000000.0,長期借款,永信,生技醫療業
2022-06-30,1716,LongtermBorrowings_per,1.41,長期借款,永信,生技醫療業
2022-06-30,1716,OtherNoncurrentLiabilities,45782000.0,其他非流動負債,永信,生技醫療業
2022-06-30,1716,OtherNoncurrentLiabilities_per,0.74,其他非流動負債,永信,生技醫療業
2022-06-30,1716,NoncurrentLiabilities,576586000.0,非流動負債合計,永信,生技醫療業
2022-06-30,1716,NoncurrentLiabilities_per,9.36,非流動負債合計,永信,生技醫療業
2022-06-30,1716,OrdinaryShare,833772000.0,普通股股本,永信,生技醫療業
2022-06-30,1716,OrdinaryShare_per,13.54,普通股股本,永信,生技醫療業
2022-06-30,1716,CapitalStock,930489000.0,股本合計,永信,生技醫療業
2022-06-30,1716,CapitalStock_per,15.11,股本合計,永信,生技醫療業
2022-06-30,1716,CapitalSurplus,530000.0,資本公積合計,永信,生技醫療業
2022-06-30,1716,CapitalSurplus_per,0.01,資本公積合計,永信,生技醫療業
2022-06-30,1716,LegalReserve,1715393000.0,法定盈餘公積,永信,生技醫療業
2022-06-30,1716,LegalReserve_per,27.86,法定盈餘公積,永信,生技醫療業
2022-06-30,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit,340220000.0,未分配盈餘,永信,生技醫療業
2022-06-30,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,5.53,未分配盈餘,永信,生技醫療業
2022-06-30,1716,RetainedEarnings,2457821000.0,保留盈餘合計,永信,生技醫療業
2022-06-30,1716,RetainedEarnings_per,39.92,保留盈餘合計,永信,生技醫療業
2022-06-30,1716,OtherEquityInterest,4743000.0,其他權益合計,永信,生技醫療業
2022-06-30,1716,OtherEquityInterest_per,0.08,其他權益合計,永信,生技醫療業
2022-06-30,1716,EquityAttributableToOwnersOfParent,3393583000.0,歸屬於母公司業主之權益合計,永信,生技醫療業
2022-06-30,1716,EquityAttributableToOwnersOfParent_per,55.11,歸屬於母公司業主之權益合計,永信,生技醫療業
2022-06-30,1716,NoncontrollingInterests,3393000.0,非控制權益,永信,生技醫療業
2022-06-30,1716,NoncontrollingInterests_per,0.06,非控制權益,永信,生技醫療業
2022-06-30,1716,TotalLiabilitiesEquity,6157464000.0,負債及權益總計,永信,生技醫療業
2022-06-30,1716,TotalLiabilitiesEquity_per,100.0,負債及權益總計,永信,生技醫療業
2022-06-30,1716,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,永信,生技醫療業
2022-06-30,1716,InvestmentAccountedForUsingEquityMethod,0.0,採用權益法之投資,永信,生技醫療業
2022-06-30,1716,InvestmentAccountedForUsingEquityMethod_per,0.0,採用權益法之投資,永信,生技醫療業
2022-06-30,1716,Liabilities,2760488000.0,負債總額,永信,生技醫療業
2022-06-30,1716,Liabilities_per,44.83,負債總額,永信,生技醫療業
2022-06-30,1716,Equity,3396976000.0,權益總額,永信,生技醫療業
2022-06-30,1716,Equity_per,55.17,權益總額,永信,生技醫療業
2022-12-31,1716,CashAndCashEquivalents,481530000.0,現金及約當現金,永信,生技醫療業
2022-12-31,1716,CashAndCashEquivalents_per,7.67,現金及約當現金,永信,生技醫療業
2022-12-31,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,63482000.0,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2022-12-31,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.01,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2022-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome,1958000.0,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2022-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome_per,0.03,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2022-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,45600000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2022-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.73,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2022-12-31,1716,FinancialAssetsAtAmortizedCost,2000000.0,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2022-12-31,1716,FinancialAssetsAtAmortizedCost_per,0.03,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2022-12-31,1716,BillsReceivableNet,205109000.0,應收票據淨額,永信,生技醫療業
2022-12-31,1716,BillsReceivableNet_per,3.27,應收票據淨額,永信,生技醫療業
2022-12-31,1716,OtherReceivable,10474000.0,其他應收款淨額,永信,生技醫療業
2022-12-31,1716,OtherReceivable_per,0.17,其他應收款淨額,永信,生技醫療業
2022-12-31,1716,AccountsReceivableNet,819347000.0,應收帳款淨額,永信,生技醫療業
2022-12-31,1716,AccountsReceivableNet_per,13.05,應收帳款淨額,永信,生技醫療業
2022-12-31,1716,AccountsReceivableDuefromRelatedPartiesNet,152374000.0,應收帳款－關係人淨額,永信,生技醫療業
2022-12-31,1716,AccountsReceivableDuefromRelatedPartiesNet_per,2.43,應收帳款－關係人淨額,永信,生技醫療業
2022-12-31,1716,Inventories,1899717000.0,存貨,永信,生技醫療業
2022-12-31,1716,Inventories_per,30.25,存貨,永信,生技醫療業
2022-12-31,1716,OtherCurrentAssets,95256000.0,其他流動資產,永信,生技醫療業
2022-12-31,1716,OtherCurrentAssets_per,1.52,其他流動資產,永信,生技醫療業
2022-12-31,1716,CurrentAssets,3731247000.0,流動資產合計,永信,生技醫療業
2022-12-31,1716,CurrentAssets_per,59.41,流動資產合計,永信,生技醫療業
2022-12-31,1716,PropertyPlantAndEquipment,2213147000.0,不動產、廠房及設備,永信,生技醫療業
2022-12-31,1716,PropertyPlantAndEquipment_per,35.24,不動產、廠房及設備,永信,生技醫療業
2022-12-31,1716,RightOfUseAsset,7400000.0,使用權資產,永信,生技醫療業
2022-12-31,1716,RightOfUseAsset_per,0.12,使用權資產,永信,生技醫療業
2022-12-31,1716,IntangibleAssets,18609000.0,無形資產,永信,生技醫療業
2022-12-31,1716,IntangibleAssets_per,0.3,無形資產,永信,生技醫療業
2022-12-31,1716,DeferredTaxAssets,117058000.0,遞延所得稅資產,永信,生技醫療業
2022-12-31,1716,DeferredTaxAssets_per,1.86,遞延所得稅資產,永信,生技醫療業
2022-12-31,1716,OtherNoncurrentAssets,80944000.0,其他非流動資產,永信,生技醫療業
2022-12-31,1716,OtherNoncurrentAssets_per,1.29,其他非流動資產,永信,生技醫療業
2022-12-31,1716,NoncurrentAssets,2549107000.0,非流動資產合計,永信,生技醫療業
2022-12-31,1716,NoncurrentAssets_per,40.59,非流動資產合計,永信,生技醫療業
2022-12-31,1716,TotalAssets,6280354000.0,資產總額,永信,生技醫療業
2022-12-31,1716,TotalAssets_per,100.0,資產總額,永信,生技醫療業
2022-12-31,1716,ShorttermBorrowings,850000000.0,短期借款,永信,生技醫療業
2022-12-31,1716,ShorttermBorrowings_per,13.53,短期借款,永信,生技醫療業
2022-12-31,1716,AccountsPayable,338739000.0,應付帳款,永信,生技醫療業
2022-12-31,1716,AccountsPayable_per,5.39,應付帳款,永信,生技醫療業
2022-12-31,1716,AccountsPayableToRelatedParties,12775000.0,應付帳款－關係人,永信,生技醫療業
2022-12-31,1716,AccountsPayableToRelatedParties_per,0.2,應付帳款－關係人,永信,生技醫療業
2022-12-31,1716,OtherPayables,527806000.0,其他應付款,永信,生技醫療業
2022-12-31,1716,OtherPayables_per,8.4,其他應付款,永信,生技醫療業
2022-12-31,1716,CurrentTaxLiabilities,103967000.0,本期所得稅負債,永信,生技醫療業
2022-12-31,1716,CurrentTaxLiabilities_per,1.66,本期所得稅負債,永信,生技醫療業
2022-12-31,1716,OtherCurrentLiabilities,56777000.0,其他流動負債,永信,生技醫療業
2022-12-31,1716,OtherCurrentLiabilities_per,0.9,其他流動負債,永信,生技醫療業
2022-12-31,1716,CurrentLiabilities,1903405000.0,流動負債合計,永信,生技醫療業
2022-12-31,1716,CurrentLiabilities_per,30.31,流動負債合計,永信,生技醫療業
2022-12-31,1716,LongtermBorrowings,131600000.0,長期借款,永信,生技醫療業
2022-12-31,1716,LongtermBorrowings_per,2.1,長期借款,永信,生技醫療業
2022-12-31,1716,OtherNoncurrentLiabilities,213093000.0,其他非流動負債,永信,生技醫療業
2022-12-31,1716,OtherNoncurrentLiabilities_per,3.39,其他非流動負債,永信,生技醫療業
2022-12-31,1716,NoncurrentLiabilities,793461000.0,非流動負債合計,永信,生技醫療業
2022-12-31,1716,NoncurrentLiabilities_per,12.63,非流動負債合計,永信,生技醫療業
2022-12-31,1716,OrdinaryShare,930489000.0,普通股股本,永信,生技醫療業
2022-12-31,1716,OrdinaryShare_per,14.82,普通股股本,永信,生技醫療業
2022-12-31,1716,CapitalStock,930489000.0,股本合計,永信,生技醫療業
2022-12-31,1716,CapitalStock_per,14.82,股本合計,永信,生技醫療業
2022-12-31,1716,CapitalSurplus,530000.0,資本公積合計,永信,生技醫療業
2022-12-31,1716,CapitalSurplus_per,0.01,資本公積合計,永信,生技醫療業
2022-12-31,1716,LegalReserve,1715393000.0,法定盈餘公積,永信,生技醫療業
2022-12-31,1716,LegalReserve_per,27.31,法定盈餘公積,永信,生技醫療業
2022-12-31,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit,526012000.0,未分配盈餘,永信,生技醫療業
2022-12-31,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,8.38,未分配盈餘,永信,生技醫療業
2022-12-31,1716,RetainedEarnings,2643613000.0,保留盈餘合計,永信,生技醫療業
2022-12-31,1716,RetainedEarnings_per,42.09,保留盈餘合計,永信,生技醫療業
2022-12-31,1716,OtherEquityInterest,5580000.0,其他權益合計,永信,生技醫療業
2022-12-31,1716,OtherEquityInterest_per,0.09,其他權益合計,永信,生技醫療業
2022-12-31,1716,EquityAttributableToOwnersOfParent,3580212000.0,歸屬於母公司業主之權益合計,永信,生技醫療業
2022-12-31,1716,EquityAttributableToOwnersOfParent_per,57.01,歸屬於母公司業主之權益合計,永信,生技醫療業
2022-12-31,1716,NoncontrollingInterests,3276000.0,非控制權益,永信,生技醫療業
2022-12-31,1716,NoncontrollingInterests_per,0.05,非控制權益,永信,生技醫療業
2022-12-31,1716,TotalLiabilitiesEquity,6280354000.0,負債及權益總計,永信,生技醫療業
2022-12-31,1716,TotalLiabilitiesEquity_per,100.0,負債及權益總計,永信,生技醫療業
2022-12-31,1716,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,永信,生技醫療業
2022-12-31,1716,Liabilities,2696866000.0,負債總額,永信,生技醫療業
2022-12-31,1716,Liabilities_per,42.94,負債總額,永信,生技醫療業
2022-12-31,1716,Equity,3583488000.0,權益總額,永信,生技醫療業
2022-12-31,1716,Equity_per,57.06,權益總額,永信,生技醫療業
2023-06-30,1716,CashAndCashEquivalents,456986000.0,現金及約當現金,永信,生技醫療業
2023-06-30,1716,CashAndCashEquivalents_per,7.5,現金及約當現金,永信,生技醫療業
2023-06-30,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,63482000.0,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2023-06-30,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.04,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2023-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome,1958000.0,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2023-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome_per,0.03,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2023-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,67687000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2023-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,1.11,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2023-06-30,1716,FinancialAssetsAtAmortizedCost,2000000.0,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2023-06-30,1716,FinancialAssetsAtAmortizedCost_per,0.03,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2023-06-30,1716,BillsReceivableNet,142748000.0,應收票據淨額,永信,生技醫療業
2023-06-30,1716,BillsReceivableNet_per,2.34,應收票據淨額,永信,生技醫療業
2023-06-30,1716,OtherReceivable,2803000.0,其他應收款淨額,永信,生技醫療業
2023-06-30,1716,OtherReceivable_per,0.05,其他應收款淨額,永信,生技醫療業
2023-06-30,1716,AccountsReceivableNet,698207000.0,應收帳款淨額,永信,生技醫療業
2023-06-30,1716,AccountsReceivableNet_per,11.46,應收帳款淨額,永信,生技醫療業
2023-06-30,1716,AccountsReceivableDuefromRelatedPartiesNet,136427000.0,應收帳款－關係人淨額,永信,生技醫療業
2023-06-30,1716,AccountsReceivableDuefromRelatedPartiesNet_per,2.24,應收帳款－關係人淨額,永信,生技醫療業
2023-06-30,1716,Inventories,1973723000.0,存貨,永信,生技醫療業
2023-06-30,1716,Inventories_per,32.4,存貨,永信,生技醫療業
2023-06-30,1716,OtherCurrentAssets,97625000.0,其他流動資產,永信,生技醫療業
2023-06-30,1716,OtherCurrentAssets_per,1.6,其他流動資產,永信,生技醫療業
2023-06-30,1716,CurrentAssets,3575959000.0,流動資產合計,永信,生技醫療業
2023-06-30,1716,CurrentAssets_per,58.7,流動資產合計,永信,生技醫療業
2023-06-30,1716,PropertyPlantAndEquipment,2169787000.0,不動產、廠房及設備,永信,生技醫療業
2023-06-30,1716,PropertyPlantAndEquipment_per,35.61,不動產、廠房及設備,永信,生技醫療業
2023-06-30,1716,RightOfUseAsset,5177000.0,使用權資產,永信,生技醫療業
2023-06-30,1716,RightOfUseAsset_per,0.08,使用權資產,永信,生技醫療業
2023-06-30,1716,IntangibleAssets,10542000.0,無形資產,永信,生技醫療業
2023-06-30,1716,IntangibleAssets_per,0.17,無形資產,永信,生技醫療業
2023-06-30,1716,DeferredTaxAssets,115892000.0,遞延所得稅資產,永信,生技醫療業
2023-06-30,1716,DeferredTaxAssets_per,1.9,遞延所得稅資產,永信,生技醫療業
2023-06-30,1716,OtherNoncurrentAssets,81533000.0,其他非流動資產,永信,生技醫療業
2023-06-30,1716,OtherNoncurrentAssets_per,1.34,其他非流動資產,永信,生技醫療業
2023-06-30,1716,NoncurrentAssets,2516404000.0,非流動資產合計,永信,生技醫療業
2023-06-30,1716,NoncurrentAssets_per,41.3,非流動資產合計,永信,生技醫療業
2023-06-30,1716,TotalAssets,6092363000.0,資產總額,永信,生技醫療業
2023-06-30,1716,TotalAssets_per,100.0,資產總額,永信,生技醫療業
2023-06-30,1716,ShorttermBorrowings,380000000.0,短期借款,永信,生技醫療業
2023-06-30,1716,ShorttermBorrowings_per,6.24,短期借款,永信,生技醫療業
2023-06-30,1716,AccountsPayable,417155000.0,應付帳款,永信,生技醫療業
2023-06-30,1716,AccountsPayable_per,6.85,應付帳款,永信,生技醫療業
2023-06-30,1716,AccountsPayableToRelatedParties,21886000.0,應付帳款－關係人,永信,生技醫療業
2023-06-30,1716,AccountsPayableToRelatedParties_per,0.36,應付帳款－關係人,永信,生技醫療業
2023-06-30,1716,OtherPayables,824727000.0,其他應付款,永信,生技醫療業
2023-06-30,1716,OtherPayables_per,13.54,其他應付款,永信,生技醫療業
2023-06-30,1716,CurrentTaxLiabilities,103381000.0,本期所得稅負債,永信,生技醫療業
2023-06-30,1716,CurrentTaxLiabilities_per,1.7,本期所得稅負債,永信,生技醫療業
2023-06-30,1716,OtherCurrentLiabilities,30188000.0,其他流動負債,永信,生技醫療業
2023-06-30,1716,OtherCurrentLiabilities_per,0.5,其他流動負債,永信,生技醫療業
2023-06-30,1716,CurrentLiabilities,1797492000.0,流動負債合計,永信,生技醫療業
2023-06-30,1716,CurrentLiabilities_per,29.5,流動負債合計,永信,生技醫療業
2023-06-30,1716,LongtermBorrowings,131600000.0,長期借款,永信,生技醫療業
2023-06-30,1716,LongtermBorrowings_per,2.16,長期借款,永信,生技醫療業
2023-06-30,1716,OtherNoncurrentLiabilities,192091000.0,其他非流動負債,永信,生技醫療業
2023-06-30,1716,OtherNoncurrentLiabilities_per,3.15,其他非流動負債,永信,生技醫療業
2023-06-30,1716,NoncurrentLiabilities,779039000.0,非流動負債合計,永信,生技醫療業
2023-06-30,1716,NoncurrentLiabilities_per,12.79,非流動負債合計,永信,生技醫療業
2023-06-30,1716,OrdinaryShare,930489000.0,普通股股本,永信,生技醫療業
2023-06-30,1716,OrdinaryShare_per,15.27,普通股股本,永信,生技醫療業
2023-06-30,1716,CapitalStock,981666000.0,股本合計,永信,生技醫療業
2023-06-30,1716,CapitalStock_per,16.11,股本合計,永信,生技醫療業
2023-06-30,1716,CapitalSurplus,530000.0,資本公積合計,永信,生技醫療業
2023-06-30,1716,CapitalSurplus_per,0.01,資本公積合計,永信,生技醫療業
2023-06-30,1716,LegalReserve,1764406000.0,法定盈餘公積,永信,生技醫療業
2023-06-30,1716,LegalReserve_per,28.96,法定盈餘公積,永信,生技醫療業
2023-06-30,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit,335908000.0,未分配盈餘,永信,生技醫療業
2023-06-30,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,5.51,未分配盈餘,永信,生技醫療業
2023-06-30,1716,RetainedEarnings,2502522000.0,保留盈餘合計,永信,生技醫療業
2023-06-30,1716,RetainedEarnings_per,41.08,保留盈餘合計,永信,生技醫療業
2023-06-30,1716,OtherEquityInterest,27667000.0,其他權益合計,永信,生技醫療業
2023-06-30,1716,OtherEquityInterest_per,0.45,其他權益合計,永信,生技醫療業
2023-06-30,1716,EquityAttributableToOwnersOfParent,3512385000.0,歸屬於母公司業主之權益合計,永信,生技醫療業
2023-06-30,1716,EquityAttributableToOwnersOfParent_per,57.65,歸屬於母公司業主之權益合計,永信,生技醫療業
2023-06-30,1716,NoncontrollingInterests,3447000.0,非控制權益,永信,生技醫療業
2023-06-30,1716,NoncontrollingInterests_per,0.06,非控制權益,永信,生技醫療業
2023-06-30,1716,TotalLiabilitiesEquity,6092363000.0,負債及權益總計,永信,生技醫療業
2023-06-30,1716,TotalLiabilitiesEquity_per,100.0,負債及權益總計,永信,生技醫療業
2023-06-30,1716,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,永信,生技醫療業
2023-06-30,1716,Liabilities,2576531000.0,負債總額,永信,生技醫療業
2023-06-30,1716,Liabilities_per,42.29,負債總額,永信,生技醫療業
2023-06-30,1716,Equity,3515832000.0,權益總額,永信,生技醫療業
2023-06-30,1716,Equity_per,57.71,權益總額,永信,生技醫療業
2023-12-31,1716,CashAndCashEquivalents,461672000.0,現金及約當現金,永信,生技醫療業
2023-12-31,1716,CashAndCashEquivalents_per,7.49,現金及約當現金,永信,生技醫療業
2023-12-31,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,63482000.0,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2023-12-31,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.03,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2023-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome,1958000.0,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2023-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome_per,0.03,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2023-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,58873000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2023-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.95,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2023-12-31,1716,FinancialAssetsAtAmortizedCost,2000000.0,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2023-12-31,1716,FinancialAssetsAtAmortizedCost_per,0.03,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2023-12-31,1716,BillsReceivableNet,199714000.0,應收票據淨額,永信,生技醫療業
2023-12-31,1716,BillsReceivableNet_per,3.24,應收票據淨額,永信,生技醫療業
2023-12-31,1716,OtherReceivable,11342000.0,其他應收款淨額,永信,生技醫療業
2023-12-31,1716,OtherReceivable_per,0.18,其他應收款淨額,永信,生技醫療業
2023-12-31,1716,AccountsReceivableNet,737952000.0,應收帳款淨額,永信,生技醫療業
2023-12-31,1716,AccountsReceivableNet_per,11.96,應收帳款淨額,永信,生技醫療業
2023-12-31,1716,AccountsReceivableDuefromRelatedPartiesNet,118856000.0,應收帳款－關係人淨額,永信,生技醫療業
2023-12-31,1716,AccountsReceivableDuefromRelatedPartiesNet_per,1.93,應收帳款－關係人淨額,永信,生技醫療業
2023-12-31,1716,Inventories,1992262000.0,存貨,永信,生技醫療業
2023-12-31,1716,Inventories_per,32.3,存貨,永信,生技醫療業
2023-12-31,1716,OtherCurrentAssets,110736000.0,其他流動資產,永信,生技醫療業
2023-12-31,1716,OtherCurrentAssets_per,1.8,其他流動資產,永信,生技醫療業
2023-12-31,1716,CurrentAssets,3699974000.0,流動資產合計,永信,生技醫療業
2023-12-31,1716,CurrentAssets_per,59.99,流動資產合計,永信,生技醫療業
2023-12-31,1716,PropertyPlantAndEquipment,2132869000.0,不動產、廠房及設備,永信,生技醫療業
2023-12-31,1716,PropertyPlantAndEquipment_per,34.58,不動產、廠房及設備,永信,生技醫療業
2023-12-31,1716,RightOfUseAsset,3306000.0,使用權資產,永信,生技醫療業
2023-12-31,1716,RightOfUseAsset_per,0.05,使用權資產,永信,生技醫療業
2023-12-31,1716,IntangibleAssets,6933000.0,無形資產,永信,生技醫療業
2023-12-31,1716,IntangibleAssets_per,0.11,無形資產,永信,生技醫療業
2023-12-31,1716,DeferredTaxAssets,100383000.0,遞延所得稅資產,永信,生技醫療業
2023-12-31,1716,DeferredTaxAssets_per,1.63,遞延所得稅資產,永信,生技醫療業
2023-12-31,1716,OtherNoncurrentAssets,99189000.0,其他非流動資產,永信,生技醫療業
2023-12-31,1716,OtherNoncurrentAssets_per,1.61,其他非流動資產,永信,生技醫療業
2023-12-31,1716,NoncurrentAssets,2467673000.0,非流動資產合計,永信,生技醫療業
2023-12-31,1716,NoncurrentAssets_per,40.01,非流動資產合計,永信,生技醫療業
2023-12-31,1716,TotalAssets,6167647000.0,資產總額,永信,生技醫療業
2023-12-31,1716,TotalAssets_per,100.0,資產總額,永信,生技醫療業
2023-12-31,1716,ShorttermBorrowings,480000000.0,短期借款,永信,生技醫療業
2023-12-31,1716,ShorttermBorrowings_per,7.78,短期借款,永信,生技醫療業
2023-12-31,1716,AccountsPayable,426212000.0,應付帳款,永信,生技醫療業
2023-12-31,1716,AccountsPayable_per,6.91,應付帳款,永信,生技醫療業
2023-12-31,1716,AccountsPayableToRelatedParties,8650000.0,應付帳款－關係人,永信,生技醫療業
2023-12-31,1716,AccountsPayableToRelatedParties_per,0.14,應付帳款－關係人,永信,生技醫療業
2023-12-31,1716,OtherPayables,546981000.0,其他應付款,永信,生技醫療業
2023-12-31,1716,OtherPayables_per,8.87,其他應付款,永信,生技醫療業
2023-12-31,1716,CurrentTaxLiabilities,84191000.0,本期所得稅負債,永信,生技醫療業
2023-12-31,1716,CurrentTaxLiabilities_per,1.37,本期所得稅負債,永信,生技醫療業
2023-12-31,1716,OtherCurrentLiabilities,44792000.0,其他流動負債,永信,生技醫療業
2023-12-31,1716,OtherCurrentLiabilities_per,0.73,其他流動負債,永信,生技醫療業
2023-12-31,1716,CurrentLiabilities,1594508000.0,流動負債合計,永信,生技醫療業
2023-12-31,1716,CurrentLiabilities_per,25.85,流動負債合計,永信,生技醫療業
2023-12-31,1716,LongtermBorrowings,131600000.0,長期借款,永信,生技醫療業
2023-12-31,1716,LongtermBorrowings_per,2.13,長期借款,永信,生技醫療業
2023-12-31,1716,OtherNoncurrentLiabilities,101617000.0,其他非流動負債,永信,生技醫療業
2023-12-31,1716,OtherNoncurrentLiabilities_per,1.65,其他非流動負債,永信,生技醫療業
2023-12-31,1716,NoncurrentLiabilities,701741000.0,非流動負債合計,永信,生技醫療業
2023-12-31,1716,NoncurrentLiabilities_per,11.38,非流動負債合計,永信,生技醫療業
2023-12-31,1716,OrdinaryShare,981666000.0,普通股股本,永信,生技醫療業
2023-12-31,1716,OrdinaryShare_per,15.92,普通股股本,永信,生技醫療業
2023-12-31,1716,CapitalStock,981666000.0,股本合計,永信,生技醫療業
2023-12-31,1716,CapitalStock_per,15.92,股本合計,永信,生技醫療業
2023-12-31,1716,CapitalSurplus,530000.0,資本公積合計,永信,生技醫療業
2023-12-31,1716,CapitalSurplus_per,0.01,資本公積合計,永信,生技醫療業
2023-12-31,1716,LegalReserve,1764406000.0,法定盈餘公積,永信,生技醫療業
2023-12-31,1716,LegalReserve_per,28.61,法定盈餘公積,永信,生技醫療業
2023-12-31,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit,700288000.0,未分配盈餘,永信,生技醫療業
2023-12-31,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,11.35,未分配盈餘,永信,生技醫療業
2023-12-31,1716,RetainedEarnings,2866902000.0,保留盈餘合計,永信,生技醫療業
2023-12-31,1716,RetainedEarnings_per,46.48,保留盈餘合計,永信,生技醫療業
2023-12-31,1716,OtherEquityInterest,18853000.0,其他權益合計,永信,生技醫療業
2023-12-31,1716,OtherEquityInterest_per,0.31,其他權益合計,永信,生技醫療業
2023-12-31,1716,EquityAttributableToOwnersOfParent,3867951000.0,歸屬於母公司業主之權益合計,永信,生技醫療業
2023-12-31,1716,EquityAttributableToOwnersOfParent_per,62.71,歸屬於母公司業主之權益合計,永信,生技醫療業
2023-12-31,1716,NoncontrollingInterests,3447000.0,非控制權益,永信,生技醫療業
2023-12-31,1716,NoncontrollingInterests_per,0.06,非控制權益,永信,生技醫療業
2023-12-31,1716,TotalLiabilitiesEquity,6167647000.0,負債及權益總計,永信,生技醫療業
2023-12-31,1716,TotalLiabilitiesEquity_per,100.0,負債及權益總計,永信,生技醫療業
2023-12-31,1716,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,永信,生技醫療業
2023-12-31,1716,Liabilities,2296249000.0,負債總額,永信,生技醫療業
2023-12-31,1716,Liabilities_per,37.23,負債總額,永信,生技醫療業
2023-12-31,1716,Equity,3871398000.0,權益總額,永信,生技醫療業
2023-12-31,1716,Equity_per,62.77,權益總額,永信,生技醫療業
2024-06-30,1716,CashAndCashEquivalents,336006000.0,現金及約當現金,永信,生技醫療業
2024-06-30,1716,CashAndCashEquivalents_per,5.47,現金及約當現金,永信,生技醫療業
2024-06-30,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,63482000.0,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2024-06-30,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.03,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2024-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome,1958000.0,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2024-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome_per,0.03,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2024-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,73067000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2024-06-30,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,1.19,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2024-06-30,1716,FinancialAssetsAtAmortizedCost,6000000.0,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2024-06-30,1716,FinancialAssetsAtAmortizedCost_per,0.1,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2024-06-30,1716,BillsReceivableNet,202522000.0,應收票據淨額,永信,生技醫療業
2024-06-30,1716,BillsReceivableNet_per,3.3,應收票據淨額,永信,生技醫療業
2024-06-30,1716,OtherReceivable,1559000.0,其他應收款淨額,永信,生技醫療業
2024-06-30,1716,OtherReceivable_per,0.03,其他應收款淨額,永信,生技醫療業
2024-06-30,1716,AccountsReceivableNet,751262000.0,應收帳款淨額,永信,生技醫療業
2024-06-30,1716,AccountsReceivableNet_per,12.24,應收帳款淨額,永信,生技醫療業
2024-06-30,1716,AccountsReceivableDuefromRelatedPartiesNet,136367000.0,應收帳款－關係人淨額,永信,生技醫療業
2024-06-30,1716,AccountsReceivableDuefromRelatedPartiesNet_per,2.22,應收帳款－關係人淨額,永信,生技醫療業
2024-06-30,1716,Inventories,1992284000.0,存貨,永信,生技醫療業
2024-06-30,1716,Inventories_per,32.46,存貨,永信,生技醫療業
2024-06-30,1716,OtherCurrentAssets,91124000.0,其他流動資產,永信,生技醫療業
2024-06-30,1716,OtherCurrentAssets_per,1.48,其他流動資產,永信,生技醫療業
2024-06-30,1716,CurrentAssets,3582564000.0,流動資產合計,永信,生技醫療業
2024-06-30,1716,CurrentAssets_per,58.37,流動資產合計,永信,生技醫療業
2024-06-30,1716,PropertyPlantAndEquipment,2107170000.0,不動產、廠房及設備,永信,生技醫療業
2024-06-30,1716,PropertyPlantAndEquipment_per,34.33,不動產、廠房及設備,永信,生技醫療業
2024-06-30,1716,RightOfUseAsset,9700000.0,使用權資產,永信,生技醫療業
2024-06-30,1716,RightOfUseAsset_per,0.16,使用權資產,永信,生技醫療業
2024-06-30,1716,IntangibleAssets,6267000.0,無形資產,永信,生技醫療業
2024-06-30,1716,IntangibleAssets_per,0.1,無形資產,永信,生技醫療業
2024-06-30,1716,DeferredTaxAssets,92726000.0,遞延所得稅資產,永信,生技醫療業
2024-06-30,1716,DeferredTaxAssets_per,1.51,遞延所得稅資產,永信,生技醫療業
2024-06-30,1716,OtherNoncurrentAssets,200360000.0,其他非流動資產,永信,生技醫療業
2024-06-30,1716,OtherNoncurrentAssets_per,3.26,其他非流動資產,永信,生技醫療業
2024-06-30,1716,NoncurrentAssets,2555098000.0,非流動資產合計,永信,生技醫療業
2024-06-30,1716,NoncurrentAssets_per,41.63,非流動資產合計,永信,生技醫療業
2024-06-30,1716,TotalAssets,6137662000.0,資產總額,永信,生技醫療業
2024-06-30,1716,TotalAssets_per,100.0,資產總額,永信,生技醫療業
2024-06-30,1716,ShorttermBorrowings,180000000.0,短期借款,永信,生技醫療業
2024-06-30,1716,ShorttermBorrowings_per,2.93,短期借款,永信,生技醫療業
2024-06-30,1716,AccountsPayable,432522000.0,應付帳款,永信,生技醫療業
2024-06-30,1716,AccountsPayable_per,7.05,應付帳款,永信,生技醫療業
2024-06-30,1716,AccountsPayableToRelatedParties,7286000.0,應付帳款－關係人,永信,生技醫療業
2024-06-30,1716,AccountsPayableToRelatedParties_per,0.12,應付帳款－關係人,永信,生技醫療業
2024-06-30,1716,OtherPayables,1004025000.0,其他應付款,永信,生技醫療業
2024-06-30,1716,OtherPayables_per,16.36,其他應付款,永信,生技醫療業
2024-06-30,1716,CurrentTaxLiabilities,99120000.0,本期所得稅負債,永信,生技醫療業
2024-06-30,1716,CurrentTaxLiabilities_per,1.61,本期所得稅負債,永信,生技醫療業
2024-06-30,1716,OtherCurrentLiabilities,77702000.0,其他流動負債,永信,生技醫療業
2024-06-30,1716,OtherCurrentLiabilities_per,1.27,其他流動負債,永信,生技醫療業
2024-06-30,1716,CurrentLiabilities,1806944000.0,流動負債合計,永信,生技醫療業
2024-06-30,1716,CurrentLiabilities_per,29.44,流動負債合計,永信,生技醫療業
2024-06-30,1716,LongtermBorrowings,83745000.0,長期借款,永信,生技醫療業
2024-06-30,1716,LongtermBorrowings_per,1.36,長期借款,永信,生技醫療業
2024-06-30,1716,OtherNoncurrentLiabilities,86189000.0,其他非流動負債,永信,生技醫療業
2024-06-30,1716,OtherNoncurrentLiabilities_per,1.4,其他非流動負債,永信,生技醫療業
2024-06-30,1716,NoncurrentLiabilities,617868000.0,非流動負債合計,永信,生技醫療業
2024-06-30,1716,NoncurrentLiabilities_per,10.07,非流動負債合計,永信,生技醫療業
2024-06-30,1716,OrdinaryShare,981666000.0,普通股股本,永信,生技醫療業
2024-06-30,1716,OrdinaryShare_per,15.99,普通股股本,永信,生技醫療業
2024-06-30,1716,CapitalStock,1088000000.0,股本合計,永信,生技醫療業
2024-06-30,1716,CapitalStock_per,17.73,股本合計,永信,生技醫療業
2024-06-30,1716,CapitalSurplus,530000.0,資本公積合計,永信,生技醫療業
2024-06-30,1716,CapitalSurplus_per,0.01,資本公積合計,永信,生技醫療業
2024-06-30,1716,LegalReserve,1830933000.0,法定盈餘公積,永信,生技醫療業
2024-06-30,1716,LegalReserve_per,29.83,法定盈餘公積,永信,生技醫療業
2024-06-30,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit,354299000.0,未分配盈餘,永信,生技醫療業
2024-06-30,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,5.77,未分配盈餘,永信,生技醫療業
2024-06-30,1716,RetainedEarnings,2587440000.0,保留盈餘合計,永信,生技醫療業
2024-06-30,1716,RetainedEarnings_per,42.16,保留盈餘合計,永信,生技醫療業
2024-06-30,1716,OtherEquityInterest,33047000.0,其他權益合計,永信,生技醫療業
2024-06-30,1716,OtherEquityInterest_per,0.54,其他權益合計,永信,生技醫療業
2024-06-30,1716,EquityAttributableToOwnersOfParent,3709017000.0,歸屬於母公司業主之權益合計,永信,生技醫療業
2024-06-30,1716,EquityAttributableToOwnersOfParent_per,60.43,歸屬於母公司業主之權益合計,永信,生技醫療業
2024-06-30,1716,NoncontrollingInterests,3833000.0,非控制權益,永信,生技醫療業
2024-06-30,1716,NoncontrollingInterests_per,0.06,非控制權益,永信,生技醫療業
2024-06-30,1716,TotalLiabilitiesEquity,6137662000.0,負債及權益總計,永信,生技醫療業
2024-06-30,1716,TotalLiabilitiesEquity_per,100.0,負債及權益總計,永信,生技醫療業
2024-06-30,1716,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,永信,生技醫療業
2024-06-30,1716,Equity,3712850000.0,權益總額,永信,生技醫療業
2024-06-30,1716,Equity_per,60.49,權益總額,永信,生技醫療業
2024-06-30,1716,Liabilities,2424812000.0,負債總額,永信,生技醫療業
2024-06-30,1716,Liabilities_per,39.51,負債總額,永信,生技醫療業
2024-12-31,1716,CashAndCashEquivalents,531906000.0,現金及約當現金,永信,生技醫療業
2024-12-31,1716,CashAndCashEquivalents_per,8.53,現金及約當現金,永信,生技醫療業
2024-12-31,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss,63482000.0,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2024-12-31,1716,CurrentFinancialAssetsAtFairvalueThroughProfitOrLoss_per,1.02,透過損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2024-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome,1958000.0,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2024-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncome_per,0.03,透過其他綜合損益按公允價值衡量之金融資產－流動,永信,生技醫療業
2024-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent,61164000.0,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2024-12-31,1716,FinancialAssetsAtFairvalueThroughOtherComprehensiveIncomeNonCurrent_per,0.98,透過其他綜合損益按公允價值衡量之金融資產－非流動,永信,生技醫療業
2024-12-31,1716,FinancialAssetsAtAmortizedCost,6000000.0,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2024-12-31,1716,FinancialAssetsAtAmortizedCost_per,0.1,按攤銷後成本衡量之金融資產－流動,永信,生技醫療業
2024-12-31,1716,BillsReceivableNet,133869000.0,應收票據淨額,永信,生技醫療業
2024-12-31,1716,BillsReceivableNet_per,2.15,應收票據淨額,永信,生技醫療業
2024-12-31,1716,OtherReceivable,14398000.0,其他應收款淨額,永信,生技醫療業
2024-12-31,1716,OtherReceivable_per,0.23,其他應收款淨額,永信,生技醫療業
2024-12-31,1716,AccountsReceivableNet,740832000.0,應收帳款淨額,永信,生技醫療業
2024-12-31,1716,AccountsReceivableNet_per,11.88,應收帳款淨額,永信,生技醫療業
2024-12-31,1716,AccountsReceivableDuefromRelatedPartiesNet,151706000.0,應收帳款－關係人淨額,永信,生技醫療業
2024-12-31,1716,AccountsReceivableDuefromRelatedPartiesNet_per,2.43,應收帳款－關係人淨額,永信,生技醫療業
2024-12-31,1716,Inventories,2027897000.0,存貨,永信,生技醫療業
2024-12-31,1716,Inventories_per,32.52,存貨,永信,生技醫療業
2024-12-31,1716,OtherCurrentAssets,124408000.0,其他流動資產,永信,生技醫療業
2024-12-31,1716,OtherCurrentAssets_per,1.99,其他流動資產,永信,生技醫療業
2024-12-31,1716,CurrentAssets,3796456000.0,流動資產合計,永信,生技醫療業
2024-12-31,1716,CurrentAssets_per,60.88,流動資產合計,永信,生技醫療業
2024-12-31,1716,PropertyPlantAndEquipment,2142195000.0,不動產、廠房及設備,永信,生技醫療業
2024-12-31,1716,PropertyPlantAndEquipment_per,34.35,不動產、廠房及設備,永信,生技醫療業
2024-12-31,1716,RightOfUseAsset,14062000.0,使用權資產,永信,生技醫療業
2024-12-31,1716,RightOfUseAsset_per,0.23,使用權資產,永信,生技醫療業
2024-12-31,1716,IntangibleAssets,5909000.0,無形資產,永信,生技醫療業
2024-12-31,1716,IntangibleAssets_per,0.09,無形資產,永信,生技醫療業
2024-12-31,1716,DeferredTaxAssets,35466000.0,遞延所得稅資產,永信,生技醫療業
2024-12-31,1716,DeferredTaxAssets_per,0.57,遞延所得稅資產,永信,生技醫療業
2024-12-31,1716,OtherNoncurrentAssets,115619000.0,其他非流動資產,永信,生技醫療業
2024-12-31,1716,OtherNoncurrentAssets_per,1.85,其他非流動資產,永信,生技醫療業
2024-12-31,1716,NoncurrentAssets,2439796000.0,非流動資產合計,永信,生技醫療業
2024-12-31,1716,NoncurrentAssets_per,39.12,非流動資產合計,永信,生技醫療業
2024-12-31,1716,TotalAssets,6236252000.0,資產總額,永信,生技醫療業
2024-12-31,1716,TotalAssets_per,100.0,資產總額,永信,生技醫療業
2024-12-31,1716,ShorttermBorrowings,400000000.0,短期借款,永信,生技醫療業
2024-12-31,1716,ShorttermBorrowings_per,6.41,短期借款,永信,生技醫療業
2024-12-31,1716,AccountsPayable,437622000.0,應付帳款,永信,生技醫療業
2024-12-31,1716,AccountsPayable_per,7.02,應付帳款,永信,生技醫療業
2024-12-31,1716,AccountsPayableToRelatedParties,10369000.0,應付帳款－關係人,永信,生技醫療業
2024-12-31,1716,AccountsPayableToRelatedParties_per,0.17,應付帳款－關係人,永信,生技醫療業
2024-12-31,1716,OtherPayables,656910000.0,其他應付款,永信,生技醫療業
2024-12-31,1716,OtherPayables_per,10.53,其他應付款,永信,生技醫療業
2024-12-31,1716,CurrentTaxLiabilities,10680000.0,本期所得稅負債,永信,生技醫療業
2024-12-31,1716,CurrentTaxLiabilities_per,0.17,本期所得稅負債,永信,生技醫療業
2024-12-31,1716,OtherCurrentLiabilities,116879000.0,其他流動負債,永信,生技醫療業
2024-12-31,1716,OtherCurrentLiabilities_per,1.87,其他流動負債,永信,生技醫療業
2024-12-31,1716,CurrentLiabilities,1636309000.0,流動負債合計,永信,生技醫療業
2024-12-31,1716,CurrentLiabilities_per,26.24,流動負債合計,永信,生技醫療業
2024-12-31,1716,LongtermBorrowings,47855000.0,長期借款,永信,生技醫療業
2024-12-31,1716,LongtermBorrowings_per,0.77,長期借款,永信,生技醫療業
2024-12-31,1716,OtherNoncurrentLiabilities,6974000.0,其他非流動負債,永信,生技醫療業
2024-12-31,1716,OtherNoncurrentLiabilities_per,0.11,其他非流動負債,永信,生技醫療業
2024-12-31,1716,NoncurrentLiabilities,519825000.0,非流動負債合計,永信,生技醫療業
2024-12-31,1716,NoncurrentLiabilities_per,8.34,非流動負債合計,永信,生技醫療業
2024-12-31,1716,OrdinaryShare,1088000000.0,普通股股本,永信,生技醫療業
2024-12-31,1716,OrdinaryShare_per,17.45,普通股股本,永信,生技醫療業
2024-12-31,1716,CapitalStock,1088000000.0,股本合計,永信,生技醫療業
2024-12-31,1716,CapitalStock_per,17.45,股本合計,永信,生技醫療業
2024-12-31,1716,CapitalSurplus,530000.0,資本公積合計,永信,生技醫療業
2024-12-31,1716,CapitalSurplus_per,0.01,資本公積合計,永信,生技醫療業
2024-12-31,1716,LegalReserve,1830933000.0,法定盈餘公積,永信,生技醫療業
2024-12-31,1716,LegalReserve_per,29.36,法定盈餘公積,永信,生技醫療業
2024-12-31,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit,733822000.0,未分配盈餘,永信,生技醫療業
2024-12-31,1716,UnappropriatedRetainedEarningsAaccumulatedDeficit_per,11.77,未分配盈餘,永信,生技醫療業
2024-12-31,1716,RetainedEarnings,2966963000.0,保留盈餘合計,永信,生技醫療業
2024-12-31,1716,RetainedEarnings_per,47.58,保留盈餘合計,永信,生技醫療業
2024-12-31,1716,OtherEquityInterest,21144000.0,其他權益合計,永信,生技醫療業
2024-12-31,1716,OtherEquityInterest_per,0.34,其他權益合計,永信,生技醫療業
2024-12-31,1716,EquityAttributableToOwnersOfParent,4076637000.0,歸屬於母公司業主之權益合計,永信,生技醫療業
2024-12-31,1716,EquityAttributableToOwnersOfParent_per,65.37,歸屬於母公司業主之權益合計,永信,生技醫療業
2024-12-31,1716,NoncontrollingInterests,3481000.0,非控制權益,永信,生技醫療業
2024-12-31,1716,NoncontrollingInterests_per,0.06,非控制權益,永信,生技醫療業
2024-12-31,1716,TotalLiabilitiesEquity,6236252000.0,負債及權益總計,永信,生技醫療業
2024-12-31,1716,TotalLiabilitiesEquity_per,100.0,負債及權益總計,永信,生技醫療業
2024-12-31,1716,NumberOfSharesInEntityHeldByEntityAndByItsSubsidiaries,0.0,母公司暨子公司所持有之母公司庫藏股股數,永信,生技醫療業
2024-12-31,1716,Equity,4080118000.0,權益總額,永信,生技醫療業
2024-12-31,1716,Equity_per,65.43,權益總額,永信,生技醫療業
2024-12-31,1716,Liabilities,2156134000.0,負債總額,永信,生技醫療業
2024-12-31,1716,Liabilities_per,34.57,負債總額,永信,生技醫療業
2019-06-30,1716,AmountDueToRelatedParties,1369000.0,應付帳款-關係人增加(減少),永信,生技醫療業
2019-06-30,1716,RepaymentOfLongTermDebt,0.0,償還長期借款,永信,生技醫療業
2019-06-30,1716,CashBalancesBeginningOfPeriod,559367000.0,期初現金及約當現金餘額,永信,生技醫療業
2019-06-30,1716,PayTheInterest,-6445000.0,支付之利息,永信,生技醫療業
2019-06-30,1716,CashBalancesEndOfPeriod,614594000.0,期末現金及約當現金餘額,永信,生技醫療業
2019-06-30,1716,OtherNonCurrentLiabilitiesIncrease,-19493000.0,其他流動資產(增加)減少,永信,生技醫療業
2019-06-30,1716,CashBalancesIncrease,55227000.0,本期現金及約當現金增加（減少）數,永信,生技醫療業
2019-06-30,1716,IncomeBeforeIncomeTaxFromContinuingOperations,510884000.0,繼續營業單位稅前淨利（淨損）,永信,生技醫療業
2019-06-30,1716,DecreaseInShortTermLoans,-195000000.0,短期借款減少,永信,生技醫療業
2019-06-30,1716,NetIncomeBeforeTax,510884000.0,本期稅前淨利（淨損）,永信,生技醫療業
2019-06-30,1716,Depreciation,133859000.0,折舊費用,永信,生技醫療業
2019-06-30,1716,AmortizationExpense,5144000.0,攤銷費用,永信,生技醫療業
2019-06-30,1716,DecreaseInDepositDeposit,-141000.0,存出保證金減少,永信,生技醫療業
2019-06-30,1716,InterestIncome,-459000.0,利息收入,永信,生技醫療業
2019-06-30,1716,CashFlowsProvidedFromFinancingActivities,-203592000.0,籌資活動之淨現金流入（流出）,永信,生技醫療業
2019-06-30,1716,RentalPrincipalRepayments,-8592000.0,租賃本金償還,永信,生技醫療業
2019-06-30,1716,CashReceivedThroughOperations,561356000.0,營運產生之現金流入（流出）,永信,生技醫療業
2019-06-30,1716,InventoryIncrease,-80236000.0,存貨(增加)減少,永信,生技醫療業
2019-06-30,1716,ReceivableIncrease,20941000.0,應收帳款(增加)減少,永信,生技醫療業
2019-06-30,1716,TotalIncomeLossItems,140166000.0,收益費損項目合計,永信,生技醫療業
2019-06-30,1716,InterestExpense,6445000.0,利息費用,永信,生技醫療業
2019-06-30,1716,AccountsPayable,54719000.0,應付帳款增加(減少),永信,生技醫療業
2019-06-30,1716,PropertyAndPlantAndEquipment,-236156000.0,取得不動產、廠房及設備,永信,生技醫療業
2019-06-30,1716,CashProvidedByInvestingActivities,-169488000.0,投資活動之淨現金流入（流出）,永信,生技醫療業
2019-06-30,1716,CashFlowsFromOperatingActivities,428307000.0,營業活動之淨現金流入(流出),永信,生技醫療業
2019-12-31,1716,AmountDueToRelatedParties,2818000.0,應付帳款-關係人增加(減少),永信,生技醫療業
2019-12-31,1716,CashBalancesBeginningOfPeriod,559367000.0,期初現金及約當現金餘額,永信,生技醫療業
2019-12-31,1716,PayTheInterest,-16179000.0,支付之利息,永信,生技醫療業
2019-12-31,1716,CashBalancesEndOfPeriod,627290000.0,期末現金及約當現金餘額,永信,生技醫療業
2019-12-31,1716,OtherNonCurrentLiabilitiesIncrease,-7744000.0,其他流動資產(增加)減少,永信,生技醫療業
2019-12-31,1716,CashBalancesIncrease,67923000.0,本期現金及約當現金增加（減少）數,永信,生技醫療業
2019-12-31,1716,IncomeBeforeIncomeTaxFromContinuingOperations,1028633000.0,繼續營業單位稅前淨利（淨損）,永信,生技醫療業
2019-12-31,1716,ProceedsFromLongTermDebt,225000000.0,舉借長期借款,永信,生技醫療業
2019-12-31,1716,NetIncomeBeforeTax,1028633000.0,本期稅前淨利（淨損）,永信,生技醫療業
2019-12-31,1716,Depreciation,265233000.0,折舊費用,永信,生技醫療業
2019-12-31,1716,AmortizationExpense,10601000.0,攤銷費用,永信,生技醫療業
2019-12-31,1716,InterestExpense,16179000.0,利息費用,永信,生技醫療業
2019-12-31,1716,CashFlowsProvidedFromFinancingActivities,-291742000.0,籌資活動之淨現金流入（流出）,永信,生技醫療業
2019-12-31,1716,InterestIncome,-846000.0,利息收入,永信,生技醫療業
2019-12-31,1716,DecreaseInShortTermLoans,-4085000000.0,短期借款減少,永信,生技醫療業
2019-12-31,1716,RentalPrincipalRepayments,-10748000.0,租賃本金償還,永信,生技醫療業
2019-12-31,1716,CashReceivedThroughOperations,1292511000.0,營運產生之現金流入（流出）,永信,生技醫療業
2019-12-31,1716,InventoryIncrease,-115522000.0,存貨(增加)減少,永信,生技醫療業
2019-12-31,1716,ReceivableIncrease,-10023000.0,應收帳款(增加)減少,永信,生技醫療業
2019-12-31,1716,TotalIncomeLossItems,282489000.0,收益費損項目合計,永信,生技醫療業
2019-12-31,1716,DecreaseInDepositDeposit,-50127000.0,存出保證金減少,永信,生技醫療業
2019-12-31,1716,AccountsPayable,42206000.0,應付帳款增加(減少),永信,生技醫療業
2019-12-31,1716,PropertyAndPlantAndEquipment,-668510000.0,取得不動產、廠房及設備,永信,生技醫療業
2019-12-31,1716,CashProvidedByInvestingActivities,-712359000.0,投資活動之淨現金流入（流出）,永信,生技醫療業
2019-12-31,1716,CashFlowsFromOperatingActivities,1072024000.0,營業活動之淨現金流入(流出),永信,生技醫療業
2020-06-30,1716,AmortizationExpense,6498000.0,攤銷費用,永信,生技醫療業
2020-06-30,1716,AmountDueToRelatedParties,5253000.0,應付帳款-關係人增加(減少),永信,生技醫療業
2020-06-30,1716,CashBalancesBeginningOfPeriod,627290000.0,期初現金及約當現金餘額,永信,生技醫療業
2020-06-30,1716,CashBalancesEndOfPeriod,550990000.0,期末現金及約當現金餘額,永信,生技醫療業
2020-06-30,1716,Depreciation,137443000.0,折舊費用,永信,生技醫療業
2020-06-30,1716,IncomeBeforeIncomeTaxFromContinuingOperations,484740000.0,繼續營業單位稅前淨利（淨損）,永信,生技醫療業
2020-06-30,1716,InterestExpense,7606000.0,利息費用,永信,生技醫療業
2020-06-30,1716,NetIncomeBeforeTax,484740000.0,本期稅前淨利（淨損）,永信,生技醫療業
2020-06-30,1716,CashFlowsProvidedFromFinancingActivities,-610091000.0,籌資活動之淨現金流入（流出）,永信,生技醫療業
2020-06-30,1716,RentalPrincipalRepayments,-5091000.0,租賃本金償還,永信,生技醫療業
2020-06-30,1716,InterestIncome,-256000.0,利息收入,永信,生技醫療業
2020-06-30,1716,PayTheInterest,-7606000.0,支付之利息,永信,生技醫療業
2020-06-30,1716,CashBalancesIncrease,-76300000.0,本期現金及約當現金增加（減少）數,永信,生技醫療業
2020-06-30,1716,RepaymentOfLongTermDebt,-200000000.0,償還長期借款,永信,生技醫療業
2020-06-30,1716,PropertyAndPlantAndEquipment,-145114000.0,取得不動產、廠房及設備,永信,生技醫療業
2020-06-30,1716,OtherNonCurrentLiabilitiesIncrease,-5008000.0,其他流動資產(增加)減少,永信,生技醫療業
2020-06-30,1716,CashProvidedByInvestingActivities,-128372000.0,投資活動之淨現金流入（流出）,永信,生技醫療業
2020-06-30,1716,DecreaseInShortTermLoans,-405000000.0,短期借款減少,永信,生技醫療業
2020-06-30,1716,CashFlowsFromOperatingActivities,662163000.0,營業活動之淨現金流入（流出）,永信,生技醫療業
2020-06-30,1716,AccountsPayable,78725000.0,應付帳款增加(減少),永信,生技醫療業
2020-06-30,1716,DecreaseInDepositDeposit,0.0,存出保證金減少,永信,生技醫療業
2020-06-30,1716,TotalIncomeLossItems,165367000.0,收益費損項目合計,永信,生技醫療業
2020-06-30,1716,ReceivableIncrease,89404000.0,應收帳款（增加）減少,永信,生技醫療業
2020-06-30,1716,InventoryIncrease,-182157000.0,存貨（增加）減少,永信,生技醫療業
2020-06-30,1716,CashReceivedThroughOperations,751251000.0,營運產生之現金流入（流出）,永信,生技醫療業
2020-12-31,1716,CashBalancesEndOfPeriod,873424000.0,期末現金及約當現金餘額,永信,生技醫療業
2020-12-31,1716,CashBalancesIncrease,246134000.0,本期現金及約當現金增加（減少）數,永信,生技醫療業
2020-12-31,1716,CashBalancesBeginningOfPeriod,627290000.0,期初現金及約當現金餘額,永信,生技醫療業
2020-12-31,1716,IncomeBeforeIncomeTaxFromContinuingOperations,922140000.0,繼續營業單位稅前淨利（淨損）,永信,生技醫療業
2020-12-31,1716,NetIncomeBeforeTax,922140000.0,本期稅前淨利（淨損）,永信,生技醫療業
2020-12-31,1716,Depreciation,244616000.0,折舊費用,永信,生技醫療業
2020-12-31,1716,AmortizationExpense,15610000.0,攤銷費用,永信,生技醫療業
2020-12-31,1716,AmountDueToRelatedParties,49313000.0,應付帳款-關係人增加(減少),永信,生技醫療業
2020-12-31,1716,ProceedsFromLongTermDebt,100000000.0,舉借長期借款,永信,生技醫療業
2020-12-31,1716,DecreaseInDepositDeposit,68370000.0,存出保證金減少,永信,生技醫療業
2020-12-31,1716,InterestExpense,14454000.0,利息費用,永信,生技醫療業
2020-12-31,1716,InterestIncome,-351000.0,利息收入,永信,生技醫療業
2020-12-31,1716,DecreaseInShortTermLoans,-430000000.0,短期借款減少,永信,生技醫療業
2020-12-31,1716,RepaymentOfLongTermDebt,0.0,償還長期借款,永信,生技醫療業
2020-12-31,1716,RentalPrincipalRepayments,-7001000.0,租賃本金償還,永信,生技醫療業
2020-12-31,1716,PayTheInterest,-15496000.0,支付之利息,永信,生技醫療業
2020-12-31,1716,CashProvidedByInvestingActivities,-178603000.0,投資活動之淨現金流入（流出）,永信,生技醫療業
2020-12-31,1716,PropertyAndPlantAndEquipment,-235039000.0,取得不動產、廠房及設備,永信,生技醫療業
2020-12-31,1716,CashFlowsProvidedFromFinancingActivities,-710022000.0,籌資活動之淨現金流入（流出）,永信,生技醫療業
2020-12-31,1716,OtherNonCurrentLiabilitiesIncrease,12463000.0,其他流動資產(增加)減少,永信,生技醫療業
2020-12-31,1716,CashFlowsFromOperatingActivities,1134759000.0,營業活動之淨現金流入（流出）,永信,生技醫療業
2020-12-31,1716,AccountsPayable,92192000.0,應付帳款增加(減少),永信,生技醫療業
2020-12-31,1716,TotalIncomeLossItems,287962000.0,收益費損項目合計,永信,生技醫療業
2020-12-31,1716,ReceivableIncrease,68641000.0,應收帳款（增加）減少,永信,生技醫療業
2020-12-31,1716,InventoryIncrease,-342401000.0,存貨（增加）減少,永信,生技醫療業
2020-12-31,1716,CashReceivedThroughOperations,1302503000.0,營運產生之現金流入（流出）,永信,生技醫療業
2021-06-30,1716,CashBalancesEndOfPeriod,622571000.0,期末現金及約當現金餘額,永信,生技醫療業
2021-06-30,1716,CashProvidedByInvestingActivities,21444000.0,投資活動之淨現金流入（流出）,永信,生技醫療業
2021-06-30,1716,CashBalancesBeginningOfPeriod,873424000.0,期初現金及約當現金餘額,永信,生技醫療業
2021-06-30,1716,IncomeBeforeIncomeTaxFromContinuingOperations,363852000.0,繼續營業單位稅前淨利（淨損）,永信,生技醫療業
2021-06-30,1716,NetIncomeBeforeTax,363852000.0,本期稅前淨利（淨損）,永信,生技醫療業
2021-06-30,1716,Depreciation,106363000.0,折舊費用,永信,生技醫療業
2021-06-30,1716,AmortizationExpense,11936000.0,攤銷費用,永信,生技醫療業
2021-06-30,1716,AccountsPayable,28029000.0,應付帳款增加(減少),永信,生技醫療業
2021-06-30,1716,AmountDueToRelatedParties,3793000.0,應付帳款-關係人增加(減少),永信,生技醫療業
2021-06-30,1716,DecreaseInDepositDeposit,11134000.0,存出保證金減少,永信,生技醫療業
2021-06-30,1716,InterestExpense,4963000.0,利息費用,永信,生技醫療業
2021-06-30,1716,PropertyAndPlantAndEquipment,-48264000.0,取得不動產、廠房及設備,永信,生技醫療業
2021-06-30,1716,CashBalancesIncrease,-250853000.0,本期現金及約當現金增加（減少）數,永信,生技醫療業
2021-06-30,1716,RentalPrincipalRepayments,-2267000.0,租賃本金償還,永信,生技醫療業
2021-06-30,1716,PayTheInterest,-4963000.0,支付之利息,永信,生技醫療業
2021-06-30,1716,DecreaseInShortTermLoans,-1550000000.0,短期借款減少,永信,生技醫療業
2021-06-30,1716,RepaymentOfLongTermDebt,-300000000.0,償還長期借款,永信,生技醫療業
2021-06-30,1716,CashFlowsProvidedFromFinancingActivities,-502267000.0,籌資活動之淨現金流入（流出）,永信,生技醫療業
2021-06-30,1716,InterestIncome,-88000.0,利息收入,永信,生技醫療業
2021-06-30,1716,CashReceivedThroughOperations,198004000.0,營運產生之現金流入（流出）,永信,生技醫療業
2021-06-30,1716,OtherNonCurrentLiabilitiesIncrease,-42997000.0,其他流動資產(增加)減少,永信,生技醫療業
2021-06-30,1716,InventoryIncrease,-235539000.0,存貨(增加)減少,永信,生技醫療業
2021-06-30,1716,ReceivableIncrease,-7088000.0,應收帳款(增加)減少,永信,生技醫療業
2021-06-30,1716,TotalIncomeLossItems,140154000.0,收益費損項目合計,永信,生技醫療業
2021-06-30,1716,CashFlowsFromOperatingActivities,230453000.0,營業活動之淨現金流入(流出),永信,生技醫療業
2021-12-31,1716,PayTheInterest,-10591000.0,支付之利息,永信,生技醫療業
2021-12-31,1716,CashBalancesIncrease,-436823000.0,本期現金及約當現金增加（減少）數,永信,生技醫療業
2021-12-31,1716,CashFlowsFromOperatingActivities,564838000.0,營業活動之淨現金流入(流出),永信,生技醫療業
2021-12-31,1716,TotalIncomeLossItems,304362000.0,收益費損項目合計,永信,生技醫療業
2021-12-31,1716,Depreciation,211582000.0,折舊費用,永信,生技醫療業
2021-12-31,1716,CashProvidedByInvestingActivities,-43286000.0,投資活動之淨現金流入（流出）,永信,生技醫療業
2021-12-31,1716,NetIncomeBeforeTax,720981000.0,本期稅前淨利（淨損）,永信,生技醫療業
2021-12-31,1716,PropertyAndPlantAndEquipment,-88446000.0,取得不動產、廠房及設備,永信,生技醫療業
2021-12-31,1716,CashBalancesBeginningOfPeriod,873424000.0,期初現金及約當現金餘額,永信,生技醫療業
2021-12-31,1716,CashBalancesEndOfPeriod,436601000.0,期末現金及約當現金餘額,永信,生技醫療業
2021-12-31,1716,AmortizationExpense,23111000.0,攤銷費用,永信,生技醫療業
2021-12-31,1716,RentalPrincipalRepayments,-4544000.0,租賃本金償還,永信,生技醫療業
2021-12-31,1716,InterestExpense,10533000.0,利息費用,永信,生技醫療業
2021-12-31,1716,ReceivableIncrease,-27656000.0,應收帳款（增加）減少,永信,生技醫療業
2021-12-31,1716,DecreaseInDepositDeposit,0.0,存出保證金減少,永信,生技醫療業
2021-12-31,1716,InventoryIncrease,-319562000.0,存貨（增加）減少,永信,生技醫療業
2021-12-31,1716,OtherNonCurrentLiabilitiesIncrease,1393000.0,其他流動資產(增加)減少,永信,生技醫療業
2021-12-31,1716,CashFlowsProvidedFromFinancingActivities,-957887000.0,籌資活動之淨現金流入（流出）,永信,生技醫療業
2021-12-31,1716,AmountDueToRelatedParties,16209000.0,應付帳款-關係人增加(減少),永信,生技醫療業
2021-12-31,1716,InterestIncome,-177000.0,利息收入,永信,生技醫療業
2021-12-31,1716,DecreaseInShortTermLoans,-1900000000.0,短期借款減少,永信,生技醫療業
2021-12-31,1716,AccountsPayable,-70705000.0,應付帳款增加(減少),永信,生技醫療業
2021-12-31,1716,ProceedsFromLongTermDebt,87000000.0,舉借長期借款,永信,生技醫療業
2021-12-31,1716,RepaymentOfLongTermDebt,-300000000.0,償還長期借款,永信,生技醫療業
2021-12-31,1716,CashReceivedThroughOperations,623843000.0,營運產生之現金流入（流出）,永信,生技醫療業
2021-12-31,1716,IncomeBeforeIncomeTaxFromContinuingOperations,720981000.0,繼續營業單位稅前淨利（淨損）,永信,生技醫療業
2022-06-30,1716,RepaymentOfLongTermDebt,0.0,償還長期借款,永信,生技醫療業
2022-06-30,1716,InventoryIncrease,57387000.0,存貨（增加）減少,永信,生技醫療業
2022-06-30,1716,ReceivableIncrease,-42421000.0,應收帳款（增加）減少,永信,生技醫療業
2022-06-30,1716,CashReceivedThroughOperations,498384000.0,營運產生之現金流入（流出）,永信,生技醫療業
2022-06-30,1716,InterestIncome,-121000.0,利息收入,永信,生技醫療業
2022-06-30,1716,DecreaseInShortTermLoans,-400000000.0,短期借款減少,永信,生技醫療業
2022-06-30,1716,RentalPrincipalRepayments,-2223000.0,租賃本金償還,永信,生技醫療業
2022-06-30,1716,OtherNonCurrentLiabilitiesIncrease,-40068000.0,其他流動資產(增加)減少,永信,生技醫療業
2022-06-30,1716,PayTheInterest,-3532000.0,支付之利息,永信,生技醫療業
2022-06-30,1716,CashBalancesIncrease,-104290000.0,本期現金及約當現金增加（減少）數,永信,生技醫療業
2022-06-30,1716,CashBalancesBeginningOfPeriod,436601000.0,期初現金及約當現金餘額,永信,生技醫療業
2022-06-30,1716,CashBalancesEndOfPeriod,332311000.0,期末現金及約當現金餘額,永信,生技醫療業
2022-06-30,1716,CashProvidedByInvestingActivities,-51503000.0,投資活動之淨現金流入（流出）,永信,生技醫療業
2022-06-30,1716,PropertyAndPlantAndEquipment,-66139000.0,取得不動產、廠房及設備,永信,生技醫療業
2022-06-30,1716,TotalIncomeLossItems,142357000.0,收益費損項目合計,永信,生技醫療業
2022-06-30,1716,InterestExpense,3532000.0,利息費用,永信,生技醫療業
2022-06-30,1716,CashFlowsProvidedFromFinancingActivities,-479948000.0,籌資活動之淨現金流入（流出）,永信,生技醫療業
2022-06-30,1716,DecreaseInDepositDeposit,30004000.0,存出保證金減少,永信,生技醫療業
2022-06-30,1716,IncomeBeforeIncomeTaxFromContinuingOperations,367569000.0,繼續營業單位稅前淨利（淨損）,永信,生技醫療業
2022-06-30,1716,NetIncomeBeforeTax,367569000.0,本期稅前淨利（淨損）,永信,生技醫療業
2022-06-30,1716,CashFlowsFromOperatingActivities,426890000.0,營業活動之淨現金流入（流出）,永信,生技醫療業
2022-06-30,1716,AmortizationExpense,10875000.0,攤銷費用,永信,生技醫療業
2022-06-30,1716,Depreciation,98865000.0,折舊費用,永信,生技醫療業
2022-06-30,1716,AmountDueToRelatedParties,-2158000.0,應付帳款-關係人增加(減少),永信,生技醫療業
2022-06-30,1716,NetCashInflowFromOperatingActivities,426890000.0,營業活動之淨現金流入,永信,生技醫療業
2022-06-30,1716,AccountsPayable,32388000.0,應付帳款,永信,生技醫療業
2022-12-31,1716,CashFlowsProvidedFromFinancingActivities,-737837000.0,籌資活動之淨現金流入（流出）,永信,生技醫療業
2022-12-31,1716,DecreaseInShortTermLoans,-850000000.0,短期借款減少,永信,生技醫療業
2022-12-31,1716,InterestIncome,-567000.0,利息收入,永信,生技醫療業
2022-12-31,1716,RentalPrincipalRepayments,-4447000.0,租賃本金償還,永信,生技醫療業
2022-12-31,1716,CashReceivedThroughOperations,1044147000.0,營運產生之現金流入（流出）,永信,生技醫療業
2022-12-31,1716,InventoryIncrease,161945000.0,存貨（增加）減少,永信,生技醫療業
2022-12-31,1716,PayTheInterest,-10447000.0,支付之利息,永信,生技醫療業
2022-12-31,1716,ReceivableIncrease,-107356000.0,應收帳款（增加）減少,永信,生技醫療業
2022-12-31,1716,TotalIncomeLossItems,280302000.0,收益費損項目合計,永信,生技醫療業
2022-12-31,1716,CashBalancesIncrease,44929000.0,本期現金及約當現金增加（減少）數,永信,生技醫療業
2022-12-31,1716,InterestExpense,10493000.0,利息費用,永信,生技醫療業
2022-12-31,1716,RepaymentOfLongTermDebt,-2060000.0,償還長期借款,永信,生技醫療業
2022-12-31,1716,CashBalancesBeginningOfPeriod,436601000.0,期初現金及約當現金餘額,永信,生技醫療業
2022-12-31,1716,DecreaseInDepositDeposit,26555000.0,存出保證金減少,永信,生技醫療業
2022-12-31,1716,CashProvidedByInvestingActivities,-110332000.0,投資活動之淨現金流入（流出）,永信,生技醫療業
2022-12-31,1716,IncomeBeforeIncomeTaxFromContinuingOperations,642795000.0,繼續營業單位稅前淨利（淨損）,永信,生技醫療業
2022-12-31,1716,PropertyAndPlantAndEquipment,-122643000.0,取得不動產、廠房及設備,永信,生技醫療業
2022-12-31,1716,NetIncomeBeforeTax,642795000.0,本期稅前淨利（淨損）,永信,生技醫療業
2022-12-31,1716,CashFlowsFromOperatingActivities,893077000.0,營業活動之淨現金流入（流出）,永信,生技醫療業
2022-12-31,1716,NetCashInflowFromOperatingActivities,893077000.0,營業活動之淨現金流入,永信,生技醫療業
2022-12-31,1716,Depreciation,192492000.0,折舊費用,永信,生技醫療業
2022-12-31,1716,ProceedsFromLongTermDebt,46660000.0,舉借長期借款,永信,生技醫療業
2022-12-31,1716,AmortizationExpense,21473000.0,攤銷費用,永信,生技醫療業
2022-12-31,1716,CashBalancesEndOfPeriod,481530000.0,期末現金及約當現金餘額,永信,生技醫療業
2022-12-31,1716,AccountsPayable,20380000.0,應付帳款,永信,生技醫療業
2023-06-30,1716,TotalIncomeLossItems,98011000.0,收益費損項目合計,永信,生技醫療業
2023-06-30,1716,PropertyAndPlantAndEquipment,-14666000.0,取得不動產、廠房及設備,永信,生技醫療業
2023-06-30,1716,NetIncomeBeforeTax,380813000.0,本期稅前淨利（淨損）,永信,生技醫療業
2023-06-30,1716,DecreaseInDepositDeposit,6805000.0,存出保證金減少,永信,生技醫療業
2023-06-30,1716,CashFlowsFromOperatingActivities,490132000.0,營業活動之淨現金流入（流出）,永信,生技醫療業
2023-06-30,1716,CashBalancesEndOfPeriod,456986000.0,期末現金及約當現金餘額,永信,生技醫療業
2023-06-30,1716,ReceivableIncrease,121416000.0,應收帳款（增加）減少,永信,生技醫療業
2023-06-30,1716,CashBalancesBeginningOfPeriod,481530000.0,期初現金及約當現金餘額,永信,生技醫療業
2023-06-30,1716,CashBalancesIncrease,-24544000.0,本期現金及約當現金增加（減少）數,永信,生技醫療業
2023-06-30,1716,InventoryIncrease,-74006000.0,存貨（增加）減少,永信,生技醫療業
2023-06-30,1716,CashFlowsProvidedFromFinancingActivities,-472232000.0,籌資活動之淨現金流入（流出）,永信,生技醫療業
2023-06-30,1716,Depreciation,86503000.0,折舊費用,永信,生技醫療業
2023-06-30,1716,OtherNonCurrentLiabilitiesIncrease,-2369000.0,其他流動資產(增加)減少,永信,生技醫療業
2023-06-30,1716,InterestExpense,4439000.0,利息費用,永信,生技醫療業
2023-06-30,1716,RentalPrincipalRepayments,-2232000.0,租賃本金償還,永信,生技醫療業
2023-06-30,1716,AmortizationExpense,8783000.0,攤銷費用,永信,生技醫療業
2023-06-30,1716,DecreaseInShortTermLoans,-850000000.0,短期借款減少,永信,生技醫療業
2023-06-30,1716,InterestIncome,-917000.0,利息收入,永信,生技醫療業
2023-06-30,1716,CashReceivedThroughOperations,568238000.0,營運產生之現金流入（流出）,永信,生技醫療業
2023-06-30,1716,AmountDueToRelatedParties,9111000.0,應付帳款-關係人增加(減少),永信,生技醫療業
2023-06-30,1716,PayTheInterest,-4439000.0,支付之利息,永信,生技醫療業
2023-06-30,1716,IncomeBeforeIncomeTaxFromContinuingOperations,380813000.0,繼續營業單位稅前淨利（淨損）,永信,生技醫療業
2023-06-30,1716,CashProvidedByInvestingActivities,-42444000.0,投資活動之淨現金流入（流出）,永信,生技醫療業
2023-06-30,1716,NetCashInflowFromOperatingActivities,490132000.0,營業活動之淨現金流入,永信,生技醫療業
2023-06-30,1716,AccountsPayable,78416000.0,應付帳款,永信,生技醫療業
2023-12-31,1716,CashProvidedByInvestingActivities,-110021000.0,投資活動之淨現金流入（流出）,永信,生技醫療業
2023-12-31,1716,PayTheInterest,-9851000.0,支付之利息,永信,生技醫療業
2023-12-31,1716,PropertyAndPlantAndEquipment,-64847000.0,取得不動產、廠房及設備,永信,生技醫療業
2023-12-31,1716,CashBalancesBeginningOfPeriod,481530000.0,期初現金及約當現金餘額,永信,生技醫療業
2023-12-31,1716,RentalPrincipalRepayments,-4115000.0,租賃本金償還,永信,生技醫療業
2023-12-31,1716,CashBalancesIncrease,-19858000.0,本期現金及約當現金增加（減少）數,永信,生技醫療業
2023-12-31,1716,CashBalancesEndOfPeriod,461672000.0,期末現金及約當現金餘額,永信,生技醫療業
2023-12-31,1716,IncomeBeforeIncomeTaxFromContinuingOperations,824400000.0,繼續營業單位稅前淨利（淨損）,永信,生技醫療業
2023-12-31,1716,ProceedsFromLongTermDebt,0.0,舉借長期借款,永信,生技醫療業
2023-12-31,1716,NetIncomeBeforeTax,824400000.0,本期稅前淨利（淨損）,永信,生技醫療業
2023-12-31,1716,CashFlowsFromOperatingActivities,855415000.0,營業活動之淨現金流入（流出）,永信,生技醫療業
2023-12-31,1716,Depreciation,172853000.0,折舊費用,永信,生技醫療業
2023-12-31,1716,AmortizationExpense,13287000.0,攤銷費用,永信,生技醫療業
2023-12-31,1716,AccountsPayable,87473000.0,應付帳款,永信,生技醫療業
2023-12-31,1716,NetCashInflowFromOperatingActivities,855415000.0,營業活動之淨現金流入,永信,生技醫療業
2023-12-31,1716,RepaymentOfLongTermDebt,0.0,償還長期借款,永信,生技醫療業
2023-12-31,1716,TotalIncomeLossItems,196693000.0,收益費損項目合計,永信,生技醫療業
2023-12-31,1716,ReceivableIncrease,80700000.0,應收帳款（增加）減少,永信,生技醫療業
2023-12-31,1716,InventoryIncrease,-92545000.0,存貨（增加）減少,永信,生技醫療業
2023-12-31,1716,CashFlowsProvidedFromFinancingActivities,-765252000.0,籌資活動之淨現金流入（流出）,永信,生技醫療業
2023-12-31,1716,InterestIncome,-1904000.0,利息收入,永信,生技醫療業
2023-12-31,1716,DecreaseInShortTermLoans,-1830000000.0,短期借款減少,永信,生技醫療業
2023-12-31,1716,InterestExpense,10170000.0,利息費用,永信,生技醫療業
2023-12-31,1716,CashReceivedThroughOperations,1026487000.0,營運產生之現金流入（流出）,永信,生技醫療業
2023-12-31,1716,DecreaseInDepositDeposit,-9104000.0,存出保證金減少,永信,生技醫療業
2024-06-30,1716,CashBalancesIncrease,-125666000.0,本期現金及約當現金增加（減少）數,永信,生技醫療業
2024-06-30,1716,CashBalancesEndOfPeriod,336006000.0,期末現金及約當現金餘額,永信,生技醫療業
2024-06-30,1716,PropertyAndPlantAndEquipment,-47990000.0,取得不動產、廠房及設備,永信,生技醫療業
2024-06-30,1716,PayTheInterest,-3242000.0,支付之利息,永信,生技醫療業
2024-06-30,1716,CashBalancesBeginningOfPeriod,461672000.0,期初現金及約當現金餘額,永信,生技醫療業
2024-06-30,1716,RentalPrincipalRepayments,-1801000.0,租賃本金償還,永信,生技醫療業
2024-06-30,1716,CashProvidedByInvestingActivities,-154453000.0,投資活動之淨現金流入（流出）,永信,生技醫療業
2024-06-30,1716,IncomeBeforeIncomeTaxFromContinuingOperations,405738000.0,繼續營業單位稅前淨利（淨損）,永信,生技醫療業
2024-06-30,1716,InterestIncome,-1146000.0,利息收入,永信,生技醫療業
2024-06-30,1716,CashReceivedThroughOperations,390732000.0,營運產生之現金流入（流出）,永信,生技醫療業
2024-06-30,1716,CashFlowsProvidedFromFinancingActivities,-301801000.0,籌資活動之淨現金流入（流出）,永信,生技醫療業
2024-06-30,1716,ReceivableIncrease,-11834000.0,應收帳款（增加）減少,永信,生技醫療業
2024-06-30,1716,TotalIncomeLossItems,82552000.0,收益費損項目合計,永信,生技醫療業
2024-06-30,1716,InterestExpense,2551000.0,利息費用,永信,生技醫療業
2024-06-30,1716,DecreaseInDepositDeposit,0.0,存出保證金減少,永信,生技醫療業
2024-06-30,1716,NetCashInflowFromOperatingActivities,330588000.0,營業活動之淨現金流入,永信,生技醫療業
2024-06-30,1716,AccountsPayable,6310000.0,應付帳款,永信,生技醫療業
2024-06-30,1716,AmortizationExpense,951000.0,攤銷費用,永信,生技醫療業
2024-06-30,1716,Depreciation,82256000.0,折舊費用,永信,生技醫療業
2024-06-30,1716,CashFlowsFromOperatingActivities,330588000.0,營業活動之淨現金流入（流出）,永信,生技醫療業
2024-06-30,1716,NetIncomeBeforeTax,405738000.0,本期稅前淨利（淨損）,永信,生技醫療業
2024-06-30,1716,DecreaseInShortTermLoans,-860000000.0,短期借款減少,永信,生技醫療業
2024-06-30,1716,InventoryIncrease,-22000.0,存貨（增加）減少,永信,生技醫療業
2024-12-31,1716,Depreciation,163951000.0,折舊費用,永信,生技醫療業
2024-12-31,1716,CashBalancesIncrease,70234000.0,本期現金及約當現金增加（減少）數,永信,生技醫療業
2024-12-31,1716,InterestExpense,8262000.0,利息費用,永信,生技醫療業
2024-12-31,1716,PayTheInterest,-8303000.0,支付之利息,永信,生技醫療業
2024-12-31,1716,CashBalancesEndOfPeriod,531906000.0,期末現金及約當現金餘額,永信,生技醫療業
2024-12-31,1716,CashProvidedByInvestingActivities,-155918000.0,投資活動之淨現金流入（流出）,永信,生技醫療業
2024-12-31,1716,NetIncomeBeforeTax,860749000.0,本期稅前淨利（淨損）,永信,生技醫療業
2024-12-31,1716,PropertyAndPlantAndEquipment,-158472000.0,取得不動產、廠房及設備,永信,生技醫療業
2024-12-31,1716,CashBalancesBeginningOfPeriod,461672000.0,期初現金及約當現金餘額,永信,生技醫療業
2024-12-31,1716,CashFlowsFromOperatingActivities,816684000.0,營業活動之淨現金流入（流出）,永信,生技醫療業
2024-12-31,1716,AmortizationExpense,1678000.0,攤銷費用,永信,生技醫療業
2024-12-31,1716,RepaymentOfLongTermDebt,-11963000.0,償還長期借款,永信,生技醫療業
2024-12-31,1716,DecreaseInShortTermLoans,-1640000000.0,短期借款減少,永信,生技醫療業
2024-12-31,1716,AccountsPayable,11410000.0,應付帳款,永信,生技醫療業
2024-12-31,1716,InterestIncome,-2499000.0,利息收入,永信,生技醫療業
2024-12-31,1716,CashReceivedThroughOperations,963618000.0,營運產生之現金流入（流出）,永信,生技醫療業
2024-12-31,1716,CashFlowsProvidedFromFinancingActivities,-590532000.0,籌資活動之淨現金流入（流出）,永信,生技醫療業
2024-12-31,1716,InventoryIncrease,-35635000.0,存貨（增加）減少,永信,生技醫療業
2024-12-31,1716,NetCashInflowFromOperatingActivities,816684000.0,營業活動之淨現金流入,永信,生技醫療業
2024-12-31,1716,ReceivableIncrease,-1536000.0,應收帳款（增加）減少,永信,生技醫療業
2024-12-31,1716,TotalIncomeLossItems,168696000.0,收益費損項目合計,永信,生技醫療業
2024-12-31,1716,DecreaseInDepositDeposit,14418000.0,存出保證金減少,永信,生技醫療業
2024-12-31,1716,RentalPrincipalRepayments,-3345000.0,租賃本金償還,永信,生技醫療業
2024-12-31,1716,IncomeBeforeIncomeTaxFromContinuingOperations,860749000.0,繼續營業單位稅前淨利（淨損）,永信,生技醫療業
